PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sadagopan, S; Veettil, MV; Chakraborty, S; Sharma-Walia, N; Paudel, N; Bottero, V; Chandran, B				Sadagopan, S.; Veettil, M. V.; Chakraborty, S.; Sharma-Walia, N.; Paudel, N.; Bottero, V.; Chandran, B.			Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival	ONCOGENE			English	Article						angiogenin; p53; KSHV; cancer; anti-apoptosis; p53 ubiquitination	ENDOTHELIAL-CELLS; SERUM-LEVELS; EXPRESSION; PROTEIN; GROWTH; PHOSPHORYLATION; PROLIFERATION; REQUIREMENT; INDUCTION; PROMOTES	Angiogenin, a 14-kDa multifunctional pro-angiogenic growth factor, is upregulated in several types of cancers. Anti-angiogenin monoclonal antibodies used as antagonists inhibited the establishment, progression and metastasis of human cancer cells in athymic mice (Olson et al., 1994). Silencing angiogenin and inhibition of angiogenin's nuclear translocation blocked cell survival and induced cell death in B-lymphoma and endothelial cells latently infected with Kaposi sarcoma-associated herpesvirus (Sadagopan et al., 2009), suggesting that actively proliferating cancer cells could be inducing angiogenin for inhibiting apoptotic pathways. However, the mechanism of cell survival and apoptosis regulation by angiogenin and their functional significance in cancer is not known. We demonstrate that angiogenin interacts with p53 and colocalizes in the nucleus. Silencing endogenous angiogenin induced p53 promoter activation and p53 target gene (p53, p21 and Bax) expression, downregulated anti-apoptotic Bcl-2 gene expression and increased p53-mediated cell death. In contrast, angiogenin expression blocked pro-apoptotic Bax and p21 expression, induced Bcl-2 and blocked cell death. Angiogenin also co-immunoprecipitated with p53 regulator protein Mdm2. Angiogenin expression resulted in the inhibition of p53 phosphorylation, increased p53-Mdm2 interaction, and consequently increased ubiquitination of p53. Taken together, these studies demonstrate that angiogenin promotes the inhibition of p53 function to mediate anti-apoptosis and cell survival. Our results reveal for the first time a novel p53 interacting function of angiogenin in anti-apoptosis and survival of cancer cells and suggest that targeting angiogenin could be an effective therapy for several cancers. Oncogene (2012) 31, 4835-4847; doi:10.1038/onc.2011.648; published online 23 January 2012	[Sadagopan, S.; Veettil, M. V.; Chakraborty, S.; Sharma-Walia, N.; Paudel, N.; Bottero, V.; Chandran, B.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Chandran, B (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol & Immunol, HM Bligh Canc Res Labs, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	bala.chandran@rosalindfranklin.edu	Chakraborty, Sayan/AAC-5622-2019	Chakraborty, Sayan/0000-0002-5591-8164	Public Health Service [AI 091767]; RFUMS-HM Bligh Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA075911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091767] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); RFUMS-HM Bligh Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Public Health Service grants, AI 091767 and the RFUMS-HM Bligh Cancer Research Fund to BC. We thank Dr AP Rapoport (University of Maryland) for providing p53 constructs. We thank Dr B Vogelstein (Johns Hopkins University) for the p53<SUP>+/+</SUP> and p53 <SUP>/</SUP> HCT116 cell lines. We thank Keith Philibert for critically reading the manuscript and Bob Dickinson for FACS analysis at the RFUMS core facility.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Barton DPJ, 1997, CLIN CANCER RES, V3, P1579; Chopra V, 1998, CANCER INVEST, V16, P152, DOI 10.3109/07357909809050029; Chopra V, 1997, J CANCER RES CLIN, V123, P167, DOI 10.1007/BF01214669; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Foulkes WD, 2007, NEW ENGL J MED, V357, P2539, DOI 10.1056/NEJMp0707422; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Hu F, 2010, ONCOGENE, V29, P5464, DOI 10.1038/onc.2010.275; Hu GF, 1998, P NATL ACAD SCI USA, V95, P9791, DOI 10.1073/pnas.95.17.9791; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li DWC, 2006, ONCOGENE, V25, P3006, DOI 10.1038/sj.onc.1209334; LI DC, 1994, J PATHOL, V172, P171, DOI 10.1002/path.1711720203; Liu SM, 2001, BIOCHEM BIOPH RES CO, V287, P305, DOI 10.1006/bbrc.2001.5568; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; MEEK DW, 1994, SEMIN CANCER BIOL, V5, P203; Milczarek GJ, 1996, LIFE SCI, V60, P1, DOI 10.1016/S0024-3205(96)00479-1; Montero S, 1998, CLIN CANCER RES, V4, P2161; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; OLSON KA, 1994, CANCER RES, V54, P4576; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sadagopan S, 2011, J VIROL, V85, P2666, DOI 10.1128/JVI.01532-10; Sadagopan S, 2009, J VIROL, V83, P3342, DOI 10.1128/JVI.02052-08; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Shimoyama S, 1996, CANCER RES, V56, P2703; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WALDMAN T, 1995, CANCER RES, V55, P5187; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	40	43	47	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	46					4835	4847		10.1038/onc.2011.648	http://dx.doi.org/10.1038/onc.2011.648			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	038YT	22266868	Green Accepted			2022-12-25	WOS:000311210700004
J	Hamada, H; Kurusu, T; Okuma, E; Nokajima, H; Kiyoduka, M; Koyano, T; Sugiyama, Y; Okada, K; Koga, J; Saji, H; Miyao, A; Hirochika, H; Yamane, H; Murata, Y; Kuchitsu, K				Hamada, Haruyasu; Kurusu, Takamitsu; Okuma, Eiji; Nokajima, Hiroshi; Kiyoduka, Masahiro; Koyano, Tomoko; Sugiyama, Yoshimi; Okada, Kazunori; Koga, Jinichiro; Saji, Hikaru; Miyao, Akio; Hirochika, Hirohiko; Yamane, Hisakazu; Murata, Yoshiyuki; Kuchitsu, Kazuyuki			Regulation of a Proteinaceous Elicitor-induced Ca2+ Influx and Production of Phytoalexins by a Putative Voltage-gated Cation Channel, OsTPC1, in Cultured Rice Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-PERMEABLE CHANNELS; MOLECULAR-CLONING; CALCIUM; DEFENSE; DEATH; GENE; IDENTIFICATION; ACTIVATION; BIOSYNTHESIS; KINASES	Pathogen/microbe-or plant-derived signaling molecules (PAMPs/MAMPs/DAMPs) or elicitors induce increases in the cytosolic concentration of free Ca2+ followed by a series of defense responses including biosynthesis of antimicrobial secondary metabolites called phytoalexins; however, the molecular links and regulatory mechanisms of the phytoalexin biosynthesis remains largely unknown. A putative voltage-gated cation channel, OsTPC1 has been shown to play a critical role in hypersensitive cell death induced by a fungal xylanase protein (TvX) in suspension-cultured rice cells. Here we show that TvX induced a prolonged increase in cytosolic Ca2+, mainly due to a Ca2+ influx through the plasma membrane. Membrane fractionation by two-phase partitioning and immunoblot analyses revealed that OsTPC1 is localized predominantly at the plasma membrane. In retrotransposon- insertional Ostpc1 knock-out cell lines harboring a Ca2+-sensitive photoprotein, aequorin, TvX-induced Ca2+ elevation was significantly impaired, which was restored by expression of OsTPC1. TvX-induced production of major diterpenoid phytoalexins and the expression of a series of diterpene cyclase genes involved in phytoalexin biosynthesis were also impaired in the Ostpc1 cells. Whole cell patch clamp analyses of OsTPC1 heterologously expressed in HEK293T cells showed its voltage-dependent Ca2+-permeability. These results suggest that OsTPC1 plays a crucial role in TvX-induced Ca2+ influx as a plasma membrane Ca2+ permeable channel consequently required for the regulation of phytoalexin biosynthesis in cultured rice cells.	[Hamada, Haruyasu; Kurusu, Takamitsu; Nokajima, Hiroshi; Kiyoduka, Masahiro; Koyano, Tomoko; Sugiyama, Yoshimi; Kuchitsu, Kazuyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Kurusu, Takamitsu; Kuchitsu, Kazuyuki] Tokyo Univ Sci, RIST, Noda, Chiba 2788510, Japan; [Okuma, Eiji; Murata, Yoshiyuki] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Okada, Kazunori; Yamane, Hisakazu] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Koga, Jinichiro] Meiji Co Ltd, Food Sci Res Labs, Sakado, Saitama 3500289, Japan; [Saji, Hikaru] Natl Inst Environm Studies, Div Environm Biol, Tsukuba, Ibaraki 3058506, Japan; [Miyao, Akio; Hirochika, Hirohiko] Natl Inst Agrobiol Sci, Div Genome & Biodivers Res, Tsukuba, Ibaraki 3058602, Japan	Tokyo University of Science; Tokyo University of Science; Okayama University; University of Tokyo; Meiji Holdings Co., Ltd.; National Institute for Environmental Studies - Japan; National Institute of Agrobiological Sciences - Japan	Kuchitsu, K (corresponding author), Tokyo Univ Sci, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	kuchitsu@rs.noda.tus.ac.jp	Kurusu, Takamitsu/GMW-8766-2022; Kurusu, Takamitsu/GMW-8785-2022; Murata, Yoshiyuki/B-2098-2011; Kuchitsu, Kazuyuki/G-3024-2013; Miyao, Akio/V-7306-2019	Kurusu, Takamitsu/0000-0001-7740-3199; Kurusu, Takamitsu/0000-0001-7740-3199; Kuchitsu, Kazuyuki/0000-0001-8854-0375; Miyao, Akio/0000-0002-2822-2866; Koga, Jinichiro/0000-0003-2106-9894	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23380027, 23117718, 21117516, 21658118, 21200067, 21780041]; Japanese Society for Promotion of Science; Japan Science and Technology Agency [221Z03504]; Nara Institute of Science and Technology; MEXT; Grants-in-Aid for Scientific Research [21200067] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Nara Institute of Science and Technology; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research No. 23380027, 23117718, 21117516, 21658118 (to K. K.) and No. 21200067, 21780041 (to T. K.) from Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan and Japanese Society for Promotion of Science, by a grant from Japan Science and Technology Agency, for Adaptable and Seamless Technology Transfer Program through target-driven R&D (221Z03504) (to T. K.), and by a Grant-in-Aid for Plant Graduate Student from Nara Institute of Science and Technology, supported by MEXT (to H.H.).	BAILEY BA, 1991, PLANT PHYSIOL, V97, P1181, DOI 10.1104/pp.97.3.1181; Balague C, 2003, PLANT CELL, V15, P365, DOI 10.1105/tpc.006999; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cho EM, 2004, PLANT J, V37, P1, DOI 10.1046/j.1365-313X.2003.01926.x; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Dadacz-Narloch B, 2011, PLANT CELL, V23, P2696, DOI 10.1105/tpc.111.086751; Elbaz M, 2002, CELL DEATH DIFFER, V9, P726, DOI 10.1038/sj.cdd.4401030; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Gelli A, 1997, PLANT PHYSIOL, V113, P269, DOI 10.1104/pp.113.1.269; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Hashimoto K, 2005, PLANT BIOTECHNOL, V22, P235, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.22.235; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Igasaki Tomohiro, 2002, Bulletin of the Forestry and Forest Products Research Institute, V1, P235; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Islam MM, 2010, PLANT CELL PHYSIOL, V51, P302, DOI 10.1093/pcp/pcq001; Jurkowski GI, 2004, MOL PLANT MICROBE IN, V17, P511, DOI 10.1094/MPMI.2004.17.5.511; Kadota Y, 2004, BIOCHEM BIOPH RES CO, V317, P823, DOI 10.1016/j.bbrc.2004.03.114; Kadota Y, 2004, PLANT CELL PHYSIOL, V45, P160, DOI 10.1093/pcp/pch020; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; KUCHITSU K, 1993, PROTOPLASMA, V174, P79, DOI 10.1007/BF01404046; Kurusu T, 2005, PLANT J, V42, P798, DOI 10.1111/j.1365-313X.2005.02415.x; Kurusu T, 2004, PLANT CELL PHYSIOL, V45, P693, DOI 10.1093/pcp/pch082; Kurusu T, 2010, PLANT SIGNAL BEHAV, V5, P1045, DOI [10.4161/psb.5.8.12407, 10.1104/pp.109.151852]; Kurusu T, 2011, J PLANT RES, V124, P415, DOI 10.1007/s10265-010-0388-4; Kurusu T, 2010, PLANT PHYSIOL, V153, P678, DOI 10.1104/pp.109.151852; LARSSON C, 1994, METHOD ENZYMOL, V228, P451; Lecourieux D, 2002, PLANT CELL, V14, P2627, DOI 10.1105/tpc.005579; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; Mithofer Axel, 2002, Biological Procedures Online, V4, P105, DOI 10.1251/bpo40; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Navazio L, 2002, PLANTA, V215, P596, DOI 10.1007/s00425-002-0776-7; Navazio L, 2001, PLANT PHYSIOL, V125, P2129, DOI 10.1104/pp.125.4.2129; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Okada A, 2009, J BIOL CHEM, V284, P26510, DOI 10.1074/jbc.M109.036871; Otomo K, 2004, BIOSCI BIOTECH BIOCH, V68, P2001, DOI 10.1271/bbb.68.2001; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; PEREZGARCIA MT, 1995, J GEN PHYSIOL, V105, P289, DOI 10.1085/jgp.105.2.289; Ranf S, 2008, PLANT J, V53, P287, DOI 10.1111/j.1365-313X.2007.03342.x; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Smallwood M, 1996, PLANTA, V198, P452, DOI 10.1007/BF00620063; Song WY, 2008, INT J BIOL SCI, V4, P116; SU RC, 1992, PLANT CELL REP, V12, P45, DOI 10.1007/BF00232422; Tanaka N, 2004, MOL GENET GENOMICS, V271, P566, DOI 10.1007/s00438-004-1002-z; Tronchet M, 2001, PLANT J, V27, P115, DOI 10.1046/j.1365-313x.2001.01072.x; Umemura K, 2002, PLANT CELL PHYSIOL, V43, P778, DOI 10.1093/pcp/pcf090; Wang YJ, 2005, J EXP BOT, V56, P3051, DOI 10.1093/jxb/eri302; Yoshioka K, 2006, PLANT CELL, V18, P747, DOI 10.1105/tpc.105.038786; Zhang XCG, 2002, PLANTA, V215, P312, DOI 10.1007/s00425-002-0739-z	57	18	20	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9931	9939		10.1074/jbc.M111.337659	http://dx.doi.org/10.1074/jbc.M111.337659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22270358	Green Published, hybrid			2022-12-25	WOS:000302167200025
J	Nambiar, M; Raghavan, SC				Nambiar, Mridula; Raghavan, Sathees C.			Mechanism of Fragility at BCL2 Gene Minor Breakpoint Cluster Region during t(14;18) Chromosomal Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V(D)J RECOMBINATION EFFICIENCY; POLYMERASE-CHAIN-REACTION; B DNA STRUCTURES; MAJOR BREAKPOINT; FOLLICULAR LYMPHOMA; GENOMIC-INSTABILITY; NUCLEOTIDE-SEQUENCE; ACTIVATING GENE; SIGNAL SEQUENCE; CODING ENDS	The t(14;18) translocation in follicular lymphoma is one of the most common chromosomal translocations. Breaks in chromosome 18 are localized at the 3'-UTR of BCL2 gene or downstream and are mainly clustered in either the major breakpoint region or the minor breakpoint cluster region (mcr). The recombination activating gene (RAG) complex induces breaks at IgH locus of chromosome 14, whereas the mechanism of fragility at BCL2 mcr remains unclear. Here, for the first time, we show that RAGs can nick mcr; however, the mechanism is unique. Three independent nicks of equal efficiency are generated, when both Mg2+ and Mn2+ are present, unlike a single nick during V(D)J recombination. Further, we demonstrate that RAG binding and nicking at the mcr are independent of nonamer, whereas a CCACCTCT motif plays a critical role in its fragility, as shown by sequential mutagenesis. More importantly, we recapitulate the BCL2 mcr translocation and find that mcr can undergo synapsis with a standard recombination signal sequence within the cells, in a RAG-dependent manner. Further, mutation to the CCACCTCT motif abolishes recombination within the cells, indicating its vital role. Hence, our data suggest a novel, physiologically relevant, nonamer-independent mechanism of RAG nicking at mcr, which may be important for generation of chromosomal translocations in humans.	[Nambiar, Mridula; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in			Council of Scientific and Industrial Research (CSIR) India [27(0164)/07/EMR-II:2007]	Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR) India (27(0164)/07/EMR-II:2007) (to S. C. R.).	Albinger-Hegyi A, 2002, AM J PATHOL, V160, P823, DOI 10.1016/S0002-9440(10)64905-X; BAKHSHI A, 1987, P NATL ACAD SCI USA, V84, P2396, DOI 10.1073/pnas.84.8.2396; BOUBNOV NV, 1995, NUCLEIC ACIDS RES, V23, P1060, DOI 10.1093/nar/23.6.1060; Buchonnet G, 2002, LEUKEMIA, V16, P1852, DOI 10.1038/sj.leu.2402568; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Galili N, 1987, Haematol Blood Transfus, V31, P167; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; KORSMEYER SJ, 1992, ANNU REV IMMUNOL, V10, P785, DOI 10.1146/annurev.immunol.10.1.785; Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lewis SM, 1997, MOL CELL BIOL, V17, P3125, DOI 10.1128/MCB.17.6.3125; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Li WH, 2001, MOL CELL BIOL, V21, P3935, DOI 10.1128/MCB.21.12.3935-3946.2001; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; Naik AK, 2010, J BIOL CHEM, V285, P7587, DOI 10.1074/jbc.M109.089631; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; NGAN BY, 1989, BLOOD, V73, P1759; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Raghavan SC, 2005, MOL CELL BIOL, V25, P6475, DOI 10.1128/MCB.25.15.6475-6484.2005; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, CELL CYCLE, V3, P762; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Rahman NS, 2006, J BIOL CHEM, V281, P12370, DOI 10.1074/jbc.M507906200; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; RETH MG, 1986, EMBO J, V5, P2131, DOI 10.1002/j.1460-2075.1986.tb04476.x; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; SAKANO H, 1981, NATURE, V290, P562, DOI 10.1038/290562a0; Santagata S, 1998, J BIOL CHEM, V273, P16325, DOI 10.1074/jbc.273.26.16325; Schatz David G., 2004, Cell, VS116, pS103, DOI 10.1016/S0092-8674(04)00042-X; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; Sharma S, 2011, CELL MOL LIFE SCI, V68, P661, DOI 10.1007/s00018-010-0472-x; Sigel A., 2000, MANGANESE ITS ROLE B, V37; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Tsai AG, 2010, BLOOD, V116, P1993, DOI 10.1182/blood-2010-05-286492; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Weinberg OK, 2007, J MOL DIAGN, V9, P530, DOI 10.2353/jmoldx.2007.070038; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	49	32	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8688	8701		10.1074/jbc.M111.307363	http://dx.doi.org/10.1074/jbc.M111.307363			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275374	Green Published, hybrid			2022-12-25	WOS:000301797800003
J	Robinson, AK; Leal, BZ; Chadwell, LV; Wang, RJ; Ilangovan, U; Kaur, Y; Junco, SE; Schirf, V; Osmulski, PA; Gaczynska, M; Hinck, AP; Demeler, B; McEwen, DG; Kim, CA				Robinson, Angela K.; Leal, Belinda Z.; Chadwell, Linda V.; Wang, Renjing; Ilangovan, Udayar; Kaur, Yogeet; Junco, Sarah E.; Schirf, Virgil; Osmulski, Pawel A.; Gaczynska, Maria; Hinck, Andrew P.; Demeler, Borries; McEwen, Donald G.; Kim, Chongwoo A.			The Growth-Suppressive Function of the Polycomb Group Protein Polyhomeotic Is Mediated by Polymerization of Its Sterile Alpha Motif (SAM) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY EXPERIMENTS; SEX-COMB; CHROMATIN; REPRESSION; SYSTEM; CORE; TEL	Polyhomeotic (Ph), a member of the Polycomb Group (PcG), is a gene silencer critical for proper development. We present a previously unrecognized way of controlling Ph function through modulation of its sterile alpha motif (SAM) polymerization leading to the identification of a novel target for tuning the activities of proteins. SAM domain containing proteins have been shown to require SAM polymerization for proper function. However, the role of the Ph SAM polymer in PcG-mediated gene silencing was uncertain. Here, we first show that Ph SAM polymerization is indeed required for its gene silencing function. Interestingly, the unstructured linker sequence N-terminal to Ph SAM can shorten the length of polymers compared with when Ph SAM is individually isolated. Substituting the native linker with a random, unstructured sequence (RLink) can still limit polymerization, but not as well as the native linker. Consequently, the increased polymeric Ph RLink exhibits better gene silencing ability. In the Drosophila wing disc, Ph RLink expression suppresses growth compared with no effect for wild-type Ph, and opposite to the overgrowth phenotype observed for polymer-deficient Ph mutants. These data provide the first demonstration that the inherent activity of a protein containing a polymeric SAM can be enhanced by increasing SAM polymerization. Because the SAM linker had not been previously considered important for the function of SAM-containing proteins, our finding opens numerous opportunities to manipulate linker sequences of hundreds of polymeric SAM proteins to regulate a diverse array of intracellular functions.	[Robinson, Angela K.; Leal, Belinda Z.; Wang, Renjing; Ilangovan, Udayar; Kaur, Yogeet; Junco, Sarah E.; Schirf, Virgil; Hinck, Andrew P.; Demeler, Borries; McEwen, Donald G.; Kim, Chongwoo A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Chadwell, Linda V.; McEwen, Donald G.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Osmulski, Pawel A.; Gaczynska, Maria] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Kim, CA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	chong@biochem.uthscsa.edu	Osmulski, Pawel/C-7751-2019	Osmulski, Pawel/0000-0002-5359-9200; Wong, Sarah/0000-0002-9992-2907; Demeler, Borries/0000-0002-2414-9518; Hinck, Andrew/0000-0003-3320-8054	NIH [RR022200/RGM103662B]; American Cancer Society [RSG-08-285-01-GMC]; American Heart Association [0830111N]; Department of Defense [BC075278]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr. Susan T. Weintraub for comments on the manuscript. The UltraScan development is supported by NIH Grant RR022200/RGM103662B (to B. D.). Computational analysis was performed at the Texas Advanced Computing Center on Lonestar and Ranger using NSF TeraGrid allocation TG-MCB070039 (to B. D.).; This work was supported by the American Cancer Society (RSG-08-285-01-GMC), the American Heart Association (0830111N), and the Department of Defense Breast Cancer Research Program (BC075278) (to C. A. K.).	Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brookes E., 2006, ANAL ULTRACENTRIFUGA, VVIII, P78; Brookes EH, 2007, GECCO P; Brookes E, 2008, COLLOID POLYM SCI, V286, P139, DOI 10.1007/s00396-007-1714-9; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Di Pietro SM, 2010, EMBO J, V29, P1033, DOI 10.1038/emboj.2010.5; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Feng SQ, 2011, EMBO REP, V12, P157, DOI 10.1038/embor.2010.188; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim CA, 2005, J BIOL CHEM, V280, P27769, DOI 10.1074/jbc.M503055200; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kyba M, 1998, DEV GENET, V22, P74, DOI 10.1002/(SICI)1520-6408(1998)22:1<74::AID-DVG8>3.3.CO;2-V; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lavigne M, 2004, MOL CELL, V13, P415, DOI 10.1016/S1097-2765(04)00006-1; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; Meruelo AD, 2009, PROTEINS, V74, P1, DOI 10.1002/prot.22232; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schatz PJ, 1996, METHOD ENZYMOL, V267, P171; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Wang RJ, 2011, BIOCHEMISTRY-US, V50, P4998, DOI 10.1021/bi101487s; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Zhang H, 2004, MOL CELL, V14, P841, DOI 10.1016/j.molcel.2004.06.001	40	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8702	8713		10.1074/jbc.M111.336115	http://dx.doi.org/10.1074/jbc.M111.336115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275371	Green Published, hybrid			2022-12-25	WOS:000301797800004
J	Basu, S; Rajakaruna, S; Menko, AS				Basu, Subhasree; Rajakaruna, Suren; Menko, A. Sue			Insulin-like Growth Factor Receptor-1 and Nuclear Factor kappa B Are Crucial Survival Signals That Regulate Caspase-3-mediated Lens Epithelial Cell Differentiation Initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-APOPTOTIC FUNCTIONS; DNA STRAND BREAKS; FACTOR-I RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; TERMINAL DIFFERENTIATION; CASPASE ACTIVATION; GENE-EXPRESSION; IGF-I; CANCER; PATHWAY	It is now known that the function of the caspase family of proteases is not restricted to effectors of programmed cell death. For example, there is a significant non-apoptotic role for caspase-3 in cell differentiation. Our own studies in the developing lens show that caspase-3 is activated downstream of the canonical mitochondrial death pathway to act as a molecular switch in signaling lens cell differentiation. Importantly, for this function, caspase-3 is activated at levels far below those that induce apoptosis. We now have provided evidence that regulation of caspase-3 for its role in differentiation induction is dependent on the insulin-like growth factor-1 receptor (IGF-1R) survival-signaling pathway. IGF-1R executed this regulation of caspase-3 by controlling the expression of molecules in the Bcl-2 and inhibitor of apoptosis protein (IAP) families. This effect of IGF-1R was mediated through NF kappa B, demonstrated here to function as a crucial downstream effector of IGF-1R. Inhibition of expression or activation of NF kappa B blocked expression of survival proteins in the Bcl-2 and IAP families and removed controls on the activation state of caspase-3. The high level of caspase-3 activation that resulted from inhibiting this IGF-1R/NF kappa B signaling pathway redirected cell fate from differentiation toward apoptosis. These results provided the first evidence that the IGF-1R/NF kappa B cell survival signal is a crucial regulator of the level of caspase-3 activation for its non-apoptotic function in signaling cell differentiation.	[Basu, Subhasree; Rajakaruna, Suren; Menko, A. Sue] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Menko, AS (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 564 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	sue.menko@jefferson.edu		Menko, A. Sue/0000-0002-7514-4696	National Institutes of Health [EY10577, EY014258]; NATIONAL EYE INSTITUTE [R01EY014258, R01EY010577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY10577 and EY014258 (to A. S. M.).	Alberobello AT, 2010, J BIOL CHEM, V285, P6563, DOI 10.1074/jbc.M109.097410; ALEMANY J, 1990, P NATL ACAD SCI USA, V87, P3353, DOI 10.1073/pnas.87.9.3353; ALEMANY J, 1989, J BIOL CHEM, V264, P17559; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; BEEBE DC, 1980, P NATL ACAD SCI-BIOL, V77, P490, DOI 10.1073/pnas.77.1.490; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bernal-Mizrachi L, 2006, P NATL ACAD SCI USA, V103, P9220, DOI 10.1073/pnas.0507809103; Black S, 2004, CELL DEATH DIFFER, V11, P90, DOI 10.1038/sj.cdd.4401307; Chandrasekher G, 2004, INVEST OPHTH VIS SCI, V45, P3577, DOI 10.1167/iovs.04-0279; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; D'Amours D, 2001, J CELL SCI, V114, P3771; Deptala A, 1998, CYTOMETRY, V33, P376, DOI 10.1002/(SICI)1097-0320(19981101)33:3<376::AID-CYTO13>3.0.CO;2-Q; Feinstein-Rotkopf Y, 2009, APOPTOSIS, V14, P980, DOI 10.1007/s10495-009-0346-6; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Karasic TB, 2010, EXP CELL RES, V316, P1994, DOI 10.1016/j.yexcr.2010.04.014; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Koto A, 2009, J CELL BIOL, V187, P219, DOI 10.1083/jcb.200905110; Larsen BD, 2010, CELL CYCLE, V9, P2940, DOI 10.4161/cc.9.15.12335; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Le ACN, 2001, DEV BIOL, V233, P394, DOI 10.1006/dbio.2001.0194; Leonard M, 2008, DEV BIOL, V319, P298, DOI 10.1016/j.ydbio.2008.04.036; Luqman S, 2010, PHYTOTHER RES, V24, P949, DOI 10.1002/ptr.3171; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; MENKO AS, 1984, DEV BIOL, V103, P129, DOI 10.1016/0012-1606(84)90014-9; Mirkes PE, 2002, TERATOLOGY, V65, P228, DOI 10.1002/tera.10049; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mogi M, 2003, J BIOL CHEM, V278, P47477, DOI 10.1074/jbc.M307055200; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Rios J, 2011, ONCOLOGY-NY, V25, P1014; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schwerk C, 2003, BIOCHEM PHARMACOL, V66, P1453, DOI 10.1016/S0006-2952(03)00497-0; Shirke S, 2001, MECH DEVELOP, V101, P167, DOI 10.1016/S0925-4773(00)00584-0; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Vasilcanu D, 2006, ONCOGENE, V25, P3186, DOI 10.1038/sj.onc.1209339; Walker J, 2009, EXP EYE RES, V88, P216, DOI 10.1016/j.exer.2008.06.020; Walker JL, 2002, DEV DYNAM, V223, P273, DOI 10.1002/dvdy.10050; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; Weber GF, 2006, INVEST OPHTH VIS SCI, V47, P4490, DOI 10.1167/iovs.06-0401; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Wesierska-Gadek J, 2004, J CELL BIOCHEM, V93, P774, DOI 10.1002/jcb.20181; Wu MX, 2009, FREE RADICAL BIO MED, V46, P62, DOI 10.1016/j.freeradbiomed.2008.09.021; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zermati Y, 2001, J EXP MED, V193, P247, DOI 10.1084/jem.193.2.247; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	54	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8384	8397		10.1074/jbc.M112.341586	http://dx.doi.org/10.1074/jbc.M112.341586			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275359	Green Published, hybrid			2022-12-25	WOS:000301349400053
J	de Boer, FK; Hogeweg, P				de Boer, Folkert K.; Hogeweg, Paulien			Less Can Be More: RNA-Adapters May Enhance Coding Capacity of Replicators	PLOS ONE			English	Article							SECONDARY STRUCTURES; EVOLUTIONARY DYNAMICS; MOLECULAR CHAPERONES; SELF-ORGANIZATION; GENE-EXPRESSION; ERROR THRESHOLD; RIBOSWITCHES; RIBOZYMES; ORIGIN; WORLD	It is still not clear how prebiotic replicators evolved towards the complexity found in present day organisms. Within the most realistic scenario for prebiotic evolution, known as the RNA world hypothesis, such complexity has arisen from replicators consisting solely of RNA. Within contemporary life, remarkably many RNAs are involved in modifying other RNAs. In hindsight, such RNA-RNA modification might have helped in alleviating the limits of complexity posed by the information threshold for RNA-only replicators. Here we study the possible role of such self-modification in early evolution, by modeling the evolution of protocells as evolving replicators, which have the opportunity to incorporate these mechanisms as a molecular tool. Evolution is studied towards a set of 25 arbitrary 'functional' structures, while avoiding all other (misfolded) structures, which are considered to be toxic and increase the death-rate of a protocell. The modeled protocells contain a genotype of different RNA-sequences while their phenotype is the ensemble of secondary structures they can potentially produce from these RNA-sequences. One of the secondary structures explicitly codes for a simple sequence-modification tool. This 'RNA-adapter' can block certain positions on other RNA-sequences through antisense base-pairing. The altered sequence can produce an alternative secondary structure, which may or may not be functional. We show that the modifying potential of interacting RNA-sequences enables these protocells to evolve high fitness under high mutation rates. Moreover, our model shows that because of toxicity of misfolded molecules, redundant coding impedes the evolution of self-modification machinery, in effect restraining the evolvability of coding structures. Hence, high mutation rates can actually promote the evolution of complex coding structures by reducing redundant coding. Protocells can successfully use RNA-adapters to modify their genotype-phenotype mapping in order to enhance the coding capacity of their genome and fit more information on smaller sized genomes.	[de Boer, Folkert K.; Hogeweg, Paulien] Univ Utrecht, Utrecht, Netherlands	Utrecht University	de Boer, FK (corresponding author), Univ Utrecht, Utrecht, Netherlands.	fkdeboer@gmail.com			Netherlands Science Organizationsimilar to(NWO) [612.060.522]	Netherlands Science Organizationsimilar to(NWO)	This research is funded by the Netherlands Science Organization similar to(NWO) under grant number 612.060.522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOERLIJST MC, 1991, PHYSICA D, V48, P17, DOI 10.1016/0167-2789(91)90049-F; Brennicke A, 1999, FEMS MICROBIOL REV, V23, P297, DOI 10.1111/j.1574-6976.1999.tb00401.x; Chen PQ, 2009, GENETICS, V183, P639, DOI 10.1534/genetics.109.106492; Csermely P, 1997, TRENDS BIOCHEM SCI, V22, P147, DOI 10.1016/S0968-0004(97)01026-8; de Boer FK, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-361; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1980, J THEOR BIOL, V85, P407, DOI 10.1016/0022-5193(80)90315-X; EIGEN M, 1978, NATURWISSENSCHAFTEN, V65, P7, DOI 10.1007/BF00420631; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Ferre-D'Amare AR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003574; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Fontana W, 2002, BIOESSAYS, V24, P1164, DOI 10.1002/bies.10190; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; HOGEWEG P, 1992, COMPUT CHEM, V16, P171, DOI 10.1016/0097-8485(92)80044-Z; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; HUYNEN MA, 1994, J MOL EVOL, V39, P71; HUYNEN MA, 1993, J THEOR BIOL, V165, P251, DOI 10.1006/jtbi.1993.1188; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Irimia M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-188; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Knight R, 2005, NUCLEIC ACIDS RES, V33, P5924, DOI 10.1093/nar/gki886; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Maynard-Smith J., 1979, NATURE, V280, P445; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Philpott A, 2000, SEMIN CELL DEV BIOL, V11, P7, DOI 10.1006/scdb.1999.0346; Richter AS, 2011, P GERM C BIOINF GCB; Sanjuan R, 2011, MOL BIOL EVOL, V28, P1333, DOI 10.1093/molbev/msq329; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; SHAPIRO BA, 1988, COMPUT APPL BIOSCI, V4, P387; Silvestre DGM, 2005, EUR PHYS J B, V47, P423, DOI 10.1140/epjb/e2005-00346-5; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 1997, J THEOR BIOL, V187, P555, DOI 10.1006/jtbi.1996.0389; Takeuchi N, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-9; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Takeuchi N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-11; Tiana G, 1998, J CHEM PHYS, V108, P757, DOI 10.1063/1.475435; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645	52	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29952	10.1371/journal.pone.0029952	http://dx.doi.org/10.1371/journal.pone.0029952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291898	Green Published, Green Submitted, gold			2022-12-25	WOS:000301570600009
J	Wu, VC; Huang, TM; Wu, PC; Wang, WJ; Chao, CT; Yang, SY; Shiao, CC; Hu, FC; Lai, CF; Lin, YF; Han, YY; Chen, YS; Hsu, RB; Young, GH; Wang, SS; Tsai, PR; Chen, YM; Chao, TT; Ko, WJ; Wu, KD				Wu, Vin-Cent; Huang, Tao-Min; Wu, Pei-Chen; Wang, Wei-Jie; Chao, Chia-Ter; Yang, Shao-Yu; Shiao, Chih-Chung; Hu, Fu-Chang; Lai, Chun-Fu; Lin, Yu-Feng; Han, Yin-Yi; Chen, Yih-Sharng; Hsu, Ron-Bin; Young, Guang-Huar; Wang, Shoei-Shen; Tsai, Pi-Ru; Chen, Yung-Ming; Chao, Ting-Ting; Ko, Wen-Je; Wu, Kwan-Dun		NSARF Grp	Preoperative Proteinuria Is Associated with Long-Term Progression to Chronic Dialysis and Mortality after Coronary Artery Bypass Grafting Surgery	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ACUTE KIDNEY INJURY; ACUTE-RENAL-FAILURE; CARDIOTHORACIC SURGERY; REPLACEMENT THERAPY; GENERAL-POPULATION; PROSPECTIVE COHORT; SERUM CREATININE; ALL-CAUSE; RISK	Aims: Preoperative proteinuria is associated with post-operative acute kidney injury (AKI), but whether it is also associated with increased long-term mortality and end -stage renal disease (ESRD) is unknown. Methods and Results: We studied 925 consecutive patients undergoing CABG. Demographic and clinical data were collected prospectively, and patients were followed for a median of 4.71 years after surgery. Proteinuria, according to dipstick tests, was defined as mild (trace to 1+) or heavy (2+ to 4+) according to the results of the dipstick test. A total of 276 (29.8%) patients had mild proteinuria before surgery and 119 (12.9%) patients had heavy proteinuria. During the follow-up, the Cox proportional hazards model demonstrated that heavy proteinuria (hazard ratio [HR], 27.17) was an independent predictor of long-term ESRD. There was a progressive increased risk for mild proteinuria ([HR], 1.88) and heavy proteinuria ([HR], 2.28) to predict all-cause mortality compared to no proteinuria. Mild ([HR], 2.57) and heavy proteinuria ([HR], 2.70) exhibited a stepwise increased ratio compared to patients without proteinuria for long-term composite catastrophic outcomes (mortality and ESRD), which were independent of the baseline GFR and postoperative acute kidney injury (AKI). Conclusion: Our study demonstrated that proteinuria is a powerful independent risk factor of long-term all-cause mortality and ESRD after CABG in addition to preoperative GFR and postoperative AKI. Our study demonstrated that proteinuria should be integrated into clinical risk prediction models for long-term outcomes after CABG. These results provide a high priority for future renal protective strategies and methods for post-operative CABG patients.	[Wu, Vin-Cent; Chao, Chia-Ter; Yang, Shao-Yu; Lai, Chun-Fu; Chen, Yung-Ming; Wu, Kwan-Dun] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Huang, Tao-Min] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Yun Lin Branch, Touliu, Taiwan; [Wu, Pei-Chen] Da Chien Gen Hosp, Div Nephrol, Dept Internal Med, Miaoli, Taiwan; [Wang, Wei-Jie] Taoyuan Gen Hosp, Dept Internal Med, Dept Hlth, Tao Yuan, Taiwan; [Chen, Yih-Sharng; Hsu, Ron-Bin; Young, Guang-Huar; Wang, Shoei-Shen; Tsai, Pi-Ru; Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Shiao, Chih-Chung] St Marys Hosp, Div Nephrol, Dept Internal Med, Luodong, Yilan, Taiwan; [Shiao, Chih-Chung] St Marys Med Nursing & Management Coll, Luodong, Yilan, Taiwan; [Hu, Fu-Chang] Int Harvard Stat Consulting Co, Taipei, Taiwan; [Lin, Yu-Feng; Han, Yin-Yi; Ko, Wen-Je] Natl Taiwan Univ Hosp, Dept Raumatol, Taipei 100, Taiwan; [Chao, Ting-Ting] Fu Jen Catholic Univ, Med Res Ctr, Cardinal Tien Hosp, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University	Wu, VC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan.	q91421028@ntu.edu.tw; kowj@ntu.edu.tw	Chao, Chia-Ter/H-7994-2019; Huang, Tao Min/C-5379-2011; Yang, SY/AAN-1918-2021; Shiao, Chih-Chung/AAM-2716-2020	Chao, Chia-Ter/0000-0003-2892-7986; Huang, Tao Min/0000-0002-9387-0798; Shiao, Chih-Chung/0000-0003-2220-7574; CHEN, YUNG-MING/0000-0002-9241-1258; Wang, Shoei-Shen/0000-0003-3201-4143; LIN, YU-FENG/0000-0002-4350-7755; LAI, CHUN-FU/0000-0003-2109-1522; Chen, Yih-Sharng/0000-0003-3846-8162; WU, KWAN-DUN/0000-0002-3339-1509; HAN, YIN-YI/0000-0001-8831-7835; YANG, SHAO-YU/0000-0001-9170-2566; WU, VIN-CENT/0000-0001-7935-0991	Ta-Tung Kidney Foundation; Taiwan National Science Council [NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4]; National Taiwan University Hospital [NTUH.098-001177, NTUH 100-001667]	Ta-Tung Kidney Foundation; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by The Ta-Tung Kidney Foundation, Taiwan National Science Council (grant NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4) and National Taiwan University Hospital grant, NTUH.098-001177, NTUH 100-001667. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Bove T, 2005, CIRCULATION, V111, P3230, DOI 10.1161/CIRCULATIONAHA.104.509141; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; DeRose JJ, 2005, J THORAC CARDIOV SUR, V129, P314, DOI 10.1016/j.jtcvs.2004.05.022; Donadelli R, 2000, AM J KIDNEY DIS, V36, P1226, DOI 10.1053/ajkd.2000.19838; Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; Haase M, 2009, J THORAC CARDIOV SUR, V138, P1370, DOI 10.1016/j.jtcvs.2009.07.007; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hillis GS, 2006, CIRCULATION, V113, P1056, DOI 10.1161/CIRCULATIONAHA.105.591990; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Huang TM, 2011, J AM SOC NEPHROL, V22, P156, DOI 10.1681/ASN.2010050553; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Konta Tsuneo, 2007, Clin Exp Nephrol, V11, P51, DOI 10.1007/s10157-006-0458-z; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Orii K, 2009, J NIHON MED SCH, V78, P156; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; Ruggenenti P, 2006, KIDNEY INT, V70, P1214, DOI 10.1038/sj.ki.5001729; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wu VC, 2011, KIDNEY INT IN PRESS; Wu VC, 2008, INTENS CARE MED, V34, P101, DOI 10.1007/s00134-007-0813-x; Wu VC, 2007, J AM COLL SURGEONS, V205, P266, DOI 10.1016/j.jamcollsurg.2007.04.006	34	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e27687	10.1371/journal.pone.0027687	http://dx.doi.org/10.1371/journal.pone.0027687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276092	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100001
J	Rosche, B; Laurent, S; Conradi, S; Hofmann, J; Ruprecht, K; Harms, L				Rosche, Berit; Laurent, Sarah; Conradi, Silja; Hofmann, Joerg; Ruprecht, Klemens; Harms, Lutz			Measles IgG Antibody Index Correlates with T2 Lesion Load on MRI in Patients with Early Multiple Sclerosis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; IMMUNE-RESPONSE; CONVERSION; PATTERNS; CRITERIA; DISEASES	Background: B cells and humoral immune responses play an important role in the pathogenesis and diagnosis of multiple sclerosis (MS). A characteristic finding in patients with MS is a polyspecific intrathecal B cell response against neurotropic viruses, specifically against measles virus, rubella virus, and varicella zoster virus, also known as an MRZ reaction (MRZR). Here, we correlated from the routine clinical diagnostics individual IgG antibody indices (AIs) of MRZR with magnetic resonance imaging (MRI) findings in patients with first MS diagnosis. Methods/Results: MRZR was determined in 68 patients with a clinically isolated syndrome (CIS) or early relapsing-remitting MS (RRMS). Absolute AI values for measles virus, rubella virus, and varicella zoster virus were correlated with T2 lesion load and gadolinium enhancing lesions on cerebral MRI (cMRI) and cMRI combined with spinal MRI (sMRI). Measles virus AI correlated significantly with T2 lesion load on cMRI (p = 0.0312, Mann-Whitney U test) and the sum of lesions on cMRI and sMRI (p = 0.0413). Varicella zoster virus AI also showed a correlation with T2 lesion load on cMRI but did not reach statistical significance (p = 0.2893). Conclusion: The results confirm MRZR as part of the polyspecific immune reaction in MS with possible prognostic impact on MRI and clinical parameters. Furthermore, the data indicate that intrathecal measles virus IgG production correlates with disease activity on cMRI and sMRI in patients with early MS.	[Rosche, Berit; Laurent, Sarah; Conradi, Silja; Ruprecht, Klemens; Harms, Lutz] Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany; [Hofmann, Joerg] Charite, Dept Virol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rosche, B (corresponding author), Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany.	berit.rosche@charite.de		Hofmann, Joerg/0000-0003-3966-515X; Laurent, Sarah Anne/0000-0001-8997-3017	Bayer Schering Pharma; Merck Serono; Biogen Idec; Teva Pharmaceuticals; Novartis	Bayer Schering Pharma(Bayer AG); Merck Serono(Merck & Company); Biogen Idec(Biogen); Teva Pharmaceuticals(Teva Pharmaceutical Industries); Novartis(Novartis)	BR receives research funding from Bayer Schering Pharma and Merck Serono. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BR receives research funding from Bayer Schering Pharma and Merck Serono. BR has participated in meetings sponsored by and received lecture fees from Biogen Idec, Bayer Schering Pharma, Merck Sorono and Teva Pharmaceuticals. KR has received funding for travel and lecture fees from Merck Serono and Bayer Schering Pharma, and receives research support from Novartis. LH has received personal compensation for activities with Biogen Idec, Serono and Teva Pharmaceuticals as a Speaker. SL, SC and JH have nothing to disclose. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Derfuss T, 2001, BRAIN, V124, P1325, DOI 10.1093/brain/124.7.1325; FELGENHAUER K, 1992, CLIN INVESTIGATOR, V70, P28, DOI 10.1007/BF00422934; Jacobi C, 2007, J NEUROIMMUNOL, V187, P139, DOI 10.1016/j.jneuroim.2007.04.002; Jarius S, 2009, J NEUROL SCI, V280, P98, DOI 10.1016/j.jns.2008.08.002; Nociti V, 2010, J NEUROIMMUNOL, V225, P149, DOI 10.1016/j.jneuroim.2010.04.007; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Reiber H, 1998, MULT SCLER, V4, P111, DOI 10.1177/135245859800400304; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Rieckmann P, 2002, NERVENARZT, V73, P556, DOI 10.1007/s00115-002-1328-x; Swanton JK, 2007, LANCET NEUROL, V6, P677, DOI 10.1016/S1474-4422(07)70176-X; Villar LM, 2002, NEUROLOGY, V58, P824, DOI 10.1212/WNL.58.5.824; WALSH MJ, 1986, J EXP MED, V163, P41, DOI 10.1084/jem.163.1.41	16	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e28094	10.1371/journal.pone.0028094	http://dx.doi.org/10.1371/journal.pone.0028094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276094	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200002
J	Schnell, O; Romagna, A; Jaehnert, I; Albrecht, V; Eigenbrod, S; Juerchott, K; Kretzschmar, H; Tonn, JC; Schichor, C				Schnell, Oliver; Romagna, Alexander; Jaehnert, Irene; Albrecht, Valerie; Eigenbrod, Sabina; Juerchott, Kathrin; Kretzschmar, Hans; Tonn, Joerg-Christian; Schichor, Christian			Kruppel-Like Factor 8 (KLF8) Is Expressed in Gliomas of Different WHO Grades and Is Essential for Tumor Cell Proliferation	PLOS ONE			English	Article							FOCAL ADHESION KINASE; KI-67 IMMUNOREACTIVITY; IN-VIVO; TRANSCRIPTION; ASTROCYTOMAS; GENE	Kruppel-like factor 8 (KLF8) has only recently been identified to be involved in tumor cell proliferation and invasion of several different tumor entities like renal cell carcinoma, hepatocellular carcinoma and breast cancer. In the present study, we show for the first time the expression of KLF8 in gliomas of different WHO grades and its functional impact on glioma cell proliferation. In order to get information about KLF8-mRNA regulation qPCR was performed and did not reveal any significant difference in samples (n = 10 each) of non-neoplastic brain (NNB), low-grade gliomas (LGG, WHO degrees II) and glioblastomas (GBM, WHO degrees IV). Immunohistochemistry of tissue samples (n = 7 LGG, 11 AA and 12 GBM) did not show any significant difference in the fraction of KLF8-immunopositive cells of all analyzed cells in LGG (87%), AA (80%) or GBM (89%). Tissue samples from cerebral breast cancer metastasis, meningiomas but also non-neoplastic brain demonstrated comparable relative cell counts as well. Moreover, there was no correlation between KLF8 expression and the expression pattern of the assumed proliferation marker Ki67, which showed high variability between different tumor grade (9% (LGG), 6% (AA) and 15% (GBM) of Ki67-immunopositive cells). Densitometric analysis of Western blotting revealed that the relative amount of KLF8-protein did also not differ between the highly aggressive and proliferative GBM (1.05) compared to LGG (0.93; p<0.05, students t-test). As demonstrated for some other non-glial cancer entities, KLF8-knockdown by shRNA in U87-MG cells confirmed its functional relevance, leading to an almost complete loss of tumor cell proliferation. Selective blocking of KLF8 might represent a novel anti-proliferative treatment strategy for malignant gliomas. Yet, its simultaneous expression in non-proliferating tissues could hamper this approach.	[Schnell, Oliver; Romagna, Alexander; Jaehnert, Irene; Albrecht, Valerie; Tonn, Joerg-Christian; Schichor, Christian] Klinikum Ludwig Maximilians Univ Munchen, Dept Neurosurg, Munich, Germany; [Eigenbrod, Sabina; Kretzschmar, Hans] Univ Munich, Ctr Neuropathol & Pr Res, Munich, Germany; [Juerchott, Kathrin] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	University of Munich; University of Munich; Max Planck Society	Schnell, O (corresponding author), Klinikum Ludwig Maximilians Univ Munchen, Dept Neurosurg, Campus Grosshadern, Munich, Germany.	Oliver.Schnell@med.uni-muenchen.de	Schichor, Christian/D-8635-2014; Tonn, Joerg/AAK-8509-2021		Stiftung Neurochirurgische Forschung of the Deutsche Gesellschaft fur Neurochirurgie (DGNC); bi-national SYSTHER-INREMOS virtual institute; German (BMBF); Slovenian Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich (SFB) 824]	Stiftung Neurochirurgische Forschung of the Deutsche Gesellschaft fur Neurochirurgie (DGNC); bi-national SYSTHER-INREMOS virtual institute; German (BMBF)(Federal Ministry of Education & Research (BMBF)); Slovenian Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by several grants from the Stiftung Neurochirurgische Forschung of the Deutsche Gesellschaft fur Neurochirurgie (DGNC) (O.S.), the bi-national SYSTHER-INREMOS virtual institute, funded by the German (BMBF) and the Slovenian Federal Ministry of Education and Research (I.J., K.J. and C.S.) and the Sonderforschungsbereich (SFB) 824 of the Deutsche Forschungsgemeinschaft (DFG) (V.A. and J.C.T.). The presented work is in partial fulfillment of the requirements for the degree of Dr. med. at the Ludwig-Maximilians-Universitat Munchen (A.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agochiya M, 1999, ONCOGENE, V18, P5646, DOI 10.1038/sj.onc.1202957; Craven RJ, 2003, SURG ONCOL, V12, P39, DOI 10.1016/S0960-7404(03)00004-5; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Fu WJ, 2010, J CANCER RES CLIN, V136, P1255, DOI 10.1007/s00432-010-0776-0; Hsu DW, 1997, J NEUROPATH EXP NEUR, V56, P857, DOI 10.1097/00005072-199708000-00003; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; McAnuff MA, 2007, J PHARM SCI-US, V96, P2922, DOI 10.1002/jps.20968; Quinones-Hinojosa A, 2005, J NEURO-ONCOL, V74, P19, DOI 10.1007/s11060-004-5758-0; Schnell O, 2008, BRAIN PATHOL, V18, P378, DOI 10.1111/j.1750-3639.2008.00137.x; Torp SH, 2002, PATHOL RES PRACT, V198, P261; Urvalek AM, 2011, AM J TRANSL RES, V3, P121; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; ZHAO JJ, 2006, SCI STKE, pPE52, DOI DOI 10.1126/STKE.3652006PE52	20	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30429	10.1371/journal.pone.0030429	http://dx.doi.org/10.1371/journal.pone.0030429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276196	gold, Green Published, Green Submitted			2022-12-25	WOS:000301457200059
J	Gao, W; Sun, WK; Qu, BQ; Cardona, CJ; Powell, K; Wegner, M; Shi, Y; Xing, Z				Gao, Wei; Sun, Wenkui; Qu, Bingqian; Cardona, Carol J.; Powell, Kira; Wegner, Marta; Shi, Yi; Xing, Zheng			Distinct Regulation of Host Responses by ERK and JNK MAP Kinases in Swine Macrophages Infected with Pandemic (H1N1) 2009 Influenza Virus	PLOS ONE			English	Article							A VIRUS; IMMUNE-RESPONSES; UNITED-STATES; RIG-I; ANTIVIRAL RESPONSES; APOPTOTIC RESPONSES; GENE-EXPRESSION; PIGS; RNA; CELLS	Swine influenza is an acute respiratory disease in pigs caused by swine influenza virus (SIV). Highly virulent SIV strains cause mortality of up to 10%. Importantly, pigs have long been considered "mixing vessels'' that generate novel influenza viruses with pandemic potential, a constant threat to public health. Since its emergence in 2009 and subsequent pandemic spread, the pandemic (H1N1) 2009 (H1N1pdm) has been detected in pig farms, creating the risk of generating new reassortants and their possible infection of humans. Pathogenesis in SIV or H1N1pdm-infected pigs remains poorly characterized. Proinflammatory and antiviral cytokine responses are considered correlated with the intensity of clinical signs, and swine macrophages are found to be indispensible in effective clearance of SIV from pig lungs. In this study, we report a unique pattern of cytokine responses in swine macrophages infected with H1N1pdm. The roles of mitogen-activated protein (MAP) kinases in the regulation of the host responses were examined. We found that proinflammatory cytokines IL-6, IL-8, IL-10, and TNF-alpha were significantly induced and their induction was ERK1/2-dependent. IFN-beta and IFN-inducible antiviral Mx and 2959-OAS were sharply induced, but the inductions were effectively abolished when ERK1/2 was inhibited. Induction of CCL5 (RANTES) was completely inhibited by inhibitors of ERK1/2 and JNK1/2, which appeared also to regulate FasL and TNF-alpha, critical for apoptosis in pig macrophages. We found that NF kappa B was activated in H1N1pdm-infected cells, but the activation was suppressed when ERK1/2 was inhibited, indicating there is cross-talk between MAP kinase and NF kappa B responses in pig macrophages. Our data suggest that MAP kinase may activate NF kappa B through the induction of RIG-1, which leads to the induction of IFN-beta in swine macrophages. Understanding host responses and their underlying mechanisms may help identify venues for effective control of SIV and assist in prevention of future influenza pandemics.	[Gao, Wei; Qu, Bingqian; Xing, Zheng] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Gao, Wei; Qu, Bingqian; Xing, Zheng] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Gao, Wei; Shi, Yi] Nanjing Univ, Sch Clin Med, Dept Resp Med, Nanjing Gen Hosp Nanjing Mil Command, Nanjing, Jiangsu, Peoples R China; [Sun, Wenkui] Second Mil Med Univ, Dept Resp Med, Nanjing Gen Hosp Nanjing Mil Command, Nanjing, Jiangsu, Peoples R China; [Cardona, Carol J.; Powell, Kira; Wegner, Marta; Xing, Zheng] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN USA	Nanjing University; Nanjing University; Nanjing General Hospital; Nanjing University; Nanjing General Hospital; Naval Medical University; University of Minnesota System; University of Minnesota Twin Cities	Gao, W (corresponding author), Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China.	zxing@umn.edu	Xing, Zheng/O-3137-2015; Xing, Zheng/G-8366-2011; Qu, Bingqian/AAD-1728-2020	Xing, Zheng/0000-0002-7288-0268; Xing, Zheng/0000-0002-7288-0268; Qu, Bingqian/0000-0002-7330-2929	National Natural Science Foundation of China [30971450/C0703]; State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University [KF-GW-200902]; Department of Homeland Security National Center for Foreign Animal and Zoonotic Disease Defense [3-V419C33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University; Department of Homeland Security National Center for Foreign Animal and Zoonotic Disease Defense(United States Department of Homeland Security (DHS))	This study was supported by grants from the National Natural Science Foundation of China (grant 30971450/C0703) and the State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University (grant KF-GW-200902). CJC and ZX were also supported in part by a grant from the Department of Homeland Security National Center for Foreign Animal and Zoonotic Disease Defense (3-V419C33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SC, 2009, MOL IMMUNOL, V46, P1744, DOI 10.1016/j.molimm.2009.01.025; Barbe F, 2011, VET J, V187, P48, DOI 10.1016/j.tvjl.2009.12.012; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; Calore EE, 2011, PATHOL RES PRACT, V207, P86, DOI 10.1016/j.prp.2010.11.003; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Charley B, 2006, ANN NY ACAD SCI, V1081, P130, DOI 10.1196/annals.1373.014; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Howden KJ, 2009, CAN VET J, V50, P1153; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Li JL, 2008, ARCH VIROL, V153, P1899, DOI 10.1007/s00705-008-0217-4; Ludwig S, 2001, J BIOL CHEM, V276, P10990, DOI 10.1074/jbc.M009902200; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qi X, 2006, ARCH VIROL, V151, P2289, DOI 10.1007/s00705-006-0796-x; Qi X, 2009, VIRUS GENES, V39, P193, DOI 10.1007/s11262-009-0375-9; Richt JA, 2003, J CLIN MICROBIOL, V41, P3198, DOI 10.1128/JCM.41.7.3198-3205.2003; Song MS, 2010, J CLIN MICROBIOL, V48, P3204, DOI 10.1128/JCM.00053-10; Van Reeth K, 2003, VACCINE, V21, P1375, DOI 10.1016/S0264-410X(02)00688-6; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Vincent AL, 2009, VET MICROBIOL, V137, P51, DOI 10.1016/j.vetmic.2009.01.003; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; WEBSTER RG, 1993, INTERVIROLOGY, V35, P16, DOI 10.1159/000150292; Weingartl HM, 2010, J VIROL, V84, P2245, DOI 10.1128/JVI.02118-09; WHO, 2010, PAND H1N1 2009 UPD 8; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Xing Z, 2008, J GEN VIROL, V89, P1288, DOI 10.1099/vir.0.83362-0; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; Xing Z, 2010, J GEN VIROL, V91, P343, DOI 10.1099/vir.0.015578-0; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhang XX, 2000, MICROB PATHOGENESIS, V28, P267, DOI 10.1006/mpat.1999.0349	40	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30328	10.1371/journal.pone.0030328	http://dx.doi.org/10.1371/journal.pone.0030328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279582	Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900059
J	Izhak, L; Wildbaum, G; Jung, S; Stein, A; Shaked, Y; Karin, N				Izhak, Liat; Wildbaum, Gizi; Jung, Steffen; Stein, Avi; Shaked, Yuval; Karin, Nathan			Dissecting the Autocrine and Paracrine Roles of the CCR2-CCL2 Axis in Tumor Survival and Angiogenesis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL PROGENITOR CELLS; PROSTATE-CANCER; BONE-MARROW; DENDRITIC CELLS; BREAST-CANCER; CHEMOKINE RECEPTORS; LUCIFERASE GENE; MYELOID CELLS; MOUSE MODEL	The CCL2 CCR2 axis is likely to contributes to the development and progression of cancer diseases by two major mechanisms; autocrine effect of CCL2 as a survival/growth factor for CCR2+ cancer cells and, the attraction of CCR2+ CX(3)CR1+tumor associated macrophages that in the absence of CCR2 hardly migrate. Thus far no in vivo system has been set up to differentiate the selective contribution of each of these features to cancer development. Here we employed a chimera animal model in which all non-malignant cells are CCR2-/-, but all cancer cells are CCR2+, combined with an adoptive transfer system of bone marrow (BM) CX(3)CR1+ cells from CCR2+ mice harboring a targeted replacement of the CX(3)CR1gene by an enhanced green fluorescent protein (EGFP) reporter gene (cx(3)cr1(gfp)), together with the CD45.1 congene. Using this system we dissected the selective contribution of CX(3)CR1+ CCR2+ cells, which comprise only about 7% of CD11b+ BM cells, to tumor development and angiogenesis. Showing that aside for their direct pro-angiogenic effect they are essential for the recruitment of other CD11b+ cells to the tumor site. We further show that the administration of CCR2-Ig, that selectively and specifically neutralize CCL2, to mice in which CCR2 is expressed only on tumor cells, further suppressed tumor development, implicating for the key role of this chemokine supporting tumor survival in an autocrine manner. This further emphasizes the important role of CCL2 as a target for therapy of cancer diseases.	[Izhak, Liat; Wildbaum, Gizi; Karin, Nathan] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Immunol, Rappaport Inst Med Res, IL-31096 Haifa, Israel; [Shaked, Yuval] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Pharmacol, Rappaport Inst Med Res, IL-31096 Haifa, Israel; [Stein, Avi] Carmel Hosp, Dept Urol, Haifa, Israel; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Carmel Medical Center; Weizmann Institute of Science	Izhak, L (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Immunol, Rappaport Inst Med Res, POB 9649, IL-31096 Haifa, Israel.	nkarin@tx.technion.ac.il	Jung, Steffen/K-1409-2012	Jung, Steffen/0000-0003-4290-5716	Israel Cancer Research Fund (ICRF); Israel Cancer Association (ICA); Israel Ministry of Health Chief Scientist; Israel Science Foundation (ISF)	Israel Cancer Research Fund (ICRF); Israel Cancer Association (ICA); Israel Ministry of Health Chief Scientist; Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by the Israel Cancer Research Fund (ICRF), the Israel Cancer Association (ICA), the Israel Ministry of Health Chief Scientist and Israel Science Foundation (ISF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JY, 2002, NAT MED, V8, P891, DOI 10.1038/nm743; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bot I, 2005, BLOOD, V106, P1147, DOI 10.1182/blood-2004-12-4839; BOTTAZZI B, 1992, J IMMUNOL, V148, P1280; del Rio ML, 2008, J IMMUNOL, V181, P6178, DOI 10.4049/jimmunol.181.9.6178; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296; Green J, 2003, KIDNEY INT, V63, P487, DOI 10.1046/j.1523-1755.2003.00773.x; Hefler L, 1999, BRIT J CANCER, V81, P855, DOI 10.1038/sj.bjc.6690776; Hsieh CL, 2005, J MOL ENDOCRINOL, V35, P293, DOI 10.1677/jme.1.01722; Izhak L, 2009, J IMMUNOL, V183, P732, DOI 10.4049/jimmunol.0802746; Izhak L, 2010, J IMMUNOL, V184, P1092, DOI 10.4049/jimmunol.0902725; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kim SJ, 2009, AM J PATHOL, V174, P1972, DOI 10.2353/ajpath.2009.080819; Knowles Helen, 2004, Novartis Found Symp, V256, P189; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mazzucchelli L, 1996, AM J PATHOL, V149, P501; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Ozaki H, 1997, EXP EYE RES, V64, P505, DOI 10.1006/exer.1996.0239; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7; Rubio N, 1998, LAB INVEST, V78, P1315; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shojaei F, 2008, DRUG RESIST UPDAT; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	45	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e28305	10.1371/journal.pone.0028305	http://dx.doi.org/10.1371/journal.pone.0028305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279523	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900002
J	Lim, XF; Jia, Q; Khong, WX; Yan, B; Premanand, B; Alonso, S; Chow, VTK; Kwang, J				Lim, Xiao Fang; Jia, Qiang; Khong, Wei Xin; Yan, Benedict; Premanand, Balraj; Alonso, Sylvie; Chow, Vincent T. K.; Kwang, Jimmy			Characterization of an Isotype-Dependent Monoclonal Antibody against Linear Neutralizing Epitope Effective for Prophylaxis of Enterovirus 71 Infection	PLOS ONE			English	Article							MOUTH-DISEASE; ENCEPHALITIS-VIRUS; IMMUNE GLOBULIN; CAPSID PROTEIN; EPIDEMIC; MICE; FOOT; IMMUNOGLOBULIN; VP1; MENINGOENCEPHALITIS	Background: Enterovirus 71 (EV71) is the main causative agent of Hand, Foot and Mouth disease (HFMD) and is associated with severe neurologic complications and mortalities. At present, there is no vaccine or therapeutic available for treatment. Methodology/Principal Finding: In this study, we generated two mAbs, denoted as mAb 51 and 53, both targeting the same linear epitope on VP1 capsid protein, spanning amino acids 215-219. In comparison, mAb 51 belonging to isotype IgM possesses neutralizing activity in vitro, whereas, mAb 53 belonging to isotype IgG1 does not have any neutralizing ability, even towards its homologous strain. When mAb 51 at 10 mg/g of body weight was administered to the 2-week-old AG129 mice one day prior to lethal challenge, 100% in vivo passive protection was observed. In contrast, the isotype control group mice, injected with an irrelevant IgM antibody before the challenge, developed limb paralysis as early as day 6 post-infection. Histological examination demonstrated that mAb 51 was able to protect against pathologic changes such as neuropil vacuolation and neuronal loss in the spinal cord, which were typical in unprotected EV-71 infected mice. BLAST analyses of that epitope revealed that it was highly conserved among all EV71 strains, but not coxsachievirus 16 (CA16). Conclusion: We have defined a linear epitope within the VP1 protein and demonstrated its neutralizing ability to be isotype dependent. The neutralizing property and highly conserved sequence potentiated the application of mAb 51 and 53 for protection against EV71 infection and diagnosis respectively.	[Lim, Xiao Fang; Jia, Qiang; Premanand, Balraj; Kwang, Jimmy] Anim Hlth Biotechnol, Temasek Life Sci Lab, Singapore, Singapore; [Khong, Wei Xin; Alonso, Sylvie; Chow, Vincent T. K.; Kwang, Jimmy] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Khong, Wei Xin; Alonso, Sylvie] Natl Univ Singapore, Yong Loo Lin Sch Med, Immunol Programme, Singapore 117595, Singapore; [Khong, Wei Xin] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Yan, Benedict] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lim, XF (corresponding author), Anim Hlth Biotechnol, Temasek Life Sci Lab, Singapore, Singapore.	kwang@tll.org.sg		Chow, Vincent/0000-0003-2634-6213	Temasek Life Sciences Laboratory, Singapore; Temasek Life Sciences Laboratory; Laboratory Animals Centre (National University of Singapore)	Temasek Life Sciences Laboratory, Singapore(National University of Singapore); Temasek Life Sciences Laboratory(National University of Singapore); Laboratory Animals Centre (National University of Singapore)(National University of Singapore)	This project is funded by Temasek Life Sciences Laboratory (http://www.tll.org.sg/), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mr Anbu Kumar Karuppannan and Dr Tanja K. Kiener for their valuable suggestions and Mr Tao Meng for the generation of RG-EV71 viruses. We also thank Temasek Life Sciences Laboratory animal care officers and Laboratory Animals Centre (National University of Singapore) for all their help and support.	Aarthi D, 2004, BIOLOGICALS, V32, P153, DOI 10.1016/j.biologicals.2004.09.001; ABZUG MJ, 1995, CLIN INFECT DIS, V20, P1201, DOI 10.1093/clinids/20.5.1201; ARMSTRONG SJ, 1990, J GEN VIROL, V71, P2313, DOI 10.1099/0022-1317-71-10-2313; BAHNEMANN HG, 1975, ARCH VIROL, V47, P47, DOI 10.1007/BF01315592; Bendig J W, 1996, Commun Dis Rep CDR Rev, V6, pR81; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; BLOMBERG J, 1974, LANCET, V2, P112; Chang GH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-106; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; DIMMOCK NJ, 1984, J GEN VIROL, V65, P1015, DOI 10.1099/0022-1317-65-6-1015; DWYER JM, 1992, NEW ENGL J MED, V326, P107; FEINSTEIN A, 1971, ANN NY ACAD SCI, V190, P104, DOI 10.1111/j.1749-6632.1971.tb13526.x; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; GELLER TJ, 1995, J NEUROL SCI, V129, P131, DOI 10.1016/0022-510X(94)00261-L; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; KENNETT ML, 1974, B WORLD HEALTH ORGAN, V51, P609; KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606; Li C, 2007, CURR MED CHEM, V14, P847, DOI 10.2174/092986707780363032; Li XL, 2009, BIOCHEM BIOPH RES CO, V390, P1126, DOI 10.1016/j.bbrc.2009.09.103; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; MCKINNEY RE, 1987, REV INFECT DIS, V9, P334; Meng T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021757; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; Salinas-Carmona MC, 2004, INFECT IMMUN, V72, P5597, DOI 10.1128/IAI.72.10.5597-5604.2004; SAMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206, DOI 10.1097/00006454-198702000-00013; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SIGOUNAS G, 1994, J CLIN IMMUNOL, V14, P134, DOI 10.1007/BF01541346; Tan CS, 2007, ARCH VIROL, V152, P1069, DOI 10.1007/s00705-007-0941-1; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Wang Li-chun, 2010, Virologica Sinica, V25, P98, DOI 10.1007/s12250-010-3102-8; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; Xu FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011388; Yokoyama Wayne M, 2006, Curr Protoc Immunol, VChapter 2, DOI 10.1002/0471142735.im0205s74; YOKOYAMA WM, 2001, CURR PROTOC IMMUNOL, pCH2	42	43	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29751	10.1371/journal.pone.0029751	http://dx.doi.org/10.1371/journal.pone.0029751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279543	Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900021
J	Yang, PH; Duan, YQ; Zhang, PR; Li, ZW; Wang, C; Dong, M; Tang, C; Xing, L; Gu, HJ; Zhao, ZP; Liu, XF; Zhang, SG; Wang, XL				Yang, Penghui; Duan, Yueqiang; Zhang, Peirui; Li, Zhiwei; Wang, Cheng; Dong, Mei; Tang, Chong; Xing, Li; Gu, Hongjing; Zhao, Zhongpeng; Liu, Xiufan; Zhang, Shaogeng; Wang, Xiliang			Multiple-Clade H5N1 Influenza Split Vaccine Elicits Broad Cross Protection against Lethal Influenza Virus Challenge in Mice by Intranasal Vaccination	PLOS ONE			English	Article							PANDEMIC INFLUENZA; IMMUNE-RESPONSES; CHINA; HEMAGGLUTININ; EVOLUTION; NUCLEOPROTEIN; INFECTION; ADJUVANT; IMPACT; SAFETY	Background: The increase in recent outbreaks and unpredictable changes of highly pathogenic avian influenza (HPAI) H5N1 in birds and humans highlights the urgent need to develop a cross-protective H5N1 vaccine. We here report our development of a multiple-clade H5N1 influenza vaccine tested for immunogenicity and efficacy to confer cross-protection in an animal model. Methodology/Principal Findings: Mice received two doses of influenza split vaccine with oil-in-water emulsion adjuvant SP01 by intranasal administration separated by two weeks. Single vaccines (3 mu g HA per dose) included rg-A/Vietnam/1203/2004(Clade 1), rg-A/Indonesia/05/2005(Clade 2.1), and rg-A/Anhui/1/2005(Clade 2.3.4). The trivalent vaccine contained 1 mu g HA per dose of each single vaccine. Importantly, complete cross-protection was observed in mice immunized using trivalent vaccine with oil-in-water emulsion adjuvant SP01 that was subsequently challenged with the lethal A/OT/SZ/097/03 influenza strain (Clade 0), whereas only the survival rate was up to 60% in single A/Anhui/1/2005 vaccine group. Conclusion/Significance: Our findings demonstrated that the multiple-clade H5N1 influenza vaccine was able to elicit a cross-protective immune response to heterologous HPAI H5N1 virus, thus giving rise to a broadly cross-reactive vaccine to potential prevention use ahead of the strain-specific pandemic influenza vaccine in the event of an HPAI H5N1 influenza outbreak. Also, the multiple-clade adjuvanted vaccine could be useful in allowing timely initiation of vaccination against unknown pandemic virus.	[Yang, Penghui; Duan, Yueqiang; Dong, Mei; Tang, Chong; Xing, Li; Gu, Hongjing; Zhao, Zhongpeng; Wang, Xiliang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhang, Peirui; Li, Zhiwei; Zhang, Shaogeng] 302 Mil Hosp, Dept Hepatobiliary, Beijing, Peoples R China; [Wang, Cheng] Soochow Univ, Coll Med, Suzhou, Peoples R China; [Liu, Xiufan] Yangzhou Univ, Minist Agr, Key Lab Anim Infect Dis, Yangzhou, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Fifth Medical Center of Chinese PLA General Hospital; Soochow University - China; Ministry of Agriculture & Rural Affairs; Yangzhou University	Yang, PH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	zhangsg302@hotmail.com; xiliangw@126.com		zhongpeng, zhao/0000-0002-9147-6252	National Natural Scientific Foundation [30800977, 30972614]; Beijing Natural Science Foundation [7112105]; National Basic Research Program (973) [2009CB522102]; National Key Technologies RD Program [2006AA02Z450, 2006AA02A204]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program (973)(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program)	The study was supported by the National Natural Scientific Foundation (30800977 and 30972614), Beijing Natural Science Foundation (7112105), National Basic Research Program (973) (2009CB522102), and National Key Technologies R&D Program (2006AA02Z450 and 2006AA02A204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Black S, 2010, VACCINE, V28, P7331, DOI 10.1016/j.vaccine.2010.08.075; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Ducatez MF, 2011, P NATL ACAD SCI USA, V108, P349, DOI 10.1073/pnas.1012457108; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Fan SF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000409; Forrest HL, 2009, VACCINE, V27, P4187, DOI 10.1016/j.vaccine.2009.04.050; Haynes JR, 2009, VACCINE, V27, P530, DOI 10.1016/j.vaccine.2008.11.011; Huang YH, 2009, J CHIN MED ASSOC, V72, P281, DOI 10.1016/S1726-4901(09)70372-7; Huber VC, 2009, VACCINE, V27, P1192, DOI 10.1016/j.vaccine.2008.12.023; Kayamuro H, 2010, J VIROL, V84, P12703, DOI 10.1128/JVI.01182-10; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; PILLET S, 2011, VACCINE; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Qiu J, 2009, NATURE, V460, P1066, DOI 10.1038/4601066a; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; Stone R, 2009, SCIENCE, V325, P1482, DOI 10.1126/science.325_1482; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; TANG C, 2011, CHINESE SCI IN PRESS; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, ANT GEN CHAR ZOON IN; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yamada T, 2008, NATURE, V454, P162, DOI 10.1038/454162a; YANG P, 2008, VET MICROBIOL, V146, P17; Yang PH, 2011, VACCINE, V29, P698, DOI 10.1016/j.vaccine.2010.11.026; Yang PH, 2010, BIOCHEM BIOPH RES CO, V396, P973, DOI 10.1016/j.bbrc.2010.05.035; Yang PH, 2010, CELL MOL IMMUNOL, V7, P116, DOI 10.1038/cmi.2009.116; Zhao ZP, 2009, VACCINE, V27, P5214, DOI 10.1016/j.vaccine.2009.06.075	33	14	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30252	10.1371/journal.pone.0030252	http://dx.doi.org/10.1371/journal.pone.0030252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279575	Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900052
J	Bernacer, J; Prensa, L; Gimenez-Amaya, JM				Bernacer, Javier; Prensa, Lucia; Manuel Gimenez-Amaya, Jose			Distribution of GABAergic Interneurons and Dopaminergic Cells in the Functional Territories of the Human Striatum	PLOS ONE			English	Article							HUMAN BASAL GANGLIA; HUNTINGTONS-DISEASE; CHOLINERGIC INTERNEURONS; MORPHOLOGICAL FEATURES; NIGROSTRIATAL PATHWAY; RECEPTOR SUBUNITS; PRIMATE STRIATUM; GABA(A) RECEPTOR; CAUDATE-NUCLEUS; CORTICAL INPUTS	Background: The afferent projections of the striatum (caudate nucleus and putamen) are segregated in three territories: associative, sensorimotor and limbic. Striatal interneurons are in part responsible for the integration of these different types of information. Among them, GABAergic interneurons are the most abundant, and can be sorted in three populations according to their content in the calcium binding proteins calretinin (CR), parvalbumin (PV) and calbindin (CB). Conversely, striatal dopaminergic cells (whose role as interneurons is still unclear) are scarce. This study aims to analyze the interneuron distribution in the striatal functional territories, as well as their organization regarding to the striosomal compartment. Methodology/Principal Findings: We used immunohistochemical methods to visualize CR, PV, CB and tyrosine hydroxylase (TH) positive striatal neurons. The interneuronal distribution was assessed by stereological methods applied to every striatal functional territory. Considering the four cell groups altogether, their density was higher in the associative (2120 +/- 91 cells/mm(3)) than in the sensorimotor (959 +/- 47 cells/mm(3)) or limbic (633 +/- 119 cells/mm(3)) territories. CB- and TH-immunoreactive (-ir) cells were distributed rather homogeneously in the three striatal territories. However, the density of CR and PV interneurons were more abundant in the associative and sensorimotor striatum, respectively. Regarding to their compartmental organization, CR-ir interneurons were frequently found in the border between compartments in the associative and sensorimotor territories, and CB-ir interneurons abounded at the striosome/matrix border in the sensorimotor domain. Conclusions/Significance: The present study demonstrates that the architecture of the human striatum in terms of its interneuron composition varies in its three functional territories. Furthermore, our data highlight the importance of CR-ir striatal interneurons in the integration of associative information, and the selective role of PV-ir interneurons in the motor territory. On the other hand, the low density of dopaminergic cells casts doubts about their role in the normal human striatum.	[Bernacer, Javier] Univ Navarra Clin, Lab Neuromorfol Func, Pamplona, Spain; [Prensa, Lucia; Manuel Gimenez-Amaya, Jose] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain	University of Navarra; Autonomous University of Madrid	Bernacer, J (corresponding author), Univ Navarra, Inst Cultura & Soc, E-31080 Pamplona, Spain.	javier.bernacer@gmail.com	Bernacer, Javier/P-5810-2014	Bernacer, Javier/0000-0002-4341-9763; Prensa Sepulveda, Lucia/0000-0003-2217-3271	Ministry of Education and Science [BFI2003-02909]; Fundacion Eugenio Rodriguez Pascual; FPI-CAM; Caja Madrid Foundation	Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fundacion Eugenio Rodriguez Pascual; FPI-CAM; Caja Madrid Foundation	This work was supported by the following grant sponsors: Ministry of Education and Science (BFI2003-02909); Fundacion Eugenio Rodriguez Pascual (to L.P.); FPI-CAM and Caja Madrid Foundation Postdoctoral Fellowship (to J.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alelu-Paz R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003378; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; Avendano C, 2005, HISTOCHEM CELL BIOL, P1; Bedard A, 2006, EXP BRAIN RES, V170, P501, DOI 10.1007/s00221-005-0233-5; BENNETT BD, 1993, BRAIN RES, V610, P305, DOI 10.1016/0006-8993(93)91414-N; Bernacer J, 2008, J NEURAL TRANSM, V115, P67, DOI 10.1007/s00702-007-0803-8; Bernacer J, 2005, J COMP NEUROL, V489, P311, DOI 10.1002/cne.20616; Bernacer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001174; Betarbet R, 1997, J NEUROSCI, V17, P6761; BJUGN R, 1993, J COMP NEUROL, V328, P406, DOI 10.1002/cne.903280307; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; Cicchetti F, 1998, SYNAPSE, V30, P284, DOI 10.1002/(SICI)1098-2396(199811)30:3<284::AID-SYN6>3.3.CO;2-D; Cossette M, 2005, PARKINSONISM RELAT D, V11, P277, DOI 10.1016/j.parkreldis.2005.02.008; Darmopil S, 2008, EUR J NEUROSCI, V27, P580, DOI 10.1111/j.1460-9568.2008.06040.x; DAWBARN D, 1985, BRAIN RES, V340, P251, DOI 10.1016/0006-8993(85)90921-7; EBLEN F, 1995, J NEUROSCI, V15, P5999; FERRANTE RJ, 1987, J NEUROPATH EXP NEUR, V46, P12, DOI 10.1097/00005072-198701000-00002; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Flores-Barrera E, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00015direct, 10.3389/fnsys.2010.00015]; Fudge JL, 2002, NEUROSCIENCE, V110, P257, DOI 10.1016/S0306-4522(01)00546-2; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; GRAVELAND GA, 1985, J COMP NEUROL, V234, P317, DOI 10.1002/cne.902340304; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; GRAYBIEL AM, 1984, NEUROSCIENCE, V13, P1157, DOI 10.1016/0306-4522(84)90293-8; GRAYBIEL AM, 1984, P NATL ACAD SCI-BIOL, V81, P7980, DOI 10.1073/pnas.81.24.7980; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Holt DJ, 1997, J COMP NEUROL, V384, P1, DOI 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Huot P, 2008, J CHEM NEUROANAT, V35, P77, DOI 10.1016/j.jchemneu.2007.06.004; Huot P, 2007, J NEUROCHEM, V101, P1441, DOI 10.1111/j.1471-4159.2006.04430.x; Ibanez-Sandoval O, 2010, J NEUROSCI, V30, P6999, DOI 10.1523/JNEUROSCI.5996-09.2010; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; Kawaguchi Y, 1997, NEUROSCI RES, V27, P1, DOI 10.1016/S0168-0102(96)01134-0; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; KIYAMA H, 1990, BRAIN RES, V525, P209, DOI 10.1016/0006-8993(90)90866-A; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Lopez de Maturana R, 2010, CNS NEUROL DISORD DR; Mai J.K., 1997, ATLAS HUMAN BRAIN; Martin R, 2000, J HISTOCHEM CYTOCHEM, V48, P1121, DOI 10.1177/002215540004800809; MARTONE ME, 1994, J CHEM NEUROANAT, V8, P47, DOI 10.1016/0891-0618(94)90035-3; Mayhew TM, 1996, J ANAT, V188, P1; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Pandey M, 2010, J BIOENERG BIOMEMBR, V42, P217, DOI 10.1007/s10863-010-9288-5; PARENT A, 1990, TRENDS NEUROSCI, V13, P254, DOI 10.1016/0166-2236(90)90105-J; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Prensa L, 1999, J COMP NEUROL, V413, P603; Prensa L, 1998, J COMP NEUROL, V390, P552; Prensa L, 2009, J NEURAL TRANSM-SUPP, P49, DOI 10.1007/978-3-211-92660-4_4; Qi Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-26; Raghavan R., 1997, ELECT CLIN BRAIN ATL; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Roberts RC, 1996, J COMP NEUROL, V374, P523; Saka E, 2003, BRAIN DEV-JPN, V25, pS15, DOI 10.1016/S0387-7604(03)90002-7; Saka E, 2002, P NATL ACAD SCI USA, V99, P9004, DOI 10.1073/pnas.132212499; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; SELDEN N, 1994, NEUROSCIENCE, V60, P621, DOI 10.1016/0306-4522(94)90491-X; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Unal B, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00041; Waldvogel HJ, 1999, J COMP NEUROL, V415, P313, DOI 10.1002/(SICI)1096-9861(19991220)415:3<313::AID-CNE2>3.0.CO;2-7; Waldvogel HJ, 2004, J COMP NEUROL, V470, P339, DOI 10.1002/cne.20005; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505; Wu Y, 2000, BRAIN RES, V863, P182, DOI 10.1016/S0006-8993(00)02135-1	71	47	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30504	10.1371/journal.pone.0030504	http://dx.doi.org/10.1371/journal.pone.0030504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272358	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400136
J	Chakraborty, R; Pydi, SP; Gleim, S; Dakshinamurti, S; Hwa, J; Chelikani, P				Chakraborty, Raja; Pydi, Sai Prasad; Gleim, Scott; Dakshinamurti, Shyamala; Hwa, John; Chelikani, Prashen			Site-Directed Mutations and the Polymorphic Variant Ala160Thr in the Human Thromboxane Receptor Uncover a Structural Role for Transmembrane Helix 4	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; 2ND EXTRACELLULAR LOOP; A(2) RECEPTOR; LIGAND-BINDING; BETA(2)-ADRENERGIC RECEPTOR; GENE; RHODOPSIN; A2; DISEASE; ASTHMA	The human thromboxane A2 receptor (TP), belongs to the prostanoid subfamily of Class A GPCRs and mediates vasoconstriction and promotes thrombosis on binding to thromboxane (TXA2). In Class A GPCRs, transmembrane (TM) helix 4 appears to be a hot spot for non-synonymous single nucleotide polymorphic (nsSNP) variants. Interestingly, A160T is a novel nsSNP variant with unknown structure and function. Additionally, within this helix in TP, Ala160(4.53) is highly conserved as is Gly164(4.57). Here we target Ala160(4.53) and Gly164(4.57) in the TP for detailed structure-function analysis. Amino acid replacements with smaller residues, A160S and G164A mutants, were tolerated, while bulkier beta-branched replacements, A160T and A160V showed a significant decrease in receptor expression (Bmax). The nsSNP variant A160T displayed significant agonist-independent activity (constitutive activity). Guided by molecular modeling, a series of compensatory mutations were made on TM3, in order to accommodate the bulkier replacements on TM4. The A160V/F115A double mutant showed a moderate increase in expression level compared to either A160V or F115A single mutants. Thermal activity assays showed decrease in receptor stability in the order, wild type>A160S>A160V>A160T>G164A, with G164A being the least stable. Our study reveals that Ala160(4.53) and Gly164(4.57) in the TP play critical structural roles in packing of TM3 and TM4 helices. Naturally occurring mutations in conjunction with site-directed replacements can serve as powerful tools in assessing the importance of regional helix-helix interactions.	[Chakraborty, Raja; Pydi, Sai Prasad; Chelikani, Prashen] Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada; [Gleim, Scott; Hwa, John] Yale Univ, Sch Med, Dept Internal Med, Cardiol Sect, New Haven, CT 06510 USA; [Dakshinamurti, Shyamala] Univ Manitoba, Dept Pediat, Winnipeg, MB R3T 2N2, Canada; [Dakshinamurti, Shyamala] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Dakshinamurti, Shyamala; Chelikani, Prashen] Manitoba Inst Child Hlth, Winnipeg, MB, Canada	University of Manitoba; Yale University; University of Manitoba; University of Manitoba	Chakraborty, R (corresponding author), Univ Manitoba, Dept Oral Biol, Winnipeg, MB, Canada.	chelikan@cc.umanitoba.ca	Chakraborty, Raja/L-6316-2017; Pydi, sai Prasad/M-9017-2016	Pydi, sai Prasad/0000-0001-7170-6519; Chelikani, Prashen/0000-0003-1129-7957	Manitoba Health Research Council (MHRC); Heart and Stroke Foundation of Canada; American Heart Association; National Institute of Health (NIH); University of Manitoba; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074190, R01HL115247] Funding Source: NIH RePORTER	Manitoba Health Research Council (MHRC); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); American Heart Association(American Heart Association); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Manitoba; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Manitoba Health Research Council (MHRC) and a New Investigator Award from Heart and Stroke Foundation of Canada to Dr. Chelikani. Dr. Hwa holds an American Heart Association Established Investigator Award and an RO1 from National Institute of Health (NIH). Dr. Dakshinamurti holds an MMSF/MHRC Dr. F. W. DuVal Clinical Research Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Thi Li for technical assistance. The use of research facilities at the Manitoba Institute of Child Health (MICH), and a University of Manitoba Graduate Fellowship to Sai Prasad Pydi is acknowledged.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Arakawa M, 2011, BBA-BIOMEMBRANES, V1808, P1170, DOI 10.1016/j.bbamem.2011.01.012; Arakawa M, 2010, PROTEIN SCI, V19, P85, DOI 10.1002/pro.285; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bowers JK, 2006, P ACM IEEE C SUP SC0, pSC06; Chelikani P, 2007, P NATL ACAD SCI USA, V104, P7027, DOI 10.1073/pnas.0702024104; Eastman P, 2010, J CHEM THEORY COMPUT, V6, P434, DOI 10.1021/ct900463w; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fontana P, 2006, THROMB HAEMOSTASIS, V96, P356, DOI 10.1160/TH06-05-0288; FUNK CD, 1993, MOL PHARMACOL, V44, P934; Geng L, 2004, ARCH BIOCHEM BIOPHYS, V423, P253, DOI 10.1016/j.abb.2004.01.001; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; HIRATA T, 1994, J CLIN INVEST, V94, P1662, DOI 10.1172/JCI117510; Hong SJ, 2005, J ALLERGY CLIN IMMUN, V115, P758, DOI 10.1016/j.jaci.2004.10.047; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Kazius J, 2008, HUM MUTAT, V29, P39, DOI 10.1002/humu.20638; Khasawneh FT, 2006, J BIOL CHEM, V281, P26951, DOI 10.1074/jbc.M507469200; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; Kinsella BT, 2001, BIOCHEM SOC T, V29, P641, DOI 10.1042/BST0290641; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leung TF, 2002, PEDIAT ALLERG IMM-UK, V13, P10, DOI 10.1034/j.1399-3038.2002.01033.x; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mumford AD, 2010, BLOOD, V115, P363, DOI 10.1182/blood-2009-08-236976; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Palikhe NS, 2011, CLIN EXP ALLERGY, V41, P179, DOI 10.1111/j.1365-2222.2010.03642.x; Piscione F, 2008, J AM COLL CARDIOL, V52, P1381, DOI 10.1016/j.jacc.2008.07.034; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; So SP, 2003, J BIOL CHEM, V278, P10922, DOI 10.1074/jbc.M209337200; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Stojanovic A, 2003, J BIOL CHEM, V278, P39020, DOI 10.1074/jbc.M303625200; Tanaka K, 2002, BIOCHEM BIOPH RES CO, V292, P776, DOI 10.1006/bbrc.2002.6713; Toledo D, 2011, J BIOL CHEM, V286, P39993, DOI 10.1074/jbc.M110.201517; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unoki M, 2000, HUM GENET, V106, P440, DOI 10.1007/s004390000267; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22	47	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29996	10.1371/journal.pone.0029996	http://dx.doi.org/10.1371/journal.pone.0029996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272267	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400046
J	Cui, YX; Johnson, T; Baumbach, A; Reeves, BC; Rogers, CA; Angelini, GD; Marsden, D; Madeddu, P				Cui, Yu-Xin; Johnson, Tom; Baumbach, Andreas; Reeves, Barnaby C.; Rogers, Chris A.; Angelini, Gianni D.; Marsden, Debbie; Madeddu, Paolo			Stepwise Optimization of the Procedure for Assessment of Circulating Progenitor Cells in Patients with Myocardial Infarction	PLOS ONE			English	Article							PERIPHERAL-BLOOD; FLOW-CYTOMETRY; CD34(+); NEOVASCULARIZATION; COMPLICATIONS; VISUALIZATION; COMPENSATION; MOBILIZATION; LYSE	Background: The number and functional activity of circulating progenitor cells (CPCs) is altered in diabetic patients. Furthermore, reduced CPC count has been shown to independently predict cardiovascular events. Validation of CPCs as a biomarker for cardiovascular risk stratification requires rigorous methodology. Before a standard operation protocol (SOP) can be designed for such a trial, a variety of technical issues have to be addressed fundamentally, which include the appropriate type of red blood cell lysis buffer, FMO or isotype controls to identify rare cell populations from background noise, optimal antibody dilutions and conditions of sample storage. We herein propose improvements in critical steps of CPC isolation, antigenic characterization and determination of functional competence for final application in a prospective investigation of CPCs as a biomarker of outcome following acute myocardial infarction. Methods and Findings: In this validation study, we refined the standard operating procedure (SOP) for flow cytometry characterisation and functional analysis of CPCs from the first 18 patients of the Progenitor Cell Response after Myocardial Infarction Study (ProMIS). ProMIS aims to verify the prognostic value of CPCs in patients with either ST elevation or non-ST elevation myocardial infarction with or without diabetes mellitus, using cardiac magnetic resonance imaging (MRI) for assessment of ventricular function as a primary endpoint. Results indicate crucial steps for SOP implementation, namely timely cell isolation after sampling, use of appropriate lysis buffer to separate blood cell types and minimize the acquisition events during flow cytometry, adoption of proper fluorophore combination and antibody titration for multiple antigenic detection and introduction of counting beads for precise quantification of functional CPC activity in migration assay. Conclusion and Significance: With systematic specification of factors influencing the enumeration of CPC by flow cytometry, the abundance and migration capacity of CPCs can be correctly assessed. Adoption of validated SOP is essential for refined comparison of patients with different comorbidities in the analysis of risk stratification.	[Cui, Yu-Xin; Johnson, Tom; Baumbach, Andreas; Reeves, Barnaby C.; Rogers, Chris A.; Angelini, Gianni D.; Marsden, Debbie; Madeddu, Paolo] Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Bristol, Avon, England	Bristol Royal Infirmary; University of Bristol	Cui, YX (corresponding author), Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Bristol, Avon, England.	yx.cui@bristol.ac.uk; madeddu@yahoo.com		angelini, gianni/0000-0002-1753-3730; Baumbach, Andreas/0000-0001-7707-2254; Johnson, Thomas/0000-0003-4638-601X	National Institute for Health Research biomedical research unit in cardiovascular medicine, Bristol, UK [2008/SS/BRU]	National Institute for Health Research biomedical research unit in cardiovascular medicine, Bristol, UK	This work was funded by the National Institute for Health Research biomedical research unit in cardiovascular medicine, Bristol, UK (Funding reference: 2008/SS/BRU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JE, 1994, NEW ENGL J MED, V330, P670, DOI 10.1056/NEJM199403103301003; Alvarez-Larran A, 2002, CYTOMETRY, V50, P249, DOI 10.1002/cyto.10129; Barnett D, 1998, BRIT J HAEMATOL, V102, P553; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen MC, 2009, DIABETIC MED, V26, P134, DOI 10.1111/j.1464-5491.2008.02649.x; Dubois C, 2010, J AM COLL CARDIOL, V55, P2232, DOI 10.1016/j.jacc.2009.10.081; Egan CG, 2008, DIABETOLOGIA, V51, P1296, DOI 10.1007/s00125-008-0939-6; Fadini GP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011488; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Freeman PM, 2009, HEART, V95, P1301, DOI 10.1136/hrt.2008.163915; Gratama JW, 2000, J IMMUNOL METHODS, V239, P13, DOI 10.1016/S0022-1759(00)00154-X; Grundmann F, 2007, CLIN RES CARDIOL, V96, P621, DOI 10.1007/s00392-007-0543-7; Hristov M, 2009, CYTOM PART A, V75A, P848, DOI 10.1002/cyto.a.20772; Jung C, 2009, INT J CARDIOL; Le Bousse-Kerdiles MC., 2004, STANDARDISED PROTOCO; Masouleh BK, 2010, J IMMUNOL METHODS; Menendez P, 1998, CYTOMETRY, V34, P264, DOI 10.1002/(SICI)1097-0320(19981215)34:6<264::AID-CYTO4>3.0.CO;2-P; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Tung JW, 2004, CLIN IMMUNOL, V110, P277, DOI 10.1016/j.clim.2003.11.016; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21	22	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30389	10.1371/journal.pone.0030389	http://dx.doi.org/10.1371/journal.pone.0030389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272341	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400119
J	Diribarne, M; Mata, X; Riviere, J; Bouet, S; Vaiman, A; Chapuis, J; Reine, F; Fleurot, R; Auvinet, G; Deretz, S; Allain, D; Schibler, L; Cribiu, EP; Guerin, G				Diribarne, Mathieu; Mata, Xavier; Riviere, Julie; Bouet, Stephan; Vaiman, Anne; Chapuis, Jerome; Reine, Fabienne; Fleurot, Renaud; Auvinet, Gerard; Deretz, Severine; Allain, Daniel; Schibler, Laurent; Cribiu, Edmond-Paul; Guerin, Gerard			LIPH Expression in Skin and Hair Follicles of Normal Coat and Rex Rabbits	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE HYPOTRICHOSIS; MESSENGER-RNA DECAY; PHOSPHATIDIC-ACID; EPITHELIAL-CELLS; WOOLLY HAIR; P2RY5 GENE; MUTATIONS; DEFICIENCY; PROTEIN; DEFECT	Natural mutations in the LIPH gene were shown to be responsible for hair growth defects in humans and for the rex short hair phenotype in rabbits. In this species, we identified a single nucleotide deletion in LIPH (1362delA) introducing a stop codon in the C-terminal region of the protein. We investigated the expression of LIPH between normal coat and rex rabbits during critical fetal stages of hair follicle genesis, in adults and during hair follicle cycles. Transcripts were three times less expressed in both fetal and adult stages of the rex rabbits than in normal rabbits. In addition, the hair growth cycle phases affected the regulation of the transcription level in the normal and mutant phenotypes differently. LIPH mRNA and protein levels were higher in the outer root sheath (ORS) than in the inner root sheath (IRS), with a very weak signal in the IRS of rex rabbits. In vitro transfection shows that the mutant protein has a reduced lipase activity compared to the wild type form. Our results contribute to the characterization of the LIPH mode of action and confirm the crucial role of LIPH in hair production.	[Diribarne, Mathieu; Mata, Xavier; Riviere, Julie; Bouet, Stephan; Vaiman, Anne; Schibler, Laurent; Cribiu, Edmond-Paul; Guerin, Gerard] INRA, Unite Genet Anim & Biol Integrat, UMR1313, Jouy En Josas, France; [Chapuis, Jerome; Reine, Fabienne] INRA, UR0892, Jouy En Josas, France; [Fleurot, Renaud] INRA, Plateforme Microscopie & Imagerie Microorganismes, Jouy En Josas, France; [Auvinet, Gerard; Deretz, Severine] INRA, UR967, Surgeres, France; [Allain, Daniel] INRA, Stn Ameliorat Genet Anim, UR631, F-31326 Castanet Tolosan, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Diribarne, M (corresponding author), INRA, Unite Genet Anim & Biol Integrat, UMR1313, Jouy En Josas, France.	gerard.guerin@jouy.inra.fr	SCHIBLER, laurent/AAQ-2630-2021; Allain, Daniel/AAT-6658-2020	Fleurot, Renaud/0000-0003-2015-0738; SCHIBLER, Laurent/0000-0003-3137-0859	Poitou-Charentes region; Animal Genetics Department; Animal Genetics and Integrative Biology unit of INRA	Poitou-Charentes region(Region Nouvelle-Aquitaine); Animal Genetics Department; Animal Genetics and Integrative Biology unit of INRA	This work was supported by a grant from the Poitou-Charentes region, the Animal Genetics Department and by the Animal Genetics and Integrative Biology unit of INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali G, 2007, HUM GENET, V121, P319, DOI 10.1007/s00439-007-0344-0; Castle WE, 1933, P NATL ACAD SCI USA, V19, P1006, DOI 10.1073/pnas.19.12.1006; Diribarne M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019281; Hiramatsu T, 2003, J BIOL CHEM, V278, P49438, DOI 10.1074/jbc.M213018200; Horev L, 2009, J AM ACAD DERMATOL, V61, P813, DOI 10.1016/j.jaad.2009.04.020; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; Jelani M, 2008, CLIN GENET, V74, P184, DOI 10.1111/j.1399-0004.2008.01011.x; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nahum S, 2009, ARCH DERMATOL RES, V301, P391, DOI 10.1007/s00403-008-0903-9; Naz G, 2009, J DERMATOL SCI, V54, P12, DOI 10.1016/j.jdermsci.2008.12.001; Pasternack SM, 2009, ARCH DERMATOL RES, V301, P621, DOI 10.1007/s00403-009-0971-5; Petukhova L, 2009, HUM HERED, V68, P117, DOI 10.1159/000212504; Rougeot J, 1989, LAPIN ANGORA; Sanchez-Martinez R, 2008, MOL CELL BIOL, V28, P3817, DOI 10.1128/MCB.01909-07; Shimomura Y, 2009, EXP DERMATOL, V18, P218, DOI 10.1111/j.1600-0625.2008.00788.x; Shinkuma S, 2010, HUM MUTAT, V31, P602, DOI 10.1002/humu.21235; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Takahashi T, 2003, J INVEST DERMATOL, V121, P448, DOI 10.1046/j.1523-1747.2003.12426.x; Teichert A, 2010, J CELL PHYSIOL, V225, P482, DOI 10.1002/jcp.22227; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Wen XY, 1998, HUM MOL GENET, V7, P743, DOI 10.1093/hmg/7.4.743; Xie ZJ, 2006, ENDOCRINOLOGY, V147, P314, DOI 10.1210/en.2005-1111; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004	25	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30073	10.1371/journal.pone.0030073	http://dx.doi.org/10.1371/journal.pone.0030073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272275	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400054
J	Facella, P; Daddiego, L; Giuliano, G; Perrotta, G				Facella, Paolo; Daddiego, Loretta; Giuliano, Giovanni; Perrotta, Gaetano			Gibberellin and Auxin Influence the Diurnal Transcription Pattern of Photoreceptor Genes via CRY1a in Tomato	PLOS ONE			English	Article							PHYTOCHROME B; CROSS-TALK; CRYPTOCHROME 1; ARABIDOPSIS CRYPTOCHROMES; PHOTOSENSORY PERCEPTION; SIGNALING PATHWAYS; AUX/IAA PROTEINS; HYPOCOTYL GROWTH; ABSCISIC-ACID; DE-ETIOLATION	Background: Plant photoreceptors, phytochromes and cryptochromes, regulate many aspects of development and growth, such as seed germination, stem elongation, seedling de-etiolation, cotyledon opening, flower induction and circadian rhythms. There are several pieces of evidence of interaction between photoreceptors and phyto-hormones in all of these physiological processes, but little is known about molecular and genetic mechanisms underlying hormone-photoreceptor crosstalk. Methodology/Principal Findings: In this work, we investigated the molecular effects of exogenous phyto-hormones to photoreceptor gene transcripts of tomato wt, as well as transgenic and mutant lines with altered cryptochromes, by monitoring day/night transcript oscillations. GA and auxin alter the diurnal expression level of different photoreceptor genes in tomato, especially in mutants that lack a working form of cryptochrome 1a: in those mutants the expression of some (IAA) or most (GA) photoreceptor genes is down regulated by these hormones. Conclusions/Significance: Our results highlight the presence of molecular relationships among cryptochrome 1a protein, hormones, and photoreceptors' gene expression in tomato, suggesting that manipulation of cryptochromes could represent a good strategy to understand in greater depth the role of phyto-hormones in the plant photoperceptive mechanism.	[Facella, Paolo; Daddiego, Loretta; Perrotta, Gaetano] Trisaia Res Ctr, Italian Natl Agcy New Technol Energy & Sustainabl, Rotondella, Italy; [Giuliano, Giovanni] Casaccia Res Ctr, Italian Natl Agcy New Technologues Energy & Susta, Rome, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Italian National Agency New Technical Energy & Sustainable Economics Development	Facella, P (corresponding author), Trisaia Res Ctr, Italian Natl Agcy New Technol Energy & Sustainabl, Rotondella, Italy.	gaetano.perrotta@enea.it	Giuliano, Giovanni/A-2701-2012; Facella, Paolo/HHC-1895-2022	Giuliano, Giovanni/0000-0002-2486-0510; Facella, Paolo/0000-0001-9076-3754; Perrotta, Gaetano/0000-0003-2037-1063	Italian Ministry of Research	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	Work supported by the Italian Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2007, PLANT PHYSIOL, V143, P1163, DOI 10.1104/pp.106.092254; Ahmad M, 1997, PLANT J, V11, P421, DOI 10.1046/j.1365-313X.1997.11030421.x; AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Alabadi D, 2004, PLANT PHYSIOL, V134, P1050, DOI 10.1104/pp.103.035451; Alabadi D, 2009, PLANT MOL BIOL, V69, P409, DOI 10.1007/s11103-008-9400-y; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Bishop GJ, 2002, PLANT CELL, V14, pS97, DOI 10.1105/tpc.001461; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; BUCKHOUT TJ, 1989, PLANT PHYSIOL, V90, P151, DOI 10.1104/pp.90.1.151; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Cao DN, 2005, PLANTA, V223, P105, DOI 10.1007/s00425-005-0057-3; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Casal JJ, 1998, PLANT PHYSIOL, V118, P19, DOI 10.1104/pp.118.1.19; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; Colon-Carmona A, 2000, PLANT PHYSIOL, V124, P1728, DOI 10.1104/pp.124.4.1728; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Ephritikhine G, 1999, PLANT J, V18, P315, DOI 10.1046/j.1365-313X.1999.00455.x; Ephritikhine G, 1999, PLANT J, V18, P303, DOI 10.1046/j.1365-313X.1999.00454.x; Facella P, 2006, FEBS LETT, V580, P4618, DOI 10.1016/j.febslet.2006.07.044; Facella P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002798; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; Foo E, 2006, PLANT J, V46, P911, DOI 10.1111/j.1365-313X.2006.02754.x; FOSTER KR, 1995, PLANT PHYSIOL, V108, P337, DOI 10.1104/pp.108.1.337; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Gazzarrini S, 2003, ANN BOT-LONDON, V91, P605, DOI 10.1093/aob/mcg064; Giliberto L, 2005, PLANT PHYSIOL, V137, P199, DOI 10.1104/pp.104.051987; GIULIANO G, 1988, EMBO J, V7, P3635, DOI 10.1002/j.1460-2075.1988.tb03244.x; Goda H, 2004, PLANT PHYSIOL, V134, P1555, DOI 10.1104/pp.103.034736; Greenboim-Wainberg Y, 2005, PLANT CELL, V17, P92, DOI 10.1105/tpc.104.028472; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Hauser BA, 1995, PLANT MOL BIOL, V29, P1143, DOI 10.1007/BF00020458; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jasoni RL, 2002, PLANT GROWTH REGUL, V36, P127, DOI 10.1023/A:1015073400206; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; Kamiya Y, 1999, CURR OPIN PLANT BIOL, V2, P398, DOI 10.1016/S1369-5266(99)00012-6; Kendrick RE, 1994, PHOTOMORPHOGENESIS P; Kerckhoffs LHJ, 1999, MOL GEN GENET, V261, P901, DOI 10.1007/s004380051037; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; Lin C., 1996, PLANT PHYSIOL, V110, P1047; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Martin-Tryon EL, 2010, PLANT PHYSIOL, V153, P364, DOI 10.1104/pp.110.900322; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Nagashima A, 2008, PLANT CELL PHYSIOL, V49, P1250, DOI 10.1093/pcp/pcn092; Nakamura A, 2003, PLANT PHYSIOL, V133, P1843, DOI 10.1104/pp.103.030031; Neff MM, 2000, GENE DEV, V14, P257; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Ninu L, 1999, PLANT J, V18, P551, DOI 10.1046/j.1365-313X.1999.00466.x; Novakova M, 2005, J EXP BOT, V56, P2877, DOI 10.1093/jxb/eri282; Ogawa M, 2004, PLANT CELL, V16, P783; Paltiel J, 2006, PLANTA, V224, P1255, DOI 10.1007/s00425-006-0305-1; Penfield S, 2009, PLANT CELL, V21, P1722, DOI 10.1105/tpc.108.064022; Perrotta G, 2000, PLANT MOL BIOL, V42, P765, DOI 10.1023/A:1006371130043; Perrotta G, 2001, PLANT CELL ENVIRON, V24, P991, DOI 10.1046/j.0016-8025.2001.00736.x; PRATT LH, 1995, PLANTA, V197, P203, DOI 10.1007/BF00239958; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Rahman A, 2001, PLANT CELL PHYSIOL, V42, P301, DOI 10.1093/pcp/pce035; Reed JW, 1996, PLANT PHYSIOL, V112, P337, DOI 10.1104/pp.112.1.337; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Reid JB, 2002, PLANT PHYSIOL, V128, P734, DOI 10.1104/pp.010607; Sambrook J., MOL CLONING LAB MANU; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; Steber CM, 1998, GENETICS, V149, P509; Swarup R, 2002, PLANT MOL BIOL, V49, P411; Symons GM, 2003, PLANTA, V216, P422, DOI 10.1007/s00425-002-0860-z; Vandenbussche F, 2005, CURR OPIN PLANT BIOL, V8, P462, DOI 10.1016/j.pbi.2005.07.007; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; Vandenbussche F, 2007, PLANT J, V49, P428, DOI 10.1111/j.1365-313X.2006.02973.x; VANTUINEN A, 1995, PLANT PHYSIOL, V108, P939, DOI 10.1104/pp.108.3.939; VANTUINEN A, 1995, MOL GEN GENET, V246, P133, DOI 10.1007/BF00294675; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Weller JL, 2000, PLANT J, V24, P345, DOI 10.1046/j.1365-313x.2000.00879.x; Weller JL, 2001, PLANT J, V25, P427, DOI 10.1046/j.1365-313x.2001.00978.x; Yu H, 2004, P NATL ACAD SCI USA, V101, P7827, DOI 10.1073/pnas.0402377101; ZERR DM, 1990, J NEUROSCI, V10, P2749; Zhao XY, 2007, PLANT PHYSIOL, V145, P106, DOI 10.1104/pp.107.099838	85	13	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30121	10.1371/journal.pone.0030121	http://dx.doi.org/10.1371/journal.pone.0030121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272283	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400061
J	Herzog, R; Schuhmann, K; Schwudke, D; Sampaio, JL; Bornstein, SR; Schroeder, M; Shevchenko, A				Herzog, Ronny; Schuhmann, Kai; Schwudke, Dominik; Sampaio, Julio L.; Bornstein, Stefan R.; Schroeder, Michael; Shevchenko, Andrej			LipidXplorer: A Software for Consensual Cross-Platform Lipidomics	PLOS ONE			English	Article							THROUGHPUT SHOTGUN LIPIDOMICS; DATA-DEPENDENT ACQUISITION; TANDEM MASS-SPECTROMETRY; MULTIPLE PRECURSOR; PHOSPHOLIPIDS; DIVERSITY; REVEALS; PLASMA; DRIVEN	LipidXplorer is the open source software that supports the quantitative characterization of complex lipidomes by interpreting large datasets of shotgun mass spectra. LipidXplorer processes spectra acquired on any type of tandem mass spectrometers; it identifies and quantifies molecular species of any ionizable lipid class by considering any known or assumed molecular fragmentation pathway independently of any resource of reference mass spectra. It also supports any shotgun profiling routine, from high throughput top-down screening for molecular diagnostic and biomarker discovery to the targeted absolute quantification of low abundant lipid species. Full documentation on installation and operation of LipidXplorer, including tutorial, collection of spectra interpretation scripts, FAQ and user forum are available through the wiki site at: https://wiki.mpi-cbg.de/wiki/lipidx/index.php/Main_Page.	[Herzog, Ronny; Schuhmann, Kai; Schwudke, Dominik; Sampaio, Julio L.; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Herzog, Ronny; Schuhmann, Kai; Bornstein, Stefan R.] Tech Univ Dresden, Dept Internal Med 3, Carl Gustav Carus Clin, Dresden, Germany; [Schwudke, Dominik] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Schroeder, Michael] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Technische Universitat Dresden	Herzog, R (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	shevchenko@mpi-cbg.de	Sampaio, Julio/S-3810-2019; Schwudke, Dominik/B-3478-2013; Schroeder, Michael/A-3040-2010	Schwudke, Dominik/0000-0002-1379-9451; Sampaio, Julio/0000-0002-2881-7827	Deutsche Forschungsgemeinschaft [TRR83]; Wellcome Trust/DBT India Alliance; NCBS-MerckCo	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust/DBT India Alliance(Wellcome Trust); NCBS-MerckCo	The work was supported by TRR83 (project A17) from Deutsche Forschungsgemeinschaft (www.dfg.de) for AS. DS was supported by Wellcome Trust/DBT India Alliance and is a recipient of NCBS-Merck&Co International Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Carvalho M, 2010, DEVELOPMENT, V137, P3675, DOI 10.1242/dev.044560; Chernushevich IV, 2001, J MASS SPECTROM, V36, P849, DOI 10.1002/jms.207; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Griffiths WJ, 2003, MASS SPECTROM REV, V22, P81, DOI 10.1002/mas.10046; Gross RW, 2011, CHEM BIOL, V18, P284, DOI 10.1016/j.chembiol.2011.01.014; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P892, DOI 10.1016/S1044-0305(00)00159-8; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Penkov S, 2010, ANGEW CHEM INT EDIT, V49, P9430, DOI 10.1002/anie.201004466; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Reich A, 2010, EXP DERMATOL, V19, pE103, DOI 10.1111/j.1600-0625.2009.01000.x; Saito K, 2009, P NATL ACAD SCI USA, V106, P8350, DOI 10.1073/pnas.0903541106; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schmelzer K, 2007, METHOD ENZYMOL, V432, P171, DOI 10.1016/S0076-6879(07)32007-7; Schuhmann K, 2011, ANAL CHEM, V83, P5480, DOI 10.1021/ac102505f; Schwudke D, 2006, ANAL CHEM, V78, P585, DOI 10.1021/ac051605m; Schwudke D, 2007, METHOD ENZYMOL, V433, P175, DOI 10.1016/S0076-6879(07)33010-3; Schwudke D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004614; Scigelova M, 2006, PROTEOMICS, P16, DOI 10.1002/pmic.200600528; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033	34	211	216	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29851	10.1371/journal.pone.0029851	http://dx.doi.org/10.1371/journal.pone.0029851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272252	Green Submitted, gold, Green Published			2022-12-25	WOS:000301454400031
J	Pallier, K; Cessot, A; Cote, JF; Just, PA; Cazes, A; Fabre, E; Danel, C; Riquet, M; Devouassoux-Shisheboran, M; Ansieau, S; Puisieux, A; Laurent-Puig, P; Blons, H				Pallier, Karine; Cessot, Anatol; Cote, Jean-Francois; Just, Pierre-Alexandre; Cazes, Aurelie; Fabre, Elizabeth; Danel, Claire; Riquet, Marc; Devouassoux-Shisheboran, Mojgan; Ansieau, Stephane; Puisieux, Alain; Laurent-Puig, Pierre; Blons, Helene			TWIST1 a New Determinant of Epithelial to Mesenchymal Transition in EGFR Mutated Lung Adenocarcinoma	PLOS ONE			English	Article							UP-REGULATION; CANCER-CELLS; ONCOGENIC COOPERATION; TUMOR PROGRESSION; GENE-EXPRESSION; GROWTH; OVEREXPRESSION; METASTASIS; MUTATIONS; MODELS	Metastasis is a multistep process and the main cause of mortality in lung cancer patients. We previously showed that EGFR mutations were associated with a copy number gain at a locus encompassing the TWIST1 gene on chromosome 7. TWIST1 is a highly conserved developmental gene involved in embryogenesis that may be reactivated in cancers promoting both malignant conversion and cancer progression through an epithelial to mesenchymal transition (EMT). The aim of this study was to investigate the possible implication of TWIST1 reactivation on the acquisition of a mesenchymal phenotype in EGFR mutated lung cancer. We studied a series of consecutive lung adenocarcinoma from Caucasian non-smokers for which surgical frozen samples were available (n = 33) and showed that TWIST1 expression was linked to EGFR mutations (P < 0.001), to low CDH1 expression (P < 0.05) and low disease free survival (P = 0.044). To validate that TWIST1 is a driver of EMT in EGFR mutated lung cancer, we used five human lung cancer cell lines and demonstrated that EMT and the associated cell mobility were dependent upon TWIST1 expression in cells with EGFR mutation. Moreover a decrease of EGFR pathway stimulation through EGF retrieval or an inhibition of TWIST1 expression by small RNA technology reversed the phenomenon. Collectively, our in vivo and in vitro findings support that TWIST1 collaborates with the EGF pathway in promoting EMT in EGFR mutated lung adenocarcinoma and that large series of EGFR mutated lung cancer patients are needed to further define the prognostic role of TWIST1 reactivation in this subgroup.	[Pallier, Karine; Cessot, Anatol; Fabre, Elizabeth; Laurent-Puig, Pierre; Blons, Helene] INSERM, UMR S775, Paris, France; [Cote, Jean-Francois] Univ Versailles St Quentin Yvelines, Hop Ambroise Pare, AP HP, Dept Pathol, Boulogne, France; [Pallier, Karine; Cessot, Anatol; Just, Pierre-Alexandre; Cazes, Aurelie; Riquet, Marc; Laurent-Puig, Pierre; Blons, Helene] Univ Paris 05, Paris, France; [Just, Pierre-Alexandre; Cazes, Aurelie; Laurent-Puig, Pierre; Blons, Helene] Hop Europeen Georges Pompidou, AP HP, Dept Biol, Paris, France; [Danel, Claire] Hop Bichat Claude Bernard, AP HP, Dept Pathol, F-75877 Paris, France; [Riquet, Marc] Hop Europeen Georges Pompidou, AP HP, Dept Thorac Surg, Paris, France; [Devouassoux-Shisheboran, Mojgan] Hop Croix Rousse, F-69317 Lyon, France; [Ansieau, Stephane; Puisieux, Alain] INSERM, U590, F-69008 Lyon, France; [Puisieux, Alain] Ctr Leon Berard, F-69373 Lyon, France; [Puisieux, Alain] Univ Lyon 1, F-69365 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Pallier, K (corresponding author), INSERM, UMR S775, Paris, France.	pierre.laurent-puig@parisdescartes.fr; helene.blons@parisdescartes.fr	laurent-puig, pierre/B-2226-2013; JUST, Pierre-Alexandre/P-1972-2017; Laurent-Puig, Pierre/K-3641-2019; Ansieau, Stephane/I-6195-2016	laurent-puig, pierre/0000-0001-8475-5459; Laurent-Puig, Pierre/0000-0001-8475-5459; PUISIEUX, Alain/0000-0002-9938-3798; Fabre, Elizabeth/0000-0002-1244-873X; , Pallier/0000-0001-6646-552X; Blons, Helene/0000-0002-0572-8426; ANSIEAU, Stephane/0000-0003-0989-2108	National Institute for Cancer (INCa)	National Institute for Cancer (INCa)	This work was supported by a grant from the National Institute for Cancer (INCa), biomedical research 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Blons H, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-25; Coate LE, 2009, LANCET ONCOL, V10, P1001, DOI 10.1016/S1470-2045(09)70155-X; Deng QF, 2009, RESPIROLOGY, V14, P371, DOI 10.1111/j.1440-1843.2009.01496.x; Gavert N, 2008, TRENDS MOL MED, V14, P199, DOI 10.1016/j.molmed.2008.03.004; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Su YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019412; Takeyama Y, 2010, CANCER LETT, V296, P216, DOI 10.1016/j.canlet.2010.04.008; Uramoto H, 2010, ANTICANCER RES, V30, P2513; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; Vesuna F, 2007, BIOCH BIOPHYS RES CO; Weinberg RA, 2008, CANCER CELL, V14, P283, DOI 10.1016/j.ccr.2008.09.009; West H, 2009, J THORAC ONCOL, V4, pS1029, DOI 10.1097/JTO.0b013e3181b27170; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yuen HF, 2007, HISTOPATHOLOGY, V50, P648, DOI 10.1111/j.1365-2559.2007.02665.x	26	50	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29954	10.1371/journal.pone.0029954	http://dx.doi.org/10.1371/journal.pone.0029954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272264	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400043
J	Saithong, T; Bumee, S; Liamwirat, C; Meechai, A				Saithong, Treenut; Bumee, Somkid; Liamwirat, Chalothorn; Meechai, Asawin			Analysis and Practical Guideline of Constraint-Based Boolean Method in Genetic Network Inference	PLOS ONE			English	Article							CLOCK-ASSOCIATED GENES; PHOTOPERIODIC CONTROL; REGULATORY NETWORKS; CIRCADIAN-RHYTHMS; EXPRESSION; MODEL; NORMALIZATION; ROLES; CCA1; TIME	Boolean-based method, despite of its simplicity, would be a more attractive approach for inferring a network from high-throughput expression data if its effectiveness has not been limited by high false positive prediction. In this study, we explored factors that could simply be adjusted to improve the accuracy of inferring networks. Our work focused on the analysis of the effects of discretisation methods, biological constraints, and stringency of Boolean function assignment on the performance of Boolean network, including accuracy, precision, specificity and sensitivity, using three sets of microarray time-series data. The study showed that biological constraints have pivotal influence on the network performance over the other factors. It can reduce the variation in network performance resulting from the arbitrary selection of discretisation methods and stringency settings. We also presented the master Boolean network as an approach to establish the unique solution for Boolean analysis. The information acquired from the analysis was summarised and deployed as a general guideline for an efficient use of Boolean-based method in the network inference. In the end, we provided an example of the use of such a guideline in the study of Arabidopsis circadian clock genetic network from which much interesting biological information can be inferred.	[Saithong, Treenut] King Mongkuts Univ Technol Thonburi, Bioinformat & Syst Biol Program, Sch Bioresources & Technol, Bangkok, Thailand; [Saithong, Treenut; Bumee, Somkid; Liamwirat, Chalothorn; Meechai, Asawin] King Mongkuts Univ Technol Thonburi, Syst Biol & Bioinformat Res Lab, Pilot Plant Dev & Training Inst, Bangkok, Thailand; [Liamwirat, Chalothorn] King Mongkuts Univ Technol Thonburi, Div Biotechnol, Sch Bioresources & Technol, Bangkok, Thailand; [Meechai, Asawin] King Mongkuts Univ Technol Thonburi, Dept Chem Engn, Fac Engn, Bangkok, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi	Saithong, T (corresponding author), King Mongkuts Univ Technol Thonburi, Bioinformat & Syst Biol Program, Sch Bioresources & Technol, Bangkok, Thailand.	treenut.sai@kmutt.ac.th	Saithong, Treenut/L-1395-2019	Saithong, Treenut/0000-0003-2888-6854	Thailand governmental	Thailand governmental	This work is supported by the Thailand governmental annual budget for the years 2010 and 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Bumee S, 2010, P 1 COMP SYST BIOL B, P71; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Farre EM, 2005, CURR BIOL, V15, P47, DOI 10.1016/j.cub.2004.12.067; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hall A.J.W., 2006, ENDOGENOUS PLANT RHY; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kawamura H, 2008, BIOSCI BIOTECH BIOCH, V72, P2770, DOI 10.1271/bbb.80321; Kiba T, 2007, PLANT CELL, V19, P2516, DOI 10.1105/tpc.107.053033; Kim Hye Kyung, 2007, INTERNATIONAL JOURNAL OF HUMAN ECOLOGY, V8, P1; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LI Y, 2010, BMC BIOINFORMATICS, V11, P1, DOI DOI 10.1186/1471-2164-11-1; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Long TA, 2008, ANNU REV CELL DEV BI, V24, P81, DOI 10.1146/annurev.cellbio.24.110707.175408; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Munkong W, CONSTRAINT BASED BOO; Nakamichi N, 2005, PLANT CELL PHYSIOL, V46, P609, DOI 10.1093/pcp/pci061; Needham CJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-85; Niwa Y, 2007, PLANT CELL PHYSIOL, V48, P925, DOI 10.1093/pcp/pcm067; Pensa RG, 2004, P ACM BIOKDD SEATTL, V4, P24, DOI DOI 10.1093/NAR/GKH092; Pokhilko A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.69; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shmulevich I, 2002, BIOINFORMATICS, V18, P555, DOI 10.1093/bioinformatics/18.4.555; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Timson DJ., 2007, DYN BIOCH PROCE BIOT, V1, P63, DOI DOI 10.1046/j.1365-8711.2003.06497.x; WORKMAN C, 2002, GENOME BIOL, V0003; Yufei Huang, 2007, Journal of Multimedia, V2, P46	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30232	10.1371/journal.pone.0030232	http://dx.doi.org/10.1371/journal.pone.0030232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272315	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400093
J	Secondi, J; Lepetz, V; Thery, M				Secondi, Jean; Lepetz, Virginie; Thery, Marc			Male Attractiveness Is Influenced by UV Wavelengths in a Newt Species but Not in Its Close Relative	PLOS ONE			English	Article							ULTRAVIOLET VISION; MATE-CHOICE; COLOR PATTERNS; SPECTRAL SENSITIVITY; POECILIA-RETICULATA; SEXUAL SELECTION; LIGHT; SIGNALS; COMMUNICATION; REFLECTANCE	Background: Functional communication in the UV range has been reported in Invertebrates and all major groups of Vertebrates but Amphibians. Although perception in this wavelength range has been shown in a few species, UV signalling has not been demonstrated in this group. One reason may be that in lentic freshwater habitats, litter decomposition generates dissolved organic carbon that absorbs UV radiation and thus hinders its use for visual signalling. We tested the effect of male UV characteristics on female sexual preference in two newt species that experience contrasting levels of UV water transmission when breeding. Methodology/Principal Findings: We analysed water spectral characteristics of a sample of breeding ponds in both species. We quantified male ventral coloration and measured male attractiveness under two lighting conditions (UV present, UV absent) using a no-choice female preference design. UV transmission was higher in Lissotriton vulgaris breeding sites. Male UV patterns also differed between experimental males of the two species. We observed a first common peak around 333 nm, higher in L. vulgaris, and a second peak around 397 nm, more frequent and higher in L. helveticus. Male attractiveness was significantly reduced in L. vulgaris when UV was not available but not in L. helveticus. Male attractiveness depended on the hue of the first UV peak in L. vulgaris. Conclusion/Significance: Our study is the first report of functional UV-based communication in Amphibians. Interestingly, male spectral characteristics and female preferences were consistent with the differences in habitat observed between the two species as L. helveticus often breeds in ponds containing more UV blocking compounds. We discuss the three hypotheses proposed so far for UV signalling in animals (enhanced signal detectability, private communication channel, indicator of individual quality).	[Secondi, Jean; Lepetz, Virginie] Univ Angers, Grp Ecol & Conservat Vertebrates, GECCO, Angers, France; [Thery, Marc] Museum Natl Hist Nat, Ctr Natl Rech Sci, UMR 7179, Brunoy, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Secondi, J (corresponding author), Univ Angers, Grp Ecol & Conservat Vertebrates, GECCO, Angers, France.	jean.secondi@univ-angers.fr		Secondi, Jean/0000-0001-8130-1195				ALBERTS AC, 1989, ANIM BEHAV, V38, P129, DOI 10.1016/S0003-3472(89)80072-7; Altshuler DL, 2001, EVOL ECOL RES, V3, P767; Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P445, DOI 10.1098/rspb.1998.0315; Bajer K, 2010, BEHAV ECOL SOCIOBIOL, V64, P2007, DOI 10.1007/s00265-010-1012-2; Bancroft BA, 2008, CONSERV BIOL, V22, P987, DOI 10.1111/j.1523-1739.2008.00966.x; Barta A, 2004, J THEOR BIOL, V226, P429, DOI 10.1016/j.jtbi.2003.09.017; Bennett ATD, 1996, NATURE, V380, P433, DOI 10.1038/380433a0; Bennett ATD, 1997, P NATL ACAD SCI USA, V94, P8618, DOI 10.1073/pnas.94.16.8618; BENNETT ATD, 1994, VISION RES, V34, P1471, DOI 10.1016/0042-6989(94)90149-X; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Church SC, 1998, NATURWISSENSCHAFTEN, V85, P189, DOI 10.1007/s001140050483; Crump D, 1999, PHOTOCHEM PHOTOBIOL, V70, P893, DOI 10.1562/0031-8655(1999)070<0893:SIIPWI>2.3.CO;2; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; DEUTSCHLANDER ME, 1995, NEUROSCI LETT, V197, P93, DOI 10.1016/0304-3940(95)11905-C; DIETZ M, 1972, NATURWISSENSCHAFTEN, V59, P316, DOI 10.1007/BF00593366; EDRICH W, 1979, J COMP PHYSIOL, V133, P111, DOI 10.1007/BF00657525; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fuller RC, 2002, P ROY SOC B-BIOL SCI, V269, P1457, DOI 10.1098/rspb.2002.2042; Garcia CM, 2002, BEHAV ECOL SOCIOBIOL, V52, P1, DOI 10.1007/s00265-002-0482-2; Gomez D., 2006, AVICOL PROGRAM ANAL; Gomez D, 2007, AM NAT, V169, pS42, DOI 10.1086/510138; Gomez D, 2009, P ROY SOC B-BIOL SCI, V276, P2351, DOI 10.1098/rspb.2009.0168; GOVARDOVSKII VI, 1974, VISION RES, V14, P1317, DOI 10.1016/0042-6989(74)90003-0; GREEN AJ, 1991, ANIM BEHAV, V41, P367, DOI 10.1016/S0003-3472(05)80489-0; Greenwood VJ, 2002, ANIM BEHAV, V64, P923, DOI 10.1006/anbe.2002.1977; Haerty W, 2007, BEHAVIOUR, V144, P797, DOI 10.1163/156853907781476445; Halliday T.R., 1977, P185; Herberstein ME, 2009, EVOL ECOL, V23, P621, DOI 10.1007/s10682-008-9260-6; HIMSTEDT W, 1979, COPEIA, P40; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Hunt S, 2003, P ROY SOC B-BIOL SCI, V270, pS25, DOI 10.1098/rsbl.2003.0009; Johanet A, 2011, HEREDITY, V106, P962, DOI 10.1038/hdy.2010.144; Johanet A, 2009, CR BIOL, V332, P548, DOI 10.1016/j.crvi.2009.02.004; Kawamura G, 2009, MAR FRESHW BEHAV PHY, V42, P19, DOI 10.1080/10236240802663580; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; LATOUCHE YD, 1979, COMP BIOCHEM PHYS A, V63, P313, DOI 10.1016/0300-9629(79)90165-8; Leal M, 2002, P ROY SOC B-BIOL SCI, V269, P351, DOI 10.1098/rspb.2001.1904; LeBas NR, 2000, P ROY SOC B-BIOL SCI, V267, P445, DOI 10.1098/rspb.2000.1020; Lim MLM, 2008, BEHAV ECOL, V19, P61, DOI 10.1093/beheco/arm100; Losey GS, 1999, J FISH BIOL, V54, P921, DOI 10.1111/j.1095-8649.1999.tb00848.x; Lythgoe J.N., 1979, ECOLOGY VISION; Lyytinen A, 2004, BEHAV ECOL, V15, P982, DOI 10.1093/beheco/arh102; McGregor PK., 1992, PLAYBACK STUDIES ANI; Mougeot F, 2005, J AVIAN BIOL, V36, P203, DOI 10.1111/j.0908-8857.2005.03424.x; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PRZYREMBEL C, 1995, J COMP PHYSIOL A, V176, P575; R Development Core Team, 2009, R FDN STAT COMP; Ries C, 2008, J ZOOL, V276, P229, DOI 10.1111/j.1469-7998.2008.00456.x; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; Schaefer HM, 2006, BEHAV ECOL, V17, P784, DOI 10.1093/beheco/arl011; Siebeck UE, 2004, ANIM BEHAV, V68, P273, DOI 10.1016/j.anbehav.2003.11.010; Siitari H, 2002, BEHAV ECOL, V13, P737, DOI 10.1093/beheco/13.6.737; Siitari H, 1999, P ROY SOC B-BIOL SCI, V266, P2125, DOI 10.1098/rspb.1999.0897; Smith EJ, 2002, BEHAV ECOL, V13, P11, DOI 10.1093/beheco/13.1.11; Stevens M, 2007, BIOSCIENCE, V57, P501, DOI 10.1641/B570607; Sztatecsny M, 2010, ANIM BEHAV, V79, P779, DOI 10.1016/j.anbehav.2010.01.003; Thorpe RS, 2001, P NATL ACAD SCI USA, V98, P3929, DOI 10.1073/pnas.071576798; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X; Uy JAC, 2000, EVOLUTION, V54, P273, DOI 10.1111/j.0014-3820.2000.tb00027.x; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Whiting MJ, 2006, ANIM BEHAV, V72, P353, DOI 10.1016/j.anbehav.2005.10.018	64	26	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30391	10.1371/journal.pone.0030391	http://dx.doi.org/10.1371/journal.pone.0030391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272342	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400120
J	Ye, JQ; Boyle, A; Shih, H; Sievers, RE; Zhang, Y; Prasad, M; Su, H; Zhou, Y; Grossman, W; Bernstein, HS; Yeghiazarians, Y				Ye, Jianqin; Boyle, Andrew; Shih, Henry; Sievers, Richard E.; Zhang, Yan; Prasad, Megha; Su, Hua; Zhou, Yan; Grossman, William; Bernstein, Harold S.; Yeghiazarians, Yerem			Sca-1(+) Cardiosphere-Derived Cells Are Enriched for Isl1-Expressing Cardiac Precursors and Improve Cardiac Function after Myocardial Injury	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; HEART; DIFFERENTIATION; CARDIOMYOCYTES; EXPRESSION; INFARCTION; THERAPY; REGENERATION; MULTIPOTENT	Background: Endogenous cardiac progenitor cells are a promising option for cell-therapy for myocardial infarction (MI). However, obtaining adequate numbers of cardiac progenitors after MI remains a challenge. Cardiospheres (CSs) have been proposed to have cardiac regenerative properties; however, their cellular composition and how they may be influenced by the tissue milieu remains unclear. Methodology/Principal Finding: Using "middle aged'' mice as CSs donors, we found that acute MI induced a dramatic increase in the number of CSs in a mouse model of MI, and this increase was attenuated back to baseline over time. We also observed that CSs from post-MI hearts engrafted in ischemic myocardium induced angiogenesis and restored cardiac function. To determine the role of Sca-1(+)CD45(-) cells within CSs, we cloned these from single cell isolates. Expression of Islet-1 (Isl1) in Sca-1(+)CD45(-) cells from CSs was 3-fold higher than in whole CSs. Cloned Sca-1(+)CD45(-) cells had the ability to differentiate into cardiomyocytes, endothelial cells and smooth muscle cells in vitro. We also observed that cloned cells engrafted in ischemic myocardium induced angiogenesis, differentiated into endothelial and smooth muscle cells and improved cardiac function in post-MI hearts. Conclusions/Significance: These studies demonstrate that cloned Sca-1(+)CD45(-) cells derived from CSs from infarcted "middle aged'' hearts are enriched for second heart field (i.e., Isl-1(+)) precursors that give rise to both myocardial and vascular tissues, and may be an appropriate source of progenitor cells for autologous cell-therapy post-MI.	[Ye, Jianqin; Boyle, Andrew; Shih, Henry; Sievers, Richard E.; Zhang, Yan; Prasad, Megha; Grossman, William; Yeghiazarians, Yerem] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Grossman, William; Bernstein, Harold S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Boyle, Andrew; Bernstein, Harold S.; Yeghiazarians, Yerem] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Bernstein, Harold S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Su, Hua] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Div Cardiol, San Francisco, CA 94143 USA; [Zhou, Yan] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ye, JQ (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA.	yeghiaza@medicine.ucsf.edu		Boyle, Andrew/0000-0002-3919-5269	Wayne and Gladys Valley Foundation; UCSF; Harold Castle Foundation	Wayne and Gladys Valley Foundation; UCSF; Harold Castle Foundation	This work was supported by the Wayne and Gladys Valley Foundation, the UCSF Cardiac Stem Cell Fund and the Harold Castle Foundation (all to Y.Y. and W.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Barile L, 2007, CARDIAC STEM CELLS I, pS9; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Boyle AJ, 2006, CIRCULATION, V114, P339, DOI 10.1161/CIRCULATIONAHA.105.590653; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; D'Alessandro DA, 2009, CIRC RES, V105, P1128, DOI 10.1161/CIRCRESAHA.109.207266; Delorme B, 1997, CIRC RES, V81, P423, DOI 10.1161/01.RES.81.3.423; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Genead R, 2010, STEM CELLS DEV, V19, P1601, DOI 10.1089/scd.2009.0483; Ghassemifar MR, 1997, IN VITRO CELL DEV-AN, V33, P622; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Khattar P, 2011, STEM CELLS DEV, V20, P1043, DOI 10.1089/scd.2010.0374; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005; Su H, 2002, P NATL ACAD SCI USA, V99, P9480, DOI 10.1073/pnas.132275299; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Yeghiazarians Y, 2011, CYTOTHERAPY IN PRESS; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zhang Y, 2007, AM J PHYSIOL-HEART C, V292, pH1187, DOI 10.1152/ajpheart.00895.2006	36	52	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30329	10.1371/journal.pone.0030329	http://dx.doi.org/10.1371/journal.pone.0030329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272337	Green Published, gold			2022-12-25	WOS:000301454400115
J	Gatti, DL				Gatti, Domenico L.			Biapenem Inactivation by B2 Metallo beta-Lactamases: Energy Landscape of the Post-Hydrolysis Reactions	PLOS ONE			English	Article							STENOTROPHOMONAS-MALTOPHILIA; ENTROPIC CONTRIBUTIONS; REACTION INTERMEDIATE; CATALYTIC MECHANISM; MOLECULAR-DYNAMICS; ANTIBIOTIC BINDING; ENZYME; CPHA; L1; CLASSIFICATION	Background: The first line of defense by bacteria against beta-lactam antibiotics is the expression of beta-lactamases, which cleave the amide bond of the beta-lactam ring. In the reaction of biapenem inactivation by B2 metallo beta-lactamases (MbLs), after the beta-lactam ring is opened, the carboxyl group generated by the hydrolytic process and the hydroxyethyl group (common to all carbapenems) rotate around the C5-C6 bond, assuming a new position that allows a proton transfer from the hydroxyethyl group to C2, and a nucleophilic attack on C3 by the oxygen atom of the same side-chain. This process leads to the formation of a bicyclic compound, as originally observed in the X-ray structure of the metallo beta-lactamase CphA in complex with product. Methodology/Principal Findings: QM/MM and metadynamics simulations of the post-hydrolysis steps in solution and in the enzyme reveal that while the rotation of the hydroxyethyl group can occur in solution or in the enzyme active site, formation of the bicyclic compound occurs primarily in solution, after which the final product binds back to the enzyme. The calculations also suggest that the rotation and cyclization steps can occur at a rate comparable to that observed experimentally for the enzymatic inactivation of biapenem only if the hydrolysis reaction leaves the N4 nitrogen of the beta-lactam ring unprotonated. Conclusions/Significance: The calculations support the existence of a common mechanism (in which ionized N4 is the leaving group) for carbapenems hydrolysis in all MbLs, and suggest a possible revision of mechanisms for B2 MbLs in which the cleavage of the beta-lactam ring is associated with or immediately followed by protonation of N4. The study also indicates that the bicyclic derivative of biapenem has significant affinity for B2 MbLs, and that it may be possible to obtain clinically effective inhibitors of these enzymes by modification of this lead compound.	[Gatti, Domenico L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Gatti, Domenico L.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA	Wayne State University; Wayne State University	Gatti, DL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	dgatti@med.wayne.edu			U.S. Public Health Service [GM69840]; Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069840] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by U.S. Public Health Service Grant GM69840 and by a Wayne State University Research Enhancement Program in Computational Biology Grant to D. L. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barducci A, 2006, J AM CHEM SOC, V128, P2705, DOI 10.1021/ja057076l; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bebrone C, 2010, DRUGS, V70, P651, DOI 10.2165/11318430-000000000-00000; Bebrone C, 2009, ANTIMICROB AGENTS CH, V53, P4464, DOI 10.1128/AAC.00288-09; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BELL S, 1984, J CHEM PHYS, V80, P2464, DOI 10.1063/1.446996; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bowers K.J., 2006, P 2006 ACM IEEE C SU, DOI [10.1109/SC.2006.54, DOI 10.1109/SC.2006.54]; Bussi G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090601; BYRD RH, 1994, MATH PROGRAM, V63, P129, DOI 10.1007/BF01582063; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Fast W, 2001, BIOCHEMISTRY-US, V40, P1640, DOI 10.1021/bi001860v; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Frere JM, 2005, J ANTIMICROB CHEMOTH, V55, P1051, DOI 10.1093/jac/dki155; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Garrity JD, 2005, BIOCHEMISTRY-US, V44, P1078, DOI 10.1021/bi048385b; Geerlings P, 2003, CHEM REV, V103, P1793, DOI 10.1021/cr990029p; GENSMANTEL NP, 1980, J CHEM SOC PERK T 2, P1725, DOI 10.1039/p29800001725; Gensmantel NP, 1978, J CHEM SOC P2, V2; GONZALEZ C, 1991, J CHEM PHYS, V95, P5853, DOI 10.1063/1.461606; GONZALEZ C, 1990, J PHYS CHEM-US, V94, P5523, DOI 10.1021/j100377a021; GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; HALGREN TA, 1977, CHEM PHYS LETT, V49, P225, DOI 10.1016/0009-2614(77)80574-5; Hall BG, 2005, J ANTIMICROB CHEMOTH, V55, P1050, DOI 10.1093/jac/dki130; Hall BG, 2003, J MOL EVOL, V57, P249, DOI 10.1007/s00239-003-2471-0; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; Hindmarsh AC, 1983, SCI COMPUT, V1, P55; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Horsfall LE, 2007, ANTIMICROB AGENTS CH, V51, P2136, DOI 10.1128/AAC.00866-06; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JENSEN A, 1983, THEOR CHIM ACTA, V63, P269, DOI 10.1007/BF01151605; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Perez-Llarena FJ, 2009, CURR MED CHEM, V16, P3740, DOI 10.2174/092986709789104957; Laio A, 2005, J PHYS CHEM B, V109, P6714, DOI 10.1021/jp045424k; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McManus-Munoz S, 1999, BIOCHEMISTRY-US, V38, P1547, DOI 10.1021/bi9826512; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; Parr R. G., 1989, DENSITY FUNCTIONAL T; Provasi D, 2010, BIOPHYS J, V98, P2347, DOI 10.1016/j.bpj.2010.01.047; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Sharma NP, 2006, BIOCHEMISTRY-US, V45, P10729, DOI 10.1021/bi060893t; Simona F, 2007, PROTEINS, V69, P595, DOI 10.1002/prot.21476; Simona F, 2009, J BIOL CHEM, V284, P28164, DOI 10.1074/jbc.M109.049502; Snider MJ, 2000, BIOCHEMISTRY-US, V39, P9746, DOI 10.1021/bi000914y; Spencer J, 2005, J AM CHEM SOC, V127, P14439, DOI 10.1021/ja0536062; Spencer J, 2001, J BIOL CHEM, V276, P33638, DOI 10.1074/jbc.M105550200; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Tioni MF, 2008, J AM CHEM SOC, V130, P15852, DOI 10.1021/ja801169j; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Villa J, 2000, P NATL ACAD SCI USA, V97, P11899, DOI 10.1073/pnas.97.22.11899; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1998, J AM CHEM SOC, V120, P10788, DOI 10.1021/ja982621m; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Warshel A, 2001, Q REV BIOPHYS, V34, P563, DOI 10.1017/S0033583501003730; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106; Wu SS, 2010, J AM CHEM SOC, V132, P17986, DOI 10.1021/ja104241g; Xu DG, 2006, J BIOL CHEM, V281, P8740, DOI 10.1074/jbc.M512517200; Xu DG, 2005, J MED CHEM, V48, P6679, DOI 10.1021/jm0505112; Xu DG, 2007, J PHYS CHEM A, V111, P5630, DOI 10.1021/jp068746s; Xu D, 2007, J AM CHEM SOC, V129, P10814, DOI 10.1021/ja072532m; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	77	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30079	10.1371/journal.pone.0030079	http://dx.doi.org/10.1371/journal.pone.0030079			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22272276	gold, Green Published, Green Submitted			2022-12-25	WOS:000301357100037
J	Luker, KE; Lewin, SA; Mihalko, LA; Schmidt, BT; Winkler, JS; Coggins, NL; Thomas, DG; Luker, GD				Luker, K. E.; Lewin, S. A.; Mihalko, L. A.; Schmidt, B. T.; Winkler, J. S.; Coggins, N. L.; Thomas, D. G.; Luker, G. D.			Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells	ONCOGENE			English	Article						chemokines; luciferase; bioluminescence; breast cancer; chemokine receptor	CHEMOKINE RECEPTOR CXCR4; IN-VIVO; ENDOTHELIAL-CELLS; DENDRITIC CELLS; PROSTATE-CANCER; EXPRESSION; MIGRATION; LUCIFERASE; FACTOR-1-ALPHA; INVOLVEMENT	Chemokine CXCL12 and receptor CXCR4 control multiple steps in primary tumor growth and metastasis in breast cancer and more than 20 other human malignancies. Mechanisms that regulate availability of CXCL12 in tumor microenvironments will substantially impact cancer progression and ongoing efforts to target the CXCL12-CXCR4 pathway for cancer chemotherapy. We used dual luciferase imaging to investigate CXCR7-dependent scavenging of CXCL12 in breast tumors in vivo and quantify effects of CXCR7 on tumor growth and metastasis of a separate population of CXCR4+ breast cancer cells. In a mouse xenograft model of human breast cancer, in vivo imaging showed that malignant cells expressing CXCR7 reduced bioluminescent CXCL12 secreted in the primary tumor microenvironment. Capitalizing on sensitive detection of bioluminescent CXCL12, we also demonstrated that CXCR7+ cells reduced amounts of chemokine released from orthotopic tumors into the circulation. Immunofluorescence staining of human primary breast cancers showed expression of CXCR4 and CXCR7 on malignant cells in approximate to 30% of cases. In most cases, CXCR4 and CXCR7 predominantly were expressed on separate populations of malignant cells in a tumor. We modeled these cases of human breast cancer by co-implanting tumor xenografts with CXCR4+ breast cancer cells, human mammary fibroblasts secreting CXCL12, and CXCR7+ or control breast cancer cells. Bioluminescence imaging showed that CXCR7+ breast cancer cells enhanced proliferation of CXCR4+ breast cancer cells in orthotopic tumors and spontaneous metastases. Treatment with a small-molecule inhibitor of CXCR7 chemokine limited the growth of CXCR4+ breast cancer cells in tumors that also contained malignant CXCR7+ cells. These studies establish a new in vivo imaging method to quantify chemokine scavenging by CXCR7 in the tumor microenvironment and identify that CXCR7+ cells promote growth and metastasis of CXCR4+ breast cancer cells.	[Luker, K. E.; Lewin, S. A.; Mihalko, L. A.; Schmidt, B. T.; Winkler, J. S.; Coggins, N. L.; Luker, G. D.] Univ Michigan, Sch Med, Ctr Mol Imaging, Dept Radiol, Ann Arbor, MI 48109 USA; [Thomas, D. G.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Luker, G. D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Luker, GD (corresponding author), Univ Michigan, Sch Med, Ctr Mol Imaging, Dept Radiol, 109 Zina Pitcher Pl,A526 BSRB, Ann Arbor, MI 48109 USA.	gluker@umich.edu		Schmidt, Bradley/0000-0002-4011-4630; luker, gary/0000-0001-6832-2581	NIH [R01CA136553, R01CA136829, P50CA093990, R24CA083099]; Fashion Footwear Association of New York (FFANY)/QVC; NATIONAL CANCER INSTITUTE [R01CA136829, R24CA083099, R01CA136553, P50CA093990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fashion Footwear Association of New York (FFANY)/QVC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by NIH grantsR01CA136553, R01CA136829, P50CA093990 and R24CA083099. Support also was provided by Fashion Footwear Association of New York (FFANY)/QVC presents Shoes on Sale. We thank ChemoCentryx for small-molecule inhibitors of CXCR7 and antibody 11G8.	Akashi T, 2008, CANCER SCI, V99, P539, DOI 10.1111/j.1349-7006.2007.00712.x; Albright CF, 2005, MOL CANCER THER, V4, P751, DOI 10.1158/1535-7163.MCT-05-0006; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Chu QYD, 2010, J SURG RES, V159, P689, DOI 10.1016/j.jss.2008.09.020; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Jiang YP, 2006, GYNECOL ONCOL, V103, P226, DOI 10.1016/j.ygyno.2006.02.036; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Konoplev S, 2011, CANCER-AM CANCER SOC, V117, P4689, DOI 10.1002/cncr.26113; Lee BC, 2004, MOL CANCER RES, V2, P327; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Meng H, 2011, CLIN CANCER RES, V17, P2426, DOI 10.1158/1078-0432.CCR-10-2385; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pablos JL, 1999, AM J PATHOL, V155, P1577, DOI 10.1016/S0002-9440(10)65474-0; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Takano S, 2010, J ONCOL, V2010, DOI 10.1155/2010/351908; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Torisawa YS, 2010, INTEGR BIOL-UK, V2, P680, DOI 10.1039/c0ib00041h; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	38	148	154	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	45					4750	4758		10.1038/onc.2011.633	http://dx.doi.org/10.1038/onc.2011.633			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	036NF	22266857	Green Accepted			2022-12-25	WOS:000311033000003
J	Preidis, GA; Saulnier, DM; Blutt, SE; Mistretta, TA; Riehle, KP; Major, AM; Venable, SF; Finegold, MJ; Petrosino, JF; Conner, ME; Versalovic, J				Preidis, Geoffrey A.; Saulnier, Delphine M.; Blutt, Sarah E.; Mistretta, Toni-Ann; Riehle, Kevin P.; Major, Angela M.; Venable, Susan F.; Finegold, Milton J.; Petrosino, Joseph F.; Conner, Margaret E.; Versalovic, James			Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine	FASEB JOURNAL			English	Article						animal models; cell movement; epithelium; metagenome	INTEGRIN-LINKED KINASE; LACTOBACILLUS-REUTERI; NECROTIZING ENTEROCOLITIS; ESCHERICHIA-COLI; CROHNS-DISEASE; HOST; HOMEOSTASIS; BACTERIA; PREBIOTICS; EXPRESSION	Beneficial microbes and probiotics show promise for the treatment of pediatric gastrointestinal diseases. However, basic mechanisms of probiosis are not well understood, and most investigations have been performed in germ-free or microbiome-depleted animals. We sought to functionally characterize probiotic-host interactions in the context of normal early development. Outbred CD1 neonatal mice were orally gavaged with one of two strains of human-derived Lactobacillus reuteri or an equal volume of vehicle. Transcriptome analysis was performed on enterocyte RNA isolated by laser-capture microdissection. Enterocyte migration and proliferation were assessed by labeling cells with 5-bromo-2'-deoxyuridine, and fecal microbial community composition was determined by 16S metagenomic sequencing. Probiotic ingestion altered gene expression in multiple canonical pathways involving cell motility. L. reuteri strain DSM 17938 dramatically increased enterocyte migration (3-fold), proliferation (34%), and crypt height (29%) compared to vehicle-treated mice, whereas strain ATCC PTA 6475 increased cell migration (2-fold) without affecting crypt proliferative activity. In addition, both probiotic strains increased the phylogenetic diversity and evenness between taxa of the fecal microbiome 24 h after a single probiotic gavage. These experiments identify two targets of probiosis in early development, the intestinal epithelium and the gut microbiome, and suggest novel mechanisms for probiotic strain-specific effects.-Preidis, G. A., Saulnier, D. M., Blutt, S. E., Mistretta, T.-A., Riehle, K. P., Major, A. M., Venable, S. F., Finegold, M. J., Petrosino, J. F., Conner, M. E., Versalovic, J. Probiotics stimulate enterocyte migration and microbial diversity in the neonatal mouse intestine. FASEB J. 26, 1960-1969 (2012). www.fasebj.org	[Versalovic, James] Texas Childrens Hosp, Feigin Ctr, Dept Pathol, Houston, TX 77030 USA; [Preidis, Geoffrey A.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Preidis, Geoffrey A.; Saulnier, Delphine M.; Mistretta, Toni-Ann; Venable, Susan F.; Finegold, Milton J.; Conner, Margaret E.; Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Blutt, Sarah E.; Petrosino, Joseph F.; Conner, Margaret E.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Riehle, Kevin P.] Baylor Coll Med, Bioinformat Res Lab, Houston, TX 77030 USA; [Petrosino, Joseph F.] Human Genome Sequencing Ctr, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Versalovic, J (corresponding author), Texas Childrens Hosp, Feigin Ctr, Dept Pathol, Ste 830,1102 Bates Ave, Houston, TX 77030 USA.	jamesv@bcm.edu	Conner, Margaret E./I-7230-2019; SAULNIER, Delphine DM/C-1307-2013; Preidis, Geoffrey A./W-5538-2019; Petrosino, Joseph F./AAF-1621-2019	Preidis, Geoffrey A./0000-0002-2206-6452; Riehle, Kevin/0000-0003-4888-2404	U.S. National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) [F30 DK081269, R01 DK065075, UH3 DK083990, P30 DK56338]; National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI24998]; National Center for Complementary and Alternative Medicine (NCCAM) [R01 AT004326]; Biogaia AB; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK065075, F30DK081269, UH3DK083990] Funding Source: NIH RePORTER	U.S. National Institute of Diabetes and Digestive and Kidney Disease (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Biogaia AB; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the U.S. National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) F30 DK081269 (G. A. P.), R01 DK065075 (J.V.), UH3 DK083990 (J.V.), and P30 DK56338 (M.J.F. and J.V.); by the National Institute of Allergy and Infectious Diseases (NIAID) RO1 AI24998 (M. E. C.); and by the National Center for Complementary and Alternative Medicine (NCCAM) R01 AT004326 (J.V.). J.V. received an unrestricted grant from Biogaia AB; he acts as an advisor and consultant to Danone. The other authors declare no conflicts of interest.	AlFaleh K, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005496.pub2, 10.1097/AOG.0b013e3181726f2f]; AlFaleh K, 2011, COCHRANE DB SYST REV, DOI [10.1097/AOG.0b013e3181726f2f, 10.1002/14651858.CD005496.pub3]; Allen SJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003048.pub3; Banasaz M, 2002, APPL ENVIRON MICROB, V68, P3031, DOI 10.1128/AEM.68.6.3031-3034.2002; Aponte GB, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007401.pub2; Boshuizen JA, 2003, J VIROL, V77, P13005, DOI 10.1128/JVI.77.24.13005-13016.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CHAO A, 1984, SCAND J STAT, V11, P265; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Food and Agricultural Organization of the United Nations and World Health Organization, 2001, HLTH NUTR PROP PROB; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Gallis Jean-Louis, 2007, BMC Physiology, V7, P8, DOI 10.1186/1472-6793-7-8; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Preidis GA, 2011, GASTROENTEROLOGY, V140, P8, DOI 10.1053/j.gastro.2010.11.010; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Savino F, 2007, PEDIATRICS, V119, pE124, DOI 10.1542/peds.2006-1222; Savino F, 2010, PEDIATRICS, V126, pE526, DOI 10.1542/peds.2010-0433; Shanahan F, 2010, GASTROENTEROLOGY, V139, P1808, DOI 10.1053/j.gastro.2010.10.025; Shannon C.E., 1963, MATH THEORY COMMUNIC; Shornikova AV, 1997, PEDIATR INFECT DIS J, V16, P1103, DOI 10.1097/00006454-199712000-00002; Shornikova AV, 1997, J PEDIATR GASTR NUTR, V24, P399, DOI 10.1097/00005176-199704000-00008; Soll RF, 2010, PEDIATRICS, V125, P1071, DOI 10.1542/peds.2010-0643; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Stappenbeck TS, 2002, METHOD ENZYMOL, V356, P167; Swidsinski A, 2008, INFLAMM BOWEL DIS, V14, P147, DOI 10.1002/ibd.20330; Swidsinski A, 2009, INFLAMM BOWEL DIS, V15, P359, DOI 10.1002/ibd.20763; Tarnow-Mordi WO, 2010, PEDIATRICS, V125, P1068, DOI 10.1542/peds.2009-2151; Thomas DW, 2010, PEDIATRICS, V126, P1217, DOI 10.1542/peds.2010-2548; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Zhang W, 2008, VACCINE, V26, P3655, DOI 10.1016/j.vaccine.2008.04.070	54	74	84	0	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1960	1969		10.1096/fj.10-177980	http://dx.doi.org/10.1096/fj.10-177980			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22267340	Green Published			2022-12-25	WOS:000303680800023
J	Velders, M; Schleipen, B; Fritzemeier, KH; Zierau, O; Diel, P				Velders, Martina; Schleipen, Burkhardt; Fritzemeier, Karl H.; Zierau, Oliver; Diel, Patrick			Selective estrogen receptor-beta activation stimulates skeletal muscle growth and regeneration	FASEB JOURNAL			English	Article						notexin; satellite cells	NECROSIS-FACTOR-ALPHA; MYOGENIC SATELLITE CELLS; FACTOR-I; NEUTROPHIL INFILTRATION; SARCOPLASMIC-RETICULUM; ER-ALPHA; EXPRESSION; RAT; INJURY; OVARIECTOMY	There is increasing evidence suggesting that estrogens augment skeletal muscle regeneration processes after injury. To study the contribution of estrogen receptors alpha and beta (ER alpha and ER beta) during muscle regeneration, skeletal muscles of ovariectomized (OVX) rats, as well as ER alpha- and ER beta-knockout (alpha Erko and beta Erko) mice, were injured with a myotoxin (notexin). OVX rats were simultaneously treated with the ER-selective ligands genistein, ER alpha agonist 16 alpha-LE2 (alpha), ER beta agonist 8 beta-VE2 (beta), or 17 beta-estradiol (E-2). OVX rats showed significantly elevated serum creatine kinase (CK) activity after muscle injury compared to intact sham-treated animals. Treatment with ER ligands significantly reduced CK activity. TNF-alpha, IL-10, and MCP-1 expression served to characterize immune responses. Treatment with all ER ligands, but particularly E-2 and beta, reduced TNF-alpha, but elevated MCP-1 and IL-10 expression. PCNA and MyoD expression served to define satellite cell activation and proliferation and were found to be up-regulated by beta and E-2. To further study muscle regeneration responses, expression of the embryonic myosin heavy chain (MHC) was analyzed. Beta and E-2 but not alpha increased embryonic MHC expression compared to OVX. The absence of ER beta in beta Erko mice negatively affected CK activity levels and expression of satellite cell and muscle regeneration markers (MHC embryonic, MyoD, Pax7) compared with alpha Erko and wild-type mice. In a classic Hershberger assay using male rats, beta stimulated muscle growth, accompanied by a strong induction of IGF-1 expression. Our data provide evidence that ER beta signaling is involved in the regulation of skeletal muscle growth and regeneration by stimulating anabolic pathways, activating satellite cells and modulating immune responses.-Velders, M., Schleipen, B., Fritzemeier, K. H., Zierau, O., Diel, P. Selective estrogen receptor-beta activation stimulates skeletal muscle growth and regeneration. FASEB J. 26, 1909-1920 (2012). www.fasebj.org	[Diel, Patrick] German Sports Univ, Deutsch Sporthsch Koln, Dept Mol & Cellular Sports Med, Inst Sports Med, D-50933 Cologne, Germany; [Fritzemeier, Karl H.] Bayer Schering Pharma AG, Berlin, Germany; [Zierau, Oliver] Tech Univ Dresden, Inst Zool, Dept Mol Cell Physiol & Endocrinol, D-01062 Dresden, Germany	German Sport University Cologne; Bayer AG; Bayer Healthcare Pharmaceuticals; Technische Universitat Dresden	Diel, P (corresponding author), German Sports Univ, Deutsch Sporthsch Koln, Dept Mol & Cellular Sports Med, Inst Sports Med, Sportpk Mungersdorf 6, D-50933 Cologne, Germany.	diel@dshs-koeln.de						AMELINK GJ, 1986, J NEUROL SCI, V76, P61, DOI 10.1016/0022-510X(86)90142-5; AMELINK GJ, 1990, ACTA PHYSIOL SCAND, V138, P115, DOI 10.1111/j.1748-1716.1990.tb08823.x; BAR PDR, 1995, BIOCHEM SOC T, V23, pS236; BAR PR, 1988, LIFE SCI, V42, P2677, DOI 10.1016/0024-3205(88)90243-3; Bar PR, 1997, BIOCHEM SOC T, V25, P50; Belcastro AN, 1998, MOL CELL BIOCHEM, V179, P135, DOI 10.1023/A:1006816123601; Borski RJ, 1996, ENDOCRINOLOGY, V137, P3253, DOI 10.1210/en.137.8.3253; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Cvoro A, 2008, J IMMUNOL, V180, P630, DOI 10.4049/jimmunol.180.1.630; Enns DL, 2008, ACTA PHYSIOL, V194, P81, DOI 10.1111/j.1748-1716.2008.01861.x; Enns DL, 2008, J APPL PHYSIOL, V104, P347, DOI 10.1152/japplphysiol.00128.2007; Feng X, 2004, ACTA PHARMACOL SIN, V25, P1489; Fritzemeier KH, 2004, E SCHERING RES FDN W, V46, P127; HARRIS JB, 1981, TOXICON, V19, P419, DOI 10.1016/0041-0101(81)90046-5; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hegele-Hartung C, 2004, P NATL ACAD SCI USA, V101, P5129, DOI 10.1073/pnas.0306720101; HELMKE S, 1986, MEMBRANE BIOCHEM, V6, P239, DOI 10.3109/09687688609065451; Hertrampf T, 2007, BONE, V40, P1529, DOI 10.1016/j.bone.2007.02.006; Hill M, 2003, J PHYSIOL-LONDON, V549, P409, DOI 10.1113/jphysiol.2002.035832; Jiang JMY, 2008, J NUTR, V138, P2106, DOI 10.3945/jn.108.093781; JIANG YL, 1992, J IMMUNOL, V148, P2423; Johansen JA, 2007, J NEUROENDOCRINOL, V19, P823, DOI 10.1111/j.1365-2826.2007.01592.x; Johnson BJ, 1996, J ANIM SCI, V74, P363; Katzenellenbogen BS, 2000, J STEROID BIOCHEM, V74, P279, DOI 10.1016/S0960-0760(00)00104-7; KOOT RW, 1991, J STEROID BIOCHEM, V40, P689, DOI 10.1016/0960-0760(91)90292-D; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MacNeil LG, 2011, AM J PHYSIOL-REG I, V300, pR1443, DOI 10.1152/ajpregu.00689.2009; Martinez CO, 2010, AM J PHYSIOL-REG I, V299, pR832, DOI 10.1152/ajpregu.00797.2009; Massimino ML, 1997, BIOCHEM BIOPH RES CO, V235, P754, DOI 10.1006/bbrc.1997.6823; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Mau M, 2008, PEDIATR RES, V63, P39, DOI 10.1203/PDR.0b013e31815b8e60; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; McCormick KM, 2004, J MUSCLE RES CELL M, V25, P21, DOI 10.1023/B:JURE.0000021398.78327.39; MCLENNAN IS, 1993, CELL TISSUE RES, V272, P193, DOI 10.1007/BF00323586; Milanesi L, 2008, J CELL BIOCHEM, V104, P1254, DOI 10.1002/jcb.21706; Milanesi L, 2009, STEROIDS, V74, P489, DOI 10.1016/j.steroids.2009.01.005; Moresi V, 2008, STEM CELLS, V26, P997, DOI 10.1634/stemcells.2007-0493; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; NG RH, 1980, P NATL ACAD SCI-BIOL, V77, P1346, DOI 10.1073/pnas.77.3.1346; Pedraza-Alva G, 2009, BIOCHEM BIOPH RES CO, V389, P360, DOI 10.1016/j.bbrc.2009.08.153; Peterson JM, 2006, J APPL PHYSIOL, V101, P1394, DOI 10.1152/japplphysiol.01453.2005; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; PLUSKAL MG, 1978, CLIN EXP PHARMACOL P, V5, P131, DOI 10.1111/j.1440-1681.1978.tb00663.x; Rehfeldt C, 2009, J AGR FOOD CHEM, V57, P852, DOI 10.1021/jf803039b; Rigoni M, 2008, J BIOL CHEM, V283, P34013, DOI 10.1074/jbc.M803243200; Schmalbruch H, 2000, MUSCLE NERVE, V23, P617, DOI 10.1002/(SICI)1097-4598(200004)23:4<617::AID-MUS22>3.0.CO;2-Y; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Sitnick M, 2006, J APPL PHYSIOL, V100, P286, DOI 10.1152/japplphysiol.00869.2005; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Sorensen MB, 2001, OBES RES, V9, P622, DOI 10.1038/oby.2001.81; Stupka N, 2001, J APPL PHYSIOL, V91, P1828, DOI 10.1152/jappl.2001.91.4.1828; Sugiura T, 2006, J PHYSIOL SCI, V56, P393, DOI 10.2170/physiolsci.RP006906; Thomas A, 2010, ACTA PHYSIOL, V198, P81, DOI 10.1111/j.1748-1716.2009.02033.x; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tiidus PM, 2005, ACTA PHYSIOL SCAND, V184, P67, DOI 10.1111/j.1365-201X.2005.01427.x; Tiidus PM, 2001, CAN J PHYSIOL PHARM, V79, P400, DOI 10.1139/cjpp-79-5-400; Tournadre Anne, 2007, Curr Rheumatol Rep, V9, P286, DOI 10.1007/s11926-007-0046-6; Tsai WJA, 2007, EXP BIOL MED, V232, P1314, DOI 10.3181/0704-RM-92; Walsh MC, 2006, OSTEOPOROSIS INT, V17, P61, DOI 10.1007/s00198-005-1900-x; WARHOL MJ, 1985, AM J PATHOL, V118, P331; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; Whiting KP, 2000, LIFE SCI, V67, P743, DOI 10.1016/S0024-3205(00)00669-X; Wiik A, 2003, ACTA PHYSIOL SCAND, V179, P381, DOI 10.1046/j.0001-6772.2003.01186.x; Wiik A, 2005, HISTOCHEM CELL BIOL, V124, P161, DOI 10.1007/s00418-005-0030-z; Wiik A, 2009, HISTOCHEM CELL BIOL, V131, P181, DOI 10.1007/s00418-008-0512-x; Zierau O, 2008, MOL CELL ENDOCRINOL, V294, P92, DOI 10.1016/j.mce.2008.08.008; Zoth N, 2010, J STEROID BIOCHEM, V122, P100, DOI 10.1016/j.jsbmb.2010.03.029	73	104	106	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1909	1920		10.1096/fj.11-194779	http://dx.doi.org/10.1096/fj.11-194779			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22278942				2022-12-25	WOS:000303680800019
J	Werthmann, RC; Volpe, S; Lohse, MJ; Calebiro, D				Werthmann, Ruth C.; Volpe, Silvia; Lohse, Martin J.; Calebiro, Davide			Persistent cAMP signaling by internalized TSH receptors occurs in thyroid but not in HEK293 cells	FASEB JOURNAL			English	Article						G-protein-coupled receptor; fluorescence resonance energy transfer; fluorescence imaging	PARATHYROID-HORMONE RECEPTOR; BINDING	G-protein-coupled receptors (GPCRs) have long been believed to activate G proteins only on the cell surface. However, we have recently shown that, in thyroid cells, the GPCR for the thyroid-stimulating hormone (TSH) can continue stimulating cAMP production after cointernalization with TSH. cAMP signaling by internalized TSH receptors (TSHRs) was persistent, whereas that by cell-surface TSHRs was apparently transient, but the reasons for the transient signaling by cell-surface TSHRs were not investigated. Here, we developed and used fluorescence resonance energy transfer (FRET)-based methods to precisely compare the kinetics of TSH binding and dissociation from cell-surface TSHRs with those of the subsequent termination of cAMP signaling directly in living cells. Our results indicate that both TSH binding to human TSHRs expressed in a human embryonic kidney cell line (HEK 293) and the ensuing cAMP signals are rapidly and fully reversible (t(1/2,off) = 2.96 +/- 1.04 and 2.70 +/- 0.73 min, respectively). The FRET measurement of TSH binding was specific, as shown by the lack of a detectable interaction between TSH and the beta(2)-adrenergic receptor expressed in control cells. Enhancing TSHR internalization by beta-arrestin 2 overexpression did not modify the reversibility of TSHR-cAMP signaling. These findings strengthen the view that the cointernalization of TSH-TSHR complexes to a signaling compartment present in thyroid, but not in HEK 293 cells, is responsible for persistent cAMP signaling.-Werthmann, R. C., Volpe, S., Lohse, M. J., Calebiro, D. Persistent cAMP signaling by internalized TSH receptors occurs in thyroid but not in HEK293 cells. FASEB J. 26, 2043-2048 (2012). www.fasebj.org	[Werthmann, Ruth C.; Volpe, Silvia; Lohse, Martin J.; Calebiro, Davide] Univ Wurzburg, Deutsch Forsch Gemeinschaft, Res Ctr Expt Biomed, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Lohse, Martin J.; Calebiro, Davide] Univ Wurzburg, Deutsch Forsch Gemeinschaft, Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Lohse, MJ (corresponding author), Univ Wurzburg, Deutsch Forsch Gemeinschaft, Res Ctr Expt Biomed, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	lohse@toxi.uni-wuerzburg.de; davide.calebiro@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510; calebiro, davide/0000-0002-3811-1553	Deutsche Forschungsgemeinschaft [CA 1014/1-1]; European Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	The authors thank Bianca Klupfel and Christian Dees for excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (grant CA 1014/1-1) and the European Research Council (advanced grant Topas).	Alberti L, 2002, J CLIN ENDOCR METAB, V87, P2549, DOI 10.1210/jc.87.6.2549; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Frenzel R, 2006, ENDOCRINOLOGY, V147, P3114, DOI 10.1210/en.2005-0687; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Neumann S, 2010, FASEB J, V24, P3992, DOI 10.1096/fj.10-161745; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Powell-Jones C. H. J., 1979, J BIOL CHEM, V10, P4001; RAPOPORT B, 1976, ENDOCRINOLOGY, V98, P1189, DOI 10.1210/endo-98-5-1189; SALTIEL AR, 1982, MOL CELL ENDOCRINOL, V28, P299, DOI 10.1016/0303-7207(82)90128-9; Van Sande J, 2003, J CLIN ENDOCR METAB, V88, P5366, DOI 10.1210/jc.2003-030664	18	46	46	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2043	2048		10.1096/fj.11-195248	http://dx.doi.org/10.1096/fj.11-195248			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22291442				2022-12-25	WOS:000303680800030
J	Khandros, E; Mollan, TL; Yu, X; Wang, XM; Yao, Y; D'Souza, J; Gell, DA; Olson, JS; Weiss, MJ				Khandros, Eugene; Mollan, Todd L.; Yu, Xiang; Wang, Xiaomei; Yao, Yu; D'Souza, Janine; Gell, David A.; Olson, John S.; Weiss, Mitchell J.			Insights into Hemoglobin Assembly through in Vivo Mutagenesis of alpha- Hemoglobin Stabilizing Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE-MEMBRANE; HEMIN DISSOCIATION; GLOBIN BINDING; BETA-CHAINS; AHSP; ERYTHROPOIESIS; THALASSEMIA; CYTOGLOBIN; OXIDATION; SUBUNITS	alpha-Hemoglobin stabilizing protein (AHSP) is believed to facilitate adult Hemoglobin A assembly and protect against toxic free alpha-globin subunits. Recombinant AHSP binds multiple forms of free alpha-globin to stabilize their structures and inhibit precipitation. However, AHSP also stimulates auto-oxidation of alpha O-2 subunit and its rapid conversion to a partially unfolded bishistidyl hemichrome structure. To investigate these biochemical properties, we altered the evolutionarily conserved AHSP proline 30 in recombinantly expressed proteins and introduced identical mutations into the endogenous murine Ahsp gene. In vitro, the P30W AHSP variant bound oxygenated alpha chains with 30-fold increased affinity. Both P30W and P30A mutant proteins also caused decreased rates of alpha O-2 autooxidation as compared with wildtype AHSP. Despite these abnormalities, mice harboring P30A or P30W Ahsp mutations exhibited no detectable defects in erythropoiesis at steady state or during induced stresses. Further biochemical studies revealed that the AHSP P30A and P30W substitutions had minimal effects on AHSP interactions with ferric alpha subunits. Together, our findings indicate that the ability of AHSP to stabilize nascent alpha chain folding intermediates prior to hemin reduction and incorporation into adult Hemoglobin A is physiologically more important than AHSP interactions with ferrous alpha O-2 subunits.	[Weiss, Mitchell J.] Childrens Hosp Philadelphia, Div Hematol, Abramson Res Ctr 316B, Philadelphia, PA 19104 USA; [Gell, David A.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Mollan, Todd L.; Olson, John S.] Rice Univ, Biochem & Cell Biol Dept, Houston, TX 77251 USA; [Khandros, Eugene; Yu, Xiang; Weiss, Mitchell J.] Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Tasmania; Menzies Institute for Medical Research; Rice University; University of Pennsylvania	Weiss, MJ (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Abramson Res Ctr 316B, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	weissmi@email.chop.edu	Weiss, Mitchell J/A-1245-2013; yu, xiang/B-1653-2010; Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403; Gell, David/0000-0003-0382-1181	National Institutes of Health [DK061692, HL087427, HL47020, GM35649, GM008362]; Robert A. Welch Foundation [C-0612]; DiGaetano family; National Institutes of Health through the NHLBI [3T32GM007170-35S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020, R01HL087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692, R56DK061692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008362, T32GM007170, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); DiGaetano family; National Institutes of Health through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061692 (to M. J. W.), HL087427 (to M. J. W.), HL47020 (to J. S. O.), GM35649 (to J. S. O.), GM008362 (to T. L. M. through the Biotechnology Predoctoral Training Program at Rice University), and 3T32GM007170-35S1 (to E. K. through the NHLBI Medical Scientist Training Program). This work was also supported by Robert A. Welch Foundation Grant C-0612 (to J. S. O.) and the DiGaetano family.	Adachi K, 2002, J BIOL CHEM, V277, P13415, DOI 10.1074/jbc.M200857200; ADVANI R, 1992, BLOOD, V79, P1058; Alter B P, 1981, Prog Clin Biol Res, V60, P157; ANTONINI E, 1966, J MOL BIOL, V17, P29, DOI 10.1016/S0022-2836(66)80092-X; ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; Baudin-Creuza V, 2004, J BIOL CHEM, V279, P36530, DOI 10.1074/jbc.M405389200; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Bogacheva O, 2008, J BIOL CHEM, V283, P36665, DOI 10.1074/jbc.M807844200; Brillet T, 2010, J BIOL CHEM, V285, P17986, DOI 10.1074/jbc.M109.098491; BRUNORI M, 1975, EUR J BIOCHEM, V53, P99, DOI 10.1111/j.1432-1033.1975.tb04046.x; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Favero ME, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/373859; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Hankeln T, 2002, J BIOL CHEM, V277, P29012, DOI 10.1074/jbc.M204009200; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11300, DOI 10.1021/bi960372d; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; JOSHI W, 1983, J LAB CLIN MED, V102, P46; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Khandros E, 2010, HEMATOL ONCOL CLIN N, V24, P1071, DOI 10.1016/j.hoc.2010.08.013; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Kumar KK, 2010, BIOCHEM J, V432, P275, DOI 10.1042/BJ20100642; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; MANNU F, 1995, BLOOD, V86, P2014, DOI 10.1182/blood.V86.5.2014.bloodjournal8652014; Mollan TL, 2012, J BIOL CHEM, V287, P11338, DOI 10.1074/jbc.M111.313247; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; Nasimuzzaman M, 2010, AM J HEMATOL, V85, P820, DOI 10.1002/ajh.21829; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Pesce A, 2002, ACTA CRYSTALLOGR D, V58, P1848, DOI 10.1107/S090744490201260X; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; RACHMILEWITZ EA, 1974, SEMIN HEMATOL, V11, P441; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; RIFKIND JM, 1994, METHOD ENZYMOL, V231, P449; ROUYERFESSARD P, 1989, J BIOL CHEM, V264, P19092; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; SCHRIER SL, 1989, BLOOD, V74, P2194; SCHULMAN HM, 1974, BIOCHEM BIOPH RES CO, V56, P220, DOI 10.1016/S0006-291X(74)80337-2; SCHULMAN HM, 1974, CAN J BIOCHEM CELL B, V52, P665, DOI 10.1139/o74-095; SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380; SHINAR E, 1989, J CLIN INVEST, V83, P404, DOI 10.1172/JCI113898; SHINAR E, 1987, BLOOD, V70, P158; SORENSEN S, 1990, BLOOD, V75, P1333; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P1, DOI 10.1017/CBO9780511596582; Sugimoto H, 2004, J MOL BIOL, V339, P873, DOI 10.1016/j.jmb.2004.04.024; Turbpaiboon C, 2006, BRIT J HAEMATOL, V132, P370, DOI 10.1111/j.1365-2141.2005.05865.x; Vasseur C, 2011, AM J HEMATOL, V86, P199, DOI 10.1002/ajh.21918; Vasseur C, 2009, CLIN BIOCHEM, V42, P1818, DOI 10.1016/j.clinbiochem.2009.05.011; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Vergara A, 2008, METHOD ENZYMOL, V436, P425, DOI 10.1016/S0076-6879(08)36024-8; Vitagliano L, 2004, EUR J BIOCHEM, V271, P1651, DOI 10.1111/j.1432-1033.2004.04054.x; Wajcman H, 2008, HEMOGLOBIN, V32, P327, DOI 10.1080/03630260802173833; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; WINTERBOURN CC, 1974, J CLIN INVEST, V54, P678, DOI 10.1172/JCI107806; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200	70	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11325	11337		10.1074/jbc.M111.313205	http://dx.doi.org/10.1074/jbc.M111.313205			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22287545	hybrid, Green Published			2022-12-25	WOS:000302780100063
J	Kawabata, T; Tanimura, S; Asai, K; Kawasaki, R; Matsumaru, Y; Kohno, M				Kawabata, Takumi; Tanimura, Susumu; Asai, Kohei; Kawasaki, Ryohei; Matsumaru, Yumi; Kohno, Michiaki			Up-regulation of Pro-apoptotic Protein Bim and Down-regulation of Anti-apoptotic Protein Mcl-1 Cooperatively Mediate Enhanced Tumor Cell Death Induced by the Combination of ERK Kinase (MEK) Inhibitor and Microtubule Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; SIGNALING PATHWAY; CANCER-THERAPY; CONSTITUTIVE ACTIVATION; DESTABILIZING AGENTS; MITOTIC ARREST; PHOSPHORYLATION; BLOCKADE; DESTRUCTION; ARRY-142886	Blockade of the ERK signaling pathway by ERK kinase (MEK) inhibitors selectively enhances the induction of apoptosis by microtubule inhibitors in tumor cells in which this pathway is constitutively activated. We examined the mechanism by which such drug combinations induce enhanced cell death by applying time-lapse microscopy to track the fate of individual cells. MEK inhibitors did not affect the first mitosis after drug exposure, but most cells remained arrested in interphase without entering a second mitosis. Low concentrations of microtubule inhibitors induced prolonged mitotic arrest followed by exit of cells from mitosis without division, with most cells remaining viable. However, the combination of a MEK inhibitor and a microtubule inhibitor induced massive cell death during prolonged mitosis. Impairment of spindle assembly checkpoint function by RNAi-mediated depletion of Mad2 or BubR1 markedly suppressed such prolonged mitotic arrest and cell death. The cell death was accompanied by up-regulation of the pro-apoptotic protein Bim (to which MEK inhibitors contributed) and by down-regulation of the anti-apoptotic protein Mcl-1 (to which microtubule and MEK inhibitors contributed synergistically). Whereas RNAi-mediated knockdown of Bim suppressed cell death, stabilization of Mcl-1 by RNAi-mediated depletion of Mule slowed its onset. Depletion of Mcl-1 sensitized tumor cells to MEK inhibitor-induced cell death, an effect that was antagonized by knockdown of Bim. The combination of MEK and microtubule inhibitors thus targets Bim and Mcl-1 in a cooperative manner to induce massive cell death in tumor cells with aberrant ERK pathway activation.	[Kawabata, Takumi; Tanimura, Susumu; Asai, Kohei; Kawasaki, Ryohei; Matsumaru, Yumi; Kohno, Michiaki] Nagasaki Univ, Lab Cell Regulat, Dept Pharmaceut Sci, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Tanimura, Susumu] Nagasaki Univ Res Ctr Genom Instabil & Carcinogen, Nagasaki 8528523, Japan; [Kohno, Michiaki] Kyoto Univ, Dept Biochem Genet, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan	Nagasaki University; Nagasaki University; Kyoto University	Kohno, M (corresponding author), Nagasaki Univ, Lab Cell Regulat, Dept Pharmaceut Sci, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	kohnom@nagasaki-u.ac.jp	Kohno, Michiaki/R-6532-2019	Kohno, Michiaki/0000-0002-7644-0059	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fennell DA, 2008, ONCOGENE, V27, P1189, DOI 10.1038/sj.onc.1210744; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Hoshino R, 2001, J BIOL CHEM, V276, P2686, DOI 10.1074/jbc.M006132200; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Kaestner P, 2010, J CELL BIOCHEM, V111, P258, DOI 10.1002/jcb.22721; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Kohno M, 2011, BIOL PHARM BULL, V34, P1781, DOI 10.1248/bpb.34.1781; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; McDaid HM, 2005, CANCER RES, V65, P2854, DOI 10.1158/0008-5472.CAN-04-4391; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; OKA H, 1995, CANCER RES, V55, P4182; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293; Tanimura S, 2003, BIOCHEM BIOPH RES CO, V304, P801, DOI 10.1016/S0006-291X(03)00670-3; Tanimura S, 2007, J BIOL CHEM, V282, P35430, DOI 10.1074/jbc.M707547200; Tanimura S, 2009, BIOCHEM BIOPH RES CO, V378, P650, DOI 10.1016/j.bbrc.2008.11.109; Watanabe K, 2010, CLIN CANCER RES, V16, P1170, DOI 10.1158/1078-0432.CCR-09-2482; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	40	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10289	10300		10.1074/jbc.M111.319426	http://dx.doi.org/10.1074/jbc.M111.319426			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22270368	Green Published, hybrid			2022-12-25	WOS:000302167200058
J	Ahmad, B; Lapidus, LJ				Ahmad, Basir; Lapidus, Lisa J.			Curcumin Prevents Aggregation in alpha-Synuclein by Increasing Reconfiguration Rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE; POLYPEPTIDES; DISEASE	alpha-Synuclein is a protein that is intrinsically disordered in vitro and prone to aggregation, particularly at high temperatures. In this work, we examined the ability of curcumin, a compound found in turmeric, to prevent aggregation of the protein. We found strong binding of curcumin to alpha-synuclein in the hydrophobic non-amyloid-beta component region and complete inhibition of oligomers or fibrils. We also found that the reconfiguration rate within the unfolded protein was significantly increased at high temperatures. We conclude that alpha-synuclein is prone to aggregation because its reconfiguration rate is slow enough to expose hydrophobic residues on the same time scale that bimolecular association occurs. Curcumin rescues the protein from aggregation by increasing the reconfiguration rate into a faster regime.	[Ahmad, Basir; Lapidus, Lisa J.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA	Michigan State University	Lapidus, LJ (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	lapidus@msu.edu	Ahmad, Basir/O-9344-2017	Ahmad, Basir/0000-0002-0120-5097	National Science Foundation [MCB-0825001]; Michigan State University High Performance Computing Center; Institute for Cyber Enabled Research	National Science Foundation(National Science Foundation (NSF)); Michigan State University High Performance Computing Center; Institute for Cyber Enabled Research	This work was supported by National Science Foundation Grant MCB-0825001.; We thank Charles Hoogstraten for helpful discussions, Gary Pielak for the kind gift of the alpha-synuclein plasmid, and Terry Ball for mutation and expression of the protein. We acknowledge the support of the Michigan State University High Performance Computing Center and the Institute for Cyber Enabled Research.	Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Amer DAM, 2006, EXP BRAIN RES, V173, P223, DOI 10.1007/s00221-006-0539-y; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Chen YJ, 2009, J PHYS CHEM B, V113, P16209, DOI 10.1021/jp904189b; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; GONNELLI M, 1995, BIOCHEMISTRY-US, V34, P13847, DOI 10.1021/bi00042a017; Kumar P, 2011, INT J MOL SCI, V12, P694, DOI 10.3390/ijms12010694; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lapidus LJ, 2002, J MOL BIOL, V319, P19, DOI 10.1016/S0022-2836(02)00193-6; Lapidus LJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258101; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Singh VR, 2007, BIOCHEMISTRY-US, V46, P10046, DOI 10.1021/bi700270j; Sneharani AH, 2010, J AGR FOOD CHEM, V58, P11130, DOI 10.1021/jf102826q; Sneharani AH, 2009, J AGR FOOD CHEM, V57, P10386, DOI 10.1021/jf902464p; SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	25	117	118	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9193	9199		10.1074/jbc.M111.325548	http://dx.doi.org/10.1074/jbc.M111.325548			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22267729	Green Published, hybrid			2022-12-25	WOS:000301797800047
J	Belyaeva, OV; Lee, SA; Adams, MK; Chang, CB; Kedishvili, NY				Belyaeva, Olga V.; Lee, Seung-Ah; Adams, Mark K.; Chang, Chenbei; Kedishvili, Natalia Y.			Short Chain Dehydrogenase/Reductase Rdhe2 Is a Novel Retinol Dehydrogenase Essential for Frog Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ACID SYNTHESIS; GENE-EXPRESSION; VITAMIN-A; ORGAN DIFFERENTIATION; CELL-DIFFERENTIATION; BILATERAL SYMMETRY; NUCLEAR RECEPTORS; BINDING-PROTEIN; XENOPUS-EMBRYOS	The enzymes responsible for the rate-limiting step in retinoic acid biosynthesis, the oxidation of retinol to retinaldehyde, during embryogenesis and in adulthood have not been fully defined. Here, we report that a novel member of the short chain dehydrogenase/reductase superfamily, frog sdr16c5, acts as a highly active retinol dehydrogenase (rdhe2) that promotes retinoic acid biosynthesis when expressed in mammalian cells. In vivo assays of rdhe2 function show that overexpression of rdhe2 in frog embryos leads to posteriorization and induction of defects resembling those caused by retinoic acid toxicity. Conversely, antisense morpholino-mediated knockdown of endogenous rdhe2 results in phenotypes consistent with retinoic acid deficiency, such as defects in anterior neural tube closure, microcephaly with small eye formation, disruption of somitogenesis, and curved body axis with bent tail. Higher doses of morpholino induce embryonic lethality. Analyses of retinoic acid levels using either endogenous retinoic acid-sensitive gene hoxd4 or retinoic acid reporter cell line both show that the levels of retinoic acid are significantly decreased in rdhe2 morphants. Taken together, these results provide strong evidence that Xenopus rdhe2 functions as a retinol dehydrogenase essential for frog embryonic development in vivo. Importantly, the retinol oxidizing activity of frog rdhe2 is conserved in its mouse homologs, suggesting that rdhe2-related enzymes may represent the previously unrecognized physiologically relevant retinol dehydrogenases that contribute to retinoic acid biosynthesis in higher vertebrates.	[Belyaeva, Olga V.; Lee, Seung-Ah; Adams, Mark K.; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; [Belyaeva, Olga V.; Lee, Seung-Ah; Adams, Mark K.; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, Birmingham, AL 35294 USA; [Chang, Chenbei] Univ Alabama Birmingham, Dept Cell Biol, Sch Dent, Birmingham, AL 35294 USA; [Chang, Chenbei] Univ Alabama Birmingham, Dept Cell Biol, Sch Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Belyaeva, OV (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, 720 20th St S,Kaul 466, Birmingham, AL 35294 USA.	belyaeva@uab.edu; nkedishvili@uab.edu		Beliaeva, Olga/0000-0003-2512-925X; Kedishvili, Natalia/0000-0001-6917-4891	National Institutes of Health [AA12153, GM83029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA12153 (to N. Y. K.) and GM83029 (to C. C.).	Albalat R, 2011, GENOME BIOL EVOL, V3, P985, DOI 10.1093/gbe/evr084; Bavik C, 1996, P NATL ACAD SCI USA, V93, P3110, DOI 10.1073/pnas.93.7.3110; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Cammas L, 2007, DEV DYNAM, V236, P2899, DOI 10.1002/dvdy.21312; Chen YL, 2001, MECH DEVELOP, V101, P91, DOI 10.1016/S0925-4773(00)00558-X; Chung SSW, 2009, DEVELOPMENT, V136, P2091, DOI 10.1242/dev.020040; Cunningham TJ, 2011, DEV DYNAM, V240, P1142, DOI 10.1002/dvdy.22583; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Durston AJ, 1998, CURR TOP DEV BIOL, V40, P111, DOI 10.1016/S0070-2153(08)60366-X; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; FELSENSTEIN, 1989, CLADISTICS, V5, P164; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Hollemann T, 1998, EMBO J, V17, P7361, DOI 10.1093/emboj/17.24.7361; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; IRIE T, 1991, ZOOL SCI, V8, P855; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Koide T, 2001, GENE DEV, V15, P2111, DOI 10.1101/gad.908801; Lee SA, 2009, CHEM-BIOL INTERACT, V178, P182, DOI 10.1016/j.cbi.2008.09.019; Liu LQ, 2012, BIRTH DEFECTS RES B, V95, P79, DOI 10.1002/bdrb.20344; Lloret-Vilaspasa F, 2010, INT J DEV BIOL, V54, P599, DOI 10.1387/ijdb.082705fl; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Matsuzaka Y, 2002, BIOCHEM BIOPH RES CO, V297, P1171, DOI 10.1016/S0006-291X(02)02344-6; MEANS AL, 1995, ANNU REV BIOCHEM, V64, P201, DOI 10.1146/annurev.bi.64.070195.001221; Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; Molotkova N, 2005, MECH DEVELOP, V122, P145, DOI 10.1016/j.mod.2004.10.008; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nie SY, 2006, DEV DYNAM, V235, P301, DOI 10.1002/dvdy.20623; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Reijntjes S, 2010, INT J DEV BIOL, V54, P1267, DOI 10.1387/ijdb.093009sr; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ross AC, 2007, VITAM HORM, V75, P197, DOI 10.1016/S0083-6729(06)75008-7; ROSS AC, 1994, ADV EXP MED BIOL, V352, P187; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; Smith D, 2001, CEREB CORTEX, V11, P894, DOI 10.1093/cercor/11.10.894; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Stern RS, 1997, LANCET, V350, P349, DOI 10.1016/S0140-6736(97)05257-4; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Villarroya F, 1999, INT J OBESITY, V23, P1, DOI 10.1038/sj.ijo.0800799; Wagner E, 2002, CEREB CORTEX, V12, P1244, DOI 10.1093/cercor/12.12.1244; WAGNER M, 1992, DEVELOPMENT, V116, P55; Yelin R, 2005, DEV BIOL, V279, P193, DOI 10.1016/j.ydbio.2004.12.014; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	65	25	26	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9061	9071		10.1074/jbc.M111.336727	http://dx.doi.org/10.1074/jbc.M111.336727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291023	Green Published, hybrid			2022-12-25	WOS:000301797800036
J	Calderon, MR; Verway, M; An, BS; Difeo, A; Bismar, TA; Ann, DK; Martignetti, JA; Shalom-Barak, T; White, JH				Calderon, Mario R.; Verway, Mark; An, Beum-Soo; DiFeo, Analisa; Bismar, Tarek A.; Ann, David K.; Martignetti, John A.; Shalom-Barak, Tali; White, John H.			Ligand-dependent Corepressor (LCoR) Recruitment by Kruppel-like Factor 6 (KLF6) Regulates Expression of the Cyclin-dependent Kinase Inhibitor CDKN1A Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER GROWTH; TUMOR-SUPPRESSOR GENE; UP-REGULATION; E-CADHERIN; TRANSCRIPTIONAL ACTIVATION; RECEPTOR COREPRESSOR; DOWN-REGULATION; REPRESSION; ANDROGEN; PROTEIN	The widely expressed transcriptional coregulator, ligand-dependent corepressor (LCoR), initially characterized as a regulator of nuclear receptor-mediated transactivation, functions through recruitment of C-terminal binding proteins (CtBPs) and histone deacetylases (HDACs) to its N-terminal and central domains, respectively. We performed a yeast two-hybrid screen for novel cofactors, and identified an interaction between the C-terminal domain of LCoR and the transcription factor Kruppel-like factor 6 (KLF6), a putative tumor suppressor in prostate cancer. Subsequent experiments revealed LCoR regulation of several KLF6 target genes notably p21(WAF1/CIP1) (CDKN1A) and to a lesser extent E-cadherin (CDH1), indicating that LCoR regulates gene transcription through multiple classes of transcription factors. In multiple cancer cells, LCoR and KLF6 bind together on the promoters of the genes encoding CDKN1A and CDH1. LCoR contributes to KLF6-mediated transcriptional repression in a promoter-and cell type-dependent manner. Its inhibition of reporter constructs driven by the CDKN1A and CDH1 promoters in PC-3 prostate carcinoma cells is sensitive to treatment with the HDAC inhibitor trichostatin A. Additionally, the LCoR cofactor CtBP1 bound the same promoters and augmented the LCoR-dependent repression in PC-3 cells. Consistent with their inferred roles in transcriptional repression, siRNA-mediated knockdown of KLF6, LCoR, or CtBP1 in PC-3 cells induced expression of CDKN1A and CDH1 and additional KLF6 target genes. We propose a novel model of LCoR function in which promoter-bound KLF6 inhibits transcription of the CDKN1A gene and other genes as well by tethering a transcriptional corepressor complex containing LCoR, with specific contributions by CtBP1 and HDACs.	[Calderon, Mario R.; Verway, Mark; An, Beum-Soo; White, John H.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [White, John H.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [DiFeo, Analisa; Martignetti, John A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [DiFeo, Analisa; Martignetti, John A.] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Bismar, Tarek A.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2V 1P9, Canada; [Ann, David K.] City Hope Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Shalom-Barak, Tali] Univ Pittsburgh, Dept OBGYN & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15213 USA	McGill University; McGill University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Calgary; City of Hope; Beckman Research Institute of City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	White, JH (corresponding author), 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	john.white@mcgill.ca	Bismar, Tarek/ABH-6129-2020; white, john h/N-9782-2013	white, john h/0000-0002-4785-2687; DiFeo, Analisa/0000-0001-8319-6763; Calderon, Mario R/0000-0001-6618-1789	Canadian Institutes of Health Research; Montreal Centre for Experimental Therapeutics in Cancer	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Montreal Centre for Experimental Therapeutics in Cancer	This work was supported in part by a Canadian Institutes of Health Research Operating grant (to J. H. W.).; Supported by a studentship from the Montreal Centre for Experimental Therapeutics in Cancer.	Aaltomaa S, 1999, PROSTATE, V39, P8; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Asim M, 2011, J BIOL CHEM, V286, P37108, DOI 10.1074/jbc.M111.292771; Baretton GB, 1999, BRIT J CANCER, V80, P546, DOI 10.1038/sj.bjc.6690390; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Devlin AM, 2005, J BIOL CHEM, V280, P25506, DOI 10.1074/jbc.M504815200; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Fizazi K, 2002, CLIN CANCER RES, V8, P775; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guo HS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-110; Hall CL, 2010, CANCER RES, V70, P9916, DOI 10.1158/0008-5472.CAN-10-0440; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Kaipparettu BA, 2008, INT J CANCER, V123, P66, DOI 10.1002/ijc.23480; Kojima S, 2000, BLOOD, V95, P1309; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Liu SX, 2003, DRUG RESIST UPDATE, V6, P183, DOI 10.1016/S1368-7646(03)00044-X; Lu S, 1999, ENDOCRINOLOGY, V140, P5054, DOI 10.1210/en.140.11.5054; Madison DL, 2010, ONCOGENE, V29, P6027, DOI 10.1038/onc.2010.338; Metzger E, 2010, NATURE, V464, P792, DOI 10.1038/nature08839; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Palijan A, 2009, J BIOL CHEM, V284, P30275, DOI 10.1074/jbc.M109.051201; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Pelzer AE, 2006, J UROLOGY, V175, P1517, DOI 10.1016/S0022-5347(05)00651-8; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Roy S, 2008, CELL CYCLE, V7, P1828, DOI 10.4161/cc.7.12.6024; Saramaki A, 2009, J BIOL CHEM, V284, P8073, DOI 10.1074/jbc.M808090200; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Sugibayashi R, 2002, ANTICANCER RES, V22, P713; Tavera-Mendoza LE, 2008, P NATL ACAD SCI USA, V105, P8250, DOI 10.1073/pnas.0709279105; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; YANG ZY, 1995, NAT MED, V1, P1052, DOI 10.1038/nm1095-1052	50	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8662	8674		10.1074/jbc.M111.311605	http://dx.doi.org/10.1074/jbc.M111.311605			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277651	hybrid, Green Published			2022-12-25	WOS:000301797800001
J	Hagen-Euteneuer, N; Lutjohann, D; Park, H; Merrill, AH; van Echten-Deckert, G				Hagen-Euteneuer, Nadine; Luetjohann, Dieter; Park, Hyejung; Merrill, Alfred H., Jr.; van Echten-Deckert, Gerhild			Sphingosine 1-Phosphate (S1P) Lyase Deficiency Increases Sphingolipid Formation via Recycling at the Expense of de Novo Biosynthesis in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; SERINE PALMITOYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; LIPID HOMEOSTASIS; CULTURED NEURONS; METABOLISM; CHOLESTEROL; PROTEINS; SALVAGE	Sphingosine 1-phosphate lyase (S1P lyase) irreversibly cleaves sphingosine 1-phosphate (S1P) in the final step of sphingolipid catabolism. As sphingoid bases and their 1-phosphate are not only metabolic intermediates but also highly bioactive lipids that modulate a wide range of physiological processes, it would be predicted that their elevation might induce adjustments in other facets of sphingolipid metabolism and/or alter cell behavior. Indeed, we have previously reported that S1P lyase deficiency causes neurodegeneration and other adverse symptoms. We next asked the question whether and how S1P lyase deficiency affects the metabolism of (glyco)sphingolipids and cholesterol, two lipid classes that might be involved in the neurodegenerative processes observed in S1P lyase-deficient mice. As predicted, there was a considerable increase in free and phosphorylated sphingoid bases upon elimination of S1P lyase, but to our surprise, rather than increasing, the mass of (glyco) sphingolipids persisted at wild type levels. This was discovered to be due to reduced de novo sphingoid base biosynthesis and a corresponding increase in the recycling of the backbones via the salvage pathway. There was also a considerable increase in cholesterol esters, although free cholesterol persisted at wild type levels, which might be secondary to the shifts in sphingolipid metabolism. All in all, these findings show that accumulation of free and phosphorylated sphingoid bases by loss of S1P lyase causes an interesting readjustment of the balance between de novo biosynthesis and recycling to maintain (glyco) sphingolipid homeostasis. These changes, and their impact on the metabolism of other cellular lipids, should be explored as possible contributors to the neurodegeneration in S1P lyase deficiency.	[van Echten-Deckert, Gerhild] Univ Bonn, Kekule Inst, Membrane Biol & Lipid Biochem Unit, Life & Med Sci LIMES Inst, D-53121 Bonn, Germany; [Luetjohann, Dieter] Univ Clin Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of Bonn; University of Bonn; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	van Echten-Deckert, G (corresponding author), Univ Bonn, Kekule Inst, Membrane Biol & Lipid Biochem Unit, Life & Med Sci LIMES Inst, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	g.echten.deckert@uni-bonn.de		Merrill, Alfred/0000-0002-6673-968X	Deutsche Forschungsgemeinschaft [EC 118/6-1]; NIH [GM069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (EC 118/6-1) (to G. v. E.-D.) and by NIH Grant GM069338 (to A. H. M.).	Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Chigorno V, 1997, EUR J BIOCHEM, V250, P661, DOI 10.1111/j.1432-1033.1997.00661.x; Chigorno V, 2005, J BIOL CHEM, V280, P2668, DOI 10.1074/jbc.M407749200; Fyrst H, 2008, BBA-MOL CELL BIOL L, V1781, P448, DOI 10.1016/j.bbalip.2008.05.005; Gillard BK, 1998, GLYCOBIOLOGY, V8, P885, DOI 10.1093/glycob/8.9.885; Hagen N, 2011, CELL DEATH DIFFER, V18, P1356, DOI 10.1038/cdd.2011.7; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Herget T, 2000, J BIOL CHEM, V275, P30344, DOI 10.1074/jbc.M000714200; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Lopes JP, 2010, AGING CELL, V9, P64, DOI 10.1111/j.1474-9726.2009.00536.x; Lutjohann D, 2004, STEROIDS, V69, P431, DOI 10.1016/j.steroids.2004.03.012; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; MANDON EC, 1991, EUR J BIOCHEM, V198, P667, DOI 10.1111/j.1432-1033.1991.tb16065.x; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; Riboni L, 1996, FEBS LETT, V391, P336, DOI 10.1016/0014-5793(96)00772-7; RIBONI L, 1994, FEBS LETT, V352, P323, DOI 10.1016/0014-5793(94)00984-8; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; van Echten-Deckert G, 2006, BBA-BIOMEMBRANES, V1758, P1978, DOI 10.1016/j.bbamem.2006.06.009; Van Veldhoven PP, 2005, CHEM PHYS LIPIDS, V136, P164; Van Veldhoven PP, 2000, METHOD ENZYMOL, V311, P244; VANECHTEN G, 1990, EUR J CELL BIOL, V51, P135; VANECHTEN G, 1990, J BIOL CHEM, V265, P9333; vanEchtenDeckert G, 1997, J BIOL CHEM, V272, P15825, DOI 10.1074/jbc.272.25.15825; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Worgall Tilla S., 2008, V49, P371, DOI 10.1007/978-1-4020-8830-8_14	42	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9128	9136		10.1074/jbc.M111.302380	http://dx.doi.org/10.1074/jbc.M111.302380			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291021	Green Published, hybrid			2022-12-25	WOS:000301797800042
J	Montefusco, DJ; Newcomb, B; Gandy, JL; Brice, SE; Matmati, N; Cowart, LA; Hannun, YA				Montefusco, David J.; Newcomb, Benjamin; Gandy, Jason L.; Brice, Sarah E.; Matmati, Nabil; Cowart, L. Ashley; Hannun, Yusuf A.			Sphingoid Bases and the Serine Catabolic Enzyme CHA1 Define a Novel Feedforward/Feedback Mechanism in the Response to Serine Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGANINE N-ACYLTRANSFERASE; HEAT-STRESS RESPONSE; SACCHAROMYCES-CEREVISIAE; DE-NOVO; THREONINE CATABOLISM; SIGNALING PATHWAY; YEAST; SPHINGOLIPIDS; BIOSYNTHESIS; CERAMIDE	Targets of bioactive sphingolipids in Saccharomyces cerevisiae were previously identified using microarray experiments focused on sphingolipid-dependent responses to heat stress. One of these heat-induced genes is the serine deamidase/dehydratase Cha1 known to be regulated by increased serine availability. This study investigated the hypothesis that sphingolipids may mediate the induction of Cha1 in response to serine availability. The results showed that inhibition of de novo synthesis of sphingolipids, pharmacologically or genetically, prevented the induction of Cha1 in response to increased serine availability. Additional studies implicated the sphingoid bases phytosphingosine and dihydrosphingosine as the likely mediators of Cha1 up-regulation. The yeast protein kinases Pkh1 and Pkh2, known sphingoid base effectors, were found to mediate CHA1 up-regulation via the transcription factor Cha4. Because the results disclosed a role for sphingolipids in negative feedback regulation of serine metabolism, we investigated the effects of disrupting this mechanism on sphingolipid levels and on cell growth. Intriguingly, exposure of the cha1 Delta strain to high serine resulted in hyperaccumulation of endogenous serine and in turn a significant accumulation of sphingoid bases and ceramides. Under these conditions, the cha1 Delta strain displayed a significant growth defect that was sphingolipid-dependent. Together, this work reveals a feedforward/feedback loop whereby the sphingoid bases serve as sensors of serine availability and mediate up-regulation of Cha1 in response to serine availability, which in turn regulates sphingolipid levels by limiting serine accumulation.	[Montefusco, David J.; Newcomb, Benjamin; Gandy, Jason L.; Brice, Sarah E.; Matmati, Nabil; Cowart, L. Ashley; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA.	hannun@musc.edu			National Institutes of Health [2R01GM063265]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444, R01GM063265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM063265 (to Y. A. H.).	Bachelor MA, 2011, J DERMATOL SCI, V63, P164, DOI 10.1016/j.jdermsci.2011.06.001; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BORNAES C, 1993, MOL CELL BIOL, V13, P7604, DOI 10.1128/MCB.13.12.7604; BORNAES C, 1992, GENETICS, V131, P531; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cerbon J, 2005, BIOCHEM J, V388, P169, DOI 10.1042/BJ20040475; Chung NJ, 2001, J BIOL CHEM, V276, P35614, DOI 10.1074/jbc.M105653200; Collart M. A., 2001, CURRENT PROTOCOLS MO; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Cowart LA, 2010, BIOCHEM J, V431, P31, DOI 10.1042/BJ20100307; Cowart LA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.3; Cowart LA, 2006, BIOCHEM J, V393, P733, DOI 10.1042/BJ20050643; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Edinger AL, 2009, BIOCHEM SOC T, V37, P253, DOI 10.1042/BST0370253; Frank MP, 2007, J CHROMATOGR B, V852, P646, DOI 10.1016/j.jchromb.2007.01.002; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; Holmberg S, 1996, GENETICS, V144, P467; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kim S, 2000, GENETICS, V156, P1519; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200; Luo GZ, 2011, J BIOL CHEM, V286, P8759, DOI 10.1074/jbc.M110.196030; MANDALA SM, 1995, J ANTIBIOT, V48, P349, DOI 10.7164/antibiotics.48.349; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Ogawa H, 2006, BBA-PROTEINS PROTEOM, V1764, P961, DOI 10.1016/j.bbapap.2006.02.010; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; PETERSEN JGL, 1988, GENETICS, V119, P527; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Reggiori F, 1998, J BIOL CHEM, V273, P30550, DOI 10.1074/jbc.273.46.30550; Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Tan EH, 2010, ANN ONCOL, V21, P217, DOI 10.1093/annonc/mdp520; Uemura S, 2007, J BIOL CHEM, V282, P8613, DOI 10.1074/jbc.M606649200; Villa NY, 2009, MOL PHARMACOL, V75, P866, DOI 10.1124/mol.108.049809; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; Yamada T, 2008, BBA-GEN SUBJECTS, V1780, P809, DOI 10.1016/j.bbagen.2008.01.020	50	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9280	9289		10.1074/jbc.M111.313445	http://dx.doi.org/10.1074/jbc.M111.313445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277656	hybrid, Green Published			2022-12-25	WOS:000301797800056
J	Lai, CW; Otero, JH; Hendershot, LM; Snapp, E				Lai, Chunwei Walter; Otero, Joel H.; Hendershot, Linda M.; Snapp, Erik			ERdj4 Protein Is a Soluble Endoplasmic Reticulum (ER) DnaJ Family Protein That Interacts with ER-associated Degradation Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDED PROTEINS; QUALITY-CONTROL; ATPASE ACTIVITY; LIVING CELLS; SACCHAROMYCES-CEREVISIAE; DISULFIDE REDUCTASE; MEMBRANE-PROTEIN; BIP; TRANSLOCON; TRANSPORT	Protein localization within cells regulates accessibility for interactions with co-factors and substrates. The endoplasmic reticulum (ER) BiP co-factor ERdj4 is up-regulated by ER stress and has been implicated in ER-associated degradation (ERAD) of multiple unfolded secretory proteins. Several other ERdj family members tend to interact selectively with nascent proteins, presumably because those ERdj proteins associate with the Sec61 translocon that facilitates entry of nascent proteins into the ER. How ERdj4 selects and targets terminally misfolded proteins for destruction remains poorly understood. In this study, we determined properties of ERdj4 that might aid in this function. ERdj4 was reported to retain its signal sequence and to be resistant to mild detergent extraction, suggesting that it was an integral membrane protein. However, live cell photobleaching analyses of GFP-tagged ERdj4 revealed that the protein exhibits diffusion coefficients uncommonly high for an ER integral membrane protein and more similar to the mobility of a soluble luminal protein. Biochemical characterization established that the ERdj4 signal sequence is cleaved to yield a soluble protein. Importantly, we found that both endogenous and overexpressed ERdj4 associate with the integral membrane protein, Derlin-1. Our findings now directly link ERdj4 to the ERAD machinery and suggest a model in which ERjd4 could help recruit clients from throughout the ER to ERAD sites.	[Lai, Chunwei Walter; Snapp, Erik] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Otero, Joel H.; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA	Yeshiva University; Albert Einstein College of Medicine; St Jude Children's Research Hospital	Snapp, E (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10464 USA.	erik-lee.snapp@einstein.yu.edu	Hendershot, Linda/N-8124-2018; Snapp, Erik Lee/H-7152-2019	Hendershot, Linda/0000-0002-5473-0274; Snapp, Erik Lee/0000-0001-9482-2272; Lai, Chunwei/0000-0003-3805-4736	National Institutes of Health [R01GM086530, 1R21AG032544, R01GM054068, T32GM07288]; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086530, R01GM054068, T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM086530 and 1R21AG032544 (to E. S. and C. W. L.) and R01GM054068 (to L. M. H. and J. H. O.).; Supported by National Institutes of Health Medical Scientist Training Program Grant T32GM07288.; Supported by the American Lebanese Syrian Associated Charities.	Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P4395, DOI 10.1128/MCB.8.10.4395; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Bulbarelli A, 2002, J CELL SCI, V115, P1689; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Dejgaard K, 2010, J PROTEOME RES, V9, P1763, DOI 10.1021/pr900900x; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Drenth JPH, 2004, GASTROENTEROLOGY, V126, P1819, DOI 10.1053/j.gastro.2004.02.023; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Heyden ABV, 2011, EMBO J, V30, P3217, DOI 10.1038/emboj.2011.233; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Lai CW, 2010, MOL BIOL CELL, V21, P1909, DOI 10.1091/mbc.E09-12-1066; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; Munro S, 1998, TRENDS CELL BIOL, V8, P11, DOI 10.1016/S0962-8924(97)01197-5; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Sbalzarini IF, 2005, BIOPHYS J, V89, P1482, DOI 10.1529/biophysj.104.057885; SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Siggia ED, 2000, BIOPHYS J, V79, P1761, DOI 10.1016/S0006-3495(00)76428-9; Snapp E.L., 2003, CURRENT PROTOCOLS CE; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Snapp EL, 2004, J CELL BIOL, V164, P997, DOI 10.1083/jcb.200312079; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Weitzmann A, 2007, FEBS J, V274, P5175, DOI 10.1111/j.1742-4658.2007.06039.x; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; ZIEGELHOFFER T, 1995, J BIOL CHEM, V270, P10412, DOI 10.1074/jbc.270.18.10412	59	55	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7969	7978		10.1074/jbc.M111.311290	http://dx.doi.org/10.1074/jbc.M111.311290			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267725	Green Published, hybrid			2022-12-25	WOS:000301349400013
J	Allantaz, F; Cheng, DT; Bergauer, T; Ravindran, P; Rossier, MF; Ebeling, M; Badi, L; Reis, B; Bitter, H; D'Asaro, M; Chiappe, A; Sridhar, S; Pacheco, GD; Burczynski, ME; Hochstrasser, D; Vonderscher, J; Matthes, T				Allantaz, Florence; Cheng, Donavan T.; Bergauer, Tobias; Ravindran, Palanikumar; Rossier, Michel F.; Ebeling, Martin; Badi, Laura; Reis, Bernhard; Bitter, Hans; D'Asaro, Matilde; Chiappe, Alberto; Sridhar, Sriram; Pacheco, Gonzalo Duran; Burczynski, Michael E.; Hochstrasser, Denis; Vonderscher, Jacky; Matthes, Thomas			Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression	PLOS ONE			English	Article							GENE-EXPRESSION; T-CELLS; MICRORNAS; BLOOD; NEUTROPHILS; NAIVE	Blood consists of different cell populations with distinct functions and correspondingly, distinct gene expression profiles. In this study, global miRNA expression profiling was performed across a panel of nine human immune cell subsets (neutrophils, eosinophils, monocytes, B cells, NK cells, CD4 T cells, CD8 T cells, mDCs and pDCs) to identify cell-type specific miRNAs. mRNA expression profiling was performed on the same samples to determine if miRNAs specific to certain cell types down-regulated expression levels of their target genes. Six cell-type specific miRNAs (miR-143; neutrophil specific, miR-125; T cells and neutrophil specific, miR-500; monocyte and pDC specific, miR-150; lymphoid cell specific, miR-652 and miR-223; both myeloid cell specific) were negatively correlated with expression of their predicted target genes. These results were further validated using an independent cohort where similar immune cell subsets were isolated and profiled for both miRNA and mRNA expression. miRNAs which negatively correlated with target gene expression in both cohorts were identified as candidates for miRNA/mRNA regulatory pairs and were used to construct a cell-type specific regulatory network. miRNA/mRNA pairs formed two distinct clusters in the network corresponding to myeloid (nine miRNAs) and lymphoid lineages (two miRNAs). Several myeloid specific miRNAs targeted common genes including ABL2, EIF4A2, EPC1 and INO80D; these common targets were enriched for genes involved in the regulation of gene expression (p<9.0E-7). Those miRNA might therefore have significant further effect on gene expression by repressing the expression of genes involved in transcriptional regulation. The miRNA and mRNA expression profiles reported in this study form a comprehensive transcriptome database of various human blood cells and serve as a valuable resource for elucidating the role of miRNA mediated regulation in the establishment of immune cell identity.	[Allantaz, Florence; Bergauer, Tobias; Ebeling, Martin; Badi, Laura; Reis, Bernhard; Pacheco, Gonzalo Duran] F Hoffmann La Roche Ltd, Pharma Res & Early Dev, Translat Res Sci, Basel, Switzerland; [Cheng, Donavan T.; Ravindran, Palanikumar; Bitter, Hans; Sridhar, Sriram; Burczynski, Michael E.; Vonderscher, Jacky] Roche, Pharma Res & Early Dev, Translat Res Sci, Nutley, NJ USA; [Rossier, Michel F.; D'Asaro, Matilde; Chiappe, Alberto; Hochstrasser, Denis] Univ Hosp Geneva, Dept Genet & Lab Med, Geneva, Switzerland; [Matthes, Thomas] Univ Hosp Geneva, Hematol Serv, Geneva, Switzerland	Roche Holding; Roche Holding; University of Geneva; University of Geneva	Allantaz, F (corresponding author), F Hoffmann La Roche Ltd, Pharma Res & Early Dev, Translat Res Sci, Basel, Switzerland.	florence.frager@hotmail.com; donavan.cheng@roche.com	Rossier, Michel/AAW-2895-2021	Reis, Bernhard/0000-0001-7611-8222	F. Hoffmann-LaRoche Ltd.	F. Hoffmann-LaRoche Ltd.(Hoffmann-La Roche)	This study was supported by F. Hoffmann-LaRoche Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; BEAULIEU AD, 1992, J BIOL CHEM, V267, P426; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; BRAMEIER M, 2010, NUCL ACIDS RES; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Griesinger F, 2002, BRIT J HAEMATOL, V119, P454, DOI 10.1046/j.1365-2141.2002.03850.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kuipers H, 2010, MOL IMMUNOL; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu SM, 2006, J ALLERGY CLIN IMMUN, V118, P496, DOI 10.1016/j.jaci.2006.04.040; Macaulay IC, 2007, BLOOD, V109, P3260, DOI 10.1182/blood-2006-07-036269; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slezak S, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-39; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-225; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zhao CQ, 2009, J PROTEOME RES, V8, P4028, DOI 10.1021/pr900364p; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	37	149	159	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29979	10.1371/journal.pone.0029979	http://dx.doi.org/10.1371/journal.pone.0029979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276136	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100021
J	Gamber, KM; Huo, LH; Ha, S; Hairston, JE; Greeley, S; Bjorbaek, C				Gamber, Kevin M.; Huo, Lihong; Ha, Sangdeuk; Hairston, Joyce E.; Greeley, Sarah; Bjorbaek, Christian			Over-Expression of Leptin Receptors in Hypothalamic POMC Neurons Increases Susceptibility to Diet-Induced Obesity	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; MESSENGER-RNA EXPRESSION; MICE OVEREXPRESSING LEPTIN; AGOUTI-RELATED PROTEIN; ARCUATE NUCLEUS; IN-VIVO; GLUCOSE-HOMEOSTASIS; LOCOMOTOR-ACTIVITY; GENE-EXPRESSION; MOUSE-BRAIN	Diet-induced obesity (DIO) in rodents is characterized by impaired activation of (s) under bar ignal-(t) under bar ransducer and (a) under bar ctivator of (t) under bar ranscription 3 (STAT3) by leptin receptors (LepRb) within the hypothalamic arcuate nucleus. This signaling defect likely plays an important role in development of DIO. However, the neuro-chemical identity of the leptin-STAT3 resistant arcuate neurons has not been determined and the underlying mechanisms responsible for development of cellular leptin resistance remain unclear. To investigate this, we first measured arcuate gene expression of known key signaling components of the LepRb signaling pathway and tested whether specifically the critical arcuate pro-opiomelanocortin (POMC) neurons are resistant to LepRb-STAT3 signaling in mice given a high-fat-diet (HFD) compared to mice provided a low-fat control diet (LFD). We found that leptin-dependent STAT3 phosphorylation was decreased within POMC neurons of HFD mice. In addition, Leprb mRNA and suppressor of cytokine signaling 3 (Socs3) mRNA were elevated in the arcuate of HFD mice. To investigate whether increased LepRb expression per se in POMC neurons can influence development of DIO and Socs3 expression, we created mice that over-express LepRb selectively in POMC neurons (POMC-LepRb). No differences in body weight, fat mass or food intake were found between LFD POMC-LepRb mice and LFD controls. Surprisingly, body weight, fat mass and caloric intake of HFD POMC-LepRb mice was markedly higher than HFD control mice. In addition, arcuate Socs3 mRNA was increased in HFD POMC-LepRb mice compared to HFD controls. These data show that specifically POMC neurons of DIO mice are resistant to STAT3 activation by leptin, indicating that those cells might play a role in development of DIO. Furthermore, over-expression of LepRb selectively in POMC neurons increases susceptibility to the development of DIO. We propose a model where over-reactivity of the leptin-LepRb signaling system in arcuate neurons may play causal a role in development of diet-induced obesity.	[Gamber, Kevin M.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Gamber, KM (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	cbjorbae@bidmc.harvard.edu	Bjorbaek, Christian/S-4727-2019	Gamber, Kevin/0000-0002-0694-7639	American Diabetes Association [7-09-BS-17]; The Richard and Susan Smith Family Foundation [7-05-PPG-02]; National Institutes of Health [DK60673, DK65743]; Endocrine Society; Boston Obesity Nutrition Research Center [DK46200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065743, P30DK046200, R01DK060673] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); The Richard and Susan Smith Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society; Boston Obesity Nutrition Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the American Diabetes Association (7-09-BS-17) and The Richard and Susan Smith Family Foundation Pinnacle Program Project (7-05-PPG-02), the National Institutes of Health (DK60673 and DK65743 and ARRA funds), the Endocrine Society (all to C.B.), and by the Boston Obesity Nutrition Research Center (DK46200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Baskin DG, 2000, REGUL PEPTIDES, V92, P9, DOI 10.1016/S0167-0115(00)00143-9; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bjorbaek C, 2009, J INVEST MED, V57, P789, DOI 10.2310/JIM.0b013e3181bb0d49; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Bradley RL, 2008, OBESITY, V16, P938, DOI 10.1038/oby.2008.39; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Guo FF, 2004, ENDOCRINOLOGY, V145, P2221, DOI 10.1210/en.2003-1312; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Huang XF, 2004, DIABETES OBES METAB, V6, P35, DOI 10.1111/j.1463-1326.2004.00312.x; Huang XF, 2003, MOL BRAIN RES, V115, P21, DOI 10.1016/S0169-328X(03)00174-8; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Isobe A, 2006, PLACENTA, V27, P912, DOI 10.1016/j.placenta.2005.10.003; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Knight ZA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011376; Lam NT, 2004, MOL ENDOCRINOL, V18, P1333, DOI 10.1210/me.2002-0193; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR143, DOI 10.1152/ajpregu.00393.2003; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Low M J, 2004, J Endocrinol Invest, V27, P95; Metlakunta AS, 2008, ENDOCRINOLOGY, V149, P1121, DOI 10.1210/en.2007-1307; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Ogus S, 2003, ENDOCRINOLOGY, V144, P2865, DOI 10.1210/en.2002-0178; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Picardi PK, 2008, ENDOCRINOLOGY, V149, P3870, DOI 10.1210/en.2007-1506; Qiu J, 2001, ENDOCRINOLOGY, V142, P348, DOI 10.1210/en.142.1.348; Reed AS, 2010, DIABETES, V59, P894, DOI 10.2337/db09-1024; Ricci MR, 2003, AM J PHYSIOL-REG I, V285, pR610, DOI 10.1152/ajpregu.00235.2003; Sahu A, 2002, J NEUROENDOCRINOL, V14, P887, DOI 10.1046/j.1365-2826.2002.00856.x; Satoh N, 1997, NEUROSCI LETT, V224, P149, DOI 10.1016/S0304-3940(97)00163-8; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Starr R, 1998, INT J BIOCHEM CELL B, V30, P1081, DOI 10.1016/S1357-2725(98)00067-3; Velloso LA, 2008, NEUROIMMUNOMODULAT, V15, P189, DOI 10.1159/000153423; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; White CL, 2009, AM J PHYSIOL-ENDOC M, V296, pE291, DOI 10.1152/ajpendo.90513.2008; Wilson BD, 1999, ENDOCRINOLOGY, V140, P2387, DOI 10.1210/en.140.5.2387; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	59	57	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30485	10.1371/journal.pone.0030485	http://dx.doi.org/10.1371/journal.pone.0030485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276206	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100050
J	Huijts, M; Duits, A; Staals, J; van Oostenbrugge, RJ				Huijts, Marjolein; Duits, Annelien; Staals, Julie; van Oostenbrugge, Robert J.			Association of Vitamin B12 Deficiency with Fatigue and Depression after Lacunar Stroke	PLOS ONE			English	Article							SCALE; LIFE	Background: In lacunar stroke patients vitamin B12 deficiency is often found and a relationship with the degree of periventricular white matter lesions (pWMLs) is suggested. Given the known relationships between WMLs and depression and between depression and fatigue after stroke, we studied both depression and fatigue in lacunar stroke patients with and without vitamin B12 deficiency. Methods: In 40 first-ever lacunar stroke patients vitamin B12 levels were determined and self-report questionnaires for fatigue and depression were completed three months after stroke. Results: Lacunar stroke patients with vitamin B12 deficiency (N = 13) reported significantly more fatigue (90.7 versus 59.4; p = .001) and depressive symptoms (6.62 versus 3.89; p < 05) than those without (N = 27). In regression analyses, vitamin B12 deficiency was significantly and independently associated with the presence of severe fatigue and clinically significant depression. Conclusions: Our preliminary results suggest a relationship between vitamin B12 deficiency and increased levels of fatigue and depression in lacunar stroke patients. If these findings could be replicated in a larger and general stroke sample, this would open treatment options and may improve quality of life after stroke.	[Huijts, Marjolein; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Duits, Annelien] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol, Maastricht, Netherlands; [Huijts, Marjolein; Duits, Annelien; van Oostenbrugge, Robert J.] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Maastricht, Netherlands; [Huijts, Marjolein; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Huijts, M (corresponding author), Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands.	M.Huijts@mumc.nl	Duits, Annelien/AFK-9032-2022	Duits, Annelien/0000-0003-0279-1806				Baik HW, 1999, ANNU REV NUTR, V19, P357, DOI 10.1146/annurev.nutr.19.1.357; Bol Y, 2009, J PSYCHOSOM RES, V66, P3, DOI 10.1016/j.jpsychores.2008.05.003; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Naess H, 2006, STROKE, V37, P1232, DOI 10.1161/01.STR.0000217652.42273.02; OBrien J, 1996, BRIT J PSYCHIAT, V168, P477, DOI 10.1192/bjp.168.4.477; Pieters B, 2009, STROKE, V40, P1623, DOI 10.1161/STROKEAHA.108.523431; Snaphaan L, 2011, EUR J NEUROL, V18, P611, DOI 10.1111/j.1468-1331.2010.03217.x; Tang WK, 2011, STROKE, V42, P2443, DOI 10.1161/STROKEAHA.111.614586; Tiemeier H, 2002, AM J PSYCHIAT, V159, P2099, DOI 10.1176/appi.ajp.159.12.2099; Van Zandvoort MJE, 1998, J NEUROL NEUROSUR PS, V65, P697, DOI 10.1136/jnnp.65.5.697; Vercoulen J., 1999, GEDRAGSTHERAPIE, V32, P131; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	14	18	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30519	10.1371/journal.pone.0030519	http://dx.doi.org/10.1371/journal.pone.0030519			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276208	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100052
J	Breiman, RF; Cosmas, L; Njuguna, H; Audi, A; Olack, B; Ochieng, JB; Wamola, N; Bigogo, GM; Awiti, G; Tabu, CW; Burke, H; Williamson, J; Oundo, JO; Mintz, ED; Feikin, DR				Breiman, Robert F.; Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George; Tabu, Collins W.; Burke, Heather; Williamson, John; Oundo, Joseph O.; Mintz, Eric D.; Feikin, Daniel R.			Population-Based Incidence of Typhoid Fever in an Urban Informal Settlement and a Rural Area in Kenya: Implications for Typhoid Vaccine Use in Africa	PLOS ONE			English	Article							SALMONELLA-TYPHI; INVASIVE BACTERIAL; NORTHERN TANZANIA; FUNGAL-INFECTIONS; DISEASE BURDEN; UNITED-STATES; BONE-MARROW; CHILDREN; BACTEREMIA; PAKISTAN	Background: High rates of typhoid fever in children in urban settings in Asia have led to focus on childhood immunization in Asian cities, but not in Africa, where data, mostly from rural areas, have shown low disease incidence. We set out to compare incidence of typhoid fever in a densely populated urban slum and a rural community in Kenya, hypothesizing higher rates in the urban area, given crowding and suboptimal access to safe water, sanitation and hygiene. Methods: During 2007-9, we conducted population-based surveillance in Kibera, an urban informal settlement in Nairobi, and in Lwak, a rural area in western Kenya. Participants had free access to study clinics; field workers visited their homes biweekly to collect information about acute illnesses. In clinic, blood cultures were processed from patients with fever or pneumonia. Crude and adjusted incidence rates were calculated. Results: In the urban site, the overall crude incidence of Salmonella enterica serovar Typhi (S. Typhi) bacteremia was 247 cases per 100,000 person-years of observation (pyo) with highest rates in children 5-9 years old (596 per 100,000 pyo) and 2-4 years old (521 per 100,000 pyo). Crude overall incidence in Lwak was 29 cases per 100,000 pyo with low rates in children 2-4 and 5-9 years old (28 and 18 cases per 100,000 pyo, respectively). Adjusted incidence rates were highest in 2-4 year old urban children (2,243 per 100,000 pyo) which were >15-fold higher than rates in the rural site for the same age group. Nearly 75% of S. Typhi isolates were multi-drug resistant. Conclusions: This systematic urban slum and rural comparison showed dramatically higher typhoid incidence among urban children,10 years old with rates similar to those from Asian urban slums. The findings have potential policy implications for use of typhoid vaccines in increasingly urban Africa.	[Breiman, Robert F.; Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George; Burke, Heather; Williamson, John; Oundo, Joseph O.; Feikin, Daniel R.] US Ctr Dis Control & Prevent, Global Dis Detect Div, Kenya Off, Nairobi, Kenya; [Breiman, Robert F.; Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George; Burke, Heather; Williamson, John; Oundo, Joseph O.; Feikin, Daniel R.] US Ctr Dis Control & Prevent, Global Dis Detect Div, Kenya Off, Kisumu, Kenya; [Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Cosmas, Leonard; Njuguna, Henry; Audi, Allan; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Bigogo, Godfrey M.; Awiti, George] Kenya Med Res Inst KEMRI, Kisumu, Kenya; [Tabu, Collins W.] Kenya Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Mintz, Eric D.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	Breiman, RF (corresponding author), US Ctr Dis Control & Prevent, Global Dis Detect Div, Kenya Off, Nairobi, Kenya.	rbreiman@ke.cdc.gov	Bigogo, Godfrey/W-3591-2019	Tabu, Collins/0000-0002-0537-1172; Audi, Allan/0000-0003-1683-554X				BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Brooks WA, 2005, EMERG INFECT DIS, V11, P326, DOI 10.3201/eid1102.040422; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; CONDRAN GA, 1978, HUM ECOL, V6, P27, DOI 10.1007/BF00888565; Crump JA, 2003, CLIN INFECT DIS, V37, P75, DOI 10.1086/375602; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; Ernst R, 1994, IMMIGRANT LIFE NEW Y, P23; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; GILMAN RH, 1975, LANCET, V1, P1211; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Hasan R, 2008, J INFECT DEV COUNTR, V2, P289; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Jain SK, 2009, CURR OPIN MOL THER, V11, P565; Kenya National Bureau of Statistics ( 2009), 2009, 2009 KEN CENS; KLUGMAN KP, 1987, LANCET, V2, P1165; Krieg NR, 1984, BERGEYS MANUAL SYSTE, P427; LEPAGE P, 1987, LANCET, V1, P1458; Levine MM, 2009, NEW ENGL J MED, V361, P403, DOI 10.1056/NEJMe0905519; Lin FYC, 2001, NEW ENGL J MED, V344, P1263, DOI 10.1056/NEJM200104263441701; Luby SP, 2010, VACCINE, V28, P4903, DOI 10.1016/j.vaccine.2010.05.040; Lutterloh EC, 2012, CLIN INFECT IN PRESS, V55; Mandomando I, 2009, TROP MED INT HEALTH, V14, P1467, DOI 10.1111/j.1365-3156.2009.02399.x; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Mweu E, 2008, TROP MED INT HEALTH, V13, P532, DOI 10.1111/j.1365-3156.2008.02031.x; Neil K, 2012, CLIN INFECT IN PRESS, V55; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; Siddiqui FJ, 2006, INT J INFECT DIS, V10, P215, DOI 10.1016/j.ijid.2005.03.010; SONG JH, 1993, J CLIN MICROBIOL, V31, P1439, DOI 10.1128/JCM.31.6.1439-1443.1993; Steele D, 2008, J INFECT DEV COUNTR, V2, P250, DOI 10.3855/jidc.217; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Tacket CO, 2007, CLIN INFECT DIS, V45, pS20, DOI 10.1086/518135; UN-HABITAT, 2010, STAT AFR CIT 2010 GO, V93; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; 2008, RELEVE EPIDEMIOLOGIQ, V83, P49	42	126	126	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29119	10.1371/journal.pone.0029119	http://dx.doi.org/10.1371/journal.pone.0029119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276105	gold, Green Submitted, Green Published			2022-12-25	WOS:000301457200006
J	Derrien, T; Estelle, J; Sola, SM; Knowles, DG; Raineri, E; Guigo, R; Ribeca, P				Derrien, Thomas; Estelle, Jordi; Marco Sola, Santiago; Knowles, David G.; Raineri, Emanuele; Guigo, Roderic; Ribeca, Paolo			Fast Computation and Applications of Genome Mappability	PLOS ONE			English	Article							RNA-SEQ; SEGMENTAL DUPLICATIONS; EVOLUTION; ELEMENTS; STRATEGY	We present a fast mapping-based algorithm to compute the mappability of each region of a reference genome up to a specified number of mismatches. Knowing the mappability of a genome is crucial for the interpretation of massively parallel sequencing experiments. We investigate the properties of the mappability of eukaryotic DNA/RNA both as a whole and at the level of the gene family, providing for various organisms tracks which allow the mappability information to be visually explored. In addition, we show that mappability varies greatly between species and gene classes. Finally, we suggest several practical applications where mappability can be used to refine the analysis of high-throughput sequencing data (SNP calling, gene expression quantification and paired-end experiments). This work highlights mappability as an important concept which deserves to be taken into full account, in particular when massively parallel sequencing technologies are employed. The GEM mappability program belongs to the GEM (GEnome Multitool) suite of programs, which can be freely downloaded for any use from its website (http://gemlibrary.sourceforge.net).	[Derrien, Thomas] Univ Rennes 1, Inst Genet & Dev IGDR, Rennes, France; [Estelle, Jordi; Marco Sola, Santiago; Raineri, Emanuele; Ribeca, Paolo] CNAG, Barcelona, Spain; [Knowles, David G.; Guigo, Roderic] Univ Pompeu Fabra, CRG, Barcelona, Spain	Universite de Rennes; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Derrien, T (corresponding author), Univ Rennes 1, Inst Genet & Dev IGDR, Rennes, France.	toma.derrien@gmail.com; paolo.ribeca@gmail.com	Derrien, Thomas/ABD-6197-2020; Guigo, Roderic/D-1303-2010; Raineri, Emanuele/AAX-7874-2020; Marco-Sola, Santiago/AAB-1471-2020; Estellé, Jordi/A-7976-2008	Guigo, Roderic/0000-0002-5738-4477; Marco-Sola, Santiago/0000-0001-7951-3914; Estellé, Jordi/0000-0002-6241-1732; Derrien, Thomas/0000-0002-8211-5789	Spanish Ministerio de Educacion y Ciencia [BIO2006-03380, CONSOLIDER CSD2007-00050]	Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work has been partially supported by grants BIO2006-03380 (to RG) and CONSOLIDER CSD2007-00050 (to RG and PR) from the Spanish Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Burrows M, 1994, ALGORITHM DATA COMPR, V1, P18; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Du J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000432; Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Huda A, 2009, GENE, V436, P12, DOI 10.1016/j.gene.2009.01.013; KAMINKER JS, 2002, GENOME BIOL, V0003; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OHNO S, 1993, CURR OPIN GENET DEV, V3, P911, DOI 10.1016/0959-437X(93)90013-F; Ohno S, 1987, Haematol Blood Transfus, V31, P511; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pasaniuc B, 2011, J COMPUT BIOL, V18, P459, DOI 10.1089/cmb.2010.0259; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Smit A, 1996, REPEATMASKER OPEN 30; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang J, 2010, BIOINFORMATICS, V26, P2501, DOI 10.1093/bioinformatics/btq460; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170	35	302	337	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30377	10.1371/journal.pone.0030377	http://dx.doi.org/10.1371/journal.pone.0030377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276185	Green Submitted, gold, Green Published			2022-12-25	WOS:000301457200055
J	Jovov, B; Araujo-Perez, F; Sigel, CS; Stratford, JK; McCoy, AN; Yeh, JJ; Keku, T				Jovov, Biljana; Araujo-Perez, Felix; Sigel, Carlie S.; Stratford, Jeran K.; McCoy, Amber N.; Yeh, Jen Jen; Keku, Temitope			Differential Gene Expression between African American and European American Colorectal Cancer Patients	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; PROSTATE-CANCER; NORMAL COLON; TUMOR; PROTEIN; PATHWAY; RNA	The incidence and mortality of colorectal cancer (CRC) is higher in African Americans (AAs) than other ethnic groups in the U. S., but reasons for the disparities are unknown. We performed gene expression profiling of sporadic CRCs from AAs vs. European Americans (EAs) to assess the contribution to CRC disparities. We evaluated the gene expression of 43 AA and 43 EA CRC tumors matched by stage and 40 matching normal colorectal tissues using the Agilent human whole genome 4x44K cDNA arrays. Gene and pathway analyses were performed using Significance Analysis of Microarrays (SAM), Ten- fold cross validation, and Ingenuity Pathway Analysis (IPA). SAM revealed that 95 genes were differentially expressed between AA and EA patients at a false discovery rate of <= 5%. Using IPA we determined that most prominent disease and pathway associations of differentially expressed genes were related to inflammation and immune response. Ten- fold cross validation demonstrated that following 10 genes can predict ethnicity with an accuracy of 94%: CRYBB2, PSPH, ADAL, VSIG10L, C17orf81, ANKRD36B, ZNF835, ARHGAP6, TRNT1 and WDR8. Expression of these 10 genes was validated by qRT- PCR in an independent test set of 28 patients (10 AA, 18 EA). Our results are the first to implicate differential gene expression in CRC racial disparities and indicate prominent difference in CRC inflammation between AA and EA patients. Differences in susceptibility to inflammation support the existence of distinct tumor microenvironments in these two patient populations.	[Jovov, Biljana; Araujo-Perez, Felix; McCoy, Amber N.; Keku, Temitope] Univ N Carolina, Dept Med Gastroenterol, Chapel Hill, NC 27515 USA; [Sigel, Carlie S.] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Stratford, Jeran K.; Yeh, Jen Jen] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Yeh, Jen Jen] Univ N Carolina, Dept Surg, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jovov, B (corresponding author), Univ N Carolina, Dept Med Gastroenterol, Chapel Hill, NC 27515 USA.	bjovov@med.unc.edu		Stratford, Jeran/0000-0003-4305-1468	Gastrointestinal Specialized Program of Research Excellence (GI SPORE) [P50 106991]; University of North Carolina Center for Gastrointestinal Biology and Disease (CGIBD) [P30 DK 34987]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Gastrointestinal Specialized Program of Research Excellence (GI SPORE); University of North Carolina Center for Gastrointestinal Biology and Disease (CGIBD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grant funding for Gastrointestinal Specialized Program of Research Excellence (GI SPORE, P50 106991) and by the University of North Carolina Center for Gastrointestinal Biology and Disease (CGIBD, P30 DK 34987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Dominik D., 2007, Cancer Biomarkers, V3, P301; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216; Camp JT, 2011, MOL CANCER RES, V9, P3, DOI 10.1158/1541-7786.MCR-10-0372; Choi JS, 2006, LUNG, V184, P355, DOI 10.1007/s00408-006-0009-0; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Dybkaer K, 2004, BIOTECHNIQUES, V37, P470, DOI 10.2144/04373RT03; Eaton AM, 2005, CANCER EPIDEM BIOMAR, V14, P2023, DOI 10.1158/1055-9965.EPI-05-0131; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones BA, 2009, CANCER EPIDEMIOL, V33, P249, DOI 10.1016/j.canep.2009.08.004; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kupfer SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026123; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Mori R, 2009, PROSTATE, V69, P12, DOI 10.1002/pros.20851; Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200; Notterman DA, 2001, CANCER RES, V61, P3124; Ollberding NJ, 2010, INT J CANC; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Prakash SK, 2000, HUM MOL GENET, V9, P477, DOI 10.1093/hmg/9.4.477; Roff A, 2008, J STEROID BIOCHEM, V112, P47, DOI 10.1016/j.jsbmb.2008.08.009; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Secher T, 2010, CANCER RES, V70, P1749, DOI 10.1158/0008-5472.CAN-09-3401; Tan EH, 2010, ANN ONCOL, V21, P217, DOI 10.1093/annonc/mdp520; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vinikoor LC, 2009, NUTR CANCER, V61, P427, DOI 10.1080/01635580802710725; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001; Williams CD, 2010, CANCER CAUSE CONTROL, V21, P1171, DOI 10.1007/s10552-010-9544-3; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	40	68	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30168	10.1371/journal.pone.0030168	http://dx.doi.org/10.1371/journal.pone.0030168			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276153	Green Published, gold			2022-12-25	WOS:000301457200037
J	Satoh, R; Tanaka, A; Kita, A; Morita, T; Matsumura, Y; Umeda, N; Takada, M; Hayashi, S; Tani, T; Shinmyozu, K; Sugiura, R				Satoh, Ryosuke; Tanaka, Akitomo; Kita, Ayako; Morita, Takahiro; Matsumura, Yasuhiro; Umeda, Nanae; Takada, Makoto; Hayashi, Sachiko; Tani, Tokio; Shinmyozu, Kaori; Sugiura, Reiko			Role of the RNA-Binding Protein Nrd1 in Stress Granule Formation and Its Implication in the Stress Response in Fission Yeast	PLOS ONE			English	Article							REGULATES CELL INTEGRITY; MESSENGER-RNA; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SEXUAL-DIFFERENTIATION; KINASE; GENE; TIA-1; ACCUMULATION; TRANSLATION	We have previously identified the RNA recognition motif (RRM)-type RNA-binding protein Nrd1 as an important regulator of the posttranscriptional expression of myosin in fission yeast. Pmk1 MAPK-dependent phosphorylation negatively regulates the RNA-binding activity of Nrd1. Here, we report the role of Nrd1 in stress-induced RNA granules. Nrd1 can localize to poly(A)-binding protein (Pabp)-positive RNA granules in response to various stress stimuli, including heat shock, arsenite treatment, and oxidative stress. Interestingly, compared with the unphosphorylatable Nrd1, Nrd1(DD) (phosphorylation-mimic version of Nrd1) translocates more quickly from the cytoplasm to the stress granules in response to various stimuli; this suggests that the phosphorylation of Nrd1 by MAPK enhances its localization to stress-induced cytoplasmic granules. Nrd1 binds to Cpc2 (fission yeast RACK) in a phosphorylation-dependent manner and deletion of Cpc2 affects the formation of Nrd1-positive granules upon arsenite treatment. Moreover, the depletion of Nrd1 leads to a delay in Pabp-positive RNA granule formation, and overexpression of Nrd1 results in an increased size and number of Pabp-positive granules. Interestingly, Nrd1 deletion induced resistance to sustained stresses and enhanced sensitivity to transient stresses. In conclusion, our results indicate that Nrd1 plays a role in stress-induced granule formation, which affects stress resistance in fission yeast.	[Satoh, Ryosuke; Tanaka, Akitomo; Kita, Ayako; Morita, Takahiro; Matsumura, Yasuhiro; Umeda, Nanae; Takada, Makoto; Sugiura, Reiko] Kinki Univ, Lab Mol Pharmacogen, Sch Pharmaceut Sci, Osaka, Japan; [Satoh, Ryosuke] Japan Soc Promot Sci, Tokyo, Japan; [Hayashi, Sachiko; Tani, Tokio] Kumamoto Univ, Dept Biol Sci, Grad Sch Sci & Technol, Kumamoto, Japan; [Shinmyozu, Kaori] RIKEN Ctr Dev Biol, Prote Support Unit, Hyogo, Japan	Kindai University (Kinki University); Japan Society for the Promotion of Science; Kumamoto University; RIKEN	Satoh, R (corresponding author), Kinki Univ, Lab Mol Pharmacogen, Sch Pharmaceut Sci, Osaka, Japan.	sugiurar@phar.kindai.ac.jp	Hayashi, Sachiko/ABF-8191-2020	Hayashi, Sachiko/0000-0003-4606-9057; Satoh, Ryosuke/0000-0002-7467-0096	Ministry of Education, Culture, Sports, Science and Technology of Japan [20112006]; Academic Frontier Project for Private Universities; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [10J05817] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Academic Frontier Project for Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to R. Sugiura). This work was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas RNA regulation (No. 20112006) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to R. Sugiura). This work was also supported in part by the Academic Frontier Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Azad AK, 1997, MOL BIOL CELL, V8, P825, DOI 10.1091/mbc.8.5.825; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Jeong HT, 2004, BIOSCI BIOTECH BIOCH, V68, P1621, DOI 10.1271/bbb.68.1621; Jeong HT, 2004, GENETICS, V167, P77, DOI 10.1534/genetics.167.1.77; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Nunez A, 2010, J BIOL CHEM, V285, P41366, DOI 10.1074/jbc.M110.173815; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; Oowatari Y, 2011, CURR GENET, V57, P191, DOI 10.1007/s00294-011-0335-5; Satoh R, 2009, MOL BIOL CELL, V20, P2473, DOI 10.1091/mbc.E08-09-0893; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Takada H, 2007, MOL BIOL CELL, V18, P4794, DOI 10.1091/mbc.E07-03-0282; TANI T, 1995, MOL BIOL CELL, V6, P1515, DOI 10.1091/mbc.6.11.1515; Toda T, 1996, MOL CELL BIOL, V16, P6752; Tsukahara K, 1998, MOL CELL BIOL, V18, P4488, DOI 10.1128/MCB.18.8.4488; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Wen WL, 2010, NUCLEIC ACIDS RES, V38, P6555, DOI 10.1093/nar/gkq555; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829	33	20	23	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29683	10.1371/journal.pone.0029683	http://dx.doi.org/10.1371/journal.pone.0029683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276125	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200019
J	Benz, C; Clucas, C; Mottram, JC; Hammarton, TC				Benz, Corinna; Clucas, Caroline; Mottram, Jeremy C.; Hammarton, Tansy C.			Cytokinesis in Bloodstream Stage Trypanosoma brucei Requires a Family of Katanins and Spastin	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; CELL-DIVISION; SEVERING ACTIVITY; INDUCIBLE EXPRESSION; TUMOR-SUPPRESSOR; RNA INTERFERENCE; ALPHA-TUBULIN; SPINDLE POLE; P80 KATANIN; LIFE-CYCLE	Microtubule severing enzymes regulate microtubule dynamics in a wide range of organisms and are implicated in important cell cycle processes such as mitotic spindle assembly and disassembly, chromosome movement and cytokinesis. Here we explore the function of several microtubule severing enzyme homologues, the katanins (KAT80, KAT60a, KAT60b and KAT60c), spastin (SPA) and fidgetin (FID) in the bloodstream stage of the African trypanosome parasite, Trypanosoma brucei. The trypanosome cytoskeleton is microtubule based and remains assembled throughout the cell cycle, necessitating its remodelling during cytokinesis. Using RNA interference to deplete individual proteins, we show that the trypanosome katanin and spastin homologues are non-redundant and essential for bloodstream form proliferation. Further, cell cycle analysis revealed that these proteins play essential but discrete roles in cytokinesis. The KAT60 proteins each appear to be important during the early stages of cytokinesis, while downregulation of KAT80 specifically inhibited furrow ingression and SPA depletion prevented completion of abscission. In contrast, RNA interference of FID did not result in any discernible effects. We propose that the stable microtubule cytoskeleton of T. brucei necessitates the coordinated action of a family of katanins and spastin to bring about the cytoskeletal remodelling necessary to complete cell division.	[Benz, Corinna; Clucas, Caroline; Mottram, Jeremy C.; Hammarton, Tansy C.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Benz, C (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Tansy.Hammarton@glasgow.ac.uk	Benz, Corinna/AAD-8702-2021; Hammarton, Tansy/A-5632-2011	Benz, Corinna/0000-0003-4367-2758; Hammarton, Tansy/0000-0002-0799-6600; Mottram, Jeremy/0000-0001-5574-3766	Medical Research Council [G120/1001]; New Investigator Research Grant [GO900239]; Research Councils UK; Wellcome Trust [070231, 084546/Z/07/Z]; Medical Research Council [G0700127, G0900239] Funding Source: researchfish; MRC [G0900239, G120/1001, G0700127] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); New Investigator Research Grant; Research Councils UK(UK Research & Innovation (UKRI)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (via a Career Development Fellowship (ref. G120/1001) and New Investigator Research Grant (ref. GO900239) to TCH), Research Councils UK (Academic Fellowship to TCH) and The Wellcome Trust (Project grant ref. 070231 to JCM and TCH, and Value In People funding ref. 084546/Z/07/Z to TCH for CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; Baines A, 2008, PROTIST, V159, P115, DOI 10.1016/j.protis.2007.09.001; BALABAN N, 1992, CELL MOTIL CYTOSKEL, V21, P138, DOI 10.1002/cm.970210207; BALABAN N, 1989, CELL MOTIL CYTOSKEL, V14, P393, DOI 10.1002/cm.970140309; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Benz C, 2007, MOL BIOCHEM PARASIT, V156, P217, DOI 10.1016/j.molbiopara.2007.08.005; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Buster D, 2002, J CELL SCI, V115, P1083; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Detmer E, 1997, EUR J CELL BIOL, V72, P378; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Dow MR, 1998, GENETICS, V150, P119; Dymek EE, 2004, EUKARYOT CELL, V3, P870, DOI 10.1128/EC.3.4.870-879.2004; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Forsythe GR, 2009, MOL BIOCHEM PARASIT, V164, P131, DOI 10.1016/j.molbiopara.2008.12.008; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, CURR OPIN MICROBIOL, V10, P520, DOI 10.1016/j.mib.2007.10.005; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2005, MOL MICROBIOL, V56, P104, DOI 10.1111/j.1365-2958.2005.04542.x; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; HEMPHILL A, 1991, J STRUCT BIOL, V107, P211, DOI 10.1016/1047-8477(91)90046-Y; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Karabay A, 2004, J NEUROSCI, V24, P5778, DOI 10.1523/JNEUROSCI.1382-04.2004; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kohl L, 1998, MOL BIOCHEM PARASIT, V93, P1, DOI 10.1016/S0166-6851(98)00014-0; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Lu CG, 2007, DEV BIOL, V302, P438, DOI 10.1016/j.ydbio.2006.09.053; Ma JT, 2010, J BIOL CHEM, V285, P15356, DOI 10.1074/jbc.M109.074591; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2011, MOL BIOL CELL, V22, P1550, DOI 10.1091/mbc.E10-12-0951; McNally KP, 2002, CELL MOTIL CYTOSKEL, V53, P337, DOI 10.1002/cm.10080; McNally KP, 2000, J CELL SCI, V113, P1623; Meng QT, 2010, PLANT MOL BIOL, V74, P537, DOI 10.1007/s11103-010-9694-4; Monnerat Severine, 2009, BMC Res Notes, V2, P46, DOI 10.1186/1756-0500-2-46; MUNDAY JC, 2010, MOL BIOCHEM PARASIT, pS166; Olego-Fernandez S, 2009, PROTIST, V160, P576, DOI 10.1016/j.protis.2009.05.003; Panteris E, 2011, CYTOSKELETON, V68, P401, DOI 10.1002/cm.20522; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Price HP, 2010, MOL BIOCHEM PARASIT, V173, P123, DOI 10.1016/j.molbiopara.2010.05.016; Qiang L, 2006, J NEUROSCI, V26, P3120, DOI 10.1523/JNEUROSCI.5392-05.2006; Rasi MQ, 2009, MOL BIOL CELL, V20, P379, DOI 10.1091/mbc.E07-10-1007; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; RINDISBACHER L, 1993, MOL BIOCHEM PARASIT, V58, P83, DOI 10.1016/0166-6851(93)90093-D; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; SASSE R, 1988, J CELL SCI, V90, P577; Schiel JA, 2011, J CELL SCI, V124, P1411, DOI 10.1242/jcs.081448; SCHNEIDER A, 1987, J CELL BIOL, V104, P431, DOI 10.1083/jcb.104.3.431; SCHNEIDER A, 1988, SCIENCE, V241, P459, DOI 10.1126/science.3393912; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Sharma R, 2008, PROTIST, V159, P137, DOI 10.1016/j.protis.2007.07.004; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; SHERWIN T, 1987, J CELL BIOL, V104, P439, DOI 10.1083/jcb.104.3.439; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Spitznagel D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012282; Srayko M, 2000, GENE DEV, V14, P1072; Sudo H, 2008, HUM MOL GENET, V17, P2524, DOI 10.1093/hmg/ddn153; Sudo H, 2007, FASEB J, V21, P2086, DOI 10.1096/fj.06-7254com; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; Vaughan S, 2008, BIOCHEM SOC T, V36, P421, DOI 10.1042/BST0360421; Vedrenne C, 2002, MOL BIOL CELL, V13, P1058, DOI 10.1091/mbc.01-06-0298; Wickstead B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015020; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1992, J CELL SCI, V103, P665; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	88	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30367	10.1371/journal.pone.0030367	http://dx.doi.org/10.1371/journal.pone.0030367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279588	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900065
J	Fritz, HM; Bowyer, PW; Bogyo, M; Conrad, PA; Boothroyd, JC				Fritz, Heather M.; Bowyer, Paul W.; Bogyo, Matthew; Conrad, Patricia A.; Boothroyd, John C.			Proteomic Analysis of Fractionated Toxoplasma Oocysts Reveals Clues to Their Environmental Resistance	PLOS ONE			English	Article							PARASITOPHOROUS VACUOLE MEMBRANE; GONDII OOCYSTS; EIMERIA-MAXIMA; WALL FORMATION; APPLE DOMAINS; WATERBORNE TOXOPLASMOSIS; PROTEIN IDENTIFICATIONS; APICOMPLEXAN PARASITES; MASS-SPECTROMETRY; STAGE CONVERSION	Toxoplasma gondii is an obligate intracellular parasite that is unique in its ability to infect a broad range of birds and mammals, including humans, leading to an extremely high worldwide prevalence and distribution. This work focuses on the environmentally resistant oocyst, which is the product of sexual replication in felids and an important source of human infection. Due to the difficulty in producing and working with oocysts, relatively little is known about how this stage is able to resist extreme environmental stresses and how they initiate a new infection, once ingested. To fill this gap, the proteome of the wall and sporocyst/sporozoite fractions of mature, sporulated oocysts were characterized using one-dimensional gel electrophoresis followed by LC-MS/MS on trypsin-digested peptides. A combined total of 1021 non-redundant T. gondii proteins were identified in the sporocyst/sporozoite fraction and 226 were identified in the oocyst wall fraction. Significantly, 172 of the identified proteins have not previously been identified in Toxoplasma proteomic studies. Among these are several of interest for their likely role in conferring environmental resistance including a family of small, tyrosinerich proteins present in the oocyst wall fractions and late embryogenesis abundant domain-containing (LEA) proteins in the cytosolic fractions. The latter are known from other systems to be key to enabling survival against desiccation.	[Fritz, Heather M.; Conrad, Patricia A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [Bowyer, Paul W.; Bogyo, Matthew; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Bowyer, Paul W.; Bogyo, Matthew] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Davis; Stanford University; Stanford University	Fritz, HM (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.	paconrad@ucdavis.edu; john.boothroyd@stanford.edu		Boothroyd, John C./0000-0001-9719-745X; Bogyo, Matthew/0000-0003-3753-4412; /0000-0002-4046-9191	National Institutes of Health (NIH) [AI41014, AI21423, RR07038, R01 AI078947]; EuPathDB.org; National Science Foundation/EID [1065990]; National Center For Research Resources [K01RR031487]; Burroughs Wellcome New Investigator in Pathogenesis Award; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031487, T32RR007038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041014, R37AI021423, R01AI021423, R01AI078947] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010917] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EuPathDB.org; National Science Foundation/EID; National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Burroughs Wellcome New Investigator in Pathogenesis Award(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants AI41014, AI21423 and a Eukaryotic Pathogens - Driving Biological Projects grant (EuPathDB.org). Oocyst production was funded by National Science Foundation/EID grant # 1065990. HF was supported by NIH T32 grant # RR07038 and Award Number K01RR031487 from the National Center For Research Resources. PB and MB were supported by NIH Grant R01 AI078947 (to MB) and a Burroughs Wellcome New Investigator in Pathogenesis Award (to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG USEP, 1999, COMB SEW OV TECHN FA; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; [Anonymous], [No title captured]; Aramini JJ, 1999, EPIDEMIOL INFECT, V122, P305, DOI 10.1017/S0950268899002113; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Belli SI, 2003, GENE, V307, P201, DOI 10.1016/S0378-1119(03)00451-7; Belli SI, 2002, INT J PARASITOL, V32, P1727, DOI 10.1016/S0020-7519(02)00212-6; Belli SI, 2003, EUKARYOT CELL, V2, P456, DOI 10.1128/EC.2.3.456-464.2003; BENENSON MW, 1982, NEW ENGL J MED, V307, P666, DOI 10.1056/NEJM198209093071107; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Bowyer PW, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001636; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown PJ, 2001, FEBS LETT, V497, P31, DOI 10.1016/S0014-5793(01)02424-3; Che FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000745; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; Dabritz HA, 2007, JAVMA-J AM VET MED A, V231, P1676, DOI 10.2460/javma.231.11.1676; de Moura L, 2006, EMERG INFECT DIS, V12, P326, DOI 10.3201/eid1202.041115; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Dubey JP, 1996, J PARASITOL, V82, P438, DOI 10.2307/3284082; DUBEY JP, 1972, J PARASITOL, V58, P1005, DOI 10.2307/3286603; Dumetre A, 2005, J MICROBIOL METH, V61, P209, DOI 10.1016/j.mimet.2004.11.024; Dumetre A, 2003, FEMS MICROBIOL REV, V27, P651, DOI 10.1016/S0168-6445(03)00071-8; Dumetre A, 2008, VET PARASITOL, V153, P209, DOI 10.1016/j.vetpar.2008.02.004; Dybas JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003899; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; El Hajj H, 2007, CELL MICROBIOL, V9, P54, DOI 10.1111/j.1462-5822.2006.00767.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Everson WV, 2002, J EUKARYOT MICROBIOL, V49, P344, DOI 10.1111/j.1550-7408.2002.tb00381.x; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; Ferguson DJP, 2004, INT J PARASITOL, V34, P347, DOI 10.1016/j.ijpara.2003.11.024; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; FRITZ H, 2011, J MICROBIOL METHODS; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Hill D, 2011, J PARASITOL, V97, P328, DOI 10.1645/GE-2782.1; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Kim K, 2008, MICROBES INFECT, V10, P978, DOI 10.1016/j.micinf.2008.07.015; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; Kuticic V, 1996, CURR TOP MICROBIOL, V219, P261; Kwok LY, 2004, MOL MICROBIOL, V51, P47, DOI 10.1046/j.1365-2958.2003.03823.x; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Lindsay DS, 2002, VET PARASITOL, V103, P309, DOI 10.1016/S0304-4017(01)00554-4; Mai K, 2009, MEM I OSWALDO CRUZ, V104, P281, DOI 10.1590/S0074-02762009000200022; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Pernas L, 2010, INT J PARASITOL, V40, P1367, DOI 10.1016/j.ijpara.2010.07.002; Possenti A, 2010, INT J PARASITOL, V40, P1639, DOI 10.1016/j.ijpara.2010.06.009; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; Reese ML, 2009, TRAFFIC, V10, P1458, DOI 10.1111/j.1600-0854.2009.00958.x; REESE ML, 2011, J BIOL CHEM; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; Rejmanek D, 2010, J PARASITOL, V96, P516, DOI 10.1645/GE-2372.1; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; SIBLEY LD, 1995, J CELL SCI, V108, P1669; Sinai AP, 2001, J CELL BIOL, V154, P95, DOI 10.1083/jcb.200101073; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tilley M, 1997, INFECT IMMUN, V65, P4598, DOI 10.1128/IAI.65.11.4598-4605.1997; Tomavo S, 2001, INT J PARASITOL, V31, P1023, DOI 10.1016/S0020-7519(01)00193-X; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Wainwright KE, 2007, J PARASITOL, V93, P925, DOI 10.1645/GE-1063R.1; Wainwright KE, 2007, APPL ENVIRON MICROB, V73, P5663, DOI 10.1128/AEM.00504-07; Xia D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r116; Zhou XW, 2005, J BIOL CHEM, V280, P34233, DOI 10.1074/jbc.M504160200; [No title captured]; CHEREMISINOFF NHOWAW	70	77	85	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29955	10.1371/journal.pone.0029955	http://dx.doi.org/10.1371/journal.pone.0029955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279555	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000299771900033
J	Mendonca, A; Aristegui, J; Vilas, JC; Montero, MF; Ojeda, A; Espino, M; Martins, A				Mendonca, Ana; Aristegui, Javier; Carlos Vilas, Juan; Fernanda Montero, Maria; Ojeda, Alicia; Espino, Minerva; Martins, Ana			Is There a Seamount Effect on Microbial Community Structure and Biomass? The Case Study of Seine and Sedlo Seamounts (Northeast Atlantic)	PLOS ONE			English	Article							PLANKTON RESPIRATION; FLOW-CYTOMETRY; CELL-VOLUME; PICOPLANKTON; BALANCE; PHYTOPLANKTON; BACTERIA; OCEAN; PHOTOSYNTHESIS; METABOLISM	Seamounts are considered to be "hotspots" of marine life but, their role in oceans primary productivity is still under discussion. We have studied the microbial community structure and biomass of the epipelagic zone (0-150 m) at two northeast Atlantic seamounts (Seine and Sedlo) and compared those with the surrounding ocean. Results from two cruises to Sedlo and three to Seine are presented. Main results show large temporal and spatial microbial community variability on both seamounts. Both Seine and Sedlo heterotrophic community (abundance and biomass) dominate during winter and summer months, representing 75% (Sedlo, July) to 86% (Seine, November) of the total plankton biomass. In Seine, during springtime the contribution to total plankton biomass is similar (47% autotrophic and 53% heterotrophic). Both seamounts present an autotrophic community structure dominated by small cells (nano and picophytoplankton). It is also during spring that a relatively important contribution (26%) of large cells to total autotrophic biomass is found. In some cases, a 'seamount effect" is observed on Seine and Sedlo microbial community structure and biomass. In Seine this is only observed during spring through enhancement of large autotrophic cells at the summit and seamount stations. In Sedlo, and despite the observed low biomasses, some clear peaks of picoplankton at the summit or at stations within the seamount area are also observed during summer. Our results suggest that the dominance of heterotrophs is presumably related to the trapping effect of organic matter by seamounts. Nevertheless, the complex circulation around both seamounts with the presence of different sources of mesoscale variability (e.g. presence of meddies, intrusion of African upwelling water) may have contributed to the different patterns of distribution, abundances and also changes observed in the microbial community.	[Mendonca, Ana; Martins, Ana] Univ Azores, Dept Oceanog & Fisheries, Horta, Portugal; [Aristegui, Javier; Carlos Vilas, Juan; Fernanda Montero, Maria; Espino, Minerva] Univ Las Palmas Gran Canaria, Inst Oceanog & Cambio Global, Gran Canaria, Spain; [Ojeda, Alicia] Inst Canario Ciencias Marinas, Gran Canaria, Spain	Universidade dos Acores; Universidad de Las Palmas de Gran Canaria	Mendonca, A (corresponding author), Univ Azores, Dept Oceanog & Fisheries, Horta, Portugal.	amendonca@uac.pt	da Silva Fernandes Martins, Ana Maria de Pinho Ferreira/X-8053-2019; Arístegui, Javier/D-5833-2013; Martins, Ana/E-3200-2010	da Silva Fernandes Martins, Ana Maria de Pinho Ferreira/0000-0002-4169-8201; Arístegui, Javier/0000-0002-7526-7741; Martins, Ana/0000-0002-4169-8201; Montero, Maria F./0000-0001-8124-8136	OASIS [EVK3-2001-00152]; CIMBA [3.3.44 (46-03-03-FDR-00043)]; ESA/FCT [PDCTE/CTA/49965/2003]; DRCT [DRCT-M2.1.2/F/008/2007]; one Doctoral Fellowship [UAc/DRCT/REF. U&D/MED.M3.1.1/I/003/2005/A]	OASIS; CIMBA; ESA/FCT; DRCT; one Doctoral Fellowship	Funding was obtained through scientific projects: Project OASIS (EVK3-2001-00152); Project CIMBA 3.3.44 (46-03-03-FDR-00043) PRODESA; ESA/FCT project OPALINA (PDCTE/CTA/49965/2003); DRCT project LAMAR (DRCT-M2.1.2/F/008/2007) and one Doctoral Fellowship (UAc/DRCT/REF. U&D/MED.M3.1.1/I/003/2005/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristegui J, 2005, J MARINE SYST, V54, P65, DOI 10.1016/j.jmarsys.2004.07.004; Aristegui J, 2004, PROG OCEANOGR, V62, P95, DOI 10.1016/j.pocean.2004.07.004; Aristegui J, 2002, AQUAT MICROB ECOL, V29, P199, DOI 10.3354/ame029199; Aristegui J, 2009, DEEP-SEA RES PT II, V56, P2646, DOI 10.1016/j.dsr2.2008.12.025; Baltar F, 2010, ISME J, V4, P975, DOI 10.1038/ismej.2010.33; Baltar F, 2009, PROG OCEANOGR, V83, P180, DOI 10.1016/j.pocean.2009.07.016; Bashmachnikov I, 2009, DEEP-SEA RES PT II, V56, P2593, DOI 10.1016/j.dsr2.2008.12.036; BECKMANN A, 2002, OCEAN DYNAM, V52, P194, DOI DOI 10.1007/S10236-002-0018-3; BLANCHOT J, 1992, J PLANKTON RES, V14, P137, DOI 10.1093/plankt/14.1.137; BONILLAFINDJI O, 2010, BIOGEOSCIENCES DISCU, V7, P2033; BORSHEIM KY, 1987, MAR ECOL PROG SER, V36, P171, DOI 10.3354/meps036171; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x; CAMPBELL L, 1993, DEEP-SEA RES PT I, V40, P2043, DOI 10.1016/0967-0637(93)90044-4; Christiansen B, 2009, DEEP-SEA RES PT II, V56, P2579, DOI 10.1016/j.dsr2.2008.12.021; COMEAU LA, 1995, DEEP-SEA RES PT I, V42, P993, DOI 10.1016/0967-0637(95)00050-G; DOWER J, 1992, DEEP-SEA RES, V39, P1139, DOI 10.1016/0198-0149(92)90061-W; Duarte CM, 2009, LIMNOL OCEANOGR, V54, P1015, DOI 10.4319/lo.2009.54.3.1015; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Duarte MC, 2001, LIMNOL OCEANOGR, V46, P425, DOI 10.4319/lo.2001.46.2.0425; FURUYA K, 1995, BIOGEOCHEMICAL PROCE, P255; Garcia-Munoz M, 2004, PROG OCEANOGR, V62, P115, DOI 10.1016/j.pocean.2004.07.005; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Gasol JM, 1999, AQUAT MICROB ECOL, V16, P251, DOI 10.3354/ame016251; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; GENIN A, 1985, J MAR RES, V43, P907, DOI 10.1357/002224085788453868; Genin Amatzia, 2007, Fish and Aquatic Resources Series, V12, P85; HAAS LW, 1982, ANN I OCEANOGR PARIS, V58, P261; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Kamiya E, 2007, J OCEANOGR, V63, P101, DOI 10.1007/s10872-007-0008-7; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machin F, 2009, DEEP-SEA RES PT II, V56, P2606, DOI 10.1016/j.dsr2.2008.12.038; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Margalef R., 1967, Oceanography and Marine Biology, V5, P257; MARTINS AM, 2007, P SOC PHOTO-OPT INS, V6743; Mendonca A, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3328872; Mohn C, 2009, DEEP-SEA RES PT II, V56, P2582, DOI 10.1016/j.dsr2.2008.12.037; Mourino B, 2001, OCEANOL ACTA, V24, P167, DOI 10.1016/S0399-1784(00)01138-5; Navarro N, 2004, AQUAT MICROB ECOL, V37, P47, DOI 10.3354/ame037047; Odate T, 1998, DEEP-SEA RES PT I, V45, P1595, DOI 10.1016/S0967-0637(98)00031-4; OLSON RJ, 1990, DEEP-SEA RES, V37, P1033, DOI 10.1016/0198-0149(90)90109-9; Parsons T.R., 1984, MANUAL CHEM BIOL MET; Partensky F, 1996, DEEP-SEA RES PT I, V43, P1191, DOI 10.1016/0967-0637(96)00056-8; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Robinson C, 2002, DEEP-SEA RES PT I, V49, P787, DOI 10.1016/S0967-0637(01)00083-8; Serret P, 2001, LIMNOL OCEANOGR, V46, P1642, DOI 10.4319/lo.2001.46.7.1642; SIERACKI ME, 1995, DEEP-SEA RES PT I, V42, P1399, DOI 10.1016/0967-0637(95)00055-B; Smayda T. J., 1965, Bulletin Inter-American Tropical Tuna Commission, V9, P465; Smith EM, 2001, LIMNOL OCEANOGR, V46, P473, DOI 10.4319/lo.2001.46.3.0473; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; TOKAREV YN, 2003, MARINE ECOLOGICAL J, V2, P46; Vaque D, 2001, AQUAT MICROB ECOL, V25, P163, DOI 10.3354/ame025163; VELDHUIS MJW, 1993, NETH J SEA RES, V31, P135, DOI 10.1016/0077-7579(93)90003-B; Vilas JC, 2009, DEEP-SEA RES PT II, V56, P2618, DOI 10.1016/j.dsr2.2008.12.023; WESSEL P, 2007, FISH AQUATIC RESOURC, V12, P3; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; WHITE M, 2007, FISH AQUATIC RESOURC, V12, P65; Williams PJL, 1998, NATURE, V394, P55; Zar JH, 1999, BIOSTATISTICAL ANAL; Zubkov MV, 2000, AQUAT MICROB ECOL, V21, P13, DOI 10.3354/ame021013	60	38	44	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29526	10.1371/journal.pone.0029526	http://dx.doi.org/10.1371/journal.pone.0029526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279538	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900016
J	Zhang, Y; Hu, RM; Wu, HJ; Jiang, WN; Sun, Y; Wang, Y; Song, YN; Jin, T; Zhang, HX; Mao, X; Zhao, ZH; Zhang, ZG				Zhang, Yan; Hu, Ruimin; Wu, Huijuan; Jiang, Weina; Sun, Yu; Wang, Yan; Song, Yanan; Jin, Tong; Zhang, Hongxia; Mao, Xin; Zhao, Zhonghua; Zhang, Zhigang			OTUB1 Overexpression in Mesangial Cells Is a Novel Regulator in the Pathogenesis of Glomerulonephritis through the Decrease of DCN Level	PLOS ONE			English	Article							NF-KAPPA-B; DEUBIQUITINATING ENZYMES; GLOMERULAR EXPRESSION; DECORIN GENE; UBIQUITIN; RAT; PROTEASES; KIDNEY; DOMAIN; RESPONSES	Background: OTUB1 is a member of OTUs (Ovarian-tumor-domain-containing proteases), a deubiquitinating enzymes family (DUBs), which was shown as a proteasome-associated DUB to be involved in the proteins Ub-dependent degradation. It has been reported that OTUB1 was expressed in kidney tissue. But its concrete cellular location and function in the kidney remain unclear. Decorin (DCN) in mesangial cells (MC) is considered to be a potentially important factor for antagonizing glomerulonephritides, and its degradation is mediated by ubiquitination. The aim of this study is to investigate the role of OTUB1 expression in MC and its relationship with DCN during glomerulonephritis. Methodology/Principal Findings: Using quantitative RT-PCR and Western blot, we demonstrated that OTUB1 mRNA and protein were constitutively expressed in cultured rat MC and found to be upregulated by the stimulation of IL-1 beta or ATS. OTUB1 overexpression was detected in the mesangial area of glomeruli in some immunocomplex mediated nephritides such as IgA nephropathy, acute diffuse proliferative glomerulonephritis and lupus nephritis by immunohistochemistry. The immunoprecipitation assay demonstrated that OTUB1 interacted with DCN. The overexpression of OTUB1 enhanced the ubiquitination and degradation of DCN in MC. Conclusion/Significance: These data showed the inflammatory injury could up-regulate OTUB1 expression in MC, which might attribute the promoting effect of OTUB1 on glomerulonephritides to the decrease of DCN level.	[Zhang, Yan; Hu, Ruimin; Wu, Huijuan; Jiang, Weina; Sun, Yu; Wang, Yan; Song, Yanan; Jin, Tong; Zhang, Hongxia; Mao, Xin; Zhao, Zhonghua; Zhang, Zhigang] Fudan Univ, Key Lab Mol Med, Chinese Educ Minist, Dept Pathol,Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University	Zhang, Y (corresponding author), Fudan Univ, Key Lab Mol Med, Chinese Educ Minist, Dept Pathol,Shanghai Med Coll, Shanghai 200433, Peoples R China.	zzg@shmu.edu.cn			National Nature Science Foundation of China [NFSC: 30570859, NFSC: 30900683]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by two grants from the National Nature Science Foundation of China (NFSC: 30570859; NFSC: 30900683). The website is http://www.nsfc.gov.cn/Portal0/default124.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Arguello MD, 2007, CELL HOST MICROBE, V2, P367, DOI 10.1016/j.chom.2007.11.005; BALAKIREV M, 2003, EMBO REPORTS, P517; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; CHENG GP, 1996, J CLIN EXP PATHOL, V12, P241; Costacurta A, 2002, J CLIN LAB ANAL, V16, P178, DOI 10.1002/jcla.10038; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; EDELMANN M, 2009, BIOCHEM J, P379; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; ISAKA Y, 1996, NAT MED, P418; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; KOMANDER D, 2008, BIOCHEM J, P77; Kuroda M, 2004, CLIN NEPHROL, V61, P7; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Makarova KS, 2000, TRENDS BIOCHEM SCI, V25, P50, DOI 10.1016/S0968-0004(99)01530-3; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mogyorosi A, 1999, NEPHROL DIAL TRANSPL, V14, P1078, DOI 10.1093/ndt/14.5.1078; Mogyorosi A, 1998, AM J PHYSIOL-RENAL, V275, pF827, DOI 10.1152/ajprenal.1998.275.5.F827; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Reyes-Turcu FE, 2009, CHEM REV, V109, P1495, DOI 10.1021/cr800470j; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; SASS GL, 1995, DEV BIOL, V167, P201, DOI 10.1006/dbio.1995.1017; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2001, FASEB J, V15, P559; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; [佟建霞 TONG Jianxia], 2006, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V26, P230; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wang HJ, 2005, EXP MOL PATHOL, V78, P17, DOI 10.1016/j.yexmp.2004.07.006; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; Wu F, 2007, EUR J MED RES, V12, P360; Wu HJ, 2010, J CELL BIOCHEM, V111, P1010, DOI 10.1002/jcb.22789; Xia QW, 2008, FRONT BIOSCI-LANDMRK, V13, P3850; YAMAMOTO T, 1987, KIDNEY INT, V32, P514, DOI 10.1038/ki.1987.240; ZHANG M, 1995, J SHANGHAI MED U, V22, P207	40	4	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29654	10.1371/journal.pone.0029654	http://dx.doi.org/10.1371/journal.pone.0029654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279542	Green Submitted, gold, Green Published			2022-12-25	WOS:000299771900020
J	Kamath-Loeb, A; Loeb, LA; Fry, M				Kamath-Loeb, Ashwini; Loeb, Lawrence A.; Fry, Michael			The Werner Syndrome Protein Is Distinguished from the Bloom Syndrome Protein by Its Capacity to Tightly Bind Diverse DNA Structures	PLOS ONE			English	Article							G4 DNA; SEQUENCE D(CGG)(N); SYNDROME HELICASE; BLM; EXONUCLEASE; SUBSTRATE; GENETICS; FEATURES; COMPLEX; QTBP42	Loss of Werner syndrome helicase-exonuclease (WRN) or of its homolog Bloom syndrome helicase (BLM) results in different inherited disorders. Whereas Werner syndrome is characterized by premature onset of aging and age-associated diseases, Bloom syndrome involves developmental abnormalities and increased predisposition to diverse malignancies. To identify biochemical differences between WRN and BLM that might contribute to the dissimilar outcomes of their loss, we compared their abilities to unwind and bind in vitro diverse DNA structures. Full-length recombinant WRN and BLM proteins expressed in and purified from Sf9 insect cells unwound to comparable extents and with similar K-m values partial DNA duplex, splayed arm DNA and G'2 bimolecular quadruplex DNA. However, WRN resolved bubble DNA similar to 25-fold more efficiently than BLM. The two enzymes were mainly distinguished by their contrasting abilities to bind DNA. WRN bound partial duplexes, bubble and splayed arm DNA and G'2 bimolecular and G4 four-molecular quadruplexes with dissociation constants of 0.25 to 25 nM. By contrast, BLM formed substantial complexes with only G4 quadruplex DNA while binding only marginally other DNA structures. We raise the possibility that in addition to its enzymatic activities WRN may act as a scaffold for the assembly on DNA of additional DNA processing proteins.	[Kamath-Loeb, Ashwini; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Gottstein Mem Canc Res Ctr, Seattle, WA 98195 USA; [Fry, Michael] Technion Israel Inst Technol, Rappaport Fac Med, Dept Biochem, Haifa, Israel	University of Washington; University of Washington Seattle; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Kamath-Loeb, A (corresponding author), Univ Washington, Dept Pathol, Gottstein Mem Canc Res Ctr, Seattle, WA 98195 USA.	mickey@tx.technion.ac.il			United States-Israel Binational Science Foundation; NCI [P01-CA77852]; NIA ARRA [R01-AG033061]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033061] Funding Source: NIH RePORTER	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA ARRA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by a grant to Michael Fry from the United States-Israel Binational Science Foundation and by NCI grant P01-CA77852 and NIA ARRA Award R01-AG033061 to Lawrence A. Loeb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 2002, SHORT PROTOCOL MOL B, p[8, 8]; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; GERMAN J, 1965, SCIENCE, V148, P506, DOI 10.1126/science.148.3669.506; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Hanada K, 2007, CELL MOL LIFE SCI, V64, P2306, DOI 10.1007/s00018-007-7121-z; Huang SR, 1998, NAT GENET, V20, P114, DOI 10.1038/2410; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Kamath-Loeb AS, 2004, J BIOL CHEM, V279, P55499, DOI 10.1074/jbc.M407128200; Kaneko H, 2004, EXPERT REV MOL DIAGN, V4, P393, DOI 10.1586/14737159.4.3.393; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Sarig G, 1997, BIOCHEM BIOPH RES CO, V237, P617, DOI 10.1006/bbrc.1997.7198; Sarig G, 1997, J BIOL CHEM, V272, P4474, DOI 10.1074/jbc.272.7.4474; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Wang Y, 2000, GENE DEV, V14, P927; Weisman-Shomer P, 2000, J BIOL CHEM, V275, P2231, DOI 10.1074/jbc.275.3.2231; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216	30	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30189	10.1371/journal.pone.0030189	http://dx.doi.org/10.1371/journal.pone.0030189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272300	gold, Green Published			2022-12-25	WOS:000301454400078
J	Oudshoorn, D; van Boheemen, S; Sanchez-Aparicio, MT; Rajsbaum, R; Garcia-Sastre, A; Versteeg, GA				Oudshoorn, Diede; van Boheemen, Sander; Sanchez-Aparicio, Maria Teresa; Rajsbaum, Ricardo; Garcia-Sastre, Adolfo; Versteeg, Gijs A.			HERC6 Is the Main E3 Ligase for Global ISG15 Conjugation in Mouse Cells	PLOS ONE			English	Article							VIRUS NS1 PROTEIN; ANTIVIRAL MOLECULE; STIMULATED GENE-15; INTERFERON; ISGYLATION; INFLUENZA; TARGETS; SYSTEM; ACTIVATION; INFECTION	Type I interferon (IFN) stimulates expression and conjugation of the ubiquitin-like modifier IFN-stimulated gene 15 (ISG15), thereby restricting replication of a wide variety of viruses. Conjugation of ISG15 is critical for its antiviral activity in mice. HECT domain and RCC1-like domain containing protein 5 (HerC5) mediates global ISGylation in human cells, whereas its closest relative, HerC6, does not. So far, the requirement of HerC5 for ISG15-mediated antiviral activity has remained unclear. One of the main obstacles to address this issue has been that no HerC5 homologue exists in mice, hampering the generation of a good knock-out model. However, mice do express a homologue of HerC6 that, in contrast to human HerC6, can mediate ISGylation. Here we report that the mouse HerC6 N-terminal RCC1-like domain (RLD) allows ISG15 conjugation when replacing the corresponding domain in the human HerC6 homologue. In addition, sequences in the C-terminal HECT domain of mouse HerC6 also appear to facilitate efficient ISGylation. Mouse HerC6 paralleled human HerC5 in localization and IFN-inducibility. Moreover, HerC6 knock-down in mouse cells abolished global ISGylation, whereas its over expression enhanced the IFN beta promoter and conferred antiviral activity against vesicular stomatitis virus and Newcastle disease virus. Together these data indicate that HerC6 is likely the functional counterpart of human HerC5 in mouse cells, suggesting that HerC6(-/-) mice may provide a feasible model to study the role of human HerC5 in antiviral responses.	[Oudshoorn, Diede; van Boheemen, Sander; Sanchez-Aparicio, Maria Teresa; Rajsbaum, Ricardo; Garcia-Sastre, Adolfo; Versteeg, Gijs A.] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Oudshoorn, D (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY USA.	Gijs.Versteeg@mssm.edu	Rajsbaum, Ricardo/AAD-4775-2020; Rajsbaum, Ricardo/F-2046-2014; Sanchez-Aparicio, Maria T/K-7568-2017	Sanchez-Aparicio, Maria T/0000-0001-6556-5924; Versteeg, Gijs/0000-0002-6150-2165; Garcia-Sastre, Adolfo/0000-0002-6551-1827	National Institute of Allergy and Infectious Diseases [U19AI083025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been partly funded by National Institute of Allergy and Infectious Diseases grant U19AI083025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Garcia-Gonzalo FR, 2005, CELL MOL LIFE SCI, V62, P1826, DOI 10.1007/s00018-005-5119-y; Hochrainer K, 2008, CELL MOL LIFE SCI, V65, P2105, DOI 10.1007/s00018-008-8148-5; Hochrainer K, 2005, GENOMICS, V85, P153, DOI 10.1016/j.ygeno.2004.10.006; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Versteeg GA, 2010, J VIROL, V84, P5423, DOI 10.1128/JVI.02395-09; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362	20	53	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29870	10.1371/journal.pone.0029870	http://dx.doi.org/10.1371/journal.pone.0029870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272257	Green Published, gold			2022-12-25	WOS:000301454400036
J	Perez-Perez, R; Lopez, JA; Garcia-Santos, E; Camafeita, E; Gomez-Serrano, M; Ortega-Delgado, FJ; Ricart, W; Fernandez-Real, JM; Peral, B				Perez-Perez, Rafael; Lopez, Juan A.; Garcia-Santos, Eva; Camafeita, Emilio; Gomez-Serrano, Maria; Ortega-Delgado, Francisco J.; Ricart, Wifredo; Fernandez-Real, Jose M.; Peral, Belen			Uncovering Suitable Reference Proteins for Expression Studies in Human Adipose Tissue with Relevance to Obesity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TYPE-2 DIABETES-MELLITUS; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; INSULIN SENSITIVITY; METABOLIC SYNDROME; DJ-1; PROTEOMICS; DISEASE; MARKERS	Background: Protein expression studies based on the two major intra-abdominal human fat depots, the subcutaneous and the omental fat, can shed light into the mechanisms involved in obesity and its co-morbidities. Here we address, for the first time, the identification and validation of reference proteins for data standardization, which are essential for accurate comparison of protein levels in expression studies based on fat from obese and non-obese individuals. Methodology and Findings: To uncover adipose tissue proteins equally expressed either in omental and subcutaneous fat depots (study 1) or in omental fat from non-obese and obese individuals (study 2), we have reanalyzed our previously published data based on two-dimensional fluorescence difference gel electrophoresis. Twenty-four proteins (12 in study 1 and 12 in study 2) with similar expression levels in all conditions tested were selected and identified by mass spectrometry. Immunoblotting analysis was used to confirm in adipose tissue the expression pattern of the potential reference proteins and three proteins were validated: PARK7, ENOA and FAA. Western Blot analysis was also used to test customary loading control proteins. ENOA, PARK7 and the customary loading control protein Beta-actin showed steady expression profiles in fat from non-obese and obese individuals, whilst FAA maintained steady expression levels across paired omental and subcutaneous fat samples. Conclusions: ENOA, PARK7 and Beta-actin are proper reference standards in obesity studies based on omental fat, whilst FAA is the best loading control for the comparative analysis of omental and subcutaneous adipose tissues either in obese and non-obese subjects. Neither customary loading control proteins GAPDH and TBB5 nor CALX are adequate standards in differential expression studies on adipose tissue. The use of the proposed reference proteins will facilitate the adequate analysis of proteins differentially expressed in the context of obesity, an aim difficult to achieve before this study.	[Perez-Perez, Rafael; Garcia-Santos, Eva; Gomez-Serrano, Maria; Peral, Belen] CSIC, Inst Invest Biomed, Madrid, Spain; [Perez-Perez, Rafael; Garcia-Santos, Eva; Gomez-Serrano, Maria; Peral, Belen] Univ Autonoma Madrid, Madrid, Spain; [Perez-Perez, Rafael; Garcia-Santos, Eva; Gomez-Serrano, Maria; Ortega-Delgado, Francisco J.; Ricart, Wifredo; Fernandez-Real, Jose M.; Peral, Belen] ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBERob, Madrid, Spain; [Lopez, Juan A.; Camafeita, Emilio] CNIC, Unidad Prote, Madrid, Spain; [Ortega-Delgado, Francisco J.; Ricart, Wifredo; Fernandez-Real, Jose M.] Hosp Dr Josep Trueta, Dept Diabet Endocrinol & Nutr, Girona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Perez-Perez, R (corresponding author), CSIC, Inst Invest Biomed, Madrid, Spain.	bperal@iib.uam.es	Lopez, Juan Antonio/G-7750-2015; Peral, Belén/F-4562-2015; Gómez-Serrano, María/AAZ-3953-2021; Ortega, Francisco José J/F-3883-2016; Fernández-Real, Jose Manuel/AGH-3599-2022	Lopez, Juan Antonio/0000-0002-9097-6060; Peral, Belén/0000-0003-4984-4020; Gómez-Serrano, María/0000-0002-9669-091X; Ortega, Francisco José J/0000-0003-2111-769X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Perez-Perez, Rafael/0000-0001-7726-5873; Ricart, Wifredo/0000-0002-3452-9098	MICINN [SAF-2009-10461, SAF-2008-02073]; Fundacion Mutua Madrilena, Spain; Pro CNIC Foundation	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Mutua Madrilena, Spain; Pro CNIC Foundation	This work was supported by Grants SAF-2009-10461 and SAF-2008-02073 from the MICINN, and from the Fundacion Mutua Madrilena, Spain (BP). The CNIC is supported by MICINN and Pro CNIC Foundation. CIBERobn is an initiative from the Instituto de Salud Carlos III. The funders had no role in study design, data collection nor analysis, decision to publish, or preparation of the manuscript.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Bashan N, 2007, ENDOCRINOLOGY, V148, P2955, DOI 10.1210/en.2006-1369; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gabrielsson BG, 2005, OBES RES, V13, P649, DOI 10.1038/oby.2005.72; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; del Pozo CH, 2011, OBES SURG, V21, P633, DOI 10.1007/s11695-010-0246-4; del Pozo CH, 2010, OBESITY, V18, P897, DOI 10.1038/oby.2009.374; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kovsan J, 2011, J CLIN ENDOCR METAB, V96, pE268, DOI 10.1210/jc.2010-1681; Liu SF, 2010, HEPATO-GASTROENTEROL, V57, P1247; MacLaren R, 2008, J LIPID RES, V49, P308, DOI 10.1194/jlr.M700199-JLR200; Mantovani G, 2009, DIABETES, V58, P620, DOI 10.2337/db08-0585; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Mcnally RS, 2011, J BIOL CHEM, V286, P4098, DOI 10.1074/jbc.M110.147371; Peinado JR, 2010, PROTEOMICS, V10, P3356, DOI 10.1002/pmic.201000350; Perez-Perez R, 2012, J PROTEOMICS, V75, P783, DOI 10.1016/j.jprot.2011.09.016; Perez-Perez R, 2009, J PROTEOME RES, V8, P1682, DOI 10.1021/pr800942k; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prokesch A, 2009, CURR MED CHEM, V16, P2952, DOI 10.2174/092986709788803132; Rai P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018074; Rasche A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-310; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Sun S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-309; TANGUAY RM, 1990, AM J HUM GENET, V47, P308; van Beek EA, 2007, PFLUG ARCH EUR J PHY, V453, P851, DOI 10.1007/s00424-006-0164-4; VANHINSBERGH VWM, 1990, BLOOD, V75, P1490; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; Wu XD, 2001, J CLIN ENDOCR METAB, V86, P5973, DOI 10.1210/jc.86.12.5973; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211	38	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30326	10.1371/journal.pone.0030326	http://dx.doi.org/10.1371/journal.pone.0030326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272336	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400114
J	Xu, WT; Zhai, ZF; Huang, KL; Zhang, N; Yuan, YF; Shang, Y; Luo, YB				Xu, Wentao; Zhai, Zhifang; Huang, Kunlun; Zhang, Nan; Yuan, Yanfang; Shang, Ying; Luo, Yunbo			A Novel Universal Primer-Multiplex-PCR Method with Sequencing Gel Electrophoresis Analysis	PLOS ONE			English	Article							GENETICALLY-MODIFIED MAIZE; GENE	In this study, a novel universal primer-multiplex-PCR (UP-M-PCR) method adding a universal primer (UP) in the multiplex PCR reaction system was described. A universal adapter was designed in the 5'-end of each specific primer pairs which matched with the specific DNA sequences for each template and also used as the universal primer (UP). PCR products were analyzed on sequencing gel electrophoresis (SGE) which had the advantage of exhibiting extraordinary resolution. This method overcame the disadvantages rooted deeply in conventional multiplex PCR such as complex manipulation, lower sensitivity, self-inhibition and amplification disparity resulting from different primers, and it got a high specificity and had a low detection limit of 0.1 ng for single kind of crops when screening the presence of genetically modified (GM) crops in mixture samples. The novel developed multiplex PCR assay with sequencing gel electrophoresis analysis will be useful in many fields, such as verifying the GM status of a sample irrespective of the crop and GM trait and so on.	[Xu, Wentao; Zhai, Zhifang; Huang, Kunlun; Yuan, Yanfang; Luo, Yunbo] China Agr Univ, Lab Food Safety, Coll Food Sci & Nutr Engn, Beijing 100094, Peoples R China; [Xu, Wentao; Huang, Kunlun; Zhang, Nan; Shang, Ying; Luo, Yunbo] Minist Agr, Supervis Inspect & Testing Ctr Genetically Modifi, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Xu, WT (corresponding author), China Agr Univ, Lab Food Safety, Coll Food Sci & Nutr Engn, Beijing 100094, Peoples R China.	caufoodsafety@gmail.com; lyb@yahoo.cn		Kunlun, Huang/0000-0002-2350-5859	National GMO Cultivation Major Project of New Varieties [2008ZX08012-001]; National Natural Science Foundation of China [30800770]; Ministry of Science and Technology; Ministry of Agriculture of China	National GMO Cultivation Major Project of New Varieties; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	The study was supported by the National GMO Cultivation Major Project of New Varieties (No. 2008ZX08012-001) and National Natural Science Foundation of China (No. 30800770). And the authors express their gratitude to the Ministry of Science and Technology and the Ministry of Agriculture of China for financial support respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WB, 2009, FOOD CONTROL, V20, P366, DOI 10.1016/j.foodcont.2008.05.021; Bassam BJ, 2007, NAT PROTOC, V2, P2649, DOI 10.1038/nprot.2007.330; BOULIKAS T, 1981, J BIOCHEM BIOPH METH, V5, P219, DOI 10.1016/0165-022X(81)90046-4; Demeke T, 2008, FOOD CONTROL, V19, P893, DOI 10.1016/j.foodcont.2007.08.020; Ding CM, 2003, P NATL ACAD SCI USA, V100, P3059, DOI 10.1073/pnas.0630494100; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Hess CJ, 2004, LEUKEMIA, V18, P1981, DOI 10.1038/sj.leu.2403520; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Inagaki S, 2004, FORENSIC SCI INT, V144, P45, DOI 10.1016/j.forsciint.2004.03.005; James D, 2003, J AGR FOOD CHEM, V51, P5829, DOI 10.1021/jf0341159; Mano J, 2009, J AGR FOOD CHEM, V57, P2640, DOI 10.1021/jf803361a; Pinar A., 2004, Central European Journal of Public Health, V12, P3; Randhawa GJ, 2009, J AGR FOOD CHEM, V57, P5167, DOI 10.1021/jf900604h; Randhawa GJ, 2009, INDIAN J AGR SCI, V79, P367; Randhawa GJ, 2009, CURR SCI INDIA, V96, P689; Randhawa GJ, 2008, CURR SCI INDIA, V95, P1729; Sambrook J, 2001, MOL CLONING LAB MANU; Shi MM, 2001, CLIN CHEM, V47, P164; Shi MM, 1999, MOL DIAGN, V4, P343, DOI 10.1016/S1084-8592(99)80011-3; Shrestha HK, 2008, J AGR FOOD CHEM, V56, P8962, DOI 10.1021/jf800501z; SOMERVILLE LL, 1981, BIOCHEM BIOPH RES CO, V102, P53, DOI 10.1016/0006-291X(81)91487-X; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Tomoaki Y, 2005, J AGR FOOD CHEM, V53, P2052; Xu WT, 2009, J AGR FOOD CHEM, V57, P395, DOI 10.1021/jf802323m; Yuan YF, 2009, J FOOD SCI, V74, pM446, DOI 10.1111/j.1750-3841.2009.01321.x; Zhang MH, 2007, FOOD CONTROL, V18, P1277, DOI 10.1016/j.foodcont.2006.09.001; Zhang YL, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng123	27	55	92	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e22900	10.1371/journal.pone.0022900	http://dx.doi.org/10.1371/journal.pone.0022900			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272223	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400001
J	Tomas, G; Tarabichi, M; Gacquer, D; Hebrant, A; Dom, G; Dumont, JE; Keutgen, X; Fahey, TJ; Maenhaut, C; Detours, V				Tomas, G.; Tarabichi, M.; Gacquer, D.; Hebrant, A.; Dom, G.; Dumont, J. E.; Keutgen, X.; Fahey, T. J., III; Maenhaut, C.; Detours, V.			A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic	ONCOGENE			English	Article						gene expression; differentiation; proliferation; cancer; thyroid	FOLLICULAR VARIANT; PAPILLARY; CARCINOMA; PROFILES; TRANSFORMATION; PHENOTYPE; LEUKEMIA	Differentiation is central to development, while dedifferentiation is central to cancer progression. Hence, a quantitative assessment of differentiation would be most useful. We propose an unbiased method to derive organ-specific differentiation indices from gene expression data and demonstrate its usefulness in thyroid cancer diagnosis. We derived a list of thyroid-specific genes by selecting automatically those genes that are expressed at higher level in the thyroid than in any other organ in a normal tissue's genome-wide gene expression compendium. The thyroid index of a tissue was defined as the median expression of these thyroid-specific genes in that tissue. As expected, the thyroid index was inversely correlated with meta-PCNA, a proliferation metagene, across a wide range of thyroid tumors. By contrast, the two indices were positively correlated in a time course of thyroid-stimulating hormone (TSH) activation of primary thyrocytes. Thus, the thyroid index captures biological information not integrated by proliferation rates. The differential diagnostic of follicular thyroid adenomas and follicular thyroid carcinoma is a notorious challenge for pathologists. The thyroid index discriminated them as accurately as did machine-learning classifiers trained on the genome-wide cancer data. Hence, although it was established exclusively from normal tissue data, the thyroid index integrates the relevant diagnostic information contained in tumoral transcriptomes. Similar results were obtained for the classification of the follicular vs classical variants of papillary thyroid cancers, that is, tumors dedifferentiating along a different route. The automated procedures demonstrated in the thyroid are applicable to other organs. Oncogene (2012) 31, 4490-4498; doi: 10.1038/onc.2011.626; published online 23 January 2012	[Tomas, G.; Tarabichi, M.; Gacquer, D.; Hebrant, A.; Dom, G.; Dumont, J. E.; Maenhaut, C.; Detours, V.] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Keutgen, X.; Fahey, T. J., III] Weill Cornell Med Coll, Div Endocrine Surg, Dept Surg, New York, NY USA	Universite Libre de Bruxelles; Cornell University	Detours, V (corresponding author), Univ Libre Bruxelles, Inst Interdisciplinary Res IRIBHM, 808 Route Lennik, B-1070 Brussels, Belgium.	vdetours@ulb.ac.be	Keutgen, Xavier/H-9323-2018; Tarabichi, Maxime/ABA-9246-2020	Keutgen, Xavier/0000-0002-4627-3560; Tarabichi, Maxime/0000-0002-1635-2348	Wallonie-Bruxelles International grant [7450/AMG/VDL/IN, WBI/doh/2009/21649]; FRIA fellowship from FNRS; Brussels-Capital IRSIB project ICT-impulse	Wallonie-Bruxelles International grant; FRIA fellowship from FNRS(Fonds de la Recherche Scientifique - FNRS); Brussels-Capital IRSIB project ICT-impulse	This research was partially funded by the Brussels-Capital IRSIB project ICT-impulse 2006, In Silico Wet Lab. GT is supported by the Wallonie-Bruxelles International grant (7450/AMG/VDL/IN, WBI/doh/2009/21649). MT is supported by a FRIA fellowship from FNRS.	Aldred MA, 2004, J CLIN ONCOL, V22, P3531, DOI 10.1200/JCO.2004.08.127; Baloch ZW, 2001, DIAGN CYTOPATHOL, V25, P231, DOI 10.1002/dc.2044; Clary KM, 2005, ACTA CYTOL, V49, P378, DOI 10.1159/000326169; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; Detours V, 2007, BRIT J CANCER, V97, P818, DOI 10.1038/sj.bjc.6603938; Finley DJ, 2004, ANN SURG, V240, P425, DOI 10.1097/01.sla.0000137128.64978.bc; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kohlmann A, 2008, BRIT J HAEMATOL, V142, P802, DOI 10.1111/j.1365-2141.2008.07261.x; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Lang BHH, 2006, WORLD J SURG, V30, P752, DOI 10.1007/s00268-005-0356-7; Lin HW, 2010, LARYNGOSCOPE, V120, pS163, DOI 10.1002/lary.21627; Lubitz CC, 2005, SURGERY, V138, P1042, DOI 10.1016/j.surg.2005.09.009; Mills KI, 2009, BLOOD, V114, P1063, DOI 10.1182/blood-2008-10-187203; Moreno JC, 2008, NEW ENGL J MED, V358, P1811, DOI 10.1056/NEJMoa0706819; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; *R DEV COR TEAM, R LANG ENV STAT COMP; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Ruschhaupt M, 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1078; Singh B, 2005, SURGERY, V138, P1048; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Taminau J, 2011, BIOINFORMATICS; van Staveren WCG, 2006, P NATL ACAD SCI USA, V103, P413, DOI 10.1073/pnas.0507354102; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; ZURZOLO C, 1991, J CELL SCI, V98, P65	37	63	64	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	41					4490	4498		10.1038/onc.2011.626	http://dx.doi.org/10.1038/onc.2011.626			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	018YR	22266856				2022-12-25	WOS:000309704500007
J	Yang, XS; Li, Q; Lin, X; Ma, YL; Yue, XJ; Tao, ZY; Wang, F; Mckeehan, WL; Wei, L; Schwartz, RJ; Chang, J				Yang, Xiangsheng; Li, Qi; Lin, Xi; Ma, Yanlin; Yue, Xiaojing; Tao, Zhenyin; Wang, Fen; Mckeehan, Wallace L.; Wei, Lei; Schwartz, Robert J.; Chang, Jiang			Mechanism of fibrotic cardiomyopathy in mice expressing truncated Rho-associated coiled-coil protein kinase 1	FASEB JOURNAL			English	Article						myocardial fibrosis; transgenic mice; serum response factor; TGF beta 1	SERUM RESPONSE FACTOR; NF-KAPPA-B; LONG-TERM INHIBITION; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH-FACTOR-BETA-1; MYOCARDIAL-INFARCTION; MEDIATED ACTIVATION; CASPASE-3 CLEAVAGE; CARDIAC FIBROSIS; ACTIN DYNAMICS	We have previously found that in failing human hearts, Rho-associated coiled-coil protein kinase 1 (ROCK1) is processed by caspase-3 into an active isoform, ROCK Delta 1. The purpose of the current investigation was to elucidate the pathological consequences of truncated ROCK1 accumulation in the heart, the associated molecular mechanism of ROCK Delta 1-mediated cardiac phenotype, and the molecular signaling between Rho kinase activation in cardiomyocytes and extracellular matrix response. We generated transgenic mice expressing ROCK Delta 1 in cardiomyocytes to mimic the situation observed in human heart disease, whereas an additional kinase-deficient mouse was generated as a control. The ROCK Delta 1 transgenic mice developed fibrotic cardiomyopathy with diastolic dysfunction. Transgenic hearts displayed activated TGF beta 1 and NF-kappa B signaling and a release of a subset of cytokines and were susceptible to angiotensin II stress. Treatment with a Rho kinase inhibitor attenuated the fibrotic phenotype. Cardiac fibroblasts differentiated into myofibroblasts when cocultured with transgenic cardiomyocytes but not with wild-type cardiomyocytes. Inhibitors of Rho kinase as well as TGF beta R1 and NF-kappa B decreased these effects. The serum response factor-dependent TGF beta 1 regulation was shown to be responsible for the Rho kinase-mediated activation of TGF beta 1 signaling. We conclude that ROCK Delta 1 is a novel fibrotic factor. Activation of TGF beta 1 and NF-kappa B signaling contributes to the Rho kinase-mediated pathological fibrosis.-Yang, X., Li, Q., Lin, X., Ma, Y., Yue, X., Tao, Z., Wang, F., Mckeehan, W. L., Wei, L., Schwartz, R. J., Chang, J. Mechanism of fibrotic cardiomyopathy in mice expressing truncated Rho-associated coiled-coil protein kinase 1. FASEB J. 26, 2105-2116 (2012). www.fasebj.org	[Yang, Xiangsheng; Lin, Xi; Yue, Xiaojing; Tao, Zhenyin; Wang, Fen; Mckeehan, Wallace L.; Chang, Jiang] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Li, Qi; Ma, Yanlin; Chang, Jiang] Hainan Med Coll, Affiliated Hosp, Hainan Prov Key Lab Human Reprod Med & Genet Res, Hainan, Peoples R China; [Wei, Lei] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Schwartz, Robert J.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Hainan Medical University; Indiana University System; Indiana University Bloomington; University of Houston System; University of Houston	Chang, J (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	jchang@ibt.tamhsc.edu	Lin, Xi/K-2473-2015	Lin, Xi/0000-0002-9034-7117; Chang, Jiang/0000-0003-3707-7557	U.S. National Heart, Lung, and Blood Institute [R01-HL-102314, R21-HL-094844, K02-HL-098956]; American Heart Association [0855030F]; National Science Foundation of China [NSFC 30860103]; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094844, R01HL072897, R01HL102314, P01HL085098, K02HL098956] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors are grateful to Dr. Vladimir N. Potaman and Alexis M. Boggs for editorial assistance on the manuscript. This work was supported by U.S. National Heart, Lung, and Blood Institute grants R01-HL-102314, R21-HL-094844, and K02-HL-098956 and American Heart Association grant-in-aid 0855030F (to J.C.); and National Science Foundation of China grant NSFC 30860103 (to Q.L.). The authors declare no conflicts of interest.	Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Chang J, 2003, CIRCULATION, V108, P407, DOI 10.1161/01.CIR.0000084502.02147.83; Chang J, 2006, P NATL ACAD SCI USA, V103, P14495, DOI 10.1073/pnas.0601911103; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Higashi M, 2003, CIRC RES, V93, P767, DOI 10.1161/01.RES.0000096650.91688.28; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KIM SJ, 1989, J BIOL CHEM, V264, P7041; Kobayashi N, 2002, CARDIOVASC RES, V55, P757, DOI 10.1016/S0008-6363(02)00457-1; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Lemarie A, 2008, J IMMUNOL, V180, P6010, DOI 10.4049/jimmunol.180.9.6010; LI G, 1998, CIRCULATION, V98, P149; Li GM, 1998, CIRCULATION, V98, pII144; Li MX, 2005, CIRCULATION, V111, P2494, DOI 10.1161/01.CIR.0000165117.71483.0C; Li Q, 2010, AM J PHYSIOL-HEART C, V298, pH1340, DOI 10.1152/ajpheart.00592.2009; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Lin X, 2012, MOL CELL BIOL, V32, P297, DOI 10.1128/MCB.05484-11; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Onai Y, 2007, AM J PHYSIOL-HEART C, V292, pH530, DOI 10.1152/ajpheart.00549.2006; Peng FF, 2008, DIABETES, V57, P1683, DOI 10.2337/db07-1149; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Rodriguez PL, 2007, CELL SIGNAL, V19, P2361, DOI 10.1016/j.cellsig.2007.07.021; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; WALTENBERGER J, 1993, AM J PATHOL, V142, P71; Wiebel FF, 2002, GENESIS, V32, P124, DOI 10.1002/gene.10049; Zhai YS, 2008, EUR J PHARMACOL, V587, P196, DOI 10.1016/j.ejphar.2008.03.006; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com	38	27	34	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					2105	2116		10.1096/fj.11-201319	http://dx.doi.org/10.1096/fj.11-201319			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22278938	Green Published			2022-12-25	WOS:000303680800036
J	Han, CY; Umemoto, T; Omer, M; Den Hartigh, LJ; Chiba, T; Leboeuf, R; Buller, CL; Sweet, IR; Pennathur, S; Abel, ED; Chait, A				Han, Chang Yeop; Umemoto, Tomio; Omer, Mohamed; Den Hartigh, Laura J.; Chiba, Tsuyoshi; Leboeuf, Renee; Buller, Carolyn L.; Sweet, Ian R.; Pennathur, Subramaniam; Abel, E. Dale; Chait, Alan			NADPH Oxidase-derived Reactive Oxygen Species Increases Expression of Monocyte Chemotactic Factor Genes in Cultured Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-DEPENDENT MECHANISM; LIPID RAFT MICRODOMAINS; LOW-GRADE INFLAMMATION; TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; ADIPOSE-TISSUE; OXIDATIVE STRESS; MITOCHONDRIAL SUPEROXIDE; GLUCOSE METABOLISM; ENDOTHELIAL-CELLS	Excess glucose and free fatty acids delivered to adipose tissue causes local inflammation, which contributes to insulin resistance. Glucose and palmitate generate reactive oxygen species (ROS) in adipocytes, leading to monocyte chemotactic factor gene expression. Docosahexaenoate (DHA) has the opposite effect. In this study, we evaluated the potential sources of ROS in the presence of excess nutrients. Differentiated 3T3-L1 adipocytes were exposed to palmitate andDHA(250 mu M) in either 5 or 25mM glucose to evaluate the relative roles of mitochondrial electron transport and NADPH oxidases (NOX) as sources of ROS. Excess glucose and palmitate did not increase mitochondrial oxidative phosphorylation. However, glucose exposure increased glycolysis. Of the NOX family members, only NOX4 was expressed in adipocytes. Moreover, its activity was increased by excess glucose and palmitate and decreased by DHA. Silencing NOX4 inhibited palmitate- and glucose-stimulated ROS generation and monocyte chemotactic factor gene expression. NADPH, a substrate for NOX, and pentose phosphate pathway activity increased with glucose but not palmitate and decreased with DHA exposure. Inhibition of the pentose phosphate pathway by glucose-6-phosphate dehydrogenase inhibitors and siRNA suppressed ROS generation and monocyte chemotactic factor gene expression induced by both glucose and palmitate. Finally, both high glucose and palmitate induced NOX4 translocation into lipid rafts, effects that were blocked by DHA. Excess glucose and palmitate generate ROS via NOX4 rather than by mitochondrial oxidation in cultured adipocytes. NOX4 is regulated by both NADPH generated in the PPP and translocation of NOX4 into lipid rafts, leading to expression of monocyte chemotactic factors.	[Chait, Alan] Univ Washington, Diabet & Obes Ctr Excellence, Div Metab Endocrinol & Nutr, Dept Med, Seattle, WA 98195 USA; [Abel, E. Dale] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA; [Abel, E. Dale] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84112 USA; [Buller, Carolyn L.; Pennathur, Subramaniam] Univ Michigan, Div Nephrol, Dept Med, Ann Arbor, MI 48105 USA	University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan	Chait, A (corresponding author), Univ Washington, Diabet & Obes Ctr Excellence, Div Metab Endocrinol & Nutr, Dept Med, 815 Mercer St,Box 358055, Seattle, WA 98195 USA.	achait@u.washington.edu		Abel, E. Dale/0000-0001-5290-0738	National Institutes of Health [HL-094352, P30-DK-035816, DK-082841, DK-089503, DK-17047, DK092065]; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094352, R01HL098227, R56HL094352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P30DK035816, P30DK017047, R24DK082841, R01DK092065, P30DK089503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-094352, P30-DK-035816, DK-082841, and DK-089503 (to S. P.), and DK-17047.; Established investigator of the American Heart Association and supported by the American Diabetes Association and National Institutes of Health Grant DK092065.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bolterman RJ, 2005, HYPERTENSION, V46, P943, DOI 10.1161/01.HYP.0000174602.59935.d5; Bullo M, 2003, OBES RES, V11, P525, DOI 10.1038/oby.2003.74; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Chang MY, 2006, ARTERIOSCL THROM VAS, V26, P494, DOI 10.1161/01.ATV.0000200135.61362.27; CLEARY MP, 1986, INT J OBESITY, V10, P193; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Foncea R, 2000, BIOL RES, V33, P89; Frayn KN, 2008, DIABETOLOGIA, V51, P394, DOI 10.1007/s00125-007-0901-z; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Golej DL, 2011, J LIPID RES, V52, P782, DOI 10.1194/jlr.M013292; Goueffic Y, 2007, ATHEROSCLEROSIS, V195, P23, DOI 10.1016/j.atherosclerosis.2006.11.023; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Han CY, 2006, ARTERIOSCL THROM VAS, V26, P1806, DOI 10.1161/01.ATV.0000227472.70734.ad; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Hansen LL, 1999, J BIOL CHEM, V274, P25078, DOI 10.1074/jbc.274.35.25078; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; KATZ J, 1966, J BIOL CHEM, V241, P727; KATZ J, 1960, J BIOL CHEM, V235, P2165; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; KOHANSKI RA, 1986, J BIOL CHEM, V261, P2272; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Li HW, 2009, HYPERTENSION, V53, P1054, DOI 10.1161/HYPERTENSIONAHA.108.120642; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Maachi M, 2004, INT J OBESITY, V28, P993, DOI 10.1038/sj.ijo.0802718; MARETTE A, 1991, BIOCHEM J, V277, P119, DOI 10.1042/bj2770119; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OLEFSKY JM, 1977, ENDOCRINOLOGY, V100, P1169; Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; Patel C, 2007, J CLIN ENDOCR METAB, V92, P4476, DOI 10.1210/jc.2007-0778; Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007; RODBELL M, 1964, J BIOL CHEM, V239, P375; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Vallet P, 2005, NEUROSCIENCE, V132, P233, DOI 10.1016/j.neuroscience.2004.12.038; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	56	123	129	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10379	10393		10.1074/jbc.M111.304998	http://dx.doi.org/10.1074/jbc.M111.304998			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22287546	hybrid, Green Published			2022-12-25	WOS:000302167200065
J	Shi, SY; Martin, RG; Duncan, RE; Choi, D; Lu, SY; Schroer, SA; Cai, EP; Luk, CT; Hopperton, KE; Domenichiello, AF; Tang, C; Naples, M; Dekker, MJ; Giacca, A; Adeli, K; Wagner, KU; Bazinet, RP; Woo, M				Shi, Sally Yu; Martin, Ruben Garcia; Duncan, Robin E.; Choi, Diana; Lu, Shun-Yan; Schroer, Stephanie A.; Cai, Erica P.; Luk, Cynthia T.; Hopperton, Kathryn E.; Domenichiello, Anthony F.; Tang, Christine; Naples, Mark; Dekker, Mark J.; Giacca, Adria; Adeli, Khosrow; Wagner, Kay-Uwe; Bazinet, Richard P.; Woo, Minna			Hepatocyte-specific Deletion of Janus Kinase 2 (JAK2) Protects against Diet-induced Steatohepatitis and Glucose Intolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; BETA-CELL HYPERPLASIA; GROWTH-HORMONE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RECEPTOR; MICE; INHIBITION; EXPRESSION; INFLAMMATION	Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of chronic liver disease and is now considered to be the hepatic manifestation of the metabolic syndrome. However, the role of steatosis per se and the precise factors required in the progression to steatohepatitis or insulin resistance remain elusive. The JAK-STAT pathway is critical in mediating signaling of a wide variety of cytokines and growth factors. Mice with hepatocyte-specific deletion of Janus kinase 2 (L-JAK2 KO mice) develop spontaneous steatosis as early as 2 weeks of age. In this study, we investigated the metabolic consequences of jak2 deletion in response to diet-induced metabolic stress. To our surprise, despite the profound hepatosteatosis, deletion of hepatic jak2 did not sensitize the liver to accelerated inflammatory injury on a prolonged high fat diet (HFD). This was accompanied by complete protection against HFD-induced whole-body insulin resistance and glucose intolerance. Improved glucose-stimulated insulin secretion and an increase in beta-cell mass were also present in these mice. Moreover, L-JAK2 KO mice had progressively reduced adiposity in association with blunted hepatic growth hormone signaling. These mice also exhibited increased resting energy expenditure on both chow and high fat diet. In conclusion, our findings indicate a key role of hepatic JAK2 in metabolism such that its absence completely arrests steatohepatitis development and confers protection against diet-induced systemic insulin resistance and glucose intolerance.	[Shi, Sally Yu; Martin, Ruben Garcia; Choi, Diana; Lu, Shun-Yan; Schroer, Stephanie A.; Cai, Erica P.; Luk, Cynthia T.; Woo, Minna] Toronto Gen Res Inst, Toronto, ON M5G 2C4, Canada; [Shi, Sally Yu; Choi, Diana; Cai, Erica P.; Luk, Cynthia T.; Woo, Minna] Univ Toronto, Inst Med Sci, Toronto, ON M5G 2M9, Canada; [Duncan, Robin E.; Hopperton, Kathryn E.; Domenichiello, Anthony F.; Bazinet, Richard P.] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada; [Tang, Christine; Giacca, Adria] Univ Toronto, Dept Physiol, Fac Med, Toronto, ON M5S 1A8, Canada; [Naples, Mark; Dekker, Mark J.; Adeli, Khosrow] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Woo, Minna] St Michaels Hosp, Dept Med, Toronto, ON M3B 1W5, Canada; [Woo, Minna] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M3B 1W5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Woo, M (corresponding author), MaRS Ctr, Toronto Med Discovery Tower,101 Coll St,10th Floo, Toronto, ON M5G 1L7, Canada.	mwoo@uhnres.utoronto.ca	Cai, Erica/ABE-4408-2020; Duncan, Robin/AAH-7465-2021; Wagner, Kay-Uwe/B-6044-2009; Martin, Ruben Garcia/AAA-8538-2021	Martin, Ruben Garcia/0000-0003-2049-4960; Shi, Sally Yu/0000-0002-5528-3824; Hopperton, Kathryn/0000-0003-0146-2744; Wagner, Kay-Uwe/0000-0002-5081-0226; Cai, Erica/0000-0003-2386-5747; Adeli, Khosrow/0000-0002-5839-5709	Canadian Institute of Health Research [MOP-191501]; Canadian Diabetes Association; Banting and Best Diabetes Centre (BBDC)-Novo Nordisk; NSERC; Spanish National Research Fellowship from Ibercaja Foundation (Spain); CIHR Federick Banting; Charles Best Canada Graduate Scholarship - Doctoral; Eliot Phillipson Clinician Scientist Training Program; BBDC	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Banting and Best Diabetes Centre (BBDC)-Novo Nordisk; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Spanish National Research Fellowship from Ibercaja Foundation (Spain); CIHR Federick Banting(Canadian Institutes of Health Research (CIHR)); Charles Best Canada Graduate Scholarship - Doctoral; Eliot Phillipson Clinician Scientist Training Program; BBDC	This work was supported by operating grants from Canadian Institute of Health Research MOP-191501 and Canadian Diabetes Association (to M. W.).; Supported by the Banting and Best Diabetes Centre (BBDC)-Novo Nordisk Studentship and the NSERC Alexander Graham Bell Canada Graduate Scholarship.; Supported by the Spanish National Research Fellowship from Ibercaja Foundation (Spain).; Supported by the CIHR Federick Banting and Charles Best Canada Graduate Scholarship - Doctoral.; Supported by the Canadian Diabetes Association Doctoral Student Research Award.; Supported by the Eliot Phillipson Clinician Scientist Training Program and the BBDC post-doctoral fellowship.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; BRAY GA, 1969, J CLIN ENDOCR METAB, V29, P119, DOI 10.1210/jcem-29-1-119; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen CT, 2008, J LIPID RES, V49, P147, DOI 10.1194/jlr.M700386-JLR200; Cheung L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-60; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Duez H, 2009, ENDOCRINOLOGY, V150, P56, DOI 10.1210/en.2008-1137; Escribano O, 2009, DIABETES, V58, P820, DOI 10.2337/db08-0551; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Huynh FK, 2010, DIABETES, V59, P3032, DOI 10.2337/db10-0074; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sos BC, 2011, J CLIN INVEST, V121, P1412, DOI 10.1172/JCI42894; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Wang LY, 2010, DIABETES, V59, P3117, DOI 10.2337/db09-1805; Wolthers T, 1996, J CLIN ENDOCR METAB, V81, P1416, DOI 10.1210/jc.81.4.1416; Wu YJ, 2011, J CLIN INVEST, V121, P2422, DOI 10.1172/JCI45027; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Younossi ZM, 1998, MODERN PATHOL, V11, P560; Zhou YC, 1999, J BIOL CHEM, V274, P2672, DOI 10.1074/jbc.274.5.2672	44	50	51	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10277	10288		10.1074/jbc.M111.317453	http://dx.doi.org/10.1074/jbc.M111.317453			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22275361	hybrid, Green Published			2022-12-25	WOS:000302167200057
J	von Lohneysen, K; Noack, D; Hayes, P; Friedman, JS; Knaus, UG				von Loehneysen, Katharina; Noack, Deborah; Hayes, Patti; Friedman, Jeffrey S.; Knaus, Ulla G.			Constitutive NADPH Oxidase 4 Activity Resides in the Composition of the B-loop and the Penultimate C Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME B(558); NOX-FAMILY; TRANSMEMBRANE; INHIBITION; GP91(PHOX); STABILITY; EVOLUTION; ARGININE; SUBUNIT; PEPTIDE	Redox regulation of signaling molecules contributes critically to propagation of intracellular signals. The main source providing reactive oxygen species (ROS) for these physiological processes are activated NADPH oxidases (Nox/Duox family). In a pathophysiological context, some NADPH oxidase complexes produce large amounts of ROS either as part of the antimicrobial immune defense or as pathologic oxidative stress in many chronic diseases. Thus, understanding the switch from a dormant, inactive conformation to the active state of these enzymes will aid the development of inhibitors. As exogenously expressed Nox4 represents the only constitutively active enzyme in this family, analysis of structural determinants that permit this active conformation was undertaken. Our focus was directed toward a cell-based analysis of the first intracellular loop, the B-loop, and the C-terminus, two regions of Nox family enzymes that are essential for electron transfer. Mutagenesis of the B-loop identified several unique residues and a polybasic motif that contribute to the catalytic activity of Nox4. By using a multifaceted approach, including Nox4-Nox2 chimeras, mutagenesis, and insertion of Nox2 domains, we show here that the penultimate 22 amino acids of Nox4 are involved in constitutive ROS generation. The appropriate spacing of the C-terminal Nox4 sequence may cooperate with a discrete arginine-based interaction site in the B-loop, providing an intrinsically active interface that could not be disrupted by peptides derived from the Nox4 C-terminus. These results indicate that accessibility for a Nox4-specific peptide inhibitor might be difficult to achieve in vivo.	[Hayes, Patti; Knaus, Ulla G.] Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 4, Ireland; [von Loehneysen, Katharina; Noack, Deborah; Friedman, Jeffrey S.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University College Dublin; Scripps Research Institute	Knaus, UG (corresponding author), Univ Coll Dublin, Conway Inst, Sch Med & Med Sci, Dublin 4, Ireland.	Ulla.Knaus@ucd.ie			National Institutes of Health [1RO1 DK080232]; Science Foundation Ireland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1 DK080232 (to J. S. F.). This work was also supported by Science Foundation Ireland award (to U. G. K.).	Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 1999, J BIOL CHEM, V274, P10451, DOI 10.1074/jbc.274.15.10451; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; DELEO FR, 1995, P NATL ACAD SCI USA, V92, P7110, DOI 10.1073/pnas.92.15.7110; Gorrell A, 2005, J BIOL CHEM, V280, P10731, DOI 10.1074/jbc.M412118200; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Jackson HM, 2010, J BIOL CHEM, V285, P10281, DOI 10.1074/jbc.M109.084939; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Liu JH, 2003, ARTERIOSCL THROM VAS, V23, P776, DOI 10.1161/01.ATV.0000066684.37829.16; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Park MY, 1997, BIOCHEM BIOPH RES CO, V234, P531, DOI 10.1006/bbrc.1997.6672; Picciocchi A, 2011, J BIOL CHEM, V286, P28357, DOI 10.1074/jbc.M111.220418; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Zhou XS, 2008, AM J PHYSIOL-HEART C, V295, pH1008, DOI 10.1152/ajpheart.00114.2008	24	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8737	8745		10.1074/jbc.M111.332494	http://dx.doi.org/10.1074/jbc.M111.332494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277655	Green Published, hybrid			2022-12-25	WOS:000301797800007
J	Chen, SY; Gulla, S; Cai, CM; Balk, SP				Chen, Shaoyong; Gulla, Sarah; Cai, Changmeng; Balk, Steven P.			Androgen Receptor Serine 81 Phosphorylation Mediates Chromatin Binding and Transcriptional Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; HUMAN LNCAP CELLS; CYCLE PROGRESSION; GENE-EXPRESSION; S-PHASE; DOMAIN; BICALUTAMIDE; SITES; G(1); EZH2	Our previous findings indicated that androgen receptor (AR) phosphorylation at serine 81 is stimulated by the mitotic cyclin-dependent kinase 1 (CDK1). In this report, we extended our previous study and confirmed that Ser-81 phosphorylation increases during mitosis, coincident with CDK1 activation. We further showed blocking cell cycle at G(1) or S phase did not disrupt androgen-induced Ser-81 phosphorylation and AR-dependent transcription, consistent with a recent report that AR was phosphorylated at Ser-81 and activated by the transcriptional CDK9. To assess the function of Ser-81 phosphorylation in prostate cancer (PCa) cells expressing endogenous AR, we developed a ligand switch strategy using a ligand-binding domain mutation (W741C) that renders AR responsive to the antagonist bicalutamide. An S81A/W741C double mutant AR stably expressed in PCa cells failed to transactivate the endogenous AR-regulated PSA or TMPRSS2 genes. ChIP showed that the S81A mutation prevented ligand-induced AR recruitment to these genes, and cellular fractionation revealed that the S81A mutation globally abrogated chromatin binding. Conversely, the AR fraction rapidly recruited to chromatin after androgen stimulation was highly enriched for Ser-81 phosphorylation. Finally, inhibition of CDK1 and CDK9 decreased AR Ser-81 phosphorylation, chromatin binding, and transcriptional activity. These findings indicate that Ser-81 phosphorylation by CDK9 stabilizes AR chromatin binding for transcription and suggest that CDK1-mediated Ser-81 phosphorylation during mitosis provides a pool of Ser-81 phosphorylation AR that can be readily recruited to chromatin for gene reactivation and may enhance AR activity in PCa.	[Chen, Shaoyong; Gulla, Sarah; Cai, Changmeng; Balk, Steven P.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Chen, SY (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Hematol Oncol Div,Dept Med, Ctr Life Sci Bldg,Rm 432,3 Blackfan Circle, Boston, MA 02215 USA.	schen@bidmc.harvard.edu	CHEN, Shaoyong/ABF-3357-2021; Cai, Changmeng/AAE-6835-2020	Cai, Changmeng/0000-0002-8701-2586	National Institutes of Health [R01CA111803, K99/R00 CA135592]; Dana-Farber/Harvard Cancer Center (DF/HCC) [P50-CA90381]; SPORE; Department of Defense [PC040499]; Career Development Award for the Beth Israel Deaconess Medical Center Prostate and Breast Cancer Research Program; Hershey Family Prostate Cancer Research Fund; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R00CA135592, K99CA135592, R01CA111803, P50CA090381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard Cancer Center (DF/HCC); SPORE; Department of Defense(United States Department of Defense); Career Development Award for the Beth Israel Deaconess Medical Center Prostate and Breast Cancer Research Program; Hershey Family Prostate Cancer Research Fund; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA111803 (to S. P. B.) and K99/R00 CA135592 (to S. C.). This work was also supported by Dana-Farber/Harvard Cancer Center (DF/HCC) Prostate Specialized Program in Research Excellence (SPORE) Grant P50-CA90381 (to S. P. B.), a SPORE Career Development Award (to S. C.), Department of Defense postdoctoral award PC040499, a Career Development Award for the Beth Israel Deaconess Medical Center Prostate and Breast Cancer Research Program, and the Hershey Family Prostate Cancer Research Fund and the Prostate Cancer Foundation.	Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Bisson WH, 2008, J MOL GRAPH MODEL, V27, P452, DOI 10.1016/j.jmgm.2008.08.001; Black BE, 2004, MOL ENDOCRINOL, V18, P834, DOI 10.1210/me.2003-0145; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Cifuentes E, 2003, J CELL PHYSIOL, V195, P337, DOI 10.1002/jcp.10317; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Hara T, 2003, CANCER RES, V63, P149; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Imbach P, 1999, BIOORG MED CHEM LETT, V9, P91, DOI 10.1016/S0960-894X(98)00691-X; JENSTER G, 1994, BIOCHEMISTRY-US, V33, P14064, DOI 10.1021/bi00251a015; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kumar S, 2008, BBA-MOL CELL RES, V1783, P59, DOI 10.1016/j.bbamcr.2007.11.002; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Masiello D, 2002, J BIOL CHEM, V277, P26321, DOI 10.1074/jbc.M203310200; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Rajgopal A, 2007, J CELL BIOCHEM, V100, P1509, DOI 10.1002/jcb.21137; Shen HC, 2005, VITAM HORM, V71, P301, DOI 10.1016/S0083-6729(05)71010-4; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Tomura A, 2001, J BIOL CHEM, V276, P28395, DOI 10.1074/jbc.M101755200; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; VANLAAR JH, 1990, BIOCHEM BIOPH RES CO, V166, P193, DOI 10.1016/0006-291X(90)91930-Q; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Wang LG, 1999, BIOCHEM BIOPH RES CO, V259, P21, DOI 10.1006/bbrc.1999.0655; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wong HY, 2004, BIOCHEM J, V383, P267, DOI 10.1042/BJ20040683; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zeng XZ, 2011, CELL CYCLE, V10, P579, DOI 10.4161/cc.10.4.14722; Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605	54	71	73	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8571	8583		10.1074/jbc.M111.325290	http://dx.doi.org/10.1074/jbc.M111.325290			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275373	Green Published, hybrid			2022-12-25	WOS:000301349400070
J	Terzian, AS; Bodach, SD; Wiewel, EW; Sepkowitz, K; Bernard, MA; Braunstein, SL; Shepard, CW				Terzian, Arpi S.; Bodach, Sara D.; Wiewel, Ellen W.; Sepkowitz, Kent; Bernard, Marie-Antoinette; Braunstein, Sarah L.; Shepard, Colin W.			Novel Use of Surveillance Data to Detect HIV-Infected Persons with Sustained High Viral Load and Durable Virologic Suppression in New York City	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PERINATALLY ACQUIRED HIV; DRUG-USERS; PROSPECTIVE COHORT; UNITED-STATES; MEDICAL-CARE; RISK; MEN; TRANSMISSION; SEX	Background: Monitoring of the uptake and efficacy of ART in a population often relies on cross-sectional data, providing limited information that could be used to design specific targeted intervention programs. Using repeated measures of viral load (VL) surveillance data, we aimed to estimate and characterize the proportion of persons living with HIV/AIDS (PLWHA) in New York City (NYC) with sustained high VL (SHVL) and durably suppressed VL (DSVL). Methods/Principal Findings: Retrospective cohort study of all persons reported to the NYC HIV Surveillance Registry who were alive and >= 12 years old by the end of 2005 and who had >= 2 VL tests in 2006 and 2007. SHVL and DSVL were defined as PLWHA with 2 consecutive VLs >= 100,000 copies/mL and PLWHA with all VLs <= 400 copies/mL, respectively. Logistic regression models using generalized estimating equations were used to model the association between SHVL and covariates. There were 56,836 PLWHA, of whom 7% had SHVL and 38% had DSVL. Compared to those without SHVL, persons with SHVL were more likely to be younger, black and have injection drug use (IDU) risk. PLWHA with SHVL were more likely to die by 2007 and be younger by nearly ten years, on average. Conclusions/Significance: Nearly 60% of PLWHA in 2005 had multiple VLs, of whom almost 40% had DSVL, suggesting successful ART uptake. A small proportion had SHVL, representing groups known to have suboptimal engagement in care. This group should be targeted for additional outreach to reduce morbidity and secondary transmission. Measures based on longitudinal analyses of surveillance data in conjunction with cross-sectional measures such as community viral load represent more precise and powerful tools for monitoring ART effectiveness and potential impact on disease transmission than cross-sectional measures alone.	[Terzian, Arpi S.; Bodach, Sara D.; Wiewel, Ellen W.; Bernard, Marie-Antoinette; Braunstein, Sarah L.; Shepard, Colin W.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Sepkowitz, Kent] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	New York City Department of Health & Mental Hygiene; Memorial Sloan Kettering Cancer Center	Terzian, AS (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY USA.	aterzian@health.nyc.gov	Wiewel, Ellen/AAN-6338-2020; Terzian, Arpi/AAE-7514-2020	Wiewel, Ellen/0000-0002-5106-0500; 				Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2007, SUMMARY VITAL STAT 2; [Anonymous], 2010, 52 NYC DEP HLTH MENT; [Anonymous], NAT HIV AIDS STRAT; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Berk ML, 2003, SOC SCI MED, V57, P1091, DOI 10.1016/S0277-9536(02)00487-2; BoHAPaC, 2010, PEDIAT HIV AIDS SURV; BophaphpIoMotN, 2003, MEAS WHAT MATT ALL P; CDC Fact Sheet, CDC FACT SHEET HIV H; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P29; Chadwick EG, 2011, AIDS, V25, P643, DOI 10.1097/QAD.0b013e32834403f6; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Diamond C, 2000, AM J PUBLIC HEALTH, V90, P115, DOI 10.2105/AJPH.90.1.115; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Foster C, 2009, AIDS PATIENT CARE ST, V23, P159, DOI 10.1089/apc.2008.0153; Frye Douglas M, 2010, PRED HIGH HIV VIR LO; Hall HI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012756; HIV Prevention Trials Network, TLC PLUS STUD EV FEA; Jenness SM, 2011, SUBST USE MISUSE, V46, P192, DOI 10.3109/10826084.2011.521467; Jenness SM, 2010, AIDS BEHAV, V14, P1353, DOI 10.1007/s10461-010-9769-x; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Koenig LJ, 2011, CURR OPIN OBSTET GYN, V23, P321, DOI 10.1097/GCO.0b013e32834a581b; Koenig LJ, J ACQUIR IMMUNE DEFI, V55, P380; Lee LM, 2003, PUBLIC HEALTH REP, V118, P400, DOI 10.1093/phr/118.5.400; Lohse N, 2006, CLIN INFECT DIS, V42, P136, DOI 10.1086/498515; Marhefka SL, AIDS CARE, P1; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Smit C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001949; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Terzian AS, 2009, J WOMENS HEALTH, V18, P1965, DOI 10.1089/jwh.2008.1090; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Validiserri R, 2011, SAN FRANCISCOS NEW A; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Wolfe D, 2010, JAIDS-J ACQ IMM DEF, V55, pS56, DOI 10.1097/QAI.0b013e3181f9c0de; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	46	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e29679	10.1371/journal.pone.0029679	http://dx.doi.org/10.1371/journal.pone.0029679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	910LV	22291892	gold, Green Published, Green Submitted			2022-12-25	WOS:000301639600004
J	Bianchi, V; Gambino, F; Muzio, L; Toniolo, D; Humeau, Y; D'Adamo, P				Bianchi, Veronica; Gambino, Frederic; Muzio, Luca; Toniolo, Daniela; Humeau, Yann; D'Adamo, Patrizia			Forebrain Deletion of alpha GDI in Adult Mice Worsens the Pre-Synaptic Deficit at Cortico-Lateral Amygdala Synaptic Connections	PLOS ONE			English	Article							VESICLE POOLS; PLASTICITY; LTP; MUTATIONS; INDUCTION	The GDI1 gene encodes alpha GDI, which retrieves inactive GDP-bound RAB from membranes to form a cytosolic pool awaiting vesicular release. Mutations in GDI1 are responsible for X-linked Intellectual Disability. Characterization of the Gdi1-null mice has revealed alterations in the total number and distribution of hippocampal and cortical synaptic vesicles, hippocampal short-term synaptic plasticity and specific short-term memory deficits in adult mice, which are possibly caused by alterations of different synaptic vesicle recycling pathways controlled by several RAB GTPases. However, interpretation of these studies is complicated by the complete ablation of Gdi1 in all cells in the brain throughout development. In this study, we generated conditionally gene-targeted mice in which the knockout of Gdi1 is restricted to the forebrain, hippocampus, cortex and amygdala and occurs only during postnatal development. Adult mutant mice reproduce the short-term memory deficit previously reported in Gdi1-null mice. Surprisingly, the delayed ablation of Gdi1 worsens the pre-synaptic phenotype at cortico-amygdala synaptic connections compared to Gdi1-null mice. These results suggest a pivotal role of alpha GDI via specific RAB GTPases acting specifically in forebrain regions at the pre-synaptic sites involved in memory formation.	[Bianchi, Veronica; D'Adamo, Patrizia] Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Neurosci, I-20132 Milan, Italy; [Gambino, Frederic; Humeau, Yann] Univ Strasbourg, UPR3212, CNRS, Strasbourg, France; [Gambino, Frederic] CMU, Dept Neurosci Fondamentales, Geneva, Switzerland; [Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Humeau, Yann] Univ Bordeaux, CNRS, UMR5297, Inst Interdiciplinaire Neurosci, Bordeaux, France	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Geneva; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bianchi, V (corresponding author), Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Neurosci, I-20132 Milan, Italy.	p.dadamo@hsr.it	Toniolo, Daniela/AAE-2969-2019; Muzio, Luca/AAB-2308-2022; D'Adamo, Patrizia/AAN-3919-2020	Toniolo, Daniela/0000-0001-9545-6032; Muzio, Luca/0000-0002-1068-865X; D'Adamo, Patrizia/0000-0002-0312-5541; gambino, frederic/0000-0002-2981-5030	Telethon, Italy [TCP04015]; Centre Nationale de la Recherche Scientifique; Agence Nationale de la Recherche [06-003-Neuro-01]; European Neuroscience Institutes Network [LSHM-CT-2005-019063]; Sanofi; Region Aquitaine	Telethon, Italy(Fondazione Telethon); Centre Nationale de la Recherche Scientifique; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Neuroscience Institutes Network(European Commission); Sanofi; Region Aquitaine(Region Nouvelle-Aquitaine)	This work was supported by grants from Telethon, Italy [TCP04015 to PD]; by Centre Nationale de la Recherche Scientifique and the Agence Nationale de la Recherche contract 06-003-Neuro-01 to YH, and by the European Neuroscience Institutes Network (Project Contract N<SUP>o</SUP> LSHM-CT-2005-019063), and Sanofi and the Region Aquitaine to YH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi V, 2009, HUM MOL GENET, V18, P105, DOI 10.1093/hmg/ddn321; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Humeau Y, 2007, J PHYSIOL-LONDON, V583, P983, DOI 10.1113/jphysiol.2007.139899; LEDOUX JE, 1985, ANN NY ACAD SCI, V444, P463, DOI 10.1111/j.1749-6632.1985.tb37611.x; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	18	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29763	10.1371/journal.pone.0029763	http://dx.doi.org/10.1371/journal.pone.0029763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291894	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600006
J	Cervello, I; Gil-Sanchis, C; Mas, A; Faus, A; Sanz, J; Moscardo, F; Higueras, G; Sanz, MA; Pellicer, A; Simon, C				Cervello, Irene; Gil-Sanchis, Claudia; Mas, Aymara; Faus, Amparo; Sanz, Jaime; Moscardo, Federico; Higueras, Gema; Angel Sanz, Miguel; Pellicer, Antonio; Simon, Carlos			Bone Marrow-Derived Cells from Male Donors Do Not Contribute to the Endometrial Side Population of the Recipient	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; STROMAL CELLS; IDENTIFICATION; MARKERS; TRANSPLANTATION; EXPRESSION; RECEPTOR	Accumulated evidence demonstrates the existence of bone marrow-derived cells origin in the endometria of women undergoing bone marrow transplantation (BMT). In these reports, cells of a bone marrow (BM) origin are able to differentiate into endometrial cells, although their contribution to endometrial regeneration is not yet clear. We have previously demonstrated the functional relevance of side population (SP) cells as the endogenous source of somatic stem cells (SSC) in the human endometrium. The present work aims to understand the presence and contribution of bone marrow-derived cells to the endometrium and the endometrial SP population of women who received BMT from male donors. Five female recipients with spontaneous or induced menstruations were selected and their endometrium was examined for the contribution of XY donor-derived cells using fluorescent in situ hybridization (FISH), telomapping and SP method investigation. We confirm the presence of XY donor-derived cells in the recipient endometrium ranging from 1.7% to 2.62%. We also identify 0.45-0.85% of the donor-derived cells in the epithelial compartment displaying CD9 marker, and 1.0-1.83% of the Vimentin-positive XY donor-derived cells in the stromal compartment. Although the percentage of endometrial SP cells decreased, possibly being due to chemotherapy applied to these patients, they were not formed by XY donor-derived cells, donor BM cells were not associated with the stem cell (SC) niches assessed by telomapping technique, and engraftment percentages were very low with no correlation between time from transplant and engraftment efficiency, suggesting random terminal differentiation. In conclusion, XY donor-derived cells of a BM origin may be considered a limited exogenous source of transdifferentiated endometrial cells rather than a cyclic source of BM donor-derived stem cells.	[Cervello, Irene; Gil-Sanchis, Claudia; Mas, Aymara; Faus, Amparo; Simon, Carlos] Fdn IVI Inst Univ IVI Univ Valencia, INCLIVA, Valencia, Spain; [Sanz, Jaime; Moscardo, Federico; Angel Sanz, Miguel] Hosp Univ La Fe, Serv Hematol, Valencia, Spain; [Higueras, Gema; Pellicer, Antonio] Hosp Univ La Fe, Serv Ginecol, Valencia, Spain; [Simon, Carlos] Ctr Invest Principe Felipe, Stem Cell Bank, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Prince Felipe Research Center	Cervello, I (corresponding author), Fdn IVI Inst Univ IVI Univ Valencia, INCLIVA, Valencia, Spain.	Carlos.Simon@ivi.es	MARTINEZ, ANTONIO PELLICER/C-4832-2015; Sanz, Jaime/K-7141-2019; Mas, Aymara/E-4409-2018; Sanz, Miguel A./F-7485-2018; Pellicer, Antonio/AAA-6005-2020; Simon, Carlos/G-2186-2014	Sanz, Jaime/0000-0001-6934-4619; Sanz, Miguel A./0000-0003-1489-1177; Pellicer, Antonio/0000-0002-8254-863X; Simon, Carlos/0000-0003-0902-9531; Mas, Aymara/0000-0002-5866-6732; Cervello, Irene/0000-0002-7018-4971; Cervello, Irene/0000-0003-4801-5538	SAF; Spanish Ministry of Science and Innovation; Fundacio Gent	SAF; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio Gent	This work has been funded by grants SAF (Plan Nacional de Biomedicina) 2008-02048 supported by the Spanish Ministry of Science and Innovation (PI: C. S.), by Fundacio Gent per Gent 08/09 (PI: C. S.) and by PROMETEO/2008/163 (PI: C. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bratincsak A, 2007, STEM CELLS, V25, P2820, DOI 10.1634/stemcells.2007-0301; Cervello I, 2007, HUM REPROD, V22, P45, DOI 10.1093/humrep/del332; Cervello I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021221; Cervello I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010964; Cervello I, 2009, REPROD SCI, V16, P200, DOI 10.1177/1933719108329955; Chan RWS, 2006, STEM CELLS, V24, P1529, DOI 10.1634/stemcells.2005-0411; Chan RWS, 2004, BIOL REPROD, V70, P1738, DOI 10.1095/biolreprod.103.024109; Cho NH, 2004, FERTIL STERIL, V81, P403, DOI 10.1016/j.fertnstert.2003.07.015; Dimitrov R, 2008, REPRODUCTION, V135, P551, DOI 10.1530/REP-07-0428; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Du H, 2009, REPROD SCI, V16, P126, DOI 10.1177/1933719108329956; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett Caroline E, 2011, J Hum Reprod Sci, V4, P49; Gargett CE, 2009, BIOL REPROD, V80, P1136, DOI 10.1095/biolreprod.108.075226; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Herzog EL, 2007, FASEB J, V21, P2592, DOI 10.1096/fj.06-7861com; Ikoma T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.026; Iohara K, 2008, STEM CELLS, V26, P2408, DOI 10.1634/stemcells.2008-0393; Jung P, 2011, NAT MED         0904; Kato K, 2007, HUM REPROD, V22, P1214, DOI 10.1093/humrep/del514; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; Martin J, 2008, CYTOTHERAPY, V10, P140, DOI 10.1080/14653240801895296; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Meng XL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-57; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Mezey E, 2011, J CELL BIOCH; Mints M, 2008, HUM REPROD, V23, P139, DOI 10.1093/humrep/dem342; Musina RA, 2008, B EXP BIOL MED+, V145, P539, DOI 10.1007/s10517-008-0136-0; Nemeth K, 2011, STEM CELLS DEV; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reis FM, 2005, J ASSIST REPROD GEN, V22, P19, DOI 10.1007/s10815-005-0816-x; Salooja N, 2001, LANCET, V358, P271, DOI 10.1016/S0140-6736(01)05482-4; Schuring AN, 2011, FERTIL STERIL, V95, P423, DOI 10.1016/j.fertnstert.2010.08.035; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056; SIMON C, 1993, J CLIN ENDOCR METAB, V77, P549, DOI 10.1210/jc.77.2.549; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Soares SR, 2005, J CLIN ENDOCR METAB, V90, P4399, DOI 10.1210/jc.2004-2252; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Tsuji S, 2008, FERTIL STERIL, V90, P1528, DOI 10.1016/j.fertnstert.2007.08.005; Wolff EF, 2007, REPROD SCI, V14, P524, DOI 10.1177/1933719107306896; Zapata AG, 2009, STEM CELLS HUMAN REP, P177	51	70	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30260	10.1371/journal.pone.0030260	http://dx.doi.org/10.1371/journal.pone.0030260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276168	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200048
J	O'Brien, LJ; Caron, JB				O'Brien, Lorna J.; Caron, Jean-Bernard			A New Stalked Filter-Feeder from the Middle Cambrian Burgess Shale, British Columbia, Canada	PLOS ONE			English	Article							STEPHEN FORMATION; EVOLUTION; CHINA; PALEOECOLOGY; COMMUNITY; BARNACLE; BIOTA	Burgess Shale-type deposits provide invaluable insights into the early evolution of body plans and the ecological structure of Cambrian communities, but a number of species, continue to defy phylogenetic interpretations. Here we extend this list to include a new soft-bodied animal, Siphusauctum gregarium n. gen. and n. sp., from the Tulip Beds (Campsite Cliff Shale Member, Burgess Shale Formation) of Mount Stephen (Yoho National Park, British Columbia). With 1,133 specimens collected, S. gregarium is clearly the most abundant animal from this locality. This stalked animal (reaching at least 20 cm in length), has a large ovoid calyx connected to a narrow bilayered stem and a small flattened or bulb-like holdfast. The calyx is enclosed by a flexible sheath with six small openings at the base, and a central terminal anus near the top encircled by indistinct openings. A prominent organ, represented by six radially symmetrical segments with comb-like elements, surrounds an internal body cavity with a large stomach, conical median gut and straight intestine. Siphusauctum gregarium was probably an active filter-feeder, with water passing through the calyx openings, capturing food particles with its comb-like elements. It often occurs in large assemblages on single bedding planes suggesting a gregarious lifestyle, with the animal living in high tier clusters. These were probably buried en masse more or less in-situ by rapid mud flow events. Siphusauctum gregarium resembles Dinomischus, another Cambrian enigmatic stalked animal. Principal points of comparison include a long stem with a calyx containing a visceral mass and bract-like elements, and a similar lifestyle albeit occupying different tiering levels. The presence in both animals of a digestive tract with a potential stomach and anus suggest a grade of organization within bilaterians, but relationships with extant phyla are not straightforward. Thus, the broader affinities of S. gregarium remain largely unconstrained.	[O'Brien, Lorna J.; Caron, Jean-Bernard] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [O'Brien, Lorna J.; Caron, Jean-Bernard] Royal Ontario Museum, Palaeobiol Div, Dept Nat Hist, Toronto, ON M5S 2C6, Canada	University of Toronto; Royal Ontario Museum	O'Brien, LJ (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	lornao@rom.on.ca		Caron, Jean-Bernard/0000-0002-1670-5502	University of Toronto (Dept of Ecology and Evolution); JBC Natural Sciences and Engineering Research Council [341944]	University of Toronto (Dept of Ecology and Evolution); JBC Natural Sciences and Engineering Research Council	LJO research is supported by fellowships from the University of Toronto (Dept of Ecology and Evolution) and JBC Natural Sciences and Engineering Research Council Discovery Grant (#341944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtson Stefan, 2000, Palaeontologia Electronica, V3, P1; Boero F, 2007, INTEGR COMP BIOL, V47, P693, DOI 10.1093/icb/icm041; Brasier M, 2004, SCIENCE, V305, P1115, DOI 10.1126/science.1102673; Briggs DEG, 2005, P ROY SOC B-BIOL SCI, V272, P2365, DOI 10.1098/rspb.2005.3224; Briggs DEG, 2005, PALEOBIOLOGY, V31, P94, DOI 10.1666/0094-8373(2005)031[0094:WSSSGA]2.0.CO;2; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P537, DOI 10.1111/j.1475-4983.2007.00656.x; Butterfield NJ, 2003, INTEGR COMP BIOL, V43, P166, DOI 10.1093/icb/43.1.166; Butterfield NJ, 2002, PALEOBIOLOGY, V28, P155, DOI 10.1666/0094-8373(2002)028<0155:LGATIO>2.0.CO;2; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Caron JB, 2010, PLOS ONE, V5, pA189, DOI 10.1371/journal.pone.0009586; Chen J.-y., 1989, Acta Palaeontologica Sinica, V28, P58; Chen J.-y., 1991, P57; Chen JY, 2003, P NATL ACAD SCI USA, V100, P8314, DOI 10.1073/pnas.1431177100; COLLINS D, 1983, SCIENCE, V222, P163, DOI 10.1126/science.222.4620.163; COLLINS D, 1981, J PALEONTOL, V55, P1006; CONWAY MS, 1993, PALAEONTOLOGY, V36, P593; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Dornbos SQ, 2005, PALAEOGEOGR PALAEOCL, V220, P47, DOI 10.1016/j.palaeo.2003.11.016; Fletcher TP, 2003, CAN J EARTH SCI, V40, P1823, DOI 10.1139/E03-057; Fletcher TP, 1998, CAN J EARTH SCI, V35, P413, DOI 10.1139/e97-120; Gould S.J, 1989, WONDERFUL LIFE BURGE, P347; Hou GG, 2006, GFF, V128, P47; Hu SX, 2007, PALAEOGEOGR PALAEOCL, V254, P307, DOI 10.1016/j.palaeo.2007.03.044; MORRIS S C, 1977, Palaeontology (Oxford), V20, P833; Morris SC, 1996, PHILOS T ROY SOC B, V351, P279, DOI 10.1098/rstb.1996.0024; MORRIS SC, 1986, PALAEONTOLOGY, V29, P423; Peng J, 2006, ACTA GEOL SIN-ENGL, V80, P498; Rigby J.K., 2004, ROYAL ONTARIO MUSEUM, V1, P1; Shu DG, 2006, SCIENCE, V312, P731, DOI 10.1126/science.1124565; Smith MR, 2010, NATURE, V465, P469, DOI 10.1038/nature09068; Sprinkle J, 2006, CAN J EARTH SCI, V43, P303, DOI 10.1139/E05-107; Walcott Charles Doolittle, 1911, Smithsonian Institution Miscellaneous Collection, V57; Whittington H. B., 1971, Proc. North American Paleontological Convention September 1969, VPart 1, P1170; [No title captured]	36	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29233	10.1371/journal.pone.0029233	http://dx.doi.org/10.1371/journal.pone.0029233			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279532	Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900010
J	Chen, CC; Hung, TH; Wang, YH; Lin, CW; Wang, PY; Lee, CY; Chen, SF				Chen, Chien-Cheng; Hung, Tai-Ho; Wang, Yen-Ho; Lin, Chii-Wann; Wang, Pei-Yi; Lee, Chun-Yen; Chen, Szu-Fu			Wogonin Improves Histological and Functional Outcomes, and Reduces Activation of TLR4/NF-kappa B Signaling after Experimental Traumatic Brain Injury	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; TOLL-LIKE RECEPTORS; SCUTELLARIA-BAICALENSIS GEORGI; FLUORO-JADE-B; GENE-EXPRESSION; INFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; FLAVONOID WOGONIN; RAT MODEL; IN-VIVO	Background: Traumatic brain injury (TBI) initiates a neuroinflammatory cascade that contributes to neuronal damage and behavioral impairment. This study was undertaken to investigate the effects of wogonin, a flavonoid with potent antiinflammatory properties, on functional and histological outcomes, brain edema, and toll-like receptor 4 (TLR4)- and nuclear factor kappa B (NF-kappa B)-related signaling pathways in mice following TBI. Methodology/Principal Findings: Mice subjected to controlled cortical impact injury were injected with wogonin (20, 40, or 50 mg.kg(-1)) or vehicle 10 min after injury. Behavioral studies, histology analysis, and measurement of blood-brain barrier (BBB) permeability and brain water content were carried out to assess the effects of wogonin. Levels of TLR4/NF-kappa B-related inflammatory mediators were also examined. Treatment with 40 mg.kg(-1) wogonin significantly improved functional recovery and reduced contusion volumes up to post-injury day 28. Wogonin also significantly reduced neuronal death, BBB permeability, and brain edema beginning at day 1. These changes were associated with a marked reduction in leukocyte infiltration, microglial activation, TLR4 expression, NF-kappa B translocation to nucleus and its DNA binding activity, matrix metalloproteinase-9 activity, and expression of inflammatory mediators, including interleukin-1 beta, interleukin-6, macrophage inflammatory protein-2, and cyclooxygenase-2. Conclusions/Significance: Our results show that post-injury wogonin treatment improved long-term functional and histological outcomes, reduced brain edema, and attenuated the TLR4/NF-kappa B-mediated inflammatory response in mouse TBI. The neuroprotective effects of wogonin may be related to modulation of the TLR4/NF-kappa B signaling pathway.	[Chen, Chien-Cheng; Wang, Pei-Yi; Lee, Chun-Yen; Chen, Szu-Fu] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chen, Chien-Cheng; Lin, Chii-Wann] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Hung, Tai-Ho] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Wang, Yen-Ho] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Wang, Yen-Ho] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Chen, Szu-Fu] Natl Def Med Ctr, Dept Biophys, Taipei, Taiwan	Cheng Hsin General Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Defense Medical Center; National Defense Medical Center	Chen, CC (corresponding author), Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	szufuchen@yahoo.com.tw	Hung, Tai-Ho/ABD-1800-2020; Hung, Tai-Ho/C-7584-2011; Lin, Chii-Wann/B-5527-2009; Chen, Szu-Fu/K-5040-2012	Hung, Tai-Ho/0000-0003-2354-7060; Lin, Chii-Wann/0000-0002-8721-3441; 	National Science Council of Taiwan, R.O.C. [98-2314-B-350-001-MY3]; Cheng Hsin General Hospital	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital	This work was supported by the National Science Council of Taiwan, R.O.C. (98-2314-B-350-001-MY3 to S.-F.C.) and the Cheng Hsin General Hospital (C.-C.C., S.-F.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Chang CF, 2011, AM J PATHOL, V178, P1749, DOI 10.1016/j.ajpath.2010.12.023; Chang YL, 2001, MOL PHARMACOL, V60, P507; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chi YS, 2003, BIOCHEM PHARMACOL, V66, P1271, DOI 10.1016/S0006-2952(03)00463-5; Cho J, 2004, BIOL PHARM BULL, V27, P1561, DOI 10.1248/bpb.27.1561; Cho JS, 2004, EUR J PHARMACOL, V485, P105, DOI 10.1016/j.ejphar.2003.11.064; Conti AC, 1998, J NEUROSCI, V18, P5663; Dong XQ, 2011, INFLAMM RES, V60, P533, DOI 10.1007/s00011-010-0300-7; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Gao ZH, 1999, BBA-GEN SUBJECTS, V1472, P643, DOI 10.1016/S0304-4165(99)00152-X; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Huang GC, 2007, INT IMMUNOPHARMACOL, V7, P1054, DOI 10.1016/j.intimp.2007.04.001; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kim H, 2001, NEUROSCI LETT, V309, P67, DOI 10.1016/S0304-3940(01)02028-6; Lee H, 2003, FASEB J, V17, P1943, DOI 10.1096/fj.03-0057fje; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Lee YM, 2011, J CARDIOVASC PHARM, V58, P133, DOI 10.1097/FJC.0b013e31821a5078; LIU XF, 1990, MOL PHARMACOL, V37, P911; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Peng J, 2009, J ETHNOPHARMACOL, V124, P257, DOI 10.1016/j.jep.2009.04.031; Piao HZ, 2008, INT IMMUNOPHARMACOL, V8, P1658, DOI 10.1016/j.intimp.2008.07.018; Piao HZ, 2004, ARCH PHARM RES, V27, P930, DOI 10.1007/BF02975846; Qi Q, 2009, PHYTOTHER RES, V23, P417, DOI 10.1002/ptr.2645; Racke MK, 2009, CURR TOP MICROBIOL, V336, P155, DOI 10.1007/978-3-642-00549-7_9; Ransohoff RM, 1998, TRENDS NEUROSCI, V21, P154, DOI 10.1016/S0166-2236(97)01198-3; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shen SC, 2006, NEUROSCIENCE, V140, P477, DOI 10.1016/j.neuroscience.2006.02.028; Son D, 2004, EUR J PHARMACOL, V493, P99, DOI 10.1016/j.ejphar.2004.04.017; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Tai MC, 2005, CNS DRUG REV, V11, P141; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Wakabayashi I, 2000, EUR J PHARMACOL, V406, P477, DOI 10.1016/S0014-2999(00)00695-6; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	49	60	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30294	10.1371/journal.pone.0030294	http://dx.doi.org/10.1371/journal.pone.0030294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272328	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400106
J	Lima, M; Navarrete, L; Gonzalez-Andujar, JL				Lima, Mauricio; Navarrete, Luis; Luis Gonzalez-Andujar, Jose			Climate Effects and Feedback Structure Determining Weed Population Dynamics in a Long-Term Experiment	PLOS ONE			English	Article							PAPAVER-RHOEAS; EMERGENCE; MODEL	Pest control is one of the areas in which population dynamic theory has been successfully applied to solve practical problems. However, the links between population dynamic theory and model construction have been less emphasized in the management and control of weed populations. Most management models of weed population dynamics have emphasized the role of the endogenous process, but the role of exogenous variables such as climate have been ignored in the study of weed populations and their management. Here, we use long-term data (22 years) on two annual weed species from a locality in Central Spain to determine the importance of endogenous and exogenous processes (local and large-scale climate factors). Our modeling study determined two different feedback structures and climate effects in the two weed species analyzed. While Descurainia sophia exhibited a second-order feedback and low climate influence, Veronica hederifolia was characterized by a first-order feedback structure and important effects from temperature and rainfall. Our results strongly suggest the importance of theoretical population dynamics in understanding plant population systems. Moreover, the use of this approach, discerning between the effect of exogenous and endogenous factors, can be fundamental to applying weed management practices in agricultural systems and to controlling invasive weedy species. This is a radical change from most approaches currently used to guide weed and invasive weedy species managements.	[Lima, Mauricio] Pontificia Univ Catolica Chile, CASEB, Santiago, Chile; [Navarrete, Luis] Inst Madrileno Invest & Desarrollo Rural Agr & Al, Dept Invest Agr, Alcala De Henares, Spain; [Luis Gonzalez-Andujar, Jose] CSIC, Inst Agr Sostenible, Dept Protecc Cultivos, Cordoba, Spain; [Luis Gonzalez-Andujar, Jose] LINCG CSIC PUC, Lab Int Cambio Global, Santiago, Chile	Pontificia Universidad Catolica de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Lima, M (corresponding author), Pontificia Univ Catolica Chile, CASEB, Alameda 340, Santiago, Chile.	andujar@cica.es	Lima, Mauricio/F-2722-2013; GONZALEZ-ANDUJAR, JOSE L./G-5671-2013	Lima, Mauricio/0000-0002-3700-2945; GONZALEZ-ANDUJAR, JOSE L./0000-0003-2356-4098	FEDER; Spanish Ministry of Innovation and Science [AGL 2009-7883]	FEDER(European Commission); Spanish Ministry of Innovation and Science(Spanish Government)	This work was supported by the FEDER funds and Spanish Ministry of Innovation and Science Grant AGL 2009-7883 (to JLG-A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; BERREBI A, 1991, AM J HEMATOL, V37, P138, DOI 10.1002/ajh.2830370219; Berryman A., 1999, PRINCIPLES POPULATIO; BERRYMAN AA, 1992, ECOLOGY, V73, P694, DOI 10.2307/1940776; BEST KF, 1977, CAN J PLANT SCI, V57, P499, DOI 10.4141/cjps77-073; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Freckleton RP, 2002, J APPL ECOL, V39, P699, DOI 10.1046/j.1365-2664.2002.00748.x; Ginzburg L. R., 2004, ECOLOGICAL ORBITS PL; Ginzburg LR, 2004, TRENDS ECOL EVOL, V19, P121, DOI 10.1016/j.tree.2003.11.004; Gonzalez-Andujar JL, 2006, AM NAT, V168, P318, DOI 10.1086/506915; Gonzalez-Andujar JL, 2000, FUNCT ECOL, V14, P524, DOI 10.1046/j.1365-2435.2000.00423.x; Hernanz JL, 2009, AGR ECOSYST ENVIRON, V133, P114, DOI 10.1016/j.agee.2009.05.009; Holst N, 2007, WEED RES, V47, P1, DOI 10.1111/j.1365-3180.2007.00534.x; Izquierdo J, 2009, WEED SCI, V57, P660, DOI 10.1614/WS-09-043.1; Larcher W, 2000, PLANT BIOSYST, V134, P279, DOI 10.1080/11263500012331350455; MORTIMER AM, 1989, WEED RES, V29, P229, DOI 10.1111/j.1365-3180.1989.tb00907.x; Pardini EA, 2009, ECOL APPL, V19, P387, DOI 10.1890/08-0845.1; Pastor J, 2006, OIKOS, V112, P698, DOI 10.1111/j.0030-1299.2006.14478.x; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; ROBERTS HA, 1978, WEED RES, V18, P41, DOI 10.1111/j.1365-3180.1978.tb01573.x; Royama T., 1992, ANAL POPULATION ECOL; THOMPSON L, 1994, J ECOL, V82, P63, DOI 10.2307/2261386; Torra J, 2008, WEED RES, V48, P136, DOI 10.1111/j.1365-3180.2007.00610.x; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	24	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30569	10.1371/journal.pone.0030569	http://dx.doi.org/10.1371/journal.pone.0030569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272362	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400140
J	Gangemi, R; Mirisola, V; Barisione, G; Fabbi, M; Brizzolara, A; Lanza, F; Mosci, C; Salvi, S; Gualco, M; Truini, M; Angelini, G; Boccardo, S; Cilli, M; Airoldi, I; Queirolo, P; Jager, MJ; Daga, A; Pfeffer, U; Ferrini, S				Gangemi, Rosaria; Mirisola, Valentina; Barisione, Gaia; Fabbi, Marina; Brizzolara, Antonella; Lanza, Francesco; Mosci, Carlo; Salvi, Sandra; Gualco, Marina; Truini, Mauro; Angelini, Giovanna; Boccardo, Simona; Cilli, Michele; Airoldi, Irma; Queirolo, Paola; Jager, Martine J.; Daga, Antonio; Pfeffer, Ulrich; Ferrini, Silvano			Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; SIGNALING PATHWAY; SYNTENIN; RECEPTOR; CELLS; MIGRATION; KIT	Uveal melanoma is an aggressive cancer that metastasizes to the liver in about half of the patients, with a high lethality rate. Identification of patients at high risk of metastases may provide indication for a frequent follow-up for early detection of metastases and treatment. The analysis of the gene expression profiles of primary human uveal melanomas showed high expression of SDCBP gene (encoding for syndecan-binding protein-1 or mda-9/syntenin), which appeared higher in patients with recurrence, whereas expression of syndecans was lower and unrelated to progression. Moreover, we found that high expression of SDCBP gene was related to metastatic progression in two additional independent datasets of uveal melanoma patients. More importantly, immunohistochemistry showed that high expression of mda-9/syntenin protein in primary tumors was significantly related to metastatic recurrence in our cohort of patients. Mda-9/syntenin expression was confirmed by RT-PCR, immunofluorescence and immunohistochemistry in cultured uveal melanoma cells or primary tumors. Interestingly, mda-9/syntenin showed both cytoplasmic and nuclear localization in cell lines and in a fraction of patients, suggesting its possible involvement in nuclear functions. A pseudo-metastatic model of uveal melanoma to the liver was developed in NOD/SCID/IL2R gamma null mice and the study of mda-9/syntenin expression in primary and metastatic lesions revealed higher mda-9/syntenin in metastases. The inhibition of SDCBP expression by siRNA impaired the ability of uveal melanoma cells to migrate in a wound-healing assay. Moreover, silencing of SDCBP in mda-9/syntenin-high uveal melanoma cells inhibited the hepatocyte growth factor (HGF)-triggered invasion of matrigel membranes and inhibited the activation of FAK, AKT and Src. Conversely syntenin overexpression in mda-9/syntenin-low uveal melanoma cells mediated opposite effects. These results suggest that mda-9/syntenin is involved in uveal melanoma progression and that it warrants further investigation as a candidate molecular marker of metastases and a potential therapeutic target.	[Gangemi, Rosaria; Barisione, Gaia; Fabbi, Marina; Brizzolara, Antonella; Ferrini, Silvano] Univ Hosp San Martino, Natl Inst Canc Res, Immunol Therapy Lab, Genoa, Italy; [Mirisola, Valentina; Angelini, Giovanna; Pfeffer, Ulrich] Univ Hosp San Martino, Natl Inst Canc Res, Lab Integrated Mol Pathol, Genoa, Italy; [Salvi, Sandra; Gualco, Marina; Truini, Mauro; Boccardo, Simona] Univ Hosp San Martino, Natl Inst Canc Res, Dept Pathol, Genoa, Italy; [Cilli, Michele] Univ Hosp San Martino, Natl Inst Canc Res, Anim Model Facil, Genoa, Italy; [Daga, Antonio] Univ Hosp San Martino, Natl Inst Canc Res, Gene Transfer Lab, Genoa, Italy; [Lanza, Francesco; Mosci, Carlo] EO Galliera Hosp, Ophthalm Oncol Ctr, Genoa, Italy; [Airoldi, Irma] G Gaslini Inst Children, Dept Expt & Lab Med, AIRC Lab Immunol & Tumors, Genoa, Italy; [Jager, Martine J.] Leiden Univ Med Ctr, Dept Ophthalmol, Leiden, Netherlands	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; Ente Ospedaliero Ospedali Galliera; University of Genoa; IRCCS Istituto Giannina Gaslini; Leiden University; Leiden University Medical Center (LUMC)	Gangemi, R (corresponding author), Univ Hosp San Martino, Natl Inst Canc Res, Immunol Therapy Lab, Genoa, Italy.	ulrich.pfeffer@istge.it	Cilli, Michele/AAB-8529-2019; Queirolo, Paola/K-6778-2016; Daga, Antonio/Z-2417-2019; Fabbi, Marina/I-1290-2012; Angelini, Giovanna/C-8476-2013; Pfeffer, Ulrich/J-7064-2016; Gangemi, Rosaria/AAB-8987-2020; Jager, Martine/AAR-3525-2020; airoldi, irma/I-6169-2017	Queirolo, Paola/0000-0002-9917-6633; Daga, Antonio/0000-0001-5845-8530; Pfeffer, Ulrich/0000-0003-0872-4671; Gangemi, Rosaria/0000-0001-8656-1965; Jager, Martine/0000-0003-2261-3820; airoldi, irma/0000-0002-4352-8396; Ferrini, Silvano/0000-0001-7254-2616; Lanza, Francesco B./0000-0003-4344-1001; ANGELINI, giovanna/0000-0003-1474-5452; Fabbi, Marina/0000-0002-4203-2022; BARISIONE, GAIA/0000-0001-6290-7503; Cilli, Michele/0000-0003-4083-8986	Istituto Superiore di Sanita : Italy-USA Program on Rare Diseases; Compagnia San Paolo, Torino, Italy; Regione Liguria, Italy; Italian Association for Cancer Research (AIRC); Regione Liguria	Istituto Superiore di Sanita : Italy-USA Program on Rare Diseases; Compagnia San Paolo, Torino, Italy(Compagnia di San Paolo); Regione Liguria, Italy; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regione Liguria(Regione Liguria)	This study was supported by grants awarded by Istituto Superiore di Sanita : Italy-USA Program on Rare Diseases and "Terapie Biologiche contro I tumori solidi"; Compagnia San Paolo, Torino, Italy; Regione Liguria, Italy; Italian Association for Cancer Research (AIRC). Dr. Mirisola is a recipient of doctoral fellowship from Regione Liguria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova OA, 2010, CLIN EXP METASTAS, V27, P91, DOI 10.1007/s10585-010-9304-5; All-Ericsson C, 2002, INVEST OPHTH VIS SCI, V43, P1; Beekman JM, 2012, ONCOGENE, V31, P2668, DOI 10.1038/onc.2011.445; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Boukerche H, 2010, ONCOGENE, V29, P3054, DOI 10.1038/onc.2010.65; Boukerche H, 2008, P NATL ACAD SCI USA, V105, P15914, DOI 10.1073/pnas.0808171105; Boukerche H, 2007, CANCER RES, V67, P1812, DOI 10.1158/0008-5472.CAN-06-3875; Chatterjee N, 2008, J BIOL CHEM, V283, P8310, DOI 10.1074/jbc.M706074200; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Cree IA, 2000, J PATHOL, V191, P112; Damato B, 2010, BRIT J CANCER, V103, P285, DOI 10.1038/sj.bjc.6605765; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Dewan MZ, 2005, BIOMED PHARMACOTHER, V59, pS375, DOI 10.1016/S0753-3322(05)80082-4; Di Cesare Sebastian, 2007, J Carcinog, V6, P2, DOI 10.1186/1477-3163-6-2; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; Estrach S, 2007, J CELL SCI, V120, P2944, DOI 10.1242/jcs.016253; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Giannoni P, 2011, HAEMATOL-HEMATOL J, V96, P1015, DOI 10.3324/haematol.2010.029736; Helmke BM, 2004, ONCOL REP, V12, P221; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Laurent C, 2011, CANCER RES, V71, P666, DOI 10.1158/0008-5472.CAN-10-0605; Lefevre G, 2004, J BIOL CHEM, V279, P31769, DOI 10.1074/jbc.M403907200; Li HC, 2009, INVEST OPHTH VIS SCI, V50, P5522, DOI 10.1167/iovs.09-3804; Lin JJ, 1998, GENE, V207, P105, DOI 10.1016/S0378-1119(97)00562-3; MA D, 1995, INVEST OPHTH VIS SCI, V36, P435; Mallikarjuna K, 2007, CURR EYE RES, V32, P281, DOI 10.1080/02713680601161220; Mirisola V, 2009, EUR J CANCER, V45, P2579, DOI 10.1016/j.ejca.2009.06.026; Mouriaux F, 2003, MELANOMA RES, V13, P161, DOI 10.1097/00008390-200304000-00008; Mouriaux F, 2001, EXP EYE RES, V73, P151, DOI 10.1006/exer.2001.1017; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2006, CANCER RES, V66, P4602, DOI 10.1158/0008-5472.CAN-05-4196; Onken MD, 2010, J MOL DIAGN, V12, P461, DOI 10.2353/jmoldx.2010.090220; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Sarkar D, 2004, PHARMACOL THERAPEUT, V104, P101, DOI 10.1016/j.pharmthera.2004.08.004; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; Verbik DJ, 1997, INT J CANCER, V73, P470, DOI 10.1002/(SICI)1097-0215(19971114)73:4<470::AID-IJC3>3.0.CO;2-X; Ye M, 2008, INVEST OPHTH VIS SCI, V49, P497, DOI 10.1167/iovs.07-0975; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	42	58	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29989	10.1371/journal.pone.0029989	http://dx.doi.org/10.1371/journal.pone.0029989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22267972	Green Published, gold, Green Submitted			2022-12-25	WOS:000301361500028
J	Jiang, XF; Pan, H; Nabhan, JF; Krishnan, R; Koziol-White, C; Panettieri, RA; Lu, Q				Jiang, Xiaofeng; Pan, Hui; Nabhan, Joseph F.; Krishnan, Ramaswamy; Koziol-White, Cynthia; Panettieri, Reynold A.; Lu, Quan			A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in beta 2-adrenergic receptor internalization and down-regulation	FASEB JOURNAL			English	Article						alendronate; beta-agonist; genetic screen; short-hairpin RNA	AIRWAY SMOOTH-MUSCLE; HUMAN BETA(1)-ADRENERGIC RECEPTOR; BETA-ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; RAB GTPASES; MOLECULAR-MECHANISMS; MAMMALIAN-CELLS; 7-TRANSMEMBRANE RECEPTORS; MEVALONATE PATHWAY; ENDOCYTIC PATHWAY	The beta 2-adrenergic receptor (beta 2AR) plays important physiological roles in the heart and lung and is the primary target of beta-agonists, the mainstay asthma drugs. Activation of beta 2AR by beta-agonists is attenuated by receptor down-regulation, which ensures transient stimulation of the receptor but reduces the efficacy of beta-agonists. Here we report the identification, through a functional genome-wide RNA interference (RNAi) screen, of new genes critically involved in beta 2AR down-regulation. We developed a lentivirus-based RNAi library consisting of 26-nt short-hairpin RNAs (shRNAs). The library was generated enzymatically from a large collection of expressed sequence tag (EST) DNAs corresponding to similar to 20,000 human genes and contains on average similar to 6 highly potent shRNAs (>75% knockdown efficiency) for each gene. Using this novel shRNA library, together with a robust cell model for beta 2AR expression, we performed fluorescence-activated cell sorting and isolated cells that, as a consequence of shRNA-mediated gene inactivation, exhibited defective agonist-induced down-regulation. The screen discovered several previously unrecognized beta 2AR regulators, including farnesyl diphosphate synthase (FDPS). We showed that inactivation of FDPS by shRNA, small interfering RNA, or the highly specific pharmaceutical inhibitor alendronate inhibited beta 2AR down-regulation. Notably, in human airway smooth muscle cells, the physiological target of beta-agonists, alendronate treatment functionally reversed agonist-induced endogenous beta 2AR loss as indicated by an increase in cAMP production. FDPS inactivation interfered with beta 2AR internalization into endosomes through disrupting the membrane localization of the Rab5 small GTPase. Furthermore, Rab5 overexpression reversed the deficient receptor down-regulation induced by alendronate, suggesting that FDPS regulates receptor down-regulation in a Rab5-dependent manner. Together, our findings reveal a FDPS-dependent mechanism in the internalization and down-regulation of beta 2AR, identify FDPS as a potential target for improving the therapeutic efficacy of beta-agonists, and demonstrate the utility of the unique EST-derived shRNA library for functional genetics studies.-Jiang, X., Pan, H., Nabhan, J. F., Krishnan, R., Koziol-White, C., Panettieri, R. A., Lu, Q. A novel EST-derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in beta 2-adrenergic receptor internalization and down-regulation. FASEB J. 26, 1995-2007 (2012). www.fasebj.org	[Jiang, Xiaofeng; Pan, Hui; Nabhan, Joseph F.; Lu, Quan] Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Dept Environm Hlth, Boston, MA 02115 USA; [Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Krishnan, Ramaswamy] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Koziol-White, Cynthia; Panettieri, Reynold A.] Univ Penn, Med Ctr, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Pennsylvania	Lu, Q (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Dept Environm Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	qlu@hsph.harvard.edu	panettieri, reynold/AAG-9485-2019		American Lung Association Biomedical Research; Harvard-National Institute of Environmental Health Sciences (NIEHS) Center [P30ES000002]; NIEHS [P42ES016454]; U.S. National Institutes of Health (NIH) [HL097796, P30ES013508]; NIH [5T32HL7118-35]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097796, T32HL007118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES016454, P30ES013508, P30ES000002] Funding Source: NIH RePORTER	American Lung Association Biomedical Research; Harvard-National Institute of Environmental Health Sciences (NIEHS) Center; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Drs. Lester Kobzik and Marianne Wessling-Resnick for critical reading of the manuscript. The authors are also grateful for the advice and help from other members of the Q.L. laboratory. Q.L. was supported by an American Lung Association Biomedical Research grant, a Harvard-National Institute of Environmental Health Sciences (NIEHS) Center grant (P30ES000002), and a NIEHS Super-fund Research Program grant (P42ES016454). R.A.P. was supported by U.S. National Institutes of Health (NIH) grants HL097796 and P30ES013508. X.J. was supported by a NIH training grant (5T32HL7118-35).	Abramson Michael J, 2003, Am J Respir Med, V2, P287; Barnes PJ, 2004, NAT REV DRUG DISCOV, V3, P831, DOI 10.1038/nrd1524; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502; Billington CK, 2003, RESP RES, V4; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Chang ACY, 2006, J VIROL, V80, P8705, DOI 10.1128/JVI.00475-06; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dohlman HG, 2002, NATURE, V418, P591, DOI 10.1038/418591a; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Hancox RJ, 1998, EUR RESPIR J, V11, P589; Haney S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-19; Haney S, 2006, CLIN REV ALLERG IMMU, V31, P181, DOI 10.1385/CRIAI:31:2:181; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Laporte JD, 1998, AM J PHYSIOL-LUNG C, V275, pL491, DOI 10.1152/ajplung.1998.275.3.L491; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; LIGGETT SB, 1991, PHARMACOL RES, V24, P29, DOI 10.1016/1043-6618(91)90119-I; Lipworth BJ, 1997, DRUG SAFETY, V16, P295, DOI 10.2165/00002018-199716050-00002; Lu Q, 2004, P NATL ACAD SCI USA, V101, P17246, DOI 10.1073/pnas.0407794101; Moncke-Buchner E, 2004, J BIOTECHNOL, V114, P99, DOI 10.1016/j.jbiotec.2004.06.014; Moore PE, 2000, AM J RESP CRIT CARE, V162, P2117, DOI 10.1164/ajrccm.162.6.9909046; Moore RH, 2004, J CELL SCI, V117, P3107, DOI 10.1242/jcs.01168; Moore RH, 1999, EUR J PHARMACOL, V369, P113, DOI 10.1016/S0014-2999(99)00055-2; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nelson HS, 2006, ANN INTERN MED, V145, P706, DOI 10.7326/0003-4819-145-9-200611070-00017; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Penn Raymond B, 2008, Proc Am Thorac Soc, V5, P47, DOI 10.1513/pats.200705-054VS; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Sharma S, 2008, J ALLERGY CLIN IMMUN, V122, P921, DOI 10.1016/j.jaci.2008.09.004; Shenoy SK, 2005, NAT CELL BIOL, V7, P1159, DOI 10.1038/ncb1205-1159; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Shore SA, 2003, RESP PHYSIOL NEUROBI, V137, P179, DOI 10.1016/S1569-9048(03)00146-0; Shore SA, 2003, J CLIN INVEST, V112, P495, DOI 10.1172/JCI200319642; Shtutman M, 2010, P NATL ACAD SCI USA, V107, P7377, DOI 10.1073/pnas.1003055107; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Tantisira KG, 2005, CURR OPIN MOL THER, V7, P209; Tattersfield AE, 2002, LANCET, V360, P1313, DOI 10.1016/S0140-6736(02)11312-2; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; TURKI J, 1995, J CLIN INVEST, V95, P1635, DOI 10.1172/JCI117838; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Walker J. K., BR J PHARM, V163, P18; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Williams BR, 2000, MOL PHARMACOL, V58, P421, DOI 10.1124/mol.58.2.421; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiao K., J BIOL CHEM, V286, P12785; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	83	8	10	2	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1995	2007		10.1096/fj.11-193870	http://dx.doi.org/10.1096/fj.11-193870			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22278941	Green Published			2022-12-25	WOS:000303680800026
J	Kobayashi, K; Sudiarta, IP; Kodama, T; Fukushima, T; Ara, K; Ozaki, K; Sekiguchi, J				Kobayashi, Kaori; Sudiarta, I. Putu; Kodama, Takeko; Fukushima, Tatsuya; Ara, Katsutoshi; Ozaki, Katsuya; Sekiguchi, Junichi			Identification and Characterization of a Novel Polysaccharide Deacetylase C (PdaC) from Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE DEACETYLASE; YYCFG 2-COMPONENT SYSTEM; SENSOR HISTIDINE KINASE; CHITIN DEACETYLASE; COLLETOTRICHUM-LINDEMUTHIANUM; STREPTOCOCCUS-PNEUMONIAE; PEPTIDOGLYCAN STRUCTURE; ENTEROCOCCUS-FAECALIS; VIRULENCE FACTOR; CELL-DIVISION	Cell wall metabolism and cell wall modification are very important processes that bacteria use to adjust to various environmental conditions. One of the main modifications is deacetylation of peptidoglycan. The polysaccharide deacetylase homologue, Bacillus subtilis YjeA (renamed PdaC), was characterized and found to be a unique deacetylase. The pdaC deletion mutant was sensitive to lysozyme treatment, indicating that PdaC acts as a deacetylase. The purified recombinant and truncated PdaC from Escherichia coli deacetylated B. subtilis peptidoglycan and its polymer, (-GlcNAc-MurNAc[-L-Ala-D-Glu]-)(n). Surprisingly, RP-HPLC and ESI-MS/MS analyses showed that the enzyme deacetylates N-acetylmuramic acid (MurNAc) not GlcNAc from the polymer. Contrary to Streptococcus pneumoniae PgdA, which shows high amino acid sequence similarity with PdaC and is a zinc-dependent GlcNAc deacetylase toward peptidoglycan, there was less dependence on zinc ion for deacetylation of peptidoglycan by PdaC than other metal ions (Mn2+, Mg2+, Ca2+). The kinetic values of the activity toward B. subtilis peptidoglycan were K-m = 4.8 mM and k(cat) = 0.32 s(-1). PdaC also deacetylated N-acetylglucosamine (GlcNAc) oligomers with a K-m = 12.3 mM and k(cat) = 0.24 s(-1) toward GlcNAc(4). Therefore, PdaC has GlcNAc deacetylase activity toward GlcNAc oligomers and MurNAc deacetylase activity toward B. subtilis peptidoglycan.	[Kobayashi, Kaori; Sudiarta, I. Putu; Sekiguchi, Junichi] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan; [Fukushima, Tatsuya] Shinshu Univ, Div Gene Res, Dept Life Sci, Res Ctr Human & Environm Sci, Ueda, Nagano 3868567, Japan; [Kodama, Takeko; Ara, Katsutoshi; Ozaki, Katsuya] Kao Corp, Biol Sci Labs, Haga, Tochigi 3213497, Japan	Shinshu University; Shinshu University; KAO Corporation	Sekiguchi, J (corresponding author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan.	jsekigu@shinshu-u.ac.jp		Sudiarta, I Putu/0000-0003-1381-388X	New Energy and Industrial Technology Department Organization (NEDO); Global COE of the Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [19380047];  [22248008];  [21780067]	New Energy and Industrial Technology Department Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Global COE of the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; 	This work was supported by Grants-in-aid for Scientific Research (B) (19380047) and (A) (22248008), a New Energy and Industrial Technology Department Organization (NEDO) grant (to J.S.), a Grant-in-aid for Young Scientists (21780067) (to T. F.), and the Global COE programs (to J.S., T. F., and I. P. S.) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ALFONSO C, 1995, CURR MICROBIOL, V30, P49, DOI 10.1007/BF00294524; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Antelmann H, 2002, PROTEOMICS, V2, P591, DOI 10.1002/1615-9861(200205)2:5<591::AID-PROT591>3.0.CO;2-8; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DEHART HP, 1995, APPL ENVIRON MICROB, V61, P1475, DOI 10.1128/AEM.61.4.1475-1479.1995; Deng DM, 2009, J BACTERIOL, V191, P394, DOI 10.1128/JB.00838-08; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; FEIN JE, 1976, J BACTERIOL, V127, P1427, DOI 10.1128/JB.127.3.1427-1442.1976; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2004, J BIOCHEM, V136, P283, DOI 10.1093/jb/mvh151; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2008, J BIOL CHEM, V283, P11117, DOI 10.1074/jbc.M706626200; Fukushima T, 2007, MOL GENET GENOMICS, V278, P371, DOI 10.1007/s00438-007-0255-8; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Gilmore ME, 2004, J BACTERIOL, V186, P80, DOI 10.1128/JB.186.1.80-89.2004; HAYASHI H, 1973, BIOCHEM BIOPH RES CO, V50, P641, DOI 10.1016/0006-291X(73)91292-8; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; KAFETZOPOULOS D, 1993, P NATL ACAD SCI USA, V90, P2564, DOI 10.1073/pnas.90.7.2564; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Ng KL, 2007, J BIOCHEM, V142, P647, DOI 10.1093/jb/mvm177; Nugroho FA, 1999, J BACTERIOL, V181, P6230, DOI 10.1128/JB.181.20.6230-6237.1999; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Popowska M, 2009, J MICROBIOL BIOTECHN, V19, P932, DOI 10.4014/jmb.0810.557; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Sambrook J., 2002, MOL CLONING LAB MANU; Severin A, 2004, MICROB DRUG RESIST, V10, P77, DOI 10.1089/1076629041310082; Silvaggi JM, 2004, J BACTERIOL, V186, P8089, DOI 10.1128/JB.186.23.8089-8095.2004; Sudiarta IP, 2010, BIOCHEM BIOPH RES CO, V398, P606, DOI 10.1016/j.bbrc.2010.07.001; Szurmant H, 2007, METHOD ENZYMOL, V422, P396, DOI 10.1016/S0076-6879(06)22020-2; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tokuyasu K, 2000, BIOCHEMISTRY-US, V39, P8837, DOI 10.1021/bi0005355; TSIGOS I, 1995, J BIOL CHEM, V270, P26286, DOI 10.1074/jbc.270.44.26286; Tsigos I, 1999, EUR J BIOCHEM, V261, P698, DOI 10.1046/j.1432-1327.1999.00311.x; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang G, 2010, INFECT IMMUN, V78, P4660, DOI 10.1128/IAI.00307-10; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	48	33	35	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9765	9776		10.1074/jbc.M111.329490	http://dx.doi.org/10.1074/jbc.M111.329490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22277649	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000302167200010
J	Li, N; Zhang, CG; Li, BQ; Liu, XH; Huang, Y; Xu, SJ; Gu, LC				Li, Ning; Zhang, Conggang; Li, Bingqing; Liu, Xiuhua; Huang, Yan; Xu, Sujuan; Gu, Lichuan			Unique Iron Coordination in Iron-chelating Molecule Vibriobactin Helps Vibrio cholerae Evade Mammalian Siderocalin-mediated Immune Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDEROPHORE; IDENTIFICATION; ENTEROBACTIN; TRANSPORT; BINDING; CLONING; SYSTEM; ACQUISITION; INFECTION; GENETICS	Iron is essential for the survival of almost all bacteria. Vibrio cholerae acquires iron through the secretion of a catecholate siderophore called vibriobactin. At present, how vibriobactin chelates ferric ion remains controversial. In addition, the mechanisms underlying the recognition of ferric vibriobactin by the siderophore transport system and its delivery into the cytoplasm specifically have not been clarified. In this study, we report the high-resolution structures of the ferric vibriobactin periplasmic binding protein ViuP and its complex with ferric vibriobactin. The holo-ViuP structure reveals that ferric vibriobactin does not adopt the same iron coordination as that of other catecholate siderophores such as enterobactin. The three catechol moieties donate five, rather than six, oxygen atoms as iron ligands. The sixth iron ligand is provided by a nitrogen atom from the second oxazoline ring. This kind of iron coordination results in the protrusion of the second catechol moiety and renders the electrostatic surface potential of ferric vibriobactin less negatively polarized compared with ferric enterobactin. To accommodate ferric vibriobactin, ViuP has a deeper subpocket to hold the protrusion of the second catechol group. This structural characteristic has not been observed in other catecholate siderophore-binding proteins. Biochemical data show that siderocalin, which is part of the mammalian innate immune system, cannot efficiently sequester ferric vibriobactin in vitro, although it can capture many catecholate siderophores with high efficiency. Our findings suggest that the unique iron coordination found in ferric vibriobactin may be utilized by some pathogenic bacteria to evade the siderocalin-mediated innate immune response of mammals.	[Li, Ning; Zhang, Conggang; Li, Bingqing; Liu, Xiuhua; Huang, Yan; Xu, Sujuan; Gu, Lichuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Liu, Xiuhua] Hebei Univ, Coll Life Sci, Baoding 071002, Peoples R China	Shandong University; Hebei University	Gu, LC (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	lcgu@sdu.edu.cn			State Key Laboratory of Microbial Technology of Shandong University; Hi-Tech Research and Development Program of China [2006AA02A324]	State Key Laboratory of Microbial Technology of Shandong University; Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the State Key Laboratory of Microbial Technology of Shandong University and by Grant 2006AA02A324 from the Hi-Tech Research and Development Program of China.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARNOLD RR, 1977, SCIENCE, V197, P263, DOI 10.1126/science.327545; BERGERON RJ, 1990, J BACTERIOL, V172, P2650, DOI 10.1128/jb.172.5.2650-2657.1990; Braun V, 1998, MET IONS BIOL SYST, V35, P67; BUTTERTON JR, 1994, J BACTERIOL, V176, P5631, DOI 10.1128/JB.176.18.5631-5638.1994; Butterton JR, 2000, J BACTERIOL, V182, P1731, DOI 10.1128/JB.182.6.1731-1738.2000; BUTTERTON JR, 1992, J BACTERIOL, V174, P3729, DOI 10.1128/JB.174.11.3729-3738.1992; Dertz EA, 2006, J AM CHEM SOC, V128, P22, DOI 10.1021/ja055898c; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRIFFITHS GL, 1984, J BIOL CHEM, V259, P383; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; KARPISHIN TB, 1992, ANGEW CHEM INT EDIT, V31, P466, DOI 10.1002/anie.199204661; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; MULDER GD, 1989, J INFECT DIS, V159, P809, DOI 10.1093/infdis/159.4.809-a; Muller A, 2006, ANGEW CHEM INT EDIT, V45, P5132, DOI 10.1002/anie.200601198; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OKUJO N, 1994, BIOMETALS, V7, P109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Strong R. K., 2005, LIPOCALINS, P83; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Wyckoff EE, 1999, J BACTERIOL, V181, P7588, DOI 10.1128/JB.181.24.7588-7596.1999; Wyckoff EE, 1997, J BACTERIOL, V179, P7055, DOI 10.1128/jb.179.22.7055-7062.1997; Wyckoff EE, 2001, J BACTERIOL, V183, P1830, DOI 10.1128/JB.183.5.1830-1834.2001; Zawadzka AM, 2009, P NATL ACAD SCI USA, V106, P21854, DOI 10.1073/pnas.0904793106	37	22	22	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8912	8919		10.1074/jbc.M111.316034	http://dx.doi.org/10.1074/jbc.M111.316034			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291019	hybrid, Green Published			2022-12-25	WOS:000301797800022
J	Ito, A; Matsuo, J; Nakamura, S; Yoshida, A; Okude, M; Hayashi, Y; Sakai, H; Yoshida, M; Takahashi, K; Yamaguchi, H				Ito, Atsushi; Matsuo, Junji; Nakamura, Shinji; Yoshida, Asahi; Okude, Miho; Hayashi, Yasuhiro; Sakai, Haruna; Yoshida, Mitsutaka; Takahashi, Kaori; Yamaguchi, Hiroyuki			Amoebal Endosymbiont Protochlamydia Induces Apoptosis to Human Immortal HEp-2 Cells	PLOS ONE			English	Article							INCLUSION MEMBRANE-PROTEINS; CHLAMYDIA-TRACHOMATIS; ORDER CHLAMYDIALES; ACANTHAMOEBAE; PNEUMONIAE; PARACHLAMYDIACEAE; IDENTIFICATION; ACTIVATION; MULTIPLIES; AMEBAS	Protochlamydia, an environmental chlamydia and obligate amoebal endosymbiotic bacterium, evolved to survive within protist hosts, such as Acanthamobae, 700 million years ago. However, these bacteria do not live in vertebrates, including humans. This raises the possibility that interactions between Protochlamydia and human cells could induce a novel cytopathic effect, leading to new insights into host-parasite relationships. Therefore, we studied the effect of Protochlamydia on the survival of human immortal cell line, HEp-2 cells and primary peripheral blood mononuclear cells (PBMC). Using mainly 4',6-diamidino-2-phenylindole staining, fluorescent in situ hybridization, transmission electron microscopy, and also TUNEL and Transwell assays, we demonstrated that the Protochlamydia induced apoptosis in HEp-2 cells. The attachment of viable bacterial cells, but not an increase of bacterial infectious progenies within the cells, was required for the apoptosis. Other chlamydiae [Parachlamydia acanthamoebae and Chlamydia trachomatis (serovars D and L2)] did not induce the same phenomena, indicating that the observed apoptosis may be specific to the Protochlamydia. Furthermore, the bacteria had no effect on the survival of primary PBMCs collected from five volunteers, regardless of activation. We concluded that Protochlamydia induces apoptosis in human-immortal HEp-2 cells and that this endosymbiont could potentially be used as a biological tool for the elucidation of novel host-parasite relationships.	[Ito, Atsushi; Matsuo, Junji; Yoshida, Asahi; Okude, Miho; Hayashi, Yasuhiro; Yamaguchi, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan; [Nakamura, Shinji; Sakai, Haruna] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Tokyo, Japan; [Yoshida, Mitsutaka; Takahashi, Kaori] Juntendo Univ, Grad Sch Med, Div Ultrastruct Res, Tokyo, Japan	Hokkaido University; Juntendo University; Juntendo University	Ito, A (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp	博之, 山口/E-1910-2012; Ito, Atsushi/GWU-9716-2022		KAKENHI; Institute for Fermentation, Osaka, Japan	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Fermentation, Osaka, Japan(Institute for Fermentation (IFO))	This study was supported in part, by grants-in-aid for scientific research from KAKENHI, and a research grant from the Institute for Fermentation, Osaka, Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedson SP, 1932, BRIT J EXP PATHOL, V13, P461; Birtles RJ, 1997, LANCET, V349, P925, DOI 10.1016/S0140-6736(05)62701-8; Campbell Lee Ann, 2003, Semin Respir Infect, V18, P48, DOI 10.1053/srin.2003.50006; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Casson N, 2008, EMERG INFECT DIS, V14, P168, DOI 10.3201/eid1401.070980; Casson N, 2006, MICROBES INFECT, V8, P1294, DOI 10.1016/j.micinf.2005.12.011; Collingro A, 2005, MICROBIOL-SGM, V151, P301, DOI 10.1099/mic.0.27406-0; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Greub G, 2003, EMERG INFECT DIS, V9, P755; Haider S, 2010, MOL MICROBIOL, V77, P687, DOI 10.1111/j.1365-2958.2010.07241.x; Heinz E, 2010, PROTEOMICS, V10, P4363, DOI 10.1002/pmic.201000302; Heinz E, 2010, J BACTERIOL, V192, P5093, DOI 10.1128/JB.00605-10; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Heuer D, 2007, INT J MED MICROBIOL, V297, P569, DOI 10.1016/j.ijmm.2007.03.011; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Into T, 2005, CELL MICROBIOL, V7, P1305, DOI 10.1111/j.1462-5822.2005.00558.x; Into T, 2004, CELL MICROBIOL, V6, P187, DOI 10.1046/j.1462-5822.2003.00356.x; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Matsumoto A., 1988, MICROBIOLOGY CHLAMYD, P21; Matsuo J, 2008, APPL ENVIRON MICROB, V74, P6397, DOI 10.1128/AEM.00841-08; Matsuo J, 2010, ENV MICROBIOL REP, V2, P524, DOI 10.1111/j.1758-2229.2009.00094.x; Matsuo J, 2010, MICROBIOL IMMUNOL, V54, P63, DOI 10.1111/j.1348-0421.2009.00182.x; Nakamura S, 2010, ENV MICROBIOL REP, V2, P611, DOI 10.1111/j.1758-2229.2010.00182.x; Ossewaarde JM, 1999, MICROBIOL-SGM, V145, P411, DOI 10.1099/13500872-145-2-411; Rokey DD, 2006, PROTEINS CHLAMYDIAL; Schachter J, 1999, CHLAMYDIA, P139; SCHRAMM N, 1995, INFECT IMMUN, V63, P324, DOI 10.1128/IAI.63.1.324-332.1995; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stratton CW, 2003, MICROBES INFECT, V5, P1249, DOI 10.1016/j.micinf.2003.09.004; Toh H, 2003, DNA RES, V10, P9, DOI 10.1093/dnares/10.1.9; WEISS E, 1989, P NATL ACAD SCI USA, V86, P1674, DOI 10.1073/pnas.86.5.1674; WHO, 2001, GLOB PREV INC CUR ST; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30270	10.1371/journal.pone.0030270	http://dx.doi.org/10.1371/journal.pone.0030270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276171	Green Published, gold			2022-12-25	WOS:000301457200051
J	Wang, S; Chen, AJ; Shi, LJ; Zhao, XF; Wang, JX				Wang, Shuai; Chen, An-Jing; Shi, Li-Jie; Zhao, Xiao-Fan; Wang, Jin-Xing			TRBP and eIF6 Homologue in Marsupenaeus japonicus Play Crucial Roles in Antiviral Response	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; RISC-LOADING COMPLEX; BINDING-PROTEIN; IN-VIVO; VIRUS-REPLICATION; MARINE SHRIMP; HIV-1 TAR; DROSOPHILA; DSRNA; IMMUNITY	Plants and invertebrates can suppress viral infection through RNA silencing, mediated by RNA-induced silencing complex (RISC). Trans-activation response RNA-binding protein (TRBP), consisting of three double-stranded RNA-binding domains, is a component of the RISC. In our previous paper, a TRBP homologue in Fenneropenaeus chinensis (Fc-TRBP) was reported to directly bind to eukaryotic initiation factor 6 (Fc-eIF6). In this study, we further characterized the function of TRBP and the involvement of TRBP and eIF6 in antiviral RNA interference (RNAi) pathway of shrimp. The double-stranded RNA binding domains (dsRBDs) B and C of the TRBP from Marsupenaeus japonicus (Mj-TRBP) were found to mediate the interaction of TRBP and eIF6. Gel-shift assays revealed that the N-terminal of Mj-TRBP dsRBD strongly binds to double-stranded RNA (dsRNA) and that the homodimer of the TRBP mediated by the C-terminal dsRBD increases the affinity to dsRNA. RNAi against either Mj-TRBP or Mj-eIF6 impairs the dsRNA-induced sequence-specific RNAi pathway and facilitates the proliferation of white spot syndrome virus (WSSV). These results further proved the important roles of TRBP and eIF6 in the antiviral response of shrimp.	[Wang, Shuai; Chen, An-Jing; Shi, Li-Jie; Zhao, Xiao-Fan; Wang, Jin-Xing] Shandong Univ, Minist Educ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China; [Wang, Shuai] Chinese Acad Sci, Wuhan Inst Virol, Wuchang, Hubei, Peoples R China	Shandong University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, S (corresponding author), Shandong Univ, Minist Educ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China.	jxwang@sdu.edu.cn	Chen, Anjing/GYE-2355-2022; Wang, Jin-Xing/AAU-1514-2021	Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [30972236, 31130056]; Ph.D. program foundation of the Ministry of Education of China [20110131130003]; National High Technology Research and Development Program of China (863 Program) [2007AA09Z425]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. program foundation of the Ministry of Education of China(Ministry of Education, China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Grant nos. 30972236 and 31130056) and the Ph.D. program foundation of the Ministry of Education of China (Grant no. 20110131130003), and this work was partly supported by the National High Technology Research and Development Program of China (863 Program) (Grant no. 2007AA09Z425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; COSENTINO GP, 1995, P NATL ACAD SCI USA, V92, P9445, DOI 10.1073/pnas.92.21.9445; Daher A, 2009, MOL CELL BIOL, V29, P254, DOI 10.1128/MCB.01030-08; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Daviet L, 2000, EUR J BIOCHEM, V267, P2419, DOI 10.1046/j.1432-1327.2000.01256.x; DE N, METHODS MOL BIOL, V725, P107; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Duarte M, 2000, J BIOMED SCI, V7, P494; Eamens AL, 2009, RNA, V15, P2219, DOI 10.1261/rna.1646909; Erard M, 1998, J MOL BIOL, V279, P1085, DOI 10.1006/jmbi.1998.1831; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gupta V, 2003, VIROLOGY, V315, P283, DOI 10.1016/S0042-6822(03)00589-0; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hitti EG, 2004, FEBS LETT, V574, P25, DOI 10.1016/j.febslet.2004.07.080; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Parker GS, 2006, RNA, V12, P807, DOI 10.1261/rna.2338706; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Robalino J, 2005, J VIROL, V79, P13561, DOI 10.1128/JVI.79.21.13561-13571.2005; Robalino J, 2007, DEV COMP IMMUNOL, V31, P539, DOI 10.1016/j.dci.2006.08.011; Rossi JJ, 2005, EMBO REP, V6, P927, DOI 10.1038/sj.embor.7400531; Roux MM, 2002, J VIROL, V76, P7140, DOI 10.1128/JVI.76.14.7140-7149.2002; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; SUK K, NUCL ACIDS RES, V39, pE43; Tirasophon W, 2005, BIOCHEM BIOPH RES CO, V334, P102, DOI 10.1016/j.bbrc.2005.06.063; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang SA, 2009, J IMMUNOL, V182, P5250, DOI 10.4049/jimmunol.0802970; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; YAMASHITA S, PROTEIN SCI, V20, P118; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	42	29	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30057	10.1371/journal.pone.0030057	http://dx.doi.org/10.1371/journal.pone.0030057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279564	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900042
J	Chen, VV; Staub, RE; Baggett, S; Chimmani, R; Tagliaferri, M; Cohen, I; Shtivelman, E				Chen, Vivian; Staub, Richard E.; Baggett, Scott; Chimmani, Ramesh; Tagliaferri, Mary; Cohen, Isaac; Shtivelman, Emma			Identification and Analysis of the Active Phytochemicals from the Anti-Cancer Botanical Extract Bezielle	PLOS ONE			English	Article							BREAST-CANCER; SCUTELLARIA-BARBATA; FLAVONOIDS; CELLS; MECHANISMS; APOPTOSIS; APIGENIN; BZL101; DIPHENYLENEIODONIUM; PREVENTION	Bezielle is a botanical extract that has selective anti-tumor activity, and has shown a promising efficacy in the early phases of clinical testing. Bezielle inhibits mitochondrial respiration and induces reactive oxygen species (ROS) in mitochondria of tumor cells but not in non-transformed cells. The generation of high ROS in tumor cells leads to heavy DNA damage and hyper-activation of PARP, followed by the inhibition of glycolysis. Bezielle therefore belongs to a group of drugs that target tumor cell mitochondria, but its cytotoxicity involves inhibition of both cellular energy producing pathways. We found that the cytotoxic activity of the Bezielle extract in vitro co-purified with a defined fraction containing multiple flavonoids. We have isolated several of these Bezielle flavonoids, and examined their possible roles in the selective anti-tumor cytotoxicity of Bezielle. Our results support the hypothesis that a major Scutellaria flavonoid, scutellarein, possesses many if not all of the biologically relevant properties of the total extract. Like Bezielle, scutellarein induced increasing levels of ROS of mitochondrial origin, progressive DNA damage, protein oxidation, depletion of reduced glutathione and ATP, and suppression of both OXPHOS and glycolysis. Like Bezielle, scutellarein was selectively cytotoxic towards cancer cells. Carthamidin, a flavonone found in Bezielle, also induced DNA damage and oxidative cell death. Two well known plant flavonoids, apigenin and luteolin, had limited and not selective cytotoxicity that did not depend on their pro-oxidant activities. We also provide evidence that the cytotoxicity of scutellarein was increased when other Bezielle flavonoids, not necessarily highly cytotoxic or selective on their own, were present. This indicates that the activity of total Bezielle extract might depend on a combination of several different compounds present within it.	[Chen, Vivian; Staub, Richard E.; Baggett, Scott; Chimmani, Ramesh; Tagliaferri, Mary; Cohen, Isaac; Shtivelman, Emma] BioNovo Inc, Emeryville, CA USA		Chen, VV (corresponding author), BioNovo Inc, Emeryville, CA USA.	emmas@bionovo.com			BioNovo, Inc.; BioNovo	BioNovo, Inc.; BioNovo	This research was supported entirely by BioNovo, Inc. The funder played a role in the decision to research Bezielle as an anti-cancer agent, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare a financial competing interest. The authors acknowledge that they are paid employees and stock holders of BioNovo, Inc, and that this study, in its entirety, was supported by funds from BioNovo. Bezielle (BZL101) is Bionovo's proprietary botanical drug candidate (FDA-IND: 59,521) for the treatment of metastatic breast cancer. Bionovo's United States Patent No. 7,700,136 covers a method of treating breast cancer using an extract of Scutellaria Barbata. This patent also covers the use of Bionovo's proprietary BezielleR formulation as a monotherapy for the treatment of breast cancer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Chen D, 2008, INT J MOL SCI, V9, P1196, DOI 10.3390/ijms9071196; Choi SI, 2007, ARCH PHARM RES, V30, P1328, DOI 10.1007/BF02980274; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; Fong S, 2008, CANCER BIOL THER, V7, P577, DOI 10.4161/cbt.7.4.5535; Horvathova K, 2001, NEOPLASMA, V48, P435; Le Marchand L, 2002, BIOMED PHARMACOTHER, V56, P296, DOI 10.1016/S0753-3322(02)00186-5; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; MAJANDER A, 1994, J BIOL CHEM, V269, P21037; Min K, 2008, FOOD CHEM TOXICOL, V46, P96, DOI 10.1016/j.fct.2007.07.002; Miyoshi N, 2007, ARCH BIOCHEM BIOPHYS, V466, P274, DOI 10.1016/j.abb.2007.07.026; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Ohigashi H, 2004, BIOFACTORS, V22, P49, DOI 10.1002/biof.5520220109; Parajuli P, 2009, PLANTA MED, V75, P41, DOI 10.1055/s-0028-1088364; Perez AT, 2010, BREAST CANCER RES TR, V120, P111, DOI 10.1007/s10549-009-0678-5; Plaumann B, 1996, ONCOGENE, V13, P1605; Rugo H, 2007, BREAST CANCER RES TR, V105, P17, DOI 10.1007/s10549-006-9430-6; SARACOGLU I, 1995, BIOL PHARM BULL, V18, P1396, DOI 10.1248/bpb.18.1396; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Shukla S, 2010, PHARM RES-DORDR, V27, P962, DOI 10.1007/s11095-010-0089-7; Vargo MA, 2006, BIOCHEM PHARMACOL, V72, P681, DOI 10.1016/j.bcp.2006.06.010; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xing JF, 2011, ACTA PHARM SIN; Yao H, 2010, J ENV SCI HLTH C, V29, P1; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zhang JL, 2003, J ASIAN NAT PROD RES, V5, P249, DOI 10.1080/1028602031000105858	26	30	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30107	10.1371/journal.pone.0030107	http://dx.doi.org/10.1371/journal.pone.0030107			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272282	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400060
J	Dougherty, EJ; Guo, C; Simons, SS; Chow, CC				Dougherty, Edward J.; Guo, Chunhua; Simons, S. Stoney, Jr.; Chow, Carson C.			Deducing the Temporal Order of Cofactor Function in Ligand-Regulated Gene Transcription: Theory and Experimental Verification	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREGULATORS; GLUCOCORTICOID-RECEPTOR; INDUCTION PROPERTIES; EXPRESSION; BINDING; TRANSACTIVATION; COACTIVATOR; AGONIST; MODULATION; COMPLEXES	Cofactors are intimately involved in steroid-regulated gene expression. Two critical questions are (1) the steps at which cofactors exert their biological activities and (2) the nature of that activity. Here we show that a new mathematical theory of steroid hormone action can be used to deduce the kinetic properties and reaction sequence position for the functioning of any two cofactors relative to a concentration limiting step (CLS) and to each other. The predictions of the theory, which can be applied using graphical methods similar to those of enzyme kinetics, are validated by obtaining internally consistent data for pair-wise analyses of three cofactors (TIF2, sSMRT, and NCoR) in U2OS cells. The analysis of TIF2 and sSMRT actions on GR-induction of an endogenous gene gave results identical to those with an exogenous reporter. Thus new tools to determine previously unobtainable information about the nature and position of cofactor action in any process displaying first-order Hill plot kinetics are now available.	[Dougherty, Edward J.; Guo, Chunhua; Simons, S. Stoney, Jr.] NIDDK, Steroid Hormones Sect, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA; [Chow, Carson C.] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dougherty, EJ (corresponding author), NIDDK, Steroid Hormones Sect, Clin Endocrinol Branch, NIH, Bethesda, MD 20892 USA.	steroids@helix.nih.gov; carsonc@niddk.nih.gov	Guo, Chunhua/N-2586-2014; Chow, Carson C/A-7970-2009	Dougherty, Edward/0000-0001-7664-9779	NIH/NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK047041, ZIADK075069, ZIADK057800, ZIADK047040] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the Intramural Research Program of the NIH/NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babur O, 2010, NUCLEIC ACIDS RES, V38, P5648, DOI 10.1093/nar/gkq287; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chooniedass-Kothari S, 2010, FEBS LETT, V584, P2218, DOI 10.1016/j.febslet.2010.04.022; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Glass CK, 2000, GENE DEV, V14, P121; Hakim O, 2009, J BIOL CHEM, V284, P6048, DOI 10.1074/jbc.C800212200; He YZ, 2007, MOL CELL BIOL, V27, P1467, DOI 10.1128/MCB.01360-06; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; Huang SM, 2000, MOL CELL BIOL, V20, P1855, DOI 10.1128/MCB.20.5.1855-1867.2000; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; Karmakar S, 2010, MOL ENDOCRINOL, V24, P1187, DOI 10.1210/me.2009-0480; Kaul S, 2002, J BIOL CHEM, V277, P12541, DOI 10.1074/jbc.M112330200; Kenakin T, 1999, TRENDS PHARMACOL SCI, V20, P400, DOI 10.1016/S0165-6147(99)01361-9; LOEB JN, 1987, MOL ENDOCRINOL, V1, P75, DOI 10.1210/mend-1-1-75; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Luo M, 2009, HUM IMMUNOL, V70, P785, DOI 10.1016/j.humimm.2009.07.029; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Newton CL, 2011, P NATL ACAD SCI USA, V108, P7172, DOI 10.1073/pnas.1015723108; Ong KM, 2010, P NATL ACAD SCI USA, V107, P7107, DOI 10.1073/pnas.0911095107; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sarlis NJ, 1999, J STEROID BIOCHEM, V68, P89, DOI 10.1016/S0960-0760(99)00021-7; Sauve FD, 2001, MOL CELL BIOL, V21, P343, DOI 10.1128/MCB.21.1.343-353.2001; Simons SS, 2008, BIOESSAYS, V30, P744, DOI 10.1002/bies.20792; Song LN, 2001, J BIOL CHEM, V276, P24806, DOI 10.1074/jbc.M102610200; Szapary D, 1996, J BIOL CHEM, V271, P30576, DOI 10.1074/jbc.271.48.30576; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Wang Q, 2004, J STEROID BIOCHEM, V91, P197, DOI 10.1016/j.jsbmb.2004.04.007; Wu SC, 2009, MOL ENDOCRINOL, V23, P1323, DOI 10.1210/me.2009-0131; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5	40	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30225	10.1371/journal.pone.0030225	http://dx.doi.org/10.1371/journal.pone.0030225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272313	gold, Green Submitted, Green Published			2022-12-25	WOS:000301454400091
J	Henry, M; Terzian, C; Peeters, M; Wain-Hobson, S; Vartanian, JP				Henry, Michel; Terzian, Christophe; Peeters, Martine; Wain-Hobson, Simon; Vartanian, Jean-Pierre			Evolution of the Primate APOBEC3A Cytidine Deaminase Gene and Identification of Related Coding Regions	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-STRANDED-DNA; IN-VIVO; LINE-1 RETROTRANSPOSITION; ANTIRETROVIRAL ACTIVITY; SOMATIC HYPERMUTATION; ENZYME APOBEC3G; EDITING ENZYMES; VIF PROTEIN; HIV-1	The APOBEC3 gene cluster encodes six cytidine deaminases (A3A-C, A3DE, A3F-H) with single stranded DNA (ssDNA) substrate specificity. For the moment A3A is the only enzyme that can initiate catabolism of both mitochondrial and nuclear DNA. Human A3A expression is initiated from two different methionine codons M1 or M13, both of which are in adequate but sub-optimal Kozak environments. In the present study, we have analyzed the genetic diversity among A3A genes across a wide range of 12 primates including New World monkeys, Old World monkeys and Hominids. Sequence variation was observed in exons 1-4 in all primates with up to 31% overall amino acid variation. Importantly for 3 hominids codon M1 was mutated to a threonine codon or valine codon, while for 5/12 primates strong Kozak M1 or M13 codons were found. Positive selection was apparent along a few branches which differed compared to positive selection in the carboxy-terminal of A3G that clusters with A3A among human cytidine deaminases. In the course of analyses, two novel non-functional A3A-related fragments were identified on chromosome 4 and 8 kb upstream of the A3 locus. This qualitative and quantitative variation among primate A3A genes suggest that subtle differences in function might ensue as more light is shed on this increasingly important enzyme.	[Henry, Michel; Wain-Hobson, Simon; Vartanian, Jean-Pierre] Inst Pasteur, Mol Retrovirol Unit, Paris, France; [Terzian, Christophe] UCBL INRA, UMR754, Lyon, France; [Terzian, Christophe] Ecole Prat Hautes Etud, Lyon, France; [Peeters, Martine] IRD, UMI 233, Montpellier, France; [Peeters, Martine] Univ Montpellier I, UMI 233, Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier	Henry, M (corresponding author), Inst Pasteur, Mol Retrovirol Unit, Paris, France.	jean-pierre.vartanian@pasteur.fr		Vartanian, Jean-Pierre/0000-0001-8079-8814	Institut Pasteur; Agence Nationale de Recherche sur le SIDA (ANRS); Agence Nationale de Recherche (ANR); l'Institut de Recherche pour le Developpement (IRD); l'Institut National de la sante et de la Recherche (INSERM); Centre National de Recherche Scientifique (CNRS)	Institut Pasteur(European Commission); Agence Nationale de Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Agence Nationale de Recherche (ANR)(French National Research Agency (ANR)); l'Institut de Recherche pour le Developpement (IRD); l'Institut National de la sante et de la Recherche (INSERM); Centre National de Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	Funding was received from the Institut Pasteur, Agence Nationale de Recherche sur le SIDA (ANRS), Agence Nationale de Recherche (ANR), l'Institut de Recherche pour le Developpement (IRD), l'Institut National de la sante et de la Recherche (INSERM) and the Centre National de Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2010, INFECT GENET EVOL, V10, P386, DOI 10.1016/j.meegid.2009.04.014; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Dang Y, 2011, J VIROL, V85, P5691, DOI 10.1128/JVI.00243-11; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Fan J, 2010, J VIROL, V84, P7278, DOI 10.1128/JVI.02239-09; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Henry M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004277; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Mahieux R, 2005, J GEN VIROL, V86, P2489, DOI 10.1099/vir.0.80973-0; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pineau P, 2005, MOL BIOL EVOL, V22, P582, DOI 10.1093/molbev/msi053; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Severi F, 2011, MOL BIOL EVOL, V28, P1125, DOI 10.1093/molbev/msq338; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wang FX, 2008, J GEN VIROL, V89, P722, DOI 10.1099/vir.0.83530-0; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Warren KS, 1999, J VIROL, V73, P7860, DOI 10.1128/JVI.73.9.7860-7865.1999; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	58	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30036	10.1371/journal.pone.0030036	http://dx.doi.org/10.1371/journal.pone.0030036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272271	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400050
J	Hossain, Z; Amyot, L; McGarvey, B; Gruber, M; Jung, J; Hannoufa, A				Hossain, Zakir; Amyot, Lisa; McGarvey, Brian; Gruber, Margaret; Jung, Jinwook; Hannoufa, Abdelali			The Translation Elongation Factor eEF-1B beta 1 Is Involved in Cell Wall Biosynthesis and Plant Development in Arabidopsis thaliana	PLOS ONE			English	Article							CELLULOSE SYNTHASE COMPLEXES; LIGNIN BIOSYNTHESIS; FUNCTIONAL-ANALYSIS; FACTOR 1A; LIGNIFICATION; DEPOSITION; EXPANSION; GENES; CRYSTALLINITY; ORGANIZATION	The eukaryotic translation elongation factor eEF-1B beta 1 (EF1B beta) is a guanine nucleotide exchange factor that plays an important role in translation elongation. In this study, we show that the EF1B beta protein is localized in the plasma membrane and cytoplasm, and that the transcripts should be expressed in most tissue types in seedlings. Sectioning of the inflorescence stem revealed that EF1B beta predominantly localizes to the xylem vessels and in the interfascicular cambium. EF1B beta gene silencing in ef beta caused a dwarf phenotype with 38% and 20% reduction in total lignin and crystalline cellulose, respectively. This loss-of-function mutant also had a lower S/G lignin monomer ratio relative to wild type plants, but no changes were detected in a gain-of-function mutant transformed with the EF1B beta gene. Histochemical analysis showed a reduced vascular apparatus, including smaller xylem vessels in the inflorescence stem of the loss-of-function mutant. Over-expression of EF1B beta in an eli1 mutant background restored a WT phenotype and abolished ectopic lignin deposition as well as cell expansion defects in the mutant. Taken together, these data strongly suggest a role for EF1B beta in plant development and cell wall formation in Arabidopsis.	[Hossain, Zakir; Amyot, Lisa; McGarvey, Brian; Jung, Jinwook; Hannoufa, Abdelali] Agr & Agri Food Canada, London, ON, Canada; [McGarvey, Brian; Hannoufa, Abdelali] Univ Western Ontario, Dept Biol, London, ON, Canada; [Gruber, Margaret] Agr & Agri Food Canada, Saskatoon, SK, Canada	Agriculture & Agri Food Canada; Western University (University of Western Ontario); Agriculture & Agri Food Canada	Hossain, Z (corresponding author), Environm Prote NB Inc, Sackville, NB, Canada.	Abdelali.Hannoufa@agr.gc.ca	Hannoufa, Abdelali/AAP-4593-2021; Hannoufa, Abdelali/GQY-7523-2022	Hannoufa, Abdelali/0000-0003-0064-620X	Agriculture and Agri-Food Canada through the ABIP; Agriculture and Agri-Food Canada through the CBioN Network [159]	Agriculture and Agri-Food Canada through the ABIP; Agriculture and Agri-Food Canada through the CBioN Network	Funding was provided by Agriculture and Agri-Food Canada through the ABIP program and the CBioN Network Project #159 (www.4.agr.gc.ca/AAFC-AAC/display-afficher.do?id = 1289590845916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Brinkmann K, 2002, J CHEM ECOL, V28, P2483, DOI 10.1023/A:1021484002582; Burn JE, 2002, PLANT PHYSIOL, V129, P797, DOI 10.1104/pp.010931; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Cano-Delgado AI, 2000, DEVELOPMENT, V127, P3395; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Foster CE, 2010, JOVE, V37; Fujita M, 2011, PLANT J, V66, P915, DOI 10.1111/j.1365-313X.2011.04552.x; Furukawa R, 2001, BBA-GEN SUBJECTS, V1527, P130, DOI 10.1016/S0304-4165(01)00157-X; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; HAUSER MT, 1995, DEVELOPMENT, V121, P1237; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; LAPIERRE C, 1985, J WOOD CHEM TECHNOL, V5, P277, DOI 10.1080/02773818508085193; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; Mitra SK, 2009, J PROTEOME RES, V8, P2752, DOI 10.1021/pr801044y; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Pagant S, 2002, PLANT CELL, V14, P2001, DOI 10.1105/tpc.002873; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Rogers LA, 2005, NEW PHYTOL, V168, P123, DOI 10.1111/j.1469-8137.2005.01496.x; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Scarpella E, 2004, NEW PHYTOL, V164, P209, DOI 10.1111/j.1469-8137.2004.01191.x; Schrick K, 2004, PLANT J, V38, P227, DOI 10.1111/j.1365-313X.2004.02039.x; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Sibout R, 2005, PLANT CELL, V17, P2059, DOI 10.1105/tpc.105.030767; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; Takahashi J, 2009, PLANT CELL PHYSIOL, V50, P1099, DOI 10.1093/pcp/pcp062; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Thevenin J, 2011, MOL PLANT, V4, P70, DOI 10.1093/mp/ssq045; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vain P, 2011, PLANT J, V66, P929, DOI 10.1111/j.1365-313X.2011.04555.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	57	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30425	10.1371/journal.pone.0030425	http://dx.doi.org/10.1371/journal.pone.0030425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272350	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400128
J	McNally, EA; Schwarcz, HP; Botton, GA; Arsenault, AL				McNally, Elizabeth A.; Schwarcz, Henry P.; Botton, Gianluigi A.; Arsenault, A. Larry			A Model for the Ultrastructure of Bone Based on Electron Microscopy of Ion-Milled Sections	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CRYSTALS; TURKEY LEG TENDON; MINERAL CRYSTALS; COLLAGEN FIBRILS; APATITE; ORGANIZATION; NUCLEATION; LESSONS; GROWTH; DENTIN	The relationship between the mineral component of bone and associated collagen has been a matter of continued dispute. We use transmission electron microscopy (TEM) of cryogenically ion milled sections of fully-mineralized cortical bone to study the spatial and topological relationship between mineral and collagen. We observe that hydroxyapatite (HA) occurs largely as elongated plate-like structures which are external to and oriented parallel to the collagen fibrils. Dark field images suggest that the structures ("mineral structures") are polycrystalline. They are approximately 5 nm thick, 70 nm wide and several hundred nm long. Using energy-dispersive X-ray analysis we show that approximately 70% of the HA occurs as mineral structures external to the fibrils. The remainder is found constrained to the gap zones. Comparative studies of other species suggest that this structural motif is ubiquitous in all vertebrates.	[McNally, Elizabeth A.; Botton, Gianluigi A.] McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON, Canada; [Schwarcz, Henry P.] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON, Canada; [Botton, Gianluigi A.] McMaster Univ, Canadian Ctr Electron Microscopy, Hamilton, ON, Canada; [Arsenault, A. Larry] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University	McNally, EA (corresponding author), McMaster Univ, Dept Mat Sci & Engn, Hamilton, ON, Canada.	schwarcz@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a grant to HPS by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARSENAULT AL, 1989, BONE MINER, V6, P165, DOI 10.1016/0169-6009(89)90048-2; Beniash E, 2011, WIRES NANOMED NANOBI, V3, P47, DOI 10.1002/wnan.105; BONAR LC, 1985, J MOL BIOL, V181, P265, DOI 10.1016/0022-2836(85)90090-7; BOYDE A, 1976, CALC TISS RES, V21, P117; CHRISTOFFERSEN J, 1991, ANAT RECORD, V230, P435, DOI 10.1002/ar.1092300402; Cressey BA, 2003, MINERAL MAG, V67, P1171, DOI 10.1180/0026461036760156; Eppell SJ, 2001, J ORTHOPAED RES, V19, P1027, DOI 10.1016/S0736-0266(01)00034-1; FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454; Fyhrie DP., 1988, SKELETAL TISSUE MECH; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Hodge A, 1963, ASPECTS PROTEIN STRU, P289; HOHLING HJ, 1971, Z ZELLFORSCH MIK ANA, V122, P36, DOI 10.1007/BF00936115; Hubbell J. H., 1996, TABLES XRAY MASS ATT; Jantou V, 2009, MICRON, V40, P495, DOI 10.1016/j.micron.2008.12.002; Jantou-Morris V, 2010, BIOMATERIALS, V31, P5275, DOI 10.1016/j.biomaterials.2010.03.025; KIM HM, 1995, J BONE MINER RES, V10, P1589; Kinney JH, 2001, J DENT RES, V80, P1555, DOI 10.1177/00220345010800061501; Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066; Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192; LANDIS WJ, 1991, J STRUCT BIOL, V107, P116, DOI 10.1016/1047-8477(91)90015-O; LEE DD, 1991, J MOL BIOL, V217, P487, DOI 10.1016/0022-2836(91)90752-R; LEES S, 1994, CALCIFIED TISSUE INT, V55, P180, DOI 10.1007/BF00425873; Liu Y, 2011, BIOMATERIALS, V32, P1291, DOI 10.1016/j.biomaterials.2010.10.018; McEwen B F, 1991, J Comput Assist Microsc, V3, P201; Nalla RK, 2005, MICRON, V36, P672, DOI 10.1016/j.micron.2005.05.011; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Pidaparti RMV, 1996, J BIOMECH, V29, P909, DOI 10.1016/0021-9290(95)00147-6; Prostak KS, 1996, CALCIFIED TISSUE INT, V59, P474, DOI 10.1007/BF00369213; ROBINSON RA, 1952, ANAT REC, V114, P383, DOI 10.1002/ar.1091140302; Sasaki N, 2002, J MATER SCI-MATER M, V13, P333, DOI 10.1023/A:1014079421895; Seto J, 2008, ADV FUNCT MATER, V18, P1905, DOI 10.1002/adfm.200800214; Silver FH, 2011, CONNECT TISSUE RES, V52, P242, DOI 10.3109/03008207.2010.551567; Siperko LM, 2001, J STRUCT BIOL, V135, P313, DOI 10.1006/jsbi.2001.4414; Su X, 2003, BONE, V32, P150, DOI 10.1016/S8756-3282(02)00945-6; Tong W, 2003, CALCIFIED TISSUE INT, V72, P592, DOI 10.1007/s00223-002-1077-7; TRAUB W, 1992, CONNECT TISSUE RES, V28, P99, DOI 10.3109/03008209209014230; TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; WEINER S, 1991, FEBS LETT, V285, P49, DOI 10.1016/0014-5793(91)80722-F; WEINER S, 1986, CALCIFIED TISSUE INT, V39, P365, DOI 10.1007/BF02555173; Wenk HR, 1999, BONE, V24, P361, DOI 10.1016/S8756-3282(98)00192-6; Ziv V, 1996, BONE, V18, P417, DOI 10.1016/8756-3282(96)00049-X; Ziv V, 1996, MICROSC RES TECHNIQ, V33, P203	44	140	140	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29258	10.1371/journal.pone.0029258	http://dx.doi.org/10.1371/journal.pone.0029258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272230	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400009
J	Smith, AL; Iwanaga, R; Drasin, DJ; Micalizzi, DS; Vartuli, RL; Tan, AC; Ford, HL				Smith, A. L.; Iwanaga, R.; Drasin, D. J.; Micalizzi, D. S.; Vartuli, R. L.; Tan, A-C; Ford, H. L.			The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer	ONCOGENE			English	Article						Six1; miRNA; TGF-beta; epithelial-to-mesenchymal transition; tumor-initiating cell	EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; MICRORNA CLUSTER; CARCINOMA CELLS; OVEREXPRESSION; METASTASIS; MECHANISM; PROTEIN; GROWTH; LUNG	The role of TGF-beta signaling in tumorigenesis is paradoxical: it can be tumor suppressive or tumor promotional, depending on context. The metastatic regulator, Six1, was recently shown to mediate this switch, providing a novel means to explain this elusive 'TGF-beta paradox'. Herein, we identify a mechanism by which Six1 activates the tumor promotional arm of TGF-beta signaling, via its ability to upregulate the miR-106b-25 microRNA cluster, and further identify a novel function for this cluster of microRNAs. Although expression of the miR-106b-25 cluster is known to overcome TGF-beta-mediated growth suppression via targeting p21 and BIM, we demonstrate for the first time that this same cluster can additionally target the inhibitory Smad7 protein, resulting in increased levels of the TGF-beta type I receptor and downstream activation of TGF-beta signaling. We further show that the miR-106b-25 cluster is sufficient to induce an epithelial-to-mesenchymal transition and a tumor initiating cell phenotype, and that it is required downstream of Six1 to induce these phenotypes. Finally, we demonstrate a significant correlation between miR-106b, Six1, and activated TGF-beta signaling in human breast cancers, and further show that high levels of miR-106b and miR-93 in breast tumors significantly predicts shortened time to relapse. These findings expand the spectrum of oncogenic functions of miR-106b-25, and may provide a novel molecular explanation, through the Six1 regulated miR-106b-25 cluster, by which TGF-beta signaling shifts from tumor suppressive to tumor promoting. Oncogene (2012) 31, 5162-5171; doi:10.1038/onc.2012.11; published online 30 January 2012	[Ford, H. L.] Univ Colorado Anschutz Med Campus, Dept Obstet & Gynecol, Program Mol Biol, Med Scientist Training Program, Aurora, CO 80045 USA; [Tan, A-C] Univ Colorado Anschutz Med Campus, Dept Med, Aurora, CO 80045 USA; [Ford, H. L.] Univ Colorado Anschutz Med Campus, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Ford, HL (corresponding author), Univ Colorado Anschutz Med Campus, Dept Obstet & Gynecol, Program Mol Biol, Med Scientist Training Program, 12700 E 19th St,RC2,Rm 3100C, Aurora, CO 80045 USA.	heide.ford@ucdenver.edu	Reever, Larson/H-9685-2019; Tan, Aik Choon/A-3135-2011	Reever, Larson/0000-0002-5692-4793; Tan, Aik Choon/0000-0003-2955-8369; Micalizzi, Douglas/0000-0002-0306-9914	National Cancer Institute [2ROI-CA095277]; American Cancer Society [RSG-07-183-01-DDC]; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0296, W81XWH-06-1-0757]; NATIONAL CANCER INSTITUTE [R01CA095277, P30CA046934] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the National Cancer Institute (2ROI-CA095277) and The American Cancer Society (no. RSG-07-183-01-DDC) to HLF. ALS is funded by a predoctoral fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-10-1-0296). DSM was funded by a predoctoral fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-06-1-0757).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Chopra VS, 2006, BIOESSAYS, V28, P445, DOI 10.1002/bies.20401; Coletta RD, 2008, CANCER RES, V68, P2204, DOI 10.1158/0008-5472.CAN-07-3141; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Ford HL, 2000, J BIOL CHEM, V275, P22245, DOI 10.1074/jbc.M002446200; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Ho J, 2011, J AM SOC NEPHROL, V22, P1053, DOI 10.1681/ASN.2010080841; Hu YL, 2010, NUCLEIC ACIDS RES, V38, P5472, DOI 10.1093/nar/gkq337; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Micalizzi DS, 2010, CANCER RES, V70, P10371, DOI 10.1158/0008-5472.CAN-10-1354; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Reichenberger KJ, 2005, CANCER RES, V65, P2668, DOI 10.1158/0008-5472.CAN-04-4286; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018	35	227	248	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2012	31	50					5162	5171		10.1038/onc.2012.11	http://dx.doi.org/10.1038/onc.2012.11			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	055WY	22286770	Green Accepted			2022-12-25	WOS:000312449800005
J	Sangwan, M; McCurdy, SR; Livne-bar, I; Ahmad, M; Wrana, JL; Chen, D; Bremner, R				Sangwan, M.; McCurdy, S. R.; Livne-bar, I.; Ahmad, M.; Wrana, J. L.; Chen, D.; Bremner, R.			Established and new mouse models reveal E2f1 and Cdk2 dependency of retinoblastoma, and expose effective strategies to block tumor initiation	ONCOGENE			English	Article						chemoprevention; retinoblastoma; Cdk; E2f; p107	CELL-CYCLE INHIBITION; FUNCTIONALLY ANTAGONIZE; DNA-BINDING; RB; P107; PROLIFERATION; APOPTOSIS; CANCER; SUPPRESSOR; PRB	RB+/- individuals develop retinoblastoma and, subsequently, many other tumors. The Rb relatives p107 and p130 protect the tumor-resistant Rb-/- mouse retina. Determining the mechanism underlying this tumor suppressor function may expose novel strategies to block Rb pathway cancers. p107/p130 are best known as E2f inhibitors, but here we implicate E2f-independent Cdk2 inhibition as the critical p107 tumor suppressor function in vivo. Like p107 loss, deleting p27 or inactivating its Cdk inhibitor (CKI) function (p27(CK-)) cooperated with Rb loss to induce retinoblastoma. Genetically, p107 behaved like a CKI because inactivating Rb and one allele each of p27 and p107 was tumorigenic. Although Rb loss induced canonical E2f targets, unexpectedly p107 loss did not further induce these genes, but instead caused post-transcriptional Skp2 induction and Cdk2 activation. Strikingly, Cdk2 activity correlated with tumor penetrance across all the retinoblastoma models. Therefore, Rb restrains E2f, but p107 inhibits cross talk to Cdk. While removing either E2f2 or E2f3 genes had little effect, removing only one E2f1 allele blocked tumorigenesis. More importantly, exposing retinoblastoma-prone fetuses to small molecule inhibitors of E2f (HLM006474) or Cdk (R547) for merely 1 week dramatically inhibited subsequent tumorigenesis in adult mice. Protection was achieved without disrupting normal proliferation. Thus, exquisite sensitivity of the cell-of-origin to E2f and Cdk activity can be exploited to prevent Rb pathway-induced cancer in vivo without perturbing normal cell division. These data suggest that E2f inhibitors, never before tested in vivo, or CKIs, largely disappointing as therapeutics, may be effective preventive agents. Oncogene (2012) 31, 5019-5028; doi:10.1038/onc.2011.654; published online 30 January 2012	[Sangwan, M.; McCurdy, S. R.; Livne-bar, I.; Ahmad, M.; Chen, D.; Bremner, R.] Univ Toronto, Toronto Western Res Inst, Univ Hlth Network, Dept Ophthalmol & Visual Sci, Toronto, ON M5T 2S8, Canada; [Sangwan, M.; McCurdy, S. R.; Livne-bar, I.; Ahmad, M.; Chen, D.; Bremner, R.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5T 2S8, Canada; [Wrana, J. L.] Univ Toronto, Dept Mol Genet, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bremner, R (corresponding author), Univ Toronto, Toronto Western Res Inst, Univ Hlth Network, Dept Ophthalmol & Visual Sci, Room Mc6-424,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	dchen@uhnres.utoronto.ca; rbremner@uhnres.utoronto.ca	Chen, Danian/GXV-7996-2022; Bremner, Rod/I-6490-2012; Wrana, Jeffrey/F-8857-2013	Bremner, Rod/0000-0001-9184-7212; Chen, Danian/0000-0002-6916-2978	Canadian Institutes for Health Research (CIHR); Foundation Fighting Blindness Canada; Ontario Institute for Cancer Research through Government of Ontario; Terry Fox Research Institute; CIHR	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation Fighting Blindness Canada; Ontario Institute for Cancer Research through Government of Ontario; Terry Fox Research Institute; CIHR(Canadian Institutes of Health Research (CIHR))	We thank Arnaud Besson and James Roberts for sharing p27<SUP>CK-/CK-</SUP> mice, and Fred Dick, Gustavo Leone and Philippe Monnier for comments. This project was funded by grants to RB from the Canadian Institutes for Health Research (CIHR), Foundation Fighting Blindness Canada, Ontario Institute for Cancer Research through funding provided by the Government of Ontario and the Terry Fox Research Institute. MS, MA and SRM were supported in part by fellowships from a CIHR training program.	Balmer A, 2006, ONCOGENE, V25, P5341, DOI 10.1038/sj.onc.1209622; Bandara LR, 1997, NAT BIOTECHNOL, V15, P896, DOI 10.1038/nbt0997-896; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Black EP, 2003, CANCER RES, V63, P3716; Boquoi A, 2009, CANCER PREV RES, V2, P800, DOI 10.1158/1940-6207.CAPR-09-0053; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Buttitta LA, 2007, DEV CELL, V12, P631, DOI 10.1016/j.devcel.2007.02.020; Castano E, 1998, MOL CELL BIOL, V18, P5380, DOI 10.1128/MCB.18.9.5380; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chibazakura T, 2004, P NATL ACAD SCI USA, V101, P4465, DOI 10.1073/pnas.0400655101; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Classon M, 2000, P NATL ACAD SCI USA, V97, P10820, DOI 10.1073/pnas.190343497; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; DePinto W, 2006, MOL CANCER THER, V5, P2644, DOI 10.1158/1535-7163.MCT-06-0355; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; Fabbrizio E, 1999, ONCOGENE, V18, P4357, DOI 10.1038/sj.onc.1202825; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Kelloff GJ, 2006, CLIN CANCER RES, V12, P3661, DOI 10.1158/1078-0432.CCR-06-1104; Lara MF, 2008, MOL CARCINOGEN, V47, P209, DOI 10.1002/mc.20376; Lara MF, 2008, MOL CARCINOGEN, V47, P105, DOI 10.1002/mc.20367; Lee EY, 2002, CANCER CELL, V2, P463, DOI 10.1016/S1535-6108(02)00207-6; Lindor NM, 2008, J NATL CANC I MONOGR, V38, P1, DOI DOI 10.1093/JNCIMONOGRAPHS/LGN001; Ma YH, 2008, CANCER RES, V68, P6292, DOI 10.1158/0008-5472.CAN-08-0121; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; McClellan KA, 2007, MOL CELL BIOL, V27, P4825, DOI 10.1128/MCB.02100-06; Montigiani S, 2003, ONCOGENE, V22, P4943, DOI 10.1038/sj.onc.1206495; Ng AK, 2010, SEMIN RADIAT ONCOL, V20, P67, DOI 10.1016/j.semradonc.2009.09.002; Padmakumar VC, 2009, MOL CELL BIOL, V29, P2582, DOI 10.1128/MCB.00952-08; Park MS, 1999, P NATL ACAD SCI USA, V96, P6382, DOI 10.1073/pnas.96.11.6382; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Rodier G, 2005, J CELL BIOL, V168, P55, DOI 10.1083/jcb.200404146; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Tetsu O, 2003, CANCER CELL, V3, P233, DOI 10.1016/S1535-6108(03)00053-9; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Yu CL, 2009, JNCI-J NATL CANCER I, V101, P581, DOI 10.1093/jnci/djp046; Zhang JK, 2004, CELL CYCLE, V3, P952; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	51	43	45	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	48					5019	5028		10.1038/onc.2011.654	http://dx.doi.org/10.1038/onc.2011.654			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	048CU	22286767	Green Accepted			2022-12-25	WOS:000311888600006
J	Yung, HW; Cox, M; van Patot, MT; Burton, GJ				Yung, Hong Wa; Cox, Mathew; van Patot, Martha Tissot; Burton, Graham J.			Evidence of endoplasmic reticulum stress and protein synthesis inhibition in the placenta of non-native women at high altitude	FASEB JOURNAL			English	Article						AKT-mTOR signaling; birth weight; hypoxia; pregnancy	INTRAUTERINE GROWTH RESTRICTION; HUMAN TERM PLACENTAE; OXIDATIVE STRESS; GENE-EXPRESSION; IN-VIVO; OXYGEN DELIVERY; CHRONIC HYPOXIA; KINASE B; TRANSLATION; PHOSPHORYLATION	Pregnancy at high altitude is associated with a reduction in birth weight of similar to 100 g/1000 m of ascent. The underlying mechanisms are unclear but may involve alteration in energy-demanding activities, such as protein synthesis. To test this hypothesis, both in vivo and in vitro approaches were used. Placental tissues from pregnant women residing at 3100 m were studied, and placental cells were incubated under hypoxia. In the 3100-m placentas, we observed dilation of endoplasmic reticulum (ER) cisternae, increased phosphorylation of eukaryotic initiation factor 2 subunit alpha (P-eIF2 alpha), reduced AKT phosphorylation, and reduced P-4E-BP1 but increased 4E-BP1 protein compared to sea level controls. These findings suggest the presence of ER stress and protein synthesis inhibition. Hypoxia (1% O-2) reduced proliferation of trophoblast-like JEG-3 cells, BeWo cells, and placental fibroblasts by similar to 40, similar to 60, and similar to 18%, respectively. Sublethal dosage of salubrinal, an eIF2 alpha phosphatase inhibitor, increased P-eIF2 alpha and reduced BeWo cell and placental fibroblast proliferation by similar to 50%. Administration of the PI-3K inhibitor LY294002 also reduced JEG-3 proliferation. Our results demonstrate that exposure to chronic hypobaric hypoxia causes mild placental ER stress, which, in turn, modulates protein synthesis and slows proliferation. These effects may account for the reduced placental villous volume, and contribute to the low birth weight that typifies high-altitude populations.-Yung, H. W., Cox, M., Tissot van Patot, M., Burton, G. J. Evidence of endoplasmic reticulum stress and protein synthesis inhibition in the placenta of non-native women at high altitude. FASEB J. 26, 1970-1981 (2012). www.fasebj.org	[Burton, Graham J.] Univ Cambridge, Physiol Lab, Ctr Trophoblast Res, Cambridge CB2 3EG, England	University of Cambridge	Burton, GJ (corresponding author), Univ Cambridge, Physiol Lab, Ctr Trophoblast Res, Downing St, Cambridge CB2 3EG, England.	gjb2@cam.ac.uk		Tissot van Patot, Martha/0000-0002-2934-366X	Wellcome Trust [084804/2/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (084804/2/08/Z).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bastide A, 2008, NUCLEIC ACIDS RES, V36, P2434, DOI 10.1093/nar/gkn093; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Carter AM, 2000, PLACENTA, V21, pS31, DOI 10.1053/plac.1999.0513; Choi SJ, 2007, AM J OBSTET GYNECOL, V196, P45, DOI 10.1016/j.ajog.2006.08.029; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Colleoni F, 2011, PLACENTA, V32, pA46; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; Espinoza J, 2001, PLACENTA, V22, P606, DOI 10.1053/plac.2001.0696; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Giussani DA, 2001, PEDIATR RES, V49, P490, DOI 10.1203/00006450-200104000-00009; Giussani DA, 2007, J PHYSIOL-LONDON, V585, P911, DOI 10.1113/jphysiol.2007.141572; Illsley NP, 2010, INT J DEV BIOL, V54, P409, DOI 10.1387/ijdb.082798ni; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; JACKSON MR, 1987, PLACENTA, V8, P487, DOI 10.1016/0143-4004(87)90077-4; JACKSON MR, 1987, J ANAT, V152, P173; Jan E, 2001, COLD SPRING HARB SYM, V66, P285, DOI 10.1101/sqb.2001.66.285; Julian CG, 2007, ARCH DIS CHILD-FETAL, V92, P372, DOI 10.1136/adc.2006.109579; Julian CG, 2009, AM J PHYSIOL-REG I, V296, pR1564, DOI 10.1152/ajpregu.90945.2008; Karim MM, 2001, J BIOL CHEM, V276, P20750, DOI 10.1074/jbc.M011068200; Keyes LE, 2003, PEDIATR RES, V54, P20, DOI 10.1203/01.PDR.0000069846.64389.DC; Kim YK, 2002, BIOCHEM BIOPH RES CO, V297, P224, DOI 10.1016/S0006-291X(02)02154-X; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; Krampl E, 2000, ULTRASOUND OBST GYN, V16, P9, DOI 10.1046/j.1469-0705.2000.00156.x; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Moore LG, 2001, AM J HUM BIOL, V13, P635, DOI 10.1002/ajhb.1102; Moore LG, 2001, AM J PHYS ANTHROPOL, V114, P42, DOI 10.1002/1096-8644(200101)114:1<42::AID-AJPA1004>3.0.CO;2-B; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; Raman L, 2005, DEV BRAIN RES, V156, P202, DOI 10.1016/j.devbrainres.2005.02.013; RESHETNIKOVA OS, 1994, AM J OBSTET GYNECOL, V171, P1560, DOI 10.1016/0002-9378(94)90402-2; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; SIEMS WG, 1992, CELL BIOCHEM FUNCT, V10, P61, DOI 10.1002/cbf.290100110; Soma Hiroaki, 2005, Medical Molecular Morphology, V38, P92, DOI 10.1007/s00795-004-0259-y; van Patot MCT, 2009, PLACENTA, V30, P523, DOI 10.1016/j.placenta.2009.04.002; van Patot MCT, 2010, AM J PHYSIOL-REG I, V298, pR166, DOI 10.1152/ajpregu.00383.2009; Walsh B, 2001, J PHYSIOL-LONDON, V537, P971; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0	58	76	78	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1970	1981		10.1096/fj.11-190082	http://dx.doi.org/10.1096/fj.11-190082			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22267338	Green Published, hybrid			2022-12-25	WOS:000303680800024
J	Wang, HT; Hu, Y; Tong, D; Huang, J; Gu, LY; Wu, XR; Chung, FL; Li, GM; Tang, MS				Wang, Hsiang-Tsui; Hu, Yu; Tong, Dan; Huang, Jian; Gu, Liya; Wu, Xue-Ru; Chung, Fung-Lung; Li, Guo-Min; Tang, Moon-Shong			Effect of Carcinogenic Acrolein on DNA Repair and Mutagenic Susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; LUNG-CANCER; DEOXYGUANOSINE ADDUCT; LIPID-PEROXIDATION; OXIDATIVE STRESS; POLYMERASE-ETA; CHINESE-WOMEN; APOPTOSIS; MITOCHONDRIA; MECHANISM	Acrolein (Acr), a ubiquitous environmental contaminant, is a human carcinogen. Acr can react with DNA to form mutagenic alpha- and gamma-hydroxy-1, N-2-cyclic propano-2'-deoxyguanosine adducts (alpha-OH-Acr-dG and gamma-OH-Acr-dG). We demonstrate here that Acr-dG adducts can be efficiently repaired by the nucleotide excision repair (NER) pathway in normal human bronchial epithelia (NHBE) and lung fibroblasts (NHLF). However, the same adducts were poorly processed in cell lysates isolated from Acr-treated NHBE and NHLF, suggesting that Acr inhibits NER. In addition, we show that Acr treatment also inhibits base excision repair and mismatch repair. Although Acr does not change the expression of XPA, XPC, hOGG1, PMS2 or MLH1genes, it causes a reduction of XPA, XPC, hOGG1, PMS2, and MLH1 proteins; this effect, however, can be neutralized by the proteasome inhibitor MG132. Acr treatment further enhances both bulky and oxidative DNA damage-induced mutagenesis. These results indicate that Acr not only damages DNA but can also modify DNA repair proteins and further causes degradation of these modified repair proteins. We propose that these two detrimental effects contribute to Acr mutagenicity and carcinogenicity.	[Wang, Hsiang-Tsui; Hu, Yu; Tang, Moon-Shong] NYU, Sch Med, Dept Environm Med, New York, NY 10987 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol & Pathol, New York, NY 10987 USA; [Tong, Dan; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Tong, Dan; Huang, Jian; Li, Guo-Min] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Chung, Fung-Lung] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20057 USA	New York University; New York University; University of Kentucky; Wuhan University; Georgetown University	Tang, MS (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10987 USA.	moon-shong.tang@nyumc.org	Li, Guo-Min/I-5016-2014	Wu, Xue-Ru/0000-0001-6058-6291; Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [CA114541, ES014641, CA99007, CA134892, GM089684, ES00260]; Kentucky Lung Cancer Research Grant; Chinese 111 project [B06018]; NATIONAL CANCER INSTITUTE [R01CA114541, R01CA134892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES014641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Grant; Chinese 111 project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA114541, ES014641, CA99007, CA134892, GM089684, and ES00260. This work was also supported by a Kentucky Lung Cancer Research Grant (to G.-M. L.) and Chinese 111 project B06018.	Bein K, 2011, MOL NUTR FOOD RES, V55, P1342, DOI 10.1002/mnfr.201100279; CHUNG FL, 1984, CANCER RES, V44, P990; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; COHEN SM, 1992, CANCER RES, V52, P3577; Comes R, 2002, 43 WHO; CURREN RD, 1988, MUTAT RES, V209, P17, DOI 10.1016/0165-7992(88)90104-2; Feng ZH, 2004, P NATL ACAD SCI USA, V101, P8598, DOI 10.1073/pnas.0402794101; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Fujioka K, 2006, ENVIRON TOXICOL, V21, P47, DOI 10.1002/tox.20153; GAO YT, 1987, INT J CANCER, V40, P604, DOI 10.1002/ijc.2910400505; Ghilarducci DP, 1995, REV ENVIRON CONTAM T, V144, P95; Hoffman D.H.S., 1990, HDB EXPT PHARM, P70; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Kawanishi M, 1998, MUTAT RES-GEN TOX EN, V417, P65, DOI 10.1016/S1383-5718(98)00093-X; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Kern JC, 2002, CHEM-BIOL INTERACT, V139, P79, DOI 10.1016/S0009-2797(01)00295-2; Ko YC, 1997, INT J EPIDEMIOL, V26, P24, DOI 10.1093/ije/26.1.24; KOO LC, 1990, INT J EPIDEMIOL, V19, pS14, DOI 10.1093/ije/19.Supplement_1.S14; Li X, 2008, FREE RADICAL BIO MED, V44, P1465, DOI 10.1016/j.freeradbiomed.2008.01.004; Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002; Mehta M, 2008, MUTAT RES-GEN TOX EN, V657, P116, DOI 10.1016/j.mrgentox.2008.08.015; Minko IG, 2003, J BIOL CHEM, V278, P784, DOI 10.1074/jbc.M207774200; Roy J, 2010, CAN J PHYSIOL PHARM, V88, P353, DOI 10.1139/Y09-134; Roy J, 2009, CHEM-BIOL INTERACT, V181, P154, DOI 10.1016/j.cbi.2009.07.001; Sanchez AM, 2003, CHEM RES TOXICOL, V16, P1019, DOI 10.1021/tx034066u; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Seow A, 2000, CANCER EPIDEM BIOMAR, V9, P1215; Siegfried JM, 2001, LANCET ONCOL, V2, P506, DOI 10.1016/S1470-2045(01)00457-0; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Sun LJ, 2006, MITOCHONDRION, V6, P136, DOI 10.1016/j.mito.2006.04.003; Tanel A, 2005, BBA-MOL CELL RES, V1743, P255, DOI 10.1016/j.bbamcr.2004.11.007; Tang MS, 2011, MOL NUTR FOOD RES, V55, P1291, DOI 10.1002/mnfr.201100148; VanderVeen LA, 2001, J BIOL CHEM, V276, P9066, DOI 10.1074/jbc.M008900200; Wang HT, 2009, CHEM RES TOXICOL, V22, P511, DOI 10.1021/tx800369y; Yang IY, 2003, J BIOL CHEM, V278, P13989, DOI 10.1074/jbc.M212535200; Yang IY, 2002, CHEM RES TOXICOL, V15, P160, DOI 10.1021/tx010123c; Yang IY, 2002, BIOCHEMISTRY-US, V41, P13826, DOI 10.1021/bi0264723; Yang IY, 2001, J BIOL CHEM, V276, P9071, DOI 10.1074/jbc.M008918200; Zhang SY, 2007, CHEM RES TOXICOL, V20, P565, DOI 10.1021/tx700023z; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	41	63	66	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12379	12386		10.1074/jbc.M111.329623	http://dx.doi.org/10.1074/jbc.M111.329623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22275365	hybrid, Green Published			2022-12-25	WOS:000302782200077
J	Fidalgo, M; Guerrero, A; Fraile, M; Iglesias, C; Pombo, CM; Zalvide, J				Fidalgo, Miguel; Guerrero, Ana; Fraile, Maria; Iglesias, Cristina; Pombo, Celia M.; Zalvide, Juan			Adaptor Protein Cerebral Cavernous Malformation 3 (CCM3) Mediates Phosphorylation of the Cytoskeletal Proteins Ezrin/Radixin/Moesin by Mammalian Ste20-4 to Protect Cells from Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20-LIKE KINASE-3 MST3; OXIDANT STRESS; GCKIII PROTEINS; CHEMICAL ANOXIA; ERM PROTEINS; IN-VITRO; EZRIN; ACTIVATION; MUTATIONS; DEATH	While studying the functions of CCM3/PDCD10, a gene encoding an adaptor protein whose mutation results in vascular malformations, we have found that it is involved in a novel response to oxidative stress that results in phosphorylation and activation of the ezrin/radixin/moesin (ERM) family of proteins. This phosphorylation protects cells from accidental cell death induced by oxidative stress. We also present evidence that ERM phosphorylation is performed by the GCKIII kinase Mst4, which is activated and relocated to the cell periphery after oxidative stress. The cellular levels of Mst4 and its activation after oxidative stress depend on the presence of CCM3, as absence of the latter impairs the phosphorylation of ERM proteins and enhances death of cells exposed to reactive oxygen species. These findings shed new light on the response of cells to oxidative stress and identify an important pathophysiological situation in which ERM proteins and their phosphorylation play a significant role.	[Zalvide, Juan] Univ Santiago de Compostela, Dept Physiol, Lab Cell Signalling & Canc Res, Sch Med, Santiago De Compostela 15705, A Coruna, Spain; Univ Santiago de Compostela, Ctr Singular Med Mol & Enfermedades Cron CIMUS, Santiago De Compostela 15705, A Coruna, Spain; Inst Invest Sanitarias IDIS, Santiago De Compostela 15705, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Zalvide, J (corresponding author), Univ Santiago de Compostela, Dept Physiol, Lab Cell Signalling & Canc Res, Sch Med, San Francisco S-N, Santiago De Compostela 15705, A Coruna, Spain.	juan.zalvide@usc.es	Pombo, Celia M/L-4479-2014; Zalvide, Juan/ABG-4050-2020; Fidalgo, Miguel/I-7006-2019; Guerrero, Ana/AAZ-2162-2021	Fidalgo, Miguel/0000-0003-1134-2674; Guerrero, Ana/0000-0002-4622-9201; Zalvide, Juan/0000-0001-7645-156X; Pombo, Celia M/0000-0003-2541-9468	Xunta de Galicia [INCITE 09 208 110 PR]; Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS) [PI080655]; Ministerio de Ciencia e Innovacion [SAF2011-24940]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS)(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Xunta de Galicia grant INCITE 09 208 110 PR (to C. M. P.) and Fondo de Investigaciones Sanitarias de la Seguridad Social (FISS) grant PI080655 and Ministerio de Ciencia e Innovacion grant SAF2011-24940 (to J. Z.).	Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Bretscher A, 1997, J CELL SCI, V110, P3011; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Chen L, 2009, STROKE, V40, P1474, DOI 10.1161/STROKEAHA.108.527135; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hipfner DR, 2004, GENE DEV, V18, P2243, DOI 10.1101/gad.303304; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; KANNO T, 1994, FREE RADICAL RES, V21, P223, DOI 10.3109/10715769409056574; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lu TJ, 2006, J BIOL CHEM, V281, P38405, DOI 10.1074/jbc.M605035200; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Nogueira E, 2008, J BIOL CHEM, V283, P16248, DOI 10.1074/jbc.M709724200; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pombo CM, 2007, FRONT BIOSCI-LANDMRK, V12, P850, DOI 10.2741/2107; Pombo CM, 1997, J BIOL CHEM, V272, P29372, DOI 10.1074/jbc.272.46.29372; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schleider E, 2011, NEUROGENETICS, V12, P83, DOI 10.1007/s10048-010-0261-6; Tamma G, 2007, AM J PHYSIOL-CELL PH, V292, pC1476, DOI 10.1152/ajpcell.00375.2006; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhou JB, 2009, MOL CELL BIOL, V29, P4167, DOI 10.1128/MCB.01067-08; Zhu Y, 2011, NEUROSURGERY, V69, P722, DOI 10.1227/NEU.0b013e318219569f	43	55	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11556	11565		10.1074/jbc.M111.320259	http://dx.doi.org/10.1074/jbc.M111.320259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22291017	Green Published, hybrid			2022-12-25	WOS:000302780100083
J	Gu, ZL; Liu, WH; Wei, J; Yan, Z				Gu, Zhenglin; Liu, Wenhua; Wei, Jing; Yan, Zhen			Regulation of N-Methyl-D-aspartic Acid (NMDA) Receptors by Metabotropic Glutamate Receptor 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-DEPENDENT MECHANISM; LONG-TERM DEPRESSION; PREFRONTAL CORTEX; SYNAPTIC-TRANSMISSION; WORKING-MEMORY; ANXIOLYTIC-LIKE; BRAIN-FUNCTION; MICE LACKING; LIM-KINASE; GROUP-II	Emerging evidence suggests that metabotropic glutamate receptors (mGluRs) are potential novel targets for brain disorders associated with the dysfunction of prefrontal cortex (PFC), a region critical for cognitive and emotional processes. Because N-methyl-D-aspartic acid receptor (NMDAR) dysregulation has been strongly associated with the pathophysiology of mental illnesses, we examined the possibility that mGluRs might be involved in modulating PFC functions by targeting postsynaptic NMDARs. We found that application of prototypical group III mGluR agonists significantly reduced NMDAR-mediated synaptic and ionic currents in PFC pyramidal neurons, which was mediated by mGluR7 localized at postsynaptic neurons and involved the beta-arrestin/ERK signaling pathway. The mGluR7 modulation of NMDAR currents was prevented by agents perturbing actin dynamics and by the inhibitor of cofilin, a major actin-depolymerizing factor. Consistently, biochemical and immunocytochemical results demonstrated that mGluR7 activation increased cofilin activity and F-actin depolymerization via an ERK-dependent mechanism. Furthermore, mGluR7 reduced the association of NMDARs with the scaffolding protein PSD-95 and the surface level of NMDARs in an actin-dependent manner. These data suggest that mGluR7, by affecting the cofilin/actin signaling, regulates NMDAR trafficking and function. Because ablation of mGluR7 leads to a variety of behavioral symptoms related to PFC dysfunction, such as impaired working memory and reduced anxiety and depression, our results provide a potential mechanism for understanding the role of mGluR7 in mental health and disorders.	[Gu, Zhenglin; Liu, Wenhua; Wei, Jing; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu		Liu, Wenhua/0000-0003-0903-8497	National Institutes of Health [MH84233, MH85774]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233, R01MH085774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH84233 and MH85774 (to Z. Y.).	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Allison DW, 1998, J NEUROSCI, V18, P2423; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Ayala JE, 2008, NEUROPHARMACOLOGY, V54, P804, DOI 10.1016/j.neuropharm.2007.12.009; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Bradley SR, 1996, J NEUROSCI, V16, P2044; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Bushell TJ, 1996, BRIT J PHARMACOL, V117, P1457, DOI 10.1111/j.1476-5381.1996.tb15306.x; Callaerts-Vegh Z, 2006, J NEUROSCI, V26, P6573, DOI 10.1523/JNEUROSCI.1497-06.2006; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cryan JF, 2003, EUR J NEUROSCI, V17, P2409, DOI 10.1046/j.1460-9568.2003.02667.x; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; Fendt M, 2008, MOL PSYCHIATR, V13, P970, DOI 10.1038/sj.mp.4002073; Field JR, 2011, TRENDS MOL MED, V17, P689, DOI 10.1016/j.molmed.2011.08.004; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Helton DR, 1998, J PHARMACOL EXP THER, V284, P651; Holscher C, 2004, BEHAV BRAIN RES, V154, P473, DOI 10.1016/j.bbr.2004.03.015; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Iacovelli L, 2002, J NEUROCHEM, V82, P216, DOI 10.1046/j.1471-4159.2002.00929.x; Jiang Q, 2006, J NEUROSCI, V26, P4318, DOI 10.1523/JNEUROSCI.0118-06.2006; Kinzie JM, 1997, J COMP NEUROL, V385, P372; Kosinski CM, 1999, J COMP NEUROL, V415, P266; Lavreysen H, 2008, CURR MED CHEM, V15, P671, DOI 10.2174/092986708783885246; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin Y, 2004, J NEUROSCI, V24, P10138, DOI 10.1523/JNEUROSCI.3159-04.2004; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Martin G, 1997, J NEUROPHYSIOL, V78, P3028, DOI 10.1152/jn.1997.78.6.3028; Martin R, 2007, EUR J NEUROSCI, V26, P312, DOI 10.1111/j.1460-9568.2007.05660.x; Masugi M, 1999, J NEUROSCI, V19, P955; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitsukawa K, 2006, NEUROPSYCHOPHARMACOL, V31, P1112, DOI 10.1038/sj.npp.1300926; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nebl G, 2004, CELL SIGNAL, V16, P235, DOI 10.1016/S0898-6568(03)00133-5; OHISHI H, 1995, J COMP NEUROL, V360, P555, DOI 10.1002/cne.903600402; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Palucha A, 2004, NEUROPHARMACOLOGY, V46, P151, DOI 10.1016/j.neuropharm.2003.09.006; Palucha A, 2007, PSYCHOPHARMACOLOGY, V194, P555, DOI 10.1007/s00213-007-0856-2; Pawlak G, 2002, J BIOL CHEM, V277, P26927, DOI 10.1074/jbc.M202261200; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Perroy J, 2000, J NEUROSCI, V20, P7896; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Pisani A, 1997, NEUROPHARMACOLOGY, V36, P845, DOI 10.1016/S0028-3908(96)00177-3; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SALT TE, 1995, NEUROSCIENCE, V65, P5, DOI 10.1016/0306-4522(94)00464-G; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Spooren WPJM, 2000, J PHARMACOL EXP THER, V295, P1267; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Wang X, 2003, J NEUROSCI, V23, P9852; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	68	45	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10265	10275		10.1074/jbc.M111.325175	http://dx.doi.org/10.1074/jbc.M111.325175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22287544	Green Published, hybrid			2022-12-25	WOS:000302167200056
J	Amunugama, R; He, YJ; Willcox, S; Forties, RA; Shim, KS; Bundschuh, R; Luo, Y; Griffith, J; Fishel, R				Amunugama, Ravindra; He, Yujiong; Willcox, Smaranda; Forties, Robert A.; Shim, Kang-Sup; Bundschuh, Ralf; Luo, Yu; Griffith, Jack; Fishel, Richard			RAD51 Protein ATP Cap Regulates Nucleoprotein Filament Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; RECA-PROTEIN; METHANOCOCCUS-VOLTAE; COMPLEX-FORMATION; HOMOLOGOUS RECOMBINATION; CRYSTAL-STRUCTURE; GENETIC-RECOMBINATION; POTASSIUM DEPENDENCE; DAMAGE RESPONSE; REPAIR PROTEINS	RAD51 mediates homologous recombination by forming an active DNA nucleoprotein filament (NPF). A conserved aspartate that forms a salt bridge with the ATP gamma-phosphate is found at the nucleotide-binding interface between RAD51 subunits of the NPF known as the ATP cap. The salt bridge accounts for the nonphysiological cation(s) required to fully activate the RAD51 NPF. In contrast, RecA homologs and most RAD51 paralogs contain a conserved lysine at the analogous structural position. We demonstrate that substitution of human RAD51(Asp-316) with lysine (HsRAD51(D316K)) decreases NPF turnover and facilitates considerably improved recombinase functions. Structural analysis shows that archaebacterial Methanococcus voltae RadA(D302K) (MvRAD51(D302K)) and HsRAD51(D316K) form extended active NPFs without salt. These studies suggest that the HsRAD51(Asp-316) salt bridge may function as a conformational sensor that enhances turnover at the expense of recombinase activity.	[Amunugama, Ravindra; Bundschuh, Ralf; Fishel, Richard] Ohio State Univ, Med Ctr, Biophys Grad Program, Columbus, OH 43210 USA; [Amunugama, Ravindra; Shim, Kang-Sup; Fishel, Richard] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Forties, Robert A.; Bundschuh, Ralf; Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Bundschuh, Ralf] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [He, Yujiong; Luo, Yu] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Willcox, Smaranda; Griffith, Jack] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Saskatchewan; University of North Carolina; University of North Carolina Chapel Hill	Fishel, R (corresponding author), Ohio State Med Ctr, Wiseman Hall,Rm 385,400 W 12th Ave, Columbus, OH 43210 USA.	rfishel@osu.edu	Bundschuh, Ralf A/B-9623-2008	Bundschuh, Ralf A/0000-0002-6699-8614	National Sciences and Engineering Research Counsel; National Research Counsel; Canadian Institutes of Health Research [63860]; Province of Saskatchewan; Western Economic Diversification Canada; University or Saskatchewan; National Institutes of Health [GM31819, ES13773, GM080176]; National Science Foundation [DMR-0706002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM080176] Funding Source: NIH RePORTER	National Sciences and Engineering Research Counsel; National Research Counsel; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University or Saskatchewan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael Poirier and Charles Bell for helpful discussions. Crystallographic work was performed at the Canadian Light Source, which is supported by National Sciences and Engineering Research Counsel, National Research Counsel, Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University or Saskatchewan.; This work was supported, in whole or in part, by National Institutes of Health Grants GM31819 and ES13773 (to J. G.) and GM080176 (to R. F.). This work was also supported by Canadian Institutes of Health Research Grant 63860 (to Y. L.) and National Science Foundation Grant DMR-0706002 (to R. B.).	Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; De Zutter SK, 1999, J MOL BIOL, V293, P769, DOI 10.1006/jmbi.1999.3200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li Y, 2009, ACTA CRYSTALLOGR D, V65, P602, DOI 10.1107/S0907444909011871; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Liu J, 2011, NATURE, V479, P245, DOI 10.1038/nature10522; Liu YL, 2004, J MOL BIOL, V337, P817, DOI 10.1016/j.jmb.2004.02.022; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Mazin AV, 1998, EMBO J, V17, P1161, DOI 10.1093/emboj/17.4.1161; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Qian XG, 2005, BIOCHEMISTRY-US, V44, P13753, DOI 10.1021/bi051222i; Qian XG, 2006, J MOL BIOL, V360, P537, DOI 10.1016/j.jmb.2006.05.058; Qian XG, 2006, J BIOL CHEM, V281, P39380, DOI 10.1074/jbc.M607785200; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; Shim KS, 2006, DNA REPAIR, V5, P718, DOI 10.1016/j.dnarep.2006.03.006; Shim KS, 2004, J BIOL CHEM, V279, P30385, DOI 10.1074/jbc.M306066200; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Symington LS, 2006, GENE DEV, V20, P2479, DOI 10.1101/gad.1477106; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wu Y, 2004, MOL CELL, V15, P423, DOI 10.1016/j.molcel.2004.07.014; Wu Y, 2005, J BIOL CHEM, V280, P722, DOI 10.1074/jbc.M411093200; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	50	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8724	8736		10.1074/jbc.M111.239426	http://dx.doi.org/10.1074/jbc.M111.239426			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275364	Green Published, hybrid			2022-12-25	WOS:000301797800006
J	Andersen, LM; Andreasen, PA; Svendsen, I; Keemink, J; Ostergaard, H; Persson, E				Andersen, Lisbeth M.; Andreasen, Peter A.; Svendsen, Ivan; Keemink, Janneke; Ostergaard, Henrik; Persson, Egon			Antibody-induced Enhancement of Factor VIIa Activity through Distinct Allosteric Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR VIIA; TISSUE FACTOR; BLOOD-COAGULATION; CRYSTAL-STRUCTURE; ENZYMATIC-ACTIVITY; INTRINSIC ACTIVITY; EXTRINSIC PATHWAY; FACTOR-IX; FACTOR-X; ACTIVATION	In the absence of its cofactor tissue factor (TF), coagulation factor VIIa (FVIIa) predominantly exists in a zymogen-like, catalytically incompetent state. Here we demonstrate that conformation-specific monoclonal antibodies (mAbs) can be used to characterize structural features determining the activity of FVIIa. We isolated two classes of mAbs, which both increased the catalytic efficiency of FVIIa more than 150-fold. The effects of the antibodies were retained with a FVIIa variant, which has been shown to be inert to allosteric activation by the natural activator TF, suggesting that the antibodies and TF employ distinct mechanisms of activation. The antibodies could be classified into two groups based on their patterns of affinities for different conformations of FVIIa. Whereas one class of antibodies affected both the K-m and k(cat), the other class mainly affected the K-m. The antibody-induced activity enhancement could be traced to maturation of the S1 substrate binding pocket and the oxyanion hole, evident by an increased affinity for p-aminobenzamidine, an increased rate of antithrombin inhibition, an increased rate of incorporation of diisopropylfluorophosphate, and an enhanced fraction of molecules with a buried N terminus of the catalytic domain in the presence of antibodies. As demonstrated by site-directed mutagenesis, the two groups of antibodies appear to have overlapping, although clearly different, epitopes in the 170-loop. Our findings suggest that binding of ligands to specific residues in the 170-loop or its spatial vicinity may stabilize the S1 pocket and the oxyanion hole, and they may have general implications for the molecular understanding of FVIIa regulatory mechanisms.	[Persson, Egon] Novo Nordisk AS, Haemostasis Biol, DK-2760 Malov, Denmark; [Andersen, Lisbeth M.; Andreasen, Peter A.; Keemink, Janneke] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Novo Nordisk; Aarhus University	Persson, E (corresponding author), Novo Nordisk AS, Haemostasis Biol, Novo Nordisk Pk,G8-1-61, DK-2760 Malov, Denmark.	egpe@novonordisk.com		Persson, Egon/0000-0003-3005-4926				Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dickinson CD, 1997, J BIOL CHEM, V272, P19875, DOI 10.1074/jbc.272.32.19875; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; Eigenbrot C, 2001, STRUCTURE, V9, P627, DOI 10.1016/S0969-2126(01)00624-4; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Kerschbaumer RJ, 2004, J BIOL CHEM, V279, P40445, DOI 10.1074/jbc.M405966200; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Larsen KS, 2007, BIOCHEM J, V405, P429, DOI 10.1042/BJ20061901; MARKWARDT F, 1968, EUR J BIOCHEM, V6, P502, DOI 10.1111/j.1432-1033.1968.tb00473.x; Menez R, 2008, J MOL BIOL, V376, P1021, DOI 10.1016/j.jmb.2007.11.052; Monroe DM, 2007, J THROMB HAEMOST, V5, P1097, DOI 10.1111/j.1538-7836.2007.02435.x; NICOLAISEN EM, 1992, FEBS LETT, V306, P157, DOI 10.1016/0014-5793(92)80989-T; Olsen OH, 2007, PROTEIN SCI, V16, P671, DOI 10.1110/ps.062504907; PEDERSEN AH, 1990, J BIOL CHEM, V265, P16786; Persson E, 2004, BIOCHEM J, V379, P497, DOI 10.1042/BJ20031596; Persson E, 2001, BIOCHEMISTRY-US, V40, P3251, DOI 10.1021/bi001612z; Persson E, 2001, J BIOL CHEM, V276, P29195, DOI 10.1074/jbc.M102187200; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Persson E, 1996, FEBS LETT, V385, P241, DOI 10.1016/0014-5793(96)00400-0; Persson E, 2010, THROMB RES, V125, pS11, DOI 10.1016/j.thromres.2010.01.023; Persson E, 2009, FEBS J, V276, P3099, DOI 10.1111/j.1742-4658.2009.07028.x; Petrovan RJ, 2002, BIOCHEMISTRY-US, V41, P9302, DOI 10.1021/bi0202169; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; Scheiflinger F, 2008, J THROMB HAEMOST, V6, P315, DOI 10.1111/j.1538-7836.2007.02868.x; SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; Yoshihara E, 1996, FEBS LETT, V394, P179, DOI 10.1016/0014-5793(96)00945-3	34	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8994	9001		10.1074/jbc.M111.312330	http://dx.doi.org/10.1074/jbc.M111.312330			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275370	hybrid, Green Published			2022-12-25	WOS:000301797800030
J	Lee, S; Jang, E; Kim, JH; Kim, JH; Lee, WH; Suk, K				Lee, Shinrye; Jang, Eunha; Kim, Jong-Heon; Kim, Jae-Hong; Lee, Won-Ha; Suk, Kyoungho			Lipocalin-type Prostaglandin D-2 Synthase Protein Regulates Glial Cell Migration and Morphology through Myristoylated Alanine-rich C-Kinase Substrate PROSTAGLANDIN D-2-INDEPENDENT EFFECTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CEREBROSPINAL-FLUID; BETA-TRACE PROTEIN; ALZHEIMERS-DISEASE; RHO-GTPASE; RAT-BRAIN; LYSOPHOSPHATIDIC ACID; ASTROCYTE MORPHOLOGY; MULTIPLE-SCLEROSIS; REACTIVE GLIOSIS; DOWN-REGULATION	Prostaglandin D synthase (PGDS) is responsible for the conversion of PGH(2) to PGD(2). Two distinct types of PGDS have been identified: hematopoietic-type PGDS (H-PGDS) and lipocalin-type PGDS (L-PGDS). L-PGDS acts as both a PGD(2)-synthesizing enzyme and as an extracellular transporter of various lipophilic small molecules. Although L-PGDS is one of the most abundant proteins in the cerebrospinal fluid, little is known about the function of L-PGDS in the central nervous system (CNS). To better understand the role of L-PGDS in the CNS, effects of L-PGDS on the migration and morphology of glial cells were investigated. The L-PGDS protein accelerated the migration of cultured glial cells. Expression of the L-pgds gene was detected in glial cells and neurons. L-PGDS protein also induced morphological changes in glia similar to the characteristic phenotypic changes in reactive gliosis. L-PGDS-induced cell migration was associated with augmented formation of actin filaments and focal adhesion, which was accompanied by activation of AKT, RhoA, and JNK pathways. L-PGDS protein injected into the mouse brain promoted migration and accumulation of astrocytes in vivo. Furthermore, the cell migration-promoting effect of L-PGDS on glial cells was independent of the PGD(2) products. The L-PGDS protein interacted with myristoylated alanine-rich protein kinase C substrate (MARCKS) to promote cell migration. These results demonstrate the critical role of L-PGDS as a secreted lipocalin in the regulation of glial cell migration and morphology. The results also indicate that L-PGDS may participate in reactive gliosis in an autocrine or paracrine manner, and may have pathological implications in neuroinflammatory diseases.	[Lee, Shinrye; Jang, Eunha; Kim, Jong-Heon; Kim, Jae-Hong; Suk, Kyoungho] Kyungpook Natl Univ, Dept Pharmacol, Brain Sci & Engn Inst, CMRI,Sch Med, Taegu 700422, South Korea; [Lee, Won-Ha] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 700422, South Korea	Kyungpook National University; Kyungpook National University	Suk, K (corresponding author), 101 Dong In, Taegu 700422, South Korea.	ksuk@knu.ac.kr			Ministry of Education, Science and Technology (MEST) of Korean government [2009-0078941]; National Research Foundation; MEST [2010-0029460]	Ministry of Education, Science and Technology (MEST) of Korean government(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Ministry of Education, Science and Technology (MEST) of Korean government Grant 2009-0078941 from the National Research Foundation and the Basic Science Research Program Grant 2010-0029460 from the National Research Foundation funded by the MEST.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Araki W, 2000, ANN NY ACAD SCI, V920, P241; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Beuckmann CT, 2000, J COMP NEUROL, V428, P62, DOI 10.1002/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; Blodorn B, 1999, J NEUROSCI RES, V57, P730; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Chen CJ, 2006, EUR J NEUROSCI, V23, P1977, DOI 10.1111/j.1460-9568.2006.04728.x; Disatnik MH, 2002, J CELL SCI, V115, P2151; Dulong S, 2004, BIOCHEM J, V382, P1015, DOI 10.1042/BJ20040347; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; ENOKIDO Y, 1992, BRAIN RES, V599, P261, DOI 10.1016/0006-8993(92)90400-4; Franz CM, 2002, DEV CELL, V2, P153, DOI 10.1016/S1534-5807(02)00120-X; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Goulimari P, 2005, J BIOL CHEM, V280, P42242, DOI 10.1074/jbc.M508690200; Grill M, 2006, NEUROPHARMACOLOGY, V50, P165, DOI 10.1016/j.neuropharm.2005.08.005; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; Hirawa N, 2002, HYPERTENSION, V39, P449, DOI 10.1161/hy0202.102835; HOFFMANN A, 1993, J NEUROCHEM, V61, P451; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; John GR, 2004, J NEUROSCI, V24, P2837, DOI 10.1523/JNEUROSCI.4789-03.2004; Joo M, 2009, AM J PHYSIOL-LUNG C, V296, pL771, DOI 10.1152/ajplung.90320.2008; Kagitani-Shimono K, 2006, NEUROPATH APPL NEURO, V32, P64, DOI 10.1111/j.1365-2990.2005.00690.x; Kalla R, 2003, GLIA, V41, P50, DOI 10.1002/glia.10176; Kalwa H, 2011, J BIOL CHEM, V286, P2320, DOI 10.1074/jbc.M110.196022; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kim S, 2007, J NEUROCHEM, V103, P2640, DOI 10.1111/j.1471-4159.2007.04995.x; Kito H, 2000, J APPL PHYSIOL, V89, P2391, DOI 10.1152/jappl.2000.89.6.2391; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lee H, 2003, FASEB J, V17, P1943, DOI 10.1096/fj.03-0057fje; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Maesaka JK, 2001, KIDNEY INT, V60, P1692, DOI 10.1046/j.1523-1755.2001.00989.x; MASANA Y, 1995, NEUROSCI RES, V23, P217, DOI 10.1016/0168-0102(95)00936-N; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; Miwa Y, 2004, BIOCHEM BIOPH RES CO, V322, P428, DOI 10.1016/j.bbrc.2004.07.143; Mohri I, 2006, J NEUROCHEM, V97, P641, DOI 10.1111/j.1471-4159.2006.03753.x; Monneret G, 2001, BLOOD, V98, P1942, DOI 10.1182/blood.V98.6.1942; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Ragolia L, 2005, J BIOL CHEM, V280, P29946, DOI 10.1074/jbc.M502927200; Ragolia L, 2003, AM J PHYSIOL-CELL PH, V284, pC119, DOI 10.1152/ajpcell.00247.2002; Ragolia L, 2001, NEUROREPORT, V12, P2623, DOI 10.1097/00001756-200108280-00008; Ragolia L, 2007, PROSTAG OTH LIPID M, V83, P25, DOI 10.1016/j.prostaglandins.2006.09.006; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; Ramakers GJA, 1998, EXP CELL RES, V245, P252, DOI 10.1006/excr.1998.4224; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schuetz E, 2004, CURR DRUG TARGETS, V5, P619, DOI 10.2174/1389450043345164; Schuligoi R, 2005, BIOCHEM BIOPH RES CO, V335, P684, DOI 10.1016/j.bbrc.2005.07.130; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Seo M, 2010, FASEB J, V24, P464, DOI 10.1096/fj.09-137562; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Suidan HS, 1997, GLIA, V21, P244, DOI 10.1002/(SICI)1098-1136(199710)21:2<244::AID-GLIA7>3.0.CO;2-6; Tanaka R, 2009, BIOCHEM BIOPH RES CO, V378, P851, DOI 10.1016/j.bbrc.2008.11.152; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Taniike M, 2002, J NEUROSCI, V22, P4885, DOI 10.1523/JNEUROSCI.22-12-04885.2002; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; Urade Y, 2000, VITAM HORM, V58, P89, DOI 10.1016/S0083-6729(00)58022-4; URADE Y, 1987, J BIOL CHEM, V262, P15132; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; URADE Y, 1985, J BIOL CHEM, V260, P2410; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; WATANABE K, 1994, BIOCHEM BIOPH RES CO, V203, P1110, DOI 10.1006/bbrc.1994.2297; Winograd-Katz SE, 2009, J CELL BIOL, V186, P423, DOI 10.1083/jcb.200901105; Xin XR, 2009, J MOL NEUROSCI, V39, P366, DOI 10.1007/s12031-009-9214-7; Zhao Y, 2000, AM J PHYSIOL-CELL PH, V279, pC1611, DOI 10.1152/ajpcell.2000.279.5.C1611	82	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9414	9428		10.1074/jbc.M111.330662	http://dx.doi.org/10.1074/jbc.M111.330662			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275363	hybrid, Green Published			2022-12-25	WOS:000301797800071
J	Paulus, A; Rossius, SGH; Dijk, M; de Vries, S				Paulus, Angela; Rossius, Sebastiaan Gijsbertus Hendrik; Dijk, Madelon; de Vries, Simon			Oxoferryl-Porphyrin Radical Catalytic Intermediate in Cytochrome bd Oxidases Protects Cells from Formation of Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; D TERMINAL OXIDASE; ESCHERICHIA-COLI; QUINOL OXIDASE; SUBUNIT-I; UBIQUINOL OXIDASE; PEROXIDASE COMPOUND; BINUCLEAR CENTER; HEME-HEME; WILD-TYPE	The quinol-linked cytochrome bd oxidases are terminal oxidases in respiration. These oxidases harbor a low spin heme b(558) that donates electrons to a binuclear heme b(595)/heme d center. The reaction with O-2 and subsequent catalytic steps of the Escherichia coli cytochrome bd-I oxidase were investigated by means of ultra-fast freeze-quench trapping followed by EPR and UV-visible spectroscopy. After the initial binding of O-2, the O-O bond is heterolytically cleaved to yield a kinetically competent heme d oxoferryl porphyrin pi-cation radical intermediate (compound I) magnetically interacting with heme b(595). Compound I accumulates to 0.75-0.85 per enzyme in agreement with its much higher rate of formation (similar to 20,000 s(-1)) compared with its rate of decay (similar to 1,900 s(-1)). Compound I is next converted to a short lived heme d oxoferryl intermediate (compound II) in a phase kinetically matched to the oxidation of heme b(558) before completion of the reaction. The results indicate that cytochrome bd oxidases like the heme-copper oxidases break the O-O bond in a single four-electron transfer without a peroxide intermediate. However, in cytochrome bd oxidases, the fourth electron is donated by the porphyrin moiety rather than by a nearby amino acid. The production of reactive oxygen species by the cytochrome bd oxidase was below the detection level of 1 per 1000 turnovers. We propose that the two classes of terminal oxidases have mechanistically converged to enzymes in which the O-O bond is broken in a single four-electron transfer reaction to safeguard the cell from the formation of reactive oxygen species.	[Paulus, Angela; Rossius, Sebastiaan Gijsbertus Hendrik; Dijk, Madelon; de Vries, Simon] Delft Univ Technol, Dept Biotechnol, Sect Enzymol, NL-2628 BC Delft, Netherlands	Delft University of Technology	de Vries, S (corresponding author), Delft Univ Technol, Dept Biotechnol, Sect Enzymol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	s.devries@tudelft.nl			ECHO from the Netherlands Organization for Scientific Research [700.54.003]	ECHO from the Netherlands Organization for Scientific Research	This work was supported by ECHO Grant 700.54.003 from the Netherlands Organization for Scientific Research (to S. d. V.).	Arutyunyan AM, 2008, BIOCHEMISTRY-US, V47, P1752, DOI 10.1021/bi701884g; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Bekker M, 2009, J BACTERIOL, V191, P5510, DOI 10.1128/JB.00562-09; Belevich I, 2007, J BIOL CHEM, V282, P28514, DOI 10.1074/jbc.M705562200; Borisov VB, 2002, BIOCHEMISTRY-US, V41, P1654, DOI 10.1021/bi0158019; Borisov VB, 2008, BIOCHEMISTRY-US, V47, P7907, DOI 10.1021/bi800435a; Borisov VB, 2006, FEBS LETT, V580, P4823, DOI 10.1016/j.febslet.2006.07.072; Borisov VB, 2011, P NATL ACAD SCI USA, V108, P17320, DOI 10.1073/pnas.1108217108; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P503, DOI 10.1016/j.bbabio.2011.02.007; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Fujii H, 1996, INORG CHEM, V35, P2373, DOI 10.1021/ic9513752; GOTOH T, 1974, ARCH BIOCHEM BIOPHYS, V163, P476, DOI 10.1016/0003-9861(74)90504-9; HAN S, 1990, P NATL ACAD SCI USA, V87, P2491, DOI 10.1073/pnas.87.7.2491; Hastings SF, 1998, EUR J BIOCHEM, V255, P317, DOI 10.1046/j.1432-1327.1998.2550317.x; HATATANAKA A, 1987, BIOCHIM BIOPHYS ACTA, V893, P289, DOI 10.1016/0005-2728(87)90050-8; HEWSON WD, 1979, J BIOL CHEM, V254, P3182; Hildebrand DP, 1998, J INORG BIOCHEM, V70, P11, DOI 10.1016/S0162-0134(98)00007-5; HILL BC, 1994, BIOCHEMISTRY-US, V33, P15110, DOI 10.1021/bi00254a021; HILL JJ, 1993, P NATL ACAD SCI USA, V90, P5863, DOI 10.1073/pnas.90.12.5863; HINKLE PC, 1967, J BIOL CHEM, V242, P5169; HOUSEMAN ALP, 1993, BIOCHEMISTRY-US, V32, P4430, DOI 10.1021/bi00067a036; INGLEDEW WJ, 1992, BIOCHEM J, V282, P255, DOI 10.1042/bj2820255; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; JUNEMANN S, 1995, J BIOL CHEM, V270, P16213, DOI 10.1074/jbc.270.27.16213; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; KAHLOW MA, 1991, BIOCHEMISTRY-US, V30, P11485, DOI 10.1021/bi00113a001; Kaila VRI, 2010, CHEM REV, V110, P7062, DOI 10.1021/cr1002003; KAYSSER TM, 1995, BIOCHEMISTRY-US, V34, P13491, DOI 10.1021/bi00041a029; Korshunov S, 2006, J BACTERIOL, V188, P6326, DOI 10.1128/JB.00554-06; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; MANDON D, 1992, INORG CHEM, V31, P4404, DOI 10.1021/ic00047a031; Mason MG, 2009, NAT CHEM BIOL, V5, P94, DOI 10.1038/nchembio.135; MEINHARDT SW, 1989, BIOCHIM BIOPHYS ACTA, V975, P175, DOI 10.1016/S0005-2728(89)80216-6; Mogi T, 2006, BIOCHEMISTRY-US, V45, P15785, DOI 10.1021/bi0615792; Mogi T, 2009, J BIOCHEM, V145, P763, DOI 10.1093/jb/mvp033; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; OOSTERHUIS WT, 1973, J CHEM PHYS, V58, P4757, DOI 10.1063/1.1679055; Osborne JP, 1999, BBA-BIOENERGETICS, V1410, P32, DOI 10.1016/S0005-2728(98)00171-6; POOLE RK, 1982, FEBS LETT, V150, P147, DOI 10.1016/0014-5793(82)81323-9; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Rappaport F, 2010, BBA-BIOENERGETICS, V1797, P1657, DOI 10.1016/j.bbabio.2010.05.010; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Schroder Imke, 2008, P1; Schunemann V, 2004, J BIOL CHEM, V279, P10919, DOI 10.1074/jbc.M307884200; SPENCER ME, 1974, J BACTERIOL, V117, P954, DOI 10.1128/JB.117.3.954-959.1974; Sun J, 1996, BIOCHEMISTRY-US, V35, P2403, DOI 10.1021/bi9518252; SUN J, 1995, BIOCHEMISTRY-US, V34, P12144, DOI 10.1021/bi00038a007; TSUBAKI M, 1981, P NATL ACAD SCI-BIOL, V78, P3581, DOI 10.1073/pnas.78.6.3581; TSUBAKI M, 1993, FEBS LETT, V335, P13, DOI 10.1016/0014-5793(93)80430-3; Vos MH, 2000, P NATL ACAD SCI USA, V97, P1554, DOI 10.1073/pnas.030528197; Wiertz FGM, 2007, J BIOL CHEM, V282, P31580, DOI 10.1074/jbc.M705520200; YANG FD, 1986, J BIOL CHEM, V261, P4987; Yang K, 2008, FEBS LETT, V582, P3705, DOI 10.1016/j.febslet.2008.09.038; Yang K, 2007, BIOCHEMISTRY-US, V46, P3270, DOI 10.1021/bi061946+; Zhang J, 2001, BIOCHEMISTRY-US, V40, P8548, DOI 10.1021/bi010469m; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	61	30	33	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8830	8838		10.1074/jbc.M111.333542	http://dx.doi.org/10.1074/jbc.M111.333542			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22287551	Green Published, hybrid			2022-12-25	WOS:000301797800015
J	Achila, D; Gulati, M; Jain, N; Britton, RA				Achila, David; Gulati, Megha; Jain, Nikhil; Britton, Robert A.			Biochemical Characterization of Ribosome Assembly GTPase RbgA in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; ESCHERICHIA-COLI; CELL-CYCLE; SUBUNIT; BIOGENESIS; YLQF; YQEH; RNA	The ribosome biogenesis GTPase A protein RbgA is involved in the assembly of the large ribosomal subunit in Bacillus subtilis, and homologs of RbgA are implicated in the biogenesis of mitochondrial, chloroplast, and cytoplasmic ribosomes in archaea and eukaryotes. The precise function of how RbgA contributes to ribosome assembly is not understood. Defects in RbgA give rise to a large ribosomal subunit that is immature and migrates at 45 S in sucrose density gradients. Here, we report a detailed biochemical analysis of RbgA and its interaction with the ribosome. We found that RbgA, like most other GTPases, exhibits a very slow k(cat) (14 h(-1)) and has a high K-m (90 mu M). Homology modeling of the RbgA switch I region using the K-loop GTPase MnmE as a template suggested that RbgA requires K+ ions for GTPase activity, which was confirmed experimentally. Interaction with 50 S subunits, but not 45 S intermediates, increased GTPase activity by similar to 55-fold. Stable association with 50 S subunits and 45 S intermediates was nucleotide-dependent, and GDP did not support strong interaction with either of the subunits. GTP and guanosine 5'-(beta,gamma-imido)triphosphate (GMPPNP) were sufficient to promote association with the 45 S intermediate, whereas only GMPPNP was able to support binding to the 50 S subunit, presumably due to the stimulation of GTP hydrolysis. These results support a model in which RbgA promotes a late step in ribosome biogenesis and that one role of GTP hydrolysis is to stimulate dissociation of RbgA from the ribosome.	[Achila, David; Gulati, Megha; Jain, Nikhil; Britton, Robert A.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University	Britton, RA (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 6175 BPS, E Lansing, MI 48824 USA.	rbritton@msu.edu	Jain, Nikhil/B-5107-2013	Jain, Nikhil/0000-0002-9091-6156	National Science Foundation [0643565]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090872] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Science Foundation CAREER Award 0643565 (to R. A. B.).	Anand B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009944; Ash MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023355; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; Culver GM, 2003, BIOPOLYMERS, V68, P234, DOI 10.1002/bip.10221; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; deLivron MA, 2008, J BACTERIOL, V190, P5944, DOI 10.1128/JB.00763-08; Dez C, 2004, CURR OPIN MICROBIOL, V7, P631, DOI 10.1016/j.mib.2004.10.007; GOLLOP N, 1991, J BACTERIOL, V173, P2265, DOI 10.1128/JB.173.7.2265-2270.1991; Heifets A, 2010, J MOL GRAPH MODEL, V29, P93, DOI 10.1016/j.jmgm.2010.05.005; Jensen BC, 2003, J BIOL CHEM, V278, P32204, DOI 10.1074/jbc.M304198200; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lin B, 2004, J BACTERIOL, V186, P481, DOI 10.1128/JB.186.2.481-489.2004; LOPEZ JM, 1979, BIOCHIM BIOPHYS ACTA, V587, P238, DOI 10.1016/0304-4165(79)90357-X; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Matsuo Y, 2007, J BIOL CHEM, V282, P25270, DOI 10.1074/jbc.M703894200; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; NOMURA M, 1970, NATURE, V228, P744, DOI 10.1038/228744a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843	33	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8417	8423		10.1074/jbc.M111.331322	http://dx.doi.org/10.1074/jbc.M111.331322			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267738	Green Published, hybrid			2022-12-25	WOS:000301349400056
J	Bae, S; Kang, T; Hong, J; Lee, S; Choi, J; Jhun, H; Kwak, A; Hong, K; Kim, E; Jo, S; Kim, S				Bae, Suyoung; Kang, Taebong; Hong, Jaewoo; Lee, Siyoung; Choi, Jida; Jhun, Hyunjhung; Kwak, Areum; Hong, Kwangwon; Kim, Eunsom; Jo, Seunghyun; Kim, Soohyun			Contradictory Functions (Activation/Termination) of Neutrophil Proteinase 3 Enzyme (PR3) in Interleukin-33 Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR ACCESSORY PROTEIN; CYTOKINE PRODUCTION; HUMAN BASOPHILS; IL-33; ST2; CELLS; GENE; EXPRESSION; MATURATION; INDUCTION	IL-1 family ligand does not possess a typical hydrophobic signal peptide and needs a processing enzyme for maturation. The maturation process of IL-33 (IL-1F11), a new member of the IL-1 family ligand, remains unclear. Precursor IL-33 ligand affinity column isolates neutrophil proteinase 3 (PR3) from human urinary proteins. PR3 is a known IL-1 family ligand-processing enzyme for IL-1 beta (IL-1F2) and IL-18 (IL-1F4), including other inflammatory cytokines. We investigated PR3 in the maturation process of precursor IL-33 because we isolated urinary PR3 by using the precursor IL-33 ligand affinity column. PR3 converted inactive human and mouse precursor IL-33 proteins to biological active forms; however, the increase of PR3 incubation time abrogated IL-33 activities. Unlike caspase-1-cleaved precursor IL-18, PR3 cut precursor IL-33 and IL-18 at various sites and yielded multibands. The increased incubation period of PR3 abated mature IL-33 in a time-dependent manner. The result is consistent with the decreased bioactivity of IL-33 along with the increased PR3 incubation time. Six different human and mouse recombinant IL-33 proteins were expressed by the predicted consensus amino acid sequence of PR3 cleavage sites and tested for bioactivities. The human IL-33/p1 was highly active, but human IL-33/p2 and p3 proteins were inactive. Our results suggest the dual functions (activation/termination) of PR3 in IL-33 biological activity.	[Bae, Suyoung; Hong, Jaewoo; Lee, Siyoung; Choi, Jida; Jhun, Hyunjhung; Kwak, Areum; Hong, Kwangwon; Kim, Eunsom; Jo, Seunghyun; Kim, Soohyun] Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, Seoul 143701, South Korea; [Kang, Taebong] Konkuk Univ, Dept Biotechnol, Coll Biomed & Hlth Sci, Chungju 380701, South Korea	Konkuk University; Konkuk University	Kim, S (corresponding author), Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, 120 Neungdong Ro, Seoul 143701, South Korea.	soohyun@konkuk.ac.kr		kang, tae-bong/0000-0003-1441-9470; Hong, Jaewoo/0000-0003-3456-3672	National Research Foundation; Korean Government [WCU R33-2008-000-10022-0, KRF-2008-313-C00644]; Ministry of Health & Welfare, Republic of Korea [A100460]	National Research Foundation; Korean Government(Korean Government); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the National Research Foundation funded by Korean Government Grants WCU R33-2008-000-10022-0 and KRF-2008-313-C00644 and Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea Grant A100460.	Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Bae S, 2010, HYBRIDOMA, V29, P17, DOI 10.1089/hyb.2009.0054; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Csernok E, 1996, CLIN EXP IMMUNOL, V105, P104, DOI 10.1046/j.1365-2249.1996.d01-715.x; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hayakawa M, 2009, BIOCHEM BIOPH RES CO, V387, P218, DOI 10.1016/j.bbrc.2009.07.018; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hong J, 2011, J BIOL CHEM, V286, P20078, DOI 10.1074/jbc.M111.219089; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; KLEMENZ R, 1989, P NATL ACAD SCI USA, V86, P5708, DOI 10.1073/pnas.86.15.5708; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lamkanfi M, 2009, IMMUNITY, V31, P5, DOI 10.1016/j.immuni.2009.06.011; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; PADRINES M, 1994, FEBS LETT, V352, P231, DOI 10.1016/0014-5793(94)00952-X; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; ROBACHEGALLEA S, 1995, J BIOL CHEM, V270, P23688, DOI 10.1074/jbc.270.40.23688; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Senn KA, 2000, EUR J IMMUNOL, V30, P1929, DOI 10.1002/1521-4141(200007)30:7&lt;1929::AID-IMMU1929&gt;3.0.CO;2-1; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sugawara S, 2001, J IMMUNOL, V167, P6568, DOI 10.4049/jimmunol.167.11.6568; Sullivan BM, 2009, IMMUNITY, V30, P12, DOI 10.1016/j.immuni.2008.12.006; Suzukawa Maho, 2008, Lab Invest, V88, P1245, DOI 10.1038/labinvest.2008.82; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; TOMINAGA S, 1992, BIOCHIM BIOPHYS ACTA, V1171, P215, DOI 10.1016/0167-4781(92)90125-J; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; TOMINAGA S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P1, DOI 10.1016/0167-4781(91)90029-L; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Wysocka M, 2008, ANAL BIOCHEM, V378, P208, DOI 10.1016/j.ab.2008.04.003	48	48	50	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8205	8213		10.1074/jbc.M111.295055	http://dx.doi.org/10.1074/jbc.M111.295055			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270365	Green Published, hybrid			2022-12-25	WOS:000301349400036
J	Withers, S; Lu, FC; Kim, H; Zhu, YM; Ralph, J; Wilkerson, CG				Withers, Saunia; Lu, Fachuang; Kim, Hoon; Zhu, Yimin; Ralph, John; Wilkerson, Curtis G.			Identification of Grass-specific Enzyme That Acylates Monolignols with p-Coumarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALLS; LIGNIN BIOSYNTHESIS; SINAPYL ACETATE; MAIZE LIGNIN; NMR; PLANTS; KENAF; UNITS; ACID; RICE	Lignin is a major component of plant cell walls that is essential to their function. However, the strong bonds that bind the various subunits of lignin, and its cross-linking with other plant cell wall polymers, make it one of the most important factors in the recalcitrance of plant cell walls against polysaccharide utilization. Plants make lignin from a variety of monolignols including p-coumaryl, coniferyl, and sinapyl alcohols to produce the three primary lignin units: p-hydroxyphenyl, guaiacyl, and syringyl, respectively, when incorporated into the lignin polymer. In grasses, these monolignols can be enzymatically preacylated by p-coumarates prior to their incorporation into lignin, and these monolignol conjugates can also be "monomer" precursors of lignin. Although monolignol p-coumarate-derived units may comprise up to 40% of the lignin in some grass tissues, the p-coumarate moiety from such conjugates does not enter into the radical coupling (polymerization) reactions of lignification. With a greater understanding of monolignol p-coumarate conjugates, grass lignins could be engineered to contain fewer pendent p-coumarate groups and more monolignol conjugates that improve lignin cleavage. We have cloned and expressed an enzyme from rice that has p-coumarate monolignol transferase activity and determined its kinetic parameters.	[Wilkerson, Curtis G.] Michigan State Univ, Dept Biochem & Mol Biol, Dept Plant Biol, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Lu, Fachuang; Kim, Hoon; Zhu, Yimin; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Lu, Fachuang; Kim, Hoon; Zhu, Yimin; Ralph, John] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Lu, Fachuang; Kim, Hoon; Ralph, John] Univ Wisconsin, Wisconsin Bioenergy Initiat, Madison, WI 53706 USA	Michigan State University; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wilkerson, CG (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, Dept Plant Biol, Great Lakes Bioenergy Res Ctr, S124 Plant Biol,178 Wilson Rd, E Lansing, MI 48824 USA.	wilker13@msu.edu	Lu, Fachuang/K-6487-2019; Ralph, John/C-3161-2009; Kim, Hoon/E-8245-2013	Ralph, John/0000-0002-6093-4521; Kim, Hoon/0000-0001-7425-7464	Department of Energy Great Lakes Bioenergy Research Center Office of Science [DE-FC02-07ER64494]	Department of Energy Great Lakes Bioenergy Research Center Office of Science(United States Department of Energy (DOE))	This work was supported by the Department of Energy Great Lakes Bioenergy Research Center Office of Science Grant DE-FC02-07ER64494.	Beuerle T, 2002, ANAL BIOCHEM, V302, P305, DOI 10.1006/abio.2001.5574; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; del Rio JC, 2008, J AGR FOOD CHEM, V56, P9525, DOI 10.1021/jf800806h; Del Rio JC, 2007, J AGR FOOD CHEM, V55, P5461, DOI 10.1021/jf0705264; Dexter R, 2007, PLANT J, V49, P265, DOI 10.1111/j.1365-313X.2006.02954.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Grabber JH, 1996, PHYTOCHEMISTRY, V43, P1189, DOI 10.1016/S0031-9422(96)00431-1; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Harkin J.M., 1967, OXIDATIVE COUPLING P, P243; HARRIS PJ, 1980, BIOCHEM SYST ECOL, V8, P153, DOI 10.1016/0305-1978(80)90008-3; HARTLEY RD, 1972, J SCI FOOD AGR, V23, P1347, DOI 10.1002/jsfa.2740231110; Hatfield RD, 1999, J SCI FOOD AGR, V79, P891, DOI 10.1002/(SICI)1097-0010(19990501)79:6&lt;891::AID-JSFA304&gt;3.0.CO;2-#; Hatfield R, 2008, PLANTA, V228, P919, DOI 10.1007/s00425-008-0791-4; Hatfield RD, 2009, PLANTA, V229, P1253, DOI 10.1007/s00425-009-0900-z; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; LANDUCCI LL, 1992, HOLZFORSCHUNG, V46, P505, DOI 10.1515/hfsg.1992.46.6.505; Li SM, 2001, NORD PULP PAP RES J, V16, P63, DOI 10.3183/npprj-2001-16-01-p063-067; Lu F. C., 2005, 13 INT S WOOD FIB PU, P233; Lu FC, 2008, ORG BIOMOL CHEM, V6, P3681, DOI 10.1039/b809464k; Lu FC, 2003, PLANT J, V35, P535, DOI 10.1046/j.1365-313X.2003.01817.x; Lu FC, 2002, CHEM COMMUN, P90, DOI 10.1039/b109876d; Lu FC, 1999, J AGR FOOD CHEM, V47, P1988, DOI 10.1021/jf981140j; Lu FC, 1998, J AGR FOOD CHEM, V46, P2911, DOI 10.1021/jf980440y; Martinez AT, 2008, PHYTOCHEMISTRY, V69, P2831, DOI 10.1016/j.phytochem.2008.09.005; Meyermans H, 2000, J BIOL CHEM, V275, P36899, DOI 10.1074/jbc.M006915200; Mitchell RAC, 2007, PLANT PHYSIOL, V144, P43, DOI 10.1104/pp.106.094995; Nakano J., 1961, TAPPI, V44, P30; Norman A., 1969, SCIENCE, V165, P784; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; R.D.C. Team, 2010, R LANGUAGE ENV STAT; Ralph J, 1998, J AGR FOOD CHEM, V46, P4616, DOI 10.1021/jf980680d; Ralph J, 1996, J NAT PROD, V59, P341, DOI 10.1021/np960143s; RALPH J, 1994, J AM CHEM SOC, V116, P9448, DOI 10.1021/ja00100a006; Ralph J., 2006, SCI LORE PLANT CELL, P285; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ralph John, 2004, Phytochemistry Reviews, V3, P79, DOI 10.1023/B:PHYT.0000047811.13837.fb; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Santoro N, 2006, ANAL BIOCHEM, V354, P70, DOI 10.1016/j.ab.2006.04.006; Sato Y., 2010, NUCLEIC ACIDS RES, pD1141; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SHIMADA M, 1971, TAPPI, V54, P72; SMITH DCC, 1955, J CHEM SOC, P2347, DOI 10.1039/jr9550002347; STOECKIGT J, 1975, Zeitschrift fuer Naturforschung Teil C Biochemie Biophysik Biologie Virologie, V30, P352; Sun RC, 1999, J WOOD CHEM TECHNOL, V19, P335, DOI 10.1080/02773819909349616; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Wagner A, 2011, PLANT J, V67, P119, DOI 10.1111/j.1365-313X.2011.04580.x	48	119	131	5	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8347	8355		10.1074/jbc.M111.284497	http://dx.doi.org/10.1074/jbc.M111.284497			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267741	hybrid, Green Published			2022-12-25	WOS:000301349400049
J	Hong, MH; Chou, YC; Wu, YC; Tsai, KN; Hu, CP; Jeng, KS; Chen, ML; Chang, CM				Hong, Ming-Hsiang; Chou, Yu-Chi; Wu, Yi-Chieh; Tsai, Kuen-Nan; Hu, Cheng-po; Jeng, King-Song; Chen, Mong-Liang; Chang, Chungming			Transforming Growth Factor-beta 1 Suppresses Hepatitis B Virus Replication by the Reduction of Hepatocyte Nuclear Factor-4 alpha Expression	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL REGULATION; VIRAL CLEARANCE; FACTOR 4-ALPHA; TGF-BETA; PRE-C	Several studies have demonstrated that cytokine-mediated noncytopathic suppression of hepatitis B virus (HBV) replication may provide an alternative therapeutic strategy for the treatment of chronic hepatitis B infection. In our previous study, we showed that transforming growth factor-beta1 (TGF-beta 1) could effectively suppress HBV replication at physiological concentrations. Here, we provide more evidence that TGF-beta 1 specifically diminishes HBV core promoter activity, which subsequently results in a reduction in the level of viral pregenomic RNA (pgRNA), core protein (HBc), nucleocapsid, and consequently suppresses HBV replication. The hepatocyte nuclear factor 4alpha (HNF-4 alpha) binding element(s) within the HBV core promoter region was characterized to be responsive for the inhibitory effect of TGF-beta 1 on HBV regulation. Furthermore, we found that TGF-beta 1 treatment significantly repressed HNF-4 alpha expression at both mRNA and protein levels. We demonstrated that RNAi-mediated depletion of HNF-4 alpha was sufficient to reduce HBc synthesis as TGF-beta 1 did. Prevention of HNF-4 alpha degradation by treating with proteasome inhibitor MG132 also prevented the inhibitory effect of TGF-beta 1. Finally, we confirmed that HBV replication could be rescued by ectopic expression of HNF-4 alpha in TGF-beta 1-treated cells. Our data clarify the mechanism by which TGF-beta 1 suppresses HBV replication, primarily through modulating the expression of HNF-4a gene.	[Hong, Ming-Hsiang; Chang, Chungming] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hong, Ming-Hsiang; Wu, Yi-Chieh; Tsai, Kuen-Nan; Chang, Chungming] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Chou, Yu-Chi; Jeng, King-Song] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Tsai, Kuen-Nan] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Hu, Cheng-po] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Chen, Mong-Liang] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; National Tsing Hua University; Tunghai University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hong, MH (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	tonychang@nhri.org.tw	Tsai, Kuen-Nan/G-4606-2019; Chang, Chung-Ming/E-3945-2010		National Health Research Institutes (NHRI), Taiwan (ROC) [MG-098-PP-08, MG-099-PP-07]	National Health Research Institutes (NHRI), Taiwan (ROC)(National Health Research Institutes - Taiwan)	This work was supported by research grants (MG-098-PP-08 and MG-099-PP-07) from the National Health Research Institutes (NHRI), Taiwan (ROC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpolat N, 2005, WORLD J GASTROENTERO, V11, P3260, DOI 10.3748/wjg.v11.i21.3260; Biermer M, 2003, J VIROL, V77, P4033, DOI 10.1128/JVI.77.7.4033-4042.2003; Billerbeck E, 2007, WORLD J GASTROENTERO, V13, P4858, DOI 10.3748/wjg.v13.i36.4858; BISSELL DM, 1995, J CLIN INVEST, V96, P447, DOI 10.1172/JCI118055; Bock CT, 2000, J VIROL, V74, P2193, DOI 10.1128/JVI.74.5.2193-2202.2000; Borlak J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004662; CALVERT J, 1994, J VIROL, V68, P2084, DOI 10.1128/JVI.68.4.2084-2090.1994; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen ML, 2010, WORLD J GASTROENTERO, V16, P5092, DOI 10.3748/wjg.v16.i40.5092; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng YC, 2009, J NEUROCHEM, V110, P947, DOI 10.1111/j.1471-4159.2009.06186.x; Chou YC, 2005, J VIROL, V79, P1813, DOI 10.1128/JVI.79.3.1813-1823.2005; Chou YC, 2007, HEPATOLOGY, V46, P672, DOI 10.1002/hep.21726; Cicchini C, 2006, J CELL PHYSIOL, V209, P230, DOI 10.1002/jcp.20730; de Lucas S, 2004, BIOCHEM BIOPH RES CO, V321, P688, DOI 10.1016/j.bbrc.2004.07.025; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; GALIBERT F, 1979, NATURE, V281, P646, DOI 10.1038/281646a0; GARCIA AD, 1993, J VIROL, V67, P3940, DOI 10.1128/JVI.67.7.3940-3950.1993; Guidotti LG, 2002, J VIROL, V76, P2617, DOI 10.1128/JVI.76.6.2617-2621.2002; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Ishikawa F, 2008, EXP CELL RES, V314, P2131, DOI 10.1016/j.yexcr.2008.03.013; KAKUMU S, 1993, LIVER, V13, P62; Kimura K, 2002, J VIROL, V76, P10702, DOI 10.1128/JVI.76.21.10702-10707.2002; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; Kuo TM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-41; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; LeJossic C, 1996, EUR J BIOCHEM, V238, P400, DOI 10.1111/j.1432-1033.1996.0400z.x; Li J, 1999, J VIROL, V73, P1239, DOI 10.1128/JVI.73.2.1239-1244.1999; Li J, 2001, J VIROL, V75, P8400, DOI 10.1128/JVI.75.18.8400-8406.2001; Li JX, 2000, GENE DEV, V14, P464; Li S, 2008, J VIROL, V82, P21, DOI 10.1128/JVI.01768-07; Lin SJ, 2003, J IMMUNOL, V171, P4708, DOI 10.4049/jimmunol.171.9.4708; Martin-Vilchez S, 2008, HEPATOLOGY, V47, P1872, DOI 10.1002/hep.22265; McClary H, 2000, J VIROL, V74, P2255, DOI 10.1128/JVI.74.5.2255-2264.2000; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mizuguchi T, 1998, J CELL PHYSIOL, V174, P273, DOI 10.1002/(SICI)1097-4652(199803)174:3<273::AID-JCP1>3.3.CO;2-1; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Murawaki Y, 1998, J GASTROEN HEPATOL, V13, P680, DOI 10.1111/j.1440-1746.1998.tb00713.x; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; RANEY AK, 1995, J VIROL, V69, P3265, DOI 10.1128/JVI.69.6.3265-3272.1995; Raney AK, 1997, J VIROL, V71, P1058, DOI 10.1128/JVI.71.2.1058-1071.1997; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Romero R, 1996, HEPATOLOGY, V23, P17, DOI 10.1053/jhep.1996.v23.pm0008550037; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; SHIRAI Y, 1994, CANCER, V73, P2275, DOI 10.1002/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Takagi S, 2010, J BIOL CHEM, V285, P4415, DOI 10.1074/jbc.M109.085431; Tang H, 2001, P NATL ACAD SCI USA, V98, P1841, DOI 10.1073/pnas.041479698; Tang H, 2001, DRUG NEWS PERSPECT, V14, P325; Tseng Ya Ping, 2010, Front Biosci (Elite Ed), V2, P1538; Wang B, 2001, HEPATOLOGY, V34, P979, DOI 10.1053/jhep.2001.28885; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; YAGINUMA K, 1989, J VIROL, V63, P2914, DOI 10.1128/JVI.63.7.2914-2920.1989; Yang GL, 2007, INT IMMUNOL, V19, P133, DOI 10.1093/intimm/dxl130; Ying CX, 2007, P NATL ACAD SCI USA, V104, P8526, DOI 10.1073/pnas.0609883104; Yu XM, 2003, J VIROL, V77, P2489, DOI 10.1128/JVI.77.4.2489-2499.2003; Yu XM, 1997, J VIROL, V71, P9366, DOI 10.1128/JVI.71.12.9366-9374.1997; Yu XM, 1996, J VIROL, V70, P8719, DOI 10.1128/JVI.70.12.8719-8726.1996; Yu XM, 2001, J VIROL, V75, P11354, DOI 10.1128/JVI.75.23.11354-11364.2001; YUH CH, 1992, J VIROL, V66, P4073, DOI 10.1128/JVI.66.7.4073-4084.1992; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zheng YY, 2004, J VIROL, V78, P6908, DOI 10.1128/JVI.78.13.6908-6914.2004	67	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30360	10.1371/journal.pone.0030360	http://dx.doi.org/10.1371/journal.pone.0030360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276183	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100038
J	Mulligan, KX; Morris, RT; Otero, YF; Wasserman, DH; McGuinness, OP				Mulligan, Kimberly X.; Morris, R. Tyler; Otero, Yolanda F.; Wasserman, David H.; McGuinness, Owen P.			Disassociation of Muscle Insulin Signaling and Insulin-Stimulated Glucose Uptake during Endotoxemia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; UPTAKE IN-VIVO; SKELETAL-MUSCLE; BLOOD-FLOW; INDIVIDUAL TISSUES; TNF-ALPHA; RESISTANCE; SEPSIS; METABOLISM	Lipopolysaccharide (LPS) elicits a strong immune response, which leads to the release of inflammatory cytokines. Increased cytokine production has been shown to impair insulin-mediated glucose disposal. LPS can alter other factors, such as muscle blood flow and insulin signaling in the myocyte, that can influence glucose disposal. We hypothesize that LPS induced impairments in cardiovascular function contribute to the associated impairments in insulin action in vivo. Male wild-type C57BL/6J mice had a catheter implanted in the jugular vein for infusions and the carotid artery for sampling 5 days prior to the hyperinsulinemic-euglycemic clamp. Mice were treated with vehicle, low-(1 ug/gBW) or high-dose (10 ug/gBW) LPS 4 hours prior to the clamp. Muscle glucose uptake (MGU) was assessed using [2(-14)C] deoxyglucose. While both low-and high-dose LPS inhibited insulin-stimulated MGU compared to vehicle-treated mice, the impairment was more significant with the high-dose treatment (similar to 25% in soleus and similar to 70% in both gastrocnemius and vastus lateralis). Interestingly, insulin signaling through the PI3-kinase pathway in the muscle was not affected by this treatment suggesting that the decrease in MGU is not directly due to impairments in muscle insulin action. Echocardiography demonstrated that high-dose LPS treatment significantly decreased stroke volume (similar to 30%), heart rate (similar to 35%), and cardiac output (similar to 50%). These observations were not seen with vehicle or low-dose LPS treatment. High-dose LPS treatment also significantly decreased muscle blood flow (similar to 70%) and whole body oxygen consumption (similar to 50%). Thus, in vivo acute endotoxemia does not impair insulin signaling through the PI3-kinase pathway in skeletal muscle and decreased tissue blood flow likely plays a central role in the impairment of glucose uptake in the muscle.	[Mulligan, Kimberly X.; Morris, R. Tyler; Otero, Yolanda F.; Wasserman, David H.; McGuinness, Owen P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med Nashville, Nashville, TN 37203 USA	Vanderbilt University	Mulligan, KX (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med Nashville, Nashville, TN 37203 USA.	owen.mcguinness@vanderbilt.edu			National Institutes of Health [DK43748, DK78188]; Vanderbilt Diabetes and Research and Training Center [DK20593]; Vanderbilt Mouse Metabolic Phenotyping Center [DK59637]; Molecular Endocrinology Training Grant [T32-DK-07563]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078188, T32DK007563, P30DK020593, R56DK043748, P60DK020593, R01DK043748, R29DK043748, U24DK059637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Diabetes and Research and Training Center; Vanderbilt Mouse Metabolic Phenotyping Center; Molecular Endocrinology Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants (DK43748, DK78188; PI: Owen McGuinness), Vanderbilt Diabetes and Research and Training Center (DK20593) and Vanderbilt Mouse Metabolic Phenotyping Center (DK59637). Kimberly Mulligan was supported by the Molecular Endocrinology Training Grant T32-DK-07563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; BARON AD, 1994, AM J PHYSIOL, V266, pE248, DOI 10.1152/ajpendo.1994.266.2.E248; BARON AD, 1994, AM J PHYSIOL, V267, pE187, DOI 10.1152/ajpendo.1994.267.2.E187; Baron AD, 1996, AM J PHYSIOL-ENDOC M, V271, pE1067, DOI 10.1152/ajpendo.1996.271.6.E1067; Bedard S, 1997, BIOCHEM J, V325, P487, DOI 10.1042/bj3250487; BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; Carvalho-Filho MA, 2006, AM J PHYSIOL-ENDOC M, V291, pE476, DOI 10.1152/ajpendo.00422.2005; Clark MG, 2003, AM J PHYSIOL-ENDOC M, V284, pE241, DOI 10.1152/ajpendo.00408.2002; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Del Aguila LF, 1999, AM J PHYSIOL-ENDOC M, V276, pE849, DOI 10.1152/ajpendo.1999.276.5.E849; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; Ellis CG, 2002, AM J PHYSIOL-HEART C, V282, pH156, DOI 10.1152/ajpheart.2002.282.1.H156; Eringa EC, 2006, ARTERIOSCL THROM VAS, V26, P274, DOI 10.1161/01.ATV.0000198248.19391.3e; Fan J, 1996, SHOCK, V6, P164, DOI 10.1097/00024382-199609010-00002; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Hallemeesch MM, 2003, AM J PHYSIOL-ENDOC M, V285, pE871, DOI 10.1152/ajpendo.00004.2002; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; LAM C, 1994, J CLIN INVEST, V94, P2077, DOI 10.1172/JCI117562; LANG CH, 1989, CIRC SHOCK, V28, P165; LANG CH, 1990, METABOLISM, V39, P1096, DOI 10.1016/0026-0495(90)90172-9; LING PR, 1994, METABOLISM, V43, P279, DOI 10.1016/0026-0495(94)90093-0; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MARTIN IK, 1995, AM J PHYSIOL-ENDOC M, V269, pE583, DOI 10.1152/ajpendo.1995.269.3.E583; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Orellana RA, 2008, PEDIATR RES, V64, P505, DOI 10.1203/PDR.0b013e318183fd4c; Park HK, 2011, DIABETES, V60, P775, DOI 10.2337/db10-1416; Petersen HA, 2003, AM J PHYSIOL-ENDOC M, V284, pE541, DOI 10.1152/ajpendo.00323.2002; Pilon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015912; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; REN JM, 1994, J BIOL CHEM, V269, P14396; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; SCHULTZ TA, 1977, AM J PHYSIOL, V233, pE514, DOI 10.1152/ajpendo.1977.233.6.E514; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tweedell A, 2011, METABOLISM, V60, P92, DOI 10.1016/j.metabol.2009.12.022; van der Crabben SN, 2009, J CLIN ENDOCR METAB, V94, P463, DOI 10.1210/jc.2008-0761; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Wasserman DH, 2011, J EXP BIOL, V214, P254, DOI 10.1242/jeb.048041; Youd JM, 2000, DIABETES, V49, P1904, DOI 10.2337/diabetes.49.11.1904	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30160	10.1371/journal.pone.0030160	http://dx.doi.org/10.1371/journal.pone.0030160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276152	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100025
J	Varma, NRS; Janic, B; Iskander, ASM; Shankar, A; Bhuiyan, MPI; Soltanian-Zadeh, H; Jiang, Q; Barton, K; Ali, MM; Arbab, AS				Varma, Nadimpalli Ravi S.; Janic, Branislava; Iskander, A. S. M.; Shankar, Adarsh; Bhuiyan, Mohammed P. I.; Soltanian-Zadeh, Hamid; Jiang, Quan; Barton, Kenneth; Ali, Meser M.; Arbab, Ali S.			Endothelial Progenitor Cells (EPCs) as Gene Carrier System for Rat Model of Human Glioma	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; THERAPY; EXPRESSION; GROWTH; TUMOR; MIGRATION; DELIVERY; SUICIDE; DIFFERENTIATION	Background: Due to their unique property to migrate to pathological lesions, stem cells are used as a delivery vehicle for therapeutic genes to tumors, especially for glioma. It is critically important to track the movement, localization, engraftment efficiency and functional capability or expression of transgenes of selected cell populations following transplantation. The purposes of this study were to investigate whether 1) intravenously administered, genetically transformed cord blood derived EPCs can carry human sodium iodide symporter (hNIS) to the sites of tumors in rat orthotopic model of human glioma and express transgene products, and 2) whether accumulation of these administered EPCs can be tracked by different in vivo imaging modalities. Methods and Results: Collected EPCs were cultured and transduced to carry hNIS. Cellular viability, differential capacity and Tc-99m uptake were determined. Five to ten million EPCs were intravenously administered and Tc-99-SPECT images were acquired on day 8, to determine the accumulation of EPCs and expression of transgenes (increase activity of Tc-99m) in the tumors. Immunohistochemistry was performed to determine endothelial cell markers and hNIS positive cells in the tumors. Transduced EPCs were also magnetically labeled and accumulation of cells was confirmed by MRI and histochemistry. SPECT analysis showed increased activity of Tc-99m in the tumors that received transduced EPCs, indicative of the expression of transgene (hNIS). Activity of Tc-99m in the tumors was also dependent on the number of administered transduced EPCs. MRI showed the accumulation of magnetically labeled EPCs. Immunohistochemical analysis showed iron and hNIS positive and, human CD31 and vWF positive cells in the tumors. Conclusion: EPC was able to carry and express hNIS in glioma following IV administration. SPECT detected migration of EPCs and expression of the hNIS gene. EPCs can be used as gene carrier/delivery system for glioma therapy as well as imaging probes.	[Varma, Nadimpalli Ravi S.; Janic, Branislava; Iskander, A. S. M.; Shankar, Adarsh; Bhuiyan, Mohammed P. I.; Soltanian-Zadeh, Hamid; Jiang, Quan; Barton, Kenneth; Ali, Meser M.; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Varma, NRS (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	saali@rad.hfh.edu	Arbab, Ali/AAS-1933-2020; Soltanian-Zadeh, Hamid/K-2903-2016; Soltanian-Zadeh, Hamid/AAD-7027-2022	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Bhuiyan, Mohammed/0000-0003-1116-0280	NIH [1R21CA129801, R01CA122031, R21NS066143, K25CA129173]; American Heart Association [SDG2230011]; NATIONAL CANCER INSTITUTE [K25CA129173, R01CA122031, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134, R01NS048349, R21NS066143] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work is supported by NIH grants 1R21CA129801 (to ASA), R01CA122031 (to ASA), R21NS066143 (to MMA), K25CA129173 (to MMA) and American Heart Association grant SDG2230011 (to BJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2006, NEURO-ONCOLOGY, V8, P119, DOI 10.1215/15228517-2005-012; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009365; Arbab AS, 2009, CURR MED IMAGING, V5, P19, DOI 10.2174/157340509787354697; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Barton KN, 2004, MOL THER, V9, P625, DOI 10.1016/j.ymthe.2004.01.011; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Buursma AR, 2006, NUCL MED COMMUN, V27, P25, DOI 10.1097/01.mnm.0000186609.12895.20; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Cao F, 2007, CLONING STEM CELLS, V9, P107, DOI 10.1089/clo.2006.0E16; Chang GY, 2007, J MOL CELL CARDIOL, V43, P18, DOI 10.1016/j.yjmcc.2007.03.809; Chen L, 1997, CANCER RES, V57, P4830; Chen LB, 2006, NUCL MED BIOL, V33, P575, DOI 10.1016/j.nucmedbio.2006.01.011; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Dickson PV, 2007, J PEDIATR SURG, V42, P48, DOI 10.1016/j.jpedsurg.2006.09.050; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Finney MR, 2010, CYTOTHERAPY, V12, P67, DOI 10.3109/14653240903300658; Janic B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005873; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Komita H, 2009, CANCER GENE THER, V16, P883, DOI 10.1038/cgt.2009.33; Kuriyama S, 1999, INT J CANCER, V81, P592, DOI 10.1002/(SICI)1097-0215(19990517)81:4<592::AID-IJC15>3.0.CO;2-I; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Oba M, 2010, MOL PHARMACEUT, V7, P501, DOI 10.1021/mp9002317; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Rad AM, 2007, BIOTECHNIQUES, V43, P627, DOI 10.2144/000112599; Rad AM, 2007, J MAGN RESON IMAGING, V26, P366, DOI 10.1002/jmri.20978; Rogulski KR, 1997, HUM GENE THER, V8, P73, DOI 10.1089/hum.1997.8.1-73; Schichor C, 2006, EXP NEUROL, V199, P301, DOI 10.1016/j.expneurol.2005.11.027; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2007, BRAIN RES; Sivanandam VG, 2008, J GENE MED, V10, P1083, DOI 10.1002/jgm.1244; Smanik PA, 1996, BIOCHEM BIOPH RES CO, V226, P339, DOI 10.1006/bbrc.1996.1358; Tatsumi T, 2003, CANCER RES, V63, P6378; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Tjuvajev JG, 2002, J NUCL MED, V43, P1072; Varma NRS, 2011, J STEM CELLS REGEN, V7, P41; Yaghoubi SS, 2005, CANCER GENE THER, V12, P329, DOI 10.1038/sj.cgt.7700795; Yu L, 2010, CANCER RES, V70, P1334, DOI 10.1158/0008-5472.CAN-09-2795	43	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30310	10.1371/journal.pone.0030310	http://dx.doi.org/10.1371/journal.pone.0030310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276177	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100033
J	Arras, M; Glauser, DL; Jirkof, P; Rettich, A; Schade, B; Cinelli, P; Pinschewer, DD; Ackermann, M				Arras, Margarete; Glauser, Daniel L.; Jirkof, Paulin; Rettich, Andreas; Schade, Benjamin; Cinelli, Paolo; Pinschewer, Daniel D.; Ackermann, Mathias			Multiparameter Telemetry as a Sensitive Screening Method to Detect Vaccine Reactogenicity in Mice	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ADJUVANTS; CHALLENGES; IMPACT; PAIN; US	Refined vaccines and adjuvants are urgently needed to advance immunization against global infectious challenges such as HIV, hepatitis C, tuberculosis and malaria. Large-scale screening efforts are ongoing to identify adjuvants with improved efficacy profiles. Reactogenicity often represents a major hurdle to the clinical use of new substances. Yet, irrespective of its importance, this parameter has remained difficult to screen for, owing to a lack of sensitive small animal models with a capacity for high throughput testing. Here we report that continuous telemetric measurements of heart rate, heart rate variability, body core temperature and locomotor activity in laboratory mice readily unmasked systemic side-effects of vaccination, which went undetected by conventional observational assessment and clinical scoring. Even minor aberrations in homeostasis were readily detected, ranging from sympathetic activation over transient pyrogenic effects to reduced physical activity and apathy. Results in real-time combined with the potential of scalability and partial automation in the industrial context suggest multiparameter telemetry in laboratory mice as a first-line screen for vaccine reactogenicity. This may accelerate vaccine discovery in general and may further the success of vaccines in combating infectious disease and cancer.	[Arras, Margarete; Jirkof, Paulin; Rettich, Andreas; Cinelli, Paolo] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Arras, Margarete] Univ Zurich Hosp, Div Surg Res, Dept Surg, CH-8091 Zurich, Switzerland; [Glauser, Daniel L.; Ackermann, Mathias] Univ Zurich, Inst Virol, Zurich, Switzerland; [Schade, Benjamin] Univ Zurich, Inst Vet Pathol, Zurich, Switzerland; [Pinschewer, Daniel D.] Univ Geneva, Dept Pathol & Immunol, World Heath Org Collaborating Ctr Neonatal Vaccin, Geneva, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University of Geneva	Arras, M (corresponding author), Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland.	margarete.arras@ltk.uzh.ch		Arras, Margarete/0000-0003-3864-9879; Jirkof, Paulin/0000-0002-7225-2325; Pinschewer, Daniel/0000-0002-1594-3189; Cinelli, Paolo/0000-0002-0163-9055				Abril C, 2004, J VIROL, V78, P3644, DOI 10.1128/JVI.78.7.3644-3653.2004; Arras Margarete, 2007, BMC Vet Res, V3, P16, DOI 10.1186/1746-6148-3-16; Baylor NW, 2002, VACCINE, V20, pS18, DOI 10.1016/S0264-410X(02)00166-4; Camm AJ, 1996, CIRCULATION, V93, P1043; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cinelli P, 2007, LAB ANIM-UK, V41, P174, DOI 10.1258/002367707780378113; Clements CJ, 2002, VACCINE, V20, pS24, DOI 10.1016/S0264-410X(02)00168-8; Coban C, 2008, HUM VACCINES, V4, P453, DOI 10.4161/hv.4.6.6200; Ebensen T, 2008, HUM VACCINES, V4, P13, DOI 10.4161/hv.4.1.5560; Edelman R, 2002, MOL BIOTECHNOL, V21, P129, DOI 10.1385/MB:21:2:129; Gehrmann J, 2000, AM J PHYSIOL-HEART C, V279, pH733, DOI 10.1152/ajpheart.2000.279.2.H733; Glenn GM, 2007, EXPERT REV VACCINES, V6, P651, DOI 10.1586/14760584.6.5.651; GOURINE VN, 1995, J THERM BIOL, V20, P405, DOI 10.1016/0306-4565(94)00077-V; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Mallapragada SK, 2008, INT J PHARMACEUT, V364, P265, DOI 10.1016/j.ijpharm.2008.06.030; Martin SS, 2009, VACCINE, V27, P6814, DOI 10.1016/j.vaccine.2009.09.013; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Peterson NC, 2004, CONTEMP TOP LAB ANIM, V43, P74; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; Sgoifo A, 1999, NEUROSCI BIOBEHAV R, V23, P915, DOI 10.1016/S0149-7634(99)00025-1; Singh M, 2006, VACCINE, V24, P1680, DOI 10.1016/j.vaccine.2005.09.046; Spani D, 2003, LAB ANIM-UK, V37, P54, DOI 10.1258/002367703762226692; Stasiak KL, 2003, CONTEMP TOP LAB ANIM, V42, P13; Teeling JL, 2007, BRAIN BEHAV IMMUN, V21, P836, DOI 10.1016/j.bbi.2007.01.012; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261; Van Sluyters RC, 2004, CONTEMP TOP LAB ANIM, V43, P48; Wilson-Welder JH, 2009, J PHARM SCI-US, V98, P1278, DOI 10.1002/jps.21523	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29726	10.1371/journal.pone.0029726	http://dx.doi.org/10.1371/journal.pone.0029726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276127	Green Accepted, Green Published, gold			2022-12-25	WOS:000301457200021
J	Wang, KQ; Hampson, P; Hazeldine, J; Krystof, V; Strnad, M; Pechan, P; Lord, JM				Wang, Keqing; Hampson, Peter; Hazeldine, Jon; Krystof, Vladimir; Strnad, Miroslav; Pechan, Paul; Lord, Janet M.			Cyclin-Dependent Kinase 9 Activity Regulates Neutrophil Spontaneous Apoptosis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DOWN-REGULATION; LEUKOCYTE APOPTOSIS; MCL-1 EXPRESSION; LIFE-SPAN; IN-VIVO; INHIBITION; CELLS; INFLAMMATION; DEATH	Neutrophils are the most abundant leukocyte and play a central role in the immune defense against rapidly dividing bacteria. However, they are also the shortest lived cell in the blood with a lifespan in the circulation of 5.4 days. The mechanisms underlying their short lifespan and spontaneous entry into apoptosis are poorly understood. Recently, the broad range cyclin-dependent kinase (CDK) inhibitor R-roscovitine was shown to increase neutrophil apoptosis, implicating CDKs in the regulation of neutrophil lifespan. To determine which CDKs were involved in regulating neutrophil lifespan we first examined CDK expression in human neutrophils and found that only three CDKs: CDK5, CDK7 and CDK9 were expressed in these cells. The use of CDK inhibitors with differing selectivity towards the various CDKs suggested that CDK9 activity regulates neutrophil lifespan. Furthermore CDK9 activity and the expression of its activating partner cyclin T1 both declined as neutrophils aged and entered apoptosis spontaneously. CDK9 is a component of the P-TEFb complex involved in transcriptional regulation and its inhibition will preferentially affect proteins with short half-lives. Treatment of neutrophils with flavopiridol, a potent CDK9 inhibitor, increased apoptosis and caused a rapid decline in the level of the anti-apoptotic protein Mcl-1, whilst Bcl2A was unaffected. We propose that CDK9 activity is a key regulator of neutrophil lifespan, preventing apoptosis by maintaining levels of short lived anti-apoptotic proteins such as Mcl-1. Furthermore, as inappropriate inhibition of neutrophil apoptosis contributes to chronic inflammatory diseases such as Rheumatoid Arthritis, CDK9 represents a novel therapeutic target in such diseases.	[Wang, Keqing; Hampson, Peter; Hazeldine, Jon; Lord, Janet M.] Univ Birmingham, Inst Biomed Res, Sch Med, MRC Ctr Immune Regulat, Birmingham, W Midlands, England; [Krystof, Vladimir; Strnad, Miroslav] Inst Expt Bot ASCR, Lab Growth Regulators, Olomouc, Czech Republic; [Krystof, Vladimir; Strnad, Miroslav] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Pechan, Paul] C3Bio Ltd, Munich, Germany	University of Birmingham; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc	Wang, KQ (corresponding author), Univ Birmingham, Inst Biomed Res, Sch Med, MRC Ctr Immune Regulat, Birmingham, W Midlands, England.	J.M.Lord@bham.ac.uk	Hazeldine, Jon/T-5725-2019; Krystof, Vladimir/B-9499-2009; Strnad, Miroslav/H-1858-2014	Krystof, Vladimir/0000-0001-5838-2118; Strnad, Miroslav/0000-0002-2806-794X; Lord, Janet/0000-0003-1030-6786; Wang, Keqing/0000-0001-6239-6344	European commission [LSHB-CT-2004-503467]; Czech Ministry of Education [MSM6198959216]; Czech Grant Agency [301/08/1649, 204/08/0511]	European commission(European CommissionEuropean Commission Joint Research Centre); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Grant Agency(Grant Agency of the Czech Republic)	This work was supported by funding from the European commission (LSHB-CT-2004-503467), the Czech Ministry of Education (MSM6198959216) and the Czech Grant Agency (301/08/1649 and 204/08/0511). JH is supported by a PhD studentship from the Biotechnology and Biological Sciences Research Council UK, and JML is a holder of an Arthritis Research UK programme grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFORD SC, 1992, J BIOL CHEM, V267, P21612; Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Arris CE, 2000, J MED CHEM, V43, P2797, DOI 10.1021/jm990628o; BRACH MA, 1992, BLOOD, V80, P2920; Carvajal RD, 2009, PANCREATOLOGY, V9, P404, DOI 10.1159/000187135; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Gojo I, 2002, CLIN CANCER RES, V8, P3527; Johnson N, 2010, BRIT J CANCER, V102, P342, DOI 10.1038/sj.bjc.6605479; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Leuenroth SJ, 2000, J LEUKOCYTE BIOL, V68, P158; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Nasreen N, 2003, J CLIN IMMUNOL, V23, P1, DOI 10.1023/A:1021958529763; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Raza K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2009; Robak T, 2009, DRUGS, V69, P2415, DOI 10.2165/11319270-000000000-00000; Rosales JL, 2004, J BIOL CHEM, V279, P53932, DOI 10.1074/jbc.M408467200; Rosato RR, 2007, MOL CANCER THER, V6, P692, DOI 10.1158/1535-7163.MCT-06-0562; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191; Scheel-Toellner D, 2002, EUR J IMMUNOL, V32, P486, DOI 10.1002/1521-4141(200202)32:2<486::AID-IMMU486>3.0.CO;2-U; Sekine C, 2008, J IMMUNOL, V180, P1954, DOI 10.4049/jimmunol.180.3.1954; Sroka IM, 2010, MOL PHARMACOL, V77, P255, DOI 10.1124/mol.109.060327; Wang KQ, 2003, J IMMUNOL, V171, P1035, DOI 10.4049/jimmunol.171.2.1035; Wang S, 2008, TRENDS PHARMACOL SCI, V29, P302, DOI 10.1016/j.tips.2008.03.003; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045	30	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30128	10.1371/journal.pone.0030128	http://dx.doi.org/10.1371/journal.pone.0030128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276149	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000301457200034
J	Calias, P; Papisov, M; Pan, J; Savioli, N; Belov, V; Huang, Y; Lotterhand, J; Alessandrini, M; Liu, N; Fischman, AJ; Powell, JL; Heartlein, MW				Calias, Pericles; Papisov, Mikhail; Pan, Jing; Savioli, Nancy; Belov, Vasily; Huang, Yan; Lotterhand, Jason; Alessandrini, Mary; Liu, Nan; Fischman, Alan J.; Powell, Jan L.; Heartlein, Michael W.			CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENZYME REPLACEMENT THERAPY; II HUNTER-SYNDROME; GROWTH FACTOR-II/MANNOSE-6-PHOSPHATE RECEPTOR; ADENOASSOCIATED VIRUS VECTOR; CENTRAL-NERVOUS-SYSTEM; MUCOPOLYSACCHARIDOSIS-II; CEREBROSPINAL-FLUID; TRANSFERRIN RECEPTOR; MONOCLONAL-ANTIBODY	A major challenge for the treatment of many central nervous system (CNS) disorders is the lack of convenient and effective methods for delivering biological agents to the brain. Mucopolysaccharidosis II (Hunter syndrome) is a rare inherited lysosomal storage disorder resulting from a deficiency of iduronate-2-sulfatase (I2S). I2S is a large, highly glycosylated enzyme. Intravenous administration is not likely to be an effective therapy for disease-related neurological outcomes that require enzyme access to the brain cells, in particular neurons and oligodendrocytes. We demonstrate that intracerebroventricular and lumbar intrathecal administration of recombinant I2S in dogs and nonhuman primates resulted in widespread enzyme distribution in the brain parenchyma, including remarkable deposition in the lysosomes of both neurons and oligodendrocytes. Lumbar intrathecal administration also resulted in enzyme delivery to the spinal cord, whereas little enzyme was detected there after intraventricular administration. Mucopolysaccharidosis II model is available in mice. Lumbar administration of recombinant I2S to enzyme deficient animals reduced the storage of glycosaminoglycans in both superficial and deep brain tissues, with concurrent morphological improvements. The observed patterns of enzyme transport from cerebrospinal fluid to the CNS tissues and the resultant biological activity (a) warrant further investigation of intrathecal delivery of I2S via lumbar catheter as an experimental treatment for the neurological symptoms of Hunter syndrome and (b) may have broader implications for CNS treatment with biopharmaceuticals.	[Calias, Pericles; Pan, Jing; Savioli, Nancy; Huang, Yan; Lotterhand, Jason; Alessandrini, Mary; Liu, Nan; Powell, Jan L.; Heartlein, Michael W.] Shire Human Genet Therapies Inc, Lexington, MA USA; [Papisov, Mikhail; Belov, Vasily] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Papisov, Mikhail; Belov, Vasily; Fischman, Alan J.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Papisov, Mikhail; Belov, Vasily; Fischman, Alan J.] Shriners Burns Hosp, Dept Nucl Med, Boston, MA USA	Shire Pharmaceuticals Limited; Harvard University; Massachusetts General Hospital; Harvard University	Calias, P (corresponding author), Shire Human Genet Therapies Inc, Lexington, MA USA.	pcalias@shire.com	Belov, Vasily/AAC-9251-2020	Belov, Vasily/0000-0002-3185-2412; Papisov, Mikhail/0000-0003-4716-2122	Shire Human Genetic Therapies, Inc.	Shire Human Genetic Therapies, Inc.	This study was sponsored by Shire Human Genetic Therapies, Inc. The funders participated in the study design and conduct, data collection and analysis, decision to publish and preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Ballantyne JC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005178; Barbu E, 2009, EXPERT OPIN DRUG DEL, V6, P553, DOI [10.1517/17425240902939143 , 10.1517/17425240902939143]; Begley DJ, 2008, CURR PHARM DESIGN, V14, P1566, DOI 10.2174/138161208784705504; Belverud S, 2008, NEUROTHERAPEUTICS, V5, P114, DOI 10.1016/j.nurt.2007.10.070; Boado RJ, 2010, J DRUG TARGET, V18, P205, DOI 10.3109/10611860903353362; Boado RJ, 2010, MOL PHARMACEUT, V7, P237, DOI 10.1021/mp900235k; Boado RJ, 2009, J BIOTECHNOL, V144, P135, DOI 10.1016/j.jbiotec.2009.08.019; Boado RJ, 2009, BIOTECHNOL BIOENG, V102, P1251, DOI 10.1002/bit.22135; Brown PD, 2004, NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chen FT, 2006, MOL GENET METAB, V87, P349, DOI 10.1016/j.ymgme.2005.11.017; Coloma MJ, 2000, PHARMACEUT RES, V17, P266, DOI 10.1023/A:1007592720793; Consiglio A, 2001, NAT MED, V7, P310, DOI 10.1038/85454; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; Defrise M, 1997, IEEE T MED IMAGING, V16, P145, DOI 10.1109/42.563660; DICHIRO G, 1976, NEUROLOGY, V26, P1; Felice BR, 2011, TOXICOL PATHOL, V39, P879, DOI 10.1177/0192623311409595; FENSTERMACHER J, 1988, ANN NY ACAD SCI, V531, P29, DOI 10.1111/j.1749-6632.1988.tb51416.x; Garcia AR, 2007, J INHERIT METAB DIS, V30, P924, DOI 10.1007/s10545-007-0641-8; Ghafoor VL, 2007, AM J HEALTH-SYST PH, V64, P2447, DOI 10.2146/ajhp060204; GhersiEgea JF, 1996, NEUROSCIENCE, V75, P1271, DOI 10.1016/0306-4522(96)00281-3; Gooch JL, 2003, PEDIATR NEUROSURG, V39, P1, DOI 10.1159/000070870; Guffon N, 2009, J PEDIATR-US, V154, P733, DOI 10.1016/j.jpeds.2008.11.041; Hamano K, 2008, ACTA NEUROPATHOL, V115, P547, DOI 10.1007/s00401-007-0325-3; Hawkes C, 2002, EUR J NEUROSCI, V15, P33, DOI 10.1046/j.0953-816x.2001.01864.x; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Hemsley KM, 2009, INT J CLIN PHARM TH, V47, pS118; Hsieh JC, 2006, NEUROSURG FOCUS, V21, P1; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Kakkis E, 2004, MOL GENET METAB, V83, P163, DOI 10.1016/j.ymgme.2004.07.003; Kakkis ED, 2002, EXPERT OPIN INV DRUG, V11, P675, DOI 10.1517/13543784.11.5.675; Kar S, 2006, NEUROBIOL AGING, V27, P199, DOI 10.1016/j.neurobiolaging.2005.03.005; Kerr JZ, 2001, CRIT REV ONCOL HEMAT, V37, P227, DOI 10.1016/S1040-8428(00)00115-3; Laterra J., 2000, PRINCIPLES NEURAL SC, P1288; Lattanzi A, 2010, HUM MOL GENET, V19, P2208, DOI 10.1093/hmg/ddq099; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Luca T, 2005, MOL THER, V12, P669, DOI 10.1016/j.ymthe.2005.06.438; Martin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350; Matheus MG, 2004, NEURORADIOLOGY, V46, P666, DOI 10.1007/s00234-004-1215-1; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Papisov M, 2010, J NUCL MED, V51; Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90; Passini MA, 2002, J NEUROSCI, V22, P6437; Patel NK, 2007, ACTA NEUROCHIR SUPPL, V97, P135; Proescholdt MG, 2000, NEUROSCIENCE, V95, P577; Qi JY, 1998, PHYS MED BIOL, V43, P1001, DOI 10.1088/0031-9155/43/4/027; Rennels M L, 1990, Adv Neurol, V52, P431; RENNELS ML, 1985, BRAIN RES, V326, P47, DOI 10.1016/0006-8993(85)91383-6; RIESELBACH RE, 1962, NEW ENGL J MED, V267, P1273, DOI 10.1056/NEJM196212202672502; Segal MB, 2005, BLOOD-CEREBROSPINAL FLUID BARRIER, P83, DOI 10.1201/9781420023404.sec2; Shihabuddin LS, 2010, NEUROPHARMACOLOGY, V58, P845, DOI 10.1016/j.neuropharm.2009.12.015; *SHIR HUM GEN THER, 2010, EL PACK INS; Soderquist RG, 2010, EXPERT OPIN DRUG DEL, V7, P285, DOI 10.1517/17425240903540205; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Vedolin L, 2007, AM J NEURORADIOL, V28, P1029, DOI 10.3174/ajnr.A0510; Vite CH, 2003, GENE THER, V10, P1874, DOI 10.1038/sj.gt.3302087; Voznyi YV, 2001, J INHERIT METAB DIS, V24, P675, DOI 10.1023/A:1012763026526; Woods NB, 2003, BLOOD, V101, P1284, DOI 10.1182/blood-2002-07-2238; Wu X, 2004, CELL MOL LIFE SCI, V61, P2588, DOI 10.1007/s00018-004-4206-9; Zhang Y, 2002, J GENE MED, V4, P183, DOI 10.1002/jgm.255	64	94	98	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30341	10.1371/journal.pone.0030341	http://dx.doi.org/10.1371/journal.pone.0030341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279584	Green Submitted, gold, Green Published			2022-12-25	WOS:000299771900061
J	Sebastiani, P; Solovieff, N; DeWan, AT; Walsh, KM; Puca, A; Hartley, SW; Melista, E; Andersen, S; Dworkis, DA; Wilk, JB; Myers, RH; Steinberg, MH; Montano, M; Baldwin, CT; Hoh, J; Perls, TT				Sebastiani, Paola; Solovieff, Nadia; DeWan, Andrew T.; Walsh, Kyle M.; Puca, Annibale; Hartley, Stephen W.; Melista, Efthymia; Andersen, Stacy; Dworkis, Daniel A.; Wilk, Jemma B.; Myers, Richard H.; Steinberg, Martin H.; Montano, Monty; Baldwin, Clinton T.; Hoh, Josephine; Perls, Thomas T.			Genetic Signatures of Exceptional Longevity in Humans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; SUSCEPTIBILITY GENES; IDENTIFIES VARIANTS; STATISTICAL-METHODS; LEIDEN LONGEVITY; RISK; CENTENARIANS; POPULATION; SIBLINGS	Like most complex phenotypes, exceptional longevity is thought to reflect a combined influence of environmental (e. g., lifestyle choices, where we live) and genetic factors. To explore the genetic contribution, we undertook a genome-wide association study of exceptional longevity in 801 centenarians (median age at death 104 years) and 914 genetically matched healthy controls. Using these data, we built a genetic model that includes 281 single nucleotide polymorphisms (SNPs) and discriminated between cases and controls of the discovery set with 89% sensitivity and specificity, and with 58% specificity and 60% sensitivity in an independent cohort of 341 controls and 253 genetically matched nonagenarians and centenarians (median age 100 years). Consistent with the hypothesis that the genetic contribution is largest with the oldest ages, the sensitivity of the model increased in the independent cohort with older and older ages (71% to classify subjects with an age at death >102 and 85% to classify subjects with an age at death >105). For further validation, we applied the model to an additional, unmatched 60 centenarians (median age 107 years) resulting in 78% sensitivity, and 2863 unmatched controls with 61% specificity. The 281 SNPs include the SNP rs2075650 in TOMM40/APOE that reached irrefutable genome wide significance (posterior probability of association = 1) and replicated in the independent cohort. Removal of this SNP from the model reduced the accuracy by only 1%. Further in-silico analysis suggests that 90% of centenarians can be grouped into clusters characterized by different "genetic signatures" of varying predictive values for exceptional longevity. The correlation between 3 signatures and 3 different life spans was replicated in the combined replication sets. The different signatures may help dissect this complex phenotype into sub-phenotypes of exceptional longevity.	[Sebastiani, Paola; Solovieff, Nadia; Hartley, Stephen W.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [DeWan, Andrew T.; Walsh, Kyle M.; Hoh, Josephine] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Chron Dis Epidemiol, New Haven, CT 06510 USA; [Puca, Annibale] IRCCS Multimed, Milan, Italy; [Puca, Annibale] CNR, Ist Tecnol Biomed, Segrate, Italy; [Melista, Efthymia] Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; [Andersen, Stacy; Perls, Thomas T.] Boston Univ, Sch Med, Dept Med, Sect Geriatr, Boston, MA 02118 USA; [Andersen, Stacy; Baldwin, Clinton T.; Perls, Thomas T.] Boston Med Ctr, Boston, MA USA; [Wilk, Jemma B.; Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Baldwin, Clinton T.] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA	Boston University; Yale University; IRCCS Multimedica; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Boston University; Boston University; Boston Medical Center; Boston University; Boston University	Sebastiani, P (corresponding author), Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.	sebas@bu.edu	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Puca, Annibale Alessandro/K-2099-2018	Walsh, Kyle/0000-0002-5879-9981; Steinberg, Martin/0000-0001-8800-8020; sebastiani, paola/0000-0001-6419-1545; Dworkis, Daniel/0000-0003-0706-5117; Perls, Thomas/0000-0002-2492-4334; Montano, Monty/0000-0002-1473-887X; Baldwin, Clinton/0000-0002-3275-9463; DeWan, Andrew/0000-0002-7679-8704; Andersen, Stacy/0000-0002-2442-6386	National Institutes of Health [R01 HL087681, K24 AG025727, R01 AR055115, RO1 AG027216, R01 NS36711-09]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027216, U19AG023122, K24AG025727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants: R01 HL087681 (to MS), K24 AG025727 (to TP), R01 AR055115 (to MM), RO1 AG027216 (to CB), R01 NS36711-09 (to RM). In the study we included 254 subjects enrolled at ELIXIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT L, 1998, AGE VALIDATION EXTRE; Atmon G, 2005, MECH AGEING DEV, V126, P341, DOI 10.1016/j.mad.2004.08.026; Atzmon G, 2004, J AM GERIATR SOC, V52, P274, DOI 10.1111/j.1532-5415.2004.52068.x; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Baker DJ, 2008, CELL CYCLE, V7, P2795, DOI 10.4161/cc.7.18.6687; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bloss CS, 2011, AGEING RES REV, V10, P191, DOI 10.1016/j.arr.2010.07.005; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Deelen J, 2011, AGING CELL; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Fraser GE, 2001, ARCH INTERN MED, V161, P1645, DOI 10.1001/archinte.161.13.1645; Goddard ME, 2009, STAT SCI, V24, P517, DOI 10.1214/09-STS306; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Hand DJ, 2009, CH CRC DATA MIN KNOW, P163, DOI 10.1201/9781420089653.ch9; HARMAN D, 1993, DRUG AGING, V3, P60, DOI 10.2165/00002512-199303010-00006; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hekimi S, 2006, NAT GENET, V38, P985, DOI 10.1038/ng1881; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hitt R, 1999, LANCET, V354, P652, DOI 10.1016/S0140-6736(99)01987-X; Holscher C, 2010, NEUROBIOL AGING, V31, P1495, DOI 10.1016/j.neurobiolaging.2008.08.023; Kerber RA, 2001, J GERONTOL A-BIOL, V56, pB130, DOI 10.1093/gerona/56.3.B130; Kooperberg C, 2010, GENET EPIDEMIOL, V34, P643, DOI 10.1002/gepi.20509; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Meuwissen THE, 2001, GENETICS, V157, P1819; MICHIE D, MACHINE LEARNING NEU; NEBEL A, 2005, SCI AGING KNOWLEDGE, pPE23; Need AC, 2009, HUM MOL GENET, V18, P4650, DOI 10.1093/hmg/ddp413; Okser S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001146; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; PAYNTER NP, JAMA, V303, P631; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2007, J GERONTOL A-BIOL, V62, P1028, DOI 10.1093/gerona/62.9.1028; Perls TT, 1998, LANCET, V351, P1560, DOI 10.1016/S0140-6736(05)61126-9; Perls TT, 1999, AGE AGEING, V28, P193, DOI 10.1093/ageing/28.2.193; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rajpathak SN, 2011, J AM GERIATR SOC, V59, P1509, DOI 10.1111/j.1532-5415.2011.03498.x; Ramoni M, 2002, MACH LEARN, V47, P91, DOI 10.1023/A:1013635829250; Ramoni M, 2001, ARTIF INTELL, V125, P209, DOI 10.1016/S0004-3702(00)00085-0; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Sebastiani P, 2005, NAT GENET, V37, P435, DOI 10.1038/ng1533; SEBASTIANI P, 2008, COMPLEX GENETIC MODE, P53; SEBASTIANI P, 2011, FRONTIERS GENETICS, V2; Solovieff N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-108; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Stessman J, 2005, MECH AGEING DEV, V126, P333, DOI 10.1016/j.mad.2004.08.025; Tan QH, 2008, AM J EPIDEMIOL, V168, P890, DOI 10.1093/aje/kwn205; Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75; Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wang JH, 2011, GENOME MED, V3, DOI 10.1186/gm217; Wang L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-147; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Willcox BJ, 2006, J GERONTOL A-BIOL, V61, P345, DOI 10.1093/gerona/61.4.345; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000864; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Young RD, 2011, CURR GERONTOL GERIAT, V2010, P1; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002	91	239	253	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29848	10.1371/journal.pone.0029848	http://dx.doi.org/10.1371/journal.pone.0029848			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279548	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900026
J	Xiang, TX; Li, LL; Yin, XD; Yuan, CF; Tan, C; Su, XW; Xiong, L; Putti, TC; Oberst, M; Kelly, K; Ren, GS; Tao, Q				Xiang, Tingxiu; Li, Lili; Yin, Xuedong; Yuan, Chenfu; Tan, Cui; Su, Xianwei; Xiong, Lei; Putti, Thomas C.; Oberst, Michael; Kelly, Kathleen; Ren, Guosheng; Tao, Qian			The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; TERMINAL HYDROLASE L1; DNA METHYLATION; PROMOTER METHYLATION; MULTIPLE CARCINOMAS; PROTEASOME PATHWAY; GENE; ESOPHAGEAL; DISEASE; NASOPHARYNGEAL	Background: Breast cancer (BrCa) is a complex disease driven by aberrant gene alterations and environmental factors. Recent studies reveal that abnormal epigenetic gene regulation also plays an important role in its pathogenesis. Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is a tumor suppressor silenced by promoter methylation in multiple cancers, but its role and alterations in breast tumorigenesis remain unclear. Methodology/Principal Findings: We found that UCHL1 was frequently downregulated or silenced in breast cancer cell lines and tumor tissues, but readily expressed in normal breast tissues and mammary epithelial cells. Promoter methylation of UCHL1 was detected in 9 of 10 breast cancer cell lines (90%) and 53 of 66 (80%) primary tumors, but rarely in normal breast tissues, which was statistically correlated with advanced clinical stage and progesterone receptor status. Pharmacologic demethylation reactivated UCHL1 expression along with concomitant promoter demethylation. Ectopic expression of UCHL1 significantly suppressed the colony formation and proliferation of breast tumor cells, through inducing G0/G1 cell cycle arrest and apoptosis. Subcellular localization study showed that UCHL1 increased cytoplasmic abundance of p53. We further found that UCHL1 induced p53 accumulation and reduced MDM2 protein level, and subsequently upregulated the expression of p21, as well as cleavage of caspase3 and PARP, but not in catalytic mutant UCHL1 C90S-expressed cells. Conclusions/Significance: UCHL1 exerts its tumor suppressive functions by inducing G0/G1cell cycle arrest and apoptosis in breast tumorigenesis, requiring its deubiquitinase activity. Its frequent silencing by promoter CpG methylation may serve as a potential tumor marker for breast cancer.	[Xiang, Tingxiu; Yin, Xuedong; Yuan, Chenfu; Tan, Cui; Ren, Guosheng; Tao, Qian] Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China; [Li, Lili; Su, Xianwei; Xiong, Lei; Tao, Qian] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci,Canc Epigenet Lab, Dept Clin Oncol,Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [Putti, Thomas C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Oberst, Michael; Kelly, Kathleen] NCI, Signal Transduct Sect, NIH, Bethesda, MD 20892 USA	Chongqing Medical University; Chinese University of Hong Kong; National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ren, GS (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Mol Oncol & Epigenet Lab, Chongqing, Peoples R China.	rgs726@163.com; qtao@clo.cuhk.edu.hk	Li, Lili/Q-5750-2018; Tao, Qian/T-4743-2018	Li, Lili/0000-0002-0292-5889; Tao, Qian/0000-0001-5383-4808	Chongqing Health Bureau; National Natural Science Foundation of China [31171243, 81072148, 81172582]; Shenzhen Science Fund for Distinguished Young Scholars [JC201005270328A]; NATIONAL CANCER INSTITUTE [ZIABC010607] Funding Source: NIH RePORTER	Chongqing Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Chongqing Health Bureau grant, National Natural Science Foundation of China (#31171243, 81072148 and 81172582) and Shenzhen Science Fund for Distinguished Young Scholars (#JC201005270328A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brait M, 2008, CANCER EPIDEM BIOMAR, V17, P2786, DOI 10.1158/1055-9965.EPI-08-0192; Brooks J, 2009, CANCER CAUSE CONTROL, V20, P1539, DOI 10.1007/s10552-009-9415-y; Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Dehan P, 2009, EXPERT REV MOL DIAGN, V9, P651, DOI 10.1586/ERM.09.53; EDWARDS YH, 1991, ANN HUM GENET, V55, P273, DOI 10.1111/j.1469-1809.1991.tb00853.x; Fujikane T, 2010, BREAST CANCER RES TR, V122, P699, DOI 10.1007/s10549-009-0600-1; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hu XT, 2009, ONCOGENE, V28, P2466, DOI 10.1038/onc.2009.92; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kuperwasser C, 2000, CANCER RES, V60, P2723; Li LL, 2010, CLIN CANCER RES, V16, P2949, DOI 10.1158/1078-0432.CCR-09-3178; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Loyo M, 2011, INT J CANCER, V128, P1393, DOI 10.1002/ijc.25443; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Miasari M, 2008, CURR CANCER DRUG TAR, V8, P118; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; Mizukami H, 2008, ANTICANCER RES, V28, P2697; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Oka D, 2009, CANCER-AM CANCER SOC, V115, P3412, DOI 10.1002/cncr.24394; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Orlowski RZ, 2003, BREAST CANCER RES, V5, P1, DOI 10.1186/bcr460; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Parrella P, 2010, BREAST CARE, V5, P66, DOI 10.1159/000309138; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Seliger B, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-90; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Shivapurkar N, 2010, CURR MOL MED, V10, P123, DOI 10.2174/156652410790963303; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Wang WJ, 2008, INT J ONCOL, V33, P1037, DOI 10.3892/ijo_00000092; Wang Y, 2009, CANCER RES, V69, P5194, DOI 10.1158/0008-5472.CAN-08-3694; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Xiang TX, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12726; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Yu J, 2008, HEPATOLOGY, V48, P508, DOI 10.1002/hep.22343; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032	39	103	113	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29783	10.1371/journal.pone.0029783	http://dx.doi.org/10.1371/journal.pone.0029783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279545	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900023
J	Falk, A; Koch, P; Kesavan, J; Takashima, Y; Ladewig, J; Alexander, M; Wiskow, O; Tailor, J; Trotter, M; Pollard, S; Smith, A; Brustle, O				Falk, Anna; Koch, Philipp; Kesavan, Jaideep; Takashima, Yasuhiro; Ladewig, Julia; Alexander, Michael; Wiskow, Ole; Tailor, Jignesh; Trotter, Matthew; Pollard, Steven; Smith, Austin; Bruestle, Oliver			Capture of Neuroepithelial-Like Stem Cells from Pluripotent Stem Cells Provides a Versatile System for In Vitro Production of Human Neurons	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN ES; DIFFERENTIATION CAPACITY; INHIBITION; PRECURSORS; FGF	Human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) provide new prospects for studying human neurodevelopment and modeling neurological disease. In particular, iPSC-derived neural cells permit a direct comparison of disease-relevant molecular pathways in neurons and glia derived from patients and healthy individuals. A prerequisite for such comparative studies are robust protocols that efficiently yield standardized populations of neural cell types. Here we show that long-term self-renewing neuroepithelial-like stem cells (lt-NES cells) derived from 3 hESC and 6 iPSC lines in two independent laboratories exhibit consistent characteristics including i) continuous expandability in the presence of FGF2 and EGF; ii) stable neuronal and glial differentiation competence; iii) characteristic transcription factor profile; iv) hindbrain specification amenable to regional patterning; v) capacity to generate functionally mature human neurons. We further show that lt-NES cells are developmentally distinct from fetal tissue-derived radial glia-like stem cells. We propose that lt-NES cells provide an interesting tool for studying human neurodevelopment and may serve as a standard system to facilitate comparative analyses of hESC and hiPSC-derived neural cells from control and diseased genetic backgrounds.	[Falk, Anna; Takashima, Yasuhiro; Wiskow, Ole; Tailor, Jignesh; Pollard, Steven; Smith, Austin] Univ Cambridge, Dept Biochem, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QW, England; [Koch, Philipp; Kesavan, Jaideep; Ladewig, Julia; Bruestle, Oliver] Univ Bonn, Inst Reconstruct Neurobiol, LIFE & BRAIN Ctr, Bonn, Germany; [Koch, Philipp; Kesavan, Jaideep; Ladewig, Julia; Bruestle, Oliver] Hertie Fdn, Bonn, Germany; [Alexander, Michael] Univ Bonn, Inst Human Genet, LIFE & BRAIN Ctr, Bonn, Germany; [Trotter, Matthew] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England	University of Cambridge; University of Bonn; University of Bonn; University of Cambridge	Falk, A (corresponding author), Univ Cambridge, Dept Biochem, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QW, England.	brustle@uni-bonn.de	Koch, Philipp/AAZ-3751-2020; Koch, Philipp/M-1186-2016; Falk, Anna/GWV-1616-2022; Pollard, Steven/B-7966-2010	Kesavan, Jaideep/0000-0003-1933-1187; Trotter, Matthew/0000-0003-3702-915X; Takashima, Yasuhiro/0000-0003-0126-7260; Falk, Anna/0000-0003-1634-8610; Koch, Philipp/0000-0003-3713-8786; Pollard, Steven/0000-0001-6428-0492; Smith, Austin/0000-0002-3029-4682	European Commission [LSHG-CT-2006-018739]; ESTOOLS [222943]; Neurostemcell [LSHB-CT-2007-037766]; UK Medical Research Council; German Research Foundation (DFG) [SFB-TR3]; German Federal Ministry for Education and Research (BMBF) [01GNO813]; Stem Cell Network North Rhine Westphalia [L-072.0055]; Hertie Foundation; Swedish Research Council; Swedish Hjarnfonden; EMBO; MRC [G1001028, G0800784] Funding Source: UKRI; Medical Research Council [G1100526, G0800784B, G0800784, MC_PC_12009, G1001028] Funding Source: researchfish; The Brain Tumour Charity [8/105] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); ESTOOLS(European Commission); Neurostemcell; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Stem Cell Network North Rhine Westphalia; Hertie Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Hjarnfonden; EMBO(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Brain Tumour Charity	This work was supported by the European Commission (http://cordis.europa.eu/; LSHG-CT-2006-018739, ESTOOLS; grant 222943, Neurostemcell; LSHB-CT-2007-037766, Neuroscreen), the UK Medical Research Council (http://www.mrc.ac.uk), the German Research Foundation (DFG; http://www.dfg.de/; SFB-TR3), the German Federal Ministry for Education and Research (BMBF; http://www.bmbf.de/; grant 01GNO813), the Stem Cell Network North Rhine Westphalia (http://www.stammzellen.nrw.de/; L-072.0055) and the Hertie Foundation (http://www.ghst.de/). AF was supported by the Swedish Research Council (http://www.vr.se) and the Swedish Hjarnfonden (http://www.hjarnfonden.se) and YT by an EMBO Long-Term Fellowship (http://www.embo.org). JT is a National Institute of Health Research (NIHR) Clinical Research Training Fellow (http://www.nihr.ac.uk) and a Raymond and Beverly Sackler Fellow (http://www.medschl.cam.ac.uk) and AS is a Medical Research Council Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Koch P, 2009, LANCET NEUROL, V8, P819, DOI 10.1016/S1474-4422(09)70202-9; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Ladewig J, 2008, STEM CELLS, V26, P1705, DOI 10.1634/stemcells.2008-0007; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; Nemati S, 2011, STEM CELLS DEV, V20, P503, DOI 10.1089/scd.2010.0143; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	28	197	202	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29597	10.1371/journal.pone.0029597	http://dx.doi.org/10.1371/journal.pone.0029597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272239	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400018
J	Prabhu, S; Raman, B; Ramakrishna, T; Rao, CM				Prabhu, Sankaralingam; Raman, Bakthisaran; Ramakrishna, Tangirala; Rao, Ch Mohan			HspB2/Myotonic Dystrophy Protein Kinase Binding Protein (MKBP) as a Novel Molecular Chaperone: Structural and Functional Aspects	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; PROGRAMMED CELL-DEATH; MYOTONIC-DYSTROPHY; SUBUNIT EXCHANGE; MOLTEN GLOBULE; ISCHEMIC-HEART; A-CRYSTALLIN; CTG REPEAT; DISEASE	The small heat shock protein, human HspB2, also known as Myotonic Dystrophy Kinase Binding Protein (MKBP), specifically associates with and activates Myotonic Dystrophy Protein Kinase (DMPK), a serine/threonine protein kinase that plays an important role in maintaining muscle structure and function. The structure and function of HspB2 are not well understood. We have cloned and expressed the protein in E. coli and purified it to homogeneity. Far-UV circular dichroic spectrum of the recombinant HspB2 shows a beta-sheet structure. Fluorescence spectroscopic studies show that the sole tryptophan residue at the 130th position is almost completely solvent-exposed. Bis-ANS binding shows that though HspB2 exhibits accessible hydrophobic surfaces, it is significantly less than that exhibited by another well characterized small HSP, alpha beta-crystallin. Sedimentation velocity measurements show that the protein exhibits concentration-dependent oligomerization. Fluorescence resonance energy transfer study shows that HspB2 oligomers exchange subunits. Interestingly, HspB2 exhibits target protein-dependent chaperone-like activity: it exhibits significant chaperone-like activity towards dithiothreitol (DTT)-induced aggregation of insulin and heat-induced aggregation of alcohol dehydrogenase, but only partially prevents the heat-induced aggregation of citrate synthase, co-precipitating with the target protein. It also significantly prevents the ordered amyloid fibril formation of alpha-synuclein. Thus, our study, for the first time, provides biophysical characterization on the structural aspects of HspB2, and shows that it exhibits target protein-dependent chaperone-like activity.	[Prabhu, Sankaralingam; Raman, Bakthisaran; Ramakrishna, Tangirala; Rao, Ch Mohan] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Prabhu, S (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	trk@ccmb.res.in; mohan@ccmb.res.in		Tangirala, Ramakrishna/0000-0002-0738-329X	Council of Scientific and Industrial Research (CSIR), New Delhi; Department of Science and Technology, Government of India	Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	S.P. acknowledges the Council of Scientific and Industrial Research (CSIR), New Delhi for the Junior Research Fellowship. Ch.M.R acknowledges J C Bose National Fellowship, Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Shama KM, 1999, CELL STRUCT FUNCT, V24, P1; Ahmad MF, 2006, J MOL BIOL, V364, P1061, DOI 10.1016/j.jmb.2006.09.085; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Arrigo AP, 1998, BIOL CHEM, V379, P19; Arrigo AP, 2000, PATHOL BIOL, V48, P280; Benndorf R, 2004, NAT GENET, V36, P547, DOI 10.1038/ng0604-547; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Danan IJ, 2007, CARDIOVASC DRUG REV, V25, P14, DOI 10.1111/j.1527-3466.2007.00002.x; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; Datta SA, 1999, J BIOL CHEM, V274, P34773, DOI 10.1074/jbc.274.49.34773; Datta SA, 2000, J BIOL CHEM, V275, P41004, DOI 10.1074/jbc.M007686200; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; Kaliman P, 2008, CELL SIGNAL, V20, P1935, DOI 10.1016/j.cellsig.2008.05.005; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; MUSCI G, 1985, BIOCHEMISTRY-US, V24, P2034, DOI 10.1021/bi00329a035; Nakagawa M, 2001, EXP CELL RES, V271, P161, DOI 10.1006/excr.2001.5362; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Pinz I, 2008, FASEB J, V22, P84, DOI 10.1096/fj.07-8130com; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; RAMAN B, 1994, J BIOL CHEM, V269, P27264; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; SANGER F, 1949, BIOCHEM J, V44, P126, DOI 10.1042/bj0440126; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095; Sun TX, 1997, J BIOL CHEM, V272, P6220, DOI 10.1074/jbc.272.10.6220; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; van den IJssel P, 1999, CURR BIOL, V9, pR103, DOI 10.1016/S0960-9822(99)80061-X; Verschuure P, 2003, EUR J CELL BIOL, V82, P523, DOI 10.1078/0171-9335-00337; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; Yoshida K, 1999, CELL STRUCT FUNCT, V24, P181, DOI 10.1247/csf.24.181	51	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29810	10.1371/journal.pone.0029810	http://dx.doi.org/10.1371/journal.pone.0029810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272249	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400028
J	Saadeh, M; Ferrante, TC; Kane, A; Shirihai, O; Corkey, BE; Deeney, JT				Saadeh, Marylana; Ferrante, Thomas C.; Kane, Ada; Shirihai, Orian; Corkey, Barbara E.; Deeney, Jude T.			Reactive Oxygen Species Stimulate Insulin Secretion in Rat Pancreatic Islets: Studies Using Mono-Oleoyl-Glycerol	PLOS ONE			English	Article							CHAIN ACYL-COA; ADENINE-NUCLEOTIDE TRANSLOCASE; REGULATED POTASSIUM CHANNEL; CIRCULATING FATTY-ACIDS; SENSITIVE K+ CHANNEL; BETA-CELLS HIT; ESTERS ACTIVATE; MALONYL-COA; GLUCOSE; METABOLISM	Chronic exposure (24-72 hrs) of pancreatic islets to elevated glucose and fatty acid leads to glucolipoxicity characterized by basal insulin hypersecretion and impaired glucose-stimulated insulin secretion (GSIS). Our aim was to determine the mechanism for basal hypersecretion of insulin. We used mono-oleoyl-glycerol (MOG) as a tool to rapidly increase lipids in isolated rat pancreatic beta-cells and in the clonal pancreatic beta-cell line INS-1 832/13. MOG (25-400 mu M) stimulated basal insulin secretion from beta-cells in a concentration dependent manner without increasing intracellular Ca2+ or O-2 consumption. Like GSIS, MOG increased NAD(P)H and reactive oxygen species (ROS). The mitochondrial reductant beta-hydroxybutyrate (beta-OHB) also increased the redox state and ROS production, while ROS scavengers abrogated secretion. Diazoxide (0.4 mM) did not prevent the stimulatory effect of MOG, confirming that the effect was independent of the K-ATP-dependent pathway of secretion. MOG was metabolized to glycerol and long-chain acyl-CoA (LC-CoA), whereas, acute oleate did not similarly increase LC-CoA. Inhibition of diacylglycerol kinase (DGK) did not mimic the effect of MOG on insulin secretion, indicating that MOG did not act primarily by inhibiting DGK. Inhibition of acyl-CoA synthetase (ACS) reduced the stimulatory effect of MOG on basal insulin secretion by 30% indicating a role for LC-CoA. These data suggest that basal insulin secretion is stimulated by increased ROS production, due to an increase in the mitochondrial redox state independent of the established components of GSIS.	[Saadeh, Marylana; Ferrante, Thomas C.; Kane, Ada; Shirihai, Orian; Corkey, Barbara E.; Deeney, Jude T.] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA	Boston University	Saadeh, M (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA.	jdeeney@bu.edu	; Corkey, Barbara/E-7712-2015	Shirihai, Orian/0000-0002-9502-2661; Koo, Ada/0000-0003-2414-0852; Corkey, Barbara/0000-0002-5467-1630; Deeney, Jude/0000-0003-0988-9419	U.S. National Institutes of Health [DK35914, DK56690]; Department of Medicine, Boston University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK035914, R01DK056690, R01DK074778, R01DK035914, R37DK035914, R01DK063356] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine, Boston University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the U.S. National Institutes of Health [DK35914, DK56690]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. David Pimentel, MD, for generously providing adenovirus containing the ROS sensing cytosolic HyPer construct. INS-1 832/13 cells were kindly provided by Dr. Christopher B. Newgard, PhD. This work was supported with equipment provided through the Cellular Imaging and the Analytical Instrumentation Cores of the Department of Medicine, Boston University School of Medicine.	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Branstrom R, 1997, J BIOL CHEM, V272, P17390, DOI 10.1074/jbc.272.28.17390; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; Civelek VN, 1996, BIOCHEM J, V315, P1015, DOI 10.1042/bj3151015; Civelek VN, 1996, BIOCHEM J, V318, P615, DOI 10.1042/bj3180615; CORKEY BE, 1988, METHOD ENZYMOL, V166, P55; Cunningham BA, 1996, AM J PHYSIOL-ENDOC M, V271, pE702, DOI 10.1152/ajpendo.1996.271.4.E702; CUSIN I, 1990, BIOCHEM J, V267, P99, DOI 10.1042/bj2670099; Deeney JT, 1996, J BIOL CHEM, V271, P18154, DOI 10.1074/jbc.271.30.18154; DEENEY JT, 1992, J BIOL CHEM, V267, P19840; Deeney JT, 2000, J BIOL CHEM, V275, P9363, DOI 10.1074/jbc.275.13.9363; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Dobbins RL, 1998, DIABETES, V47, P1613, DOI 10.2337/diabetes.47.10.1613; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Gravena C, 2002, J ENDOCRINOL, V173, P73, DOI 10.1677/joe.0.1730073; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; Hamming KSC, 2008, MOL ENDOCRINOL, V22, P2293, DOI 10.1210/me.2008-0053; Hayes KC, 2001, CURR OPIN LIPIDOL, V12, P55, DOI 10.1097/00041433-200102000-00010; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jayaram B, 2011, ISLETS, V3, P48, DOI 10.4161/isl.3.2.15016; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; KUWAJIMA M, 1988, METABOLISM, V37, P597, DOI 10.1016/0026-0495(88)90178-3; Larsson O, 1996, J BIOL CHEM, V271, P10623, DOI 10.1074/jbc.271.18.10623; Las G, 2006, DIABETES, V55, P3478, DOI 10.2337/db06-0687; MARBAN SL, 1989, DEV GENET, V10, P356, DOI 10.1002/dvg.1020100503; MCGARRY JD, 1981, BIOCHEM J, V200, P217, DOI 10.1042/bj2000217; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Noel RJ, 1997, J BIOL CHEM, V272, P18621, DOI 10.1074/jbc.272.30.18621; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Peyot ML, 2004, DIABETES, V53, P1733, DOI 10.2337/diabetes.53.7.1733; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Prentki M, 1998, Journ Annu Diabetol Hotel Dieu, P17; Rasband W.S., IMAGE J; RIZZA RA, 1985, DIABETOLOGIA, V28, P70; SCHONFELD P, 1991, BIOMED BIOCHIM ACTA, V50, P841; Segall L, 1999, AM J PHYSIOL-ENDOC M, V277, pE521, DOI 10.1152/ajpendo.1999.277.3.E521; SHRAGO E, 1978, LIFE SCI, V22, P1, DOI 10.1016/0024-3205(78)90403-4; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Wang XL, 2004, DIABETES, V53, P129, DOI 10.2337/diabetes.53.1.129; Warnotte C, 1999, MOL CELL ENDOCRINOL, V153, P147, DOI 10.1016/S0303-7207(99)00069-6; Webster NJ, 2008, ENDOCRINOLOGY, V149, P3679, DOI 10.1210/en.2007-1138; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; ZAWALICH WS, 1990, MOL CELL ENDOCRINOL, V68, P129, DOI 10.1016/0303-7207(90)90185-B; ZAWALICH WS, 1989, DIABETOLOGIA, V32, P360, DOI 10.1007/BF00277259; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	56	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30200	10.1371/journal.pone.0030200	http://dx.doi.org/10.1371/journal.pone.0030200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272304	Green Published, gold			2022-12-25	WOS:000301454400082
J	Schonerr, C; Ruuth, K; Kamaraj, S; Wang, CL; Yang, HL; Combaret, V; Djos, A; Martinsson, T; Christensen, JG; Palmer, RH; Hallberg, B				Schonerr, C.; Ruuth, K.; Kamaraj, S.; Wang, C-L; Yang, H-L; Combaret, V.; Djos, A.; Martinsson, T.; Christensen, J. G.; Palmer, R. H.; Hallberg, B.			Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells	ONCOGENE			English	Article						neuroblastoma; anaplastic lymphoma kinase; ALK; MYCN; transcription factor	N-MYC; TYROSINE KINASE; ACTIVATING MUTATIONS; LUNG-CANCER; C-MET; EXPRESSION; INHIBITOR; PROTEIN; CRIZOTINIB; RECEPTOR	Neuroblastoma is a neural crest-derived embryonal tumour of the postganglionic sympathetic nervous system and a disease with several different chromosomal gains and losses, which include MYCN-amplified neuroblastoma on chromosome 2, deletions of parts of the chromosomes 1p and 11q, gain of parts of 17q and triploidy. Recently, activating mutations of the ALK (Anaplastic Lymphoma Kinase) RTK (Receptor Tyrosine Kinase) gene have been described in neuroblastoma. A meta-analysis of neuroblastoma cases revealed that ALK mutations (49 of 709 cases) in relation to genomic subtype were most frequently observed in MYCN amplified tumours (8.9%), correlating with a poor clinical outcome. MYCN proteins target proliferation and apoptotic pathways, and have an important role in the progression of neuroblastoma. Here, we show that both wild-type and gain-of-function mutants in ALK are able to stimulate transcription at the MYCN promoter and initiate mRNA transcription of the MYCN gene in both neuronal and neuroblastoma cell lines. Further, this stimulation of MYCN gene transcription and de novo MYCN protein expression is abrogated by specific ALK inhibitors, such as crizotinib (PF-2341066), NVP-TAE684, and by small interfering RNA to ALK resulting in a decrease in proliferation rate. Finally, co-transfection of ALK gain-of-function mutations together with MYCN leads to an increase in transformation potential. Taken together, our results indicate that ALK signalling regulates initiation of transcription of the MYCN gene providing a possible explanation for the poor clinical outcome observed when MYCN is amplified together with activated ALK. Oncogene (2012) 31, 5193 - 5200; doi:10.1038/onc.2012.12; published online 30 January 2012	[Schonerr, C.; Ruuth, K.; Kamaraj, S.; Palmer, R. H.; Hallberg, B.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Wang, C-L; Yang, H-L] Beijing Forestry Univ, Coll Life Sci & Biotechnol, Beijing, Peoples R China; [Combaret, V.] Ctr Leon Berard, FNCLCC, Lab Rech Translat, F-69373 Lyon, France; [Djos, A.; Martinsson, T.] Univ Gothenburg, Dept Clin Genet, Gothenburg, Sweden; [Christensen, J. G.] La Jolla Labs, Global Res & Dev, Dept Res Pharmacol, La Jolla, CA USA	Umea University; Beijing Forestry University; UNICANCER; Centre Leon Berard; University of Gothenburg	Palmer, RH (corresponding author), Umea Univ, Dept Mol Biol, Bldg 6L, S-90187 Umea, Sweden.	Ruth.Palmer@molbiol.umu.se; Bengt.Hallberg@molbiol.umu.se	Martinsson, Tommy/J-4140-2013; sattu, kamaraj/L-7247-2015	Martinsson, Tommy/0000-0002-9403-3123; sattu, kamaraj/0000-0002-3559-8423; Djos, Anna/0000-0002-5250-2163	Swedish Cancer Society [BH 08-0597]; Children's Cancer Foundation [BH 08/084, RHP 08/074]; Swedish Research Council [RHP 621-2003-3399]; Lions Cancer Society; Association for International Cancer Research [RHP 08-0177]; Umea	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Society; Association for International Cancer Research; Umea	We thank Marc Vigny and Arturo Sala for support and the pGL2-N-myc-luc plasmid, respectively. Crizotinib was a generous gift from Pfizer and the neuroblastoma cell lines were from Valerie Combaret, Centre Leon Berard, France under MTA. This work has been supported by grants from the Swedish Cancer Society (BH 08-0597), the Children's Cancer Foundation (BH 08/084; RHP 08/074), the Swedish Research Council (RHP 621-2003-3399), Lions Cancer Society, Umea, Association for International Cancer Research (RHP 08-0177). SK is a Children's Cancer Foundation fellow (NBCNSPDHEL09/002). RHP is a Swedish Cancer Foundation Research Fellow.	Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Berthier A, 2011, HUM PATHOL, V42, P301, DOI 10.1016/j.humpath.2010.07.024; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brognard J, 2011, CURR OPIN GENET DEV, V21, P4, DOI 10.1016/j.gde.2010.10.012; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; COMBARET V, 1995, INT J CANCER, V61, P185, DOI 10.1002/ijc.2910610208; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Goodman LA, 1997, CLIN EXP METASTAS, V15, P130, DOI 10.1023/A:1018448710006; Gualdrini F, 2010, ONCOTARGET, V1, P278; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Hallberg Bengt, 2011, F1000 Med Rep, V3, P21, DOI 10.3410/M3-21; Hallberg B, 2010, NEW ENGL J MED, V363, P1760, DOI 10.1056/NEJMe1010404; Hatzi E, 2000, ADV EXP MED BIOL, V476, P239; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li YJ, 2011, NEOPLASIA, V13, P1, DOI 10.1593/neo.101120; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Martinsson T, 2011, CANCER RES, V71, P98, DOI 10.1158/0008-5472.CAN-10-2366; Michels E, 2007, GENE CHROMOSOME CANC, V46, P1098, DOI 10.1002/gcc.20496; Misawa A, 2003, INT J CANCER, V104, P233, DOI 10.1002/ijc.10914; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Schleiermacher G, 2003, CANCER GENET CYTOGEN, V141, P32, DOI 10.1016/S0165-4608(02)00644-1; Schonherr C, 2010, ONCOGENE, V29, P2817, DOI 10.1038/onc.2010.27; Schonherr C, 2011, BIOCHEM J, V440, P405, DOI 10.1042/BJ20101796; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Tartari CJ, 2008, J BIOL CHEM, V283, P3743, DOI 10.1074/jbc.M706067200; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Yang HL, 2007, J EXP ZOOL PART B, V308B, P269, DOI 10.1002/jez.b.21146; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	49	70	70	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2012	31	50					5193	5200		10.1038/onc.2012.12	http://dx.doi.org/10.1038/onc.2012.12			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	055WY	22286764				2022-12-25	WOS:000312449800008
J	Aleshin, AE; Schraufstatter, IU; Stec, B; Bankston, LA; Liddington, RC; DiScipio, RG				Aleshin, Alexander E.; Schraufstatter, Ingrid U.; Stec, Boguslaw; Bankston, Laurie A.; Liddington, Robert C.; DiScipio, Richard G.			Structure of Complement C6 Suggests a Mechanism for Initiation and Unidirectional, Sequential Assembly of Membrane Attack Complex (MAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I MODULES; PORE FORMATION; CRYSTAL-STRUCTURE; COMPONENT; BINDING; PROTEINS; REVEALS; SYSTEM; C7; C9	The complement membrane attack complex (MAC) is formed by the sequential assembly of C5b with four homologous proteins as follows: one copy each of C6, C7, and C8 and 12-14 copies of C9. Together these form a lytic pore in bacterial membranes. C6 through C9 comprise a MAC-perforin domain flanked by 4-9 "auxiliary" domains. Here, we report the crystal structure of C6, the first and longest of the pore proteins to be recruited by C5b. Comparisons with the structures of the C8 alpha beta gamma heterodimer and perforin show that the central domain of C6 adopts a "closed" (perforin-like) state that is distinct from the "open" conformations in C8. We further show that C6, C8 alpha, and C8 beta contain three homologous subdomains ("upper," "lower," and "regulatory") related by rotations about two hinge points. In C6, the regulatory segment includes four auxiliary domains that stabilize the closed conformation, inhibiting release of membrane-inserting elements. In C8 beta, rotation of the regulatory segment is linked to an opening of the central beta-sheet of its clockwise partner, C8 alpha. Based on these observations, we propose a model for initiation and unidirectional propagation of the MAC in which the auxiliary domains play key roles: in the assembly of the C5b-8 initiation complex; in driving and regulating the opening of the beta-sheet of the MAC-performin domain of each new recruit as it adds to the growing pore; and in stabilizing the final pore. Our model of the assembled pore resembles those of the cholesterol-dependent cytolysins but is distinct from that recently proposed for perforin.	[Aleshin, Alexander E.; Stec, Boguslaw; Bankston, Laurie A.; Liddington, Robert C.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Schraufstatter, Ingrid U.; DiScipio, Richard G.] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Sanford Burnham Prebys Medical Discovery Institute; Torrey Pines Institute for Molecular Studies, California	Liddington, RC (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org		Stec, Boguslaw/0000-0002-8696-0349	National Institutes of Health [R21 HL094878]; United States Army Medical Research and Materiel Command [DAMD17-03-2-0038]; Multiple Sclerosis National Research Institute [4061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Multiple Sclerosis National Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 HL094878 (to I. U. S.). This work was also supported by United States Army Medical Research and Materiel Command Grant DAMD17-03-2-0038 (to R. C. L.) and Multiple Sclerosis National Research Institute Grant 4061 (to R. G. D.).	Adams P. D., 2010, ACTA CRYSTALLOGR D, V66, P2123; Arias-Moreno X, 2010, PROTEINS, V78, P950, DOI 10.1002/prot.22619; BHAKDI S, 1980, J IMMUNOL, V124, P2451; BHAKDI S, 1978, P NATL ACAD SCI USA, V75, P5655, DOI 10.1073/pnas.75.11.5655; Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Corvini M, 2004, ANN ALLERG ASTHMA IM, V93, P200, DOI 10.1016/S1081-1206(10)61476-7; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; DiScipio R. G, 1998, COMPLEMENT SYSTEM, P50; DISCIPIO RG, 1988, J BIOL CHEM, V263, P549; DISCIPIO RG, 1992, J BIOL CHEM, V267, P17087; DiScipio RG, 1999, J BIOL CHEM, V274, P31811, DOI 10.1074/jbc.274.45.31811; DISCIPIO RG, 1989, J BIOL CHEM, V264, P16197; DISCIPIO RG, 1994, PROTEIN EXPRES PURIF, V5, P170, DOI 10.1006/prep.1994.1027; DOURMASHKIN RR, 1978, IMMUNOLOGY, V35, P205; DUCRET F, 1988, REV MED INTERNE, V9, P534, DOI 10.1016/S0248-8663(88)80021-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; HAEFLIGER JA, 1989, J BIOL CHEM, V264, P18041; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hofsteenge J, 1999, J BIOL CHEM, V274, P32786, DOI 10.1074/jbc.274.46.32786; HU VW, 1981, J IMMUNOL, V127, P380; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kimura A, 2009, DEV COMP IMMUNOL, V33, P77, DOI 10.1016/j.dci.2008.07.005; Kimura A, 2009, FISH SHELLFISH IMMUN, V27, P768, DOI 10.1016/j.fsi.2009.08.008; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; KOLB WP, 1975, P NATL ACAD SCI USA, V72, P1687, DOI 10.1073/pnas.72.5.1687; LAINE RO, 1989, NATURE, V341, P63, DOI 10.1038/341063a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; Lovelace LL, 2011, J BIOL CHEM, V286, P17585, DOI 10.1074/jbc.M111.219766; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Orren A, 2004, SAMJ S AFR MED J, V94, P345; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phelan MM, 2009, J BIOL CHEM, V284, P19637, DOI 10.1074/jbc.M901993200; Plumb ME, 1999, BIOCHEMISTRY-US, V38, P8478, DOI 10.1021/bi9904858; PODACK ER, 1980, J EXP MED, V151, P301, DOI 10.1084/jem.151.2.301; PODACK ER, 1981, P NATL ACAD SCI-BIOL, V78, P4544, DOI 10.1073/pnas.78.7.4544; PODACK ER, 1984, J BIOL CHEM, V259, P8641; PODACK ER, 1982, J EXP MED, V156, P268, DOI 10.1084/jem.156.1.268; PODACK ER, 1978, J IMMUNOL, V120, P1841; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Scibek JJ, 2002, BIOCHEMISTRY-US, V41, P14546, DOI 10.1021/bi026641j; SHINKAI Y, 1988, NATURE, V334, P525, DOI 10.1038/334525a0; SILVERSMITH RE, 1986, BIOCHEMISTRY-US, V25, P7717, DOI 10.1021/bi00371a065; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; STECKEL EW, 1983, J BIOL CHEM, V258, P4318; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suzuki MM, 2002, J MOL EVOL, V54, P671, DOI 10.1007/s00239-001-0068-z; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Taylor KM, 1997, IMMUNOLOGY, V91, P20, DOI 10.1046/j.1365-2567.1997.00225.x; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Thai CT, 2005, J IMMUNOL, V174, P6227, DOI 10.4049/jimmunol.174.10.6227; Thai CT, 2004, J IMMUNOL, V173, P4547, DOI 10.4049/jimmunol.173.7.4547; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; TSCHOPP J, 1984, J BIOL CHEM, V259, P7857; TSCHOPP J, 1985, J IMMUNOL, V134, P495; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; WURZNER R, 1995, J CLIN INVEST, V95, P1877, DOI 10.1172/JCI117868; WURZNER R, 1995, IMMUNOLOGY, V85, P214; ZALMAN LS, 1990, MOL IMMUNOL, V27, P533, DOI 10.1016/0161-5890(90)90072-8	70	70	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10210	10222		10.1074/jbc.M111.327809	http://dx.doi.org/10.1074/jbc.M111.327809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22267737	Green Published, hybrid			2022-12-25	WOS:000302167200052
J	Pruitt, RN; Chumbler, NM; Rutherford, SA; Farrow, MA; Friedman, DB; Spiller, B; Lacy, DB				Pruitt, Rory N.; Chumbler, Nicole M.; Rutherford, Stacey A.; Farrow, Melissa A.; Friedman, David B.; Spiller, Ben; Lacy, D. Borden			Structural Determinants of Clostridium difficile Toxin A Glucosyltransferase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; RHO-PROTEINS; SURFACE BINDING; DOMAIN; CLEAVAGE; CELLS; ENTEROTOXIN; SITE; GLYCOSYLTRANSFERASES; GLUCOSYLATION	The principle virulence factors in Clostridium difficile pathogenesis are TcdA and TcdB, homologous glucosyltransferases capable of inactivating small GTPases within the host cell. We present crystal structures of the TcdA glucosyltransferase domain in the presence and absence of the co-substrate UDPglucose. Although the enzymatic core is similar to that of TcdB, the proposed GTPase-binding surface differs significantly. We show that TcdA is comparable with TcdB in its modification of Rho family substrates and that, unlike TcdB, TcdA is also capable of modifying Rap family GTPases both in vitro and in cells. The glucosyltransferase activities of both toxins are reduced in the context of the holotoxin but can be restored with autoproteolytic activation and glucosyltransferase domain release. These studies highlight the importance of cellular activation in determining the array of substrates available to the toxins once delivered into the cell.	[Pruitt, Rory N.; Rutherford, Stacey A.; Farrow, Melissa A.; Spiller, Ben; Lacy, D. Borden] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, Nashville, TN 37232 USA; [Chumbler, Nicole M.] Vanderbilt Univ, Chem & Phys Biol Grad Program, Sch Med, Nashville, TN 37232 USA; [Friedman, David B.; Lacy, D. Borden] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Spiller, Ben] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Lacy, DB (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Sch Med, A-5301 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	borden.lacy@vanderbilt.edu	Lacy, D. Borden/AFQ-2203-2022	Lacy, Borden/0000-0003-2273-8121	National Institutes of Health [P30DK058404]; National Institutes of Health, NIAID [AI095755-01]; Burroughs Wellcome Foundation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, T32GM065086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P30DK058404 (Vanderbilt Digestive Disease Research Center) and National Institutes of Health, NIAID, Grant AI095755-01. This work was also supported by an Investigator in Pathogenesis of Infectious Disease award from the Burroughs Wellcome Foundation (to D. B. L.). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Barth H, 2001, J BIOL CHEM, V276, P10670, DOI 10.1074/jbc.M009445200; Chaves-Olarte E, 1999, J BIOL CHEM, V274, P11046, DOI 10.1074/jbc.274.16.11046; ChavesOlarte E, 1997, J CLIN INVEST, V100, P1734, DOI 10.1172/JCI119698; Ciesla WP, 1998, J BIOL CHEM, V273, P16021, DOI 10.1074/jbc.273.26.16021; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; DOVE CH, 1990, INFECT IMMUN, V58, P480, DOI 10.1128/IAI.58.2.480-488.1990; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLORIN I, 1986, MICROB PATHOGENESIS, V1, P373, DOI 10.1016/0882-4010(86)90069-0; Frisch C, 2003, BIOCHEM BIOPH RES CO, V300, P706, DOI 10.1016/S0006-291X(02)02919-4; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Giannasca PJ, 2004, VACCINE, V22, P848, DOI 10.1016/j.vaccine.2003.11.030; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Hofmann F, 1997, J BIOL CHEM, V272, P11074; Huelsenbeck J, 2007, INFECT IMMUN, V75, P801, DOI 10.1128/IAI.01705-06; Jank T, 2007, J BIOL CHEM, V282, P35222, DOI 10.1074/jbc.M703138200; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kreimeyer I, 2011, N-S ARCH PHARMACOL, V383, P253, DOI 10.1007/s00210-010-0574-x; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; LYERLY DM, 1992, INFECT IMMUN, V60, P4633, DOI 10.1128/IAI.60.11.4633-4639.1992; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Mesmin B, 2004, J BIOL CHEM, V279, P49876, DOI 10.1074/jbc.M406903200; MITCHELL TJ, 1986, GUT, V27, P78, DOI 10.1136/gut.27.1.78; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; RIEGLER M, 1995, J CLIN INVEST, V95, P2004, DOI 10.1172/JCI117885; Rupnik M, 2005, MICROBIOL-SGM, V151, P199, DOI 10.1099/mic.0.27474-0; Savidge TC, 2003, GASTROENTEROLOGY, V125, P413, DOI 10.1016/S0016-5085(03)00902-8; Schirmer J, 2004, BBA-GEN SUBJECTS, V1673, P66, DOI 10.1016/j.bbagen.2004.03.014; Spyres LM, 2003, INFECT IMMUN, V71, P3294, DOI 10.1128/IAI.71.6.3294-3301.2003; SULLIVAN NM, 1982, INFECT IMMUN, V35, P1032, DOI 10.1128/IAI.35.3.1032-1040.1982; VONEICHELSTREIBER C, 1990, GENE, V96, P107, DOI 10.1016/0378-1119(90)90348-U; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Ziegler MOP, 2008, J MOL BIOL, V377, P1346, DOI 10.1016/j.jmb.2007.12.065	51	61	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8013	8020		10.1074/jbc.M111.298414	http://dx.doi.org/10.1074/jbc.M111.298414			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267739	Green Published, hybrid			2022-12-25	WOS:000301349400017
J	Tachikawa, M; Kanagawa, M; Yu, CC; Kobayashi, K; Toda, T				Tachikawa, Masaji; Kanagawa, Motoi; Yu, Chih-Chieh; Kobayashi, Kazuhiro; Toda, Tatsushi			Mislocalization of Fukutin Protein by Disease-causing Missense Mutations Can Be Rescued with Treatments Directed at Folding Amelioration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; FUKUYAMA-TYPE; LAMININ-BINDING; ABNORMAL GLYCOSYLATION; GENE-MUTATIONS; MUSCLE-CELLS; PHENOTYPE; LOCALIZATION	Fukuyama-type congenital muscular dystrophy (FCMD), the second most common childhood muscular dystrophy in Japan, is caused by alterations in the fukutin gene. Mutations in fukutin cause abnormal glycosylation of alpha-dystroglycan, a cell surface laminin receptor; however, the exact function and pathophysiological role of fukutin are unclear. Although the most prevalent mutation in Japan is a founder retrotransposal insertion, point mutations leading to abnormal glycosylation of alpha-dystroglycan have been reported, both in Japan and elsewhere. To understand better the molecular pathogenesis of fukutin-deficient muscular dystrophies, we constructed 13 disease-causing missense fukutin mutations and examined their pathological impact on cellular localization and alpha-dystroglycan glycosylation. When expressed in C2C12 myoblast cells, wild-type fukutin localizes to the Golgi apparatus, whereas the missense mutants A170E, H172R, H186R, and Y371C instead accumulated in the endoplasmic reticulum. Protein O-mannose beta 1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) also mislocalizes when co-expressed with these missense mutants. The results of nocodazole and brefeldin A experiments suggested that these mutant proteins were not transported to the Golgi via the anterograde pathway. Furthermore, we found that low temperature culture or curcumin treatment corrected the subcellular location of these missense mutants. Expression studies using fukutin-null mouse embryonic stem cells showed that the activity responsible for generating the laminin-binding glycan of alpha-dystroglycan was retained in these mutants. Together, our results suggest that some disease-causing missense mutations cause abnormal folding and localization of fukutin protein, and therefore we propose that folding amelioration directed at correcting the cellular localization may provide a therapeutic benefit to glycosylation-deficient muscular dystrophies.	[Tachikawa, Masaji; Kanagawa, Motoi; Yu, Chih-Chieh; Kobayashi, Kazuhiro; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan	Kobe University	Toda, T (corresponding author), Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan.	toda@med.kobe-u.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Kanagawa, Motoi/0000-0003-0984-6398	Ministry of Health, Labor, and Welfare of Japan of National Center of Neurology and Psychiatry [23B-5]; Research on Psychiatric and Neurological Diseases and Mental Health [H20-016]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23249049]; Japan Society for the Promotion of Science [18790220]; Takeda Science Foundation; Global COE (Centers of Excellence) Program Frontier Biomedical Science Underlying Organelle Network Biology	Ministry of Health, Labor, and Welfare of Japan of National Center of Neurology and Psychiatry; Research on Psychiatric and Neurological Diseases and Mental Health; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Global COE (Centers of Excellence) Program Frontier Biomedical Science Underlying Organelle Network Biology	This work was supported by the Ministry of Health, Labor, and Welfare of Japan Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry 23B-5 and Research on Psychiatric and Neurological Diseases and Mental Health (H20-016), Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research (A) 23249049 (to T. T.), Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (B) 18790220 (to M. T.), Takeda Science Foundation (to M. K.), and Global COE (Centers of Excellence) Program Frontier Biomedical Science Underlying Organelle Network Biology.	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Aravind L, 1999, CURR BIOL, V9, pR836, DOI 10.1016/S0960-9822(00)80039-1; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2005, HUM MOL GENET, V14, P657, DOI 10.1093/hmg/ddi062; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615, DOI 10.1152/ajplung.1995.268.4.L615; Cotarelo RP, 2008, CLIN GENET, V73, P139, DOI 10.1111/j.1399-0004.2007.00936.x; de Bernabe DBV, 2003, J MED GENET, V40, P845; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dolatshad NF, 2005, EXP CELL RES, V309, P370, DOI 10.1016/j.yexcr.2005.06.017; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2006, ANN NEUROL, V60, P603, DOI 10.1002/ana.21006; Hafner-Bratkovic I, 2008, J NEUROCHEM, V104, P1553, DOI 10.1111/j.1471-4159.2007.05105.x; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kawahara G, 2010, HUM MOL GENET, V19, P623, DOI 10.1093/hmg/ddp528; Keramaris-Vrantsis E, 2007, MUSCLE NERVE, V36, P455, DOI 10.1002/mus.20833; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kobayashi K, 2001, FEBS LETT, V489, P192, DOI 10.1016/S0014-5793(01)02088-9; Kondo-Iida E, 1999, HUM MOL GENET, V8, P2303, DOI 10.1093/hmg/8.12.2303; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; Manzini MC, 2008, HUM MUTAT, V29, pE231, DOI 10.1002/humu.20844; Matsumoto H, 2005, NEUROMUSCULAR DISORD, V15, P342, DOI 10.1016/j.nmd.2005.01.009; Matsumoto H, 2004, J BIOCHEM, V135, P709, DOI 10.1093/jb/mvh086; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Murakami T, 2006, ANN NEUROL, V60, P597, DOI 10.1002/ana.20973; Ono K, 2006, J NEUROCHEM, V97, P105, DOI 10.1111/j.1471-4159.2006.03707.x; Pey AL, 2008, J CLIN INVEST, V118, P2858, DOI 10.1172/JCI34355; Silan F, 2003, ANN NEUROL, V53, P392, DOI 10.1002/ana.10491; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vuillaumier-Barrot S, 2009, NEUROMUSCULAR DISORD, V19, P182, DOI 10.1016/j.nmd.2008.12.005; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512; Yoshioka M, 2008, BRAIN DEV-JPN, V30, P59, DOI 10.1016/j.braindev.2007.05.012	43	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8398	8406		10.1074/jbc.M111.300905	http://dx.doi.org/10.1074/jbc.M111.300905			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275357	Green Published, hybrid			2022-12-25	WOS:000301349400054
J	Shan, Q; Lynch, JW				Shan, Qiang; Lynch, Joseph W.			Incompatibility between a Pair of Residues from the Pre-M1 Linker and Cys-loop Blocks Surface Expression of the Glycine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; LONG QT SYNDROME; X-RAY-STRUCTURE; NICOTINIC RECEPTORS; ACETYLCHOLINE-RECEPTOR; AGONIST BINDING; ENDOPLASMIC-RETICULUM; CHARGED RESIDUES; CHLORIDE CHANNEL; QUALITY-CONTROL	Regulation of cell membrane excitability can be achieved either by modulating the functional properties of cell membrane-expressed single channels or by varying the number of expressed channels. Whereas the structural basis underlying single channel properties has been intensively studied, the structural basis contributing to surface expression is less well characterized. Here we demonstrate that homologous substitution of the pre-M1 linker from the beta subunit prevents surface expression of the alpha 1 glycine receptor chloride channel. By investigating a series of chimeras comprising alpha 1 and beta subunits, we hypothesized that this effect was due to incompatibility between a pair of positively charged residues, which lie in close proximity to each other in the tertiary structure, from the pre-M1 linker and Cys-loop. Abolishing either positive charge restored surface expression. We propose that incompatibility (electrostatic repulsion) between this pair of residues misfolds the glycine receptor, and in consequence, the protein is retained in the cytoplasm and prevented from surface expression by the quality control machinery. This hypothesis suggests a novel mechanism, i.e. residue incompatibility, for explaining the mutation-induced reduction in channel surface expression, often present in the cases of hereditary hyperekplexia.	[Shan, Qiang] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia; [Shan, Qiang; Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Lynch, Joseph W.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Sydney; University of Queensland; University of Queensland	Shan, Q (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2050, Australia.	qshan@yahoo.com	Lynch, Joseph/C-8636-2009		Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Australian Research Council and the National Health and Medical Research Council of Australia.	Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Chang YC, 2009, ACTA PHARMACOL SIN, V30, P663, DOI 10.1038/aps.2009.51; Christianson JC, 2004, EMBO J, V23, P4156, DOI 10.1038/sj.emboj.7600436; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Mercado J, 2006, J NEUROSCI, V26, P2031, DOI 10.1523/JNEUROSCI.4555-05.2006; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Purohit P, 2007, NATURE, V446, P930, DOI 10.1038/nature05721; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Shan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028105; Shan QA, 2010, J NEUROSCI METH, V193, P86, DOI 10.1016/j.jneumeth.2010.08.033; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Villmann C, 2009, J NEUROCHEM, V111, P837, DOI 10.1111/j.1471-4159.2009.06372.x; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	44	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2012	287	10					7535	7542		10.1074/jbc.M111.325126	http://dx.doi.org/10.1074/jbc.M111.325126			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	902SL	22267740	hybrid, Green Published			2022-12-25	WOS:000301060200054
J	Lee, J; Jiffar, T; Kupferman, ME				Lee, Junegoo; Jiffar, Tilahun; Kupferman, Michael E.			A Novel Role for BDNF-TrkB in the Regulation of Chemotherapy Resistance in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							NEUROTROPHIC RECEPTOR TRKB; BLADDER-CANCER; MDR1; EXPRESSION; ANOIKIS; NEUROBLASTOMA; GENE; TRANSCRIPTION; METHYLATION; METASTASIS	Mechanisms of resistance for HNSCC to cisplatin (CDDP), the foundational chemotherapeutic agent in the treatment of this disease, remain poorly understood. We previously demonstrated that cisplatin resistance (CR) can be overcome by targeting Trk receptor. In the current study, we explored the potential mechanistic role of the BDNF-TrkB signaling system in the development of CDDP resistance in HNSCC. Utilizing an in vitro system of acquired CR, we confirmed a substantial up-regulation of both BDNF and TrkB at the protein and mRNA levels in CR cells, suggesting an autocrine pathway dysregulation in this system. Exogenous BDNF stimulation led to an enhanced expression of the drug-resistance and antiapoptotic proteins MDR1 and XiAP, respectively, in a dose-dependently manner, demonstrating a key role for BDNF-TrkB signaling in modulating the response to cytotoxic agents. In addition, modulation of TrkB expression induced an enhanced sensitivity of cells to CDDP in HNSCC. Moreover, genetic suppression of TrkB resulted in changes in expression of Bim, XiAP, and MDR1 contributing to HNSCC survival. To elucidate intracellular signaling pathways responsible for mechanisms underlying BDNF/TrkB induced CDDP-resistance, we analyzed expression levels of these molecules following inhibition of Akt. Inhibition of Akt eliminated BDNF effect on MDR1 and Bim expression in OSC-19P cells as well as modulated expressions of MDR1, Bim, and XiAP in OSC-19CR cells. These results suggest BDNF/TrkB system plays critical roles in CDDP-resistance development by utilizing Akt-dependent signaling pathways.	[Lee, Junegoo; Jiffar, Tilahun; Kupferman, Michael E.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Lee, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA.	mekupfer@mdanderson.org			NIH [K08-DE019185]; Joint American-College of Surgeons - Triological Society; MD Anderson Cancer Center; Sheila Newar Cancer Research Foundation; National Institutes of Health through M.D. Anderson's Cancer Center [CA016672]; Characterized Cell Line core, NCI [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE019185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint American-College of Surgeons - Triological Society; MD Anderson Cancer Center; Sheila Newar Cancer Research Foundation; National Institutes of Health through M.D. Anderson's Cancer Center; Characterized Cell Line core, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work is supported by the following funding sources: NIH Grant K08-DE019185 (MEK), Joint American-College of Surgeons - Triological Society Grant (MEK), MD Anderson Cancer Center Physician-Scientist Program (MEK) and Sheila Newar Cancer Research Foundation. This research is also supported in part by the National Institutes of Health through M.D. Anderson's Cancer Center Support Grant CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; STR DNA fingerprinting was done by the Cancer Center Support grant funded Characterized Cell Line core, NCI # CA16672.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Almeida S, 2009, NEUROBIOL DIS, V35, P448, DOI 10.1016/j.nbd.2009.06.006; Baker EK, 2005, ONCOGENE, V24, P8061, DOI 10.1038/sj.onc.1208955; Boisvert-Adamo K, 2008, ONCOGENE, V27, P3301, DOI 10.1038/sj.onc.1211003; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Coley HM, 2009, EJC SUPPL, V7, P3, DOI 10.1016/S1359-6349(09)70003-5; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Coppin CML, 1996, J CLIN ONCOL, V14, P2901, DOI 10.1200/JCO.1996.14.11.2901; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eicher C, 2011, INT J ONCOL, V38, P447, DOI 10.3892/ijo.2010.860; Geiger TR, 2005, CANCER RES, V65, P7033, DOI 10.1158/0008-5472.CAN-05-0709; Han LH, 2007, MED HYPOTHESES, V68, P407, DOI 10.1016/j.mehy.2006.05.038; Ho R, 2002, CANCER RES, V62, P6462; Hoffmann AC, 2010, NEOPLASIA, V12, P628, DOI 10.1593/neo.10402; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Huo HR, 2010, CANCER RES, V70, P8726, DOI 10.1158/0008-5472.CAN-10-0755; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiffar T, 2011, ONCOGENE; Kantharidis P, 1997, CLIN CANCER RES, V3, P2025; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Kupferman Michael E, 2009, J Exp Ther Oncol, V8, P117; Lai PC, 2010, ONCOL REP, V24, P1265, DOI 10.3892/or_00000981; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Li Z, 2007, MOL CANCER THER, V6, P3113, DOI 10.1158/1535-7163.MCT-07-0133; Li ZJ, 2007, EXPERT OPIN THER TAR, V11, P1611, DOI 10.1517/14728222.11.12.1611; Middlemas DS, 1999, J NEURO-ONCOL, V45, P27, DOI 10.1023/A:1006342423175; Nemati F, 2010, ANTI-CANCER DRUG, V21, P25, DOI 10.1097/CAD.0b013e3283300a29; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Poplawski T., 2008, Experimental Oncology, V30, P112; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Schulte JH, 2005, ONCOGENE, V24, P165, DOI 10.1038/sj.onc.1208000; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Sharma G, 2010, CLIN BIOCHEM, V43, P373, DOI 10.1016/j.clinbiochem.2009.10.009; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Weinreb O, 2006, J NEURAL TRANSM-SUPP, P457; Yague E, 2003, J BIOL CHEM, V278, P10344, DOI 10.1074/jbc.M211093200; Yilmaz T, 2010, CANC BIOL THER, P10; Zhu NX, 2008, MOL CANCER THER, V7, P1101, DOI 10.1158/1535-7163.MCT-08-0179	43	39	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30246	10.1371/journal.pone.0030246	http://dx.doi.org/10.1371/journal.pone.0030246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276165	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100028
J	Zhang, T; Wu, ZQ; Du, J; Hu, YF; Liu, LG; Yang, F; Jin, Q				Zhang, Ting; Wu, Zhiqiang; Du, Jiang; Hu, Yongfeng; Liu, Liguo; Yang, Fan; Jin, Qi			Anti- Japanese-Encephalitis-Viral Effects of Kaempferol and Daidzin and Their RNA-Binding Characteristics	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; B-VIRUS ACTIVITIES; IN-VITRO; SOY ISOFLAVONES; ALKALOIDS BERBERINE; BIOAVAILABILITY; FLAVIVIRUSES; FLAVONOIDS; PALMATINE; EXTRACTS	New therapeutic tools and molecular targets are needed for treatment of Japanese encephalitis virus (JEV) infections. JEV requires an alpha-1 translational frameshift to synthesize the NS1' protein required for viral neuroinvasiveness. Several flavonoids have been shown to possess antiviral activity in vitro against a wide spectrum of viruses. To date, the antiviral activities of flavonol kaempferol (Kae) and isoflavonoid daidzin (Dai) against JEV have not been described. Methodology/Principal Findings: The 50% cytotoxic concentration (CC50) and 50% effective concentration (EC50) against JEV were investigated in BHK21 cells by MTS reduction. Activity against viral genomic RNA and proteins was measured by real-time RT-PCR and western blotting. The frameshift site RNA-binding characterization was also determined by electrospray ionization mass spectrometry, isothermal titration calorimetry and autodocking analysis. EC50 values of Kae and Dai were 12.6 and 25.9 mu M against JEV in cells pretreated before infection, whereas in cells infected before treatment, EC50 was 21.5 and 40.4 mu M, respectively. Kae exhibited more potent activity against JEV and RNA binding in cells following internalization through direct inhibition of viral replication and protein expression, indicating that its antiviral activity was principally due to direct virucidal effects. The JEV frameshift site RNA (fsRNA) was selected as a target for assaying Kae and Dai. ITC of fsRNA revealed an apparent K-b value for Kae that was nine fold stronger than that for Dai. This binding was confirmed and localized to the RNA using ESI-MS and autodock analysis. Kae could form non-covalent complexes with fsRNA more easily than Dai could. Conclusions/Significance: Kae demonstrates more potent antiviral activity against JEV than does Dai. The mode of action of Kae as an anti-JEV agent seems to be related to its ability to inactivate virus by binding with JEV fsRNA.	[Zhang, Ting] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhang, T (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China.	ymf129@163.com; jinqi36@yahoo.com.cn	Zhang, Ting/S-8215-2019; wu, zhi/GXH-3041-2022		Ministry of Science and Technology of China [2011CB504902]; National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment'' [2009ZX10004-102]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2009IPB112]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment''; Institute of Pathogen Biology, Chinese Academy of Medical Sciences	The work was supported by the National Basic Research Program (Grant No. 2011CB504902) from the Ministry of Science and Technology of China, National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment'' (2009ZX10004-102), and an intramural grant from the Institute of Pathogen Biology, Chinese Academy of Medical Sciences (2009IPB112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOROS M, 1992, J NAT PROD, V55, P1732, DOI 10.1021/np50090a003; Andres A, 2009, J NUTR BIOCHEM, V20, P563, DOI 10.1016/j.jnutbio.2009.04.004; Brown L, 2008, J ETHNOPHARMACOL, V119, P588, DOI 10.1016/j.jep.2008.06.028; Cassidy A, 2006, J AOAC INT, V89, P1182; Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14; Giri P, 2008, MOL BIOSYST, V4, P341, DOI 10.1039/b716356h; Greiner LL, 2001, J ANIM SCI, V79, P3113; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hendrich AB, 2006, ACTA PHARMACOL SIN, V27, P27, DOI 10.1111/j.1745-7254.2006.00238.x; HENION J, 1993, THER DRUG MONIT, V15, P563, DOI 10.1097/00007691-199312000-00020; Hills SL, 2009, EMERG INFECT DIS, V15, P1333, DOI 10.3201/eid1508.090149; Holt PA, 2008, J CHEM INF MODEL, V48, P1602, DOI 10.1021/ci800063v; Islam M, 2007, BIOPHYS CHEM, V125, P508, DOI 10.1016/j.bpc.2006.11.001; Islam MM, 2009, DNA CELL BIOL, V28, P637, DOI 10.1089/dna.2009.0930; Islam MM, 2009, J PHYS CHEM B, V113, P1210, DOI 10.1021/jp806597w; Jeong HJ, 2009, BIOORGAN MED CHEM, V17, P6816, DOI 10.1016/j.bmc.2009.08.036; Kanakis CD, 2007, CELL BIOCHEM BIOPHYS, V49, P29, DOI 10.1007/s12013-007-0037-2; Kempen EC, 2000, ANAL CHEM, V72, P5411, DOI 10.1021/ac000540e; Kubo Y, 2003, ARCH VIROL, V148, P1899, DOI 10.1007/s00705-003-0164-z; Levesque D, 2007, BIOCHEM J, V403, P129, DOI 10.1042/BJ20061216; Li JY, 2008, BIOL PHARM BULL, V31, P743, DOI 10.1248/bpb.31.743; Li JY, 2008, ANTIVIR RES, V79, P114, DOI 10.1016/j.antiviral.2008.03.001; Liu AL, 2008, BIOORGAN MED CHEM, V16, P7141, DOI 10.1016/j.bmc.2008.06.049; Liu Y, 2010, METHODS MOL BIOL, V613, P1, DOI 10.1007/978-1-60327-418-0_1; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Marcheschi RJ, 2009, ACS CHEM BIOL, V4, P844, DOI 10.1021/cb900167m; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Morris JR, 1998, J ANIM SCI, V76, P2759; Nafisi S, 2009, J PHOTOCH PHOTOBIO B, V94, P1, DOI 10.1016/j.jphotobiol.2008.08.001; Nielsen ILF, 2007, NUTR CANCER, V57, P1, DOI 10.1080/01635580701267677; Orhan DD, 2009, MICROBIOL RES; Penn SG, 1997, J AM SOC MASS SPECTR, V8, P244, DOI 10.1016/S1044-0305(96)00242-5; Robin V, 2001, ANTIVIR CHEM CHEMOTH, V12, P283, DOI 10.1177/095632020101200503; Rosu F, 2003, BIOCHEMISTRY-US, V42, P10361, DOI 10.1021/bi034531m; Rosu F, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf081; Rosu F, 2008, BIOCHIMIE, V90, P1074, DOI 10.1016/j.biochi.2008.01.005; Salvati AL, 2004, ANTIMICROB AGENTS CH, V48, P2233, DOI 10.1128/AAC.48.6.2233-2243.2004; Saxena SK, 2009, J INFECT DEV COUNTR, V3, P517, DOI 10.3855/jidc.470; Tarahovsky YS, 2008, PLANT SIGNAL BEHAV, V3, P609, DOI 10.4161/psb.3.8.6359; van den Hurk AF, 2008, EMERG INFECT DIS, V14, P1736, DOI 10.3201/eid1411.071368; van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510; Van Dyke MW, 2010, METHODS MOL BIOL, V613, P193, DOI 10.1007/978-1-60327-418-0_12; Verge S, 2002, TETRAHEDRON LETT, V43, P2363, DOI 10.1016/S0040-4039(02)00255-1; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wright B, 2010, BRIT J PHARMACOL, V159, P1312, DOI 10.1111/j.1476-5381.2009.00632.x	45	39	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30259	10.1371/journal.pone.0030259	http://dx.doi.org/10.1371/journal.pone.0030259			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276167	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100029
J	Monach, PA; Kumpers, P; Lukasz, A; Tomasson, G; Specks, U; Stone, JH; Cuthbertson, D; Krischer, J; Carette, S; Ding, LN; Hoffman, GS; Ikle, D; Kallenberg, CGM; Khalidi, NA; Langford, CA; Seo, P; St Clair, EW; Spiera, R; Tchao, N; Ytterberg, SR; Haubitz, M; Merkel, PA				Monach, Paul A.; Kuempers, Philipp; Lukasz, Alexander; Tomasson, Gunnar; Specks, Ulrich; Stone, John H.; Cuthbertson, David; Krischer, Jeffrey; Carette, Simon; Ding, Linna; Hoffman, Gary S.; Ikle, David; Kallenberg, Cees G. M.; Khalidi, Nader A.; Langford, Carol A.; Seo, Philip; St Clair, E. William; Spiera, Robert; Tchao, Nadia; Ytterberg, Steven R.; Haubitz, Marion; Merkel, Peter A.			Circulating Angiopoietin-2 as a Biomarker in ANCA-Associated Vasculitis	PLOS ONE			English	Article							SOLUBLE ADHESION MOLECULES; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; TIE-2 LIGAND ANGIOPOIETIN-2; CRITICALLY-ILL PATIENTS; C-REACTIVE PROTEIN; WEGENERS-GRANULOMATOSIS; E-SELECTIN; FOLLOW-UP; SYSTEMIC VASCULITIS; DISEASE-ACTIVITY	The endothelial-specific Angiopoietin-Tie2 ligand-receptor system is an important regulator of endothelial activation. Binding of angiopoietin-2 (Ang-2) to Tie2 receptor renders the endothelial barrier responsive to pro-inflammatory cytokines. We previously showed that circulating Ang-2 correlated with disease severity in a small cohort of critically ill patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. The current study reassessed Ang-2 as a biomarker of disease activity and relapse in AAV. Circulating Ang-2 was measured in 162 patients with severe AAV (BVAS/WG >= 3, with or without glomerulonephritis) in a clinical trial. Ang-2 levels during active AAV were compared to levels in the same patients during remission (BVAS/WG = 0). Levels in clinical subsets of AAV were compared, and association with future disease course was assessed. Ang-2 levels were elevated in severe disease (median 3.0 ng/ml, interquartile range 1.9-4.4) compared to healthy controls (1.2, 0.9-1.5). However, they did not reliably decline with successful treatment (median 2.6 ng/ml, interquartile range 1.9-3.8, median change -0.1). Ang-2 correlated weakly with BVAS/WG score (r = 0.17), moderately with markers of systemic inflammation (r = 0.25-0.41), and inversely with renal function (r = -0.36). Levels were higher in patients with glomerulonephritis, but levels adjusted for renal dysfunction were no different in patients with or without glomerulonephritis. Levels were higher in patients with newly diagnosed AAV and lower in patients in whom treatment had recently been started. Ang-2 levels during active disease did not predict response to treatment, and Ang-2 levels in remission did not predict time to flare. Thus, Ang-2 appears to have limited practical value in AAV as a biomarker of disease activity at time of measurement or for predicting future activity.	[Monach, Paul A.; Tomasson, Gunnar; Merkel, Peter A.] Boston Univ, Rheumatol Sect, Dept Med, Sch Med,Vasculitis Ctr, Boston, MA 02215 USA; [Kuempers, Philipp; Lukasz, Alexander; Haubitz, Marion] Hannover Med Sch, Dept Hypertens & Nephrol, D-3000 Hannover, Germany; [Kuempers, Philipp] Univ Hosp Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med, Munster, Germany; [Specks, Ulrich] Mayo Clin Coll Med, Div Pulm & Crit Care Med, Rochester, MN USA; [Stone, John H.] Massachusetts Gen Hosp, Rheumatol Unit, Boston, MA 02114 USA; [Cuthbertson, David; Krischer, Jeffrey] Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA; [Carette, Simon] Univ Toronto, Div Rheumatol, Toronto, ON, Canada; [Ding, Linna] NIAID, Bethesda, MD 20892 USA; [Hoffman, Gary S.; Langford, Carol A.] Cleveland Clin, Ctr Vasculitis Care & Res, Cleveland, OH 44106 USA; [Ikle, David] Rho, Fed Syst Div, Chapel Hill, NC USA; [Kallenberg, Cees G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Khalidi, Nader A.] McMaster Univ, Div Rheumatol, Hamilton, ON, Canada; [Seo, Philip] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA; [St Clair, E. William] Duke Univ, Div Rheumatol & Immunol, Durham, NC USA; [Spiera, Robert] Hosp Special Surg, Div Rheumatol, New York, NY 10021 USA; [Tchao, Nadia] Immune Tolerance Network, San Francisco, CA USA; [Ytterberg, Steven R.] Mayo Clin Coll Med, Div Rheumatol, Rochester, MN USA	Boston University; Hannover Medical School; University of Munster; Mayo Clinic; Harvard University; Massachusetts General Hospital; State University System of Florida; University of South Florida; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cleveland Clinic Foundation; Rho; University of Groningen; McMaster University; Johns Hopkins University; Duke University; Immune Tolerance Network; Mayo Clinic	Monach, PA (corresponding author), Boston Univ, Rheumatol Sect, Dept Med, Sch Med,Vasculitis Ctr, Boston, MA 02215 USA.	pmonach@bu.edu	Spiera, Robert/W-7479-2019; Cuthbertson, David/AAC-7703-2019; Ikle, David/AAK-7541-2020; Krischer, Jeffrey P/I-5004-2012	Ikle, David/0000-0003-0091-5246; Monach, Paul/0000-0003-4937-0515; Seo, Philip/0000-0003-3435-6737	National Institute of Arthritis and Musculoskeletal and Skin Diseases [U54AR057319, RC1 AR058303, P60 AR047785]; National Center for Research Resources [U54 RR019497]; National Institute of Neurological Disorders and Stroke [NS064808]; Office of Rare Diseases Research; NIH [N01 AI15416, M01 RR00533, K24 AR02224]; National Institute of Allergy and Infectious Diseases; Juvenile Diabetes Research Foundation; National Center for Research Resources (NCRR) [RR024150-01, RR025005, K24 AR049185, K23 AR052820]; Boston University [RR 025771]; Arthritis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771, M01RR000533, UL1RR024150, UL1RR025005, U54RR019497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002224, K24AR049185, RC1AR058303, U54AR057319, P60AR047785, K23AR052820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS064808] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Rare Diseases Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Boston University; Arthritis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was sponsored by the Vasculitis Clinical Research Consortium which has received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR057319, RC1 AR058303, and P60 AR047785), the National Center for Research Resources (U54 RR019497), the National Institute of Neurological Disorders and Stroke (NS064808), and the Office of Rare Diseases Research. The Rituximab in ANCA-Associated Vasculitis (RAVE) trial was performed with the support of the Immune Tolerance Network (NIH Contract #N01 AI15416), an international clinical research consortium supported by the National Institute of Allergy and Infectious Diseases and the Juvenile Diabetes Research Foundation. Genentech and Biogen Idec provided the study medications and partial funding of the clinical trial. For this ancillary study, Genentech had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. At the Mayo Clinic and Foundation, the trial was supported by a Clinical and Translational Science Award from the National Center for Research Resources (NCRR) (RR024150-01); at Johns Hopkins University, by grants from the NCRR (RR025005) and career development awards (K24 AR049185 to Dr. Stone, and K23 AR052820 to Dr. Seo); and at Boston University, by a Clinical and Translational Science Award (RR 025771), grants from the National Institutes of Health (M01 RR00533) and a career development award (K24 AR02224 to Dr. Merkel). Dr. Monach was also supported by an Arthritis Investigator Award from the Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara J, 2001, NEPHROL DIAL TRANSPL, V16, P276, DOI 10.1093/ndt/16.2.276; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boehme MWJ, 1996, AM J MED, V101, P387, DOI 10.1016/S0002-9343(96)00230-6; Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, J HYPERTENS, V27, P1641, DOI 10.1097/HJH.0b013e32832be575; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Erdbruegger U, 2008, RHEUMATOLOGY, V47, P1820, DOI 10.1093/rheumatology/ken373; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Finkielman JD, 2007, ANN INTERN MED, V147, P611, DOI 10.7326/0003-4819-147-9-200711060-00005; Girard T, 2001, RHEUMATOLOGY, V40, P147, DOI 10.1093/rheumatology/40.2.147; Hergesell O, 1996, THROMB HAEMOSTASIS, V75, P892; HIND CRK, 1984, CLIN NEPHROL, V21, P341; Kalsch AI, 2010, J RHEUMATOL, V37, P2319, DOI 10.3899/jrheum.100302; KERR GS, 1993, ARTHRITIS RHEUM, V36, P365, DOI 10.1002/art.1780360312; Kumpers P, 2009, ANN RHEUM DIS, V68, P1638, DOI 10.1136/ard.2008.094664; Kumpers P, 2008, CRIT CARE, V12, DOI 10.1186/cc7130; KUMPERS P, 2009, NEPHROL DIAL TRANSPL; Kyndt X, 1999, AM J MED, V106, P527, DOI 10.1016/S0002-9343(99)00064-9; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lukasz A, 2008, CRIT CARE, V12, DOI 10.1186/cc6966; Monach PA, 2011, ARTHRITIS RHEUM-US, V63, P3988, DOI 10.1002/art.30615; MROWKA C, 1994, CLIN INVESTIGATOR, V72, P762; Ohta N, 2001, AURIS NASUS LARYNX, V28, P311, DOI 10.1016/S0385-8146(01)00097-9; Olle EW, 2007, PROTEOM CLIN APPL, V1, P1212, DOI 10.1002/prca.200600906; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Schneeweis C, 2010, CLIN EXP RHEUMATOL, V28, pS62; Sproson EL, 2007, RHINOLOGY, V45, P63; STEGEMAN CA, 1994, ARTHRITIS RHEUM, V37, P1228, DOI 10.1002/art.1780370818; Stone JH, 2001, ARTHRITIS RHEUM, V44, P912, DOI 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; Whitcomb DC, 2010, AM J GASTROENTEROL, V105, P2287, DOI 10.1038/ajg.2010.183; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567	41	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30197	10.1371/journal.pone.0030197	http://dx.doi.org/10.1371/journal.pone.0030197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279570	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900048
J	Sakoulas, G; Nam, SJ; Loesgen, S; Fenical, W; Jensen, PR; Nizet, V; Hensler, M				Sakoulas, George; Nam, Sang-Jip; Loesgen, Sandra; Fenical, William; Jensen, Paul R.; Nizet, Victor; Hensler, Mary			Novel Bacterial Metabolite Merochlorin A Demonstrates in vitro Activity against Multi-Drug Resistant Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							LINEZOLID RESISTANCE; GENE; NONSUSCEPTIBILITY; ISOLATE	Background: We evaluated the in vitro activity of a merochlorin A, a novel compound with a unique carbon skeleton, against a spectrum of clinically relevant bacterial pathogens and against previously characterized clinical and laboratory Staphylococcus aureus isolates with resistance to numerous antibiotics. Methods: Merochlorin A was isolated and purified from a marine-derived actinomycete strain CNH189. Susceptibility testing for merochlorin A was performed against previously characterized human pathogens using broth microdilution and agar dilution methods. Cytotoxicity was assayed in tissue culture assays at 24 and 72 hours against human HeLa and mouse sarcoma L929 cell lines. Results: The structure of as new antibiotic, merochlorin A, was assigned by comprehensive spectroscopic analysis. Merochlorin A demonstrated in vitro activity against Gram-positive bacteria, including Clostridium dificile, but not against Gram negative bacteria. In S. aureus, susceptibility was not affected by ribosomal mutations conferring linezolid resistance, mutations in dlt or mprF conferring resistance to daptomycin, accessory gene regulator knockout mutations, or the development of the vancomycin-intermediate resistant phenotype. Merochlorin A demonstrated rapid bactericidal activity against MRSA. Activity was lost in the presence of 20% serum. Conclusions: The unique meroterpenoid, merochlorin A demonstrated excellent in vitro activity against S. aureus and C. dificile and did not show cross-resistance to contemporary antibiotics against Gram positive organisms. The activity was, however, markedly reduced in 20% human serum. Future directions for this compound may include evaluation for topical use, coating biomedical devices, or the pursuit of chemically modified derivatives of this compound that retain activity in the presence of serum.	[Sakoulas, George; Nizet, Victor; Hensler, Mary] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Nam, Sang-Jip; Loesgen, Sandra; Fenical, William; Jensen, Paul R.] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Fenical, William; Nizet, Victor; Hensler, Mary] Univ Calif San Diego, Sch Pharm & Pharmaceut Sci, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Sakoulas, G (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA.	gsakoulas@ucsd.edu	Nizet, Victor/AAF-3190-2019	jensen, paul/0000-0003-2349-1888; Nizet, Victor/0000-0003-3847-0422; Fenical, William/0000-0002-8955-1735	National Institutes of Health [RO1-GM08555]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by National Institutes of Health Grant RO1-GM08555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P902; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P813; Coates T, 2009, J ANTIMICROB CHEMOTH, V64, P9, DOI 10.1093/jac/dkp159; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Craig W, 1996, ANTIBIOTICS LAB MED, P296; Jarvis WR, 2007, AM J INFECT CONTROL, V35, P631, DOI 10.1016/j.ajic.2007.10.009; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Meka VG, 2004, J INFECT DIS, V190, P311, DOI 10.1086/421471; Sakoulas G, 2003, J INFECT DIS, V187, P929, DOI 10.1086/368128; Sakoulas G, 2003, J ANTIMICROB CHEMOTH, V51, P1039, DOI 10.1093/jac/dkg194; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Sakoulas G, 2008, CLIN INFECT DIS, V46, pS360, DOI 10.1086/533592; Sakoulas G, 2008, J CLIN MICROBIOL, V46, P220, DOI 10.1128/JCM.00660-07; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Yang SJ, 2009, J INFECT DIS, V200, P1916, DOI 10.1086/648473; Zurenko GE, 1996, ANTIMICROB AGENTS CH, V40, P839, DOI 10.1128/AAC.40.4.839	19	56	56	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29439	10.1371/journal.pone.0029439	http://dx.doi.org/10.1371/journal.pone.0029439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279537	Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900015
J	Hsiao, M; Morris, SK; Bassani, DG; Montgomery, AL; Thakur, JS; Jha, P				Hsiao, Marvin; Morris, Shaun K.; Bassani, Diego G.; Montgomery, Ann L.; Thakur, J. S.; Jha, Prabhat			Factors Associated with Physician Agreement on Verbal Autopsy of over 11500 Injury Deaths in India	PLOS ONE			English	Article							ADULT DEATHS; VALIDATION	Introduction: Worldwide, injuries account for 9.8% of all deaths. The majority of these deaths occur in low-and middle-income countries where vital registration systems are often inadequate. Verbal autopsy (VA) is a tool used to ascertain cause of death in such settings. Validation studies for VA using hospital diagnosed causes of death as comparisons have shown that injury deaths can be reliably diagnosed by VA. However, no study has assessed the factors that may affect physicians' abilities to code specific causes of injury death using VA. Method/Principal Findings: This study used data from over 11 500 verbal autopsies of injury deaths from the Million Death Study (MDS) in which 6.3 million people in India were monitored from 2001-2003 for vital events. Deaths that occurred in the MDS were coded by two independent physicians. This study focused on whether physician agreement on the classification of injury deaths was affected by characteristics of the deceased and respondent. Agreement was analyzed using three primary methods: 1) kappa statistic; 2) sensitivity and specificity analysis using the final VA diagnosed category of injury death as gold standard; and 3) multivariate logistic regression using a conceptual hierarchical model. The overall agreement for all injury deaths was 77.9% with a kappa of 0.74 (99% CI 0.74-0.75). Deaths in the injury categories of "transport'', "falls'', "drowning'' and "other unintentional injury'' occurring outside the home were associated with greater physician agreement than those occurring at home. In contrast, self-inflicted injury deaths that occurred outside the home were associated with lower physician agreement. Conclusions/Significance: With few exceptions, most characteristics of the deceased and the respondent did not influence physician agreement on the classification of injury deaths. Physician training and continued adaptation of the VA tool should focus on the reasons these factors influenced physician agreement.	[Hsiao, Marvin; Morris, Shaun K.; Bassani, Diego G.; Montgomery, Ann L.; Thakur, J. S.; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Hsiao, Marvin] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada; [Morris, Shaun K.] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Infect Dis, Toronto, ON M5B 1W8, Canada; [Bassani, Diego G.; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 1W8, Canada; [Bassani, Diego G.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Thakur, J. S.] Post Grad Inst Med Educ & Res PGIMER, Dept Community Med, Chandigarh, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Hsiao, M (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	marvin.my.hsiao@gmail.com	Bassani, Diego/G-2827-2015	Bassani, Diego/0000-0001-6704-3820; Jha, Prabhat/0000-0001-7067-8341				[Anonymous], SCAND J PUBLIC HLT S; Byass P, 2006, SCAND J PUBLIC HEALT, V34, P26, DOI 10.1080/14034940510032202; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Morris SK, 2010, PLOS ONE, V5, pA170, DOI 10.1371/journal.pone.0009583; Murray CJL, 2007, PLOS MED, V4, P1739, DOI 10.1371/journal.pmed.0040327; Quigley MA, 1999, INT J EPIDEMIOL, V28, P1081, DOI 10.1093/ije/28.6.1081; Reichenheim ME, 2004, STATA J, V4, P421, DOI 10.1177/1536867X0400400404; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; StataCorp L, 2007, STAT DAT AN STAT SOF; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; World Health Organisation, 2019, INT STAT CLASS DIS R; World Health Organization, 2008, The global burden of disease: 2004 update; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181	20	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30336	10.1371/journal.pone.0030336	http://dx.doi.org/10.1371/journal.pone.0030336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272338	gold, Green Published			2022-12-25	WOS:000301454400116
J	Kortman, GAM; Boleij, A; Swinkels, DW; Tjalsma, H				Kortman, Guus A. M.; Boleij, Annemarie; Swinkels, Dorine W.; Tjalsma, Harold			Iron Availability Increases the Pathogenic Potential of Salmonella Typhimurium and Other Enteric Pathogens at the Intestinal Epithelial Interface	PLOS ONE			English	Article							SUPPLEMENTATION; CHILDREN; PERMEABILITY; EXPRESSION; INFECTION; COMMUNITY; TRANSPORT; VIRULENCE; HEPCIDIN; SYSTEM	Recent trials have questioned the safety of untargeted oral iron supplementation in developing regions. Excess of luminal iron could select for enteric pathogens at the expense of beneficial commensals in the human gut microflora, thereby increasing the incidence of infectious diseases. The objective of the current study was to determine the effect of high iron availability on virulence traits of prevalent enteric pathogens at the host-microbe interface. A panel of enteric bacteria was cultured under iron-limiting conditions and in the presence of increasing concentrations of ferric citrate to assess the effect on bacterial growth, epithelial adhesion, invasion, translocation and epithelial damage in vitro. Translocation and epithelial integrity experiments were performed using a transwell system in which Caco-2 cells were allowed to differentiate to a tight epithelial monolayer mimicking the intestinal epithelial barrier. Growth of Salmonella typhimurium and other enteric pathogens was increased in response to iron. Adhesion of S. typhimurium to epithelial cells markedly increased when these bacteria were pre-incubated with increasing iron concentration (P = 0.0001), whereas this was not the case for the nonpathogenic Lactobacillus plantarum (P = 0.42). Cellular invasion and epithelial translocation of S. typhimurium followed the trend of increased adhesion. Epithelial damage was increased upon incubation with S. typhimurium or Citrobacter freundii that were pre-incubated under iron-rich conditions. In conclusion, our data fit with the consensus that oral iron supplementation is not without risk as iron could, in addition to inducing pathogenic overgrowth, also increase the virulence of prevalent enteric pathogens.	[Kortman, Guus A. M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis IGMD, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kortman, GAM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands.	H.Tjalsma@labgk.umcn.nl	Swinkels, Dorine W./H-8098-2014; Kortman, Guus AM/F-9690-2010; Boleij, Annemarie/L-3975-2013; Tjalsma, Harold/I-7146-2012	Swinkels, Dorine W./0000-0002-1040-9446; Boleij, Annemarie/0000-0003-4495-5880; Kortman, Guus/0000-0002-8076-0661	Dutch Cancer Society [KUN 2006-3591]; Dutch Digestive Diseases Foundation [WO 10-53]	Dutch Cancer Society(KWF Kankerbestrijding); Dutch Digestive Diseases Foundation	This work was in part supported by the Dutch Cancer Society (KUN 2006-3591) and the Dutch Digestive Diseases Foundation (WO 10-53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Behrens I, 2001, PHARM RES-DORDR, V18, P1138, DOI 10.1023/A:1010974909998; Boleij A, 2011, J INFECT IN PRESS; Boleij A, 2011, J INFECT DIS, V203, P1101, DOI 10.1093/infdis/jiq169; Bullen JJ, 2005, FEMS IMMUNOL MED MIC, V43, P325, DOI 10.1016/j.femsim.2004.11.010; Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Ferruzza S, 2003, CELL MOL BIOL, V49, P89; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Foster SL, 2001, J NUTR, V131, P1452, DOI 10.1093/jn/131.5.1452; Gera T, 2002, BMJ-BRIT MED J, V325, P1142, DOI 10.1136/bmj.325.7373.1142; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Hansen SL, 2010, J DAIRY SCI, V93, P656, DOI 10.3168/jds.2009-2341; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; JEPSON MA, 1995, INFECT IMMUN, V63, P356, DOI 10.1128/IAI.63.1.356-359.1995; Kemna EHJM, 2007, HAEMATOLOGICA, V93, P90, DOI 10.3324/haematol.11705; Kohler H, 2007, AM J PHYSIOL-GASTR L, V293, pG178, DOI 10.1152/ajpgi.00535.2006; Natoli M, 2009, TOXICOL IN VITRO, V23, P1510, DOI 10.1016/j.tiv.2009.06.016; Nchito M, 2006, T ROY SOC TROP MED H, V100, P791, DOI 10.1016/j.trstmh.2005.10.016; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; PANDEY A, 1994, APPL MICROBIOL BIOT, V40, P735, DOI [10.1007/BF00173337, 10.1007/s002530050058]; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Teixido L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019711; Tompkins GR, 2001, CURR MICROBIOL, V43, P38, DOI 10.1007/s002840010257; Werner T, 2010, GUT; WHO, 2006, CONCL REC WHO CONS P; WHO UNICEF, 2006, WHO STAT IR SUPPL YO; WHO/UNICEF, 2009, DIARRH WHY CHILDR AR; *WHO UNICEF, 2004, FOC AN INT APPR EFF; Zimmermann MB, 2010, AM J CLIN NUTR; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	34	130	133	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29968	10.1371/journal.pone.0029968	http://dx.doi.org/10.1371/journal.pone.0029968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272265	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400044
J	Kubinyi, E; Vas, J; Hejjas, K; Ronai, Z; Bruder, I; Turcsan, B; Sasvari-Szekely, M; Miklosi, A				Kubinyi, Eniko; Vas, Judit; Hejjas, Krisztina; Ronai, Zsolt; Bruder, Ildiko; Turcsan, Borbala; Sasvari-Szekely, Maria; Miklosi, Adam			Polymorphism in the Tyrosine Hydroxylase (TH) Gene Is Associated with Activity-Impulsivity in German Shepherd Dogs	PLOS ONE			English	Article							DOPAMINE-D4 RECEPTOR GENE; REPEAT POLYMORPHISM; PERSONALITY-TRAITS; CANIS-FAMILIARIS; BEHAVIOR TEST; MODEL; ATTENTION; SEARCH; TEMPERAMENT; VALIDATION	We investigated the association between repeat polymorphism in intron 4 of the tyrosine hydroxylase (TH) gene and two personality traits, activity-impulsivity and inattention, in German Shepherd Dogs. The behaviour of 104 dogs was characterized by two instruments: (1) the previously validated Dog-Attention Deficit Hyperactivity Disorder Rating Scale (Dog-ADHD RS) filled in by the dog owners and (2) the newly developed Activity-impulsivity Behavioural Scale (AIBS) containing four subtests, scored by the experimenters. Internal consistency, inter-observer reliability, test-retest reliability and convergent validity were demonstrated for AIBS. Dogs possessing at least one short allele were proved to be more active-impulsive by both instruments, compared to dogs carrying two copies of the long allele (activity-impulsivity scale of Dog-ADHD RS: p = 0.007; AIBS: p = 0.023). The results have some potential to support human studies; however, further research should reveal the molecular function of the TH gene variants, and look for the effect in more breeds.	[Kubinyi, Eniko; Vas, Judit; Bruder, Ildiko; Turcsan, Borbala; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Hejjas, Krisztina; Ronai, Zsolt; Sasvari-Szekely, Maria] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary	Eotvos Lorand University; Semmelweis University	Kubinyi, E (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	kubinyie@gmail.com	Kubinyi, Eniko/B-5824-2013; Turcsán, Borbála/I-7983-2018; Ronai, Zsolt/A-2473-2008; Vas, Judit/GRJ-7640-2022; Miklosi, Adam/N-5147-2017	Kubinyi, Eniko/0000-0002-4468-9845; Turcsán, Borbála/0000-0002-0197-5243; Ronai, Zsolt/0000-0002-0909-7932; Miklosi, Adam/0000-0003-4831-8985	EU [FP7 ICT-215554 LIREC]; Hungarian Scientific Research Fund [K 84036]; Bolyai Foundation of the Hungarian Academy of Sciences	EU(European Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Foundation of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the EU FP7 ICT-215554 LIREC, the Hungarian Scientific Research Fund (K 84036) and the Bolyai Foundation of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JN, 2007, PSYCHIAT GENET, V17, P23, DOI 10.1097/YPG.0b013e32801140f2; Chase K, 2009, J HERED, P1; Diederich C, 2006, APPL ANIM BEHAV SCI, V97, P51, DOI 10.1016/j.applanim.2005.11.018; DuPaul G. J., 1998, ADHD RATING SCALE 4; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Hejjas K, 2007, ANIM GENET, V38, P629, DOI 10.1111/j.1365-2052.2007.01657.x; Hejjas K, 2009, GENES BRAIN BEHAV, V8, P330, DOI 10.1111/j.1601-183X.2008.00475.x; Hejjas K, 2007, MAMM GENOME, V18, P871, DOI 10.1007/s00335-007-9070-0; Hennessy MB, 2001, APPL ANIM BEHAV SCI, V73, P217, DOI 10.1016/S0168-1591(01)00139-3; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Konno A, 2011, BIOL LETT; Korsten P, 2010, MOL ECOL, V19, P832, DOI 10.1111/j.1365-294X.2009.04518.x; Kwan VSY, 2008, SOC COGNITION, V26, P129, DOI 10.1521/soco.2008.26.2.129; Lit L, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-1; Maejima M, 2007, APPL ANIM BEHAV SCI, V107, P287, DOI 10.1016/j.applanim.2006.10.005; Momozawa Y, 2005, MAMM GENOME, V16, P538, DOI 10.1007/s00335-005-0021-3; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Ostrander EA, 2000, TRENDS GENET, V16, P117, DOI 10.1016/S0168-9525(99)01958-7; Overall KL, 2000, PROG NEURO-PSYCHOPH, V24, P727, DOI 10.1016/S0278-5846(00)00104-4; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Persson ML, 1997, PSYCHIAT RES, V72, P73, DOI 10.1016/S0165-1781(97)00068-1; Persson ML, 2000, PSYCHIAT RES, V95, P1, DOI 10.1016/S0165-1781(00)00160-8; Pongracz P, 2005, J COMP PSYCHOL, V119, P136, DOI 10.1037/0735-7036.119.2.136; Rooney NJ, 2007, APPL ANIM BEHAV SCI, V103, P90, DOI 10.1016/j.applanim.2006.03.016; Ruefenacht S, 2002, APPL ANIM BEHAV SCI, V79, P113, DOI 10.1016/S0168-1591(02)00134-X; Schwandt ML, 2010, BIOL PSYCHIAT, V67, P323, DOI 10.1016/j.biopsych.2009.10.016; Serretti A, 1998, AM J MED GENET, V81, P127, DOI 10.1002/(SICI)1096-8628(19980328)81:2<127::AID-AJMG1>3.3.CO;2-X; Sharma P, 1998, HYPERTENSION, V32, P676, DOI 10.1161/01.HYP.32.4.676; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Spady TC, 2008, AM J HUM GENET, V82, P10, DOI 10.1016/j.ajhg.2007.12.001; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; Takeuchi Y, 2005, J VET MED SCI, V67, P861, DOI 10.1292/jvms.67.861; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Tochigi M, 2006, NEUROSCI RES, V54, P180, DOI 10.1016/j.neures.2005.11.003; Topal J, 2009, ADV STUD BEHAV, V39, P71, DOI 10.1016/S0065-3454(09)39003-8; Vas J, 2007, APPL ANIM BEHAV SCI, V103, P105, DOI 10.1016/j.applanim.2006.03.017; Wan M, 2009, APPL ANIM BEHAV SCI, V121, P206, DOI 10.1016/j.applanim.2009.09.015; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4	43	43	43	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30271	10.1371/journal.pone.0030271	http://dx.doi.org/10.1371/journal.pone.0030271			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272320	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000301454400098
J	Li, B; Antonyak, MA; Zhang, J; Cerione, RA				Li, B.; Antonyak, M. A.; Zhang, J.; Cerione, R. A.			RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells	ONCOGENE			English	Article						microvesicles; oncosomes; RhoA; ROCK; LIMK; tissue transglutaminase	LIM-KINASE; PROSTATE-CANCER; TISSUE TRANSGLUTAMINASE; IN-VIVO; ROCK; METASTASIS; EXOSOMES; PHOSPHORYLATION; MEDIATORS; INVASION	Vesicular structures called microvesicles (MVs) that are shed from the surfaces of cancer cells are capable of transferring oncogenic cargo to recipient cancer cells, as well as to normal cells, sending mitogenic signals that greatly enhance tumor growth. Because MVs are stable in the circulation, they also may have a key role in secondary colonization and metastasis. Thus, understanding how MVs are generated could have important consequences for interfering with cancer progression. Here we report that the small GTPase RhoA triggers a specific signaling pathway essential for MV biogenesis in various human cancer cells. Inhibiting the activity of different proteins comprising this pathway blocks MV biogenesis in the donor cancer cells and prevents oncogenic transformation in cell culture as well as tumor growth in mice. Although RhoA has often been implicated in human cancer, these findings now highlight a previously unappreciated role for this GTPase in malignant transformation, and demonstrate that blocking MV biogenesis may offer novel approaches for interfering with malignant transformation.	[Li, B.; Antonyak, M. A.; Zhang, J.; Cerione, R. A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Li, B.; Cerione, R. A.] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Li, Bo/O-7127-2019; Li, Bo/M-2192-2013; Li, Bo/Y-2835-2019; Li, Bo/M-2192-2013	Li, Bo/0000-0002-7979-8339; Li, Bo/0000-0002-7979-8339; Li, Bo/0000-0001-8256-5045	NIH; Komen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, R01GM040654] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cindy Westmiller for her secretarial assistance and the NIH and the Komen Foundation for funding.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Catellana D, 2009, CANCER RES, V69, P785; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Hao S., 2006, Experimental Oncology, V28, P126; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; Micuda S, 2010, CURR CANCER DRUG TAR, V10, P127, DOI 10.2174/156800910791054202; Muralidharan-Chari V, 2009, CURR BIOL, V19, P1875, DOI 10.1016/j.cub.2009.09.059; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Petrache I, 2003, FASEB J, V17, P407, DOI 10.1096/fj.02-0672com; Rak J, 2010, SEMIN THROMB HEMOST, V36, P888, DOI 10.1055/s-0030-1267043; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Teis D, 2009, CELL, V137, DOI 10.1016/j.cell.2009.03.027; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048	35	214	216	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	45					4740	4749		10.1038/onc.2011.636	http://dx.doi.org/10.1038/onc.2011.636			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	036NF	22266864	Green Accepted			2022-12-25	WOS:000311033000002
J	Thaler, S; Schmidt, M; Schad, A; Sleeman, JP				Thaler, S.; Schmidt, M.; Schad, A.; Sleeman, J. P.			RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development	ONCOGENE			English	Article						RASSF1A; estrogen receptor alpha; senescence; breast cancer inhibition	ONCOGENE-INDUCED SENESCENCE; C-MYC; ACTIVATION; BCL-2; DNA; CELLS; MICE; TRANSFORMATION; PROLIFERATION; METHYLATION	The Ras association domain family 1 isoform A (RASSF1A) is a tumor suppressor whose inactivation is implicated in the development of many human cancers, including breast carcinomas. Little is known about the tumor-suppressive function of RASSF1A in breast tissue and whether its inactivation is mechanistically involved in the initiation and progression of breast tumors. Here, we show that RASSF1A inhibits breast cancer growth in vivo, and suppresses estrogen receptor (ER alpha) expression and function. Reconstitution of RASSF1A in MCF7 cells led to decreased ER alpha levels and reduced sensitivity to estrogen (E2). Concomitantly, we observed decreased expression of Id1 as well as the E2-responsive genes Bcl-2 and c-Myc that cooperatively contribute to the immortalization and transformation of breast epithelial cells. This downregulation was associated with induction of cell-cycle arrest and senescence that constitute early barriers to cancer initiation and progression. Knockdown of ER alpha showed that downregulation of ER alpha suffices to increase senescence and inhibit expression of Bcl-2, c-Myc and Id1. However, enforced expression of ER alpha only partially rescued RASSF1A-mediated growth inhibition and senescence, suggesting that suppression of ER alpha expression and activity is not the only mechanism by which RASSF1A inhibits growth and survival of breast cancer cells. Ectopic expression of Bcl-2, c-Myc and Id1 had little or no effect on RASSF1A-mediated growth arrest, indicating that RASSF1A acts dominantly over these oncogenes. Mechanistically, RASSF1A was found to suppress ER alpha expression through Akt1. It also transiently inhibited ER alpha-induced Ras-MAPK activity after exposure of cells to E2. Together, our data show that RASSF1A acts as a tumor suppressor in ER alpha+ mammary epithelial cells, in part through inhibiting ER alpha expression and activity. These findings suggest that RASSF1A has a key role in suppressing the transformation of human breast epithelial cells and ER alpha+ breast cancer initiation.	[Thaler, S.] Heidelberg Univ, Univ Med Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Med Fac Mannheim, D-68167 Mannheim, Germany; [Schmidt, M.] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, Mainz, Germany; [Schad, A.] Johannes Gutenberg Univ Mainz, Dept Pathol, D-6500 Mainz, Germany; [Sleeman, J. P.] Kernforschungszentrum Karlsruhe GmbH, Inst Genet & Toxikol, D-7500 Karlsruhe, Germany	Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Helmholtz Association; Karlsruhe Institute of Technology	Thaler, S (corresponding author), Heidelberg Univ, Univ Med Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Med Fac Mannheim, TRIDOMUS Gebaude Haus C,Ludolf Krehl Str 13-17, D-68167 Mannheim, Germany.	Sonja.Thaler@medma.uni-heidelberg.de	Schmidt, Marcus/H-3383-2013; Thaler, Sonja/AAC-4784-2020; Sleeman, Jonathan P/H-2515-2013	Schmidt, Marcus/0000-0003-1365-2414; Sleeman, Jonathan P/0000-0003-1718-7687	Deutsche Forschungsgemeinschaft [TH1523/1-2]; MAIFOR	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MAIFOR	We are grateful to Selma Huber and workers in the KIT rodent facility and Gitta Flaig for excellent technical assistance. We thank Robert Weinberg for kindly providing pBabe-neo; William Hahn for providing pBabe-Neo-Myr-Flag-AKT1 and pWZL Blast myc and Jean Zhao for pWZL Neo Myr Flag AKT3. pMIG Bcl-2 was created in the laboratory of Stanley Korsmeyer and was kindly provided from Dana Farber Cancer Institute. This study was supported by Deutsche Forschungsgemeinschaft grant TH1523/1-2 to ST and MAIFOR (ST and MS).	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P584, DOI 10.1093/carcin/bgl190; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Chen L, 2009, CANCER LETT, V278, P210, DOI 10.1016/j.canlet.2009.01.008; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Clarke RB, 1997, CANCER RES, V57, P4987; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DUBIK D, 1992, ONCOGENE, V7, P1587; Faridi J, 2003, CLIN CANCER RES, V9, P2933; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Fowler AM, 2006, MOL ENDOCRINOL, V20, P291, DOI 10.1210/me.2005-0288; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; KASID A, 1985, SCIENCE, V228, P725, DOI 10.1126/science.4039465; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Lawson JS, 1999, LANCET, V354, P1787, DOI 10.1016/S0140-6736(99)04936-3; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li TH, 2006, AM J PATHOL, V168, P1998, DOI 10.2353/ajpath.2006.051089; Lin CQ, 2000, CANCER RES, V60, P1332; Magro G, 2000, HISTOPATHOLOGY, V36, P515, DOI 10.1046/j.1365-2559.2000.00907.x; Migliaccio A, 2002, ANN NY ACAD SCI, V963, P185; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Mueller SO, 2002, ENDOCRINOLOGY, V143, P2357, DOI 10.1210/en.143.6.2357; Norton JD, 1998, MOL CELL BIOL, V18, P2371, DOI 10.1128/MCB.18.4.2371; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; Planas-Silva MD, 2007, EXP MOL PATHOL, V82, P85, DOI 10.1016/j.yexmp.2006.09.001; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; REED JC, 1990, MOL CELL BIOL, V10, P4370, DOI 10.1128/MCB.10.8.4370; Shaaban AM, 2002, AM J PATHOL, V160, P597, DOI 10.1016/S0002-9440(10)64879-1; Shinozaki M, 2005, CLIN CANCER RES, V11, P2156, DOI 10.1158/1078-0432.CCR-04-1810; Shoker BS, 2000, J CLIN PATHOL, V53, P778, DOI 10.1136/jcp.53.10.778; Shoker BS, 1999, J PATHOL, V188, P237; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Sunami E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2098; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Yang QF, 1999, PATHOL INT, V49, P775, DOI 10.1046/j.1440-1827.1999.00942.x; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	53	16	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	47					4912	4922		10.1038/onc.2011.658	http://dx.doi.org/10.1038/onc.2011.658			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	041VU	22266866				2022-12-25	WOS:000311430200003
J	Mogilenko, DA; Orlov, SV; Trulioff, AS; Ivanov, AV; Nagumanov, VK; Kudriavtsev, IV; Shavva, VS; Tanyanskiy, DA; Perevozchikov, AP				Mogilenko, Denis A.; Orlov, Sergey V.; Trulioff, Andrey S.; Ivanov, Andrey V.; Nagumanov, Vadim K.; Kudriavtsev, Igor V.; Shavva, Vladimir S.; Tanyanskiy, Dmitry A.; Perevozchikov, Andrej P.			Endogenous apolipoprotein A-I stabilizes ATP-binding cassette transporter A1 and modulates Toll-like receptor 4 signaling in human macrophages	FASEB JOURNAL			English	Article						TNF-alpha; IL-1 beta; NOS2; LPS; lipid rafts	HIGH-DENSITY-LIPOPROTEIN; NECROSIS-FACTOR-ALPHA; WHITE BLOOD-CELLS; E MESSENGER-RNA; INFLAMMATORY RESPONSE; CHOLESTEROL EFFLUX; LIPID RAFTS; TNF-ALPHA; APOA-I; EXPRESSION	Apolipoprotein A-I (ApoA-I) is the main functional protein component of human high-density lipoproteins. ApoA-I shows various anti-inflammatory and atheroprotective properties toward macrophages; however, endogenous apoA-I expression has not been investigated in macrophages. We have shown that endogenous apoA-I gene is expressed in human macrophages at both mRNA and protein levels. Endogenous ApoA-I is localized in intracellular vesicles and at the external side of the plasma membrane in association with ATP-binding cassette transporter A1 (ABCA1) and lipid rafts in macrophages. We have shown that endogenous ApoA-I stabilizes ABCA1, moreover, down-regulation of ApoA-I by siRNA results in an increase of Toll-like receptor 4 (TLR4) mRNA and membrane surface protein expression, as well as an enhancement of bacterial lipopolysaccharide (LPS)-induced expression of tumor necrosis factor-alpha (TNF-alpha), interleukin 1 alpha (IL-1 beta), and inducible nitric oxide synthase (NOS2) genes in human macrophages. TNF-alpha stimulates ApoA-I expression and secretion (1.2 +/- 0.2 vs. 4.3 +/- 0.9 ng/mg total protein) in macrophages. Obtained results suggest that endogenous ApoA-I has anti-inflammatory properties, presumably due to ABCA1 stabilization in macrophages; these results elucidate the cell type-specific mechanism of the TNF-alpha-mediated regulation of apoA-I gene expression in monocytes and macrophages.-Mogilenko, D. A., Orlov, S. V., Trulioff, A. S., Ivanov, A. V., Nagumanov, V. K., Kudriavtsev, I. V., Shavva, V. S., Tanyanskiy, D. A., Perevozchikov, A. P. Endogenous apolipoprotein A-I stabilizes ATP-binding cassette transporter A1 and modulates Toll-like receptor 4 signaling in human macrophages. FASEB J. 26, 2019-2030 (2012). www.fasebj.org	[Mogilenko, Denis A.; Orlov, Sergey V.; Tanyanskiy, Dmitry A.; Perevozchikov, Andrej P.] Russian Acad Med Sci, Inst Expt Med, Dept Biochem, St Petersburg 197376, Russia; [Trulioff, Andrey S.] Russian Acad Med Sci, Inst Expt Med, Dept Immunol, St Petersburg 197376, Russia; [Mogilenko, Denis A.; Orlov, Sergey V.; Shavva, Vladimir S.; Perevozchikov, Andrej P.] St Petersburg State Univ, Dept Embryol, St Petersburg, Russia; [Nagumanov, Vadim K.; Kudriavtsev, Igor V.] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg, Russia; [Ivanov, Andrey V.] NW Reg Med Ctr, St Petersburg, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Saint Petersburg State University; Saint Petersburg State University	Mogilenko, DA (corresponding author), Russian Acad Med Sci, Inst Expt Med, Dept Biochem, Acad Pavlov St 12, St Petersburg 197376, Russia.	denis@iem.sp.ru; serge@iem.sp.ru; app@iem.sp.ru	Perevozchikov, Andrej/M-9744-2015; Orlov, Sergey V./N-6823-2014; Kudryavtsev, Igor/D-2124-2013; Tanyanskiy, Dmitry/G-3307-2015; Mogilenko, Denis/H-4436-2013; Mogilenko, Denis/ABE-9454-2021; Ivanov, Andrei/J-6062-2015; Trulioff, Andrey/AAF-5844-2021	Perevozchikov, Andrej/0000-0001-7049-3224; Orlov, Sergey V./0000-0002-3134-1989; Kudryavtsev, Igor/0000-0001-7204-7850; Tanyanskiy, Dmitry/0000-0002-5321-8834; Mogilenko, Denis/0000-0001-5427-5243; Ivanov, Andrei/0000-0002-1676-7754; Trulioff, Andrey/0000-0002-7495-446X; Shavva, Vladimir S./0000-0002-5080-8636	Russian Fund of Basic Research [09-04-01301, 11-04-02012-a]	Russian Fund of Basic Research(Russian Foundation for Basic Research (RFBR))	The authors thank C. Benken (St. Petersburg State University, St. Petersburg, Russia) and Dr. S. A. Podzorova (Pavlov Institute of Physiology, Russian Academy of Sciences, St. Petersburg, Russia) for methodological assistance with the LSCM, Dr. E. B. Dizhe (Institute of Experimental Medicine, Russian Academy of Medical Sciences, Russia) for methodological assistance with HepG2 cell cultivation, and Dr. A. D. Denisenko (Institute of Experimental Medicine) for helpful discussions and reviewing the manuscript. The work has been supported by the Russian Fund of Basic Research (grants 09-04-01301 and 11-04-02012-a).	Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barter PJ, 1996, CURR OPIN LIPIDOL, V7, P82, DOI 10.1097/00041433-199604000-00006; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Doherty NS, 1998, ELECTROPHORESIS, V19, P355, DOI 10.1002/elps.1150190234; DUAN HW, 1995, J CLIN INVEST, V96, P915, DOI 10.1172/JCI118139; EGGERMAN TL, 1991, J LIPID RES, V32, P821; EPAND RM, 1994, ARTERIOSCLER THROMB, V14, P1775, DOI 10.1161/01.ATV.14.11.1775; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; *I LAB AN RES COMM, 1996, GUID CAR US LAB AN; Ishiguro H, 2001, J BIOL CHEM, V276, P36742, DOI 10.1074/jbc.M106027200; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Major AS, 2001, ARTERIOSCL THROM VAS, V21, P1790, DOI 10.1161/hq1101.097798; Martinez-Lopez E, 2007, LIVER INT, V27, P930, DOI 10.1111/j.1478-3231.2007.01509.x; MCVICAR JP, 1984, P NATL ACAD SCI-BIOL, V81, P1356, DOI 10.1073/pnas.81.5.1356; Mogilenko DA, 2010, BIOCHEM BIOPH RES CO, V402, P477, DOI 10.1016/j.bbrc.2010.10.053; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Nuno-Gonzalez P, 2005, BBA-MOL BASIS DIS, V1740, P350, DOI 10.1016/j.bbadis.2004.11.003; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Orlov SV, 2010, BIOCHEM BIOPH RES CO, V398, P224, DOI 10.1016/j.bbrc.2010.06.064; Rye KA, 2008, ARTERIOSCL THROM VAS, V28, P1890, DOI 10.1161/ATVBAHA.108.173575; Song H, 1998, CYTOKINE, V10, P275, DOI 10.1006/cyto.1997.0291; Srivastava R, 2000, MOL CELL BIOCHEM, V209, P131, DOI 10.1023/A:1007111830472; Su YR, 2008, ARTERIOSCL THROM VAS, V28, P1439, DOI 10.1161/ATVBAHA.107.160093; Suzuki M, 2010, CIRCULATION, V122, P1919, DOI 10.1161/CIRCULATIONAHA.110.961193; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tedla N, 2004, IMMUNOLOGY, V113, P338, DOI 10.1111/j.1365-2567.2004.01972.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; WU AL, 1979, J BIOL CHEM, V254, P7316; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	40	35	41	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					2019	2030		10.1096/fj.11-193946	http://dx.doi.org/10.1096/fj.11-193946			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22271762				2022-12-25	WOS:000303680800028
J	Guo, L; Mishra, G; Markham, JE; Li, MY; Tawfall, A; Welti, R; Wang, XM				Guo, Liang; Mishra, Girish; Markham, Jonathan E.; Li, Maoyin; Tawfall, Amanda; Welti, Ruth; Wang, Xuemin			Connections between Sphingosine Kinase and Phospholipase D in the Abscisic Acid Signaling Pathway in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; STOMATAL CLOSURE; GUARD-CELLS; TRANSDUCTION; PROTEIN; BINDING; GROWTH; SPHINGOSINE-1-PHOSPHATE; SPHINGOLIPIDS; EXPRESSION	Phosphatidic acid (PA) and phytosphingosine 1-phosphate (phyto-S1P) both are lipid messengers involved in plant response to abscisic acid (ABA). Our previous data indicate that PA binds to sphingosine kinase (SPHK) and increases its phyto-S1P-producing activity. To understand the cellular and physiological functions of the PA-SPHK interaction, we isolated Arabidopsis thaliana SPHK mutants sphk1-1 and sphk2-1 and characterized them, together with phospholipase D alpha 1 knockout, pld alpha 1, in plant response to ABA. Compared with wild-type (WT) plants, the SPHK mutants and pld alpha 1 all displayed decreased sensitivity to ABA-promoted stomatal closure. Phyto-S1P promoted stomatal closure in sphk1-1 and sphk2-1, but not in pld alpha 1, whereas PA promoted stomatal closure in sphk1-1, sphk2-1, and pld alpha 1. The ABA activation of PLD alpha 1 in leaves and protoplasts was attenuated in the SPHK mutants, and the ABA activation of SPHK was reduced in pld alpha 1. In response to ABA, the accumulation of long-chain base phosphates was decreased in pld alpha 1, whereas PA production was decreased in SPHK mutants, compared with WT. Collectively, these results indicate that SPHK and PLD alpha 1 act together in ABA response and that SPHK and phyto-S1P act upstream of PLD alpha 1 and PA in mediating the ABA response. PA is involved in the activation of SPHK, and activation of PLD alpha 1 requires SPHK activity. The data suggest that SPHK/phyto-S1P and PLD alpha 1A are co-dependent in amplification of response to ABA, mediating stomatal closure in Arabidopsis.	[Guo, Liang; Mishra, Girish; Li, Maoyin; Tawfall, Amanda; Wang, Xuemin] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Guo, Liang; Mishra, Girish; Markham, Jonathan E.; Li, Maoyin; Tawfall, Amanda; Wang, Xuemin] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Welti, Ruth] Kansas State Univ, Div Biol, Kansas Lipid Res Ctr, Manhattan, KS 66506 USA	University of Missouri System; University of Missouri Saint Louis; Donald Danforth Plant Science Center; Kansas State University	Wang, XM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	wangxue@umsl.edu	Guo, Liang/AAW-4739-2021; Wang, Xuemin/M-2853-2013	Guo, Liang/0000-0001-7191-5062; Markham, Jennifer/0000-0003-2397-3131; wang, xuemin/0000-0002-6251-6745; Welti, Ruth/0000-0003-4373-2538; Li, Maoyin/0000-0002-9976-1349	National Science Foundation [IOS-0818740, EPS 0236913, MCB 0455318, 0920663, DBI 0521587]; United States Department of Agriculture [2007-35318-18393]; United States Department of Energy [DE-SC0001295]; Kansas Technology Enterprise Corporation; Kansas IDeA Network of Bio-medical Research Excellence (K-INBRE); National Institutes of Health [P20RR16475]; Kansas State University; Div Of Molecular and Cellular Bioscience [0920663] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); United States Department of Energy(United States Department of Energy (DOE)); Kansas Technology Enterprise Corporation; Kansas IDeA Network of Bio-medical Research Excellence (K-INBRE); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Science Foundation Grant IOS-0818740, United States Department of Agriculture Grant 2007-35318-18393, and United States Department of Energy Grant DE-SC0001295.; PA analyses were performed at the Kansas Lipidomics Research Center, where equipment acquisition and method development were funded by National Science Foundation Grants EPS 0236913, MCB 0455318 and 0920663, the DBI 0521587, Kansas Technology Enterprise Corporation, Kansas IDeA Network of Bio-medical Research Excellence (K-INBRE), National Institutes of Health Grant P20RR16475, and the Kansas State University.	Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; Chen M, 2008, PLANT CELL, V20, P1862, DOI 10.1105/tpc.107.057851; Chen M, 2006, PLANT CELL, V18, P3576, DOI 10.1105/tpc.105.040774; Coursol S, 2005, PLANT PHYSIOL, V137, P724, DOI 10.1104/pp.104.055806; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Dunn TM, 2004, ANN BOT-LONDON, V93, P483, DOI 10.1093/aob/mch071; Guo L, 2011, J BIOL CHEM, V286, P13336, DOI 10.1074/jbc.M110.190892; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hong YY, 2008, MOL PLANT, V1, P262, DOI 10.1093/mp/ssm025; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Imai H, 2005, PLANT CELL PHYSIOL, V46, P375, DOI 10.1093/pcp/pci023; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Li MY, 2006, PLANT PHYSIOL, V140, P761, DOI 10.1104/pp.105.070995; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Lynch DV, 2009, TRENDS PLANT SCI, V14, P463, DOI 10.1016/j.tplants.2009.06.008; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ritchie S, 1998, P NATL ACAD SCI USA, V95, P2697, DOI 10.1073/pnas.95.5.2697; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Testerink C, 2007, J EXP BOT, V58, P3905, DOI 10.1093/jxb/erm243; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Worrall D, 2008, PLANT J, V56, P64, DOI 10.1111/j.1365-313X.2008.03579.x; Xiao S, 2010, PLANT CELL, V22, P1463, DOI 10.1105/tpc.110.075333; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992	42	76	86	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8286	8296		10.1074/jbc.M111.274274	http://dx.doi.org/10.1074/jbc.M111.274274			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275366	hybrid, Green Published			2022-12-25	WOS:000301349400043
J	Zappelli, C; van der Zwaan, C; Thijssen-Timmer, DC; Mertens, K; Meijer, AB				Zappelli, Claudia; van der Zwaan, Carmen; Thijssen-Timmer, Daphne C.; Mertens, Koen; Meijer, Alexander B.			Novel Role for Galectin-8 Protein as Mediator of Coagulation Factor V Endocytosis by Megakaryocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTHROMBINASE COMPLEX; PARTIAL GLYCOSYLATION; THROMBIN GENERATION; BINDING PROTEINS; PLASMA; DOMAIN; CELLS; EXPRESSION; RECOGNITION; PLATELETS	Galectin-8 (Gal8) interacts with beta-galactoside-containing glycoproteins and has recently been implicated to play a role in platelet activation. It has been suggested that Gal8 may also interact with platelet coagulation factor V (FV). This indispensable cofactor is stored in alpha-granules of platelets via a poorly understood endocytic mechanism that only exists in megakaryocytes (platelet precursor cells). In this study, we now assessed the putative role of Gal8 for FV biology. Surface plasmon resonance analysis and a solid phase binding assay revealed that Gal8 binds FV. The data further show that beta-galactosides block the interaction between FV and Gal8. These findings indicate that Gal8 specifically interacts with FV in a carbohydrate-dependent manner. Confocal microscopy studies and flow cytometry analysis demonstrated that megakaryocytic DAMI cells internalize FV. Flow cytometry showed that these cells express Gal8 on their cell surface. Reducing the functional presence of Gal8 on the cells either by an anti-Gal8 antibody or by siRNA technology markedly impaired the endocytic uptake of FV. Compatible with the apparent role of Gal8 for FV uptake, endocytosis of FV was also affected in the presence of beta-galactosides. Strikingly, thrombopoietin-differentiated DAMI cells, which represent a more mature megakaryocytic state, not only lose the capacity to express cell-surface bound Gal8 but also lose the ability to internalize FV. Collectively, our data reveal a novel role for the tandem repeat Gal8 in promoting FV endocytosis.	[Zappelli, Claudia; van der Zwaan, Carmen; Mertens, Koen; Meijer, Alexander B.] Sanquin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Thijssen-Timmer, Daphne C.] Sanquin Res, Dept Hematopoiesis, NL-1105 AZ Amsterdam, Netherlands; [Thijssen-Timmer, Daphne C.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Mertens, Koen; Meijer, Alexander B.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut, NL-3435 CG Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University	Meijer, AB (corresponding author), Sanquin Res, Dept Plasma Prot, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	s.meijer@sanquin.nl			Sanquin Blood Supply Foundation [PPOC-10-012]	Sanquin Blood Supply Foundation	This work was supported by Grant PPOC-10-012 from Sanquin Blood Supply Foundation.	Romaniuk MA, 2010, BIOCHEM J, V432, P535, DOI 10.1042/BJ20100538; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Bos MHA, 2005, J THROMB HAEMOST, V3, P522, DOI 10.1111/j.1538-7836.2005.01181.x; Bouchard BA, 2008, J THROMB HAEMOST, V6, P638, DOI 10.1111/j.1538-7836.2008.02894.x; Bouchard BA, 2005, J THROMB HAEMOST, V3, P541, DOI 10.1111/j.1538-7836.2005.01190.x; Camire RM, 1998, BLOOD, V92, P3035, DOI 10.1182/blood.V92.9.3035.421k54_3035_3041; Carlsson S, 2007, GLYCOBIOLOGY, V17, P906, DOI 10.1093/glycob/cwm059; DAHLBACK B, 1980, J CLIN INVEST, V66, P583, DOI 10.1172/JCI109890; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Giampaolo A, 2005, BRIT J HAEMATOL, V128, P108, DOI 10.1111/j.1365-2141.2004.05279.x; Gould WR, 2004, J BIOL CHEM, V279, P2383, DOI 10.1074/jbc.M308600200; Graham JE, 2009, HEALTH PSYCHOL, V28, P621, DOI 10.1037/a0015208; GREENBERG SM, 1988, BLOOD, V72, P1968; HANDAGAMA P, 1993, BLOOD, V82, P135, DOI 10.1182/blood.V82.1.135.bloodjournal821135; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Ideo H, 2003, GLYCOBIOLOGY, V13, P713, DOI 10.1093/glycob/cwg094; Kim SW, 1999, BIOCHEMISTRY-US, V38, P11448, DOI 10.1021/bi991275y; Leffler H, 2001, Results Probl Cell Differ, V33, P57; Lev PR, 2011, PLATELETS, V22, P28, DOI 10.3109/09537104.2010.515271; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Nicolaes GAF, 1999, BIOCHEMISTRY-US, V38, P13584, DOI 10.1021/bi991165r; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Pacienza N, 2008, FASEB J, V22, P1113, DOI 10.1096/fj.07-9524com; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Phillips JE, 2004, J THROMB HAEMOST, V2, P1806, DOI 10.1111/j.1538-7836.2004.00919.x; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Segers K, 2007, THROMB HAEMOSTASIS, V98, P530, DOI 10.1160/TH07-02-0150; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Suehiro Y, 2005, THROMB HAEMOSTASIS, V94, P585, DOI 10.1160/TH05-02-0141; TRACY PB, 1984, J CLIN INVEST, V74, P1221, DOI 10.1172/JCI111531; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Zhu WQ, 2001, BIOCHEM BIOPH RES CO, V280, P1183, DOI 10.1006/bbrc.2001.4256; Zick Y, 2002, GLYCOCONJUGATE J, V19, P517, DOI 10.1023/B:GLYC.0000014081.55445.af	42	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8327	8335		10.1074/jbc.M111.305151	http://dx.doi.org/10.1074/jbc.M111.305151			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267735	hybrid, Green Published			2022-12-25	WOS:000301349400047
J	Belton, A; Gabrovsky, A; Bae, YK; Reeves, R; Iacobuzio-Donahue, C; Huso, DL; Resar, LMS				Belton, Amy; Gabrovsky, Alexander; Bae, Young Kyung; Reeves, Ray; Iacobuzio-Donahue, Christine; Huso, David L.; Resar, Linda M. S.			HMGA1 Induces Intestinal Polyposis in Transgenic Mice and Drives Tumor Progression and Stem Cell Properties in Colon Cancer Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MESENCHYMAL TRANSITION; TRANSFORMATION; LOCALIZATION; PROTEINS; SEQUENCE; GROWTH; AKNA; I/Y	Background: Although metastatic colon cancer is a leading cause of cancer death worldwide, the molecular mechanisms that enable colon cancer cells to metastasize remain unclear. Emerging evidence suggests that metastatic cells develop by usurping transcriptional networks from embryonic stem (ES) cells to facilitate an epithelial-mesenchymal transition (EMT), invasion, and metastatic progression. Previous studies identified HMGA1 as a key transcription factor enriched in ES cells, colon cancer, and other aggressive tumors, although its role in these settings is poorly understood. Methods/Principal Findings: To determine how HMGA1 functions in metastatic colon cancer, we manipulated HMGA1 expression in transgenic mice and colon cancer cells. We discovered that HMGA1 drives proliferative changes, aberrant crypt formation, and intestinal polyposis in transgenic mice. In colon cancer cell lines from poorly differentiated, metastatic tumors, knock-down of HMGA1 blocks anchorage-independent cell growth, migration, invasion, xenograft tumorigenesis and three-dimensional colonosphere formation. Inhibiting HMGA1 expression blocks tumorigenesis at limiting dilutions, consistent with depletion of tumor-initiator cells in the knock-down cells. Knock-down of HMGA1 also inhibits metastatic progression to the liver in vivo. In metastatic colon cancer cells, HMGA1 induces expression of Twist1, a gene involved in embryogenesis, EMT, and tumor progression, while HMGA1 represses E-cadherin, a gene that is down-regulated during EMT and metastatic progression. In addition, HMGA1 is among the most enriched genes in colon cancer compared to normal mucosa. Conclusions: Our findings demonstrate for the first time that HMGA1 drives proliferative changes and polyp formation in the intestines of transgenic mice and induces metastatic progression and stem-like properties in colon cancer cells. These findings indicate that HMGA1 is a key regulator, both in metastatic progression and in the maintenance of a stem-like state. Our results also suggest that HMGA1 or downstream pathways could be rational therapeutic targets in metastatic, poorly differentiated colon cancer.	[Belton, Amy; Gabrovsky, Alexander; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Bae, Young Kyung] Yeungnam Univ, Coll Med, Dept Pathol, Taegu, South Korea; [Reeves, Ray] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Iacobuzio-Donahue, Christine; Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Iacobuzio-Donahue, Christine; Huso, David L.; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Yeungnam University; Washington State University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Belton, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA.	lresar@jhmi.edu	Iacobuzio-Donahue, Christine/ABF-1295-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Bae, Young Kyung/0000-0002-6689-9413; Gabrovsky, Alexander/0000-0002-5057-4358	National Institutes of Health (NIH) [RO1CA092339, R21CA2149550, NIH T32HL007525]; Maryland Stem Cell Research Fund; NATIONAL CANCER INSTITUTE [R01CA092339] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007525] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from The National Institutes of Health (NIH) RO1CA092339 and R21CA2149550 to L. Resar, NIH T32HL007525 to A. Belton, and the Maryland Stem Cell Research Fund to L. Resar and A. Belton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Chiappetta G, 1996, ONCOGENE, V13, P2439; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Dhar A, 2004, ONCOGENE, V23, P4466, DOI 10.1038/sj.onc.1207581; Di Cello F, 2008, MOL CANCER THER, V7, P2090, DOI 10.1158/1535-7163.MCT-07-2282; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; Dolde CE, 2002, BREAST CANCER RES TR, V71, P181, DOI 10.1023/A:1014444114804; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hillion J, 2009, MOL CANCER RES, V7, P1803, DOI 10.1158/1541-7786.MCR-08-0336; Hillion J, 2008, CANCER RES, V68, P10121, DOI 10.1158/0008-5472.CAN-08-2121; Hock R, 2007, TRENDS CELL BIOL, V28, P7394; Hommura F, 2004, MOL CANCER RES, V2, P305; Hristov A, 2010, MODERN PATHOL, V22, P43; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; JOHNSON KR, 1992, GENOMICS, V12, P503, DOI 10.1016/0888-7543(92)90441-T; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; Karp JE, 2011, BLOOD, V117, P3302, DOI 10.1182/blood-2010-09-310862; Kim DH, 1999, INT J CANCER, V84, P376, DOI 10.1002/(SICI)1097-0215(19990820)84:4<376::AID-IJC8>3.0.CO;2-N; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Ma WB, 2011, CELL RES, V21, P1564, DOI 10.1038/cr.2011.84; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moliterno AR, 2011, CELL RES, V21, P1528, DOI 10.1038/cr.2011.96; Nelson DM, 2011, LEUK LYMPHOMA; Pedulla ML, 2001, GENE, V271, P51, DOI 10.1016/S0378-1119(01)00500-5; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Resar LM, 2011, BLOOD, V117, P5788, DOI 10.1182/blood-2011-04-346668; Resar LMS, 2010, CANCER RES, V70, P436, DOI 10.1158/0008-5472.CAN-09-1212; Schuldenfrei A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-549; Shah S, 2011, HISTOL HIST IN PRESS; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Tesfaye A, 2007, HIGH MOBILITY GROUP, V9, P3998; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Wood LJ, 2000, CANCER RES, V60, P4256; Xu Y, 2004, CANCER RES, V64, P3371, DOI 10.1158/0008-5472.CAN-04-0044; Zhou GL, 2001, P NATL ACAD SCI USA, V98, P13966, DOI 10.1073/pnas.241526198	43	87	94	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30034	10.1371/journal.pone.0030034	http://dx.doi.org/10.1371/journal.pone.0030034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276142	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100022
J	Riuzzi, F; Sorci, G; Beccafico, S; Donato, R				Riuzzi, Francesca; Sorci, Guglielmo; Beccafico, Sara; Donato, Rosario			S100B Engages RAGE or bFGF/FGFR1 in Myoblasts Depending on Its Own Concentration and Myoblast Density. Implications for Muscle Regeneration	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; P38-ALPHA/BETA MAPK; MYOTUBE FORMATION; M-CADHERIN; P38 MAPK; RECEPTOR; PROTEIN; PROLIFERATION	In high-density myoblast cultures S100B enhances basic fibroblast growth factor (bFGF) receptor 1 (FGFR1) signaling via binding to bFGF and blocks its canonical receptor, receptor for advanced glycation end-products (RAGE), thereby stimulating proliferation and inhibiting differentiation. Here we show that upon skeletal muscle injury S100B is released from myofibers with maximum release at day 1 post-injury in coincidence with satellite cell activation and the beginning of the myoblast proliferation phase, and declining release thereafter in coincidence with reduced myoblast proliferation and enhanced differentiation. By contrast, levels of released bFGF are remarkably low at day 1 post-injury, peak around day 5 and decline thereafter. We also show that in low-density myoblast cultures S100B binds RAGE, but not bFGF/FGFR1 thereby simultaneously stimulating proliferation via ERK1/2 and activating the myogenic program via p38 MAPK. Clearance of S100B after a 24-h treatment of low-density myoblasts results in enhanced myotube formation compared with controls as a result of increased cell numbers and activated myogenic program, whereas chronic treatment with S100B results in stimulation of proliferation and inhibition of differentiation due to a switch of the initial low-density culture to a high-density culture. However, at relatively high doses, S100B stimulates the mitogenic bFGF/FGFR1 signaling in low-density myoblasts, provided bFGF is present. We propose that S100B is a danger signal released from injured muscles that participates in skeletal muscle regeneration by activating the promyogenic RAGE or the mitogenic bFGF/FGFR1 depending on its own concentration, the absence or presence of bFGF, and myoblast density.	[Riuzzi, Francesca] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; Univ Perugia, Ist Interuniv Miol, I-06100 Perugia, Italy	University of Perugia; University of Perugia	Riuzzi, F (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy.	donato@unipg.it	Donato, Rosario/I-3943-2019	Sorci, Guglielmo/0000-0002-1973-9679; Riuzzi, Francesca/0000-0001-7908-3379	Ministero dell'Universita e della Ricerca [2004054293, 2007LNKSYS, 2007AWZTHH_004, 2009WBFZYM_002]; Association Francaise contre les Myopathies [12992]; Associazione Italiana per la Ricerca sul Cancro [Associazione Italiana per la Ricerca sul Cancro (Project 6021]; Fondazione Cassa di Risparmio di Perugia [2007.0218.020, 2009.020.0021]; POR UMBRIA FSE	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia); POR UMBRIA FSE	This work was supported by Ministero dell'Universita e della Ricerca (PRIN 2004054293, 2007LNKSYS, 2007AWZTHH_004 and 2009WBFZYM_002), Association Francaise contre les Myopathies (Project 12992), Associazione Italiana per la Ricerca sul Cancro (Project 6021) and Fondazione Cassa di Risparmio di Perugia (2007.0218.020 and 2009.020.0021) funds. SB is a recipient of a fellowship from POR UMBRIA FSE 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcuri C, 2002, NEUROSCIENCE, V109, P371, DOI 10.1016/S0306-4522(01)00330-X; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charrasse S, 2007, MOL BIOL CELL, V18, P1734, DOI 10.1091/mbc.E06-08-0766; CHEN G, 1992, J CELL PHYSIOL, V153, P563, DOI 10.1002/jcp.1041530318; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; De Mori R, 2007, ARTERIOSCL THROM VAS, V27, P2377, DOI 10.1161/ATVBAHA.107.153429; DONATO R, 1988, J BIOL CHEM, V263, P106; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Galbiati F, 1999, J BIOL CHEM, V274, P30315, DOI 10.1074/jbc.274.42.30315; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Lovett FA, 2006, J CELL SCI, V119, P4828, DOI 10.1242/jcs.03278; Ma WC, 2007, INVEST OPHTH VIS SCI, V48, P1355, DOI 10.1167/iovs.06-0738; Neville C, 1997, METHOD CELL BIOL, V52, P85, DOI 10.1016/S0091-679X(08)60375-1; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Palumbo R, 2004, J CELL BIOL, V164, P441, DOI 10.1083/jcb.200304135; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Rauvala H, 2007, CURR MOL MED, V7, P725, DOI 10.2174/156652407783220750; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Riuzzi F, 2006, J BIOL CHEM, V281, P8242, DOI 10.1074/jbc.M509436200; Riuzzi F, 2011, J CELL SCI IN PRESS; Riuzzi F, 2007, AM J PATHOL, V171, P947, DOI 10.2353/ajpath.2007.070049; Riuzzi F, 2011, J CELL SCI, V124, P2389, DOI 10.1242/jcs.084491; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Steiner J, 2011, BRAIN BEHAV IMMUN, V25, P1233, DOI 10.1016/j.bbi.2011.03.015; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tubaro C, 2010, J CELL PHYSIOL, V223, P270, DOI 10.1002/jcp.22035; Winter B, 2000, J CELL SCI, V113, P4211; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973	47	34	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28700	10.1371/journal.pone.0028700	http://dx.doi.org/10.1371/journal.pone.0028700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276098	gold, Green Submitted, Green Published			2022-12-25	WOS:000301568100004
J	Rahman, MN; Vlahakis, JZ; Vukomanovic, D; Lee, W; Szarek, WA; Nakatsu, K; Jia, ZC				Rahman, Mona N.; Vlahakis, Jason Z.; Vukomanovic, Dragic; Lee, Wallace; Szarek, Walter A.; Nakatsu, Kanji; Jia, Zongchao			A Novel, "Double-Clamp'' Binding Mode for Human Heme Oxygenase-1 Inhibition	PLOS ONE			English	Article							IMIDAZOLE-DIOXOLANE COMPOUNDS; RAY CRYSTAL-STRUCTURE; THIOL/DISULFIDE REDOX SWITCH; NITRIC-OXIDE SYNTHASE; REGULATORY MOTIFS; MONOXIDE; METALLOPORPHYRINS; ANTIOXIDANT; EXPRESSION; COMPLEX	The development of heme oxygenase (HO) inhibitors is critical in dissecting and understanding the HO system and for potential therapeutic applications. We have established a program to design and optimize HO inhibitors using structure-activity relationships in conjunction with X-ray crystallographic analyses. One of our previous complex crystal structures revealed a putative secondary hydrophobic binding pocket which could be exploited for a new design strategy by introducing a functional group that would fit into this potential site. To test this hypothesis and gain further insights into the structural basis of inhibitor binding, we have synthesized and characterized 1-(1H-imidazol-1-yl)-4,4-diphenyl-2-butanone (QC-308). Using a carbon monoxide (CO) formation assay on rat spleen microsomes, the compound was found to be similar to 15 times more potent (IC50 = 0.27 +/- 0.07 mu M) than its monophenyl analogue, which is already a potent compound in its own right (QC-65; IC50 = 4.0 +/- 1.8 mu M). The crystal structure of hHO-1 with QC-308 revealed that the second phenyl group in the western region of the compound is indeed accommodated by a definitive secondary proximal hydrophobic pocket. Thus, the two phenyl moieties are each stabilized by distinct hydrophobic pockets. This "double-clamp'' binding offers additional inhibitor stabilization and provides a new route for improvement of human heme oxygenase inhibitors.	[Rahman, Mona N.; Vukomanovic, Dragic; Lee, Wallace; Nakatsu, Kanji; Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Vlahakis, Jason Z.; Szarek, Walter A.] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Rahman, MN (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	jia@queensu.ca	Rahman, Mona/GRF-6475-2022	Rahman, Mona Naeema/0000-0002-9782-0173	Canadian Institute of Health Research [CIHR MOP-64305, CIHR MOP-77810]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca, CIHR MOP-64305, CIHR MOP-77810). Dr. Zongchao Jia is a Killam Research Fellow and holds a Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton SD, 1999, DRUG METAB DISPOS, V27, P1214; Asad SF, 2001, CHEM-BIOL INTERACT, V137, P59, DOI 10.1016/S0009-2797(01)00209-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; COOK MN, 1995, CAN J PHYSIOL PHARM, V73, P515, DOI 10.1139/y95-065; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denagel D. C., 1998, Society for Neuroscience Abstracts, V24, P2058; Di Francesco L, 2009, CIRC RES, V104, P506, DOI 10.1161/CIRCRESAHA.108.191114; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrera J A, 1994, Bioorg Med Chem, V2, P181, DOI 10.1016/S0968-0896(00)82013-1; Gardner JD, 2010, J BIOL INORG CHEM, V15, P1117, DOI 10.1007/s00775-010-0672-8; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Grundemar L, 1997, TRENDS PHARMACOL SCI, V18, P193, DOI 10.1016/S0165-6147(97)90622-2; Hayashi S, 2004, GENE, V336, P241, DOI 10.1016/j.gene.2004.04.002; Huang TJ, 2001, ANTIOXID REDOX SIGN, V3, P685, DOI 10.1089/15230860152543023; Huber WJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI 10.1021/bi701496z; Huber WJ, 2009, DRUG METAB DISPOS, V37, P857, DOI 10.1124/dmd.108.025023; Huber WJ, 2009, BIOCHEMISTRY-US, V48, P190, DOI 10.1021/bi801912z; Hum M, 2010, J PHARMACOL EXP THER, V334, P981, DOI 10.1124/jpet.110.168492; Imuta N, 2007, ANTIOXID REDOX SIGN, V9, P543, DOI 10.1089/ars.2006.1519; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kinobe RT, 2006, BRIT J PHARMACOL, V147, P307, DOI 10.1038/sj.bjp.0706555; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; LUO DS, 1994, EUR J PHARM-MOLEC PH, V267, P263, DOI 10.1016/0922-4106(94)90149-X; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Maines MD, 1996, UROLOGY, V47, P727, DOI 10.1016/S0090-4295(96)00010-6; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEFFERT MK, 1994, NEURON, V13, P1225, DOI 10.1016/0896-6273(94)90060-4; Minetti M, 1998, ARCH BIOCHEM BIOPHYS, V352, P165, DOI 10.1006/abbi.1998.0584; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nowis D, 2006, ONCOGENE, V25, P3365, DOI 10.1038/sj.onc.1209378; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Rahman MN, 2008, J MED CHEM, V51, P5943, DOI 10.1021/jm800505m; Rahman MN, 2010, J INORG BIOCHEM, V104, P324, DOI 10.1016/j.jinorgbio.2009.10.011; Rahman MN, 2009, J MED CHEM, V52, P4946, DOI 10.1021/jm900434f; Roman G, 2007, BIOORGAN MED CHEM, V15, P3225, DOI 10.1016/j.bmc.2007.02.034; Roman G, 2010, CHEM BIOL DRUG DES, V75, P68, DOI 10.1111/j.1747-0285.2009.00909.x; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schuller DJ, 1998, PROTEIN SCI, V7, P1836, DOI 10.1002/pro.5560070820; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sugishima M, 2007, BIOCHEMISTRY-US, V46, P1860, DOI 10.1021/bi062264p; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Vlahakis JZ, 2006, J MED CHEM, V49, P4437, DOI 10.1021/jm0511435; Vlahakis JZ, 2011, J PHARMACOL TOX MET, V63, P79, DOI 10.1016/j.vascn.2010.05.015; Vlahakis JZ, 2009, BIOORGAN MED CHEM, V17, P2461, DOI 10.1016/j.bmc.2009.01.078; Vlahakis JZ, 2005, BIOORG MED CHEM LETT, V15, P1457, DOI 10.1016/j.bmcl.2004.12.075; VREMAN HJ, 1988, ANAL BIOCHEM, V168, P31, DOI 10.1016/0003-2697(88)90006-1; Vreman HJ, 2002, CARBON MONOXIDE CARD; Vukomanovic D, 2010, CAN J PHYSIOL PHARM, V88, P480, DOI [10.1139/Y10-004, 10.1139/y10-004]; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651	60	21	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29514	10.1371/journal.pone.0029514	http://dx.doi.org/10.1371/journal.pone.0029514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276118	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200016
J	Verdoodt, F; Willems, M; Mouton, S; De Mulder, K; Bert, W; Houthoofd, W; Smith, J; Ladurner, P				Verdoodt, Freija; Willems, Maxime; Mouton, Stijn; De Mulder, Katrien; Bert, Wim; Houthoofd, Wouter; Smith, Julian, III; Ladurner, Peter			Stem Cells Propagate Their DNA by Random Segregation in the Flatworm Macrostomum lignano	PLOS ONE			English	Article							LABEL-RETAINING CELLS; IMMORTAL STRAND HYPOTHESIS; SELF-RENEWAL; SELECTIVE SEGREGATION; REGENERATION; PROLIFERATION; PLANARIAN; QUIESCENT; NICHES; CYCLE	Adult stem cells are proposed to have acquired special features to prevent an accumulation of DNA-replication errors. Two such mechanisms, frequently suggested to serve this goal are cellular quiescence, and non-random segregation of DNA strands during stem cell division, a theory designated as the immortal strand hypothesis. To date, it has been difficult to test the in vivo relevance of both mechanisms in stem cell systems. It has been shown that in the flatworm Macrostomum lignano pluripotent stem cells (neoblasts) are present in adult animals. We sought to address by which means M. lignano neoblasts protect themselves against the accumulation of genomic errors, by studying the exact mode of DNA-segregation during their division. In this study, we demonstrated four lines of in vivo evidence in favor of cellular quiescence. Firstly, performing BrdU pulse-chase experiments, we localized ` Label-Retaining Cells' (LRCs). Secondly, EDU pulse-chase combined with Vasa labeling demonstrated the presence of neoblasts among the LRCs, while the majority of LRCs were differentiated cells. We showed that stem cells lose their label at a slow rate, indicating cellular quiescence. Thirdly, CldU/ IdU2 double labeling studies confirmed that label-retaining stem cells showed low proliferative activity. Finally, the use of the actin inhibitor, cytochalasin D, unequivocally demonstrated random segregation of DNA-strands in LRCs. Altogether, our data unambiguously demonstrated that the majority of neoblasts in M. lignano distribute their DNA randomly during cell division, and that label-retention is a direct result of cellular quiescence, rather than a sign of co-segregation of labeled strands.	[Verdoodt, Freija; Bert, Wim; Houthoofd, Wouter] Univ Ghent, Dept Biol, Nematol Unit, B-9000 Ghent, Belgium; [Willems, Maxime] Univ Ghent, Dept Pharmaceut, Lab Pharmaceut Technol, B-9000 Ghent, Belgium; [Mouton, Stijn] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Mouton, Stijn] Univ Med Ctr Utrecht, Utrecht, Netherlands; [De Mulder, Katrien] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Smith, Julian, III] Winthrop Univ, Dept Biol, Rock Hill, SC 29733 USA; [Ladurner, Peter] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Ladurner, Peter] Univ Innsbruck, CMBI, A-6020 Innsbruck, Austria	Ghent University; Ghent University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Ghent University; University of Innsbruck; University of Innsbruck	Verdoodt, F (corresponding author), Univ Ghent, Dept Biol, Nematol Unit, B-9000 Ghent, Belgium.	peter.ladurner@uibk.ac.at	Bert, Wim/D-4511-2013	Bert, Wim/0000-0002-5864-412X; Verdoodt, Freija/0000-0002-8243-697X; Ladurner, Peter/0000-0002-0323-9266; Mouton, Stijn/0000-0002-1123-6268	(Institute for the Promotion of Innovation through Science and Technology in Flanders, IWTVlaanderen); FWF (Austria) [18099]	(Institute for the Promotion of Innovation through Science and Technology in Flanders, IWTVlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWF (Austria)(Austrian Science Fund (FWF))	This work was supported by an IWT doctoral grant (Institute for the Promotion of Innovation through Science and Technology in Flanders, IWTVlaanderen) to FV, MW and SM, and by FWF grant 18099 to PL (Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agata K, 2003, CURR OPIN GENET DEV, V13, P492, DOI 10.1016/j.gde.2003.08.009; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alison MR, 2009, J PATHOL, V217, P144, DOI 10.1002/path.2498; Alvarado AS, 2004, PHILOS T R SOC B, V359, P759, DOI 10.1098/rstb.2004.1465; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; BAGUNA J, 1981, NATURE, V290, P14, DOI 10.1038/290014b0; BAGUNA J, 1981, HYDROBIOLOGIA, V84, P181, DOI 10.1007/BF00026179; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bode A, 2006, CELL TISSUE RES, V325, P577, DOI 10.1007/s00441-006-0196-2; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cairns J, 2006, GENETICS, V174, P1069, DOI 10.1534/genetics.104.66886; Clayton JE, 2008, DEV BIOL, V313, P603, DOI 10.1016/j.ydbio.2007.10.051; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; De Mulder K, 2010, CELL TISSUE RES, V339, P527, DOI 10.1007/s00441-009-0915-6; De Mulder K, 2009, DEV BIOL, V334, P198, DOI 10.1016/j.ydbio.2009.07.019; DUBOIS F, 1948, CR SOC BIOL, V142, P699; Egger B, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-41; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Handberg-Thorsager M, 2008, FRONT BIOSCI-LANDMRK, V13, P6374, DOI 10.2741/3160; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Karpowicz P, 2009, EUR J CELL BIOL, V88, P397, DOI 10.1016/j.ejcb.2009.03.001; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; KUROKI T, 1989, JPN J CANCER RES, V80, P637, DOI 10.1111/j.1349-7006.1989.tb01690.x; Ladurner P, 2000, DEV BIOL, V226, P231, DOI 10.1006/dbio.2000.9867; Ladurner Peter, 2008, P75, DOI 10.1007/978-1-4020-8274-0_5; LANGE CS, 1968, EXP GERONTOL, V3, P219, DOI 10.1016/0531-5565(68)90005-3; LANGE CS, 1968, INT J RADIAT BIOL RE, V14, P373, DOI 10.1080/09553006814551221; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Mouton S, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-15; Mouton S, 2009, EXP GERONTOL, V44, P243, DOI 10.1016/j.exger.2008.11.007; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Nimeth KT, 2004, DEV DYNAM, V230, P91, DOI 10.1002/dvdy.20035; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pfister D, 2008, DEV BIOL, V319, P146, DOI 10.1016/j.ydbio.2008.02.045; Pfister D, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-9; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Rieger R, 1988, FORTSCHR ZOOL, V36, P525; Rossi L, 2008, CELL MOL LIFE SCI, V65, P16, DOI 10.1007/s00018-007-7426-y; Scharer L, 2007, ANIM BIOL, V57, P121, DOI 10.1163/157075607780377992; Scharer L, 2004, BEHAV ECOL SOCIOBIOL, V56, P420, DOI 10.1007/s00265-004-0802-9; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Sotiropoulou PA, 2008, STEM CELLS, V26, P2964, DOI 10.1634/stemcells.2008-0634; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; STEPH.F, 1961, J EMBRYOL EXP MORPH, V9, P642; Tannenbaum E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041914; Tsai RYL, 2002, DEV CELL, V2, P707, DOI 10.1016/S1534-5807(02)00195-8; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WEI ZG, 1995, INVEST OPHTH VIS SCI, V36, P236; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	66	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30227	10.1371/journal.pone.0030227	http://dx.doi.org/10.1371/journal.pone.0030227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276162	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200045
J	Nacher, JC; Schwartz, JM				Nacher, Jose C.; Schwartz, Jean-Marc			Modularity in Protein Complex and Drug Interactions Reveals New Polypharmacological Properties	PLOS ONE			English	Article							COMMUNITY STRUCTURE; NETWORK MOTIFS; TARGETS; DEFICIENCY; ALZHEIMERS; PREDICTION; FEATURES; BIOLOGY; YEAST	Recent studies have highlighted the importance of interconnectivity in a large range of molecular and human disease-related systems. Network medicine has emerged as a new paradigm to deal with complex diseases. Connections between protein complexes and key diseases have been suggested for decades. However, it was not until recently that protein complexes were identified and classified in sufficient amounts to carry out a large-scale analysis of the human protein complex system. We here present the first systematic and comprehensive set of relationships between protein complexes and associated drugs and analyzed their topological features. The network structure is characterized by a high modularity, both in the bipartite graph and in its projections, indicating that its topology is highly distinct from a random network and that it contains a rich and heterogeneous internal modular structure. To unravel the relationships between modules of protein complexes, drugs and diseases, we investigated in depth the origins of this modular structure in examples of particular diseases. This analysis unveils new associations between diseases and protein complexes and highlights the potential role of polypharmacological drugs, which target multiple cellular functions to combat complex diseases driven by gain-of-function mutations.	[Nacher, Jose C.] Future Univ Hakodate, Dept Complex & Intelligent Syst, Hakodate, Hokkaido, Japan; [Schwartz, Jean-Marc] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England	Future University Hakodate; University of Manchester	Nacher, JC (corresponding author), Future Univ Hakodate, Dept Complex & Intelligent Syst, Hakodate, Hokkaido, Japan.	nacher@fun.ac.jp	Schwartz, Jean-Marc/AAS-8274-2020	Schwartz, Jean-Marc/0000-0002-6472-0184	MEXT Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [23700352] Funding Source: KAKEN	MEXT Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Scientific Research from MEXT Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Beyer A, 2005, BIOINFORMATICS, V21, P1610, DOI 10.1093/bioinformatics/bti223; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; CHIGNELL CF, 1969, MOL PHARMACOL, V5, P244; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Diao YB, 2007, J THEOR BIOL, V247, P608, DOI 10.1016/j.jtbi.2007.04.007; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guillaume JL, 2006, PHYSICA A, V371, P795, DOI 10.1016/j.physa.2006.04.047; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Halperin I, 2009, NEUROTHERAPEUTICS, V6, P128, DOI 10.1016/j.nurt.2008.10.033; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Hlavacek WS, 2003, BIOTECHNOL BIOENG, V84, P783, DOI 10.1002/bit.10842; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Kovacs IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012528; Laudon H, 2007, PHYSIOL BEHAV, V92, P115, DOI 10.1016/j.physbeh.2007.05.037; Lee SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-126; Ma'ayan A, 2007, MT SINAI J MED, V74, P27, DOI 10.1002/msj.20002; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Morris AAM, 1996, ANN NEUROL, V40, P25, DOI 10.1002/ana.410400107; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Newman M. E. J., 2004, PHYS REV, V69; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Park K, 2008, PROTEINS, V71, P960, DOI 10.1002/prot.21780; Pereira-Leal JB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r51; Rodriguez-Soca Y, 2010, J PROTEOME RES, V9, P1182, DOI 10.1021/pr900827b; Rubin GM, 2001, NATURE, V409, P820, DOI 10.1038/35057277; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spiro Zoltan, 2008, J Biol, V7, P20, DOI 10.1186/jbiol81; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Van der Schyf CJ, 2006, J NEUROCHEM, V99, P1033, DOI 10.1111/j.1471-4159.2006.04141.x; Van Laarhoven P. J., 1987, SIMULATED ANNEALING, P7, DOI DOI 10.1007/978-94-015-7744-1; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Veselovsky AV, 2007, CURR COMPUT-AID DRUG, V3, P51, DOI 10.2174/157340907780058754; Wang CQ, 2011, J DRUG TARGET, V19, P354, DOI 10.3109/1061186X.2010.504261; Wang XJ, 2011, BRIEF FUNCT GENOMICS, V10, P280, DOI 10.1093/bfgp/elr024; Wegener E., 2008, V186, P237, DOI 10.1007/978-3-540-72843-6_10; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	58	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30028	10.1371/journal.pone.0030028	http://dx.doi.org/10.1371/journal.pone.0030028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279562	gold, Green Published, Green Submitted			2022-12-25	WOS:000299771900040
J	Radicchi, F; Baronchelli, A; Amaral, LAN				Radicchi, Filippo; Baronchelli, Andrea; Amaral, Luis A. N.			Rationality, Irrationality and Escalating Behavior in Lowest Unique Bid Auctions	PLOS ONE			English	Article							ELECTRONIC MARKETPLACES; PREFERENCE REVERSAL; RANDOM SEARCHES; SCALING LAWS; LEVY FLIGHTS; PATTERNS; INTERNET; CONTEXT	Information technology has revolutionized the traditional structure of markets. The removal of geographical and time constraints has fostered the growth of online auction markets, which now include millions of economic agents worldwide and annual transaction volumes in the billions of dollars. Here, we analyze bid histories of a little studied type of online auctions - lowest unique bid auctions. Similarly to what has been reported for foraging animals searching for scarce food, we find that agents adopt Levy flight search strategies in their exploration of "bid space". The Levy regime, which is characterized by a power-law decaying probability distribution of step lengths, holds over nearly three orders of magnitude. We develop a quantitative model for lowest unique bid online auctions that reveals that agents use nearly optimal bidding strategies. However, agents participating in these auctions do not optimize their financial gain. Indeed, as long as there are many auction participants, a rational profit optimizing agent would choose not to participate in these auction markets.	[Radicchi, Filippo; Amaral, Luis A. N.] Northwestern Univ, Howard Hughes Med Inst HHMI, Evanston, IL 60208 USA; [Radicchi, Filippo; Amaral, Luis A. N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Radicchi, Filippo] Univ Rovira & Virgili, Dept Engn Quim, Tarragona, Catalunya, Spain; [Baronchelli, Andrea] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain; [Amaral, Luis A. N.] Northwestern Univ, NW Inst Complex Syst NICO, Evanston, IL USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; Universitat Rovira i Virgili; Universitat Politecnica de Catalunya; Northwestern University	Radicchi, F (corresponding author), Northwestern Univ, Howard Hughes Med Inst HHMI, Evanston, IL 60208 USA.	amaral@northwestern.edu	Amaral, LAN/A-4980-2008; Baronchelli, Andrea/F-9550-2016; Amaral, Luis N./C-5485-2009; Radicchi, Filippo/B-4407-2009	Amaral, LAN/0000-0002-3762-789X; Baronchelli, Andrea/0000-0002-0255-0829; Radicchi, Filippo/0000-0002-8352-1287	National Science Foundation (NSF)	National Science Foundation (NSF)(National Science Foundation (NSF))	Funding from National Science Foundation (NSF) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augenblick N., 2009, CONSUMER PRODU UNPUB; Bakos Y, 1998, COMMUN ACM, V41, P35, DOI 10.1145/280324.280330; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Basar T., 1995, DYNAMIC NONCOOPERATI; Bazerman MH, 1992, NEGOTIATING RATIONAL; Berkolaiko G, 1997, PHYS REV E, V55, P1395, DOI 10.1103/PhysRevE.55.1395; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; BYERS JW, 2010, 10010592 ARXIV; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; GRETHER DM, 1979, AM ECON REV, V69, P623; Grieger M, 2003, EUR J OPER RES, V144, P280, DOI 10.1016/S0377-2217(02)00394-6; HINNOSAAR T, 2010, PENNY AUCTIONS UNPUB; HUGHES DH, 1981, P NATL ACAD SCI USA, V78, P3287; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; KRISHNA V., 2002, AUCTION THEORY; Lucking-Reiley D, 2000, J IND ECON, V48, P227; Lucking-Reiley D, 2007, J IND ECON, V55, P223, DOI 10.1111/j.1467-6451.2007.00309.x; MALONE TW, 1987, COMMUN ACM, V30, P484, DOI 10.1145/214762.214766; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; MCAFEE RP, 1987, ECON LETT, V23, P343, DOI 10.1016/0165-1765(87)90142-X; MEYERSON R, 1981, MATH OPER RES, V6, P58; MILGROM PR, 1982, ECONOMETRICA, V50, P1089, DOI 10.2307/1911865; MITTAL S, 2010, EQUILIBRIUM A UNPUB; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; PLATT BC, 2010, PAY TO BID AUC UNPUB; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; RAPOPORT A, 1970, N PERSON GAME THEORY; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; SHUBIK M, 1971, J CONFLICT RESOLUT, V15, P109, DOI 10.1177/002200277101500111; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; STAW BM, 1989, SCIENCE, V246, P216, DOI 10.1126/science.246.4927.216; STAW BM, 1976, ORGAN BEHAV HUM PERF, V16, P27, DOI 10.1016/0030-5073(76)90005-2; TVERSKY A, 1990, AM ECON REV, V80, P204; van Heck E, 1998, COMMUN ACM, V41, P99, DOI 10.1145/278476.278495; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 2010, NATURE, V465, P1018, DOI 10.1038/4651018a; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wald C, 2008, SCIENCE, V322, P1624, DOI 10.1126/science.322.5908.1624	41	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29910	10.1371/journal.pone.0029910	http://dx.doi.org/10.1371/journal.pone.0029910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	885IH	22279553	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000299771900031
J	Claisse, JT; Pondella, DJ; Williams, JP; Sadd, J				Claisse, Jeremy T.; Pondella, Daniel J., II; Williams, Jonathan P.; Sadd, James			Using GIS Mapping of the Extent of Nearshore Rocky Reefs to Estimate the Abundance and Reproductive Output of Important Fishery Species	PLOS ONE			English	Article							SEMICOSSYPHUS-PULCHER LABRIDAE; ADULT CALIFORNIA SHEEPHEAD; MARINE RESERVES; KELP BASS; PARALABRAX-CLATHRATUS; HABITAT UTILIZATION; MOVEMENT PATTERNS; TEMPORAL PATTERNS; LIFE-HISTORIES; MATERNAL AGE	Kelp Bass (Paralabrax clathratus) and California Sheephead (Semicossyphus pulcher) are economically and ecologically valuable rocky reef fishes in southern California, making them likely indicator species for evaluating resource management actions. Multiple spatial datasets, aerial and satellite photography, underwater observations and expert judgment were used to produce a comprehensive map of nearshore natural rocky reef habitat for the Santa Monica Bay region (California, USA). It was then used to examine the relative contribution of individual reefs to a regional estimate of abundance and reproductive potential of the focal species. For the reefs surveyed for fishes (i.e. 18 out of the 22 in the region, comprising 82% the natural rocky reef habitat <30 m depth, with a total area of 1850 ha), total abundance and annual egg production of California Sheephead were 451 thousand fish (95% CI: 369 to 533 thousand) and 203 billion eggs (95% CI: 135 to 272 billion). For Kelp Bass, estimates were 805 thousand fish (95% CI: 669 to 941thousand) and 512 billion eggs (95% CI: 414 to 610 billion). Size structure and reef area were key factors in reef-specific contributions to the regional egg production. The size structures of both species illustrated impacts from fishing, and results demonstrate the potential that relatively small increases in the proportion of large females on larger reefs could have on regional egg production. For California Sheephead, a substantial proportion of the regional egg production estimate (>30%) was produced from a relatively small proportion of the regional reef area (c. 10%). Natural nearshore rocky reefs make up only 11% of the area in the newly designated MPAs in this region, but results provide some optimism that regional fisheries could benefit through an increase in overall reproductive output, if adequate increases in size structure of targeted species are realized.	[Claisse, Jeremy T.; Pondella, Daniel J., II; Williams, Jonathan P.] Occidental Coll, Dept Biol, Vantuna Res Grp, Los Angeles, CA 90041 USA; [Sadd, James] Occidental Coll, Dept Geol, Los Angeles, CA 90041 USA	Occidental College; Occidental College	Claisse, JT (corresponding author), Occidental Coll, Dept Biol, Vantuna Res Grp, Los Angeles, CA 90041 USA.	claisse@oxy.edu	Williams, Jonathan/AAX-3534-2020	Williams, Jonathan/0000-0002-4829-2474	Santa Monica Bay Restoration Commission; Southern California Coastal Water Research Project; Montrose Settlements Restoration Program; Sanitation Districts of Los Angeles County; Port of Los Angeles; Chevron Products Company	Santa Monica Bay Restoration Commission; Southern California Coastal Water Research Project; Montrose Settlements Restoration Program; Sanitation Districts of Los Angeles County; Port of Los Angeles; Chevron Products Company	Funding for this study was provided by the Santa Monica Bay Restoration Commission (http://www.santamonicabay.org), the Southern California Coastal Water Research Project (http://www.sccwrp.org), Montrose Settlements Restoration Program (www.montroserestoration.gov/), Sanitation Districts of Los Angeles County (www.lacsd.org), Port of Los Angeles (www.portoflosangeles.org) and Chevron Products Company (www.chevronelsegundo.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airame S, 2008, CHANNEL ISLANDS MARI; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Allen LG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P1; Alonzo SH, 2004, STATUS CALIFORNIA SH; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; ANDERSON TW, 1989, B MAR SCI, V44, P681; [Anonymous], CDFG AB REC MAN PLAN; Barnett AM, 1991, PRODUCTION VALUATION; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Bight' 08_Rocky_Reef_Committee, 2008, SO CAL BIGHT 2008 RE; Burnham K. P., 2002, MODEL SELECTION MULT, P484; Carr JP, 2009, BIOL CONSERV, V142, P477, DOI 10.1016/j.biocon.2008.10.004; Caselle JE, 2011, CAN J FISH AQUAT SCI, V68, P288, DOI 10.1139/F10-140; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; COWEN RK, 1985, J MAR RES, V43, P719, DOI 10.1357/002224085788440376; COWEN RK, 1990, COPEIA, P787; Curley BG, 2002, MAR FRESHWATER RES, V53, P1197, DOI 10.1071/MF01199; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DEMARTINI EE, 1994, B MAR SCI, V55, P484; Dojiri M, 2003, MAR ENVIRON RES, V56, P1, DOI 10.1016/S0141-1136(03)00003-5; Domeier ML, 2001, CALIFORNIAS MARINE L, P209; Erisman BE, 2006, J FISH BIOL, V68, P157, DOI 10.1111/j.0022-1112.2006.00886.x; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Feder HM, 1974, CALIF DEPT FISH GAME, V160, P144; Findlay AM, 2002, MAR ECOL PROG SER, V238, P237, DOI 10.3354/meps238237; Ford T., 2010, URBAN COAST, V2, P43; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; Froeschke John T., 2006, Bulletin Southern California Academy of Sciences, V105, P128, DOI 10.3160/0038-3872(2006)105[128:TFAIAO]2.0.CO;2; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Graham MH, 2003, TRENDS ECOL EVOL, V18, P33, DOI 10.1016/S0169-5347(02)00006-X; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hamilton SL, 2007, ECOL APPL, V17, P2268, DOI 10.1890/06-1930.1; Hamilton SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024580; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Hapke C, 20061251 US GEOL SUR; HOLBROOK SJ, 1990, AUST J ECOL, V15, P489, DOI 10.1111/j.1442-9993.1990.tb01473.x; HOLBROOK SJ, 1994, AM ZOOL, V34, P463; Kellner JB, 2005, BIOGEOGRAPHIC ASSESS, P89; Lewis R.D., 1989, GUIDE ARTIFICIAL REE; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Loke-Smith K, 2011, THESIS CALIFORNIA ST; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Love MS, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P567; Love MS, 1996, FISH B-NOAA, V94, P472; Love RM, 1991, PROBABLY MORE YOU WA, P381; Lowe CG, 2003, MAR ECOL PROG SER, V256, P205, DOI 10.3354/meps256205; MCCORMICK MI, 1987, MAR BIOL, V96, P469, DOI 10.1007/BF00397964; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; ODA DL, 1993, CAL COOP OCEAN FISH, V34, P122; Paddack MJ, 2000, ECOL APPL, V10, P855, DOI 10.2307/2641050; PATTON ML, 1985, B MAR SCI, V37, P279; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pondella D.J., 2009, URBAN COAST, V1, P33; Pondella DJ, 2008, MAR BIOL, V154, P307, DOI 10.1007/s00227-008-0924-0; Pondella DJ, 2002, ICES J MAR SCI, V59, pS88, DOI 10.1006/jmsc.2002.1219; PONDELLA DJ, 1994, B MAR SCI, V55, P1216; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schiff K, 2003, MAR ENVIRON RES, V56, P225, DOI 10.1016/S0141-1136(02)00332-X; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Smith SG, 2011, FISHERIES RES; Steele MA, 2002, MAR ECOL PROG SER, V235, P195, DOI 10.3354/meps235195; Stephens J.S., 2001, CALIFORNIAS MARINE L, P155; STEPHENS JS, 1994, B MAR SCI, V55, P1224; Sundberg Michael A., 2009, Bulletin Southern California Academy of Sciences, V108, P16, DOI 10.3160/0038-3872-108.1.16; Taylor BM, 2010, MAR ECOL PROG SER, V411, P243, DOI 10.3354/meps08672; Tetreault I, 2007, ECOL APPL, V17, P2251, DOI 10.1890/06-0161.1; Topping DT, 2006, MAR ECOL PROG SER, V326, P257, DOI 10.3354/meps326257; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; White JW, 2008, ECOLOGY, V89, P1323, DOI 10.1890/07-0840.1	73	8	11	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30290	10.1371/journal.pone.0030290	http://dx.doi.org/10.1371/journal.pone.0030290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272326	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400104
J	Killian, RL; Flippin, JD; Herrera, CM; Almenar-Queralt, A; Goldstein, LSB				Killian, Rhiannon L.; Flippin, Jessica D.; Herrera, Cheryl M.; Almenar-Queralt, Angels; Goldstein, Lawrence S. B.			Kinesin Light Chain 1 Suppression Impairs Human Embryonic Stem Cell Neural Differentiation and Amyloid Precursor Protein Metabolism	PLOS ONE			English	Article							AXONAL-TRANSPORT; HEAVY-CHAIN; TARGETED DISRUPTION; ALZHEIMERS-DISEASE; HUMAN BLASTOCYSTS; MOTOR DOMAIN; MOUSE; IDENTIFICATION; NEURONS; LOCALIZATION	The etiology of sporadic Alzheimer disease (AD) is largely unknown, although evidence implicates the pathological hallmark molecules amyloid beta (A beta) and phosphorylated Tau. Work in animal models suggests that altered axonal transport caused by Kinesin-1 dysfunction perturbs levels of both A beta and phosphorylated Tau in neural tissues, but the relevance of Kinesin-1 dependent functions to the human disease is unknown. To begin to address this issue, we generated human embryonic stem cells (hESC) expressing reduced levels of the kinesin light chain 1 (KLC1) Kinesin-1 subunit to use as a source of human neural cultures. Despite reduction of KLC1, undifferentiated hESC exhibited apparently normal colony morphology and pluripotency marker expression. Differentiated neural cultures derived from KLC1-suppressed hESC contained neural rosettes but further differentiation revealed obvious morphological changes along with reduced levels of microtubule-associated neural proteins, including Tau and less secreted A beta, supporting the previously established connection between KLC1, Tau and A beta. Intriguingly, KLC1-suppressed neural precursors (NPs), isolated using a cell surface marker signature known to identify cells that give rise to neurons and glia, unlike control cells, failed to proliferate. We suggest that KLC1 is required for normal human neural differentiation, ensuring proper metabolism of AD-associated molecules APP and Tau and for proliferation of NPs. Because impaired APP metabolism is linked to AD, this human cell culture model system will not only be a useful tool for understanding the role of KLC1 in regulating the production, transport and turnover of APP and Tau in neurons, but also in defining the essential function(s) of KLC1 in NPs and their progeny. This knowledge should have important implications for human neurodevelopmental and neurodegenerative diseases.	[Killian, Rhiannon L.; Flippin, Jessica D.; Herrera, Cheryl M.; Almenar-Queralt, Angels; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Killian, Rhiannon L.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Killian, RL (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	aalmenar@ucsd.edu; lgoldstein@ucsd.edu			California Institute for Regenerative Medicine [RC1-00116-1, T1-00003]	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was funded by the California Institute for Regenerative Medicine (http://www.cirm.ca.gov/), grant numbers RC1-00116-1 and T1-00003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Chen C, 2011, DEVELOPMENT, V138, P507, DOI 10.1242/dev.060939; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Brendza RP, 2000, MOL BIOL CELL, V11, P1329, DOI 10.1091/mbc.11.4.1329; CABEZAARVELAIZ Y, 1993, DNA CELL BIOL, V12, P881, DOI 10.1089/dna.1993.12.881; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Dvash T, 2006, PEDIATR RES, V60, P111, DOI 10.1203/01.pdr.0000228349.24676.17; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Falzone TL, 2010, HUM MOL GENET; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Jolly AL, 2010, P NATL ACAD SCI USA, V107, P12151, DOI 10.1073/pnas.1004736107; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; KODAMA HA, 1982, J CELL PHYSIOL, V112, P83, DOI 10.1002/jcp.1041120113; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lamerdin JE, 1996, GENOMICS, V34, P399, DOI 10.1006/geno.1996.0303; Lazarov O, 2002, J NEUROSCI, V22, P9785; Malgrange B, 2011, CELL MOL LIFE SCI, V68, P635, DOI 10.1007/s00018-010-0557-6; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; RODIONOV VI, 1993, J CELL BIOL, V123, P1811, DOI 10.1083/jcb.123.6.1811; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tarnok A, 2010, CYTOM PART A, V77A, P6, DOI 10.1002/cyto.a.20844; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29755	10.1371/journal.pone.0029755	http://dx.doi.org/10.1371/journal.pone.0029755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272245	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400024
J	Ma, PF; Guo, ZH; Li, DZ				Ma, Peng-Fei; Guo, Zhen-Hua; Li, De-Zhu			Rapid Sequencing of the Bamboo Mitochondrial Genome Using Illumina Technology and Parallel Episodic Evolution of Organelle Genomes in Grasses	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PLANT MITOCHONDRIAL; PHYLOGENETIC ANALYSIS; ANGIOSPERM PHYLOGENY; CHLOROPLAST GENOMES; SUBSTITUTION RATES; LEVEL CHARACTERS; SCALE DATA; DNA; GENES	Background: Compared to their counterparts in animals, the mitochondrial (mt) genomes of angiosperms exhibit a number of unique features. However, unravelling their evolution is hindered by the few completed genomes, of which are essentially Sanger sequenced. While next-generation sequencing technologies have revolutionized chloroplast genome sequencing, they are just beginning to be applied to angiosperm mt genomes. Chloroplast genomes of grasses (Poaceae) have undergone episodic evolution and the evolutionary rate was suggested to be correlated between chloroplast and mt genomes in Poaceae. It is interesting to investigate whether correlated rate change also occurred in grass mt genomes as expected under lineage effects. A time-calibrated phylogenetic tree is needed to examine rate change. Methodology/Principal Findings: We determined a largely completed mt genome from a bamboo, Ferrocalamus rimosivaginus (Poaceae), through Illumina sequencing of total DNA. With combination of de novo and reference-guided assembly, 39.5-fold coverage Illumina reads were finally assembled into scaffolds totalling 432,839 bp. The assembled genome contains nearly the same genes as the completed mt genomes in Poaceae. For examining evolutionary rate in grass mt genomes, we reconstructed a phylogenetic tree including 22 taxa based on 31 mt genes. The topology of the well-resolved tree was almost identical to that inferred from chloroplast genome with only minor difference. The inconsistency possibly derived from long branch attraction in mtDNA tree. By calculating absolute substitution rates, we found significant rate change (similar to 4-fold) in mt genome before and after the diversification of Poaceae both in synonymous and nonsynonymous terms. Furthermore, the rate change was correlated with that of chloroplast genomes in grasses. Conclusions/Significance: Our result demonstrates that it is a rapid and efficient approach to obtain angiosperm mt genome sequences using Illumina sequencing technology. The parallel episodic evolution of mt and chloroplast genomes in grasses is consistent with lineage effects.	[Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Ma, Peng-Fei; Guo, Zhen-Hua; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China; [Ma, Peng-Fei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, PF (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	guozhenhua@mail.kib.ac.cn; dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Natural Science Foundation of China [31170204]; Chinese Academy of Sciences [KSCX-YW-N-029, KSCX2-YW-N-067]; Yunnan Provincial Government through an innovation team	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Provincial Government through an innovation team	This project is supported by National Natural Science Foundation of China (no. 31170204), the Chinese Academy of Sciences under the knowledge innovation program (grants KSCX-YW-N-029 and KSCX2-YW-N-067), and Yunnan Provincial Government through an innovation team program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Alverson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016404; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Boore JL, 2008, PHILOS T R SOC B, V363, P1445, DOI 10.1098/rstb.2007.2234; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bouchenak-Khelladi Y, 2010, BOT J LINN SOC, V162, P543, DOI 10.1111/j.1095-8339.2010.01041.x; Bowe LM, 1996, MOL BIOL EVOL, V13, P1159, DOI 10.1093/oxfordjournals.molbev.a025680; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Clifton SW, 2004, PLANT PHYSIOL, V136, P3486, DOI 10.1104/pp.104.044602; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Davila JI, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-64; EyreWalker A, 1997, MOL BIOL EVOL, V14, P455, DOI 10.1093/oxfordjournals.molbev.a025781; Fujii S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-209; GAUT BS, 1992, J MOL EVOL, V35, P292, DOI 10.1007/BF00161167; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; HSU CL, 1989, PLANT MOL BIOL, V13, P467, DOI 10.1007/BF00015558; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; KELLOGG EA, 1993, SYST BIOL, V42, P415, DOI 10.2307/2992482; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lockhart P, 2006, MOL BIOL EVOL, V23, P40, DOI 10.1093/molbev/msj005; Lu MZ, 1998, PLANT MOL BIOL, V37, P225, DOI 10.1023/A:1005972513322; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-17; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Mower JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-265; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Neafsey Daniel E, 2011, Genome Biol, V12, P303, DOI 10.1186/gb-2011-12-3-303; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ogihara Y, 2005, NUCLEIC ACIDS RES, V33, P6235, DOI 10.1093/nar/gki925; Ong HC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-55; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Parkinson CL, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-73; Picardi E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S14; Piperno DR, 2005, SCIENCE, V310, P1126, DOI 10.1126/science.1121020; Qiu YL, 2006, TAXON, V55, P837, DOI 10.2307/25065680; Qiu YL, 2010, J SYST EVOL, V48, P391, DOI 10.1111/j.1759-6831.2010.00097.x; Rodriguez-Moreno L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-424; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sloan DB, 2008, MOL BIOL EVOL, V25, P243, DOI 10.1093/molbev/msm266; Sloan DB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-274; Sloan DB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-260; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Soria-Hernanz DF, 2008, MOL BIOL EVOL, V25, P1282, DOI 10.1093/molbev/msn074; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wolf PG, 2011, PLANT MOL BIOL, V76, P251, DOI 10.1007/s11103-010-9706-4; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu CS, 2011, GENOME BIOL EVOL; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang WP, 2000, MOL PHYLOGENET EVOL, V15, P135, DOI 10.1006/mpev.1999.0729; Zhang Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297; [No title captured]	71	25	27	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30297	10.1371/journal.pone.0030297	http://dx.doi.org/10.1371/journal.pone.0030297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272330	gold, Green Submitted, Green Published			2022-12-25	WOS:000301454400108
J	Marr, N; Foglia, J; Terebiznik, M; Athenstaedt, K; Zaremberg, V				Marr, Nancy; Foglia, Julena; Terebiznik, Mauricio; Athenstaedt, Karin; Zaremberg, Vanina			Controlling Lipid Fluxes at Glycerol-3-phosphate Acyltransferase Step in Yeast UNIQUE CONTRIBUTION OF Gat1p TO OLEIC ACID-INDUCED LIPID PARTICLE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PHOSPHATIDIC-ACID; PHOSPHOLIPID-SYNTHESIS; PARTICLES; PROTEINS; IDENTIFICATION; BIOSYNTHESIS; LOCALIZATION; SENSITIVITY	The ability to channel excess fatty acids into neutral lipids like triacylglycerol (TAG) is a critical strategy used by cells to maintain lipid homeostasis. Upon activation to acyl-CoA, fatty acids become readily available as substrates for acyltransferases involved in neutral lipid synthesis. Neutral lipids are then packed into organelles derived from the endoplasmic reticulum called lipid particles (LPs). The first acylation step in the de novo pathway for TAG synthesis is catalyzed by glycerol-3-phosphate acyltransferases (GPATs). Two isoforms, Gat1p/Gpt2p and Gat2p/Sct1p, are present in the yeast Saccharomyces cerevisiae. Previous evidence indicated that these enzymes contribute differentially to the synthesis of TAG in actively growing cells. In this work we studied the role of the yeast GPATs in the formation of LPs induced by a surplus of oleic acid. Yeast lacking Gat1p (but not Gat2p) were sensitive to oleate and failed to accumulate LPs induced by this unsaturated fatty acid. It is shown that oleate induces dephosphorylation of Gat1p as well as an increment in its levels. Most importantly, we identified novel Gat1p crescent structures that are formed in the presence of oleate. These structures are connected with the endoplasmic reticulum and are intimately associated with LPs. Nosuch structures were observed for Gat2p. Acrucial point of control of lipid fluxes at the GPAT step is proposed.	[Marr, Nancy; Foglia, Julena; Zaremberg, Vanina] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Terebiznik, Mauricio] Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada; [Athenstaedt, Karin] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	University of Calgary; University of Toronto; University Toronto Scarborough; Graz University of Technology	Zaremberg, V (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vzarembe@ucalgary.ca		Athenstaedt, Karin/0000-0001-7198-3989	National Sciences and Engineering Research Council; Austrian Science Fund [P21251]; Austrian Science Fund (FWF) [P 21251] Funding Source: researchfish	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by operating grants from the National Sciences and Engineering Research Council (to V. Z. and M. T.), a University Faculty Award from National Sciences and Engineering Research Council (to V. Z.), and by Austrian Science Fund Project P21251 (to K. A.).	Athenstaedt K, 2006, PROTEOMICS, V6, P1450, DOI 10.1002/pmic.200500339; Athenstaedt K, 1997, J BACTERIOL, V179, P7611, DOI 10.1128/jb.179.24.7611-7616.1997; Athenstaedt K, 1999, J BACTERIOL, V181, P1458, DOI 10.1128/JB.181.5.1458-1463.1999; Bratschi MW, 2009, EUKARYOT CELL, V8, P1184, DOI 10.1128/EC.00085-09; Coleman RA, 2007, CELL METAB, V5, P87, DOI 10.1016/j.cmet.2007.01.004; Connerth M, 2010, J BIOL CHEM, V285, P26832, DOI 10.1074/jbc.M110.122085; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; DAUM G, 1982, J BIOL CHEM, V257, P3028; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gidda SK, 2011, TRAFFIC, V12, P452, DOI 10.1111/j.1600-0854.2011.01160.x; Gimeno RE, 2008, J LIPID RES, V49, P2079, DOI 10.1194/jlr.R800013-JLR200; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HAID A, 1983, METHOD ENZYMOL, V96, P192; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Tatchell K, 2002, METHOD ENZYMOL, V351, P661; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zheng ZF, 2001, J BIOL CHEM, V276, P41710, DOI 10.1074/jbc.M104749200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	29	18	18	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10251	10264		10.1074/jbc.M111.314112	http://dx.doi.org/10.1074/jbc.M111.314112			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22267742	hybrid, Green Published			2022-12-25	WOS:000302167200055
J	Gersch, M; List, A; Groll, M; Sieber, SA				Gersch, Malte; List, Anja; Groll, Michael; Sieber, Stephan A.			Insights into Structural Network Responsible for Oligomerization and Activity of Bacterial Virulence Regulator Caseinolytic Protease P (ClpP) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; BETA-LACTONES; COMPLEX; ANTIBIOTICS; RECOGNITION; PROTEOLYSIS; ACTIVATION; INHIBITORS	The barrel-shaped caseinolytic protease P (ClpP) is a main virulence regulator in the bacterial pathogen Staphylococcus aureus (SaClpP). It consists of two heptameric rings forming a homotetradecamer with an inner chamber that houses the 14 active sites. We recently showed that SaClpP is able to adopt a compressed, inactive conformation. We present here the 2.3 angstrom resolution structure of SaClpP in its closed, active conformation as well as the structure of the S98A mutant. Comprehensive mutational analysis aiming at destabilizing one or the other or both conformations was able to pinpoint key residues involved in this catalytic switch and in the heptamer-heptamer interaction. By probing the active site serine with a covalently modifying beta-lactone probe, we could show that the tetradecameric organization is essential for a proper formation of the active site. Structural data suggest that a highly conserved hydrogen-bonding network links oligomerization to activity. A comparison of ClpP structures from different organisms provides suggestive evidence for the presence of a universal mechanism regulating ClpP activity in which binding of one subunit to the corresponding subunit on the other ring interface is necessary for the functional assembly of the catalytic triad and thus for protease function. This mechanism ensures controlled access to the active sites of a highly unspecific protease.	[Gersch, Malte; List, Anja; Groll, Michael; Sieber, Stephan A.] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, D-85747 Garching, Germany	Technical University of Munich	Sieber, SA (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany.	stephan.sieber@tum.de	Groll, Michael/F-5572-2015		Deutsche Forschungsgemeinschaft [SFB749]; Center for Integrated Protein Science Munich; European Research Council (ERC); German National Academic Foundation; Fonds der Chemischen Industrie, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; European Research Council (ERC)(European Research Council (ERC)); German National Academic Foundation; Fonds der Chemischen Industrie, Germany(Fonds der Chemischen Industrie)	This work was supported by the Deutsche Forschungsgemeinschaft (Emmy Noether program), SFB749, Center for Integrated Protein Science Munich, and the European Research Council (ERC starting grant). Data collection was conducted at the Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland.; Recipient of fellowships from the German National Academic Foundation and the Fonds der Chemischen Industrie, Germany.	Baker T. A., 2012, BIOCHIM BIOPHYS ACTA, V1825, P15; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bottcher T, 2009, CHEMBIOCHEM, V10, P663, DOI 10.1002/cbic.200800743; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Frees D, 2005, INFECT IMMUN, V73, P8100, DOI 10.1128/IAI.73.12.8100-8108.2005; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kang SG, 2005, J BIOL CHEM, V280, P35424, DOI 10.1074/jbc.M507240200; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Kim DY, 2008, J MOL BIOL, V379, P760, DOI 10.1016/j.jmb.2008.04.036; Kimber MS, 2010, STRUCTURE, V18, P798, DOI 10.1016/j.str.2010.04.008; Kolygo K, 2009, J STRUCT BIOL, V168, P267, DOI 10.1016/j.jsb.2009.07.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Rathore S, 2010, MOL MICROBIOL, V77, P873, DOI 10.1111/j.1365-2958.2010.07251.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; TURK D, 1992, THESIS TU MUNCHEN MU; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zeiler E, 2011, ANGEW CHEM INT EDIT, V50, P11001, DOI 10.1002/anie.201104391; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848	37	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9484	9494		10.1074/jbc.M111.336222	http://dx.doi.org/10.1074/jbc.M111.336222			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291011	hybrid, Green Published			2022-12-25	WOS:000301797800077
J	Quanz, M; Herbette, A; Sayarath, M; de Koning, L; Dubois, T; Sun, JS; Dutreix, M				Quanz, Maria; Herbette, Aurelie; Sayarath, Mano; de Koning, Leanne; Dubois, Thierry; Sun, Jian-Sheng; Dutreix, Marie			Heat Shock Protein 90 alpha (Hsp90 alpha) Is Phosphorylated in Response to DNA Damage and Accumulates in Repair Foci	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; NF-KAPPA-B; CATALYTIC SUBUNIT; CELL-SURFACE; TUMOR-CELLS; NUCLEAR TRANSLOCATION; RADIATION RESPONSE; KINASE-ACTIVITY; HSP90; ACTIVATION	DNA damage triggers a complex signaling cascade involving a multitude of phosphorylation events. We found that the threonine 7 (Thr-7) residue of heat shock protein 90 alpha (Hsp90 alpha) was phosphorylated immediately after DNA damage. The phosphorylated Hsp90 alpha then accumulated at sites of DNA double strand breaks and formed repair foci with slow kinetics, matching the repair kinetics of complex DNA damage. The phosphorylation of Hsp90 alpha was dependent on phosphatidylinositol 3-kinase-like kinases, including the DNA-dependent protein kinase (DNA-PK) in particular. DNA-PK plays an essential role in the repair of DNA double strand breaks by nonhomologous end-joining and in the signaling of DNA damage. It is also present in the cytoplasm of the cell and has been suggested to play a role in cytoplasmic signaling pathways. Using stabilized double-stranded DNA molecules to activate DNA-PK, we showed that an active DNA-PK complex could be assembled in the cytoplasm, resulting in phosphorylation of the cytoplasmic pool of Hsp90 alpha. In vivo, reverse phase protein array data for tumors revealed that basal levels of Thr-7-phosphorylated Hsp90 alpha were correlated with phosphorylated histone H2AX levels. The Thr-7 phosphorylation of the ubiquitously produced and secreted Hsp90 alpha may therefore serve as a surrogate biomarker of DNA damage. These findings shed light on the interplay between central DNA repair enzymes and an essential molecular chaperone.	[Quanz, Maria; Dutreix, Marie] Univ Paris 11, Inst Curie, Ctr Univ, CNRS,INSERM,UMR3347,U1021, F-91405 Orsay, France; [Quanz, Maria; Herbette, Aurelie; Sayarath, Mano; Sun, Jian-Sheng] DNA Therapeut, F-91058 Evry, France; [de Koning, Leanne; Dubois, Thierry] Inst Curie, Dept Rech Translat, F-75010 Paris, France; [Sun, Jian-Sheng] Museum Natl Hist Nat, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Museum National d'Histoire Naturelle (MNHN)	Quanz, M (corresponding author), Univ Paris 11, Inst Curie, Ctr Univ, CNRS,INSERM,UMR3347,U1021, Bat 112, F-91405 Orsay, France.	maria.quanz@curie.fr	Quanz, Maria/AAA-4424-2020; Dubois, Thierry/D-2852-2017	Dubois, Thierry/0000-0003-4739-6164	Institut Curie; CNRS; INSERM; l'Agence National de le Recherche [ANR-08-Biot-009-02]; DNA Therapeutics SA	Institut Curie; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); l'Agence National de le Recherche(French National Research Agency (ANR)); DNA Therapeutics SA	This work was supported by Institut Curie, CNRS, INSERM, and l'Agence National de le Recherche Grant ANR-08-Biot-009-02. M. Quanz is recipient of a Ph.D. fellowship cofinanced by DNA Therapeutics SA. A. Herbette and M. Sayarath are employees of DNA Therapeutics SA. M. Dutreix and J-S. Sun are cofounders of DNA Therapeutics SA, the company holding the patent for Dbait 32Hc.	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; Basu S, 1998, BIOCHEM BIOPH RES CO, V247, P79, DOI 10.1006/bbrc.1998.8741; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bisht KS, 2003, CANCER RES, V63, P8984; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen JS, 2010, J BIOL CHEM, V285, P25458, DOI 10.1074/jbc.M110.139345; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Gulmann C, 2006, J PATHOL, V208, P595, DOI 10.1002/path.1958; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Kim JE, 2009, CELL CYCLE, V8, P2932; Koike M, 2005, EXP CELL RES, V305, P266, DOI 10.1016/j.yexcr.2004.12.027; Krull S, 2010, EMBO J, V29, P1659, DOI 10.1038/emboj.2010.54; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; LEESMILLER SP, 1989, J BIOL CHEM, V264, P17275; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu SK, 2008, CANCER METAST REV, V27, P445, DOI 10.1007/s10555-008-9137-8; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Matsumoto Y, 2005, J RADIAT RES, V46, P215, DOI 10.1269/jrr.46.215; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Moore R, 2004, ONCOGENE, V23, P6726, DOI 10.1038/sj.onc.1207675; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; PERDEW GH, 1993, EXP CELL RES, V209, P350, DOI 10.1006/excr.1993.1320; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; PRABHAKAR BS, 1990, J CLIN INVEST, V86, P1301, DOI 10.1172/JCI114838; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Quanz M, 2009, CLIN CANCER RES, V15, P1308, DOI 10.1158/1078-0432.CCR-08-2108; Quanz M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006298; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Sidera K, 2008, CELL CYCLE, V7, P1564, DOI 10.4161/cc.7.11.6054; Song YT, 2005, J BIOL CHEM, V280, P34178, DOI 10.1074/jbc.M505420200; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Takemura H, 2006, J BIOL CHEM, V281, P30814, DOI 10.1074/jbc.M603747200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Weitzman MD, 2004, DNA REPAIR, V3, P1165, DOI 10.1016/j.dnarep.2004.03.018; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	68	71	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8803	8815		10.1074/jbc.M111.320887	http://dx.doi.org/10.1074/jbc.M111.320887			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270370	Green Published, hybrid			2022-12-25	WOS:000301797800013
J	de Castro, RO; Zhang, J; Groves, JR; Barbu, EA; Siraganian, RP				de Castro, Rodrigo Orlandini; Zhang, Juan; Groves, Jacqueline R.; Barbu, Emilia Alina; Siraganian, Reuben P.			Once Phosphorylated, Tyrosines in Carboxyl Terminus of Protein-tyrosine Kinase Syk Interact with Signaling Proteins, Including TULA-2, a Negative Regulator of Mast Cell Degranulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; AFFINITY IGE RECEPTOR; ACTIVATION LOOP TYROSINES; ADAPTER PROTEINS; ACTIN CYTOSKELETON; PHOSPHATASE; SLP-76; SHIP; IDENTIFICATION; SPECIFICITY	Activation of the high affinity IgE-binding receptor (Fc epsilon RI) results in the tyrosine phosphorylation of two conserved tyrosines located close to the COOH terminus of the protein-tyrosine kinase Syk. Synthetic peptides representing the last 10 amino acids of the tail of Syk with these two tyrosines either nonphosphorylated or phosphorylated were used to precipitate proteins from mast cell lysates. Proteins specifically precipitated by the phosphorylated peptide were identified by mass spectrometry. These included the adaptor proteins SLP-76, Nck-1, Grb2, and Grb2-related adaptor downstream of Shc (GADS) and the protein phosphatases SHIP-1 and TULA-2 (also known as UBASH3B or STS-1). The presence of these in the precipitates was further confirmed by immunoblotting. Using the peptides as probes in far Western blots showed direct binding of the phosphorylated peptide to Nck-1 and SHIP-1. Immunoprecipitations suggested that there were complexes of these proteins associated with Syk especially after receptor activation; in these complexes are Nck, SHIP-1, SLP-76, Grb2, and TULA-2 (UBASH3B or STS-1). The decreased expression of TULA-2 by treatment of mast cells with siRNA increased the Fc epsilon RI-induced tyrosine phosphorylation of the activation loop tyrosines of Syk and the phosphorylation of phospholipase C-gamma 2. There was parallel enhancement of the receptor-induced degranulation and activation of nuclear factor for T cells or nuclear factor kappa B, indicating that TULA-2, like SHIP-1, functions as a negative regulator of Fc epsilon RI signaling in mast cells. Therefore, once phosphorylated, the terminal tyrosines of Syk bind complexes of proteins that are positive and negative regulators of signaling in mast cells.	[de Castro, Rodrigo Orlandini; Zhang, Juan; Groves, Jacqueline R.; Barbu, Emilia Alina; Siraganian, Reuben P.] NIDCR, Receptors & Signal Transduct Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Siraganian, RP (corresponding author), NIDCR, Receptors & Signal Transduct Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA.	rs53x@nih.gov			National Institutes of Health, NIDCR	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health National Institutes of Health Intramural Research Program, NIDCR.	Agrawal R, 2008, J CELL BIOCHEM, V104, P953, DOI 10.1002/jcb.21678; Alvarez-Errico D, 2009, IMMUNOL REV, V232, P195, DOI 10.1111/j.1600-065X.2009.00834.x; Barbu EA, 2010, J BIOL CHEM, V285, P15761, DOI 10.1074/jbc.M110.109413; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Carpino N, 2009, MOL IMMUNOL, V46, P3224, DOI 10.1016/j.molimm.2009.08.015; Chen XW, 2010, J BIOL CHEM, V285, P31268, DOI 10.1074/jbc.M110.114181; Chen YT, 2009, BIOCHEMISTRY-US, V48, P8129, DOI 10.1021/bi9008648; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; de Castro RO, 2011, J SIGNAL TRANSDUCT, DOI DOI 10.1155/2011/507291; de Castro RO, 2010, J BIOL CHEM, V285, P26674, DOI 10.1074/jbc.M110.134262; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Frese S, 2006, J BIOL CHEM, V281, P18236, DOI 10.1074/jbc.M512917200; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; GOLDSTEIN B, 1989, BIOPHYS J, V56, P955, DOI 10.1016/S0006-3495(89)82741-9; HendricksTaylor LR, 1997, J BIOL CHEM, V272, P1363, DOI 10.1074/jbc.272.2.1363; Huber M, 2002, IMMUNOL LETT, V82, P17, DOI 10.1016/S0165-2478(02)00012-3; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jordan MS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002501; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kambayashi T, 2009, IMMUNOL REV, V232, P99, DOI 10.1111/j.1600-065X.2009.00825.x; Kettner A, 2003, MOL CELL BIOL, V23, P2395, DOI 10.1128/MCB.23.7.2395-2406.2003; Kimura T, 1996, MOL CELL BIOL, V16, P1471; Kimura T, 1997, J BIOL CHEM, V272, P13991, DOI 10.1074/jbc.272.21.13991; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Liu SK, 1999, CURR BIOL, V9, P67, DOI 10.1016/S0960-9822(99)80017-7; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Odai H, 1997, BLOOD, V89, P2745, DOI 10.1182/blood.V89.8.2745; Pivniouk VI, 1999, J CLIN INVEST, V103, P1737; Raguz J, 2007, FEBS LETT, V581, P4767, DOI 10.1016/j.febslet.2007.08.077; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; San Luis B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177634; Siraganian RP, 2010, FEBS LETT, V584, P4933, DOI 10.1016/j.febslet.2010.08.006; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Smirnova EV, 2008, VIROLOGY, V372, P10, DOI 10.1016/j.virol.2007.10.012; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; Thomas DH, 2010, BLOOD, V116, P2570, DOI 10.1182/blood-2010-02-268136; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wu JN, 2004, J IMMUNOL, V172, P6768, DOI 10.4049/jimmunol.172.11.6768; Yamasaki S, 2008, INT IMMUNOL, V20, P1289, DOI 10.1093/intimm/dxn085; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 1998, J IMMUNOL, V161, P4366; Zhang J, 2007, J BIOL CHEM, V282, P37669, DOI 10.1074/jbc.M705168200; Zhang JA, 2010, J IMMUNOL, V184, P7178, DOI 10.4049/jimmunol.0904169; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	59	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8194	8204		10.1074/jbc.M111.326850	http://dx.doi.org/10.1074/jbc.M111.326850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267732	hybrid, Green Published			2022-12-25	WOS:000301349400035
J	Bastea, LI; Doppler, H; Balogun, B; Storz, P				Bastea, Ligia I.; Doeppler, Heike; Balogun, Bolanle; Storz, Peter			Protein Kinase D1 Maintains the Epithelial Phenotype by Inducing a DNA-Bound, Inactive SNAI1 Transcriptional Repressor Complex	PLOS ONE			English	Article							BREAST-CARCINOMA PROGRESSION; NF-KAPPA-B; E-CADHERIN; MESENCHYMAL TRANSITION; TUMOR PROGRESSION; PROMOTES METASTASIS; MEDIATED ACTIVATION; 14-3-3 BINDING; PHOSPHORYLATION; EXPRESSION	Background: Protein Kinase D1 is downregulated in its expression in invasive ductal carcinoma of the breast and in invasive breast cancer cells, but its functions in normal breast epithelial cells is largely unknown. The epithelial phenotype is maintained by cell-cell junctions formed by E-cadherin. In cancer cells loss of E-cadherin expression contributes to an invasive phenotype. This can be mediated by SNAI1, a transcriptional repressor for E-cadherin that contributes to epithelial-to-mesenchymal transition (EMT). Methodology/Principal Findings: Here we show that PKD1 in normal murine mammary gland (NMuMG) epithelial cells is constitutively-active in its basal state and prevents a transition to a mesenchymal phenotype. Investigation of the involved mechanism suggested that PKD1 regulates the expression of E-cadherin at the promoter level through direct phosphorylation of the transcriptional repressor SNAI1. PKD1-mediated phosphorylation of SNAI1 occurs in the nucleus and generates a nuclear, inactive DNA/SNAI1 complex that shows decreased interaction with its co-repressor Ajuba. Analysis of human tissue samples with a newly-generated phosphospecific antibody for PKD1-phosphorylated SNAI1 showed that regulation of SNAI1 through PKD1 occurs in vivo in normal breast ductal tissue and is decreased or lost in invasive ductal carcinoma. Conclusions/Significance: Our data describe a mechanism of how PKD1 maintains the breast epithelial phenotype. Moreover, they suggest, that the analysis of breast tissue for PKD-mediated phosphorylation of SNAI1 using our novel phosphoS11-SNAI1-specific antibody may allow predicting the invasive potential of breast cancer cells.	[Bastea, Ligia I.; Doeppler, Heike; Balogun, Bolanle; Storz, Peter] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Bastea, LI (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	storz.peter@mayo.edu			Florida Department of Health [10BG11]; Mayo Clinic Breast Cancer SPORE [CA116201-03DR4]; NIH [GM086438, CA140182]; NATIONAL CANCER INSTITUTE [R01CA140182, P50CA116201] Funding Source: NIH RePORTER	Florida Department of Health; Mayo Clinic Breast Cancer SPORE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Bankhead-Coley grant (10BG11) from the Florida Department of Health, the Mayo Clinic Breast Cancer SPORE (CA116201-03DR4) and NIH grants GM086438 and CA140182 (all to PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Barisic S, 2011, EMBO REP, V12, P527, DOI 10.1038/embor.2011.53; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheng CW, 2001, ONCOGENE, V20, P3814, DOI 10.1038/sj.onc.1204505; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Cowell CF, 2009, J CELL BIOCHEM, V106, P714, DOI 10.1002/jcb.22067; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jaggi M, 2005, CANCER RES, V65, P483; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Seki K, 2003, J BIOL CHEM, V278, P41862, DOI 10.1074/jbc.M308336200; Song J, 2006, AM J PHYSL CELL PHYS; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Watkins JL, 2008, P NATL ACAD SCI USA, V105, P18378, DOI 10.1073/pnas.0809661105; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	48	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30459	10.1371/journal.pone.0030459	http://dx.doi.org/10.1371/journal.pone.0030459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276203	gold, Green Submitted, Green Published			2022-12-25	WOS:000301568100048
J	Li, FCH; Yen, JC; Chan, SHH; Chang, AYW				Li, Faith C. H.; Yen, Jiin-Cherng; Chan, Samuel H. H.; Chang, Alice Y. W.			Bioenergetics Failure and Oxidative Stress in Brain Stem Mediates Cardiovascular Collapse Associated with Fatal Methamphetamine Intoxication	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; SYSTEMIC ARTERIAL-PRESSURE; MITOCHONDRIAL RESPIRATORY-CHAIN; ENDOPLASMIC-RETICULUM STRESS; ACUTE MEVINPHOS INTOXICATION; INTENSIVE-CARE UNIT; NECROTIC CELL-DEATH; HEART-RATE SIGNALS; PROLIFE ROLE; VASOMOTOR COMPONENT	Background: Whereas sudden death, most often associated with cardiovascular collapse, occurs in abusers of the psychostimulant methamphetamine (METH), the underlying mechanism is much less understood. The demonstration that successful resuscitation of an arrested heart depends on maintained functionality of the rostral ventrolateral medulla (RVLM), which is responsible for the maintenance of stable blood pressure, suggests that failure of brain stem cardiovascular regulation, rather than the heart, holds the key to cardiovascular collapse. We tested the hypothesis that cessation of brain stem cardiovascular regulation because of a loss of functionality in RVLM mediated by bioenergetics failure and oxidative stress underlies the cardiovascular collapse elicited by lethal doses of METH. Methodology/Principal Findings: Survival rate, cardiovascular responses and biochemical or morphological changes in RVLM induced by intravenous administration of METH in Sprague-Dawley rats were investigated. High doses of METH induced significant mortality within 20 min that paralleled concomitant the collapse of arterial pressure or heart rate and loss of functionality in RVLM. There were concurrent increases in the concentration of METH in serum and ventrolateral medulla, along with tissue anoxia, cessation of microvascular perfusion and necrotic cell death in RVLM. Furthermore, mitochondrial respiratory chain enzyme activity or electron transport capacity and ATP production in RVLM were reduced, and mitochondria-derived superoxide anion level was augmented. All those detrimental physiological and biochemical events were reversed on microinjection into RVLM of a mobile electron carrier in the mitochondrial respiratory chain, coenzyme Q10; a mitochondria-targeted antioxidant and superoxide anion scavenger, Mito-TEMPO; or an oxidative stress-induced necrotic cell death inhibitor, IM-54. Conclusion: We conclude that sustained anoxia and cessation of local blood flow that leads to bioenergetics failure and oxidative stress because of mitochondrial dysfunction, leading to acute necrotic cell death in RVLM underpins cardiovascular collapse elicited by lethal doses of METH.	[Li, Faith C. H.; Yen, Jiin-Cherng] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Li, Faith C. H.; Chan, Samuel H. H.; Chang, Alice Y. W.] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan	National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital	Li, FCH (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan.	cgmf.kmc@gmail.com			Chang Gung Medical Foundation; Chang Gung Memorial Hospital, Taiwan, Republic of China [CMRPG891071]	Chang Gung Medical Foundation; Chang Gung Memorial Hospital, Taiwan, Republic of China(Chang Gung Memorial Hospital)	This work was supported by the Chang Gung Medical Foundation and the Chang Gung Memorial Hospital, Taiwan, Republic of China (Grant number CMRPG891071 to A.Y.W.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago Mihoko, 2006, Legal Medicine, V8, P235, DOI 10.1016/j.legalmed.2006.03.002; Bachmann RF, 2009, INT J NEUROPSYCHOPH, V12, P805, DOI 10.1017/S1461145708009802; Bowyer JF, 2006, SYNAPSE, V60, P521, DOI 10.1002/syn.20324; Brown JM, 2005, J NEUROCHEM, V95, P429, DOI 10.1111/j.1471-4159.2005.03379.x; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Chan JYH, 2006, NEUROPHARMACOLOGY, V51, P1109, DOI 10.1016/j.neuropharm.2006.06.024; Chan JYH, 2007, J BIOL CHEM, V282, P4585, DOI 10.1074/jbc.M603394200; Chan JYH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017375; Chan JYH, 2005, PROG NEUROBIOL, V77, P396, DOI 10.1016/j.pneurobio.2005.11.004; CHAN P, 1994, J TOXICOL-CLIN TOXIC, V32, P147, DOI 10.3109/15563659409000444; Chan SHH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-17; Chan SHH, 2005, CIRC RES, V97, P772, DOI 10.1161/01.RES.0000185804.79157.C0; Chan SHH, 2011, BRIT J PHAR IN PRESS; Chang AYW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007744; Chang AYW, 2009, SHOCK, V32, P651, DOI 10.1097/SHK.0b013e3181a71027; Choi J, 1997, ARCH PHARM RES, V20, P46, DOI 10.1007/BF02974041; Clarke P, 2009, FEBS J, V276, P6049, DOI 10.1111/j.1742-4658.2009.07328.x; CODY JT, 1992, J CHROMATOGR-BIOMED, V580, P77, DOI 10.1016/0378-4347(92)80529-Y; Dai KY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-72; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Dodo K, 2005, BIOORG MED CHEM LETT, V15, P3114, DOI 10.1016/j.bmcl.2005.04.016; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; Inoue Hiromasa, 2006, Legal Medicine, V8, P150, DOI 10.1016/j.legalmed.2005.12.004; Johnson BA, 2005, INT J NEUROPSYCHOPH, V8, P203, DOI 10.1017/S1461145704005036; Kadara H, 2007, CANCER BIOL THER, V6, P705, DOI 10.4161/cbt.6.5.3963; Karila L, 2010, BRIT J CLIN PHARMACO, V69, P578, DOI 10.1111/j.1365-2125.2010.03639.x; KATSUMATA S, 1993, FORENSIC SCI INT, V62, P209, DOI 10.1016/0379-0738(93)90209-S; Kaye S, 2008, ADDICTION, V103, P1353, DOI 10.1111/j.1360-0443.2008.02231.x; Kerrigan S, 2001, CLIN CHEM, V47, P540; Kiyatkin EA, 2007, EUR J NEUROSCI, V26, P1242, DOI 10.1111/j.1460-9568.2007.05741.x; Kiyatkin EA, 2009, INT REV NEUROBIOL, V88, P65, DOI 10.1016/S0074-7742(09)88004-5; KOJIMA T, 1984, FORENSIC SCI INT, V24, P87, DOI 10.1016/0379-0738(84)90156-7; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V272, pH485, DOI 10.1152/ajpheart.1997.272.1.H485; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V273, pH1291, DOI 10.1152/ajpheart.1997.273.3.H1291; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li FCH, 2005, ANN NY ACAD SCI, V1042, P195, DOI 10.1196/annals.1338.048; Li PL, 2001, CIRCULATION, V103, P2114; Liang HL, 2010, FREE RADICAL BIO MED, V49, P1550, DOI 10.1016/j.freeradbiomed.2010.08.018; Liu HH, 2011, J CELL BIOCHEM, V112, P3695, DOI 10.1002/jcb.23303; Lu CC, 2010, MOL NUTR FOOD RES, V54, P967, DOI 10.1002/mnfr.200900265; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; Maxwell JC, 2008, DRUG ALCOHOL REV, V27, P229, DOI 10.1080/09595230801919460; Miyashita Tomoko, 2007, J Forensic Leg Med, V14, P444, DOI 10.1016/j.jflm.2007.01.006; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Naganska E, 2001, FOLIA NEUROPATHOL, V39, P129; PALLIS C, 1983, BRIT MED J, V286, P39, DOI 10.1136/bmj.286.6358.39; Saito T, 1996, J Clin Forensic Med, V3, P183, DOI 10.1016/S1353-1131(96)90025-5; Sharma HS, 2009, J CHEM NEUROANAT, V37, P18, DOI 10.1016/j.jchemneu.2008.08.002; Shaw KP, 1999, J FORENSIC SCI, V44, P27; Shibata S, 1991, Neurol Med Chir (Tokyo), V31, P49, DOI 10.2176/nmc.31.49; Sodeoka M, 2010, CHEM REC, V10, P308, DOI 10.1002/tcr.201000031; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; Takekawa K, 2007, J FORENSIC SCI, V52, P1219, DOI 10.1111/j.1556-4029.2007.00518.x; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Tyagi N, 2010, J RECEPT SIG TRANSD, V30, P78, DOI 10.3109/10799891003614808; Varner KJ, 2002, J PHARMACOL EXP THER, V301, P152, DOI 10.1124/jpet.301.1.152; VITALE M, 1993, HISTOCHEMISTRY, V100, P223, DOI 10.1007/BF00269095; Wu CW, 2007, TOXICOL APPL PHARM, V220, P243, DOI 10.1016/j.taap.2007.01.011; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yang CH, 1995, J PHARMACOL EXP THER, V275, P1568; Yen DHT, 2005, SHOCK, V23, P353, DOI 10.1097/01.shk.0000156673.44063.e8; Yen DHT, 2004, SHOCK, V21, P358, DOI 10.1097/00024382-200404000-00011; Yen DHT, 2000, CRIT CARE MED, V28, P2805, DOI 10.1097/00003246-200008000-00021; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011	65	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30589	10.1371/journal.pone.0030589	http://dx.doi.org/10.1371/journal.pone.0030589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276218	gold, Green Published, Green Submitted			2022-12-25	WOS:000301457200068
J	O'Brien, AM; Hanson, BM; Farina, SA; Wu, JY; Simmering, JE; Wardyn, SE; Forshey, BM; Kulick, ME; Wallinga, DB; Smith, TC				O'Brien, Ashley M.; Hanson, Blake M.; Farina, Sarah A.; Wu, James Y.; Simmering, Jacob E.; Wardyn, Shylo E.; Forshey, Brett M.; Kulick, Marie E.; Wallinga, David B.; Smith, Tara C.			MRSA in Conventional and Alternative Retail Pork Products	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; UNITED-STATES; EMERGENCY-DEPARTMENT; PORCINE ORIGIN; MEAT-PRODUCTS; ANIMAL ORIGIN; INFECTIONS; PREVALENCE; ST398	In order to examine the prevalence of Staphylococcus aureus on retail pork, three hundred ninety-five pork samples were collected from a total of 36 stores in Iowa, Minnesota, and New Jersey. S. aureus was isolated from 256 samples (64.8%, 95% confidence interval [CI] 59.9%-69.5%). S. aureus was isolated from 67.3% (202/300) of conventional pork samples and from 56.8% (54/95) of alternative pork samples (labeled `` raised without antibiotics'' or `` raised without antibiotic growth promotants''). Two hundred and thirty samples (58.2%, 95% CI 53.2%-63.1%) were found to carry methicillin-sensitive S. aureus (MSSA). MSSA was isolated from 61.0% (183/300) of conventional samples and from 49.5% (47/95) of alternative samples. Twenty-six pork samples (6.6%, 95% CI 4.3%-9.5%) carried methicillin-resistant S. aureus (MRSA). No statistically significant differences were observed for the prevalence of S. aureus in general, or MSSA or MRSA specifically, when comparing pork products from conventionally raised swine and swine raised without antibiotics, a finding that contrasts with a prior study from the Netherlands examining both conventional and "biologic" meat products. In our study spa types associated with "livestock-associated" ST398 (t034, t011) were found in 26.9% of the MRSA isolates, while 46.2% were spa types t002 and t008-common human types of MRSA that also have been found in live swine. The study represents the largest sampling of raw meat products for MRSA contamination to date in the U. S. MRSA prevalence on pork products was higher than in previous U. S.-conducted studies, although similar to that in Canadian studies.	[O'Brien, Ashley M.; Hanson, Blake M.; Farina, Sarah A.; Wu, James Y.; Simmering, Jacob E.; Wardyn, Shylo E.; Smith, Tara C.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA; [O'Brien, Ashley M.; Hanson, Blake M.; Farina, Sarah A.; Wu, James Y.; Simmering, Jacob E.; Wardyn, Shylo E.; Forshey, Brett M.; Smith, Tara C.] Ctr Emerging Infect Dis, Coralville, IA USA; [Forshey, Brett M.] Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA USA; [Kulick, Marie E.; Wallinga, David B.] Inst Agr & Trade Policy, Minneapolis, MN USA	University of Iowa; University of Iowa	Smith, TC (corresponding author), Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA.	tara-smith@uiowa.edu	Hanson, Blake/AAL-8522-2021	Hanson, Blake/0000-0003-2949-7818; Simmering, Jacob/0000-0001-9172-0983; Smith, Tara C./0000-0003-3747-1116	Claneil Foundation	Claneil Foundation	This study was funded, in part, with support from the Claneil Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosgelmez-Tinaz G, 2006, EUR J CLIN MICROBIOL, V25, P410, DOI 10.1007/s10096-006-0153-8; Chan PA, 2008, J FOOD AGRIC ENVIRON, V6, P71; Clinical and Laboratory Standard Institute (CBI), 2009, PERF STAND ANT SUS S; [CLSI Institute CaLS], 2006, M07A7 CLSI I CALS; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; de Jonge R, 2010, EUROSURVEILLANCE, V15, P17; Declercq P, 2008, INFECTION, V36, P590, DOI 10.1007/s15010-007-7029-4; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Frazee BW, 2005, ANN EMERG MED, V45, P311, DOI 10.1016/j.annemergmed.2004.10.011; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Larson KRL, 2011, APPL ENVIRON MICROB, V77, P696, DOI 10.1128/AEM.01128-10; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lozano C, 2011, EMERG INFECT DIS, V17, P138, DOI 10.3201/eid1701.100307; Lozano C, 2009, J ANTIMICROB CHEMOTH, V64, P1325, DOI 10.1093/jac/dkp378; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mulders MN, 2010, EPIDEMIOL INFECT, P1; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Pu S, 2008, APPL ENV MICROBIOL; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Sunde M, 2011, J VET DIAGN INVEST, V23, P348, DOI 10.1177/104063871102300226; Van Cleef BA, 2010, EPIDEMIOL INFECT, P1; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; Van Hoecke H, 2009, LARYNGOSCOPE, V119, P137, DOI 10.1002/lary.20030; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Van Loo IHM, 2007, EMERG INFECT DIS, V13, P1753, DOI 10.3201/eid1311.070358; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x; Weese JS, 2010, CAN VET J, V51, P749; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026	40	99	99	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30092	10.1371/journal.pone.0030092	http://dx.doi.org/10.1371/journal.pone.0030092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276147	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200032
J	Boerrigter, B; Trip, P; Bogaard, HJ; Groepenhoff, H; Oosterveer, F; Westerhof, N; Noordegraaf, AV				Boerrigter, Bart; Trip, Pia; Bogaard, Harm Jan; Groepenhoff, Herman; Oosterveer, Frank; Westerhof, Nico; Noordegraaf, Anton Vonk			Right Atrial Pressure Affects the Interaction between Lung Mechanics and Right Ventricular Function in Spontaneously Breathing COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; END-EXPIRATORY PRESSURE; VENOUS RETURN; HEMODYNAMIC-RESPONSE; CARDIAC-OUTPUT; RESPIRATION; EXERCISE; STANDARDIZATION; PERFORMANCE; EMPHYSEMA	Introduction: It is generally known that positive pressure ventilation is associated with impaired venous return and decreased right ventricular output, in particular in patients with a low right atrial pressure and relative hypovolaemia. Altered lung mechanics have been suggested to impair right ventricular output in COPD, but this relation has never been firmly established in spontaneously breathing patients at rest or during exercise, nor has it been determined whether these cardiopulmonary interactions are influenced by right atrial pressure. Methods: Twenty-one patients with COPD underwent simultaneous measurements of intrathoracic, right atrial and pulmonary artery pressures during spontaneous breathing at rest and during exercise. Intrathoracic pressure and right atrial pressure were used to calculate right atrial filling pressure. Dynamic changes in pulmonary artery pulse pressure during expiration were examined to evaluate changes in right ventricular output. Results: Pulmonary artery pulse pressure decreased up to 40% during expiration reflecting a decrease in stroke volume. The decline in pulse pressure was most prominent in patients with a low right atrial filling pressure. During exercise, a similar decline in pulmonary artery pressure was observed. This could be explained by similar increases in intrathoracic pressure and right atrial pressure during exercise, resulting in an unchanged right atrial filling pressure. Conclusions: We show that in spontaneously breathing COPD patients the pulmonary artery pulse pressure decreases during expiration and that the magnitude of the decline in pulmonary artery pulse pressure is not just a function of intrathoracic pressure, but also depends on right atrial pressure.	[Boerrigter, Bart; Trip, Pia; Bogaard, Harm Jan; Groepenhoff, Herman; Oosterveer, Frank; Westerhof, Nico; Noordegraaf, Anton Vonk] Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands; [Westerhof, Nico] Vrije Univ Amsterdam Med Ctr, Dept Physiol, Inst Cardiovasc Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Boerrigter, B (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands.	b.boerrigter@vumc.nl		Bogaard, Harm Jan/0000-0001-5371-0346	Netherlands Organisation for Scientific Research (NWO)-VIDI [917.96.306]; Actelion; Bayer; GlaxoSmithKline; Pfizer	Netherlands Organisation for Scientific Research (NWO)-VIDI(Netherlands Organization for Scientific Research (NWO)); Actelion; Bayer(Bayer AG); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer)	AVN was supported by the Netherlands Organisation for Scientific Research (NWO)-VIDI (project number 917.96.306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AVN reports receiving lecture fees from Actelion, Bayer, GlaxoSmithKline, and Pfizer and serving on steering committees for Actelion, Bayer, and Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The remaining authors have declared that no competing interests exist.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Bogaard HJ, 1998, EUR RESPIR J, V12, P374, DOI 10.1183/09031936.98.12020374; BRECHER GA, 1955, CIRC RES, V3, P210, DOI 10.1161/01.RES.3.2.210; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; COURNAND A, 1948, AM J PHYSIOL, V152, P162; COURNAND A, 1947, FED PROC, V6, P92; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; GRANT BJB, 1992, J APPL PHYSIOL, V72, P535, DOI 10.1152/jappl.1992.72.2.535; GUYTON AC, 1957, AM J PHYSIOL, V189, P609, DOI 10.1152/ajplegacy.1957.189.3.609; HOFFMAN JIE, 1965, J APPL PHYSIOL, V20, P865, DOI 10.1152/jappl.1965.20.5.865; Holverda S, 2009, HEART, V95, P137, DOI 10.1136/hrt.2007.138172; IZUMI S, 1994, INTERNAL MED, V33, P326, DOI 10.2169/internalmedicine.33.326; Jellinek H, 2000, CRIT CARE MED, V28, P672, DOI 10.1097/00003246-200003000-00012; Luecke T, 2005, CRIT CARE, V9, P607, DOI 10.1186/cc3877; MAHLER DA, 1984, AM REV RESPIR DIS, V130, P722; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; NAKHJAVAN FK, 1966, CIRCULATION, V33, P8, DOI 10.1161/01.CIR.33.1.8; ROBOTHAM JL, 1980, AM REV RESPIR DIS, V121, P677; SANTAMORE WP, 1994, AM J PHYSIOL-HEART C, V267, pH2163, DOI 10.1152/ajpheart.1994.267.6.H2163; STEWART RI, 1986, CHEST, V89, P199, DOI 10.1378/chest.89.2.199; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Wong BYL, 2010, NEW ENGL J MED, V362, P1639	23	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30208	10.1371/journal.pone.0030208	http://dx.doi.org/10.1371/journal.pone.0030208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272306	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400084
J	Dada, L; Gonzalez, AR; Urich, D; Soberanes, S; Manghi, TS; Chiarella, SE; Chandel, NS; Budinger, GRS; Mutlu, GM				Dada, Laura; Gonzalez, Angel R.; Urich, Daniela; Soberanes, Saul; Manghi, Tomas S.; Chiarella, Sergio E.; Chandel, Navdeep S.; Budinger, G. R. Scott; Mutlu, Goekhan M.			Alcohol Worsens Acute Lung Injury by Inhibiting Alveolar Sodium Transport through the Adenosine A1 Receptor	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RESPIRATORY-DISTRESS-SYNDROME; FLUID CLEARANCE; NA,K-ATPASE ENDOCYTOSIS; EXTRACELLULAR ADENOSINE; ETHANOL INGESTION; EPITHELIAL-CELLS; PULMONARY-EDEMA; ABUSE; GLUTATHIONE	Objective: Alcohol intake increases the risk of acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) and is associated with poor outcomes in patients who develop these syndromes. No specific therapies are currently available to treat or decrease the risk of ARDS in patients with alcoholism. We have recently shown increased levels of lung adenosine inhibit alveolar fluid clearance, an important predictor of outcome in patients with ARDS. We hypothesized that alcohol might worsen lung injury by increasing lung adenosine levels, resulting in impaired active Na+ transport in the lung. Methods: We treated wild-type mice with alcohol administered i.p. to achieve blood alcohol levels associated with moderate to severe intoxication and measured the rate of alveolar fluid clearance and Na,K-ATPase expression in peripheral lung tissue and assessed the effect of alcohol on survival during exposure to hyperoxia. We used primary rat alveolar type II cells to investigate the mechanisms by which alcohol regulates alveolar Na+ transport. Results: Exposure to alcohol reduced alveolar fluid clearance, downregulated Na,K-ATPase in the lung tissue and worsened hyperoxia-induced lung injury. Alcohol caused an increase in BAL fluid adenosine levels. A similar increase in lung adenosine levels was observed after exposure to hyperoxia. In primary rat alveolar type II cells alcohol and adenosine decreased the abundance of the Na,K-ATPase at the basolateral membrane via a mechanism that required activation of the AMPK. Conclusions: Alcohol decreases alveolar fluid clearance and impairs survival from acute lung injury. Alcohol induced increases in lung adenosine levels may be responsible for reduction in alveolar fluid clearance and associated worsening of lung injury.	[Dada, Laura; Gonzalez, Angel R.; Urich, Daniela; Soberanes, Saul; Manghi, Tomas S.; Chiarella, Sergio E.; Chandel, Navdeep S.; Budinger, G. R. Scott; Mutlu, Goekhan M.] Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Dada, L (corresponding author), Northwestern Univ, Dept Med, Div Pulm & Crit Care Med, Feinberg Sch Med, Chicago, IL 60611 USA.	g-mutlu@northwestern.edu		Chiarella, Sergio/0000-0002-0445-4929	National Institutes of Health [ES015024, ES013995, P01HL071643]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015024, R01ES013995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grant Support: National Institutes of Health ES015024 (GMM), ES013995 (GRSB), and P01HL071643 (LD, GMM, NSC and GRSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELL M, 1994, NEW ENGL J MED, V331, P537, DOI 10.1056/NEJM199408253310810; Azzam ZS, 2002, CIRCULATION, V105, P497, DOI 10.1161/hc0402.102848; Bellmeyer A, 2007, AM J RESP CRIT CARE, V175, P587, DOI 10.1164/rccm.200603-312OC; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; Brown LAS, 2001, ALCOHOL CLIN EXP RES, V25, P1078, DOI 10.1111/j.1530-0277.2001.tb02320.x; Budinger GRS, 2005, J CLIN INVEST, V115, P828, DOI 10.1172/JCI200524681; Budinger GRS, 1996, AM J PHYSIOL-LUNG C, V270, pL44, DOI 10.1152/ajplung.1996.270.1.L44; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P866; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Dada LA, 2007, CELL SIGNAL, V19, P1893, DOI 10.1016/j.cellsig.2007.04.013; Dohrman DP, 1997, ALCOHOL HEALTH RES W, V21, P136; Dumasius V, 2002, CHEST, V121, p33S, DOI 10.1378/chest.121.3_suppl.33S; Dumasius V, 2001, CIRC RES, V89, P907, DOI 10.1161/hh2201.100204; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Factor P, 1998, J CLIN INVEST, V102, P1421, DOI 10.1172/JCI3214; Factor P, 2007, P NATL ACAD SCI USA, V104, P4083, DOI 10.1073/pnas.0601117104; GENTRY RT, 1983, PHYSIOL BEHAV, V31, P529, DOI 10.1016/0031-9384(83)90077-X; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Guidot DM, 2000, ALCOHOL CLIN EXP RES, V24, P1070, DOI 10.1097/00000374-200007000-00019; Guidot DM, 2005, J INVEST MED, V53, P235, DOI 10.2310/6650.2005.53506; Guidot DM, 2000, AM J PHYSIOL-LUNG C, V279, pL127, DOI 10.1152/ajplung.2000.279.1.L127; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Hallows KR, 2003, AM J PHYSIOL-CELL PH, V284, pC1297, DOI 10.1152/ajpcell.00227.2002; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Huszar E, 1996, CHROMATOGRAPHIA, V42, P318, DOI 10.1007/BF02290317; Joshi PC, 2007, AM J PHYSIOL-LUNG C, V292, pL813, DOI 10.1152/ajplung.00348.2006; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; KRAUSS SW, 1993, MOL PHARMACOL, V44, P1021; Lecuona E, 2009, J CELL SCI, V122, P3915, DOI 10.1242/jcs.046953; Li J, 2011, EUR J PHARMACOL, V654, P295, DOI 10.1016/j.ejphar.2010.12.040; Moss M, 2003, CRIT CARE MED, V31, P869, DOI 10.1097/01.CCM.0000055389.64497.11; Moss M, 1996, JAMA-J AM MED ASSOC, V275, P50, DOI 10.1001/jama.275.1.50; Mutlu G, 2005, CIRC RES, V96, P999, DOI 10.1161/01.RES.0000164554.21993.AC; Mutlu GM, 2005, AM J PHYSIOL-LUNG C, V289, pL685, DOI 10.1152/ajplung.00247.2005; Mutlu GM, 2004, AM J RESP CRIT CARE, V170, P1270, DOI 10.1164/rccm.200404-470CP; Mutlu GM, 2004, CRIT CARE MED, V32, P1607, DOI 10.1097/01.CCM.0000130825.84691.E2; Mutlu GM, 2004, CIRC RES, V94, P1091, DOI 10.1161/01.RES.0000125623.56442.20; Mutlu GM, 2008, AM J RESP CELL MOL, V38, P127, DOI 10.1165/rcmb.2007-0198TR; NAGY LE, 1989, MOL PHARMACOL, V36, P744; NAGY LE, 1990, J BIOL CHEM, V265, P1946; Neely CF, 1997, AM J PHYSIOL-LUNG C, V272, pL353, DOI 10.1152/ajplung.1997.272.2.L353; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Ridge KM, 2003, CIRC RES, V92, P453, DOI 10.1161/01.RES.0000059414.10360.F2; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vizi E, 2002, J ALLERGY CLIN IMMUN, V109, P446, DOI 10.1067/mai.2002.121955; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Welch LC, 2010, FEBS LETT, V584, P3985, DOI 10.1016/j.febslet.2010.08.002; Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC	58	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30448	10.1371/journal.pone.0030448	http://dx.doi.org/10.1371/journal.pone.0030448			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272351	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400129
J	Diepold, K; Bomans, K; Wiedmann, M; Zimmermann, B; Petzold, A; Schlothauer, T; Mueller, R; Moritz, B; Stracke, JO; Molhoj, M; Reusch, D; Bulau, P				Diepold, Katharina; Bomans, Katrin; Wiedmann, Michael; Zimmermann, Boris; Petzold, Andreas; Schlothauer, Tilman; Mueller, Robert; Moritz, Bernd; Stracke, Jan Olaf; Molhoj, Michael; Reusch, Dietmar; Bulau, Patrick			Simultaneous Assessment of Asp Isomerization and Asn Deamidation in Recombinant Antibodies by LC-MS following Incubation at Elevated Temperatures	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; MASS-SPECTROMETRY; ASPARTATE ISOMERIZATION; ASPARAGINE DEAMIDATION; IDENTIFICATION; SUCCINIMIDE; PROTEINS; SITES; HETEROGENEITY; QUANTIFICATION	The degradation of proteins by asparagine deamidation and aspartate isomerization is one of several chemical degradation pathways for recombinant antibodies. In this study, we have identified two solvent accessible degradation sites (light chain aspartate-56 and heavy chain aspartate-99/101) in the complementary-determining regions of a recombinant IgG1 antibody susceptible to isomerization under elevated temperature conditions. For both hot-spots, the degree of isomerization was found to be significantly higher than the deamidation of asparagine-(387, 392, 393) in the conserved CH3 region, which has been identified as being solvent accessible and sensitive to chemical degradation in previous studies. In order to reduce the time for simultaneous identification and functional evaluation of potential asparagine deamidation and aspartate isomerization sites, a test system employing accelerated temperature conditions and proteolytic peptide mapping combined with quantitative UPLC-MS was developed. This method occupies the formulation buffer system histidine/HCl (20 mM; pH 6.0) for denaturation/reduction/digestion and eliminates the alkylation step. The achieved degree of asparagine deamidation and aspartate isomerization was adequate to identify the functional consequence by binding studies. In summary, the here presented approach greatly facilitates the evaluation of fermentation, purification, formulation, and storage conditions on antibody asparagine deamidation and aspartate isomerization by monitoring susceptible marker peptides located in the complementary-determining regions of recombinant antibodies.	[Diepold, Katharina; Bomans, Katrin; Wiedmann, Michael; Petzold, Andreas; Schlothauer, Tilman; Stracke, Jan Olaf; Molhoj, Michael; Reusch, Dietmar; Bulau, Patrick] Roche Diagnost GmbH, Pharma Res & Dev Penzberg, Penzberg, Germany; [Zimmermann, Boris] Roche Diagnost GmbH, Pharma Biotech Penzberg, Penzberg, Germany; [Mueller, Robert] F Hoffmann La Roche & Co Ltd, Late Stage Pharmaceut & Proc Dev, CH-4002 Basel, Switzerland; [Moritz, Bernd] F Hoffmann La Roche & Co Ltd, Analyt Res & Dev, Basel, Switzerland	Roche Holding; Roche Holding; Roche Holding; Roche Holding	Diepold, K (corresponding author), Roche Diagnost GmbH, Pharma Res & Dev Penzberg, Penzberg, Germany.	patrick.bulau@roche.com		Bulau, Patrick/0000-0002-7121-2954				Cacia J, 1996, BIOCHEMISTRY-US, V35, P1897, DOI 10.1021/bi951526c; CARR SA, 1991, ANAL CHEM, V63, P2802, DOI 10.1021/ac00024a003; Chelius D, 2005, ANAL CHEM, V77, P6004, DOI 10.1021/ac050672d; Chu GC, 2007, PHARM RES-DORDR, V24, P1145, DOI 10.1007/s11095-007-9241-4; Cournoyer JJ, 2005, PROTEIN SCI, V14, P452, DOI 10.1110/ps.041062905; FLATMARK T, 1968, J BIOL CHEM, V243, P1623; HARDING JJ, 1989, MECH AGEING DEV, V50, P7, DOI 10.1016/0047-6374(89)90054-7; Harris RJ, 2005, DEV BIOLOGICALS, V122, P117; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Hensel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017708; Huang HZ, 2009, ANAL CHEM, V81, P1686, DOI 10.1021/ac802708s; Huang LH, 2005, ANAL CHEM, V77, P1432, DOI 10.1021/ac0494174; KROON DJ, 1992, PHARMACEUT RES, V9, P1386, DOI 10.1023/A:1015894409623; KWONG MY, 1994, PROTEIN SCI, V3, P147; LOWENSON J, 1988, BLOOD CELLS, V14, P103; OTA IM, 1987, J BIOL CHEM, V262, P8522; PABORJI M, 1994, PHARMACEUT RES, V11, P764, DOI 10.1023/A:1018948901599; POTTER SM, 1993, PROTEIN SCI, V2, P1648, DOI 10.1002/pro.5560021011; Robinson NE, 2006, RAPID COMMUN MASS SP, V20, P3535, DOI 10.1002/rcm.2767; Schmid DG, 2001, ANAL CHEM, V73, P6008, DOI 10.1021/ac0104274; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; TESHIMA G, 1991, J BIOL CHEM, V266, P13544; Timm V, 2010, J CHROMATOGR B, V878, P777, DOI 10.1016/j.jchromb.2010.01.036; Vlasak J, 2008, CURR PHARM BIOTECHNO, V9, P468, DOI 10.2174/138920108786786402; Wakankar AA, 2006, J PHARM SCI-US, V95, P2321, DOI 10.1002/jps.20740; Xiao G, 2007, ANAL CHEM, V79, P2714, DOI 10.1021/ac0617870; Yan BX, 2009, J PHARM SCI-US, V98, P3509, DOI 10.1002/jps.21655; Yang HQ, 2010, ELECTROPHORESIS, V31, P1764, DOI 10.1002/elps.201000027; Yu XC, 2011, ANAL CHEM, V83, P5912, DOI 10.1021/ac200750u; Zabrouskov V, 2006, BIOCHEMISTRY-US, V45, P987, DOI 10.1021/bi0517584; Zhang J, 2011, ANAL BIOCHEM, V410, P234, DOI 10.1016/j.ab.2010.11.040	31	85	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30295	10.1371/journal.pone.0030295	http://dx.doi.org/10.1371/journal.pone.0030295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272329	gold, Green Submitted, Green Published			2022-12-25	WOS:000301454400107
J	Fratta Pasini, A; Albiero, A; Stranieri, C; Cominacini, M; Pasini, A; Mozzini, C; Vallerio, P; Cominacini, L; Garbin, U				Fratta Pasini, Anna; Albiero, Anna; Stranieri, Chiara; Cominacini, Mattia; Pasini, Andrea; Mozzini, Chiara; Vallerio, Paola; Cominacini, Luciano; Garbin, Ulisse			Serum Oxidative Stress-Induced Repression of Nrf2 and GSH Depletion: A Mechanism Potentially Involved in Endothelial Dysfunction of Young Smokers	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; NITRIC-OXIDE BIOSYNTHESIS; FLOW-MEDIATED DILATATION; ARTERIES IN-VIVO; OXIDIZED PHOSPHOLIPIDS; CIGARETTE-SMOKING; BRACHIAL-ARTERY; DEPENDENT DILATION; HEME OXYGENASE-1; HEALTHY SMOKERS	Background: Although oxidative stress plays a major role in endothelial dysfunction (ED), the role of glutathione (GSH), of nuclear erythroid-related factor 2 (Nrf2) and of related antioxidant genes (ARE) are yet unknown. In this study we combined an in vivo with an in vitro model to assess whether cigarette smoking affects flow-mediated vasodilation (FMD), GSH concentrations and the Nrf2/ARE pathway in human umbilical vein endothelial cells (HUVECs). Methods and Results: 52 healthy subjects (26 non-smokers and 26 heavy smokers) were enrolled in this study. In smokers we demonstrated increased oxidative stress, i.e., reduced concentrations of GSH and increased concentrations of oxidation products of the phospholipid 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (oxPAPC) in serum and in peripheral blood mononuclear cells (PBMC), used as in vivo surrogates of endothelial cells. Moreover we showed impairment of FMD in smokers and a positive correlation with the concentration of GSH in PBMC of all subjects. In HUVECs exposed to smokers' serum but not to non-smokers' serum we found that oxidative stress increased, whereas nitric oxide and GSH concentrations decreased; interestingly the expression of Nrf2, of heme oxygenase-1 (HO-1) and of glutamate-cysteine ligase catalytic (GCLC) subunit, the rate-limiting step of synthesis of GSH, was decreased. To test the hypothesis that the increased oxidative stress in smokers may have a causal role in the repression of Nrf2/ARE pathway, we exposed HUVECs to increasing concentrations of oxPAPC and found that at the highest concentration (similar to that found in smokers' serum) the expression of Nrf2/ARE pathway was reduced. The knockdown of Nrf2 was associated to a significant reduction of HO-1 and GCLC expression induced by oxPAPC in ECs. Conclusions: In young smokers with ED a novel further consequence of increased oxidative stress is a repression of Nrf2/ARE pathway leading to GSH depletion.	[Fratta Pasini, Anna; Albiero, Anna; Stranieri, Chiara; Cominacini, Mattia; Pasini, Andrea; Mozzini, Chiara; Vallerio, Paola; Cominacini, Luciano; Garbin, Ulisse] Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy	University of Verona	Fratta Pasini, A (corresponding author), Univ Verona, Dept Med, Sect Internal Med D, I-37100 Verona, Italy.	anna.frattapasini@univr.it	cominacini, luciano/B-2775-2011; Stranieri, Chiara/GWV-1749-2022; mozzini, chiara/AAW-3028-2021		Fondazione Cariverona, Verona, Italy; Ministry of University and Scientific Research of Italy	Fondazione Cariverona, Verona, Italy(Fondazione Cariverona); Ministry of University and Scientific Research of Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by Fondazione Cariverona, Verona, Italy; by grants from the Ministry of University and Scientific Research of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua RS, 2003, CIRCULATION, V107, P2342, DOI 10.1161/01.CIR.0000066691.52789.BE; Barua RS, 2001, CIRCULATION, V104, P1905, DOI 10.1161/hc4101.097525; Benowitz NL, 2003, PROG CARDIOVASC DIS, V46, P91, DOI 10.1016/S0033-0620(03)00087-2; Bochkov VN, 2010, ANTIOXID REDOX SIGN, V12, P1009, DOI 10.1089/ars.2009.2597; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Chen L, 1997, AM J PHYSIOL, V42, P1854; Cominacini L, 2005, J AM COLL CARDIOL, V46, P799, DOI 10.1016/j.jacc.2005.05.063; Cominacini L, 1998, J HYPERTENS, V16, P1913, DOI 10.1097/00004872-199816121-00010; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Cortese-Krott MM, 2009, AM J PHYSIOL-CELL PH, V296, pC811, DOI 10.1152/ajpcell.00643.2008; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Dulak J, 2008, CURR OPIN LIPIDOL, V19, P505, DOI 10.1097/MOL.0b013e32830d81e9; Feletou M, 2006, AM J PHYSIOL-HEART C, V291, pH985, DOI 10.1152/ajpheart.00292.2006; Fennessy FM, 2003, CIRCULATION, V107, P410, DOI 10.1161/01.CIR.0000046447.72402.47; Fratta Pasini A, 2007, ARTERIOSCL THROM VAS, V27, P1991, DOI 10.1161/ATVBAHA.107.142695; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Garbin U, 2007, PHARMACOL RES, V56, P515, DOI 10.1016/j.phrs.2007.09.015; Garbin U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008225; Gemignani V, 2008, ULTRASOUND MED BIOL, V34, P385, DOI 10.1016/j.ultrasmedbio.2007.08.006; Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; HASHIMOTO M, 1995, CIRCULATION, V92, P3431, DOI 10.1161/01.CIR.92.12.3431; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen H, 2001, TOXICOLOGY, V160, P207, DOI 10.1016/S0300-483X(00)00450-9; OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308; Pae HO, 2010, NITRIC OXIDE-BIOL CH, V23, P251, DOI 10.1016/j.niox.2010.08.002; Park EM, 1998, FREE RADICAL BIO MED, V25, P79, DOI 10.1016/S0891-5849(98)00041-0; Pasini Anna Fratta, 2005, Journal of Hypertension, V23, P589, DOI 10.1097/01.hjh.0000160216.86597.ff; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Raij L, 2001, J HYPERTENS, V19, P891, DOI 10.1097/00004872-200105000-00009; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Siepi D, 2002, ANN NUTR METAB, V46, P32, DOI 10.1159/000046750; Stamler JS, 1996, NUTR REV, V54, P1; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Tanriverdi H, 2006, CIRC J, V70, P593, DOI 10.1253/circj.70.593; UBBINK JB, 1991, J CHROMATOGR-BIOMED, V565, P441, DOI 10.1016/0378-4347(91)80407-4; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yufu K, 2007, HYPERTENS RES, V30, P607, DOI 10.1291/hypres.30.607; ZANG LY, 1995, FREE RADICAL BIO MED, V19, P161, DOI 10.1016/0891-5849(94)00236-D	49	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30291	10.1371/journal.pone.0030291	http://dx.doi.org/10.1371/journal.pone.0030291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272327	Green Published, gold			2022-12-25	WOS:000301454400105
J	Lee, B; LeDuc, PR; Schwartz, R				Lee, Byoungkoo; LeDuc, Philip R.; Schwartz, Russell			Three-Dimensional Stochastic Off-Lattice Model of Binding Chemistry in Crowded Environments	PLOS ONE			English	Article							BIOCHEMICAL REACTIONS; REACTION-KINETICS; PROTEIN; STABILITY; DIFFUSION; VISCOSITY; AGENTS	Molecular crowding is one of the characteristic features of the intracellular environment, defined by a dense mixture of varying kinds of proteins and other molecules. Interaction with these molecules significantly alters the rates and equilibria of chemical reactions in the crowded environment. Numerous fundamental activities of a living cell are strongly influenced by the crowding effect, such as protein folding, protein assembly and disassembly, enzyme activity, and signal transduction. Quantitatively predicting how crowding will affect any particular process is, however, a very challenging problem because many physical and chemical parameters act synergistically in ways that defy easy analysis. To build a more realistic model for this problem, we extend a prior stochastic off-lattice model from two-dimensional (2D) to three-dimensional (3D) space and examine how the 3D results compare to those found in 2D. We show that both models exhibit qualitatively similar crowding effects and similar parameter dependence, particularly with respect to a set of parameters previously shown to act linearly on total reaction equilibrium. There are quantitative differences between 2D and 3D models, although with a generally gradual nonlinear interpolation as a system is extended from 2D to 3D. However, the additional freedom of movement allowed to particles as thickness of the simulation box increases can produce significant quantitative change as a system moves from 2D to 3D. Simulation results over broader parameter ranges further show that the impact of molecular crowding is highly dependent on the specific reaction system examined.	[Lee, Byoungkoo; Schwartz, Russell] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Lee, Byoungkoo; LeDuc, Philip R.; Schwartz, Russell] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [LeDuc, Philip R.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [LeDuc, Philip R.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Lee, B (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	russells@andrew.cmu.edu	LeDuc, Philip/M-1103-2014; Schwartz, Russell/A-1998-2016	LeDuc, Philip/0000-0001-6397-2905; Schwartz, Russell/0000-0002-4970-2252	National Institutes of Health NIAID [1R01AI076318]; National Science Foundation [CMMI-0856187, CMMI-1013748]; Office of Naval Research [N000140910215]; NATIONAL CANCER INSTITUTE [R01CA140214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076318] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health NIAID award #1R01AI076318 (RS). This work was supported also in part by the National Science Foundation (CMMI-0856187 and CMMI-1013748) and the Office of Naval Research (N000140910215) (PRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BICKNESE S, 1993, BIOPHYS J, V65, P1272, DOI 10.1016/S0006-3495(93)81179-2; Christiansen A, 2010, BIOCHEMISTRY-US, V49, P6519, DOI 10.1021/bi100578x; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Eide JL, 2006, J PHYS CHEM B, V110, P2318, DOI 10.1021/jp054191+; Elcock AH, 2003, P NATL ACAD SCI USA, V100, P2340, DOI 10.1073/pnas.0535055100; Gong HJ, 2008, BIOPHYS J, V95, P1674, DOI 10.1529/biophysj.107.127498; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Grima R, 2006, BIOPHYS CHEM, V124, P1, DOI 10.1016/j.bpc.2006.04.019; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Izvekov S, 2005, J PHYS CHEM B, V109, P2469, DOI 10.1021/jp044629q; Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+; Kim JS, 2010, BIOPHYS J, V98, P951, DOI 10.1016/j.bpj.2009.11.022; LEBOWITZ JL, 1965, J CHEM PHYS, V43, P774, DOI 10.1063/1.1696842; Leduc P, 2007, CELL BIOCHEM BIOPHYS, V48, P16, DOI 10.1007/s12013-007-0012-y; Lee B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00097; Lee B, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031911; Lee B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041918; Lindner RA, 1997, BIOPHYS CHEM, V66, P57, DOI 10.1016/S0301-4622(97)00011-2; McPhie P, 2006, J MOL BIOL, V361, P7, DOI 10.1016/j.jmb.2006.05.075; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Phillip Y, 2009, BIOPHYS J, V97, P875, DOI 10.1016/j.bpj.2009.05.026; Pincus DL, 2009, J PHYS CHEM B, V113, P359, DOI 10.1021/jp807755b; Puskar KM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041904; Puskar K, 2006, CELL BIOCHEM BIOPHYS, V45, P195; Puskar Kathleen, 2004, Mech Chem Biosyst, V1, P123; Ridgway D, 2008, BIOPHYS J, V94, P3748, DOI 10.1529/biophysj.107.116053; Rosen J, 2011, J PHYS CHEM B, V115, P2683, DOI 10.1021/jp200625k; ROSS PD, 1979, BIOCHEM BIOPH RES CO, V88, P1308, DOI 10.1016/0006-291X(79)91123-9; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; SENGERS JV, 1986, J PHYS CHEM REF DATA, V15, P1291, DOI 10.1063/1.555763; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Tsao D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011936; van Zon JS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2137716; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Weber M, 2010, EMBO J, V29, P2861, DOI 10.1038/emboj.2010.183; Wenner JR, 1999, BIOPHYS J, V77, P3234, DOI 10.1016/S0006-3495(99)77154-7; Wieczorek G, 2008, BIOPHYS J, V95, P5030, DOI 10.1529/biophysj.108.136291; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	41	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30131	10.1371/journal.pone.0030131	http://dx.doi.org/10.1371/journal.pone.0030131			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272286	Green Submitted, Green Published, gold			2022-12-25	WOS:000301454400064
J	Shanmugasundararaj, S; Lehle, S; Yamodo, HI; Husain, SS; Tseng, C; Nguyen, K; Addona, GH; Miller, KW				Shanmugasundararaj, Sivananthaperumal; Lehle, Simon; Yamodo, Herve I.; Husain, S. Shaukat; Tseng, Claire; Nguyen, Khanh; Addona, George H.; Miller, Keith W.			The Location and Nature of General Anesthetic Binding Sites on the Active Conformation of Firefly Luciferase; A Time Resolved Photolabeling Study	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; COMPETITIVE-BINDING; PHASE-TRANSITION; STRUCTURAL BASIS; MOLECULAR-BASIS; DIETHYL-ETHER; IN-VITRO; INHIBITION; SYSTEM; BIOLUMINESCENCE	Firefly luciferase is one of the few soluble proteins that is acted upon by a wide variety of general anesthetics and alcohols; they inhibit the ATP-driven production of light. We have used time-resolved photolabeling to locate the binding sites of alcohols during the initial light output, some 200 ms after adding ATP. The photolabel 3-azioctanol inhibited the initial light output with an IC50 of 200 mu M, close to its general anesthetic potency. Photoincorporation of [H-3]3-azioctanol into luciferase was saturable but weak. It was enhanced 200 ms after adding ATP but was negligible minutes later. Sequencing of tryptic digests by HPLC-MSMS revealed a similar conformation-dependence for photoincorporation of 3-azioctanol into Glu-313, a residue that lines the bottom of a deep cleft (vestibule) whose outer end binds luciferin. An aromatic diazirine analog of benzyl alcohol with broader side chain reactivity reported two sites. First, it photolabeled two residues in the vestibule, Ser-286 and Ile-288, both of which are implicated with Glu-313 in the conformation change accompanying activation. Second, it photolabeled two residues that contact luciferin, Ser-316 and Ser-349. Thus, time resolved photolabeling supports two mechanisms of action. First, an allosteric one, in which anesthetics bind in the vestibule displacing water molecules that are thought to be involved in light output. Second, a competitive one, in which anesthetics bind isosterically with luciferin. This work provides structural evidence that supports the competitive and allosteric actions previously characterized by kinetic studies.	[Shanmugasundararaj, Sivananthaperumal; Lehle, Simon; Yamodo, Herve I.; Husain, S. Shaukat; Nguyen, Khanh; Addona, George H.; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Tseng, Claire; Addona, George H.; Miller, Keith W.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Shanmugasundararaj, S (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA.	k_miller@helix.mgh.harvard.edu			United States Public Health Service [GM 069726, 058448]; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069726, P01GM058448] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the United States Public Health Service to KM (GM 069726 & 058448) and by the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Elizabeth Kelly for assistance with the anesthetic potency measurements. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081) [32].	Addona GH, 1999, ANAL BIOCHEM, V267, P135, DOI 10.1006/abio.1998.2959; ADEY G, 1975, LIFE SCI, V17, P1849, DOI 10.1016/0024-3205(75)90469-5; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Bertaccini EJ, 2007, ANESTH ANALG, V104, P318, DOI 10.1213/01.ane.0000253029.67331.8d; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; CHURCH RFR, 1970, J ORG CHEM, V35, P2465, DOI 10.1021/jo00833a001; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Das J, 2011, CHEM REV, V111, P4405, DOI 10.1021/cr1002722; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; FRANKS NP, 1985, NATURE, V316, P349, DOI 10.1038/316349a0; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; HALSEY MJ, 1970, NATURE, V227, P1363, DOI 10.1038/2271363b0; Husain SS, 2006, J MED CHEM, V49, P4818, DOI 10.1021/jm051207b; Husain SS, 1999, J MED CHEM, V42, P3300, DOI 10.1021/jm9806300; MIDDLETON AJ, 1976, PROC R SOC SER B-BIO, V193, P173, DOI 10.1098/rspb.1976.0038; MOSS GWJ, 1991, P NATL ACAD SCI USA, V88, P134, DOI 10.1073/pnas.88.1.134; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Navizet I, 2010, J AM CHEM SOC, V132, P706, DOI 10.1021/ja908051h; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ringe D, 1995, CURR OPIN STRUC BIOL, V5, P825, DOI 10.1016/0959-440X(95)80017-4; SCHOENBO.BP, 1967, NATURE, V214, P1120, DOI 10.1038/2141120a0; Shevchenko A, 2001, ANAL BIOCHEM, V296, P279, DOI 10.1006/abio.2001.5321; Song CI, 2011, J AM CHEM SOC, V133, P12040, DOI 10.1021/ja201752p; Szarecka A, 2007, BIOPHYS J, V93, P1895, DOI 10.1529/biophysj.106.102780; UEDA I, 1965, ANESTHESIOLOGY, V26, P603, DOI 10.1097/00000542-196509000-00003; UEDA I, 1973, ANESTHESIOLOGY, V38, P425, DOI 10.1097/00000542-197305000-00002; Ueda I, 1998, TOXICOL LETT, V101, P405, DOI 10.1016/S0378-4274(98)00214-8; Ueda I, 1998, BIOPHYS J, V75, P1052, DOI 10.1016/S0006-3495(98)77594-0; WOOD SC, 1995, MOL PHARMACOL, V47, P121	32	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29854	10.1371/journal.pone.0029854	http://dx.doi.org/10.1371/journal.pone.0029854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272253	Green Submitted, gold, Green Published			2022-12-25	WOS:000301454400032
J	Tropini, C; Roth, EA; Zanic, M; Gardner, MK; Howard, J				Tropini, Carolina; Roth, Elizabeth A.; Zanic, Marija; Gardner, Melissa K.; Howard, Jonathon			Islands Containing Slowly Hydrolyzable GTP Analogs Promote Microtubule Rescues	PLOS ONE			English	Article							STABILIZE MICROTUBULES; IN-VITRO; DYNAMICS; TUBULIN; LATTICE; HYDROLYSIS; INFORMATION; ENDS; MCAK; CAP	Microtubules are dynamic polymers of GTP- and GDP-tubulin that undergo stochastic transitions between growing and shrinking phases. Rescues, the conversion from shrinking to growing, have recently been proposed to be to the result of regrowth at GTP-tubulin islands within the lattice of growing microtubules. By introducing mixed GTP/GDP/GMPCPP (GXP) regions within the lattice of dynamic microtubules, we reconstituted GXP islands in vitro (GMPCPP is the slowly hydrolyzable GTP analog guanosine-59'-[(alpha,beta)-methyleno]triphosphate). We found that such islands could reproducibly induce rescues and that the probability of rescue correlated with both the size of the island and the percentage of GMPCPP-tubulin within the island. The islands slowed the depolymerization rate of shortening microtubules and promoted regrowth more readily than GMPCPP seeds. Together, these findings provide new mechanistic insights supporting the possibility that rescues could be triggered by enriched GTP-tubulin regions and present a new tool for studying such rescue events in vitro.	[Tropini, Carolina; Roth, Elizabeth A.; Zanic, Marija; Gardner, Melissa K.; Howard, Jonathon] Marine Biol Lab Physiol Course, Woods Hole, MA USA; [Zanic, Marija; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Gardner, Melissa K.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Tropini, Carolina] Stanford Univ, Biophys Program, Dept Biol Struct, Stanford, CA 94305 USA; [Roth, Elizabeth A.] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA USA	Russian Academy of Sciences; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; University of California System; University of California Los Angeles	Tropini, C (corresponding author), Marine Biol Lab Physiol Course, Woods Hole, MA USA.	howard@mpi-cbg.de	Howard, Jonathon/D-4229-2011; Tropini, Carolina/H-2992-2019; Howard, Jonathon/J-7492-2016	Howard, Jonathon/0000-0003-0086-1196; Tropini, Carolina/0000-0002-7542-1577; Howard, Jonathon/0000-0003-0086-1196; Zanic, Marija/0000-0002-5127-5819	National Institutes of Health [R13GM085967, P50GM068763]; Ruth L. Kirschstein National Research Service [GM007185]; Stanford Graduate Fellowship; Bruce and Elizabeth Dunlevie Bio-X Stanford Interdisciplinary Graduate Fellowship; Max Planck Society; International Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, R13GM085967, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); Bruce and Elizabeth Dunlevie Bio-X Stanford Interdisciplinary Graduate Fellowship; Max Planck Society(Max Planck Society); International Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Sources of Funding: National Institutes of Health grants to the Marine Biological Laboratory at Woods Hole (R13GM085967 and P50GM068763), the Ruth L. Kirschstein National Research Service Award to Dr. Roth (GM007185), the Stanford Graduate Fellowship and the Bruce and Elizabeth Dunlevie Bio-X Stanford Interdisciplinary Graduate Fellowship to Dr. Tropini, a Cross-Disciplinary Fellowship from the International Human Frontier Science Program to Dr. Zanic, the Max Planck Society to Dr. Howard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford A. J., 2006, CELL BIOL, P155; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; Cassimeris L, 2009, CURR BIOL, V19, pR174, DOI 10.1016/j.cub.2008.12.035; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585	21	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30103	10.1371/journal.pone.0030103	http://dx.doi.org/10.1371/journal.pone.0030103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272281	gold, Green Submitted, Green Published			2022-12-25	WOS:000301454400059
J	Butler, MO; Imataki, O; Yamashita, Y; Tanaka, M; Ansen, S; Berezovskaya, A; Metzler, G; Milstein, MI; Mooney, MM; Murray, AP; Mano, H; Nadler, LM; Hirano, N				Butler, Marcus O.; Imataki, Osamu; Yamashita, Yoshihiro; Tanaka, Makito; Ansen, Sascha; Berezovskaya, Alla; Metzler, Genita; Milstein, Matthew I.; Mooney, Mary M.; Murray, Andrew P.; Mano, Hiroyuki; Nadler, Lee M.; Hirano, Naoto			Ex Vivo Expansion of Human CD8(+) T Cells Using Autologous CD4(+) T Cell Help	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ANTIGEN-PRESENTING CELLS; CUTTING EDGE; ADOPTIVE IMMUNOTHERAPY; METASTATIC MELANOMA; CANCER REGRESSION; TRANSFER THERAPY; CD27 EXPRESSION; PHASE-I; IMMUNITY	Background: Using in vivo mouse models, the mechanisms of CD4(+) T cell help have been intensively investigated. However, a mechanistic analysis of human CD4(+) T cell help is largely lacking. Our goal was to elucidate the mechanisms of human CD4(+) T cell help of CD8(+) T cell proliferation using a novel in vitro model. Methods/Principal Findings: We developed a genetically engineered novel human cell-based artificial APC, aAPC/mOKT3, which expresses a membranous form of the anti-CD3 monoclonal antibody OKT3 as well as other immune accessory molecules. Without requiring the addition of allogeneic feeder cells, aAPC/mOKT3 enabled the expansion of both peripheral and tumor-infiltrating T cells, regardless of HLA-restriction. Stimulation with aAPC/mOKT3 did not expand Foxp3(+) regulatory T cells, and expanded tumor infiltrating lymphocytes predominantly secreted Th1-type cytokines, interferonthis aAPC-based system, the presence of autologous CD4(+) T cells was associated with significantly improved CD8(+) T cell expansion in vitro. The CD4(+) T cell derived cytokines IL-2 and IL-21 were necessary but not sufficient for this effect. However, CD4(+) T cell help of CD8(+) T cell proliferation was partially recapitulated by both adding IL-2/IL-21 and by upregulation of IL21 receptor on CD8(+) T cells. Conclusions: We have developed an in vitro model that advances our understanding of the immunobiology of human CD4(+) T cell help of CD8(+) T cells. Our data suggests that human CD4(+) T cell help can be leveraged to expand CD8(+) T cells in vitro.	[Butler, Marcus O.; Imataki, Osamu; Tanaka, Makito; Ansen, Sascha; Berezovskaya, Alla; Metzler, Genita; Milstein, Matthew I.; Mooney, Mary M.; Murray, Andrew P.; Nadler, Lee M.; Hirano, Naoto] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Butler, Marcus O.; Imataki, Osamu; Tanaka, Makito; Ansen, Sascha; Nadler, Lee M.; Hirano, Naoto] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Butler, Marcus O.; Imataki, Osamu; Tanaka, Makito; Ansen, Sascha; Nadler, Lee M.; Hirano, Naoto] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yamashita, Yoshihiro; Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Shimotsuke, Tochigi, Japan; [Mano, Hiroyuki] Univ Tokyo, Dept Med Genom, Tokyo, Japan; [Hirano, Naoto] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Immune Therapy Program, Toronto, ON M4X 1K9, Canada; [Hirano, Naoto] Univ Toronto, Dept Immunol, Toronto, ON, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Jichi Medical University; University of Tokyo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Butler, MO (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	nhirano@uhnres.utoronto.ca		Murray, Andrew/0000-0003-3657-4738; Butler, Marcus/0000-0002-9840-7057	Madeleine Franchi Ovarian Research Fund; Dunkin Donuts Rising Stars Awards; Cancer Research Institute; NIH [K22 CA129240, R01 CA148673]; American Society of Hematology; NATIONAL CANCER INSTITUTE [K22CA129240, R01CA148673] Funding Source: NIH RePORTER	Madeleine Franchi Ovarian Research Fund; Dunkin Donuts Rising Stars Awards; Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Madeleine Franchi Ovarian Research Fund (MOB), Dunkin Donuts Rising Stars Awards (MOB and NH), a grant from the Cancer Research Institute (LMN), NIH grant K22 CA129240 (NH), NIH grant R01 CA148673 (NH), and the American Society of Hematology Scholar Award (NH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AK, 2008, SCAND J IMMUNOL, V68, P103, DOI 10.1111/j.1365-3083.2008.02118.x; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Berger C, 2009, CURR OPIN IMMUNOL, V21, P224, DOI 10.1016/j.coi.2009.02.010; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bollard CM, 2007, BLOOD, V110, P2838, DOI 10.1182/blood-2007-05-091280; Butler M, 2009, BLOOD, V114, P782; Butler MO, 2007, CLIN CANCER RES, V13, P1857, DOI 10.1158/1078-0432.CCR-06-1905; Butler MO, 2010, INT IMMUNOL, V22, P863, DOI 10.1093/intimm/dxq440; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; de Totero D, 2006, BLOOD, V107, P3708, DOI 10.1182/blood-2005-09-3535; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Haque T, 2007, BLOOD, V110, P1123, DOI 10.1182/blood-2006-12-063008; Hirano N, 2006, BLOOD, V107, P1528, DOI 10.1182/blood-2005-05-2073; Huang JP, 2006, J IMMUNOL, V176, P7726, DOI 10.4049/jimmunol.176.12.7726; Huang JP, 2005, J IMMUNOTHER, V28, P258, DOI 10.1097/01.cji.0000158855.92792.7a; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Klebanoff CA, 2005, TRENDS IMMUNOL, V26, P111, DOI 10.1016/j.it.2004.12.003; Kobayashi N, 2007, CLIN CANCER RES, V13, P902, DOI 10.1158/1078-0432.CCR-06-2363; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kusuda T, 2005, ONCOL REP, V13, P1153; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; Levine BL, 1997, J IMMUNOL, V159, P5921; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Mackensen A, 2006, J CLIN ONCOL, V24, P5060, DOI 10.1200/JCO.2006.07.1100; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Marth C, 2004, AM J OBSTET GYNECOL, V191, P1598, DOI 10.1016/j.ajog.2004.05.007; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Mihm MC, 1996, LAB INVEST, V74, P43; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Numbenjapon T, 2006, LEUKEMIA, V20, P1889, DOI 10.1038/sj.leu.2404329; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Parmiani G, 2007, J IMMUNOL, V178, P1975, DOI 10.4049/jimmunol.178.4.1975; Peggs KS, 2003, LANCET, V362, P1375, DOI 10.1016/S0140-6736(03)14634-X; Pellegrini M, 2010, TRENDS PHARMACOL SCI, V31, P356, DOI 10.1016/j.tips.2010.05.003; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Prazma CM, 2007, J IMMUNOL, V179, P4550, DOI 10.4049/jimmunol.179.7.4550; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Shimizu J, 1999, J IMMUNOL, V163, P5211; Soiffer R, 1998, P NATL ACAD SCI USA, V95, P13141, DOI 10.1073/pnas.95.22.13141; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sun JC, 2004, J IMMUNOL, V172, P3385, DOI 10.4049/jimmunol.172.6.3385; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wilke CM, 2010, INT J CANCER, V127, P748, DOI 10.1002/ijc.25464; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046; Zhou JH, 2005, J IMMUNOTHER, V28, P53, DOI 10.1097/00002371-200501000-00007	71	40	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2012	7	1							e30229	10.1371/journal.pone.0030229	http://dx.doi.org/10.1371/journal.pone.0030229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OY	22279573	Green Published, Green Submitted, gold			2022-12-25	WOS:000301357100047
J	Dudgeon, C; Peng, R; Wang, P; Sebastiani, A; Yu, J; Zhang, L				Dudgeon, C.; Peng, R.; Wang, P.; Sebastiani, A.; Yu, J.; Zhang, L.			Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3 beta and NF-kappa B to suppress tumor cell growth	ONCOGENE			English	Article						sorafenib; PUMA; apoptosis; NF-kappa B; GSK3 beta; colon cancer	MULTIKINASE INHIBITOR; DOWN-REGULATION; RAF/MEK/ERK PATHWAY; MEDIATED APOPTOSIS; ANTITUMOR-ACTIVITY; CANCER-THERAPY; UP-REGULATION; PHASE-II; KINASE; COMBINATION	Aberrant Ras/Raf/MEK/ERK signaling is one of the most prevalent oncogenic alterations and confers survival advantage to tumor cells. Inhibition of this pathway can effectively suppress tumor cell growth. For example, sorafenib, a multi-kinase inhibitor targeting c-Raf and other oncogenic kinases, has been used clinically for treating advanced liver and kidney tumors, and also has shown efficacy against other malignancies. However, how inhibition of oncogenic signaling by sorafenib and other drugs suppresses tumor cell growth remains unclear. In this study, we found that sorafenib kills cancer cells by activating PUMA (p53-upregulated modulator of apoptosis), a p53 target and a BH3-only Bcl-2 family protein. Sorafenib treatment induces PUMA in a variety of cancer cells irrespective of their p53 status. Surprisingly, the induction of PUMA by sorafenib is mediated by I kappa B-independent activation of nuclear factor (NF)-kappa B, which directly binds to the PUMA promoter to activate its transcription. NF-kappa B activation by sorafenib requires glycogen synthase kinase 3 beta activation, subsequent to ERK inhibition. Deficiency in PUMA abrogates sorafenib-induced apoptosis and caspase activation, and renders sorafenib resistance in colony formation and xenograft tumor assays. Furthermore, the chemosensitization effect of sorafenib is dependent on PUMA, and involves concurrent PUMA induction through different pathways. BH3 mimetics potentiate the anti-cancer effects of sorafenib, and restore sorafenib sensitivity in resistant cells. Together, these results demonstrate a key role of PUMA-dependent apoptosis in therapeutic inhibition of Ras/Raf/MEK/ERK signaling. They provide a rationale for manipulating the apoptotic machinery to improve sensitivity and overcome resistance to the therapies that target oncogenic kinase signaling.	[Zhang, L.] Univ Pittsburgh, Hillman Canc Ctr, Dept Pharmacol & Chem Biol, UPCI Res Pavil, Pittsburgh, PA 15213 USA; [Yu, J.] Univ Pittsburgh, Inst Canc, Dept Pathol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, L (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, Dept Pharmacol & Chem Biol, UPCI Res Pavil, Room 2-42A,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	zhanglx@upmc.edu	Zhang, Lin/A-7389-2009; Yu, Jian/A-8301-2009	Zhang, Lin/0000-0003-0018-3903; Yu, Jian/0000-0002-4021-1000; Dudgeon, Crissy/0000-0001-9010-2569	NIH [CA106348, CA121105]; American Cancer Society [RSG-07-156-01-CNE, RGS-10-124-01-CCE]; Flight Attendant Medical Research Institute, NIH [CA129829]; NIH National Research Service [F32CA139882]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA121105, F32CA139882, R01CA106348, R01CA129829] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Flight Attendant Medical Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Monica E Buchanan, Brian Leibowitz, Mathew F Brown and other lab members for critical reading and helpful discussion, and Drs Jennifer R Grandis and Jing Hu for help with analyses of STAT1, STAT3, eIF4E and GSK3 beta. This work is supported by NIH grants CA106348 and CA121105 and American Cancer Society grant RSG-07-156-01-CNE (LZ); Flight Attendant Medical Research Institute, NIH grant CA129829 and American Cancer Society grant RGS-10-124-01-CCE (JY); NIH National Research Service Award postdoctoral fellowship grant F32CA139882 (CD); and China Scholarship Council (RP). LZ is a scholar of the V Foundation for Cancer Research.	Augustine CK, 2010, MOL CANCER THER, V9, P2090, DOI 10.1158/1535-7163.MCT-10-0073; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dudgeon C, 2010, MOL CANCER THER, V9, P2893, DOI 10.1158/1535-7163.MCT-10-0635; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gomez-Benito M, 2005, MOL PHARMACOL, V67, P1991, DOI 10.1124/mol.104.007021; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Hong DS, 2009, CLIN CANCER RES, V15, P7061, DOI 10.1158/1078-0432.CCR-09-1241; Huang SB, 2010, MOL CANCER THER, V9, P742, DOI 10.1158/1535-7163.MCT-09-1004; Kim C, 2010, INVEST NEW DRUGS; Kohli M, 2004, P NATL ACAD SCI USA, V101, P16897, DOI 10.1073/pnas.0403405101; Li H, 2011, CANCER RES, V71, P3625, DOI 10.1158/0008-5472.CAN-10-4475; Lind JSW, 2010, CLIN CANCER RES, V16, P3078, DOI 10.1158/1078-0432.CCR-09-3033; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Martin AP, 2009, MOL PHARMACOL, V76, P327, DOI 10.1124/mol.109.056309; Martinelli E, 2010, CLIN CANCER RES, V16, P4990, DOI 10.1158/1078-0432.CCR-10-0923; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Molhoek KR, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-39; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Plastaras JP, 2007, CANCER RES, V67, P9443, DOI 10.1158/0008-5472.CAN-07-1473; Qiu W, 2010, P NATL ACAD SCI USA, V107, P20027, DOI 10.1073/pnas.1010430107; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sun Q, 2009, ONCOGENE, V28, P2348, DOI 10.1038/onc.2009.108; Sun WJ, 2010, J CLIN ONCOL, V28, P2947, DOI 10.1200/JCO.2009.27.7988; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Wilhelm S, 2002, CURR PHARM DESIGN, V8, P2255, DOI 10.2174/1381612023393026; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu J, 2006, CLIN CANCER RES, V12, P2928, DOI 10.1158/1078-0432.CCR-05-2429; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Yue W, 2008, CARCINOGENESIS, V29, P84, DOI 10.1093/carcin/bgm267; Zhang G, 2008, CLIN CANCER RES, V14, P5385, DOI 10.1158/1078-0432.CCR-08-0469; Zhang L, 2007, DRUG RESIST UPDATE, V10, P207, DOI 10.1016/j.drup.2007.08.002; Zhang W, 2008, LEUKEMIA, V22, P808, DOI 10.1038/sj.leu.2405098	51	57	58	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	46					4848	4858		10.1038/onc.2011.644	http://dx.doi.org/10.1038/onc.2011.644			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	038YT	22286758	Green Accepted, Bronze			2022-12-25	WOS:000311210700005
J	Isobe, Y; Arita, M; Matsueda, S; Iwamoto, R; Fujihara, T; Nakanishi, H; Taguchi, R; Masuda, K; Sasaki, K; Urabe, D; Inoue, M; Arai, H				Isobe, Yosuke; Arita, Makoto; Matsueda, Shinnosuke; Iwamoto, Ryo; Fujihara, Takuji; Nakanishi, Hiroki; Taguchi, Ryo; Masuda, Koji; Sasaki, Kenji; Urabe, Daisuke; Inoue, Masayuki; Arai, Hiroyuki			Identification and Structure Determination of Novel Anti-inflammatory Mediator Resolvin E3, 17,18-Dihydroxyeicosapentaenoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID MEDIATORS; FATTY-ACIDS; INFLAMMATION; RESOLUTION; OMEGA-3-FATTY-ACIDS; BIOSYNTHESIS; PRODUCTS; ASPIRIN; FAMILY; N-3	Bioactive mediators derived from omega-3 eicosapentaenoic acid (EPA) elicit potent anti-inflammatory actions. Here, we identified novel EPA metabolites, including 8,18-dihydroxyei-cosapentaenoic acid (8,18-diHEPE), 11,18-diHEPE, 12,18-diHEPE, and 17,18-diHEPE from 18-HEPE. Unlike resolvins E1 and E2, both of which are biosynthesized by neutrophils via the 5-lipoxygenase pathway, these metabolites are biosynthesized by eosinophils via the 12/15-lipoxygenase pathway. Among them, two stereoisomers of 17,18-diHEPE, collectively termed resolvin E3 (RvE3), displayed a potent anti-inflammatory action by limiting neutrophil infiltration in zymosan-induced peritonitis. The planar structure of RvE3 was unambiguously determined to be 17,18-dihydroxy-5Z, 8Z, 11Z, 13E, 15E-EPE by high resolution NMR, and the two stereoisomers were assigned to have 17,18R- and 17,18S-dihydroxy groups, respectively, using chemically synthesized 18R- and 18S-HEPE as precursors. Both 18R- and 18S-RvE3 inhibited neutrophil chemotaxis in vitro at low nanomolar concentrations. These findings suggest that RvE3 contributes to the beneficial actions of EPA in controlling inflammation and related diseases.	[Isobe, Yosuke; Arita, Makoto; Matsueda, Shinnosuke; Arai, Hiroyuki] Univ Tokyo, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Sasaki, Kenji; Urabe, Daisuke; Inoue, Masayuki] Univ Tokyo, Dept Integral Analyt Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Isobe, Yosuke; Iwamoto, Ryo; Fujihara, Takuji; Masuda, Koji] Univ Tokyo, Grad Sch Pharmaceut Sci, Business Acad Collaborat Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Nakanishi, Hiroki; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Bunkyo Ku, Tokyo 1130033, Japan; [Fujihara, Takuji; Masuda, Koji] Shionogi Res Labs, Toyonaka, Osaka 5610825, Japan; [Arita, Makoto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Shionogi & Company Limited; Japan Science & Technology Agency (JST)	Arita, M (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	marita@mol.f.u-tokyo.ac.jp		Nakanishi, Hiroki/0000-0002-5108-1598; Arita, Makoto/0000-0001-9902-0463	Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology; Core Research for Evolutional Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ono Medical Research Foundation; Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry; Grants-in-Aid for Scientific Research [23227004] Funding Source: KAKEN	Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (to M. A.), Core Research for Evolutional Science and Technology (to H. A. and R. T.), grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. A.), Ono Medical Research Foundation (to M. A.), and the Program for Promotion of Basic and Applied Research for Innovations in Bio-Oriented industry (to H. A.).	Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; MACMILLAN DK, 1994, J BIOL CHEM, V269, P26663; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Ogawa S, 2009, ORG LETT, V11, P3602, DOI 10.1021/ol901350g; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; POWELL WS, 1995, J IMMUNOL, V154, P4123; Sakagami H, 2005, J BIOL CHEM, V280, P23084, DOI 10.1074/jbc.M413438200; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027	27	172	178	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10525	10534		10.1074/jbc.M112.340612	http://dx.doi.org/10.1074/jbc.M112.340612			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22275352	hybrid, Green Published			2022-12-25	WOS:000302167200078
J	Wei, ZK; Peterson, JM; Lei, X; Cebotaru, L; Wolfgang, MJ; Baldeviano, GC; Wong, GW				Wei, Zhikui; Peterson, Jonathan M.; Lei, Xia; Cebotaru, Liudmila; Wolfgang, Michael J.; Baldeviano, G. Christian; Wong, G. William			C1q/TNF-related Protein-12 (CTRP12), a Novel Adipokine That Improves Insulin Sensitivity and Glycemic Control in Mouse Models of Obesity and Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET RETINAL DEGENERATION; C1Q/TNF FAMILY-MEMBERS; FATTY-ACID OXIDATION; BETA-CELL FUNCTION; ADIPOSE-TISSUE; MACULAR DEGENERATION; GLUCOSE-HOMEOSTASIS; ADIPONECTIN; KINASE; GENE	Despite the prevalence of insulin resistance and type 2 diabetes mellitus, their underlying mechanisms remain incompletely understood. Many secreted endocrine factors and the intertissue cross-talk they mediate are known to be dysregulated in type 2 diabetes mellitus. Here, we describe CTRP12, a novel adipokine with anti-diabetic actions. The mRNA and circulating levels of CTRP12 were decreased in a mouse model of obesity, but its expression in adipocytes was increased by the anti-diabetic drug rosiglitazone. A modest rise in circulating levels of CTRP12 by recombinant protein administration was sufficient to lower blood glucose in wild-type, leptin-deficient ob/ob, and diet-induced obese mice. A short term elevation of serum CTRP12 by adenovirus-mediated expression improved glucose tolerance and insulin sensitivity, normalized hyperglycemia and hyperinsulinemia, and lowered postprandial insulin resistance in obese and diabetic mice. CTRP12 improves insulin sensitivity in part by enhancing insulin signaling in the liver and adipose tissue. Further, CTRP12 also acts in an insulin-independent manner; in cultured hepatocytes and adipocytes, CTRP12 directly activated the PI3K-Akt signaling pathway to suppress gluconeogenesis and promote glucose uptake, respectively. Collectively, these data establish CTRP12 as a novel metabolic regulator linking adipose tissue to whole body glucose homeostasis through insulin-dependent and independent mechanisms.	[Wei, Zhikui; Peterson, Jonathan M.; Lei, Xia; Cebotaru, Liudmila; Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; [Cebotaru, Liudmila] Johns Hopkins Univ, Dept Ophthalmol, Sch Med, Baltimore, MD 21205 USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Dept Biol Chem, Sch Med, Baltimore, MD 21205 USA; [Baldeviano, G. Christian] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21205 USA; [Wei, Zhikui; Peterson, Jonathan M.; Lei, Xia; Wolfgang, Michael J.; Wong, G. William] Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wei, Zhikui/0000-0002-2311-9800; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171, NS072241]; American Heart Association [SDG2260721, SDG2310008, PRE3790034]; Baltimore Diabetes Research and Training Center [P60DK079637]; American Heart Association; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, P60DK079637, P30DK079637, R01DK084171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center; American Heart Association(American Heart Association); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK084171 (to G. W. W.) and NS072241 (to M. J. W.). This work was also supported in part by American Heart Association Grants SDG2260721 (to G. W. W.) and SDG2310008 (to M. J. W.) and Baltimore Diabetes Research and Training Center Grant P60DK079637.; Supported by American Heart Association Fellowship PRE3790034.; Supported by National Institutes of Health National Research Service Award F32DK084607. Present address: Dept. of Health Sciences, School of Public Health, East Tennessee State University, Johnson City, TN 37614.	Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; CANTELLO BCC, 1994, J MED CHEM, V37, P3977, DOI 10.1021/jm00049a017; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; de Raemy-Schenk AM, 2006, ASSAY DRUG DEV TECHN, V4, P525, DOI 10.1089/adt.2006.4.525; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hutley LJ, 2003, EUR J CLIN INVEST, V33, P574, DOI 10.1046/j.1365-2362.2003.01178.x; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	38	111	123	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10301	10315		10.1074/jbc.M111.303651	http://dx.doi.org/10.1074/jbc.M111.303651			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22275362	Green Published, hybrid			2022-12-25	WOS:000302167200059
J	Carter, AS; Tahmaseb, K; Compton, SA; Matson, SW				Carter, Annamarie S.; Tahmaseb, Kambiz; Compton, Sarah A.; Matson, Steven W.			Resolving Holliday Junctions with Escherichia coli UvrD Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK REVERSAL; NICKED CIRCULAR DNA; MISMATCH REPAIR; GENE-PRODUCT; II UVRD; RECOMBINATION PROTEINS; BRANCH MIGRATION; GENOME STABILITY; POLYMERASE-I; FULLY DUPLEX	The Escherichia coli UvrD helicase is known to function in the mismatch repair and nucleotide excision repair pathways and has also been suggested to have roles in recombination and replication restart. The primary intermediate DNA structure in these two processes is the Holliday junction. UvrD has been shown to unwind a variety of substrates including partial duplex DNA, nicked DNA, forked DNA structures, blunt duplex DNA and RNA-DNA hybrids. Here, we demonstrate that UvrD also catalyzes the robust unwinding of Holliday junction substrates. To characterize this unwinding reaction we have employed steady-state helicase assays, pre-steady-state rapid quench helicase assays, DNaseI footprinting, and electron microscopy. We conclude that UvrD binds initially to the junction compared with binding one of the blunt ends of the four-way junction to initiate unwinding and resolves the synthetic substrate into two double-stranded fork structures. We suggest that UvrD, along with its mismatch repair partners, MutS and MutL, may utilize its ability to unwind Holliday junctions directly in the prevention of homeologous recombination. UvrD may also be involved in the resolution of stalled replication forks by unwinding the Holliday junction intermediate to allow bypass of the blockage.	[Carter, Annamarie S.; Tahmaseb, Kambiz; Matson, Steven W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Carter, Annamarie S.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Compton, Sarah A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Matson, SW (corresponding author), Univ N Carolina, Dept Biol, CB 3280,Coker Hall, Chapel Hill, NC 27599 USA.	smatson@bio.unc.edu			National Institutes of Health [GM33476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health Grant GM33476 (to S. W. M.).	ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Cadman CJ, 2006, J MOL BIOL, V362, P18, DOI 10.1016/j.jmb.2006.06.032; CARON PR, 1985, P NATL ACAD SCI USA, V82, P4925, DOI 10.1073/pnas.82.15.4925; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; ELBOROUGH KM, 1990, EMBO J, V9, P2931, DOI 10.1002/j.1460-2075.1990.tb07484.x; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Flores MJ, 2004, EMBO REP, V5, P983, DOI 10.1038/sj.embor.7400262; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; KUHN B, 1979, COLD SPRING HARB SYM, V43, P63, DOI 10.1101/SQB.1979.043.01.011; KUHN B, 1979, J BIOL CHEM, V254, P1343; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; LUNDBLAD V, 1985, GENETICS, V109, P3; Maluf NK, 2003, J BIOL CHEM, V278, P31930, DOI 10.1074/jbc.M304223200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; MAPLES VF, 1982, P NATL ACAD SCI-BIOL, V79, P5616, DOI 10.1073/pnas.79.18.5616; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; MATSON SW, 1989, P NATL ACAD SCI USA, V86, P4430, DOI 10.1073/pnas.86.12.4430; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; MATSON SW, 1986, J BIOL CHEM, V261, P169; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; McGlynn P, 2002, TRENDS GENET, V18, P413, DOI 10.1016/S0168-9525(02)02720-8; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; MENDONCA VM, 1993, J BACTERIOL, V175, P4641, DOI 10.1128/JB.175.15.4641-4651.1993; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; OEDA K, 1982, NATURE, V298, P98, DOI 10.1038/298098a0; Petranovic M, 2001, BIOCHIMIE, V83, P1041, DOI 10.1016/S0300-9084(01)01346-3; RADMAN M, 1995, PHILOS T ROY SOC B, V347, P97, DOI 10.1098/rstb.1995.0015; RUNYON GT, 1989, J BIOL CHEM, V264, P17502; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P602, DOI 10.1021/bi00053a028; RUNYON GT, 1990, P NATL ACAD SCI USA, V87, P6383, DOI 10.1073/pnas.87.16.6383; RUNYON GT, 1993, BIOCHEMISTRY-US, V32, P4128, DOI 10.1021/bi00066a039; Stambuk S, 1998, GENETICS, V150, P533; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; WASHBURN BK, 1993, J BACTERIOL, V175, P341, DOI 10.1128/JB.175.2.341-350.1993; WESSEL R, 1990, EUR J BIOCHEM, V189, P277, DOI 10.1111/j.1432-1033.1990.tb15487.x; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; ZIEG J, 1978, J BACTERIOL, V134, P958, DOI 10.1128/JB.134.3.958-966.1978	50	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8126	8134		10.1074/jbc.M111.314047	http://dx.doi.org/10.1074/jbc.M111.314047			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267744	Green Published, hybrid			2022-12-25	WOS:000301349400028
J	Chan, KH; Li, T; Wong, CO; Wong, KB				Chan, Kwok-Ho; Li, Ting; Wong, Ching-On; Wong, Kam-Bo			Structural Basis for GTP-Dependent Dimerization of Hydrogenase Maturation Factor HypB	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; HELICOBACTER-PYLORI; METAL-BINDING; BRADYRHIZOBIUM-JAPONICUM; ACCESSORY PROTEINS; RALSTONIA-EUTROPHA; NICKEL; CYANIDE; UREASE	Maturation of [NiFe]-hydrogenase requires the insertion of iron, cyanide and carbon monoxide, followed by nickel, to the catalytic core of the enzyme. Hydrogenase maturation factor HypB is a metal-binding GTPase that is essential for the nickel delivery to the hydrogenase. Here we report the crystal structure of Archeoglobus fulgidus HypB (AfHypB) in apo-form. We showed that AfHypB recognizes guanine nucleotide using Asp-194 on the G5 loop despite having a non-canonical NKxA G4-motif. Structural comparison with the GTP gamma S-bound Methanocaldococcus jannaschii HypB identifies conformational changes in the switch I region, which bring an invariant Asp-72 to form an intermolecular salt-bridge with another invariant residue Lys-148 upon GTP binding. Substitution of K148A abolished GTP-dependent dimerization of AfHypB, but had no significant effect on the guanine nucleotide binding and on the intrinsic GTPase activity. In vivo complementation study in Escherichia coli showed that the invariant lysine residue is required for in vivo maturation of hydrogenase. Taken together, our results suggest that GTP-dependent dimerization of HypB is essential for hydrogenase maturation. It is likely that a nickel ion is loaded to an extra metal binding site at the dimeric interface of GTP-bound HypB and transferred to the hydrogenase upon GTP hydrolysis.	[Chan, Kwok-Ho; Li, Ting; Wong, Ching-On; Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chan, KH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; Chan, Kwok Ho/0000-0002-6693-2682; Wong, Ching On/0000-0002-8602-2125	Research Grants Council of Hong Kong [CUHK4610/06M]; University Grants Committee of Hong Kong [SEG CUHK08]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); University Grants Committee of Hong Kong	This work is supported by a General Research Fund from Research Grants Council of Hong Kong (Project code: CUHK4610/06M) and the equipment used is supported in part by an One-Off Special Equipment Grant from University Grants Committee of Hong Kong (Project code: SEG CUHK08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian Mohammad Reza, 2002, Methods Mol Biol, V189, P45; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Cai F, 2011, J BIOL INORG CHEM, V16, P857, DOI 10.1007/s00775-011-0782-y; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Dias AV, 2008, BIOCHEMISTRY-US, V47, P11981, DOI 10.1021/bi801337x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forzi L, 2007, FEBS LETT, V581, P3317, DOI 10.1016/j.febslet.2007.06.028; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; FU CL, 1995, P NATL ACAD SCI USA, V92, P2333, DOI 10.1073/pnas.92.6.2333; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gawronski JD, 2004, ANAL BIOCHEM, V327, P114, DOI 10.1016/j.ab.2003.12.024; Hoffmann D, 2006, FEBS J, V273, P4516, DOI 10.1111/j.1742-4658.2006.05460.x; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Lenz O, 2007, FEBS LETT, V581, P3322, DOI 10.1016/j.febslet.2007.06.027; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Loscher S, 2005, FEBS LETT, V579, P4287, DOI 10.1016/j.febslet.2005.06.063; MAIER T, 1993, J BACTERIOL, V175, P630, DOI 10.1128/JB.175.3.630-635.1993; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003; Mehta N, 2003, MICROB PATHOGENESIS, V35, P229, DOI 10.1016/S0882-4010(03)00151-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olson JW, 1997, MOL MICROBIOL, V24, P119, DOI 10.1046/j.1365-2958.1997.3251690.x; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Olson JW, 2000, J BACTERIOL, V182, P1702, DOI 10.1128/JB.182.6.1702-1705.2000; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Paschos A, 2001, FEBS LETT, V488, P9, DOI 10.1016/S0014-5793(00)02408-X; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; REY L, 1994, J BACTERIOL, V176, P6066, DOI 10.1128/jb.176.19.6066-6073.1994; Roseboom W, 2005, FEBS LETT, V579, P469, DOI 10.1016/j.febslet.2004.12.013; Sydor AM, 2011, J BACTERIOL, V193, P1359, DOI 10.1128/JB.01333-10; Theodoratou E, 2005, BIOCHEM SOC T, V33, P108, DOI 10.1042/BST0330108; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Watanabe S, 2009, J MOL BIOL, V394, P448, DOI 10.1016/j.jmb.2009.09.030; WAUGH R, 1986, BIOCHIMIE, V68, P157, DOI 10.1016/S0300-9084(86)81080-X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2005, FEBS LETT, V579, P4292, DOI 10.1016/j.febslet.2005.06.064; Xia W, 2009, J AM CHEM SOC, V131, P10031, DOI 10.1021/ja900543y; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	49	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30547	10.1371/journal.pone.0030547	http://dx.doi.org/10.1371/journal.pone.0030547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276211	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100055
J	Briand, E; Bormans, M; Quiblier, C; Salencon, MJ; Humbert, JF				Briand, Enora; Bormans, Myriam; Quiblier, Catherine; Salencon, Marie-Jose; Humbert, Jean-Francois			Evidence of the Cost of the Production of Microcystins by Microcystis aeruginosa under Differing Light and Nitrate Environmental Conditions	PLOS ONE			English	Article							TOXIC CYANOBACTERIUM; PLANKTOTHRIX-RUBESCENS; SPATIOTEMPORAL CHANGES; GENETIC DIVERSITY; NONTOXIC STRAINS; GROWTH-RATE; COMPETITION; COOPERATION; QUANTIFICATION; POPULATIONS	The cyanobacterium Microcystis aeruginosa is known to proliferate in freshwater ecosystems and to produce microcystins. It is now well established that much of the variability of bloom toxicity is due to differences in the relative proportions of microcystin-producing and non-microcystin-producing cells in cyanobacterial populations. In an attempt to elucidate changes in their relative proportions during cyanobacterial blooms, we compared the fitness of the microcystin-producing M. aeruginosa PCC 7806 strain (WT) to that of its non-microcystin-producing mutant (MT). We investigated the effects of two light intensities and of limiting and non-limiting nitrate concentrations on the growth of these strains in monoculture and co-culture experiments. We also monitored various physiological parameters, and microcystin production by the WT strain. In monoculture experiments, no significant difference was found between the growth rates or physiological characteristics of the two strains during the exponential growth phase. In contrast, the MT strain was found to dominate the WT strain in co-culture experiments under favorable growth conditions. Moreover, we also found an increase in the growth rate of the MT strain and in the cellular MC content of the WT strain. Our findings suggest that differences in the fitness of these two strains under optimum growth conditions were attributable to the cost to microcystin-producing cells of producing microcystins, and to the putative existence of cooperation processes involving direct interactions between these strains.	[Briand, Enora; Bormans, Myriam] Univ Rennes, Rennes, France; [Briand, Enora; Quiblier, Catherine] Museum Natl Hist Nat, F-75231 Paris, France; [Quiblier, Catherine] Univ Paris Diderot, Paris, France; [Salencon, Marie-Jose] Environm Def Fund Rand, Dept LNHE, Chatou, France; [Humbert, Jean-Francois] French Natl Inst Agr Res, UMR Biogeochim & Ecol Milleux Continent BIOEMCO, Paris, France	Universite de Rennes; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Sorbonne Universite	Briand, E (corresponding author), Univ Rennes, Rennes, France.	humbert@biologie.ens.fr	Briand, Enora/AAS-8520-2020; Briand, Enora/P-6074-2016	Briand, Enora/0000-0001-8996-0072; Bormans, Myriam/0000-0002-4755-6327; Humbert, Jean-Francois/0000-0002-1519-5651	Electricite de France Research & Development (EDF R D); Alpha Natural Resources (ANR)	Electricite de France Research & Development (EDF R D); Alpha Natural Resources (ANR)(French National Research Agency (ANR))	This work was conducted in the framework of a research program with Electricite de France Research & Development (EDF R& D). This work was also funded by the Alpha Natural Resources (ANR) Research Program SEST 2007 (project MATRICS). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; This research was partly funded by Electricite de France Research&Development (EDF R&D). Marie-Jose Salencon is employed by Electricite de France Research&Development (EDF R&D). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. All other authors have declared that no competing interests exist.	Alexova R, 2011, ENVIRON MICROBIOL, V13, P1064, DOI 10.1111/j.1462-2920.2010.02412.x; Baxa DV, 2010, HARMFUL ALGAE, V9, P342, DOI 10.1016/j.hal.2010.01.001; BOTES DP, 1985, J CHEM SOC PERK T 1, P2747, DOI 10.1039/p19850002747; Briand E, 2008, ENVIRON MICROBIOL, V10, P3337, DOI 10.1111/j.1462-2920.2008.01730.x; Briand E, 2008, APPL ENVIRON MICROB, V74, P3839, DOI 10.1128/AEM.02343-07; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Briand JF, 2005, MICROB ECOL, V50, P418, DOI 10.1007/s00248-005-0186-z; Briand JF, 2003, VET RES, V34, P361, DOI 10.1051/vetres:2003019; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Davis TW, 2010, AQUAT MICROB ECOL, V61, P149, DOI 10.3354/ame01445; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dittmann E, 2001, MICROBIOL-SGM, V147, P3113, DOI 10.1099/00221287-147-11-3113; Dittmann E, 1997, MOL MICROBIOL, V26, P779, DOI 10.1046/j.1365-2958.1997.6131982.x; Downing TG, 2005, MICROB ECOL, V49, P468, DOI 10.1007/s00248-004-0054-2; Foster KR, 2007, TRENDS GENET, V23, P74, DOI 10.1016/j.tig.2006.12.003; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Ha JH, 2009, ENVIRON SCI TECHNOL, V43, P812, DOI 10.1021/es801265f; Hesse K, 2001, FEMS MICROBIOL ECOL, V37, P39, DOI 10.1111/j.1574-6941.2001.tb00851.x; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Kaebernick M, 2002, APPL ENVIRON MICROB, V68, P449, DOI 10.1128/AEM.68.2.449-455.2002; Kardinaal WEA, 2007, APPL ENVIRON MICROB, V73, P2939, DOI 10.1128/AEM.02892-06; Kardinaal WEA, 2005, AQUAT ECOL SER, V3, P41; Kehr JC, 2006, MOL MICROBIOL, V59, P893, DOI 10.1111/j.1365-2958.2005.05001.x; Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x; KUIPERGOODMAN T, 1999, TOXIC CYANOBACTERIA, P41; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P6723, DOI 10.1128/AEM.69.11.6723-6730.2003; Long BM, 2001, APPL ENVIRON MICROB, V67, P278, DOI 10.1128/AEM.67.1.278-283.2001; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; Manganelli M, 2010, WATER RES, V44, P1297, DOI 10.1016/j.watres.2009.10.045; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; Renaud SL, 2011, APPL ENVIRON MICROB, V77, P7016, DOI 10.1128/AEM.05246-11; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sabart M, 2010, APPL ENVIRON MICROB, V76, P4750, DOI 10.1128/AEM.02531-09; Sabart M, 2009, ENV MICROBIOL REP, V1, P263, DOI 10.1111/j.1758-2229.2009.00042.x; Schatz D, 2007, ENVIRON MICROBIOL, V9, P965, DOI 10.1111/j.1462-2920.2006.01218.x; Schreiber U., 1998, P320; Sevilla E, 2008, ENVIRON MICROBIOL, V10, P2476, DOI 10.1111/j.1462-2920.2008.01663.x; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; UTKILEN H, 1995, APPL ENVIRON MICROB, V61, P797, DOI 10.1128/AEM.61.2.797-800.1995; Van de Waal DB, 2011, ISME J, V5, P1438, DOI 10.1038/ismej.2011.28; Van de Waal DB, 2010, FEMS MICROBIOL ECOL, V74, P430, DOI 10.1111/j.1574-6941.2010.00958.x; Van de Waal DB, 2009, ECOL LETT, V12, P1326, DOI 10.1111/j.1461-0248.2009.01383.x; Yoshida M, 2007, FEMS MICROBIOL LETT, V266, P49, DOI 10.1111/j.1574-6968.2006.00496.x; Zilliges Y, 2008, J BACTERIOL, V190, P2871, DOI 10.1128/JB.01867-07; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	47	70	73	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29981	10.1371/journal.pone.0029981	http://dx.doi.org/10.1371/journal.pone.0029981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276137	Green Published, gold			2022-12-25	WOS:000301457200025
J	Mikitova, V; Levine, TP				Mikitova, Veronika; Levine, Timothy P.			Analysis of the Key Elements of FFAT-Like Motifs Identifies New Proteins That Potentially Bind VAP on the ER, Including Two AKAPs and FAPP2	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; PLASMA-MEMBRANE; STRUCTURAL BASIS; FIBROUS SHEATH; LIPID TRANSFER; REQUIRES; LOCALIZATION; TRAFFICKING; COMPLEX	Background: Two phenylalanines (FF) in an acidic tract (FFAT)-motifs were originally described as having seven elements: an acidic flanking region followed by 6 residues (EFFDA-E). Such motifs are found in several lipid transfer protein (LTP) families, and they interact with a protein on the cytosolic face of the ER called vesicle-associated membrane protein-associated protein (VAP). Mutation of which causes ER stress and motor neuron disease, making it important to determine which proteins bind VAP. Among other proteins that bind VAP, some contain FFAT-like motifs that are missing one or more of the seven elements. Defining how much variation is tolerated in FFAT-like motifs is a preliminary step prior to the identification of the full range of VAP interactors. Results: We used a quantifiable in vivo system that measured ER targeting in a reporter yeast strain that over-expressed VAP to study the effect of substituting different elements of FFAT-like motifs in turn. By defining FFAT-like motifs more widely than before, we found them in novel proteins the functions of which had not previously been directly linked to the ER, including: two PKA anchoring proteins, AKAP220 and AKAP110; a family of plant LTPs; and the glycolipid LTP phosphatidylinositol-four-phosphate adaptor-protein-2 (FAPP-2). Conclusion: All of the seven essential elements of a FFAT motif tolerate variation, and weak targeting to the ER via VAP is still detected if two elements are substituted. In addition to the strong FFAT motifs already known, there are additional proteins with weaker FFAT-like motifs, which might be functionally important VAP interactors.	[Mikitova, Veronika; Levine, Timothy P.] UCL, Inst Ophthalmol, Dept Cell Biol, London, England	University of London; University College London	Mikitova, V (corresponding author), Inst Fdn Caubet Cimera, Bunyola, Spain.	tim.levine@ucl.ac.uk		Levine, Timothy/0000-0002-7231-0775	Wellcome Trust, UK [082119/Z/07/Z]	Wellcome Trust, UK(Wellcome Trust)	The work was funded entirely by the Wellcome Trust, UK, grant number 082119/Z/07/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Bajpai M, 2006, BIOL REPROD, V74, P109, DOI 10.1095/biolreprod.105.043588; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Bui M, 2010, J BIOL CHEM, V285, P31590, DOI 10.1074/jbc.M110.101584; Cao XW, 2009, P NATL ACAD SCI USA, V106, P21121, DOI 10.1073/pnas.0911789106; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; De Vos KJ, 2011, HUM MOL GENET; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Fujita A, 2000, J CELL SCI, V113, P103; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Haaf A, 1998, J MOL BIOL, V284, P1611, DOI 10.1006/jmbi.1998.2291; Halter D, 2007, JCB CURRENT; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; Kodama M, 2010, MOL CELL BIOL, V30, P1620, DOI 10.1128/MCB.00810-09; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Langeberg LK, 2005, J CELL SCI, V118, P3217, DOI 10.1242/jcs.02416; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Lapierre LA, 1999, J CELL SCI, V112, P3723; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mammoto A, 2000, J BIOL CHEM, V275, P13167, DOI 10.1074/jbc.C000096200; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MILLER JD, 1995, J CELL BIOL, V128, P273, DOI 10.1083/jcb.128.3.273; Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Petersen NHT, 2008, FEBS J, V275, P4378, DOI 10.1111/j.1742-4658.2008.06584.x; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Saravanan RS, 2009, PLANT J, V58, P817, DOI 10.1111/j.1365-313X.2009.03815.x; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sengupta S, 2010, BBA-MOL CELL RES, V1803, P796, DOI 10.1016/j.bbamcr.2010.03.017; Shi JH, 2010, BIOCHEMISTRY-US, V49, P3887, DOI 10.1021/bi902057a; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sroubek J, 2011, J BIOL CHEM, V286, P21927, DOI 10.1074/jbc.M110.201699; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Tuuf J, 2007, BBA-MOL CELL BIOL L, V1771, P1353, DOI 10.1016/j.bbalip.2007.09.001; Tuuf J, 2009, BIOCHEM BIOPH RES CO, V388, P395, DOI 10.1016/j.bbrc.2009.08.023; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Walker AK, 2011, IUBMB LIFE; West G, 2004, ACTA CRYSTALLOGR D, V60, P703, DOI 10.1107/S090744490400109X; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zeng JB, 1999, P NATL ACAD SCI USA, V96, P2840, DOI 10.1073/pnas.96.6.2840	80	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30455	10.1371/journal.pone.0030455	http://dx.doi.org/10.1371/journal.pone.0030455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276202	gold, Green Published, Green Submitted			2022-12-25	WOS:000301457200064
J	Yokoi, T; Seko, Y; Yokoi, T; Makino, H; Hatou, S; Yamada, M; Kiyono, T; Umezawa, A; Nishina, H; Azuma, N				Yokoi, Tadashi; Seko, Yuko; Yokoi, Tae; Makino, Hatsune; Hatou, Shin; Yamada, Masakazu; Kiyono, Tohru; Umezawa, Akihiro; Nishina, Hiroshi; Azuma, Noriyuki			Establishment of Functioning Human Corneal Endothelial Cell Line with High Growth Potential	PLOS ONE			English	Article							SURFACE EPITHELIAL-CELLS; OLDER DONORS; IN-VITRO; YOUNG; KERATOPLASTY; PROTEIN; TRANSPLANTATION; PROLIFERATION; RETROVIRUSES; EXPRESSION	Hexagonal-shaped human corneal endothelial cells (HCEC) form a monolayer by adhering tightly through their intercellular adhesion molecules. Located at the posterior corneal surface, they maintain corneal translucency by dehydrating the corneal stroma, mainly through the Na+- and K+-dependent ATPase (Na+/K+-ATPase). Because HCEC proliferative activity is low in vivo, once HCEC are damaged and their numbers decrease, the cornea begins to show opacity due to overhydration, resulting in loss of vision. HCEC cell cycle arrest occurs at the G1 phase and is partly regulated by cyclin-dependent kinase inhibitors (CKIs) in the Rb pathway (p16-CDK4/CyclinD1-pRb). In this study, we tried to activate proliferation of HCEC by inhibiting CKIs. Retroviral transduction was used to generate two new HCEC lines: transduced human corneal endothelial cell by human papillomavirus type E6/E7 (THCEC (E6/E7)) and transduced human corneal endothelial cell by Cdk4R24C/CyclinD1 (THCEH (Cyclin)). Reverse transcriptase polymerase chain reaction analysis of gene expression revealed little difference between THCEC (E6/E7), THCEH (Cyclin) and non-transduced HCEC, but cell cycle-related genes were up-regulated in THCEC (E6/E7) and THCEH (Cyclin). THCEH (Cyclin) expressed intercellular molecules including ZO-1 and N-cadherin and showed similar Na+/K+-ATPase pump function to HCEC, which was not demonstrated in THCEC (E6/E7). This study shows that HCEC cell cycle activation can be achieved by inhibiting CKIs even while maintaining critical pump function and morphology.	[Yokoi, Tadashi; Seko, Yuko; Yokoi, Tae; Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Dept Ophthalomol, Tokyo, Japan; [Yokoi, Tadashi; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, Tokyo, Japan; [Makino, Hatsune; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo, Japan; [Hatou, Shin] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Yamada, Masakazu] Natl Tokyo Med Ctr, Div Vis Res, Natl Inst Sensory Organs, Tokyo, Japan; [Kiyono, Tohru] Natl Canc Ctr, Div Virol, Tokyo, Japan; [Seko, Yuko] Natl Rehabil Ctr Persons Disabil, Sensory Funct Sect, Res Inst, Tokyo, Japan	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Keio University; National Cancer Center - Japan	Yokoi, T (corresponding author), Natl Ctr Child Hlth & Dev, Dept Ophthalomol, Tokyo, Japan.	azuma-n@ncchd.go.jp		Hatou, Shin/0000-0001-9273-5909	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18390473]; Grants-in-Aid for Scientific Research [22390327, 24659770] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant (# 18390473) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; BARFORT P, 1974, EXP EYE RES, V19, P11, DOI 10.1016/0014-4835(74)90067-0; BOURNE WM, 1994, OPHTHALMOLOGY, V101, P1014; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Coster DJ, 2005, AM J OPHTHALMOL, V140, P1112, DOI 10.1016/j.ajo.2005.07.024; Enomoto K, 2006, INVEST OPHTH VIS SCI, V47, P4330, DOI 10.1167/iovs.05-1581; Fan TJ, 2011, MOL VIS, V17, P469; Fan TJ, 2009, MOL VIS, V15, P1070; Gagnon MM, 1997, CORNEA, V16, P314; Haga K, 2007, CANCER SCI, V98, P147, DOI 10.1111/j.1349-7006.2006.00373.x; Hashemian Mohammad Nasser, 2006, BMC Ophthalmol, V6, P9; Hatou S, 2009, CURR EYE RES, V34, P347, DOI 10.1080/02713680902829624; Ishino Y, 2008, MOL VIS, V14, P61; Kikuchi M, 2006, INVEST OPHTH VIS SCI, V47, P4803, DOI 10.1167/iovs.06-0521; Kim Hyun-Ju, 2006, Korean J Ophthalmol, V20, P47; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; LAING RA, 1976, EXP EYE RES, V22, P587, DOI 10.1016/0014-4835(76)90003-8; LANDSHMAN N, 1988, INVEST OPHTH VIS SCI, V29, P1100; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Narisawa-Saito M, 2008, CANCER RES, V68, P5699, DOI 10.1158/0008-5472.CAN-07-6862; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084; Padilla MDB, 2004, CORNEA, V23, P129, DOI 10.1097/00003226-200403000-00005; Price FW, 2005, J REFRACT SURG, V21, P339; Rane SG, 2002, MOL CELL BIOL, V22, P644, DOI 10.1128/MCB.22.2.644-656.2002; ROBINSON HL, 1982, REV INFECT DIS, V4, P1015; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; SCHULTZ RO, 1984, AM J OPHTHALMOL, V98, P401, DOI 10.1016/0002-9394(84)90120-X; Sekiguchi T, 1998, ONCOGENE, V16, P369, DOI 10.1038/sj.onc.1201539; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Shiraishi A, 2007, CORNEA, V26, pS55, DOI 10.1097/ICO.0b013e31812f6b67; SLINGSBY JG, 1981, ARCH OPHTHALMOL-CHIC, V99, P1041; Terry MA, 2001, CORNEA, V20, P239, DOI 10.1097/00003226-200104000-00001; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Valtink M, 2008, CELLS TISSUES ORGANS, V187, P286, DOI 10.1159/000113406; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814; Zhu C, 2008, MOL VIS, V14, P1805; Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693	41	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29677	10.1371/journal.pone.0029677	http://dx.doi.org/10.1371/journal.pone.0029677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276123	gold, Green Submitted, Green Published			2022-12-25	WOS:000301457200018
J	Bjorkqvist, M; Ohlsson, M; Minthon, L; Hansson, O				Bjorkqvist, Maria; Ohlsson, Mattias; Minthon, Lennart; Hansson, Oskar			Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; CSF BIOMARKERS; WORK GROUP; DIAGNOSIS; DEMENTIA; SIGNATURE	There is an urgent need for biomarkers in plasma to identify Alzheimer's disease (AD). It has previously been shown that a signature of 18 plasma proteins can identify AD during pre-dementia and dementia stages (Ray et al, Nature Medicine, 2007). We quantified the same 18 proteins in plasma from 174 controls, 142 patients with AD, and 88 patients with other dementias. Only three of these proteins (EGF, PDG-BB and MIP-1 delta) differed significantly in plasma between controls and AD. The 18 proteins could classify patients with AD from controls with low diagnostic precision (area under the ROC curve was 63%). Moreover, they could not distinguish AD from other dementias. In conclusion, independent validation of results is important in explorative biomarker studies.	[Bjorkqvist, Maria] Lund Univ, Brain Dis Biomarker Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden; [Minthon, Lennart] Lund Univ, Clin Memory Res Unit, Dept Clin Sci Malmo, Malmo, Sweden; [Minthon, Lennart; Hansson, Oskar] Skane Univ Hosp, Neuropsychiat Clin, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital	Bjorkqvist, M (corresponding author), Lund Univ, Brain Dis Biomarker Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden.	maria.bjorkqvist@med.lu.se	Ohlsson, Mattias/G-5790-2011; Hansson, Oskar/A-7134-2013	Hansson, Oskar/0000-0001-8467-7286; Ohlsson, Mattias/0000-0003-1145-4297; Bjorkqvist, Maria/0000-0001-8550-0431	Swedish Research Council; Swedish Brain Power; Skane County Counsil; Lund University; Torsten and Ragnar Soderberg Foundation; BenteRexed foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power; Skane County Counsil; Lund University; Torsten and Ragnar Soderberg Foundation; BenteRexed foundation	This work was supported by the Swedish Research Council, the Swedish Brain Power, the Regional Agreement on Medical Training and Clinical Research (ALF) between Skane County Counsil and Lund University and the Torsten and Ragnar Soderberg Foundation. MB is supported by BenteRexed foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP, 1987, DIAGN STAT MAN MENT; Bishop C. M., 1995, NEURAL NETWORKS PATT; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; de Paula MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017481; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; HOSMER DW, 1989, APPL LOGISTIC REGRES; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Knudsen LS, 2008, BIOMARKERS, V13, P59, DOI 10.1080/13547500701615017; Marksteiner J, 2011, NEUROBIOL AGING, V32, P539, DOI 10.1016/j.neurobiolaging.2009.03.011; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Soares HD, 2009, ANN NY ACAD SCI, V1180, P56, DOI 10.1111/j.1749-6632.2009.05066.x; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299	26	84	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29868	10.1371/journal.pone.0029868	http://dx.doi.org/10.1371/journal.pone.0029868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279551	gold, Green Published			2022-12-25	WOS:000299771900029
J	Denman, CJ; Senyukov, VV; Somanchi, SS; Phatarpekar, PV; Kopp, LM; Johnson, JL; Singh, H; Hurton, L; Maiti, SN; Huls, MH; Champlin, RE; Cooper, LJN; Lee, DA				Denman, Cecele J.; Senyukov, Vladimir V.; Somanchi, Srinivas S.; Phatarpekar, Prasad V.; Kopp, Lisa M.; Johnson, Jennifer L.; Singh, Harjeet; Hurton, Lenka; Maiti, Sourindra N.; Huls, M. Helen; Champlin, Richard E.; Cooper, Laurence J. N.; Lee, Dean A.			Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells	PLOS ONE			English	Article							CELLULAR CYTOTOXICITY ADCC; IN-VITRO EXPANSION; CD8(+) T-CELLS; MOUSE NK CELLS; PERIPHERAL-BLOOD; ADOPTIVE TRANSFER; CLINICAL-GRADE; MONOCLONAL-ANTIBODY; GAMMA PRODUCTION; SCALE EXPANSION	NK cells have therapeutic potential for a wide variety of human malignancies. However, because NK cells expand poorly in vitro, have limited life spans in vivo, and represent a small fraction of peripheral white blood cells, obtaining sufficient cell numbers is the major obstacle for NK-cell immunotherapy. Genetically-engineered artificial antigen-presenting cells (aAPCs) expressing membrane-bound IL-15 (mbIL15) have been used to propagate clinical-grade NK cells for human trials of adoptive immunotherapy, but ex vivo proliferation has been limited by telomere shortening. We developed K562-based aAPCs with membrane-bound IL-21 (mbIL21) and assessed their ability to support human NK-cell proliferation. In contrast to mbIL15, mbIL21-expressing aAPCs promoted log-phase NK cell expansion without evidence of senescence for up to 6 weeks of culture. By day 21, parallel expansion of NK cells from 22 donors demonstrated a mean 47,967-fold expansion (median 31,747) when co-cultured with aAPCs expressing mbIL21 compared to 825-fold expansion (median 325) with mbIL15. Despite the significant increase in proliferation, mbIL21-expanded NK cells also showed a significant increase in telomere length compared to freshly obtained NK cells, suggesting a possible mechanism for their sustained proliferation. NK cells expanded with mbIL21 were similar in phenotype and cytotoxicity to those expanded with mbIL15, with retained donor KIR repertoires and high expression of NCRs, CD16, and NKG2D, but had superior cytokine secretion. The mbIL21-expanded NK cells showed increased transcription of the activating receptor CD160, but otherwise had remarkably similar mRNA expression profiles of the 96 genes assessed. mbIL21-expanded NK cells had significant cytotoxicity against all tumor cell lines tested, retained responsiveness to inhibitory KIR ligands, and demonstrated enhanced killing via antibody-dependent cell cytotoxicity. Thus, aAPCs expressing mbIL21 promote improved proliferation of human NK cells with longer telomeres and less senescence, supporting their clinical use in propagating NK cells for adoptive immunotherapy.	[Denman, Cecele J.; Senyukov, Vladimir V.; Somanchi, Srinivas S.; Phatarpekar, Prasad V.; Kopp, Lisa M.; Johnson, Jennifer L.; Singh, Harjeet; Hurton, Lenka; Maiti, Sourindra N.; Huls, M. Helen; Cooper, Laurence J. N.; Lee, Dean A.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Phatarpekar, Prasad V.; Hurton, Lenka; Cooper, Laurence J. N.; Lee, Dean A.] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA; [Champlin, Richard E.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Denman, CJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA.	dale@mdanderson.org	Somanchi, Srinivas S/D-5995-2013; Lee, Dean Anthony/AAK-8443-2021	Lee, Dean Anthony/0000-0001-6693-5392; Kopp, Lisa/0000-0002-3412-4189; Hurton, Lenka/0000-0001-5670-5155	NIH [R21CA114251]; University of Texas MD Anderson Cancer Center; St. Baldrick's Foundation; Mike Doiron Legends of Friendswood; NCI Cancer Center [CA 16672]; NATIONAL CANCER INSTITUTE [R01CA141303, R21CA114251, P30CA016672, P01CA049639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center; St. Baldrick's Foundation; Mike Doiron Legends of Friendswood; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by NIH grant R21CA114251, the University of Texas MD Anderson Cancer Center Physician Scientist Program, the Johnson Fund, the St. Baldrick's Foundation (http://www.stbaldricks.org/), the Mike Doiron Legends of Friendswood, and NCI Cancer Center Support (Core) Grant CA 16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu N, 2007, CANCER LETT, V256, P196, DOI 10.1016/j.canlet.2007.06.001; Alici E, 2008, BLOOD, V111, P3155, DOI 10.1182/blood-2007-09-110312; Ansen S, 2008, CLIN CANCER RES, V14, P6125, DOI 10.1158/1078-0432.CCR-08-1146; Bachanova V, 2010, CANCER IMMUNOL IMMUN, V59, P1739, DOI 10.1007/s00262-010-0896-z; Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263; Barakonyi A, 2004, J IMMUNOL, V173, P5349, DOI 10.4049/jimmunol.173.9.5349; Barao I, 2003, BIOL BLOOD MARROW TR, V9, P727, DOI 10.1016/j.bbmt.2003.09.002; Barkholt L, 2009, IMMUNOTHERAPY, V1, P753, DOI 10.2217/IMT.09.47; Berg M, 2010, CYTOTHERAPY, V12, P969, DOI 10.3109/14653249.2010.536216; Berg M, 2009, CYTOTHERAPY, V11, P341, DOI 10.1080/14653240902807034; Boissel L, 2008, BIOL BLOOD MARROW TR, V14, P1031, DOI 10.1016/j.bbmt.2008.06.016; Bonanno G, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-46; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Brandt K, 2007, CYTOKINE GROWTH F R, V18, P223, DOI 10.1016/j.cytogfr.2007.04.003; Buddingh EP, 2011, CANCER IMMUNOL IMMUN, V60, P575, DOI 10.1007/s00262-010-0965-3; Burgess SJ, 2006, J IMMUNOL, V176, P1490, DOI 10.4049/jimmunol.176.3.1490; Carlens S, 2001, HUM IMMUNOL, V62, P1092, DOI 10.1016/S0198-8859(01)00313-5; Cassard L, 2008, INT J CANCER, V123, P2832, DOI 10.1002/ijc.23870; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Cho D, 2009, KOREAN J LAB MED, V29, P89, DOI 10.3343/kjlm.2009.29.2.89; Cholujova D, 2008, IMMUNOBIOLOGY, V213, P629, DOI 10.1016/j.imbio.2008.02.006; Clausen J, 2004, BIOL BLOOD MARROW TR, V10, P691, DOI 10.1016/j.bbmt.2004.06.009; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Clausen J, 2001, J HEMATOTH STEM CELL, V10, P513, DOI 10.1089/15258160152509127; Clemenceau B, 2006, J IMMUNOTHER, V29, P53; Clemenceau B, 2006, BLOOD, V107, P4669, DOI 10.1182/blood-2005-09-3775; Davies JK, 2010, CANCER RES, V70, P3915, DOI 10.1158/0008-5472.CAN-09-3845; de Rham C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2336; Decot V, 2010, EXP HEMATOL, V38, P351, DOI 10.1016/j.exphem.2010.02.006; Farag SS, 2002, BLOOD, V100, P1935, DOI 10.1182/blood-2002-02-0350; Fujisaki H, 2009, CANCER RES, V69, P4010, DOI 10.1158/0008-5472.CAN-08-3712; Fujisaki H, 2009, BRIT J HAEMATOL, V145, P606, DOI 10.1111/j.1365-2141.2009.07667.x; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Geller MA, 2011, CYTOTHERAPY, V13, P98, DOI 10.3109/14653249.2010.515582; Giustiniani J, 2007, J IMMUNOL, V178, P1293, DOI 10.4049/jimmunol.178.3.1293; Giustiniani J, 2009, J IMMUNOL, V182, P63, DOI 10.4049/jimmunol.182.1.63; Gong W, 2010, TISSUE ANTIGENS; HERBERMAN RB, 1981, SCIENCE, V214, P24, DOI 10.1126/science.7025208; Hurton LV, 2010, LEUKEMIA, V24, P1059, DOI 10.1038/leu.2010.19; Iliopoulou EG, 2010, CANCER IMMUNOL IMMUN, V59, P1781, DOI 10.1007/s00262-010-0904-3; Jung ST, 2011, CURR OPIN BIOTECHNOL; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Klingemann HG, 2004, CYTOTHERAPY, V6, P15, DOI 10.1080/14653240310004548; Koehl U, 2005, KLIN PADIATR, V217, P345, DOI 10.1055/s-2005-872520; Koehl U, 2004, BLOOD CELL MOL DIS, V33, P261, DOI 10.1016/j.bcmd.2004.08.013; Konnikova L, 2005, CANCER RES, V65, P6516, DOI 10.1158/0008-5472.CAN-05-0924; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Le Bouteiller P, 2002, P NATL ACAD SCI USA, V99, P16963, DOI 10.1073/pnas.012681099; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Lu HZ, 2011, HUM IMMUNOL, V72, P538, DOI 10.1016/j.humimm.2011.03.022; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; Meyer-Monard S, 2009, TRANSFUSION, V49, P362, DOI 10.1111/j.1537-2995.2008.01969.x; Miller JS, 2009, CYTOTHERAPY, V11, P259, DOI 10.1080/14653240902888000; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Minamiguchi H, 2005, BIOL BLOOD MARROW TR, V11, P487, DOI 10.1016/j.bbmt.2005.04.003; Nitta E, 2011, BLOOD, V117, P4169, DOI 10.1182/blood-2010-08-297390; Numbenjapon T, 2006, LEUKEMIA, V20, P1889, DOI 10.1038/sj.leu.2404329; Parham P, 2003, NAT REV IMMUNOL, V3, P108, DOI 10.1038/nri999; Parkhurst MR, 2011, CLIN CANCER RES, V17, P6287, DOI 10.1158/1078-0432.CCR-11-1347; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Perez SA, 2006, INT IMMUNOL, V18, P49, DOI 10.1093/intimm/dxh348; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; Pittari G, 2010, BONE MARROW TRANSPL, V45, P862, DOI 10.1038/bmt.2009.265; Portevin D, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-82; Reim F, 2009, CANCER RES, V69, P8058, DOI 10.1158/0008-5472.CAN-09-0834; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Rose MJJ, 2009, J IMMUNOL, V183, P4502, DOI 10.4049/jimmunol.0803323; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Satwani P, 2011, CYTOTHERAPY; Shi J, 2008, BRIT J HAEMATOL, V143, P641, DOI 10.1111/j.1365-2141.2008.07340.x; Siegler U, 2010, CYTOTHERAPY, V12, P750, DOI 10.3109/14653241003786155; Singh H, 2011, CANC RES; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Sivori S, 2003, EUR J IMMUNOL, V33, P3439, DOI 10.1002/eji.200324533; Skak K, 2008, IMMUNOLOGY, V123, P575, DOI 10.1111/j.1365-2567.2007.02730.x; Somanchi SS, 2011, J VIS EXP; Sondergaard H, 2009, J IMMUNOL, V183, P7326, DOI 10.4049/jimmunol.0902697; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Strengell M, 2003, J IMMUNOL, V170, P5464, DOI 10.4049/jimmunol.170.11.5464; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Sutlu T, 2011, CYTOTHERAPY; Sutlu T, 2010, CYTOTHERAPY, V12, P1044, DOI 10.3109/14653249.2010.504770; Takaki R, 2005, J IMMUNOL, V175, P2167, DOI 10.4049/jimmunol.175.4.2167; Tokuyama H, 2008, INT J CANCER, V122, P2526, DOI 10.1002/ijc.23365; Tomala J, 2009, J IMMUNOL, V183, P4904, DOI 10.4049/jimmunol.0900284; Toomey JA, 2003, J LEUKOCYTE BIOL, V74, P233, DOI 10.1189/jlb.0303097; Torelli GF, 2002, BRIT J HAEMATOL, V116, P299, DOI 10.1046/j.1365-2141.2002.03277.x; Torelli GF, 2005, HAEMATOLOGICA, V90, P785; Tran KQ, 2008, J IMMUNOTHER, V31, P742, DOI 10.1097/CJI.0b013e31818403d5; Vitale M, 2004, EUR J IMMUNOL, V34, P1715, DOI 10.1002/eji.200425100; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Warren HS, 2003, J IMMUNOL METHODS, V280, P135, DOI 10.1016/S0022-1759(03)00106-6; Wendt K, 2007, IMMUNOLOGY, V122, P486, DOI 10.1111/j.1365-2567.2007.02675.x; Wu ZF, 2010, J MOL CELL BIOL, V2, P217, DOI 10.1093/jmcb/mjq012; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973; Zhang H, 2011, J IMMUNOTHER, V34, P187, DOI 10.1097/CJI.0b013e31820d2a21	100	355	394	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30264	10.1371/journal.pone.0030264	http://dx.doi.org/10.1371/journal.pone.0030264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279576	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900053
J	Lehmann, T; Hess, M; Melzer, RR				Lehmann, Tobias; Hess, Martin; Melzer, Roland R.			Wiring a Periscope - Ocelli, Retinula Axons, Visual Neuropils and the Ancestrality of Sea Spiders	PLOS ONE			English	Article							CRAB LIMULUS-POLYPHEMUS; ARTHROPOD PHYLOGENY; CUPIENNIUS-SALEI; ONE BRAIN; EYES; EVOLUTION; ORGANIZATION; MORPHOLOGY; SYSTEMS; NEUROANATOMY	The Pycnogonida or sea spiders are cryptic, eight-legged arthropods with four median ocelli in a 'periscope' or eye tubercle. In older attempts at reconstructing phylogeny they were Arthropoda incertae sedis, but recent molecular trees placed them as the sister group either to all other euchelicerates or even to all euarthropods. Thus, pycnogonids are among the oldest extant arthropods and hold a key position for the understanding of arthropod evolution. This has stimulated studies of new sets of characters conductive to cladistic analyses, e. g. of the chelifores and of the hox gene expression pattern. In contrast knowledge of the architecture of the visual system is cursory. A few studies have analysed the ocelli and the uncommon "pseudoinverted'' retinula cells. Moreover, analyses of visual neuropils are still at the stage of Hanstrom's early comprehensive works. We have therefore used various techniques to analyse the visual fibre pathways and the structure of their interrelated neuropils in several species. We found that pycnogonid ocelli are innervated to first and second visual neuropils in close vicinity to an unpaired midline neuropil, i.e. possibly the arcuate body, in a way very similar to ancestral euarthropods like Euperipatoides rowelli (Onychophora) and Limulus polyphemus (Xiphosura). This supports the ancestrality of pycnogonids and sheds light on what eyes in the pycnogonid ground plan might have 'looked' like. Recently it was suggested that arthropod eyes originated from simple ocelli similar to larval eyes. Hence, pycnogonid eyes would be one of the early offshoots among the wealth of more sophisticated arthropod eyes.	[Lehmann, Tobias; Melzer, Roland R.] Bavarian State Collect Zool, Munich, Germany; [Lehmann, Tobias; Hess, Martin] Univ Munich, Dept Biol 1, Planegg Martinsried, Germany	University of Munich	Lehmann, T (corresponding author), Bavarian State Collect Zool, Munich, Germany.	lehmann@zsm.mwn.de			Graduiertenstipendium (BayEFG) from the Universitat Bayern e.V.; Deutsche Forschungsgemeinschaft (DFG) [Me 2683/6-1]	Graduiertenstipendium (BayEFG) from the Universitat Bayern e.V.; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by a Graduiertenstipendium (BayEFG) from the Universitat Bayern e.V. to T. Lehmann, and by the Deutsche Forschungsgemeinschaft (DFG Me 2683/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN JS, 1980, NEUROANATOMICAL TECH; Brenneis G, 2008, EVOL DEV, V10, P717, DOI 10.1111/j.1525-142X.2008.00285.x; CALMAN BG, 1991, J COMP NEUROL, V313, P553, DOI 10.1002/cne.903130402; CHAMBERLAIN SC, 1980, J COMP NEUROL, V192, P387, DOI 10.1002/cne.901920212; COLONNIER M, 1964, J ANAT, V98, P327; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; GOODMAN LJ, 1975, CELL TISSUE RES, V157, P467; Hanstrom B, 1928, VERGLEICHENDE ANATOM; Harzsch S, 2006, DEV DYNAM, V235, P2641, DOI 10.1002/dvdy.20866; Helfer H, 1935, BRONNS KLASSEN ORDNU, V5, P1; Hess M, 1996, HELGOLANDER MEERESUN, V50, P25, DOI 10.1007/BF02367135; Homberg U, 2008, ARTHROPOD STRUCT DEV, V37, P347, DOI 10.1016/j.asd.2008.01.008; HUDSPETH AJ, 1977, J PHYSIOL-LONDON, V272, P1; Jager M, 2006, NATURE, V441, P506, DOI 10.1038/nature04591; Jarvis J.H., 1973, Marine Behav Physiol, V2, P1; JARVIS JH, 1979, MAR BEHAV PHYSIOL, V6, P307, DOI 10.1080/10236247909378576; Manuel M, 2006, DEV GENES EVOL, V216, P481, DOI 10.1007/s00427-006-0095-2; Maxmen A, 2005, NATURE, V437, P1144, DOI 10.1038/nature03984; Mayer G, 2006, ARTHROPOD STRUCT DEV, V35, P231, DOI 10.1016/j.asd.2006.06.003; Melzer RR, 2009, J MORPHOL, V270, P1524, DOI 10.1002/jmor.10779; Melzer RR, 1997, NATURWISSENSCHAFTEN, V84, P542, DOI 10.1007/s001140050442; Paulus H.F., 1979, P299; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Siveter DJ, 2004, NATURE, V431, P978, DOI 10.1038/nature02928; Sokolow I, 1911, Z WISS ZOOL ABT A, V98, P339; Strausfeld NJ, 2006, ARTHROPOD STRUCT DEV, V35, P169, DOI 10.1016/j.asd.2006.06.002; Strausfeld NJ, 2006, P ROY SOC B-BIOL SCI, V273, P1857, DOI 10.1098/rspb.2006.3536; STRAUSFELD NJ, 1993, J COMP NEUROL, V328, P63, DOI 10.1002/cne.903280105; STRAUSFELD NJ, 1993, J COMP NEUROL, V328, P43, DOI 10.1002/cne.903280104; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; WIGGLESWORTH VB, 1957, PROC R SOC SER B-BIO, V147, P185, DOI 10.1098/rspb.1957.0043; WINTER G, 1980, Z ZOOL SYST EVOL, V18, P27	35	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30474	10.1371/journal.pone.0030474	http://dx.doi.org/10.1371/journal.pone.0030474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279594	gold, Green Published, Green Submitted			2022-12-25	WOS:000299771900071
J	Ubuka, T; Mukai, M; Wolfe, J; Beverly, R; Clegg, S; Wang, A; Hsia, S; Li, M; Krause, JS; Mizuno, T; Fukuda, Y; Tsutsui, K; Bentley, GE; Wingfield, JC				Ubuka, Takayoshi; Mukai, Motoko; Wolfe, Jordan; Beverly, Ryan; Clegg, Sarah; Wang, Ariel; Hsia, Serena; Li, Molly; Krause, Jesse S.; Mizuno, Takanobu; Fukuda, Yujiro; Tsutsui, Kazuyoshi; Bentley, George E.; Wingfield, John C.			RNA Interference of Gonadotropin-Inhibitory Hormone Gene Induces Arousal in Songbirds	PLOS ONE			English	Article							QUAIL COTURNIX-JAPONICA; LUTEINIZING-HORMONE; CDNA CLONING; IDENTIFICATION; BEHAVIOR; RECEPTOR; BRAIN; SONG; HYPOTHALAMUS; EXPRESSION	Gonadotropin-inhibitory hormone (GnIH) was originally identified in quail as a hypothalamic neuropeptide inhibitor of pituitary gonadotropin synthesis and release. However, GnIH neuronal fibers do not only terminate in the median eminence to control anterior pituitary function but also extend widely in the brain, suggesting it has multiple roles in the regulation of behavior. To identify the role of GnIH neurons in the regulation of behavior, we investigated the effect of RNA interference (RNAi) of the GnIH gene on the behavior of white-crowned sparrows, a highly social songbird species. Administration of small interfering RNA against GnIH precursor mRNA into the third ventricle of male and female birds reduced resting time, spontaneous production of complex vocalizations, and stimulated brief agonistic vocalizations. GnIH RNAi further enhanced song production of short duration in male birds when they were challenged by playbacks of novel male songs. These behaviors resembled those of breeding birds during territorial defense. The overall results suggest that GnIH gene silencing induces arousal. In addition, the activities of male and female birds were negatively correlated with GnIH mRNA expression in the paraventricular nucleus. Density of GnIH neuronal fibers in the ventral tegmental area was decreased by GnIH RNAi treatment in female birds, and the number of gonadotropin-releasing hormone neurons that received close appositions of GnIH neuronal fiber terminals was negatively correlated with the activity of male birds. In summary, GnIH may decrease arousal level resulting in the inhibition of specific motivated behavior such as in reproductive contexts.	[Ubuka, Takayoshi; Wolfe, Jordan; Beverly, Ryan; Clegg, Sarah; Wang, Ariel; Hsia, Serena; Li, Molly; Bentley, George E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ubuka, Takayoshi; Wolfe, Jordan; Beverly, Ryan; Clegg, Sarah; Wang, Ariel; Hsia, Serena; Li, Molly; Bentley, George E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Mukai, Motoko; Krause, Jesse S.; Wingfield, John C.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Ubuka, Takayoshi; Mizuno, Takanobu; Fukuda, Yujiro; Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Shinjuku Ku, Tokyo, Japan; [Mukai, Motoko] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis; Waseda University; Cornell University	Ubuka, T (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	t.ubuka@aoni.waseda.jp	Mukai, Motoko/L-9910-2014	Mukai, Motoko/0000-0002-5695-3826; Ubuka, Takayoshi/0000-0002-4731-8118; Krause, Jesse/0000-0001-8678-4309	USA National Science Foundation [IOS-0750540]; Endowed Chair in Physiology, University of California Davis; Ministry of Education, Science and Culture, Japan [18107002, 22132004, 22227002]; Grants-in-Aid for Scientific Research [22227002] Funding Source: KAKEN	USA National Science Foundation(National Science Foundation (NSF)); Endowed Chair in Physiology, University of California Davis(University of California System); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	J.C.W. acknowledges support IOS-0750540 from the USA National Science Foundation and the Endowed Chair in Physiology, University of California Davis. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (18107002, 22132004 and 22227002 to K. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltants D, 2000, J CHEM NEUROANAT, V18, P117, DOI 10.1016/S0891-0618(99)00054-X; Bentley GE, 2006, HORM BEHAV, V49, P550, DOI 10.1016/j.yhbeh.2005.12.005; Bentley GE, 2003, J NEUROENDOCRINOL, V15, P794, DOI 10.1046/j.1365-2826.2003.01062.x; BURGUS R, 1972, P NATL ACAD SCI USA, V69, P278, DOI 10.1073/pnas.69.1.278; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chilton G., 1995, WHITE CROWNED SPARRO; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; HILL BG, 1985, CONDOR, V87, P327, DOI 10.2307/1367211; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Hoyer D, 2006, J RECEPT SIG TRANSD, V26, P527, DOI 10.1080/10799890600929663; Johnson MA, 2007, HORM BEHAV, V51, P171, DOI 10.1016/j.yhbeh.2006.09.009; KING JA, 1982, J BIOL CHEM, V257, P722; Krebs MD, 2011, CHEM-EUR J, V17, P3054, DOI 10.1002/chem.201003144; Kriegsfeld LJ, 2006, P NATL ACAD SCI USA, V103, P2410, DOI 10.1073/pnas.0511003103; LEWIS JW, 1981, J COMP NEUROL, V196, P347, DOI 10.1002/cne.901960212; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Makimura H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-18; Maney DL, 1997, HORM BEHAV, V32, P11, DOI 10.1006/hbeh.1997.1399; MATSUO H, 1971, BIOCHEM BIOPH RES CO, V43, P1334, DOI 10.1016/S0006-291X(71)80019-0; MIYAMOTO K, 1982, BIOCHEM BIOPH RES CO, V107, P820, DOI 10.1016/0006-291X(82)90596-4; MIYAMOTO K, 1984, P NATL ACAD SCI-BIOL, V81, P3874, DOI 10.1073/pnas.81.12.3874; MOSS RL, 1973, SCIENCE, V181, P177, DOI 10.1126/science.181.4095.177; Nelson DA, 2011, BEHAV ECOL SOCIOBIOL, V65, P1103, DOI 10.1007/s00265-010-1120-z; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Osugi T, 2004, J ENDOCRINOL, V182, P33, DOI 10.1677/joe.0.1820033; Pfaff D. W., 2006, BRAIN AROUSAL INFORM; Pfaff D, 2008, ANN NY ACAD SCI, V1129, P11, DOI 10.1196/annals.1417.019; PFAFF DW, 1973, SCIENCE, V182, P1148, DOI 10.1126/science.182.4117.1148; Qi Y, 2009, J NEUROENDOCRINOL, V21, P690, DOI 10.1111/j.1365-2826.2009.01886.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SPITLERNABORS KJ, 1983, CONDOR, V85, P491, DOI 10.2307/1367993; Stevenson TJ, 2009, ENDOCRINOLOGY, V150, P1826, DOI 10.1210/en.2008-1435; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Thakker DR, 2005, MOL PSYCHIATR, V10, P782, DOI 10.1038/sj.mp.4001687; Thakker DR, 2004, P NATL ACAD SCI USA, V101, P17270, DOI 10.1073/pnas.0406214101; Tobari Y, 2010, PEPTIDES, V31, P816, DOI 10.1016/j.peptides.2010.01.015; Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Ubuka T, 2006, ENDOCRINOLOGY, V147, P1187, DOI 10.1210/en.2005-1178; Ubuka T, 2003, J ENDOCRINOL, V178, P311, DOI 10.1677/joe.0.1780311; Ubuka T., 2010, HORMONES REPROD VERT, V4, P1; Ubuka T, 2008, INTEGR COMP BIOL, V48, P560, DOI 10.1093/icb/icn019; Ubuka T, 2008, ENDOCRINOLOGY, V149, P4229; Ubuka T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008400; Ubuka T, 2009, J COMP NEUROL, V517, P841, DOI 10.1002/cne.22191; Ubuka T, 2009, J ENDOCRINOL, V201, P81, DOI 10.1677/JOE-08-0508; Ubuka T, 2009, GEN COMP ENDOCR, V162, P301, DOI 10.1016/j.ygcen.2009.04.001; Ukena K, 2003, CELL TISSUE RES, V312, P73, DOI 10.1007/s00441-003-0700-x; Weil ZM, 2010, P NATL ACAD SCI USA, V107, P2265, DOI 10.1073/pnas.0914014107; WINGFIELD JC, 1991, J ZOOL, V225, P43, DOI 10.1111/j.1469-7998.1991.tb03800.x; WINGFIELD JC, 1975, STEROIDS, V26, P311, DOI 10.1016/0039-128X(75)90077-X; Yin H, 2005, J ENDOCRINOL, V184, P257, DOI 10.1677/joe.1.05926	56	58	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30202	10.1371/journal.pone.0030202	http://dx.doi.org/10.1371/journal.pone.0030202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279571	gold, Green Published, Green Submitted			2022-12-25	WOS:000299771900049
J	Ungermannova, D; Parker, SJ; Nasveschuk, CG; Wang, W; Quade, B; Zhan, G; Kuchta, RD; Phillips, AJ; Liu, XD				Ungermannova, Dana; Parker, Seth J.; Nasveschuk, Christopher G.; Wang, Wei; Quade, Bettina; Zhan, Gan; Kuchta, Robert D.; Phillips, Andrew J.; Liu, Xuedong			Largazole and Its Derivatives Selectively Inhibit Ubiquitin Activating Enzyme (E1)	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; MULTICATALYTIC PROTEINASE COMPLEX; BIOLOGICAL EVALUATION; CANCER-THERAPY; PROTEASOME; ANALOGS; SYSTEM; CONJUGATION; CULLIN; NEDD8	Protein ubiquitination plays an important role in the regulation of almost every aspect of eukaryotic cellular function; therefore, its destabilization is often observed in most human diseases and cancers. Consequently, developing inhibitors of the ubiquitination system for the treatment of cancer has been a recent area of interest. Currently, only a few classes of compounds have been discovered to inhibit the ubiquitin-activating enzyme (E1) and only one class is relatively selective in E1 inhibition in cells. We now report that Largazole and its ester and ketone analogs selectively inhibit ubiquitin conjugation to p27(Kip1) and TRF1 in vitro. The inhibitory activity of these small molecules on ubiquitin conjugation has been traced to their inhibition of the ubiquitin E1 enzyme. To further dissect the mechanism of E1 inhibition, we analyzed the effects of these inhibitors on each of the two steps of E1 activation. We show that Largazole and its derivatives specifically inhibit the adenylation step of the E1 reaction while having no effect on thioester bond formation between ubiquitin and E1. E1 inhibition appears to be specific to human E1 as Largazole ketone fails to inhibit the activation of Uba1p, a homolog of E1 in Schizosaccharomyces pombe. Moreover, Largazole analogs do not significantly inhibit SUMO E1. Thus, Largazole and select analogs are a novel class of ubiquitin E1 inhibitors and valuable tools for studying ubiquitination in vitro. This class of compounds could be further developed and potentially be a useful tool in cells.	[Ungermannova, Dana; Parker, Seth J.; Nasveschuk, Christopher G.; Wang, Wei; Quade, Bettina; Zhan, Gan; Kuchta, Robert D.; Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Phillips, Andrew J.] Yale Univ, Dept Chem, New Haven, CT USA	University of Colorado System; University of Colorado Boulder; Yale University	Ungermannova, D (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	Xuedong.Liu@Colorado.edu		LIU, XUEDONG/0000-0001-7209-4964; Parker, Seth/0000-0001-7971-8848	National Institutes of Health [CA107089]; United States Army [W81XWH-10-1-0989]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army(United States Department of DefenseUnited States Army)	This work was supported by a grant from the National Institutes of Health (CA107089) to XL and United States Army grants no. W81XWH-10-1-0989 to XL and AJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowers A, 2008, J AM CHEM SOC, V130, P11219, DOI 10.1021/ja8033763; Bowers AA, 2009, ORG LETT, V11, P1301, DOI 10.1021/ol900078k; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Chen F, 2009, CHEMMEDCHEM, V4, P1269, DOI 10.1002/cmdc.200900125; Chiba T, 2004, CURR PROTEIN PEPT SC, V5, P177, DOI 10.2174/1389203043379783; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Eldridge AG, 2010, CELL DEATH DIFFER, V17, P4, DOI 10.1038/cdd.2009.82; Garber K, 2005, J NATL CANCER I, V97, P166, DOI 10.1093/jnci/97.3.166; Ghosh AK, 2008, ORG LETT, V10, P3907, DOI 10.1021/ol8014623; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; HERSHKO A, 1982, ANNU REV BIOCHEM, V51, P335, DOI 10.1146/annurev.bi.51.070182.002003; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; ImajohOhmi S, 1995, BIOCHEM BIOPH RES CO, V217, P1070, DOI 10.1006/bbrc.1995.2878; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; Lu XQ, 2010, J AM CHEM SOC, V132, P1748, DOI 10.1021/ja9088549; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Nasveschuk CG, 2008, ORG LETT, V10, P3595, DOI 10.1021/ol8013478; Newkirk TL, 2009, NAT PROD REP, V26, P1293, DOI 10.1039/b817886k; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Seiser T, 2008, ANGEW CHEM INT EDIT, V47, P6483, DOI 10.1002/anie.200802043; Sekizawa R, 2002, J NAT PROD, V65, P1491, DOI 10.1021/np020098q; Shinohara K, 1996, BIOCHEM J, V317, P385, DOI 10.1042/bj3170385; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Souto JA, 2010, J MED CHEM, V53, P4654, DOI 10.1021/jm100244y; Taori K, 2008, J AM CHEM SOC, V130, P1806, DOI 10.1021/ja7110064; Tsukamoto S, 2005, BIOORG MED CHEM LETT, V15, P191, DOI 10.1016/j.bmcl.2004.10.012; Ungermannova D, 2005, J BIOL CHEM, V280, P30301, DOI 10.1074/jbc.M411103200; VINITSKY A, 1992, BIOCHEMISTRY-US, V31, P9421, DOI 10.1021/bi00154a014; VINITSKY A, 1994, J BIOL CHEM, V269, P29860; Wang B, 2011, J ORG CHEM; Wang W, 2004, J BIOL CHEM, V279, P51362, DOI 10.1074/jbc.M405944200; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Ying YC, 2008, ORG LETT, V10, P4021, DOI 10.1021/ol801532s; Ying YC, 2008, J AM CHEM SOC, V130, P8455, DOI 10.1021/ja8013727; Zeng X, 2010, ORG LETT, V12, P1368, DOI 10.1021/ol100308a; Zeng ZX, 2010, DEV CELL, V18, P214, DOI 10.1016/j.devcel.2010.01.007	46	56	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29208	10.1371/journal.pone.0029208	http://dx.doi.org/10.1371/journal.pone.0029208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279528	gold, Green Submitted, Green Published			2022-12-25	WOS:000299771900006
J	Aratake, S; Tomura, T; Saitoh, S; Yokokura, R; Kawanishi, Y; Shinjo, R; Reimer, JD; Tanaka, J; Maekawa, H				Aratake, Satoe; Tomura, Tomohiko; Saitoh, Seikoh; Yokokura, Ryouma; Kawanishi, Yuichi; Shinjo, Ryuichi; Reimer, James Davis; Tanaka, Junichi; Maekawa, Hideaki			Soft Coral Sarcophyton (Cnidaria: Anthozoa: Octocorallia) Species Diversity and Chemotypes	PLOS ONE			English	Article							COMPLEMENTARY SECONDARY METABOLITES; GREAT-BARRIER-REEF; SCLERACTINIAN CORAL; MARINE TERPENES; ALCYONACEA; COELENTERATA; VARIABILITY; DITERPENES; COMMUNITY	Research on the soft coral genus Sarcophyton extends over a wide range of fields, including marine natural products and the isolation of a number of cembranoid diterpenes. However, it is still unknown how soft corals produce this diverse array of metabolites, and the relationship between soft coral diversity and cembranoid diterpene production is not clear. In order to understand this relationship, we examined Sarcophyton specimens from Okinawa, Japan, by utilizing three methods: morphological examination of sclerites, chemotype identification, and phylogenetic examination of both Sarcophyton (utilizing mitochondrial protein-coding genes MutS homolog: msh1) and their endosymbiotic Symbiodinium spp. (utilizing nuclear internal transcribed spacer of ribosomal DNA: ITS-rDNA). Chemotypes, molecular phylogenetic clades, and sclerites of Sarcophyton trocheliophorum specimens formed a clear and distinct group, but the relationships between chemotypes, molecular phylogenetic clade types and sclerites of the most common species, Sarcophyton glaucum, was not clear. S. glaucum was divided into four clades. A characteristic chemotype was observed within one phylogenetic clade of S. glaucum. Identities of symbiotic algae Symbiodinium spp. had no apparent relation to chemotypes of Sarcophyton spp. This study demonstrates that the complex results observed for S. glaucum are due to the incomplete and complex taxonomy of this species group. Our novel method of identification should help contribute to classification and taxonomic reassessment of this diverse soft coral genus.	[Aratake, Satoe; Tomura, Tomohiko] Univ Ryukyus, Grad Sch Sci & Engn, Nishihara, Okinawa 90301, Japan; [Saitoh, Seikoh; Kawanishi, Yuichi; Maekawa, Hideaki] Univ Ryukyus, Trop Biosphere Res Ctr, Ctr Mol Biosci, Nishihara, Okinawa 90301, Japan; [Yokokura, Ryouma; Tanaka, Junichi] Univ Ryukyus, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 90301, Japan; [Shinjo, Ryuichi] Univ Ryukyus, Dept Phys & Earth Sci, Nishihara, Okinawa 90301, Japan; [Reimer, James Davis] Univ Ryukyus, TRO SIS, Rising Star Program, Nishihara, Okinawa 90301, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus; University of the Ryukyus; University of the Ryukyus	Aratake, S (corresponding author), Univ Ryukyus, Grad Sch Sci & Engn, Nishihara, Okinawa 90301, Japan.	hidemae@comb.u-ryukyu.ac.jp	Reimer, James Davis/AAP-1331-2020	Tanaka, Junichi/0000-0002-8672-7379	Ministry of Education, Culture, Sports, Science and Technology Japan; Grants-in-Aid for Scientific Research [21540496] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The project of "Research of insertion mechanism into the genome of movable gene with its transporter and development of the general gene introduction system'' was supported by Ministry of Education, Culture, Sports, Science and Technology Japan. International Research Hub Project for Climate Change and Coral Reef/Island Dynamics, University of the Ryukyus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSLADE P, 1991, Beagle, V8, P189; Alderslade Philip, 1993, Precious Corals & Octocoral Research, V1, P20; Benayahu Y, 2004, ZOOL STUD, V43, P537; Benayahu Y., 2009, Zoologische Mededelingen (Leiden), V83, P863; Blunt JW, 2004, NAT PROD REP, V21, P1, DOI 10.1039/b305250h; Chanmethakul T, 2010, ZOOL STUD, V49, P72; COLL JC, 1982, J EXP MAR BIOL ECOL, V60, P293, DOI 10.1016/0022-0981(82)90166-6; DINESEN Z D, 1983, Coral Reefs, V1, P229, DOI 10.1007/BF00304420; Fabricius KE, 1997, CORAL REEFS, V16, P159, DOI 10.1007/s003380050070; Fleury B, 2006, MAR ECOL-EVOL PERSP, V27, P204, DOI 10.1111/j.1439-0485.2006.00106.x; Fleury BG, 2004, J EXP MAR BIOL ECOL, V303, P115, DOI 10.1016/j.jembe.2003.11.006; FUJIKI H, 1989, J CANCER RES CLIN, V115, P25, DOI 10.1007/BF00391595; Fukatsu T, 2007, J NAT PROD, V70, P407, DOI 10.1021/np060596p; Griffith JK, 1997, MAR FRESHWATER RES, V48, P129, DOI 10.1071/MF96086; Gross Harald, 2006, Phytochemistry Reviews, V5, P115, DOI 10.1007/s11101-005-5464-3; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hegazy MEF, 2011, MAR DRUGS, V9, P1243, DOI 10.3390/md9071243; Hunter Cynthia L., 1997, P1599; Kita M, 2010, CHEM REC, V10, P57, DOI 10.1002/tcr.200900007; KOBAYASHI M, 1988, CHEM PHARM BULL, V36, P2331; KOBAYASHI M, 1990, CHEM PHARM BULL, V38, P815; KOBAYASHI M, 1979, CHEM PHARM BULL, V27, P2382; Koh M, 2000, BIOSCI BIOTECH BIOCH, V64, P858, DOI 10.1271/bbb.64.858; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Li C, 1984, NANHAI STUD MAR SINI, V6, P103; Ma AY, 2008, J NAT PROD, V71, P1152, DOI 10.1021/np800003w; MAIDA M, 1993, J CHEM ECOL, V19, P2285, DOI 10.1007/BF00979664; Maida M, 2001, MAR ECOL-P S Z N I, V22, P397, DOI 10.1046/j.1439-0485.2001.01709.x; McFadden CS, 2006, INVERTEBR BIOL, V125, P288, DOI 10.1111/j.1744-7410.2006.00070.x; McFadden CS, 2010, INTEGR COMP BIOL, V50, P389, DOI 10.1093/icb/icq056; PASS MA, 1989, COMP BIOCHEM PHYS C, V94, P677, DOI 10.1016/0742-8413(89)90131-X; Pawlowski J, 2001, J EUKARYOT MICROBIOL, V48, P368, DOI 10.1111/j.1550-7408.2001.tb00326.x; RIEGL B, 1995, B MAR SCI, V56, P676; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWAN R, 1992, P NATL ACAD SCI USA, V89, P3639, DOI 10.1073/pnas.89.8.3639; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sammarco P.W., 1983, Coral Reefs, V1, P173, DOI 10.1007/BF00571194; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka J, 2005, GALAXEA, V7, P1; TURSCH B, 1982, MAR BIOL, V68, P321, DOI 10.1007/BF00409597; VERSEVELDT J., 1982, ZOOL VERH-LEIDEN, V192, P1; Verseveldt J, 1983, ZOOL VERHANDEL LEIDE, V208, P3; White T., 1990, PCR PROTOCOLS GUIDE, P315	45	39	40	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30410	10.1371/journal.pone.0030410	http://dx.doi.org/10.1371/journal.pone.0030410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272344	gold, Green Submitted, Green Published			2022-12-25	WOS:000301454400122
J	Baxter, EM; Jarvis, S; Palarea-Albaladejo, J; Edwards, SA				Baxter, Emma M.; Jarvis, Susan; Palarea-Albaladejo, Javier; Edwards, Sandra A.			The Weaker Sex? The Propensity for Male-Biased Piglet Mortality	PLOS ONE			English	Article							MATERNAL INVESTMENT; DOMESTIC PIGS; NEONATAL PIG; WEIGHT-GAIN; TRADE-OFF; RATIO; BEHAVIOR; BIRTH; ALLOCATION; CONFLICT	For the most part solutions to farm animal welfare issues, such as piglet mortality, are likely to lie within the scientific disciplines of environmental design and genetic selection, however understanding the ecological basis of some of the complex dynamics observed between parent and offspring could make a valuable contribution. One interesting, and often discussed, aspect of mortality is the propensity for it to be sex-biased. This study investigated whether known physiological and behavioural indicators of piglet survival differed between the sexes and whether life history strategies (often reported in wild or feral populations) relating to parental investment were being displayed in a domestic population of pigs. Sex ratio (proportion of males (males/males+females)) at birth was 0.54 and sex allocation (maternal investment measured as piglet birth weight/litter weight) was statistically significantly male-biased at 0.55 (t(35) = 2.51 P = 0.017), suggesting that sows invested more in sons than daughters during gestation. Despite this investment in birth weight, a known survival indicator, total pre-weaning male mortality was statistically significantly higher than female mortality (12% vs. 7% respectively z = 2.06 P = 0.040). Males tended to suffer from crushing by the sow more than females and statistically significantly more males died from disease-related causes. Although males were born on average heavier, with higher body mass index and ponderal index, these differences were not sustained. In addition male piglets showed impaired thermoregulation compared to females. These results suggest male-biased mortality exists despite greater initial maternal investment, and therefore reflects the greater susceptibility of this sex to causal mortality factors. Life history strategies are being displayed by a domestic population of pigs with sows in this study displaying a form of parental optimism by allocating greater resources at birth to males and providing an over-supply of this more vulnerable sex in expectation of sex-biased mortality.	[Baxter, Emma M.] Scottish Agr Coll, Edinburgh, Midlothian, Scotland; [Jarvis, Susan] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland; [Palarea-Albaladejo, Javier] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Edwards, Sandra A.] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Scottish Agricultural College; University of Edinburgh; James Hutton Institute; Newcastle University - UK	Baxter, EM (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	Emma.Baxter@sac.ac.uk	Palarea-Albaladejo, Javier/J-5591-2013	Palarea-Albaladejo, Javier/0000-0003-0162-669X; Edwards, Sandra/0000-0002-8890-0112; Baxter, Emma/0000-0003-3370-7371	Scottish Government [WP2.4]; Scottish Government Rural and Environment Science and Analytical Services	Scottish Government; Scottish Government Rural and Environment Science and Analytical Services	This work was supported by the Scottish Government under WP2.4 and the Scottish Government Rural and Environment Science and Analytical Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGERS B, 1991, CAN J ANIM SCI, V71, P51, DOI 10.4141/cjas91-006; ALGERS B, 1985, APPL ANIM BEHAV SCI, V14, P49, DOI 10.1016/0168-1591(85)90037-1; Andersen IL, 2006, APPL ANIM BEHAV SCI, V97, P85, DOI 10.1016/j.applanim.2005.11.020; Bandrick M, 2011, Vet Rec, V168, P100, DOI 10.1136/vr.c6163; Baxter EM, 2008, THERIOGENOLOGY, V69, P773, DOI 10.1016/j.theriogenology.2007.12.007; Baxter EM, 2009, LIVEST SCI, V124, P266, DOI 10.1016/j.livsci.2009.02.008; CASTREN H, 1991, LIVEST PROD SCI, V28, P321, DOI 10.1016/0301-6226(91)90013-G; CHEN ZY, 1993, J ANIM SCI, V71, P1895, DOI 10.2527/1993.7171895x; Clutton-Brock T.H., 1994, P347; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; Darwin G., 1871, P423; DEPASSILLE AMB, 1988, CAN J ANIM SCI, V68, P325, DOI 10.4141/cjas88-037; Fernandez-Llario P, 1999, ANIM BEHAV, V58, P1079, DOI 10.1006/anbe.1999.1234; Forbes LS, 1998, J THEOR BIOL, V192, P3, DOI 10.1006/jtbi.1997.0596; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; FRASER D, 1995, APPL ANIM BEHAV SCI, V44, P139, DOI 10.1016/0168-1591(95)00610-5; Fraser D, 1990, J Reprod Fertil Suppl, V40, P355; Gaskins H. R., 1995, P39; Gustafsson M, 1999, APPL ANIM BEHAV SCI, V62, P305, DOI 10.1016/S0168-1591(98)00236-6; Held S, 2005, ANIM COGN, V8, P114, DOI 10.1007/s10071-004-0242-y; Herpin P., 1995, P57; Herpin P, 2001, J ANIM SCI, V79, P5; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; HOLLAND RE, 1990, CLIN MICROBIOL REV, V3, P345, DOI 10.1128/CMR.3.4.345-375.1990; HORRELL I, 1992, APPL ANIM BEHAV SCI, V33, P319, DOI 10.1016/S0168-1591(05)80069-3; James WH, 1998, ANIM BEHAV, V55, P767, DOI 10.1006/anbe.1997.0676; JENSEN P, 1986, APPL ANIM BEHAV SCI, V16, P131, DOI 10.1016/0168-1591(86)90105-X; Kalmbach E, 2005, BEHAV ECOL, V16, P442, DOI 10.1093/beheco/ari018; KLAVER J, 1981, J ANIM SCI, V52, P1091, DOI 10.2527/jas1981.5251091x; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Krackow S, 1997, PHYSIOL BEHAV, V63, P81, DOI 10.1016/S0031-9384(97)00393-4; LEDIVIDICH J, 1991, BIOL NEONATE, V59, P268, DOI 10.1159/000243360; Marchant JN, 2001, ANIM SCI, V72, P19, DOI 10.1017/S135772980005551X; *MEAT LIV COMM, 2006, PIG YB 2006; Meikle DB, 1997, ANIM BEHAV, V53, P428, DOI 10.1006/anbe.1996.0376; Meikle DB, 1998, ANIM BEHAV, V55, P770, DOI 10.1006/anbe.1997.0677; MEIKLE DB, 1993, ANIM BEHAV, V46, P79, DOI 10.1006/anbe.1993.1163; Mendl M, 1998, ANIM BEHAV, V55, P773, DOI 10.1006/anbe.1997.0678; Mendl M, 1997, ANIM BEHAV, V53, P432, DOI 10.1006/anbe.1996.0380; MENDL M, 1995, ANIM BEHAV, V50, P1361, DOI 10.1016/0003-3472(95)80051-4; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Mock DW, 1998, ANIM BEHAV, V56, P1, DOI 10.1006/anbe.1998.0842; Moses RA, 1998, ANIM BEHAV, V55, P563, DOI 10.1006/anbe.1997.0643; MOUNT LE, 1966, BRIT MED BULL, V22, P84, DOI 10.1093/oxfordjournals.bmb.a070444; Muirhead MR., 1997, MANAGING PIG HLTH TR; Nishida S., 1977, Japanese Journal of Animal Reproduction, V23, P55; Ono KA, 1996, BEHAV ECOL SOCIOBIOL, V38, P31, DOI 10.1007/s002650050214; Pope WF, 1994, EMBRYONIC MORTALITY, P53; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Puppe B, 2007, APPL ANIM BEHAV SCI, V105, P75, DOI 10.1016/j.applanim.2006.05.016; Reynolds John D., 1994, P53; Rutkowska J, 2011, P ROY SOC B-BIOL SCI, V278, P2962, DOI 10.1098/rspb.2010.2654; Salmon H, 2009, DEV COMP IMMUNOL, V33, P384, DOI 10.1016/j.dci.2008.07.007; SPINKA M, 1995, APPL ANIM BEHAV SCI, V43, P197, DOI 10.1016/0168-1591(95)00560-F; Stearns S.C., 1992, pi; STOLBA A, 1980, APPL ANIM ETHOL, V6, P382, DOI 10.1016/0304-3762(80)90140-6; STOLBA A, 1981, APPL ANIM ETHOL, V7, P388, DOI 10.1016/0304-3762(81)90072-9; TRILLMICH F, 1986, BEHAV ECOL SOCIOBIOL, V19, P157; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tuchscherer M, 2000, THERIOGENOLOGY, V54, P371, DOI 10.1016/S0093-691X(00)00355-1; Weary DM, 1996, ANIM BEHAV, V51, P619, DOI 10.1006/anbe.1996.0066; Wells JCK, 2003, Q REV BIOL, V78, P169, DOI 10.1086/374952; WESTROM BR, 1985, BIOL NEONATE, V47, P359, DOI 10.1159/000242140; WILLIAMS GC, 1979, PROC R SOC SER B-BIO, V205, P567, DOI 10.1098/rspb.1979.0085	65	60	60	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30318	10.1371/journal.pone.0030318	http://dx.doi.org/10.1371/journal.pone.0030318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272334	Green Submitted, gold, Green Published			2022-12-25	WOS:000301454400112
J	Goldin, E; Zheng, W; Motabar, O; Southall, N; Choi, JH; Marugan, J; Austin, CP; Sidransky, E				Goldin, Ehud; Zheng, Wei; Motabar, Omid; Southall, Noel; Choi, Jae Hyuk; Marugan, Juan; Austin, Christopher P.; Sidransky, Ellen			High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase	PLOS ONE			English	Article							ACID BETA-GLUCOSIDASE; ISOFAGOMINE INCREASES; MIGLUSTAT; MUTATION; TYPE-1	Gaucher disease (GD), the most common lysosomal storage disorder, results from the inherited deficiency of the lysosomal enzyme glucocerebrosidase (GCase). Previously, wildtype GCase was used for high throughput screening (HTS) of large collections of compounds to identify small molecule chaperones that could be developed as new therapies for GD. However, the compounds identified from HTS usually showed reduced potency later in confirmatory cell-based assays. An alternate strategy is to perform HTS on mutant enzyme to identify different lead compounds, including those enhancing mutant enzyme activities. We developed a new screening assay using enzyme extract prepared from the spleen of a patient with Gaucher disease with genotype N370S/N370S. In tissue extracts, GCase is in a more native physiological environment, and is present with the native activator saposin C and other potential cofactors. Using this assay, we screened a library of 250,000 compounds and identified novel modulators of mutant GCase including 14 new lead inhibitors and 30 lead activators. The activities of some of the primary hits were confirmed in subsequent cell-based assays using patient-derived fibroblasts. These results suggest that primary screening assays using enzyme extracted from tissues is an alternative approach to identify high quality, physiologically relevant lead compounds for drug development.	[Goldin, Ehud; Motabar, Omid; Choi, Jae Hyuk; Sidransky, Ellen] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Zheng, Wei; Motabar, Omid; Southall, Noel; Choi, Jae Hyuk; Marugan, Juan; Austin, Christopher P.] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI)	Goldin, E (corresponding author), NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA.	goldine@mail.nih.gov	Zheng, Wei/GOE-5990-2022; Southall, Noel T/H-8991-2012; Zheng, Wei/J-8889-2014	Southall, Noel T/0000-0003-4500-880X; Zheng, Wei/0000-0003-1034-0757	Molecular Libraries Initiative of the NIH Roadmap for Medical Research; National Human Genome Research Institute; National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000002, ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200336] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Molecular Libraries Initiative of the NIH Roadmap for Medical Research and the Intramural Research Programs of the National Human Genome Research Institute and National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; DANIELS LB, 1981, CLIN CHIM ACTA, V115, P369, DOI 10.1016/0009-8981(81)90251-5; Fares F, 2008, PRENATAL DIAG, V28, P236, DOI 10.1002/pd.1943; Flanagan JJ, 2009, HUM MUTAT, V30, P1683, DOI 10.1002/humu.21121; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; HO MW, 1973, BIOCHEM J, V136, P821, DOI 10.1042/bj1360821; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Khanna R, 2010, FEBS J, V277, P1618, DOI 10.1111/j.1742-4658.2010.07588.x; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Marugan JJ, 2011, J MED CHEM, V54, P1033, DOI 10.1021/jm1008902; Marugan JJ, 2010, EUR J MED CHEM, V45, P1880, DOI 10.1016/j.ejmech.2010.01.027; Motabar Omid, 2010, Curr Chem Genomics, V4, P67, DOI 10.2174/1875397301004010067; National Center for Biochenology Information, PUBCHEM BIOASSAY DAT; Pastores GM, 2009, CURR MED RES OPIN, V25, P23, DOI 10.1185/03007990802576518 ; Schiffmann R, 2008, ANN NEUROL, V64, P514, DOI 10.1002/ana.21491; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Sidransky E, 2004, MOL GENET METAB, V83, P6, DOI 10.1016/j.ymgme.2004.08.015; Southall N. A., 2009, HDB DRUG SCREENING, P442; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Taddei TH, 2009, AM J HEMATOL, V84, P208, DOI 10.1002/ajh.21362; Tylki-Szymanska A, 2007, CLIN GENET, V72, P538, DOI 10.1111/j.1399-0004.2007.00899.x; VANWEELY S, 1993, J CLIN INVEST, V91, P1167, DOI 10.1172/JCI116276; Wei RR, 2011, J BIOL CHEM, V286, P299, DOI 10.1074/jbc.M110.150433; Yu ZQ, 2007, FEBS J, V274, P4944, DOI 10.1111/j.1742-4658.2007.06042.x; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104	27	56	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29861	10.1371/journal.pone.0029861	http://dx.doi.org/10.1371/journal.pone.0029861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272254	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400033
J	Lyons, L; ELBeltagy, M; Bennett, G; Wigmore, P				Lyons, Laura; ELBeltagy, Maha; Bennett, Geoffrey; Wigmore, Peter			Fluoxetine Counteracts the Cognitive and Cellular Effects of 5-Fluorouracil in the Rat Hippocampus by a Mechanism of Prevention Rather than Recovery	PLOS ONE			English	Article							ADULT NEUROGENESIS; ADJUVANT CHEMOTHERAPY; MEMORY DEFICITS; PROLIFERATION; ANTIDEPRESSANTS; GROWTH; METHOTREXATE; STIMULATION; PERFORMANCE; INHIBITION	5-Fluorouracil (5-FU) is a cytostatic drug associated with chemotherapy-induced cognitive impairments that many cancer patients experience after treatment. Previous work in rodents has shown that 5-FU reduces hippocampal cell proliferation, a possible mechanism for the observed cognitive impairment, and that both effects can be reversed by co-administration of the antidepressant, fluoxetine. In the present study we investigate the optimum time for administration of fluoxetine to reverse or prevent the cognitive and cellular effects of 5-FU. Male Lister-hooded rats received 5 injections of 5-FU (25 mg/kg, i.p.) over 2 weeks. Some rats were co-administered with fluoxetine (10 mg/kg/day, in drinking water) for 3 weeks before and during (preventative) or after (recovery) 5-FU treatment or both time periods (throughout). Spatial memory was tested using the novel location recognition (NLR) test and proliferation and survival of hippocampal cells was quantified using immunohistochemistry. 5-FU-treated rats showed cognitive impairment in the NLR task and a reduction in cell proliferation and survival in the subgranular zone of the dentate gyrus, compared to saline treated controls. These impairments were still seen for rats administered fluoxetine after 5-FU treatment, but were not present when fluoxetine was administered both before and during 5-FU treatment. The results demonstrate that fluoxetine is able to prevent but not reverse the cognitive and cellular effects of 5-FU. This provides information on the mechanism by which fluoxetine acts to protect against 5-FU and indicates when it would be beneficial to administer the antidepressant to cancer patients.	[Lyons, Laura; Bennett, Geoffrey; Wigmore, Peter] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England; [ELBeltagy, Maha] Menoufiya Univ, Dept Anat, Shibin Al Kawm, Egypt	University of Nottingham; Egyptian Knowledge Bank (EKB); Menofia University	Lyons, L (corresponding author), Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England.	peter.wigmore@nottingham.ac.uk	Elbeltagy, Maha/Y-1139-2019	Elbeltagy, Maha/0000-0002-4777-2388	Cancer Research United Kingdom	Cancer Research United Kingdom(Cancer Research UK)	This project was funded by Cancer Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles Tim A, 2002, Clin Breast Cancer, V3 Suppl 3, pS84, DOI 10.3816/CBC.2002.s.018; Alfaro CL, 2000, J CLIN PHARMACOL, V40, P58, DOI 10.1177/00912700022008702; Alme M, 2007, NEURAL PLAST; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; CACCIA S, 1990, PSYCHOPHARMACOLOGY, V100, P509, DOI 10.1007/BF02244004; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chiou SH, 2006, BIOCHEM BIOPH RES CO, V343, P391, DOI 10.1016/j.bbrc.2006.02.180; Cloonan SM, 2010, LEUKEMIA LYMPHOMA, V51, P523, DOI 10.3109/10428190903552112; Conley RK, 2007, EUR J PHARMACOL, V564, P138, DOI 10.1016/j.ejphar.2007.02.063; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; ELBeltagy M, 2010, BEHAV BRAIN RES, V208, P112, DOI 10.1016/j.bbr.2009.11.017; FOLEY J, 2008, PSYCHOPHARMACOLOGY B, V208, P112; Freeman SL, 2006, GASTROENTEROLOGY, V131, P97, DOI 10.1053/j.gastro.2006.04.013; Frick LR, 2008, BIOCHEM PHARMACOL, V75, P1817, DOI 10.1016/j.bcp.2008.01.015; Gallassi R, 2006, J AFFECT DISORDERS, V91, P243, DOI 10.1016/j.jad.2006.01.018; Gandal MJ, 2008, NEUROSCIENCE, V157, P95, DOI 10.1016/j.neuroscience.2008.08.060; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Huang FS, 2002, AM J PHYSIOL-GASTR L, V282, pG432, DOI 10.1152/ajpgi.00166.2001; Huang GJ, 2006, BIOL PSYCHIAT, V59, P619, DOI 10.1016/j.biopsych.2005.09.016; Jia L, 2008, WORLD J GASTROENTERO, V14, P4377, DOI 10.3748/wjg.14.4377; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Kreukels BPC, 2008, CLIN BREAST CANCER, V8, P80, DOI 10.3816/CBC.2008.n.006; Krishnan A, 2008, BIOCHEM PHARMACOL, V75, P1924, DOI 10.1016/j.bcp.2008.02.013; Levkovitz Y, 2002, BRAIN RES BULL, V58, P345, DOI 10.1016/S0361-9230(01)00780-8; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lyons L, 2011, PSYCHOPHARMACOLOGY, V215, P105, DOI 10.1007/s00213-010-2122-2; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; Matsuda Tomohiro, 2005, Breast Cancer, V12, P279, DOI 10.2325/jbcs.12.279; MAYHEW TM, 1988, PLACENTA, V9, P565, DOI 10.1016/0143-4004(88)90001-X; Mowla A, 2007, J CLIN PSYCHOPHARM, V27, P67, DOI 10.1097/jcp.0b013e31802e0002; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; MUSTAFA S, 2008, EUROPEAN J NEUROSCIE, V10, P1460; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; Pinnock SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013652; Prendergast MA, 1996, PHYSIOL BEHAV, V60, P311, DOI 10.1016/0031-9384(95)02234-1; Schagen SB, 1999, CANCER, V85, P640, DOI 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Seigers R, 2009, BEHAV BRAIN RES, V201, P279, DOI 10.1016/j.bbr.2009.02.025; Sharp JL, 2002, CONTEMP TOP LAB ANIM, V41, P8; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Taillibert S, 2007, CURR OPIN ONCOL, V19, P623, DOI 10.1097/CCO.0b013e3282f0e224; Thompson MR, 2004, NEUROPSYCHOPHARMACOL, V29, P694, DOI 10.1038/sj.npp.1300347; Wefel JS, 2004, BRIT J CANCER, V90, P1691, DOI 10.1038/sj.bjc.6601772; Wigmore PM, 2010, ADV EXP MED BIOL, V678, P157; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	51	58	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30010	10.1371/journal.pone.0030010	http://dx.doi.org/10.1371/journal.pone.0030010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272269	Green Submitted, gold, Green Published			2022-12-25	WOS:000301454400048
J	Othumpangat, S; Walton, C; Piedimonte, G				Othumpangat, Sreekumar; Walton, Cheryl; Piedimonte, Giovanni			MicroRNA-221 Modulates RSV Replication in Human Bronchial Epithelium by Targeting NGF Expression	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; RNA INTERFERENCE; MIR-222; NEUROTROPHINS; INFLAMMATION; SURVIVAL; THERAPY; VIRUSES; ROLES	Background: Early-life infection by respiratory syncytial virus (RSV) is associated with aberrant expression of the prototypical neurotrophin nerve growth factor (NGF) and its cognate receptors in human bronchial epithelium. However, the chain of events leading to this outcome, and its functional implications for the progression of the viral infection, has not been elucidated. This study sought to test the hypothesis that RSV infection modulates neurotrophic pathways in human airways by silencing the expression of specific microRNAs (miRNAs), and that this effect favors viral growth by interfering with programmed death of infected cells. Methodology: Human bronchial epithelial cells infected with green fluorescent protein-expressing RSV (rgRSV) were screened with multiplex qPCR arrays, and miRNAs significantly affected by the virus were analyzed for homology with mRNAs encoding neurotrophic factors or receptors. Mimic sequences of selected miRNAs were transfected into noninfected bronchial cells to confirm the role of each of them in regulating neurotrophins expression at the gene and protein level, and to study their influence on cell cycle and viral replication. Principal Findings: RSV caused downregulation of 24 miRNAs and upregulation of 2 (p<0.01). Homology analysis of microarray data revealed that 6 of those miRNAs exhibited a high degree of complementarity to NGF and/or one of its cognate receptors TrKA and p75(NTR). Among the selected miRNAs, miR-221 was significantly downregulated by RSV and its transfection in bronchial epithelial cells maximally inhibited gene and protein expression of NGF and TrKA, increased apoptotic cell death, and reduced viral replication and infectivity. Conclusions/Significance: Our data suggest that RSV upregulates the NGF-TrKA axis in human airways by silencing miR-221 expression, and this favors viral replication by interfering with the apoptotic death of infected cells. Consequently, the targeted delivery of exogenous miRNAs to the airways may provide a new strategy for future antiviral therapies based on RNA interference.	[Othumpangat, Sreekumar] W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA; W Virginia Univ, Pediat Res Inst, Sch Med, Morgantown, WV 26506 USA	West Virginia University; West Virginia University	Othumpangat, S (corresponding author), W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA.	gpiedimonte@hsc.wvu.edu		Othumpangat, Sreekumar/0000-0002-6563-611X	National Institutes of Health [RO1HL61007]; West Virginia University Pediatric Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); West Virginia University Pediatric Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant RO1HL61007 (to GP) and by the West Virginia University Pediatric Research Institute endowment (to GP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Astor TL, 2011, AM J RESP CRIT CARE, V183, P427, DOI 10.1164/rccm.201009-1488ED; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chakraborty S, 2011, AM J RESP CRIT CARE, V183; Davidson-Moncada J, 2010, ANN NY ACAD SCI, V1183, P183, DOI 10.1111/j.1749-6632.2009.05121.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garaci E, 1999, P NATL ACAD SCI USA, V96, P14013, DOI 10.1073/pnas.96.24.14013; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Othumpangat S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006444; Scuri M, 2010, J TOXICOL ENV HEAL A, V73, P1353, DOI 10.1080/15287394.2010.497436; Scuri Mario, 2010, Inflammation & Allergy Drug Targets, V9, P173; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Techaarpornkul S, 2001, J VIROL, V75, P6825, DOI 10.1128/JVI.75.15.6825-6834.2001; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wright M, 2011, PEDIATR PULM, V46, P324, DOI 10.1002/ppul.21377; Zamora MR, 2011, AM J RESP CRIT CARE, V183, P531, DOI 10.1164/rccm.201003-0422OC; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	29	63	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30030	10.1371/journal.pone.0030030	http://dx.doi.org/10.1371/journal.pone.0030030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272270	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400049
J	Wei, N; Liu, SS; Chan, KKL; Ngan, HYS				Wei, Na; Liu, Stephanie S.; Chan, Karen K. L.; Ngan, Hextan Y. S.			Tumour Suppressive Function and Modulation of Programmed Cell Death 4 (PDCD4) in Ovarian Cancer	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; INITIATION-FACTOR 4A; EUKARYOTIC TRANSLATION; EXPRESSION; PROTEIN; TRANSFORMATION; GENE; APOPTOSIS; BINDING; PROGRAMMED-CELL-DEATH-4	Background: Programmed cell death 4 (PDCD4), originally identified as the neoplastic transformation inhibitor, was attenuated in various cancer types. Our previous study demonstrated a continuous down-regulation of PDCD4 expression in the sequence of normal-borderline-malignant ovarian tissue samples and a significant correlation of PDCD4 expression with disease-free survival. The objective of the current study was to further investigate the function and modulation of PDCD4 in ovarian cancer cells. Principal Findings: We demonstrated that ectopic PDCD4 expression significantly inhibited cell proliferation by inducing cell cycle arrest at G(1) stage and up-regulation of cell cycle inhibitors of p27 and p21. Cell migration and invasion were also inhibited by PDCD4. PDCD4 over-expressing cells exhibited elevated phosphatase and tensin homolog (PTEN) and inhibited protein kinase B (p-Akt). In addition, the expression of PDCD4 was up-regulated and it was exported to the cytoplasm upon serum withdrawal treatment, but it was rapidly depleted via proteasomal degradation upon serum re-administration. Treatment of a phosphoinositide 3-kinase (PI3K) inhibitor prevented the degradation of PDCD4, indicating the involvement of PI3K-Akt pathway in the modulation of PDCD4. Conclusion: PDCD4 may play a critical function in arresting cell cycle progression at key checkpoint, thus inhibiting cell proliferation, as well as suppressing tumour metastasis. The PI3K-Akt pathway was implied to be involved in the regulation of PDCD4 degradation in ovarian cancer cells. In response to the stress condition, endogenous PDCD4 was able to shuttle between cell compartments to perform its diverted functions.	[Wei, Na; Liu, Stephanie S.; Chan, Karen K. L.; Ngan, Hextan Y. S.] Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Wei, N (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	gyonc@hku.hk	Chan, Karen/E-4041-2015	Chan, Karen/0000-0001-9947-4713; Ngan, Hextan Y S/0000-0003-3945-159X	University of Hong Kong	University of Hong Kong(University of Hong Kong)	This study was supported by an internal grant from the University of Hong Kong Seed Funding Programme for Basic Research [to K.K.L.C.], and by a donation from the Wong Check She Charitable Foundation [to H.Y.S.N.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Bohm M, 2003, ONCOGENE, V22, P4905, DOI 10.1038/sj.onc.1206710; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Cmarik JL, 1999, P NATL ACAD SCI USA, V96, P14037, DOI 10.1073/pnas.96.24.14037; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Goke R, 2004, ANN NY ACAD SCI, V1014, P220, DOI 10.1196/annals.1294.024; Goke R, 2004, AM J PHYSIOL-CELL PH, V287, pC1541, DOI 10.1152/ajpcell.00025.2004; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Hwang SK, 2010, J AEROSOL MED PULM D; Jansen AP, 2005, CANCER RES, V65, P6034, DOI 10.1158/0008-5472.CAN-04-2119; Jansen AP, 2004, MOL CANCER THER, V3, P103; Jiang Y, 2010, BIOMED PHARMACOTHER; Lankat-Buttgereit B, 2008, APOPTOSIS, V13, P157, DOI 10.1007/s10495-007-0153-x; Lee S, 2006, ONCOL REP, V16, P747; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Onishi Y, 1998, GENE, V215, P453, DOI 10.1016/S0378-1119(98)00313-8; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Schmid T, 2008, CANCER RES, V68, P1254, DOI 10.1158/0008-5472.CAN-07-1719; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Singh P, 2009, ONCOGENE, V28, P3758, DOI 10.1038/onc.2009.239; Wei N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-70; Wei ZT, 2009, CANCER SCI, V100, P1408, DOI 10.1111/j.1349-7006.2009.01210.x; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Zakowicz H, 2005, RNA, V11, P261, DOI 10.1261/rna.7191905; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhang SH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-71	34	45	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30311	10.1371/journal.pone.0030311	http://dx.doi.org/10.1371/journal.pone.0030311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272332	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400110
J	Wu, MT; Chatterji, S; Eisen, JA				Wu, Martin; Chatterji, Sourav; Eisen, Jonathan A.			Accounting For Alignment Uncertainty in Phylogenomics	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TREE; SELECTION; IMPROVEMENT; ACCURACY; PROTEIN; BLOCKS	Uncertainty in multiple sequence alignments has a large impact on phylogenetic analyses. Little has been done to evaluate the quality of individual positions in protein sequence alignments, which directly impact the accuracy of phylogenetic trees. Here we describe ZORRO, a probabilistic masking program that accounts for alignment uncertainty by assigning confidence scores to each alignment position. Using the BALIBASE database and in simulation studies, we demonstrate that masking by ZORRO significantly reduces the alignment uncertainty and improves the tree accuracy.	[Wu, Martin] Univ Virginia, Dept Biol, Charlottesville, VA 22901 USA; [Chatterji, Sourav; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of Virginia; University of California System; University of California Davis; University of California System; University of California Davis	Wu, MT (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22901 USA.	mw4yv@virginia.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Wu, Martin/0000-0003-3093-4077	Gordon and Betty Moore Foundation [1660]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This was supported by Grant 1660 from the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Bucka-Lassen K, 1999, BIOINFORMATICS, V15, P122, DOI 10.1093/bioinformatics/15.2.122; Cammarano P, 1999, J MOL EVOL, V49, P524, DOI 10.1007/PL00006574; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Durbin R, 1998, BIOL SEQUENCE ANAL P, p[xi, 356]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; Grundy WN, 1999, J EXP ZOOL, V285, P128, DOI 10.1002/(SICI)1097-010X(19990815)285:2<128::AID-JEZ5>3.0.CO;2-C; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall BG, 2005, MOL BIOL EVOL, V22, P792, DOI 10.1093/molbev/msi066; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Hwang UW, 1998, MOL PHYLOGENET EVOL, V9, P470, DOI 10.1006/mpev.1998.0518; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; LAKE JA, 1991, MOL BIOL EVOL, V8, P378; Landan G, 2007, MOL BIOL EVOL, V24, P1380, DOI 10.1093/molbev/msm060; Lassmann T, 2005, NUCLEIC ACIDS RES, V33, P7120, DOI 10.1093/nar/gki1020; Lassmann T, 2002, FEBS LETT, V529, P126, DOI 10.1016/S0014-5793(02)03189-7; Lee MSY, 2001, TRENDS ECOL EVOL, V16, P681, DOI 10.1016/S0169-5347(01)02313-8; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Pei JM, 2006, NUCLEIC ACIDS RES, V34, P4364, DOI 10.1093/nar/gkl514; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; Rosenberg MS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-102; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Schwartz AS, 2007, BIOINFORMATICS, V23, pE24, DOI 10.1093/bioinformatics/btl311; Schwartz AS, 2006, ARXIVQBIOQM0510052; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; States DJ, 1991, SEQUENCE ANAL PRIMER, P89; Stoye J, 1998, BIOINFORMATICS, V14, P157, DOI 10.1093/bioinformatics/14.2.157; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Van Walle I, 2005, BIOINFORMATICS, V21, P1267, DOI 10.1093/bioinformatics/bth493; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	52	135	136	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30288	10.1371/journal.pone.0030288	http://dx.doi.org/10.1371/journal.pone.0030288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272325	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400103
J	Yi, YH; Chang, YS; Lin, CH; Lew, TS; Tang, CY; Tseng, WL; Tseng, CP; Lo, SJ				Yi, Yung-Hsiang; Chang, Yu-Sun; Lin, Chi-Hung; Lew, Tien-Shen; Tang, Chih-Yung; Tseng, Wei-Lien; Tseng, Ching-Ping; Lo, Szecheng J.			Integrin-mediated Membrane Blebbing Is Dependent on Sodium-Proton Exchanger 1 and Sodium-Calcium Exchanger 1 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER; CELL-ADHESION; RECOMBINANT RHODOSTOMIN; NA+/CA2+ EXCHANGERS; HUMAN PLATELETS; NHE1; ACTIVATION; BINDING; DIMERS; FLOW	Integrin signaling and membrane blebbing modulate cell adhesion, spreading, and migration. However, the relationship between integrin signaling and membrane blebbing is unclear. Here, we show that an integrin-ligand interaction induces both membrane blebbing and changes in membrane permeability. Sodium-proton exchanger 1 (NHE1) and sodium-calcium exchanger 1 (NCX1) are membrane proteins located on the bleb membrane. Inhibition of NHE1 disrupts membrane blebbing and decreases changes in membrane permeability. However, inhibition of NCX1 enhances cell blebbing; cells become swollen because of NHE1 induced intracellular sodium accumulation. Our study found that NHE1 induced sodium influx is a driving force for membrane bleb growth, while sodium efflux (and calcium influx) induced by NCX1 in a reverse mode results in membrane bleb retraction. Together, these findings reveal a novel function for NHE1 and NCX1 in membrane blebbing and permeability, and establish a link between membrane blebbing and integrin signaling.	[Yi, Yung-Hsiang; Lo, Szecheng J.] Chang Gung Univ, Dept Biomed Sci, Tao Yuan 333, Taiwan; [Yi, Yung-Hsiang; Chang, Yu-Sun] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 333, Taiwan; [Tseng, Wei-Lien; Tseng, Ching-Ping] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan; [Lin, Chi-Hung; Lo, Szecheng J.] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Lew, Tien-Shen] Natl Yang Ming Univ, Dept Physiol, Taipei 112, Taiwan; [Tang, Chih-Yung] Natl Taiwan Univ, Dept Physiol, Taipei 100, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University	Lo, SJ (corresponding author), Chang Gung Univ, Dept Biomed Sci, Tao Yuan 333, Taiwan.	losj@mail.cgu.edu.tw		TANG, CHIH-YUNG/0000-0003-1065-2865; Chang, Yu-Sun/0000-0002-6457-3890; TSENG, CHING-PING/0000-0002-2587-210X	Chang Gung Memorial Hospital; Ministry of Education; National Science Council, R.O.C.	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Education; National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Chang Gung Memorial Hospital, the Ministry of Education, and the National Science Council, R.O.C.; We thank Scott C. Schuyler (CGU), Simon Silver (CGU visiting professor), and Tung-Tien Sun (New York University) for reviewing the manuscript. We thank two anonymous reviews for their suggestions to the manuscript and NOVA Medical Documentation for proofreading service. We thank Dr. Tsung-Yu Chen (National Yang-Ming University) for providing electrophysiology equipment. Chang Gung University, the Biophotonics Interdisciplinary Research Center, and the Genome Research Center of National Yang-Ming University provided and supported microscopy services.	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Chang CP, 2001, BIOCHEM J, V357, P57, DOI 10.1042/0264-6021:3570057; Chang HH, 1997, J BIOMED SCI, V4, P235, DOI 10.1007/BF02253423; Chang HH, 1999, EXP CELL RES, V250, P387, DOI 10.1006/excr.1999.4547; Chang HH, 1997, TOXICON, V35, P195, DOI 10.1016/S0041-0101(96)00121-3; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Demaurex N, 1996, J CELL BIOL, V133, P1391, DOI 10.1083/jcb.133.6.1391; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Fuster D, 2008, J GEN PHYSIOL, V132, P465, DOI 10.1085/jgp.200810016; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Hilgemann Donald W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS47, DOI 10.1111/j.1540-8167.2006.00383.x; Hisamitsu T, 2006, BIOCHEMISTRY-US, V45, P13346, DOI 10.1021/bi0608616; Hsieh CF, 2006, J BIOL CHEM, V281, P25466, DOI 10.1074/jbc.M601793200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Norman L, 2011, EUR J CELL BIOL, V90, P37, DOI 10.1016/j.ejcb.2010.09.013; Ritter M, 2001, CELL PHYSIOL BIOCHEM, V11, P1, DOI 10.1159/000047787; Roberts DE, 2004, J BIOL CHEM, V279, P19421, DOI 10.1074/jbc.M308864200; Salsmann A, 2006, EUR J CELL BIOL, V85, P249, DOI 10.1016/j.ejcb.2005.08.003; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Woods D, 2001, MOL CELL BIOL, V21, P3192, DOI 10.1128/MCB.21.9.3192-3205.2001; Wu MP, 2008, BRAIN RES, V1201, P41, DOI 10.1016/j.brainres.2008.01.042; Yi YH, 2009, J BIOL CHEM, V284, P3855, DOI 10.1074/jbc.M804334200	34	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10316	10324		10.1074/jbc.M111.244962	http://dx.doi.org/10.1074/jbc.M111.244962			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22270364	hybrid, Green Published			2022-12-25	WOS:000302167200060
J	Hsu, CC; Hu, CD				Hsu, Chih-Chao; Hu, Chang-Deng			Critical Role of N-terminal End-localized Nuclear Export Signal in Regulation of Activating Transcription Factor 2 (ATF2) Subcellular Localization and Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; INTRAMOLECULAR INHIBITION; HETERODIMER FORMATION; TRANSDUCTION PATHWAY; PROTEIN-KINASES; PHOSPHORYLATION; BINDING; FAMILY; DOMAIN; LEUCINE	Activating transcription factor 2 (ATF2) belongs to the basic leucine zipper family of transcription factors. ATF2 regulates target gene expression by binding to the cyclic AMP-response element as a homodimer or a heterodimer with c-Jun. Cytoplasmic localization of ATF2 was observed in melanoma, brain tissue from patients with Alzheimer disease, prostate cancer specimens, and ionizing radiation-treated prostate cancer cells, suggesting that alteration of ATF2 subcellular localization may be involved in the pathogenesis of these diseases. We previously demonstrated that ATF2 is a nucleocytoplasmic shuttling protein, and it contains two nuclear localization signals in the basic region and one nuclear export signal (NES) in the leucine zipper domain (named LZ-NES). In the present study, we demonstrate that a hydrophobic stretch in the N terminus, (MKFKLHV7)-M-1, also functions as an NES (termed N-NES) in a chromosome region maintenance 1 (CRM1)-dependent manner. Mutation of both N-NES and LZ-NES results in a predominant nuclear localization, whereas mutation of each individual NES only partially increases the nuclear localization. These results suggest that cytoplasmic localization of ATF2 requires function of at least one of the NESs. Further, mutation of N-NES enhances the transcriptional activity of ATF2, suggesting that the novel NES negatively regulates the transcriptional potential of ATF2. Thus, ATF2 subcellular localization is probably modulated by multiple mechanisms, and further understanding of the regulation of ATF2 subcellular localization under various pathological conditions will provide insight into the pathophysiological role of ATF2 in human diseases.	Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hu, CD (corresponding author), 575 Stadium Mall Dr, W Lafayette, IN 47907 USA.	hu1@purdue.edu			National Science Foundation; American Heart Association; United States Department of Defense; Purdue University Center for Cancer Research; Purdue Research Foundation; Ronal W. Dollens Graduate Scholarship in the Life Sciences; National Institutes of Health, NCI [CCSG CA23168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); United States Department of Defense(United States Department of Defense); Purdue University Center for Cancer Research; Purdue Research Foundation; Ronal W. Dollens Graduate Scholarship in the Life Sciences; National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by grants from the National Science Foundation, American Heart Association, and the United States Department of Defense and by Purdue University Center for Cancer Research Small Grants.; Supported by the Purdue Research Foundation Graduate Fellowship and Ronal W. Dollens Graduate Scholarship in the Life Sciences.; We thank Christopher Suarez for critically reading the manuscript. DNA sequencing was conducted in the Purdue University Center for Cancer Research Genomic Core Facility, supported by National Institutes of Health, NCI, Grant CCSG CA23168 (to the Purdue University Center for Cancer Research).	ABDELHAFIZ HA, 1992, MOL ENDOCRINOL, V6, P2079, DOI 10.1210/me.6.12.2079; ALI SA, 1995, BIOTECHNIQUES, V18, P746; Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; BENBROOK DM, 1990, ONCOGENE, V5, P295; Berger AJ, 2003, CANCER RES, V63, P8103; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Deng XH, 2011, AM J CANCER RES, V1, P834; Deng XH, 2008, CANCER RES, V68, P9663, DOI 10.1158/0008-5472.CAN-08-2229; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Duyndam MCA, 1999, ONCOGENE, V18, P2311, DOI 10.1038/sj.onc.1202584; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hong SH, 2004, J BIOL CHEM, V279, P16996, DOI 10.1074/jbc.M311752200; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ishida S, 2000, JPN J CANCER RES, V91, P174, DOI 10.1111/j.1349-7006.2000.tb00929.x; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Le NH, 2004, J BIOL CHEM, V279, P27472, DOI 10.1074/jbc.M312183200; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Ma Q, 2007, J CELL BIOCHEM, V101, P477, DOI 10.1002/jcb.21198; Moitra J, 1997, BIOCHEMISTRY-US, V36, P12567, DOI 10.1021/bi971424h; Murai N, 2003, J BIOL CHEM, V278, P44791, DOI 10.1074/jbc.M308059200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Poupon V, 2002, J BIOL CHEM, V277, P8941, DOI 10.1074/jbc.M108385200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Ricote M, 2006, J PATHOL, V208, P401, DOI 10.1002/path.1910; Salameh A, 2010, J BIOL CHEM, V285, P23094, DOI 10.1074/jbc.M109.087221; Sano Y, 1998, J BIOL CHEM, V273, P29098, DOI 10.1074/jbc.273.44.29098; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yamada T, 1997, BRAIN RES, V749, P329, DOI 10.1016/S0006-8993(96)01356-X; Yamasaki T, 2009, J BIOL CHEM, V284, P8567, DOI 10.1074/jbc.M808719200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	56	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8621	8632		10.1074/jbc.M111.294272	http://dx.doi.org/10.1074/jbc.M111.294272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275354	hybrid, Green Published			2022-12-25	WOS:000301349400074
J	Kumar, S; Singh, S; Hinze, D; Josten, M; Sahl, HG; Siepmann, M; Walter, J				Kumar, Sathish; Singh, Sandesh; Hinze, Desiree; Josten, Michaele; Sahl, Hans-Georg; Siepmann, Martin; Walter, Jochen			Phosphorylation of Amyloid-beta Peptide at Serine 8 Attenuates Its Clearance via Insulin-degrading and Angiotensin-converting Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; A-BETA; EXTRACELLULAR LEVELS; COMMON VARIANTS; PROTEIN; DEGRADATION; PROTEOLYSIS; PATHOGENESIS	Background: Amyloid-beta peptide (A beta) is degraded by different proteases. We recently demonstrated phosphorylation of A beta. Results: Phosphorylation of A beta decreases its clearance by microglial BV-2 cells and selectively inhibits the cleavage by insulin-degrading and angiotensin-converting enzymes. Conclusion: Phosphorylation at Ser-8 negatively regulates A beta degradation. Significance: Phosphorylation could play a dual role in A beta metabolism. It decreases the clearance by microglial cells and also promotes A beta aggregation.	[Kumar, Sathish; Singh, Sandesh; Hinze, Desiree; Siepmann, Martin; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Josten, Michaele; Sahl, Hans-Georg] Univ Bonn, Pharmaceut Microbiol Sect, Inst Med Microbiol Immunol & Parasitol, D-53115 Bonn, Germany	University of Bonn; University of Bonn	Walter, J (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	jochen.walter@ukb.uni-bonn.de	Walter, Jochen/B-3677-2014; Wang, Caihong/T-5837-2019; Kumar, Sathish/L-1367-2019	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912; Kumar, Sathish/0000-0002-2792-7047	Deutsche Forschungsgemeinschaft [WA1477/6, SFB645, KFO177/WA1477/4]; BONFOR Program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BONFOR Program	This work was supported by Deutsche Forschungsgemeinschaft Grants WA1477/6, SFB645, and KFO177/WA1477/4 and the BONFOR Program.	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Alvira-Botero Ximena, 2010, Curr Aging Sci, V3, P219; Authier F, 1996, CLIN INVEST MED, V19, P149; Barker R, 2010, BRAIN RES, V1355, P7, DOI 10.1016/j.brainres.2010.08.025; Randall JB, 2006, NAT MED, V12, P856, DOI 10.1038/nm1438; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Bulloj A, 2010, J ALZHEIMERS DIS, V19, P79, DOI 10.3233/JAD-2010-1206; Carson JA, 2002, J NEUROCHEM, V81, P1, DOI 10.1046/j.1471-4159.2002.00855.x; Cirrito JR, 2003, J NEUROSCI, V23, P8844; COLE GM, 1992, ANN NY ACAD SCI, V674, P103; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Deane R, 2008, CURR PHARM DESIGN, V14, P1601, DOI 10.2174/138161208784705487; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; DeWitt DA, 1998, EXP NEUROL, V149, P329, DOI 10.1006/exnr.1997.6738; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Eikelenboom P, 2011, CURR ALZHEIMER RES, V8, P142, DOI 10.2174/156720511795256080; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Fawcett J, 2001, J BIOL CHEM, V276, P11552, DOI 10.1074/jbc.M007988200; Fiala M, 2005, J ALZHEIMERS DIS, V7, P221, DOI 10.3233/jad-2005-7304; Fluhrer R, 2004, J BIOL CHEM, V279, P1585, DOI 10.1074/jbc.M306653200; Fukami S, 2002, NEUROSCI RES, V43, P39, DOI 10.1016/S0168-0102(02)00015-9; Glebov K, 2011, J BIOL CHEM, V286, P22711, DOI 10.1074/jbc.C110.217893; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata Nobuhisa, 2003, Nihon Yakurigaku Zasshi, V122, P5; Johnson GVW, 2006, J ALZHEIMERS DIS, V9, P243; Kamino K, 1996, NEUROSCI LETT, V208, P195, DOI 10.1016/0304-3940(96)12587-8; Kehoe PG, 1999, NAT GENET, V21, P71, DOI 10.1038/5009; Kumar S, 2011, AGING-US, V3, P803, DOI 10.18632/aging.100362; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Liu YX, 2007, PEPTIDES, V28, P2348, DOI 10.1016/j.peptides.2007.09.015; Madani R, 2003, TRENDS MOL MED, V9, P183, DOI 10.1016/S1471-4914(03)00050-9; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Masters CL, 2006, BRAIN, V129, P2823, DOI 10.1093/brain/awl251; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Milton NGN, 2005, SUB CELL BIOCHEM, V38, P381; Milton NGN, 2001, NEUROREPORT, V12, P3839, DOI 10.1097/00001756-200112040-00047; Miners JS, 2011, AM J TRANSL RES, V3, P73; Miners S, 2009, AM J TRANSL RES, V1, P163; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Oba R, 2005, EUR J NEUROSCI, V21, P733, DOI 10.1111/j.1460-9568.2005.03912.x; Panchal M, 2007, CURR NEUROVASC RES, V4, P240, DOI 10.2174/156720207782446315; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; ROSSOR MN, 1993, ANN NY ACAD SCI, V695, P198, DOI 10.1111/j.1749-6632.1993.tb23052.x; ROTH R A, 1985, Diabetes Research and Clinical Practice, V1, P31, DOI 10.1016/S0168-8227(85)80026-7; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; TANZI RE, 1989, TRENDS NEUROSCI, V12, P152, DOI 10.1016/0166-2236(89)90055-6; Thornton-Wells TA, 2008, GENET EPIDEMIOL, V32, P187, DOI 10.1002/gepi.20294; Tucker HM, 2000, J NEUROCHEM, V75, P2172, DOI 10.1046/j.1471-4159.2000.0752172.x; Tucker HM, 2000, J NEUROSCI, V20, P3937; Turner AJ, 2004, ANN NY ACAD SCI, V1035, P1, DOI 10.1196/annals.1332.001; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Walter J, 1999, P NATL ACAD SCI USA, V96, P1391, DOI 10.1073/pnas.96.4.1391; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	75	54	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8641	8651		10.1074/jbc.M111.279133	http://dx.doi.org/10.1074/jbc.M111.279133			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267728	Green Published, hybrid			2022-12-25	WOS:000301349400076
J	Wang, SB; Song, P; Zou, MH				Wang, Shaobin; Song, Ping; Zou, Ming-Hui			Inhibition of AMP-activated Protein Kinase alpha (AMPK alpha) by Doxorubicin Accentuates Genotoxic Stress and Cell Death in Mouse Embryonic Fibroblasts and Cardiomyocytes ROLE OF p53 AND SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHRACYCLINE-INDUCED CARDIOTOXICITY; NUCLEOTIDE EXCISION-REPAIR; TUMOR-SUPPRESSOR P53; DNA-DAMAGE; INDUCED CARDIOMYOPATHY; INDUCED APOPTOSIS; OXIDATIVE-STRESS; SKELETAL-MUSCLE; TRANSGENIC MICE; GLUCOSE-UPTAKE	Doxorubicin, an anthracycline antibiotic, is widely used in cancer treatment. Doxorubicin produces genotoxic stress and p53 activation in both carcinoma and non-carcinoma cells. Although its side effects in non-carcinoma cells, especially in heart tissue, are well known, the molecular targets of doxorubicin are poorly characterized. Here, we report that doxorubicin inhibits AMP-activated protein kinase (AMPK) resulting in SIRT1 dysfunction and p53 accumulation. Spontaneously immortalized mouse embryonic fibroblasts (MEFs) or H9C2 cardiomyocyte were exposed to doxorubicin at different doses and durations. Cell death and p53, SIRT1, and AMPK levels were examined by Western blot. In MEFs, doxorubicin inhibited AMPK activation, increased cell death, and induced robust p53 accumulation. Genetic deletion of AMPK alpha 1 reduced NAD(+) levels and SIRT1 activity and significantly increased the levels of p53 and cell death. Pre-activation of AMPK by 5-aminoimidazole-4-carboxamide ribonucleoside or transfection with an adenovirus encoding a constitutively active AMPK (AMPK-CA) markedly reduced the effects of doxorubicin in MEFs from Ampk alpha 1 knock-out mice. Conversely, pre-inhibition of Ampk further sensitized MEFs to doxorubicin-induced cell death. Genetic knockdown of p53 protected both wild-type and Ampk alpha 1(-/-) MEFs from doxorubicin-induced cell death. p53 accumulation in Ampk alpha 1(-/-) MEFs was reversed by SIRT1 activation by resveratrol. Taken together, these data suggest that AMPK inhibition by doxorubicin causes p53 accumulation and SIRT1 dysfunction in MEFs and further suggest that pharmacological activation of AMPK might alleviate the side effects of doxorubicin.	[Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med,Div Mol Med, Oklahoma City, OK 73104 USA; [Song, Ping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Med, Oklahoma City, OK 73104 USA; [Wang, Shaobin] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med,Div Mol Med, BSEB 306A, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu	wang, shaobin/A-2415-2015; Song, Ping/D-6972-2011; Song, Ping/N-8456-2018; wang, shaobin/D-7168-2011; wang, shaobin/L-8539-2015; Wang, Shaobin/C-5507-2008	wang, shaobin/0000-0002-0931-7210; Song, Ping/0000-0002-2654-6162; Song, Ping/0000-0002-6143-4270; Wang, Shaobin/0000-0002-1751-9162	National Institutes of Health [HL074399, HL079584, HL080499, HL089920, HL096032, HL105157, HL110448]; American Diabetes Association; Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089920, R01HL105157, R01HL096032, R01HL110488, R01HL080499, R43HL110448, R01HL079584, R01HL074399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL074399, HL079584, HL080499, HL089920, HL096032, HL105157, and HL110448. This work was also supported by a research award from the American Diabetes Association and by the Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center (all to M.-H. Z.).; A recipient of the National Established Investigator Award from the American Heart Association. To whom correspondence should be addressed: BSEB 306A, Sect. of Molecular Medicine, Dept. of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK 73104. Tel.: 405-271-3974; Fax: 405-271-3973; E-mail: ming-hui-zou@ouhsc.edu.	Asensio-Lopez MC, 2011, FREE RADICAL BIO MED, V51, P1861, DOI 10.1016/j.freeradbiomed.2011.08.015; Borras C, 2011, FREE RADICAL RES, V45, P643, DOI 10.3109/10715762.2011.571685; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Chen K, 2011, J BIOL CHEM, V286, P21993, DOI 10.1074/jbc.M111.225805; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Garner E, 2008, CELL CYCLE, V7, P277, DOI 10.4161/cc.7.3.5328; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nithipongvanitch R, 2007, ANTIOXID REDOX SIGN, V9, P1001, DOI 10.1089/ars.2007.1632; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Simunek T, 2009, PHARMACOL REP, V61, P154; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tokarska-Schlattner M, 2005, AM J PHYSIOL-HEART C, V289, pH37, DOI 10.1152/ajpheart.01057.2004; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	61	76	80	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8001	8012		10.1074/jbc.M111.315812	http://dx.doi.org/10.1074/jbc.M111.315812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267730	hybrid, Green Published			2022-12-25	WOS:000301349400016
J	Oliveira, L; Madureira, P; Andrade, EB; Bouaboud, A; Morello, E; Ferreira, P; Poyart, C; Trieu-Cuot, P; Dramsi, S				Oliveira, Liliana; Madureira, Pedro; Andrade, Elva Bonifacio; Bouaboud, Abdelouhab; Morello, Eric; Ferreira, Paula; Poyart, Claire; Trieu-Cuot, Patrick; Dramsi, Shaynoor			Group B Streptococcus GAPDH Is Released upon Cell Lysis, Associates with Bacterial Surface, and Induces Apoptosis in Murine Macrophages	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; FIBRONECTIN-BINDING PROTEIN; HUMAN PHARYNGEAL CELL; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SUPEROXIDE-DISMUTASE; ACID BIOSYNTHESIS; HUMAN PLASMINOGEN; ALPHA-ENOLASE; VIRULENCE; GENE	Glyceraldehyde 3-phosphate dehydrogenases (GAPDH) are cytoplasmic glycolytic enzymes that, despite lacking identifiable secretion signals, have been detected at the surface of several prokaryotic and eukaryotic organisms where they exhibit non-glycolytic functions including adhesion to host components. Group B Streptococcus (GBS) is a human commensal bacterium that has the capacity to cause life-threatening meningitis and septicemia in newborns. Electron microscopy and fluorescence-activated cell sorter (FACS) analysis demonstrated the surface localization of GAPDH in GBS. By addressing the question of GAPDH export to the cell surface of GBS strain NEM316 and isogenic mutant derivatives of our collection, we found that impaired GAPDH presence in the surface and supernatant of GBS was associated with a lower level of bacterial lysis. We also found that following GBS lysis, GAPDH can associate to the surface of many living bacteria. Finally, we provide evidence for a novel function of the secreted GAPDH as an inducer of apoptosis of murine macrophages.	[Oliveira, Liliana; Madureira, Pedro; Andrade, Elva Bonifacio; Ferreira, Paula] Univ Porto, ICBAS, P-4100 Oporto, Portugal; [Oliveira, Liliana; Madureira, Pedro; Andrade, Elva Bonifacio; Ferreira, Paula] IBMC, Oporto, Portugal; [Oliveira, Liliana; Bouaboud, Abdelouhab; Poyart, Claire] Univ Paris 05, Inst Cochin, Fac Med, Ctr Natl Rech Sci,UMR 8104, Paris, France; [Oliveira, Liliana; Bouaboud, Abdelouhab; Poyart, Claire] Inst Natl Sante & Rech Med, U1016, Paris, France; [Morello, Eric; Trieu-Cuot, Patrick; Dramsi, Shaynoor] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, CNRS, URA 2172, Paris, France	Universidade do Porto; Universidade do Porto; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Oliveira, L (corresponding author), Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	shaynoor.dramsi@pasteur.fr	POYART, Claire/P-4225-2017; Oliveira, Liliana/K-5859-2013; Andrade, Elva Bonifácio/K-3096-2013; Madureira, Pedro/D-2174-2013; Ferreira, Paula/J-6149-2013; Oliveira, Liliana/AAX-9115-2021; MORELLO, Eric/P-8087-2016	POYART, Claire/0000-0003-2158-6293; Oliveira, Liliana/0000-0001-5222-7600; Andrade, Elva Bonifácio/0000-0002-1941-580X; Madureira, Pedro/0000-0003-4078-800X; Ferreira, Paula/0000-0001-8639-9224; Oliveira, Liliana/0000-0001-5222-7600; MORELLO, Eric/0000-0002-2009-4919; TRIEU-CUOT, Patrick/0000-0002-2768-9587	Fondation pour La Recherche Medicale; Agence Nationale de la Recherche [ERA-NET PathoGenoMics ANR-06-PATHO-001-01]; SUDOE [SOE1/P1/E014]; FCT [SFRH/BD/38121/2007]	Fondation pour La Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); SUDOE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from the Fondation pour La Recherche Medicale (to C. P), from the Agence Nationale de la Recherche "ERA-NET PathoGenoMics ANR-06-PATHO-001-01" (to P. T.-C.) and from SUDOE-FEDER IMMUNONET SOE1/P1/E014 (to P. F.). L. Oliveira was supported by PhD FCT fellowship SFRH/BD/38121/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambaud C, 2006, J BIOL CHEM, V281, P31812, DOI 10.1074/jbc.M606249200; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Bryan EM, 2000, PLASMID, V44, P183, DOI 10.1006/plas.2000.1484; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Courtney HS, 1996, INFECT IMMUN, V64, P2415, DOI 10.1128/IAI.64.7.2415-2419.1996; D'Costa SS, 2000, METHODS, V21, P165, DOI 10.1006/meth.2000.0988; Da Costa AF, INT J MOL MED, V27, P739; Dramsi S, 2004, MOL MICROBIOL, V53, P639, DOI 10.1111/j.1365-2958.2004.04138.x; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edwards MS, 2005, GROUP B STREPTOCOCCA, P1091; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Fettucciari K, 2000, J IMMUNOL, V165, P3923, DOI 10.4049/jimmunol.165.7.3923; Fettucciari K, 2006, J IMMUNOL, V176, P7542, DOI 10.4049/jimmunol.176.12.7542; Forquin MP, 2007, INFECT IMMUN, V75, P2063, DOI 10.1128/IAI.01565-06; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hughes MJG, 2002, INFECT IMMUN, V70, P1254, DOI 10.1128/IAI.70.3.1254-1259.2002; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Machata S, 2005, J BACTERIOL, V187, P8385, DOI 10.1128/JB.187.24.8385-8394.2005; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Madureira P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002363; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Nau R, 2002, CLIN MICROBIOL REV, V15, P95, DOI 10.1128/CMR.15.1.95-110.2002; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Pancholi V, 1997, J EXP MED, V186, P1633, DOI 10.1084/jem.186.10.1633; PANCHOLI V, 1993, P NATL ACAD SCI USA, V90, P8154, DOI 10.1073/pnas.90.17.8154; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pasztor L, 2010, J BIOL CHEM, V285, P36794, DOI 10.1074/jbc.M110.167312; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; PODBIELSKI A, 1994, MED MICROBIOL IMMUN, V183, P239, DOI 10.1007/BF00198458; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Suvorov AN, 1997, INFECT IMMUN, V65, P191, DOI 10.1128/IAI.65.1.191-196.1997; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Ulett GC, 2005, J INFECT DIS, V191, P1761, DOI 10.1086/429693; Ulett GC, 2005, J IMMUNOL, V175, P2555, DOI 10.4049/jimmunol.175.4.2555; Ulett GC, 2003, J INFECT DIS, V188, P1049, DOI 10.1086/378202; Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311; Yamamoto Y, 2006, MOL MICROBIOL, V62, P772, DOI 10.1111/j.1365-2958.2006.05406.x	50	62	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29963	10.1371/journal.pone.0029963	http://dx.doi.org/10.1371/journal.pone.0029963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291899	Green Published, gold			2022-12-25	WOS:000301570600010
J	van Mourik, S; Kaufmann, K; van Dijk, ADJ; Angenent, GC; Merks, RMH; Molenaar, J				van Mourik, Simon; Kaufmann, Kerstin; van Dijk, Aalt D. J.; Angenent, Gerco C.; Merks, Roeland M. H.; Molenaar, Jaap			Simulation of Organ Patterning on the Floral Meristem Using a Polar Auxin Transport Model	PLOS ONE			English	Article							FLOWER DEVELOPMENT; ARABIDOPSIS; CANALIZATION; PHYLLOTAXIS; INITIATION; EFFLUX; LEAF	An intriguing phenomenon in plant development is the timing and positioning of lateral organ initiation, which is a fundamental aspect of plant architecture. Although important progress has been made in elucidating the role of auxin transport in the vegetative shoot to explain the phyllotaxis of leaf formation in a spiral fashion, a model study of the role of auxin transport in whorled organ patterning in the expanding floral meristem is not available yet. We present an initial simulation approach to study the mechanisms that are expected to play an important role. Starting point is a confocal imaging study of Arabidopsis floral meristems at consecutive time points during flower development. These images reveal auxin accumulation patterns at the positions of the organs, which strongly suggests that the role of auxin in the floral meristem is similar to the role it plays in the shoot apical meristem. This is the basis for a simulation study of auxin transport through a growing floral meristem, which may answer the question whether auxin transport can in itself be responsible for the typical whorled floral pattern. We combined a cellular growth model for the meristem with a polar auxin transport model. The model predicts that sepals are initiated by auxin maxima arising early during meristem outgrowth. These form a pre-pattern relative to which a series of smaller auxin maxima are positioned, which partially overlap with the anlagen of petals, stamens, and carpels. We adjusted the model parameters corresponding to properties of floral mutants and found that the model predictions agree with the observed mutant patterns. The predicted timing of the primordia outgrowth and the timing and positioning of the sepal primordia show remarkable similarities with a developing flower in nature.	[van Mourik, Simon; van Dijk, Aalt D. J.; Molenaar, Jaap] Univ Wageningen & Res Ctr, Plant Sci Grp, Wageningen, Netherlands; [Kaufmann, Kerstin] Univ Wageningen & Res Ctr, Mol Biol Lab, Wageningen, Netherlands; [Merks, Roeland M. H.] Ctr Wiskunde & Informat, Amsterdam, Netherlands; [Angenent, Gerco C.] Ctr BioSyst Genom, Wageningen, Netherlands; [Merks, Roeland M. H.] Netherlands Inst Syst Biol, Amsterdam, Netherlands; [van Mourik, Simon; van Dijk, Aalt D. J.; Angenent, Gerco C.; Merks, Roeland M. H.; Molenaar, Jaap] Netherlands Consortium Syst Biol, Amsterdam, Netherlands	Wageningen University & Research; Wageningen University & Research; Centre for BioSystems Genomics	van Mourik, S (corresponding author), Univ Wageningen & Res Ctr, Plant Sci Grp, Wageningen, Netherlands.	simon.vanmourik@wur.nl	Kaufmann, Kerstin/GXF-3402-2022; Merks, Roeland/A-2249-2008; Angenent, Gerco C./A-5993-2011; Kaufmann, Kerstin/A-2662-2012; van Mourik, Simon/D-9006-2013	Kaufmann, Kerstin/0000-0001-7960-6256; Merks, Roeland/0000-0002-6152-687X; Kaufmann, Kerstin/0000-0001-7960-6256; van Dijk, Aalt-Jan/0000-0002-8872-5123	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research; European Community [230974]; Netherlands Organization for Scientific Research (NWO, NWO-VENI) [863.08.027]	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research; European Community(European Commission); Netherlands Organization for Scientific Research (NWO, NWO-VENI)(Netherlands Organization for Scientific Research (NWO))	This work was cofinanced by the Netherlands Consortium for Systems Biology (NCSB) which is part of the Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research. The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement n<SUP>o</SUP> 230974, and the Netherlands Organization for Scientific Research (NWO, NWO-VENI Grant 863.08.027 to AvD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloni R, 2006, PLANTA, V223, P315, DOI 10.1007/s00425-005-0088-9; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Benjamins R, 2001, DEVELOPMENT, V128, P4057; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Cheng YF, 2007, J INTEGR PLANT BIOL, V49, P99, DOI 10.1111/j.1744-7909.2006.00412.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; CRONE W, 1993, AM J BOT, V80, P1419, DOI 10.2307/2445671; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; GOLDSMITH MHM, 1981, P NATL ACAD SCI-BIOL, V78, P976, DOI 10.1073/pnas.78.2.976; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Kramer EM, 2009, TRENDS PLANT SCI, V14, P242, DOI 10.1016/j.tplants.2009.02.005; Merks RMH, 2007, TRENDS PLANT SCI, V12, P384, DOI 10.1016/j.tplants.2007.08.004; Merks RMH, 2011, PLANT PHYSIOL, V155, P656, DOI 10.1104/pp.110.167619; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MITCHISON GJ, 1980, PROC R SOC SER B-BIO, V209, P489, DOI 10.1098/rspb.1980.0109; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rolland-Lagan AG, 2005, PLANT J, V44, P854, DOI 10.1111/j.1365-313X.2005.02581.x; Smith RS, 2006, CAN J BOT, V84, P1635, DOI 10.1139/B06-133; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stoma S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000207; Tobena-Santamaria R, 2002, GENE DEV, V16, P753, DOI 10.1101/gad.219502; Urbanus SL, 2010, PLANT J; Wabnik K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.103; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	33	33	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e28762	10.1371/journal.pone.0028762	http://dx.doi.org/10.1371/journal.pone.0028762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22291882	Green Published, gold, Green Submitted			2022-12-25	WOS:000301570600001
J	Hauberg-Lotte, L; Klingenberg, H; Scharf, C; Bohm, M; Plessl, J; Friedrich, F; Volker, U; Becker, A; Reinhold-Hurek, B				Hauberg-Lotte, Lena; Klingenberg, Hannah; Scharf, Christian; Boehm, Melanie; Plessl, Joerg; Friedrich, Frauke; Voelker, Uwe; Becker, Anke; Reinhold-Hurek, Barbara			Environmental Factors Affecting the Expression of pilAB as Well as the Proteome and Transcriptome of the Grass Endophyte Azoarcus sp Strain BH72	PLOS ONE			English	Article							QUORUM-SENSING SYSTEMS; TO-CELL COMMUNICATION; TIME RT-PCR; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; BURKHOLDERIA-CENOCEPACIA; MICROARRAY ANALYSIS; TWITCHING MOTILITY; GENE-EXPRESSION; RICE ROOTS	Background: Bacterial communication is involved in regulation of cellular mechanisms such as metabolic processes, microbe-host interactions or biofilm formation. In the nitrogen-fixing model endophyte of grasses Azoarcus sp. strain BH72, known cell-cell signaling systems have not been identified; however, the pilA gene encoding the structural protein of type IV pili that are essential for plant colonization appears to be regulated in a population density-dependent manner. Methodology/Principal Findings: Our data suggest that pilAB expression is affected by population density, independent of autoinducers typical for Gram-negative bacteria, likely depending on unknown secreted molecule(s) that can be produced by different bacterial species. We used transcriptomic and proteomic approaches to identify target genes and proteins differentially regulated in conditioned supernatants in comparison to standard growth conditions. Around 8% of the 3992 protein-coding genes of Azoarcus sp. and 18% of the detected proteins were differentially regulated. Regulatory proteins and transcription factors among the regulated proteins indicated a complex hierarchy. Differentially regulated genes and proteins were involved in processes such as type IV pili formation and regulation, metal and nutrient transport, energy metabolism, and unknown functions mediated by hypothetical proteins. Four of the newly discovered target genes were further analyzed and in general they showed regulation patterns similar to pilAB. The expression of one of them was shown to be induced in plant roots. Conclusion/Significance: This study is the first global approach to initiate characterization of cell density-dependent gene regulation mediated by soluble molecule(s) in the model endophyte Azoarcus sp. strain BH72. Our data suggest that the putative signaling molecule(s) are also produced by other Proteobacteria and might thus be used for interspecies communication. This study provides the foundation for the development of robust reporter systems for Azoarcus sp. to analyze mechanisms and molecules involved in the population-dependent gene expression in this endophyte in future.	[Hauberg-Lotte, Lena; Klingenberg, Hannah; Boehm, Melanie; Plessl, Joerg; Friedrich, Frauke; Reinhold-Hurek, Barbara] Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany; [Scharf, Christian; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Scharf, Christian] Univ Med Greifswald, Dept Otorhinolaryngol, Greifswald, Germany; [Becker, Anke] Univ Freiburg, Inst Biol 3, Fac Biol, Freiburg, Germany	University of Bremen; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Freiburg	Hauberg-Lotte, L (corresponding author), Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany.	breinhold@uni-bremen.de	Scharf, Christian/A-7931-2011	Scharf, Christian/0000-0001-6806-6450; Becker, Anke/0000-0003-4561-9184; Volker, Uwe/0000-0002-5689-3448	Deutsche Forschungsgemeinschaft, Germany [RE 756/14-1]; University of Bremen: ZF [02/114/05]	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); University of Bremen: ZF	Funding provided by the Deutsche Forschungsgemeinschaft, Germany (RE 756/14-1 to BR-H); University of Bremen: ZF (02/114/05 to BR-H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Barnard AML, 2007, ANAL BIOANAL CHEM, V387, P415, DOI 10.1007/s00216-006-0701-1; Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bertani I, 2004, APPL ENVIRON MICROB, V70, P5493, DOI 10.1128/AEM.70.9.5493-5502.2004; Bohm M, 2007, MOL PLANT MICROBE IN, V20, P526, DOI 10.1094/MPMI-20-5-0526; Boon C, 2008, ISME J, V2, P27, DOI 10.1038/ISMEJ.2007.76; Boulette ML, 2007, J BACTERIOL, V189, P6957, DOI 10.1128/JB.00621-07; Boyd JM, 2000, MOL MICROBIOL, V36, P153, DOI 10.1046/j.1365-2958.2000.01836.x; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Simionato AVC, 2007, J MASS SPECTROM, V42, P1375, DOI [10.1002/jms.1325, 10.1002/jms.1181]; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; De Pina K, 1999, J BACTERIOL, V181, P670, DOI 10.1128/JB.181.2.670-674.1999; DeLisa MP, 2001, J BACTERIOL, V183, P5239, DOI 10.1128/JB.183.18.5239-5247.2001; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Dorr J, 1998, MOL MICROBIOL, V30, P7, DOI 10.1046/j.1365-2958.1998.01010.x; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Egener T, 1999, MOL PLANT MICROBE IN, V12, P813, DOI 10.1094/MPMI.1999.12.9.813; Egener T, 1998, MOL PLANT MICROBE IN, V11, P71, DOI 10.1094/MPMI.1998.11.1.71; Ernst FD, 2005, MICROBIOL-SGM, V151, P533, DOI 10.1099/mic.0.27404-0; Ethier J, 2000, MOL MICROBIOL, V38, P891, DOI 10.1046/j.1365-2958.2000.02189.x; Fuqua C, 1998, CURR OPIN MICROBIOL, V1, P183, DOI 10.1016/S1369-5274(98)80009-X; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gonzalez JE, 2003, MICROBIOL MOL BIOL R, V67, P574, DOI 10.1128/MMBR.67.4.574-592.2003; Hauberg L, 2010, PROTEOMICS, V10, P458, DOI 10.1002/pmic.200900307; HOBBS M, 1993, MOL MICROBIOL, V7, P669, DOI 10.1111/j.1365-2958.1993.tb01158.x; Hurek T, 1997, J BACTERIOL, V179, P4172, DOI 10.1128/jb.179.13.4172-4178.1997; Hurek T, 2003, J BIOTECHNOL, V106, P169, DOI 10.1016/j.jbiotec.2003.07.010; HUREK T, 1994, J BACTERIOL, V176, P1913, DOI 10.1128/jb.176.7.1913-1923.1994; JEFFERSON RA, 1987, EMBO J, V6, P3901; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Marketon MM, 2002, J BACTERIOL, V184, P3466, DOI 10.1128/JB.184.13.3466-3475.2002; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Merritt J, 2005, MOL MICROBIOL, V57, P960, DOI 10.1111/j.1365-2958.2005.04733.x; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; REINHOLDHUREK B, 1993, INT J SYST BACTERIOL, V43, P574, DOI 10.1099/00207713-43-3-574; REINHOLDHUREK B, 1993, J BACTERIOL, V175, P7056, DOI 10.1128/jb.175.21.7056-7065.1993; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Steidle A, 2001, APPL ENVIRON MICROB, V67, P5761, DOI 10.1128/AEM.67.12.5761-5770.2001; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Whitchurch CB, 2005, MOL MICROBIOL, V55, P1357, DOI 10.1111/j.1365-2958.2005.04479.x; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	60	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30421	10.1371/journal.pone.0030421	http://dx.doi.org/10.1371/journal.pone.0030421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276194	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100045
J	Kumar, R; Lawrence, ML; Watt, J; Cooksey, AM; Burgess, SC; Nanduri, B				Kumar, Ranjit; Lawrence, Mark L.; Watt, James; Cooksey, Amanda M.; Burgess, Shane C.; Nanduri, Bindu			RNA-Seq Based Transcriptional Map of Bovine Respiratory Disease Pathogen "Histophilus somni 2336"	PLOS ONE			English	Article							SMALL NONCODING RNAS; SYSTEMS BIOLOGY; PUBLIC-HEALTH; HOST-PATHOGEN; GENOME; IDENTIFICATION; ANNOTATION; DISCOVERY; COMPLEXITY; REGIONS	Genome structural annotation, i.e., identification and demarcation of the boundaries for all the functional elements in a genome (e.g., genes, non-coding RNAs, proteins and regulatory elements), is a prerequisite for systems level analysis. Current genome annotation programs do not identify all of the functional elements of the genome, especially small non-coding RNAs (sRNAs). Whole genome transcriptome analysis is a complementary method to identify "novel" genes, small RNAs, regulatory regions, and operon structures, thus improving the structural annotation in bacteria. In particular, the identification of non-coding RNAs has revealed their widespread occurrence and functional importance in gene regulation, stress and virulence. However, very little is known about non-coding transcripts in Histophilus somni, one of the causative agents of Bovine Respiratory Disease (BRD) as well as bovine infertility, abortion, septicemia, arthritis, myocarditis, and thrombotic meningoencephalitis. In this study, we report a single nucleotide resolution transcriptome map of H. somni strain 2336 using RNA-Seq method. The RNA-Seq based transcriptome map identified 94 sRNAs in the H. somni genome of which 82 sRNAs were never predicted or reported in earlier studies. We also identified 38 novel potential protein coding open reading frames that were absent in the current genome annotation. The transcriptome map allowed the identification of 278 operon (total 730 genes) structures in the genome. When compared with the genome sequence of a non-virulent strain 129Pt, a disproportionate number of sRNAs (similar to 30%) were located in genomic region unique to strain 2336 (similar to 18% of the total genome). This observation suggests that a number of the newly identified sRNAs in strain 2336 may be involved in strain-specific adaptations.	[Kumar, Ranjit; Lawrence, Mark L.; Nanduri, Bindu] Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA; [Kumar, Ranjit; Lawrence, Mark L.; Cooksey, Amanda M.; Nanduri, Bindu] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Kumar, Ranjit] Univ Alabama Birmingham, Ctr Clin & Translat Sci, Birmingham, AL USA; [Watt, James] Eagle Appl Sci LLC, San Antonio, TX USA; [Burgess, Shane C.] Univ Arizona, Coll Agr & Life Sci, Tucson, AZ USA	Mississippi State University; Mississippi State University; University of Alabama System; University of Alabama Birmingham; University of Arizona	Kumar, R (corresponding author), Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA.	ranjit58@gmail.com			Institute for Genomics, Biocomputing and Biotechnology, Mississippi; National Science Foundation (Mississippi) [0903787]; USDA (United States Department of Agriculture) AFRI (Agriculture and Food Research Initiative) [2006-35600-17688]	Institute for Genomics, Biocomputing and Biotechnology, Mississippi; National Science Foundation (Mississippi)(National Science Foundation (NSF)); USDA (United States Department of Agriculture) AFRI (Agriculture and Food Research Initiative)	This project was supported partially by the Institute for Genomics, Biocomputing and Biotechnology, Mississippi and the National Science Foundation (Mississippi EPSCoR (Experimental Program to Stimulate Competitive Research)-0903787) and from USDA (United States Department of Agriculture) AFRI (Agriculture and Food Research Initiative) grant number 2006-35600-17688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2011, MBIO, V2, DOI 10.1128/mBio.00325-10; Akama T, 2009, J BACTERIOL, V191, P3321, DOI 10.1128/JB.00120-09; Backofen R, 2010, RNA BIOL, V7, P33, DOI 10.4161/rna.7.1.10655; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Bumann D, 2010, J PROTEOMICS, V73, P2267, DOI 10.1016/j.jprot.2010.08.004; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Ellis JA, 2001, VET CLIN N AM-FOOD A, V17, P535, DOI 10.1016/S0749-0720(15)30005-0; Forst CV, 2006, DRUG DISCOV TODAY, V11, P220, DOI 10.1016/S1359-6446(05)03735-9; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Kapil S, 1997, VET CLIN N AM-FOOD A, V13, P455, DOI 10.1016/S0749-0720(15)30308-X; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Kozhenkov S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-7; Kuckleburg CJ, 2005, MICROB PATHOGENESIS, V38, P23, DOI 10.1016/j.micpath.2004.10.006; Kulkarni RV, 2007, METHODS, V43, P131, DOI 10.1016/j.ymeth.2007.04.001; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-350; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Mao F, 2008, NUCL ACIDS RES; Martin J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S10; Nannini E, 2010, CURR OPIN PHARMACOL, V10, P516, DOI 10.1016/j.coph.2010.06.006; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Palleja A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-335; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Peng XX, 2009, CURR OPIN MICROBIOL, V12, P432, DOI 10.1016/j.mib.2009.06.003; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sandal I, 2010, TRENDS MICROBIOL, V18, P90, DOI 10.1016/j.tim.2009.11.006; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sturdevant DE, 2010, FUTURE MICROBIOL, V5, P205, DOI 10.2217/FMB.09.125; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106	45	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29435	10.1371/journal.pone.0029435	http://dx.doi.org/10.1371/journal.pone.0029435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276113	Green Published, gold			2022-12-25	WOS:000301568100010
J	Basu, A; Rojas, H; Banerjee, H; Cabrera, IB; Perez, KY; De Leon, M; Casiano, CA				Basu, Anamika; Rojas, Heather; Banerjee, Hiya; Cabrera, Irena B.; Perez, Kayla Y.; De Leon, Marino; Casiano, Carlos A.			Expression of the Stress Response Oncoprotein LEDGF/p75 in Human Cancer: A Study of 21 Tumor Types	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GROWTH-FACTOR; OXIDATIVE STRESS; FIELD CANCERIZATION; PROSTATE-CANCER; NUP98-LEDGF FUSION; PROTEIN EXPRESSION; PROTEOMIC ANALYSIS; COACTIVATORS P52; GENE	Oxidative stress-modulated signaling pathways have been implicated in carcinogenesis and therapy resistance. The lens epithelium derived growth factor p75 (LEDGF/p75) is a transcription co-activator that promotes resistance to stress-induced cell death. This protein has been implicated in inflammatory and autoimmune conditions, HIV-AIDS, and cancer. Although LEDGF/p75 is emerging as a stress survival oncoprotein, there is scarce information on its expression in human tumors. The present study was performed to evaluate its expression in a comprehensive panel of human cancers. Transcript expression was examined in the Oncomine cancer gene microarray database and in a TissueScan Cancer Survey Panel quantitative polymerase chain reaction (Q-PCR) array. Protein expression was assessed by immunohistochemistry (IHC) in cancer tissue microarrays (TMAs) containing 1735 tissues representing single or replicate cores from 1220 individual cases (985 tumor and 235 normal tissues). A total of 21 major cancer types were analyzed. Analysis of LEDGF/p75 transcript expression in Oncomine datasets revealed significant upregulation (tumor vs. normal) in 15 out of 17 tumor types. The TissueScan Cancer Q-PCR array revealed significantly elevated LEDGF/p75 transcript expression in prostate, colon, thyroid, and breast cancers. IHC analysis of TMAs revealed significant increased levels of LEDGF/p75 protein in prostate, colon, thyroid, liver and uterine tumors, relative to corresponding normal tissues. Elevated transcript or protein expression of LEDGF/p75 was observed in several tumor types. These results further establish LEDGF/p75 as a cancer-related protein, and provide a rationale for ongoing studies aimed at understanding the clinical significance of its expression in specific human cancers.	[Basu, Anamika; Cabrera, Irena B.; Perez, Kayla Y.; De Leon, Marino; Casiano, Carlos A.] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Basu, Anamika; Cabrera, Irena B.; Perez, Kayla Y.; De Leon, Marino; Casiano, Carlos A.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA; [Rojas, Heather] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA USA; [Banerjee, Hiya] Med Univ S Carolina, Div Biostat & Epidemiol, Charleston, SC 29425 USA; [Casiano, Carlos A.] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA	Loma Linda University; Loma Linda University; Loma Linda University; Medical University of South Carolina; Loma Linda University	Basu, A (corresponding author), Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.	abasu@llu.edu	De Leon, Marino/A-6922-2009	De Leon, Marino/0000-0001-6576-785X	National Institutes of Health (NIH) National Center on Minority Health and Health Disparities [NIH-NCMHD] [5P20MD001632]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center on Minority Health and Health Disparities [NIH-NCMHD]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Institutes of Health (NIH) National Center on Minority Health and Health Disparities [NIH-NCMHD 5P20MD001632 (MDL, CAC)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja HG, 2000, CANCER RES, V60, P6227; Basu A, 2011, PROSTATE        0727; Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; Brown-Bryan TA, 2008, MOL CANCER RES, V6, P1293, DOI 10.1158/1541-7786.MCR-08-0125; Cha MK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-93; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Daugaard M, 2007, CANCER RES, V67, P2559, DOI 10.1158/0008-5472.CAN-06-4121; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Fatma N, 2000, INVEST OPHTH VIS SCI, V41, P2648; Ganapathy V, 2004, ARTHRITIS RHEUM-US, V50, P684, DOI 10.1002/art.20095; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Grand FH, 2005, LEUKEMIA RES, V29, P1469, DOI 10.1016/j.leukres.2005.05.002; Haaland CM, 2009, INT J ONCOL, V35, P537, DOI 10.3892/ijo_00000365; Heaphy CM, 2006, INT J CANCER, V119, P108, DOI 10.1002/ijc.21815; Huang TS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-31; Hussey DJ, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-20; Kalinichenko SV, 2008, LUNG CANCER, V62, P173, DOI 10.1016/j.lungcan.2008.03.022; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Leoh LS, 2009, PATHOGENESIS THERAPY, P135; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lou C, 2009, CANCER SCI, V100, P996, DOI 10.1111/j.1349-7006.2009.01138.x; Matsui H, 2001, INVEST OPHTH VIS SCI, V42, P2935; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Mena S, 2009, MUTAT RES-GEN TOX EN, V674, P36, DOI 10.1016/j.mrgentox.2008.09.017; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Morerio C, 2005, LEUKEMIA RES, V29, P467, DOI 10.1016/j.leukres.2004.09.002; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Ochs RL, 2000, J ALLERGY CLIN IMMUN, V105, P1211, DOI 10.1067/mai.2000.107039; Orntoft TF, 2002, MOL CELL PROTEOMICS, V1, P37, DOI 10.1074/mcp.M100019-MCP200; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Poeschla EM, 2008, CELL MOL LIFE SCI, V65, P1403, DOI 10.1007/s00018-008-7540-5; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Roesch-Ely M, 2010, J PATHOL, V221, P462, DOI 10.1002/path.2726; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Sharma P, 2000, BIOCHEM BIOPH RES CO, V276, P1320, DOI 10.1006/bbrc.2000.3606; Shin JH, 2008, NEUROSCI LETT, V435, P131, DOI 10.1016/j.neulet.2008.02.029; Singh DP, 2000, BIOCHEM BIOPH RES CO, V267, P373, DOI 10.1006/bbrc.1999.1979; Singh DP, 2000, GENE, V242, P265, DOI 10.1016/S0378-1119(99)00506-5; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Takeichi T, 2010, J INVEST DERMATOL, V130, P2760, DOI 10.1038/jid.2010.203; Trujillo KA, 2010, INT J CANC      1123; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wu X, 2002, CELL DEATH DIFFER, V9, P915, DOI 10.1038/sj.cdd.4401063; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	50	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30132	10.1371/journal.pone.0030132	http://dx.doi.org/10.1371/journal.pone.0030132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276150	Green Submitted, Green Published, gold			2022-12-25	WOS:000301457200035
J	Llamas, B; Holland, ML; Chen, KF; Cropley, JE; Cooper, A; Suter, CM				Llamas, Bastien; Holland, Michelle L.; Chen, Kefei; Cropley, Jennifer E.; Cooper, Alan; Suter, Catherine M.			High-Resolution Analysis of Cytosine Methylation in Ancient DNA	PLOS ONE			English	Article							EPIGENETIC VARIATION; INHERITANCE; PATTERNS; DISEASE; GENOME	Epigenetic changes to gene expression can result in heritable phenotypic characteristics that are not encoded in the DNA itself, but rather by biochemical modifications to the DNA or associated chromatin proteins. Interposed between genes and environment, these epigenetic modifications can be influenced by environmental factors to affect phenotype for multiple generations. This raises the possibility that epigenetic states provide a substrate for natural selection, with the potential to participate in the rapid adaptation of species to changes in environment. Any direct test of this hypothesis would require the ability to measure epigenetic states over evolutionary timescales. Here we describe the first single-base resolution of cytosine methylation patterns in an ancient mammalian genome, by bisulphite allelic sequencing of loci from late Pleistocene Bison priscus remains. Retrotransposons and the differentially methylated regions of imprinted loci displayed methylation patterns identical to those derived from fresh bovine tissue, indicating that methylation patterns are preserved in the ancient DNA. Our findings establish the biochemical stability of methylated cytosines over extensive time frames, and provide the first direct evidence that cytosine methylation patterns are retained in DNA from ancient specimens. The ability to resolve cytosine methylation in ancient DNA provides a powerful means to study the role of epigenetics in evolution.	[Llamas, Bastien] Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA 5042, Australia; [Llamas, Bastien; Chen, Kefei; Cooper, Alan] Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Holland, Michelle L.; Cropley, Jennifer E.; Suter, Catherine M.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Cropley, Jennifer E.; Suter, Catherine M.] Univ New S Wales, Fac Med, Sydney, NSW, Australia	Flinders University South Australia; University of Adelaide; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Llamas, B (corresponding author), Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA, Australia.	alan.cooper@adelaide.edu.au; c.suter@victorchang.edu.au	Cooper, Alan/E-8171-2012; Llamas, Bastien/AAK-1693-2021; Llamas, Bastien/Y-2781-2018; Chen, Kefei/AAX-1920-2021	Cooper, Alan/0000-0002-7738-7851; Llamas, Bastien/0000-0002-5550-9176; Llamas, Bastien/0000-0002-5550-9176; Chen, Kefei/0000-0002-2380-3805; Holland, Michelle/0000-0003-0775-2902; Cropley, Jennifer/0000-0001-6078-2604	Australian Research Council (ARC) [DP0773602]; National Health and Medical Research Council (NHMRC) [459412]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the Australian Research Council (ARC #DP0773602) and the National Health and Medical Research Council (NHMRC #459412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Cooper A, 2000, SCIENCE, V289, P1139; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guerrero-Bosagna C, 2005, EVOL DEV, V7, P341, DOI 10.1111/j.1525-142X.2005.05033.x; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; JABLONKA E, 1989, J THEOR BIOL, V139, P69, DOI 10.1016/S0022-5193(89)80058-X; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103	21	54	55	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30226	10.1371/journal.pone.0030226	http://dx.doi.org/10.1371/journal.pone.0030226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276161	gold, Green Published			2022-12-25	WOS:000301457200044
J	Tsalkova, T; Mei, FC; Cheng, XD				Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong			A Fluorescence-Based High-Throughput Assay for the Discovery of Exchange Protein Directly Activated by Cyclic AMP (EPAC) Antagonists	PLOS ONE			English	Article							SELECTIVE CAMP ANALOG; CATALYTIC SUBUNIT; I-ALPHA; RAP1; MECHANISM; KINASE; BETA; BINDING	Background: The discovery, more than ten years ago, of exchange proteins directly activated by cAMP (EPAC) as a new family of intracellular cAMP receptors revolutionized the cAMP signaling research field. Extensive studies have revealed that the cAMP signaling network is much more complex and dynamic as many cAMP-related cellular processes, previously thought to be controlled by protein kinase A, are found to be also mediated by EPAC proteins. Although there have been many important discoveries in the roles of EPACs greater understanding of their physiological function in cAMP-mediated signaling is impeded by the absence of EPAC-specific antagonist. Methodology/Principal Findings: To overcome this deficit, we have developed a fluorescence-based high throughput assay for screening EPAC specific antagonists. Our assay is highly reproducible and simple to perform using the "mix and measure" format. A pilot screening using the NCI-DTP diversity set library led to the identification of small chemical compounds capable of specifically inhibiting cAMP-induced EPAC activation while not affecting PKA activity. Conclusions/Significance: Our study establishes a robust high throughput screening assay that can be effectively applied for the discovery of EPAC-specific antagonists, which may provide valuable pharmacological tools for elucidating the biological functions of EPAC and for promoting an understanding of disease mechanisms related to EPAC/cAMP signaling.	[Tsalkova, Tamara] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Tsalkova, T (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	xcheng@utmb.edu	Cheng, Xiaodong/O-8176-2019	Cheng, Xiaodong/0000-0002-3479-1694	National Institute of Health [5R01GM066170, 1R21NS066510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066510] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Health, 5R01GM066170 and 1R21NS066510. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; CHEPURNY O, 2009, J BIOL CHEM; Christensen AE, 2003, J BIOL CHEM; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Mei FC, 2005, MOL BIOSYST, V1, P325, DOI 10.1039/b511267b; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Rehmann H, 2003, J BIOL CHEM; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; vandenBerghe N, 1997, ONCOGENE, V15, P845, DOI 10.1038/sj.onc.1201407; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Yu SN, 2004, BIOCHEMISTRY-US, V43, P1908, DOI 10.1021/bi0354435; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	21	46	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30441	10.1371/journal.pone.0030441	http://dx.doi.org/10.1371/journal.pone.0030441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276201	Green Submitted, Green Published, gold			2022-12-25	WOS:000301457200063
J	Tong, ZQ; Balzer, EM; Dallas, MR; Hung, WC; Stebe, KJ; Konstantopoulos, K				Tong, ZiQiu; Balzer, Eric M.; Dallas, Matthew R.; Hung, Wei-Chien; Stebe, Kathleen J.; Konstantopoulos, Konstantinos			Chemotaxis of Cell Populations through Confined Spaces at Single-Cell Resolution	PLOS ONE			English	Article							IN-VITRO; MIGRATION; CYTOSKELETON; INVASION; TUBULIN; DRUGS	Cell migration is crucial for both physiological and pathological processes. Current in vitro cell motility assays suffer from various drawbacks, including insufficient temporal and/or optical resolution, or the failure to include a controlled chemotactic stimulus. Here, we address these limitations with a migration chamber that utilizes a self-sustaining chemotactic gradient to induce locomotion through confined environments that emulate physiological settings. Dynamic real-time analysis of both population-scale and single-cell movement are achieved at high resolution. Interior surfaces can be functionalized through adsorption of extracellular matrix components, and pharmacological agents can be administered to cells directly, or indirectly through the chemotactic reservoir. Direct comparison of multiple cell types can be achieved in a single enclosed system to compare inherent migratory potentials. Our novel microfluidic design is therefore a powerful tool for the study of cellular chemotaxis, and is suitable for a wide range of biological and biomedical applications.	[Tong, ZiQiu; Balzer, Eric M.; Dallas, Matthew R.; Hung, Wei-Chien; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21202 USA; [Tong, ZiQiu; Balzer, Eric M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA; [Tong, ZiQiu; Balzer, Eric M.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Dallas, Matthew R.; Hung, Wei-Chien; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD USA; [Stebe, Kathleen J.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania	Tong, ZQ (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21202 USA.	konstant@jhu.edu	Tong, Ziqiu/AAR-6182-2020; Konstantopoulos, Konstantinos/A-7045-2011	Tong, Ziqiu/0000-0003-4183-1858; 	National Cancer Institute [T32-CA130840, U54-CA143868, RO1-CA101135]; Kleberg Foundation; National Science Foundation [DGE-0549350]; NATIONAL CANCER INSTITUTE [T32CA130840, R01CA101135, U54CA143868] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (awards T32-CA130840, U54-CA143868, and RO1-CA101135), Kleberg Foundation, and National Science Foundation (DGE-0549350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bhattacharjee N, 2010, INTEGR BIOL-UK, V2, P669, DOI 10.1039/c0ib00038h; Breckenridge MT, 2010, BIOMED MICRODEVICES, V12, P543, DOI 10.1007/s10544-010-9411-8; Campbell K, 2007, LAB CHIP, V7, P264, DOI 10.1039/b610011b; Cavanagh LL, 2008, IMMUNOL CELL BIOL, V86, P428, DOI 10.1038/icb.2008.25; Chaw KC, 2006, MICROVASC RES, V72, P153, DOI 10.1016/j.mvr.2006.06.003; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Ghosh M, 2008, LANGMUIR, V24, P8134, DOI 10.1021/la8006525; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hay ED, 1993, CURR OPIN CELL BIOL, V5, P1029, DOI 10.1016/0955-0674(93)90088-8; Heneweer M, 2005, TOXICOL SCI, V83, P257, DOI 10.1093/toxsci/kfi025; Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Mosadegh B, 2008, BIOTECHNOL BIOENG, V100, P1205, DOI 10.1002/bit.21851; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Rolli CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008726; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Shaw Leslie M., 2004, V294, P97; Sherwood DR, 2006, TRENDS CELL BIOL, V16, P250, DOI 10.1016/j.tcb.2006.03.004; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Skoge M, INTEGR BIOL CAMB, V2, P659; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Torisawa YS, 2009, INTEGR BIOL-UK, V1, P649, DOI 10.1039/b915965g; van der Meer AD, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/823148; Wang JS, 2005, CELL MOTIL CYTOSKEL, V62, P35, DOI 10.1002/cm.20083; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; ZICHA D, 1991, J CELL SCI, V99, P769	44	121	122	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29211	10.1371/journal.pone.0029211	http://dx.doi.org/10.1371/journal.pone.0029211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279529	gold, Green Published, Green Submitted			2022-12-25	WOS:000299771900007
J	Bryan, AK; Engler, A; Gulati, A; Manalis, SR				Bryan, Andrea K.; Engler, Alex; Gulati, Amneet; Manalis, Scott R.			Continuous and Long-Term Volume Measurements with a Commercial Coulter Counter	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SINGLE CELLS; GROWTH; SIZE; APOPTOSIS; PARTICLES; CYTOMETRY; IMAGES	We demonstrate a method to enhance the time resolution of a commercial Coulter counter and enable continuous and long-term cell size measurements for growth rate analyses essential to understanding basic cellular processes, such as cell size regulation and cell cycle progression. Our simple modifications to a commercial Coulter counter create controllable cell culture conditions within the sample compartment and combine temperature control with necessary adaptations to achieve measurement stability over several hours. We also wrote custom software, detailed here, to analyze instrument data files collected by either this continuous method or standard, periodic sampling. We use the continuous method to measure the growth rate of yeast in G1 during a prolonged arrest and, in different samples, the dependency of growth rate on cell size and cell cycle position in arrested and proliferating cells. We also quantify with high time resolution the response of mouse lymphoblast cell culture to drug treatment. This method provides a technique for continuous measurement of cell size that is applicable to a large variety of cell types and greatly expands the set of analysis tools available for the Coulter counter.	[Bryan, Andrea K.; Engler, Alex; Gulati, Amneet; Manalis, Scott R.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Bryan, Andrea K.; Engler, Alex; Gulati, Amneet; Manalis, Scott R.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bryan, AK (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	scottm@media.mit.edu		Engler, Alexander/0000-0001-8691-2614	US National Institutes of Health [R01GM085457, R21CA137695]; National Cancer Institute Physical Sciences Oncology Center at the Massachusetts Institute of Technology [U54CA143874]; NATIONAL CANCER INSTITUTE [U54CA143874, R21CA137695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085457] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Physical Sciences Oncology Center at the Massachusetts Institute of Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	EUREKA Exceptional, Unconventional Research Enabling Knowledge Acceleration (R01GM085457) and contract R21CA137695, both from the US National Institutes of Health (nih.gov). National Cancer Institute Physical Sciences Oncology Center at the Massachusetts Institute of Technology (U54CA143874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos LG, 2002, J MICROSC-OXFORD, V205, P125, DOI 10.1046/j.0022-2720.2001.00976.x; Amon A, 2002, METHOD ENZYMOL, V351, P457; Baumgartner S, 2009, BIOPHYS J, V96, P4336, DOI 10.1016/j.bpj.2009.02.051; BERGE LI, 1990, J COLLOID INTERF SCI, V138, P480, DOI 10.1016/0021-9797(90)90230-L; BERGE LI, 1990, MEAS SCI TECHNOL, V1, P471, DOI 10.1088/0957-0233/1/6/001; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bortner CD, 2004, PFLUG ARCH EUR J PHY, V448, P313, DOI 10.1007/s00424-004-1266-5; BOYD CM, 1995, J PLANKTON RES, V17, P41, DOI 10.1093/plankt/17.1.41; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; Coulter W. H., 1956, P NATIONAL ELECTRONI, V12, P1034, DOI [10.1038/366591a0, DOI 10.1038/366591A0]; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Givan AL, 2001, FLOW CYTOMETERY 1 PR; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/nmeth.1452, 10.1038/NMETH.1452]; Goranov A, 2009, GENE DEV, P1408; HARTWELL LH, 1973, J BACTERIOL, V115, P966, DOI 10.1128/JB.115.3.966-974.1973; Hua SZ, 2009, LAB CHIP, V9, P251, DOI 10.1039/b806003g; HURLEY J, 1970, BIOPHYS J, V10, P74, DOI 10.1016/S0006-3495(70)86286-5; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Srinivasa G, 2008, I S BIOMED IMAGING, P348, DOI 10.1109/ISBI.2008.4541004; Sun JS, 2010, LAB CHIP, V10, P2986, DOI 10.1039/c005029f; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; WOLDRINGH CL, 1993, J BACTERIOL, V175, P3174, DOI 10.1128/JB.175.10.3174-3181.1993	22	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29866	10.1371/journal.pone.0029866	http://dx.doi.org/10.1371/journal.pone.0029866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272256	gold, Green Published			2022-12-25	WOS:000301454400035
J	Gagnon, PR; Harms, KE; Platt, WJ; Passmore, HA; Myers, JA				Gagnon, Paul R.; Harms, Kyle E.; Platt, William J.; Passmore, Heather A.; Myers, Jonathan A.			Small-Scale Variation in Fuel Loads Differentially Affects Two Co-Dominant Bunchgrasses in a Species-Rich Pine Savanna	PLOS ONE			English	Article							PLANT-POPULATIONS; FIRE; COMMUNITY; DISTURBANCE; PALUSTRIS; INVASIBILITY; COEXISTENCE; ECOSYSTEMS; DIVERSITY; DOMINANCE	Ecological disturbances frequently control the occurrence and patterning of dominant plants in high-diversity communities like C-4 grasslands and savannas. In such ecosystems disturbance-related processes can have important implications for species, and for whole communities when those species are dominant, yet mechanistic understanding of such processes remains fragmentary. Multiple bunchgrass species commonly co-dominate disturbance-dependent and species-rich pine savannas, where small-scale fuel heterogeneity may influence bunchgrass survival and growth following fires. We quantified how fire in locally varying fuel loads influenced dynamics of dominant C-4 bunchgrasses in a species-rich pine savanna in southeastern Louisiana, USA. We focused on two congeneric, co-dominant species (Schizachyrium scoparium and S. tenerum) with similar growth forms, functional traits and reproductive strategies to highlight effects of fuel heterogeneity during fires. In experimental plots with either reduced or increased fuels versus controls with unmanipulated fuels, we compared: 1) bunchgrass damage and 2) mortality from fires; 3) subsequent growth and 4) flowering. Compared to controls, fire with increased fuels caused greater damage, mortality and subsequent flowering, but did not affect post-fire growth. Fire with reduced fuels had no effect on any of the four measures. The two species responded differently to fire with increased fuels - S. scoparium incurred measurably more damage and mortality than S. tenerum. Logistic regression indicated that the larger average size of S. tenerum tussocks made them resistant to more severe burning where fuels were increased. We speculate that locally increased fuel loading may be important in pine savannas for creating colonization sites because where fuels are light or moderate, dominant bunchgrasses persist through fires. Small-scale heterogeneity in fires, and differences in how species tolerate fire may together promote shared local dominance by different bunchgrasses.	[Gagnon, Paul R.; Harms, Kyle E.; Platt, William J.; Passmore, Heather A.; Myers, Jonathan A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Harms, Kyle E.] Smithsonian Trop Res Inst, Balboa, Panama	Louisiana State University System; Louisiana State University; Smithsonian Institution; Smithsonian Tropical Research Institute	Gagnon, PR (corresponding author), Murray State Univ, Dept Biol Sci, Murray, KY 42071 USA.	pgagnon@murraystate.edu			National Science Foundation [DEB 0516175]; Division Of Environmental Biology [0950302] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Science Foundation (DEB 0516175) provided financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; ALBERTSON F. W., 1965, ECOLOGY, V46, P714, DOI 10.2307/1935011; [Anonymous], 2006, SAS MIXED MODELS; Benton TG, 1996, AM NAT, V147, P115, DOI 10.1086/285843; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Brewer JS, 2009, PLANT ECOL, V200, P141, DOI 10.1007/s11258-008-9440-z; Bruna EM, 2003, ECOLOGY, V84, P932, DOI 10.1890/0012-9658(2003)084[0932:APPIFH]2.0.CO;2; Bruna EM, 2009, J VEG SCI, V20, P569, DOI 10.1111/j.1654-1103.2009.01060.x; Busby PE, 2008, J TORREY BOT SOC, V135, P346, DOI 10.3159/08-RA-004.1; COLLINS SL, 1990, FIRE N AM TALLGRASS, P81; Crone EE, 2001, EVOLUTION, V55, P2611; Earley Lawrence, 2004, LOOKING LONGLEAF FAL; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Emery SM, 2006, OIKOS, V115, P549, DOI 10.1111/j.2006.0030-1299.15172.x; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Gagnon PR, 2008, ECOLOGY, V89, P612, DOI 10.1890/07-1255.1; Gagnon PR, 2007, FOREST ECOL MANAG, V241, P288, DOI 10.1016/j.foreco.2007.01.002; Gagnon PR, 2011, BIOL CONSERV, V144, P830, DOI 10.1016/j.biocon.2010.11.015; Gibson D. J., 2009, GRASSES GRASSLAND EC; Gilbert B, 2009, AM NAT, V174, P850, DOI 10.1086/647903; Grime J.P., 1987, SYMP BRIT ECOL SOC, V26, P413; Hiers JK, 2009, INT J WILDLAND FIRE, V18, P315, DOI 10.1071/WF08084; Keddy PA, 2006, APPL VEG SCI, V9, P17, DOI 10.1658/1402-2001(2006)9[17:POHPDI]2.0.CO;2; Kirkman LK, 2001, AM J BOT, V88, P2119, DOI 10.2307/3558437; Loudermilk EL, 2009, INT J WILDLAND FIRE, V18, P676, DOI 10.1071/WF07138; Mitchell RJ, 2009, J FOREST, V107, P391; Myers JA, 2011, ECOLOGY, V92, P676, DOI 10.1890/10-1001.1; Noel JM, 1998, CONSERV BIOL, V12, P533, DOI 10.1046/j.1523-1739.1998.96124.x; Papaik MJ, 2006, J ECOL, V94, P1011, DOI 10.1111/j.1365-2745.2006.01153.x; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pierce S, 2007, J ECOL, V95, P698, DOI 10.1111/j.1365-2745.2007.01242.x; Platt William J., 1999, P23; Platt WJ, 2006, APPL VEG SCI, V9, P37, DOI 10.1658/1402-2001(2006)9[37:PSOIOG]2.0.CO;2; PLATT WJ, 1988, AM NAT, V131, P491, DOI 10.1086/284803; REBERTUS AJ, 1989, ECOLOGY, V70, P60, DOI 10.2307/1938412; *SAS I INC, 2005, SAS ONL DOC 9 1 3; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Smith MD, 1999, OECOLOGIA, V120, P605, DOI 10.1007/s004420050896; Smith MD, 2004, OIKOS, V106, P253, DOI 10.1111/j.0030-1299.2004.13057.x; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; SOUSA WP, 1979, ECOL MONOGR, V49, P227, DOI 10.2307/1942484; Thaxton JM, 2006, ECOLOGY, V87, P1331, DOI 10.1890/0012-9658(2006)87[1331:SFVAFI]2.0.CO;2; Varner JM, 2005, RESTOR ECOL, V13, P536, DOI 10.1111/j.1526-100X.2005.00067.x; WALKER J, 1984, VEGETATIO, V55, P163, DOI 10.1007/BF00045019; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; WILLIAMSON GB, 1981, NATURE, V293, P643, DOI 10.1038/293643a0	48	15	15	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29674	10.1371/journal.pone.0029674	http://dx.doi.org/10.1371/journal.pone.0029674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272241	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400020
J	Titus, MA; Zeithaml, B; Kantor, B; Li, XP; Haack, K; Moore, DT; Wilson, EM; Mohler, JL; Kafri, T				Titus, Mark A.; Zeithaml, Brian; Kantor, Boris; Li, Xiangping; Haack, Karin; Moore, Dominic T.; Wilson, Elizabeth M.; Mohler, James L.; Kafri, Tal			Dominant-Negative Androgen Receptor Inhibition of Intracrine Androgen-Dependent Growth of Castration-Recurrent Prostate Cancer	PLOS ONE			English	Article							N-TERMINAL DOMAIN; GENE-EXPRESSION; INTRATUMORAL ANDROGENS; ACTIVATION; THERAPY; CELLS; RAT; TESTOSTERONE; PROGRESSION; BINDING	Background: Prostate cancer (CaP) is the second leading cause of cancer death in American men. Androgen deprivation therapy is initially effective in CaP treatment, but CaP recurs despite castrate levels of circulating androgen. Continued expression of the androgen receptor (AR) and its ligands has been linked to castration-recurrent CaP growth. Principal Finding: In this report, the ligand-dependent dominant-negative AR Delta 142-337 (ARDTR) was expressed in castration-recurrent CWR-R1 cell and tumor models to elucidate the role of AR signaling. Expression of AR Delta TR decreased CWR-R1 tumor growth in the presence and absence of exogenous testosterone (T) and improved survival in the presence of exogenous T. There was evidence for negative selection of AR Delta TR transgene in T-treated mice. Mass spectrometry revealed castration-recurrent CaP dihydrotestosterone (DHT) levels sufficient to activate AR and AR Delta TR. In the absence of exogenous testosterone, CWR-R1-AR Delta TR and control cells exhibited altered androgen profiles that implicated epithelial CaP cells as a source of intratumoral AR ligands. Conclusion: The study provides in vivo evidence that activation of AR signaling by intratumoral AR ligands is required for castration-recurrent CaP growth and that epithelial CaP cells produce sufficient active androgens for CaP recurrence during androgen deprivation therapy. Targeting intracrine T and DHT synthesis should provide a mechanism to inhibit AR and growth of castration-recurrent CaP.	[Titus, Mark A.; Mohler, James L.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Mohler, James L.] SUNY Buffalo, Dept Urol, Sch Med & Biotechnol, Buffalo, NY 14260 USA; [Zeithaml, Brian; Kantor, Boris; Li, Xiangping; Haack, Karin; Kafri, Tal] Univ N Carolina, Sch Med, UNC Gene Therapy Ctr, Chapel Hill, NC USA; [Wilson, Elizabeth M.] Univ N Carolina, Sch Med, Labs Reprod Biol, Chapel Hill, NC USA; [Kantor, Boris; Moore, Dominic T.; Wilson, Elizabeth M.; Mohler, James L.; Kafri, Tal] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Kafri, Tal] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Titus, MA (corresponding author), Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA.	Tal_Kafri@med.unc.edu	, Animal Studies Core/AAF-4432-2022; li, xiang/GWM-6319-2022; , Animal Studies Core/ADK-4234-2022		National Cancer Institute [PO1-CA77739, 2RO1 DK058702-10]; National Cancer Institute Cancer Center [CA016156, CA034026]; National Institute of Child Health and Human Development, National Institutes of Health (NIH) [HD16910]; Department of Defense [W81XWH-10-1-0273]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016910, R37HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058702] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Human Development, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by PO1-CA77739 and 2RO1 DK058702-10 from the National Cancer Institute and National Cancer Institute Cancer Center Support Grants CA016156 and CA034026 to Roswell Park Cancer Institute and University of North Carolina, respectively, US Public Health Service Grants HD16910 from National Institute of Child Health and Human Development, National Institutes of Health (NIH), and the Department of Defense Prostate Cancer Research Program W81XWH-10-1-0273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; ANDERSSON S, 1990, P NATL ACAD SCI USA, V87, P3640, DOI 10.1073/pnas.87.10.3640; Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2012, MOL CELL ENDOCRINOL, V348, P403, DOI 10.1016/j.mce.2011.03.026; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bayer M, 2008, MOL THER, V16, P1968, DOI 10.1038/mt.2008.199; Bayne CW, 1998, J CLIN ENDOCR METAB, V83, P206, DOI 10.1210/jc.83.1.206; BELANGER B, 1989, J STEROID BIOCHEM, V32, P695, DOI 10.1016/0022-4731(89)90514-1; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Culig Z, 1998, PROSTATE, V35, P63, DOI 10.1002/(SICI)1097-0045(19980401)35:1<63::AID-PROS9>3.0.CO;2-I; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Frank O, 2004, BLOOD, V104, P3543, DOI 10.1182/blood-2004-03-0852; GELLER J, 1979, J STEROID BIOCHEM, V11, P631, DOI 10.1016/0022-4731(79)90092-X; Gregory CW, 2001, J MOL ENDOCRINOL, V27, P309, DOI 10.1677/jme.0.0270309; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P2892; Gregory CW, 2001, CANCER RES, V61, P4315; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He XY, 2003, J STEROID BIOCHEM, V87, P191, DOI 10.1016/j.jsbmb.2003.07.007; Heemers H, 2001, MOL ENDOCRINOL, V15, P1817, DOI 10.1210/me.15.10.1817; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Ikonen T, 1998, FEBS LETT, V430, P393, DOI 10.1016/S0014-5793(98)00701-7; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Kantor B, 2009, P NATL ACAD SCI USA, V106, P18786, DOI 10.1073/pnas.0905859106; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; Lih FB, 2010, ANAL CHEM, V82, P6000, DOI 10.1021/ac100460x; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Luu-The V, 2005, J STEROID BIOCHEM, V93, P269, DOI 10.1016/j.jsbmb.2005.01.003; Luu-The V, 2008, BEST PRACT RES CL EN, V22, P207, DOI 10.1016/j.beem.2008.01.008; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Mohler JL, 2011, CLIN CANCER RES, V17, P5844, DOI 10.1158/1078-0432.CCR-11-0644; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; PALVIMO JJ, 1993, MOL ENDOCRINOL, V7, P1399, DOI 10.1210/me.7.11.1399; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; Ryan CJ, 2007, CLIN CANCER RES, V13, P2030, DOI 10.1158/1078-0432.CCR-06-2344; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Titus MA, 2005, CLIN CANCER RES, V11, P4365, DOI 10.1158/1078-0432.CCR-04-0738; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Vander Griend DJ, 2009, ANDROGEN RECEPTOR LI; White RD, 1997, EUR UROL, V31, P1; WONG CI, 1993, J BIOL CHEM, V268, P19004; Yang JW, 2011, ONCOTARGET, V2, P358; Zhou ZX, 1993, MOL BILOGICAL ASPECT	59	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30192	10.1371/journal.pone.0030192	http://dx.doi.org/10.1371/journal.pone.0030192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272301	Green Submitted, Green Published, gold			2022-12-25	WOS:000301454400079
J	Yin, P; Roqueiro, D; Huang, L; Owen, JK; Xie, A; Navarro, A; Monsivais, D; Coon, JS; Kim, JJ; Dai, Y; Bulun, SE				Yin, Ping; Roqueiro, Damian; Huang, Lei; Owen, Jonas K.; Xie, Anna; Navarro, Antonia; Monsivais, Diana; Coon, John S.; Kim, J. Julie; Dai, Yang; Bulun, Serdar E.			Genome-Wide Progesterone Receptor Binding: Cell Type-Specific and Shared Mechanisms in T47D Breast Cancer Cells and Primary Leiomyoma Cells	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; ESTROGEN PLUS PROGESTIN; HUMAN UTERINE LEIOMYOMA; HEALTHY POSTMENOPAUSAL WOMEN; INITIATIVE RANDOMIZED-TRIAL; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTIONAL REGULATION; RESPONSE ELEMENT; MITOTIC-ACTIVITY	Background: Progesterone, via its nuclear receptor (PR), exerts an overall tumorigenic effect on both uterine fibroid (leiomyoma) and breast cancer tissues, whereas the antiprogestin RU486 inhibits growth of these tissues through an unknown mechanism. Here, we determined the interaction between common or cell-specific genome-wide binding sites of PR and mRNA expression in RU486-treated uterine leiomyoma and breast cancer cells. Principal Findings: ChIP-sequencing revealed 31,457 and 7,034 PR-binding sites in breast cancer and uterine leiomyoma cells, respectively; 1,035 sites overlapped in both cell types. Based on the chromatin-PR interaction in both cell types, we statistically refined the consensus progesterone response element to G.ACA...TGT.C. We identified two striking differences between uterine leiomyoma and breast cancer cells. First, the cis-regulatory elements for HSF, TEF-1, and C/EBP alpha and beta were statistically enriched at genomic RU486/PR-targets in uterine leiomyoma, whereas E2F, FOXO1, FOXA1, and FOXF sites were preferentially enriched in breast cancer cells. Second, 51.5% of RU486-regulated genes in breast cancer cells but only 6.6% of RU486-regulated genes in uterine leiomyoma cells contained a PR-binding site within 5 kb from their transcription start sites (TSSs), whereas 75.4% of RU486-regulated genes contained a PR-binding site farther than 50 kb from their TSSs in uterine leiomyoma cells. RU486 regulated only seven mRNAs in both cell types. Among these, adipophilin (PLIN2), a pro-differentiation gene, was induced via RU486 and PR via the same regulatory region in both cell types. Conclusions: Our studies have identified molecular components in a RU486/PR-controlled gene network involved in the regulation of cell growth, cell migration, and extracellular matrix function. Tissue-specific and common patterns of genome-wide PR binding and gene regulation may determine the therapeutic effects of antiprogestins in uterine fibroids and breast cancer.	[Yin, Ping; Owen, Jonas K.; Xie, Anna; Navarro, Antonia; Monsivais, Diana; Coon, John S.; Kim, J. Julie; Bulun, Serdar E.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol Res, Chicago, IL 60611 USA; [Roqueiro, Damian; Huang, Lei; Dai, Yang] Univ Illinois, Dept Bioengn, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yin, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol Res, Chicago, IL 60611 USA.	yangdai@uic.edu; s-bulun@northwestern.edu	Roqueiro, Damian/AAE-2240-2020	Kim, J Julie/0000-0001-9834-8213; Roqueiro, Damian/0000-0002-9195-5915	National Institutes of Health [P01-057877]; Chicago Biomedical Consortium; The Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; The Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant P01-057877, and the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barbarisi A, 2001, J CELL PHYSIOL, V186, P414, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E; BECK CA, 1993, P NATL ACAD SCI USA, V90, P4441, DOI 10.1073/pnas.90.10.4441; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bo Hideki, 2004, Journal of Nippon Medical School, V71, P172, DOI 10.1272/jnms.71.172; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brayman MJ, 2006, MOL ENDOCRINOL, V20, P2278, DOI 10.1210/me.2005-0343; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041; Burroughs KD, 2000, BIOL REPROD, V63, P1322, DOI 10.1095/biolreprod63.5.1322; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chen W, 2006, J CLIN ENDOCR METAB, V91, P1296, DOI 10.1210/jc.2005-2379; Cheng YH, 2011, J MOL ENDOCRINOL, V46, P139, DOI 10.1530/JME-10-0064; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Chong BM, 2011, TRENDS ENDOCRIN MET, V22, P211, DOI 10.1016/j.tem.2011.04.003; Chwalisz K, 2007, FERTIL STERIL, V87, P1399, DOI 10.1016/j.fertnstert.2006.11.094; Conneely OM, 2003, STEROIDS, V68, P771, DOI 10.1016/S0039-128X(03)00126-0; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; KAWAGUCHI K, 1989, AM J OBSTET GYNECOL, V160, P637, DOI 10.1016/S0002-9378(89)80046-8; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim JJ, 2011, MOL CELL EN IN PRESS; KLEINHITPASS L, 1991, NUCLEIC ACIDS RES, V19, P1227, DOI 10.1093/nar/19.6.1227; Kobayashi S, 2010, MOL ENDOCRINOL, V24, P2292, DOI 10.1210/me.2010-0289; KRAMER B, 1994, BBA-GENE STRUCT EXPR, V1219, P413, DOI 10.1016/0167-4781(94)90066-3; LAMMINEN S, 1992, GYNECOL OBSTET INVES, V34, P111, DOI 10.1159/000292738; Law DJ, 1999, BIOCHEM BIOPH RES CO, V262, P113, DOI 10.1006/bbrc.1999.1180; Lazzaro MA, 2006, MOL ENDOCRINOL, V20, P2406, DOI 10.1210/me.2005-0213; Lee TF, 2010, J CELL PHYSIOL, V223, P648, DOI 10.1002/jcp.22063; Li XT, 2004, MECH AGEING DEV, V125, P669, DOI 10.1016/j.mad.2004.04.007; Liang Y, 2007, CANCER RES, V67, P9929, DOI 10.1158/0008-5472.CAN-07-1103; LIEBERMAN BA, 1993, MOL ENDOCRINOL, V7, P515, DOI 10.1210/me.7.4.515; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Martini PGV, 2001, ENDOCRINOLOGY, V142, P3493, DOI 10.1210/en.142.8.3493; Matsuo H, 1997, J CLIN ENDOCR METAB, V82, P293, DOI 10.1210/jc.82.1.293; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; MURPHY AA, 1993, J CLIN ENDOCR METAB, V76, P513, DOI 10.1210/jc.76.2.513; MUSGROVE EA, 1993, MOL CELL BIOL, V13, P3577, DOI 10.1128/MCB.13.6.3577; NORDEEN SK, 1990, MOL ENDOCRINOL, V4, P1866, DOI 10.1210/mend-4-12-1866; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; PANI L, 1992, MOL CELL BIOL, V12, P552, DOI 10.1128/MCB.12.2.552; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Perrault D, 1996, J CLIN ONCOL, V14, P2709, DOI 10.1200/JCO.1996.14.10.2709; Peterson RS, 1997, CELL GROWTH DIFFER, V8, P69; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Robertson JFR, 1999, EUR J CANCER, V35, P214, DOI 10.1016/S0959-8049(98)00388-8; Roqueiro DFJ, 2010, P 2010 IEEE IN PRESS; ROSSI MJ, 1992, ENDOCRINOLOGY, V130, P1716, DOI 10.1210/en.130.3.1716; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SARTORIUS CA, 1993, J BIOL CHEM, V268, P9262; Shyamala G, 1999, J MAMMARY GLAND BIOL, V4, P89, DOI 10.1023/A:1018760721173; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; TILTMAN AJ, 1985, INT J GYNECOL PATHOL, V4, P89, DOI 10.1097/00004347-198506000-00001; VIGNON F, 1983, J CLIN ENDOCR METAB, V56, P1124, DOI 10.1210/jcem-56-6-1124; Wade HE, 2010, MOL CELL BIOL, V30, P1866, DOI 10.1128/MCB.01060-09; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Yao M, 2007, CLIN CANCER RES, V13, P152, DOI 10.1158/1078-0432.CCR-06-1877; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119; Yin P, 2010, CANCER RES, V70, P1722, DOI 10.1158/0008-5472.CAN-09-2612; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	79	64	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29021	10.1371/journal.pone.0029021	http://dx.doi.org/10.1371/journal.pone.0029021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272226	Green Submitted, Green Published, gold			2022-12-25	WOS:000301454400005
J	Bangert, A; Cristofanon, S; Eckhardt, I; Abhari, BA; Kolodziej, S; Hacker, S; Vellanki, SHK; Lausen, J; Debatin, KM; Fulda, S				Bangert, A.; Cristofanon, S.; Eckhardt, I.; Abhari, B. A.; Kolodziej, S.; Haecker, S.; Vellanki, S. H. K.; Lausen, J.; Debatin, K-M; Fulda, S.			Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP	ONCOGENE			English	Article						apoptosis; TRAIL; glioblastoma; HDACI; cFLIP	NF-KAPPA-B; LYMPHOCYTIC-LEUKEMIA CELLS; DRUG-INDUCED APOPTOSIS; HDAC INHIBITORS; MALIGNANT GLIOMA; CANCER-CELLS; DEATH; FLIP; ACTIVATION; EXPRESSION	Glioblastoma is the most common primary brain tumor with a very poor prognosis, calling for novel treatment strategies. Here, we provide first evidence that histone deacetylase inhibitors (HDACI) prime glioblastoma cells for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) -induced apoptosis at least in part by c-myc-mediated downregulation of cellular FLICE-inhibitory protein (cFLIP). Pretreatment with distinct HDACI (MS275, suberoylanilide hydroxamic acid, valproic acid) significantly enhances TRAIL-induced apoptosis in several glioblastoma cell lines. Monitoring a panel of apoptosis-regulatory proteins revealed that MS275 reduces the expression of cFLIP(L) and cFLIP(S). This leads to decreased recruitment of cFLIP(L) and cFLIP(S) and increased activation of caspase-8 to the TRAIL death-inducing signaling complex, resulting in enhanced cleavage of caspase-8, -9 and -3 and caspase-dependent apoptosis. Also, MS275 promotes TRAIL-triggered processing of Bid, activation of Bax, loss of mitochondrial membrane potential and release of cytochrome c. MS275-mediated downregulation of cFLIP occurs at the mRNA level independent of proteasome-or caspase-mediated degradation, and is preceded by upregulation of nuclear levels of c-myc, a transcriptional repressor of cFLIP. Notably, MS275 causes increased binding of c-myc to the cFLIP promoter and reduces cFLIP promoter activity. Indeed, knockdown of c-myc partially rescues cFLIP(L) from MS275-inferred downregulation and significantly decreases TRAIL-and MS275-induced apoptosis. Also, overexpression of cFLIP(L) or cFLIP(S) significantly reduces MS275- and TRAIL-induced apoptosis. Importantly, MS275 sensitizes primary cultured glioblastoma cells towards TRAIL and cooperates with TRAIL to reduce long-term clonogenic survival of glioblastoma cells and to suppress glioblastoma growth in vivo underscoring the clinical relevance of this approach. Thus, these findings demonstrate that HDACI represent a promising strategy to prime glioblastoma for TRAIL-induced apoptosis by targeting cFLIP.	[Cristofanon, S.; Eckhardt, I.; Abhari, B. A.; Fulda, S.] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany; [Bangert, A.; Haecker, S.; Vellanki, S. H. K.; Debatin, K-M; Fulda, S.] Univ Childrens Hosp, Ulm, Germany; [Kolodziej, S.; Lausen, J.] Inst Biomed Res, Frankfurt, Germany	Goethe University Frankfurt; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Komturstr 3A, D-60528 Frankfurt, Germany.	simone.fulda@kgu.de	Debatin, Klaus-Michael/J-9704-2014	Debatin, Klaus-Michael/0000-0002-8397-1886; Fulda, Simone/0000-0002-0459-6417	Deutsche Forschungsgemeinschaft; Else Kroner-Fresenius-Stiftung; European Community (ApopTrain, APO-SYS);  [IAP6/18]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; European Community (ApopTrain, APO-SYS)(European CommissionEuropean Commission Joint Research Centre); 	We thank O Micheau (Dijon, France) and M Leverkus (Mannheim, Germany) for providing cFLIP vectors. This work has been partially supported by grants from the Deutsche Forschungsgemeinschaft, Else Kroner-Fresenius-Stiftung, European Community (ApopTrain, APO-SYS) and IAP6/18 (to SF).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Aguilera DG, 2009, J NEURO-ONCOL, V93, P303, DOI 10.1007/s11060-008-9788-x; Aron JL, 2003, BLOOD, V102, P652, DOI 10.1182/blood-2002-12-3794; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Carlisi D, 2009, EUR J CANCER, V45, P2425, DOI 10.1016/j.ejca.2009.06.024; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Eyupoglu LY, 2006, MOL CANCER THER, V5, P1248, DOI 10.1158/1535-7163.MCT-05-0533; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Fulda S, 1997, CANCER RES, V57, P3823; Fulda S, 2008, CURR CANCER DRUG TAR, V8, P132, DOI 10.2174/156800908783769355; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Guo F, 2004, CANCER RES, V64, P2580, DOI 10.1158/0008-5472.CAN-03-2629; Hacker S, 2009, ONCOGENE, V28, P3097, DOI 10.1038/onc.2009.161; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hernandez A, 2001, SURGERY, V130, P265, DOI 10.1067/msy.2001.115897; Inoue S, 2009, MOL CANCER THER, V8, P3088, DOI 10.1158/1535-7163.MCT-09-0451; Karl S, 2009, J CELL MOL MED, V13, P4239, DOI 10.1111/j.1582-4934.2009.00888.x; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kim EH, 2005, ONCOGENE, V24, P6877, DOI 10.1038/sj.onc.1208851; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuijlen JMA, 2010, NEUROPATH APPL NEURO, V36, P168, DOI 10.1111/j.1365-2990.2010.01069.x; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; MICHEAU O, 2006, APOPTOSIS CANC THERA, P120; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitchell KO, 2000, CANCER RES, V60, P6318; Nieminen AI, 2007, EMBO J, V26, P1055, DOI 10.1038/sj.emboj.7601551; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Pathil A, 2006, HEPATOLOGY, V43, P425, DOI 10.1002/hep.21054; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Salon C, 2006, CELL DEATH DIFFER, V13, P260, DOI 10.1038/sj.cdd.4401739; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Simonini MV, 2006, P NATL ACAD SCI USA, V103, P1587, DOI 10.1073/pnas.0510341103; Singh TR, 2005, ONCOGENE, V24, P4609, DOI 10.1038/sj.onc.1208585; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Watanabe K, 2005, CELL DEATH DIFFER, V12, P10, DOI 10.1038/sj.cdd.4401507; Weidinger C, 2008, ENDOCR-RELAT CANCER, V15, P917, DOI 10.1677/ERC-08-0153	48	61	63	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	44					4677	4688		10.1038/onc.2011.614	http://dx.doi.org/10.1038/onc.2011.614			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	032MW	22266862				2022-12-25	WOS:000310724400003
J	Morais, S; Salama-Alber, O; Barak, Y; Hadar, Y; Wilson, DB; Lamed, R; Shoham, Y; Bayer, EA				Morais, Sarah; Salama-Alber, Orly; Barak, Yoav; Hadar, Yitzhak; Wilson, David B.; Lamed, Raphael; Shoham, Yuval; Bayer, Edward A.			Functional Association of Catalytic and Ancillary Modules Dictates Enzymatic Activity in Glycoside Hydrolase Family 43 beta-Xylosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-ARABINOFURANOSIDASE; GEOBACILLUS-STEAROTHERMOPHILUS; BIOCHEMICAL-CHARACTERIZATION; SELENOMONAS-RUMINANTIUM; STREPTOMYCES-LIVIDANS; BIFUNCTIONAL PROTEIN; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; ESCHERICHIA-COLI; EXPRESSION	beta-Xylosidases are hemicellulases that hydrolyze short xylo-oligosaccharides into xylose units, thus complementing endoxylanase degradation of the hemicellulose component of lignocellulosic substrates. Here, we describe the cloning, characterization, and kinetic analysis of a glycoside hydrolase family 43 beta-xylosidase (Xyl43A) from the aerobic cellulolytic bacterium, Thermobifida fusca. Temperature and pH optima of 55-60 degrees C and 5.5-6, respectively, were determined. The apparent K-m value was 0.55 mM, using p-nitrophenyl xylopyranoside as substrate, and the catalytic constant (k(cat)) was 6.72 s(-1). T. fusca Xyl43A contains a catalytic module at the N terminus and an ancillary module (termed herein as Module-A) of undefined function at the C terminus. We expressed the two recombinant modules independently in Escherichia coli and examined their remaining catalytic activity and binding properties. The separation of the two Xyl43A modules caused the complete loss of enzymatic activity, whereas potent binding to xylan was fully maintained in the catalytic module and partially in the ancillary Module-A. Nondenaturing gel electrophoresis revealed a specific noncovalent coupling of the two modules, thereby restoring enzymatic activity to 66.7% (relative to the wild-type enzyme). Module-A contributes a phenylalanine residue that functions as an essential part of the active site, and the two juxtaposed modules function as a single functional entity.	[Morais, Sarah; Salama-Alber, Orly; Barak, Yoav; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Morais, Sarah; Hadar, Yitzhak] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel; [Wilson, David B.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Ramat Aviv, Israel; [Shoham, Yuval] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Cornell University; Tel Aviv University; Technion Israel Institute of Technology	Bayer, EA (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	ed.bayer@weizmann.ac.il	Shoham, Yuval/M-4409-2013	Morais, Sarah/0000-0001-9026-2386	United States-Israel Binational Science Foundation, Jerusalem, Israel; Israeli Centers of Research Excellence (I-CORE) [Center 152/11]; Alternative Energy Research Initiative Bioenergy Consortium; Weizmann Institute of Science Alternative Energy Research Initiative; Israel Science Foundation [966/09, 159/07, 24/11]	United States-Israel Binational Science Foundation, Jerusalem, Israel(US-Israel Binational Science Foundation); Israeli Centers of Research Excellence (I-CORE); Alternative Energy Research Initiative Bioenergy Consortium; Weizmann Institute of Science Alternative Energy Research Initiative; Israel Science Foundation(Israel Science Foundation)	This work was supported in part by grants from the United States-Israel Binational Science Foundation, Jerusalem, Israel, Israeli Centers of Research Excellence (I-CORE) Program (Center 152/11), Alternative Energy Research Initiative Bioenergy Consortium, Brazilian friends of the Weizmann Institute of Science Alternative Energy Research Initiative (research grants from Charles Rothschild, Mario Fleck, and Roberto and Renata Ruhman), Technion-Niedersachsen Research Cooperation Program, and Israel Science Foundation Grants 966/09, 159/07, and 24/11.	Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; BACHMANN SL, 1991, APPL ENVIRON MICROB, V57, P2121, DOI 10.1128/AEM.57.8.2121-2130.1991; Barker IJ, 2010, J PHYS CHEM B, V114, P15389, DOI 10.1021/jp107886e; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Blanco J, 1997, APPL MICROBIOL BIOT, V48, P208, DOI 10.1007/s002530051040; Bourgois TM, 2007, APPL MICROBIOL BIOT, V75, P1309, DOI 10.1007/s00253-007-0956-2; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Burstein T, 2009, FEBS LETT, V583, P879, DOI 10.1016/j.febslet.2009.02.013; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Caspi J, 2006, BIOCATAL BIOTRANSFOR, V24, P3, DOI 10.1080/10242420600598046; Chun YC, 1998, J MICROBIOL BIOTECHN, V8, P28; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; GHANGAS GS, 1989, J BACTERIOL, V171, P2963, DOI 10.1128/jb.171.6.2963-2969.1989; GOSALBES MJ, 1991, J BACTERIOL, V173, P7705, DOI 10.1128/jb.173.23.7705-7710.1991; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; IRWIN D, 1994, APPL ENVIRON MICROB, V60, P763, DOI 10.1128/AEM.60.3.763-770.1994; Jordan DB, 2007, BBA-PROTEINS PROTEOM, V1774, P1192, DOI 10.1016/j.bbapap.2007.06.010; Kim JH, 2004, CAN J MICROBIOL, V50, P835, DOI 10.1139/W04-077; KLUEPFEL D, 1990, BIOCHEM J, V267, P45, DOI 10.1042/bj2670045; Kukolya J, 2002, INT J SYST EVOL MICR, V52, P1193, DOI [10.1099/ijs.0.01925-0, 10.1099/00207713-52-4-1193]; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; LaGrange DC, 1997, APPL MICROBIOL BIOT, V47, P262; Leal TF, 2004, FEMS MICROBIOL LETT, V241, P41, DOI 10.1016/j.femsle.2004.10.003; Matsuo N, 2000, BIOCHEM J, V346, P9, DOI 10.1042/0264-6021:3460009; McKie VA, 1997, BIOCHEM J, V323, P547, DOI 10.1042/bj3230547; MORIYAMA H, 1987, EUR J BIOCHEM, V166, P539, DOI 10.1111/j.1432-1033.1987.tb13547.x; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Pons T, 2004, PROTEINS, V54, P424, DOI 10.1002/prot.10604; Price N. C., 2001, FUNDAMENTALS ENZYMOL, P133; RICHARDS FM, 1958, P NATL ACAD SCI USA, V44, P162, DOI 10.1073/pnas.44.2.162; SAKKA K, 1993, BIOSCI BIOTECH BIOCH, V57, P268, DOI 10.1271/bbb.57.268; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; Smaali I, 2006, APPL MICROBIOL BIOT, V73, P582, DOI 10.1007/s00253-006-0512-5; Tabka MG, 2006, ENZYME MICROB TECH, V39, P897, DOI 10.1016/j.enzmictec.2006.01.021; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; UTT EA, 1991, APPL ENVIRON MICROB, V57, P1227, DOI 10.1128/AEM.57.4.1227-1234.1991; van den Broek LAM, 2005, APPL MICROBIOL BIOT, V67, P641, DOI 10.1007/s00253-004-1850-9; Vandermarliere E, 2007, ACTA CRYSTALLOGR F, V63, P692, DOI 10.1107/S1744309107033702; Whitehead TR, 2001, CURR MICROBIOL, V43, P293, DOI 10.1007/s002840010304; WILSON DB, 1992, CRIT REV BIOTECHNOL, V12, P45, DOI 10.3109/07388559209069187; Wilson DB, 2004, CHEM REC, V4, P72, DOI 10.1002/tcr.20002; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078; Yoshida S, 2010, J BACTERIOL, V192, P5424, DOI 10.1128/JB.00503-10	45	24	29	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9213	9221		10.1074/jbc.M111.314286	http://dx.doi.org/10.1074/jbc.M111.314286			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270362	hybrid, Green Published			2022-12-25	WOS:000301797800049
J	Solis, E; Zdravkovic, I; Tomlinson, ID; Noskov, SY; Rosenthal, SJ; De Felice, LJ				Solis, Ernesto, Jr.; Zdravkovic, Igor; Tomlinson, Ian D.; Noskov, Sergei Y.; Rosenthal, Sandra J.; De Felice, Louis J.			4-(4-(Dimethylamino)phenyl)-1-methylpyridinium (APP(+)) Is a Fluorescent Substrate for the Human Serotonin Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIDEPRESSANT BINDING-SITE; REUPTAKE INHIBITORS; NEUROTRANSMITTER TRANSPORTERS; NOREPINEPHRINE TRANSPORTERS; TRICYCLIC ANTIDEPRESSANTS; HALOPERIDOL METABOLITES; BACTERIAL HOMOLOG; XENOPUS OOCYTES; LIVING CELLS; DOPAMINE	Monoamine transporters terminate synaptic neurotransmission and are molecular targets for antidepressants and psychostimulants. Fluorescent reporters can monitor real-time transport and are amenable for high-throughput screening. However, until now, their use has mostly been successful to study the catecholamine transporters but not the serotonin (5HT) transporter. Here, we use fluorescence microscopy, electrophysiology, pharmacology, and molecular modeling to compare fluorescent analogs of 1-methyl-4-phenylpyridinium (MPP+) as reporters for the human serotonin transporter (hSERT) in single cells. The fluorescent substrate 4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP(+)) exhibits superior fluorescence uptake in hSERT-expressing HEK293 cells than other MPP+ analogs tested. APP(+) uptake is Na+-and Cl--dependent, displaced by 5HT, and inhibited by fluoxetine, suggesting APP(+) specifically monitors hSERT activity. ASP(+), which was previously used to study catecholamine transporters, is 10 times less potent than APP(+) at inhibiting 5HT uptake and has minimal hSERT-mediated uptake. Furthermore, in hSERT-expressing oocytes voltage-clamped to -60 mV, APP(+) induced fluoxetine-sensitive hSERT-mediated inward currents, indicating APP(+) is a substrate, whereas ASP(+) induced hSERT-mediated outward currents and counteracted 5HT-induced hSERT currents, indicating ASP(+) possesses activity as an inhibitor. Extra-precise ligand receptor docking of APP(+) and ASP(+) in an hSERT homology model showed both ASP(+) and APP(+) docked favorably within the active region; accordingly, comparable concentrations are required to elicit their opposite electrophysiological responses. We conclude APP(+) is better suited than ASP(+) to study hSERT transport fluorometrically.	[Solis, Ernesto, Jr.] Vanderbilt Univ, Sch Med, Grad Training Program Neurosci, Nashville, TN 37235 USA; [Solis, Ernesto, Jr.; De Felice, Louis J.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Zdravkovic, Igor; Noskov, Sergei Y.] Univ Calgary, Dept Biol Sci, Inst Biocomplex & Informat, Calgary, AB T2N 1N4, Canada; [Tomlinson, Ian D.; Rosenthal, Sandra J.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37235 USA	Vanderbilt University; Virginia Commonwealth University; University of Calgary; Vanderbilt University	Solis, E (corresponding author), 1101 E Marshall St,Room 3-038M, Richmond, VA 23298 USA.	esolis3@vcu.edu		De Felice, Louis/0000-0002-4594-3171; Solis, Jr., Ernesto/0000-0001-9406-9540; Noskov, Sergei/0000-0001-7769-335X	National Institutes of Health [1RC1DA028112-01, DA026947-01A1, EB003728, 5RO3MH61874-02]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH061874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026947, RC1DA028112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants 1RC1DA028112-01, DA026947-01A1, EB003728, and 5RO3MH61874-02.	Adams SV, 2003, BIOPHYS J, V85, P1548, DOI 10.1016/S0006-3495(03)74587-1; Adams SV, 2002, BIOPHYS J, V83, P3268, DOI 10.1016/S0006-3495(02)75328-9; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Bancaud A, 2009, EMBO J, V28, P3785, DOI 10.1038/emboj.2009.340; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1996, MOL PHARMACOL, V50, P957; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Bryan-Lluka LJ, 1999, N-S ARCH PHARMACOL, V360, P109, DOI 10.1007/s002109900060; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; Budygin EA, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0002.2002; Busch AE, 1996, J BIOL CHEM, V271, P32599, DOI 10.1074/jbc.271.51.32599; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; CHANG ASS, 1989, P NATL ACAD SCI USA, V86, P9611, DOI 10.1073/pnas.86.23.9611; Daws LC, 2009, PHARMACOL THERAPEUT, V121, P89, DOI 10.1016/j.pharmthera.2008.10.004; DeFelice LJ, 1996, BIOPHYS J, V70, P579, DOI 10.1016/S0006-3495(96)79604-2; Desai VG, 1996, BRAIN RES, V715, P1, DOI 10.1016/0006-8993(95)01255-9; FEIGHNER JP, 1994, FORTSCHR NEUROL PSYC, V62, P9; Field JR, 2010, J BIOL CHEM, V285, P11270, DOI 10.1074/jbc.M109.093658; Fowler A, 2006, J BIOMOL SCREEN, V11, P1027, DOI 10.1177/1087057106294698; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; GLUCK MR, 1994, J NEUROCHEM, V63, P655; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Haunso A, 2007, J BIOMOL SCREEN, V12, P378, DOI 10.1177/1087057107299524; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168; Hohage H, 1998, J PHARMACOL EXP THER, V286, P305; Iwamoto H, 2006, J NEUROSCI, V26, P9851, DOI 10.1523/JNEUROSCI.1862-06.2006; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Jorgensen S, 2008, J NEUROSCI METH, V169, P168, DOI 10.1016/j.jneumeth.2007.12.004; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; KEYES SR, 1982, J BIOL CHEM, V257, P1172; KRUEGER MJ, 1993, J NEUROCHEM, V61, P1546, DOI 10.1111/j.1471-4159.1993.tb13653.x; Li CZ, 2006, CLIN EXP PHARMACOL P, V33, P1088, DOI 10.1111/j.1440-1681.2006.04491.x; Machaca K, 1998, BIOPHYS J, V74, P1286, DOI 10.1016/S0006-3495(98)77842-7; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Mason JN, 2005, J NEUROSCI METH, V143, P3, DOI 10.1016/j.jneumeth.2004.09.028; Mehrens T, 2000, J AM SOC NEPHROL, V11, P1216, DOI 10.1681/ASN.V1171216; Murali S, 2006, J PHYS CHEM A, V110, P28, DOI 10.1021/jp053878r; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Nelson N, 1998, J NEUROCHEM, V71, P1785; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ramsey IS, 2002, J BIOL CHEM, V277, P14475, DOI 10.1074/jbc.M110783200; Richelson E, 1996, J CLIN PSYCHOPHARM, V16, pS7, DOI 10.1097/00004714-199606002-00002; Richelson E, 1996, J CLIN PSYCHOPHARM, V16, pS1, DOI 10.1097/00004714-199606002-00001; Rudnick G, 1998, J BIOENERG BIOMEMBR, V30, P173, DOI 10.1023/A:1020573325823; RUDNICK G, 1993, MOL PHARMACOL, V43, P271; Rudnick G, 1998, METHOD ENZYMOL, V296, P233; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Schwartz JW, 2006, HANDB EXP PHARM, V175, P23; Schwartz JW, 2005, J BIOL CHEM, V280, P19177, DOI 10.1074/jbc.M412923200; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Stahl SM, 1998, J AFFECT DISORDERS, V51, P215, DOI 10.1016/S0165-0327(98)00221-3; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Tsuruda PR, 2010, J PHARMACOL TOXICOL, V61, P192, DOI 10.1016/j.vascn.2009.12.003; Vaswani M, 2004, EXPERT OPIN INV DRUG, V13, P349, DOI 10.1517/13543784.13.4.349; Vaswani M, 2003, PROG NEURO-PSYCHOPH, V27, P85, DOI 10.1016/S0278-5846(02)00338-X; Wang HW, 2006, ACTA PHARMACOL SIN, V27, P289, DOI 10.1111/j.1745-7254.2006.00274.x; White KJ, 2005, AAPS J, V7; Wright AM, 1998, BRAIN RES, V788, P215, DOI 10.1016/S0006-8993(97)01551-5; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zapata A, 2007, J BIOL CHEM, V282, P35842, DOI 10.1074/jbc.M611758200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	71	35	35	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8852	8863		10.1074/jbc.M111.267757	http://dx.doi.org/10.1074/jbc.M111.267757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291010	Green Published, hybrid			2022-12-25	WOS:000301797800017
J	Wittnam, JL; Portelius, E; Zetterberg, H; Gustavsson, MK; Schilling, S; Koch, B; Demuth, HU; Blennow, K; Wirths, O; Bayer, TA				Wittnam, Jessica L.; Portelius, Erik; Zetterberg, Henrik; Gustavsson, Mikael K.; Schilling, Stephan; Koch, Birgit; Demuth, Hans-Ulrich; Blennow, Kaj; Wirths, Oliver; Bayer, Thomas A.			Pyroglutamate Amyloid beta (A beta) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL HETEROGENEITY; GLUTAMINYL CYCLASE; MAJOR COMPONENT; SENILE PLAQUES; NEURON LOSS; PEPTIDES; PROTEIN; DEPOSITS; NEURODEGENERATION; AMYLOIDOGENICITY	Pyroglutamate-modified A beta peptides at amino acid position three (A beta(pE3-42)) are gaining considerable attention as potential key players in the pathogenesis of Alzheimer disease (AD). A beta(pE3-42) is abundant in AD brain and has a high aggregation propensity, stability and cellular toxicity. The aim of the present work was to study the direct effect of elevated A beta(pE3-42) levels on ongoing AD pathology using transgenic mouse models. To this end, we generated a novel mouse model (TBA42) that produces A beta(pE3-42). TBA42 mice showed age-dependent behavioral deficits and A beta(pE3-42) accumulation. The A beta profile of an established AD mouse model, 5XFAD, was characterized using immunoprecipitation followed by mass spectrometry. Brains from 5XFAD mice demonstrated a heterogeneous mixture of full-length, N-terminal truncated, and modified A beta peptides: A beta(1-42), A beta(1-40), A beta(pE3-40), A beta(pE3-42), A beta(3-42), A beta(4-42), and A beta(5-42). 5XFAD and TBA42 mice were then crossed to generate transgenic FAD42 mice. At 6 months of age, FAD42 mice showed an aggravated behavioral phenotype compared with single transgenic 5XFAD or TBA42 mice. ELISA and plaque load measurements revealed that A beta(pE3) levels were elevated in FAD42 mice. No change in A beta(x-42) or other A beta isoforms was discovered by ELISA and mass spectrometry. These observations argue for a seeding effect of A beta(pE-42) in FAD42 mice.	[Wittnam, Jessica L.; Wirths, Oliver; Bayer, Thomas A.] Univ Gottingen, Univ Med Gottingen, Div Mol Psychiat, D-37075 Gottingen, Germany; [Portelius, Erik; Zetterberg, Henrik; Gustavsson, Mikael K.; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Clin Neurochem Lab, S-41345 Gothenburg, Sweden; [Schilling, Stephan; Koch, Birgit; Demuth, Hans-Ulrich] Probiodrug AG, D-06120 Halle, Saale, Germany	University of Gottingen; University of Gothenburg; Vivoryon Therapeutics	Bayer, TA (corresponding author), Univ Gottingen, Univ Med Gottingen, Div Mol Psychiat, Von Siebold Str 5, D-37075 Gottingen, Germany.	tbayer@gwdg.de	Wirths, Oliver/C-7342-2019	Wirths, Oliver/0000-0002-4115-0334				Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; AWADE AC, 1994, PROTEINS, V20, P34, DOI 10.1002/prot.340200106; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Christensen DZ, 2010, NEUROBIOL AGING, V31, P1153, DOI 10.1016/j.neurobiolaging.2008.07.022; Christensen DZ, 2008, ACTA NEUROPATHOL, V116, P647, DOI 10.1007/s00401-008-0451-6; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; Cynis H, 2011, EMBO MOL MED, V3, P545, DOI 10.1002/emmm.201100158; Galimberti D, 2006, NEUROBIOL AGING, V27, P1763, DOI 10.1016/j.neurobiolaging.2005.10.007; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; MORI H, 1992, J BIOL CHEM, V267, P17082; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Piccini A, 2007, ARCH NEUROL-CHICAGO, V64, P738, DOI 10.1001/archneur.64.5.738; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Portelius E, 2007, J PROTEOME RES, V6, P4433, DOI 10.1021/pr0703627; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Portelius E, 2009, NEURODEGENER DIS, V6, P258, DOI 10.1159/000264639; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Russo C, 1997, FEBS LETT, V409, P411, DOI 10.1016/S0014-5793(97)00564-4; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Tekirian TL, 1998, J NEUROPATH EXP NEUR, V57, P76, DOI 10.1097/00005072-199801000-00009; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wirths O, 2008, NEUROBIOL AGING, V29, P891, DOI 10.1016/j.neurobiolaging.2006.12.004; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	58	66	72	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8154	8162		10.1074/jbc.M111.308601	http://dx.doi.org/10.1074/jbc.M111.308601			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267726	Green Published, hybrid			2022-12-25	WOS:000301349400031
J	Eitel, J; Meixenberger, K; van Laak, C; Orlovski, C; Hocke, A; Schmeck, B; Hippenstiel, S; N'Guessan, PD; Suttorp, N; Opitz, B				Eitel, Julia; Meixenberger, Karolin; van Laak, Claudia; Orlovski, Christine; Hocke, Andreas; Schmeck, Bernd; Hippenstiel, Stefan; N'Guessan, Philippe Dje; Suttorp, Norbert; Opitz, Bastian			Rac1 Regulates the NLRP3 Inflammasome Which Mediates IL-1beta Production in Chlamydophila pneumoniae Infected Human Mononuclear Cells	PLOS ONE			English	Article							CHLAMYDIA-PNEUMONIAE; CASPASE-1 ACTIVATION; NALP3 INFLAMMASOME; ACTIN CYTOSKELETON; EPITHELIAL-CELLS; GENE-EXPRESSION; HOST-DEFENSE; RHO-GTPASES; MACROPHAGES; TRACHOMATIS	Chlamydophila pneumoniae causes acute respiratory tract infections and has been associated with development of asthma and atherosclerosis. The production of IL-1 beta, a key mediator of acute and chronic inflammation, is regulated on a transcriptional level and additionally on a posttranslational level by inflammasomes. In the present study we show that C. pneumoniae-infected human mononuclear cells produce IL-1 beta protein depending on an inflammasome consisting of NLRP3, the adapter protein ASC and caspase-1. We further found that the small GTPase Rac1 is activated in C. pneumoniae-infected cells. Importantly, studies with specific inhibitors as well as siRNA show that Rac1 regulates inflammasome activation in C. pneumoniae-infected cells. In conclusion, C. pneumoniae infection of mononuclear cells stimulates IL-1 beta production dependent on a NLRP3 inflammasome-mediated processing of proIL-1 beta which is controlled by Rac1.	[Eitel, Julia; Meixenberger, Karolin; van Laak, Claudia; Orlovski, Christine; Hocke, Andreas; Schmeck, Bernd; Hippenstiel, Stefan; N'Guessan, Philippe Dje; Suttorp, Norbert; Opitz, Bastian] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Eitel, J (corresponding author), Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany.	bastian.opitz@charite.de		Suttorp, Norbert/0000-0002-3958-1151; Opitz, Bastian/0000-0003-1276-836X; Schmeck, Bernd/0000-0002-2767-3606; Hippenstiel, Stefan/0000-0002-5146-1064	Deutsche Forschungsgemeinschaft [OP 86/5-1, OP 86/7-1, SFB/TR84]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (OP 86/5-1, OP 86/7-1, SFB/TR84 project A1 to B.O., and SFB/TR84 project Z1a to A.C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Buss C, 2010, J IMMUNOL, V184, P3072, DOI 10.4049/jimmunol.0902947; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Eitel J, 2008, J IMMUNOL, V181, P2664, DOI 10.4049/jimmunol.181.4.2664; Fong IW, 1999, INFECT IMMUN, V67, P6048, DOI 10.1128/IAI.67.11.6048-6055.1999; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hansbro PM, 2004, PHARMACOL THERAPEUT, V101, P193, DOI 10.1016/j.pharmthera.2003.10.007; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Krull M, 2005, THROMB HAEMOSTASIS, V94, P319, DOI 10.1160/TH05-04-0261; Lee DJ, 2000, J BIOL CHEM, V275, P141, DOI 10.1074/jbc.275.1.141; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Maass M, 1998, ATHEROSCLEROSIS, V140, pS25, DOI 10.1016/S0021-9150(98)00117-8; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Netea MG, 2002, EUR J IMMUNOL, V32, P1188, DOI 10.1002/1521-4141(200204)32:4<1188::AID-IMMU1188>3.3.CO;2-1; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; ROTHERMEL CD, 1989, INFECT IMMUN, V57, P2705, DOI 10.1128/IAI.57.9.2705-2711.1989; SAIKKU P, 1992, ANN INTERN MED, V116, P273, DOI 10.7326/0003-4819-116-4-273; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schmeck B, 2006, AM J PHYSIOL-LUNG C, V290, pL730, DOI 10.1152/ajplung.00271.2005; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; SHOR A, 1992, S AFR MED J, V82, P158; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Wong KW, 2006, J BIOL CHEM, V281, P40379, DOI 10.1074/jbc.M605387200; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	56	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30379	10.1371/journal.pone.0030379	http://dx.doi.org/10.1371/journal.pone.0030379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276187	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100040
J	Macias, D; Landry, MR; Gershunov, A; Miller, AJ; Franks, PJS				Macias, Diego; Landry, Michael R.; Gershunov, Alexander; Miller, Arthur J.; Franks, Peter J. S.			Climatic Control of Upwelling Variability along the Western North-American Coast	PLOS ONE			English	Article							CALIFORNIA CURRENT SYSTEM; PACIFIC DECADAL OSCILLATION; SOUTHERN CALIFORNIA; EL-NINO; PRODUCTION REGIMES; WIND STRESS; ALBORAN SEA; OCEAN; PRODUCTIVITY; TEMPERATURE	The high biological production of the California Current System (CCS) results from the seasonal development of equatorward alongshore winds that drive coastal upwelling. While several climatic fluctuation patterns influence the dynamics and biological productivity of the CCS, including the El Nino-Southern Oscillation (ENSO), the Pacific Decadal Oscillation index (PDO) and the North Pacific Gyre Oscillation (NPGO), the mechanisms of interaction between climatic oscillations and the CCS upwelling dynamics have remained obscure. Here, we use Singular Spectral Analysis (SSA) to reveal, for the first time, low-frequency concordance between the time series of climatic indices and upwelling intensity along the coast of western North America. Based on energy distributions in annual, semiannual and low-frequency signals, we can divide the coast into three distinct regions. While the annual upwelling signal dominates the energy spectrum elsewhere, low-frequency variability is maximal in the regions south of 33 degrees N. Non-structured variability associated with storms and turbulent mixing is enhanced at northerly locations. We found that the low-frequency signal is significantly correlated with different climatic indices such as PDO, NPGO and ENSO with the correlation patterns being latitude-dependent. We also analyzed the correlations between this upwelling variability and sea surface temperature (SST) and sea level pressure (SLP) throughout the North Pacific to visualize and interpret the large-scale teleconnection dynamics in the atmosphere that drive the low-frequency coastal winds. These results provide new insights into the underlying mechanisms connecting climatic patterns with upwelling dynamics, which could enhance our prediction and forecast capabilities of the effects of future oceanographic and climatic variability in the CCS.	[Macias, Diego] CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Cadiz, Spain; [Landry, Michael R.; Franks, Peter J. S.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Gershunov, Alexander; Miller, Arthur J.] Univ Calif San Diego, Scripps Inst Oceanog, CASPO Div, La Jolla, CA 92093 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	Macias, D (corresponding author), CSIC, Inst Ciencias Marinas Andalucia, Dept Ecol & Coastal Management, Cadiz, Spain.	diego.macias@icman.csic.es	Landry, Michael/HGF-1043-2022; Macías, Diego/G-1972-2010	Macías, Diego/0000-0002-7772-255X; Miller, Arthur/0000-0003-3459-2676	Spanish Ministry of Science [EX2008-0394]; National Science Foundation [OCE 04-17616, OCE10-26607, OCE06-47815, OCE09-60770]; National Oceanic and Atmospheric Administration through the Experimental Climate Prediction Center and Integrated Ocean Observation System [NA17RJ1231]; Directorate For Geosciences [0960770, 1026607] Funding Source: National Science Foundation	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration through the Experimental Climate Prediction Center and Integrated Ocean Observation System; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	DM was funded by a postdoctoral contract by the Spanish Ministry of Science (contract no EX2008-0394). This work was supported by National Science Foundation funding (OCE 04-17616 and OCE10-26607) for the California Current Ecosystem Long Term Ecological Research site. Funding to AJM was provided by the National Science Foundation under OCE06-47815 and OCE09-60770, and by National Oceanic and Atmospheric Administration through the Experimental Climate Prediction Center and Integrated Ocean Observation System (NA17RJ1231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JS, 1980, ANNU REV FLUID MECH, V12, P389, DOI 10.1146/annurev.fl.12.010180.002133; Alvarez A, 2000, GEOPHYS RES LETT, V27, P2709, DOI 10.1029/1999GL011226; Bakun Andrew, 1973, W COAST N AM 1946 71, P112; Berger WH, 1989, DAHL WORKSH PROD OC; Bograd SJ, 2005, J MAR RES, V63, P863, DOI 10.1357/002224005774464229; Bograd SJ, 2001, GEOPHYS RES LETT, V28, P275, DOI 10.1029/2000GL012047; Bograd SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035933; Carr ME, 2003, DEEP-SEA RES PT II, V50, P3199, DOI 10.1016/j.dsr2.2003.07.015; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; Castro CG, 2002, PROG OCEANOGR, V54, P171, DOI 10.1016/S0079-6611(02)00048-4; CHELTON DB, 1982, J MAR RES, V40, P1095; Chhak K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030203; Chhak KC, 2009, J CLIMATE, V22, P1255, DOI 10.1175/2008JCLI2639.1; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Di Lorenzo E, 2003, DEEP-SEA RES PT II, V50, P2371, DOI 10.1016/S0967-0645(03)00125-5; Di Lorenzo E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038261; Favre A, 2006, CLIM DYNAM, V26, P617, DOI 10.1007/s00382-005-0101-9; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Franco G, 2008, CLIMATIC CHANGE, V87, pS7, DOI 10.1007/s10584-007-9359-8; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Gruber N, 2006, DEEP-SEA RES PT I, V53, P1483, DOI 10.1016/j.dsr.2006.06.005; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; Kelly KA, 1998, J GEOPHYS RES-OCEANS, V103, P13067, DOI 10.1029/97JC03760; Kim HJ, 2009, PROG OCEANOGR, V82, P137, DOI 10.1016/j.pocean.2009.05.002; LYNN RJ, 1990, J GEOPHYS RES-OCEANS, V95, P12995, DOI 10.1029/JC095iC08p12995; Lynn RJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001787; Macias D, 2007, J MAR RES, V65, P523, DOI 10.1357/002224007782689085; Mackas DL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027930; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantyla AW, 2008, J MARINE SYST, V73, P48, DOI 10.1016/j.jmarsys.2007.08.001; Margolis H, 2009, EPIDEMIOLOGY, V20, pS222, DOI 10.1097/01.ede.0000362743.41229.58; McGowan JA, 2003, DEEP-SEA RES PT II, V50, P2567, DOI 10.1016/S0967-0645(03)00135-8; McGowan John A., 1993, P203; Mendelssohn R, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002330; Mendelssohn R, 2002, PROG OCEANOGR, V53, P141, DOI 10.1016/S0079-6611(02)00028-9; Moore AM, 2009, J PHYS OCEANOGR, V39, P702, DOI 10.1175/2008JPO3740.1; Muller-Karger FE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021346; Murphree T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016366; Newman M, 2003, J CLIMATE, V16, P3853, DOI 10.1175/1520-0442(2003)016<3853:EVOTPD>2.0.CO;2; Nezlin NP, 2003, REMOTE SENS ENVIRON, V84, P234, DOI 10.1016/S0034-4257(02)00109-8; Parrish R.H., 1981, Biological Oceanography, V1, P175; Rao BD, 1989, IEE T SIGNAL PROCESS, V37; Rebstock GA, 2003, DEEP-SEA RES PT II, V50, P2583, DOI 10.1016/S0967-0645(03)00124-3; Schneider N, 2005, J CLIMATE, V18, P4355, DOI 10.1175/JCLI3527.1; Schwing FB, 1997, J GEOPHYS RES-OCEANS, V102, P3421, DOI 10.1029/96JC03591; Schwing FB, 1996, NOAATMNMFSSWFSC231 U; Schwing FB, 2010, J MARINE SYST, V79, P245, DOI 10.1016/j.jmarsys.2008.11.027; Smith RL, 2001, PROG OCEANOGR, V49, P63, DOI 10.1016/S0079-6611(01)00016-7; SMITH SV, 1993, REV GEOPHYS, V31, P75, DOI 10.1029/92RG02584; Song H, 2011, DYNAM ATMOS OCEANS, V52, P170, DOI 10.1016/j.dynatmoce.2011.03.001; Thomas AC, 2009, PROG OCEANOGR, V83, P386, DOI 10.1016/j.pocean.2009.07.020; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; VAUTARD R, 1992, PHYSICA D, V58, P95, DOI 10.1016/0167-2789(92)90103-T; Wainwright TC, 2007, ECOL MODEL, V202, P120, DOI 10.1016/j.ecolmodel.2006.06.019; Walsh JJ, 2001, NATURE, V350; Wooster WS, 1963, E BOUNDARY CURRENTS, P253	57	36	39	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30436	10.1371/journal.pone.0030436	http://dx.doi.org/10.1371/journal.pone.0030436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276199	Green Published, gold			2022-12-25	WOS:000301457200061
J	Nickerson, NK; Mohammad, KS; Gilmore, JL; Crismore, E; Bruzzaniti, A; Guise, TA; Foley, J				Nickerson, Nicole K.; Mohammad, Khalid S.; Gilmore, Jennifer L.; Crismore, Erin; Bruzzaniti, Angela; Guise, Theresa A.; Foley, John			Decreased Autocrine EGFR Signaling in Metastatic Breast Cancer Cells Inhibits Tumor Growth in Bone and Mammary Fat Pad	PLOS ONE			English	Article							GENE-EXPRESSION; FACTOR RECEPTOR; ZD1839 IRESSA; AMPHIREGULIN; ESTROGEN; GLAND; OSTEOBLASTS; CARCINOMA; TAMOXIFEN; LIGANDS	Breast cancer metastasis to bone triggers a vicious cycle of tumor growth linked to osteolysis. Breast cancer cells and osteoblasts express the epidermal growth factor receptor (EGFR) and produce ErbB family ligands, suggesting participation of these growth factors in autocrine and paracrine signaling within the bone microenvironment. EGFR ligand expression was profiled in the bone metastatic MDA-MB-231 cells (MDA-231), and agonist-induced signaling was examined in both breast cancer and osteoblast-like cells. Both paracrine and autocrine EGFR signaling were inhibited with a neutralizing amphiregulin antibody, PAR34, whereas shRNA to the EGFR was used to specifically block autocrine signaling in MDA-231 cells. The impact of these was evaluated with proliferation, migration and gene expression assays. Breast cancer metastasis to bone was modeled in female athymic nude mice with intratibial inoculation of MDA-231 cells, and cancer cell-bone marrow co-cultures. EGFR knockdown, but not PAR34 treatment, decreased osteoclasts formed in vitro (p, 0.01), reduced osteolytic lesion tumor volume (p<0.01), increased survivorship in vivo (p<0.001), and resulted in decreased MDA-231 growth in the fat pad (p<0.01). Fat pad shEGFR-MDA-231 tumors produced in nude mice had increased necrotic areas and decreased CD31-positive vasculature. shEGFR-MDA-231 cells also produced decreased levels of the proangiogenic molecules macrophage colony stimulating factor-1 (MCSF-1) and matrix metalloproteinase 9 (MMP9), both of which were decreased by EGFR inhibitors in a panel of EGFR-positive breast cancer cells. Thus, inhibiting autocrine EGFR signaling in breast cancer cells may provide a means for reducing paracrine factor production that facilitates microenvironment support in the bone and mammary gland.	[Nickerson, Nicole K.; Gilmore, Jennifer L.; Crismore, Erin; Foley, John] Indiana Univ Sch Med, Med Sci Program, Bloomington, IN USA; [Mohammad, Khalid S.; Guise, Theresa A.] Indiana Univ Sch Med, Dept Med, Div Endocrinol, Indianapolis, IN USA; [Mohammad, Khalid S.; Guise, Theresa A.; Foley, John] Indiana Univ Sch Med, Indiana Univ Canc Ctr, Indianapolis, IN USA; [Bruzzaniti, Angela] Indiana Univ, Sch Dent, Dept Oral Biol, Indianapolis, IN USA; [Bruzzaniti, Angela; Foley, John] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA; [Foley, John] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Nickerson, NK (corresponding author), Indiana Univ Sch Med, Med Sci Program, Bloomington, IN USA.	jgfoley@indiana.edu	Bruzzaniti, Angela/AAP-2225-2020; Mohammad, Khalid/AAE-9569-2022; Mohammad, Khalid/AFE-4205-2022		Department of Defense [W81XWH-09-1-0003]; Susan G. Komen [KG081561]; Indiana University Breast Cancer Research Program [29-875-62]	Department of Defense(United States Department of Defense); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); Indiana University Breast Cancer Research Program	NKN was supported by a Department of Defense Breast Cancer Research Program, Predoctoral Traineeship Award (W81XWH-09-1-0003); JLG received a Susan G. Komen Postdoctoral Award; and JF received grants from Susan G. Komen for the Cure (KG081561) and the Indiana University Breast Cancer Research Program (29-875-62). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2009, J ORAL MAXIL SURG, V67, P1373, DOI 10.1016/j.joms.2009.03.048; Balbis A, 2010, J CELL BIOCHEM, V109, P1103, DOI 10.1002/jcb.22505; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BERTHON P, 1992, INT J CANCER, V52, P92, DOI 10.1002/ijc.2910520117; Bhagavathula N, 2005, AM J PATHOL, V166, P1009, DOI 10.1016/S0002-9440(10)62322-X; Bos PD, 2009, NATURE; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; Ciardiello F, 2001, CLIN CANCER RES, V7, P1459; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; DAVIDSON NE, 1987, MOL ENDOCRINOL, V1, P216, DOI 10.1210/mend-1-3-216; Foley J, SEMIN CELL DEV BIOL; Furugaki K, 2011, CLIN EXP METASTASIS; Gerstenfeld LC, 2006, J HISTOCHEM CYTOCHEM, V54, P1215, DOI 10.1369/jhc.6A6959.2006; Gilmore JL, 2008, BREAST CANCER RES TR, V110, P493, DOI 10.1007/s10549-007-9748-8; Gilmore JL, 2009, MOL CANCER RES, V7, P1714, DOI 10.1158/1541-7786.MCR-09-0131; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Lee JE, 2004, ANTICANCER RES, V24, P3961; Lorch G, 2007, BRIT J CANCER, V97, P183, DOI 10.1038/sj.bjc.6603828; Lu X, 2009, GENES DEV; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Moulder SL, 2001, CANCER RES, V61, P8887; Park SI, 2011, CANC MICROENVIRON; Price JT, 1999, CANCER RES, V59, P5475; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Qin L, 2005, J CELL BIOCHEM, V96, P632, DOI 10.1002/jcb.20550; Roda JM, 2011, J IMMUNOL, V187, P1970, DOI 10.4049/jimmunol.1100841; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Scandlyn MJ, 2008, BRIT J CANCER, V99, P1056, DOI 10.1038/sj.bjc.6604634; Sebastian J, 1998, CELL GROWTH DIFFER, V9, P777; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Voloshin T, BLOOD; Willmarth NE, 2006, J BIOL CHEM, V281, P37728, DOI 10.1074/jbc.M606532200; Willmarth NE, 2009, CELL SIGNAL, V21, P212, DOI 10.1016/j.cellsig.2008.10.003; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Yang JP, 2008, J CELL PHYSIOL, V214, P730, DOI 10.1002/jcp.21268; Yang XR, J NATL CANC I, V103, P250	49	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30255	10.1371/journal.pone.0030255	http://dx.doi.org/10.1371/journal.pone.0030255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276166	gold, Green Published, Green Submitted			2022-12-25	WOS:000301457200047
J	Chan, CH; Wilbanks, CC; Makhatadze, GI; Wong, KB				Chan, Chi-Ho; Wilbanks, Cecily C.; Makhatadze, George I.; Wong, Kam-Bo			Electrostatic Contribution of Surface Charge Residues to the Stability of a Thermophilic Protein: Benchmarking Experimental and Predicted pKa Values	PLOS ONE			English	Article							PH MOLECULAR-DYNAMICS; PK(A) VALUES; STAPHYLOCOCCAL NUCLEASE; THERMOCOCCUS-CELER; WATER PENETRATION; TITRATION CURVES; RATIONAL DESIGN; SALT BRIDGES; STABILIZATION; OPTIMIZATION	Optimization of the surface charges is a promising strategy for increasing thermostability of proteins. Electrostatic contribution of ionizable groups to the protein stability can be estimated from the differences between the pKa values in the folded and unfolded states of a protein. Using this pKa-shift approach, we experimentally measured the electrostatic contribution of all aspartate and glutamate residues to the stability of a thermophilic ribosomal protein L30e from Thermococcus celer. The pKa values in the unfolded state were found to be similar to model compound pKas. The pKa values in both the folded and unfolded states obtained at 298 and 333 K were similar, suggesting that electrostatic contribution of ionizable groups to the protein stability were insensitive to temperature changes. The experimental pKa values for the L30e protein in the folded state were used as a benchmark to test the robustness of pKa prediction by various computational methods such as H++, MCCE, MEAD, pKD, PropKa, and UHBD. Although the predicted pKa values were affected by crystal contacts that may alter the side-chain conformation of surface charged residues, most computational methods performed well, with correlation coefficients between experimental and calculated pKa values ranging from 0.49 to 0.91 (p<0.01). The changes in protein stability derived from the experimental pKa-shift approach correlate well (r = 0.81) with those obtained from stability measurements of charge-to-alanine substituted variants of the L30e protein. Our results demonstrate that the knowledge of the pKa values in the folded state provides sufficient rationale for the redesign of protein surface charges leading to improved protein stability.	[Chan, Chi-Ho; Wong, Kam-Bo] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Hong Kong, Hong Kong, Peoples R China; [Wilbanks, Cecily C.; Makhatadze, George I.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Wilbanks, Cecily C.; Makhatadze, George I.] Rensselaer Polytech Inst, Dept Chem, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Wilbanks, Cecily C.; Makhatadze, George I.] Rensselaer Polytech Inst, Dept Biol Chem, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA	Chinese University of Hong Kong; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Chan, CH (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Hong Kong, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373	Research Council of Hong Kong [479307]; National Science Foundation [MCB-0110396]; Direct For Biological Sciences [0818419] Funding Source: National Science Foundation	Research Council of Hong Kong(Hong Kong Research Grants Council); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the General Research Fund of Research Council of Hong Kong (project no. 479307). Research on electrostatic interactions in GIM lab is supported by a grant from the National Science Foundation (MCB-0110396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasako A, 1997, J BIOL CHEM, V272, P18686, DOI 10.1074/jbc.272.30.18686; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BASHFORD D, OBJECT ORIENTED PROG, P233; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Czepas J, 2004, ACTA CRYSTALLOGR D, V60, P275, DOI 10.1107/S0907444903026271; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fitch CA, 2002, BIOPHYS J, V82, P3289, DOI 10.1016/S0006-3495(02)75670-1; Fu HL, 2009, PROTEINS, V77, P491, DOI 10.1002/prot.22509; GILSON MK, 1993, PROTEINS, V15, P266, DOI 10.1002/prot.340150305; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Grimsley GR, 1999, PROTEIN SCI, V8, P1843, DOI 10.1110/ps.8.9.1843; Gunner MR, 2011, PROTEINS, V79, P3306, DOI 10.1002/prot.23124; Jimenez-Cruz CA, 2011, PHYS CHEM CHEM PHYS, V13, P17056, DOI 10.1039/c1cp21193e; Kajander Tommi, 2006, V340, P151; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Lee CF, 2005, BIOCHEMISTRY-US, V44, P16817, DOI 10.1021/bi0519654; Lee CF, 2005, J MOL BIOL, V348, P419, DOI 10.1016/j.jmb.2005.02.052; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loladze VV, 1999, BIOCHEMISTRY-US, V38, P16419, DOI 10.1021/bi992271w; Lumb KJ, 1996, SCIENCE, V271, P1137, DOI 10.1126/science.271.5252.1137; Machuqueiro M, 2011, PROTEINS, V79, P3437, DOI 10.1002/prot.23115; MADURA JD, 1994, REV COMP CH, V5, P229, DOI 10.1002/9780470125823.ch4; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nielsen JE, 2007, J MOL GRAPH MODEL, V25, P691, DOI 10.1016/j.jmgm.2006.05.007; Nielsen JE, 2009, METHOD ENZYMOL, V454, P233, DOI 10.1016/S0076-6879(08)03809-3; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Peterson RW, 1999, J MOL BIOL, V286, P1609, DOI 10.1006/jmbi.1999.2574; Pokala N, 2001, J STRUCT BIOL, V134, P269, DOI 10.1006/jsbi.2001.4349; Sanchez-Ruiz JM, 2001, TRENDS BIOTECHNOL, V19, P132, DOI 10.1016/S0167-7799(00)01548-1; Schweiker KL, 2007, PROTEIN SCI, V16, P2694, DOI 10.1110/ps.073091607; Schweiker Katrina L., 2009, V490, P261, DOI 10.1007/978-1-59745-367-7_11; Schweiker KL, 2009, METHOD ENZYMOL, V454, P175, DOI 10.1016/S0076-6879(08)03807-X; Shan JF, 2011, PROTEINS, V79, P3346, DOI 10.1002/prot.23098; SHRAGER RI, 1972, BIOCHEMISTRY-US, V11, P541, DOI 10.1021/bi00754a010; Sondergaard CR, 2008, J MOL BIOL, V376, P269, DOI 10.1016/j.jmb.2007.09.070; Street AG, 1999, STRUCTURE, V7, pR105, DOI 10.1016/S0969-2126(99)80062-8; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Tynan-Connolly BM, 2006, NUCLEIC ACIDS RES, V34, pW48, DOI 10.1093/nar/gkl192; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Whitten ST, 2000, BIOCHEMISTRY-US, V39, P14292, DOI 10.1021/bi001015c; Wong KB, 2003, PROTEIN SCI, V12, P1483, DOI 10.1110/ps.0302303; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; YAMAZAKI T, 1994, NMR XRAY EVIDENCE HI; YANG AS, 1992, J MOL BIOL, V227, P889, DOI 10.1016/0022-2836(92)90229-D	50	27	27	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30296	10.1371/journal.pone.0030296	http://dx.doi.org/10.1371/journal.pone.0030296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279578	Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900055
J	Freed, LA; Cann, RL				Freed, Leonard A.; Cann, Rebecca L.			Changes in Timing, Duration, and Symmetry of Molt of Hawaiian Forest Birds	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; CLIMATE-CHANGE; ANNUAL CYCLE; PASSERINE BIRDS; BREEDING BIRDS; FOOD; COSTS; AKEPA; POPULATION; FEATHERS	Food limitation greatly affects bird breeding performance, but the effect of nutritive stress on molt has barely been investigated outside of laboratory settings. Here we show changes in molting patterns for an entire native Hawaiian bird community at 1650-1900 m elevation on the Island of Hawaii between 1989-1999 and 2000-2006, associated with severe food limitation throughout the year beginning in 2000. Young birds and adults of all species took longer to complete their molt, including months never or rarely used during the 1989-1999 decade. These included the cold winter months and even the early months of the following breeding season. In addition, more adults of most species initiated their molt one to two months earlier, during the breeding season. Suspended molt, indicated by birds temporarily not molting primary flight feathers during the months of peak primary molt, increased in prevalence. Food limitation reached the point where individuals of all species had asymmetric molt, with different primary flight feathers molted on each wing. These multiple changes in molt, unprecedented in birds, had survival consequences. Adult birds captured during January to March, 2000-2004, had lower survival in four of five species with little effect of extended molt. Extended molt may be adaptive for a nutrient stressed bird to survive warm temperatures but not cool winter temperatures that may obliterate the energy savings. The changing molt of Hawaiian birds has many implications for conservation and for understanding life history aspects of molt of tropical birds.	[Freed, Leonard A.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Cann, Rebecca L.] Univ Hawaii Manoa, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Freed, LA (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	lfreed@hawaii.edu			John D. and Catherine T. MacArthur Foundation [8900287]; Environmental Protection Agency [82909301]	John D. and Catherine T. MacArthur Foundation; Environmental Protection Agency(United States Environmental Protection Agency)	John D. and Catherine T. MacArthur Foundation (8900287). Environmental Protection Agency (82909301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; BALDWIN PAUL H., 1953, UNIV CALIFORNIA PUBL ZOOL, V52, P285; BALMFORD A, 1993, P ROY SOC B-BIOL SCI, V252, P245, DOI 10.1098/rspb.1993.0072; Barta Z, 2006, OIKOS, V112, P580, DOI 10.1111/j.0030-1299.2006.14240.x; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Camp R. J., 2009, HCSU011 U HAW HIL; Coppack T, 2004, ADV ECOL RES, V35, P131, DOI 10.1016/S0065-2504(04)35007-5; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; DRENT RH, 1980, ARDEA, V68, P225; EVANS PGH, 1986, IBIS, V128, P558, DOI 10.1111/j.1474-919X.1986.tb02706.x; FOGDEN MPL, 1972, IBIS, V114, P307, DOI 10.1111/j.1474-919X.1972.tb00831.x; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; Freed LA, 2005, CONDOR, V107, P753, DOI 10.1650/7820.1; Freed LA, 2001, STUD AVIAN BIOL-SER, P173; Freed LA, 2008, J PARASITOL, V94, P1009, DOI 10.1645/GE-1378.1; Freed LA, 2007, EVOL ECOL RES, V9, P157; Freed LA, 2010, CONDOR, V112, P213, DOI 10.1525/cond.2010.090092; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Freed LA, 2009, EVOL ECOL RES, V11, P731; Freed LA, 2008, EVOL ECOL RES, V10, P931; Fretz JS, 2002, AUK, V119, P166, DOI 10.1642/0004-8038(2002)119[0166:SOFAFA]2.0.CO;2; GWINNER E, 1990, SCIENCE, V249, P906, DOI 10.1126/science.249.4971.906; Hedenstrom A, 1999, J EXP BIOL, V202, P67; Hemborg C, 1998, BEHAV ECOL SOCIOBIOL, V43, P19, DOI 10.1007/s002650050462; Hemborg C, 1999, ANN ZOOL FENN, V36, P1; Jenni L., 1994, BIOL MOULT BIRDS; KING JR, 1985, AM ZOOL, V25, P955; KING JR, 1984, AUK, V101, P168, DOI 10.1093/auk/101.1.168; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; Marini MA, 2001, CONDOR, V103, P767, DOI 10.1650/0010-5422(2001)103[0767:APOMAR]2.0.CO;2; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; MILLER ALDEN H., 1963, UNIV CALIF PUBL ZOOL, V66, P1; Moller A.P., 1997, ASYMMETRY DEV STABIL; Morales J, 2007, ECOSCIENCE, V14, P31, DOI 10.2980/1195-6860(2007)14[31:EMILSA]2.0.CO;2; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Murphy Mary E., 1996, P158; MURPHY ME, 1988, CAN J ZOOL, V66, P1403, DOI 10.1139/z88-206; NEGRO JJ, 1994, ARDEA, V82, P263; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Perkins R.C.L., 1903, FAUNA HAWAIIENSIS, V1, Part. 4, P365; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; PRYSJONES RP, 1982, J FIELD ORNITHOL, V53, P352; RALPH CJ, 1994, CONDOR, V96, P151, DOI 10.2307/1369072; RICKLEFS RE, 1980, AUK, V97, P38; Ricklefs Robert T., 1996, P1; Rohwer S, 2008, CONDOR, V110, P799, DOI 10.1525/cond.2008.8320; Scott J.M., 1986, STUD AVIAN BIOL, V9, P1; SNOW D. W., 1964, ZOOLOGICA [NEW YORK], V49, P1; STILES FG, 1980, IBIS, V122, P322, DOI 10.1111/j.1474-919X.1980.tb00886.x; STUTCHBURY BJM, 2001, BEHAV ECOLOGY TROPIC, P1; Swaddle JP, 1996, J AVIAN BIOL, V27, P103, DOI 10.2307/3677139; SWADDLE JP, 1994, P ROY SOC B-BIOL SCI, V255, P147, DOI 10.1098/rspb.1994.0021; THOMAS ALR, 1993, P ROY SOC B-BIOL SCI, V254, P181, DOI 10.1098/rspb.1993.0144; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Van Riper SG, 2000, BIRDS N AM; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARD P, 1969, J ZOOL, V157, P25; WILLOUGHBY EJ, 1986, CONDOR, V88, P461, DOI 10.2307/1368272; Wolfe JD, 2009, WILSON J ORNITHOL, V121, P556, DOI 10.1676/08-111.1; ZANN R, 1985, IBIS, V127, P184, DOI 10.1111/j.1474-919X.1985.tb05054.x; [No title captured]	64	29	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29834	10.1371/journal.pone.0029834	http://dx.doi.org/10.1371/journal.pone.0029834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279547	Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900025
J	Zong, M; Satoh, A; Yu, MK; Siu, KY; Ng, WY; Chan, HC; Tanner, JA; Yu, S				Zong, Min; Satoh, Ayano; Yu, Mei Kuen; Siu, Ka Yu; Ng, Wing Yan; Chan, Hsiao Chang; Tanner, Julian A.; Yu, Sidney			TRAPPC9 Mediates the Interaction between p150(Glued) and COPII Vesicles at the Target Membrane	PLOS ONE			English	Article							TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT; MAMMALIAN-CELLS; LIVING CELLS; ER EXIT; APPARATUS; DYNACTIN; PROTEIN; MICROTUBULES	Background: The transport of endoplasmic reticulum (ER)-derived COPII vesicles toward the ER-Golgi intermediate compartment (ERGIC) requires cytoplasmic dynein and is dependent on microtubules. p150(Glued), a subunit of dynactin, has been implicated in the transport of COPII vesicles via its interaction with COPII coat components Sec23 and Sec24. However, whether and how COPII vesicle tether, TRAPP (Transport protein particle), plays a role in the interaction between COPII vesicles and microtubules is currently unknown. Principle Findings: We address the functional relationship between COPII tether TRAPP and dynactin. Overexpressed TRAPP subunits interfered with microtubule architecture by competing p150(Glued) away from the MTOC. TRAPP subunit TRAPPC9 bound directly to p150(Glued) via the same carboxyl terminal domain of p150(Glued) that binds Sec23 and Sec24. TRAPPC9 also inhibited the interaction between p150(Glued) and Sec23/Sec24 both in vitro and in vivo, suggesting that TRAPPC9 serves to uncouple p150(Glued) from the COPII coat, and to relay the vesicle-dynactin interaction at the target membrane. Conclusions: These findings provide a new perspective on the function of TRAPP as an adaptor between the ERGIC membrane and dynactin. By preserving the connection between dynactin and the tethered and/or fused vesicles, TRAPP allows nascent ERGIC to continue the movement along the microtubules as they mature into the cis-Golgi.	[Zong, Min; Siu, Ka Yu; Ng, Wing Yan; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Satoh, Ayano] Okayama Univ, Okayama, Japan; [Yu, Mei Kuen; Chan, Hsiao Chang; Yu, Sidney] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Tanner, Julian A.; Yu, Sidney] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China	Chinese University of Hong Kong; Okayama University; Chinese University of Hong Kong; University of Hong Kong	Zong, M (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	Sidney.yu@cuhk.edu.hk	Satoh, Ayano/B-2423-2011; Zong, Min/B-6706-2016; Chan, Hsiao Chang/E-1507-2016; Bin Sidney Yu, Siu/R-4936-2018; Tanner, Julian A./C-4412-2009	Satoh, Ayano/0000-0003-3736-1283; Zong, Min/0000-0001-9381-5791; Bin Sidney Yu, Siu/0000-0001-9643-2729; Tanner, Julian A./0000-0002-5459-1526	Hong Kong Research Grant Council [479410]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work is supported by the general research fund to SY (grant number 479410) by the Hong Kong Research Grant Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lord C, 2011, NATURE, V473, P181, DOI 10.1038/nature09969; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; ROGALSKI AA, 1984, J CELL BIOL, V99, P1101, DOI 10.1083/jcb.99.3.1101; Roghi C, 1999, J CELL SCI, V112, P4673; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SCRIVENS PJ, 2011, MOL BIOL CELL; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Stephens DJ, 2000, J CELL SCI, V113, P2177; Tang BL, 1997, MOL CELL BIOL, V17, P256, DOI 10.1128/MCB.17.1.256; Trahey Meg, 2010, F1000 Biol Rep, V2, P47; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; WEHLAND J, 1983, P NATL ACAD SCI-BIOL, V80, P4286, DOI 10.1073/pnas.80.14.4286; YAMASAKI A, 2009, MOL BIOL CELL; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044; Zahoor MA, 2010, J GEN VIROL, V91, P1939, DOI 10.1099/vir.0.020990-0; Zong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023350	36	33	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29995	10.1371/journal.pone.0029995	http://dx.doi.org/10.1371/journal.pone.0029995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279557	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900035
J	Chan, CW; Spathis, R; Reiff, DM; McGrath, SE; Garruto, RM; Lum, JK				Chan, Chim W.; Spathis, Rita; Reiff, Dana M.; McGrath, Stacy E.; Garruto, Ralph M.; Lum, J. Koji			Diversity of Plasmodium falciparum Chloroquine Resistance Transporter (pfcrt) Exon 2 Haplotypes in the Pacific from 1959 to 1979	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; TRANSMEMBRANE PROTEIN PFCRT; SOUTHWEST PACIFIC; MALARIA-ERADICATION; GENETIC DIVERSITY; CEREBRAL MALARIA; DRUG-RESISTANCE; EPIDEMIOLOGY; MUTATIONS; VANUATU	Nearly one million deaths are attributed to malaria every year. Recent reports of multi-drug treatment failure of falciparum malaria underscore the need to understand the molecular basis of drug resistance. Multiple mutations in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) are involved in chloroquine resistance, but the evolution of complex haplotypes is not yet well understood. Using over 4,500 archival human serum specimens collected from 19 Pacific populations between 1959 and 1979, the period including and just prior to the appearance of chloroquine treatment failure in the Pacific, we PCR-amplified and sequenced a portion of the pfcrt exon 2 from 771 P. falciparum-infected individuals to explore the spatial and temporal variation in falciparum malaria prevalence and the evolution of chloroquine resistance. In the Pacific, the prevalence of P. falciparum varied considerably across ecological zones. On the island of New Guinea, the decreases in prevalence of P. falciparum in coastal, high-transmission areas over time were contrasted by the increase in prevalence during the same period in the highlands, where transmission was intermittent. We found 78 unique pfcrt haplotypes consisting of 34 amino acid substitutions and 28 synonymous mutations. More importantly, two pfcrt mutations (N75D and K76T) implicated in chloroquine resistance were present in parasites from New Hebrides (now Vanuatu) eight years before the first report of treatment failure. Our results also revealed unexpectedly high levels of genetic diversity in pfcrt exon 2 prior to the historical chloroquine resistance selective sweep, particularly in areas where disease burden was relatively low. In the Pacific, parasite genetic isolation, as well as host acquired immune status and genetic resistance to malaria, were important contributors to the evolution of chloroquine resistance in P. falciparum.	[Chan, Chim W.; Spathis, Rita; Reiff, Dana M.; Lum, J. Koji] SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY USA; [Chan, Chim W.; Spathis, Rita; Reiff, Dana M.; Garruto, Ralph M.] SUNY Binghamton, Lab Biomed Anthropol & Neurosci, Binghamton, NY USA; [Chan, Chim W.; Spathis, Rita; Reiff, Dana M.; McGrath, Stacy E.; Garruto, Ralph M.; Lum, J. Koji] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Garruto, Ralph M.; Lum, J. Koji] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Chan, CW (corresponding author), SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY USA.	aramidus44@gmail.com		Chan, Chim/0000-0002-4039-2649; Garruto, Ralph M./0000-0003-4985-8190	United States National Institutes of Health [R01GM080593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080593] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for the study was provided by the United States National Institutes of Health (R01GM080593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 1999, AM J TROP MED HYG, V60, P1056, DOI 10.4269/ajtmh.1999.60.1056; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], 2009, WORLD MAL REP 2009; Ariey F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-34; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BOWDEN DK, 1982, MED J AUSTRALIA, V2, P561, DOI 10.5694/j.1326-5377.1982.tb132573.x; BROWN P, 1976, AM J TROP MED HYG, V25, P775, DOI 10.4269/ajtmh.1976.25.775; Chan CW, 2006, ACTA TROP, V99, P15, DOI 10.1016/j.actatropica.2006.05.011; CLYDE DF, 1976, J TROP MED HYG, V79, P38; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; DULAY IS, 1987, PAPUA NEW GUINEA MED, V30, P281; Durand R, 2001, MOL BIOCHEM PARASIT, V114, P95, DOI 10.1016/S0166-6851(01)00247-X; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; GENTON B, 1995, NATURE, V378, P564, DOI 10.1038/378564a0; Hastings IM, 2005, ACTA TROP, V94, P218, DOI 10.1016/j.actatropica.2005.04.003; HILL AVS, 1988, BLOOD, V72, P9; Huaman MC, 2004, AM J TROP MED HYG, V71, P40, DOI 10.4269/ajtmh.2004.71.40; Joy RJT, 1999, MED HIST, V43, P192, DOI 10.1017/S002572730006508X; Kaneko A, 1998, ACTA TROP, V70, P285, DOI 10.1016/S0001-706X(98)00035-7; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lim P, 2003, ANTIMICROB AGENTS CH, V47, P87, DOI 10.1128/AAC.47.1.87-94.2003; Lum JK, 2007, ACTA TROP, V103, P102, DOI 10.1016/j.actatropica.2007.05.012; Lum JK, 2004, ACTA TROP, V90, P181, DOI 10.1016/j.actatropica.2003.09.022; Mehlotra RK, 2005, J INFECT DIS, V192, P2174, DOI 10.1086/497694; Mehlotra RK, 2001, P NATL ACAD SCI USA, V98, P12689, DOI 10.1073/pnas.221440898; METSELAAR D, 1961, AM J TROP MED HYG, V10, P327, DOI 10.4269/ajtmh.1961.10.327; Mgone CS, 1996, T ROY SOC TROP MED H, V90, P228, DOI 10.1016/S0035-9203(96)90223-0; Mita T, 2004, MOL BIOCHEM PARASIT, V135, P159, DOI 10.1016/j.molbiopara.2004.01.011; Mita T, 2006, ACTA TROP, V98, P137, DOI 10.1016/j.actatropica.2006.03.002; Mueller I, 2005, AM J TROP MED HYG, V72, P554, DOI 10.4269/ajtmh.2005.72.554; Mueller I, 2003, P N G MED J, V3-4, P166; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Nagesha HS, 2003, AM J TROP MED HYG, V68, P398, DOI 10.4269/ajtmh.2003.68.398; Nei M., 1987, MOL EVOLUTIONARY GEN; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Okombo J, 2011, MOL BIOCHEM PARASIT, V177, P77, DOI 10.1016/j.molbiopara.2011.01.012; PARKINSON AD, 1980, MED J AUSTRALIA, V2, P637; Peters W., 1984, Antimalarial drugs. 1: Biological background, experimental methods, and drug resistance. (Handbook of Experimental Pharmacology, Volume 68 No. 1.), P423; PETERS W, 1962, ANN TROP MED PARASIT, V56, P20, DOI 10.1080/00034983.1962.11686085; RADFORD AJ, 1976, ANN TROP MED PARASIT, V70, P11, DOI 10.1080/00034983.1976.11687091; Saito-Nakano Y, 2008, AM J TROP MED HYG, V79, P613, DOI 10.4269/ajtmh.2008.79.613; SERJEANTSON SW, 1989, PAPUA NEW GUINEA MED, V32, P5; SIMON F, 1986, T ROY SOC TROP MED H, V80, P996, DOI 10.1016/0035-9203(86)90290-7; SMITHURST B. A., 1970, Southeast Asian Journal of Tropical Medicine and Public Health, V1, P117; SPENCER M, 1992, PAPUA NEW GUINEA MED, V35, P33; Sweeney A. W., 2000, Parassitologia (Rome), V42, P33; Sweeney AW, 1996, INT J PARASITOL, V26, P1035, DOI 10.1016/S0020-7519(97)81288-X; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; WARHURST DC, 1981, BIOCHEM PHARMACOL, V30, P3323, DOI 10.1016/0006-2952(81)90606-7; WARSAME M, 1991, T ROY SOC TROP MED H, V85, P565, DOI 10.1016/0035-9203(91)90343-W; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Yung A P, 1976, Med J Aust, V2, P845	57	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30213	10.1371/journal.pone.0030213	http://dx.doi.org/10.1371/journal.pone.0030213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272308	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400086
J	Elsherif, L; Wang, XR; Grachoff, M; Wolska, BM; Geenen, DL; O'Bryan, JP				Elsherif, Laila; Wang, Xuerong; Grachoff, Milana; Wolska, Beata M.; Geenen, David L.; O'Bryan, John P.			Cardiac-Specific Expression of the Tetracycline Transactivator Confers Increased Heart Function and Survival Following Ischemia Reperfusion Injury	PLOS ONE			English	Article							ISCHAEMIA/REPERFUSION INJURY; GENE-EXPRESSION; INFARCT SIZE; MOUSE HEARTS; IN-VIVO; TRANSGENESIS; MICE; MYOCARDIUM; PATHWAY; IMPACT	Mice expressing the tetracycline transactivator (tTA) transcription factor driven by the rat alpha-myosin heavy chain promoter (alpha-MHC-tTA) are widely used to dissect the molecular mechanisms involved in cardiac development and disease. However, these alpha-MHC-tTA mice exhibit a gain-of-function phenotype consisting of robust protection against ischemia/reperfusion injury in both in vitro and in vivo models in the absence of associated cardiac hypertrophy or remodeling. Cardiac function, as assessed by echocardiography, did not differ between alpha-MHC-tTA and control animals, and there were no noticeable differences observed between the two groups in HW/TL ratio or LV end-diastolic and end-systolic dimensions. Protection against ischemia/reperfusion injury was assessed using isolated perfused hearts where alpha-MHC-tTA mice had robust protection against ischemia/reperfusion injury which was not blocked by pharmacological inhibition of PI3Ks with LY294002. Furthermore, alpha-MHC-tTA mice subjected to coronary artery ligation exhibited significantly reduced infarct size compared to control animals. Our findings reveal that alpha-MHC-tTA transgenic mice exhibit a gain-of-function phenotype consisting of robust protection against ischemia/reperfusion injury similar to cardiac pre- and post-conditioning effects. However, in contrast to classical pre- and post-conditioning, the alpha-MHC-tTA phenotype is not inhibited by the classic preconditioning inhibitor LY294002 suggesting involvement of a non-PI3K-AKT signaling pathway in this phenotype. Thus, further study of the alpha-MHC-tTA model may reveal novel molecular targets for therapeutic intervention during ischemic injury.	[Elsherif, Laila; Wang, Xuerong; O'Bryan, John P.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA; [Grachoff, Milana; Wolska, Beata M.; Geenen, David L.] Univ Illinois, Coll Med, Cardiol Sect, Dept Med, Chicago, IL USA; [Wolska, Beata M.; Geenen, David L.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA; [Wolska, Beata M.; Geenen, David L.; O'Bryan, John P.] Univ Illinois, Coll Med, Cardiovasc Res Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Elsherif, L (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA.	obryanj@uic.edu	Elsherif, Laila/AAT-9307-2021	O'Bryan, John/0000-0001-5386-1080	National Institutes of Health [HL090651]; Department of Defense [PR080428]; Foundation Jerome Lejeune; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Foundation Jerome Lejeune; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from the National Institutes of Health (HL090651), the Department of Defense (PR080428), and the Foundation Jerome Lejeune. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; DEBOER LWV, 1980, P NATL ACAD SCI-BIOL, V77, P6119, DOI 10.1073/pnas.77.10.6119; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Loyer X, 2008, CIRCULATION, V117, P3187, DOI 10.1161/CIRCULATIONAHA.107.741702; McCloskey DT, 2005, PHYSIOL GENOMICS, V22, P118, DOI 10.1152/physiolgenomics.00016.2005; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; O'Bryan JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3152re10; PASSMAN RS, 1994, J CLIN INVEST, V94, P2421, DOI 10.1172/JCI117609; Redel A, 2008, EXP BIOL MED, V233, P84, DOI 10.3181/0612-RM-308; Reichelt ME, 2009, EXP PHYSIOL, V94, P54, DOI 10.1113/expphysiol.2008.043554; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Sainte-Marie Y, 2007, FASEB J, V21, P3133, DOI 10.1096/fj.07-8357com; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Sutherland FJ, 2003, CLIN EXP PHARMACOL P, V30, P867, DOI 10.1046/j.1440-1681.2003.03925.x; Tian R, 1999, P NATL ACAD SCI USA, V96, P13536, DOI 10.1073/pnas.96.23.13536; Turnbull L, 2006, AM J PHYSIOL-HEART C, V290, pH1103, DOI 10.1152/ajpheart.00732.2005; Wang QD, 2001, ACTA PHYSIOL SCAND, V171, P123, DOI 10.1046/j.1365-201x.2001.00788.x; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Yu ZH, 1996, CIRC RES, V79, P691, DOI 10.1161/01.RES.79.4.691	21	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30129	10.1371/journal.pone.0030129	http://dx.doi.org/10.1371/journal.pone.0030129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272284	Green Published, gold			2022-12-25	WOS:000301454400062
J	Pavlowsky, A; Alarcon, JM				Pavlowsky, Alice; Alarcon, Juan Marcos			Interaction between Long-Term Potentiation and Depression in CA1 Synapses: Temporal Constrains, Functional Compartmentalization and Protein Synthesis	PLOS ONE			English	Article							LATERAL PERFORANT PATH; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; GAMMA-OSCILLATIONS; DENTATE GYRUS; HETEROSYNAPTIC LTD; THETA OSCILLATIONS; PYRAMIDAL NEURONS; GENE-EXPRESSION; SPATIAL MEMORY	Information arriving at a neuron via anatomically defined pathways undergoes spatial and temporal encoding. A proposed mechanism by which temporally and spatially segregated information is encoded at the cellular level is based on the interactive properties of synapses located within and across functional dendritic compartments. We examined cooperative and interfering interactions between long-term synaptic potentiation (LTP) and depression (LTD), two forms of synaptic plasticity thought to be key in the encoding of information in the brain. Two approaches were used in CA1 pyramidal neurons of the mouse hippocampus: (1) induction of LTP and LTD in two separate synaptic pathways within the same apical dendritic compartment and across the basal and apical dendritic compartments; (2) induction of LTP and LTD separated by various time intervals (0-90 min). Expression of LTP/LTD interactions was spatially and temporally regulated. While they were largely restricted within the same dendritic compartment (compartmentalized), the nature of the interaction (cooperation or interference) depended on the time interval between inductions. New protein synthesis was found to regulate the expression of the LTP/LTD interference. We speculate that mechanisms for compartmentalization and protein synthesis confer the spatial and temporal modulation by which neurons encode multiplex information in plastic synapses.	[Pavlowsky, Alice; Alarcon, Juan Marcos] Suny Downstate Med Ctr, Dept Pathol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Pavlowsky, A (corresponding author), Suny Downstate Med Ctr, Dept Pathol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA.	juanmarcos.alarcon@downstate.edu	pavlowsky, alice/ABB-6528-2021	pavlowsky, alice/0000-0001-6873-0577	Phillipe Foundation	Phillipe Foundation	AP had an additional external funding by the Phillipe Foundation. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM WC, 1994, P NATL ACAD SCI USA, V91, P10049, DOI 10.1073/pnas.91.21.10049; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; ABRAHAM WC, 1985, J PHYSIOL-LONDON, V363, P335, DOI 10.1113/jphysiol.1985.sp015714; Alarcon JM, 2006, J NEUROSCI, V26, P256, DOI 10.1523/JNEUROSCI.3196-05.2006; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; Bartsch D, 2000, CELL, V103, P595, DOI 10.1016/S0092-8674(00)00163-X; Bastiaansen MCM, 2002, NEUROIMAGE, V17, P1479, DOI 10.1006/nimg.2002.1275; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Chen CF, 2001, NEURON, V31, P510, DOI 10.1016/S0896-6273(01)00405-6; CHRISTIE BR, 1995, HIPPOCAMPUS, V5, P52, DOI 10.1002/hipo.450050107; CHRISTIE BR, 1994, NEUROSCI LETT, V167, P41, DOI 10.1016/0304-3940(94)91023-5; CHRISTIE BR, 1995, J NEUROPHYSIOL, V74, P1244, DOI 10.1152/jn.1995.74.3.1244; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Cowan AI, 1998, J NEUROPHYSIOL, V79, P13, DOI 10.1152/jn.1998.79.1.13; Deuchars J, 1996, NEUROSCIENCE, V74, P1009, DOI 10.1016/S0306-4522(96)00251-5; Diba K, 2008, J NEUROSCI, V28, P13448, DOI 10.1523/JNEUROSCI.3824-08.2008; Dolleman-Van Der Weel M. J., 1996, Journal of Comparative Neurology, V364, P637, DOI 10.1002/(SICI)1096-9861(19960122)364:4<637::AID-CNE3>3.0.CO;2-4; Doyere V, 1997, J NEUROPHYSIOL, V77, P571, DOI 10.1152/jn.1997.77.2.571; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Drew GM, 1998, NEUROREPORT, V9, P1827, DOI 10.1097/00001756-199806010-00029; Dudek SM, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0002.2001; Fenton AA, 2008, J NEUROSCI, V28, P11250, DOI 10.1523/JNEUROSCI.2862-08.2008; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Holland LL, 1998, J NEUROSCI, V18, P887; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; KATZ B, 1970, J PHYSIOL-LONDON, V207, P789, DOI 10.1113/jphysiol.1970.sp009095; Kelemen E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000403; Kloosterman F, 2001, J NEUROPHYSIOL, V86, P2435, DOI 10.1152/jn.2001.86.5.2435; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kosub KA, 2005, NEUROSCI LETT, V374, P29, DOI 10.1016/j.neulet.2004.10.028; KOTZ KJ, 1994, J CELL BIOL, V124, P463, DOI 10.1083/jcb.124.4.463; Kramar EA, 2003, NEUROSCIENCE, V118, P387, DOI 10.1016/S0306-4522(02)00916-8; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Le Ray D, 2004, HIPPOCAMPUS, V14, P1011, DOI 10.1002/hipo.20021; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Marder CP, 2003, J NEUROSCI, V23, P112; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MULLER D, 1995, NEURON, V14, P599, DOI 10.1016/0896-6273(95)90316-X; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OTANI S, 1995, LEARN MEMORY, V2, P101, DOI 10.1101/lm.2.2.101; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; PANG K, 1993, BRAIN RES, V632, P150, DOI 10.1016/0006-8993(93)91150-Q; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Reymann KG, 2006, NEUROPHARMACOLOGY; Rodionov V, 2003, CURR BIOL, V13, P1837, DOI 10.1016/j.cub.2003.10.027; Roth-Alpermann C, 2006, P NATL ACAD SCI USA, V103, P11039, DOI 10.1073/pnas.0600894103; Sajikumar S, 2004, NEUROBIOL LEARN MEM, V82, P12, DOI 10.1016/j.nlm.2004.03.003; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; Salinska E, 2003, NEUROCHEM INT, V43, P469, DOI 10.1016/S0197-0186(03)00036-6; Schuman EM, 2006, J NEUROSCI, V26, P7143, DOI 10.1523/JNEUROSCI.1796-06.2006; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; STEWARD O, 1986, J NEUROSCI, V6, P412; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Wang HY, 1999, J NEUROPHYSIOL, V82, P2024, DOI 10.1152/jn.1999.82.4.2024; Wang ZR, 2003, NEURON, V37, P463, DOI 10.1016/S0896-6273(02)01189-3; WHITE G, 1990, J NEUROPHYSIOL, V64, P1186, DOI 10.1152/jn.1990.64.4.1186; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Young JZ, 2005, J NEUROSCI, V25, P7221, DOI 10.1523/JNEUROSCI.0909-05.2005	89	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29865	10.1371/journal.pone.0029865	http://dx.doi.org/10.1371/journal.pone.0029865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272255	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400034
J	Rawlinson, D; Kowadlo, G				Rawlinson, David; Kowadlo, Gideon			Generating Adaptive Behaviour within a Memory-Prediction Framework	PLOS ONE			English	Article							BASAL GANGLIA; INFERENCE; CORTEX	The Memory-Prediction Framework (MPF) and its Hierarchical-Temporal Memory implementation (HTM) have been widely applied to unsupervised learning problems, for both classification and prediction. To date, there has been no attempt to incorporate MPF/HTM in reinforcement learning or other adaptive systems; that is, to use knowledge embodied within the hierarchy to control a system, or to generate behaviour for an agent. This problem is interesting because the human neocortex is believed to play a vital role in the generation of behaviour, and the MPF is a model of the human neocortex. We propose some simple and biologically-plausible enhancements to the Memory-Prediction Framework. These cause it to explore and interact with an external world, while trying to maximize a continuous, time-varying reward function. All behaviour is generated and controlled within the MPF hierarchy. The hierarchy develops from a random initial configuration by interaction with the world and reinforcement learning only. Among other demonstrations, we show that a 2-node hierarchy can learn to successfully play "rocks, paper, scissors" against a predictable opponent.	[Rawlinson, David] Univ Melbourne, Dept Elect & Elect Engn, Natl ICT Australia, Melbourne, Vic 3010, Australia; [Kowadlo, Gideon] Outware Mobile Pty Ltd, Melbourne, Vic, Australia	NICTA; University of Melbourne	Rawlinson, D (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, Natl ICT Australia, Melbourne, Vic 3010, Australia.	david.rawlinson@nicta.com.au		Kowadlo, Gideon/0000-0001-6036-1180				[Anonymous], 2005, INTELLIGENCE; [Anonymous], 2001, P 18 INT C MACHINE L; Attias H., 2003, INT WORKSHOP ARTIFIC, P9; Barto AG, 2003, DISCRETE EVENT DYN S, V13, P41, DOI 10.1023/A:1025696116075; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Dayan P., 2001, ENCY COGNITIVE SCI; Garalevicius S. J., 2007, P 20 INT FLOR ART IN, P92; George D, 2005, IEEE IJCNN, P1812; George D., 2008, THESIS STANFORD U; George D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000532; Gold JI, 2003, TRENDS NEUROSCI, V26, P12, DOI 10.1016/S0166-2236(02)00002-4; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hawkins J, 2009, PHILOS T R SOC B, V364, P1203, DOI 10.1098/rstb.2008.0322; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Jaakkola T, 1995, ADV NEURAL INFORM PR; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kim J.H., 1983, INT JT C ART INT, P0; Kohonen T., 2001, SELF ORG MAPS, P501; Kwang-Ho Seok, 2008, 2008 International Conference on Control, Automation and Systems (ICCAS), P2058, DOI 10.1109/ICCAS.2008.4694474; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Littman M, 1994, ANIMALS ANIMATS; Marthi B, 2005, P NAT C ART INT, V20; Maxwell JB, 2008, ISMIR 2008; Miller JW, 2006, P SPIE INT SOC OPTIC, V6384, P63840; Morse A., 2009, P 31 ANN C COGN SCI; Morse AF, 2010, IEEE T AUTON MENT DE, V2, P325, DOI 10.1109/TAMD.2010.2087020; Numenta, 2010, HIER TEMP MEM INCL H; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pinto R, 2009, P 7 ENIA BRAZILIAN M; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Reiner A, 2009, ADV BEHAV BIOL, V58, P3, DOI 10.1007/978-1-4419-0340-2_1; Russell S, 2009, ARTIFICIAL INTELLIGE; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Skelly M, 2008, THESIS CASE W RESERV; Stocco A, 2010, PSYCHOL REV, V117, P541, DOI 10.1037/a0019077; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1999, ARTIF INTELL, V112, P181, DOI 10.1016/S0004-3702(99)00052-1; Thornton J, 2008, AI 2008 ADV ARTIFICI; Thornton J, 2006, AI 2006 ADV ARTIFICI; Toussaint M, 2006, P 26 INT C MACH LEAR; van Doremalen J, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P2566; van Hasselt H, 2001, REINFORCEMENT LEARNI; Vlassis N, 2009, P 26 INT C MACH LEAR	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29264	10.1371/journal.pone.0029264	http://dx.doi.org/10.1371/journal.pone.0029264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272231	Green Published, gold			2022-12-25	WOS:000301454400010
J	Wong, CK; Leung, KML; Qiu, HN; Chow, JYS; Choi, AOK; Lam, CWK				Wong, Chun-Kwok; Leung, Karen Ming-Lam; Qiu, Huai-Na; Chow, Joyce Yin-Sau; Choi, Angela On Kei; Lam, Christopher Wai-Kei			Activation of Eosinophils Interacting with Dermal Fibroblasts by Pruritogenic Cytokine IL-31 and Alarmin IL-33: Implications in Atopic Dermatitis	PLOS ONE			English	Article							T-CELLS; SCRATCHING BEHAVIOR; NC/NGA MICE; EXPRESSION; RECEPTOR; INTERLEUKIN-31; MECHANISMS; CHEMOKINES; DISEASE; INVOLVEMENT	Background: IL-31 is a pruritogenic cytokine, and IL-33 is an alarmin for damaging inflammation. They together relate to the pathogenesis of atopic dermatitis (AD). Eosinophil infiltration into the inner dermal compartment is a predominant pathological feature of AD. We herein investigated the in vitro inflammatory effects of IL-31 and IL-33 on the activation of human eosinophils and dermal fibroblasts. Methodology/Principal Findings: Receptors, adhesion molecules and signaling molecules were assessed by Western blot or flow cytometry. Chemokines and cytokine were quantitated by multiplex assay. Functional IL-31 receptor component IL-31RA, OSMR-beta and IL-33 receptor component ST2 were constitutively expressed on the surface of eosinophils. Co-culture of eosinophils and fibroblasts significantly induced pro-inflammatory cytokine IL-6 and AD-related chemokines CXCL1, CXCL10, CCL2 and CCL5. Such inductions were further enhanced with IL-31 and IL-33 stimulation. IL-31 and IL-33 could significantly provoke the release of CXCL8 from eosinophils and fibroblasts, respectively, which was further enhanced upon co-culture. In co-culture, eosinophils and fibroblasts were the main source for the release of CCL5, and IL-6, CXCL1, CXCL8, CXCL10 and CCL2, respectively. Direct interaction between eosinophils and fibroblasts was required for CXCL1, CXCL10, CXCL8 and CCL5 release. Cell surface expression of intercellular adhesion molecule-1 on eosinophils and fibroblasts was up-regulated in co-culture upon IL-31 and IL-33 stimulation. The interaction between eosinophils and fibroblasts under IL-31 and IL-33 stimulation differentially activated extracellular signal-regulated kinase, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase, nuclear factor-kappa B and phosphatidylinositol 3-kinase-Akt pathways. Using specific signaling molecule inhibitors, the differential induction of IL-31 and IL-33-mediated release of cytokines and chemokines such as IL-6 and CXCL8 from co-culture should be related to their distinct activation profile of intracellular signaling pathways. Conclusions/Significance: The above findings suggest a crucial immunopathological role of IL-31 and IL-33 in AD through the activation of eosinophils-fibroblasts interaction via differential intracellular signaling mechanisms.	[Wong, Chun-Kwok; Leung, Karen Ming-Lam; Qiu, Huai-Na; Chow, Joyce Yin-Sau; Choi, Angela On Kei; Lam, Christopher Wai-Kei] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Lam, Christopher Wai-Kei] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, Taipa, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Macau University of Science & Technology	Wong, CK (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China.	ck-wong@cuhk.edu.hk	Wong, CK/H-3256-2016	Wong, CK/0000-0002-5637-8331	Research Grant Committee, Hong Kong [CUHK475708]	Research Grant Committee, Hong Kong(Hong Kong Research Grants Council)	This work was supported by the Research Grant Committee General Research Fund, Hong Kong (Project ref. no. CUHK475708, Principal investigator: CKW, Co-investigator: CWKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae Chang-Joon, 2010, Allergology International, V59, P389, DOI 10.2332/allergolint.10-OA-0207; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; BRUIJNZEEL PLB, 1993, CLIN EXP ALLERGY, V23, P97, DOI 10.1111/j.1365-2222.1993.tb00304.x; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; Cheung PFY, 2008, J IMMUNOL, V180, P5625, DOI 10.4049/jimmunol.180.8.5625; Cheung PFY, 2010, INT IMMUNOL, V22, P453, DOI 10.1093/intimm/dxq027; Chow JYS, 2010, CELL MOL IMMUNOL, V7, P26, DOI 10.1038/cmi.2009.106; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; del Giudice MM, 2006, ALLERGY ASTHMA PROC, V27, P451, DOI 10.2500/aap.2006.27.2887; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Diveu C, 2004, EUR CYTOKINE NETW, V15, P291; Dreuw A, 2004, J BIOL CHEM, V279, P36112, DOI 10.1074/jbc.M401122200; Farina G, 2011, ANN RHEUM DIS, V70, P544, DOI 10.1136/ard.2010.132464; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Homey B, 2006, J ALLERGY CLIN IMMUN, V118, P178, DOI 10.1016/j.jaci.2006.03.047; Hong SW, 2011, ALLERGY, V66, P351, DOI 10.1111/j.1398-9995.2010.02483.x; Jawa RS, 2008, J INTERF CYTOK RES, V28, P207, DOI 10.1089/jir.2007.0057; Jenerowicz Dorotaz, 2006, Acta Dermatovenerol Croat, V14, P73; Kanda N, 2007, CLIN EXP ALLERGY, V37, P1074, DOI 10.1111/j.1365-2222.2007.02743.x; Kasraie S, 2011, ALLERGY, V66, P845, DOI 10.1111/j.1398-9995.2011.02545.x; Kiehl P, 2001, BRIT J DERMATOL, V145, P720, DOI 10.1046/j.1365-2133.2001.04456.x; Kim NH, 2007, J INVEST DERMATOL, V127, P2612, DOI 10.1038/sj.jid.5700900; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; LEE CE, 1992, J ALLERGY CLIN IMMUN, V89, P1010, DOI 10.1016/0091-6749(92)90224-P; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Navarini AA, 2011, J ALLERGY CLIN IMMUN, V128, P1128, DOI 10.1016/j.jaci.2011.09.009; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; NICKOLOFF BJ, 1990, J INVEST DERMATOL, V94, pS151, DOI 10.1111/1523-1747.ep12876134; Nobbe S, 2012, ACTA DERM-VENEREOL, V92, P24, DOI 10.2340/00015555-1191; Pastore S, 2005, J IMMUNOL, V174, P5047, DOI 10.4049/jimmunol.174.8.5047; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Raap U, 2008, J ALLERGY CLIN IMMUN, V122, P421, DOI 10.1016/j.jaci.2008.05.047; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schroder JM, 1999, BIOL CHEM, V380, P889, DOI 10.1515/BC.1999.109; Simon D, 2004, ALLERGY, V59, P561, DOI 10.1111/j.1398-9995.2004.00476.x; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Taniuchi S, 2001, J DERMATOL SCI, V26, P79, DOI 10.1016/S0923-1811(00)00151-1; TOSHITANI A, 1993, J INVEST DERMATOL, V100, P299, DOI 10.1111/1523-1747.ep12469875; UEHARA M, 1990, CLIN EXP DERMATOL, V15, P264, DOI 10.1111/j.1365-2230.1990.tb02086.x; Wardlaw A, 2004, CLIN EXP ALLERGY, V34, P676, DOI 10.1111/j.1365-2222.2004.1944.x; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803; Wong CK, 2007, AM J RESP CELL MOL, V37, P85, DOI 10.1165/rcmb.2006-0457OC; Wong CK, 2007, EUR J IMMUNOL, V37, P2337, DOI 10.1002/eji.200636866; Wong CK, 2003, ADV CLIN CHEM, V37, P1, DOI 10.1016/S0065-2423(03)37005-2; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418	51	65	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29815	10.1371/journal.pone.0029815	http://dx.doi.org/10.1371/journal.pone.0029815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272250	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400029
J	Lee, MH; Na, H; Kim, EJ; Lee, HW; Lee, MO				Lee, M-H; Na, H.; Kim, E-J; Lee, H-W; Lee, M-O			Poly(ADP-ribosyl)ation of p53 induces gene-specific transcriptional repression of MTA1	ONCOGENE			English	Article						MTA1; p53; PARP-1; poly(ADP-ribose)ylation	DNA-DAMAGE RESPONSE; HEPATOCELLULAR-CARCINOMA; COVALENT POLY(ADP-RIBOSYL)ATION; UNMETHYLATED STATE; POLYMERASE PARP; EXPRESSION; BINDING; PROTEIN; METASTASIS; APOPTOSIS	The metastasis-associated protein 1 (MTA1) is overexpressed in various human cancers and is closely connected with aggressive phenotypes; however, little is known about the transcriptional regulation of the MTA1 gene. This study identified the MTA1 gene as a target of p53-mediated transrepression. The MTA1 promoter contains two putative p53 response elements (p53REs), which were repressed by the p53-inducing drug 5-fluorouracil (5-FU). Notably, 5-FU treatment decreased MTA1 expression only in p53 wild-type cells. p53 and histone deacetylases 1/2 were recruited, and acetylation of H3K9 was decreased on the promoter region including the p53REs after 5-FU treatment. Proteomics analysis of the p53 repressor complex, which was pulled down by the MTA1 promoter, revealed that the poly(ADP-ribose) polymerase 1 (PARP-1) was part of the complex. Interestingly, p53 was poly(ADP-ribose)ylated by PARP-1, and the p53-mediated transrepression of the MTA1 gene required poly(ADP-ribose)ylation of p53. In summary, we report a novel function for poly(ADP-ribose)ylation of p53 in the gene-specific regulation of the transcriptional mode of p53 on the promoter of MTA1. Oncogene (2012) 31, 5099-5107; doi:10.1038/onc.2012.2; published online 30 January 2012	[Lee, M-H; Na, H.; Kim, E-J; Lee, M-O] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea; [Lee, M-H; Na, H.; Lee, M-O] Seoul Natl Univ, BioMAX Inst, Seoul 151742, South Korea; [Lee, H-W] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Lee, H-W] Yonsei Univ, Lab Anim Res Ctr, Seoul 120749, South Korea	Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University	Lee, MO (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea.	molee@snu.ac.kr	Na, Hyelin/K-7303-2016	Na, Hyelin/0000-0002-9118-5084	NRF [2009-0080757]; SRC/ERC [R11-2007-107-01001-0]	NRF; SRC/ERC(European Research Council (ERC))	This work was supported by grants from the NRF (2009-0080757), and the SRC/ERC (R11-2007-107-01001-0).	Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Esteve PO, 2005, P NATL ACAD SCI USA, V102, P1000, DOI 10.1073/pnas.0407729102; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kai L, 2011, PROSTATE, V71, P268, DOI 10.1002/pros.21240; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kumari SR, 1998, CANCER RES, V58, P5075; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Li DQ, 2010, J BIOL CHEM, V285, P19802, DOI 10.1074/jbc.M109.085258; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Lu H, 2011, J BIOL CHEM, V286, P20335, DOI 10.1074/jbc.M110.215632; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Mehrotra P, 2011, J BIOL CHEM, V286, P1767, DOI 10.1074/jbc.M110.157768; Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200; Moon HE, 2006, ONCOL REP, V16, P929; Morton JP, 2008, AM J PATHOL, V172, P1081, DOI 10.2353/ajpath.2008.070778; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; O'Shaughnessy J, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.1007; Petty RD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-434; Porta C, 2005, ONCOGENE, V24, P605, DOI 10.1038/sj.onc.1208204; Qian HL, 2005, CLIN EXP METASTAS, V22, P653, DOI 10.1007/s10585-006-9005-2; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Simbulan-Rosenthal CM, 1999, CANCER RES, V59, P2190; Sung YH, 2010, CANCER RES, V70, P10454, DOI 10.1158/0008-5472.CAN-10-0031; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang B, 2010, CELL CYCLE, V9, P870, DOI 10.4161/cc.9.5.10825; Wang B, 2009, P NATL ACAD SCI USA, V106, P14373, DOI 10.1073/pnas.0903284106; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; WesierskaGadek J, 1996, BIOCHEM BIOPH RES CO, V224, P96, DOI 10.1006/bbrc.1996.0990; Yap TA, 2011, CA-CANCER J CLIN, V61, P31, DOI 10.3322/caac.20095; Yoo YG, 2008, ONCOGENE, V27, P3405, DOI 10.1038/sj.onc.1211000; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Zampieri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004717; Zardo G, 1998, J BIOL CHEM, V273, P16517, DOI 10.1074/jbc.273.26.16517	44	38	41	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2012	31	49					5099	5107		10.1038/onc.2012.2	http://dx.doi.org/10.1038/onc.2012.2			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	049RK	22286760				2022-12-25	WOS:000312000900006
J	Kudo, K; Gavin, E; Das, S; Amable, L; Shevde, LA; Reed, E				Kudo, K.; Gavin, E.; Das, S.; Amable, L.; Shevde, L. A.; Reed, E.			Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct repair	ONCOGENE			English	Article						Gli1; ERCC1; XPD; XRCC1; cisplatin; ovarian cancer	MESSENGER-RNA LEVELS; NUCLEOTIDE EXCISION-REPAIR; HEDGEHOG PATHWAY; GENE-EXPRESSION; CANCER-CELLS; RESISTANCE; SURVIVAL; TRANSCRIPTION; EXPOSURE; TISSUES	The transcription of ERCC1 and other nucleotide excision repair (NER) genes is strongly influenced by c-jun. C-jun is transcriptionally regulated by Gli proteins of the Hedgehog pathway. We therefore studied the possible relationships between Gli1, c-jun, and the upregulation of ERCC1, XPD and XRCC1 in cisplatin-resistant human ovarian cancer cells. We studied the paired human ovarian cancer cell lines A2780 and A2780-CP70. We used a shRNA construct that specifically degrades Gli1 message. Genes we assessed for mRNA and/or protein levels included: c-jun, ERCC1, XPD, XRCC1, Gli1, Gli2, SHH, IHH, GAPDH and a-tubulin. Platinum-DNA adduct repair was assessed by atomic absorbance spectrometry with Zeeman background correction. Use of the anti-Gli1 shRNA in cisplatin-resistant cells resulted in a block of the cell's ability to upregulate genes in response to cisplatin treatment, including: c-jun, ERCC1, XPD and XRCC1. This block in upregulation of c-jun was concurrent with a change in the phosphorylation pattern of the c-jun protein, shifting that pattern from a Ser63/73 dominant pattern, to a Thr91/93 dominant pattern. A2780-CP70 cells were treated at their cisplatin IC50, and DNA repair was assessed after pretreatment with anti-Gli1 shRNA or scrambled shRNA control. Control cells repaired 78% of platinum-DNA adducts at 12 h, compared with 33% repair in cells pretreated with anti-Gli1 shRNA resulting in a 2.4-fold difference. Pretreatment of A2780-CP70 cells with anti-Gli1 shRNA resulted in supra-additive cell killing with cisplatin; shifting the cisplatin IC50 (half maximal inhibitory concentration) from 30 mu M to 5 mu M. Pretreatment of these cells with cyclopamine did not shift the cisplatin IC50. We conclude that the transcriptional protein Gli1 is important in the upregulation of these three DNA repair genes in human ovarian cancer cells, and that Gli1 strongly influences platinum-DNA adduct repair, and cellular sensitivity to cisplatin. This Gli1 role has c-jun as an intermediate in the pathway. In all, inhibition of Gli1 by a specific shRNA inhibits the upregulation of c-jun Ser63/73, and also inhibits the upregulation of three genes essential to NER (ERCC1, XPD) and base excision repair (XRCC1).	[Kudo, K.; Gavin, E.; Das, S.; Amable, L.; Shevde, L. A.; Reed, E.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA	University of South Alabama	Reed, E (corresponding author), Univ S Alabama, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	eddiereed@usouthal.edu			Mitchell Cancer Institute, University of South Alabama, Mobile	Mitchell Cancer Institute, University of South Alabama, Mobile	This work was supported by funds from two endowments at the Mitchell Cancer Institute, University of South Alabama, Mobile: the Abraham Mitchell endowment, and the Point Clear Charities endowment.	Altaha R, 2004, INT J MOL MED, V14, P959; Bellmunt J, 2007, ANN ONCOL, V18, P522, DOI 10.1093/annonc/mdl435; Bhattacharya R, 2008, CLIN CANCER RES, V14, P7659, DOI 10.1158/1078-0432.CCR-08-1414; Bonovich M, 2002, CANCER GENE THER, V9, P62, DOI 10.1038/sj/cgt/7700409; Chang HH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-6; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; DABHOLKAR M, 1993, MUTAT RES, V293, P151, DOI 10.1016/0921-8777(93)90066-P; Dabholkar M, 2000, BIOCHEM PHARMACOL, V60, P1611, DOI 10.1016/S0006-2952(00)00448-2; DABHOLKAR M, 1992, J NATL CANCER I, V84, P1512, DOI 10.1093/jnci/84.19.1512; DABHOLKAR M, 1994, J CLIN INVEST, V94, P703, DOI 10.1172/JCI117388; Dabholkar MD, 1996, MOL CARCINOGEN, V17, P1, DOI 10.1002/(SICI)1098-2744(199609)17:1<1::AID-MC1>3.0.CO;2-M; DABHOLKAR MD, 1995, CANCER RES, V55, P1261; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Desouza LA, 2011, ENDOCRINOLOGY, V152, P1989, DOI 10.1210/en.2010-1396; Kim MK, 2008, CLIN CANCER RES, V14, P4225, DOI 10.1158/1078-0432.CCR-07-4848; Kriyak TC, 2011, GYNECOL ONCOL, V122, P121, DOI 10.1016/j.ygyno.2011.03.027; Laner-Plamberger S, 2009, ONCOGENE, V28, P1639, DOI 10.1038/onc.2009.10; Li Q, 1999, CELL MOL LIFE SCI, V55, P456, DOI 10.1007/s000180050302; Li QD, 1998, J BIOL CHEM, V273, P23419, DOI 10.1074/jbc.273.36.23419; Li QD, 1999, BIOCHEM PHARMACOL, V57, P347, DOI 10.1016/S0006-2952(98)00291-3; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Metzger R, 1998, J CLIN ONCOL, V16, P309, DOI 10.1200/JCO.1998.16.1.309; Mimnaugh EG, 2000, BIOCHEM PHARMACOL, V60, P1343, DOI 10.1016/S0006-2952(00)00455-X; PARKER RJ, 1991, J CLIN INVEST, V87, P772, DOI 10.1172/JCI115080; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Reed E, 2003, CLIN CANCER RES, V9, P5299; Reed E, 2005, CLIN CANCER RES, V11, P6100, DOI 10.1158/1078-0432.CCR-05-1083; Reed E, 1998, CANCER TREAT REV, V24, P331, DOI 10.1016/S0305-7372(98)90056-1; REED E, 1988, ATOM SPECTROSC, V9, P93; Reed E, 1998, CYTOTECHNOLOGY, V27, P187, DOI 10.1023/A:1008016922425; Reed E, 2008, CANC PRINCIPLES PRAC, P419; REED E, 2006, CANC CHEMOTHERAPY BI, P332; Reed E, 2006, NEW ENGL J MED, V355, P1054, DOI 10.1056/NEJMe068162; Reed E, 2010, CLIN CANCER RES, V16, P4511, DOI 10.1158/1078-0432.CCR-10-0528; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Shirota Y, 2001, J CLIN ONCOL, V19, P4298, DOI 10.1200/JCO.2001.19.23.4298; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Sugahara F, 2011, DEVELOPMENT, V138, P1217, DOI 10.1242/dev.059360; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Verhoeven EEA, 2000, J BIOL CHEM, V275, P5120, DOI 10.1074/jbc.275.7.5120; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Von Hoff DD, 2009, CANCER CELL, V16, P7, DOI 10.1016/j.ccr.2009.06.011; Wei J, 2008, BRIT J CANCER, V98, P1398, DOI 10.1038/sj.bjc.6604317; WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0; Xu HL, 1998, PLANT J, V13, P823, DOI 10.1046/j.1365-313X.1998.00081.x; ZHEN WP, 1992, MOL CELL BIOL, V12, P3689, DOI 10.1128/MCB.12.9.3689; Zhong XS, 2000, INT J ONCOL, V17, P375	48	48	52	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	44					4718	4724		10.1038/onc.2011.610	http://dx.doi.org/10.1038/onc.2011.610			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	032MW	22266871				2022-12-25	WOS:000310724400007
J	Ursini-Siegel, J; Hardy, WR; Zheng, Y; Ling, C; Zuo, D; Zhang, C; Podmore, L; Pawson, T; Muller, WJ				Ursini-Siegel, J.; Hardy, W. R.; Zheng, Y.; Ling, C.; Zuo, D.; Zhang, C.; Podmore, L.; Pawson, T.; Muller, W. J.			The ShcA SH2 domain engages a 14-3-3/PI3 ' K signaling complex and promotes breast cancer cell survival	ONCOGENE			English	Article						ShcA; SH2 domain; breast cancer; polyoma virus middle T; AKT; signal transduction	DEPENDENT ACTIVATION; ADAPTER PROTEIN; TYROSINE; BINDING; PROGRESSION; TUMORS; GROWTH; GRB2; PHOSPHORYLATION; ASSOCIATION	The ShcA adapter protein transmits activating signals downstream of receptor and cytoplasmic tyrosine kinases through the establishment of phosphotyrosine-dependent complexes. In this regard, ShcA possesses both a phosphotyrosine-binding domain (PTB) and Src homology 2 domain (SH2), which bind phosphotyrosine residues in a sequence-specific manner. Although the majority of receptor tyrosine kinases expressed in breast cancer cells bind the PTB domain, very little is known regarding the biological importance of SH2-driven ShcA signaling during mammary tumorigenesis. To address this, we employed transgenic mice expressing a mutant ShcA allele harboring a non-functional SH2 domain (ShcR397K) under the transcriptional control of the endogenous ShcA promoter. Using transplantation approaches, we demonstrate that SH2-dependent ShcA signaling within the mammary epithelial compartment is essential for breast tumor outgrowth, survival and the development of lung metastases. We further show that the ShcA SH2 domain activates the AKT pathway, potentially through a novel SH2-mediated complex between ShcA, 14-3-3 xi and the p85 regulatory subunit of phosphatidylinositol 3 (PI3') kinase. This study is the first to demonstrate that the SH2 domain of ShcA is critical for tumor survival during mammary tumorigenesis. Oncogene (2012) 31, 5038-5044; doi:10.1038/onc.2012.4; published online 30 January 2012	[Ursini-Siegel, J.; Podmore, L.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Hardy, W. R.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Zheng, Y.; Zhang, C.; Pawson, T.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Ling, C.; Zuo, D.; Muller, W. J.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada	Lady Davis Institute; McGill University; University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McGill University	Ursini-Siegel, J (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	giuseppina.ursini-siegel@mcgill.ca	Pawson, Tony J/E-4578-2013		CBCRA; CIHR [MOP-89751, MOP-111143, MOP6849]; Terry Fox team [020002]; Terry Fox Foundation/CIHR [TFF105268]; CIHR/FRSQ	CBCRA; CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox team; Terry Fox Foundation/CIHR(Canadian Institutes of Health Research (CIHR)); CIHR/FRSQ(Fonds de la Recherche en Sante du QuebecCanadian Institutes of Health Research (CIHR))	We thank Dr Peter Siegel for critical reading of this manuscript and Vasilios Papavasiliou for assisting with the injection studies. This work was supported by CBCRA, CIHR (MOP-89751) and Terry Fox team (020002) grants to WJM, a CIHR operating grant to JU-S (MOP-111143) and CIHR (MOP6849) and Terry Fox Foundation/CIHR (TFF105268) grants to TP JU-S is the recipient of a CIHR New Investigator Salary Support award. LP is supported by a CIHR/FRSQ training grant in cancer research of the McGill Integrated Cancer Research Training Program (MICRTP). WJM is supported by a CRC chair in molecular oncology. TP is a CIHR distinguished scientist.	ALIMANDI M, 1995, ONCOGENE, V10, P1813; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Barry EF, 2009, J BIOL CHEM, V284, P12080, DOI 10.1074/jbc.M807637200; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; Bone H, 2000, CELL SIGNAL, V12, P183, DOI 10.1016/S0898-6568(99)00088-1; CAMPBELL KS, 1994, P NATL ACAD SCI USA, V91, P6344, DOI 10.1073/pnas.91.14.6344; Cook RS, 2011, CANCER RES, V71, P3941, DOI 10.1158/0008-5472.CAN-10-3775; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Davol PA, 2003, CANCER RES, V63, P6772; DILWORTH SM, 1982, P NATL ACAD SCI-BIOL, V79, P1059, DOI 10.1073/pnas.79.4.1059; Frackelton AR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1631; George R, 2008, J MOL BIOL, V377, P740, DOI 10.1016/j.jmb.2007.12.040; Gillgrass A, 2003, ONCOGENE, V22, P9151, DOI 10.1038/sj.onc.1206983; Gotoh N, 1996, EMBO J, V15, P6197, DOI 10.1002/j.1460-2075.1996.tb01008.x; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hardy WR, 2007, SCIENCE, V317, P251, DOI 10.1126/science.1140114; Hodgson JG, 2005, CANCER RES, V65, P9695, DOI 10.1158/0008-5472.CAN-05-0755; Ishiguro Y, 1999, ENDOCRINOLOGY, V140, P3992, DOI 10.1210/en.140.9.3992; Jones RA, 2009, ONCOGENE, V28, P2152, DOI 10.1038/onc.2009.79; Komiya Y, 2008, J BIOL CHEM, V283, P18753, DOI 10.1074/jbc.M802530200; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Ling C, 2010, GENE DEV, V24, P947, DOI 10.1101/gad.1896810; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Neal CL, 2011, ONCOGENE; Orlando FA, 2009, ANN SURG ONCOL, V16, P2270, DOI 10.1245/s10434-009-0500-y; Patrussi L, 2005, ONCOGENE, V24, P2218, DOI 10.1038/sj.onc.1208384; Ranger JJ, 2009, CANCER RES, V69, P6823, DOI 10.1158/0008-5472.CAN-09-1684; Rauh MJ, 1999, MOL CELL BIOL, V19, P8169; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Su CH, 2011, CANCER RES, V71, P884, DOI 10.1158/0008-5472.CAN-10-2518; Telles E, 2009, EXP CELL RES, V315, P1448, DOI 10.1016/j.yexcr.2009.01.018; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Ursini-Siegel J, 2007, MOL CELL BIOL, V27, P6361, DOI 10.1128/MCB.00686-07; Ursini-Siegel J, 2010, CANCER RES, V70, P7776, DOI 10.1158/0008-5472.CAN-10-2229; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Vijapurkar U, 1998, J BIOL CHEM, V273, P20996, DOI 10.1074/jbc.273.33.20996; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Zhang ZG, 2004, STEROIDS, V69, P523, DOI 10.1016/j.steroids.2004.05.012; Zhou MM, 1995, J BIOL CHEM, V270, P31119, DOI 10.1074/jbc.270.52.31119	45	14	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	48					5038	5044		10.1038/onc.2012.4	http://dx.doi.org/10.1038/onc.2012.4			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	048CU	22286768				2022-12-25	WOS:000311888600008
J	Salah, Z; Uziely, B; Jaber, M; Maoz, M; Cohen, I; Hamburger, T; Maly, B; Peretz, T; Bar-Shavit, R				Salah, Zaidoun; Uziely, Beatrice; Jaber, Mohammad; Maoz, Miriam; Cohen, Irit; Hamburger, Tamar; Maly, Bella; Peretz, Tamar; Bar-Shavit, Rachel			Regulation of human protease-activated receptor 1 (hPar1) gene expression in breast cancer by estrogen	FASEB JOURNAL			English	Article						thrombin; tumor; ERE; tissue microarray	TRANSCRIPTIONAL REGULATION; TISSUE MICROARRAYS; GROWTH-FACTOR; IDENTIFICATION; ALPHA; PHOSPHORYLATION; OVEREXPRESSION; COAGULATION; RESISTANCE; PATHWAYS	A pivotal role is attributed to the estrogenreceptor (ER) pathway in mediating the effect of estrogen in breast cancer progression. Yet the precise mechanisms of cancer development by estrogen remain poorly understood. Advancing tumor categorization a step forward, and identifying cellular gene fingerprints to accompany histopathological assessment may provide targets for therapy as well as vehicles for evaluating the response to treatment. We report here that in breast carcinoma, estrogen may induce tumor development by eliciting protease-activated receptor-1 (PAR(1)) gene expression. Induction of PAR(1) was shown by electrophoretic mobility shift assay, luciferase reporter gene driven by the hPar(1) promoter, and chromatin-immunoprecipitation analyses. Functional estrogen regulation of hPar1 in breast cancer was demonstrated by an endothelial tube-forming network. Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P =0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients. We propose that estrogen transcriptionally regulates hPar(1), culminating in an aggressive gene imprint in breast cancer. While ER+ patients are traditionally treated with hormone therapy, the presence of PAR(1) identifies a group of patients that requires additional treatment, such as anti-PAR(1) biological vehicles or chemotherapy.-Salah, Z., Uziely, B., Jaber, M., Maoz, M., Cohen, I., Hamburger, T., Maly, B., Peretz, T., B.-S, R. Regulation of human protease-activated receptor 1 (hPar1) gene expression in breast cancer by estrogen. FASEB J. 26, 2031-2042 (2012). www.fasebj.org	[Salah, Zaidoun; Uziely, Beatrice; Jaber, Mohammad; Maoz, Miriam; Cohen, Irit; Hamburger, Tamar; Peretz, Tamar; Bar-Shavit, Rachel] Hadassah Hebrew Univ Hosp, Sharett Inst Oncol, IL-91120 Jerusalem, Israel; [Maly, Bella] Hadassah Hebrew Univ Hosp, Dept Oncol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Bar-Shavit, R (corresponding author), Hadassah Hebrew Univ Hosp, Sharett Inst Oncol, POB 12000, IL-91120 Jerusalem, Israel.	rachel.bar-shavit@ekmd.huji.ac.il			Israel Scientific Foundation (ISF); Ministry of Industry and Trade	Israel Scientific Foundation (ISF)(Israel Science Foundation); Ministry of Industry and Trade	This work was supported in part by funds from the Israel Scientific Foundation (ISF) and the Ministry of Industry and Trade, Nofar project (to R.B.).	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Applanat MP, 2008, ADV EXP MED BIOL, V617, P437, DOI 10.1007/978-0-387-69080-3_42; Becker RC, 2009, LANCET, V373, P919, DOI 10.1016/S0140-6736(09)60230-0; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Cascio S, 2007, J BIOL CHEM, V282, P3498, DOI 10.1074/jbc.M606244200; Charpentier AH, 2000, CANCER RES, V60, P5977; Clarke RB, 1997, CANCER RES, V57, P4987; Cohen I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011135; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Creighton CJ, 2008, CANCER RES, V68, P7493, DOI 10.1158/0008-5472.CAN-08-1404; DANIEL CW, 1987, CANCER RES, V47, P6052; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Hoos A, 2001, AM J PATHOL, V158, P1245, DOI 10.1016/S0002-9440(10)64075-8; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Li FZ, 1996, J BIOL CHEM, V271, P26320, DOI 10.1074/jbc.271.42.26320; LIPPMAN ME, 1975, NATURE, V256, P592, DOI 10.1038/256592a0; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Miao HQ, 1997, J CLIN INVEST, V99, P1565, DOI 10.1172/JCI119319; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Osborne CK, 1998, BREAST CANCER RES TR, V51, P227, DOI 10.1023/A:1006132427948; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; RICKLES FR, 1983, BLOOD, V62, P14; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Salah Z, 2008, ONCOGENE, V27, P6866, DOI 10.1038/onc.2008.324; Salah Z, 2007, CANCER RES, V67, P9835, DOI 10.1158/0008-5472.CAN-07-1886; Schiff R, 2005, BREAST CANCER RES, V7, P205, DOI 10.1186/bcr1287; SILBERSTEIN GB, 1994, ENDOCRINOLOGY, V134, P84, DOI 10.1210/en.134.1.84; Song RXD, 2006, ENDOCR-RELAT CANCER, V13, pS3, DOI 10.1677/erc.1.01322; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WAKELING AE, 1992, CANCER SURV, V14, P71; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; White HD, 2011, AM HEART J, V161, P450, DOI 10.1016/j.ahj.2010.10.043; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yin YJ, 2003, FASEB J, V17, P163, DOI 10.1096/fj.02-0316com	49	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					2031	2042		10.1096/fj.11-194704	http://dx.doi.org/10.1096/fj.11-194704			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22291441				2022-12-25	WOS:000303680800029
J	Zullo, AJ; Lee, S				Zullo, Alfred J.; Lee, Sunhee			Mycobacterial Induction of Autophagy Varies by Species and Occurs Independently of Mammalian Target of Rapamycin Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; TUBERCULOSIS; LC3; MACROPHAGES; MATURATION; SURVIVAL; PROTEIN; IDENTIFICATION; MACROAUTOPHAGY; MECHANISMS	The interaction of host cells with mycobacteria is complex and can lead to multiple outcomes ranging from bacterial clearance to latent infection. Although many factors are involved, the mammalian autophagy pathway is recognized as a determinant that can influence the course of infection. Intervention aimed at utilizing autophagy to clear infection requires an examination of the autophagy and signal transduction induced by mycobacteria under native conditions. With both pathogenic and non-pathogenic mycobacteria, we show that infection correlates with an increase in the mammalian target of rapamycin (mTOR) activity indicating that autophagy induction by mycobacteria occurs in an mTOR-independent manner. Analysis of Mycobacterium smegmatis and Mycobacterium bovis bacille Calmette-Guerin (BCG), which respectively induce high and low autophagy responses, indicates that lipid material is capable of inducing both autophagy and mTOR signaling. Although mycobacterial infection potently induces mTOR activity, we confirm that bacterial viability can be reduced by rapamycin treatment. In addition, our work demonstrates that BCG can reduce autophagy responses to M. smegmatis suggesting that specific mechanisms are used by BCG to minimize host cell autophagy. We conclude that autophagy induction and mTOR signaling take place concurrently during mycobacterial infection and that host autophagy responses to any given mycobacterium stem from multiple factors, including the presence of activating macromolecules and inhibitory mechanisms.	Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Lee, S (corresponding author), Duke Human Vaccine Inst, Global Hlth Res Bldg,909 S LaSalle St, Durham, NC 27710 USA.	sunhee.lee@duke.edu			National Institutes of Health [R21 AI095723-01, U54 AI057157]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095723, U54AI057157, UC6AI058607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AI095723-01 and U54 AI057157 (Southeast Regional Center of Excellence for Emerging Infections and Biodefense). Tuberculosis research was performed in the NIAID Regional Biocontainment Laboratory at Duke (UC6 AI058607). Flow cytometry was performed in the Duke Human Vaccine Institute Research Flow Cytometry Shared Resource Facility (Durham, NC) under the direction of Dr. John F. Whitesides.	Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Lerena MC, 2011, CELL MICROBIOL, V13, P814, DOI 10.1111/j.1462-5822.2011.01581.x; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Crotzer VL, 2010, IMMUNOLOGY, V131, P9, DOI 10.1111/j.1365-2567.2010.03321.x; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Ha SD, 2010, J BIOL CHEM, V285, P2120, DOI 10.1074/jbc.M109.065813; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knodler LA, 2011, CELL MICROBIOL, V13, P1319, DOI 10.1111/j.1462-5822.2011.01632.x; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ogawa M, 2011, MICROBIOL IMMUNOL, V55, P459, DOI 10.1111/j.1348-0421.2011.00343.x; OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996; Ponpuak M, 2011, AUTOPHAGY, V7, P336, DOI 10.4161/auto.7.3.14500; Salh B, 1998, J IMMUNOL, V161, P6947; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tamai K, 2007, BIOCHEM BIOPH RES CO, V360, P721, DOI 10.1016/j.bbrc.2007.06.105; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093; Zullo AJ, 2009, J BIOL CHEM, V284, P12504, DOI 10.1074/jbc.M809436200	36	66	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12668	12678		10.1074/jbc.M111.320135	http://dx.doi.org/10.1074/jbc.M111.320135			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22275355	hybrid, Green Published			2022-12-25	WOS:000302903700007
J	Lynch, TP; Ferrer, CM; Jackson, SR; Shahriari, KS; Vosseller, K; Reginato, MJ				Lynch, Thomas P.; Ferrer, Christina M.; Jackson, S. RaElle; Shahriari, Kristina S.; Vosseller, Keith; Reginato, Mauricio J.			Critical Role of O-Linked beta-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXM1; GENE-EXPRESSION PROFILES; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; NUTRIENT SENSOR; METABOLISM; PROGRESSION; BREAST; GLYCOSYLATION; MECHANISMS	Background: Cancer cells display altered metabolism and expression of the nutrient sensor O-linked beta-N-acetylglucosamine transferase (OGT). Results: Through regulation of FoxM1, OGT contributes to increased invasion, angiogenesis, and metastasis of prostate cancer cells. Conclusion: OGT plays a critical role in prostate cancer. Significance: OGT may provide a novel therapeutic target for treating prostate cancer.	[Lynch, Thomas P.; Ferrer, Christina M.; Jackson, S. RaElle; Shahriari, Kristina S.; Vosseller, Keith; Reginato, Mauricio J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University	Reginato, MJ (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St, Philadelphia, PA 19102 USA.	mauricio.reginato@drexelmed.edu	Reginato, Mauricio/I-6155-2013	Reginato, Mauricio/0000-0002-7541-4094	National Institutes of Health [R01 CA155413]; Drexel University College of Medicine CURE; NATIONAL CANCER INSTITUTE [R01CA155413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Drexel University College of Medicine CURE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA155413 (to M. J. R.). This work was also supported by Drexel University College of Medicine CURE grants.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Bright RK, 1997, CANCER RES, V57, P995; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Dahl E, 2005, J PATHOL, V205, P21, DOI 10.1002/path.1687; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GATENBY RA, 1995, J THEOR BIOL, V176, P447, DOI 10.1006/jtbi.1995.0212; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Lynch TP, 2011, CELL CYCLE, V10, P1712, DOI 10.4161/cc.10.11.15561; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Marshall Stephen, 2006, Sci STKE, V2006, pre7; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Sauer CG, 2004, VIRCHOWS ARCH, V444, P518, DOI 10.1007/s00428-004-1016-2; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Yang DK, 2009, HUM PATHOL, V40, P464, DOI 10.1016/j.humpath.2008.10.001; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang L, 2004, PROSTATE CANCER P D, V7, P327, DOI 10.1038/sj.pcan.4500750; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	46	203	214	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11070	11081		10.1074/jbc.M111.302547	http://dx.doi.org/10.1074/jbc.M111.302547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22275356	hybrid, Green Published			2022-12-25	WOS:000302780100035
J	Teijido, O; Ujwal, R; Hillerdal, CO; Kullman, L; Rostovtseva, TK; Abramson, J				Teijido, Oscar; Ujwal, Rachna; Hillerdal, Carl-Olof; Kullman, Lisen; Rostovtseva, Tatiana K.; Abramson, Jeff			Affixing N-terminal alpha-Helix to the Wall of the Voltage-dependent Anion Channel Does Not Prevent Its Voltage Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; NEUROSPORA-CRASSA; CRYSTAL-STRUCTURE; VDAC CHANNELS; BCL-2 FAMILY; CELL-DEATH; LOOP 3; PROTEIN; PORIN; OLIGOMERIZATION	The voltage-dependent anion channel (VDAC) governs the free exchange of ions and metabolites between the mitochondria and the rest of the cell. The three-dimensional structure of VDAC1 reveals a channel formed by 19 beta-strands and an N-terminal alpha-helix located near the midpoint of the pore. The position of this alpha-helix causes a narrowing of the cavity, but ample space for metabolite passage remains. The participation of the N-terminus of VDAC1 in the voltage-gating process has been well established, but the molecular mechanism continues to be debated; however, the majority of models entail large conformational changes of this N-terminal segment. Here we report that the pore-lining N-terminal alpha-helix does not undergo independent structural rearrangements during channel gating. We engineered a double Cys mutant in murine VDAC1 that cross-links the alpha-helix to the wall of the beta-barrel pore and reconstituted the modified protein into planar lipid bilayers. The modified murine VDAC1 exhibited typical voltage gating. These results suggest that the N-terminal alpha-helix is located inside the pore of VDAC in the open state and remains associated with beta-strand 11 of the pore wall during voltage gating.	[Teijido, Oscar; Rostovtseva, Tatiana K.] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Ujwal, Rachna; Abramson, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Hillerdal, Carl-Olof; Kullman, Lisen] Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Uppsala University	Rostovtseva, TK (corresponding author), Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov; jabramson@mednet.ucla.edu			Eunice Kennedy Shriver NICHD, National Institutes of Health; National Institutes of Health [RO1 GM078844]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health (to O. T. and T. K. R.) and National Institutes of Health Grant RO1 GM078844 (to J. A.).	Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bainbridge G, 1998, FEBS LETT, V432, P117, DOI 10.1016/S0014-5793(98)00846-1; Bainbridge G, 1998, J MOL BIOL, V275, P171, DOI 10.1006/jmbi.1997.1474; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Casadio R, 2002, FEBS LETT, V520, P1, DOI 10.1016/S0014-5793(02)02758-8; Chaptal V, 2010, J STRUCT BIOL, V171, P82, DOI 10.1016/j.jsb.2010.02.005; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Colombini M, 1996, Ion Channels, V4, P169; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Das S, 2008, CIRC RES, V103, P983, DOI 10.1161/CIRCRESAHA.108.178970; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; De Pinto Vito, 2003, Ital J Biochem, V52, P17; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2009, J AM CHEM SOC, V131, P12970, DOI 10.1021/ja902012x; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Jacotot E, 2001, J EXP MED, V193, P509, DOI 10.1084/jem.193.4.509; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; REYMANN S, 1995, BIOCHEM MOL MED, V54, P75, DOI 10.1006/bmme.1995.1011; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Shao L, 1996, BIOPHYS J, V71, P778, DOI 10.1016/S0006-3495(96)79277-9; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; Tsujimoto Y, 2002, BIOSCIENCE REP, V22, P47, DOI 10.1023/A:1016061006256; Ujwal R, 2009, CHANNELS, V3, P167, DOI 10.4161/chan.3.3.9196; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Xu X, 2001, J MEMBRANE BIOL, V180, P73, DOI 10.1007/s002320010060; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; Zizi M, 1998, BIOPHYS J, V75, P704, DOI 10.1016/S0006-3495(98)77560-5	48	59	59	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11437	11445		10.1074/jbc.M111.314229	http://dx.doi.org/10.1074/jbc.M111.314229			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22275367	Green Published, hybrid			2022-12-25	WOS:000302780100072
J	Comas-Casellas, E; Martinez-Barriocanal, A; Miro, F; Ejarque-Ortiz, A; Schwartz, S; Martin, M; Sayos, J				Comas-Casellas, Emma; Martinez-Barriocanal, Agueda; Miro, Francesc; Ejarque-Ortiz, Aroa; Schwartz, Simo, Jr.; Martin, Margarita; Sayos, Joan			Cloning and Characterization of CD300d, a Novel Member of the Human CD300 Family of Immune Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; HIGH-AFFINITY RECEPTOR; ENDOPLASMIC-RETICULUM; INHIBITORY RECEPTOR; CELL-SURFACE; FUNCTIONAL-CHARACTERIZATION; IMMUNOGLOBULIN SUPERFAMILY; INTRACELLULAR EXPRESSION; MYELOID CELLS; PROTEIN	Herein we present the cloning and molecular characterization of CD300d, a member of the human CD300 family of immune receptors. CD300d cDNA was cloned from RNA obtained from human peripheral blood mononuclear cells, and RT-PCR revealed the gene to be expressed in cells of myeloid lineage. The cloned cDNA encoded for a type I protein with a single extracellular Ig V-type domain and a predicted molecular mass of 21.5 kDa. The short cytoplasmic tail is lacking in any known signaling motif, but there is a negatively charged residue (glutamic acid) within the transmembrane domain. CD300d forms complexes with the CD300 family members, with the exception of CD300c. Contrary to other activating members of the CD300 family of receptors, surface expression of CD300d in COS-7-transfected cells required the presence of an immunoreceptor tyrosine-based activating motif-bearing adaptor (Fc epsilon R gamma). Accordingly, we found that CD300d was able to recruit Fc epsilon R gamma. Unexpectedly, we could not detect CD300d on the surface of cells expressing Fc epsilon R gamma, suggesting the existence of unknown mechanisms regulating the trafficking of this molecule. The presence of other CD300 molecules also did not modify the intracellular expression of CD300d. In fact, the presence of CD300d decreased the levels of surface expression of CD300f but not CD300c. Our data suggest that the function of CD300d would be related to the regulation of the expression of other CD300 molecules and the composition of CD300 complexes on the cell surface.	[Comas-Casellas, Emma; Martinez-Barriocanal, Agueda; Ejarque-Ortiz, Aroa; Sayos, Joan] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, CIBBIM Nanomed Program,Immunobiol Grp, Barcelona 08035, Spain; [Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, CIBBIM Nanomed Program,Drug Delivery & Targeting, Barcelona 08035, Spain; [Comas-Casellas, Emma; Martinez-Barriocanal, Agueda; Ejarque-Ortiz, Aroa; Schwartz, Simo, Jr.; Sayos, Joan] Inst Salud Carlos III, Networking Res Ctr Bioengn Biomat & Nanomed, Barcelona 08035, Spain; [Miro, Francesc] Inst Res Biomed, Gene Translat Lab, Barcelona 08028, Spain; [Martin, Margarita] Univ Barcelona, Fac Med, Biochem Unit, Inst Invest Biomed August Pi i Sunyer, Barcelona 7, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Martinez-Barriocanal, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Inst Recerca, CIBBIM Nanomed Program,Immunobiol Grp, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.	agueda.martinez@vhir.org	Martinez, Agueda/AAB-7186-2019; Sayos, Joan/B-6119-2009; Schwartz, Simo/H-7776-2012; Miro-Mur, Francesc A./AAT-3013-2020; Andorra, Margarita Martin/H-2025-2015	Martinez, Agueda/0000-0002-8809-160X; Sayos, Joan/0000-0002-4664-3461; Miro-Mur, Francesc A./0000-0003-3936-2693; Andorra, Margarita Martin/0000-0002-9245-4899; Schwartz, Simo/0000-0001-8297-7971; Comas-Casellas, Emma/0000-0002-8567-6848	Plan Nacional I+D [SAF2009-07548]; Fondo de Investigaciones Sanitarias [PI080366, PI1100045]; Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya [2009 SGR 493]; Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III [CP06/00058]	Plan Nacional I+D; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Plan Nacional I+D Grant SAF2009-07548, Fondo de Investigaciones Sanitarias Grants PI080366 and PI1100045, and Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya Grant 2009 SGR 493.; Supported by Contract "Juan de la Cierva" from the Ministerio de Ciencia e Innovacion.; Supported by Contract "Miguel Servet" from the Fondo de Investigaciones Sanitarias from the Instituto de Salud Carlos III (CP06/00058). To whom correspondence may be addressed: Hospital Universitari Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain. Tel.: 34-93-489-30-00(ext. 3753); Fax: 34-93-489-38-93; E-mail: joan.sayos@vhir.org.	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Albrecht B, 2000, J IMMUNOL, V165, P5686, DOI 10.4049/jimmunol.165.10.5686; Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Alvarez-Errico D, 2007, J IMMUNOL, V178, P808, DOI 10.4049/jimmunol.178.2.808; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Clark GJ, 2009, IMMUNOBIOLOGY, V214, P730, DOI 10.1016/j.imbio.2009.06.004; Clark GJ, 2000, TISSUE ANTIGENS, V55, P101, DOI 10.1034/j.1399-0039.2000.550201.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Hasegawa S, 1999, BLOOD, V93, P2543, DOI 10.1182/blood.V93.8.2543.408k14_2543_2551; Heit B, 2005, J CELL SCI, V118, P5205, DOI 10.1242/jcs.02632; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Martinez-Barriocanal A, 2006, J IMMUNOL, V177, P2819, DOI 10.4049/jimmunol.177.5.2819; Martinez-Barriocanal A, 2010, J BIOL CHEM, V285, P41781, DOI 10.1074/jbc.M110.140889; Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Platzer B, 2010, J BIOL CHEM, V285, P15314, DOI 10.1074/jbc.M110.104281; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064; Sayos J, 2001, BLOOD, V97, P3867, DOI 10.1182/blood.V97.12.3867; Seminario MC, 1999, J IMMUNOL, V162, P6893; Shnyder SD, 2002, J HISTOCHEM CYTOCHEM, V50, P557, DOI 10.1177/002215540205000413; Smith KM, 1998, J IMMUNOL, V161, P7; Speckman RA, 2003, HUM GENET, V112, P34, DOI 10.1007/s00439-002-0851-y; Takatsu H, 2006, BIOCHEM BIOPH RES CO, V348, P183, DOI 10.1016/j.bbrc.2006.07.047; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Umemoto E, 2006, J EXP MED, V203, P1603, DOI 10.1084/jem.20052543; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034	32	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9682	9693		10.1074/jbc.M111.279224	http://dx.doi.org/10.1074/jbc.M111.279224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22291008	Green Published, hybrid			2022-12-25	WOS:000302167200003
J	Niture, SK; Jaiswal, AK				Niture, Suryakant K.; Jaiswal, Anil K.			Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; NUCLEAR EXPORT; KINASE-C; DEATH; MICE; ACTIVATION; PATHWAY; PHOSPHORYLATION; TRANSCRIPTION; DEGRADATION	Nuclear transcription factor Nrf2 regulates the expression and coordinated induction of a battery of genes encoding cytoprotective and drug transporter proteins in response to chemical and radiation stress. This leads to reduced apoptosis, enhanced cell survival, and increased drug resistance. In this study, we investigated the role of Nrf2 in up-regulation of antiapoptotic protein Bcl-2 and its contribution to stress-induced apoptosis and cell survival. Exposure of mouse hepatoma (Hepa-1) and human hepatoblastoma (HepG2) cells to antioxidant tert-butylhydroquinone led to induction of Bcl-2. Mutagenesis and transfection assays identified an antioxidant response element between nucleotides -3148 and -3140 on the reverse strand of the Bcl-2 gene promoter that was essential for activation of Bcl-2 gene expression. Band/supershift and ChIP assays demonstrated binding of Nrf2 to Bcl-2 antioxidant response element. Alterations in Nrf2 led to altered Bcl-2 induction and cellular apoptosis. Moreover, dysfunctional/mutant inhibitor of Nrf2 (INrf2) in human lung cancer cells failed to degrade Nrf2, resulting in an increased Bcl-2 level and decreased etoposide-and UV/gamma radiation-mediated DNA fragmentation. In addition, siRNA-mediated down-regulation of Nrf2 also led to decreased apoptosis and increased cell survival. Furthermore, the specific knockdown of Bcl-2 in Nrf2-activated tumor cells led to increased etoposide-induced apoptosis and decreased cell survival and growth/proliferation. These data provide the first evidence of Nrf2 in control of Bcl-2 expression and apoptotic cell death with implications in antioxidant protection, survival of cancer cells, and drug resistance.	[Niture, Suryakant K.; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu		Niture, Suryakant/0000-0003-0613-9399	National Institutes of Health [RO1 GM047466]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM047466.	Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Goel A, 2010, NUTR CANCER, V62, P919, DOI 10.1080/01635581.2010.509835; Hu XM, 2006, MOL CELL BIOL, V26, P940, DOI 10.1128/MCB.26.3.940-954.2006; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Niture SK, 2011, CELL DEATH DIFFER, V18, P439, DOI 10.1038/cdd.2010.114; Niture SK, 2011, J BIOL CHEM, V286, P28821, DOI 10.1074/jbc.M111.255042; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Vollrath V, 2006, BIOCHEM J, V395, P599, DOI 10.1042/BJ20051518; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	40	337	361	5	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9873	9886		10.1074/jbc.M111.312694	http://dx.doi.org/10.1074/jbc.M111.312694			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22275372	Green Published, hybrid			2022-12-25	WOS:000302167200020
J	Wilson, M; Hogstrand, C; Maret, W				Wilson, Matthew; Hogstrand, Christer; Maret, Wolfgang			Picomolar Concentrations of Free Zinc(II) Ions Regulate Receptor Protein-tyrosine Phosphatase beta Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC DOMAIN; CELL; INHIBITION; ZN(II); FLUCTUATIONS; COORDINATION; PURIFICATION; EQUILIBRIA; TARGETS; STATE	As key enzymes in the regulation of biological phosphorylations, protein-tyrosine phosphatases are central to the control of cellular signaling and metabolism. Zinc(II) ions are known to inhibit these enzymes, but the physiological significance of this inhibition has remained elusive. Employing metal buffering for strict metal control and performing a kinetic analysis, we now demonstrate that zinc(II) ions are reversible inhibitors of the cytoplasmic catalytic domain of the receptor protein-tyrosine phosphatase beta (also known as vascular endothelial protein-tyrosine phosphatase). The K-t(Zn) value is 21 +/- 7 pM, 6 orders of magnitude lower than zinc inhibition reported previously for this enzyme. It exceeds the affinity of the most potent synthetic small molecule inhibitors targeting these enzymes. Inhibition is in the range of cellular zinc( II) ion concentrations, suggesting that zinc regulates this enzyme, which is involved in vascular physiology and angiogenesis. Thus, for some enzymes that are not recognized as zinc metalloenzymes, zinc binding inhibits rather than activates as in classical zinc enzymes. Activation then requires removal of the inhibitory zinc.	[Maret, Wolfgang] Kings Coll London, Met Metab Grp, Div Diabet & Nutr Sci, Sch Med, London SE1 9NH, England; Kings Coll London, Dept Biochem, Sch Biomed Sci, London SE1 9NH, England	University of London; King's College London; University of London; King's College London	Maret, W (corresponding author), Kings Coll London, Met Metab Grp, Div Diabet & Nutr Sci, Sch Med, Franklin Wilkins Bldg 3-79,150 Stamford St, London SE1 9NH, England.	wolfgang.maret@kcl.ac.uk	Hogstrand, Christer/C-9041-2013	Hogstrand, Christer/0000-0001-7545-6975	King's College London	King's College London	This work was supported by funding provided by King's College London.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Anwar ZM, 2005, J CHIN CHEM SOC-TAIP, V52, P863, DOI 10.1002/jccs.200500121; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Brandao TAS, 2010, J BIOL CHEM, V285, P15874, DOI 10.1074/jbc.M109.066951; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; Chen CY, 2009, BIOCHEMISTRY-US, V48, P1399, DOI 10.1021/bi801973z; COULSTON L, 1980, DIABETES, V29, P665, DOI 10.2337/diabetes.29.8.665; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Evdokimov AG, 2006, ACTA CRYSTALLOGR D, V62, P1435, DOI 10.1107/S0907444906037784; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Fischer EH, 1999, ADV ENZYME REGUL, V39, P359, DOI 10.1016/S0065-2571(98)00014-4; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Haase H, 2003, EXP CELL RES, V291, P289, DOI 10.1016/S0014-4827(03)00406-3; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Ho Y, 2008, MOL PHARMACOL, V74, P1141, DOI 10.1124/mol.108.049064; Hogstrand C, 1999, TOXICOLOGY, V133, P139, DOI 10.1016/S0300-483X(99)00020-7; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang Z, 1999, J BIOMOL SCREEN, V4, P327, DOI 10.1177/108705719900400608; Jansen J, 2011, BIOMED HEALTH RES, V76, P514, DOI 10.3233/978-1-60750-816-8-514; Krezel A, 2003, INORG CHEM, V42, P1994, DOI 10.1021/ic025969y; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Krezel A, 2008, J BIOL INORG CHEM, V13, P401, DOI 10.1007/s00775-007-0330-y; Krezel A, 2007, J AM CHEM SOC, V129, P10911; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Maret W, 1999, P NATL ACAD SCI USA, V96, P1936, DOI 10.1073/pnas.96.5.1936; Maret W, 2011, J BIOL INORG CHEM, V16, P1079, DOI 10.1007/s00775-011-0800-0; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; RABENSTEIN DL, 1969, J AM CHEM SOC, V91, P2492, DOI 10.1021/ja01038a017; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Samet JM, 2010, ANNU REV PHARMACOL, V50, P215, DOI 10.1146/annurev.pharmtox.010909.105841; SIMONS TJB, 1991, J MEMBRANE BIOL, V123, P63, DOI 10.1007/BF01993964; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; WILLIAMS RJP, 1984, ENDEAVOUR, V8, P65, DOI 10.1016/0160-9327(84)90040-1; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; ZANDER NF, 1991, BIOCHEMISTRY-US, V30, P6964, DOI 10.1021/bi00242a022; ZHAO ZZ, 1993, J BIOL CHEM, V268, P2816; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	47	125	126	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9322	9326		10.1074/jbc.C111.320796	http://dx.doi.org/10.1074/jbc.C111.320796			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275360	hybrid, Green Published			2022-12-25	WOS:000301797800060
J	Ding, Y; Ko, MH; Pehar, M; Kotch, F; Peters, NR; Luo, Y; Salamat, SM; Puglielli, L				Ding, Yun; Ko, Mi Hee; Pehar, Mariana; Kotch, Frank; Peters, Noel R.; Luo, Yun; Salamat, Shahriar M.; Puglielli, Luigi			Biochemical Inhibition of the Acetyltransferases ATase1 and ATase2 Reduces beta-Secretase (BACE1) Levels and A beta Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; BRAIN; OLIGOMERS; NEURONS; MEMORY; CELLS; ER	The cellular levels of beta-site APP cleaving enzyme 1 (BACE1), the rate-limiting enzyme for the generation of the Alzheimer disease (AD) amyloid beta-peptide (A beta), are tightly regulated by two ER-based acetyl-CoA:lysine acetyltransferases, ATase1 and ATase2. Here we report that both acetyltransferases are expressed in neurons and glial cells, and are up-regulated in the brain of AD patients. We also report the identification of first and second generation compounds that inhibit ATase1/ATase2 and down-regulate the expression levels as well as activity of BACE1. The mechanism of action involves competitive and non-competitive inhibition as well as generation of unstable intermediates of the ATases that undergo degradation.	[Puglielli, Luigi] Univ Wisconsin Madison, Dept Med, VAH GRECC, Madison, WI 53705 USA; [Ding, Yun; Puglielli, Luigi] Univ Wisconsin Madison, Neurosci Training Program, Madison, WI 53705 USA; [Kotch, Frank; Peters, Noel R.; Luo, Yun] Univ Wisconsin Madison, Small Mol Screening Facil, Madison, WI 53705 USA; [Salamat, Shahriar M.] Univ Wisconsin Madison, Dept Pathol, Madison, WI 53705 USA; [Puglielli, Luigi] VA Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center	Puglielli, L (corresponding author), Univ Wisconsin Madison, Dept Med, VAH GRECC, 2500 Overlook Terrace, Madison, WI 53705 USA.	lp1@medicine.wisc.edu			National Institutes of Health (NIH)/NIA [AG028569, AG033514]; Department of Veterans Affairs; Rotary Coins for Alzheimer Research Trust; UW Institute for Clinical and Translational Research; NCRR/NIH [1UL1RR025011]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG033514, R01AG028569] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs(US Department of Veterans Affairs); Rotary Coins for Alzheimer Research Trust; UW Institute for Clinical and Translational Research; NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported, in whole or in part, by National Institutes of Health (NIH)/NIA Grants AG028569 and AG033514, Department of Veterans Affairs, Rotary Coins for Alzheimer Research Trust Fund, and UW Institute for Clinical and Translational Research (funded through an NCRR/NIH Clinical and Translational Science Award, 1UL1RR025011).	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Costantini C, 2006, EMBO J, V25, P1997, DOI 10.1038/sj.emboj.7601062; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Haass C, 2001, NAT NEUROSCI, V4, P859, DOI 10.1038/nn0901-859; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jonas MC, 2008, EMBO REP, V9, P916, DOI 10.1038/embor.2008.132; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Ko MH, 2007, J BIOL CHEM, V282, P19742, DOI 10.1074/jbc.M611426200; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Pehar M, 2010, AGING CELL, V9, P174, DOI 10.1111/j.1474-9726.2010.00547.x; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Puglielli L, 2008, NEUROBIOL AGING, V29, P795, DOI 10.1016/j.neurobiolaging.2007.01.010; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rodriguez JJ, 2011, MOL NEUROBIOL, V43, P87, DOI 10.1007/s12035-010-8157-x; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599	27	31	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8424	8433		10.1074/jbc.M111.310136	http://dx.doi.org/10.1074/jbc.M111.310136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267734	hybrid, Green Published			2022-12-25	WOS:000301349400057
J	Pagiatakis, C; Gordon, JW; Ehyai, S; McDermott, JC				Pagiatakis, Christina; Gordon, Joseph W.; Ehyai, Saviz; McDermott, John C.			A Novel RhoA/ROCK-CPI-17-MEF2C Signaling Pathway Regulates Vascular Smooth Muscle Cell Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR MEF2C; SERUM RESPONSE FACTOR; MYOSIN PHOSPHATASE; PROTEIN PHOSPHATASE-1; MARKER GENES; MYOCARDIN; DIFFERENTIATION; KINASE; CPI-17; ACTIVATION	Differentiation of vascular smooth muscle cells (VSMC) is a fundamental aspect of normal development and vascular disease. During contraction, VSMCs modulate calcium sensitivity through RhoA/ROCK-mediated inhibition of the myosin light chain phosphatase complex (MLCP). Previous studies have demonstrated that this signaling pathway functions in parallel to increase the expression of smooth muscle genes through the myocardin-family of co-activators. MEF2C fulfills a critical role in VSMC differentiation and regulates myocardin expression, leading us to investigate whether the RhoA/ROCK signaling cascade might regulate MEF2 activity. Depolarization-induced calcium signaling increased the expression of myocardin, which was sensitive to ROCK and p38 MAPK inhibition. We previously identified protein phosphatase 1 alpha (PP1 alpha), a known catalytic subunit of the MLCP in VSMCs, as a potent repressor of MEF2 activity. PP1 alpha inhibition resulted in increased expression of myocardin, while ectopic expression of PP1 alpha inhibited the induction of myocardin by MEF2C. Consistent with these data, shRNA-mediated suppression of a PP1 alpha inhibitor, CPI-17, reduced myocardin expression and inhibited VSMC differentiation, suggesting a pivotal role for CPI-17 in regulating MEF2 activity. These data constitute evidence of a novel signaling cascade that links RhoA-mediated calcium sensitivity to MEF2-dependent myocardin expression in VSMCs through a mechanism involving p38 MAPK, PP1 alpha, and CPI-17.	[Pagiatakis, Christina; Gordon, Joseph W.; Ehyai, Saviz; McDermott, John C.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [McDermott, John C.] York Univ, CRMS, Toronto, ON M3J 1P3, Canada; [Gordon, Joseph W.; McDermott, John C.] York Univ, MHRC, Toronto, ON M3J 1P3, Canada; [McDermott, John C.] York Univ, CRBI, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada; York University - Canada	McDermott, JC (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	jmcderm@yorku.ca	Pagiatakis, Christina/AAB-3844-2019	Pagiatakis, Christina/0000-0002-9315-9648; Gordon, Joseph/0000-0002-0061-2168	Heart and Stroke Foundation of Canada (HSFC)	Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada)	This work was supported by a grant from the Heart and Stroke Foundation of Canada (HSFC) (to J. C. M.).	Chu SJ, 2006, AM J PHYSIOL-LUNG C, V291, pL983, DOI 10.1152/ajplung.00454.2005; Cohen PTW, 2002, J CELL SCI, V115, P241; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Drake CJ, 1998, ANN NY ACAD SCI, V857, P155, DOI 10.1111/j.1749-6632.1998.tb10115.x; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Eto M, 2004, P NATL ACAD SCI USA, V101, P8888, DOI 10.1073/pnas.0307812101; ETO M, 1995, J BIOCHEM, V118, P1104, DOI 10.1093/oxfordjournals.jbchem.a124993; Eto M, 2007, STRUCTURE, V15, P1591, DOI 10.1016/j.str.2007.10.014; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Gong MC, 1996, P NATL ACAD SCI USA, V93, P1340, DOI 10.1073/pnas.93.3.1340; Gordon JW, 2009, J BIOL CHEM, V284, P19027, DOI 10.1074/jbc.M109.000539; Hamaguchi T, 2000, BIOCHEM BIOPH RES CO, V274, P825, DOI 10.1006/bbrc.2000.3225; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Kim JI, 2009, HISTOCHEM CELL BIOL, V132, P191, DOI 10.1007/s00418-009-0604-2; Koyama M, 2000, FEBS LETT, V475, P197, DOI 10.1016/S0014-5793(00)01654-9; Lin Q, 1998, DEVELOPMENT, V125, P4565; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Martin K, 2009, CIRC RES, V105, P214, DOI 10.1161/CIRCRESAHA.109.199984; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Morin S, 2005, J BIOL CHEM, V280, P32272, DOI 10.1074/jbc.M507640200; Ornatsky OI, 1999, NUCLEIC ACIDS RES, V27, P2646, DOI 10.1093/nar/27.13.2646; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Perry RLS, 2009, MOL CELL BIOL, V29, P3355, DOI 10.1128/MCB.00227-08; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Zhao M, 1999, MOL CELL BIOL, V19, P21	36	50	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8361	8370		10.1074/jbc.M111.286203	http://dx.doi.org/10.1074/jbc.M111.286203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22275376	hybrid, Green Published			2022-12-25	WOS:000301349400051
J	Qu, Z; Li, LZ; Luo, JY; Wang, P; Yu, SB; Mou, TM; Zheng, XF; Hu, ZL				Qu, Zhen; Li, Lanzhi; Luo, Junyuan; Wang, Peng; Yu, Sibin; Mou, Tongmin; Zheng, Xingfei; Hu, Zhongli			QTL Mapping of Combining Ability and Heterosis of Agronomic Traits in Rice Backcross Recombinant Inbred Lines and Hybrid Crosses	PLOS ONE			English	Article							GENETIC-BASIS; ORYZA-SATIVA; MAIZE; YIELD; IDENTIFICATION; POPULATION; MARKERS; PERFORMANCE; PREDICTION; COMPONENTS	Background: Combining ability effects are very effective genetic parameters in deciding the next phase of breeding programs. Although some breeding strategies on the basis of evaluating combining ability have been utilized extensively in hybrid breeding, little is known about the genetic basis of combining ability. Combining ability is a complex trait that is controlled by polygenes. With the advent and development of molecular markers, it is feasible to evaluate the genetic bases of combining ability and heterosis of elite rice hybrids through QTL analysis. Methodology/Principal Findings: In the present study, we first developed a QTL-mapping method for dissecting combining ability and heterosis of agronomic traits. With three testcross populations and a BCRIL population in rice, biometric and QTL analyses were conducted for ten agronomic traits. The significance of general combining ability and special combining ability for most of the traits indicated the importance of both additive and non-additive effects on expression levels. A large number of additive effect QTLs associated with performance per se of BCRIL and general combining ability, and dominant effect QTLs associated with special combining ability and heterosis were identified for the ten traits. Conclusions/Significance: The combining ability of agronomic traits could be analyzed by the QTL mapping method. The characteristics revealed by the QTLs for combining ability of agronomic traits were similar with those by multitudinous QTLs for agronomic traits with performance per se of BCRIL. Several QTLs (1-6 in this study) were identified for each trait for combining ability. It demonstrated that some of the QTLs were pleiotropic or linked tightly with each other. The identification of QTLs responsible for combining ability and heterosis in the present study provides valuable information for dissecting genetic basis of combining ability.	[Qu, Zhen; Li, Lanzhi; Zheng, Xingfei; Hu, Zhongli] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Qu, Zhen] Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China; [Li, Lanzhi] Hunan Agr Univ, Hunan Prov Key Lab Biol & Control Plant Dis & Ins, Coll Biosafety Sci & Technol, Changsha, Hunan, Peoples R China; [Luo, Junyuan; Wang, Peng; Yu, Sibin; Mou, Tongmin] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Wuhan University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Hunan Agricultural University; Huazhong Agricultural University	Qu, Z (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	tongminmou@yahoo.com.cn; huzhongli@whu.edu.cn		, sibin/0000-0003-0458-7526; WANG, PENG/0000-0001-5927-6739	973 Program [2011CB100102, 2006CB101707]; National Natural Science Foundation of China [31000666]; Hunan Provincial Education Department [10C0817]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Education Department(Hunan Provincial Education Department)	This work was financially supported by the 973 Program (No. 2011CB100102 and 2006CB101707), the National Natural Science Foundation of China (No. 31000666) and the Scientific Research Fund of Hunan Provincial Education Department (No. 10C0817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestre M, 2008, GENET MOL RES, V7, P1106, DOI 10.4238/vol7-4gmr491; Basbag S, 2007, HEREDITAS, V144, P185, DOI 10.1111/j.2007.0018-0661.01998.x; Cerna FJ, 1997, THEOR APPL GENET, V95, P460, DOI 10.1007/s001220050583; Franco MC, 2001, EUPHYTICA, V118, P265, DOI 10.1023/A:1017560118666; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; Groh S, 1998, CROP SCI, V38, P1062, DOI 10.2135/cropsci1998.0011183X003800040030x; Hossain M., 1995, Geojournal, V35, P286, DOI 10.1007/BF00989136; Jordan DR, 2003, THEOR APPL GENET, V106, P559, DOI 10.1007/s00122-002-1144-5; Joshi SK, 2004, HEREDITAS, V141, P115, DOI 10.1111/j.1601-5223.2004.01730.x; Joshi SP, 2001, BIOCHEM GENET, V39, P179, DOI 10.1023/A:1010293325482; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Liu XC, 2004, BREEDING SCI, V54, P341, DOI 10.1270/jsbbs.54.341; MO H, 1991, Acta Agronomica Sinica, V17, P1; Mo HD, 1982, J JIANGSU AGR COLL, V3, P51; ROJAS BA, 1952, AGRON J, V44, P462, DOI 10.2134/agronj1952.00021962004400090002x; Roy Bidhan, 2001, Indian Journal of Genetics and Plant Breeding, V61, P162; Schrag TA, 2006, THEOR APPL GENET, V113, P1037, DOI 10.1007/s00122-006-0363-6; Schrag TA, 2010, THEOR APPL GENET, V120, P451, DOI 10.1007/s00122-009-1208-x; Shukla SK, 2008, PLANT BREEDING, V127, P28, DOI 10.1111/j.1439-0523.2007.01432.x; Verma OP, 2004, FIELD CROP RES, V88, P91, DOI 10.1016/S0378-4290(03)00080-7; WALEJKO RN, 1977, CROP SCI, V17, P647, DOI 10.2135/cropsci1977.0011183X001700040043x; Wang P, 2012, MOL BREEDING, V29, P99, DOI 10.1007/s11032-010-9529-7; Xiao J, 1996, THEOR APPL GENET, V92, P230, DOI 10.1007/BF00223380; Xiao JH, 1996, NATURE, V384, P223, DOI 10.1038/384223a0; XIAO JH, 1995, GENETICS, V140, P745; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xiong LX, 1999, THEOR APPL GENET, V98, P243, DOI 10.1007/s001220051064; You AQ, 2006, GENETICS, V172, P1287, DOI 10.1534/genetics.105.047209; Yu ChuanYuan, 2008, Acta Agronomica Sinica, V34, P1308, DOI 10.1016/S1875-2780(08)60044-9; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Yuan L. P., 1988, Hybrid rice. Proceedings of an international symposium, Changsha, China, 6-10 October 1986., P7; ZENG ZB, 1994, GENETICS, V136, P1457	32	43	47	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e28463	10.1371/journal.pone.0028463	http://dx.doi.org/10.1371/journal.pone.0028463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291881	Green Published, gold			2022-12-25	WOS:000301703800002
J	Migdalska, AM; van der Weyden, L; Ismail, O; White, JK; Sanchez-Andrade, G; Logan, DW; Arends, MJ; Adams, DJ				Migdalska, Anna M.; van der Weyden, Louise; Ismail, Ozama; White, Jacqueline K.; Sanchez-Andrade, Gabriela; Logan, Darren W.; Arends, Mark J.; Adams, David J.		Sanger Mouse Genetics Project	Modeling Partial Monosomy for Human Chromosome 21q11.2-q21.1 Reveals Haploinsufficient Genes Influencing Behavior and Fat Deposition	PLOS ONE			English	Article							SOCIAL RECOGNITION; CRITICAL REGION; DELETION; MICE; PATIENT; OBESITY; MEMORY; RESOURCE; TRISOMY; RIP140	Haploinsufficiency of part of human chromosome 21 results in a rare condition known as Monosomy 21. This disease displays a variety of clinical phenotypes, including intellectual disability, craniofacial dysmorphology, skeletal and cardiac abnormalities, and respiratory complications. To search for dosage-sensitive genes involved in this disorder, we used chromosome engineering to generate a mouse model carrying a deletion of the Lipi-Usp25 interval, syntenic with 21q11.2-q21.1 in humans. Haploinsufficiency for the 6 genes in this interval resulted in no gross morphological defects and behavioral analysis performed using an open field test, a test of anxiety, and tests for social interaction were normal in monosomic mice. Monosomic mice did, however, display impaired memory retention compared to control animals. Moreover, when fed a high-fat diet (HFD) monosomic mice exhibited a significant increase in fat mass/fat percentage estimate compared with controls, severe fatty changes in their livers, and thickened subcutaneous fat. Thus, genes within the Lipi-Usp25 interval may participate in memory retention and in the regulation of fat deposition.	[Migdalska, Anna M.; van der Weyden, Louise; Ismail, Ozama; White, Jacqueline K.; Sanchez-Andrade, Gabriela; Logan, Darren W.; Adams, David J.; Sanger Mouse Genetics Project] Wellcome Trust Sanger Inst, Cambridge, England; [Arends, Mark J.] Univ Cambridge, Dept Pathol, Addenbrookes Hosp, Cambridge CB2 1QP, England	Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Migdalska, AM (corresponding author), Wellcome Trust Sanger Inst, Cambridge, England.	da1@sanger.ac.uk	Migdalska-Richards, Anna/E-4214-2018; Ismail, Ozama/AFQ-9517-2022; Logan, Darren/D-5629-2009; van der Weyden, Louise/AAV-5711-2021	Migdalska-Richards, Anna/0000-0001-6992-0751; Logan, Darren/0000-0003-1545-5510; van der Weyden, Louise/0000-0002-0645-1879; Adams, David/0000-0001-9490-0306; Ismail, Ozama/0000-0002-0871-3924	Wellcome Trust; Cancer Research-UK; Kay Kendall Leukaemia Fund; Cancer Research UK [13031] Funding Source: researchfish; Medical Research Council [G0600717B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research-UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust and by Cancer Research-UK. LvdW is supported by the Kay Kendall Leukaemia Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Ahlbom BE, 1996, AM J MED GENET, V64, P501; Asnicar MA, 2001, ENDOCRINOLOGY, V142, P4394, DOI 10.1210/en.142.10.4394; Besson V, 2007, HUM MOL GENET, V16, P2040, DOI 10.1093/hmg/ddm152; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; CHETTOUH Z, 1995, AM J HUM GENET, V57, P62; Engelmann M, 2011, NAT PROTOC, V6, P1152, DOI 10.1038/nprot.2011.353; HEITMANN BL, 1995, AM J CLIN NUTR, V61, P1213, DOI 10.1093/ajcn/61.6.1213; Joosten AMS, 1997, PRENATAL DIAG, V17, P271, DOI 10.1002/(SICI)1097-0223(199703)17:3<271::AID-PD51>3.0.CO;2-P; Katzaki E, 2010, AM J MED GENET A, V152A, P1711, DOI 10.1002/ajmg.a.33478; Katzenstein JM, 2009, NEUROCASE, V15, P97, DOI 10.1080/13554790802631910; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; KORENBERG JR, 1991, HUM GENET, V87, P112, DOI 10.1007/BF00204163; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lindstrand A, 2010, CLIN GENET, V77, P145, DOI 10.1111/j.1399-0004.2009.01289.x; Liu PT, 1998, GENETICS, V150, P1155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan J, 2001, DIABETES, V50, P686, DOI 10.2337/diabetes.50.3.686; Lyle R, 2009, EUR J HUM GENET, V17, P454, DOI 10.1038/ejhg.2008.214; Mitsui S, 2009, EUR J NEUROSCI, V30, P2368, DOI 10.1111/j.1460-9568.2009.07029.x; Mori MA, 2004, AM J MED GENET A, V127A, P69, DOI 10.1002/ajmg.a.20622; Nieters A, 2002, EUR J NUTR, V41, P210, DOI 10.1007/s00394-002-0378-y; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; POEHLMAN ET, 1986, AM J CLIN NUTR, V43, P723, DOI 10.1093/ajcn/43.5.723; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Richter K, 2005, LEARN MEMORY, V12, P407, DOI 10.1101/lm.97505; Riegel M, 2005, EUR J MED GENET, V48, P167, DOI 10.1016/j.ejmg.2005.01.026; Roberson EDO, 2011, EUR J HUM GENET, V19, P235, DOI 10.1038/ejhg.2010.150; Robertson E, 1987, TERATOCARCINOMAS EMB; ROLAND B, 1990, CLIN GENET, V37, P423; Sato M, 2010, FASEB J, V24, P2375, DOI 10.1096/fj.09-145466; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Tinkel-Vernon H, 2003, AM J MED GENET A, V120A, P142, DOI 10.1002/ajmg.a.10210; Wakui K, 2002, J HUM GENET, V47, P511, DOI 10.1007/s100380200076; Wang DY, 2010, FASEB J, V24, P947, DOI 10.1096/fj.09-140806; Wen XY, 2003, HUM MOL GENET, V12, P1131, DOI 10.1093/hmg/ddg124; White R, 2000, NAT MED, V6, P1368, DOI 10.1038/82183; Yu T, 2010, MAMM GENOME, V21, P258, DOI 10.1007/s00335-010-9262-x; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	43	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29681	10.1371/journal.pone.0029681	http://dx.doi.org/10.1371/journal.pone.0029681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276124	Green Submitted, Green Published, gold			2022-12-25	WOS:000301568100015
J	Streitberger, KJ; Sack, I; Krefting, D; Pfuller, C; Braun, J; Paul, F; Wuerfel, J				Streitberger, Kaspar-Josche; Sack, Ingolf; Krefting, Dagmar; Pfueller, Caspar; Braun, Juergen; Paul, Friedemann; Wuerfel, Jens			Brain Viscoelasticity Alteration in Chronic-Progressive Multiple Sclerosis	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; ROBUST; ACCURATE; IMAGES; MRI; OPTIMIZATION; REGISTRATION; DIAGNOSIS; CRITERIA	Introduction: Viscoelastic properties indicate structural alterations in biological tissues at multiple scales with high sensitivity. Magnetic Resonance Elastography (MRE) is a novel technique that directly visualizes and quantitatively measures biomechanical tissue properties in vivo. MRE recently revealed that early relapsing-remitting multiple sclerosis (MS) is associated with a global decrease of the cerebral mechanical integrity. This study addresses MRE and MR volumetry in chronic-progressive disease courses of MS. Methods: We determined viscoelastic parameters of the brain parenchyma in 23 MS patients with primary or secondary chronic progressive disease course in comparison to 38 age-and gender-matched healthy individuals by multifrequency MRE, and correlated the results with clinical data, T2 lesion load and brain volume. Two viscoelastic parameters, the shear elasticity mu and the powerlaw exponent alpha, were reduced according to the springpot model and compared to literature values of relapsing-remitting MS. Results: In chronic-progressive MS patients, mu and alpha were reduced by 20.5% and 6.1%, respectively, compared to healthy controls. MR volumetry yielded a weaker correlation: Total brain volume loss in MS patients was in the range of 7.5% and 1.7% considering the brain parenchymal fraction. All findings were significant (P<0.001). Conclusions: Chronic-progressive MS disease courses show a pronounced reduction of the cerebral shear elasticity compared to early relapsing-remitting disease. The powerlaw exponent alpha decreased only in the chronic-progressive stage of MS, suggesting an alteration in the geometry of the cerebral mechanical network due to chronic neuroinflammation.	[Streitberger, Kaspar-Josche; Sack, Ingolf; Krefting, Dagmar] Charite, Dept Radiol, D-13353 Berlin, Germany; [Pfueller, Caspar; Paul, Friedemann; Wuerfel, Jens] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Pfueller, Caspar; Paul, Friedemann; Wuerfel, Jens] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Pfueller, Caspar; Paul, Friedemann; Wuerfel, Jens] Max Delbruck Ctr Mol Med, Berlin, Germany; [Braun, Juergen] Charite, Inst Med Informat, D-13353 Berlin, Germany; [Wuerfel, Jens] Univ Lubeck, Inst Neuroradiol, Lubeck, Germany; [Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Streitberger, KJ (corresponding author), Charite, Dept Radiol, D-13353 Berlin, Germany.	ingolf.sack@charite.de	Paul, Friedemann/ABF-9415-2020	paul, friedemann/0000-0002-6378-0070; Braun, Jurgen/0000-0001-5183-7546; Wuerfel, Jens/0000-0002-0034-8053; Krefting, Dagmar/0000-0002-7238-5339	German Research Foundation [Exc 257, Sa 901/3]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Exc 257 to F. P. and C. P. and Sa 901/3 to I. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Charil A, 2006, LANCET NEUROL, V5, P841, DOI 10.1016/S1474-4422(06)70572-5; Freimann FB, 2011, NEURORADIOLOGY  0503; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Gurtovenko AA, 2005, ADV POLYM SCI, V182, P171, DOI 10.1007/b135561; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Klatt D, 2010, PHYS MED BIOL, V55, P6445, DOI 10.1088/0031-9155/55/21/007; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Riek K, 2011, MR ELASTOGRAPHY MICE, P1476; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Sastre-Garriga J, 2005, BRAIN, V128, P1454, DOI 10.1093/brain/awh498; Schregel K, 2011, BIOMECHANICAL PROPER; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	29	155	160	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29888	10.1371/journal.pone.0029888	http://dx.doi.org/10.1371/journal.pone.0029888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276134	Green Accepted, Green Published, gold			2022-12-25	WOS:000301568100019
J	Yan, QY; van der Gast, CJ; Yu, YH				Yan, Qingyun; van der Gast, Christopher J.; Yu, Yuhe			Bacterial Community Assembly and Turnover within the Intestines of Developing Zebrafish	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; FAUNAL SIMILARITY; GENETIC-ANALYSIS; NATURE-RESERVES; WASTE-WATER; IN-VIVO; DIVERSITY; MICROBIOTA; TAXA; SIZE	Background: The majority of animal associated microorganisms are present in digestive tract communities. These intestinal communities arise from selective pressures of the gut habitats as well as host's genotype are regarded as an extra 'organ' regulate functions that have not evolved wholly on the host. They are functionally essential in providing nourishment, regulating epithelial development, and influencing immunity in the vertebrate host. As vertebrates are born free of microorganisms, what is poorly understood is how intestinal bacterial communities assemble and develop in conjunction with the development of the host. Methodology/Principal Findings: Set within an ecological framework, we investigated the bacterial community assembly and turnover within the intestinal habitats of developing zebrafish (from larvae to adult animals). Spatial and temporal species-richness relationships and Mantel and partial Mantel tests revealed that turnover was low and that richness and composition was best predicted by time and not intestinal volume (habitat size) or changes in food diet. We also observed that bacterial communities within the zebrafish intestines were deterministically assembled (reflected by the observed low turnover) switching to stochastic assembly in the later stages of zebrafish development. Conclusions/Significance: This study is of importance as it provides a novel insight into how intestinal bacterial communities assemble in tandem with the host's development (from early to adult stages). It is our hope that by studying intestinal microbiota of this vertebrate model with such or some more refined approaches in the future could well provide ecological insights for clinical benefit. In addition, this study also adds to our still fledgling knowledge of how spatial and temporal species-richness relationships are shaped and provides further mounting evidence that bacterial community assembly and dynamics are shaped by both deterministic and stochastic considerations.	[Yan, Qingyun; Yu, Yuhe] Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China; [van der Gast, Christopher J.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; UK Centre for Ecology & Hydrology (UKCEH)	Yan, QY (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China.	yhyu@ihb.ac.cn	van der Gast, Christopher/G-1153-2011	van der Gast, Christopher/0000-0003-1101-4048	Major State Basic Research Development Program of China [2009CB118705]; National Natural Science Foundation of China [30970358]; UK Natural Environment Research Council (NERC); Natural Environment Research Council [CEH010021] Funding Source: researchfish	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Major State Basic Research Development Program of China (2009CB118705) and the National Natural Science Foundation of China (30970358). CJvdG was supported by the UK Natural Environment Research Council (NERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2003, ECOL LETT, V6, P749, DOI 10.1046/j.1461-0248.2003.00497.x; Ager D, 2010, ENVIRON MICROBIOL, V12, P670, DOI 10.1111/j.1462-2920.2009.02107.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Ayarza JM, 2011, MICROB ECOL, V61, P486, DOI 10.1007/s00248-010-9762-y; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barnes RJ, 2010, J HAZARD MATER, V184, P73, DOI 10.1016/j.jhazmat.2010.08.006; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; Belasky P, 1996, PALAEOGEOGR PALAEOCL, V122, P119, DOI 10.1016/0031-0182(95)00092-5; Bell T, 2005, SCIENCE, V308, P1884, DOI 10.1126/science.1111318; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Cremonesi L, 1997, BIOTECHNIQUES, V22, P326, DOI 10.2144/97222rr01; Diamond J.M., 1975, P342; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Faro A, 2009, ZEBRAFISH, V6, P361, DOI 10.1089/zeb.2009.0617; Fowler J., 1998, PRACTICAL STAT FIELD, P130; GILPIN ME, 1980, NATURE, V285, P567, DOI 10.1038/285567a0; GRAFEN A, 2006, MODERN STAT LIFE SCI; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; HIGGS AJ, 1980, NATURE, V285, P568, DOI 10.1038/285568a0; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hubbell Stephen P., 2001, V32, pi; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Oliver A, 2012, MICROBIAL ECOLOGICAL THEORY: CURRENT PERSPECTIVES, P71; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; RAUP DM, 1979, J PALEONTOL, V53, P1213; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2007, PEDIATR PULM, P146; Rawls JF, 2007, P NATL ACAD SCI USA, V104, P7622, DOI 10.1073/pnas.0702386104; Reche I, 2005, ECOLOGY, V86, P1715, DOI 10.1890/04-1587; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowan AK, 2003, FEMS MICROBIOL ECOL, V43, P195, DOI 10.1111/j.1574-6941.2003.tb01059.x; Shi XJ, 2008, TOXICOL APPL PHARM, V230, P23, DOI 10.1016/j.taap.2008.01.043; SIMBERLOFF D, 1982, AM NAT, V120, P41, DOI 10.1086/283968; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smoot JC, 2010, AQUAT BIOL, V8, P105, DOI 10.3354/ab00202; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; van der Gast CJ, 2008, ADV APPL MICROBIOL, V64, P167, DOI 10.1016/S0065-2164(08)00406-1; van der Gast CJ, 2006, ENVIRON MICROBIOL, V8, P1048, DOI 10.1111/j.1462-2920.2006.00996.x; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; van der Gast CJ, 2005, ENVIRON MICROBIOL, V7, P1220, DOI 10.1111/j.1462-2920.2005.00802.x; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Yu YH, 2008, FEMS MICROBIOL ECOL, V63, P328, DOI 10.1111/j.1574-6941.2007.00430.x	52	69	73	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30603	10.1371/journal.pone.0030603	http://dx.doi.org/10.1371/journal.pone.0030603			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276219	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000301457200069
J	Al-Mulla, F; Bitar, MS; Feng, JW; Park, S; Yeung, KC				Al-Mulla, Fahd; Bitar, Milad S.; Feng, Jingwei; Park, Sungdae; Yeung, Kam C.			A New Model for Raf Kinase Inhibitory Protein Induced Chemotherapeutic Resistance	PLOS ONE			English	Article							NF-KAPPA-B; INDUCIBLE EXPRESSION; OXIDATIVE STRESS; CELL SENSITIVITY; CANCER-CELLS; NRF2; KEAP1; RKIP; GENE; UBIQUITINATION	Therapeutic resistance remains the most challenging aspect of treating cancer. Raf kinase inhibitory protein (RKIP) emerged as a molecule capable of sensitizing cancerous cells to radio- and chemotherapy. Moreover, this small evolutionary conserved molecule, endows significant resistance to cancer therapy when its expression is reduced or lost. RKIP has been shown to inhibit the Raf-MEK-ERK, NF kappa B, GRK and activate the GSK3 beta signaling pathways. Inhibition of Raf-MEK-ERK and NF kappa B remains the most prominent pathways implicated in the sensitization of cells to therapeutic drugs. Our purpose was to identify a possible link between RKIP-KEAP 1-NRF2 and drug resistance. To that end, RKIP-KEAP 1 association was tested in human colorectal cancer tissues using immunohistochemistry. RKIP miRNA silencing and its inducible overexpression were employed in HEK-293 immortalized cells, HT29 and HCT116 colon cancer cell lines to further investigate our aim. We show that RKIP enhanced Kelch-like ECH-associated protein1 (KEAP 1) stability in colorectal cancer tissues and HT29 CRC cell line. RKIP silencing in immortalized HEK-293 cells (termed HEK-499) correlated significantly with KEAP 1 protein degradation and subsequent NRF2 addiction in these cells. Moreover, RKIP depletion in HEK-499, compared to control cells, bestowed resistance to supra physiological levels of H2O2 and Cisplatin possibly by upregulating NF-E2-related nuclear factor 2 (NRF2) responsive genes. Similarly, we observed a direct correlation between the extent of apoptosis, after treatment with Adriamycin, and the expression levels of RKIP/KEAP 1 in HT29 but not in HCT116 CRC cells. Our data illuminate, for the first time, the NRF2-KEAP 1 pathway as a possible target for personalized therapeutic intervention in RKIP depleted cancers.	[Al-Mulla, Fahd] Kuwait Univ, Dept Pathol, Hlth Sci Ctr, Fac Med, Safat, Kuwait; [Bitar, Milad S.] Kuwait Univ, Dept Pharmacol, Hlth Sci Ctr, Fac Med, Safat, Kuwait; [Feng, Jingwei; Park, Sungdae; Yeung, Kam C.] Univ Toledo, Dept Biochem & Canc Biol, Coll Med, Toledo, OH 43606 USA	Kuwait University; Kuwait University; University System of Ohio; University of Toledo	Al-Mulla, F (corresponding author), Kuwait Univ, Dept Pathol, Hlth Sci Ctr, Fac Med, Safat, Kuwait.	fahd@al-mulla.org	Al-Mulla, Fahd/E-2068-2015	Al-Mulla, Fahd/0000-0001-5409-3829	Kuwait University [MG02/08]; Kuwait Foundation for the Advancement of Sciences [2006-1302-07]; Research Administration of Kuwait University [GM01/01, GM01/05]; University of Texas Health Science Center (UTHSC); Health Sciences Center, Kuwait University	Kuwait University; Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS)); Research Administration of Kuwait University; University of Texas Health Science Center (UTHSC); Health Sciences Center, Kuwait University	This study was supported by funds from Kuwait University grant (MG02/08) and the Kuwait Foundation for the Advancement of Sciences grant number (2006-1302-07). RCF is supported by GM01/01 and GM01/05 grants from Research Administration of Kuwait University. KCY was supported in part by a University of Texas Health Science Center (UTHSC) Translation Research Stimulation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the staff of the Research Core Facility (RCF) at the Health Sciences Center, Kuwait University for their excellent support and technical assistance. Mr. Waleed Al-Ali for his help with Immunohistochemistry, Betty Thomas in the Proteomics Unit, Sunitha Pramod for their help with the Western blotting, confocal microscope and tissue culture and Dr. Oliver Rath for the cells used in the study.	Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499; al-Mulla F, 2011, MOL BIOSYST, V7, P928, DOI 10.1039/c0mb00208a; Al-Mulla F, 2011, CANCER RES, V71, P1334, DOI 10.1158/0008-5472.CAN-10-3102; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Baritaki S, 2010, CRIT REV IMMUNOL, V30, P31, DOI 10.1615/CritRevImmunol.v30.i1.20; Baritaki S, 2009, CANCER RES, V69, P8376, DOI 10.1158/0008-5472.CAN-09-1069; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chen Y, 2009, MED ONCOL, V26, P463, DOI 10.1007/s12032-008-9147-y; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Fourquet S, 2010, J BIOL CHEM, V285, P8463, DOI 10.1074/jbc.M109.051714; Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hu R, 2006, LIFE SCI, V79, P1944, DOI 10.1016/j.lfs.2006.06.019; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Katsuoka F, 2005, J BIOL CHEM, V280, P4483, DOI 10.1074/jbc.M411451200; Keller ET, 2004, CANCER LETT, V207, P131, DOI 10.1016/j.canlet.2004.02.006; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Li HZ, 2008, MOL CANCER RES, V6, P917, DOI 10.1158/1541-7786.MCR-08-0093; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Ruan L, 2010, J CELL BIOCHEM, V110, P975, DOI 10.1002/jcb.22611; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Schuierer MM, 2006, ONCOL REP, V16, P451; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Tang HH, 2010, FEBS LETT, V584, P662, DOI 10.1016/j.febslet.2009.12.051; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Umemoto M, 2001, BRIT J CANCER, V85, P1032, DOI 10.1054/bjoc.2001.2034; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Woods KM, 2008, INT J RADIAT ONCOL, V72, P153, DOI 10.1016/j.ijrobp.2008.04.072; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200	46	29	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29532	10.1371/journal.pone.0029532	http://dx.doi.org/10.1371/journal.pone.0029532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279539	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900017
J	Kathrani, A; Holder, A; Catchpole, B; Alvarez, L; Simpson, K; Werling, D; Allenspach, K				Kathrani, Aarti; Holder, Angela; Catchpole, Brian; Alvarez, Lorena; Simpson, Kenneth; Werling, Dirk; Allenspach, Karin			TLR5 Risk-Associated Haplotype for Canine Inflammatory Bowel Disease Confers Hyper-Responsiveness to Flagellin	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-5; BLOOD MONONUCLEAR-CELLS; EPITHELIAL BARRIER; DENDRITIC CELLS; MESSENGER-RNA; EXPRESSION; RECOGNITION; BACTERIA; ACTIVATION; RESPONSES	Single nucleotide polymorphisms (SNP) in the TLR5 gene have been associated with human inflammatory bowel disease (IBD) and animal models of this disease. We recently demonstrated a significant association between three non-synonymous SNPs in the canine TLR5 gene and IBD in German shepherd dogs (GSDs). However, so far, no direct link between these SNPs and a disturbance in TLR5 function was shown. In the present study, we determined the functional significance of the canine TLR5 SNPs by transfecting the identified risk-protective and risk-associated haplotype into human embryonic kidney cells (HEK) and assessed nuclear factor-kappa B (NF-kB) activation and CXCL8 production after stimulation. In addition, a whole blood assay for TLR5 activation was developed using blood derived from carrier dogs of either haplotype. There was a significant increase in NF-kappa B activity when cells transfected with the risk-associated TLR5 haplotype were stimulated with flagellin compared to the cells expressing the risk-protective TLR5 haplotype. This difference in NFkB activation correlated with CXCL8 expression in the supernatant measured by ELISA. Furthermore, whole blood taken from carrier dogs of the risk-associated TLR5 haplotype produced significantly more TNF after stimulation with flagellin compared to that taken from carriers of the risk-protective haplotype. Thus, we show for the first time a direct functional impact of the canine IBD risk-associated TLR5 haplotype, which results in hyper-responsiveness to flagellin compared to the IBD risk-protective TLR5 haplotype. Our data potentially suggest that similarly to human IBD and experimental models, TLR5 may also play a role in canine IBD. Blocking the hyper-responsive receptor found in susceptible dogs with IBD may alleviate the inappropriate inflammation seen in this disease.	[Kathrani, Aarti; Alvarez, Lorena; Allenspach, Karin] Univ London, Dept Vet Clin Sci, Royal Vet Coll, Hatfield, Herts, England; [Holder, Angela; Catchpole, Brian; Werling, Dirk] Univ London, Dept Pathol & Infect Dis, Royal Vet Coll, Hatfield, Herts, England; [Simpson, Kenneth] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; Cornell University	Kathrani, A (corresponding author), Univ London, Dept Vet Clin Sci, Royal Vet Coll, Hatfield, Herts, England.	kallenspach@rvc.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044	Biological Sciences Research Council; Pfizer	Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer)	Funding was provided by the Biological Sciences Research Council and Pfizer. Pfizer did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biological Sciences Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Bachmann M, 2006, CELL MICROBIOL, V8, P289, DOI 10.1111/j.1462-5822.2005.00621.x; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Fritz JH, 2008, TRENDS IMMUNOL, V29, P41, DOI 10.1016/j.it.2007.10.002; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Gewirtz AT, 2006, AM J PHYSIOL-GASTR L, V290, pG1157, DOI 10.1152/ajpgi.00544.2005; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; House AK, 2008, VET IMMUNOL IMMUNOP, V124, P230, DOI 10.1016/j.vetimm.2008.03.012; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kathrani A, 2011, TISSUE ANTIGENS, V78, P94, DOI 10.1111/j.1399-0039.2011.01707.x; Kathrani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015740; Magalhaes JG, 2007, SEMIN IMMUNOL, V19, P106, DOI 10.1016/j.smim.2006.12.006; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Ortega-Cava CF, 2006, CLIN VACCINE IMMUNOL, V13, P132, DOI 10.1128/CVI.13.1.132-138.2006; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Schagat T, 2007, CELL NOTES, V17, P9; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Stanislawowski M, 2009, J PHYSIOL PHARMACOL, V60, P71; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Szebeni B, 2008, CLIN EXP IMMUNOL, V151, P34, DOI 10.1111/j.1365-2249.2007.03531.x; Uematsu S, 2009, J GASTROENTEROL, V44, P803, DOI 10.1007/s00535-009-0094-y; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vicente-Suarez I, 2009, IMMUNOL LETT, V125, P114, DOI 10.1016/j.imlet.2009.06.007; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Wong CK, 2007, AM J RESP CELL MOL, V37, P85, DOI 10.1165/rcmb.2006-0457OC; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	37	39	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30117	10.1371/journal.pone.0030117	http://dx.doi.org/10.1371/journal.pone.0030117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279566	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900044
J	Olivier, M; Foret, B; Le Vern, Y; Guilloteau, LA				Olivier, Michel; Foret, Benjamin; Le Vern, Yves; Guilloteau, Laurence A.			Capacities of Migrating CD1b(+) Lymph Dendritic Cells to Present Salmonella Antigens to Naive T Cells	PLOS ONE			English	Article							AFFERENT LYMPH; FUNCTIONAL SPECIALIZATION; IMMUNE-RESPONSE; IFN-GAMMA; IN-VIVO; INFECTION; SHEEP; SUBSETS; IMMUNIZATION; ABORTUSOVIS	Dendritic cells (DCs) are well known as professional antigen-presenting cells (APC) able to initiate specific T-cell responses to pathogens in lymph nodes (LN) draining the site of infection. However, the respective contribution of migratory and LN-resident DCs in this process remains unclear. As DC subsets represent important targets for vaccination strategies, more precise knowledge of DC subsets able to present vaccine antigens to T cells efficiently is required. To investigate the capacities of DCs migrating in the lymph (L-DCs) to initiate a specific T-cell response, we used physiologically generated DCs collected from a pseudoafferent lymphatic cannulation model in sheep. The CD1b(+) L-DCs were assessed for presenting antigens from the vaccine attenuated strain of Salmonella enterica serovar Abortusovis. CD1b(+) L-DCs were able to phagocytose, process and to present efficiently Salmonella antigens to effector/memory T cells in vitro. They were shown to be efficient APC for the priming of allogeneic naive T cells associated with inducing both IFN-gamma and IL-4 responses. They were also efficient in presenting Salmonella antigens to autologous naive T cells associated with inducing both IFN-gamma and IL-10 responses. The capacities of L-DCs to process and present Salmonella antigens to T cells were investigated in vivo after conjunctival inoculation of Salmonella. The CD1b(+) L-DCs collected after inoculation were able to induce the proliferative response of CD4(+) T cells suggesting the in vivo capture of Salmonella antigens by the CD1b(+) L-DCs, and their potential to present them directly to CD4(+) T cells. In this study, CD1b(+) L-DCs present potential characteristics of APC to initiate by themselves T cell priming in the LN. They could be used as target cells for driving immune activation in vaccinal strategies.	[Olivier, Michel; Foret, Benjamin; Le Vern, Yves; Guilloteau, Laurence A.] Inst Natl Rech Agron, Infectiol Anim & Sante Publ UR1282, Nouzilly, France	INRAE	Olivier, M (corresponding author), Inst Natl Rech Agron, Infectiol Anim & Sante Publ UR1282, Nouzilly, France.	Laurence.Guilloteau@tours.inra.fr			Institut National de la Recherche Agronomique (INRA)	Institut National de la Recherche Agronomique (INRA)	This work was funded by the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson CP, 2008, DEV COMP IMMUNOL, V32, P837, DOI 10.1016/j.dci.2007.12.004; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Brunner E, 2002, NONPARAMETRIC ANAL L; BUJDOSO R, 1990, International Reviews of Immunology, V6, P177, DOI 10.3109/08830189009056628; Cagiola M, 2007, VET MICROBIOL, V121, P330, DOI 10.1016/j.vetmic.2006.12.018; Chan SSM, 2008, J LEUKOCYTE BIOL, V83, P272, DOI 10.1189/jlb.0607401; Contreras V, 2010, J IMMUNOL, V185, P3313, DOI 10.4049/jimmunol.1000824; de Veer M, 2010, VACCINE, V28, P6597, DOI 10.1016/j.vaccine.2010.07.056; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Epardaud M, 2004, J LEUKOCYTE BIOL, V76, P553, DOI 10.1189/jlb.0404223; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gohin I, 1997, VET IMMUNOL IMMUNOP, V60, P111, DOI 10.1016/S0165-2427(97)00090-1; Guilloteau LA, 2006, VACCINE, V24, P3461, DOI 10.1016/j.vaccine.2006.02.007; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hope JC, 2005, J IMMUNOL METHODS, V301, P114, DOI 10.1016/j.jim.2005.04.010; LANTIER F, 1981, INFECT IMMUN, V34, P492, DOI 10.1128/IAI.34.2.492-497.1981; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Lei LY, 2007, VET IMMUNOL IMMUNOP, V120, P177, DOI 10.1016/j.vetimm.2007.06.031; MACKAY CR, 1992, EUR J IMMUNOL, V22, P887, DOI 10.1002/eji.1830220402; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Mount AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001691; Norimatsu M, 2004, VET IMMUNOL IMMUNOP, V98, P193, DOI 10.1016/j.vetimm.2003.12.008; Pascale F, 2008, J IMMUNOL, V180, P5963, DOI 10.4049/jimmunol.180.9.5963; Pedersen LG, 2002, VET IMMUNOL IMMUNOP, V88, P111, DOI 10.1016/S0165-2427(02)00139-3; Randolph GJ, 2006, IMMUNITY, V25, P15, DOI 10.1016/j.immuni.2006.07.003; Ryan S, 2000, J VIROL, V74, P10096, DOI 10.1128/JVI.74.21.10096-10103.2000; Schwartz-Cornil I, 2006, NAT PROTOC, V1, P874, DOI 10.1038/nprot.2006.147; Segura E, 2009, CURR OPIN IMMUNOL, V21, P105, DOI 10.1016/j.coi.2009.03.011; Suraud V, 2008, MICROBES INFECT, V10, P1370, DOI 10.1016/j.micinf.2008.08.003; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Yrlid U, 2002, J IMMUNOL, V169, P108, DOI 10.4049/jimmunol.169.1.108	37	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30430	10.1371/journal.pone.0030430	http://dx.doi.org/10.1371/journal.pone.0030430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279590	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900067
J	Dasgupta, I; Tanifum, EA; Srivastava, M; Phatak, SS; Cavasotto, CN; Analoui, M; Annapragada, A				Dasgupta, Indrani; Tanifum, Eric A.; Srivastava, Mayank; Phatak, Sharangdhar S.; Cavasotto, Claudio N.; Analoui, Mostafa; Annapragada, Ananth			Non Inflammatory Boronate Based Glucose-Responsive Insulin Delivery Systems	PLOS ONE			English	Article							NUCLEAR TRANSLOCATION; PHASE-BEHAVIOR; CONCANAVALIN-A; KAPPA-B; CHOLESTEROL; MEMBRANES; MIXTURES	Boronic acids, known to bind diols, were screened to identify non-inflammatory cross-linkers for the preparation of glucose sensitive and insulin releasing agglomerates of liposomes (Agglomerated Vesicle Technology-AVT). This was done in order to select a suitable replacement for the previously used cross-linker, ConcanavalinA (ConA), a lectin known to have both toxic and inflammatory effects in vivo. Lead-compounds were selected from screens that involved testing for inflammatory potential, cytotoxicity and glucose-binding. These were then conjugated to insulin-encapsulating nanoparticles and agglomerated via sugar-boronate ester linkages to form AVTs. In vitro, the particles demonstrated triggered release of insulin upon exposure to physiologically relevant concentrations of glucose (10 mmoles/L-40 mmoles/L). The agglomerates were also shown to be responsive to multiple spikes in glucose levels over several hours, releasing insulin at a rate defined by the concentration of the glucose trigger.	[Dasgupta, Indrani; Phatak, Sharangdhar S.; Cavasotto, Claudio N.] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Tanifum, Eric A.; Srivastava, Mayank; Annapragada, Ananth] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Tanifum, Eric A.; Srivastava, Mayank; Annapragada, Ananth] Baylor Coll Med, Houston, TX 77030 USA; [Analoui, Mostafa] Cense Biosci Inc, Manvel, TX USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine	Dasgupta, I (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA.	avannapr@texaschildrenshospital.org	Annapragada, Ananth/GOK-1576-2022; Cavasotto, Claudio/GQY-7627-2022	Annapragada, Ananth/0000-0002-3156-9617; Cavasotto, Claudio/0000-0002-1372-0379	Gillson-Longenbaugh Foundation; SBIR [1R43DK083819-01]; National Cancer Institute [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK083819] Funding Source: NIH RePORTER	Gillson-Longenbaugh Foundation; SBIR; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an unrestricted gift from Gillson-Longenbaugh Foundation and SBIR (1R43DK083819-01) awarded to Cense Biosciences, Inc.. The NMR spectra were acquired at NMR facility at the M.D. Anderson Cancer Center which is supported by the National Cancer Institute Cancer Center support grant CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev VL, 2003, ANAL CHEM, V75, P2316, DOI 10.1021/ac030021m; Ballerstadt R, 2006, BIOSENS BIOELECTRON, V22, P275, DOI 10.1016/j.bios.2006.01.008; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bhavane R, 2003, J CONTROL RELEASE, V93, P15, DOI 10.1016/S0168-3659(03)00359-6; Bhavane R, 2007, INT J NANOMED, V2, P407; BROWNLEE M, 1979, SCIENCE, V206, P1190, DOI 10.1126/science.505005; Dowlut M, 2006, J AM CHEM SOC, V128, P4226, DOI 10.1021/ja057798c; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Hermanson GT, 1996, BIOCONJUGATE TECHNIQ, P169; Hoogwerf BJ, 2005, INT J DIABETES DEV C, V25, P63, DOI DOI 10.4103/0973-3930.22774; Hovorka R, 2006, DIABETIC MED, V23, P1, DOI 10.1111/j.1464-5491.2005.01672.x; Jin XJ, 2009, BIOMACROMOLECULES, V10, P1337, DOI 10.1021/bm8010006; Kabilan S, 2004, IEEE SENS P OCT 24 2; Karathanasis E, 2007, INT J NANOMED, V2, P501; KUIVILA HG, 1954, J ORG CHEM, V19, P780, DOI 10.1021/jo01370a013; Li SQ, 2009, BIOMACROMOLECULES, V10, P113, DOI 10.1021/bm8009768; Mannock DA, 2010, BBA-BIOMEMBRANES, V1798, P376, DOI 10.1016/j.bbamem.2009.09.002; Matsumoto A, 2003, BIOMACROMOLECULES, V4, P1410, DOI 10.1021/bm034139o; McDonough PM, 2009, ASSAY DRUG DEV TECHN, V7, P440, DOI 10.1089/adt.2009.0196; Morelock MM, 2005, ASSAY DRUG DEV TECHN, V3, P483, DOI 10.1089/adt.2005.3.483; Norrlid CJ, 1995, J AM CHEM SOC, V117, P1479; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Schneider HJ, 2007, SENSORS-BASEL, V7, P1578, DOI 10.3390/s7081578; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SMUTZER G, 1985, BIOCHIM BIOPHYS ACTA, V814, P274, DOI 10.1016/0005-2736(85)90445-6; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Tanna S, 2006, BIOMATERIALS, V27, P1586, DOI 10.1016/j.biomaterials.2005.08.011; Tonyushkina Ksenia, 2009, J Diabetes Sci Technol, V3, P971; Wang BL, 2009, LANGMUIR, V25, P12522, DOI 10.1021/la901776a; Yu S, 2009, J MEMBRANE SCI, V339, P138, DOI 10.1016/j.memsci.2009.04.041	30	11	16	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29585	10.1371/journal.pone.0029585	http://dx.doi.org/10.1371/journal.pone.0029585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272238	Green Submitted, Green Published, gold			2022-12-25	WOS:000301454400017
J	Holland, DP; Sanders, GD; Hamilton, CD; Stout, JE				Holland, David P.; Sanders, Gillian D.; Hamilton, Carol D.; Stout, Jason E.			Strategies for Treating Latent Multiple-Drug Resistant Tuberculosis: A Decision Analysis	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; DIRECTLY OBSERVED THERAPY; MYCOBACTERIUM-TUBERCULOSIS; FLUOROQUINOLONE RESISTANCE; NITROIMIDAZOPYRAN PA-824; PREVENTIVE THERAPY; LOW-RISK; INFECTION; PYRAZINAMIDE; HEALTH	Background: The optimal treatment for latent multiple-drug resistant tuberculosis infection remains unclear. In anticipation of future clinical trials, we modeled the expected performance of six potential regimens for treatment of latent multiple-drug resistant tuberculosis. Methods: A computerized Markov model to analyze the total cost of treatment for six different regimens: Pyrazinamide/ethambutol, moxifloxacin monotherapy, moxifloxacin/pyrazinamide, moxifloxacin/ethambutol, moxifloxacin/ethionamide, and moxifloxacin/PA-824. Efficacy estimates were extrapolated from mouse models and examined over a wide range of assumptions. Results: In the base-case, moxifloxacin monotherapy was the lowest cost strategy, but moxifloxacin/ethambutol was cost-effective at an incremental cost-effectiveness ratio of $21,252 per quality-adjusted life-year. Both pyrazinamide-containing regimens were dominated due to their toxicity. A hypothetical regimen of low toxicity and even modest efficacy was cost-effective compared to "no treatment." Conclusion: In our model, moxifloxacin/ethambutol was the preferred treatment strategy under a wide range of assumptions; pyrazinamide-containing regimens fared poorly because of high rates of toxicity. Although more data are needed on efficacy of treatments for latent MDR-TB infection, data on toxicity and treatment discontinuation, which are easier to obtain, could have a substantial impact on public health practice.	[Holland, David P.; Sanders, Gillian D.; Hamilton, Carol D.; Stout, Jason E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Holland, David P.; Hamilton, Carol D.; Stout, Jason E.] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC 27710 USA; [Hamilton, Carol D.] FHI 360, Durham, NC USA	Duke University; Duke University; FHI 360	Holland, DP (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	david.p.holland@duke.edu		Stout, Jason/0000-0002-6698-8176	Southeast Regional Center for Excellence in Emerging Infections and Biodefense (National Institutes of Health (NIH) [U54 AI057157]; NIH [K01-A108372-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083782, U54AI057157] Funding Source: NIH RePORTER	Southeast Regional Center for Excellence in Emerging Infections and Biodefense (National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Southeast Regional Center for Excellence in Emerging Infections and Biodefense (National Institutes of Health (NIH) U54 AI057157) and and NIH K01-A108372-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Bennett DE, 2008, AM J RESP CRIT CARE, V177, P348, DOI 10.1164/rccm.200701-057OC; BROWN RE, 1995, ARCH INTERN MED, V155, P1595, DOI 10.1001/archinte.155.15.1595; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; Burman WJ, 1997, CHEST, V112, P63, DOI 10.1378/chest.112.1.63; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; COMSTOCK GW, 1975, AM J EPIDEMIOL, V101, P363, DOI 10.1093/oxfordjournals.aje.a112105; Devasia RA, 2009, AM J RESP CRIT CARE, V180, P365, DOI 10.1164/rccm.200901-0146OC; Fraser A, 2006, INT J TUBERC LUNG D, V10, P19; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Ginsberg AM, 2009, ANTIMICROB AGENTS CH, V53, P3720, DOI 10.1128/AAC.00106-09; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Guo N, 2008, VALUE HEALTH, V11, P1154, DOI 10.1111/j.1524-4733.2008.00355.x; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; HORN DL, 1994, NEW ENGL J MED, V330, P1241, DOI 10.1056/NEJM199404283301718; Hu Y, 2008, INT J TUBERC LUNG D, V12, P69; Huang TS, 2005, J ANTIMICROB CHEMOTH, V56, P1058, DOI 10.1093/jac/dki353; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; LECOEUR HF, 1989, AM REV RESPIR DIS, V140, P1189, DOI 10.1164/ajrccm/140.5.1189; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Lou HX, 2002, PHARMACOTHERAPY, V22, P701, DOI 10.1592/phco.22.9.701.34065; *NASA, GROSS DOM PROD DEFL; Nuermberger E, 2005, AM J RESP CRIT CARE, V172, P1452, DOI 10.1164/rccm.200507-1047OC; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Papastavros T, 2002, CAN MED ASSOC J, V167, P131; Rajbhandary SS, 2004, INT J TUBERC LUNG D, V8, P1012; Ridzon R, 1997, CLIN INFECT DIS, V24, P1264, DOI 10.1093/clinids/24.6.1264; RILEY RL, 1962, AM REV RESPIR DIS, V85, P511; Sacks LV, 1998, ARCH INTERN MED, V158, P1916, DOI 10.1001/archinte.158.17.1916; Salpeter EE, 1998, AM J EPIDEMIOL, V147, P398; Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Senneville E, 2007, J CHEMOTHERAPY, V19, P688, DOI 10.1179/joc.2007.19.6.688; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; SNIDER DE, 1985, AM REV RESPIR DIS, V132, P125; Snyder DC, 1999, AM J RESP CRIT CARE, V160, P582, DOI 10.1164/ajrccm.160.2.9901049; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; STEVENS JP, 1995, CHEST, V108, P712, DOI 10.1378/chest.108.3.712; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930; Xu P, 2009, ANTIMICROB AGENTS CH, V53, P3170, DOI 10.1128/AAC.00177-09; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744; Younossian AB, 2005, EUR RESPIR J, V26, P462, DOI 10.1183/09031936.05.00006205; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	49	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30194	10.1371/journal.pone.0030194	http://dx.doi.org/10.1371/journal.pone.0030194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272302	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400080
J	Masuko, K; Okazaki, S; Satoh, M; Tanaka, G; Ikeda, T; Torii, R; Ueda, E; Nakano, T; Danbayashi, M; Tsuruoka, T; Ohno, Y; Yagi, H; Yabe, N; Yoshida, H; Tahara, T; Kataoka, S; Oshino, T; Shindo, T; Niwa, S; Ishimoto, T; Baba, H; Hashimoto, Y; Saya, H; Masuko, T				Masuko, Kazue; Okazaki, Shogo; Satoh, Mayumi; Tanaka, Goh; Ikeda, Tatsuya; Torii, Ryota; Ueda, Eri; Nakano, Takashi; Danbayashi, Masaaki; Tsuruoka, Tomoyo; Ohno, Yoshiya; Yagi, Hideki; Yabe, Noritsugu; Yoshida, Hideaki; Tahara, Tomoyuki; Kataoka, Shiro; Oshino, Taichi; Shindo, Takayuki; Niwa, Shin-ichiro; Ishimoto, Takatsugu; Baba, Hideo; Hashimoto, Yoshiyuki; Saya, Hideyuki; Masuko, Takashi			Anti-Tumor Effect against Human Cancer Xenografts by a Fully Human Monoclonal Antibody to a Variant 8-Epitope of CD44R1 Expressed on Cancer Stem Cells	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; PROSPECTIVE IDENTIFICATION; BIVATUZUMAB MERTANSINE; EXTRACELLULAR DOMAIN; RECEPTOR; CHEMOTHERAPY; ACTIVATION; CARCINOMA; ISOFORMS; HEAD	Background: CD44 is a major cellular receptor for hyaluronic acids. The stem structure of CD44 encoded by ten normal exons can be enlarged by ten variant exons (v1-v10) by alternative splicing. We have succeeded in preparing MV5 fully human IgM and its class-switched GV5 IgG monoclonal antibody (mAb) recognizing the extracellular domain of a CD44R1 isoform that contains the inserted region coded by variant (v8, v9 and v10) exons and is expressed on the surface of various human epithelial cancer cells. Methods and Principal Findings: We demonstrated the growth inhibition of human cancer xenografts by a GV5 IgG mAb reshaped from an MV5 IgM. The epitope recognized by MV5 and GV5 was identified to a v8-coding region by the analysis of mAb binding to various recombinant CD44 proteins by enzyme-linked immunosorbent assay. GV5 showed preferential reactivity against various malignant human cells versus normal human cells assessed by flow cytometry and immunohistological analysis. When ME180 human uterine cervix carcinoma cells were subcutaneously inoculated to athymic mice with GV5, significant inhibition of tumor formation was observed. Furthermore, intraperitoneal injections of GV5markedly inhibited the growth of visible established tumors from HSC-3 human larynx carcinoma cells that had been subcutaneously transplanted one week before the first treatment with GV5. From in vitro experiments, antibody-dependent cellular cytotoxicity and internalization of CD44R1 seemed to be possible mechanisms for in vivo anti-tumor activity by GV5. Conclusions: CD44R1 is an excellent molecular target for mAb therapy of cancer, possibly superior to molecules targeted by existing therapeutic mAb, such as Trastuzumab and Cetuximab recognizing human epidermal growth factor receptor family.	[Masuko, Kazue; Okazaki, Shogo; Satoh, Mayumi; Tanaka, Goh; Ikeda, Tatsuya; Torii, Ryota; Ueda, Eri; Nakano, Takashi; Danbayashi, Masaaki; Tsuruoka, Tomoyo; Ohno, Yoshiya; Yagi, Hideki; Masuko, Takashi] Kinki Univ, Sch Pharm, Cell Biol Lab, Dept Pharmaceut Sci, Higashiosaka, Osaka 577, Japan; [Yabe, Noritsugu] Kohjin Bio Co Ltd, Saitama, Japan; [Yoshida, Hideaki; Tahara, Tomoyuki; Kataoka, Shiro] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo, Japan; [Oshino, Taichi; Shindo, Takayuki; Niwa, Shin-ichiro] Link Genom Inc, Chuo Ku, Tokyo, Japan; [Ishimoto, Takatsugu; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Honjo, Kumamoto, Japan; [Hashimoto, Yoshiyuki] Tohoku Univ, Sendai, Miyagi 980, Japan; [Saya, Hideyuki] Keio Univ, Sch Med, Div Gene Regulat, Inst Adv Med Res,Shinjuku Ku, Tokyo, Japan; [Masuko, Takashi] Kinki Univ, Pharmaceut Res & Technol Inst, Higashiosaka, Osaka 577, Japan	Kindai University (Kinki University); Kyowa Kirin Ltd; Kumamoto University; Tohoku University; Keio University; Kindai University (Kinki University)	Masuko, K (corresponding author), Kinki Univ, Sch Pharm, Cell Biol Lab, Dept Pharmaceut Sci, Higashiosaka, Osaka 577, Japan.	masuko@phar.kindai.ac.jp	Saya, Hideyuki/J-4325-2013; Ishimoto, Takatsugu/AAP-1356-2020; Okazaki, Shogo/A-8119-2014	Ishimoto, Takatsugu/0000-0003-1852-1835; Yagi, Hideki/0000-0002-1550-029X; Saya, Hideyuki/0000-0001-6610-1902	Kinki University; MEXT (Ministry of Education, Culture, Sports, Science and Technology); A-STEP (Adaptable and Seamless Technology Transfer Program through Research Development); Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [22700889] Funding Source: KAKEN	Kinki University; MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); A-STEP (Adaptable and Seamless Technology Transfer Program through Research Development); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the "Academic Frontier" Project of Kinki University (2005-2007) and "Antiaging Center" Project of Kinki University (2008-2012) for Private Universities: matching fund subsidy from MEXT (Ministry of Education, Culture, Sports, Science and Technology), and also supported by the "A-STEP (Adaptable and Seamless Technology Transfer Program through Research & Development)" Project (2009-2011): matching fund subsidy from Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bell MV, 1998, MOL CELL BIOL, V18, P5930, DOI 10.1128/MCB.18.10.5930; Bruno S, 2000, CARCINOGENESIS, V21, P893, DOI 10.1093/carcin/21.5.893; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colnot DR, 2000, J NUCL MED, V41, P1999; COSMAN D, 1994, STEM CELLS, V12, P440, DOI 10.1002/stem.5530120501; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Czuczman MS, 2004, J CLIN ONCOL, V22, P4711, DOI 10.1200/JCO.2004.04.020; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; DOUGHERTY GJ, 1991, J EXP MED, V174, P1, DOI 10.1084/jem.174.1.1; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hara K, 1999, BIOCHEM BIOPH RES CO, V262, P720, DOI 10.1006/bbrc.1999.1051; Hara K, 2000, ONCOGENE, V19, P6209, DOI 10.1038/sj.onc.1204019; Ishida Isao, 2002, Cloning and Stem Cells, V4, P91, DOI 10.1089/153623002753632084; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Itoh K, 2009, CANCER SCI, V100, P126, DOI 10.1111/j.1349-7006.2008.00998.x; JAMASBI RJ, 1978, CANCER RES, V38, P261; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; KASPRZYK PG, 1992, CANCER RES, V52, P2771; Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; MACKAY CR, 1994, J CELL BIOL, V124, P71, DOI 10.1083/jcb.124.1.71; Maloney DG, 1997, J CLIN ONCOL, V15, P3266, DOI 10.1200/JCO.1997.15.10.3266; MASUKO T, 1985, JPN J CANCER RES, V76, P386; Masuko T, 2011, CANCER SCI, V102, P25, DOI 10.1111/j.1349-7006.2010.01741.x; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Ohkawa M, 2011, BIOCHEM BIOPH RES CO, V406, P649, DOI 10.1016/j.bbrc.2011.02.135; Ohno Y, 2008, CANCER SCI, V99, P1000, DOI 10.1111/j.1349-7006.2008.00770.x; Okamoto I, 1998, J NATL CANCER I, V90, P307, DOI 10.1093/jnci/90.4.307; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; REFF ME, 1994, BLOOD, V83, P435; Riechelmann H, 2008, ORAL ONCOL, V44, P823, DOI 10.1016/j.oraloncology.2007.10.009; SETO M, 1983, CANCER RES, V43, P4768; Shishido T, 2000, INT J CANCER, V87, P311, DOI 10.1002/1097-0215(20000801)87:3<311::AID-IJC1>3.0.CO;2-W; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sneath RJS, 1998, J CLIN PATHOL-MOL PA, V51, P191, DOI 10.1136/mp.51.4.191; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; YAGITA H, 1986, J IMMUNOL, V136, P2055	45	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29728	10.1371/journal.pone.0029728	http://dx.doi.org/10.1371/journal.pone.0029728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272243	Green Submitted, Green Published, gold			2022-12-25	WOS:000301454400022
J	Soykan, CU; Brand, LA; Ries, L; Stromberg, JC; Hass, C; Simmons, DA; Patterson, WJD; Sabo, JL				Soykan, Candan U.; Brand, L. Arriana; Ries, Leslie; Stromberg, Juliet C.; Hass, Christine; Simmons, David A., Jr.; Patterson, William J. D.; Sabo, John L.			Multitaxonomic Diversity Patterns along a Desert Riparian-Upland Gradient	PLOS ONE			English	Article							OREGON COAST RANGE; SPECIES-DIVERSITY; ZONES; COMMUNITIES; VARIABILITY; VEGETATION; ABUNDANCE; RICHNESS	Riparian areas are noted for their high biodiversity, but this has rarely been tested across a wide range of taxonomic groups. We set out to describe species richness, species abundance, and community similarity patterns for 11 taxonomic groups (forbs & grasses, shrubs, trees, solpugids, spiders, scarab beetles, butterflies, lizards, birds, rodents, and mammalian carnivores) individually and for all groups combined along a riparian-upland gradient in semiarid southeastern Arizona, USA. Additionally, we assessed whether biological characteristics could explain variation in diversity along the gradient using five traits (trophic level, body size, life span, thermoregulatory mechanism, and taxonomic affiliation). At the level of individual groups diversity patterns varied along the gradient, with some having greater richness and/or abundance in riparian zones whereas others were more diverse and/or abundant in upland zones. Across all taxa combined, riparian zones contained significantly more species than the uplands. Community similarity between riparian and upland zones was low, and beta diversity was significantly greater than expected for most taxonomic groups, though biological traits explained little variance in diversity along the gradient. These results indicate heterogeneity amongst taxa in how they respond to the factors that structure ecological communities in riparian landscapes. Nevertheless, across taxonomic groups the overall pattern is one of greater species richness and abundance in riparian zones, coupled with a distinct suite of species.	[Soykan, Candan U.; Stromberg, Juliet C.; Simmons, David A., Jr.; Patterson, William J. D.; Sabo, John L.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Brand, L. Arriana] Univ Arizona, Dept Hydrol & Water Resources, Sustainabil Semiarid Hydrol & Riparian Areas SAHR, Tucson, AZ 85721 USA; [Ries, Leslie] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Hass, Christine] Drylands Inst, Tucson, AZ USA	Arizona State University; Arizona State University-Tempe; University of Arizona; University System of Maryland; University of Maryland College Park	Soykan, CU (corresponding author), NOAA, SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Santa Cruz, CA 95060 USA.	candan.soykan@noaa.gov	Hass, Christine/N-8383-2019; Sabo, John L/B-1872-2013	Hass, Christine/0000-0003-2876-6828; Ries, Leslie/0000-0002-5953-9284	ASU School of Life Sciences; ASU College of Liberal Arts and Sciences; The ASU School of Life Sciences Undergraduate Research (SOLUR); Biology Research Experience for Undergraduates (BREU) Programs; The Nature Conservancy, through a Rodney Johnson/Katherine Ordway Stewardship Endowment; Fort Huachuca Wildlife Office; Strategic Environment Research and Development (SERDP) project [CS-1100]; SAHRA (Sustainability of semi-Arid Hydrology and Riparian Areas) under the STC of the National Science Foundation [EAR-9876800]	ASU School of Life Sciences; ASU College of Liberal Arts and Sciences; The ASU School of Life Sciences Undergraduate Research (SOLUR); Biology Research Experience for Undergraduates (BREU) Programs; The Nature Conservancy, through a Rodney Johnson/Katherine Ordway Stewardship Endowment; Fort Huachuca Wildlife Office; Strategic Environment Research and Development (SERDP) project; SAHRA (Sustainability of semi-Arid Hydrology and Riparian Areas) under the STC of the National Science Foundation	The projects on solpugids, spiders, scarab beetles, lizards, and small mammals were funded by the ASU School of Life Sciences (formerly Department of Biology), ASU College of Liberal Arts and Sciences, The ASU School of Life Sciences Undergraduate Research (SOLUR) and Biology Research Experience for Undergraduates (BREU) Programs. The project on mammalian carnivores was funded by grants to C.C. Hass from The Nature Conservancy, through a Rodney Johnson/Katherine Ordway Stewardship Endowment, and the Fort Huachuca Wildlife Office. The avian and lepidopteran portions of this research were funded by the Strategic Environment Research and Development (SERDP) project CS-1100. The avian portion was also funded by SAHRA (Sustainability of semi-Arid Hydrology and Riparian Areas) under the STC Program of the National Science Foundation, Agreement No. EAR-9876800. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAX L, 2008, MIX COMPREHENSIVE FR; Bax Leon, 2006, BMC Med Res Methodol, V6, P50, DOI 10.1186/1471-2288-6-50; Brand LA, 2009, ECOLOGY CONSERVATION; Colwell RK, 2009, ESTIMATES STAT ESTIM; Gomez DM, 1998, NORTHWEST SCI, V72, P293; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Gurevitch J, 2002, METAANAL COMBINING R, P347; Hannon L, 2009, ECOLOGY CONSERVATION; HOOD GM, POPTOOLS VERSION 3 2; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston M. A., 1994, BIOL DIVERSITY; Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; MCCOMB WC, 1993, NORTHWEST SCI, V67, P181; MCGARIGAL K, 1992, J WILDLIFE MANAGE, V56, P10, DOI 10.2307/3808786; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; National Research Council (NRC), 2002, RIP AR FUNCT STRAT M; Peres CA, 1997, J TROP ECOL, V13, P381, DOI 10.1017/S0266467400010580; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rosen PC, 2009, ECOLOGY CONSERVATION; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Rykken JJ, 2007, ECOL APPL, V17, P1168, DOI 10.1890/06-0901; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Sabo JL, 2006, ECOLOGY, V87, P2128, DOI 10.1890/0012-9658(2006)87[2128:RZIRRB]2.0.CO;2; Sanzone DM, 2003, OECOLOGIA, V134, P238, DOI 10.1007/s00442-002-1113-3; Schade JD, 2003, J VEG SCI, V14, P743, DOI 10.1658/1100-9233(2003)014[0743:TIOPCO]2.0.CO;2; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; SIGLER MF, 1988, FISH B-NOAA, V86, P445; Soykan CU, 2009, ECOGRAPHY, V32, P354, DOI 10.1111/j.1600-0587.2008.05615.x; Stromberg JC, 2007, DIVERS DISTRIB, V13, P70, DOI 10.1111/j.1472-4642.2006.00295.x; Stromberg J. C, 2009, ECOLOGY CONSERVATION; Stromberg JC, 1996, ECOL APPL, V6, P113, DOI 10.2307/2269558; Stromberg JC, ECOLOGY CONSERVATION; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA, PARTITION 3 0 USERS	37	31	34	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e28235	10.1371/journal.pone.0028235	http://dx.doi.org/10.1371/journal.pone.0028235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272224	Green Submitted, gold, Green Published			2022-12-25	WOS:000301454400002
J	Xu, SX; Ju, JF; Zhou, XM; Wang, L; Zhou, KY; Yang, G				Xu, Shixia; Ju, Jianfeng; Zhou, Xuming; Wang, Lian; Zhou, Kaiya; Yang, Guang			Considerable MHC Diversity Suggests That the Functional Extinction of Baiji Is Not Related to Population Genetic Collapse	PLOS ONE			English	Article							HISTOCOMPATIBILITY COMPLEX POLYMORPHISM; CLASS-II VARIATION; NATURAL-SELECTION; LIPOTES-VEXILLIFER; SEQUENCE VARIATION; FINLESS PORPOISES; LOCI; RECOMBINATION; VARIABILITY; OVERDOMINANT	To further extend our understanding of the mechanism causing the current nearly extinct status of the baiji (Lipotes vexillifer), one of the most critically endangered species in the world, genetic diversity at the major histocompatibility complex (MHC) class II DRB locus was investigated in the baiji. Nine highly divergent DRB alleles were identified in 17 samples, with an average of 28.4 (13.2%) nucleotide difference and 16.7 (23.5%) amino acid difference between alleles. The unexpectedly high levels of DRB allelic diversity in the baiji may partly be attributable to its evolutionary adaptations to the freshwater environment which is regarded to have a higher parasite diversity compared to the marine environment. In addition, balancing selection was found to be the main mechanisms in generating sequence diversity at baiji DRB gene. Considerable sequence variation at the adaptive MHC genes despite of significant loss of neutral genetic variation in baiji genome might suggest that intense selection has overpowered random genetic drift as the main evolutionary forces, which further suggested that the critically endangered or nearly extinct status of the baiji is not an outcome of genetic collapse.	[Xu, Shixia; Ju, Jianfeng; Zhou, Xuming; Wang, Lian; Zhou, Kaiya; Yang, Guang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Xu, SX (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	gyang@njnu.edu.cn		Zhou, Xuming/0000-0002-1100-6294	National Natural Science Foundation of China (NSFC) [30830016]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was financially supported by the key project of National Natural Science Foundation of China (NSFC) grant no. 30830016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amills M, 2004, HEREDITY, V93, P266, DOI 10.1038/sj.hdy.6800499; Baker CS, 2006, IMMUNOGENETICS, V58, P283, DOI 10.1007/s00251-006-0080-y; Becker L, 2009, IMMUNOGENETICS, V61, P281, DOI 10.1007/s00251-009-0362-2; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Hedrick PW, 2000, EVOLUTION, V54, P2145; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; IUCN 2011, 2009, IUCN RED LIST THREAT; Kennedy LJ, 2002, IMMUNOGENETICS, V54, P348, DOI 10.1007/s00251-002-0465-5; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; Lochmiller RL, 1996, OIKOS, V76, P594, DOI 10.2307/3546356; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mikko S, 1997, J HERED, V88, P499, DOI 10.1093/oxfordjournals.jhered.a023144; Munguia-Vega A, 2007, MOL ECOL, V16, P4051, DOI 10.1111/j.1365-294X.2007.03319.x; Murray BW, 1998, IMMUNOGENETICS, V48, P242, DOI 10.1007/s002510050428; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nevo EN, 1997, PHILOS T R SOC B, V352, P381, DOI 10.1098/rstb.1997.0028; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Reeves RR, 2003, 139 IUCN SSC CET SPE, V139; Richardson DS, 2003, MOL ECOL, V12, P3523, DOI 10.1046/j.1365-294X.2003.02005.x; Richman AD, 2003, GENET RES, V82, P89, DOI 10.1017/S0016672303006347; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SATTA Y, 1994, P NATL ACAD SCI USA, V91, P7184, DOI 10.1073/pnas.91.15.7184; Simkova A, 2006, EVOL ECOL, V20, P465, DOI 10.1007/s10682-006-0014-z; SLADE RW, 1992, P ROY SOC B-BIOL SCI, V249, P163, DOI 10.1098/rspb.1992.0099; SMITH JM, 1992, J MOL EVOL, V34, P126; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; TAKAHATA N, 1990, GENETICS, V124, P967; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TROWSDALE J, 1989, IMMUNOGENETICS, V29, P19, DOI 10.1007/BF02341609; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Turvey ST, 2010, P ROY SOC B-BIOL SCI, V277, P3139, DOI 10.1098/rspb.2010.0584; Van Bressem MF, 1999, DIS AQUAT ORGAN, V38, P53, DOI 10.3354/dao038053; Vassilakos D, 2009, MOL BIOL EVOL, V26, P681, DOI 10.1093/molbev/msn296; Wan QH, 2006, MOL ECOL, V15, P2441, DOI 10.1111/j.1365-294X.2006.02966.x; Weber DS, 2004, MOL ECOL, V13, P711, DOI 10.1111/j.1365-294X.2004.02095.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Xu SX, 2008, MOL PHYLOGENET EVOL, V47, P36, DOI 10.1016/j.ympev.2007.05.026; Xu SX, 2007, IMMUNOGENETICS, V59, P581, DOI 10.1007/s00251-007-0223-9; Xu SX, 2010, J MOL EVOL, V71, P6, DOI 10.1007/s00239-010-9357-8; Yang G, 2005, J HERED, V96, P310, DOI 10.1093/jhered/esi055; Yang G, 2003, ACTA THERIOL, V48, P469, DOI 10.1007/BF03192493; Yang G, 2007, CONSERV BIOL, V20, P60; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YUHKI N, 1990, P NATL ACAD SCI USA, V87, P836, DOI 10.1073/pnas.87.2.836; Zhang X, 2003, AQUAT CONSERV, V13, P51, DOI 10.1002/aqc.547; Zhou K., 1998, Aquatic Mammals, V24, P123; ZHOU K, 1977, Acta Zoologica Sinica, V23, P72; Zhou K., 1982, J NANJING NOR COLL N, V4, P71; ZHOU K, 2002, ENCY MARINE MAMMALS, P58; Zhou K, 1958, CHINESE SCI BULL, V1, P21; Zhou Kaiya, 1994, Reports of the International Whaling Commission Special Issue, V15, P347	69	7	8	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30423	10.1371/journal.pone.0030423	http://dx.doi.org/10.1371/journal.pone.0030423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272349	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400127
J	Zago, CA; Bortoluci, KR; Sardinha, LR; Pretel, FD; Castillo-Mendez, SI; do Rosario, APF; Hiyane, MI; Muxel, SM; Rodriguez-Malaga, SM; Abrahamsohn, IA; Alvarez, JM; Lima, MRD				Zago, Claudia A.; Bortoluci, Karina R.; Sardinha, Luiz R.; Pretel, Fernando D.; Castillo-Mendez, Sheyla I.; Freitas do Rosario, Ana Paula; Hiyane, Meire I.; Muxel, Sandra M.; Rodriguez-Malaga, Sergio M.; Abrahamsohn, Ises A.; Alvarez, Jose M.; D'Imperio Lima, Maria Regina			Anti-IL-2 Treatment Impairs the Expansion of T-reg Cell Population during Acute Malaria and Enhances the Th1 Cell Response at the Chronic Disease	PLOS ONE			English	Article							PLASMODIUM-CHABAUDI-CHABAUDI; IN-VITRO; EXPRESSION; INFECTION; IL-2; GAMMA; MICE; LYMPHOCYTES; IMMUNITY; BLOOD	Plasmodium chabaudi infection induces a rapid and intense splenic CD4(+) T cell response that contributes to both disease pathogenesis and the control of acute parasitemia. The subsequent development of clinical immunity to disease occurs concomitantly with the persistence of low levels of chronic parasitemia. The suppressive activity of regulatory T (T-reg) cells has been implicated in both development of clinical immunity and parasite persistence. To evaluate whether IL-2 is required to induce and to sustain the suppressive activity of T-reg cells in malaria, we examined in detail the effects of anti-IL-2 treatment with JES6-1 monoclonal antibody (mAb) on the splenic CD4(+) T cell response during acute and chronic P. chabaudi AS infection in C57BL/6 mice. JES6-1 treatment on days 0, 2 and 4 of infection partially inhibits the expansion of the CD4(+)CD25(+)Foxp3(+) cell population during acute malaria. Despite the concomitant secretion of IL-2 and expression of high affinity IL-2 receptor by large CD4(+) T cells, JES6-1 treatment does not impair effector CD4+ T cell activation and IFN-gamma production. However, at the chronic phase of the disease, an enhancement of cellular and humoral responses occurs in JES6-1-treated mice, with increased production of TNF-alpha and parasite-specific IgG2a antibodies. Furthermore, JES6-1 mAb completely blocked the in vitro proliferation of CD4(+) T cells from non-treated chronic mice, while it further increased the response of CD4(+) T cells from JES6-1-treated chronic mice. We conclude that JES6-1 treatment impairs the expansion of T-reg cell population during early P. chabaudi malaria and enhances the Th1 cell response in the late phase of the disease.	[Zago, Claudia A.; Bortoluci, Karina R.; Pretel, Fernando D.; Castillo-Mendez, Sheyla I.; Freitas do Rosario, Ana Paula; Hiyane, Meire I.; Muxel, Sandra M.; Rodriguez-Malaga, Sergio M.; Abrahamsohn, Ises A.; Alvarez, Jose M.; D'Imperio Lima, Maria Regina] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Bortoluci, Karina R.] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [Bortoluci, Karina R.] Univ Fed Sao Paulo, Ctr Terapia Celular & Mol CTC Mol, Sao Paulo, Brazil; [Sardinha, Luiz R.] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein	Zago, CA (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil.	cazago@usp.br	Muxel, Sandra/F-7464-2012; Sardinha, Luiz Roberto/C-2367-2012; Alvarez, Jose M/I-6181-2012; Bortoluci, Karina/P-9296-2019; Freitas do Rosário, Ana Paula/G-2451-2012; D'Império Lima, Maria Regina/I-4747-2012; Rodriguez-Málaga, Sérgio/AGJ-8068-2022; Bortoluci, Karina/C-6018-2012	Muxel, Sandra/0000-0003-0118-5361; Alvarez, Jose M/0000-0002-9711-4914; Bortoluci, Karina/0000-0001-6780-5397; D'Império Lima, Maria Regina/0000-0002-4683-7709; Rodriguez-Málaga, Sérgio/0000-0003-3899-4031; Bortoluci, Karina/0000-0001-6780-5397; Castillo, Sheyla/0000-0002-0655-1781	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Batchelder JM, 2003, EXP PARASITOL, V105, P159, DOI 10.1016/j.exppara.2003.12.003; Berretta F, 2011, J IMMUNOL, V186, P4862, DOI 10.4049/jimmunol.1003777; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Cambos M, 2008, INT J PARASITOL, V38, P229, DOI 10.1016/j.ijpara.2007.07.006; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cavinato RA, 2001, PARASITE IMMUNOL, V23, P587, DOI 10.1046/j.1365-3024.2001.00419.x; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; DEPPER JM, 1983, J IMMUNOL, V131, P690; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Dooms H, 2004, J IMMUNOL, V172, P5973, DOI 10.4049/jimmunol.172.10.5973; Elias RM, 2005, J IMMUNOL, V174, P790, DOI 10.4049/jimmunol.174.2.790; FALANGA PB, 1987, EUR J IMMUNOL, V17, P599, DOI 10.1002/eji.1830170504; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; do Rosario APF, 2008, J IMMUNOL, V181, P8344, DOI 10.4049/jimmunol.181.12.8344; Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Helmby H, 2000, INFECT IMMUN, V68, P1485, DOI 10.1128/IAI.68.3.1485-1490.2000; HO M, 1988, J IMMUNOL, V141, P2755; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Khoruts A, 1998, J EXP MED, V187, P225, DOI 10.1084/jem.187.2.225; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; LANGHORNE J, 1985, CELL IMMUNOL, V90, P251, DOI 10.1016/0008-8749(85)90187-X; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lima MRD, 1996, SCAND J IMMUNOL, V43, P263; Lyddane C, 2006, J IMMUNOL, V176, P3306, DOI 10.4049/jimmunol.176.6.3306; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; MALEK TR, 1984, J IMMUNOL, V133, P1976; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Mota MM, 1998, INFECT IMMUN, V66, P4080; Muxel SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022434; RaziWolf Z, 1996, P NATL ACAD SCI USA, V93, P2903, DOI 10.1073/pnas.93.7.2903; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; STEVENSON MM, 1990, INFECT IMMUN, V58, P3225, DOI 10.1128/IAI.58.10.3225-3232.1990; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Van Parijs L, 1997, J IMMUNOL, V159, P5336; Vanhaesebroeck B, 2011, CURR TOP MICROBIOL, V347, P1, DOI 10.1007/82_2010_65; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vu MD, 2007, BLOOD, V110, P2501, DOI 10.1182/blood-2007-01-070748; WHO, 2008, VECT PAR DIS REG TRE; Winkler S, 1998, INFECT IMMUN, V66, P6040, DOI 10.1128/IAI.66.12.6040-6044.1998	46	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29894	10.1371/journal.pone.0029894	http://dx.doi.org/10.1371/journal.pone.0029894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272258	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400037
J	Sartorius, T; Lutz, SZ; Hoene, M; Waak, J; Peter, A; Weigert, C; Rammensee, HG; Kahle, PJ; Haring, HU; Hennige, AM				Sartorius, Tina; Lutz, Stefan Z.; Hoene, Miriam; Waak, Jens; Peter, Andreas; Weigert, Cora; Rammensee, Hans-Georg; Kahle, Philipp J.; Haering, Hans-Ulrich; Hennige, Anita M.			Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture	FASEB JOURNAL			English	Article						locomotion; TLR2/4	INTRAMYOCELLULAR LIPID-CONTENT; ADIPOSE-TISSUE; FATTY-ACIDS; BETA-CELLS; IRS-2 EXPRESSION; MICE LACKING; RESISTANCE; OBESITY; MUTATION; HYPERINSULINEMIA	Impaired insulin action in the brain represents an early step in the progression toward type 2 diabetes, and elevated levels of saturated free fatty acids are known to impair insulin action in prediabetic subjects. One potential mediator that links fatty acids to inflammation and insulin resistance is the Toll-like receptor (TLR) family. Therefore, C3H/HeJ/TLR2-KO (TLR2/4-deficient) mice were fed a high-fat diet (HFD), and insulin action in the brain as well as cortical and locomotor activity was analyzed by using telemetric implants. TLR2/4-deficient mice were protected from HFD-induced glucose intolerance and insulin resistance in the brain and displayed an improvement in cortical and locomotor activity that was not observed in C3H/HeJ mice. Sleep recordings revealed a 42% increase in rapid eye movement sleep in the deficient mice during daytime, and these mice spent 41% more time awake during the night period. Treatment of control mice with a neutralizing IL-6 antibody improved insulin action in the brain as well as cortical activity and diminished osteopontin protein to levels of the TLR2/4-deficient mice. Together, our data suggest that the lack of functional TLR2/4 protects mice from a fat-mediated impairment in insulin action, brain activity, locomotion, and sleep architecture by an IL-6/osteopontin-dependent mechanism.-Sartorius, T., Lutz, S. Z., Hoene, M., Waak, J., Peter, A., Weigert, C., Rammensee, H.-G., Kahle, P. J., Haring, H.-U., Hennige, A. M. Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture. FASEB J. 26, 1799-1809 (2012). www.fasebj.org	[Sartorius, Tina; Lutz, Stefan Z.; Hoene, Miriam; Peter, Andreas; Weigert, Cora; Haering, Hans-Ulrich; Hennige, Anita M.] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, D-72076 Tubingen, Germany; [Waak, Jens; Kahle, Philipp J.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, D-72076 Tubingen, Germany; [Waak, Jens; Kahle, Philipp J.] Univ Tubingen, German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany; [Rammensee, Hans-Georg] Univ Tubingen, Inst Cell Biol, Dept Immunol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Otfried Mueller Str 10, D-72076 Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de			Deutsche Forschungsgemeinschaft [HE 3653/3-1]; German Federal Ministry of Education and Research (BMBF) [DLR01GI0925]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported in part by a grant from the Deutsche Forschungsgemeinschaft (HE 3653/3-1) and the German Federal Ministry of Education and Research (BMBF; DLR01GI0925) to the German Center for Diabetes Research (DZDeV). The authors gratefully acknowledge the helpful contribution to a more precise analysis of sleep parameters of Dr. Sonja Binder and Dr. Manfred Hallschmid (Department of Neuroendocrinology, University of Luebeck, Luebeck, Germany). The authors thank Lucy Liaw (Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME, USA) for providing the OPN-null mice, and Dr. Johannes M. Weiss (Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany) for assistance. The authors also thank A. Janessa, E. Metzinger, D. Neuscheler, and H. Runge for excellent technical assistance.	Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Baracchi F, 2008, BRAIN BEHAV IMMUN, V22, P982, DOI 10.1016/j.bbi.2008.02.001; Benarroch EE, 2010, NEUROLOGY, V74, P919, DOI 10.1212/WNL.0b013e3181d3e44b; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Brechtel K, 2001, MAGNET RESON MED, V45, P179, DOI 10.1002/1522-2594(200102)45:2<179::AID-MRM1023>3.0.CO;2-D; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Guthoff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019482; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Hanley AJG, 2004, DIABETES, V53, P1773, DOI 10.2337/diabetes.53.7.1773; Heni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021594; Hennige AM, 2009, DIABETOLOGIA, V52, P2416, DOI 10.1007/s00125-009-1522-5; Hennige AM, 2005, DIABETES, V54, P361, DOI 10.2337/diabetes.54.2.361; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V209, P17, DOI 10.1016/j.mce.2003.08.003; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Ogawa W, 2008, SCIENCE, V322, P1483, DOI 10.1126/science.1167571; Oliveira AG, 2011, DIABETES, V60, P784, DOI 10.2337/db09-1907; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Samuvel DJ, 2010, J BIOL CHEM, V285, P3916, DOI 10.1074/jbc.M109.033951; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Sinton CM, 1999, J SLEEP RES, V8, P197, DOI 10.1046/j.1365-2869.1999.00158.x; Spath-Schwalbe E, 1998, J CLIN ENDOCR METAB, V83, P1573, DOI 10.1210/jc.83.5.1573; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; Tschritter O, 2009, DIABETOLOGIA, V52, P169, DOI 10.1007/s00125-008-1187-5; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Tschritter O, 2009, J CLIN ENDOCR METAB, V94, P4600, DOI 10.1210/jc.2009-0469; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75	49	28	30	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1799	1809		10.1096/fj.11-191023	http://dx.doi.org/10.1096/fj.11-191023			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22278939				2022-12-25	WOS:000303680800008
J	Bigford, GE; Chaudhry, NS; Keane, RW; Holohean, AM				Bigford, Gregory E.; Chaudhry, Nauman S.; Keane, Robert W.; Holohean, Alice M.			5-Hydroxytryptamine 5HT2C Receptors Form a Protein Complex with N-Methyl-D-aspartate GluN2A Subunits and Activate Phosphorylation of Src Protein to Modulate Motoneuronal Depolarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUMBAR SPINAL-CORD; MESSENGER-RNA EXPRESSION; GATED ION CHANNELS; NMDA RECEPTORS; 5-HT2C RECEPTORS; FROG MOTONEURONS; CONSTITUTIVE ACTIVITY; TYROSINE KINASE; AMINO-ACID; GLUTAMATE RECEPTORS	Background: 5-Hydroxytryptamine (5HT) modulates N-methyl-D-aspartate ( NMDA) depolarization. Results: 5HT2C co-immunoprecipitates with GluN2A and enhances NMDA motoneuronal depolarization through phosphorylation of Src(Tyr-416). Conclusion: 5HT modulates NMDA through Src phosphorylation in a molecular complex that is localized in the processes of spinal neurons. Significance: 5HT2C modulation of NMDA excitation is coordinated by a molecular complex.	[Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; [Holohean, Alice M.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33101 USA; [Bigford, Gregory E.; Chaudhry, Nauman S.; Keane, Robert W.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33101 USA; [Bigford, Gregory E.; Keane, Robert W.; Holohean, Alice M.] Miami Vet Affairs Med Ctr, Res Serv, Miami, FL 33125 USA	University of Miami; University of Miami; University of Miami	Holohean, AM (corresponding author), Vet Affairs Med Ctr, Res Serv 151, 1201 NW 16th St, Miami, FL 33125 USA.	aholohean@gmail.com	Bigford, Gregory/GMW-4031-2022		Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; Lois Pope Neuroscience Research Fellowship; Miami Project to Cure Paralysis	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); Lois Pope Neuroscience Research Fellowship; Miami Project to Cure Paralysis	The work was supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Program.; Supported by a Lois Pope Neuroscience Research Fellowship.; We greatly appreciate the help and expertise of Doris Nonner with culturing spinal neurons and Jessie S. Truettner with the development of primers and RT-PCR experiments. We also thank John C. Hackman, W. Dalton Dietrich, and The Miami Project to Cure Paralysis for their support.	Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Alvarez FJ, 1998, J COMP NEUROL, V393, P69; Banes A, 1999, J PHARMACOL EXP THER, V291, P1179; Barnes N. M., 1999, NEUROPHARMACOLOGY, V524, P171; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Barthet G, 2007, MOL BIOL CELL, V18, P1979, DOI 10.1091/mbc.E06-12-1080; Beato M, 1998, P ROY SOC B-BIOL SCI, V265, P2073, DOI 10.1098/rspb.1998.0542; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; Bockaert J, 2004, BIOCHEM SOC T, V32, P851, DOI 10.1042/BST0320851; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Gardiner Katheleen, 2006, Briefings in Functional Genomics & Proteomics, V5, P37, DOI 10.1093/bfgp/ell006; Gurevich I, 2002, J NEUROSCI, V22, P10529; HACKMAN JC, 1987, BRAIN RES, V407, P94, DOI 10.1016/0006-8993(87)91222-4; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; HELLENDALL RP, 1993, EXP NEUROL, V120, P186, DOI 10.1006/exnr.1993.1054; HELTON LA, 1994, NEUROREPORT, V5, P2617, DOI 10.1097/00001756-199412000-00053; Hentall ID, 2006, NEUROSCIENCE, V142, P893, DOI 10.1016/j.neuroscience.2006.06.038; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Holmes GM, 2005, BRAIN RES, V1057, P65, DOI 10.1016/j.brainres.2005.07.047; HOLOHEAN AM, 1992, BRAIN RES, V579, P8, DOI 10.1016/0006-8993(92)90736-S; Holohean AM, 2004, BRIT J PHARMACOL, V143, P351, DOI 10.1038/sj.bjp.0705935; HOLOHEAN AM, 1992, NEUROSCIENCE, V48, P469, DOI 10.1016/0306-4522(92)90506-W; HOLOHEAN AM, 1990, NEUROSCIENCE, V34, P555, DOI 10.1016/0306-4522(90)90164-Y; Holohean AM, 1999, BRIT J PHARMACOL, V126, P333, DOI 10.1038/sj.bjp.0702263; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Husi H, 2001, TRENDS NEUROSCI, V24, P259, DOI 10.1016/S0166-2236(00)01792-6; KAUFMAN LM, 1983, SCIENCE, V220, P1394, DOI 10.1126/science.6857258; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lanfranco MF, 2009, J NEUROSCI METH, V179, P247, DOI 10.1016/j.jneumeth.2009.01.027; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2008, J PHYSIOL-LONDON, V586, P3855, DOI 10.1113/jphysiol.2008.153593; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; MacLean JN, 2001, J NEUROPHYSIOL, V86, P1131, DOI 10.1152/jn.2001.86.3.1131; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MENGOD G, 1990, BRAIN RES, V524, P139, DOI 10.1016/0006-8993(90)90502-3; MORO O, 1993, J BIOL CHEM, V268, P22273; Murray KC, 2011, J NEUROPHYSIOL, V105, P731, DOI 10.1152/jn.00774.2010; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nagy GG, 2004, EUR J NEUROSCI, V20, P3301, DOI 10.1111/j.1460-9568.2004.03798.x; Nakae A, 2008, NEUROSCI RES, V60, P228, DOI 10.1016/j.neures.2007.10.004; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Okabe S, 1997, RESP PHYSIOL, V110, P151, DOI 10.1016/S0034-5687(97)00080-7; Pflieger JF, 2002, J NEUROSCI, V22, P5108, DOI 10.1523/JNEUROSCI.22-12-05108.2002; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; Pluder F, 2006, PHARMACOL THERAPEUT, V112, P1, DOI 10.1016/j.pharmthera.2006.03.001; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; RIDET JL, 1994, J NEUROSCI RES, V38, P109, DOI 10.1002/jnr.490380114; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sandyk R, 2006, INT J NEUROSCI, V116, P775, DOI 10.1080/00207450600754087; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Shay BL, 2005, J NEUROPHYSIOL, V94, P2867, DOI 10.1152/jn.00465.2005; SHOPE SB, 1993, BRAIN RES, V630, P207, DOI 10.1016/0006-8993(93)90658-A; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Takadera T, 2004, BRAIN RES, V1020, P196, DOI 10.1016/j.brainres.2004.06.035; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wallis DI, 1998, CAN J PHYSIOL PHARM, V76, P347, DOI 10.1139/cjpp-76-3-347; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; Yang M, 2001, J NEUROCHEM, V77, P580, DOI 10.1046/j.1471-4159.2001.00255.x; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; ZISKINDCONHAIM L, 1990, J NEUROSCI, V10, P125	81	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11049	11059		10.1074/jbc.M111.277806	http://dx.doi.org/10.1074/jbc.M111.277806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22291020	Green Published, hybrid			2022-12-25	WOS:000302780100033
J	Kuo, PL; Huang, MS; Cheng, DE; Hung, JY; Yang, CJ; Chou, SH				Kuo, Po-Lin; Huang, Ming-Shyan; Cheng, Da-En; Hung, Jen-Yu; Yang, Chih-Jen; Chou, Shah-Hwa			Lung Cancer-derived Galectin-1 Enhances Tumorigenic Potentiation of Tumor-associated Dendritic Cells by Expressing Heparin-binding EGF-like Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HB-EGF; GASTRIC-CANCER; TRANSACTIVATION; AMPHIREGULIN; INFLAMMATION; DISINTEGRIN; MIGRATION; THERAPY; LIGANDS; ADAM17	The interaction between cancer cells and their microenvironment is a vicious cycle that enhances the survival and progression of cancer, resulting in metastasis. This study is the first to indicate that lung cancer-derived galectin-1 secretion is responsible for stimulating tumor-associated dendritic cells (TADCs) production of mature heparin-binding EGF-like growth factor (HBEGF), which, in turn, increases cancer progression. Treatment of galectin-1, present in large amounts in lung cancer conditioned medium and lung cancer patient sera, mimicked the inductive effect of lung cancer conditioned medium on the expression and ectodomain shedding of HBEGF by TNF alpha-converting enzyme/a disintegrin and metalloproteinase 9 (ADAM9) and ADAM17. Significant upregulation of HBEGF has been seen in tumor-infiltrating CD11c(+) dendritic cells in human lung cancer samples. Active cleavage of HBEGF in TADCs by ADAM9 and ADAM17 is associated with increased protein kinase C delta and Lyn signaling. Enhancement of HBEGF production in TADCs increased the proliferation, migration, and epithelial-to-mesenchymal transition abilities of lung cancer. In contrast, inhibiting HBEGF by siRNA suppressed TADC-mediated cancer progression. Moreover, mice injected with galectin-1 knockdown Lewis lung carcinoma showed decreased expression and ectodomain shedding of HBEGF and reduced incidence of cancer development, resulting in increased survival rates. We demonstrate here for the first time that human and mouse DCs are a source of HBEGF, an EGFR ligand with tumorigenic properties. Antagonists of the effect of lung cancer-derived galectin-1 on DCs and anti-HB-EGF blocking antibodies could, therefore, have therapeutic potential as antitumor agents.	[Kuo, Po-Lin] Kaohsiung Med Univ, Inst Clin Med, Coll Med, Kaohsiung 807, Taiwan; [Kuo, Po-Lin; Huang, Ming-Shyan] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung 807, Taiwan; [Kuo, Po-Lin; Huang, Ming-Shyan; Hung, Jen-Yu; Yang, Chih-Jen] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung 807, Taiwan; [Huang, Ming-Shyan; Hung, Jen-Yu; Yang, Chih-Jen] Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Kaohsiung 807, Taiwan; [Cheng, Da-En; Hung, Jen-Yu; Yang, Chih-Jen] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan; [Chou, Shah-Hwa] Kaohsiung Med Univ Hosp, Dept Chest Surg, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kuo, PL (corresponding author), Kaohsiung Med Univ, Inst Clin Med, Coll Med, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	kuopolin@seed.net.tw			National Science Council of Taiwan [NSC 99-2320-B-037-017-MY3]; Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taipei, Taiwan [DOH101-TD-C-111-002]; Kaohsiung Medical University Research Foundation [KMUER011]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taipei, Taiwan; Kaohsiung Medical University Research Foundation	This work was supported by National Science Council of Taiwan grants (NSC 99-2320-B-037-017-MY3), an Excellence for Cancer Research Center grant, the Department of Health, Executive Yuan, Taipei, Taiwan Grant DOH101-TD-C-111-002, and Kaohsiung Medical University Research Foundation Grant KMUER011.	Andrews J, 2011, CANCER J, V17, P104, DOI 10.1097/PPO.0b013e318213f3cf; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; Box C, 2010, SEMIN CANCER BIOL, V20, P128, DOI 10.1016/j.semcancer.2010.06.004; Bremnes RM, 2011, J THORAC ONCOL, V6, P824, DOI 10.1097/JTO.0b013e3182037b76; Cao YJ, 2011, CANCER RES, V71, P1235, DOI 10.1158/0008-5472.CAN-10-2217; Dominguez-Soto A, 2011, J IMMUNOL, V186, P2192, DOI 10.4049/jimmunol.1000475; Eikawa S, 2010, J IMMUNOL, V185, P6734, DOI 10.4049/jimmunol.1000225; Gandhi MK, 2007, BLOOD, V110, P1326, DOI 10.1182/blood-2007-01-066100; Hu CE, 2011, SCAND J GASTROENTERO, V46, P156, DOI 10.3109/00365521.2010.516450; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kiss J, 2007, EXP HEMATOL, V35, P305, DOI 10.1016/j.exphem.2006.09.015; Koh HS, 2009, MOL CELLS, V28, P553, DOI 10.1007/s10059-009-0150-8; Kuo PL, 2011, J IMMUNOL, V186, P1521, DOI 10.4049/jimmunol.1002940; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Kwong C, 2011, J IMMUNOL, V186, P1781, DOI 10.4049/jimmunol.1002998; Mantovani A, 2010, CYTOKINE GROWTH F R, V21, P27, DOI 10.1016/j.cytogfr.2009.11.007; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Miyamoto S, 2008, ADV EXP MED BIOL, V622, P281, DOI 10.1007/978-0-387-68969-2_23; Nakagawa M, 2009, CANCER SCI, V100, P654, DOI 10.1111/j.1349-7006.2009.01089.x; Nakao S, 2011, AM J PATHOL, V178, P1913, DOI 10.1016/j.ajpath.2011.01.011; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; Sagmeister S, 2008, J HEPATOL, V49, P955, DOI 10.1016/j.jhep.2008.06.031; Sautes-Fridman C, 2011, CANCER METAST REV, V30, P13, DOI 10.1007/s10555-011-9279-y; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Uchiyama K, 2009, EUR J PHARM SCI, V38, P504, DOI 10.1016/j.ejps.2009.09.016; Yasumoto K, 2011, CLIN CANCER RES, V17, P3619, DOI 10.1158/1078-0432.CCR-10-2475; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794; Yotsumoto F, 2010, INT J CANCER, V127, P2707, DOI 10.1002/ijc.25472; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	34	34	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9753	9764		10.1074/jbc.M111.321190	http://dx.doi.org/10.1074/jbc.M111.321190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22291012	hybrid, Green Published			2022-12-25	WOS:000302167200009
J	Pazgier, M; Wei, G; Ericksen, B; Jung, G; Wu, ZB; de Leeuw, E; Yuan, WR; Szmacinski, H; Lu, WY; Lubkowski, J; Lehrer, RI; Lu, WY				Pazgier, Marzena; Wei, Gang; Ericksen, Bryan; Jung, Grace; Wu, Zhibin; de Leeuw, Erik; Yuan, Weirong; Szmacinski, Henryk; Lu, Wei-Yue; Lubkowski, Jacek; Lehrer, Robert I.; Lu, Wuyuan			Sometimes It Takes Two to Tango CONTRIBUTIONS OF DIMERIZATION TO FUNCTIONS OF HUMAN alpha-DEFENSIN HNP1 PEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-DEFENSINS; PRECURSOR LIPID II; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; PANETH CELLS; MECHANISM; DIMER; PROTEIN; BINDING; HD5	Human myeloid alpha-defensins called HNPs play multiple roles in innate host defense. The Trp-26 residue of HNP1 was previously shown to contribute importantly to its ability to kill S. aureus, inhibit anthrax lethal factor (LF), bind gp120 of HIV-1, dimerize, and undergo further self-association. To gain additional insights into the functional significance of dimerization, we compared wild type HNP1 to dimerization-impaired, N-methylated HNP1 monomers and to disulfide-tethered obligate HNP1 dimers. The structural effects of these modifications were confirmed by x-ray crystallographic analyses. Like the previously studied W26A mutation, N-methylation of Ile-20 dramatically reduced the ability of HNP1 to kill Staphylococcus aureus, inhibit LF, and bind gp120. Importantly, this modification had minimal effect on the ability of HNP1 to kill Escherichia coli. The W26A and MeIle-20 mutations impaired defensin activity synergistically. N-terminal covalent tethering rescued the ability of W26A-HNP1 to inhibit LF but failed to restore its defective killing of S. aureus. Surface plasmon resonance studies revealed that Trp-26 mediated the association of monomers and canonical dimers of HNP1 to immobilized HNP1, LF, and gp120, and also indicated a possible mode of tetramerization of HNP1 mediated by Ile-20 and Leu-25. This study demonstrates that dimerization contributes to some but not all of the many and varied activities of HNP1.	[Pazgier, Marzena; Lubkowski, Jacek] NCI, Macromol Assembly Struct & Cell Signaling Sect, NIH, Frederick, MD 21702 USA; [Pazgier, Marzena; Wei, Gang; Ericksen, Bryan; Wu, Zhibin; de Leeuw, Erik; Yuan, Weirong; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Szmacinski, Henryk; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wei, Gang; Lu, Wei-Yue] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Jung, Grace; Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Fudan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lubkowski, J (corresponding author), NCI, Macromol Assembly Struct & Cell Signaling Sect, NIH, Frederick, MD 21702 USA.	lubkowsj@mail.nih.gov; wlu@ihv.umaryland.edu	Lu, Weiyue/E-7938-2010; Ericksen, Bryan/F-9047-2012; Wei, Gang/AAH-7377-2019; Lu, Wuyuan/J-8452-2017; Lu, Wuyuan/B-2268-2010	Wei, Gang/0000-0002-9600-0982; Lu, Wuyuan/0000-0003-1318-9968; Ericksen, Bryan/0000-0002-8016-8289	United States Department of Energy, Office of Science [W-31-109-Eng38]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-Eng38]; National Institutes of Health [AI072732, AI061482]; NCI, Center for Cancer Research; National Natural Science Foundation of China [30701060]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072732, R01AI061482] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science(United States Department of Energy (DOE)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the X-ray Crystallography Core Facility of the University of Maryland at Baltimore for providing crystallographic equipment and resources. Use of the Advanced Photon Source was supported by the United States Department of Energy, Offices of Science and of Basic Energy Sciences, under Contract W-31-109-Eng38.; This work was supported, in whole or in part, by National Institutes of Health Grants AI072732 and AI061482 (to W. L.) and by the Intramural Research Program, NCI, Center for Cancer Research (to J. L.).; Supported by National Natural Science Foundation of China Grant 30701060.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Bevins CL, 2006, BIOCHEM SOC T, V34, P263, DOI 10.1042/BST0340263; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 1986, Semin Respir Infect, V1, P107; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hornef MW, 2004, NAT IMMUNOL, V5, P836, DOI 10.1038/ni1094; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kim C, 2005, P NATL ACAD SCI USA, V102, P4830, DOI 10.1073/pnas.0500508102; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Lehrer RI, 2009, INFECT IMMUN, V77, P4028, DOI 10.1128/IAI.00232-09; Lu WY, 1997, BIOCHEMISTRY-US, V36, P673, DOI 10.1021/bi9625612; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Taylor K, 2007, ANTIMICROB AGENTS CH, V51, P1719, DOI 10.1128/AAC.01531-06; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Yang D, 2007, CURR PHARM DESIGN, V13, P3131, DOI 10.2174/138161207782110453; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang YA, 2010, BIOCHEMISTRY-US, V49, P9770, DOI 10.1021/bi101512j	52	34	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8944	8953		10.1074/jbc.M111.332205	http://dx.doi.org/10.1074/jbc.M111.332205			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270360	Green Published, hybrid			2022-12-25	WOS:000301797800025
J	Lee, K; Tan, J; Morris, MB; Rizzoti, K; Hughes, J; Cheah, PS; Felquer, F; Liu, X; Piltz, S; Lovell-Badge, R; Thomas, PQ				Lee, Kristie; Tan, Jacqueline; Morris, Michael B.; Rizzoti, Karine; Hughes, James; Cheah, Pike See; Felquer, Fernando; Liu, Xuan; Piltz, Sandra; Lovell-Badge, Robin; Thomas, Paul Q.			Congenital Hydrocephalus and Abnormal Subcommissural Organ Development in Sox3 Transgenic Mice	PLOS ONE			English	Article							X-LINKED HYPOPITUITARISM; TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; GENE; DIFFERENTIATION; EXPRESSION; DEFICIENCY; MECHANISMS; BRAIN; IDENTIFICATION	Congenital hydrocephalus (CH) is a life-threatening medical condition in which excessive accumulation of CSF leads to ventricular expansion and increased intracranial pressure. Stenosis (blockage) of the Sylvian aqueduct (Aq; the narrow passageway that connects the third and fourth ventricles) is a common form of CH in humans, although the genetic basis of this condition is unknown. Mouse models of CH indicate that Aq stenosis is associated with abnormal development of the subcommmissural organ (SCO) a small secretory organ located at the dorsal midline of the caudal diencephalon. Glycoproteins secreted by the SCO generate Reissner's fibre (RF), a thread-like structure that descends into the Aq and is thought to maintain its patency. However, despite the importance of SCO function in CSF homeostasis, the genetic program that controls SCO development is poorly understood. Here, we show that the X-linked transcription factor SOX3 is expressed in the murine SCO throughout its development and in the mature organ. Importantly, overexpression of Sox3 in the dorsal diencephalic midline of transgenic mice induces CH via a dose-dependent mechanism. Histological, gene expression and cellular proliferation studies indicate that Sox3 overexpression disrupts the development of the SCO primordium through inhibition of diencephalic roof plate identity without inducing programmed cell death. This study provides further evidence that SCO function is essential for the prevention of hydrocephalus and indicates that overexpression of Sox3 in the dorsal midline alters progenitor cell differentiation in a dose-dependent manner.	[Lee, Kristie; Hughes, James; Cheah, Pike See; Felquer, Fernando; Liu, Xuan; Piltz, Sandra; Thomas, Paul Q.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Tan, Jacqueline] Murdoch Childrens Res Inst, Pituitary Res Unit, Melbourne, Vic, Australia; [Morris, Michael B.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Morris, Michael B.] Royal N Shore Hosp, Kolling Inst Med Res, Sydney, NSW, Australia; [Morris, Michael B.] Royal N Shore Hosp, Sydney Ctr Dev & Regenerat Med, Sydney, NSW, Australia; [Rizzoti, Karine; Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Cheah, Pike See] Univ Putra Malaysia, Dept Human Anat, Serdang, Malaysia	University of Adelaide; Murdoch Children's Research Institute; University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; MRC National Institute for Medical Research; Universiti Putra Malaysia	Lee, K (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	paul.thomas@adelaide.edu.au	Thomas, Paul Q/K-4497-2012; Cheah, Pike-See/F-4978-2014; Rizzoti, Karine/AAW-1090-2021; Morris, Michael/AAP-6590-2021	Rizzoti, Karine/0000-0003-0711-5452; Morris, Michael/0000-0002-1286-4784; Cheah, Pike See/0000-0003-2181-2502; Lovell-Badge, Robin/0000-0001-9364-4179	Australian Research Council [DP0881509]; Pfizer Australia; UK Medical Research Council [U117512772]; Medical Research Council [MC_U117562207] Funding Source: researchfish; MRC [MC_U117562207] Funding Source: UKRI	Australian Research Council(Australian Research Council); Pfizer Australia(PfizerPfizer Australia); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Australian Research Council (DP0881509 to PQT; http://www.arc.gov.au/). PQT is a Pfizer Australia Research Fellow. Work in the laboratory of RLB is funded by the UK Medical Research Council(U117512772) and performed under approval of the UK home office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PQT is supported by a Fellowship from Pfizer Australia. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Baas D, 2006, EUR J NEUROSCI, V24, P1020, DOI 10.1111/j.1460-9568.2006.05002.x; Bach A, 2003, DEVELOPMENT, V130, P4025, DOI 10.1242/dev.00609; BALLYCUIF L, 1995, MECH DEVELOP, V53, P23, DOI 10.1016/0925-4773(95)00421-1; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Blackshear PJ, 2003, DEVELOPMENT, V130, P4539, DOI 10.1242/dev.00661; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Castaneyra-Perdomo A, 2004, EUR J ANAT, V8, P107; Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011; Chizhikov VV, 2004, NAT REV NEUROSCI, V5, P808, DOI 10.1038/nrn1520; Collignon J, 1996, DEVELOPMENT, V122, P509; Davy BE, 2003, HUM MOL GENET, V12, P1163, DOI 10.1093/hmg/ddg122; Dee CT, 2008, DEV BIOL, V320, P289, DOI 10.1016/j.ydbio.2008.05.542; Dietrich P, 2009, HUM MOL GENET, V18, P142, DOI 10.1093/hmg/ddn324; Estivill-Torrus G, 2001, MECH DEVELOP, V109, P215, DOI 10.1016/S0925-4773(01)00527-5; Galarza M, 2002, NEUROSURG REV, V25, P205, DOI 10.1007/s10143-002-0208-y; Garne E, 2010, EUR J PAEDIATR NEURO, V14, P150, DOI 10.1016/j.ejpn.2009.03.005; Goncalves-Mendes N, 2003, GENE, V312, P263, DOI 10.1016/S0378-1119(03)00622-X; Haverkamp F, 1999, EUR J PEDIATR, V158, P474, DOI 10.1007/s004310051123; Holmberg J, 2008, DEVELOPMENT, V135, P1843, DOI 10.1242/dev.020180; Huh MS, 2009, PHYSIOLOGY, V24, P117, DOI 10.1152/physiol.00039.2008; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; LagerstromFermer M, 1997, AM J HUM GENET, V60, P910; Lang B, 2006, J CLIN INVEST, V116, P1924, DOI 10.1172/JCI27597; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lim Y, 2007, BRAIN RES REV, V53, P17, DOI 10.1016/j.brainresrev.2006.06.004; Louvi A, 2000, DEVELOPMENT, V127, P4061; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; Nakajima M, 2011, BRAIN RES, V1382, P275, DOI 10.1016/j.brainres.2011.01.048; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; OVERHOLSER MD, 1954, ANAT REC, V120, P917, DOI 10.1002/ar.1091200407; RAKIC P, 1968, AM J ANAT, V122, P317, DOI 10.1002/aja.1001220210; Rizzoti K, 2004, NAT GENET, V36, P247, DOI 10.1038/ng1309; RODRIGUEZ EM, 1990, CELL TISSUE RES, V262, P105, DOI 10.1007/BF00327751; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Shih YH, 2010, DEVELOPMENT, V137, P2671, DOI 10.1242/dev.054130; Solomon NM, 2002, GENOMICS, V79, P553, DOI 10.1006/geno.2002.6741; STRAIN L, 1994, AM J HUM GENET, V54, P236; Sutton E, 2011, J CLIN INVEST, V121, P328, DOI 10.1172/JCI42580; Urase K, 1998, DEV BRAIN RES, V111, P77, DOI 10.1016/S0165-3806(98)00124-2; Vio K, 2000, EXP BRAIN RES, V135, P41, DOI 10.1007/s002210000474; Wolff DJ, 1997, HUM GENET, V100, P256, DOI 10.1007/s004390050501; Wong J, 2007, FRONT BIOSCI, V12, P2085, DOI 10.2741/2213; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	50	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e29041	10.1371/journal.pone.0029041	http://dx.doi.org/10.1371/journal.pone.0029041			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291885	Green Published, gold, Green Submitted			2022-12-25	WOS:000301703800004
J	Hartmann, S; Helm, C; Nickel, B; Meyer, M; Struck, TH; Tiedemann, R; Selbig, J; Bleidorn, C				Hartmann, Stefanie; Helm, Conrad; Nickel, Birgit; Meyer, Matthias; Struck, Torsten H.; Tiedemann, Ralph; Selbig, Joachim; Bleidorn, Christoph			Exploiting Gene Families for Phylogenomic Analysis of Myzostomid Transcriptome Data	PLOS ONE			English	Article							SPECIES TREES; GENOME; PROGRAM; DUPLICATION; SUPERMATRIX; ALGORITHM; SEQUENCES; NUCLEAR; EVENTS; INFER	Background: In trying to understand the evolutionary relationships of organisms, the current flood of sequence data offers great opportunities, but also reveals new challenges with regard to data quality, the selection of data for subsequent analysis, and the automation of steps that were once done manually for single-gene analyses. Even though genome or transcriptome data is available for representatives of most bilaterian phyla, some enigmatic taxa still have an uncertain position in the animal tree of life. This is especially true for myzostomids, a group of symbiotic ( or parasitic) protostomes that are either placed with annelids or flatworms. Methodology: Based on similarity criteria, Illumina-based transcriptome sequences of one myzostomid were compared to protein sequences of one additional myzostomid and 29 reference metazoa and clustered into gene families. These families were then used to investigate the phylogenetic position of Myzostomida using different approaches: Alignments of 989 sequence families were concatenated, and the resulting superalignment was analyzed under a Maximum Likelihood criterion. We also used all 1,878 gene trees with at least one myzostomid sequence for a supertree approach: the individual gene trees were computed and then reconciled into a species tree using gene tree parsimony. Conclusions: Superalignments require strictly orthologous genes, and both the gene selection and the widely varying amount of data available for different taxa in our dataset may cause anomalous placements and low bootstrap support. In contrast, gene tree parsimony is designed to accommodate multilocus gene families and therefore allows a much more comprehensive data set to be analyzed. Results of this supertree approach showed a well-resolved phylogeny, in which myzostomids were part of the annelid radiation, and major bilaterian taxa were found to be monophyletic.	[Hartmann, Stefanie; Selbig, Joachim] Univ Potsdam, Dept Bioinformat, Inst Biochem & Biol, Potsdam, Germany; [Helm, Conrad; Bleidorn, Christoph] Univ Leipzig, Inst Biol 2, Leipzig, Germany; [Nickel, Birgit; Meyer, Matthias] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Struck, Torsten H.] Zool Res Museum Alexander Koenig, Bonn, Germany; [Tiedemann, Ralph; Bleidorn, Christoph] Univ Potsdam, Dept Evolutionary Biol, Inst Biochem & Biol, Potsdam, Germany	University of Potsdam; Leipzig University; Max Planck Society; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Potsdam	Hartmann, S (corresponding author), Univ Potsdam, Dept Bioinformat, Inst Biochem & Biol, Potsdam, Germany.	bleidorn@rz.uni-leipzig.de	Hartmann, Stefanie/H-4413-2011	Tiedemann, Ralph/0000-0002-2604-6336; Bleidorn, Christoph/0000-0001-7295-6616	Deutsche Forschungsgemeinschaft [BL787/2-1, BL787/2-2, TI349/4-1]; European Union due to ASSEMBLE [227799]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union due to ASSEMBLE	This study was funded by the priority program "Deep Metazoan Phylogeny" of the Deutsche Forschungsgemeinschaft (www.dfg.de) (BL787/2-1 and BL787/2-2 to CB, TI349/4-1 to RT). CB was supported by the European Union due to ASSEMBLE (http://www.assemblemarine.org) grant agreement no. 227799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bansal MS, 2007, LECT NOTES COMPUT SC, V4453, P238; Bansal MS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S42; Berglund-Sonnhammer AC, 2006, J MOL EVOL, V63, P240, DOI 10.1007/s00239-005-0096-1; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bleidorn C, 2007, MOL BIOL EVOL, V24, P1690, DOI 10.1093/molbev/msm086; Bleidorn C, 2009, DEV GENES EVOL, V219, P211, DOI 10.1007/s00427-009-0282-z; Bleidorn C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-150; Boutet Emmanuel, 2007, V406, P89; Burleigh JG, 2011, SYST BIOL, V60, P117, DOI 10.1093/sysbio/syq072; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Cotton JA, 2003, MOL PHYLOGENET EVOL, V29, P298, DOI 10.1016/S1055-7903(03)00109-X; Cotton JA, 2002, P ROY SOC B-BIOL SCI, V269, P1555, DOI 10.1098/rspb.2002.2074; COTTON JA, 2004, COMPU BIOL, V4, P107; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eeckhaut I, 2000, P ROY SOC B-BIOL SCI, V267, P1383, DOI 10.1098/rspb.2000.1154; Eeckhaut I, 2005, HYDROBIOLOGIA, V535, P253, DOI 10.1007/s10750-004-5636-y; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; FECKHAUT I, 1993, DIS AQUAT ORGAN, V15, P207; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Holton TA, 2010, GENOME BIOL EVOL, V2, P310, DOI 10.1093/gbe/evq016; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kircher M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-382; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Lanterbecq D, 2010, MOL PHYLOGENET EVOL, V54, P357, DOI 10.1016/j.ympev.2009.08.011; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Meyer M., 2010, COLD SPRING HARB PRO; Page R D M, 2002, Pac Symp Biocomput, P536; Paps J, 2009, P ROY SOC B-BIOL SCI, V276, P1245, DOI 10.1098/rspb.2008.1574; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Sanderson MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S3; Slowinski JB, 1999, SYST BIOL, V48, P814, DOI 10.1080/106351599260030; Slowinski JB, 1997, MOL PHYLOGENET EVOL, V8, P349, DOI 10.1006/mpev.1997.0434; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Zmasek CM, 2001, BIOINFORMATICS, V17, P821, DOI 10.1093/bioinformatics/17.9.821	47	29	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29843	10.1371/journal.pone.0029843	http://dx.doi.org/10.1371/journal.pone.0029843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276131	Green Submitted, gold, Green Published			2022-12-25	WOS:000301568100017
J	Shoji, M; Yoshizaki, S; Mizuguchi, H; Okuda, K; Shimada, M				Shoji, Masaki; Yoshizaki, Shinji; Mizuguchi, Hiroyuki; Okuda, Kenji; Shimada, Masaru			Immunogenic Comparison of Chimeric Adenovirus 5/35 Vector Carrying Optimized Human Immunodeficiency Virus Clade C Genes and Various Promoters	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; T-CELLS; RECOMBINANT ADENOVIRUS; THERAPEUTIC LEVELS; VACCINE VECTOR; RHESUS-MONKEYS; MVA VECTORS; IN-VIVO; HIV; TYPE-1	Adenovirus vector-based vaccine is a promising approach to protect HIV infection. However, a recent phase IIb clinical trial using the vector did not show its protective efficacy against HIV infection. To improve the vaccine, we explored the transgene protein expression and its immunogenicity using optimized codon usage, promoters and adaptors. We compared protein expression and immunogenicity of adenovirus vector vaccines carrying native or codon usage-optimized HIV-1 clade C gag and env genes expression cassettes driven by different promoters (CMV, CMVi, and CA promoters) and adapters (IRES and F2A). The adenovirus vector vaccine containing optimized gag gene produced higher Gag protein expression and induced higher immune responses than the vector containing native gag gene in mice. Furthermore, CA promoter generated higher transgene expression and elicited higher immune responses than other two popularly used promoters (CMV and CMVi). The second gene expression using F2A adaptor resulted in higher protein expression and immunity than that of using IRES and direct fusion protein. Taken together, the adenovirus vector containing the expression cassette with CA promoter, optimized HIV-1 clade C gene and an F2A adaptor produced the best protein expression and elicited the highest transgene-specific immune responses. This finding would be promising for vaccine design and gene therapy.	[Shoji, Masaki; Yoshizaki, Shinji; Shimada, Masaru] Yokohama City Univ, Dept Mol Biodef Res, Yokohama, Kanagawa 232, Japan; [Shoji, Masaki; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Osaka, Japan; [Mizuguchi, Hiroyuki] Natl Inst Biomed Innovat, Lab Gene Transfer & Regulat, Ibaraki, Osaka, Japan; [Okuda, Kenji] Fukushimura Hosp, Choju Med Inst, Toyohasi, Aichi, Japan	Yokohama City University; Osaka University; National Institute of Health Sciences - Japan	Shoji, M (corresponding author), Yokohama City Univ, Dept Mol Biodef Res, Yokohama, Kanagawa 232, Japan.	mshimada@yokohama-cu.ac.jp		Mizuguchi, Hiroyuki/0000-0003-0594-8178; Shimada, Masaru/0000-0002-5271-4238	Ministry of Education, Science, Sports and Culture of Japan; Yokohama City University, Japan; Research Foundation for Advanced Medical Research Center; Japanese National Institute of Biomedical Innovation [05 1]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama City University, Japan; Research Foundation for Advanced Medical Research Center; Japanese National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This work was partially supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan; a grant for the Strategic Research Project of Yokohama City University, Japan; Research Foundation for Advanced Medical Research Center and a grant from the Japanese National Institute of Biomedical Innovation (No. 05 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe S, 2009, J GENE MED, V11, P570, DOI 10.1002/jgm.1332; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Clay TM, 2001, CLIN CANCER RES, V7, P1127; Fang JM, 2007, MOL THER, V15, P1153, DOI 10.1038/sj.mt.6300142; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; Mizuguchi H, 2002, GENE, V285, P69, DOI 10.1016/S0378-1119(02)00410-9; MOLLA A, 1992, NATURE, V356, P255, DOI 10.1038/356255a0; Moore JP, 2008, SCIENCE, V320, P753, DOI 10.1126/science.1154258; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; SESHIDHAR RP, 2003, VIROLOGY, V311, P384; Shimada M, 2009, GENE THER, V16, P218, DOI 10.1038/gt.2008.152; Shinoda K, 2004, VACCINE, V22, P3676, DOI 10.1016/j.vaccine.2004.03.015; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; van Harmelen J, 2001, AIDS RES HUM RETROV, V17, P1527, DOI 10.1089/08892220152644232; WADELL G, 1984, CURR TOP MICROBIOL, V110, P191; Wang HB, 2010, GENE THER, V17, P4, DOI 10.1038/gt.2009.122; Whiteside TL, 2003, CLIN CANCER RES, V9, P641; Xin KQ, 2007, VACCINE, V25, P3809, DOI 10.1016/j.vaccine.2007.01.117; Xin KQ, 2005, GENE THER, V12, P1769, DOI 10.1038/sj.gt.3302590; Xu ZL, 2001, GENE, V272, P149, DOI 10.1016/S0378-1119(01)00550-9; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004	48	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30302	10.1371/journal.pone.0030302	http://dx.doi.org/10.1371/journal.pone.0030302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276174	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200052
J	Baird, E; Byrne, MJ; Smolka, J; Warrant, EJ; Dacke, M				Baird, Emily; Byrne, Marcus J.; Smolka, Jochen; Warrant, Eric J.; Dacke, Marie			The Dung Beetle Dance: An Orientation Behaviour?	PLOS ONE			English	Article							NAVIGATION; BALL	An interesting feature of dung beetle behaviour is that once they have formed a piece of dung into a ball, they roll it along a straight path away from the dung pile. This straight-line orientation ensures that the beetles depart along the most direct route, guaranteeing that they will not return to the intense competition (from other beetles) that occurs near the dung pile. Before rolling a new ball away from the dung pile, dung beetles perform a characteristic "dance," in which they climb on top of the ball and rotate about their vertical axis. This dance behaviour can also be observed during the beetles' straight-line departure from the dung pile. The aim of the present study is to investigate the purpose of the dung beetle dance. To do this, we explored the circumstances that elicit dance behaviour in the diurnal ball-rolling dung beetle, Scarabaeus (Kheper) nigroaeneus. Our results reveal that dances are elicited when the beetles lose control of their ball or lose contact with it altogether. We also find that dances can be elicited by both active and passive deviations of course and by changes in visual cues alone. In light of these results, we hypothesise that the dung beetle dance is a visually mediated mechanism that facilitates straight-line orientation in ball-rolling dung beetles by allowing them to 1) establish a roll bearing and 2) return to this chosen bearing after experiencing a disturbance to the roll path.	[Baird, Emily; Smolka, Jochen; Warrant, Eric J.; Dacke, Marie] Lund Univ, Dept Biol, Lund, Sweden; [Byrne, Marcus J.] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Johannesburg, South Africa	Lund University; University of Witwatersrand	Baird, E (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Emily.Baird@biol.lu.se	Byrne, Marcus/AAF-9789-2021; Smolka, Jochen/N-6282-2014; Baird, Emily/G-8763-2014	Smolka, Jochen/0000-0003-2958-0697; Baird, Emily/0000-0003-3625-3897; Warrant, Eric/0000-0001-7480-7016; Byrne, Marcus/0000-0002-5155-2599	United States Air Force Office of Scientific Research [FA8655-07-C-4011]; Swedish Research Council; Wenner-Gren Foundation; Crafoord Foundation; Royal Physiographic Society of Lund	United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundation; Crafoord Foundation; Royal Physiographic Society of Lund	This study was funded by the United States Air Force Office of Scientific Research (grant no. FA8655-07-C-4011), the Swedish Research Council, Wenner-Gren Foundation, Crafoord Foundation and the Royal Physiographic Society of Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird E, 2010, J COMP PHYSIOL A, V196, P801, DOI 10.1007/s00359-010-0559-8; BARTHOLOMEW GA, 1978, J EXP BIOL, V73, P65; Byrne M, 2003, J COMP PHYSIOL A, V189, P411, DOI 10.1007/s00359-003-0415-1; Cheung A, 2007, BIOL CYBERN, V97, P47, DOI 10.1007/s00422-007-0158-0; Dacke M, 2004, P ROY SOC B-BIOL SCI, V271, P361, DOI 10.1098/rspb.2003.2594; Dacke M, 2003, NATURE, V424, P33, DOI 10.1038/424033a; Dacke M, 2003, J EXP BIOL, V206, P1535, DOI 10.1242/jeb.00289; Lent DD, 2010, P NATL ACAD SCI USA, V107, P16348, DOI 10.1073/pnas.1006021107; MATTHEWS ERIC G., 1963, PSYCHE, V70, P75, DOI 10.1155/1963/23630; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; ROSSEL S, 1984, J COMP PHYSIOL, V154, P607, DOI 10.1007/BF01350213; SANTSCHI F, 1911, REV SUISSE ZOOL, V19, P305; Ugolini A, 2006, J COMP PHYSIOL A, V192, P45, DOI 10.1007/s00359-005-0046-9; WEHNER R, 1990, ETHOL ECOL EVOL, V2, P27, DOI 10.1080/08927014.1990.9525492	14	34	35	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30211	10.1371/journal.pone.0030211	http://dx.doi.org/10.1371/journal.pone.0030211			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279572	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900050
J	Mostaghel, EA; Solomon, KR; Pelton, K; Freeman, MR; Montgomery, RB				Mostaghel, Elahe A.; Solomon, Keith R.; Pelton, Kristine; Freeman, Michael R.; Montgomery, R. Bruce			Impact of Circulating Cholesterol Levels on Growth and Intratumoral Androgen Concentration of Prostate Tumors	PLOS ONE			English	Article							DEPRIVATION THERAPY; CANCER-RISK; RECEPTOR MUTATIONS; SERUM-CHOLESTEROL; DIETARY PATTERNS; LOWERING DRUGS; LIPID RAFTS; STATIN USE; MEN; PROGRESSION	Prostate cancer (PCa) is the second most common cancer in men. Androgen deprivation therapy (ADT) leads to tumor involution and reduction of tumor burden. However, tumors eventually reemerge that have overcome the absence of gonadal androgens, termed castration resistant PCa (CRPC). Theories underlying the development of CRPC include androgen receptor (AR) mutation allowing for promiscuous activation by non-androgens, AR amplification and overexpression leading to hypersensitivity to low androgen levels, and/or tumoral uptake and conversion of adrenally derived androgens. More recently it has been proposed that prostate tumor cells synthesize their own androgens through de novo steroidogenesis, which involves the step-wise synthesis of androgens from cholesterol. Using the in vivo LNCaP PCa xenograft model, previous data from our group demonstrated that a hypercholesterolemia diet potentiates prostatic tumor growth via induction of angiogenesis. Using this same model we now demonstrate that circulating cholesterol levels are significantly associated with tumor size (R = 0.3957, p = 0.0049) and intratumoral levels of testosterone (R = 0.41, p = 0.0023) in LNCaP tumors grown in hormonally intact mice. We demonstrate tumoral expression of cholesterol uptake genes as well as the spectrum of steroidogenic enzymes necessary for androgen biosynthesis from cholesterol. Moreover, we show that circulating cholesterol levels are directly correlated with tumoral expression of CYP17A, the critical enzyme required for de novo synthesis of androgens from cholesterol (R = 0.4073, p = 0.025) Since hypercholesterolemia does not raise circulating androgen levels and the adrenal gland of the mouse synthesizes minimal androgens, this study provides evidence that hypercholesterolemia increases intratumoral de novo steroidogenesis. Our results are consistent with the hypothesis that cholesterol-fueled intratumoral androgen synthesis may accelerate the growth of prostate tumors, and suggest that treatment of CRPC may be optimized by inclusion of cholesterol reduction therapies in conjunction with therapies targeting androgen synthesis and the AR.	[Mostaghel, Elahe A.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Mostaghel, Elahe A.; Montgomery, R. Bruce] Univ Washington, Dept Med, Seattle, WA USA; [Solomon, Keith R.; Pelton, Kristine] Childrens Hosp Boston, Dept Orthopaed Surg, Boston, MA USA; [Solomon, Keith R.; Freeman, Michael R.] Childrens Hosp Boston, Dept Urol, Boston, MA USA; [Solomon, Keith R.] Harvard Univ, Sch Med, Dept Orthopaed Surg, Boston, MA USA; [Freeman, Michael R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Freeman, Michael R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mostaghel, EA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	keith.solomon@childrens.harvard.edu			Prostate Cancer Foundation; Damon Runyon Cancer Research Foundation [CI-40-08]; National Institutes of Health [P50 CA97186, R01 CA101046, R01 CA143777]; United States Army Department of Defense [PCRP W81XWH-08-1-0150]; NATIONAL CANCER INSTITUTE [P50CA097186, R01CA143777, R01CA101046] Funding Source: NIH RePORTER	Prostate Cancer Foundation; Damon Runyon Cancer Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Prostate Cancer Foundation (EAM); Damon Runyon Cancer Research Foundation (Damon Runyon-Genentech Clinical Investigator Award CI-40-08, EAM), and the National Institutes of Health (Pacific Northwest Prostate Cancer SPORE P50 CA97186, EAM, RBM; R01 CA101046, KRS; R01 CA143777, MRF) and the United States Army Department of Defense (PCRP W81XWH-08-1-0150, MRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Batty GD, 2011, CANCER CAUSE CONTROL, V22, P311, DOI 10.1007/s10552-010-9691-6; Breau RH, 2010, J UROLOGY, V184, P494, DOI 10.1016/j.juro.2010.03.149; Browning DRL, 2007, INT J CANCER, V120, P833, DOI 10.1002/ijc.22366; Colombel M, 2005, CANCER RES, V65, P300; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dillard PR, 2008, MOL CELL ENDOCRINOL, V295, P115, DOI 10.1016/j.mce.2008.08.013; Farwell WR, 2011, JNCI-J NATL CANCER I, V103, P885, DOI 10.1093/jnci/djr108; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Friis S, 2005, INT J CANCER, V114, P643, DOI 10.1002/ijc.20758; Geller J, 1979, Prog Clin Biol Res, V33, P103; GELLER J, 1979, J STEROID BIOCHEM, V11, P631, DOI 10.1016/0022-4731(79)90092-X; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Gutt R, 2010, J CLIN ONCOL, V28, P2653, DOI 10.1200/JCO.2009.27.3003; Hall SA, 2007, CANCER EPIDEM BIOMAR, V16, P1587, DOI 10.1158/1055-9965.EPI-07-0306; Hamilton RJ, 2010, CANCER-AM CANCER SOC, V116, P3389, DOI 10.1002/cncr.25308; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Iso H, 2009, INT J CANCER, V125, P2679, DOI 10.1002/ijc.24668; Jacobs EJ, 2007, CANCER EPIDEM BIOMAR, V16, P2213, DOI 10.1158/1055-9965.EPI-07-0448; Jurado J, 2004, AM J CARDIOL, V93, P641, DOI 10.1016/j.amjcard.2003.11.040; Knopp RH, 2003, EUR HEART J, V24, P729, DOI 10.1016/S0195-668X(02)00807-2; Kolonel LN, 1999, JNCI-J NATL CANCER I, V91, P414, DOI 10.1093/jnci/91.5.414; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Labrie F, 2004, SEMIN REPROD MED, V22, P299, DOI 10.1055/s-2004-861547; Liao YD, 2003, INT J CANCER, V107, P676, DOI 10.1002/ijc.11471; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Michaud DS, 2001, CANCER CAUSE CONTROL, V12, P557, DOI 10.1023/A:1011256201044; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mondul AM, 2010, CANCER CAUSE CONTROL, V21, P61, DOI 10.1007/s10552-009-9434-8; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Mostaghel EA, 2008, BEST PRACT RES CL EN, V22, P243, DOI 10.1016/j.beem.2008.01.003; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Murtola TJ, 2007, CANCER EPIDEM BIOMAR, V16, P2226, DOI 10.1158/1055-9965.EPI-07-0599; Nishiyama T, 2004, CLIN CANCER RES, V10, P7121, DOI 10.1158/1078-0432.CCR-04-0913; Page ST, 2007, J ANDROL, V28, P734, DOI 10.2164/jandrol.107.002790; Platz EA, 2008, INT J CANCER, V123, P1693, DOI 10.1002/ijc.23715; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Platz EA, 2009, CANCER EPIDEM BIOMAR, V18, P2807, DOI 10.1158/1055-9965.EPI-09-0472; Reid AHM, 2008, NAT CLIN PRACT UROL, V5, P610, DOI 10.1038/ncpuro1237; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P1247, DOI 10.1002/cncr.23304; Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279; Shimizu Y, 2007, BJU INT, V100, P685, DOI 10.1111/j.1464-410X.2007.07014.x; Singer EA, 2008, EXPERT OPIN PHARMACO, V9, P211, DOI 10.1517/14656566.9.2.211 ; Singer EA, 2008, CAN J UROL, V15, P4381; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Solomon KR, 2009, AM J PATHOL, V174, P1017, DOI 10.2353/ajpath.2009.080551; Swyer GIM, 1942, CANCER RES, V2, P372; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Taplin ME, 1999, CANCER RES, V59, P2511; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Thibault A, 1996, CLIN CANCER RES, V2, P483; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; VANWEERDEN WM, 1992, LIFE SCI, V50, P857, DOI 10.1016/0024-3205(92)90204-3; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Walker M, 2005, INT J CANCER, V116, P592, DOI 10.1002/ijc.21112; Wu K, 2006, CANCER EPIDEM BIOMAR, V15, P167, DOI 10.1158/1055-9965.EPI-05-0100; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Zhuang LY, 2002, CANCER RES, V62, P2227	69	92	95	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30062	10.1371/journal.pone.0030062	http://dx.doi.org/10.1371/journal.pone.0030062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279565	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900043
J	Shieh, JM; Wei, TT; Tang, YA; Huang, SM; Wen, WL; Chen, MY; Cheng, HC; Salunke, SB; Chen, CS; Lin, PP; Chen, CT; Wang, YC				Shieh, Jiunn-Min; Wei, Tzu-Tang; Tang, Yen-An; Huang, Sin-Ming; Wen, Wei-Ling; Chen, Mei-Yu; Cheng, Hung-Chi; Salunke, Santosh B.; Chen, Ching-Shih; Lin, Pinpin; Chen, Chien-Tien; Wang, Yi-Ching			Mitochondrial Apoptosis and FAK Signaling Disruption by a Novel Histone Deacetylase Inhibitor, HTPB, in Antitumor and Antimetastatic Mouse Models	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CELL-DEATH; CANCER-THERAPY; ACTIVATION; HALLMARKS; FIBRONECTIN; COMBINATION; MECHANISMS; PATHWAYS; PROTEINS	Background: Compound targeting histone deacetylase (HDAC) represents a new era in molecular cancer therapeutics. However, effective HDAC inhibitors for the treatment of solid tumors remain to be developed. Methodology/Principal Findings: Here, we propose a novel HDAC inhibitor, N-Hydroxy-4-(4-phenylbutyryl-amino) benzamide (HTPB), as a potential chemotherapeutic drug for solid tumors. The HDAC inhibition of HTPB was confirmed using HDAC activity assay. The antiproliferative and anti-migratory mechanisms of HTPB were investigated by cell proliferation, flow cytometry, DNA ladder, caspase activity, Rho activity, F-actin polymerization, and gelatin-zymography for matrix metalloproteinases (MMPs). Mice with tumor xenograft and experimental metastasis model were used to evaluate effects on tumor growth and metastasis. Our results indicated that HTPB was a pan-HDAC inhibitor in suppressing cell viability specifically of lung cancer cells but not of the normal lung cells. Upon HTPB treatment, cell cycle arrest was induced and subsequently led to mitochondria-mediated apoptosis. HTPB disrupted F-actin dynamics via downregulating RhoA activity. Moreover, HTPB inhibited activity of MMP2 and MMP9, reduced integrin-beta 1/focal adhesion complex formation and decreased pericellular poly-fibronectin assemblies. Finally, intraperitoneal injection or oral administration of HTPB efficiently inhibited A549 xenograft tumor growth in vivo without side effects. HTPB delayed lung metastasis of 4T1 mouse breast cancer cells. Acetylation of histone and non-histone proteins, induction of apoptotic-related proteins and dephosphorylation of focal adhesion kinase were confirmed in treated mice. Conclusions/Significance: These results suggested that intrinsic apoptotic pathway may involve in anti-tumor growth effects of HTPB in lung cancer cells. HTPB significantly suppresses tumor metastasis partly through inhibition of integrin-beta 1/FAK/MMP/RhoA/F-actin pathways. We have provided convincing preclinical evidence that HTPB is a potent HDAC targeted inhibitor and is thus a promising candidate for lung cancer chemotherapy.	[Shieh, Jiunn-Min] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Wei, Tzu-Tang; Chen, Mei-Yu; Wang, Yi-Ching] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Tang, Yen-An; Cheng, Hung-Chi; Wang, Yi-Ching] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Huang, Sin-Ming; Wen, Wei-Ling] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Cheng, Hung-Chi] Natl Cheng Kung Univ, Inst Biochem, Tainan 70101, Taiwan; [Salunke, Santosh B.; Chen, Chien-Tien] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Lin, Pinpin] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University; National Taiwan Normal University; National Cheng Kung University; National Tsing Hua University; University System of Ohio; Ohio State University; National Health Research Institutes - Taiwan	Shieh, JM (corresponding author), Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan.	ctchen@mx.nthu.edu.tw; ycw5798@mail.ncku.edu.tw	Wang, Yi-Ching/J-8702-2019; Lin, PinPin/A-2006-2019; Lin, Pinpin/B-2668-2010; WEI, TZU-TANG/AAT-8447-2020	Wang, Yi-Ching/0000-0002-7694-2067; Lin, PinPin/0000-0001-5459-907X; Lin, Pinpin/0000-0001-5459-907X; 	Chi Mei Medical Center, Taiwan [CMNCKU9906]; National Science Council, Taiwan [NSC100-2325-B-400-012, NSC 100-2325-B-006-009]	Chi Mei Medical Center, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants CMNCKU9906 from the Chi Mei Medical Center, Taiwan (JMS) and NSC100-2325-B-400-012 (PL) and NSC 100-2325-B-006-009 from the National Science Council, Taiwan (YCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Cheng HC, 2003, J BIOL CHEM, V278, P24600, DOI 10.1074/jbc.M303424200; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gojo I, 2007, BLOOD, V109, P2781, DOI 10.1182/blood-2006-05-021873; Gossage L, 2010, CLIN CANCER RES, V16, P1973, DOI 10.1158/1078-0432.CCR-09-3182; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lazebnik Y, 2010, NAT REV CANCER, V10, P232, DOI 10.1038/nrc2827; Levitzki A, 2010, MOL ASPECTS MED, V31, P287, DOI 10.1016/j.mam.2010.04.001; Liu LT, 2003, CANCER RES, V63, P3069; Lu Q, 2005, J MED CHEM, V48, P5530, DOI 10.1021/jm0503749; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marsoni S, 2008, EPIGENETICS-US, V3, P164, DOI 10.4161/epi.3.3.6253; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nemunaitis JJ, 2003, CANCER J, V9, P58, DOI 10.1097/00130404-200301000-00010; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Siddiqa A, 2008, CANCER BIOL THER, V7, P740, DOI 10.4161/cbt.7.5.6163; Takada Y, 2006, J BIOL CHEM, V281, P5612, DOI 10.1074/jbc.M507213200; Tang YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012417; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	33	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30240	10.1371/journal.pone.0030240	http://dx.doi.org/10.1371/journal.pone.0030240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279574	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900051
J	Calderari, S; Chougnet, C; Clemessy, M; Kempf, H; Corvol, P; Larger, E				Calderari, Sophie; Chougnet, Cecile; Clemessy, Maud; Kempf, Herve; Corvol, Pierre; Larger, Etienne			Angiopoietin 2 Alters Pancreatic Vascularization in Diabetic Conditions	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INSULIN GENE-EXPRESSION; CELL PROLIFERATION; FACTOR-A; IN-VIVO; ISLETS; ANGIOGENESIS; VEGF; REVASCULARIZATION; RATS	Aims/hypothesis: Islet vascularization, by controlling beta-cell mass expansion in response to increased insulin demand, is implicated in the progression to glucose intolerance and type 2 diabetes. We investigated how hyperglycaemia impairs expansion and differentiation of the growing pancreas. We have grafted xenogenic (avian) embryonic pancreas in severe combined immuno-deficient (SCID) mouse and analyzed endocrine and endothelial development in hyperglycaemic compared to normoglycaemic conditions. Methods: 14 dpi chicken pancreases were grafted under the kidney capsule of normoglycaemic or hyperglycaemic, streptozotocin-induced, SCID mice and analyzed two weeks later. Vascularization was analyzed both quantitatively and qualitatively using either in situ hybridization with both mouse-and chick-specific RNA probes for VEGFR2 or immunohistochemistry with an antibody to nestin, a marker of endothelial cells that is specific for murine cells. To inhibit angiopoietin 2 (Ang2), SCID mice were treated with 4 mg/kg IP L1-10 twice/week. Results: In normoglycaemic condition, chicken-derived endocrine and exocrine cells developed well and intragraft vessels were lined with mouse endothelial cells. When pancreases were grafted in hyperglycaemic mice, growth and differentiation of the graft were altered and we observed endothelial discontinuities, large blood-filled spaces. Vessel density was decreased. These major vascular anomalies were associated with strong over-expression of chick-Ang2. To explore the possibility that Ang2 over-expression could be a key step in vascular disorganization induced by hyperglycaemia, we treated mice with L1-10, an Ang-2 specific inhibitor. Inhibition of Ang2 improved vascularization and beta-cell density. Conclusions: This work highlighted an important role of Ang2 in pancreatic vascular defects induced by hyperglycaemia.	[Calderari, Sophie; Chougnet, Cecile; Clemessy, Maud; Kempf, Herve; Corvol, Pierre; Larger, Etienne] Coll France, INSERM, U833, F-75231 Paris, France; [Kempf, Herve] Nancy Univ, CNRS, UMR 7561, Lab Physiopathol Pharmacol & Ingn Articulaires, Vandoeuvre Les Nancy, France; [Larger, Etienne] Univ Paris 05, Fac Med, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; UDICE-French Research Universities; Universite Paris Cite	Calderari, S (corresponding author), Ctr Rech Cordeliers, INSERM, UMRS 872, Paris, France.	sophie.calderari@crc.jussieu.fr	Kempf, Herve/F-1171-2011	Kempf, Herve/0000-0003-1818-2327; Calderari, Sophie/0000-0002-9669-681X	ALFEDIAM/Novo Nordisk Pharmaceutique SAS; Assistance Publique des Hopitaux de Paris; SERVIER laboratories	ALFEDIAM/Novo Nordisk Pharmaceutique SAS; Assistance Publique des Hopitaux de Paris; SERVIER laboratories	SC was supported by a ALFEDIAM/Novo Nordisk Pharmaceutique SAS post-doctoral fellowship; CC was supported by a fellowship from the "Assistance Publique des Hopitaux de Paris". A part of this work was supported by a grant from SERVIER laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Bureau W, 2006, AM J PHYSIOL-HEART C, V291, pH948, DOI 10.1152/ajpheart.00734.2005; Carmeliet P, 2000, NAT MED, V6, P1102, DOI 10.1038/80430; Chen JX, 2008, ARTERIOSCL THROM VAS, V28, P1606, DOI 10.1161/ATVBAHA.108.169235; Chua RA, 2009, AUTOIMMUNITY, V42, P574, DOI 10.1080/08916930903002461; Colen KL, 1999, J PEDIATR SURG, V34, P781, DOI 10.1016/S0022-3468(99)90373-1; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cui X, 2011, NEUROBIOL DIS, V43, P285, DOI 10.1016/j.nbd.2011.04.005; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; DieterlenLievre F, 1997, POULTRY SCI, V76, P78, DOI 10.1093/ps/76.1.78; Duvillie B, 2002, ENDOCRINOLOGY, V143, P1530, DOI 10.1210/en.143.4.1530; Eberhard D, 2010, TRENDS ENDOCRIN MET, V21, P457, DOI 10.1016/j.tem.2010.03.003; Eichmann A, 1998, DEVELOPMENT, V125, P743; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Gibly RF, 2011, DIABETOLOGIA, V54, P2494, DOI 10.1007/s00125-011-2243-0; Giroix MH, 2011, DIABETOLOGIA, V54, P2451, DOI 10.1007/s00125-011-2223-4; Ham JN, 2009, PEDIATR RES, V66, P42, DOI 10.1203/PDR.0b013e3181a282a5; Hammerman MR, 2004, AM J TRANSPLANT, V4, P14, DOI 10.1111/j.1600-6135.2004.0341.x; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Hughes SH, 2004, FOLIA BIOL-PRAGUE, V50, P107; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Jiang BH, 1999, P NATL ACAD SCI USA, V96, P2077, DOI 10.1073/pnas.96.5.2077; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kaido TJ, 2010, J CELL PHYSIOL, V224, P101, DOI 10.1002/jcp.22101; Kampfer H, 2001, LAB INVEST, V81, P361, DOI 10.1038/labinvest.3780244; Kawasaki F, 2005, AM J PHYSIOL-ENDOC M, V288, pE510, DOI 10.1152/ajpendo.00128.2004; Kim SK, 1997, DEVELOPMENT, V124, P4243; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Larger E, 2004, DIABETES, V53, P752, DOI 10.2337/diabetes.53.3.752; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lim HS, 2005, ATHEROSCLEROSIS, V180, P113, DOI 10.1016/j.atherosclerosis.2004.11.004; Lim HS, 2004, DIABETES CARE, V27, P2918, DOI 10.2337/diacare.27.12.2918; Luft T, 2011, BLOOD, V118, P1685, DOI 10.1182/blood-2011-02-334821; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsuura K, 2009, MECH DEVELOP, V126, P817, DOI 10.1016/j.mod.2009.07.009; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Mattsson G, 2006, PANCREATOLOGY, V6, P86, DOI 10.1159/000090027; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; NAKAMURA M, 1989, DIABETES RES CLIN PR, V7, P169, DOI 10.1016/0168-8227(89)90002-8; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Qiao L, 2011, BURNS, V37, P1015, DOI 10.1016/j.burns.2011.03.020; Rasul S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-55; Richards OC, 2010, ENDOCR REV, V31, P343, DOI 10.1210/er.2009-0035; Savary K, 2005, BLOOD, V105, P103, DOI 10.1182/blood-2004-04-1570; Shinohara M, 2000, Int J Exp Diabetes Res, V1, P89, DOI 10.1155/EDR.2000.89; SIBONY M, 1995, LAB INVEST, V73, P586; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Su DM, 2007, DIABETES, V56, P2274, DOI 10.2337/db07-0371; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tuo QH, 2008, AM J PHYSIOL-HEART C, V294, pH2547, DOI 10.1152/ajpheart.01250.2007; VAJKOCZY P, 1995, AM J PATHOL, V146, P1397; Villeneuve J, 2008, BRAIN PATHOL, V18, P401, DOI 10.1111/j.1750-3639.2008.00139.x; Westra J, 2011, RHEUMATOLOGY, V50, P665, DOI 10.1093/rheumatology/keq378; Xue Y, 2008, P NATL ACAD SCI USA, V105, P10167, DOI 10.1073/pnas.0802486105	60	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29438	10.1371/journal.pone.0029438	http://dx.doi.org/10.1371/journal.pone.0029438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272235	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400014
J	Lerch, JK; Kuo, F; Motti, D; Morris, R; Bixby, JL; Lemmon, VP				Lerch, Jessica K.; Kuo, Frank; Motti, Dario; Morris, Richard; Bixby, John L.; Lemmon, Vance P.			Isoform Diversity and Regulation in Peripheral and Central Neurons Revealed through RNA-Seq	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; CELL-DIFFERENTIATION; OVER-REPRESENTATION; NERVE REGENERATION; AXON REGENERATION; SENSORY NEURONS; BINDING SITES; SPINAL-CORD; TRANSCRIPTION	To fully understand cell type identity and function in the nervous system there is a need to understand neuronal gene expression at the level of isoform diversity. Here we applied Next Generation Sequencing of the transcriptome (RNA-Seq) to purified sensory neurons and cerebellar granular neurons (CGNs) grown on an axonal growth permissive substrate. The goal of the analysis was to uncover neuronal type specific isoforms as a prelude to understanding patterns of gene expression underlying their intrinsic growth abilities. Global gene expression patterns were comparable to those found for other cell types, in that a vast majority of genes were expressed at low abundance. Nearly 18% of gene loci produced more than one transcript. More than 8000 isoforms were differentially expressed, either to different degrees in different neuronal types or uniquely expressed in one or the other. Sensory neurons expressed a larger number of genes and gene isoforms than did CGNs. To begin to understand the mechanisms responsible for the differential gene/isoform expression we identified transcription factor binding sites present specifically in the upstream genomic sequences of differentially expressed isoforms, and analyzed the 3' untranslated regions (3' UTRs) for microRNA (miRNA) target sites. Our analysis defines isoform diversity for two neuronal types with diverse axon growth capabilities and begins to elucidate the complex transcriptional landscape in two neuronal populations.	[Lerch, Jessica K.; Kuo, Frank; Motti, Dario; Morris, Richard; Bixby, John L.; Lemmon, Vance P.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Morris, Richard; Bixby, John L.] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Bixby, John L.] Univ Miami, Miller Sch Med, Dept Cellular & Mol Pharmacol, Miami, FL 33136 USA; [Lemmon, Vance P.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Lerch, JK (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	jbixby@miami.edu; vlemmon@med.miami.edu	Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576; Bixby, John/0000-0003-1633-5318; Motti, Dario/0000-0002-7714-4040	National Institutes of Health [HD057632, NS059866]; U.S. Army [W81XWH-05-1-0061]; Buoniconti Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army(United States Department of DefenseUnited States Army); Buoniconti Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (HD057632), (NS059866), U.S. Army (W81XWH-05-1-0061), and the Buoniconti Foundation. VPL holds the Walter G. Ross Distinguished Chair in Developmental Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beck D, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-19; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Blackmore MG, 2010, MOL CELL NEUROSCI, V44, P43, DOI 10.1016/j.mcn.2010.02.002; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; GALLO V, 1987, J NEUROSCI, V7, P2203; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kazantseva A, 2009, J NEUROCHEM, V109, P807, DOI 10.1111/j.1471-4159.2009.06005.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Malin D, 2009, J CELL SCI, V122, P995, DOI 10.1242/jcs.040378; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marstrand TT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001623; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; MCQUARRIE IG, 1977, BRAIN RES, V132, P443, DOI 10.1016/0006-8993(77)90193-7; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musatov S, 2004, P NATL ACAD SCI USA, V101, P3627, DOI 10.1073/pnas.0308289101; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; OTTEN U, 1980, NATURE, V287, P158, DOI 10.1038/287158a0; Park C, 2011, GASTROENTEROLOGY, V141, P164, DOI 10.1053/j.gastro.2011.03.058; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Smith RP, 2011, MOL CELL NEUROSCI, V46, P32, DOI 10.1016/j.mcn.2010.07.015; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thangnipon W, 1983, Brain Res, V313, P177; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101; Usher LC, 2010, J NEUROSCI, V30, P4693, DOI 10.1523/JNEUROSCI.0302-10.2010; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	62	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30417	10.1371/journal.pone.0030417	http://dx.doi.org/10.1371/journal.pone.0030417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272348	Green Submitted, Green Published, gold			2022-12-25	WOS:000301454400126
J	Kajla, S; Mondol, AS; Nagasawa, A; Zhang, YG; Kato, M; Matsuno, K; Yabe-Nishimura, C; Kamata, T				Kajla, Seheli; Mondol, Abdus S.; Nagasawa, Atsushi; Zhang, Yugen; Kato, Masayoshi; Matsuno, Kuniharu; Yabe-Nishimura, Chihiro; Kamata, Tohru			A crucial role for Nox 1 in redox-dependent regulation of Wnt-beta-catenin signaling	FASEB JOURNAL			English	Article						NADPH oxidase; Rac1; nucleoredoxin; reactive oxygen species	HYDROGEN-PEROXIDE; EPITHELIAL-CELLS; NADPH OXIDASE-1; COLON-CANCER; RAS; SUPEROXIDE; EXPRESSION; TRANSFORMATION; GROWTH; TIAM1	Canonical Wnt signaling critically regulates cell fate and proliferation in developmental stages and adult tissues. Redox regulation through nucleoredoxin (NRX) has recently been identified in canonical Wnt signaling. However, the source of reactive oxygen species (ROS) affecting the redox state of NRX remains elusive. Our principal aim in this study was to investigate whether superoxide-generating NADPH oxidase1 (Nox1) is involved in NRX-regulated Wnt signaling in intestinal and colon epithelial cells. Here, we demonstrate that Wnt treatment of mouse intestinal cells induces production of ROS through Nox1. This Nox1 action is regulated by Rac1 GTPase through Wnt-induced activation of the Rac1 guanine nucleotide exchange factor Vav2 by Src-mediated tyrosine phosphorylation. Nox1-generated ROS oxidize and inactivate NRX, thereby releasing the NRX-dependent suppression of Wnt-beta-catenin signaling through dissociation of NRX from Dvl. Nox1 small-interference RNA inhibits cell response to Wnt, including stabilization of beta-catenin, expression of cyclin D1 and c-Myc via the TCF transcription factor, and accelerated cell proliferation. Nox1 mediates Wnt-induced cell growth in colon cancer cells with the normal Wnt pathway, but not in APC-deficient colon cancer cells, which are constitutively active in Wnt signaling. Together, these results suggest the mediating role of Nox1 in redox-dependent regulation of canonical Wnt-beta-catenin signaling and provide further insight into the regulatory mechanism of the Wnt pathway.-Kajla, S., Mondol, A. S., Nagasawa, A., Zhang, Y., Kato, M., Matsuno, K., Yabe-Nishimura, C., Kamata, T. A crucial role for Nox 1 in redox-dependent regulation of Wnt-beta-catenin signaling. FASEB J. 26, 2049-2059 (2012). www.fasebj.org	[Kajla, Seheli; Mondol, Abdus S.; Nagasawa, Atsushi; Zhang, Yugen; Kato, Masayoshi; Kamata, Tohru] Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, Matsumoto, Nagano 3908621, Japan; [Matsuno, Kuniharu; Yabe-Nishimura, Chihiro] Kyoto Prefectural Univ Med, Dept Pharmacol, Kyoto, Japan	Shinshu University; Kyoto Prefectural University of Medicine	Kamata, T (corresponding author), Shinshu Univ, Grad Sch Med, Dept Mol Biol & Biochem, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	kamatat@shinshu-u.ac.jp			Ministry of Science and Culture of Japan	Ministry of Science and Culture of Japan	The authors thank Dr. M. Kawakubo, Department of Laboratory Medicine, Shinshu University for technical assistance. The authors are grateful to F. Ushiyama for assistance in manuscript preparation. This work was supported by a grant on Cancer Research in Applied Areas from the Ministry of Science and Culture of Japan (T.K.).	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; BOLEN JB, 1987, ONCOGENE RES, V1, P149; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Geiszt M, 2003, J IMMUNOL, V171, P299, DOI 10.4049/jimmunol.171.1.299; Gianni D, 2008, MOL BIOL CELL, V19, P2984, DOI 10.1091/mbc.E08-02-0138; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kawahara T, 2004, J IMMUNOL, V172, P3051, DOI 10.4049/jimmunol.172.5.3051; Komatsu D, 2008, ONCOGENE, V27, P4724, DOI 10.1038/onc.2008.102; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Laurent E, 2008, INT J CANCER, V123, P100, DOI 10.1002/ijc.23423; Liu JY, 2009, J CELL SCI, V122, P324, DOI 10.1242/jcs.033720; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Rimerman RA, 2000, J BIOL CHEM, V275, P14736, DOI 10.1074/jbc.M910241199; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shinohara M, 2007, J BIOL CHEM, V282, P17640, DOI 10.1074/jbc.M609450200; Shinohara M, 2010, J BIOL CHEM, V285, P4481, DOI 10.1074/jbc.M109.071779; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Wu YL, 1998, FEBS LETT, V440, P111, DOI 10.1016/S0014-5793(98)01415-X; Yokoyama N, 2009, J CELL SCI, V122, P4439, DOI 10.1242/jcs.051847; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	36	82	83	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2049	2059		10.1096/fj.11-196360	http://dx.doi.org/10.1096/fj.11-196360			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22278940				2022-12-25	WOS:000303680800031
J	Geng, H; Sakato, M; DeRocco, V; Yamane, K; Du, CW; Erie, DA; Hingorani, M; Hsieh, P				Geng, Hui; Sakato, Miho; DeRocco, Vanessa; Yamane, Kazuhiko; Du, Chunwei; Erie, Dorothy A.; Hingorani, Manju; Hsieh, Peggy			Biochemical Analysis of the Human Mismatch Repair Proteins hMutS alpha MSH2(G674A)-MSH6 and MSH2-MSH6(T1219D)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; NUCLEOTIDE-BINDING SITES; HUMAN NUCLEAR EXTRACTS; MUTL-ALPHA; DNA-REPAIR; DOMINANT MUTATIONS; MISPAIR-BINDING; ATR KINASE; COMPLEX; MSH2	The heterodimeric human MSH2-MSH6 protein initiates DNA mismatch repair (MMR) by recognizing mismatched bases that result from replication errors. Msh2(G674A) or Msh6(T1217D) mice that have mutations in or near the ATP binding site of MSH2 or ATP hydrolysis catalytic site of MSH6 develop cancer and have a reduced lifespan due to loss of the MMR pathway (Lin, D. P., Wang, Y., Scherer, S. J., Clark, A. B., Yang, K., Avdievich, E., Jin, B., Werling, U., Parris, T., Kurihara, N., Umar, A., Kucherlapati, R., Lipkin, M., Kunkel, T. A., and Edelmann, W. (2004) Cancer Res. 64, 517522; Yang, G., Scherer, S. J., Shell, S. S., Yang, K., Kim, M., Lipkin, M., Kucherlapati, R., Kolodner, R. D., and Edelmann, W. (2004) Cancer Cell 6, 139150). Mouse embryonic fibroblasts from these mice retain an apoptotic response to DNA damage. Mutant human MutS alpha proteins MSH2(G674A)-MSH6(wt) and MSH2(wt)-MSH6T(1219D) are profiled in a variety of functional assays and as expected fail to support MMR in vitro, although they retain mismatch recognition activity. Kinetic analyses of DNA binding and ATPase activities and examination of the excision step of MMR reveal that the two mutants differ in their underlying molecular defects. MSH2(wt)-MSH6(T1219D) fails to couple nucleotide binding and mismatch recognition, whereas MSH2(G674A)-MSH6(wt) has a partial defect in nucleotide binding. Nevertheless, both mutant proteins remain bound to the mismatch and fail to promote efficient excision thereby inhibiting MMR in vitro in a dominant manner. Implications of these findings for MMR and DNA damage signaling by MMR proteins are discussed.	[Geng, Hui; Yamane, Kazuhiko; Du, Chunwei; Hsieh, Peggy] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; [Sakato, Miho; Hingorani, Manju] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA; [DeRocco, Vanessa; Erie, Dorothy A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wesleyan University; University of North Carolina; University of North Carolina Chapel Hill	Hsieh, P (corresponding author), 9000 Rockville Pike,5 Mem Dr,MSC 0538,Bldg 5 Rm 3, Bethesda, MD 20892 USA.	peggyh@intra.niddk.nih.gov			National Institutes of Health of NIDDK [F31 GM087096, GM 079480]; State of Connecticut Department of Public Health [2011-0138]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052030] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1022203] Funding Source: National Science Foundation	National Institutes of Health of NIDDK; State of Connecticut Department of Public Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NIDDK (to H. G., C. D., K.Y., and P. H.) and Grants F31 GM087096 (to V. R.) and GM 079480 (to D. A. E.). This work was also supported by State of Connecticut Department of Public Health Grant 2011-0138 (to M.H.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Berends MJW, 2002, AM J HUM GENET, V70, P26, DOI 10.1086/337944; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; BRENOWITZ M, 1991, J BIOL CHEM, V266, P1281; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; Drotschmann K, 1999, P NATL ACAD SCI USA, V96, P2970, DOI 10.1073/pnas.96.6.2970; FANG WH, 1993, J BIOL CHEM, V268, P11838; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Geng H, 2011, ANAL BIOCHEM, V413, P179, DOI 10.1016/j.ab.2011.02.017; GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs-Palmer E, 2007, J MOL BIOL, V366, P1087, DOI 10.1016/j.jmb.2006.11.092; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jiricny J, 1998, EMBO J, V17, P6427, DOI 10.1093/emboj/17.22.6427; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; KARRAN P, 1992, NUCLEIC ACIDS RES, V20, P2933, DOI 10.1093/nar/20.12.2933; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2004, J BIOL CHEM, V279, P43879, DOI 10.1074/jbc.M406380200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin DP, 2004, CANCER RES, V64, P517, DOI 10.1158/0008-5472.CAN-03-2957; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Lutzen A, 2008, MUTAT RES-FUND MOL M, V645, P44, DOI 10.1016/j.mrfmmm.2008.08.015; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Martik D, 2004, J BIOL CHEM, V279, P28402, DOI 10.1074/jbc.M312108200; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Wang HX, 2002, J BIOL CHEM, V277, P26136, DOI 10.1074/jbc.M200357200; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Woods MO, 2007, HUM MUTAT, V28, P669, DOI 10.1002/humu.20502; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708; York SJ, 2006, J BIOL CHEM, V281, P22674, DOI 10.1074/jbc.M603667200; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	54	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9777	9791		10.1074/jbc.M111.316919	http://dx.doi.org/10.1074/jbc.M111.316919			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22277660	Green Published, hybrid			2022-12-25	WOS:000302167200011
J	Bao, BA; Lai, CP; Naus, CC; Morgan, JR				Bao, Brian A.; Lai, Charles P.; Naus, Christian C.; Morgan, Jeffrey R.			Pannexin1 Drives Multicellular Aggregate Compaction via a Signaling Cascade That Remodels the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEATION PORE INHIBITION; MEDIATED CELL-ADHESION; ATP RELEASE; PHARMACOLOGICAL-PROPERTIES; P2X(7) RECEPTOR; 1 CHANNELS; EXPRESSION; CONNEXIN-43; FAMILY; DYNAMICS	Pannexin 1 (Panx1) is a novel gap junction protein shown to have tumor-suppressive properties. To model its in vivo role in the intratumor biomechanical environment, we investigated whether Panx1 channels modulate the dynamic assembly of multicellular C6 glioma aggregates. Treatment with carbenoxolone and probenecid, which directly and specifically block Panx1 channels, respectively, showed that Panx1 is involved in accelerating aggregate assembly. Experiments further showed that exogenous ATP can reverse the inhibitive effects of carbenoxolone and that aggregate compaction is sensitive to the purinergic antagonist suramin. With a close examination of the F-actin microfilament network, these findings show that Panx1 channels act as conduits for ATP release that stimulate the P2X7 purinergic receptor pathway, in turn up-regulating actomyosin function. Using a unique three-dimensional scaffold-free method to quantify multicellular interactions, this study shows that Panx1 is intimately involved in regulating intercellular biomechanical interactions pivotal in the progression of cancer.	[Bao, Brian A.; Morgan, Jeffrey R.] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Lai, Charles P.; Naus, Christian C.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	Brown University; University of British Columbia	Morgan, JR (corresponding author), Brown Univ, Biomed Ctr, G-B 393,171 Meeting St, Providence, RI 02912 USA.	Jeffrey_morgan@brown.edu	Lai, Charles Pin-Kuang/D-5442-2017	Lai, Charles Pin-Kuang/0000-0001-8050-7060; Morgan, Jeffrey/0000-0002-7546-3443	National Institutes of Health [R01EB008664-01A1]; Brown University; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded, in whole or in part, by National Institutes of Health Grant R01EB008664-01A1. This work was also supported by the Brown University M.D./Ph.D. program and the Canadian Institutes of Health Research (CCN). J. R. M. has an equity interest in MicroTissues, Inc. This relationship has been reviewed and managed by Brown University in accordance with its conflict of interest policies.	Bao B, 2011, FASEB J, V25, P255, DOI 10.1096/fj.10-155291; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; Cotrina ML, 1998, J NEUROSCI, V18, P8794; Dahl Gerhard, 2009, P287, DOI 10.1007/978-1-59745-489-6_12; Dean DM, 2009, CELL MOTIL CYTOSKEL, V66, P129, DOI 10.1002/cm.20335; Dean DM, 2008, TISSUE ENG PT A, V14, P1989, DOI 10.1089/ten.tea.2007.0320; Demou ZN, 2010, ANN BIOMED ENG, V38, P3509, DOI 10.1007/s10439-010-0097-0; Dubyak GR, 2009, AM J PHYSIOL-CELL PH, V296, pC235, DOI 10.1152/ajpcell.00639.2008; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Foty RA, 1996, DEVELOPMENT, V122, P1611; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Koike C, 2002, BRIT J CANCER, V86, P947, DOI 10.1038/sj.bjc.6600158; Lai CPK, 2009, ONCOGENE, V28, P4402, DOI 10.1038/onc.2009.283; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Li S, 2011, ENDOCRINOLOGY, V152, P2342, DOI 10.1210/en.2010-1216; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MOSCONA A, 1952, J ANAT, V86, P287; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Napolitano AP, 2007, TISSUE ENG, V13, P2087, DOI 10.1089/ten.2006.0190; Naus CCG, 2002, CAN J PHYSIOL PHARM, V80, P136, DOI 10.1139/Y02-009; Omelchenko T, 2001, P NATL ACAD SCI USA, V98, P8632, DOI 10.1073/pnas.151247698; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Rago AP, 2009, TISSUE ENG PT A, V15, P387, DOI 10.1089/ten.tea.2008.0107; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sabala P, 2001, BRIT J PHARMACOL, V132, P393, DOI 10.1038/sj.bjp.0703843; Shieh AC, 2011, ANN BIOMED ENG, V39, P1379, DOI 10.1007/s10439-011-0252-2; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Wei W, 2008, CANCER LETT, V260, P79, DOI 10.1016/j.canlet.2007.10.025; Youssef J, 2011, P NATL ACAD SCI USA, V108, P6993, DOI 10.1073/pnas.1102559108; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	47	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8407	8416		10.1074/jbc.M111.306522	http://dx.doi.org/10.1074/jbc.M111.306522			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267745	Green Published, hybrid			2022-12-25	WOS:000301349400055
J	Friedland, KD; Stock, C; Drinkwater, KF; Link, JS; Leaf, RT; Shank, BV; Rose, JM; Pilskaln, CH; Fogarty, MJ				Friedland, Kevin D.; Stock, Charles; Drinkwater, Kenneth F.; Link, Jason S.; Leaf, Robert T.; Shank, Burton V.; Rose, Julie M.; Pilskaln, Cynthia H.; Fogarty, Michael J.			Pathways between Primary Production and Fisheries Yields of Large Marine Ecosystems	PLOS ONE			English	Article							FISH PRODUCTION; GLOBAL FISHERIES; GROWTH-RATES; PHYTOPLANKTON; TEMPERATURE; MODEL; TRENDS; CARBON; RATIO; LAKE	The shift in marine resource management from a compartmentalized approach of dealing with resources on a species basis to an approach based on management of spatially defined ecosystems requires an accurate accounting of energy flow. The flow of energy from primary production through the food web will ultimately limit upper trophic-level fishery yields. In this work, we examine the relationship between yield and several metrics including net primary production, chlorophyll concentration, particle-export ratio, and the ratio of secondary to primary production. We also evaluate the relationship between yield and two additional rate measures that describe the export of energy from the pelagic food web, particle export flux and mesozooplankton productivity. We found primary production is a poor predictor of global fishery yields for a sample of 52 large marine ecosystems. However, chlorophyll concentration, particle-export ratio, and the ratio of secondary to primary production were positively associated with yields. The latter two measures provide greater mechanistic insight into factors controlling fishery production than chlorophyll concentration alone. Particle export flux and mesozooplankton productivity were also significantly related to yield on a global basis. Collectively, our analyses suggest that factors related to the export of energy from pelagic food webs are critical to defining patterns of fishery yields. Such trophic patterns are associated with temperature and latitude and hence greater yields are associated with colder, high latitude ecosystems.	[Friedland, Kevin D.; Leaf, Robert T.] NOAA, Natl Marine Fisheries Serv, Narragansett, RI 02882 USA; [Stock, Charles] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA; [Drinkwater, Kenneth F.] Inst Marine Res, N-5024 Bergen, Norway; [Drinkwater, Kenneth F.] Bjerknes Ctr Climate Res, Bergen, Norway; [Link, Jason S.; Shank, Burton V.; Fogarty, Michael J.] Natl Marine Fisheries Serv, Woods Hole, MA 02543 USA; [Rose, Julie M.] Natl Marine Fisheries Serv, Milford, MA USA; [Pilskaln, Cynthia H.] Sch Marine Sci & Technol, New Bedford, MA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Institute of Marine Research - Norway; Bjerknes Centre for Climate Research; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Friedland, KD (corresponding author), NOAA, Natl Marine Fisheries Serv, Narragansett, RI 02882 USA.	kevin.friedland@noaa.gov	Leaf, Robert/AAE-7345-2019; Stock, Charles A/H-1281-2012	Leaf, Robert/0000-0002-2955-3149; Stock, Charles A/0000-0001-9549-8013; Link, Jason/0000-0003-2740-7161	Comparative Analysis of Marine Ecosystems Organization (CAMEO); Marine Ecosystems of Norway; US (MENU); Research Council of Norway	Comparative Analysis of Marine Ecosystems Organization (CAMEO); Marine Ecosystems of Norway; US (MENU); Research Council of Norway(Research Council of Norway)	This work was in part supported by Comparative Analysis of Marine Ecosystems Organization (CAMEO) grants for Fisheries Production Modeling Workshops to J. Link and B. Megrey (2010) and J. Link and S. Gaichas (2011). And, by the Marine Ecosystems of Norway and the US (MENU) project, part II, funded by the Research Council of Norway, which supported K. Drinkwater. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Armstrong RA, 1999, J PLANKTON RES, V21, P445, DOI 10.1093/plankt/21.3.445; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Campbell J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001444; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Chassot E, 2007, MAR ECOL PROG SER, V343, P45, DOI 10.3354/meps06919; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cloern JE, 1995, LIMNOL OCEANOGR, V40, P1313, DOI 10.4319/lo.1995.40.7.1313; Collie JS, 2009, ICES J MAR SCI, V66, P2223, DOI 10.1093/icesjms/fsp180; Conti L, 2010, MAR ECOL PROG SER, V410, P233, DOI 10.3354/meps08630; CUSHING DH, 1971, ADV MAR BIOL, V9, P255, DOI 10.1016/S0065-2881(08)60344-2; DOWNING JA, 1990, CAN J FISH AQUAT SCI, V47, P1929, DOI 10.1139/f90-217; Dunne JP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002390; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Friedrichs MAM, 2009, J MARINE SYST, V76, P113, DOI 10.1016/j.jmarsys.2008.05.010; Gaichas S, 2009, PROG OCEANOGR, V81, P47, DOI 10.1016/j.pocean.2009.04.005; Garrison LP, 2000, MAR ECOL PROG SER, V202, P231, DOI 10.3354/meps202231; GAVIS J, 1975, LIMNOL OCEANOGR, V20, P211, DOI 10.4319/lo.1975.20.2.0211; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; HARGRAVE BT, 1985, MAR ECOL PROG SER, V20, P221, DOI 10.3354/meps020221; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; HOUDE ED, 1993, ESTUARIES, V16, P161, DOI 10.2307/1352488; HOUDE ED, 1989, FISH B-NOAA, V87, P471; HUNTLEY ME, 1992, AM NAT, V140, P201, DOI 10.1086/285410; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; IVERSON RL, 1990, LIMNOL OCEANOGR, V35, P1593, DOI 10.4319/lo.1990.35.7.1593; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Jones R., 1982, THEORY MANAGEMENT TR, V9, P195; Kiorboe T, 1997, SCI MAR, V61, P141; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Legendre L, 1998, MAR ECOL PROG SER, V164, P1, DOI 10.3354/meps164001; Libralato S, 2008, MAR ECOL PROG SER, V355, P107, DOI 10.3354/meps07224; Link JS, 2009, PROG OCEANOGR, V81, P29, DOI 10.1016/j.pocean.2009.04.004; Link JS, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P98; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Marquis E, 2011, ICES J MAR SCI, V68, P803, DOI 10.1093/icesjms/fsr027; Megrey BA, 2009, PROG OCEANOGR, V81, P2, DOI 10.1016/j.pocean.2009.04.002; MELACK JM, 1976, T AM FISH SOC, V105, P575, DOI 10.1577/1548-8659(1976)105<575:PPAFYI>2.0.CO;2; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; MOREL A, 1989, LIMNOL OCEANOGR, V34, P1545, DOI 10.4319/lo.1989.34.8.1545; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; NIXON SW, 1988, LIMNOL OCEANOGR, V33, P1005, DOI 10.4319/lo.1988.33.4_part_2.1005; O'Brien TD, 2005, NMFSFSPO73 NOAA, V73; OGLESBY RT, 1977, J FISH RES BOARD CAN, V34, P2271, DOI 10.1139/f77-305; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2007, AMBIO, V36, P290, DOI 10.1579/0044-7447(2007)36[290:TSAUPD]2.0.CO;2; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Ramseier Rene O., 2000, Journal of Northwest Atlantic Fishery Science, V27, P35, DOI 10.2960/J.v27.a4; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Saba VS, 2011, BIOGEOSCIENCES, V8, P489, DOI 10.5194/bg-8-489-2011; Sathyendranath S, 2009, MAR ECOL PROG SER, V383, P73, DOI 10.3354/meps07998; Sherman K, 2009, AMBIO, V38, P215, DOI 10.1579/0044-7447-38.4.215; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Sokal R. R., 1981, BIOMETRY; Stock C, 2010, DEEP-SEA RES PT I, V57, P95, DOI 10.1016/j.dsr.2009.10.006; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Ware D, 2000, FISH OCEANOGR, P161; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; Wehrens R., 2007, PLS PARTIAL LEAST SQ; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141	70	159	165	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28945	10.1371/journal.pone.0028945	http://dx.doi.org/10.1371/journal.pone.0028945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276100	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100006
J	Saha, MN; Jiang, H; Yang, YJ; Zhu, XY; Wang, XM; Schimmer, AD; Qiu, LG; Chang, H				Saha, Manujendra N.; Jiang, Hua; Yang, Yijun; Zhu, Xiaoyun; Wang, Xiaoming; Schimmer, Aaron D.; Qiu, Lugui; Chang, Hong			Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; SMALL-MOLECULE RITA; N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASE; C-JUN; IN-VITRO; ANTIMYELOMA ACTIVITY; DEPENDENT APOPTOSIS; EFFICIENT APOPTOSIS; STRESS	The low frequency of p53 alterations e.g., mutations/deletions (similar to 10%) in multiple myeloma (MM) makes this tumor type an ideal candidate for p53-targeted therapies. RITA is a small molecule which can induce apoptosis in tumor cells by activating the p53 pathway. We previously showed that RITA strongly activates p53 while selectively inhibiting growth of MM cells without inducing genotoxicity, indicating its potential as a drug lead for p53-targeted therapy in MM. However, the molecular mechanisms underlying the pro-apoptotic effect of RITA are largely undefined. Gene expression analysis by microarray identified a significant number of differentially expressed genes associated with stress response including c-Jun N-terminal kinase (JNK) signaling pathway. By Western blot analysis we further confirmed that RITA induced activation of p53 in conjunction with up-regulation of phosphorylated ASK-1, MKK-4 and c-Jun. These results suggest that RITA induced the activation of JNK signaling. Chromatin immunoprecipitation (ChIP) analysis showed that activated c-Jun binds to the activator protein-1 (AP-1) binding site of the p53 promoter region. Disruption of the JNK signal pathway by small interfering RNA (siRNA) against JNK or JNK specific inhibitor, SP-600125 inhibited the activation of p53 and attenuated apoptosis induced by RITA in myeloma cells carrying wild type p53. On the other hand, p53 transcriptional inhibitor, PFT-alpha or p53 siRNA not only inhibited the activation of p53 transcriptional targets but also blocked the activation of c-Jun suggesting the presence of a positive feedback loop between p53 and JNK. In addition, RITA in combination with dexamethasone, known as a JNK activator, displays synergistic cytotoxic responses in MM cell lines and patient samples. Our study unveils a previously undescribed mechanism of RITA-induced p53-mediated apoptosis through JNK signaling pathway and provides the rationale for combination of p53 activating drugs with JNK activators in the treatment of MM.	[Saha, Manujendra N.; Yang, Yijun; Zhu, Xiaoyun; Chang, Hong] Toronto Gen Hosp, Res Inst, Div Mol & Cellular Biol, Toronto, ON, Canada; [Saha, Manujendra N.; Yang, Yijun; Zhu, Xiaoyun; Chang, Hong] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Jiang, Hua] Shanghai Jiao Tong Univ, Dept Hematol Oncol, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Wang, Xiaoming; Schimmer, Aaron D.] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Qiu, Lugui] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China; [Qiu, Lugui] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Qiu, Lugui] Peking Union Med Coll, Tianjin, Peoples R China; [Chang, Hong] Univ Hlth Network, Dept Lab Hematol & Med Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Shanghai Jiao Tong University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Saha, MN (corresponding author), Toronto Gen Hosp, Res Inst, Div Mol & Cellular Biol, Toronto, ON, Canada.	Hong.Chang@uhn.on.ca		Schimmer, Aaron/0000-0003-4023-3899	Canadian Institute of Health Research (CIHR); Leukemia and Lymphoma Society of Canada (LLSC); Cancer Research Society (CRS)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada (LLSC); Cancer Research Society (CRS)	This study is supported in part by the grants from Canadian Institute of Health Research (CIHR), Leukemia and Lymphoma Society of Canada (LLSC), and Cancer Research Society (CRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1997, P NATL ACAD SCI USA, V94, P1686, DOI 10.1073/pnas.94.5.1686; Anderson KC, 2005, SEMIN HEMATOL, V42, pS3, DOI 10.1053/j.seminhematol.2005.10.001; Avet-Loiseau H, 1999, BRIT J HAEMATOL, V106, P717, DOI 10.1046/j.1365-2141.1999.01615.x; Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Carew JS, 2008, CANCER RES, V68, P4783, DOI 10.1158/0008-5472.CAN-07-6483; Chang H, 2005, BLOOD, V105, P358, DOI 10.1182/blood-2004-04-1363; Chen LJ, 2010, BLOOD, V115, P61, DOI 10.1182/blood-2009-03-210526; Chng WJ, 2007, LEUKEMIA, V21, P582, DOI 10.1038/sj.leu.2404524; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Fan MY, 2001, CANCER RES, V61, P4450; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; GINSBERG D, 1990, ONCOGENE, V5, P1285; Grinkevich VV, 2009, CANCER CELL, V15, P441, DOI 10.1016/j.ccr.2009.03.021; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kobayashi T, 2010, LEUKEMIA, V24, P843, DOI 10.1038/leu.2010.25; Krajewski M, 2005, NAT MED, V11, P1135, DOI 10.1038/nm1105-1135; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; Nahi H, 2008, BRIT J HAEMATOL, V141, P445, DOI 10.1111/j.1365-2141.2008.07046.x; Raab MS, 2009, BLOOD, V113, P1513, DOI 10.1182/blood-2008-05-157040; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Saha MN, 2010, MOL CANCER THER, V9, P3041, DOI 10.1158/1535-7163.MCT-10-0471; Saha MN, 2010, CANCER BIOL THER, V9, P936, DOI 10.4161/cbt.9.11.11882; Saha MN, 2010, CANCER BIOL THER, V10, P567, DOI 10.4161/cbt.10.6.12535; Saha MN, 2010, J CLIN PATHOL, V63, P204, DOI 10.1136/jcp.2009.070961; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; She QB, 2002, ONCOGENE, V21, P1580, DOI 10.1038/sj.onc.1205239; Shimada K, 2003, CARCINOGENESIS, V24, P1067, DOI 10.1093/carcin/bgg058; Singh AV, 2011, BLOOD, V117, P5692, DOI 10.1182/blood-2010-12-323857; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Zhang H, 2002, J BIOL CHEM, V277, P43648, DOI 10.1074/jbc.M203214200; Zhang JP, 2000, CLIN EXP IMMUNOL, V122, P20, DOI 10.1046/j.1365-2249.2000.01344.x; Zhao CY, 2010, CANCER RES, V70, P3372, DOI 10.1158/0008-5472.CAN-09-2787; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	42	55	60	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30215	10.1371/journal.pone.0030215	http://dx.doi.org/10.1371/journal.pone.0030215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276160	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100026
J	Kotrschal, A; Rasanen, K; Kristjansson, BK; Senn, M; Kolm, N				Kotrschal, Alexander; Rasanen, Katja; Kristjansson, Bjarni K.; Senn, Mike; Kolm, Niclas			Extreme Sexual Brain Size Dimorphism in Sticklebacks: A Consequence of the Cognitive Challenges of Sex and Parenting?	PLOS ONE			English	Article							GASTEROSTEUS-ACULEATUS; MATE CHOICE; EVOLUTION; DIVERGENCE; SELECTION; SYSTEM; MORPHS	Selection pressures that act differently on males and females produce numerous differences between the sexes in morphology and behaviour. However, apart from the controversial report that males have slightly heavier brains than females in humans, evidence for substantial sexual dimorphism in brain size is scarce. This apparent sexual uniformity is surprising given that sexually distinct selection pressures are ubiquitous and that brains are one of the most plastic vertebrate organs. Here we demonstrate the highest level of sexual brain size dimorphism ever reported in any vertebrate: male three-spined stickleback of two morphs in an Icelandic lake have 23% heavier brains than females. We suggest that this dramatic sexual size dimorphism is generated by the many cognitively demanding challenges that males are faced in this species, such as an elaborate courtship display, the construction of an ornate nest and a male-only parental care system. However, we consider also alternative explanations for smaller brains in females, such as life-history trade-offs. Our demonstration of unprecedented levels of sexual dimorphism in brain size in the three-spined stickleback implies that behavioural and life-history differences among the sexes can have strong effects also on neural development and proposes new fields of research for understanding brain evolution.	[Kotrschal, Alexander; Kolm, Niclas] Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden; [Rasanen, Katja; Senn, Mike] Eawag, Dept Aquat Ecol, Zurich, Switzerland; [Rasanen, Katja; Senn, Mike] ETH, Inst Integrat Biol, Zurich, Switzerland; [Kristjansson, Bjarni K.] Holar Univ Coll, Dept Aquaculture & Fish Biol, Holar, Iceland	Uppsala University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Kotrschal, A (corresponding author), Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, Uppsala, Sweden.	alexander.kotrschal@ebc.uu.se	Kristjánsson, Bjarni K./B-4349-2013; Kotrschal, Alexander/ABB-8987-2021; Kotrschal, Alexander/AEV-1376-2022	Kristjánsson, Bjarni K./0000-0001-6984-5771; Kotrschal, Alexander/0000-0003-3473-1402; Rasanen, Katja/0000-0002-6293-2634; Kolm, Niclas/0000-0001-5791-336X	Swedish Research Council; Icelandic Research Council [090225022]; Carl Tryggers Foundation [CTS 09: 202]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Icelandic Research Council; Carl Tryggers Foundation	This work was funded through grants from the Swedish Research Council (2009-5157,www.vr.se) to NK and from the Icelandic Research Council to KR and BKK (090225022, www.rannis.is). AK was supported by a Carl Tryggers Foundation postdoctoral stipend (CTS 09: 202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Andersson Malte, 1994; Bakker TCM, 1999, NATURE, V401, P234, DOI 10.1038/45727; Bell A.M., 1994, EVOLUTIONARY BIOL TH; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Einarsson A, 2004, AQUAT ECOL, V38, P317, DOI 10.1023/B:AECO.0000032090.72702.a9; Forstmeier W, 2011, ANATOMICAL IN PRESS; Gahr M, 1994, DIFFERENCES SEXES; Garamszegi LZ, 2005, BEHAV ECOL, V16, P335, DOI 10.1093/beheco/arh167; Garamszegi LZ, 2005, P ROY SOC B-BIOL SCI, V272, P159, DOI 10.1098/rspb.2004.2940; Gislason GM, 1998, INT VER THEOR ANGEW, V26, P2244; GITTLEMAN JL, 1994, P NATL ACAD SCI USA, V91, P5495, DOI 10.1073/pnas.91.12.5495; Gonda A, 2009, J EVOLUTION BIOL, V22, P1721, DOI 10.1111/j.1420-9101.2009.01782.x; Gonzalez-Voyer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014355; Gonzalez-Voyer A, 2009, P ROY SOC B-BIOL SCI, V276, P161, DOI 10.1098/rspb.2008.0979; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Iwaniuk AN, 2001, CAN J ZOOL, V79, P759, DOI 10.1139/cjz-79-5-759; Jacobs LF, 1996, TRENDS ECOL EVOL, V11, pA82; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; Kristjansson BK, 2002, BIOL J LINN SOC, V76, P247, DOI 10.1046/j.1095-8312.2002.00063.x; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; Maklakov AA, 2011, BIOL LETTERS, V7, P730, DOI 10.1098/rsbl.2011.0341; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; MILINSKI M, 1992, P ROY SOC B-BIOL SCI, V250, P229, DOI 10.1098/rspb.1992.0153; Olafsdottir GA, 2007, J EVOLUTION BIOL, V20, P1870, DOI 10.1111/j.1420-9101.2007.01375.x; Olafsdottir GA, 2006, BIOL LETTERS, V2, P250, DOI 10.1098/rsbl.2006.0456; Pakkenberg H, 1964, ACTA ANATOMICA, P56; Park PJ, 2010, J EVOLUTION BIOL, V23, P1261, DOI 10.1111/j.1420-9101.2010.01987.x; Pitnick S, 2006, P ROY SOC B-BIOL SCI, V273, P719, DOI 10.1098/rspb.2005.3367; SCHLUTER D, 1992, NATURE, V359, P181, DOI 10.1038/359181a0; Senn M, 2010, THESIS U ZURICH SWIT; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Titschack E, 1921, ZOOLOGISCHE JB ABTEI, V39, P83; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696	37	51	51	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30055	10.1371/journal.pone.0030055	http://dx.doi.org/10.1371/journal.pone.0030055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276144	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200030
J	Rueda, CM; Velilla, PA; Chougnet, CA; Montoya, CJ; Rugeles, MT				Mauricio Rueda, Cesar; Andrea Velilla, Paula; Chougnet, Claire A.; Julio Montoya, Carlos; Teresa Rugeles, Maria			HIV-Induced T-Cell Activation/Exhaustion in Rectal Mucosa Is Controlled Only Partially by Antiretroviral Treatment	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EXPRESS HIGH-LEVELS; MICROBIAL TRANSLOCATION; INFECTED PATIENTS; INDOLEAMINE 2,3-DIOXYGENASE; DISEASE PROGRESSION; IMMUNE RESTORATION; VIRAL SUPPRESSION; PD-1 EXPRESSION; DENDRITIC CELLS	Peripheral blood T-cells from untreated HIV-1-infected patients exhibit reduced immune responses, usually associated with a hyperactivated/exhausted phenotype compared to HAART treated patients. However, it is not clear whether HAART ameliorates this altered phenotype of T-cells in the gastrointestinal-associated lymphoid tissue (GALT), the main site for viral replication. Here, we compared T-cells from peripheral blood and GALT of two groups of chronically HIV-1-infected patients: untreated patients with active viral replication, and patients on suppressive HAART. We characterized the T-cell phenotype by measuring PD-1, CTLA-4, HLA-DR, CD25, Foxp3 and granzyme A expression by flow cytometry; mRNA expression of T-bet, GATA-3, ROR-gamma t and Foxp3, and was also evaluated in peripheral blood mononuclear cells and rectal lymphoid cells. In HIV-1+ patients, the frequency of PD-1(+) and CTLA-4(+) T-cells (both CD4+ and CD8+ T cells) was higher in the GALT than in the blood. The expression of PD-1 by T-cells from GALT was higher in HIV-1-infected subjects with active viral replication compared to controls. Moreover, the expression per cell of PD-1 and CTLA-4 in CD4(+) T-cells from blood and GALT was positively correlated with viral load. HAART treatment decreased the expression of CTLA-4 in CD8(+) T cells from blood and GALT to levels similar as those observed in controls. Frequency of Granzyme A(+) CD8(+) T-cells in both tissues was low in the untreated group, compared to controls and HAART-treated patients. Finally, a switch towards Treg polarization was found in untreated patients, in both tissues. Together, these findings suggest that chronic HIV-1 infection results in an activated/exhausted T-cell phenotype, despite T-cell polarization towards a regulatory profile; these alterations are more pronounced in the GALT compared to peripheral blood, and are only partiality modulated by HAART.	[Mauricio Rueda, Cesar; Andrea Velilla, Paula; Julio Montoya, Carlos; Teresa Rugeles, Maria] Univ Antioquia, Grp Inmunovirol, Medellin, Antioquia, Colombia; [Chougnet, Claire A.] Univ Cincinnati, Coll Med, Dept Pediat, Div Mol Immunol,Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH USA	Universidad de Antioquia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Rueda, CM (corresponding author), Univ Antioquia, Grp Inmunovirol, Medellin, Antioquia, Colombia.	mtrugel@udea.edu.co		Velilla, Paula A/0000-0003-0885-1320	Colciencias [111540820490-1]; Vicerrectoria de Investigaciones, Universidad de Antioquia, Medellin, Colombia; National Institutes of Health [R01 AI068524]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068524] Funding Source: NIH RePORTER	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Vicerrectoria de Investigaciones, Universidad de Antioquia, Medellin, Colombia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Colciencias (grant 111540820490-1), Programa de Sostenibilidad 2011-2012 (Vicerrectoria de Investigaciones, Universidad de Antioquia, Medellin, Colombia) and National Institutes of Health R01 AI068524 (to CAC). CMR is a recipient of a doctoral scholarship. The funders had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Aiuti F, 2006, AIDS REV, V8, P88; Andersson J, 1999, AIDS, V13, P1295, DOI 10.1097/00002030-199907300-00005; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beriou G, 2009, BLOOD, V113, P4240, DOI 10.1182/blood-2008-10-183251; Boasso A, 2005, BLOOD, V105, P1574, DOI 10.1182/blood-2004-06-2089; Brandt L, 2011, JAIDS-J ACQ IMM DEF, V57, P101, DOI 10.1097/QAI.0b013e318215a991; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Che KF, 2010, EUR J IMMUNOL, V40, P2248, DOI 10.1002/eji.201040377; Chege D, 2011, AIDS, V25, P741, DOI 10.1097/QAD.0b013e328344cefb; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; D'Souza M, 2007, J IMMUNOL, V179, P1979, DOI 10.4049/jimmunol.179.3.1979; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Eggena MP, 2005, J INFECT DIS, V191, P694, DOI 10.1086/427516; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Ito T, 2005, J IMMUNOL, V174, P6648, DOI 10.4049/jimmunol.174.11.6648; Jansen CA, 2005, AIDS, V19, P1145, DOI 10.1097/01.aids.0000176214.17990.94; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Muthumani K, 2008, J VIROL, V82, P11536, DOI 10.1128/JVI.00485-08; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Park MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2361; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Roberts T, 2007, J INFECT DIS, V195, P870, DOI 10.1086/511277; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Salgado M, 2011, CLIN IMMUNOL, V139, P110, DOI 10.1016/j.clim.2011.02.008; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Shacklett BL, 2004, J IMMUNOL, V173, P641, DOI 10.4049/jimmunol.173.1.641; Shaw JM, 2011, J VIROL, V85, P11422, DOI 10.1128/JVI.05608-11; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Yang OO, 2005, VIROLOGY, V332, P16, DOI 10.1016/j.virol.2004.11.028; Yu G, 2008, TRANSPL IMMUNOL, V18, P208, DOI 10.1016/j.trim.2007.08.006; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791	55	45	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30307	10.1371/journal.pone.0030307	http://dx.doi.org/10.1371/journal.pone.0030307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276176	Green Submitted, Green Published, gold			2022-12-25	WOS:000301457200053
J	Dolegowska, B; Blogowski, W; Domanski, L				Dolegowska, Barbara; Blogowski, Wojciech; Domanski, Leszek			Association between the Perioperative Antioxidative Ability of Platelets and Early Post-Transplant Function of Kidney Allografts: A Pilot Study	PLOS ONE			English	Article							REPERFUSION INJURY; ACTIVATION; EXPRESSION; MARKERS; PREDICT	Background: Recent studies have demonstrated that the actions of platelets may unfavorably influence post-transplant function of organ allografts. In this study, the association between post-transplant graft function and the perioperative activity of platelet antioxidants was examined among kidney recipients divided into early (EGF), slow (SGF), and delayed graft function (DGF) groups. Methodology/Principal Findings: Activities of superoxide dismutase, catalase, glutathione transferase (GST), glutathione peroxidase, and glucose-6-phosphate dehydrogenase (G6P) were determined and levels of glutathione, oxidized glutathione, and isoprostane were measured in blood samples collected immediately before and during the first and fifth minutes of renal allograft reperfusion. Our results demonstrated a significant increase in isoprostane levels in all groups. Interestingly, in DGF patients, significantly lower levels of perioperative activity of catalase (p < 0.02) and GST (p < 0.02) were observed. Moreover, in our study, the activity of platelet antioxidants was associated with intensity of perioperative oxidative stress. For discriminating SGF/DGF from EGF, sensitivity, specificity, and positive and negative predictive values of platelet antioxidants were 81-91%, 50-58%, 32-37%, and 90-90.5%, respectively. Conclusions: During renal transplantation, significant changes occur in the activity of platelet antioxidants. These changes seem to be associated with post-transplant graft function and can be potentially used to differentiate between EGF and SGF/DGF. To the best of our knowledge, this is the first study to reveal the potential protective role of platelets in the human transplantation setting.	[Dolegowska, Barbara; Blogowski, Wojciech] Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, Szczecin, Poland; [Domanski, Leszek] Pomeranian Med Univ, Dept Nephrol Transplantat & Internal Med, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University	Dolegowska, B (corresponding author), Pomeranian Med Univ, Dept Lab Diagnost & Mol Med, Szczecin, Poland.	drannab@wp.pl	Dolegowska, Barbara/O-4851-2014; Domanski, Leszek LD/P-1621-2014	Dolegowska, Barbara/0000-0003-3138-1013; Domanski, Leszek LD/0000-0002-4712-7821				Dolegowska B, 2010, NEPHROL DIAL TRANSPL, V25, P4061, DOI 10.1093/ndt/gfq320; Dolegowska B, 2010, J AM COLL SURGEONS, V211, P587, DOI 10.1016/j.jamcollsurg.2010.06.391; Dolegowska B, 2009, CLIN TRANSPLANT, V23, P716, DOI 10.1111/j.1399-0012.2009.00983.x; Dolegowska B, 2009, TRANSPL INT, V22, P546, DOI 10.1111/j.1432-2277.2008.00829.x; Dolegowska B, 2009, PLATELETS, V20, P242, DOI 10.1080/09537100902849836; Domanski L, 2006, TRANSPL P, V38, P35, DOI 10.1016/j.transproceed.2005.11.083; ECHLER G, 1983, AM J MED TECHNOL, V49, P259; Esch JSA, 2010, PLATELETS, V21, P348, DOI 10.3109/09537101003739897; Freedman JE, 2008, ARTERIOSCL THROM VAS, V28, pS11, DOI 10.1161/ATVBAHA.107.159178; Godin N, 2010, KIDNEY INT, V77, P1086, DOI 10.1038/ki.2010.63; Hariharan N, 2011, ANTIOXID REDOX SIGN, V14, P2179, DOI 10.1089/ars.2010.3488; Juttner B, 2009, THROMB RES, V124, P433, DOI 10.1016/j.thromres.2009.06.011; Kirk AD, 2009, AM J TRANSPLANT, V9, P14, DOI 10.1111/j.1600-6143.2008.02473.x; Kitamura M, 2008, CLIN EXP NEPHROL, V12, P317, DOI 10.1007/s10157-008-0060-7; Kosieradzki M, 2003, TRANSPLANTATION, V75, P1221, DOI 10.1097/01.TP.0000065282.46425.87; Kwiatkowski S, 2009, BIOMARKERS, V14, P406, DOI 10.1080/13547500903045583; Lee DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022360; Martel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018812; Moreno JM, 2010, J PHYSIOL PHARMACOL, V61, P325; Morrell CN, 2007, AM J TRANSPLANT, V7, P2447, DOI 10.1111/j.1600-6143.2007.01958.x; Pacchiarini L, 1996, HAEMATOLOGICA, V81, P497; Pandey NR, 2000, INT J CARDIOL, V76, P33, DOI 10.1016/S0167-5273(00)00344-2; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Reid TJ, 1999, TRANSFUSION, V39, P616, DOI 10.1046/j.1537-2995.1999.39060616.x; Renner B, 2010, J IMMUNOL, V185, P4393, DOI 10.4049/jimmunol.0903239; Rothwell SW, 2000, TRANSFUSION, V40, P988, DOI 10.1046/j.1537-2995.2000.40080988.x; Schroppel B, 2010, J AM SOC NEPHROL, V21, P536, DOI 10.1681/ASN.2009040390; Shaheen MF, 2010, TRANSPL P, V42, P273, DOI 10.1016/j.transproceed.2009.12.052; Shapiro MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023011; Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x; Sternberg DI, 2008, J THORAC CARDIOV SUR, V135, P679, DOI 10.1016/j.jtcvs.2007.09.058; Tahara M, 2005, TRANSPLANTATION, V80, P213, DOI 10.1097/01.TP.0000165092.07375.C9; Wachowicz B, 2002, PLATELETS, V13, P175, DOI 10.1080/09533710022149395; Xu H, 2006, J CLIN INVEST, V116, P769, DOI 10.1172/JCI27155; Yuan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025811; Zynek-Litwin M, 2010, NEPHROL DIAL TRANSPL, V25, P2346, DOI 10.1093/ndt/gfq041	36	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29779	10.1371/journal.pone.0029779	http://dx.doi.org/10.1371/journal.pone.0029779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279544	gold, Green Published, Green Submitted			2022-12-25	WOS:000299771900022
J	Pan, N; Jahan, I; Kersigo, J; Duncan, JS; Kopecky, B; Fritzsch, B				Pan, Ning; Jahan, Israt; Kersigo, Jennifer; Duncan, Jeremy S.; Kopecky, Benjamin; Fritzsch, Bernd			A Novel Atoh1 "Self-Terminating" Mouse Model Reveals the Necessity of Proper Atoh1 Level and Duration for Hair Cell Differentiation and Viability	PLOS ONE			English	Article							INNER-EAR MORPHOGENESIS; SENSORY EPITHELIA; MOLECULAR-BASIS; NULL MICE; MATH1; EXPRESSION; HEARING; GENE; SURVIVAL; FATE	Atonal homolog1 (Atoh1) is a bHLH transcription factor essential for inner ear hair cell differentiation. Targeted expression of Atoh1 at various stages in development can result in hair cell differentiation in the ear. However, the level and duration of Atoh1 expression required for proper hair cell differentiation and maintenance remain unknown. We generated an Atoh1 conditional knockout (CKO) mouse line using Tg(Atoh1-cre), in which the cre expression is driven by an Atoh1 enhancer element that is regulated by Atoh1 protein to "self-terminate'' its expression. The mutant mice show transient, limited expression of Atoh1 in all hair cells in the ear. In the organ of Corti, reduction and delayed deletion of Atoh1 result in progressive loss of almost all the inner hair cells and the majority of the outer hair cells within three weeks after birth. The remaining cells express hair cell marker Myo7a and attract nerve fibers, but do not differentiate normal stereocilia bundles. Some Myo7a-positive cells persist in the cochlea into adult stages in the position of outer hair cells, flanked by a single row of pillar cells and two to three rows of disorganized Deiters cells. Gene expression analyses of Atoh1, Barhl1 and Pou4f3, genes required for survival and maturation of hair cells, reveal earlier and higher expression levels in the inner compared to the outer hair cells. Our data show that Atoh1 is crucial for hair cell mechanotransduction development, viability, and maintenance and also suggest that Atoh1 expression level and duration may play a role in inner vs. outer hair cell development. These genetically engineered Atoh1 CKO mice provide a novel model for establishing critical conditions needed to regenerate viable and functional hair cells with Atoh1 therapy.	[Pan, Ning; Jahan, Israt; Kersigo, Jennifer; Duncan, Jeremy S.; Kopecky, Benjamin; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Pan, N (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	ning-pan@uiowa.edu; bernd-fritzsch@uiowa.edu	Duncan, Jeremy/E-8176-2013; Duncan, Jeremy/K-7230-2013	Fritzsch, Bernd/0000-0002-4882-8398; Duncan, Jeremy/0000-0002-5555-3273	NIH [R01 DC 005590, P30 DC 010362]; Office of the Vice President for Research; College of Liberal Arts & Sciences at the University of Iowa; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590, P30DC010362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research; College of Liberal Arts & Sciences at the University of Iowa; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants R01 DC 005590 (to B. F.) and P30 DC 010362 (http://www.nidcd.nih.gov). The authors also acknowledge the support from the Office of the Vice President for Research (https://research.uiowa.edu/ovpr/office-vp-research) and College of Liberal Arts & Sciences (http://www.clas.uiowa.edu) at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyantseva IA, 2003, TRENDS MOL MED, V9, P458, DOI 10.1016/j.molmed.2003.09.008; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Bouchard M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-89; Chellappa R, 2008, MOL CELL BIOL, V28, P1905, DOI 10.1128/MCB.01454-07; Chen P, 2002, DEVELOPMENT, V129, P2495; Christophorou NAD, 2010, DEV BIOL, V345, P180, DOI 10.1016/j.ydbio.2010.07.007; Cotanche DA, 2010, HEARING RES, V266, P18, DOI 10.1016/j.heares.2010.04.012; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Duncan J, 2011, JOVE-J VIS EXP, DOI 10.3791/2451; Duncan JS, 2011, INT J DEV BIOL, V55, P297, DOI 10.1387/ijdb.103178jd; Friedman TB, 1999, AM J MED GENET, V89, P147, DOI 10.1002/(SICI)1096-8628(19990924)89:3<147::AID-AJMG5>3.0.CO;2-6; Fritzsch B, 2004, PROG BRAIN RES, V146, P265, DOI 10.1016/S0079-6123(03)46017-2; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Fritzsch B, 2011, HEARING RES, V276, P16, DOI 10.1016/j.heares.2011.01.007; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Helms AW, 2000, DEVELOPMENT, V127, P1185; Hertzano R, 2004, HUM MOL GENET, V13, P2143, DOI 10.1093/hmg/ddh218; Hildebrand MS, 2008, MOL THER, V16, P224, DOI 10.1038/sj.mt.6300351; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Izumikawa M, 2008, HEARING RES, V240, P52, DOI 10.1016/j.heares.2008.02.007; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jahan I, 2010, CELL TISSUE RES, V341, P95, DOI 10.1007/s00441-010-0984-6; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Kopecky B, 2011, PHARMACEUTICALS, V4, P848, DOI 10.3390/ph4060848; Krijnen PAJ, 2010, J MOL CELL CARDIOL, V49, P781, DOI 10.1016/j.yjmcc.2010.07.017; Li SG, 2002, DEVELOPMENT, V129, P3523; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Pan N, 2009, CELL TISSUE RES, V337, P407, DOI 10.1007/s00441-009-0826-6; Pauley S, 2008, PANMINERVA MED, V50, P41; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Poirrier AL, 2010, TOXICOL LETT, V193, P41, DOI 10.1016/j.toxlet.2009.12.003; Praetorius M, 2010, ACTA OTO-LARYNGOL, V130, P215, DOI 10.3109/00016480903019251; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Schlosser G, 2010, INT REV CEL MOL BIO, V283, P129, DOI 10.1016/S1937-6448(10)83004-7; Sciarretta C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-103; Sekerkova G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002032; Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Xiang MQ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-2; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zou D, 2008, HUM MOL GENET, V17, P3340, DOI 10.1093/hmg/ddn229	53	85	92	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30358	10.1371/journal.pone.0030358	http://dx.doi.org/10.1371/journal.pone.0030358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279587	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900064
J	Collett, GP; Goh, XF; Linton, EA; Redman, CWG; Sargent, IL				Collett, Gavin P.; Goh, Xue Fang; Linton, Elizabeth A.; Redman, Christopher W. G.; Sargent, Ian L.			RhoE Is Regulated by Cyclic AMP and Promotes Fusion of Human BeWo Choriocarcinoma Cells	PLOS ONE			English	Article							HUMAN TROPHOBLASTIC CELLS; SYNCYTIAL FUSION; EXPRESSION; DIFFERENTIATION; APOPTOSIS; TRANSCRIPTION; PROTEINS; PLACENTA; RECEPTOR; GCM1	Fusion of placental villous cytotrophoblasts with the overlying syncytiotrophoblast is essential for the maintenance of successful pregnancy, and disturbances in this process have been implicated in pathological conditions such as pre-eclampsia and intra-uterine growth retardation. In this study we examined the role of the Rho GTPase family member RhoE in trophoblast differentiation and fusion using the BeWo choriocarcinoma cell line, a model of villous cytotrophoblast fusion. Treatment of BeWo cells with the cell permeable cyclic AMP analogue dibutyryl cyclic AMP (dbcAMP) resulted in a strong upregulation of RhoE at 24h, coinciding with the onset of fusion. Using the protein kinase A (PKA)-specific cAMP analogue N-6-phenyl-cAMP, and a specific inhibitor of PKA (14-22 amide, PKI), we found that upregulation of RhoE by cAMP was mediated through activation of PKA signalling. Silencing of RhoE expression by RNA interference resulted in a significant decrease in dbcAMP-induced fusion. However, expression of differentiation markers human chorionic gonadotrophin and placental alkaline phosphatase was unaffected by RhoE silencing. Finally, we found that RhoE upregulation by dbcAMP was significantly reduced under hypoxic conditions in which cell fusion is impaired. These results show that induction of RhoE by cAMP is mediated through PKA and promotes BeWo cell fusion but has no effect on functional differentiation, supporting evidence that these two processes may be controlled by separate or diverging pathways.	[Collett, Gavin P.; Goh, Xue Fang; Linton, Elizabeth A.; Redman, Christopher W. G.; Sargent, Ian L.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Oxford	Collett, GP (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	Gavin.Collett@obs-gyn.ox.ac.uk			Wellcome Trust [GR079862MA]; MRC [MR/J003360/1] Funding Source: UKRI; Medical Research Council [MR/J003360/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, programme grant no. GR079862MA (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; Benirschke K., 2000, PATHOLOGY HUMAN PLAC; Boswell SA, 2007, J BIOL CHEM, V282, P4850, DOI 10.1074/jbc.M610532200; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Chang CW, 2005, MOL CELL BIOL, V25, P8401, DOI 10.1128/MCB.25.19.8401-8414.2005; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Chiang MH, 2009, J BIOL CHEM, V284, P17411, DOI 10.1074/jbc.M109.016170; Collett GP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010529; Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Getsios S, 2003, DEV BIOL, V257, P41, DOI 10.1016/S0012-1606(03)00041-1; Han J, 2010, ENDOCRINOLOGY, V151, P1732, DOI 10.1210/en.2009-0845; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Keryer G, 1998, J CELL SCI, V111, P995; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Kudo Y, 2003, BBA-MOL BASIS DIS, V1638, P63, DOI 10.1016/S0925-4439(03)00043-7; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Liebig T, 2009, MOL BIOL CELL, V20, P452, DOI 10.1091/mbc.E07-11-1197; Lin L, 1999, PLACENTA, V20, P109, DOI 10.1053/plac.1998.0337; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; MIDGLEY AR, 1963, SCIENCE, V141, P349, DOI 10.1126/science.141.3578.349; Muroi Y, 2009, REPRODUCTION, V138, P945, DOI 10.1530/REP-09-0082; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Orendi K, 2010, REPRODUCTION, V140, P759, DOI 10.1530/REP-10-0221; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Rashid-Doubell F, 2007, PLACENTA, V28, P139, DOI 10.1016/j.placenta.2005.12.005; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Robinson JM, 2009, BIOL REPROD, V81, P33, DOI 10.1095/biolreprod.108.074591; Rote NS, 2004, PLACENTA, V25, P673, DOI 10.1016/j.placenta.2004.02.008; Ruebner M, 2010, J MOL MED, V88, P1143, DOI 10.1007/s00109-010-0656-8; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schubert SW, 2008, NUCLEIC ACIDS RES, V36, P3834, DOI 10.1093/nar/gkn306; Shimomura A, 2009, J VET MED SCI, V71, P1591, DOI 10.1292/jvms.001591; Shurin GV, 2008, J IMMUNOTHER, V31, P491, DOI 10.1097/CJI.0b013e318176fae4; Talens-Visconti R, 2010, J NEUROCHEM, V112, P1074, DOI 10.1111/j.1471-4159.2009.06526.x; Tannetta DS, 2008, PLACENTA, V29, P680, DOI 10.1016/j.placenta.2008.04.009; Vargas A, 2008, PLACENTA, V29, P170, DOI 10.1016/j.placenta.2007.10.012; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	48	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30453	10.1371/journal.pone.0030453	http://dx.doi.org/10.1371/journal.pone.0030453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272352	Green Submitted, gold, Green Published			2022-12-25	WOS:000301454400130
J	Nzounza, P; Chazal, M; Guedj, C; Schmitt, A; Masse, JM; Randriamampita, C; Pique, C; Ramirez, BC				Nzounza, Patrycja; Chazal, Maxime; Guedj, Chloe; Schmitt, Alain; Masse, Jean-Marc; Randriamampita, Clotilde; Pique, Claudine; Ramirez, Bertha Cecilia			The Scaffolding Protein Dlg1 Is a Negative Regulator of Cell-Free Virus Infectivity but Not of Cell-to-Cell HIV-1 Transmission in T Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS; IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; VIROLOGICAL SYNAPSES; IMMUNE SYNAPSE; TYPE-1; SPREAD; LYMPHOCYTES; MACROPHAGES; ENV	Background: Cell-to-cell virus transmission of Human immunodeficiency virus type-1 (HIV-1) is predominantly mediated by cellular structures such as the virological synapse (VS). The VS formed between an HIV-1-infected T cell and a target T cell shares features with the immunological synapse (IS). We have previously identified the human homologue of the Drosophila Discs Large (Dlg1) protein as a new cellular partner for the HIV-1 Gag protein and a negative regulator of HIV-1 infectivity. Dlg1, a scaffolding protein plays a key role in clustering protein complexes in the plasma membrane at cellular contacts. It is implicated in IS formation and T cell signaling, but its role in HIV-1 cell-to-cell transmission was not studied before. Methodology/Principal Findings: Kinetics of HIV-1 infection in Dlg1-depleted Jurkat T cells show that Dlg1 modulates the replication of HIV-1. Single-cycle infectivity tests show that this modulation does not take place during early steps of the HIV-1 life cycle. Immunofluorescence studies of Dlg1-depleted Jurkat T cells show that while Dlg1 depletion affects IS formation, it does not affect HIV-1-induced VS formation. Co-culture assays and quantitative cell-to-cell HIV-1 transfer analyses show that Dlg1 depletion does not modify transfer of HIV-1 material from infected to target T cells, or HIV-1 transmission leading to productive infection via cell contact. Dlg1 depletion results in increased virus yield and infectivity of the viral particles produced. Particles with increased infectivity present an increase in their cholesterol content and during the first hours of T cell infection these particles induce higher accumulation of total HIV-1 DNA. Conclusion: Despite its role in the IS formation, Dlg1 does not affect the VS and cell-to-cell spread of HIV-1, but plays a role in HIV-1 cell-free virus transmission. We propose that the effect of Dlg1 on HIV-1 infectivity is at the stage of virus entry.	[Nzounza, Patrycja; Chazal, Maxime; Guedj, Chloe; Schmitt, Alain; Masse, Jean-Marc; Randriamampita, Clotilde; Pique, Claudine; Ramirez, Bertha Cecilia] Inst Cochin, INSERM, U1016, Paris, France; [Nzounza, Patrycja; Chazal, Maxime; Guedj, Chloe; Schmitt, Alain; Masse, Jean-Marc; Randriamampita, Clotilde; Pique, Claudine; Ramirez, Bertha Cecilia] CNRS, UMR8104, Paris, France; [Nzounza, Patrycja; Chazal, Maxime; Guedj, Chloe; Schmitt, Alain; Masse, Jean-Marc; Randriamampita, Clotilde; Pique, Claudine; Ramirez, Bertha Cecilia] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Nzounza, P (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.	cecilia.ramirez@inserm.fr	sourisseau, marion/M-7542-2014; RAMIREZ, Cecilia/O-6100-2017; Pique, Claudine/O-6088-2017	RAMIREZ, Cecilia/0000-0002-6670-9827; Pique, Claudine/0000-0001-8690-2440; Randriamampita, Clotilde/0000-0001-8594-7831; CHAZAL, Maxime/0000-0002-3144-5032	SIDACTION; Agence Nationale de Recherche contre le SIDA (ANRS); Institut Cochin; French Ministere de la Recherche et la Technologie (MRT)	SIDACTION; Agence Nationale de Recherche contre le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Institut Cochin; French Ministere de la Recherche et la Technologie (MRT)	This study was supported by grants from SIDACTION, the Agence Nationale de Recherche contre le SIDA (ANRS) and from the Institut Cochin. PN is supported by a fellowship from the French Ministere de la Recherche et la Technologie (MRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfsen A, 2005, MOL BIOL CELL, V16, P4267, DOI 10.1091/mbc.E05-03-0192; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Blot V, 2004, J CELL SCI, V117, P3983, DOI 10.1242/jcs.01266; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Brussel A, 2004, J VIROL, V78, P11263, DOI 10.1128/JVI.78.20.11263-11271.2004; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Del Portillo A, 2011, J VIROL, V85, P7169, DOI 10.1128/JVI.00231-11; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Freed EO, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-77; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Fujii K, 2009, VIROLOGY, V391, P284, DOI 10.1016/j.virol.2009.06.016; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Hanada T, 1997, J BIOL CHEM, V272, P26899, DOI 10.1074/jbc.272.43.26899; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2004, TRAFFIC, V5, P643, DOI 10.1111/j.1600-0854.2004.00209.X; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Martin-Cofreces NB, 2008, J CELL BIOL, V182, P951, DOI 10.1083/jcb.200801014; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Morrow MP, 2010, MOL PHARMACOL, V78, P215, DOI 10.1124/mol.110.065029; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Nieva JL, 2011, J MOL RECOGNIT, V24, P642, DOI 10.1002/jmr.1092; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Ott DE, 2008, REV MED VIROL, V18, P159, DOI 10.1002/rmv.570; Perugi F, 2009, MOL BIOL CELL, V20, P498, DOI 10.1091/mbc.E08-02-0189; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Saez-Cirion A, 2002, J BIOL CHEM, V277, P21776, DOI 10.1074/jbc.M202255200; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Stephenson ST, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-107; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Vasiliver-Shamis G, 2010, VIRUSES-BASEL, V2, P1239, DOI 10.3390/v2051239; VONBRUNN A, 1993, VACCINE, V11, P817, DOI 10.1016/0264-410X(93)90356-3; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004	62	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30130	10.1371/journal.pone.0030130	http://dx.doi.org/10.1371/journal.pone.0030130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272285	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400063
J	Schoennagel, T; Veblen, TT; Negron, JF; Smith, JM				Schoennagel, Tania; Veblen, Thomas T.; Negron, Jose F.; Smith, Jeremy M.			Effects of Mountain Pine Beetle on Fuels and Expected Fire Behavior in Lodgepole Pine Forests, Colorado, USA	PLOS ONE			English	Article							SUB-ALPINE FOREST; CROWN FIRE; STAND CHARACTERISTICS; CONIFEROUS FORESTS; WESTERN; SEVERITY; CLIMATE; VARIABILITY; MANAGEMENT; OUTBREAKS	In Colorado and southern Wyoming, mountain pine beetle (MPB) has affected over 1.6 million ha of predominantly lodgepole pine forests, raising concerns about effects of MPB-caused mortality on subsequent wildfire risk and behavior. Using empirical data we modeled potential fire behavior across a gradient of wind speeds and moisture scenarios in Green stands compared three stages since MPB attack (Red [1-3 yrs], Grey [4-10 yrs], and Old-MPB [similar to 30 yrs]). MPB killed 50% of the trees and 70% of the basal area in Red and Grey stages. Across moisture scenarios, canopy fuel moisture was one-third lower in Red and Grey stages compared to the Green stage, making active crown fire possible at lower wind speeds and less extreme moisture conditions. More-open canopies and high loads of large surface fuels due to treefall in Grey and Old-MPB stages significantly increased surface fireline intensities, facilitating active crown fire at lower wind speeds (>30-55 km/hr) across all moisture scenarios. Not accounting for low foliar moistures in Red and Grey stages, and large surface fuels in Grey and Old-MPB stages, underestimates the occurrence of active crown fire. Under extreme burning conditions, minimum wind speeds for active crown fire were 25-35 km/hr lower for Red, Grey and Old-MPB stands compared to Green. However, if transition to crown fire occurs (outside the stand, or within the stand via ladder fuels or wind gusts >65 km/hr), active crown fire would be sustained at similar wind speeds, suggesting observed fire behavior may not be qualitatively different among MPB stages under extreme burning conditions. Overall, the risk (probability) of active crown fire appears elevated in MPB-affected stands, but the predominant fire hazard (crown fire) is similar across MPB stages and is characteristic of lodgepole pine forests where extremely dry, gusty weather conditions are key factors in determining fire behavior.	[Schoennagel, Tania] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Schoennagel, Tania; Veblen, Thomas T.; Smith, Jeremy M.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Negron, Jose F.] US Forest Serv, Rocky Mt Res Stn, Ft Collins, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; United States Department of Agriculture (USDA); United States Forest Service	Schoennagel, T (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	tschoe@colorado.edu	Veblen, Thomas T./U-6461-2018; negron, jose/AAE-1935-2020		National Science Foundation [0743498]; Office Of Internatl Science &Engineering [0966472] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Science Foundation (grant # 0743498): www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini FA, 1997, INT J WILDLAND FIRE, V7, P21, DOI 10.1071/WF9970021; Andrews P.A., 2008, RMRSGTR106 US DEP AG; Bebi P, 2003, ECOLOGY, V84, P362, DOI 10.1890/0012-9658(2003)084[0362:IBFASB]2.0.CO;2; Bigler C, 2005, ECOLOGY, V86, P3018, DOI 10.1890/05-0011; Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Bigler C, 2011, CAN J FOREST RES, V41, P331, DOI 10.1139/X10-217; Brown J. K., 1978, USDA Forest Service Research Paper, Intermountain Forest and Range Experiment Station; Brown J.K., 1982, INT129 USDA FOR SERV; Brown J.K., 1974, INT16 USDA FOR SER; BROWN JK, 2003, RMRSGTR105 US FOR SE; Buma B, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00038.1; Byram G.M., 1959, FOREST FIRE CONTROL, P61; Campbell EM, 2007, J INTEGR PLANT BIOL, V49, P168, DOI 10.1111/j.1744-7909.2007.00423.x; Carroll AL, 2004, PACIF FOR C, V399, P223; Cruz MG, 2010, INT J WILDLAND FIRE, V19, P377, DOI 10.1071/WF08132; Derose RJ, 2009, ECOSCIENCE, V16, P28, DOI 10.2980/16-1-3160; Duncan RP, 1989, NEW ZEALAND NATURAL, V16; Eisenhart KS, 2000, CAN J FOREST RES, V30, P1788, DOI 10.1139/cjfr-30-11-1788; Fettig CJ, 2007, FOREST ECOL MANAG, V238, P24, DOI 10.1016/j.foreco.2006.10.011; Gibson Ken, 2009, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P51; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Gude P, 2008, J FOREST, V106, P198; Hartford R. A., 1992, International Journal of Wildland Fire, V2, P139, DOI 10.1071/WF9920139; Hirsch KG, 1999, P JOINT FIR SCI C WO, P251; Hoffman C.M., 2011, THESIS U IDAHO; Jenkins MJ, 2008, FOREST ECOL MANAG, V254, P16, DOI 10.1016/j.foreco.2007.09.045; Jolly WM, MOUNTAIN PINE BEETLE; Kashian DM, 2005, ECOLOGY, V86, P643, DOI 10.1890/03-0828; Klutsch JG, 2011, WEST J APPL FOR, V26, P101, DOI 10.1093/wjaf/26.3.101; Klutsch JG, 2009, FOREST ECOL MANAG, V258, P641, DOI 10.1016/j.foreco.2009.04.034; Kulakowski D, 2011, FOREST ECO IN PRESS; Kulakowski D, 2007, ECOLOGY, V88, P759, DOI 10.1890/06-0124; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lessard G, 1987, FOREST PEST CONDITIO, P11; Logan J.A., 2001, AM ENTOMOL, V47, P160; Lutes DC, 2006, RMRSGTR164CD USDA F; Lynch HJ, 2006, ECOSYSTEMS, V9, P1318, DOI 10.1007/s10021-006-0173-3; Mitchell Russel G., 1998, Western Journal of Applied Forestry, V13, P23; Page W, 2007, FOREST SCI, V53, P662; Page WG, 2007, FOREST SCI, V53, P507; Parsons RA, 2011, ECOL MODEL, V222, P679, DOI 10.1016/j.ecolmodel.2010.10.023; Pelz K. A., 2011, THESIS COLORADO STAT; Pollet J, 2002, INT J WILDLAND FIRE, V11, P1, DOI 10.1071/WF01045; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Reinhardt ED, 2003, RMRSGRT116 USDA FOR; Reinhardt E, 2006, CAN J FOREST RES, V36, P2803, DOI 10.1139/X06-157; Rothermel R.C., 1972, MATH MODEL PREDICTIN; ROTHERMEL R. C., 1991, INT438 USDA FOR SERV; Safranyik L, 2004, PACIF FOR C, V399, P33; Safranyik L, 1974, 124 CAN FOR SERV; Schoennagel T, 2004, J VEG SCI, V15, P797, DOI 10.1111/j.1654-1103.2004.tb02323.x; Schoennagel T, 2007, ECOLOGY, V88, P2891, DOI 10.1890/06-1860.1; Schroeder D., 2009, FIRE BEHAV SIMULATED; Scott J.H., 2005, STANDARD FIRE BEHAV, P72; Scott JH, 2001, RMRSRP29 USDA FOR; Simard M, 2011, ECOL MONOGR, V81, P3, DOI 10.1890/10-1176.1; Smith JM, 1980, DENDROECOLOGICAL REC; Stokes M.A., 1968, INTRO TREERING DATIN; Tinker DB, 2000, ECOSYSTEMS, V3, P472, DOI 10.1007/s100210000041; Turner MG, 1999, INT J WILDLAND FIRE, V9, P21, DOI 10.1071/WF99003; VEBLEN TT, 1991, J BIOGEOGR, V18, P707, DOI 10.2307/2845552; VEBLEN TT, 1989, CAN J FOREST RES, V19, P1218, DOI 10.1139/x89-186; Veblen TT, 2001, CAN J FOREST RES, V31, P2089, DOI 10.1139/cjfr-31-12-2089; Wagner C. E. van, 1977, Canadian Journal of Forest Research, V7, P23, DOI 10.1139/x77-004; WANG JR, 1995, FOREST ECOL MANAG, V78, P127, DOI 10.1016/0378-1127(95)03590-0; West DR, 2010, THESIS COLORADO STAT; XANTHOPOULOS G, 1993, CAN J FOREST RES, V23, P253, DOI 10.1139/x93-034	68	80	80	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30002	10.1371/journal.pone.0030002	http://dx.doi.org/10.1371/journal.pone.0030002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272268	Green Published, gold			2022-12-25	WOS:000301454400047
J	Gu, L; Ngo, S; Guo, ZF				Gu, Lei; Ngo, Sam; Guo, Zhefeng			Solid-support Electron Paramagnetic Resonance (EPR) Studies of A beta 40 Monomers Reveal a Structured State with Three Ordered Segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; SPIN-LABELED PROTEINS; ALZHEIMERS-DISEASE; CONFORMATIONAL EQUILIBRIA; MASS-SPECTROMETRY; NITROXIDE MOTION; KEY RESIDUES; T4 LYSOZYME; PEPTIDES; DYNAMICS	Alzheimer disease is associated with the pathological accumulation of amyloid-beta peptide (A beta) in the brain. Soluble A beta oligomers formed during early aggregation process are believed to be neurotoxins and causative agents in Alzheimer disease. A beta monomer is the building block for amyloid assemblies. A comprehensive understanding of the structural features of A beta monomer is crucial for delineating the mechanism of A beta oligomerization. Here we investigated the structures of A beta 40 monomer using a solid-support approach, in which A beta 40 monomers are tethered on the solid support via an N-terminal His tag to prevent further aggregation. EPR spectra of tethered A beta 40 with spin labels at 18 different positions show that A beta 40 monomers adopt a completely disordered structure under denaturing conditions. Under native conditions, however, EPR spectra suggest that A beta 40 monomers adopt both a disordered state and a structured state. The structured state of A beta 40 monomer has three more ordered segments at 14-18, 29-30, and 38-40. Interactions between these segments may stabilize the structured state, which likely plays an important role in A beta aggregation.	[Gu, Lei; Ngo, Sam; Guo, Zhefeng] Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Guo, ZF (corresponding author), Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	zhefeng@ucla.edu	Gu, Lei/GWQ-6785-2022; Guo, Zhefeng/A-2069-2013	Guo, Zhefeng/0000-0003-1992-7255	Larry L. Hillblom Foundation	Larry L. Hillblom Foundation	This work was supported by the Larry L. Hillblom Foundation.	Amirgoulova EV, 2004, CHEMPHYSCHEM, V5, P552, DOI 10.1002/cphc.200400024; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bora RP, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3249609; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Carson M, 2007, ACTA CRYSTALLOGR D, V63, P295, DOI 10.1107/S0907444906052024; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Cote S, 2011, J CHEM THEORY COMPUT, V7, P2584, DOI 10.1021/ct1006967; Danielsson J, 2006, MAGN RESON CHEM, V44, pS114, DOI 10.1002/mrc.1814; Fanucci GE, 2006, CURR OPIN STRUC BIOL, V16, P644, DOI 10.1016/j.sbi.2006.08.008; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; GUO Z, 2003, THESIS U CALIFORNIA; Guo ZF, 2008, PROTEIN SCI, V17, P228, DOI 10.1110/ps.073174008; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Irie K, 2005, J BIOSCI BIOENG, V99, P437, DOI 10.1263/jbb.99.437; Iurascu MI, 2009, ANAL BIOANAL CHEM, V395, P2509, DOI 10.1007/s00216-009-3164-3; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Klug CS, 2008, METHOD CELL BIOL, V84, P617, DOI 10.1016/S0091-679X(07)84020-9; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lim KH, 2007, CHEMBIOCHEM, V8, P1251, DOI 10.1002/cbic.200700194; Lim KH, 2007, BIOCHEM BIOPH RES CO, V353, P443, DOI 10.1016/j.bbrc.2006.12.043; Lopez CJ, 2009, PROTEIN SCI, V18, P1637, DOI 10.1002/pro.180; McCoy J, 2011, P NATL ACAD SCI USA, V108, P1331, DOI 10.1073/pnas.1017877108; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Murakami K, 2007, CHEMBIOCHEM, V8, P2308, DOI 10.1002/cbic.200700240; Ngo S, 2011, BIOCHEM BIOPH RES CO, V414, P512, DOI 10.1016/j.bbrc.2011.09.097; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schneider D. J., 1989, SPIN LABELING THEORY, P1; Sepkhanova I, 2009, APPL MAGN RESON, V36, P209, DOI 10.1007/s00723-009-0019-1; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Sgourakis NG, 2011, J MOL BIOL, V405, P570, DOI 10.1016/j.jmb.2010.10.015; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang SSS, 2003, BIOCHEMISTRY-US, V42, P9507, DOI 10.1021/bi0342766; Wilchek M, 2003, J BIOCHEM BIOPH METH, V55, P67, DOI 10.1016/S0165-022X(02)00178-1; Wilchek M, 1999, REACT FUNCT POLYM, V41, P263, DOI 10.1016/S1381-5148(99)00042-5; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Yan YL, 2007, BIOCHEM BIOPH RES CO, V362, P410, DOI 10.1016/j.bbrc.2007.07.198; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	52	14	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9081	9089		10.1074/jbc.M111.292086	http://dx.doi.org/10.1074/jbc.M111.292086			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277652	Green Published, hybrid			2022-12-25	WOS:000301797800038
J	Kaur, H; Ganguli, D; Bachhawat, AK				Kaur, Hardeep; Ganguli, Dwaipayan; Bachhawat, Anand K.			Glutathione Degradation by the Alternative Pathway (DUG Pathway) in Saccharomyces cerevisiae Is Initiated by (Dug2p-Dug3p)(2) Complex, a Novel Glutamine Amidotransferase (GATase) Enzyme Acting on Glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCYL AMINOPEPTIDASE; SULFUR METABOLISM; ESCHERICHIA-COLI; AMINO-ACIDS; TRANSPEPTIDASE; YEAST; SYNTHASE; PROTEIN; TRANSFERASE; ACTIVATION	The recently identified, fungi-specific alternative pathway of glutathione degradation requires the participation of three genes, DUG1, DUG2, and DUG3. Dug1p has earlier been shown to function as a Cys-Gly-specific dipeptidase. In the present study, we describe the characterization of Dug2p and Dug3p. Dug3p has a functional glutamine amidotransferase (GATase) II domain that is catalytically important for glutathione degradation as demonstrated through mutational analysis. Dug2p, which has an N-terminal WD40 and a C-terminal M20A peptidase domain, has no peptidase activity. The previously demonstrated Dug2p-Dug3p interaction was found to be mediated through the WD40 domain of Dug2p. Dug2p was also shown to be able to homodimerize, and this was mediated by its M20A peptidase domain. In vitro reconstitution assays revealed that Dug2p and Dug3p were required together for the cleavage of glutathione into glutamate and Cys-Gly. Purification through gel filtration chromatography confirmed the formation of a Dug2p-Dug3p complex. The functional complex had a molecular weight that corresponded to (Dug2p-Dug3p)(2) in addition to higher molecular weight oligomers and displayed Michaelis-Menten kinetics. (Dug2p-Dug3p)(2) had a K-m for glutathione of 1.2 mM, suggesting a novel GATase enzyme that acted on glutathione. Dug1p activity in glutathione degradation was found to be restricted to its Cys-Gly peptidase activity, which functioned downstream of the (Dug2p-Dug3p)(2) GATase. The DUG2 and DUG3 genes, but not DUG1, were derepressed by sulfur limitation. Based on these studies and the functioning of GATases, a mechanism is proposed for the functioning of the Dug proteins in the degradation of glutathione.	[Kaur, Hardeep; Ganguli, Dwaipayan; Bachhawat, Anand K.] Inst Microbial Technol, Chandigarh 160036, India; [Bachhawat, Anand K.] Indian Inst Sci Educ & Res IISER Mohali, Sas Nagar, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Indian Institute of Science Education & Research (IISER) - Mohali	Bachhawat, AK (corresponding author), IISERM, Sas Nagar 140306, Punjab, India.	anand@iisermohali.ac.in			Department of Science and Technology; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a grant-in-aid project from the Department of Science and Technology and Department of Biotechnology, Government of India (to A. K. B.).; Recipient of a research fellowship form Council of Scientific and Industrial Research, Government of India.	[Anonymous], 1991, Methods Enzymol, V194, P1; BAROUKI R, 1984, J BIOL CHEM, V259, P7970; Blaiseau PL, 1997, MOL CELL BIOL, V17, P3640, DOI 10.1128/MCB.17.7.3640; Cappiello M, 2004, BIOCHEM J, V378, P35, DOI 10.1042/BJ20031336; FAHEY RC, 1987, METHOD ENZYMOL, V143, P85; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P268, DOI 10.1073/pnas.76.1.268; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Ito S, 2009, GEN THORAC CARDIOVAS, V57, P591, DOI 10.1007/s11748-009-0445-x; JASPERS CJ, 1984, BIOCHIMIE, V66, P71, DOI 10.1016/0300-9084(84)90193-7; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; Kumar C, 2003, FEMS MICROBIOL LETT, V219, P187, DOI 10.1016/S0378-1097(03)00059-4; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; Mehdi K, 2001, BIOCHEM J, V359, P631, DOI 10.1042/0264-6021:3590631; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Milewski S, 2002, BBA-PROTEIN STRUCT M, V1597, P173, DOI 10.1016/S0167-4838(02)00318-7; Mouilleron S, 2006, J BIOL CHEM, V281, P4404, DOI 10.1074/jbc.M511689200; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; Nakano Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1790, DOI 10.1271/bbb.60027; Ohkama-Ohtsu N, 2008, PLANT PHYSIOL, V148, P1603, DOI 10.1104/pp.108.125716; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; PENNINCKX M, 1980, EUR J BIOCHEM, V104, P119, DOI 10.1111/j.1432-1033.1980.tb04407.x; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Sambrook J., 2002, MOL CLONING LAB MANU; Smith JL, 1998, CURR OPIN STRUC BIOL, V8, P686, DOI 10.1016/S0959-440X(98)80087-0; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Springael JY, 2003, BIOCHEM J, V371, P589, DOI 10.1042/BJ20021893; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; van den Heuvel RHH, 2004, CELL MOL LIFE SCI, V61, P669, DOI 10.1007/s00018-003-3316-0; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203	38	29	30	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8920	8931		10.1074/jbc.M111.327411	http://dx.doi.org/10.1074/jbc.M111.327411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277648	hybrid, Green Published			2022-12-25	WOS:000301797800023
J	Mori, Y; Matsui, T; Furutani, Y; Yoshihara, Y; Fukuda, M				Mori, Yasunori; Matsui, Takahide; Furutani, Yutaka; Yoshihara, Yoshihiro; Fukuda, Mitsunori			Small GTPase Rab17 Regulates Dendritic Morphogenesis and Postsynaptic Development of Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE PROTEIN; LONG-TERM POTENTIATION; RECYCLING ENDOSOMES; AMPA RECEPTORS; FILOPODIA FORMATION; EPITHELIAL-CELLS; NMDA RECEPTOR; PC12 CELLS; TRAFFICKING; BINDING	Neurons are compartmentalized into two morphologically, molecularly, and functionally distinct domains: axons and dendrites, and precise targeting and localization of proteins within these domains are critical for proper neuronal functions. It has been reported that several members of the Rab family small GTPases that are key mediators of membrane trafficking, regulate axon-specific trafficking events, but little has been elucidated regarding the molecular mechanisms that underlie dendrite-specific membrane trafficking. Here we show that Rab17 regulates dendritic morphogenesis and postsynaptic development in mouse hippocampal neurons. Rab17 is localized at dendritic growth cones, shafts, filopodia, and mature spines, but it is mostly absent in axons. We also found that Rab17 mediates dendrite growth and branching and that it does not regulate axon growth or branching. Moreover, shRNA-mediated knockdown of Rab17 expression resulted in a dramatically reduced number of dendritic spines, probably because of impaired filopodia formation. These findings have revealed the first molecular link between membrane trafficking and dendritogenesis.	[Mori, Yasunori; Matsui, Takahide; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan; [Furutani, Yutaka; Yoshihara, Yoshihiro] RIKEN Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan	Tohoku University; RIKEN	Fukuda, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Lab Membrane Trafficking Mech,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Yoshihara, Yoshihiro/N-6481-2015; Matsui, Takahide/S-4986-2018; Fukuda, MItsunori/I-1511-2015; Furutani, Yutaka/C-3652-2017	Yoshihara, Yoshihiro/0000-0002-0319-7166; Matsui, Takahide/0000-0002-3342-0170; Fukuda, MItsunori/0000-0002-8620-5853; Furutani, Yutaka/0000-0002-2945-0166	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; (Basic & Translational Research Center for Global Brain Science) of the MEXT of Japan; Grants-in-Aid for Scientific Research [20113006, 22700324] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); (Basic & Translational Research Center for Global Brain Science) of the MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to Y. M., Y. F., Y. Y., and M. F.) and by a grant from the Global COE Program (Basic & Translational Research Center for Global Brain Science) of the MEXT of Japan (to Y. M. and M. F.).	Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Dailey ME, 1996, J NEUROSCI, V16, P2983; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fei H, 2008, TRAFFIC, V9, P1425, DOI 10.1111/j.1600-0854.2008.00771.x; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Fukuda M, 2002, J BIOL CHEM, V277, P4601, DOI 10.1074/jbc.C100588200; Fukuda M, 2010, HISTOL HISTOPATHOL, V25, P1473, DOI 10.14670/HH-25.1473; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Gronborg M, 2010, J NEUROSCI, V30, P2, DOI 10.1523/JNEUROSCI.4074-09.2010; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; HARA T, 1992, EMBO J, V11, P1875, DOI 10.1002/j.1460-2075.1992.tb05239.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunziker W, 1998, J BIOL CHEM, V273, P15734, DOI 10.1074/jbc.273.25.15734; Ibata K, 2002, NEUROSCI RES, V43, P401, DOI 10.1016/S0168-0102(02)00066-4; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Matsuno H, 2006, J NEUROSCI, V26, P1776, DOI 10.1523/JNEUROSCI.2651-05.2006; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yu E, 2008, P NATL ACAD SCI USA, V105, P16003, DOI 10.1073/pnas.0804825105; Zacchi P, 1998, J CELL BIOL, V140, P1039, DOI 10.1083/jcb.140.5.1039; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	44	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8963	8973		10.1074/jbc.M111.314385	http://dx.doi.org/10.1074/jbc.M111.314385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291024	hybrid, Green Published			2022-12-25	WOS:000301797800027
J	Hanania, R; Sun, HS; Xu, KW; Pustylnik, S; Jeganathan, S; Harrison, RE				Hanania, Raed; Sun, He Song; Xu, Kewei; Pustylnik, Sofia; Jeganathan, Sujeeve; Harrison, Rene E.			Classically Activated Macrophages Use Stable Microtubules for Matrix Metalloproteinase-9 (MMP-9) Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATINASE-B; POSTTRANSLATIONAL MODIFICATION; ENDOPLASMIC-RETICULUM; CELL-SURFACE; CALRETICULIN; EXPRESSION; PROTEIN; MEMBRANE; BINDING; METALLOPROTEINASE-9	As major effector cells of the innate immune response, macrophages must adeptly migrate from blood to infected tissues. Endothelial transmigration is accomplished by matrix metalloproteinase (MMP)-induced degradation of basement membrane and extracellular matrix components. The classical activation of macrophages with LPS and IFN-gamma causes enhanced microtubule (MT) stabilization and secretion of MMPs. Macrophages up-regulate MMP-9 expression and secretion upon immunological challenge and require its activity for migration during the inflammatory response. However, the dynamics of MMP-9 production and intracellular distribution as well as the mechanisms responsible for its trafficking are unknown. Using immunofluorescent imaging, we localized intracellular MMP-9 to small Golgi-derived cytoplasmic vesicles that contained calreticulin and protein-disulfide isomerase in activated RAW 264.7 macrophages. We demonstrated vesicular organelles of MMP-9 aligned along stable subsets of MTs and showed that selective modulation of MT dynamics contributes to the enhanced trafficking of MMP-9 extracellularly. We found a Rab3D-dependent association of MMP-9 vesicles with the molecular motor kinesin, whose association with the MT network was greatly enhanced after macrophage activation. Finally, we implicated kinesin 5B and 3B isoforms in the effective trafficking of MMP-9 extracellularly.	[Sun, He Song; Xu, Kewei; Pustylnik, Sofia; Jeganathan, Sujeeve; Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [Hanania, Raed] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada	University of Toronto; University Toronto Scarborough; University of Ottawa	Harrison, RE (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada.	harrison@utsc.utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP-68992]; Ontario Early Researcher Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-68992 (to R. E. H.).; Recipient of a CIHR New Investigator Award and an Ontario Early Researcher Award. To whom correspondence should be addressed. Tel.: 416-287-7377; Fax: 416-287-7676; E-mail: harrison@utsc.utoronto.ca.	Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Baksh S, 1995, J BIOL CHEM, V270, P31338, DOI 10.1074/jbc.270.52.31338; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Binker MG, 2007, CELL MICROBIOL, V9, P2153, DOI 10.1111/j.1462-5822.2007.00946.x; Binker MG, 2007, J IMMUNOL, V179, P3780, DOI 10.4049/jimmunol.179.6.3780; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; BU CH, 1995, J BIOL CHEM, V270, P18563, DOI 10.1074/jbc.270.31.18563; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; HIGGINBOTHAM JN, 1992, CLIN EXP IMMUNOL, V88, P492; Johnson S, 2001, TRENDS CELL BIOL, V11, P122, DOI 10.1016/S0962-8924(01)01926-2; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Khandani A, 2007, J LEUKOCYTE BIOL, V82, P417, DOI 10.1189/jlb.0706469; KJELDSEN L, 1994, BLOOD, V83, P1640, DOI 10.1182/blood.V83.6.1640.bloodjournal8361640; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; LIAO GJ, 1995, J CELL SCI, V108, P3473; Makowski GS, 1996, ANAL BIOCHEM, V236, P353, DOI 10.1006/abio.1996.0179; MANFREDI JJ, 1982, J CELL BIOL, V94, P688, DOI 10.1083/jcb.94.3.688; Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Millar AL, 2002, HISTOL HISTOPATHOL, V17, P929, DOI 10.14670/HH-17.929; Min DQ, 2002, J IMMUNOL, V168, P2449, DOI 10.4049/jimmunol.168.5.2449; MITCHISON TJ, 1995, PHILOS T ROY SOC B, V349, P299, DOI 10.1098/rstb.1995.0117; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NAKATA T, 1995, J CELL BIOL, V131, P1039, DOI 10.1083/jcb.131.4.1039; NASH PD, 1994, MOL CELL BIOCHEM, V135, P71, DOI 10.1007/BF00925962; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nguyen HL, 1997, J CELL SCI, V110, P281; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Patel PC, 2009, MOL CELL PROTEOMICS, V8, P2500, DOI 10.1074/mcp.M900190-MCP200; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pruijt JFM, 1999, P NATL ACAD SCI USA, V96, P10863, DOI 10.1073/pnas.96.19.10863; Rahat MA, 2006, J LEUKOCYTE BIOL, V79, P706, DOI 10.1189/jlb.0605302; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88; Ross M. H., 2006, HISTOLOGY TEXT ATLAS, P256; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rupani R, 2004, PIGM CELL RES, V17, P281, DOI 10.1111/j.1600-0749.2004.00148.x; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Silver KE, 2011, J IMMUNOL, V186, P816, DOI 10.4049/jimmunol.1002161; Skubitz KM, 2000, FEBS LETT, V469, P52, DOI 10.1016/S0014-5793(00)01240-0; TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; von Bredow DC, 1998, BIOCHEM J, V331, P965, DOI 10.1042/bj3310965; WATANABE H, 1993, J CELL SCI, V104, P991; Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb.0306152; Wiesner C, 2010, BLOOD, V116, P1559, DOI 10.1182/blood-2009-12-257089; WIRTH JJ, 1985, INFECT IMMUN, V49, P61, DOI 10.1128/IAI.49.1.61-66.1985; Wu M, 2007, MATRIX BIOL, V26, P463, DOI 10.1016/j.matbio.2007.02.005; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200	72	71	71	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8468	8483		10.1074/jbc.M111.290676	http://dx.doi.org/10.1074/jbc.M111.290676			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270361	Green Published, hybrid			2022-12-25	WOS:000301349400061
J	Yan, D; Avtanski, D; Saxena, NK; Sharma, D				Yan, Dan; Avtanski, Dimiter; Saxena, Neeraj K.; Sharma, Dipali			Leptin-induced Epithelial-Mesenchymal Transition in Breast Cancer Cells Requires beta-Catenin Activation via Akt/GSK3- and MTA1/Wnt1 Protein-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS-ASSOCIATED PROTEIN-1; MAMMARY-TUMOR GROWTH; CARCINOMA CELLS; IN-VIVO; HISTONE ACETYLTRANSFERASES; SIGNALING PROMOTES; FEMALE MICE; STEM-CELLS; E-CADHERIN; RECEPTOR	Perturbations in the adipocytokine profile, especially higher levels of leptin, are a major cause of breast tumor progression and metastasis; the underlying mechanisms, however, are not well understood. In particular, it remains elusive whether leptin is involved in epithelial-mesenchymal transition (EMT). Here, we provide molecular evidence that leptin induces breast cancer cells to undergo a transition from epithelial to spindle-like mesenchymal morphology. Investigating the downstream mediator(s) that may direct leptin-induced EMT, we found functional interactions between leptin, metastasis-associated protein 1 (MTA1), and Wnt1 signaling components. Leptin increases accumulation and nuclear translocation of beta-catenin leading to increased promoter recruitment. Silencing of beta-catenin or treatment with the small molecule inhibitor, ICG-001, inhibits leptin-induced EMT, invasion, and tumorsphere formation. Mechanistically, leptin stimulates phosphorylation of glycogen synthase kinase 3 beta (GSK3 beta) via Akt activation resulting in a substantial decrease in the formation of the GSK3 beta-LKB1-Axin complex that leads to increased accumulation of beta-catenin. Leptin treatment also increases Wnt1 expression that contributes to GSK3 beta phosphorylation. Inhibition of Wnt1 abrogates leptin-stimulated GSK3 beta phosphorylation. We also discovered that leptin increases the expression of an important modifier of Wnt1 signaling, MTA1, which is integral to leptin-mediated regulation of the Wnt/beta-catenin pathway as silencing of MTA1 inhibits leptin-induced Wnt1 expression, GSK3 beta phosphorylation, and beta-catenin activation. Furthermore, analysis of leptin-treated breast tumors shows increased expression of Wnt1, pGSK3 beta, and vimentin along with higher nuclear accumulation of beta-catenin and reduced E-cadherin expression providing in vivo evidence for a previously unrecognized cross-talk between leptin and MTA1/Wnt signaling in epithelial-mesenchymal transition of breast cancer cells.	[Avtanski, Dimiter; Sharma, Dipali] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Avtanski, Dimiter; Sharma, Dipali] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Yan, Dan] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Saxena, Neeraj K.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Emory University; University System of Maryland; University of Maryland Baltimore	Sharma, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, 1650 Orleans St,CRB 1,Rm 145, Baltimore, MD 21231 USA.	dsharma7@jhmi.edu	Yan, Dan/B-1793-2012; Avtanski, Dimiter/W-6187-2018	Yan, Dan/0000-0001-7531-5814; Avtanski, Dimiter/0000-0002-4479-6448	National Institutes of Health [K01DK076742, R03DK089130, R01CA131294]; NATIONAL CANCER INSTITUTE [R01CA131294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076742, R03DK089130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK076742 and R03DK089130 (to N. K. S.) and R01CA131294 (to D. S.).	Ahima RS, 2004, PHYSIOL BEHAV, V81, P223, DOI 10.1016/j.physbeh.2004.02.014; Artac M., 2011, MED ONCOL IN PRESS; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Candidus S, 1996, CANCER RES, V56, P49; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chua SC, 2004, AM J PHYSIOL-ENDOC M, V286, pE384, DOI 10.1152/ajpendo.00349.2003; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Cleary MP, 2004, EXP BIOL MED, V229, P182, DOI 10.1177/153537020422900207; Cleary MP, 2003, BREAST CANCER RES TR, V77, P205, DOI 10.1023/A:1021891825399; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dogan S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1840; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Fusco R, 2010, ENDOCR-RELAT CANCER, V17, P373, DOI 10.1677/ERC-09-0340; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; Gonzalez RR, 2001, ENDOCRINE, V15, P157, DOI 10.1385/ENDO:15:2:157; Gonzalez RR, 2001, ENDOCRINE, V16, P21, DOI 10.1385/ENDO:16:1:21; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Grossmann ME, 2010, CANCER METAST REV, V29, P641, DOI 10.1007/s10555-010-9252-1; Guo SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021467; Hajra KM, 2002, CANCER RES, V62, P1613; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ishikawa M, 2004, CLIN CANCER RES, V10, P4325, DOI 10.1158/1078-0432.CCR-03-0749; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Knight BB, 2011, ENDOCR-RELAT CANCER, V18, P413, DOI 10.1530/ERC-11-0075; Kumar R, 2010, CANCER RES, V70, P6649, DOI 10.1158/0008-5472.CAN-10-0909; Kumar R, 2010, CANCER RES, V70, P6598, DOI 10.1158/0008-5472.CAN-10-0907; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; McMurtry V, 2009, CLIN EXP METASTAS, V26, P197, DOI 10.1007/s10585-008-9231-x; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; Park J, 2010, AM J PATHOL, V177, P3133, DOI 10.2353/ajpath.2010.100595; Pinteaux E, 2007, J NEUROCHEM, V102, P826, DOI 10.1111/j.1471-4159.2007.04559.x; Ray A, 2010, EXPERT OPIN THER TAR, V14, P443, DOI 10.1517/14728221003716466; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Sharma D, 2002, P NATL ACAD SCI USA, V99, P7934, DOI 10.1073/pnas.122004799; Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892; Singh RR, 2007, J MAMMARY GLAND BIOL, V12, P115, DOI 10.1007/s10911-007-9043-7; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Tessitore L, 2000, INT J MOL MED, V5, P421; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; Yang AD, 2006, CANCER RES, V66, P46, DOI 10.1158/0008-5472.CAN-05-3086; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zheng Q, 2011, ENDOCR-RELAT CANCER, V18, P491, DOI 10.1530/ERC-11-0102; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	65	152	156	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8598	8612		10.1074/jbc.M111.322800	http://dx.doi.org/10.1074/jbc.M111.322800			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270359	hybrid, Green Published			2022-12-25	WOS:000301349400072
J	Li, AL; Song, YX; Wang, ZN; Gao, P; Miao, Y; Zhu, JL; Yue, ZY; Xu, HM				Li, Ai-Lin; Song, Yong-Xi; Wang, Zhen-Ning; Gao, Peng; Miao, Yuan; Zhu, Jin-Liang; Yue, Zhen-Yu; Xu, Hui-Mian			Polymorphisms and a Haplotype in Heparanase Gene Associations with the Progression and Prognosis of Gastric Cancer in a Northern Chinese Population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PARAFFIN-EMBEDDED TISSUE; MALDI-TOF MS; MESSENGER-RNA; EXPRESSION; RISK; SUSCEPTIBILITY; EPIDEMIOLOGY; DNA; METASTASIS	Background: Human heparanase plays an important role in cancer development and single nucleotide polymorphisms (SNPs) in the heparanase gene (HPSE) have been shown to be correlated with gastric cancer. The present study examined the associations between individual SNPs or haplotypes in HPSE and susceptibility, clinicopathological parameters and prognosis of gastric cancer in a large sample of the Han population in northern China. Methodology/Principal Findings: Genomic DNA was extracted from formalin-fixed, paraffin-embedded normal gastric tissue samples from 404 patients and from blood from 404 healthy controls. Six SNPs were genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. A chi-square (chi 2) test and unconditional logistic regression were used to analyze the risk of gastric cancer; a Log-rank test and Cox proportional hazards model were used to produce survival analysis and a Kaplan-Meier method was used to map survival curves. The mean genotyping success rates were more than 99% in both groups. Haplotype CA in the block composed of rs11099592 and rs4693608 had a greater distribution in the group of Borrmann types 3 and 4 (P = 0.037), the group of a greater number of lymph node metastases (N3 vs N0 group, P = 0.046), and moreover was correlated to poor survival (CG vs CA: HR = 0.645, 95%CI: 0.421-0.989, P = 0.044). In addition, genotypes rs4693608 AA and rs4364254 TT were associated with poor survival (P = 0.030, HR = 1.527, 95%CI: 1.042-2.238 for rs4693608 AA; P = 0.013, HR = 1.546, 95%CI: 1.096-2.181 for rs4364254 TT). There were no correlations between individual SNPs or haplotypes and gastric cancer risk. Conclusions/Significance: A functional haplotype in HPSE was found, which included the important SNP rs4693608. SNPs in HPSE play an important role in gastric cancer progression and survival, and perhaps may be a molecular marker for prognosis and treatment values.	[Li, Ai-Lin; Song, Yong-Xi; Wang, Zhen-Ning; Gao, Peng; Zhu, Jin-Liang; Yue, Zhen-Yu; Xu, Hui-Mian] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Li, Ai-Lin] China Med Univ, Hosp 1, Dept Radiotherapy, Shenyang, Peoples R China; [Miao, Yuan] China Med Univ, Hosp 1, Dept Pathol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	wang, zhen ning/E-1878-2011; Miao, Yuan/AAG-9754-2021; yue, zhenyu/GRF-4856-2022; Gao, Peng/B-8031-2013	wang, zhen ning/0000-0003-0557-3097; 	National Science Foundation of China [30972879, 81172370]; Specialized Research Fund for the Doctoral Program of Higher Education [200801590006]; Natural Science Foundation of Liaoning Province [20092129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by the National Science Foundation of China (No. 30972879 and No. 81172370), a Specialized Research Fund for the Doctoral Program of Higher Education (No. 200801590006) and the Natural Science Foundation of Liaoning Province (No. 20092129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernig T, 2006, EXPERT REV MOL DIAGN, V6, P319, DOI 10.1586/14737159.6.3.319; Bonnen PE, 2002, GENOME RES, V12, P1846, DOI 10.1101/gr.483802; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Cannon-Albright LA, 2011, BMC RES NOTES, P4; Chanock S, 2003, SEMIN HEMATOL, V40, P321, DOI 10.1016/S0037-1963(03)00198-7; Chen JQ, 2004, WORLD J GASTROENTERO, V10, P776; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Endo K, 2001, ANTICANCER RES, V21, P3365; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gilbert MTP, 2007, ELECTROPHORESIS, V28, P2361, DOI 10.1002/elps.200600589; Hagleitner MM, 2011, PEDIATR BLOOD CANCER, V56, P35, DOI 10.1002/pbc.22654; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Horn H, 2010, PHARMACOGENET GENOM, V20, P598, DOI 10.1097/FPC.0b013e32833deb16; Jaremko M, 2005, HUM MUTAT, V25, P232, DOI 10.1002/humu.20141; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Justenhoven C, 2004, CANCER EPIDEM BIOMAR, V13, P2059; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Levy-Adam F, 2008, PLOS ONE, P3; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Nasser NJ, 2008, CELL MOL LIFE SCI, V65, P1706, DOI 10.1007/s00018-008-7584-6; Ohkawa T, 2004, LAB INVEST, V84, P1289, DOI 10.1038/labinvest.3700159; Ostrovsky O, 2007, LEUKEMIA, V21, P2296, DOI 10.1038/sj.leu.2404821; Ostrovsky O, 2007, ACTA HAEMATOL-BASEL, V117, P57, DOI 10.1159/000096790; Ostrovsky O, 2010, BLOOD, V115, P2319, DOI 10.1182/blood-2009-08-236455; Ostrovsky O, 2009, J LEUKOCYTE BIOL, V86, P445, DOI 10.1189/jlb.1208735; Overdevest JB, 2009, CLIN CHEM, V55, P684, DOI 10.1373/clinchem.2008.118554; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pusch W, 2002, PHARMACOGENOMICS, V3, P537, DOI 10.1517/14622416.3.4.537; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Ralph S, 2007, CANCER SCI, V98, P844, DOI 10.1111/j.1349-7006.2007.00461.x; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Tregouet DA, 2004, EUR J HUM GENET, V12, P971, DOI 10.1038/sj.ejhg.5201238; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2008, CONNECT TISSUE RES, V49, P207, DOI 10.1080/03008200802143281; Wang ZN, 2005, J SURG ONCOL, V90, P59, DOI 10.1002/jso.20250; Wang ZN, 2005, MODERN PATHOL, V18, P205, DOI 10.1038/modpathol.3800282; Winter PC, 2008, LEUKEMIA, V22, P1629, DOI 10.1038/leu.2008.36; Xu YY, 2009, ASIAN PAC J CANCER P, V10, P151; Yin M, 2009, AM J TRANSL RES, V1, P44; Yue ZY, 2010, J SURG ONCOL, V102, P68, DOI 10.1002/jso.21584; Zhou H, 2011, PLOS ONE, P6	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30277	10.1371/journal.pone.0030277	http://dx.doi.org/10.1371/journal.pone.0030277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276173	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100031
J	Martinaud, O; Pouliquen, D; Gerardin, E; Loubeyre, M; Hirsbein, D; Hannequin, D; Cohen, L				Martinaud, Olivier; Pouliquen, Dorothee; Gerardin, Emmanuel; Loubeyre, Maud; Hirsbein, David; Hannequin, Didier; Cohen, Laurent			Visual Agnosia and Posterior Cerebral Artery Infarcts: An Anatomical-Clinical Study	PLOS ONE			English	Article							FUSIFORM FACE AREA; PURE TOPOGRAPHICAL DISORIENTATION; WORD FORM AREA; OBJECT RECOGNITION; TERRITORY INFARCTS; NEURAL BASIS; PARAHIPPOCAMPAL; CORTEX; PROSOPAGNOSIA; DISSOCIATIONS	Background: To evaluate systematically the cognitive deficits following posterior cerebral artery (PCA) strokes, especially agnosic visual disorders, and to study anatomical-clinical correlations. Methods and Findings: We investigated 31 patients at the chronic stage (mean duration of 29.1 months post infarct) with standardized cognitive tests. New experimental tests were used to assess visual impairments for words, faces, houses, and objects. Forty-one healthy subjects participated as controls. Brain lesions were normalized, combined, and related to occipitotemporal areas responsive to specific visual categories, including words (VWFA), faces (FFA and OFA), houses (PPA) and common objects (LOC). Lesions were located in the left hemisphere in 15 patients, in the right in 13, and bilaterally in 3. Visual field defects were found in 23 patients. Twenty patients had a visual disorder in at least one of the experimental tests (9 with faces, 10 with houses, 7 with phones, 3 with words). Six patients had a deficit just for a single category of stimulus. The regions of maximum overlap of brain lesions associated with a deficit for a given category of stimuli were contiguous to the peaks of the corresponding functional areas as identified in normal subjects. However, the strength of anatomical-clinical correlations was greater for words than for faces or houses, probably due to the stronger lateralization of the VWFA, as compared to the FFA or the PPA. Conclusions: Agnosic visual disorders following PCA infarcts are more frequent than previously reported. Dedicated batteries of tests, such as those developed here, are required to identify such deficits, which may escape clinical notice. The spatial relationships of lesions and of regions activated in normal subjects predict the nature of the deficits, although individual variability and bilaterally represented systems may blur those correlations.	[Martinaud, Olivier; Pouliquen, Dorothee; Loubeyre, Maud; Hannequin, Didier] Rouen Univ Hosp, Dept Neurol, Rouen, France; [Martinaud, Olivier; Cohen, Laurent] GH Pitie Salpetriere, CRICM, INSERM, UMR S 975, Paris, France; [Martinaud, Olivier; Cohen, Laurent] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Gerardin, Emmanuel] Rouen Univ Hosp, Dept Neuroradiol, Rouen, France; [Hirsbein, David] Rouen Univ Hosp, Dept Ophthalmol, Rouen, France; [Hannequin, Didier] Fac Med & Pharm, IFRMP, INSERM, U614, Rouen, France; [Cohen, Laurent] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France	CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Martinaud, O (corresponding author), Rouen Univ Hosp, Dept Neurol, Rouen, France.	olivier.martinaud@chu-rouen.fr	Martinaud, Olivier/AAS-9307-2020	cohen, laurent/0000-0002-5010-9085				Agniel A, 1992, PROTOCOLE MONTREAL T; Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Baddeley A.D., 1994, DOORS PEOPLE TEST TE; Barrash J, 1998, J CLIN EXP NEUROPSYC, V20, P807, DOI 10.1076/jcen.20.6.807.1114; Barrash J, 2000, NEUROPSYCHOLOGIA, V38, P820, DOI 10.1016/S0028-3932(99)00131-1; Barton JJS, 2008, NEUROPSYCHOLOGIA, V46, P2214, DOI 10.1016/j.neuropsychologia.2008.02.014; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Benton A., 1983, CONTRIBUTION NEUROPS; BENTON AL, 1978, ARCH NEUROL-CHICAGO, V35, P364, DOI 10.1001/archneur.1978.00500300038006; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; BRANDT T, 1995, NERVENARZT, V66, P267; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P2051, DOI 10.1016/j.neuropsychologia.2010.03.026; Cai Q, 2010, CEREB CORTEX, V20, P1153, DOI 10.1093/cercor/bhp175; Cals N, 2002, J NEUROL, V249, P855, DOI 10.1007/s00415-002-0742-0; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V23, P1256, DOI 10.1016/j.neuroimage.2004.07.052; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P664, DOI 10.1037/0894-4105.19.5.664; DAMASIO AR, 1983, NEUROLOGY, V33, P1573, DOI 10.1212/WNL.33.12.1573; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Deloche G., 1997, DO80; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Dien J, 2009, NEUROPSYCHOLOGIA, V47, P1, DOI 10.1016/j.neuropsychologia.2008.08.024; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2007, J NEUROSCI, V27, P226, DOI 10.1523/JNEUROSCI.3619-06.2007; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine BC, 2003, NEUROCASE, V9, P380, DOI 10.1076/neur.9.5.380.16556; Duchaine BC, 2003, NEUROPSYCHOLOGIA, V41, P713, DOI 10.1016/S0028-3932(02)00222-1; Duchaine BC, 2003, PERCEPTION, V32, P827, DOI 10.1068/p5067; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 2001, COGNITIVE NEUROPSYCH, V18, P481, DOI 10.1080/02643290125929; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Epstein RA, 2007, J NEUROSCI, V27, P6141, DOI 10.1523/JNEUROSCI.0799-07.2007; Farah M., 2004, VISUAL AGNOSIA; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Garrido L, 2008, J NEUROPSYCHOL, V2, P119, DOI 10.1348/174866407X246843; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gilaie-Dotan S, 2007, CEREB CORTEX, V17, P325, DOI 10.1093/cercor/bhj150; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; HABIB M, 1987, CORTEX, V23, P73, DOI 10.1016/S0010-9452(87)80020-5; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HECAEN H, 1980, CORTEX, V16, P525, DOI 10.1016/S0010-9452(80)80001-3; Henry C, 2005, NEUROPSYCHOLOGIA, V43, P1983, DOI 10.1016/j.neuropsychologia.2005.04.007; Ishai A, 2002, NEUROIMAGE, V17, P1729, DOI 10.1006/nimg.2002.1330; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kumral E, 2004, EUR J NEUROL, V11, P237, DOI 10.1046/j.1468-1331.2003.00750.x; Leff AP, 2006, J NEUROL NEUROSUR PS, V77, P1004, DOI 10.1136/jnnp.2005.086983; Leff AP, 2001, BRAIN, V124, P510, DOI 10.1093/brain/124.3.510; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Mendez MF, 2003, NEUROPSYCHOLOGIA, V41, P1387, DOI 10.1016/S0028-3932(03)00041-1; MILANDRE L, 1994, REV NEUROL-FRANCE, V150, P133; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park S, 2009, NEUROIMAGE, V47, P1747, DOI 10.1016/j.neuroimage.2009.04.058; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; PESSIN MS, 1987, ANN NEUROL, V21, P290, DOI 10.1002/ana.410210311; Pflugshaupt T, 2009, BRAIN, V132, P1907, DOI 10.1093/brain/awp141; Pourtois G, 2005, J COGNITIVE NEUROSCI, V17, P1043, DOI 10.1162/0898929054475181; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Rhodes G, 2004, J COGNITIVE NEUROSCI, V16, P189, DOI 10.1162/089892904322984508; Riddoch M. J., 1993, BORB BIRMINGHAM OBJE; Rossion B, 2003, BRAIN, V126, P2381, DOI 10.1093/brain/awg241; Servan J, 1992, CEREBROVASC DIS; Sewards TV, 2011, NEUROPSYCHOLOGIA, V49, P277, DOI 10.1016/j.neuropsychologia.2010.11.018; Sivan A.B., 1992, BENTON VISUAL RETENT; Takahashi N, 2002, CORTEX, V38, P717, DOI 10.1016/S0010-9452(08)70039-X; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Van der Linden M, 2004, EVALUATION TROUBLES, P25; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 1997, WECHSLER ADULT INTEL; Yamamoto Y, 1999, ARCH NEUROL-CHICAGO, V56, P824, DOI 10.1001/archneur.56.7.824	85	26	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30433	10.1371/journal.pone.0030433	http://dx.doi.org/10.1371/journal.pone.0030433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276198	Green Submitted, Green Published, gold			2022-12-25	WOS:000301568100047
J	Elsaesser, O; Leiter, U; Buettner, PG; Eigentler, TK; Meier, F; Weide, B; Metzler, G; Breuninger, H; Garbe, C				Elsaesser, Otmar; Leiter, Ulrike; Buettner, Petra G.; Eigentler, Thomas K.; Meier, Friedegund; Weide, Benjamin; Metzler, Gisela; Breuninger, Helmut; Garbe, Claus			Prognosis of Sentinel Node Staged Patients with Primary Cutaneous Melanoma	PLOS ONE			English	Article							LYMPH-NODES; BIOPSY; RECURRENCE; PATTERNS; LYMPHADENECTOMY; EXPERIENCE	Background: This study investigated survival probabilities and prognostic factors in sentinel lymph node biopsy (SLNB) staged patients with cutaneous melanoma (CM) with the aim of defining subgroups of patients who are at higher risk for recurrences and who should be considered for adjuvant clinical trials. Methods: Patients with primary CM who underwent SLNB in the Department of Dermatology, University of Tuebingen, Germany, between 1996 and 2009 were included into this study. Survival probabilities and prognostic factors were evaluated by Kaplan-Meier and multivariate Cox proportional hazard models. Results: 1909 SLNB staged patients were evaluated. Median follow-up time was 44 months. Median tumor thickness was 1.8 mm, ulceration was present in 31.8% of cases. The 5-year Overall Survival (OS) was 90.3% in SLNB negative patients (IB 96.2%, IIA 87.0%, IIB 78.1%, IIC 72.6%). Patients with micrometastases (stage IIIA/B) had a 5-year OS rate of 70.9% which was clearly less favorable than for stages I-II. Multivariate analysis revealed tumor thickness, ulceration, body site, histopathologic subtype and SLNB status as independent significant prognostic factors. Conclusion: Survival rates of patients with primary CM in stages I-II were shown to be much more favorable than previously reported from non sentinel node staged collectives. For future clinical trials, sample size calculations should be adapted using survival probabilities based on sentinel node staging.	[Elsaesser, Otmar; Leiter, Ulrike; Eigentler, Thomas K.; Meier, Friedegund; Weide, Benjamin; Metzler, Gisela; Breuninger, Helmut; Garbe, Claus] Univ Tubingen, Ctr Dermatooncol, Dept Dermatol, Tubingen, Germany; [Elsaesser, Otmar; Leiter, Ulrike; Eigentler, Thomas K.; Meier, Friedegund; Weide, Benjamin; Metzler, Gisela; Breuninger, Helmut; Garbe, Claus] Univ Tubingen, Cent Malignant Melanoma Registry, German Dermatol Soc, Tubingen, Germany; [Buettner, Petra G.; Garbe, Claus] James Cook Univ, Skin Canc Res Grp, Sch Publ Hlth & Trop Med, Townsville, Qld 4811, Australia	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; James Cook University	Elsaesser, O (corresponding author), Univ Tubingen, Ctr Dermatooncol, Dept Dermatol, Tubingen, Germany.	ulrike.leiter@med.uni-tuebingen.de	Weide, Benjamin/N-3698-2013; Garbe, Claus/ABH-2128-2021; Eigentler, Thomas/K-8570-2015	Garbe, Claus/0000-0001-8530-780X; Eigentler, Thomas/0000-0003-0019-2770; Leiter, Ulrike/0000-0002-8019-1577				Balch CM, 2010, J CLIN ONCOL, V28, P2452, DOI 10.1200/JCO.2009.27.1627; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2009, J AM ACAD DERMATOL, V60, P872, DOI 10.1016/j.jaad.2008.09.067; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Cascinelli N, 2000, ANN SURG ONCOL, V7, P469, DOI 10.1007/s10434-000-0469-z; Chao C, 2002, AM J SURG, V184, P520, DOI 10.1016/S0002-9610(02)01102-9; Essner R, 1999, ANN SURG ONCOL, V6, P442, DOI 10.1007/s10434-999-0442-4; Gadd MA, 1999, ARCH SURG-CHICAGO, V134, P381, DOI 10.1001/archsurg.134.4.381; Garbe C, 2002, RECENT RESULTS CANC, V160, P205; Gershenwald JE, 1998, J CLIN ONCOL, V16, P2253, DOI 10.1200/JCO.1998.16.6.2253; Kunte C, 2010, MELANOMA RES, V20, P330, DOI 10.1097/CMR.0b013e32833ba9ff; Mandala M, 2009, EUR J CANCER, V45, P2537, DOI 10.1016/j.ejca.2009.05.034; McMasters KM, 2001, SURGERY, V130, P151, DOI 10.1067/msy.2001.115830; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; Morton Donald L, 2008, Nat Clin Pract Oncol, V5, P510, DOI 10.1038/ncponc1205; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Nowecki ZI, 2003, MELANOMA RES, V13, P35, DOI 10.1097/00008390-200302000-00007; Phan GQ, 2009, CANCER CONTROL, V16, P234, DOI 10.1177/107327480901600305; van der Ploeg APT, 2011, J CLIN ONCOL, V29, P2206, DOI 10.1200/JCO.2010.31.6760; Wagner JD, 2000, PLAST RECONSTR SURG, V105, P1774, DOI 10.1097/00006534-200004050-00028; Yee VSK, 2005, ANN SURG ONCOL, V12, P429, DOI 10.1245/ASO.2005.03.074; Zogakis TG, 2005, ARCH SURG-CHICAGO, V140, P865, DOI 10.1001/archsurg.140.9.865	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29791	10.1371/journal.pone.0029791	http://dx.doi.org/10.1371/journal.pone.0029791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276129	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000301457200023
J	Addessi, E; Borgi, M; Palagi, E				Addessi, Elsa; Borgi, Marta; Palagi, Elisabetta			Is Primatology an Equal-Opportunity Discipline?	PLOS ONE			English	Article							GENDER-DIFFERENCES; WOMENS UNDERREPRESENTATION; SCIENCE; FEMALE; PUBLICATION; OUTPUT; INDEX; BIAS	The proportion of women occupying academic positions in biological sciences has increased in the past few decades, but women are still under-represented in senior academic ranks compared to their male colleagues. Primatology has been often singled out as a model of "equal-opportunity'' discipline because of the common perception that women are more represented in Primatology than in similar fields. But is this indeed true? Here we show that, although in the past 15 years the proportion of female primatologists increased from the 38% of the early 1990s to the 57% of 2008, Primatology is far from being an "equal-opportunity'' discipline, and suffers the phenomenon of "glass ceiling'' as all the other scientific disciplines examined so far. In fact, even if Primatology does attract more female students than males, at the full professor level male members significantly outnumber females. Moreover, regardless of position, IPS male members publish significantly more than their female colleagues. Furthermore, when analyzing gender difference in scientific productivity in relation to the name order in the publications, it emerged that the scientific achievements of female primatologists (in terms of number and type of publications) do not always match their professional achievements (in terms of academic position). However, the gender difference in the IPS members' number of publications does not correspond to a similar difference in their scientific impact (as measured by their H index), which may indicate that female primatologists' fewer articles are of higher impact than those of their male colleagues.	[Addessi, Elsa; Palagi, Elisabetta] CNR, Ist Sci & Tecnol Cogniz, Unita Primatol Cognitiva, Rome, Italy; [Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy; [Borgi, Marta] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Pisa; Istituto Superiore di Sanita (ISS)	Addessi, E (corresponding author), CNR, Ist Sci & Tecnol Cogniz, Unita Primatol Cognitiva, Rome, Italy.	elsa.addessi@istc.cnr.it; betta.palagi@museo.unipi.it	Addessi, Elsa/B-8329-2015; Borgi, Marta/J-9249-2016	Addessi, Elsa/0000-0002-5553-7732; Borgi, Marta/0000-0001-7496-6383				Bornmann L, 2007, J INFORMETR, V1, P226, DOI 10.1016/j.joi.2007.03.001; Burrelli J, 2008, 08308 NSF DIV SCI RE; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Ceci SJ, 2009, PSYCHOL BULL, V135, P218, DOI 10.1037/a0014412; *COMM GEND DIFF CA, 2009, GEND DIFF CRIT TRANS; Costas R, 2007, J INFORMETR, V1, P193, DOI 10.1016/j.joi.2007.02.001; Crangle CE, 2009, NATURE, V459, P774, DOI 10.1038/459774c; Cyranoski D, 2001, NATURE, V410, P404, DOI 10.1038/35068702; Ding WW, 2006, SCIENCE, V313, P665, DOI 10.1126/science.1124832; Ecklund EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022590; European Commission Directorate General for Research, 2009, 23856 EUR DIR GEN RE; Fedigan L. M., 1997, WOMEN HUMAN EVOLUTIO, P56; Fedigan LM, 2001, WOMEN CULTURE SOC, P46; FEDIGAN LM, 1994, AM ANTHROPOL, V96, P529, DOI 10.1525/aa.1994.96.3.02a00050; Haraway Donna, 1986, FEMINIST APPROACHES, P77; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hrdy S. B., 1986, FEMINIST APPROACHES, P119; Ledin A, 2007, EMBO REP, V8, P982, DOI 10.1038/sj.embor.7401109; Marsh H.W., 2009, NATURE, V459, P602; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Martinez ED, 2007, EMBO REP, V8, P977, DOI 10.1038/sj.embor.7401110; National Science Foundation Division of Science Resources Statistics, 2003, 03322 NSF DIV SCI RE; Noble Brian E., 2000, P436; Nusslein-Volhard C, 2008, CURR BIOL, V18, pR185, DOI 10.1016/j.cub.2008.01.052; Penas CS, 2006, J INF SCI, V32, P480, DOI 10.1177/0165551506066058; Steinpreis RE, 1999, SEX ROLES, V41, P509, DOI 10.1023/A:1018839203698; Strum S. C., 1999, NEW PHYS ANTHR, P67; Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127; Trix F, 2003, DISCOURSE SOC, V14, P191, DOI 10.1177/0957926503014002277; Turner TR, 2002, AM J PHYS ANTHROPOL, V118, P111, DOI 10.1002/ajpa.10062; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; Wilson E K, 2001, Trends Cell Biol, V11, P453, DOI 10.1016/S0962-8924(01)02182-1; Yamamoto MEE, 2000, PRIMATOL BRASIL, V7, P349; 2008, NATURE, V451, P865	34	16	17	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30458	10.1371/journal.pone.0030458	http://dx.doi.org/10.1371/journal.pone.0030458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907XU	22272353	Green Submitted, Green Published, gold			2022-12-25	WOS:000301454400131
J	Fujita, E; Tanabe, Y; Imhof, BA; Momoi, MY; Momoi, T				Fujita, Eriko; Tanabe, Yuko; Imhof, Beat A.; Momoi, Mariko Y.; Momoi, Takashi			Cadm1-Expressing Synapses on Purkinje Cell Dendrites Are Involved in Mouse Ultrasonic Vocalization Activity	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; AUTISM SPECTRUM DISORDER; ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; LANGUAGE DISORDERS; FUNCTIONAL MRI; GENE; MICE; EXPRESSION; MUTATIONS	Foxp2(R552H) knock-in (KI) mouse pups with a mutation related to human speech-language disorders exhibit poor development of cerebellar Purkinje cells and impaired ultrasonic vocalization (USV), a communication tool for mother-offspring interactions. Thus, human speech and mouse USV appear to have a Foxp2-mediated common molecular basis in the cerebellum. Mutations in the gene encoding the synaptic adhesion molecule CADM1 (RA175/Necl2/SynCAM1/Cadm1) have been identified in people with autism spectrum disorder (ASD) who have impaired speech and language. In the present study, we show that both Cadm1-deficient knockout (KO) pups and Foxp2(R552H) KI pups exhibit impaired USV and smaller cerebellums. Cadm1 was preferentially localized to the apical-distal portion of the dendritic arbor of Purkinje cells in the molecular layer of wild-type pups, and VGluT1 level decreased in the cerebellum of Cadm1 KO mice. In addition, we detected reduced immunoreactivity of Cadm1 and VGluT1 on the poorly developed dendritic arbor of Purkinje cells in the Foxp2(R552H) KI pups. However, Cadm1 mRNA expression was not altered in the Foxp2(R552H) KI pups. These results suggest that although the Foxp2 transcription factor does not target Cadm1, Cadm1 at the synapses of Purkinje cells and parallel fibers is necessary for USV function. The loss of Cadm1-expressing synapses on the dendrites of Purkinje cells may be associated with the USV impairment that Cadm1 KO and Foxp2(R552H) KI mice exhibit.	[Fujita, Eriko; Tanabe, Yuko; Momoi, Takashi] Int Univ Hlth & Welf, Ctr Med Sci, Ohtawara, Tochigi, Japan; [Fujita, Eriko; Momoi, Mariko Y.] Jichi Med Univ, Dept Pediat, Shimotsukeshi, Tochigi, Japan; [Imhof, Beat A.] Univ Geneva, Dept Pathol & Immunol, Ctr Med Univ, Geneva, Switzerland	International University of Health & Welfare; Jichi Medical University; University of Geneva	Fujita, E (corresponding author), Int Univ Hlth & Welf, Ctr Med Sci, Ohtawara, Tochigi, Japan.	mymomoi@jichi.ac.jp; momoi@iuhw.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [21200011, 21700377]; Ministry of the Health, Labour and Welfare, Japan [10103243]; Grants-in-Aid for Scientific Research [22591135] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of the Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) of the Ministry of Education, Culture, Sports, Science and Technology, Japan (21200011, 21700377), Grants-in-Aid for Health Labour Scientific Research of the Ministry of the Health, Labour and Welfare, Japan (10103243). We are extremely grateful to all the families. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Dietrich S, 2008, NEUROREPORT, V19, P1751, DOI 10.1097/WNR.0b013e3283193e9e; Fujita E, 2006, MOL CELL BIOL, V26, P718, DOI 10.1128/MCB.26.2.718-726.2006; Fujita E, 2005, DEV BRAIN RES, V154, P199, DOI 10.1016/j.devbrainres.2004.10.015; Fujita E, 2003, EXP CELL RES, V287, P57, DOI 10.1016/S0014-4827(03)00095-8; Fujita E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.23; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Fujita E, 2007, AM J PATHOL, V171, P1800, DOI 10.2353/ajpath.2007.070261; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Newbury DF, 2010, NEURON, V68, P309, DOI 10.1016/j.neuron.2010.10.001; RITVO ER, 1986, AM J PSYCHIAT, V143, P862; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Takayanagi Y, 2010, BIOCHEM BIOPH RES CO, V396, P703, DOI 10.1016/j.bbrc.2010.04.165; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Xue G, 2004, NEUROIMAGE, V22, P1, DOI 10.1016/j.neuroimage.2004.01.013; Zhiling Y, 2008, BIOCHEM BIOPH RES CO, V377, P926, DOI 10.1016/j.bbrc.2008.10.107	24	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30151	10.1371/journal.pone.0030151	http://dx.doi.org/10.1371/journal.pone.0030151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272290	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400068
J	Godo, OR; Samuelsen, A; Macaulay, GJ; Patel, R; Hjollo, SS; Horne, J; Kaartvedt, S; Johannessen, JA				Godo, Olav R.; Samuelsen, Annette; Macaulay, Gavin J.; Patel, Ruben; Hjollo, Solfrid Saetre; Horne, John; Kaartvedt, Stein; Johannessen, Johnny A.			Mesoscale Eddies Are Oases for Higher Trophic Marine Life	PLOS ONE			English	Article							NORTHERN MID-ATLANTIC; SPATIAL-DISTRIBUTION; FISH; BEHAVIOR; PATTERNS; SHELF; OCEAN; GULF; PHYTOPLANKTON; COMMUNITIES	Mesoscale eddies stimulate biological production in the ocean, but knowledge of energy transfers to higher trophic levels within eddies remains fragmented and not quantified. Increasing the knowledge base is constrained by the inability of traditional sampling methods to adequately sample biological processes at the spatio-temporal scales at which they occur. By combining satellite and acoustic observations over spatial scales of 10 s of km horizontally and 100 s of m vertically, supported by hydrographical and biological sampling we show that anticyclonic eddies shape distribution and density of marine life from the surface to bathyal depths. Fish feed along density structures of eddies, demonstrating that eddies catalyze energy transfer across trophic levels. Eddies create attractive pelagic habitats, analogous to oases in the desert, for higher trophic level aquatic organisms through enhanced 3-D motion that accumulates and redistributes biomass, contributing to overall bioproduction in the ocean. Integrating multidisciplinary observation methodologies promoted a new understanding of biophysical interaction in mesoscale eddies. Our findings emphasize the impact of eddies on the patchiness of biomass in the sea and demonstrate that they provide rich feeding habitat for higher trophic marine life.	[Godo, Olav R.; Macaulay, Gavin J.; Patel, Ruben; Hjollo, Solfrid Saetre] Inst Marine Res, N-5024 Bergen, Norway; [Samuelsen, Annette; Johannessen, Johnny A.] Nansen Environm & Remote Sensing Ctr, Bergen, Norway; [Horne, John] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Kaartvedt, Stein] Univ Oslo, Dept Biol, Oslo, Norway; [Kaartvedt, Stein] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Johannessen, Johnny A.] Univ Bergen, Inst Geophys, Bergen, Norway	Institute of Marine Research - Norway; Nansen Environmental & Remote Sensing Center (NERSC); University of Washington; University of Washington Seattle; University of Oslo; King Abdullah University of Science & Technology; University of Bergen	Godo, OR (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	olavrune@imr.no	Samuelsen, Annette/HGB-2277-2022	Horne, John/0000-0002-3610-5379; Godo, Olav Rune/0000-0001-8826-8068; Macaulay, Gavin/0000-0003-2518-6537; Hjollo, Solfrid Saetre/0000-0003-2897-474X	Census of Marine Life; Norwegian Research Council [9026I/S40]	Census of Marine Life; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was partly carried out and funded by the Census of Marine Life project MAR-ECO (www.mar-eco.no). Further, the work was supported by a grant from the Norwegian Research Council (9026I/S40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, SCIENCE, V212, P1091, DOI 10.1126/science.212.4499.1091; Atwood E, 2010, FISH OCEANOGR, V19, P493, DOI 10.1111/j.1365-2419.2010.00559.x; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P1, DOI 10.1016/j.dsr2.2007.10.001; Bergstad OA, 2002, OCEANOL ACTA, V25, P219, DOI 10.1016/S0399-1784(02)01203-3; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; BRANDT SB, 1983, MAR BIOL, V74, P231, DOI 10.1007/BF00403447; Browman HI, 2005, MAR ECOL PROG SER, V287, P266; BURD AC, 1951, NATURE, V167, P624, DOI 10.1038/167624a0; DENMAN KL, 1983, LIMNOL OCEANOGR, V28, P801, DOI 10.4319/lo.1983.28.5.0801; Farmer D, 1999, SCIENCE, V283, P188, DOI 10.1126/science.283.5399.188; FOOTE KG, 1990, J ACOUST SOC AM, V87, P16, DOI 10.1121/1.399282; Gallager SM, 2004, MAR ECOL PROG SER, V267, P27, DOI 10.3354/meps267027; Genin A, 2005, SCIENCE, V308, P860, DOI 10.1126/science.1107834; Godo OR, 2009, ICES J MAR SCI, V66, P1143, DOI 10.1093/icesjms/fsp098; Goldthwait SA, 2008, DEEP-SEA RES PT II, V55, P1360, DOI 10.1016/j.dsr2.2008.01.003; Govoni JJ, 2010, ICES J MAR SCI, V67, P403, DOI 10.1093/icesjms/fsp269; Greenwood JE, 2007, DEEP-SEA RES PT II, V54, P1029, DOI 10.1016/j.dsr2.2006.10.004; GRIFFITHS FB, 1986, DEEP-SEA RES, V33, P1907, DOI 10.1016/0198-0149(86)90085-3; Harding GC, 2005, FISH OCEANOGR, V14, P112, DOI 10.1111/j.1365-2419.2004.00325.x; Hjellvik V, 2004, CAN J FISH AQUAT SCI, V61, P2237, DOI 10.1139/F04-161; Hoge FE, 2005, REMOTE SENS ENVIRON, V95, P444, DOI 10.1016/j.rse.2004.12.017; JOHANNESSEN JA, 1989, J PHYS OCEANOGR, V19, P3, DOI 10.1175/1520-0485(1989)019<0003:TDSOME>2.0.CO;2; Johannessen JA, 1996, J GEOPHYS RES-OCEANS, V101, P6651, DOI 10.1029/95JC02962; Johnsen E, 2007, ICES J MAR SCI, V64, P1202, DOI 10.1093/icesjms/fsm110; Kaartvedt S, 2009, MAR ECOL PROG SER, V390, P237, DOI 10.3354/meps08196; Kai ET, 2010, PROG OCEANOGR, V86, P214, DOI 10.1016/j.pocean.2010.04.010; Klein P, 2009, ANNU REV MAR SCI, V1, P351, DOI 10.1146/annurev.marine.010908.163704; Ladd C, 2009, DEEP-SEA RES PT II, V56, P2460, DOI 10.1016/j.dsr2.2009.02.007; Lavender KL, 2005, DEEP-SEA RES PT I, V52, P767, DOI 10.1016/j.dsr.2004.12.007; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Love RH, 2004, DEEP-SEA RES PT I, V51, P1, DOI 10.1016/j.dsr.2003.09.004; MacKenzie BR, 2000, OCEANOL ACTA, V23, P357, DOI 10.1016/S0399-1784(00)00142-0; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 1999, J GEOPHYS RES-OCEANS, V104, P13381, DOI 10.1029/1999JC900021; Molinero JC, 2004, CR BIOL, V327, P1103, DOI 10.1016/j.crvi.2004.09.004; Muhling BA, 2007, DEEP-SEA RES PT II, V54, P1113, DOI 10.1016/j.dsr2.2006.05.045; NEILSON JD, 1990, ADV MAR BIOL, V26, P115, DOI 10.1016/S0065-2881(08)60200-X; Ona E, 2007, J ACOUST SOC AM, V121, pEL145, DOI 10.1121/1.2710741; Opdal AF, 2008, DEEP-SEA RES PT II, V55, P45, DOI 10.1016/j.dsr2.2007.09.002; Orlov AM, 2003, INDIAN J MAR SCI, V32, P95; PEARCY WG, 1977, LIMNOL OCEANOGR, V22, P846, DOI 10.4319/lo.1977.22.5.0846; ROTHSCHILD BJ, 1988, J PLANKTON RES, V10, P465, DOI 10.1093/plankt/10.3.465; Rubio A, 2005, PROG OCEANOGR, V66, P142, DOI 10.1016/j.pocean.2004.07.012; Saetre R, 1999, CONT SHELF RES, V19, P1809, DOI 10.1016/S0278-4343(99)00041-2; Sims DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007351; SUNDBY S, 1990, J PLANKTON RES, V12, P1153, DOI 10.1093/plankt/12.6.1153; Wenneek TL, 2008, DEEP-SEA RES PT II, V55, P6, DOI 10.1016/j.dsr2.2007.09.017; WIEBE PH, 1985, J GEOPHYS RES-OCEANS, V90, P8885, DOI 10.1029/JC090iC05p08885; Yasuma H, 2003, ICES J MAR SCI, V60, P584, DOI 10.1016/S1054-3139(03)00058-4; Yebra L, 2009, DEEP-SEA RES PT I, V56, P703, DOI 10.1016/j.dsr.2008.11.008	53	139	141	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30161	10.1371/journal.pone.0030161	http://dx.doi.org/10.1371/journal.pone.0030161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272294	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400072
J	Ono, H; Imoto, I; Kozaki, K; Tsuda, H; Matsui, T; Kurasawa, Y; Muramatsu, T; Sugihara, K; Inazawa, J				Ono, H.; Imoto, I.; Kozaki, K.; Tsuda, H.; Matsui, T.; Kurasawa, Y.; Muramatsu, T.; Sugihara, K.; Inazawa, J.			SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation	ONCOGENE			English	Article						SIX1; epithelial-mesenchymal transition; colorectal cancer; ZEB1; miR-200 family; CDH1	TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; HOMEOPROTEIN SIX1; GENE-EXPRESSION; FEEDBACK LOOP; TUMOR PROGRESSION; METASTASIS; OVEREXPRESSION; REPRESSOR; FAMILY	Epithelial-mesenchymal transition (EMT) has a major role in cancer progression, as well as normal organ development and human pathology such as organ fibrosis and wound healing. Here, we performed a gene expression array specialized in EMT of colorectal cancer (CRC). From a comprehensive gene expression analysis using epithelial- and mesenchymal-like CRC cell lines, and following the ontology (GO) analysis, SIX1 gene was identified to be an EMT-related gene in CRC. Using SW480 cells stably transfected with a SIX1 expression construct and their control counterparts, we demonstrated that SIX1 overexpression represses CDH1 expression and promotes EMT in CRC. SIX1-induced CDH1 repression and EMT in CRC cells were correlated at least in part with posttranscriptional ZEB1 activation and miR-200-family transcriptional repression. In primary tumors of CRC, in accord with the functional findings, aberrant expression of SIX1 in cancer cells was observed at the disruption of the basement membrane and at the tumor invasive front, where tumor cells underwent EMT in vivo. Taken together, SIX1 overexpression is suggested to occur in carcinogenesis, and contribute to repression of CDH1 expression and promotion of EMT partly through repression of miR-200-family expression and activation of ZEB1 in CRC. Oncogene (2012) 31, 4923-4934; doi:10.1038/onc.2011.646; published online 30 January 2012	[Inazawa, J.] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1138510, Japan; [Ono, H.; Sugihara, K.] Tokyo Med & Dent Univ, Grad Sch, Dept Surg, Tokyo 1138510, Japan; [Imoto, I.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Genet, Tokushima 770, Japan; [Tsuda, H.] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Tsuda, H.] Natl Canc Ctr, Clin Labs, Tokyo, Japan; [Matsui, T.] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Tokyo 1138510, Japan; [Matsui, T.] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo 1138510, Japan; [Inazawa, J.] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo 1138510, Japan; [Inazawa, J.] Tokyo Med & Dent Univ, Global Ctr Excellence Program Frontier Res Mol De, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokushima University; National Cancer Center - Japan; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	johinaz.cgen@mri.tmd.ac.jp	Kozaki, Ken-ichi/M-6281-2014; Imoto, Issei/AAD-5799-2020; Matsui, Takeshi/C-4730-2017	Kozaki, Ken-ichi/0000-0003-3286-819X; 	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan; New Energy and Industrial Technology Development Organization (NEDO); Grants-in-Aid for Scientific Research [22134002, 23390077, 21790267] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants-in-aid for Scientific Research (A), (B) (C) and on Priority Areas, and the Global Center of Excellence (GCOE) Program; International Research Center for Molecular Science in Tooth and Bone Diseases from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan; and a grant from the New Energy and Industrial Technology Development Organization (NEDO). We thank Yoko Takagi, Ayako Takahashi, Rumi Mori and Kathy Masker for technical assistance.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Coletta RD, 2008, CANCER RES, V68, P2204, DOI 10.1158/0008-5472.CAN-07-3141; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Hajra KM, 2002, CANCER RES, V62, P1613; Haruki S, 2010, CARCINOGENESIS, V31, P1027, DOI 10.1093/carcin/bgq053; Hoshino H, 2009, BIOCHEM BIOPH RES CO, V390, P1061, DOI 10.1016/j.bbrc.2009.10.117; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Khanna C, 2001, CANCER RES, V61, P3750; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Micalizzi DS, 2010, CANCER RES, V70, P10371, DOI 10.1158/0008-5472.CAN-10-1354; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Ng KT, 2006, BRIT J CANCER, V95, P1050, DOI 10.1038/sj.bjc.6603399; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rodriguez S, 2008, DEV BIOL, V314, P40, DOI 10.1016/j.ydbio.2007.10.056; Roy HK, 2005, DIGEST DIS SCI, V50, P42, DOI 10.1007/s10620-005-1275-z; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Tanami H, 2005, LAB INVEST, V85, P1118, DOI 10.1038/labinvest.3700312; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wan F, 2008, INT J CANCER, V123, P32, DOI 10.1002/ijc.23463; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628	42	88	92	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	47					4923	4934		10.1038/onc.2011.646	http://dx.doi.org/10.1038/onc.2011.646			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	041VU	22286765				2022-12-25	WOS:000311430200004
J	Jawhara, S; Mogensen, E; Maggiotto, F; Fradin, C; Sarazin, A; Dubuquoy, L; Maes, E; Guerardel, Y; Janbon, G; Poulain, D				Jawhara, Samir; Mogensen, Estelle; Maggiotto, Francois; Fradin, Chantal; Sarazin, Aurore; Dubuquoy, Laurent; Maes, Emmanuel; Guerardel, Yann; Janbon, Guilhem; Poulain, Daniel			Murine Model of Dextran Sulfate Sodium-induced Colitis Reveals Candida glabrata Virulence and Contribution of beta-Mannosyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALBICANS SEROTYPE-A; CELL-WALL MANNAN; CHEMICALLY-INDUCED COLITIS; INTENSIVE-CARE-UNIT; MONOCLONAL-ANTIBODIES; PATHOGENIC YEAST; INTESTINAL COLONIZATION; INFLAMMATORY RESPONSES; INVASIVE CANDIDIASIS; EPITHELIAL-CELLS	Candida glabrata, like Candida albicans, is an opportunistic yeast pathogen that has adapted to colonize all segments of the human gastrointestinal tract and vagina. The C. albicans cell wall expresses beta-1,2-linked mannosides (beta-Mans), promoting its adherence to host cells and tissues. Because beta-Mans are also present in C. glabrata, their role in C. glabrata colonization and virulence was investigated in a murine model of dextran sulfate sodium (DSS)-induced colitis. Five clustered genes of C. glabrata encoding beta-mannosyltransferases, BMT2-BMT6, were deleted simultaneously. beta-Man expression was studied by Western blotting, flow cytometry, and NMR analysis. Mortality, clinical, histologic, and colonization scores were determined in mice receiving DSS and different C. glabrata strains. The results show that C. glabrata bmt2-6 strains had a significant reduction in beta-1,2-Man expression and a disappearance of beta-1,2mannobiose in the acid-stable domain. A single gavage of C. glabrata wild-type strain in mice with DSS-induced colitis caused a loss of body weight, colonic inflammation, and mortality. Mice receiving C. glabrata bmt2-6 mutant strains had normal body weight and reduced colonic inflammation. Lower numbers of colonies of C. glabrata bmt2-6 were recovered from stools and different parts of the gastrointestinal tract. Histopathologic examination revealed that the wild-type strain had a greater ability to colonize tissue and cause tissue damage. These results showed that C. glabrata has a high pathogenic potential in DSS-induced colitis, where beta-Mans contribute to colonization and virulence.	[Jawhara, Samir; Maggiotto, Francois; Fradin, Chantal; Sarazin, Aurore; Dubuquoy, Laurent; Maes, Emmanuel; Guerardel, Yann; Poulain, Daniel] Univ Lille Nord France, F-59000 Lille, France; [Jawhara, Samir; Maggiotto, Francois; Fradin, Chantal; Sarazin, Aurore; Dubuquoy, Laurent; Poulain, Daniel] Univ Lille 2, F-59000 Lille, France; [Jawhara, Samir; Maggiotto, Francois; Fradin, Chantal; Sarazin, Aurore; Dubuquoy, Laurent; Poulain, Daniel] INSERM U995, F-59000 Lille, France; [Mogensen, Estelle; Janbon, Guilhem] Inst Pasteur, F-75724 Paris, France; [Poulain, Daniel] Serv Parasitol Mycol, F-59000 Lille, France; [Poulain, Daniel] Ctr Hosp Reg Univ Lille, F-59000 Lille, France; [Maes, Emmanuel; Guerardel, Yann] Univ Lille 1, UGSF, F-59650 Villeneuve Dascq, France; [Maes, Emmanuel; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Poulain, D (corresponding author), Fac Med Lille, INSERM U995, 1 Pl Verdun, F-59045 Lille, France.	jawhars@ccf.org; dpoulain@univ-lille2.fr	Janbon, Guilhem/AAL-6607-2021; Fradin, Chantal/N-2382-2018; Dubuquoy, laurent/J-4978-2015; Jawhara, Samir/A-9310-2019; Jawhara, Samir/AAC-5789-2019; Poulain, Daniel/C-8683-2014; Dubuquoy, Laurent/N-1623-2019; Janbon, Guilhem/AAW-7398-2021; Poulain, Daniel/I-6095-2018	Fradin, Chantal/0000-0002-3883-4401; Dubuquoy, laurent/0000-0003-3596-5497; Jawhara, Samir/0000-0002-2759-975X; Jawhara, Samir/0000-0002-2759-975X; Janbon, Guilhem/0000-0002-4788-1154; Guerardel, Yann/0000-0003-4967-9512; Poulain, Daniel/0000-0002-0729-5468	ERA-NET [ANR 09 MIEN 03 01]; Lesaffre International [C0592-1]; Centre Commun de Mesure RMN de l'Universite de Lille 1	ERA-NET; Lesaffre International; Centre Commun de Mesure RMN de l'Universite de Lille 1	This work was supported in part by ERA-NET Pathogenomics 006 02 "Fungal Glycoshield Project"; ANR 09 MIEN 03 01 "CaBMTs" project " Structure and Functions of Candida albicans beta-1,2-Mannosyltransferases"; and FP7 Health 260338 " ALLFUN" project " Fungi in the Setting of Inflammation, Allergy, and Autoimmune Diseases: Translating Basic Science into Clinical Practices."; Supported by Lesaffre International Grant C0592-1. Present address: Dept. of Molecular Cardiology, Lerner Research Institute/NB5-48, 9500 Euclid Ave., Cleveland, OH 44195. E-mail: jawhars@ccf.org.; We thank Annick Masset, Caroline Dubuquoy, Emilie Gantier, and Edmone Erdual for excellent technical assistance and Val Hopwood for editing the manuscript. The 400 MHz facility was funded by the Centre Commun de Mesure RMN de l'Universite de Lille 1.	Cormack BP, 1999, GENETICS, V151, P979; Cutler JE, 2001, MED MYCOL, V39, P75, DOI 10.1080/714030992; Dalle F, 2003, INFECT IMMUN, V71, P7061, DOI 10.1128/IAI.71.12.7061-7068.2003; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Dongari-Bagtzoglou A, 2009, ORAL MICROBIOL IMMUN, V24, P249, DOI 10.1111/j.1399-302X.2009.00505.x; Dromer F, 2002, ANTIMICROB AGENTS CH, V46, P3869, DOI 10.1128/AAC.46.12.3869-3876.2002; Edlind TD, 2010, ANTIMICROB AGENTS CH, V54, P4733, DOI 10.1128/AAC.00605-10; Elguezabal N, 2004, ORAL DIS, V10, P81, DOI 10.1046/j.1354-523X.2003.00969.x; Elguezabal N, 2009, EUR J ORAL SCI, V117, P474, DOI 10.1111/j.1600-0722.2009.00642.x; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; FAILLE C, 1992, CARBOHYD RES, V236, P17, DOI 10.1016/0008-6215(92)85004-J; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Fradin C, 2000, INFECT IMMUN, V68, P4391, DOI 10.1128/IAI.68.8.4391-4398.2000; Fradin C, 2008, INFECT IMMUN, V76, P4509, DOI 10.1128/IAI.00368-08; Fukazawa Y, 1997, J MED VET MYCOL, V35, P87; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; HOPWOOD V, 1986, INFECT IMMUN, V54, P222, DOI 10.1128/IAI.54.1.222-227.1986; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Jawhara S, 2008, J INFECT DIS, V197, P972, DOI 10.1086/528990; Jawhara S, 2007, MED MYCOL, V45, P691, DOI 10.1080/13693780701523013; Jouault T, 1997, CLIN DIAGN LAB IMMUN, V4, P328, DOI 10.1128/CDLI.4.3.328-333.1997; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; KOBAYASHI H, 1992, PHYTOCHEMISTRY, V31, P1147, DOI 10.1016/0031-9422(92)80250-I; KOBAYASHI H, 1992, ARCH BIOCHEM BIOPHYS, V294, P662, DOI 10.1016/0003-9861(92)90739-J; KOBAYASHI H, 1992, CARBOHYD RES, V231, P105, DOI 10.1016/0008-6215(92)84012-H; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee I, 2010, AM J INFECT CONTROL, V38, P740, DOI 10.1016/j.ajic.2010.02.016; Li L, 2007, J DENT RES, V86, P204, DOI 10.1177/154405910708600304; Maes E, 2009, J BIOCHEM, V145, P413, DOI 10.1093/jb/mvp008; Martinez-Esparza Maria, 2009, V470, P85, DOI 10.1007/978-1-59745-204-5_8; Masuoka J, 2004, INFECT IMMUN, V72, P6230, DOI 10.1128/IAI.72.11.6230-6236.2004; Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200; Mille C, 2008, J BIOL CHEM, V283, P9724, DOI 10.1074/jbc.M708825200; MIYAKAWA Y, 1992, INFECT IMMUN, V60, P2493, DOI 10.1128/IAI.60.6.2493-2499.1992; Mohanty S, 2007, INDIAN J MED RES, V126, P216; Okawa Y, 2006, BIOL PHARM BULL, V29, P187, DOI 10.1248/bpb.29.187; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Playford EG, 2010, DRUGS, V70, P823, DOI 10.2165/10898550-000000000-00000; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; SHIBATA N, 1989, CARBOHYD RES, V187, P239, DOI 10.1016/0008-6215(89)80006-0; Shibata N, 2007, BIOCHEM J, V404, P365, DOI 10.1042/BJ20070081; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Suzuki Shigeo, 1997, Current Topics in Medical Mycology, V8, P57; Swinne D, 2009, EPIDEMIOL INFECT, V137, P1037, DOI 10.1017/S0950268808001763; Tada R, 2008, MICROB PATHOGENESIS, V44, P379, DOI 10.1016/j.micpath.2007.10.013; Trick WE, 2002, CLIN INFECT DIS, V35, P627, DOI 10.1086/342300; TRINEL PA, 1992, INFECT IMMUN, V60, P3845, DOI 10.1128/IAI.60.9.3845-3851.1992; Whittem C.G., 2010, J VIS EXP	52	31	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11313	11324		10.1074/jbc.M111.329300	http://dx.doi.org/10.1074/jbc.M111.329300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22291009	hybrid, Green Published			2022-12-25	WOS:000302780100062
J	Pou, C; la Cour, CM; Stoddart, LA; Millan, MJ; Milligan, G				Pou, Chantevy; la Cour, Clotilde Mannoury; Stoddart, Leigh A.; Millan, Mark J.; Milligan, Graeme			Functional Homomers and Heteromers of Dopamine D-2L and D-3 Receptors Co-exist at the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANNABINOID CB1 RECEPTOR; G-PROTEIN ACTIVATION; TIME-RESOLVED FRET; OPIOID RECEPTOR; OREXIN OX1; AGONIST; BRAIN; DIMERIZATION; BINDING; DIMERS	Human dopamine D-2long and D-3 receptors were modified by N-terminal addition of SNAP or CLIP forms of O-6-alkylguanine-DNA-alkyltransferase plus a peptide epitope tag. Cells able to express each of these four constructs only upon addition of an antibiotic were established and used to confirm regulated and inducible control of expression, the specificity of SNAP and CLIP tag covalent labeling reagents, and based on homogenous time-resolved fluorescence resonance energy transfer, the presence of cell surface D-2long and D-3 receptor homomers. Following constitutive expression of reciprocal constructs, potentially capable of forming and reporting the presence of cell surface D-2long-D-3 heteromers, individual clones were assessed for levels of expression of the constitutively expressed protomer. This was unaffected by induction of the partner protomer and the level of expression of the partner required to generate detectable cell surface D-2long-D-3 heteromers was defined. Such homomers and heteromers were found to co-exist and using a reconstitution of function approach both homomers and heteromers of D-2long and D-3 receptors were shown to be functional, potentially via trans-activation of associated G protein. These studies demonstrate the ability of dopamine D-2long and D-3 receptors to form both homomers and heteromers, and show that in cells expressing each subtype a complex mixture of homomers and heteromers co-exists at steady state. These data are of potential importance both to disorders in which D-2long and D-3 receptors are implicated, like schizophrenia and Parkinson disease, and also to drugs exerting their actions via these sites.	[Pou, Chantevy; Stoddart, Leigh A.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [la Cour, Clotilde Mannoury; Millan, Mark J.] Inst Rech Servier, Unite Rech & Decouverte Neurosci, F-78290 Croissy Sur Seine, France	University of Glasgow; Servier; Institut de Recherches Internationales Servier	Milligan, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519; Stoddart, Leigh/0000-0002-4469-0600	MRC [G0900050] Funding Source: UKRI; Medical Research Council [G0900050] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Alvarez-Curto E, 2010, ANAL BIOANAL CHEM, V398, P167, DOI 10.1007/s00216-010-3823-4; Armstrong D, 2001, J BIOL CHEM, V276, P22621, DOI 10.1074/jbc.M006936200; Baragli A, 2007, CELL SIGNAL, V19, P2304, DOI 10.1016/j.cellsig.2007.07.007; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Burt AR, 1996, BIOCHEM J, V320, P227, DOI 10.1042/bj3200227; Carrillo JJ, 2003, J BIOL CHEM, V278, P42578, DOI 10.1074/jbc.M306165200; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Franco R, 2010, SYNAPSE, V64, P566, DOI 10.1002/syn.20775; Gardner EL, 2011, ADV PSYCHOSOM MED, V30, P22, DOI 10.1159/000324065; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gupta A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000807; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hasbi A, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-26; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Joyce JN, 2001, SYNAPSE, V40, P137, DOI 10.1002/syn.1035; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Lane JR, 2008, J PHARMACOL EXP THER, V325, P319, DOI 10.1124/jpet.107.134296; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; Leck KJ, 2006, NEUROPHARMACOLOGY, V51, P597, DOI 10.1016/j.neuropharm.2006.05.002; Lee SP, 2003, BIOCHEMISTRY-US, V42, P11023, DOI 10.1021/bi0345539; LIST SJ, 1981, P NATL ACAD SCI-BIOL, V78, P2620, DOI 10.1073/pnas.78.4.2620; Liu XY, 2011, CELL, V147, P447, DOI 10.1016/j.cell.2011.08.043; Maggio R, 2003, J NEUROCHEM, V87, P631, DOI 10.1046/j.1471-4159.2003.02038.x; Maggio R, 2009, PARKINSONISM RELAT D, V15, pS2, DOI 10.1016/S1353-8020(09)70826-0; Maggio R, 2010, CURR OPIN PHARMACOL, V10, P100, DOI 10.1016/j.coph.2009.10.001; Maggio Roberto, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS139, DOI 10.1016/j.parkreldis.2008.04.018; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2004, BIOCHEM SOC T, V32, P847, DOI 10.1042/BST0320847; Milligan G, 2009, BRIT J PHARMACOL, V158, P1, DOI 10.1111/j.1476-5381.2009.00422.x; Milligan G, 2007, CURR OPIN PHARMACOL, V7, P521, DOI 10.1016/j.coph.2007.06.007; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Newman-Tancredi A, 1999, MOL PHARMACOL, V55, P564; Nickolls SA, 2004, NEUROPHARMACOLOGY, V47, P860, DOI 10.1016/j.neuropharm.2004.06.010; Nimchinsky EA, 1997, J BIOL CHEM, V272, P29229, DOI 10.1074/jbc.272.46.29229; Novi F, 2007, J NEUROCHEM, V102, P1410, DOI 10.1111/j.1471-4159.2007.04660.x; O'Dowd BF, 2011, EUR J PHARMACOL, V658, P74, DOI 10.1016/j.ejphar.2011.02.030; Pascal G, 2005, MOL PHARMACOL, V68, P905, DOI 10.1124/mol.105.013847; Perreault ML, 2011, CNS NEUROSCI THER, V17, P52, DOI 10.1111/j.1755-5949.2010.00228.x; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Rashid AJ, 2007, TRENDS PHARMACOL SCI, V28, P551, DOI 10.1016/j.tips.2007.10.001; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Schetz J. A., 2007, HDB CONT NEUROPHARMA, P221; Smith NJ, 2010, PHARMACOL REV, V62, P701, DOI 10.1124/pr.110.002667; Tadori Y, 2011, EUR J PHARMACOL, V666, P43, DOI 10.1016/j.ejphar.2011.05.050; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Van Craenenbroeck K, 2011, FEBS J, V278, P1333, DOI 10.1111/j.1742-4658.2011.08052.x; Wang M, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-25; Ward RJ, 2011, J BIOL CHEM, V286, P37414, DOI 10.1074/jbc.M111.287649; Ward RJ, 2011, BRIT J PHARMACOL, V162, P1439, DOI 10.1111/j.1476-5381.2010.01156.x; Xu JB, 2010, SYNAPSE, V64, P449, DOI 10.1002/syn.20748	61	38	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8864	8878		10.1074/jbc.M111.326678	http://dx.doi.org/10.1074/jbc.M111.326678			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291025	Green Published, hybrid			2022-12-25	WOS:000301797800018
J	Bragado, P; Estrada, Y; Sosa, MS; Avivar-Valderas, A; Cannan, D; Genden, E; Teng, M; Ranganathan, AC; Wen, HC; Kapoor, A; Bernstein, E; Aguirre-Ghiso, JA				Bragado, Paloma; Estrada, Yeriel; Sosa, Maria Soledad; Avivar-Valderas, Alvaro; Cannan, David; Genden, Eric; Teng, Marita; Ranganathan, Aparna C.; Wen, Huei-Chi; Kapoor, Avnish; Bernstein, Emily; Aguirre-Ghiso, Julio A.			Analysis of Marker-Defined HNSCC Subpopulations Reveals a Dynamic Regulation of Tumor Initiating Properties	PLOS ONE			English	Article							CANCER STEM-CELLS; ALDEHYDE DEHYDROGENASE; HUMAN CARCINOMA; UROKINASE RECEPTOR; MELANOMA-CELLS; IN-VIVO; CHROMATIN-STRUCTURE; SELF-RENEWAL; COLON-CANCER; GROWTH	Head and neck squamous carcinoma (HNSCC) tumors carry dismal long-term prognosis and the role of tumor initiating cells (TICs) in this cancer is unclear. We investigated in HNSCC xenografts whether specific tumor subpopulations contributed to tumor growth. We used a CFSE-based label retentions assay, CD49f (alpha 6-integrin) surface levels and aldehyde dehydrogenase (ALDH) activity to profile HNSCC subpopulations. The tumorigenic potential of marker-positive and -negative subpopulations was tested in nude (Balb/c nu/nu) and NSG (NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ) mice and chicken embryo chorioallantoic membrane (CAM) assays. Here we identified in HEp3, SQ20b and FaDu HNSCC xenografts a subpopulation of G0/G1-arrested slow-cycling CD49f(high)/ALDH1A1(high)/H3K4/K27me3(low) subpopulation (CD49f+) of tumor cells. A strikingly similar CD49f(high)/H3K27me3(low) subpopulation is also present in primary human HNSCC tumors and metastases. While only sorted CD49f(high)/ALDH(high), label retaining cells (LRC) proliferated immediately in vivo, with time the CD49f(low)/ALDH(low), non-LRC (NLRC) tumor cell subpopulations were also able to regain tumorigenic capacity; this was linked to restoration of CD49f(high)/ALDH(high), label retaining cells. In addition, CD49f is required for HEp3 cell tumorigenicity and to maintain low levels of H3K4/K27me3. CD49f+ cells also displayed reduced expression of the histone-lysine N-methyltransferase EZH2 and ERK1/2phosphorylation. This suggests that although transiently quiescent, their unique chromatin structure is poised for rapid transcriptional activation. CD49f- cells can "reprogram" and also achieve this state eventually. We propose that in HNSCC tumors, epigenetic mechanisms likely driven by CD49f signaling dynamically regulate HNSCC xenograft phenotypic heterogeneity. This allows multiple tumor cell subpopulations to drive tumor growth suggesting that their dynamic nature renders them a "moving target" and their eradication might require more persistent strategies.	[Bragado, Paloma; Estrada, Yeriel; Sosa, Maria Soledad; Avivar-Valderas, Alvaro; Wen, Huei-Chi; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Div Hematol & Oncol, Dept Med, New York, NY 10029 USA; [Bragado, Paloma; Estrada, Yeriel; Sosa, Maria Soledad; Avivar-Valderas, Alvaro; Cannan, David; Genden, Eric; Teng, Marita; Ranganathan, Aparna C.; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Dept Otolaryngol, New York, NY USA; [Kapoor, Avnish; Bernstein, Emily] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Kapoor, Avnish; Bernstein, Emily] Mt Sinai Sch Med, Dept Dermatol, New York, NY USA; [Bernstein, Emily; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Bernstein, Emily; Aguirre-Ghiso, Julio A.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bragado, P (corresponding author), Mt Sinai Sch Med, Div Hematol & Oncol, Dept Med, New York, NY 10029 USA.	julio.aguirre-ghiso@mssm.edu	Wen, Huei-Chi/ABD-7417-2021; Bragado Domingo, Paloma/A-8679-2015	Bragado Domingo, Paloma/0000-0002-7642-1245; Aguirre-Ghiso, Julio/0000-0002-6694-6507	National Institutes of Health-Nactional Cancer Institute [5R24CA095823-04]; National Science Fundation [DBI-9724504]; National Institutes of Health [1 S10RR0 9145-01]; Samuel Waxman Cancer Research Foundation; National Cancer Institute [CA109182]; national institute of environmental Health Science [ES017146]; New York State Stem cell Science (NYSTEM); NYSTEM IDEA [C024285]; National Institute of Dental and Craneofacial Research [DE020121]; NATIONAL CANCER INSTITUTE [R24CA095823, R01CA109182] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017146] Funding Source: NIH RePORTER	National Institutes of Health-Nactional Cancer Institute; National Science Fundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); national institute of environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); New York State Stem cell Science (NYSTEM); NYSTEM IDEA; National Institute of Dental and Craneofacial Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Confocal laser scanning microscopy was performed at the Mount Sinai School of medicine-Microscopy Shared Resources Facility, supported with funding from National Institutes of Health-Nactional Cancer Institute shared resources grant (5R24CA095823-04), National Science Fundation Major Research Instrumentation grant (DBI-9724504) and National Institutes of Health shared instrumentation grant (1 S10RR0 9145-01). This work was supported by grants from the Samuel Waxman Cancer Research Foundation Tumor Dormancy Program, National Cancer Institute (CA109182), national institute of environmental Health Science (ES017146) and New York State Stem cell Science (NYSTEM) to J.A.A-G, NYSTEM IDEA Award C024285 to E. B., and National Institute of Dental and Craneofacial Research (DE020121 to A.C.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863; Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brummendorf TH, 1998, J EXP MED, V188, P1117, DOI 10.1084/jem.188.6.1117; Brummendorf TH, 1999, ANN NY ACAD SCI, V872, P265, DOI 10.1111/j.1749-6632.1999.tb08471.x; Cho DY, 2011, CELL TRANSPLANT, V20, P121, DOI 10.3727/096368910X532774; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; CORTESINA G, 1995, ACTA OTO-LARYNGOL, V115, P328, DOI 10.3109/00016489509139322; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Essers MAG, 2010, MOL ONCOL, V4, P443, DOI 10.1016/j.molonc.2010.06.001; Garzino-Demo P, 1998, ORAL ONCOL, V34, P204, DOI 10.1016/S1368-8375(97)00059-6; Ghiso JAA, 1999, EUR J BIOCHEM, V263, P295, DOI 10.1046/j.1432-1327.1999.00507.x; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Graziano M, 1998, EXP CELL RES, V240, P75, DOI 10.1006/excr.1997.3900; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Inoue K, 2009, LAB INVEST, V89, P844, DOI 10.1038/labinvest.2009.48; Izadyar F, 2011, HUM REPROD, V26, P1296, DOI 10.1093/humrep/der026; Jiang S, 2010, HISTOCHEM CELL BIOL, V133, P455, DOI 10.1007/s00418-010-0684-z; Jo MJ, 2010, CANCER RES, V70, P8948, DOI 10.1158/0008-5472.CAN-10-1936; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Myers Eugene N, 2010, Otolaryngol Pol, V64, P204, DOI 10.1016/S0030-6657(10)70017-2; Myers Eugene N, 2010, Otolaryngol Pol, V64, P136, DOI 10.1016/S0030-6657(10)70049-4; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; OSSOWSKI L, 1983, CELL, V33, P323, DOI 10.1016/0092-8674(83)90414-2; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; OSSOWSKI L, 1987, J CELL PHYSIOL, V133, P288, DOI 10.1002/jcp.1041330212; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Trusolino L, 2000, FASEB J, V14, P1629, DOI 10.1096/fj.14.11.1629; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weinberg R, 2010, NAT MED, V16, P758, DOI 10.1038/nm0710-758; WENZEL CT, 1995, ARCH OTOLARYNGOL, V121, P1279; Yang L, 2006, CANCER RES, V66, P7957, DOI 10.1158/0008-5472.CAN-05-3208	61	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29974	10.1371/journal.pone.0029974	http://dx.doi.org/10.1371/journal.pone.0029974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276135	Green Submitted, Green Published, gold			2022-12-25	WOS:000301568100020
J	Puig, KL; Floden, AM; Adhikari, R; Golovko, MY; Combs, CK				Puig, Kendra L.; Floden, Angela M.; Adhikari, Ramchandra; Golovko, Mikhail Y.; Combs, Colin K.			Amyloid Precursor Protein and Proinflammatory Changes Are Regulated in Brain and Adipose Tissue in a Murine Model of High Fat Diet-Induced Obesity	PLOS ONE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; BODY-MASS INDEX; TUMOR-NECROSIS-FACTOR; MONOCYTIC LINEAGE CELLS; INSULIN-RESISTANCE; MICROGLIAL CELLS; METABOLIC SYNDROME; INTERFERON-GAMMA; MESSENGER-RNAS; OLDER-ADULTS	Background: Middle age obesity is recognized as a risk factor for Alzheimer's disease (AD) although a mechanistic linkage remains unclear. Based upon the fact that obese adipose tissue and AD brains are both areas of proinflammatory change, a possible common event is chronic inflammation. Since an autosomal dominant form of AD is associated with mutations in the gene coding for the ubiquitously expressed transmembrane protein, amyloid precursor protein (APP) and recent evidence demonstrates increased APP levels in adipose tissue during obesity it is feasible that APP serves some function in both disease conditions. Methodology/Principal Findings: To determine whether diet-induced obesity produced proinflammatory changes and altered APP expression in brain versus adipose tissue, 6 week old C57BL6/J mice were maintained on a control or high fat diet for 22 weeks. Protein levels and cell-specific APP expression along with markers of inflammation and immune cell activation were compared between hippocampus, abdominal subcutaneous fat and visceral pericardial fat. APP stimulation-dependent changes in macrophage and adipocyte culture phenotype were examined for comparison to the in vivo changes. Conclusions/Significance: Adipose tissue and brain from high fat diet fed animals demonstrated increased TNF-alpha and microglial and macrophage activation. Both brains and adipose tissue also had elevated APP levels localizing to neurons and macrophage/adipocytes, respectively. APP agonist antibody stimulation of macrophage cultures increased specific cytokine secretion with no obvious effects on adipocyte culture phenotype. These data support the hypothesis that high fat diet-dependent obesity results in concomitant pro-inflammatory changes in brain and adipose tissue that is characterized, in part, by increased levels of APP that may be contributing specifically to inflammatory changes that occur.	[Puig, Kendra L.; Floden, Angela M.; Adhikari, Ramchandra; Golovko, Mikhail Y.; Combs, Colin K.] Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Puig, KL (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58201 USA.	colin.combs@med.und.edu		Golovko, Mikhail/0000-0003-1749-3158	NIH/NCRR [1P20 RR17699]; NIH/NIA [1R01AG026330]; National Science Foundation Research Experience for Undergraduates (REU) [0639227]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026330] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation Research Experience for Undergraduates (REU)(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH/NCRR 1P20 RR17699, NIH/NIA 1R01AG026330, and in part by National Science Foundation Research Experience for Undergraduates (REU) Site Grant no. 0639227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Balakrishnan K, 2005, J ALZHEIMERS DIS, V8, P269; BANATI RB, 1995, J CEREBR BLOOD F MET, V15, P647, DOI 10.1038/jcbfm.1995.80; BANATI RB, 1994, NEUROPATH APPL NEURO, V20, P194; BANATI RB, 1995, GLIA, V14, P209, DOI 10.1002/glia.440140306; BANATI RB, 1994, NEUROREPORT, V5, P1359, DOI 10.1097/00001756-199406270-00016; BANATI RB, 1993, GLIA, V9, P199, DOI 10.1002/glia.440090305; Barile L, 1993, Arch Med Res, V24, P189; BAUER J, 1991, FEBS LETT, V282, P335, DOI 10.1016/0014-5793(91)80508-Z; BENDOTTI C, 1988, P NATL ACAD SCI USA, V85, P3628, DOI 10.1073/pnas.85.10.3628; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Bitting L, 1996, J BIOL CHEM, V271, P16084, DOI 10.1074/jbc.271.27.16084; BLUME AJ, 1989, NEUROBIOL AGING, V10, P406, DOI 10.1016/0197-4580(89)90077-8; Blume AJ, 1989, NEUROBIOL AGING, V10, P412; Borst SE, 2005, LIFE SCI, V77, P2156, DOI 10.1016/j.lfs.2005.03.021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS AW, 1977, J BIOL CHEM, V252, P1998; Coenen KR, 2007, DIABETES, V56, P564, DOI 10.2337/db06-1375; Combs CK, 1999, J NEUROSCI, V19, P928; DOHERTY TM, 1993, J IMMUNOL, V151, P7151; Eskelinen MH, 2008, INT J GERIATR PSYCH, V23, P741, DOI 10.1002/gps.1969; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Fain JN, 2010, OBESITY, V18, P890, DOI 10.1038/oby.2009.335; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Fernyhough ME, 2004, CYTOTECHNOLOGY, V46, P163, DOI 10.1007/s10616-005-2602-0; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Floden AM, 2006, J NEUROSCI, V26, P4644, DOI 10.1523/JNEUROSCI.4822-05.2006; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; GEHRMANN J, 1995, GLIA, V15, P141, DOI 10.1002/glia.440150206; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Golovko MY, 2008, J LIPID RES, V49, P893, DOI 10.1194/jlr.D700030-JLR200; Gomez-Casanovas E, 2001, ARTHRITIS RHEUM, V44, P66, DOI 10.1002/1529-0131(200101)44:1<66::AID-ANR10>3.0.CO;2-H; Gunstad J, 2008, INT J NEUROSCI, V118, P1582, DOI 10.1080/00207450701392282; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Gunstad J, 2006, J GERIATR PSYCH NEUR, V19, P59, DOI 10.1177/0891988705284738; HAASS C, 1991, J NEUROSCI, V11, P3783; Hayden KM, 2007, NEUROLOGY, V69, P275, DOI 10.1212/01.wnl.0000265223.25679.2a; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hughes TF, 2009, NEUROLOGY, V72, P1741, DOI 10.1212/WNL.0b013e3181a60a58; HUNG AY, 1992, P NATL ACAD SCI USA, V89, P9439, DOI 10.1073/pnas.89.20.9439; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jeong SK, 2005, DEMENT GERIATR COGN, V19, P91, DOI 10.1159/000082659; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kim DH, 2008, AM J PHYSIOL-ENDOC M, V295, pE1038, DOI 10.1152/ajpendo.00061.2008; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kohjima M, 2010, ENDOCRINOLOGY, V151, P1532, DOI 10.1210/en.2009-1196; Laitinen MH, 2006, DEMENT GERIATR COGN, V22, P99, DOI 10.1159/000093478; LANG E, 1992, BIOCHEM BIOPH RES CO, V187, P783, DOI 10.1016/0006-291X(92)91264-Q; Leahey TM, 2007, NUTR NEUROSCI, V10, P205, DOI 10.1080/10284150701676156; LEBLANC AC, 1991, FEBS LETT, V292, P171, DOI 10.1016/0014-5793(91)80861-V; Lee YH, 2008, OBESITY, V16, P1493, DOI 10.1038/oby.2008.267; Lee YH, 2007, J CARDIOPULM REHABIL, V27, P2; Lee YH, 2009, NEUROENDOCRINOLOGY, V90, P383, DOI 10.1159/000235555; Levin-Allerhand J A, 2002, J Nutr Health Aging, V6, P315; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lorton D, 1996, J NEUROIMMUNOL, V67, P21, DOI 10.1016/S0165-5728(96)00030-6; Lorton D, 2000, NEUROBIOL AGING, V21, P463, DOI 10.1016/S0197-4580(00)00092-0; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Matsubara Y, 2009, ANN NUTR METAB, V54, P258, DOI 10.1159/000229506; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Meijer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017154; MONNING U, 1994, FEBS LETT, V342, P267, DOI 10.1016/0014-5793(94)80514-8; MONNING U, 1995, J BIOL CHEM, V270, P7104, DOI 10.1074/jbc.270.13.7104; Moroz N, 2008, J ALZHEIMERS DIS, V15, P29; NAKARAI H, 2011, INNATE IMMUN; O'Rourke RW, 2009, INT J OBESITY, V33, P978, DOI 10.1038/ijo.2009.133; OHYAGI Y, 1993, MOL BRAIN RES, V18, P127, DOI 10.1016/0169-328X(93)90181-N; Poitou C, 2006, OBESITY, V14, P309, DOI 10.1038/oby.2006.40; Poussin C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003385; Profenno LA, 2008, AM J MED GENET B, V147B, P822, DOI 10.1002/ajmg.b.30694; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Raffaitin C, 2009, DIABETES CARE, V32, P169, DOI 10.2337/dc08-0272; Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93; Razay G, 2006, DEMENT GERIATR COGN, V22, P173, DOI 10.1159/000094586; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Schmechel D E, 1988, Alzheimer Dis Assoc Disord, V2, P96, DOI 10.1097/00002093-198802020-00002; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SMITH CJ, 1993, MOL BRAIN RES, V17, P328, DOI 10.1016/0169-328X(93)90018-K; SOLA C, 1993, MOL BRAIN RES, V17, P41, DOI 10.1016/0169-328X(93)90071-V; Sommer G, 2009, J CELL BIOCHEM, V108, P1418, DOI 10.1002/jcb.22382; Sondag CM, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-22; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Sondag CM, 2006, J NEUROCHEM, V97, P449, DOI 10.1111/j.1471-4159.2006.03759.x; Sondag CM, 2004, J BIOL CHEM, V279, P14456, DOI 10.1074/jbc.M313747200; Thirumangalakudi L, 2008, J NEUROCHEM, V106, P475, DOI 10.1111/j.1471-4159.2008.05415.x; van Dielen FMH, 2001, INT J OBESITY, V25, P1759, DOI 10.1038/sj.ijo.0801825; Wallet MA, 2010, CELL IMMUNOL, V262, P84, DOI 10.1016/j.cellimm.2010.02.013; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065; WILLOUGHBY DA, 1992, EXP NEUROL, V118, P332, DOI 10.1016/0014-4886(92)90191-R; Wu SZ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-2	103	98	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30378	10.1371/journal.pone.0030378	http://dx.doi.org/10.1371/journal.pone.0030378			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276186	Green Submitted, gold, Green Published			2022-12-25	WOS:000301457200056
J	Ho, T; Vessey, KA; Cappai, R; Dinet, V; Mascarelli, F; Ciccotosto, GD; Fletcher, EL				Ho, Tracy; Vessey, Kirstan A.; Cappai, Roberto; Dinet, Virginie; Mascarelli, Frederic; Ciccotosto, Giuseppe D.; Fletcher, Erica L.			Amyloid Precursor Protein Is Required for Normal Function of the Rod and Cone Pathways in the Mouse Retina	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; ALZHEIMERS-DISEASE; DIRECTION SELECTIVITY; TRANSGENIC MICE; BIPOLAR CELLS; OSCILLATORY POTENTIALS; COGNITIVE IMPAIRMENT; COPPER LEVELS; IN-VIVO; A-BETA	Amyloid precursor protein (APP) is a transmembrane glycoprotein frequently studied for its role in Alzheimer's disease. Our recent study in APP knockout (KO) mice identified an important role for APP in modulating normal neuronal development in the retina. However the role APP plays in the adult retina and whether it is required for vision is unknown. In this study we evaluated the role of APP in retinal function and morphology comparing adult wildtype (WT) and APP-KO mice. APP was expressed on neuronal cells of the inner retina, including horizontal, cone bipolar, amacrine and ganglion cells in WT mice. The function of the retina was assessed using the electroretinogram and although the rod photoreceptor responses were similar in APP-KO and WT mice, the post-photoreceptor, inner retinal responses of both the rod and cone pathways were reduced in APP-KO mice. These changes in inner retinal function did not translate to a substantial change in visual acuity as assessed using the optokinetic response or to changes in the gross cellular structure of the retina. These findings indicate that APP is not required for basic visual function, but that it is involved in modulating inner retinal circuitry.	[Ho, Tracy; Vessey, Kirstan A.; Fletcher, Erica L.] Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic, Australia; [Ho, Tracy; Cappai, Roberto; Ciccotosto, Giuseppe D.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Ho, Tracy; Cappai, Roberto; Ciccotosto, Giuseppe D.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Dinet, Virginie; Mascarelli, Frederic] Univ Paris 05, Ctr Rech Cordeliers, Paris, France; [Dinet, Virginie; Mascarelli, Frederic] Inst Natl Sante & Rech Med, Paris, France; [Dinet, Virginie; Mascarelli, Frederic] Univ Paris 06, Paris, France	University of Melbourne; University of Melbourne; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Ho, T (corresponding author), Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic, Australia.	e.fletcher@unimelb.edu.au	Mascarelli, Frederic/L-8916-2018; Cappai, Roberto/B-3347-2010; Fletcher, Erica/E-6364-2012	Dinet, virginie/0000-0002-5458-0253; Cappai, Roberto/0000-0002-9505-8496; Fletcher, Erica/0000-0001-9412-9523; Ho, Tracy/0000-0002-9277-7823; Vessey, Kirstan/0000-0003-1031-1964	National Health and Medical Research Council (NHMRC) of Australia [566815, 400202]; Retina Australia; Macular Degeneration Foundation; Agence Nationale de la Recherche	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Retina Australia; Macular Degeneration Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (No. 566815 to ELF, No. 400202 to RC), and with grants from Retina Australia, the Macular Degeneration Foundation and the Agence Nationale de la Recherche (FM and VD). RC is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AU, 2002, EUR NEUROL, V47, P165, DOI 10.1159/000047976; Bellingham SA, 2004, J NEUROCHEM, V91, P423, DOI 10.1111/j.1471-4159.2004.02731.x; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Chen ST, 1997, NEUROREPORT, V8, P713, DOI 10.1097/00001756-199702100-00027; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Danesh-Meyer HV, 2006, NEUROLOGY, V67, P1852, DOI 10.1212/01.wnl.0000244490.07925.8b; Dinet V, 2011, ACTA NEUROPATHOL, V121, P351, DOI 10.1007/s00401-010-0762-2; Dong CJ, 2002, VISION RES, V42, P1081, DOI 10.1016/S0042-6989(02)00032-9; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Goldblum D, 2007, INVEST OPHTH VIS SCI, V48, P5085, DOI 10.1167/iovs.06-1249; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Herard AS, 2006, NEUROBIOL AGING, V27, P1740, DOI 10.1016/j.neurobiolaging.2005.10.020; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kaden D, 2011, EUR J CELL BIOL; Kirby E, 2010, J ALZHEIMERS DIS, V21, P15, DOI 10.3233/JAD-2010-080785; Lee KJ, 2010, NEUROSCIENCE, V169, P344, DOI 10.1016/j.neuroscience.2010.04.078; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; LOFFLER KU, 1995, INVEST OPHTH VIS SCI, V36, P24; Lukasiewicz PD, 2004, VISION RES, V44, P3289, DOI 10.1016/j.visres.2004.07.023; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; May CA, 2008, ACTA OPHTHALMOL, V86, P395, DOI 10.1111/j.1600-0420.2007.01054.x; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; Needham BE, 2008, J PATHOL, V215, P155, DOI 10.1002/path.2343; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Pinto LH, 2007, VISUAL NEUROSCI, V24, P111, DOI 10.1017/S0952523807070149; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shimazawa M, 2008, J NEUROCHEM, V107, P279, DOI 10.1111/j.1471-4159.2008.05606.x; Shirato S, 2008, EXP EYE RES, V86, P914, DOI 10.1016/j.exer.2008.03.008; Ueno S, 2004, INVEST OPHTH VIS SCI, V45, P1033, DOI 10.1167/iovs.03-0657; Vessey KA, 2011, J COMP NEUROL, V519, P506, DOI 10.1002/cne.22530; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wang X, 2000, EXP BRAIN RES, V132, P476, DOI 10.1007/s002210000360; Wang ZL, 2009, J NEUROSCI, V29, P10788, DOI 10.1523/JNEUROSCI.2132-09.2009; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; White AR, 1998, J NEUROSCI, V18, P6207; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yang L, 2007, NEUROSCIENCE, V149, P768, DOI 10.1016/j.neuroscience.2007.08.025; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zhou ZJ, 2008, J PHYSIOL-LONDON, V586, P4371, DOI 10.1113/jphysiol.2008.159020	63	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29892	10.1371/journal.pone.0029892	http://dx.doi.org/10.1371/journal.pone.0029892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279552	gold, Green Published			2022-12-25	WOS:000299771900030
J	Stefan, MI; Marshall, DP; Le Novere, N				Stefan, Melanie I.; Marshall, David P.; Le Novere, Nicolas			Structural Analysis and Stochastic Modelling Suggest a Mechanism for Calmodulin Trapping by CaMKII	PLOS ONE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; D-ASPARTIC ACID; DENDRITIC SPINE; MOLECULAR-BASIS; MUTANT MICE; CALCIUM; ACTIVATION; ALPHA; AUTOPHOSPHORYLATION	Activation of CaMKII by calmodulin and the subsequent maintenance of constitutive activity through autophosphorylation at threonine residue 286 (Thr286) are thought to play a major role in synaptic plasticity. One of the effects of autophosphorylation at Thr286 is to increase the apparent affinity of CaMKII for calmodulin, a phenomenon known as "calmodulin trapping". It has previously been suggested that two binding sites for calmodulin exist on CaMKII, with high and low affinities, respectively. We built structural models of calmodulin bound to both of these sites. Molecular dynamics simulation showed that while binding of calmodulin to the supposed low-affinity binding site on CaMKII is compatible with closing (and hence, inactivation) of the kinase, and could even favour it, binding to the high-affinity site is not. Stochastic simulations of a biochemical model showed that the existence of two such binding sites, one of them accessible only in the active, open conformation, would be sufficient to explain calmodulin trapping by CaMKII. We can explain the effect of CaMKII autophosphorylation at Thr286 on calmodulin trapping: It stabilises the active state and therefore makes the high-affinity binding site accessible. Crucially, a model with only one binding site where calmodulin binding and CaMKII inactivation are strictly mutually exclusive cannot reproduce calmodulin trapping. One of the predictions of our study is that calmodulin binding in itself is not sufficient for CaMKII activation, although high-affinity binding of calmodulin is.	[Stefan, Melanie I.; Marshall, David P.; Le Novere, Nicolas] EMBL European Bioinformat Inst, Hinxton, S Cambs, England	European Molecular Biology Laboratory (EMBL)	Stefan, MI (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	lenov@ebi.ac.uk		Stefan, Melanie/0000-0002-6086-7357				[Anonymous], 2009, PYMOL MOL GRAPH SYST; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brnjic S, 2010, MOL BIOSYST, V6, P767, DOI 10.1039/b920805d; Byrne MJ, 2009, J COMPUT NEUROSCI, V27, P621, DOI 10.1007/s10827-009-0173-3; Case D. A., 2002, AMBER 7; Chin D, 2002, BIOCHEMISTRY-US, V41, P14001, DOI 10.1021/bi025640o; Cohen MB, 2009, J CELL BIOCHEM, V106, P363, DOI 10.1002/jcb.22022; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; Dosemeci A, 1996, BIOPHYS J, V70, P2493, DOI 10.1016/S0006-3495(96)79821-1; HANLEY RM, 1988, BIOCHEM BIOPH RES CO, V152, P122, DOI 10.1016/S0006-291X(88)80688-0; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hoffman L, 2011, EMBO J, V30, P1251, DOI 10.1038/emboj.2011.40; Holmes WR, 2000, J COMPUT NEUROSCI, V8, P65, DOI 10.1023/A:1008969032563; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Jama AM, 2009, J BIOL CHEM, V284, P28146, DOI 10.1074/jbc.M109.005900; Kolodziej SJ, 2000, J BIOL CHEM, V275, P14354, DOI 10.1074/jbc.275.19.14354; Kubota Y, 2001, J COMPUT NEUROSCI, V11, P263, DOI 10.1023/A:1013727331979; Le Novere N, 2001, BIOINFORMATICS, V17, P575, DOI 10.1093/bioinformatics/17.6.575; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lucic V, 2008, EUR BIOPHYS J BIOPHY, V38, P83, DOI 10.1007/s00249-008-0362-4; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1985, J PHYSIOL-LONDON, V361, P65, DOI 10.1113/jphysiol.1985.sp015633; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Okamoto H, 2000, BIOSYSTEMS, V55, P65, DOI 10.1016/S0303-2647(99)00084-2; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Pepke S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000675; Petersen JD, 2003, J NEUROSCI, V23, P11270; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHULMAN H, 1978, NATURE, V271, P478, DOI 10.1038/271478a0; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Singla SI, 2001, J BIOL CHEM, V276, P29353, DOI 10.1074/jbc.M101744200; Stefan MI, 2008, P NATL ACAD SCI USA, V105, P10768, DOI 10.1073/pnas.0804672105; Strack S, 1997, J NEUROCHEM, V68, P2119; Tse JKY, 2007, BIOCHEMISTRY-US, V46, P4017, DOI 10.1021/bi700013y; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6404, DOI 10.1021/bi036224m; Wall ME, 1997, STRUCTURE, V5, P1599, DOI 10.1016/S0969-2126(97)00308-0; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342; Zeng SY, 2010, J NEUROPHYSIOL, V103, P1798, DOI 10.1152/jn.91235.2008; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1	56	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29406	10.1371/journal.pone.0029406	http://dx.doi.org/10.1371/journal.pone.0029406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279535	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000299771900013
J	Bogdanik, LP; Chapman, HD; Miers, KE; Serreze, DV; Burgess, RW				Bogdanik, Laurent P.; Chapman, Harold D.; Miers, Kathy E.; Serreze, David V.; Burgess, Robert W.			A MusD Retrotransposon Insertion in the Mouse Slc6a5 Gene Causes Alterations in Neuromuscular Junction Maturation and Behavioral Phenotypes	PLOS ONE			English	Article							MUSCLE ACETYLCHOLINE-RECEPTOR; SUBUNIT MESSENGER-RNAS; RAT SPINAL-CORD; SKELETAL-MUSCLE; NMDA RECEPTOR; GLYCINE TRANSPORTERS; DIFFERENTIAL REGULATION; SYNAPTIC-TRANSMISSION; ELECTRICAL-ACTIVITY; MYOGENIC FACTORS	Glycine is the major inhibitory neurotransmitter in the spinal cord and some brain regions. The presynaptic glycine transporter, GlyT2, is required for sustained glycinergic transmission through presynaptic reuptake and recycling of glycine. Mutations in SLC6A5, encoding GlyT2, cause hereditary hyperekplexia in humans, and similar phenotypes in knock-out mice, and variants are associated with schizophrenia. We identified a spontaneous mutation in mouse Slc6a5, caused by a MusD retrotransposon insertion. The GlyT2 protein is undetectable in homozygous mutants, indicating a null allele. Homozygous mutant mice are normal at birth, but develop handling-induced spasms at five days of age, and only survive for two weeks, but allow the study of early activity-regulated developmental processes. At the neuromuscular junction, synapse elimination and the switch from embryonic to adult acetylcholine receptor subunits are hastened, consistent with a presumed increase in motor neuron activity, and transcription of acetylcholine receptors is elevated. Heterozygous mice, which show no reduction in lifespan but nonetheless have reduced levels of GlyT2, have a normal thermal sensitivity with the hot-plate test, but differences in repetitive grooming and decreased sleep time with home-cage monitoring. Open-field and elevated plus-maze tests did not detect anxiety-like behaviors; however, the latter showed a hyperactivity phenotype. Importantly, grooming and hyperactivity are observed in mouse schizophrenia models. Thus, mutations in Slc6a5 show changes in neuromuscular junction development as homozygotes, and behavioral phenotypes as heterozygotes, indicating their usefulness for studies related to glycinergic dysfunction.	[Bogdanik, Laurent P.; Chapman, Harold D.; Miers, Kathy E.; Serreze, David V.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Bogdanik, LP (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Robert.burgess@jax.org		Burgess, Robert/0000-0002-9229-3407; Bogdanik, Laurent/0000-0001-7015-6631	National Institutes of Health [NS054154, DK46266]; Juvenile Diabetes Research Foundation; Arthur K. Watson Charitable Trust; Myasthenia Gravis Association; Muscular Dystrophy Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046266, R29DK046266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Arthur K. Watson Charitable Trust; Myasthenia Gravis Association; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institutes of Health (NS054154 to RWB, http://www.ninds.nih.gov/, DK46266 to DVS, http://www2.niddk.nih.gov/), the Juvenile Diabetes Research Foundation (DVS, http://www.jdrf.org/), and fellowships from the Arthur K. Watson Charitable Trust, the Myasthenia Gravis Association, and the Muscular Dystrophy Association (LPB, https://www.mga-charity.org/web/guest; http://www.mda.org/; and internal to The Jackson Laboratory, www.jax.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Jamra R, 2006, PSYCHIAT GENET, V16, P91, DOI 10.1097/01.ypg.0000199450.07786.ab; Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Alvarez FJ, 1999, J PHYSIOL-LONDON, V515, P787, DOI 10.1111/j.1469-7793.1999.787ab.x; Ballard TM, 2002, J NEUROSCI, V22, P6713; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Betz H, 2006, BIOCHEM SOC T, V34, P55, DOI 10.1042/BST0340055; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; BEYER C, 1985, LIFE SCI, V37, P875, DOI 10.1016/0024-3205(85)90523-5; Bradaia A, 2004, J PHYSIOL-LONDON, V559, P169, DOI 10.1113/jphysiol.2004.068858; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Dawe GS, 2009, ANN ACAD MED SINGAP, V38, P425; Deng X, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-58; DUCLERT A, 1991, NEUROREPORT, V2, P25, DOI 10.1097/00001756-199101000-00006; Dugue GP, 2005, J NEUROSCI, V25, P6490, DOI 10.1523/JNEUROSCI.1500-05.2005; ECCLES JC, 1954, J PHYSIOL-LONDON, V126, P524, DOI 10.1113/jphysiol.1954.sp005226; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; Eulenburg V, 2006, BIOCHEM BIOPH RES CO, V348, P400, DOI 10.1016/j.bbrc.2006.07.080; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; FYFFE REW, 1991, BRAIN RES, V547, P175; Gill JL, 2011, NEUROBIOL DIS, V43, P184, DOI 10.1016/j.nbd.2011.03.010; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; GU Y, 1988, NEURON, V1, P117, DOI 10.1016/0896-6273(88)90195-X; Haranishi Y, 2010, ANESTH ANALG, V110, P615, DOI 10.1213/ANE.0b013e3181c7ebbb; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Harvey RJ, 2008, FRONT MOL NEUROSCI, V1; HOLOPAINEN I, 1989, J NEUROSCI RES, V24, P374, DOI 10.1002/jnr.490240306; HOLSTEGE JC, 1991, BRAIN RES, V566, P308, DOI 10.1016/0006-8993(91)91715-D; JANSEN JKS, 1990, PROG NEUROBIOL, V34, P39, DOI 10.1016/0301-0082(90)90025-C; JURSKY F, 1995, J NEUROCHEM, V64, P1026; Kalueff A V, 2009, EXPT ANIMAL MODELS N; Kano H, 2007, P NATL ACAD SCI USA, V104, P19034, DOI 10.1073/pnas.0705483104; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; Labrie V, 2010, NEUROSCI BIOBEHAV R, V34, P351, DOI 10.1016/j.neubiorev.2009.08.002; Mager DL, 2000, J VIROL, V74, P7221, DOI 10.1128/JVI.74.16.7221-7229.2000; MARTINOU JC, 1991, J NEUROSCI, V11, P1291; Martinowich K, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-11; McCool BA, 2007, BEHAV BRAIN RES, V178, P70, DOI 10.1016/j.bbr.2006.12.002; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Missias AC, 1997, DEVELOPMENT, V124, P5075; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Monti JM, 2004, SLEEP MED REV, V8, P133, DOI 10.1016/S1087-0792(02)00158-2; Mosca TJ, 2005, P NATL ACAD SCI USA, V102, P3477, DOI 10.1073/pnas.0406164102; NEVILLE CM, 1992, CELL MOL NEUROBIOL, V12, P511, DOI 10.1007/BF00711232; NUMBERGER M, 1991, EMBO J, V10, P2957, DOI 10.1002/j.1460-2075.1991.tb07846.x; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; Ornung G, 1998, EXP BRAIN RES, V118, P517, DOI 10.1007/s002210050308; Personius KE, 2000, BRAIN RES BULL, V53, P513, DOI 10.1016/S0361-9230(00)00384-1; PRODY CA, 1991, J BIOL CHEM, V266, P22588; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Reiss J, 2001, AM J HUM GENET, V68, P208, DOI 10.1086/316941; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; RENSHAW B, 1946, J NEUROPHYSIOL, V9, P191, DOI 10.1152/jn.1946.9.3.191; Ribet D, 2004, GENOME RES, V14, P2261, DOI 10.1101/gr.2924904; Rodgers RJ, 2010, EUR J PHARMACOL, V646, P31, DOI 10.1016/j.ejphar.2010.08.005; Rousseau F, 2008, J NEUROSCI, V28, P9755, DOI 10.1523/JNEUROSCI.0509-08.2008; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Sherman SE, 1996, PAIN, V66, P321, DOI 10.1016/0304-3959(96)03063-1; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tsai G, 2004, P NATL ACAD SCI USA, V101, P8485, DOI 10.1073/pnas.0402662101; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5; WITZEMANN V, 1991, FEBS LETT, V282, P259, DOI 10.1016/0014-5793(91)80490-T; Xiong W, 2011, NAT CHEM BIOL, V7, P296, DOI 10.1038/nchembio.552; Yee BK, 2006, J NEUROSCI, V26, P3169, DOI 10.1523/JNEUROSCI.5120-05.2006; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349	75	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30217	10.1371/journal.pone.0030217	http://dx.doi.org/10.1371/journal.pone.0030217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272310	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400088
J	Gitau, EN; Tuju, J; Stevenson, L; Kimani, E; Karanja, H; Marsh, K; Bull, PC; Urban, BC				Gitau, Evelyn N.; Tuju, James; Stevenson, Liz; Kimani, Eva; Karanja, Henry; Marsh, Kevin; Bull, Peter C.; Urban, Britta C.			T-Cell Responses to the DBL alpha-Tag, a Short Semi-Conserved Region of the Plasmodium falciparum Membrane Erythrocyte Protein 1	PLOS ONE			English	Article							FUNCTIONAL SPECIALIZATION; ANTIGENIC VARIATION; CYTOKINE PRODUCTION; ACQUIRED-IMMUNITY; MALARIA; SURFACE; TH1; EXPRESSION; FAMILY; IL-10	The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a variant surface antigen expressed on mature forms of infected erythrocytes. It is considered an important target of naturally acquired immunity. Despite its extreme sequence heterogeneity, variants of PfEMP1 can be stratified into distinct groups. Group A PfEMP1 have been independently associated with low host immunity and severe disease in several studies and are now of potential interest as vaccine candidates. Although antigen-specific antibodies are considered the main effector mechanism in immunity to malaria, the induction of efficient and long-lasting antibody responses requires CD4+ T-cell help. To date, very little is known about CD4+ T-cell responses to PfEMP1 expressed on clinical isolates. The DBL alpha-tag is a small region from the DBL alpha-domain of PfEMP1 that can be amplified with universal primers and is accessible in clinical parasite isolates. We identified the dominant expressed PfEMP1 in 41 individual clinical parasite isolates and expressed the corresponding DBL alpha-tag as recombinant antigen. Individual DBL alpha-tags were then used to activate CD4+ T-cells from acute and convalescent blood samples in children who were infected with the respective clinical parasite isolate. Here we show that CD4+ T-cell responses to the homologous DBL alpha-tag were induced in almost all children during acute malaria and maintained in some for 4 months. Children infected with parasites that dominantly expressed group A-like PfEMP1 were more likely to maintain antigen-specific IFN gamma-producing CD4+ T-cells than children infected with parasites dominantly expressing other PfEMP1. These results suggest that group A-like PfEMP1 may induce long-lasting effector memory T-cells that might be able to provide rapid help to variant-specific B cells. Furthermore, a number of children induced CD4+ T-cell responses to heterologous DBL alpha-tags, suggesting that CD4+ T-cells may recognise shared epitopes between several DBL alpha-tags.	[Gitau, Evelyn N.; Tuju, James; Stevenson, Liz; Kimani, Eva; Karanja, Henry; Marsh, Kevin; Bull, Peter C.; Urban, Britta C.] Ctr Geog Med Coast, KEMRI Wellcome Trust Collaborat Programme, Kilifi, Kenya; [Gitau, Evelyn N.; Urban, Britta C.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Marsh, Kevin; Bull, Peter C.] Univ Oxford, Ctr Trop Med, Nuffield Dept Internal Med, Oxford, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford	Gitau, EN (corresponding author), Ctr Geog Med Coast, KEMRI Wellcome Trust Collaborat Programme, Kilifi, Kenya.	b.urban@liv.ac.uk	Urban, Britta/W-6087-2018	Urban, Britta/0000-0002-4197-8393; Bull, Peter/0000-0002-7674-6752; Gitau, Evelyn/0000-0002-5270-7492	Wellcome Trust [079082, 077176, 084535, 084538]	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by Wellcome Trust Senior Fellowship Award to BCU (079082). KM and PCB are supported by Wellcome Trust Programme grants (077176, 084535) and JT is supported by a Wellcome Trust Strategic Award (084538). BCU and PCB are members of the EU FP6 and FP7 Networks of Excellence BioMalPar and EviMalaR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp CEM, 2002, J INFECT DIS, V185, P812, DOI 10.1086/339521; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; DELPRETE G, 1993, J IMMUNOL, V150, P353; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; HVIID L, 1991, FEMS MICROBIOL IMMUN, V76, P219, DOI 10.1016/0378-1097(91)90070-Q; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Ndungu FM, 2006, J IMMUNOL, V176, P5504, DOI 10.4049/jimmunol.176.9.5504; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; PLEBANSKI M, 1992, IMMUNOLOGY, V75, P86; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Sanni Latifu A, 2002, Malar J, V1, P7, DOI 10.1186/1475-2875-1-7; Stephens R, 2005, BLOOD, V106, P1676, DOI 10.1182/blood-2004-10-4047; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; Warimwe GM, 2009, P NATL ACAD SCI US; Zhang HH, 2010, J IMMUNOL, V185, P6646, DOI 10.4049/jimmunol.0904156	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30095	10.1371/journal.pone.0030095	http://dx.doi.org/10.1371/journal.pone.0030095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272280	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000301454400058
J	Guo, Y; Gong, HS; Zhang, J; Xie, WL; Tian, C; Chen, C; Shi, Q; Wang, SB; Xu, Y; Zhang, BY; Dong, XP				Guo, Yan; Gong, Han-Shi; Zhang, Jin; Xie, Wu-Ling; Tian, Chan; Chen, Cao; Shi, Qi; Wang, Shao-Bin; Xu, Yin; Zhang, Bao-Yun; Dong, Xiao-Ping			Remarkable Reduction of MAP2 in the Brains of Scrapie-Infected Rodents and Human Prion Disease Possibly Correlated with the Increase of Calpain	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; ALZHEIMERS-DISEASE; AMYLOID-BETA; TAU-PROTEIN; IN-VITRO; FRAGMENT; DISRUPTION; APOPTOSIS; PRP; OVEREXPRESSION	Microtubule-associated protein 2 (MAP2) belongs to the family of heat stable MAPs, which takes part in neuronal morphogenesis, maintenance of cellular architecture and internal organization, cell division and cellular processes. To obtain insight into the possible alteration and the role of MAP2 in transmissible spongiform encephalopathies (TSEs), the MAP2 levels in the brain tissues of agent 263K-infected hamsters and human prion diseases were evaluated. Western blots and IHC revealed that at the terminal stages of the diseases, MAP2 levels in the brain tissues of scrapie infected hamsters, a patient with genetic Creutzfeldt-Jakob disease (G114V gCJD) and a patient with fatal familial insomnia (FFI) were almost undetectable. The decline of MAP2 was closely related with prolonged incubation time. Exposure of SK-N-SH neuroblastoma cell line to cytotoxic PrP106-126 peptide significantly down-regulated the cellular MAP2 level and remarkably disrupted the microtubule structure, but did not alter the level of tubulin. Moreover, the levels of calpain, which mediated the degradation of a broad of cytoskeletal proteins, were significantly increased in both PrP106-126 treated SK-NSH cells and brain tissues of 263K prion-infected hamsters. Our data indicate that the decline of MAP2 is a common phenomenon in TSEs, which seems to occur at an early stage of incubation period. Markedly increased calpain level might contribute to the reduction of MAP2.	[Guo, Yan; Gong, Han-Shi; Zhang, Jin; Xie, Wu-Ling; Tian, Chan; Chen, Cao; Shi, Qi; Wang, Shao-Bin; Xu, Yin; Zhang, Bao-Yun; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Guo, Y (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	zhjoohyn@sina.com; dongxp238@sina.com	WANG, SHAO-BIN/Z-1810-2018; Xu, Yin/AAO-7503-2021; Chen, Cao/CAF-1246-2022; Wang, Shaobin/C-5507-2008	WANG, SHAO-BIN/0000-0002-6699-9406; Chen, Cao/0000-0002-5193-9283; Wang, Shaobin/0000-0002-1751-9162	China Mega-Project for Infectious Disease [2009ZX10004-101, 2008ZX10004-008]; National Basic Research Program of China (973 Program) [2007CB310505]; Chinese National Natural Science Foundation [30800975]; SKLID (State Key Laboratory for Infectious Disease Prevention and Control) Development [2008SKLID102, 2011SKLID204, 2011SKLID211]	China Mega-Project for Infectious Disease; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); SKLID (State Key Laboratory for Infectious Disease Prevention and Control) Development	This work was supported by China Mega-Project for Infectious Disease (2009ZX10004-101, 2008ZX10004-008), National Basic Research Program of China (973 Program) (2007CB310505), Chinese National Natural Science Foundation Grant (30800975) and SKLID (State Key Laboratory for Infectious Disease Prevention and Control) Development Grant (2008SKLID102, 2011SKLID204 and 2011SKLID211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2002, ACTA NEUROPATHOL, V103, P377, DOI 10.1007/s00401-001-0476-6; Bertipaglia I., 2007, V45, P29; Brown DR, 1998, J NEUROSCI RES, V52, P260, DOI 10.1002/(SICI)1097-4547(19980501)52:3<260::AID-JNR2>3.3.CO;2-P; Brown DR, 2000, BIOCHEM J, V346, P785, DOI 10.1042/0264-6021:3460785; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.3.CO;2-B; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Dehmelt L, 2005, GENOME BIOL, V6; Dewar D, 1997, ACTA NEUROPATHOL, V93, P71, DOI 10.1007/s004010050584; Dong CF, 2008, ARCH BIOCHEM BIOPHYS, V470, P83, DOI 10.1016/j.abb.2007.11.007; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Ettaiche M, 2000, J BIOL CHEM, V275, P36487, DOI 10.1074/jbc.C000579200; Fifre A, 2006, J BIOL CHEM, V281, P229, DOI 10.1074/jbc.M507378200; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Gao RM, 2004, BIOMED ENVIRON SCI, V17, P8; Han J, 2006, SCI CHINA SER C, V49, P473, DOI 10.1007/s11427-006-2019-9; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Irving EA, 1996, ACTA NEUROPATHOL, V92, P186, DOI 10.1007/s004010050507; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li XL, 2011, J MOL NEUROSCI, V43, P316, DOI 10.1007/s12031-010-9443-9; Lopes JP, 2007, CELL MOL NEUROBIOL, V27, P943, DOI 10.1007/s10571-007-9224-3; McHattie SJ, 1999, J NEUROCYTOL, V28, P149, DOI 10.1023/A:1007028323666; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; O'Donovan CN, 2001, J BIOL CHEM, V276, P43516, DOI 10.1074/jbc.M103894200; Osiecka KM, 2009, PROTEINS, V77, P279, DOI 10.1002/prot.22435; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; RIEDERER B, 1985, P NATL ACAD SCI USA, V82, P6006, DOI 10.1073/pnas.82.17.6006; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Seo JS, 2010, NEUROBIOL AGING; Shafit-Zagardo B, 1998, MOL NEUROBIOL, V16, P149, DOI 10.1007/BF02740642; Shi Q, 2011, NEUROPATHOLOGY; Shi XH, 2010, INFECT GENET EVOL, V10, P292, DOI 10.1016/j.meegid.2010.01.007; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1046/j.1365-2613.2000.00169.x; Xiao ZJ, 2010, BRAIN RES, V1361, P115, DOI 10.1016/j.brainres.2010.09.019; Yamaguchi S, 2008, BRAIN RES BULL, V76, P282, DOI 10.1016/j.brainresbull.2008.02.010; Yao HL, 2005, J VET MED B, V52, P437, DOI 10.1111/j.1439-0450.2005.00897.x; Zhou R-M, 2011, PLOS ONE, V26, P379; Zhou RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023079	43	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30163	10.1371/journal.pone.0030163	http://dx.doi.org/10.1371/journal.pone.0030163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272295	Green Submitted, gold, Green Published			2022-12-25	WOS:000301454400073
J	Siu, HC; Jin, L; Xiong, MM				Siu, Hoicheong; Jin, Li; Xiong, Momiao			Manifold Learning for Human Population Structure Studies	PLOS ONE			English	Article							STRATIFICATION; REDUCTION	The dimension of the population genetics data produced by next-generation sequencing platforms is extremely high. However, the "intrinsic dimensionality" of sequence data, which determines the structure of populations, is much lower. This motivates us to use locally linear embedding (LLE) which projects high dimensional genomic data into low dimensional, neighborhood preserving embedding, as a general framework for population structure and historical inference. To facilitate application of the LLE to population genetic analysis, we systematically investigate several important properties of the LLE and reveal the connection between the LLE and principal component analysis (PCA). Identifying a set of markers and genomic regions which could be used for population structure analysis will provide invaluable information for population genetics and association studies. In addition to identifying the LLE-correlated or PCA-correlated structure informative marker, we have developed a new statistic that integrates genomic information content in a genomic region for collectively studying its association with the population structure and LASSO algorithm to search such regions across the genomes. We applied the developed methodologies to a low coverage pilot dataset in the 1000 Genomes Project and a PHASE III Mexico dataset of the HapMap. We observed that 25.1%, 44.9% and 21.4% of the common variants and 89.2%, 92.4% and 75.1% of the rare variants were the LLE-correlated markers in CEU, YRI and ASI, respectively. This showed that rare variants, which are often private to specific populations, have much higher power to identify population substructure than common variants. The preliminary results demonstrated that next generation sequencing offers a rich resources and LLE provide a powerful tool for population structure analysis.	[Siu, Hoicheong; Jin, Li] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Xiong, Momiao] Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX USA	Fudan University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Siu, HC (corresponding author), Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	Momiao.Xiong@uth.tmc.edu	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	CORT from the National Institutes of Health [1R01HL106034-01, 1R01AR057120-01, 1U01HG005728-01, P01 AR052915-01A1, P50 AR054144-01]; NIAMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106034] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054144, P01AR052915, R01AR057120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104411] Funding Source: NIH RePORTER	CORT from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by Grant 1R01HL106034-01, 1R01AR057120-01, 1U01HG005728-01, P01 AR052915-01A1 and P50 AR054144-01 CORT from the National Institutes of Health and NIAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Belkin M, 2002, ADV NEUR IN, V14, P585; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Cai Deng, 2007, IEEE INT C COMP VIS; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Friedman J, 2007, ANN APPL STAT, V1, P302, DOI 10.1214/07-AOAS131; Guan WH, 2009, GENET EPIDEMIOL, V33, P508, DOI 10.1002/gepi.20403; Henn BM, 2010, HUM MOL GENET, V19, pR221, DOI 10.1093/hmg/ddq403; Izenman A. J., 2008, MODERN MULTIVARIATE; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; Kosman E, 2005, MOL ECOL, V14, P415, DOI 10.1111/j.1365-294X.2005.02416.x; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Lee AB, 2010, ANN APPL STAT, V4, P179, DOI 10.1214/09-AOAS281; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nielsen R, 2010, NATURE, V467, P1050, DOI 10.1038/4671050a; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Saul LK, 2002, CIS0218 MS; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Venter JC, 2010, NATURE, V464, P676, DOI 10.1038/464676a; Wang R, 2009, IEEE T PATTERN 0223; Yan SC, 2007, IEEE T PATTERN ANAL, V29, P40, DOI 10.1109/TPAMI.2007.250598; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013734; Zhang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007928; Zhang Jun, 2009, BMC Proc, V3 Suppl 7, pS110; Zhang W, 2011, IEEE T KNOWL DATA EN, V23, P600, DOI 10.1109/TKDE.2010.143	42	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29901	10.1371/journal.pone.0029901	http://dx.doi.org/10.1371/journal.pone.0029901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272259	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400038
J	Balasubramanian, PG; Beckmann, A; Warnken, U; Schnolzer, M; Schuler, A; Bornberg-Bauer, E; Holstein, TW; Ozbek, S				Balasubramanian, Prakash G.; Beckmann, Anna; Warnken, Uwe; Schnoelzer, Martina; Schueler, Andreas; Bornberg-Bauer, Erich; Holstein, Thomas W.; Oezbek, Suat			Proteome of Hydra Nematocyst	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CNIDARIAN NEMATOCYST; BIOLOGICAL ROLES; MINI-COLLAGENS; RICH PROTEIN; VENOM; CELL; DISCHARGE; EVOLUTION; WALL; MINICOLLAGENS	Stinging cells or nematocytes of jellyfish and other cnidarians represent one of the most poisonous and sophisticated cellular inventions in animal evolution. This ancient cell type is unique in containing a giant secretory vesicle derived from the Golgi apparatus. The organelle structure within the vesicle comprises an elastically stretched capsule (nematocyst) to which a long tubule is attached. During exocytosis, the barbed part of the tubule is accelerated with > 5 million g in < 700 ns, enabling a harpoon-like discharge (Nuchter, T., Benoit, M., Engel, U., Ozbek, S., and Holstein, T. W. (2006) Curr. Biol. 16, R316-R318). Hitherto, the molecular components responsible for the organelle's biomechanical properties were largely unknown. Here, we describe the proteome of nematocysts from the freshwater polyp Hydra magnipapillata. Our analysis revealed an unexpectedly complex secretome of 410 proteins with venomous and lytic but also adhesive or fibrous properties. In particular, the insoluble fraction of the nematocyst represents a functional extracellular matrix structure of collagenous and elastic nature. This finding suggests an evolutionary scenario in which exocytic vesicles harboring a venomous secretome assembled a sophisticated predatory structure from extracellular matrix motif proteins.	[Holstein, Thomas W.; Oezbek, Suat] Heidelberg Univ, Ctr Organismal Studies, Dept Mol Evolut & Genom, D-69120 Heidelberg, Germany; [Warnken, Uwe; Schnoelzer, Martina] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Schueler, Andreas; Bornberg-Bauer, Erich] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munster	Holstein, TW (corresponding author), Heidelberg Univ, Ctr Organismal Studies, Dept Mol Evolut & Genom, Neuenheimer Feld 230, D-69120 Heidelberg, Germany.	holstein@uni-hd.de; suat.oezbek@cos.uni-heidelberg.de	Özbek, Suat/D-3701-2014; Bornberg-Bauer, Erich/A-1563-2013	Bornberg-Bauer, Erich/0000-0002-1826-3576; Linn, Anna/0000-0002-6897-4114; Ozbek, Suat/0000-0003-2569-3942; Holstein, Thomas/0000-0003-0480-4674	Deutsche Forschungsgemeinschaft [HO 1088-4/1-2]; Heidelberg Excellence Cluster CellNetworks; Volkswagen Foundation [I184 830]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberg Excellence Cluster CellNetworks; Volkswagen Foundation(Volkswagen)	This work was supported by Deutsche Forschungsgemeinschaft Grant HO 1088-4/1-2, the Heidelberg Excellence Cluster CellNetworks, and the Volkswagen Foundation (I184 830).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JF, 2009, J PROTEOME RES, V8, P1474, DOI 10.1021/pr8008429; Bosmans F, 2007, TOXICON, V49, P550, DOI 10.1016/j.toxicon.2006.11.029; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; Cavalier-Smith T, 2009, INT J BIOCHEM CELL B, V41, P307, DOI 10.1016/j.biocel.2008.10.002; CHAPMAN GB, 1959, J BIOPHYS BIOCHEM CY, V5, P69, DOI 10.1083/jcb.5.1.69; CHAPMAN GB, 1959, J BIOPHYS BIOCHEM CY, V5, P79, DOI 10.1083/jcb.5.1.79; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; CLEMENTS S, 1985, J BIOL CHEM, V260, P3471; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; Denker E, 2008, CURR BIOL, V18, pR858, DOI 10.1016/j.cub.2008.07.031; Eble JA, 2010, MATRIX BIOL, V29, P239, DOI 10.1016/j.matbio.2010.01.004; Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029; Hausmann K, 1978, Int Rev Cytol, V52, P197, DOI 10.1016/S0074-7696(08)60757-3; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holland JW, 2011, P ROY SOC B-BIOL SCI, V278, P546, DOI 10.1098/rspb.2010.1301; HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186; HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402; HOLSTEIN TW, 1990, NATURE, V346, P21, DOI 10.1038/346021b0; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hwang JS, 2007, P NATL ACAD SCI USA, V104, P14735, DOI 10.1073/pnas.0703331104; Jungo F, 2005, TOXICON, V45, P293, DOI 10.1016/j.toxicon.2004.10.018; Koch AW, 1998, J CELL SCI, V111, P1545; Koonin EV, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-21; KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159; LENHOFF HM, 1957, BIOCHIM BIOPHYS ACTA, V26, P204, DOI 10.1016/0006-3002(57)90074-4; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; MARISCAL RN, 1974, Z ZELLFORSCH MIK ANA, V147, P149, DOI 10.1007/BF00582789; Meier S, 2007, J MOL BIOL, V368, P718, DOI 10.1016/j.jmb.2007.02.026; Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; Ozbek S, 2004, J BIOL CHEM, V279, P52016, DOI 10.1074/jbc.M407613200; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Sher D, 2009, TOXICON, V54, P1148, DOI 10.1016/j.toxicon.2009.02.036; Szczepanek S, 2002, J CELL SCI, V115, P745; Vollrath F, 2005, CURR BIOL, V15, pR364, DOI 10.1016/j.cub.2005.05.014; WEBER J, 1989, EUR J BIOCHEM, V184, P465, DOI 10.1111/j.1432-1033.1989.tb15039.x; WEBER J, 1990, J BIOL CHEM, V265, P9664; WESTFALL JA, 1983, J CELL SCI, V63, P245; WONG RSC, 1979, J BIOL CHEM, V254, P4800; YAROSS MS, 1978, J CELL SCI, V34, P1	49	71	73	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9672	9681		10.1074/jbc.M111.328203	http://dx.doi.org/10.1074/jbc.M111.328203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22291027	hybrid, Green Published			2022-12-25	WOS:000302167200002
J	Plantier, L; Besnard, V; Xu, Y; Ikegami, M; Wert, SE; Hunt, AN; Postle, AD; Whitsett, JA				Plantier, Laurent; Besnard, Valerie; Xu, Yan; Ikegami, Machiko; Wert, Susan E.; Hunt, Alan N.; Postle, Anthony D.; Whitsett, Jeffrey A.			Activation of Sterol-response Element-binding Proteins (SREBP) in Alveolar Type II Cells Enhances Lipogenesis Causing Pulmonary Lipotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL ACID LIPASE; HERMANSKY-PUDLAK-SYNDROME; GENE-EXPRESSION; SURFACTANT HOMEOSTASIS; EPITHELIAL-CELLS; LUNG MATURATION; NEUTRAL LIPIDS; KNOCKOUT MICE; C/EBP-ALPHA; DISEASE	Pulmonary inflammation is associated with altered lipid synthesis and clearance related to diabetes, obesity, and various inherited metabolic disorders. In many tissues, lipogenesis is regulated at the transcriptional level by the activity of sterol-response element-binding proteins (SREBP). The role of SREBP activation in the regulation of lipid metabolism in the lung was assessed in mice in which both Insig1 and Insig2 genes, encoding proteins that bind and inhibit SREBPs in the endoplasmic reticulum, were deleted in alveolar type 2 cells. Although deletion of either Insig1 or Insig2 did not alter SREBP activity or lipid homeostasis, deletion of both genes (Insig1/2(Delta/Delta) mice) activated SREBP1, causing marked accumulation of lipids that consisted primarily of cholesterol esters and triglycerides in type 2 epithelial cells and alveolar macrophages. Neutral lipids accumulated in type 2 cells in association with the increase in mRNAs regulating fatty acid, cholesterol synthesis, and inflammation. Although bronchoalveolar lavage fluid phosphatidylcholine was modestly decreased, lung phospholipid content and lung function were maintained. Insig1/2(Delta/Delta) mice developed lung inflammation and airspace abnormalities associated with the accumulation of lipids in alveolar type 2 cells, alveolar macrophages, and within alveolar spaces. Deletion of Insig1/2 activated SREBP-enhancing lipogenesis in respiratory epithelial cells resulting in lipotoxicity-related lung inflammation and tissue remodeling.	[Whitsett, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Sect Neonatol Perinatal & Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA; [Hunt, Alan N.; Postle, Anthony D.] Univ Southampton, Fac Med, Div Clin & Expt Sci, Southampton SO16 6YD, Hants, England	Cincinnati Children's Hospital Medical Center; University of Southampton	Whitsett, JA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Sect Neonatol Perinatal & Pulm Biol, Perinatal Inst, MLC7029,3333 Burnet Ave, Cincinnati, OH 45229 USA.	jeff.whitsett@cchmc.org	Plantier, Laurent/GVT-8757-2022; Hunt, Alan N/A-7432-2008	Hunt, Alan N/0000-0001-5938-2152; Postle, Anthony/0000-0001-7361-0756; , Yan/0000-0003-2025-027X; Plantier, Laurent/0000-0002-3426-2936; Besnard, Valerie/0000-0002-2614-629X	National Institutes of Health [HL085610, HL105433]; Societe de Pneumologie de Langue Francaise; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105433, R01HL085610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Societe de Pneumologie de Langue Francaise; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085610 (to J. A. W.) and HL105433 (to Y. X.).; Supported by a travel grant from the Societe de Pneumologie de Langue Francaise.	Agassandian M, 2004, AM J RESP CELL MOL, V31, P227, DOI 10.1165/rcmb.2004-0038OC; Baldan A, 2008, J IMMUNOL, V180, P3560, DOI 10.4049/jimmunol.180.5.3560; Besnard V, 2007, AM J PHYSIOL-LUNG C, V293, pL1395, DOI 10.1152/ajplung.00275.2007; Besnard V, 2010, AM J PHYSIOL-LUNG C, V298, pL646, DOI 10.1152/ajplung.00409.2009; Besnard V, 2009, J BIOL CHEM, V284, P4018, DOI 10.1074/jbc.M805388200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Bullard JE, 2005, AM J RESP CRIT CARE, V172, P1026, DOI 10.1164/rccm.200503-504OC; Dave V, 2006, J CLIN INVEST, V116, P2597, DOI 10.1172/JCI27331; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Du H, 1998, MOL GENET METAB, V64, P126, DOI 10.1006/mgme.1998.2707; Ecker J, 2007, BIOCHEM BIOPH RES CO, V352, P805, DOI 10.1016/j.bbrc.2006.11.087; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Feng Y, 2001, ATHEROSCLEROSIS, V158, P331, DOI 10.1016/S0021-9150(01)00453-1; Foster DJ, 2010, AM J PHYSIOL-LUNG C, V298, pL392, DOI 10.1152/ajplung.00041.2009; GREENSPAN P, 1985, J LIPID RES, V26, P781; GREGORY TJ, 1991, J CLIN INVEST, V88, P1976, DOI 10.1172/JCI115523; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ikegami M, 2008, J APPL PHYSIOL, V104, P1753, DOI 10.1152/japplphysiol.00875.2007; KODOLOVA IM, 1982, ARK PATOL, V44, P35; Leonenko Z, 2007, BIOPHYS J, V93, P674, DOI 10.1529/biophysj.107.106310; Lian XM, 2005, AM J PATHOL, V167, P813, DOI 10.1016/S0002-9440(10)62053-6; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lyerla TA, 2003, AM J PHYSIOL-LUNG C, V285, pL643, DOI 10.1152/ajplung.00024.2003; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Minai OA, 2000, RESP MED, V94, P1241, DOI 10.1053/rmed.2000.0942; Nakatani Y, 2000, VIRCHOWS ARCH, V437, P304, DOI 10.1007/s004280000241; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Postle AD, 2006, J LIPID RES, V47, P1322, DOI 10.1194/jlr.M600054-JLR200; REINILA A, 1977, DIABETOLOGIA, V13, P305, DOI 10.1007/BF01223270; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Soccio RE, 2002, P NATL ACAD SCI USA, V99, P6943, DOI 10.1073/pnas.052143799; TORDAY J, 1995, BBA-LIPID LIPID MET, V1254, P198, DOI 10.1016/0005-2760(94)00184-Z; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; van Moorsel CHM, 2010, AM J RESP CRIT CARE, V182, P1419, DOI 10.1164/rccm.200906-0953OC; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wert SE, 2000, P NATL ACAD SCI USA, V97, P5972, DOI 10.1073/pnas.100448997; Whitsett JA, 2010, INNATE IMMUN-LONDON, V16, P138, DOI 10.1177/1753425910366879; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yan ZH, 1998, J BIOL CHEM, V273, P10948, DOI 10.1074/jbc.273.18.10948; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC	46	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10099	10114		10.1074/jbc.M111.303669	http://dx.doi.org/10.1074/jbc.M111.303669			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22267724	Green Published, hybrid			2022-12-25	WOS:000302167200042
J	Lee, SH; Moon, JH; Yoon, SK; Yoon, JB				Lee, Seung-Hoon; Moon, Joo-Hong; Yoon, Sungjoo Kim; Yoon, Jong-Bok			Stable Incorporation of ATPase Subunits into 19 S Regulatory Particle of Human Proteasome Requires Nucleotide Binding and C-terminal Tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; ASSEMBLY PATHWAY; STRUCTURAL BASIS; AAA SUBUNITS; ROLES; ACTIVATION; COMPLEX; PA700; DEUBIQUITINATION; RECOGNITION	The 26 S proteasome is a large multi-subunit protein complex that degrades ubiquitinated proteins in eukaryotic cells. Proteasome assembly is a complex process that involves formation of six- and seven-membered ring structures from homologous subunits. Here we report that the assembly of hexameric Rpt ring of the 19 S regulatory particle (RP) requires nucleotide binding but not ATP hydrolysis. Disruption of nucleotide binding to an Rpt subunit by mutation in the Walker A motif inhibits the assembly of the Rpt ring without affecting heterodimer formation with its partner Rpt subunit. Coexpression of the base assembly chaperones S5b and PAAF1 with mutant Rpt1 and Rpt6, respectively, relieves assembly inhibition of mutant Rpts by facilitating their interaction with adjacent Rpt dimers. The mutation in the Walker B motif which impairs ATP hydrolysis does not affect Rpt ring formation. Incorporation of a Walker B mutant Rpt subunit abrogates the ATPase activity of the 19 S RP, suggesting that failure of the mutant Rpt to undergo the conformational transition from an ATP-bound to an ADP-bound state impairs conformational changes in the other five wild-type Rpts in the Rpt ring. In addition, we demonstrate that the C-terminal tails of Rpt subunits possessing core particle (CP)-binding affinities facilitate the cellular assembly of the 19SRP, implying that the 20 S CP may function as a template for base assembly in human cells. Taken together, these results suggest that the ATP-bound conformational state of an Rpt subunit with the exposed C-terminal tail is competent for cellular proteasome assembly.	[Yoon, Jong-Bok] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Lee, Seung-Hoon; Moon, Joo-Hong; Yoon, Jong-Bok] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Yoon, Sungjoo Kim] Catholic Univ Korea, Dept Biomed Sci, Seoul 137040, South Korea	Yonsei University; Yonsei University; Catholic University of Korea	Yoon, JB (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, 262 Seongsanno, Seoul 120749, South Korea.	yoonj@yonsei.ac.kr		Yoon, Jong-Bok/0000-0002-3563-0702	NRF; MEST [2009-0081317]; Korean Ministry of Science and Technology; Translational Research Center for Protein Function Control, NSF	NRF; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Translational Research Center for Protein Function Control, NSF	This work was supported in part by a mid-career Researcher Program through an NRF Grant funded by the MEST (No. 2009-0081317), by grants from the Korean Ministry of Science and Technology through the Studies on Ubiquitome Functions Project, and from the Translational Research Center for Protein Function Control, NSF.	Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; Kumar B, 2010, J BIOL CHEM, V285, P39523, DOI 10.1074/jbc.M110.153627; Kusmierczyk AR, 2008, BIOL CHEM, V389, P1143, DOI 10.1515/BC.2008.130; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Park S, 2010, BIOCHEM SOC T, V38, P6, DOI 10.1042/BST0380006; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021	42	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9269	9279		10.1074/jbc.M111.316208	http://dx.doi.org/10.1074/jbc.M111.316208			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275368	hybrid, Green Published			2022-12-25	WOS:000301797800055
J	Musset, B; Clark, RA; DeCoursey, TE; Petheo, GL; Geiszt, M; Chen, YM; Cornell, JE; Eddy, CA; Brzyski, RG; El Jamali, A				Musset, Boris; Clark, Robert A.; DeCoursey, Thomas E.; Petheo, Gabor L.; Geiszt, Miklos; Chen, Yumin; Cornell, John E.; Eddy, Carlton A.; Brzyski, Robert G.; El Jamali, Amina			NOX5 in Human Spermatozoa EXPRESSION, FUNCTION, AND REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE NOX5-S; ESOPHAGEAL ADENOCARCINOMA CELLS; OXYGEN SPECIES PRODUCTION; HUMAN SPERM SUSPENSIONS; GATED PROTON CHANNEL; HUMAN EOSINOPHILS; SUPEROXIDE-PRODUCTION; RESPIRATORY BURST; ELECTRON CURRENTS; HUMAN NEUTROPHILS	Physiological and pathological processes in spermatozoa involve the production of reactive oxygen species (ROS), but the identity of the ROS-producing enzyme system(s) remains a matter of speculation. We provide the first evidence that NOX5 NADPH oxidase is expressed and functions in human spermatozoa. Immunofluorescence microscopy detected NOX5 protein in both the flagella/neck region and the acrosome. Functionally, spermatozoa exposed to calcium ionophore, phorbol ester, or H2O2 exhibited superoxide anion production, which was blocked by addition of superoxide dismutase, a Ca2+ chelator, or inhibitors of either flavoprotein oxidases (diphenylene iododonium) or NOX enzymes (GKT136901). Consistent with our previous overexpression studies, we found that H2O2-induced superoxide production by primary sperm cells was mediated by the non-receptor tyrosine kinase c-Abl. Moreover, the H(V)1 proton channel, which was recently implicated in spermatozoa motility, was required for optimal superoxide production by spermatozoa. Immunoprecipitation experiments suggested an interaction among NOX5, c-Abl, and H(V)1. H2O2 treatment increased the proportion of motile sperm in a NOX5-dependent manner. Statistical analyses showed a pH-dependent correlation between superoxide production and enhanced sperm motility. Collectively, our findings show that NOX5 is a major source of ROS in human spermatozoa and indicate a role for NOX5-dependent ROS generation in human spermatozoa motility.	[Clark, Robert A.; El Jamali, Amina] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Chen, Yumin; Cornell, John E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Eddy, Carlton A.; Brzyski, Robert G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Musset, Boris; DeCoursey, Thomas E.] Rush Univ, Med Ctr, Dept Physiol & Mol Biophys, Chicago, IL 60612 USA; [Petheo, Gabor L.; Geiszt, Miklos] Semmelweis Univ, Fac Med, Dept Physiol, H-1085 Budapest, Hungary	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Rush University; Semmelweis University	El Jamali, A (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	AkoulouzeBik@uthscsa.edu	Musset, Boris/AAD-4158-2022; Musset, Boris/J-2520-2013; Petheő, Gábor/O-1149-2017; Clark, Robert/Q-6764-2019; DeCoursey, Thomas/A-6820-2009	Musset, Boris/0000-0001-8242-8817; Musset, Boris/0000-0001-8242-8817; Petheő, Gábor/0000-0002-1773-4129; Clark, Robert/0000-0002-4892-3619; DeCoursey, Thomas/0000-0002-4263-180X	National Institutes of Health [T32 HL04776, UL1 RR025767, KL2 RR025766, K01 DK084297, R01-GM087507, P30 CA054174, P30 AG013319, P01 AG019316]; Iacocca Family Foundation; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000118, UL1TR000149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025766, UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK084297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316, P30AG013319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iacocca Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL04776 (to A. E. J.), UL1 RR025767 (to A. E. J.), Clinical and Translational Science Awards pilot funding (to A. E. J.), KL2 RR025766 (to A. E. J.), K01 DK084297 (to A. E. J.), and Career Development Award R01-GM087507 (to T. E. D.) and an award from the Iacocca Family Foundation (to B. M.). Robert Clark is a scientific co-founder, member of the Scientific Advisory Board, and equity holder in GenKyoTex SA, a Swiss biotechnology start-up company with a primary goal of developing clinically useful inhibitors of the NOX family of NADPH oxidases.; Optical Imaging Facility of the University of Texas Health Science Center at San Antonio, which is supported by National Institutes of Health Grants P30 CA054174 (Cancer Therapy and Research Center), P30 AG013319 (Nathan Shock Center), and P01 AG019316 (Aging, Oxidative Stress and Cell Death). We thank Dr. Craig Witz for arranging initial access to human sperm samples from the University of Texas Medicine Fertility Center, Drs. Victoria Frohlich and Shivani Maffi for expert guidance on confocal microscopy image acquisition and analysis, Maria Gamez and Mario de la Pena for expert technical assistance, and Drs. Susan Smith, Yves Gorin, and Denis Feliers for helpful discussions.	Aitken R John, 2010, Handb Exp Pharmacol, P99, DOI 10.1007/978-3-642-02062-9_7; Aitken RJ, 1998, J CELL SCI, V111, P645; AITKEN RJ, 1990, INT J ANDROL, V13, P433, DOI 10.1111/j.1365-2605.1990.tb01051.x; Aitken RJ, 2004, FREE RADICAL BIO MED, V36, P994, DOI 10.1016/j.freeradbiomed.2004.01.017; AITKEN RJ, 1994, REPROD FERT DEVELOP, V6, P19, DOI 10.1071/RD9940019; Aitken RJ, 1998, J REPROD FERTIL, P109; Aitken RJ, 2000, J ANDROL, V21, P491; Alexandrino AP, 2011, SPINAL CORD, V49, P435, DOI 10.1038/sc.2010.122; Armstrong JS, 2002, INT J ANDROL, V25, P223, DOI 10.1046/j.1365-2605.2002.00351.x; Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; BelAiba RS, 2007, FREE RADICAL BIO MED, V42, P446, DOI 10.1016/j.freeradbiomed.2006.10.054; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; De Jonge C, 2005, HUM REPROD UPDATE, V11, P205, DOI 10.1093/humupd/dmi010; de Lamirande E, 1998, J ANDROL, V19, P585; de Lamirande E, 1997, Rev Reprod, V2, P48, DOI 10.1530/revreprod/2.1.48; de Lamirande E, 2008, BBA-PROTEINS PROTEOM, V1784, P106, DOI 10.1016/j.bbapap.2007.08.024; de Lamirande E, 2009, FREE RADICAL BIO MED, V46, P502, DOI 10.1016/j.freeradbiomed.2008.11.004; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; DeCoursey TE, 2010, PHYSIOLOGY, V25, P27, DOI 10.1152/physiol.00039.2009; DELAMIRANDE E, 1992, J ANDROL, V13, P368; DELAMIRANDE E, 1993, FREE RADICAL BIO MED, V14, P157, DOI 10.1016/0891-5849(93)90006-G; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; El Jamali A, 2008, FREE RADICAL BIO MED, V44, P868, DOI 10.1016/j.freeradbiomed.2007.11.020; Florman HM, 2010, CELL, V140, P310, DOI 10.1016/j.cell.2010.01.035; Ford WCL, 1997, INT J ANDROL, V20, P44; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; Hong J, 2010, CANCER RES, V70, P1247, DOI 10.1158/0008-5472.CAN-09-2774; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Jay DB, 2008, FREE RADICAL BIO MED, V45, P329, DOI 10.1016/j.freeradbiomed.2008.04.024; Kamiguti AS, 2005, J IMMUNOL, V175, P8424, DOI 10.4049/jimmunol.175.12.8424; KESSOPOULOU E, 1992, J REPROD FERTIL, V94, P463; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lishko PV, 2010, J PHYSIOL-LONDON, V588, P4667, DOI 10.1113/jphysiol.2010.194142; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; MacLeod J, 1943, AM J PHYSIOL, V138, P0512, DOI 10.1152/ajplegacy.1943.138.3.512; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Morgan D., 2002, J GEN PHYSIOL, V119, P2477; Morgan D, 2007, J PHYSIOL-LONDON, V579, P327, DOI 10.1113/jphysiol.2006.124248; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Moustafa MH, 2004, HUM REPROD, V19, P129, DOI 10.1093/humrep/deh024; Musset B, 2010, J BIOL CHEM, V285, P5117, DOI 10.1074/jbc.C109.082727; Neri-Vidaurri PD, 2006, BIOCHEM BIOPH RES CO, V343, P105, DOI 10.1016/j.bbrc.2006.02.095; PARRISH JJ, 1987, J ANDROL, V8, P259; Petheo GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014081; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Resch CT, 2011, BIOCHEM CELL BIOL, V89, P130, DOI [10.1139/O10-149, 10.1139/o10-149]; Richer SC, 2001, MOL HUM REPROD, V7, P237, DOI 10.1093/molehr/7.3.237; Rivlin J, 2004, BIOL REPROD, V70, P518, DOI 10.1095/biolreprod.103.020487; ROGERS C, 1988, J FORENSIC SCI, V33, P77; Sabeur K, 2007, REPRODUCTION, V134, P263, DOI 10.1530/REP-06-0120; Salles N, 2005, EXP GERONTOL, V40, P353, DOI 10.1016/j.exger.2005.01.007; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Si J, 2007, J BIOL CHEM, V282, P16244, DOI 10.1074/jbc.M700297200; Sotolongo B, 2000, J CELL BIOCHEM, P23; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; VIJAYAKUMAR R, 1986, ARCH ANDROLOGY, V17, P223, DOI 10.3109/01485018608990199; WHITE DR, 1989, GAMETE RES, V22, P163, DOI 10.1002/mrd.1120220205; Whittington K, 1999, INT J ANDROL, V22, P229, DOI 10.1046/j.1365-2605.1999.00173.x; WHO, 2010, EX PROC HUM SEM; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	72	104	109	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9376	9388		10.1074/jbc.M111.314955	http://dx.doi.org/10.1074/jbc.M111.314955			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291013	Green Published, hybrid			2022-12-25	WOS:000301797800068
J	Wynn, RM; Li, J; Brautigam, CA; Chuang, JL; Chuang, DT				Wynn, R. Max; Li, Jun; Brautigam, Chad A.; Chuang, Jacinta L.; Chuang, David T.			Structural and Biochemical Characterization of Human Mitochondrial Branched-chain alpha-Ketoacid Dehydrogenase Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; CATALYTIC SUBUNIT; CHAPERONINS GROEL; ESCHERICHIA-COLI; PROTEIN; PYRUVATE; COMPLEX; BINDING; EXPRESSION; DOMAIN	The branched-chain alpha-ketoacid dehydrogenase phosphatase (BDP) component of the human branched-chain alpha-ketoacid dehydrogenase complex (BCKDC) has been expressed in Escherichia coli and purified in the soluble form. The monomeric BDP shows a strict dependence on Mn2+ ions for phosphatase activity, whereas Mg2+ and Ca2+ ions do not support catalysis. Metal binding constants for BDP, determined by competition isothermal titration calorimetry, are 2.4 nM and 10 mu M for Mn2+ and Mg2+ ions, respectively. Using the phosphorylated decarboxylase component (p-E1b) of BCKDC as a substrate, BDP shows a specific activity of 68 nmol/min/mg. The Ca2+-independent binding of BDP to the 24-meric transacylase (dihydrolipoyl transacylase; E2b) core of BCKDC results in a 3-fold increase in the dephosphorylation rate of p-E1b. However, the lipoyl prosthetic group on E2b is not essential for BDP binding or E2b-stimulated phosphatase activity. Acidic residues in the C-terminal linker of the E2b lipoyl domain are essential for the interaction between BDP and E2b. The BDP structure was determined by x-ray crystallography to 2.4 angstrom resolution. The BDP structure is dominated by a central beta-sandwich. There are two protrusions forming a narrow cleft similar to 10 angstrom wide, which constitutes the active site. The carboxylate moieties of acidic residues Asp-109, Asp-207, Asp-298, and Asp-337 in the active-site cleft participate in binding two metal ions. Substitutions of these residues with alanine nullify BDP phosphatase activity. Alteration of the nearby Arg-104 increases the Km for p-E1b peptide by 60-fold, suggesting that this residue is critical for the recognition of the native p-E1b protein.	[Wynn, R. Max; Li, Jun; Brautigam, Chad A.; Chuang, Jacinta L.; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wynn, RM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	richard.wynn@utsouthwestern.edu; david.chuang@utsouthwestern.edu		Wynn, Richard/0000-0002-1879-2136; Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [DK26758, DK62306, DK92921]; Welch Foundation [I-1286]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062306, R01DK062306, R01DK026758, R01DK092921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK26758, DK62306, and DK92921. This work was also supported by Welch Foundation Grant I-1286.; The x-ray data are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, which is operated by the University of Chicago at Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. We are indebted to Brittany Young for technical assistance.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baldwin ET, 1998, STRUCTURE, V6, P923, DOI 10.1016/S0969-2126(98)00093-8; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Bevington PR., 2002, DATA REDUCTION ERROR; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; Chuang JL, 2002, J BIOL CHEM, V277, P36905, DOI 10.1074/jbc.C200430200; Clugston SL, 2004, BIOCHEM J, V377, P309, DOI 10.1042/BJ20030271; DAMUNI Z, 1986, P NATL ACAD SCI USA, V83, P285, DOI 10.1073/pnas.83.2.285; DAMUNI Z, 1987, J BIOL CHEM, V262, P5129; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; DAVIE JR, 1995, J BIOL CHEM, V270, P19861, DOI 10.1074/jbc.270.34.19861; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; HARRIS RA, 1986, BIOCHEM J, V234, P285, DOI 10.1042/bj2340285; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Hedl M, 2004, PROTEIN SCI, V13, P687, DOI 10.1110/ps.03367504; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Huang YS, 1999, BIOCHEM J, V339, P503, DOI 10.1042/0264-6021:3390503; Hwang B, 2009, BIOCHEM J, V423, P243, DOI 10.1042/BJ20090390; Irmler A, 2001, P NATL ACAD SCI USA, V98, P12978, DOI 10.1073/pnas.231254998; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Karpova T, 2004, BBA-PROTEINS PROTEOM, V1700, P43, DOI 10.1016/j.bbapap.2004.03.013; Kato M, 2006, EMBO J, V25, P5983, DOI 10.1038/sj.emboj.7601444; Komaki KI, 2003, BBA-GENE STRUCT EXPR, V1630, P130, DOI 10.1016/j.bbaexp.2003.09.004; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Levin MD, 2002, BIOPHYS J, V82, P1809, DOI 10.1016/S0006-3495(02)75531-8; Lu G, 2008, CLIN EXP PHARMACOL P, V35, P107, DOI 10.1111/j.1440-1681.2007.04843.x; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Oyarzabal A, 2011, J INHERIT METAB DIS, V34, pS79; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; PAUL HS, 1982, J BIOL CHEM, V257, P4875; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Su JY, 2011, J BIOL CHEM, V286, P13481, DOI 10.1074/jbc.M109.036467; Turkan A, 2004, BIOCHEMISTRY-US, V43, P15073, DOI 10.1021/bi048901y; Turkan A, 2002, J BIOL CHEM, V277, P14976, DOI 10.1074/jbc.M108434200; Vassylyev DG, 2007, J MOL BIOL, V370, P417, DOI 10.1016/j.jmb.2007.05.002; Velazquez-Campoy A, 2001, ARCH BIOCHEM BIOPHYS, V390, P169, DOI 10.1006/abbi.2001.2333; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; Wynn RM, 2000, METHOD ENZYMOL, V324, P179; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; WYNN RM, 1992, J BIOL CHEM, V267, P12400; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; ZHAO Y, 1993, BIOCHEM J, V290, P395, DOI 10.1042/bj2900395	64	16	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9178	9192		10.1074/jbc.M111.314963	http://dx.doi.org/10.1074/jbc.M111.314963			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291014	Green Published, hybrid			2022-12-25	WOS:000301797800046
J	Zhou, L; Jones, EV; Murai, KK				Zhou, Lei; Jones, Emma V.; Murai, Keith K.			EphA Signaling Promotes Actin-based Dendritic Spine Remodeling through Slingshot Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SEMLIKI-FOREST-VIRUS; AMPA RECEPTOR TRAFFICKING; FOCAL ADHESION KINASE; SYNAPTIC PLASTICITY; COFILIN DEPHOSPHORYLATION; HIPPOCAMPAL SYNAPSES; EXCITATORY SYNAPSES; CORTICAL-NEURONS; ADULT CORTEX	Actin cytoskeletal remodeling plays a critical role in transforming the morphology of subcellular structures across various cell types. In the brain, restructuring of dendritic spines through actin cytoskeleletal reorganization is implicated in the regulation of synaptic efficacy and the storage of information in neural circuits. However, the upstream pathways that provoke actin-based spine changes remain only partly understood. Here we show that EphA receptor signaling remodels spines by triggering a sequence of events involving actin filament rearrangement and synapse/spine reorganization. Rapid EphA signaling over minutes activates the actin filament depolymerizing/severing factor cofilin, alters F-actin distribution in spines, and causes transient spine elongation through the phosphatases slingshot 1 (SSH1) and calcineurin/protein phosphatase 2B (PP2B). This early phase of spine extension is followed by synaptic reorganization events that take place over minutes to hours and involve the relocation of pre/postsynaptic components and ultimately spine retraction. Thus, EphA receptors utilize discrete cellular and molecular pathways to promote actin-based structural plasticity of excitatory synapses.	[Zhou, Lei; Jones, Emma V.; Murai, Keith K.] McGill Univ, Dept Neurol & Neurosurg, Montreal Gen Hosp, Res Inst,Hlth Ctr,Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	McGill University	Murai, KK (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Gen Hosp, Res Inst,Hlth Ctr,Ctr Res Neurosci, 1650 Cedar Ave L7-212, Montreal, PQ H3G 1A4, Canada.	keith.murai@mcgill.ca			Canadian Institutes of Health Research; Canada Research Chairs Program; Canadian Foundation for Innovation; EJLB Foundation; Research Institute of the McGill University Health Centre	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); EJLB Foundation; Research Institute of the McGill University Health Centre	This work was supported by the Canadian Institutes of Health Research, the Canada Research Chairs Program, the Canadian Foundation for Innovation, and the EJLB Foundation (to K. K. M.).; Supported by a studentship from Research Institute of the McGill University Health Centre.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; DiCiommo DP, 1998, J BIOL CHEM, V273, P18060, DOI 10.1074/jbc.273.29.18060; Eaton BA, 2003, GENE DEV, V17, P2075, DOI 10.1101/gad.1113703; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Hering H, 2003, J NEUROSCI, V23, P11759; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hsieh SHK, 2006, J NEUROSCI, V26, P1006, DOI 10.1523/JNEUROSCI.2806-05.2006; Huang TY, 2008, DEV CELL, V15, P691, DOI 10.1016/j.devcel.2008.09.017; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Irie F, 2008, P NATL ACAD SCI USA, V105, P12307, DOI 10.1073/pnas.0801302105; Jones EV, 2012, METHODS MOL BIOL, V814, P341, DOI 10.1007/978-1-61779-452-0_22; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kueh HY, 2008, P NATL ACAD SCI USA, V105, P16531, DOI 10.1073/pnas.0807394105; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Lundstrom Kenneth, 2003, Methods Mol Med, V76, P503; Mateos JM, 2007, J PHYSIOL-LONDON, V581, P129, DOI 10.1113/jphysiol.2006.120550; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Yuen EY, 2009, J NEUROSCI, V29, P550, DOI 10.1523/JNEUROSCI.5050-08.2009; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	79	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9346	9359		10.1074/jbc.M111.302802	http://dx.doi.org/10.1074/jbc.M111.302802			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22282498	Green Published, hybrid			2022-12-25	WOS:000301797800066
J	Gray, NE; Lam, LN; Yang, KR; Zhou, AY; Koliwad, S; Wang, JC				Gray, Nora E.; Lam, Lily N.; Yang, Karen; Zhou, Anna Y.; Koliwad, Suneil; Wang, Jen-Chywan			Angiopoietin-like 4 (Angptl4) Protein Is a Physiological Mediator of Intracellular Lipolysis in Murine Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; HUMAN ADIPOSE-TISSUE; TRIGLYCERIDE-METABOLISM; GLUCOCORTICOID EXPOSURE; CUSHINGS-SYNDROME; TARGET GENE; PATHOPHYSIOLOGY; LIPOGENESIS; PERILIPIN; INSULIN	Intracellular triacylglycerol (TG) hydrolysis and fatty acid release by the white adipose tissue (WAT) during a fast is stimulated by counter-regulatory factors acting in concert, although how adipocytes integrate these lipolytic inputs is unknown. We tested the role of angiopoietin-like 4 (Angptl4), a secreted protein induced by fasting or glucocorticoid treatment, in modulating intracellular adipocyte lipolysis. Glucocorticoid receptor blockade prevented fasting-induced tissue Angptl4 expression and WAT TG hydrolysis in mice, and TG hydrolysis induced by fasts of 6 or 24 h was greatly reduced in mice lacking Angptl4 (Angptl4(-/-)). Glucocorticoid treatment mimicked the lipolytic effects of fasting, although with slower kinetics, and this too required Angptl4. Thus, fasting-induced WAT TG hydrolysis requires glucocorticoid action and Angptl4. Both fasting and glucocorticoid treatment also increased WAT cAMP levels and downstream phosphorylation of lipolytic enzymes. Angptl4 deficiency markedly reduced these effects, suggesting that Angptl4 may stimulate lipolysis by modulating cAMP-dependent signaling. In support of this, cAMP levels and TG hydrolysis were reduced in primary Angptl4(-/-) murine adipocytes treated with catecholamines, which stimulate cAMP-dependent signaling to promote lipolysis, and was restored by treatment with purified human ANGPTL4. Remarkably, human ANGPTL4 treatment alone increased cAMP levels and induced lipolysis in these cells. Pharmacologic agents revealed that Angptl4 modulation of cAMP-dependent signaling occurs upstream of adenylate cyclase and downstream of receptor activation. We show that Angptl4 is a glucocorticoid-responsive mediator of fasting induced intracellular lipolysis and stimulates cAMP signaling in adipocytes. Such a role is relevant to diseases of aberrant lipolysis, such as insulin resistance.	[Koliwad, Suneil] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Gray, Nora E.; Lam, Lily N.; Yang, Karen; Zhou, Anna Y.; Wang, Jen-Chywan] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Koliwad, Suneil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Koliwad, S (corresponding author), Univ Calif San Francisco, Ctr Diabet, 513 Parnassus Ave, San Francisco, CA 94143 USA.	skoliwad@diabetes.ucsf.edu; walwang@berkeley.edu	Wang, Jen-Chywan/AAX-4445-2020	Wang, Jen-Chywan/0000-0001-6030-6886	National Institutes of Health [DK83591]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083591, P30DK026743, K08DK080174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK83591.	Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002; Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Arnaldi G, 2010, NEUROENDOCRINOLOGY, V92, P86, DOI 10.1159/000314213; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BERDANIER CD, 1989, FASEB J, V3, P2179, DOI 10.1096/fasebj.3.10.2666232; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Gravholt CH, 2002, OBES RES, V10, P774, DOI 10.1038/oby.2002.105; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Kim HK, 2010, DIABETES, V59, P2772, DOI 10.2337/db10-0145; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; KRIEGER DT, 1971, J CLIN ENDOCR METAB, V32, P266, DOI 10.1210/jcem-32-2-266; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lichtenstein L, 2010, BBA-MOL CELL BIOL L, V1801, P415, DOI 10.1016/j.bbalip.2009.12.015; Macfarlane DP, 2008, J ENDOCRINOL, V197, P189, DOI 10.1677/JOE-08-0054; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Miida T, 2010, CURR OPIN LIPIDOL, V21, P70, DOI 10.1097/MOL.0b013e328333269e; Pivonello R, 2010, NEUROENDOCRINOLOGY, V92, P77, DOI 10.1159/000314319; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Samra JS, 1998, J CLIN ENDOCR METAB, V83, P626, DOI 10.1210/jc.83.2.626; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SEITZ HJ, 1976, METABOLISM, V25, P1545, DOI 10.1016/0026-0495(76)90107-4; SNYDER F, 1959, BIOCHIM BIOPHYS ACTA, V34, P244; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Wang YX, 2004, J NUTR, V134, P1032; Yamaguchi T, 2010, BIOL PHARM BULL, V33, P342, DOI 10.1248/bpb.33.342; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200	40	76	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8444	8456		10.1074/jbc.M111.294124	http://dx.doi.org/10.1074/jbc.M111.294124			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267746	Green Published, hybrid			2022-12-25	WOS:000301349400059
J	Ciriza, J; Hall, D; Lu, A; De Sena, JR; Al-Kuhlani, M; Garcia-Ojeda, ME				Ciriza, Jesus; Hall, Dominique; Lu, Alison; De Sena, Joseph Robert; Al-Kuhlani, Mufadhal; Garcia-Ojeda, Marcos E.			Single-Cell Analysis of Murine Long-Term Hematopoietic Stem Cells Reveals Distinct Patterns of Gene Expression during Fetal Migration	PLOS ONE			English	Article							BONE-MARROW; N-CADHERIN; ADHESION MOLECULE-1; ENDOCHONDRAL OSSIFICATION; SELECTIN LIGANDS; PROGENITOR CELLS; NICHE; LIVER; ENGRAFTMENT; DIFFERENTIATION	Background: Long-term hematopoietic stem cells (LT-HSCs) migrate from the fetal liver (FL) to the fetal bone marrow (FBM) during development. Various adhesion and chemotactic receptor genes have been implicated in the migration of adult LT-HSCs. However, their role in the migration of fetal LT-HSCs is not clearly understood due, in part, to the rare number of these cells in fetal tissues, which preclude classical gene expression analysis. The aim of this study is to characterize the expression of migration related genes in fetal LT-HSC across different anatomical locations during development. Methodology/Principal Findings: We isolated fetal LT-HSC from different developmental stages, as well as different anatomical locations, and performed single-cell multiplex RT-qPCR and flow cytometry analysis of eight molecules involved in adult LT-HSC migration. Our results show that the gene expression of the chemokine receptor Cxcr4 in LT-HSC varies across developmental microenvironments and times, while the cadherin Cdh2 (Ncad) and the calcium receptor Casr show higher gene expression and variability only in FBM at 17.5 days post coitum (dpc). The cadherin Cdh5 (Vecad) maintains high expression variability only during fetal development, while the integrin subunit Itga5 (alpha 5) increases its variability after 14.5 dpc. The integrin subunits Itga4 (alpha 4) and Itgal (Lfa1), as well as the selectin ligand Selplg (Psgl1), did not show differences in their expression in single LT-HSCs irrespective of the developmental times or anatomical microenvironments studied. Conclusions/Significance: Our data demonstrate that the expression pattern of phenotypically identical, single LT-HSCs fluctuates as a function of developmental stage and anatomical microenvironment. This is the first exhaustive gene expression comparison of migration-related molecules in fetal tissues across developmental times, enhancing the understanding of LT-HSC migration fate decisions during development.	[Ciriza, Jesus; Hall, Dominique; Lu, Alison; De Sena, Joseph Robert; Al-Kuhlani, Mufadhal; Garcia-Ojeda, Marcos E.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95344 USA	University of California System; University of California Merced	Ciriza, J (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95344 USA.	mgarcia-ojeda@ucmerced.edu	Ciriza, Jesus/M-3821-2018	Ciriza, Jesus/0000-0002-8666-622X	University of California; Government of Navarra, Spain; California Institute [TG2-01163]	University of California(University of California System); Government of Navarra, Spain; California Institute	This work was funded by the University of California Merced start-up funds. JC was partially funded by a postdoctoral fellowship from the Government of Navarra, Spain and the California Institute for Regenerative Medicine Stem Cell Training Program Award (TG2-01163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Ayres-Silva JD, 2011, CELL TISSUE RES, V344, P455, DOI 10.1007/s00441-011-1170-1; Benson DA, 2010, NUCL ACIDS RES; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Ciriza J, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt14; Domen J, 1999, MOL MED TODAY, V5, P201, DOI 10.1016/S1357-4310(99)01464-1; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Hidalgo A, 2002, J CLIN INVEST, V110, P559, DOI 10.1172/JCI200214047; Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857; Jacobsen K, 1996, BLOOD, V87, P73; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2005, BLOOD, V106, P903, DOI 10.1182/blood-2004-12-4960; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Lam BS, 2010, BLOOD; Lefebvre V, 2010, CURR TOP DEV BIOL, V90, P291, DOI 10.1016/S0070-2153(10)90008-2; Li HY, 2010, AM J PHYSIOL-CELL PH, V299, pC422, DOI 10.1152/ajpcell.00562.2009; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; McKinney-Freeman SL, 2009, BLOOD, V114, P268, DOI 10.1182/blood-2008-12-193888; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Papayannopoulou T, 2001, BLOOD, V97, P1282, DOI 10.1182/blood.V97.5.1282; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Walter U, 2000, EUR J IMMUNOL, V30, P1224, DOI 10.1002/1521-4141(200004)30:4<1224::AID-IMMU1224>3.0.CO;2-B; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wu JY, 2009, J BONE MINER RES, V24, P759, DOI [10.1359/JBMR.090225, 10.1359/jbmr.090225]; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	55	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30542	10.1371/journal.pone.0030542	http://dx.doi.org/10.1371/journal.pone.0030542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276210	gold, Green Submitted, Green Published			2022-12-25	WOS:000301568100054
J	Kim, SH; Pezzoli, L; Yacouba, H; Coulibaly, T; Djingarey, MH; Perea, WA; Wierzba, TF				Kim, Sung Hye; Pezzoli, Lorenzo; Yacouba, Harouna; Coulibaly, Tiekoura; Djingarey, Mamoudou H.; Perea, William A.; Wierzba, Thomas F.			Whom and Where Are We Not Vaccinating? Coverage after the Introduction of a New Conjugate Vaccine against Group A Meningococcus in Niger in 2010	PLOS ONE			English	Article							IMMUNIZATION COVERAGE; BURKINA-FASO; MENINGITIS; CAMPAIGN; AFRICA	MenAfriVac is a new conjugate vaccine against Neisseria meningitidis serogroup A developed for the African "meningitis belt". In Niger, the first two phases of the MenAfriVac introduction campaign were conducted targeting 3,135,942 individuals aged 1 to 29 years in the regions of Tillaberi, Niamey, and Dosso, in September and December 2010. We evaluated the campaign and determined which sub-populations or areas had low levels of vaccination coverage in the regions of Tillaberi and Niamey. After Phase I, conducted in the Filingue district, we estimated coverage using a 30615 cluster-sampling survey and nested lot quality assurance (LQA) analysis in the clustered samples to identify which subpopulations (defined by age 1-14/15-29 and sex) had unacceptable vaccination coverage (<70%). After Phase II, we used Clustered Lot Quality Assurance Sampling (CLQAS) to assess if any of eight districts in Niamey and Tillaberi had unacceptable vaccination coverage (<75%) and estimated overall coverage. Estimated vaccination coverage was 77.4% (95% CI: 84.6-70.2) as documented by vaccination cards and 85.5% (95% CI: 79.7-91.2) considering verbal history of vaccination for Phase I; 81.5% (95% CI: 86.1-77.0) by card and 93.4% (95% CI: 91.0-95.9) by verbal history for Phase II. Based on vaccination cards, in Filingue, we identified both the male and female adult (age 15-29) subpopulations as not reaching 70% coverage; and we identified three (one in Tillaberi and two in Niamey) out of eight districts as not reaching 75% coverage confirmed by card. Combined use of LQA and cluster sampling was useful to estimate vaccination coverage and to identify pockets with unacceptable levels of coverage (adult population and three districts). Although overall vaccination coverage was satisfactory, we recommend continuing vaccination in the areas or sub-populations with low coverage and reinforcing the social mobilization of the adult population.	[Kim, Sung Hye; Wierzba, Thomas F.] Int Vaccine Inst, Translat Res Div, Seoul, South Korea; [Pezzoli, Lorenzo] Consultant Meningitis Vaccine Project, London, England; [Yacouba, Harouna] Minist Publ Hlth, Dept Surveillance Stat & Epidem Response, Niamey, Niger; [Coulibaly, Tiekoura] World Hlth Org, Expanded Programme Immunizat, Niamey, Niger; [Djingarey, Mamoudou H.] World Hlth Org, Meningitis Vaccine Project Focal Point, Intercountry Support Team W Africa, Ouagadougou, Burkina Faso; [Perea, William A.] World Hlth Org, Epidem Readiness & Intervent, Geneva, Switzerland	International Vaccine Institute; World Health Organization; World Health Organization; World Health Organization	Kim, SH (corresponding author), World Hlth Org, Div Pacific Tech Support, Suva, Fiji.	sunghye.kim@post.harvard.edu	Pezzoli, Lorenzo/AAA-9894-2019		government of the Republic of Korea	government of the Republic of Korea(Korean Government)	The study was supported by the government of the Republic of Korea, via Air-ticket Solidarity Contribution, to the government of Niger.(www.odakorea.go.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P47; [Anonymous], 1996, MON IMM SERV US LOT; BORGDORFF MW, 1988, J TROP MED HYG, V91, P35; Deitchler M, 2007, INT J EPIDEMIOL, V36, P858, DOI 10.1093/ije/dym092; Greenland K, 2011, TROP MED INT HEALTH, V16, P863, DOI 10.1111/j.1365-3156.2011.02770.x; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Haddad S, 2010, HEALTH POLICY PLANN, V25, P393, DOI 10.1093/heapol/czq007; HOSHAWWOODARD S, 2001, DESCRIPTION COMPARIS; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; LANATA CF, 1990, INT J EPIDEMIOL, V19, P1086, DOI 10.1093/ije/19.4.1086; MYATT M, 2001, SAMPLELQ SAMPLE SIZE; Pezzoli L, 2011, EPIDEMIOL INFECT, P1, DOI DOI 10.1017/S0950268811000331; Pezzoli L, 2010, TROP MED INT HEALTH, V15, P540, DOI 10.1111/j.1365-3156.2010.02482.x; Pezzoli L, 2009, TROP MED INT HEALTH, V14, P355, DOI 10.1111/j.1365-3156.2009.02231.x; Singh J, 1996, B WORLD HEALTH ORGAN, V74, P269; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Stephens DS, 2008, J INFECT DIS, V197, P643, DOI 10.1086/527402; Stephens DS, 2004, CURR INFECT DIS REP, V6, P351; Thompson F, 2011, B WORLD HEALTH ORGAN, V89, P550, DOI 10.2471/BLT.11.020811; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; WHO, 2005, IMM COV CLUST SURV R; World Health Organization, 1997, WKLY EPIDEMIOL REC, V72, P313; World Health Organization, 2010, WKLY EPIDEMIOL REC, V84, P325; Zuber PLF, 2003, J INFECT DIS, V187, pS86, DOI 10.1086/368052	25	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29116	10.1371/journal.pone.0029116	http://dx.doi.org/10.1371/journal.pone.0029116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276104	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100008
J	Wang, Y; Sun, G; Ji, ZH; Xing, C; Liang, YC				Wang, Yao; Sun, Guang; Ji, Zhaohua; Xing, Chong; Liang, Yanchun			Weighted Change-Point Method for Detecting Differential Gene Expression in Breast Cancer Microarray Data	PLOS ONE			English	Article							PROSTATE-CANCER; GASTRIC-CANCER; HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; COLORECTAL-CANCER; PROTEIN; OVEREXPRESSION; METHYLATION; ACTIVATION; PATTERNS	In previous work, we proposed a method for detecting differential gene expression based on change-point of expression profile. This non-parametric change-point method gave promising result in both simulation study and public dataset experiment. However, the performance is still limited by the less sensitiveness to the right bound and the statistical significance of the statistics has not been fully explored. To overcome the insensitiveness to the right bound we modified the original method by adding a weight function to the D-n statistic. Simulation study showed that the weighted change-point statistics method is significantly better than the original NPCPS in terms of ROC, false positive rate, as well as change-point estimate. The mean absolute error of the estimated change-point by weighted change-point method was 0.03, reduced by more than 50% comparing with the original 0.06, and the mean FPR was reduced by more than 55%. Experiment on microarray Dataset I resulted in 3974 differentially expressed genes out of total 5293 genes; experiment on microarray Dataset II resulted in 9983 differentially expressed genes among total 12576 genes. In summary, the method proposed here is an effective modification to the previous method especially when only a small subset of cancer samples has DGE.	[Wang, Yao; Xing, Chong; Liang, Yanchun] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Natl Educ Minist, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Sun, Guang] China Japan Union Hosp, Dept Breast & Thyroid Surg, Changchun, Peoples R China; [Ji, Zhaohua] Jilin Univ, Dept Commun Engn, Changchun 130023, Peoples R China; [Ji, Zhaohua] Inner Mongolia Normal Univ, Coll Comp Sci & Technol, Hohhot, Peoples R China; [Xing, Chong] Changchun Univ, Guanghua Coll, Changchun, Peoples R China	Jilin University; Jilin University; Jilin University; Inner Mongolia Normal University; Changchun University	Liang, YC (corresponding author), Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Natl Educ Minist, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	ycliang@jlu.edu.cn			National High-technology Development Project [2009AA02Z307]; National Natural Science Foundation of China [10872077, 60703025]; Education Department of Jilin Province of China [2011449]; Natural Science Foundation of Inner Mongolia of China [2011MS0907]; Research Program at Universities of Inner Mongolia Autonomous Region [NJ10320]	National High-technology Development Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Jilin Province of China; Natural Science Foundation of Inner Mongolia of China; Research Program at Universities of Inner Mongolia Autonomous Region	This work was supported in part by the National High-technology Development Project (2009AA02Z307), the National Natural Science Foundation of China (10872077, 60703025), the Education Department of Jilin Province (2011449) of China, the Natural Science Foundation of Inner Mongolia (2011MS0907) of China, and Research Program at Universities of Inner Mongolia Autonomous Region (NJ10320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Cheng CW, 2010, CLIN CHIM ACTA, V411, P234, DOI 10.1016/j.cca.2009.11.009; Chong PK, 2010, PROTEOMICS, V10, P3210, DOI 10.1002/pmic.201000127; Davies Simon R, 2008, J Exp Ther Oncol, V7, P327; Drenth JPH, 1996, IMMUNOLOGY, V88, P355, DOI 10.1046/j.1365-2567.1996.d01-672.x; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Entschladen F, 2011, CELL CYCLE, V10, P1086, DOI 10.4161/cc.10.7.15208; Field JK, 2005, INT J ONCOL, V27, P105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Graham K, 2010, BRIT J CANCER, V102, P1284, DOI 10.1038/sj.bjc.6605576; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Han X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-476; Han Yan-Chun, 2007, Ai Zheng, V26, P48; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hayashi H, 2010, INT J CANCER, V126, P2563, DOI 10.1002/ijc.24987; Hu JH, 2008, BIOINFORMATICS, V24, P2193, DOI 10.1093/bioinformatics/btn372; Ji ZH, 2010, INT J DATA IN PRESS; Kim JH, 2004, HEPATOLOGY, V39, P129, DOI 10.1002/hep.20017; Kumar D, 2011, PROJECT INFORM FUNCT; Kumar S, 2000, MODERN PATHOL, V13, P988, DOI 10.1038/modpathol.3880179; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Lian H, 2008, BIOSTATISTICS, V9, P411, DOI 10.1093/biostatistics/kxm042; Liang P, 2003, NAT REV CANCER, V3, P869, DOI 10.1038/nrc1214; Liu Y, 2011, J INVEST DERMATOL, V131, P1570, DOI 10.1038/jid.2011.62; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Lyons-Weiler J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-110; Ma Z, 2007, CURR BIOL, V17, P722, DOI 10.1016/j.cub.2007.03.014; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Menigatti M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-124; MIETTINEN M, 1987, ARCH PATHOL LAB MED, V111, P813; Motadi L, 2005, P AM ASS CANC RES, V46; Nandana S, 2010, PROSTATE, V70, P591, DOI 10.1002/pros.21093; Pan Wei, 2003, Functional & Integrative Genomics, V3, P117; Pasini FS, 2006, P AM ASS CANC RES, V47; Renier C, 2010, J NEURO-ONCOL, V96, P331, DOI 10.1007/s11060-009-9971-8; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Storey JD, 2003, SAM THRESHOLDING FAL; Tan ZP, 2000, J CHINA U SCI TECHNO, V6, P270; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020060; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wu BL, 2007, BIOSTATISTICS, V8, P566, DOI 10.1093/biostatistics/kxl029; Wu P, 2010, CELL DEATH DIFFER, V17, P109, DOI 10.1038/cdd.2009.142; Yang Y., 2008, Experimental Oncology, V30, P81; Zegerman P, 2000, ONCOGENE, V19, P161, DOI 10.1038/sj.onc.1203234; Zhang HB, 2011, NAT NEUROSCI, V14, P874, DOI 10.1038/nn.2835; Zhaohua Ji, 2010, Proceedings of the 2010 3rd International Congress on Image and Signal Processing (CISP 2010 ), P3142, DOI 10.1109/CISP.2010.5648037	57	22	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29860	10.1371/journal.pone.0029860	http://dx.doi.org/10.1371/journal.pone.0029860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276133	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100018
J	Akiyama, R; Agren, J				Akiyama, Reiko; Agren, Jon			Magnitude and Timing of Leaf Damage Affect Seed Production in a Natural Population of Arabidopsis thaliana (Brassicaceae)	PLOS ONE			English	Article							INDUCED RESPONSES; FITNESS COMPONENTS; PLANT-RESISTANCE; HERBIVORY; TOLERANCE; DEFOLIATION; EVOLUTION; ECOLOGY; DEFENSE; COSTS	Background: The effect of herbivory on plant fitness varies widely. Understanding the causes of this variation is of considerable interest because of its implications for plant population dynamics and trait evolution. We experimentally defoliated the annual herb Arabidopsis thaliana in a natural population in Sweden to test the hypotheses that (a) plant fitness decreases with increasing damage, (b) tolerance to defoliation is lower before flowering than during flowering, and (c) defoliation before flowering reduces number of seeds more strongly than defoliation during flowering, but the opposite is true for effects on seed size. Methodology/Principal Findings: In a first experiment, between 0 and 75% of the leaf area was removed in May from plants that flowered or were about to start flowering. In a second experiment, 0, 25%, or 50% of the leaf area was removed from plants on one of two occasions, in mid April when plants were either in the vegetative rosette or bolting stage, or in mid May when plants were flowering. In the first experiment, seed production was negatively related to leaf area removed, and at the highest damage level, also mean seed size was reduced. In the second experiment, removal of 50% of the leaf area reduced seed production by 60% among plants defoliated early in the season at the vegetative rosettes, and by 22% among plants defoliated early in the season at the bolting stage, but did not reduce seed output of plants defoliated one month later. No seasonal shift in the effect of defoliation on seed size was detected. Conclusions/Significance: The results show that leaf damage may reduce the fitness of A. thaliana, and suggest that in this population leaf herbivores feeding on plants before flowering should exert stronger selection on defence traits than those feeding on plants during flowering, given similar damage levels.	[Akiyama, Reiko; Agren, Jon] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, Uppsala, Sweden	Uppsala University	Akiyama, R (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	reiko.akiyama@ebc.uu.se	Ågren, Jon/E-6093-2011	Ågren, Jon/0000-0001-9573-2463	Nakajima Foundation; Tullbergs stiftelse; Sernanders stiftelse; Linneska stipendiestiftelsen; Swedish Research Council	Nakajima Foundation; Tullbergs stiftelse; Sernanders stiftelse; Linneska stipendiestiftelsen; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by stipends from the Nakajima Foundation, Tullbergs stiftelse, Sernanders stiftelse, and Linneska stipendiestiftelsen to RA, and by a grant from the Swedish Research Council to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, EVOLUTION, V53, P1093, DOI [10.2307/2640814, 10.1111/j.1558-5646.1999.tb04524.x]; Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Al-Shehbaz Ihsan A, 2002, Arabidopsis Book, V1, pe0001, DOI 10.1199/tab.0001; Arany AM, 2005, PLANT BIOLOGY, V7, P549, DOI 10.1055/s-2005-865831; Banta JA, 2010, OIKOS, V119, P359, DOI 10.1111/j.1600-0706.2009.17726.x; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Boege K, 2007, ECOL LETT, V10, P177, DOI 10.1111/j.1461-0248.2006.01012.x; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Cipollini D, 2003, BASIC APPL ECOL, V4, P79, DOI 10.1078/1439-1791-00134; Del-Val EK, 2005, J ECOL, V93, P1005, DOI 10.1111/j.1365-2745.2005.01011.x; Diaz C, 2008, PLANT PHYSIOL, V147, P1437, DOI 10.1104/pp.108.119040; Du DL, 2008, AM J BOT, V95, P84, DOI 10.3732/ajb.95.1.84; Earley EJ, 2009, AM J BOT, V96, P786, DOI 10.3732/ajb.0800149; Garcia MB, 2002, AM J BOT, V89, P1295, DOI 10.3732/ajb.89.8.1295; Handley R, 2005, ECOL ENTOMOL, V30, P284, DOI 10.1111/j.0307-6946.2005.00699.x; Harvey JA, 2007, PLANT ECOL, V189, P117, DOI 10.1007/s11258-006-9204-6; Hochwender CG, 2000, OECOLOGIA, V122, P361, DOI 10.1007/s004420050042; HORTON M, 1994, AM J BOT, V81, P278, DOI 10.2307/2445453; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Karban R, 1997, INDUCED RESPONSE HER; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Knight TM, 2003, AM J BOT, V90, P1207, DOI 10.3732/ajb.90.8.1207; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; KRANNITZ PG, 1991, AM J BOT, V78, P446, DOI 10.2307/2444967; Lehtila K, 2004, ECOL STU AN, V173, P257; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Marshall DL, 2005, ANN BOT-LONDON, V95, P1049, DOI 10.1093/aob/mci116; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Matthes MC, 2008, PLANTA, V228, P1021, DOI 10.1007/s00425-008-0804-3; Mauricio R, 1997, ECOLOGY, V78, P1301, DOI 10.1890/0012-9658(1997)078[1301:VITDSO]2.0.CO;2; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; Napp-Zinn K, 1985, CRC HDB FLOWERING, V1, P492; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; OBESO JR, 1994, OIKOS, V71, P506, DOI 10.2307/3545839; RATCLIFFE D, 1961, J ECOL, V49, P187, DOI 10.2307/2257433; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Sullivan AT, 2009, ECOLOGY, V90, P1346, DOI 10.1890/08-0629.1; Susko DJ, 2009, PLANT ECOL, V202, P169, DOI 10.1007/s11258-008-9462-6; Tifffn P, 2002, ECOLOGY, V83, P1981, DOI 10.1890/0012-9658(2002)083[1981:CATODA]2.0.CO;2; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; TRUMBLE JT, 1993, ANNU REV ENTOMOL, V38, P93, DOI 10.1146/annurev.en.38.010193.000521; Tucker C, 2010, OECOLOGIA, V164, P1005, DOI 10.1007/s00442-010-1738-6; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wolfinger, 1996, SAS SYSTEM MIXED MOD, P423	51	24	24	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30015	10.1371/journal.pone.0030015	http://dx.doi.org/10.1371/journal.pone.0030015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276140	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000301457200028
J	Motta, FN; Bastos, IMD; Faudry, E; Ebel, C; Lima, MM; Neves, D; Ragno, M; Barbosa, JARG; de Freitas, SM; Santana, JM				Motta, Flavia Nader; Bastos, Izabela M. D.; Faudry, Eric; Ebel, Christine; Lima, Meire M.; Neves, David; Ragno, Michel; Barbosa, Joao Alexandre R. G.; de Freitas, Sonia Maria; Santana, Jaime Martins			The Trypanosoma cruzi Virulence Factor Oligopeptidase B (OPBTc) Assembles into an Active and Stable Dimer	PLOS ONE			English	Article							CHAGAS-DISEASE CARDIOMYOPATHY; PROLYL OLIGOPEPTIDASE; MAMMALIAN-CELLS; LEISHMANIA-MAJOR; PEPTIDASE; PARASITE; PURIFICATION; PROTEINS; BRUCEI; ULTRACENTRIFUGATION	Oligopeptidase B, a processing enzyme of the prolyl oligopeptidase family, is considered as an important virulence factor in trypanosomiasis. Trypanosoma cruzi oligopeptidase B (OPBTc) is involved in host cell invasion by generating a Ca2+-agonist necessary for recruitment and fusion of host lysosomes at the site of parasite attachment. The underlying mechanism remains unknown and further structural and functional characterization of OPBTc may help clarify its physiological function and lead to the development of new therapeutic molecules to treat Chagas disease. In the present work, size exclusion chromatography and analytical ultracentrifugation experiments demonstrate that OPBTc is a dimer in solution, an association salt and pH-resistant and independent of intermolecular disulfide bonds. The enzyme retains its dimeric structure and is fully active up to 42 degrees C. OPBTc is inactivated and its tertiary, but not secondary, structure is disrupted at higher temperatures, as monitored by circular dichroism and fluorescence spectroscopy. It has a highly stable secondary structure over a broad range of pH, undergoes subtle tertiary structure changes at low pH and is less stable under moderate ionic strength conditions. These results bring new insights into the structural properties of OPBTc, contributing to future studies on the rational design of OPBTc inhibitors as a promising strategy for Chagas disease chemotherapy.	[Motta, Flavia Nader; Bastos, Izabela M. D.; Lima, Meire M.; Neves, David; Santana, Jaime Martins] Univ Brasilia, Dept Cell Biol, Pathogen Host Interface Lab, Brasilia, DF, Brazil; [Bastos, Izabela M. D.] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil; [Faudry, Eric; Ragno, Michel] INSERM, UMR S Biol Canc & Infect 1036, Grenoble, France; [Faudry, Eric; Ragno, Michel] CNRS, ERL 5261, Grenoble, France; [Faudry, Eric; Ragno, Michel] UJF Grenoble 1, Grenoble, France; [Faudry, Eric; Ragno, Michel] CEA, DSV iRTSV, Grenoble, France; [Ebel, Christine] CEA, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Ebel, Christine] CNRS, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Ebel, Christine] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Barbosa, Joao Alexandre R. G.] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [de Freitas, Sonia Maria] Univ Brasilia, Dept Cell Biol, Biophys Lab, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Universidade Catolica de Brasilia; Universidade de Brasilia	Motta, FN (corresponding author), Univ Brasilia, Dept Cell Biol, Pathogen Host Interface Lab, Brasilia, DF, Brazil.	jsantana@unb.br	Santana, Jaime/H-5319-2013; Barbosa, João/GVT-7916-2022; Barbosa, João Alexandre/E-2261-2012; Faudry, Eric/I-9154-2014	Barbosa, João Alexandre/0000-0002-0534-481X; Faudry, Eric/0000-0001-9958-6029; Bastos, Izabela/0000-0002-2785-4255; Ebel, Christine/0000-0002-6912-500X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX); Financiadora de Estudos e Projetos (FINEP); Laboratorio Nacional de Luz Sincrotron (LNLS)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Laboratorio Nacional de Luz Sincrotron (LNLS)	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX), Financiadora de Estudos e Projetos (FINEP) and Laboratorio Nacional de Luz Sincrotron (LNLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos IMD, 2005, BIOCHEM J, V388, P29, DOI 10.1042/BJ20041049; Bastos IMD, 2010, MICROBES INFECT, V12, P457, DOI 10.1016/j.micinf.2010.02.007; Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; BURLEIGH BA, 1995, J BIOL CHEM, V270, P5172, DOI 10.1074/jbc.270.10.5172; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Coetzer THT, 2008, BIOCHIMIE, V90, P336, DOI 10.1016/j.biochi.2007.10.011; Cunha-Neto E, 2011, AUTOIMMUN REV, V10, P163, DOI 10.1016/j.autrev.2010.09.019; Guedes HLD, 2007, PARASITOL RES, V101, P853, DOI [10.1007/s00436-007-0552-5, 10.1007/s00436-007-0630-8]; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Fernandes LC, 2005, MICROBES INFECT, V7, P375, DOI 10.1016/j.micinf.2004.11.009; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gerczei T, 2000, J MOL GRAPH MODEL, V18, P7, DOI 10.1016/S1093-3263(99)00042-X; Ismail NIM, 2010, J BIOCHEM, V147, P201, DOI 10.1093/jb/mvp156; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Lakowicz JR, 2004, PRINCIPLE FLUORESCEN, P698; Lauria-Pires L, 2000, AM J TROP MED HYG, V63, P111, DOI 10.4269/ajtmh.2000.63.111; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; McLuskey K, 2010, J BIOL CHEM, V285, P39249, DOI 10.1074/jbc.M110.156679; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Morty RE, 2005, FEBS LETT, V579, P2191, DOI 10.1016/j.febslet.2005.03.014; Morty RE, 1998, FEBS LETT, V433, P251, DOI 10.1016/S0014-5793(98)00914-4; Munday JC, 2011, MOL BIOCHEM PARASIT, V175, P49, DOI 10.1016/j.molbiopara.2010.09.003; Polgar L, 1997, PROTEINS, V28, P375; Ponstingl H, 2005, PROG BIOPHYS MOL BIO, V89, P9, DOI 10.1016/j.pbiomolbio.2004.07.010; Qureshi SH, 2003, BIOCHEMISTRY-US, V42, P1684, DOI 10.1021/bi0271042; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rea D, 2006, ACTA CRYSTALLOGR F, V62, P808, DOI 10.1107/S1744309106027874; Rumfeldt JAO, 2008, PROG BIOPHYS MOL BIO, V98, P61, DOI 10.1016/j.pbiomolbio.2008.05.004; SANTANA JM, 1992, BIOCHEM BIOPH RES CO, V187, P1466, DOI 10.1016/0006-291X(92)90467-Y; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Swenerton RK, 2011, J BIOL CHEM, V286, P429, DOI 10.1074/jbc.M110.138313; Tsuji A, 2004, J BIOCHEM, V136, P673, DOI 10.1093/jb/mvh163; Usuki H, 2009, BBA-PROTEINS PROTEOM, V1794, P1673, DOI 10.1016/j.bbapap.2009.07.024; Westerhuis WHJ, 2000, ANAL BIOCHEM, V284, P143, DOI 10.1006/abio.2000.4684; Yoshida Nobuko, 2008, V47, P82	38	23	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30431	10.1371/journal.pone.0030431	http://dx.doi.org/10.1371/journal.pone.0030431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276197	gold, Green Published, Green Submitted			2022-12-25	WOS:000301457200060
J	Siddiqui, S; Tsuchiya, K; Risse, PA; Bullimore, SR; Benedetti, A; Martin, JG				Siddiqui, Sana; Tsuchiya, Kimitake; Risse, Paul-Andre; Bullimore, Sharon R.; Benedetti, Andrea; Martin, James G.			Site of Allergic Airway Narrowing and the Influence of Exogenous Surfactant in the Brown Norway Rat	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; MICROVASCULAR LEAKAGE; PULMONARY SURFACTANT; ANTIGEN CHALLENGE; TISSUE MECHANICS; LUNG-FUNCTION; HISTAMINE; RESPONSES; METHACHOLINE; CONSTRICTION	Background: The parameters R-N (Newtonian resistance), G (tissue damping), and H (tissue elastance) of the constant phase model of respiratory mechanics provide information concerning the site of altered mechanical properties of the lung. The aims of this study were to compare the site of allergic airway narrowing implied from respiratory mechanics to a direct assessment by morphometry and to evaluate the effects of exogenous surfactant administration on the site and magnitude of airway narrowing. Methods: We induced airway narrowing by ovalbumin sensitization and challenge and we tested the effects of a natural surfactant lacking surfactant proteins A and D (Infasurf (R)) on airway responses. Sensitized, mechanically ventilated Brown Norway rats underwent an aerosol challenge with 5% ovalbumin or vehicle. Other animals received nebulized surfactant prior to challenge. Three or 20 minutes after ovalbumin challenge, airway luminal areas were assessed on snap-frozen lungs by morphometry. Results: At 3 minutes, R-N and G detected large airway narrowing whereas at 20 minutes G and H detected small airway narrowing. Surfactant inhibited R-N at the peak of the early allergic response and ovalbumin-induced increase in bronchoalveolar lavage fluid cysteinyl leukotrienes and amphiregulin but not IgE-induced mast cell activation in vitro. Conclusion: Allergen challenge triggers the rapid onset of large airway narrowing, detected by R-N and G, and subsequent peripheral airway narrowing detected by G and H. Surfactant inhibits airway narrowing and reduces mast cell-derived mediators.	[Siddiqui, Sana] McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada; McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada	McGill University; McGill University	Siddiqui, S (corresponding author), McGill Univ, Meakins Christie Labs, Dept Med, Montreal, PQ, Canada.	james.martin@mcgill.ca		Martin, James/0000-0001-7574-5363	Canadian Institutes of Health Research [MOP-93747]; J. T. Costello Memorial Research Fund; Quebec Respiratory Health Training Program; McGill Internal Studentship (Alexander McFee Fellowship)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); J. T. Costello Memorial Research Fund; Quebec Respiratory Health Training Program; McGill Internal Studentship (Alexander McFee Fellowship)	This work was supported by a grant from the Canadian Institutes of Health Research (MOP-93747) and the J. T. Costello Memorial Research Fund. SS was supported by a studentship from the Quebec Respiratory Health Training Program (2008-2009) and a McGill Internal Studentship (Alexander McFee Fellowship 2009-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIRAV I, 1993, J APPL PHYSIOL, V75, P2239, DOI 10.1152/jappl.1993.75.5.2239; Babu KS, 2003, EUR RESPIR J, V21, P1046, DOI 10.1183/09031936.03.00069202; Bates JHT, 2009, IEEE ENG MED BIO, P170, DOI 10.1109/IEMBS.2009.5333302; BATES JHT, 1994, J APPL PHYSIOL, V76, P616, DOI 10.1152/jappl.1994.76.2.616; Bayat S, 2009, AM J RESP CRIT CARE, V180, P296, DOI 10.1164/rccm.200808-1211OC; BROWN RH, 1993, J APPL PHYSIOL, V74, P2615, DOI 10.1152/jappl.1993.74.6.2615; Chen BT, 2004, MAGN RESON MED, V52, P1080, DOI 10.1002/mrm.20251; CHURCH MK, 1975, BRIT J PHARMACOL, V55, pP315; DU T, 1992, AM REV RESPIR DIS, V146, P1037, DOI 10.1164/ajrccm/146.4.1037; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; EVANS TW, 1988, AM REV RESPIR DIS, V138, P395, DOI 10.1164/ajrccm/138.2.395; FREDBERG JJ, 1985, J APPL PHYSIOL, V58, P1914, DOI 10.1152/jappl.1985.58.6.1914; Gillis HL, 1999, ANN BIOMED ENG, V27, P14, DOI 10.1114/1.161; Hall GL, 1999, CLIN EXP ALLERGY, V29, P562, DOI 10.1046/j.1365-2222.1999.00471.x; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; HEROLD CJ, 1991, RADIOLOGY, V181, P369, DOI 10.1148/radiology.181.2.1924774; Hite RD, 2005, AM J PHYSIOL-LUNG C, V288, pL610, DOI 10.1152/ajplung.00273.2004; Hohlfeld JM, 1999, AM J RESP CRIT CARE, V159, P1803, DOI 10.1164/ajrccm.159.6.9806145; Jarjour NN, 1999, AM J RESP CRIT CARE, V160, P336, DOI 10.1164/ajrccm.160.1.9806155; Kaczka DW, 2009, J APPL PHYSIOL, V106, P520, DOI 10.1152/japplphysiol.90576.2008; KOBAYASHI T, 1991, J APPL PHYSIOL, V71, P530, DOI 10.1152/jappl.1991.71.2.530; LAM S, 1991, J ALLERGY CLIN IMMUN, V87, P842, DOI 10.1016/0091-6749(91)90131-7; Lundblad LKA, 2007, AM J RESP CRIT CARE, V175, P768, DOI 10.1164/rccm.200610-1410OC; Lutchen KR, 1996, J APPL PHYSIOL, V80, P1841, DOI 10.1152/jappl.1996.80.5.1841; LUTCHEN KR, 1994, J APPL PHYSIOL, V77, P373, DOI 10.1152/jappl.1994.77.1.373; Lutchen KR, 1997, J APPL PHYSIOL, V83, P1192, DOI 10.1152/jappl.1997.83.4.1192; Macklem PT, 1996, AM J RESP CRIT CARE, V153, P83, DOI 10.1164/ajrccm.153.1.8542167; Malherbe DC, 2005, AM J PHYSIOL-LUNG C, V289, pL856, DOI 10.1152/ajplung.00009.2005; MARTIN JG, 1993, AM REV RESPIR DIS, V147, P104, DOI 10.1164/ajrccm/147.1.104; NAGASE T, 1994, AM J RESP CRIT CARE, V150, P218, DOI 10.1164/ajrccm.150.1.8025752; Olivenstein R, 1997, PULM PHARMACOL THER, V10, P223, DOI 10.1006/pupt.1997.0095; PLOPPER CG, 1983, EXP LUNG RES, V5, P79, DOI 10.3109/01902148309061506; Saez AO, 1996, J APPL PHYSIOL, V80, P437, DOI 10.1152/jappl.1996.80.2.437; SCHURCH S, 1978, P NATL ACAD SCI USA, V75, P3417, DOI 10.1073/pnas.75.7.3417; Siddiqui S, 2010, J APPL PHYSIOL, V109, P1170, DOI 10.1152/japplphysiol.01168.2009; Tamaoka M, 2008, EUR RESPIR J, V32, P1213, DOI 10.1183/09031936.00166907; Wang JY, 2007, IMMUNOBIOLOGY, V212, P417, DOI 10.1016/j.imbio.2007.01.002; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Wright SM, 2000, J APPL PHYSIOL, V89, P1283, DOI 10.1152/jappl.2000.89.4.1283; YAGER D, 1989, J APPL PHYSIOL, V66, P2873, DOI 10.1152/jappl.1989.66.6.2873; YU SH, 1993, BIOCHIM BIOPHYS ACTA, V1167, P264, DOI 10.1016/0005-2760(93)90228-2; Zerhouni E A, 1993, J Thorac Imaging, V8, P265, DOI 10.1097/00005382-199323000-00002	45	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29381	10.1371/journal.pone.0029381	http://dx.doi.org/10.1371/journal.pone.0029381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276110	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200011
J	Kisa, O; Tarhan, G; Gunal, S; Albay, A; Durmaz, R; Saribas, Z; Zozio, T; Alp, A; Ceyhan, I; Tombak, A; Rastogi, N				Kisa, Ozgul; Tarhan, Gulnur; Gunal, Selami; Albay, Ali; Durmaz, Riza; Saribas, Zeynep; Zozio, Thierry; Alp, Alpaslan; Ceyhan, Ismail; Tombak, Ahmet; Rastogi, Nalin			Distribution of Spoligotyping Defined Genotypic Lineages among Drug-Resistant Mycobacterium tuberculosis Complex Clinical Isolates in Ankara, Turkey	PLOS ONE			English	Article							GENETIC DIVERSITY; GLOBAL DISTRIBUTION; EASTERN TURKEY; EPIDEMIOLOGY; STRAINS; FAMILIES; DATABASE	Background: Investigation of genetic heterogeneity and spoligotype-defined lineages of drug-resistant Mycobacterium tuberculosis clinical isolates collected during a three-year period in two university hospitals and National Tuberculosis Reference and Research Laboratory in Ankara, Turkey. Methods and Findings: A total of 95 drug-resistant M. tuberculosis isolates collected from three different centers were included in this study. Susceptibility testing of the isolates to four major antituberculous drugs was performed using proportion method on Lowenstein-Jensen medium and BACTEC 460-TB system. All clinical isolates were typed by using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) methods. Seventy-three of the 95 (76.8%) drug resistant M. tuberculosis isolates were isoniazid-resistant, 45 (47.4%) were rifampicin-resistant, 32 (33.7%) were streptomycin-resistant and 31 (32.6%) were ethambutol-resistant. The proportion of multidrug-resistant isolates (MDR) was 42.1%. By using spoligotyping, 35 distinct patterns were observed; 75 clinical isolates were grouped in 15 clusters (clustering rate of 79%) and 20 isolates displayed unique patterns. Five of these 20 unique patterns corresponded to orphan patterns in the SITVIT2 database, while 4 shared types containing 8 isolates were newly created. The most prevalent M. tuberculosis lineages were: Haarlem (23/95, 24.2%), ill-defined T superfamily (22/95, 23.2%), the Turkey family (19/95, 20%; previously designated as LAM7-TUR), Beijing (6/95, 6.3%), and Latin-America & Mediterranean (LAM, 5/95 or 5.3%), followed by Manu (3/95, 3.2%) and S (1/95, 1%) lineages. Four of the six Beijing family isolates (66.7%) were MDR. A combination of IS6110-RFLP and spoligotyping reduced the clustering rate from 79% to 11.5% among the drug resistant isolates. Conclusions: The results obtained showed that ill-defined T, Haarlem, the Turkey family (previously designated as LAM7-TUR family with high phylogeographical specifity for Turkey), Beijing and LAM were predominant lineages observed in almost 80% of the drug-Resistant M. tuberculosis complex clinical isolates in Ankara, Turkey.	[Kisa, Ozgul; Albay, Ali] Gulhane Mil Med Acad, Dept Med Microbiol, Ankara, Turkey; [Kisa, Ozgul; Albay, Ali] Hacettepe Univ, Sch Med, Ankara, Turkey; [Tarhan, Gulnur; Ceyhan, Ismail; Tombak, Ahmet] Refik Saydam Hyg Ctr, TB Reference & Res Lab, Ankara, Turkey; [Gunal, Selami; Durmaz, Riza] Inonu Univ, Dept Med Microbiol, Fac Med, Malatya, Turkey; [Saribas, Zeynep; Alp, Alpaslan] Hacettepe Univ, Fac Med, Dept Med Microbiol, TR-06100 Ankara, Turkey; [Zozio, Thierry; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO Supranat TB Reference Lab, Unite TB & Mycobacteries, Abymes, Guadeloupe, France	Gulhane Military Medical Academy; Hacettepe University; Refik Saydam Hifzissihha Merkezi Baskanligi; Inonu University; Hacettepe University	Kisa, O (corresponding author), Gulhane Mil Med Acad, Dept Med Microbiol, Ankara, Turkey.	okisa@gata.edu.tr	RASTOGI, NALIN/AAP-1958-2020; ALP, ALPASLAN/I-8366-2013; Günal, Selami/AAA-7246-2021	RASTOGI, NALIN/0000-0002-7199-7747; ALP, ALPASLAN/0000-0001-7856-7590; Günal, Selami/0000-0002-4752-5176; Albay, Ali/0000-0003-2778-8910				Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Balci I, 2000, J INT MED RES, V28, P300, DOI 10.1177/147323000002800606; Bengisun JS, 2000, SCAND J INFECT DIS, V32, P507, DOI 10.1080/003655400458785; Brudey K, 2004, J CLIN MICROBIOL, V42, P3046, DOI 10.1128/JCM.42.7.3046-3051.2004; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cavusoglu C, 2004, ANN SAUDI MED, V24, P102, DOI 10.5144/0256-4947.2004.102; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Durmaz R, 2007, J CLIN MICROBIOL, V45, P4027, DOI 10.1128/JCM.01308-07; Durmaz R, 2007, INFECT GENET EVOL, V7, P513, DOI 10.1016/j.meegid.2007.03.003; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Gencer B, 2005, AM J INFECT DIS, V1, P5; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kisa O, 2003, INT J ANTIMICROB AG, V22, P456, DOI 10.1016/S0924-8579(03)00160-2; Kisa O, 2007, RES MICROBIOL, V158, P318, DOI 10.1016/j.resmic.2007.01.004; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; *MIN HLTH TURK, 2010, FIGHT TUB 2010 REP; Otlu B, 2009, NEW MICROBIOL, V32, P255; Puustinen K, 2003, J CLIN MICROBIOL, V41, P1525, DOI 10.1128/JCM.41.4.1525-1528.2003; SIDDIQI SH, 1996, BACTEC TB SYSTEM PRO; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sola C, 2001, EMERG INFECT DIS, V7, P390; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; TAHAOGLU K, 1994, TUBERCLE LUNG DIS, V75, P324, DOI 10.1016/0962-8479(94)90076-0; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Zozio T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-44	31	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30331	10.1371/journal.pone.0030331	http://dx.doi.org/10.1371/journal.pone.0030331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279583	Green Published, gold			2022-12-25	WOS:000299771900060
J	Brown, CM; Russell, AP				Brown, Caleb Marshall; Russell, Anthony P.			Homology and Architecture of the Caudal Basket of Pachycephalosauria (Dinosauria: Ornithischia): The First Occurrence of Myorhabdoi in Tetrapoda	PLOS ONE			English	Article							OSSIFIED TENDON; NORTH-AMERICA; TAIL; TRANSFORMATIONS; EVOLUTION; ANATOMY; SYSTEM; CLUB	Background: Associated postcranial skeletons of pachycephalosaurids, most notably those of Stegoceras and Homalocephale, reveal enigmatic osseous structures not present in other tetrapod clades. The homology and functional significance of these structures have remained elusive as they were originally interpreted to be abdominal ribs or gastralia, and more recently have been interpreted as de novo structures in the tail. Principal Findings: Analysis of these structures in nearly all pachycephalosaurid skeletons has facilitated a complete description of their architecture, and the establishment of patterns consistent with those of myorhabdoid ossifications - ossifications of the myoseptal tendons associated with myomeres. The presence and structure of myorhabdoid ossifications are well established for teleost fish, but this marks their first recognition within Tetrapoda. These elements are both structurally and histologically distinct from the deep, paraxial ossified tendon bundles of other ornithischian clades, although they may have performed a similar function in the stiffening of the tail. Conclusions/Significance: These myorhabdoi are not de novo structures, but are instead ossifications (and therefore more amenable to fossilization) of the normally unossified plesiomorphic caudal myosepta of vertebrates. The ubiquitous ossification of these structures in pachycephalosaurids (all specimens preserving the tail also exhibit myorhabdoid ossifications) suggests it is a likely synapomorphic condition for Pachycephalosauria.	[Brown, Caleb Marshall] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Russell, Anthony P.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Toronto; University of Calgary	Brown, CM (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	caleb.brown@utoronto.ca		Brown, Caleb/0000-0001-6463-8677	NSERC (Natural Sciences and Engineering Research Council of Canada); Doris O. and Samuel P. Welles Fund Travel Grant (UCMP); Montessori High School at University Circle (Cleveland, OH); Cleveland Museum of Natural History; Lubrizol Corp	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Doris O. and Samuel P. Welles Fund Travel Grant (UCMP); Montessori High School at University Circle (Cleveland, OH); Cleveland Museum of Natural History; Lubrizol Corp(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by an NSERC (Natural Sciences and Engineering Research Council of Canada) Alexander Graham Bell Canada Scholarship and Doris O. and Samuel P. Welles Fund Travel Grant (UCMP) to CMB and an NSERC Discovery Grant to APR, as well as financial contributions from Montessori High School at University Circle (Cleveland, OH), the Cleveland Museum of Natural History, and Lubrizol Corp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen V, 2009, ANAT REC, V292, P1442, DOI 10.1002/ar.20973; Arbour VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006738; Bellairs A.D., 1985, Biology of Reptilia, V15, P301; BROWN BARNUM, 1933, AMER MUS NOVITATES, V669, P1; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Chapman WM, 1944, J MORPHOL, V74, P311, DOI 10.1002/jmor.1050740205; Claessens LPAM, 2004, J VERTEBR PALEONTOL, V24, P89, DOI 10.1671/A1116-8; COOMBS WP, 1995, CAN J EARTH SCI, V32, P902, DOI 10.1139/e95-075; Dal Sasso Cristiano, 2011, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V37, P1; de Margerie E, 2002, J ANAT, V201, P521, DOI 10.1046/j.1469-7580.2002.00118.x; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; Evans DC, 2011, J VERTEBR PALEONTOL, V31, P84, DOI 10.1080/02724634.2011.546287; Forster C.A., 1990, Journal of Vertebrate Paleontology, V10, P273; FREY E, 1989, AM ZOOL, V29, P857; GALTON PM, 1974, J PALEONTOL, V48, P1048; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gemballa S, 2006, J MORPHOL, V267, P477, DOI 10.1002/jmor.10412; Gemballa S, 2004, J MORPHOL, V259, P155, DOI 10.1002/jmor.10175; Gemballa S, 2003, P ROY SOC B-BIOL SCI, V270, P1229, DOI 10.1098/rspb.2003.2345; Gemballa S, 2003, ZOOLOGY, V106, P29, DOI 10.1078/0944-2006-00087; Gilmore C. W., 1924, Bull No 1 Dept of Geol University of Alberta, P1; Goodwin MB, 1998, J VERTEBR PALEONTOL, V18, P363, DOI 10.1080/02724634.1998.10011064; Holmes R, 2007, J PALEONTOL, V81, P411, DOI 10.1666/0022-3360(2007)81[411:AOTTIC]2.0.CO;2; Kafuku T, 1995, JAPANESE J ICHTHYOLO, V1, P89; Lambe L. M., 1902, Contributions to Canadian Palaeontology, Viii, pUnpaginated; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Mallison H, 2011, PALAEONTOL ELECTRON, V14; Maryanska T., 1974, PALEONTOLOGICA POLON, V26, P133; Maryanska T, 2004, DINOSAURIA, 2ND EDITION, P464; NORMAN D B, 1980, Institut Royal des Sciences Naturelles de Belgique Memoires, P1; Organ CL, 2006, ANAT REC PART A, V288A, P782, DOI 10.1002/ar.a.20341; Organ CL, 2005, J VERTEBR PALEONTOL, V25, P602, DOI 10.1671/0272-4634(2005)025[0602:THOOTI]2.0.CO;2; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; PARKS W. A., 1926, UNIV TORONTO STUDIES GEOL SER, V21, P1; Patterson C., 1995, SMITHSON CONTRIB ZOO, V559, P1, DOI [DOI 10.5479/SI.00810282.559, https://doi.org/10.5479/si.00810282.559]; PERLE A, 1982, Acta Palaeontologica Polonica, V27, P115; Persons WS, 2011, ANAT REC, V294, P119, DOI 10.1002/ar.21290; Schott RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021092; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Snively E., 2008, PALAEONTOL ELECTRON, V11, P17; Snively E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021422; SUES H-D, 1987, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V198, P1; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; Weishampel DB, DINOSAURIA; Williamson TE, 2002, J VERTEBR PALEONTOL, V22, P779, DOI 10.1671/0272-4634(2002)022[0779:ANGODP]2.0.CO;2; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19	48	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30212	10.1371/journal.pone.0030212	http://dx.doi.org/10.1371/journal.pone.0030212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272307	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400085
J	Nahmod, KA; Walther, T; Cambados, N; Fernandez, N; Meiss, R; Tappenbeck, N; Wang, Y; Raffo, D; Simian, M; Schwiebs, A; Pozner, RG; Bass, JIF; Pozzi, AG; Geffner, JR; Kordon, EC; Schere-Levy, C				Nahmod, Karen A.; Walther, Thomas; Cambados, Nadia; Fernandez, Natalia; Meiss, Roberto; Tappenbeck, Nils; Wang, Yong; Raffo, Diego; Simian, Marina; Schwiebs, Anja; Pozner, Roberto G.; Fuxman Bass, Juan I.; Pozzi, Andrea G.; Geffner, Jorge R.; Kordon, Edith C.; Schere-Levy, Carolina			AT(1) receptor blockade delays postlactational mammary gland involution: a novel role for the renin angiotensin system	FASEB JOURNAL			English	Article						AKT; angiotensin II; apoptosis; metalloproteases; STAT3	SMOOTH-MUSCLE-CELLS; II TYPE-1 RECEPTOR; NF-KAPPA-B; EPITHELIAL-CELLS; BREAST-CANCER; MICE LACKING; CARDIOVASCULAR-DISEASE; RAT CARDIOMYOCYTES; MESSENGER-RNA; IN-VITRO	Angiotensin II (AngII), the main effector peptide of the renin-angiotensin system (RAS), participates in multiple biological processes, including cell growth, apoptosis, and tissue remodeling. Since AngII activates, in different cell types, signal transducing pathways that are critical for mammary gland postlactational regression, we investigated the role of the RAS during this process. We found that exogenous administration of AngII in mammary glands of lactating Balb/c mice induced epithelium apoptosis [2.9+/-0.5% (control) vs. 9.6+/-1.1% (AngII); P < 0.001] and activation of the proapoptotic factor STAT3, an effect inhibited by irbesartan, an AT(1) receptor blocker. Subsequently, we studied the expression kinetics of RAS components during involution. We found that angiotensin-converting enzyme (ACE) mRNA expression peaked 6 h after weaning (5.7-fold; P<0.01), while induction of angiotensinogen and AT(1) and AT(2) receptors expression was detected 96 h after weaning (6.2-, 10-, and 6.2-fold increase, respectively; P<0.01). To assess the role of endogenously generated AngII, mice were treated with losartan, an AT(1) receptor blocker, during mammary involution. Mammary glands from losartan-treated mice showed activation of the survival factors AKT and BCL-(XL), significantly lower LIF and TNF-alpha mRNA expression (P<0.05), reduced apoptosis [12.1+/-2.1% (control) vs. 4.8+/-0.7% (losartan); P<0.001] and shedding of epithelial cells, inhibition of MMP-9 activity in a dose-dependent manner (80%; P<0.05; with losartan IC50 value of 6.9 mg/kg/d] and lower collagen deposition and adipocyte invasion causing a delayed involution compared to vehicle-treated mice. Furthermore, mammary glands of forced weaned AT(1A)- and/or AT(1B)-deficient mice exhibited retarded apoptosis of epithelial cells [6.3+/-0.95% (WT) vs. 3.3+/-0.56% (AT(1A)/AT(1B) DKO); P<0.05] with remarkable delayed postlactational regression compared to wild-type animals. Taken together, these results strongly suggest that AngII, via the AT(1) receptor, plays a major role in mouse mammary gland involution identifying a novel role for the RAS.-Nahmod, K. A., Walther, T., Cambados, N., Fernandez, N., Meiss, R., Tappenbeck, N., Wang, Y., Raffo, D., Simian, M., Schwiebs, A., Pozner, R. G., Fuxman Bass, J. I., Pozzi, A. G., Geffner, J. R., Kordon, E. C., Schere-Levy, C. AT(1) receptor blockade delays postlactational mammary gland involution: a novel role for the renin angiotensin system. FASEB J. 26, 1982-1994 (2012). www.fasebj.org	[Nahmod, Karen A.; Meiss, Roberto; Pozner, Roberto G.; Fuxman Bass, Juan I.; Geffner, Jorge R.] Natl Acad Med Buenos Aires, Inst Hematol Res, Buenos Aires, DF, Argentina; [Walther, Thomas; Tappenbeck, Nils; Wang, Yong; Schwiebs, Anja] Univ Giessen, Dept Expt Cardiol, Giessen, Germany; [Walther, Thomas; Tappenbeck, Nils; Wang, Yong; Schwiebs, Anja] Univ Hull, Hull York Med Sch, Ctr Cardiovasc & Metab Res, Kingston Upon Hull HU6 7RX, N Humberside, England; [Cambados, Nadia; Fernandez, Natalia; Pozzi, Andrea G.; Kordon, Edith C.; Schere-Levy, Carolina] Univ Buenos Aires, Fac Exact & Nat Sci, Consejo Nacl Invest Cient & Tecn CONICET, Inst Physiol Mol Biol & Neurosci, RA-1428 Buenos Aires, DF, Argentina; [Raffo, Diego; Simian, Marina] Univ Buenos Aires, Res Area, Inst Oncol Angel H Roffo, RA-1428 Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; Justus Liebig University Giessen; University of Hull; University of York - UK; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Schere-Levy, C (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, IFIBYNE CONICET, RA-1428 Buenos Aires, DF, Argentina.	caschere@fibertel.com.ar		Fernandez, Natalia Brenda/0000-0001-9170-2101; Simian, Marina/0000-0003-2070-3793	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 2008-1979, PICT 31948, PICT 00325]; Roemmers Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-200801-00859]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Deutscher Akademischer Austausch Dienst [DA0809]; Susan G. Komen for the Cure Foundation [BCTR0600341]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Roemmers Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Deutscher Akademischer Austausch Dienst; Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation)	The authors thank Dr. Monica Vermeulen for helping with in vivo experiments, Dr. Nancy Hynes (Friedrich Meischer Institute, Basel, Switzerland) for providing the HC11 cell line, and Dr. Omar Coso (University of Buenos Aires) for kindly providing some of the antibodies used for signal transduction studies. The authors are grateful to Beatriz Loria for excellent technical assistance. This work was supported by research grants awarded to K.N. from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; PICT 2008-1979) and Roemmers Foundation (2009); to C. S. L. from ANPCyT (PICT 31948) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 112-200801-00859); to T. W. and C. S. L. from Ministerio de Ciencia, Tecnologia e Innovacion Productiva-Deutscher Akademischer Austausch Dienst (DA0809); and to M. S. from ANPCyT (PICT 00325) and the Susan G. Komen for the Cure Foundation (BCTR0600341). The authors declare no conflicts of interest.	Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Browatzki M, 2005, J VASC RES, V42, P415, DOI 10.1159/000087451; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Clauser E, 1996, EUR J ENDOCRINOL, V134, P403, DOI 10.1530/eje.0.1340403; Crandall DL, 1999, ENDOCRINOLOGY, V140, P154, DOI 10.1210/en.140.1.154; De Paepe B, 2001, HISTOCHEM CELL BIOL, V116, P247, DOI 10.1007/s004180100313; Diep QN, 2001, HYPERTENSION, V37, P604, DOI 10.1161/01.HYP.37.2.604; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Eguchi S, 2001, J BIOL CHEM, V276, P7957, DOI 10.1074/jbc.M008570200; Gembardt F, 2005, PEPTIDES, V26, P1270, DOI 10.1016/j.peptides.2005.01.009; Gembardt F, 2008, FASEB J, V22, P3068, DOI 10.1096/fj.08-108316; Gross V, 2000, KIDNEY INT, V57, P191, DOI 10.1046/j.1523-1755.2000.00820.x; Guo RW, 2008, REGUL PEPTIDES, V147, P37, DOI 10.1016/j.regpep.2007.12.005; Herr D, 2008, GYNECOL ONCOL, V109, P418, DOI 10.1016/j.ygyno.2008.02.019; Ibanez P, 2007, J GASTROEN HEPATOL, V22, P846, DOI 10.1111/j.1440-1746.2006.04700.x; Inwang ER, 1997, BRIT J CANCER, V75, P1279, DOI 10.1038/bjc.1997.217; Kodama H, 1998, CIRC RES, V82, P244; KOJIMA M, 1994, CIRCULATION, V89, P2204, DOI 10.1161/01.CIR.89.5.2204; Kosugi M, 2006, CLIN CANCER RES, V12, P2888, DOI 10.1158/1078-0432.CCR-05-2213; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Luchtefeld M, 2005, BIOCHEM BIOPH RES CO, V328, P183, DOI 10.1016/j.bbrc.2004.12.152; Lund LR, 1996, DEVELOPMENT, V122, P181; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; NAHMOD VE, 1978, SCIENCE, V202, P1091, DOI 10.1126/science.152460; Oliverio MI, 1998, P NATL ACAD SCI USA, V95, P15496, DOI 10.1073/pnas.95.26.15496; Pan J, 1999, CIRC RES, V84, P1127, DOI 10.1161/01.RES.84.10.1127; Phillips M Ian, 2002, Curr Opin Investig Drugs, V3, P569; PHILLIPS MI, 1993, REGUL PEPTIDES, V43, P1; Quaglino A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-55; Rahman M, 2004, EUR J PHARMACOL, V485, P243, DOI 10.1016/j.ejphar.2003.11.074; Rhodes DR, 2009, P NATL ACAD SCI USA, V106, P10284, DOI 10.1073/pnas.0900351106; Roks AJM, 2003, J HYPERTENS, V21, P1269, DOI 10.1097/00004872-200307000-00013; Sadoshima J, 2000, CIRC RES, V86, P1187, DOI 10.1161/01.RES.86.12.1187; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; Levy CS, 2010, J CELL BIOCHEM, V110, P857, DOI 10.1002/jcb.22595; Schere-Levy C, 2003, EXP CELL RES, V282, P35, DOI 10.1006/excr.2002.5666; Schorr K, 1999, CANCER RES, V59, P2541; Schwertfeger KL, 2001, MOL ENDOCRINOL, V15, P867, DOI 10.1210/me.15.6.867; Silver RB, 2004, P NATL ACAD SCI USA, V101, P13607, DOI 10.1073/pnas.0403208101; Sutherland KD, 2007, J MAMMARY GLAND BIOL, V12, P15, DOI 10.1007/s10911-007-9034-8; Tahmasebi M, 2006, BRIT J CANCER, V95, P67, DOI 10.1038/sj.bjc.6603213; TALHOUK RS, 1991, DEVELOPMENT, V112, P439; Tybitanclova K, 2005, MOL CELL ENDOCRINOL, V244, P42, DOI 10.1016/j.mce.2005.01.015; Unger T, 2002, AM J CARDIOL, V89, p10A; Unger T, 2002, AM J CARDIOL, V89, p3A; VINSON GP, 1995, MOL MED TODAY, V1, P35, DOI 10.1016/1357-4310(95)80018-2; Walton KD, 2001, MECH DEVELOP, V109, P281, DOI 10.1016/S0925-4773(01)00549-4; Wang JM, 2003, J CARDIOVASC PHARM, V41, P593, DOI 10.1097/00005344-200304000-00012; Watson Christine J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000196; YAMAZAKI T, 1995, CIRC RES, V77, P258, DOI 10.1161/01.RES.77.2.258; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391; Zampetaki A, 2005, AM J PHYSIOL-HEART C, V288, pH2946, DOI 10.1152/ajpheart.00919.2004; Zhang LP, 2005, ARTERIOSCL THROM VAS, V25, P1148, DOI 10.1161/01.ATV.0000164624.00099.e7; Zhao L, 2002, MOL ENDOCRINOL, V16, P2902, DOI 10.1210/me.2001-0330; Zhao YB, 2010, J CELL PHYSIOL, V225, P168, DOI 10.1002/jcp.22209; Zhou YB, 2005, J MOL CELL CARDIOL, V38, P693, DOI 10.1016/j.yjmcc.2005.02.009; Zhuo JL, 1998, J HYPERTENS, V16, P2027, DOI 10.1097/00004872-199816121-00026; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	59	8	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					1982	1994		10.1096/fj.11-191932	http://dx.doi.org/10.1096/fj.11-191932			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22286690				2022-12-25	WOS:000303680800025
J	Apostolatos, A; Song, SJ; Acosta, S; Peart, M; Watson, JE; Bickford, P; Cooper, DR; Patel, NA				Apostolatos, Andre; Song, Shijie; Acosta, Sandra; Peart, Mishka; Watson, James E.; Bickford, Paula; Cooper, Denise R.; Patel, Niketa A.			Insulin Promotes Neuronal Survival via the Alternatively Spliced Protein Kinase C delta II Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; PKC-DELTA; BCL-X; INDUCED APOPTOSIS; IMPROVES MEMORY; NT2 CELLS; DEATH; PHOSPHORYLATION; HUMANS; BETA	Insulin signaling pathways in the brain regulate food uptake and memory and learning. Insulin and protein kinase C (PKC) pathways are integrated and function closely together. PKC activation in the brain is essential for learning and neuronal repair. Intranasal delivery of insulin to the central nervous system (CNS) has been shown to improve memory, reduce cerebral atrophy, and reverse neurodegeneration. However, the neuronal molecular mechanisms of these effects have not been studied in depth. PKC delta plays a central role in cell survival. Its splice variants, PKC delta I and PKC delta II, are switches that determine cell survival and fate. PKC delta I promotes apoptosis, whereas PKC delta II promotes survival. Here, we demonstrate that insulin promotes alternative splicing of PKC delta II isoform in HT22 cells. The expression of PKC delta I splice variant remains unchanged. Insulin increases PKC delta II alternative splicing via the PI3K pathway. We further demonstrate that Akt kinase mediates phosphorylation of the splicing factor SC35 to promote PKC delta II alternative splicing. Using overexpression and knockdown assays, we demonstrate that insulin increases expression of Bcl2 and bcl-xL via PKC delta II. We demonstrate increased cell proliferation and increased BrdU incorporation in insulin-treated cells as well as in HT22 cells overexpressing PKC delta II. Finally, we demonstrate in vivo that intranasal insulin promotes cognitive function in mice with concomitant increases in PKC delta II expression in the hippocampus. This is the first report of insulin, generally considered a growth or metabolic hormone, regulating the alternative isoform expression of a key signaling kinase in neuronal cells such that it results in increased neuronal survival.	[Patel, Niketa A.] James A Haley Vet Hosp, Res Serv VAR 151, Tampa, FL 33612 USA; [Apostolatos, Andre; Cooper, Denise R.; Patel, Niketa A.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Acosta, Sandra; Bickford, Paula] Univ S Florida, Dept Neurol, Tampa, FL 33612 USA; [Peart, Mishka] Univ S Florida, Honors Coll, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Patel, NA (corresponding author), James A Haley Vet Hosp, Res Serv VAR 151, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	npatel@health.usf.edu	Bickford, Paula C/J-5970-2012	Bickford, Paula C/0000-0001-9657-7725; Patel, Niketa A./0000-0003-4811-8596; Apostolatos, Andre/0000-0002-4527-7084	National Institutes of Health from NIDDK [54393]; Dept. of Veterans Affairs; University of South Florida; Veterans Affairs [I01BX003689] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Dept. of Veterans Affairs(US Department of Veterans Affairs); University of South Florida; Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant 54393 (to D. R. C.) from NIDDK. This work was also supported by a Dept. of Veterans Affairs Medical Research grant (to N. A. P.) and by a Neuroscience Collaborative grant, University of South Florida (to N. A. P.).	ABEDOHMAE S, 1993, BIOCHEM BIOPH RES CO, V191, P915, DOI 10.1006/bbrc.1993.1304; Adamczyk A, 2010, FEBS LETT, V584, P3504, DOI 10.1016/j.febslet.2010.07.019; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Alkon DL, 2005, P NATL ACAD SCI USA, V102, P16432, DOI 10.1073/pnas.0508001102; Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Benedict C, 2007, NEUROPSYCHOPHARMACOL, V32, P239, DOI 10.1038/sj.npp.1301193; Bonini JS, 2005, PHARMACOL BIOCHEM BE, V80, P63, DOI 10.1016/j.pbb.2004.10.008; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chang MY, 2007, MOL CELL BIOL, V27, P4293, DOI 10.1128/MCB.00031-07; Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682; Conboy L, 2009, BIOCHEM PHARMACOL, V77, P1254, DOI 10.1016/j.bcp.2008.12.011; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Ferri P, 2006, J NEUROBIOL, V66, P793, DOI 10.1002/neu.20255; Francis G, 2009, DIABETES, V58, P934, DOI 10.2337/db08-1287; Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288; Fujiki M, 2006, J NEUROTRAUM, V23, P1164, DOI 10.1089/neu.2006.23.1164; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Gal A, 2008, BRAIN RES BULL, V76, P349, DOI 10.1016/j.brainresbull.2007.11.001; Gallagher HC, 2001, J NEUROCHEM, V77, P425, DOI 10.1046/j.1471-4159.2001.00235.x; Hallschmid M, 2004, DIABETES, V53, P3024, DOI 10.2337/diabetes.53.11.3024; Jiang K, 2008, BIOCHEMISTRY-US, V47, P787, DOI 10.1021/bi7019782; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Kern W, 1999, DIABETES, V48, P557, DOI 10.2337/diabetes.48.3.557; Kilpatrick LE, 2002, AM J PHYSIOL-CELL PH, V283, pC48, DOI 10.1152/ajpcell.00385.2001; Kim JD, 2011, BIOCHEM BIOPH RES CO, V410, P177, DOI 10.1016/j.bbrc.2011.04.096; Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008; Liu SM, 2011, CELL SIGNAL, V23, P1366, DOI 10.1016/j.cellsig.2011.03.019; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; McCracken MA, 2003, MOL CANCER THER, V2, P273; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Park CR, 2000, PHYSIOL BEHAV, V68, P509, DOI 10.1016/S0031-9384(99)00220-6; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Patel NA, 2004, MOL ENDOCRINOL, V18, P899, DOI 10.1210/me.2003-0391; Patel NA, 2006, GENE EXPRESSION, V13, P73, DOI 10.3727/000000006783991890; Peluso JJ, 2001, ENDOCRINOLOGY, V142, P4203, DOI 10.1210/en.142.10.4203; Putt KS, 2005, CHEMBIOCHEM, V6, P53, DOI 10.1002/cbic.200400330; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Sasaki T, 2006, J NEUROSCI RES, V84, P1187, DOI 10.1002/jnr.21036; Schmidt H, 2009, J MED GENET, V46, P217, DOI 10.1136/jmg.2008.062141; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P47, DOI 10.1016/j.physbeh.2004.07.022; Yip WK, 2008, ONCOL REP, V19, P319; Zhang JD, 2009, BIOCHEM BIOPH RES CO, V386, P750, DOI 10.1016/j.bbrc.2009.06.129; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504	50	63	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9299	9310		10.1074/jbc.M111.313080	http://dx.doi.org/10.1074/jbc.M111.313080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275369	Green Published, hybrid			2022-12-25	WOS:000301797800058
J	Zhu, J; Lin, SJ; Zou, C; Makanji, Y; Jardetzky, TS; Woodruff, TK				Zhu, Jie; Lin, S. Jack; Zou, Chao; Makanji, Yogeshwar; Jardetzky, Theodore S.; Woodruff, Teresa K.			Inhibin alpha-Subunit N Terminus Interacts with Activin Type IB Receptor to Disrupt Activin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; TGF-BETA FAMILY; BIOLOGICAL-ACTIVITY; OVARIAN FOLLICLES; DYNAMIC CHANGES; INDIAN WOMEN; BINDING-SITE; FOLLISTATIN; PITUITARY; BETAGLYCAN	Inhibin is a heterodimeric peptide hormone produced in the ovary that antagonizes activin signaling and FSH synthesis in the pituitary. The inhibin beta-subunit interacts with the activin type II receptor (ActRII) to functionally antagonize activin. The inhibin alpha-subunit mature domain (N terminus) arose relatively early during the evolution of the hormone, and inhibin function is decreased by an antibody directed against the alpha-subunit N-terminal extension region or by deletion of the N-terminal region. We hypothesized that the alpha-subunit N-terminal extension region interacts with the activin type I receptor (ALK4) to antagonize activin signaling in the pituitary. Human or chicken free alpha-subunit inhibited activin signaling in a pituitary gonadotrope-derived cell line (L beta T2) in a dose-dependent manner, whereas an N-terminal extension deletion mutant did not. An alpha-subunit N-terminal peptide, but not a control peptide, was able to inhibit activin A signaling and decrease activin-stimulated FSH synthesis. Biotinylated inhibin A, but not activin A, bound ALK4. Soluble ALK4-ECD bioneutralized human free alpha-subunit in L beta T2 cells, but did not affect activin A function. Competitive binding ELISAs with N-terminal mutants and an N-terminal region peptide confirmed that this region is critical for direct interaction of the alpha-subunit with ALK4. These data expand our understanding of how endocrine inhibin achieves potent antagonism of local, constitutive activin action in the pituitary, through a combined mechanism of competitive binding of both ActRII and ALK4 by each subunit of the inhibin heterodimer, in conjunction with the co-receptor betaglycan, to block activin receptor-ligand binding, complex assembly, and downstream signaling.	[Zhu, Jie; Makanji, Yogeshwar; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Lin, S. Jack; Zou, Chao; Jardetzky, Theodore S.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Northwestern University; Feinberg School of Medicine; Stanford University	Woodruff, TK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, 303 E Super St,Lurie 10-250, Chicago, IL 60611 USA.	tkw@northwestern.edu		Woodruff, Teresa/0000-0002-1197-3399	National Institutes of Health/NICHD [R01 HD37096, HD041857]; NHMRC [GNT1016460]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD041857] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037096] Funding Source: NIH RePORTER	National Institutes of Health/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health/NICHD Grant R01 HD37096 (to T. K. W.). We also thank NIH/NICHD (HD041857) (to T. S. J.) and NHMRC (GNT1016460) (to Y. M.).	Antenos M, 2007, MOL ENDOCRINOL, V21, P1670, DOI 10.1210/me.2007-0050; Bernard DJ, 2001, RECENT PROG HORM RES, V56, P417, DOI 10.1210/rp.56.1.417; Besecke LM, 1997, ENDOCRINOLOGY, V138, P2841, DOI 10.1210/en.138.7.2841; Bilezikjian LM, 2006, REPRODUCTION, V132, P207, DOI 10.1530/rep.1.01073; CARROLL RS, 1991, ENDOCRINOLOGY, V129, P3299, DOI 10.1210/endo-129-6-3299; Chand AL, 2007, HUM REPROD, V22, P3241, DOI 10.1093/humrep/dem323; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chapman SC, 2003, ENDOCRINOLOGY, V144, P5640, DOI 10.1210/en.2003-0670; Chapman SC, 2002, MOL CELL ENDOCRINOL, V196, P79, DOI 10.1016/S0303-7207(02)00227-7; Cook RW, 2005, J BIOL CHEM, V280, P40177, DOI 10.1074/jbc.M504591200; Cook RW, 2004, SEMIN REPROD MED, V 22, P269, DOI 10.1055/s-2004-831902; DEPAOLO LV, 1991, P SOC EXP BIOL MED, V198, P500; Dixit H, 2006, HUM REPROD, V21, P1643, DOI 10.1093/humrep/del129; Dixit H, 2004, HUM REPROD, V19, P1760, DOI 10.1093/humrep/deh342; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; FINDLAY JK, 1989, J ENDOCRINOL, V120, P59, DOI 10.1677/joe.0.1200059; FINDLAY JK, 1990, REPROD FERT DEVELOP, V2, P205, DOI 10.1071/RD9900205; Fischer WH, 1999, J PROTEIN CHEM, V18, P437, DOI 10.1023/A:1020640725959; Geng LY, 2008, THERIOGENOLOGY, V70, P35, DOI 10.1016/j.theriogenology.2008.02.013; GLENCROSS RG, 1994, J REPROD FERTIL, V100, P599, DOI 10.1530/jrf.0.1000599; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; HILLIER SG, 1987, J ENDOCRINOL, V113, pR3, DOI 10.1677/joe.0.113R003; Jimenez-Krassel F, 2003, ENDOCRINOLOGY, V144, P1876, DOI 10.1210/en.2002-221077; KNIGHT PG, 1989, J MOL ENDOCRINOL, V2, P189, DOI 10.1677/jme.0.0020189; Lebrun JJ, 1997, MOL CELL BIOL, V17, P1682, DOI 10.1128/MCB.17.3.1682; LEE VWK, 1986, J ENDOCRINOL, V109, P379, DOI 10.1677/joe.0.1090379; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Makanji Y, 2008, J BIOL CHEM, V283, P16743, DOI 10.1074/jbc.M801045200; Marozzi A, 2002, HUM REPROD, V17, P1741, DOI 10.1093/humrep/17.7.1741; MASON AJ, 1986, BIOCHEM BIOPH RES CO, V135, P957, DOI 10.1016/0006-291X(86)91021-1; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, MOL CELL, V29, P149, DOI 10.1016/j.molcel.2008.01.006; Phillips DJ, 2004, GROWTH FACTORS, V22, P13, DOI 10.1080/08977190410001688687; Rebar RW, 2008, ANN NY ACAD SCI, V1135, P138, DOI 10.1196/annals.1429.000; RIVIER C, 1991, ENDOCRINOLOGY, V128, P2223, DOI 10.1210/endo-128-5-2223; RIVIER C, 1986, SCIENCE, V234, P205, DOI 10.1126/science.3092356; RIVIER C, 1987, HORM RES, V28, P104, DOI 10.1159/000180934; RIVIER J, 1985, BIOCHEM BIOPH RES CO, V133, P120, DOI 10.1016/0006-291X(85)91849-2; Robertson DM, 2008, MENOPAUSE, V15, P1139, DOI 10.1097/gme.0b013e3181735687; Robertson DM, 2000, REV REPROD, V5, P131, DOI 10.1530/ror.0.0050131; SCHNEYER AL, 1994, ENDOCRINOLOGY, V135, P667, DOI 10.1210/en.135.2.667; Schneyer AL, 2000, J CLIN ENDOCR METAB, V85, P3319, DOI 10.1210/jc.85.9.3319; SCOTT RS, 1980, ENDOCRINOLOGY, V107, P1536, DOI 10.1210/endo-107-5-1536; Shelling AN, 2000, HUM REPROD, V15, P2644, DOI 10.1093/humrep/15.12.2644; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2004, MOL CELL ENDOCRINOL, V225, P9, DOI 10.1016/j.mce.2004.02.007; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; VALE W, 1988, RECENT PROG HORM RES, V44, P1; Wiater E, 2003, J BIOL CHEM, V278, P7934, DOI 10.1074/jbc.M209710200; WOODRUFF TK, 1993, ENDOCRINOLOGY, V132, P2332, DOI 10.1210/en.132.6.2332; Woodruff TK, 1996, ENDOCRINOLOGY, V137, P5463, DOI 10.1210/en.137.12.5463; WOODRUFF TK, 1990, ANNU REV PHYSIOL, V52, P807, DOI 10.1146/annurev.ph.52.030190.004111; WOODRUFF TK, 1988, SCIENCE, V239, P1296, DOI 10.1126/science.3125611; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; XU JM, 1995, J BIOL CHEM, V270, P6308, DOI 10.1074/jbc.270.11.6308; YAMASHIRO D, 1984, P NATL ACAD SCI-BIOL, V81, P5399, DOI 10.1073/pnas.81.17.5399; Zhu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009457	61	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8060	8070		10.1074/jbc.M111.293381	http://dx.doi.org/10.1074/jbc.M111.293381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267736	hybrid, Green Published			2022-12-25	WOS:000301349400022
J	Du, H; Guan, GB; Xie, J; Sun, Y; Tong, YJ; Zhang, LX; Huang, GH				Du, Han; Guan, Guobo; Xie, Jing; Sun, Yuan; Tong, Yaojun; Zhang, Lixin; Huang, Guanghua			Roles of Candida albicans Gat2, a GATA-Type Zinc Finger Transcription Factor, in Biofilm Formation, Filamentous Growth and Virulence	PLOS ONE			English	Article							REGULATES HYPHAL DEVELOPMENT; PROTEIN-KINASE; PATHWAY; CPH2; EFG1	Candida albicans is the most common human fungal pathogen, causing not only superficial infections, but also life-threatening systemic disease. C. albicans can grow in several morphological forms including unicellular yeast-form, elongated hyphae and pseudohyphae. In certain natural environments, C. albicans also exists as biofilms, which are structured and surface-attached microbial communities. Transcription factors play a critical role in morphogenesis and biofilm development. In this study, we identified four adhesion-promoting transcription factors (Tec1, Cph1, Ume6 and Gat2) by screening a transcription factor overexpression library. Sequence analysis indicates that Gat2 is a GATA-type zinc finger transcription factor. Here we showed that the gat2/gat2 mutant failed to form biofilms on the plastic and silicone surfaces. Overexpression of GAT2 gene promoted filamentous and invasive growth on agar containing Lee's medium, while deletion of this gene had an opposite effect. However, inactivation of Gat2 had no obvious effect on N-acetyl-glucosamine (GlcNAc) induced hyphal development. In a mouse model of systemic infection, the gat2/gat2 mutant showed strongly attenuated virulence. Our results suggest that Gat2 plays a critical role in C. albicans biofilm formation, filamentous growth and virulence.	[Du, Han; Guan, Guobo; Xie, Jing; Sun, Yuan; Huang, Guanghua] Chinese Acad Sci, State Key Lab Mycol, Inst Microbiol, Beijing, Peoples R China; [Xie, Jing; Tong, Yaojun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Tong, Yaojun; Zhang, Lixin] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Du, H (corresponding author), Chinese Acad Sci, State Key Lab Mycol, Inst Microbiol, Beijing, Peoples R China.	huanggh@im.ac.cn	Guan, Guobo/AAK-1827-2021; Tong, Yaojun/U-6068-2018	Tong, Yaojun/0000-0003-4042-2462; Huang, Guanghua/0000-0002-4761-7548; Du, Han/0000-0002-8488-6755; Zhang, Lixin/0000-0003-0894-9520	Chinese Academy of Sciences; National Natural Science Foundation of China [30873129]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by the grant of "100 Talent Program'' from Chinese Academy of Sciences to GH and National Natural Science Foundation of China (30873129) to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Chen JY, 2002, MOL MICROBIOL, V46, P1335, DOI 10.1046/j.1365-2958.2002.03249.x; Chen JY, 2000, MOL CELL BIOL, V20, P8696, DOI 10.1128/MCB.20.23.8696-8708.2000; Cottier F, 2009, FEMS MICROBIOL LETT, V295, P1, DOI 10.1111/j.1574-6968.2009.01564.x; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Hnisz D, 2011, METHODS MOL BIOL, V734, P303, DOI 10.1007/978-1-61779-086-7_15; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Huang GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000806; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Sahni N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000363; Schweizer A, 2000, MOL MICROBIOL, V38, P435, DOI 10.1046/j.1365-2958.2000.02132.x; SIMONETTI N, 1974, NATURE, V250, P344, DOI 10.1038/250344a0; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Yi S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001117	28	40	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29707	10.1371/journal.pone.0029707	http://dx.doi.org/10.1371/journal.pone.0029707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276126	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200020
J	Sanchez-Gracia, A; Castresana, J				Sanchez-Gracia, Alejandro; Castresana, Jose			Impact of Deep Coalescence on the Reliability of Species Tree Inference from Different Types of DNA Markers in Mammals	PLOS ONE			English	Article							GENE TREES; DIVERGENCE TIMES; POPULATION SIZES; MOLECULAR CLOCK; PHYLOGEOGRAPHY; EVOLUTION; PHYLOGENETICS; PROBABILITY; SEQUENCES; GENEALOGY	An important challenge for phylogenetic studies of closely related species is the existence of deep coalescence and gene tree heterogeneity. However, their effects can vary between species and they are often neglected in phylogenetic analyses. In addition, a practical problem in the reconstruction of shallow phylogenies is to determine the most efficient set of DNA markers for a reliable estimation. To address these questions, we conducted a multilocus simulation study using empirical values of nucleotide diversity and substitution rates obtained from a wide range of mammals and evaluated the performance of both gene tree and species tree approaches to recover the known speciation times and topological relationships. We first show that deep coalescence can be a serious problem, more than usually assumed, for the estimation of speciation times in mammals using traditional gene trees. Furthermore, we tested the performance of different sets of DNA markers in the determination of species trees using a coalescent approach. Although the best estimates of speciation times were obtained, as expected, with the use of an increasing number of nuclear loci, our results show that similar estimations can be obtained with a much lower number of genes and the incorporation of a mitochondrial marker, with its high information content. Thus, the use of the combined information of both nuclear and mitochondrial markers in a species tree framework is the most efficient option to estimate recent speciation times and, consequently, the underlying species tree.	[Sanchez-Gracia, Alejandro; Castresana, Jose] Inst Evolutionary Biol CSIC UPF, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE)	Sanchez-Gracia, A (corresponding author), Univ Barcelona, Dept Genet, Barcelona, Spain.	jose.castresana@csic.es	Sanchez-Gracia, Alejandro/F-4686-2014; Castresana, Jose/K-3437-2014	Sanchez-Gracia, Alejandro/0000-0003-4543-4577; Castresana, Jose/0000-0002-9391-8050	Ministerio de Ciencia e Innovacion (Spain) [CGL2008-00434/BOS]; Juan de la Cierva from the Ministerio de Ciencia e Innovacion (Spain)	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva from the Ministerio de Ciencia e Innovacion (Spain)	This work was supported by grant number CGL2008-00434/BOS from the Plan Nacional I+ D+ I of the Ministerio de Ciencia e Innovacion (Spain) to JC. AS-G was supported by a Juan de la Cierva postdoctoral contract from the Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnason U, 1998, J MOL EVOL, V47, P718, DOI 10.1007/PL00006431; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Egea R, 2007, NUCLEIC ACIDS RES, V35, pD624, DOI 10.1093/nar/gkl833; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Huang HT, 2009, SYST BIOL, V58, P527, DOI 10.1093/sysbio/syp047; Igea J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-369; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, ESTIMATING SPECIES T; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Rannala B, 2003, GENETICS, V164, P1645; Rosenberg NA, 2002, THEOR POPUL BIOL, V61, P225, DOI 10.1006/tpbi.2001.1568; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1989, GENETICS, V122, P957; TAKAHATA N, 1985, GENETICS, V110, P325; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470	33	33	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30239	10.1371/journal.pone.0030239	http://dx.doi.org/10.1371/journal.pone.0030239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276164	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200046
J	Wang, ZR; Shah, AD; Tate, AR; Denaxas, S; Shawe-Taylor, J; Hemingway, H				Wang, Zhuoran; Shah, Anoop D.; Tate, A. Rosemary; Denaxas, Spiros; Shawe-Taylor, John; Hemingway, Harry			Extracting Diagnoses and Investigation Results from Unstructured Text in Electronic Health Records by Semi-Supervised Machine Learning	PLOS ONE			English	Article							SYSTEM	Background: Electronic health records are invaluable for medical research, but much of the information is recorded as unstructured free text which is time-consuming to review manually. Aim: To develop an algorithm to identify relevant free texts automatically based on labelled examples. Methods: We developed a novel machine learning algorithm, the 'Semi-supervised Set Covering Machine' (S3CM), and tested its ability to detect the presence of coronary angiogram results and ovarian cancer diagnoses in free text in the General Practice Research Database. For training the algorithm, we used texts classified as positive and negative according to their associated Read diagnostic codes, rather than by manual annotation. We evaluated the precision (positive predictive value) and recall (sensitivity) of S3CM in classifying unlabelled texts against the gold standard of manual review. We compared the performance of S3CM with the Transductive Vector Support Machine (TVSM), the original fully-supervised Set Covering Machine (SCM) and our 'Freetext Matching Algorithm' natural language processor. Results: Only 60% of texts with Read codes for angiogram actually contained angiogram results. However, the S3CM algorithm achieved 87% recall with 64% precision on detecting coronary angiogram results, outperforming the fully-supervised SCM (recall 78%, precision 60%) and TSVM (recall 2%, precision 3%). For ovarian cancer diagnoses, S3CM had higher recall than the other algorithms tested (86%). The Freetext Matching Algorithm had better precision than S3CM (85% versus 74%) but lower recall (62%). Conclusions: Our novel S3CM machine learning algorithm effectively detected free texts in primary care records associated with angiogram results and ovarian cancer diagnoses, after training on pre-classified test sets. It should be easy to adapt to other disease areas as it does not rely on linguistic rules, but needs further testing in other electronic health record datasets.	[Wang, Zhuoran; Shawe-Taylor, John] UCL, Dept Comp Sci, London, England; [Wang, Zhuoran] Heriot Watt Univ, Sch Math & Comp Sci, Edinburgh, Midlothian, Scotland; [Shah, Anoop D.; Denaxas, Spiros; Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, Clin Epidemiol Grp, London, England; [Tate, A. Rosemary] Univ Sussex, Dept Informat, Brighton, E Sussex, England	University of London; University College London; Heriot Watt University; University of London; University College London; University of Sussex	Wang, ZR (corresponding author), UCL, Dept Comp Sci, London, England.	anoop@doctors.org.uk	Tate, Anne Rosemary/AAK-4512-2020; Shah, Anoop Dinesh/D-4396-2014; Hemingway, Harry/C-1219-2009	Shah, Anoop Dinesh/0000-0002-8907-5724; Hemingway, Harry/0000-0003-2279-0624; Denaxas, Spiros/0000-0001-9612-7791; Shawe-Taylor, John/0000-0002-2030-0073	Wellcome Trust [086091/Z/08/Z, 0938/30/Z/10/Z]; National Institute of Health Research [RP-PG-0407-10314]; European Community under the PASCAL2 Network of Excellence; National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research(National Institute for Health Research (NIHR)); European Community under the PASCAL2 Network of Excellence(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The research leading to these results has received funding from the Wellcome Trust (086091/Z/08/Z; http://www.wellcome.ac.uk/) and the National Institute of Health Research (RP-PG-0407-10314; http://www.nihr.ac.uk/) under the project CALIBER (Cardiovascular Disease Research Using Linked Bespoke Studies). This work was supported in part by the IST Programme of the European Community, under the PASCAL2 Network of Excellence. Anoop Shah is supported by a Wellcome Trust Clinical Research Training Fellowship (0938/30/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aronson AR, 2007, P WORKSH BIONLP 2007, P105; Clark C, 2008, J AM MED INFORM ASSN, V15, P36, DOI 10.1197/jamia.M2442; Crammer K., 2007, BIOLOGICAL TRANSLATI, P129; DeLisle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013377; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Fung BCM, 2003, SIAM PROC S, P59; Ginter F, 2009, INT J MED INFORM, V78, pE1, DOI 10.1016/j.ijmedinf.2009.02.003; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Li Y, 2010, P 1 ACM INT HLTH INF, P744; MARCHAND M, 2002, J MACHINE LEARNING R, V3, P723; NHS Information Centre, 2011, READ COD; Pakhomov Sergeui, 2008, AMIA Annu Symp Proc, P545; Pakhomov SSV, 2007, AM HEART J, V153, P666, DOI 10.1016/j.ahj.2006.12.022; Pakhomov SV, 2005, J BIOMED INFORM, V38, P145, DOI 10.1016/j.jbi.2004.11.016; Rosales R, 2007, ICMLA 2007: SIXTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P530, DOI 10.1109/ICMLA.2007.103; Rosales Romer, 2010, AMIA Annu Symp Proc, V2010, P682; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Schulz S, 2002, P M ASS COMP LING JU, P61; Sindhwani V., 2006, Proceedings of the Twenty-Ninth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P477, DOI 10.1145/1148170.1148253; Suominen H., 2008, P ICML UAI COLT WORK; Tate AR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000025; Tate AR, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-42	22	41	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30412	10.1371/journal.pone.0030412	http://dx.doi.org/10.1371/journal.pone.0030412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907YS	22276193	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000301457200058
J	Zhang, XT; Ding, L; Kang, LG; Wang, ZY				Zhang, XinTian; Ding, Ling; Kang, LianGuo; Wang, Zhao-Yi			Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ICI 182,780 FASLODEX; PURE ANTIESTROGEN; REMAINING CHALLENGES; VARIANT ER-ALPHA-36; HIPPOCAMPAL-NEURONS; TAMOXIFEN TREATMENT; INDUCED APOPTOSIS; PLASMA-MEMBRANE; SRC	It is prevailingly thought that the antiestrogens tamoxifen and ICI 182, 780 are competitive antagonists of the estrogenbinding site of the estrogen receptor-alpha (ER-alpha). However, a plethora of evidence demonstrated both antiestrogens exhibit agonist activities in different systems such as activation of the membrane-initiated signaling pathways. The mechanisms by which antiestrogens mediate estrogen-like activities have not been fully established. Previously, a variant of ER-a, EP-a36, has been cloned and showed to mediate membrane-initiated estrogen and antiestrogen signaling in cells only expressing ER-a36. Here, we investigated the molecular mechanisms underlying the antiestrogen signaling in ERnegative breast cancer MDA-MB-231 and MDA-MB-436 cells that express high levels of endogenous ER-alpha 36. We found that the effects of both 4-hydoxytamoxifen (4-OHT) and ICI 182, 780 (ICI) exhibited a non-monotonic, or biphasic dose response curve; antiestrogens at low concentrations, elicited a mitogenic signaling pathway to stimulate cell proliferation while at high concentrations, antiestrogens inhibited cell growth. Antiestrogens at l nM induced the phosphorylation of the Src-Y416 residue, an event to activate Src, while at 5 mM induced Src-Y527 phosphorylation that inactivates Src. Antiestrogens at 1 nM also induced phosphorylation of the MAPK/ERK and activated the Cyclin D1 promoter activity through the Src/EGFR/ STAT5 pathways but not at 5 mu M. Knock-down of ER-alpha 36 abrogated the biphasic antiestrogen signaling in these cells. Our results thus indicated that ER-alpha 36 mediates biphasic antiestrogen signaling in the ER-negative breast cancer cells and Src functions as a switch of antiestrogen signaling dependent on concentrations of antiestrogens through the EGFR/STAT5 pathway.	[Zhang, XinTian; Kang, LianGuo; Wang, Zhao-Yi] Creighton Univ, Dept Med Microbiol & Immunol, Sch Med, Omaha, NE 68178 USA; [Ding, Ling] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Creighton University; Zhejiang University	Zhang, XT (corresponding author), Creighton Univ, Dept Med Microbiol & Immunol, Sch Med, Omaha, NE 68178 USA.	zywang@creighton.edu			United States National Institutes of Health (NIH) [DK070016]; Nebraska Tobacco Settlement Biomedical Research Program Award [LB-595]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070016] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Program Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a United States National Institutes of Health (NIH) grant DK070016 and a Nebraska Tobacco Settlement Biomedical Research Program Award (LB-595) to Z.Y. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinton RD, 2001, LEARN MEMORY, V8, P121, DOI 10.1101/lm.39601; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Das SK, 1997, P NATL ACAD SCI USA, V94, P12786, DOI 10.1073/pnas.94.24.12786; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; Dudley MW, 2000, P NATL ACAD SCI USA, V97, P3696, DOI 10.1073/pnas.040558197; FAWELL SE, 1990, P NATL ACAD SCI USA, V87, P6883, DOI 10.1073/pnas.87.17.6883; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Gu Q, 1999, ENDOCRINOLOGY, V140, P660, DOI 10.1210/en.140.2.660; HOWELL A, 1990, BAILLIERE CLIN ENDOC, V4, P67, DOI 10.1016/S0950-351X(05)80316-7; Kang LG, 2010, J CELL MOL MED, V14, P1485, DOI 10.1111/j.1582-4934.2009.00877.x; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kurebayashi J, 1998, ONCOLOGY-BASEL, V55, P23, DOI 10.1159/000055256; Lee LMJ, 2008, ANTICANCER RES, V28, P479; Lin SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009013; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; MAHFOUDI A, 1995, P NATL ACAD SCI USA, V92, P4206, DOI 10.1073/pnas.92.10.4206; Mandlekar S, 2000, CANCER RES, V60, P5995; Mandlekar S, 2001, APOPTOSIS, V6, P469, DOI 10.1023/A:1012437607881; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Nethrapalli IS, 2001, ENDOCRINOLOGY, V142, P5145, DOI 10.1210/en.142.12.5145; Nichols M, 1998, EMBO J, V17, P765, DOI 10.1093/emboj/17.3.765; NICHOLSON RI, 1995, ANN NY ACAD SCI, V761, P148, DOI 10.1111/j.1749-6632.1995.tb31376.x; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Obrero M, 2002, J BIOL CHEM, V277, P45695, DOI 10.1074/jbc.M208092200; OSBORNE CK, 1992, J CLIN ONCOL, V10, P304, DOI 10.1200/JCO.1992.10.2.304; OSBORNE CK, 1991, J NATL CANCER I, V83, P1477, DOI 10.1093/jnci/83.20.1477; Pearce ST, 2003, J BIOL CHEM, V278, P7630, DOI 10.1074/jbc.M211129200; Pendaries C, 2002, P NATL ACAD SCI USA, V99, P2205, DOI 10.1073/pnas.042688499; Robertson JA, 2001, J STEROID BIOCHEM, V77, P281, DOI 10.1016/S0960-0760(01)00061-9; Segars JH, 2002, TRENDS ENDOCRIN MET, V13, P349, DOI 10.1016/S1043-2760(02)00633-1; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi L, 2009, J CLIN ONCOL, V27, P3423, DOI 10.1200/JCO.2008.17.2254; Sibonga JD, 1998, ENDOCRINOLOGY, V139, P3736, DOI 10.1210/en.139.9.3736; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; Vranic S, 2011, J CLIN PATHOL, V64, P54, DOI 10.1136/jcp.2010.082776; WAKELING AE, 1991, CANCER RES, V51, P3867; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Wong JK, 2003, J NEUROSCI, V23, P4984; Wu JB, 2005, INT J ONCOL, V27, P1647; Yamashita H, 2003, ONCOGENE, V22, P1638, DOI 10.1038/sj.onc.1206277; Zhang CC, 2000, J BIOL CHEM, V275, P479, DOI 10.1074/jbc.275.1.479; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zhao LQ, 2006, J PHARMACOL EXP THER, V319, P1124, DOI 10.1124/jpet.106.109504; Zhao LQ, 2005, BRAIN RES REV, V49, P472, DOI 10.1016/j.brainresrev.2005.01.009; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	52	44	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30174	10.1371/journal.pone.0030174	http://dx.doi.org/10.1371/journal.pone.0030174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276155	Green Submitted, Green Published, gold			2022-12-25	WOS:000301457200039
J	Cintra, DE; Ropelle, ER; Moraes, JC; Pauli, JR; Morari, J; de Souza, CT; Grimaldi, R; Stahl, M; Carvalheira, JB; Saad, MJ; Velloso, LA				Cintra, Dennys E.; Ropelle, Eduardo R.; Moraes, Juliana C.; Pauli, Jose R.; Morari, Joseane; de Souza, Claudio T.; Grimaldi, Renato; Stahl, Marcela; Carvalheira, Jose B.; Saad, Mario J.; Velloso, Licio A.			Unsaturated Fatty Acids Revert Diet-Induced Hypothalamic Inflammation in Obesity	PLOS ONE			English	Article							LEPTIN RECEPTOR; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; IN-VIVO; ENERGY; BRAIN; ACCUMULATION; SENSITIVITY; INHIBITION	Background: In experimental models, hypothalamic inflammation is an early and determining factor in the installation and progression of obesity. Pharmacological and gene-based approaches have proven efficient in restraining inflammation and correcting the obese phenotypes. However, the role of nutrients in the modulation of hypothalamic inflammation is unknown. Methodology/Principal Findings: Here we show that, in a mouse model of diet-induced obesity, partial substitution of the fatty acid component of the diet by flax seed oil (rich in C18:3) or olive oil (rich in C18:1) corrects hypothalamic inflammation, hypothalamic and whole body insulin resistance, and body adiposity. In addition, upon icv injection in obese rats, both omega 3 and omega 9 pure fatty acids reduce spontaneous food intake and body mass gain. These effects are accompanied by the reversal of functional and molecular hypothalamic resistance to leptin/insulin and increased POMC and CART expressions. In addition, both, omega 3 and omega 9 fatty acids inhibit the AMPK/ACC pathway and increase CPT1 and SCD1 expression in the hypothalamus. Finally, acute hypothalamic injection of omega 3 and omega 9 fatty acids activate signal transduction through the recently identified GPR120 unsaturated fatty acid receptor. Conclusions/Significance: Unsaturated fatty acids can act either as nutrients or directly in the hypothalamus, reverting diet-induced inflammation and reducing body adiposity. These data show that, in addition to pharmacological and genetic approaches, nutrients can also be attractive candidates for controlling hypothalamic inflammation in obesity.	[Cintra, Dennys E.; Moraes, Juliana C.; Morari, Joseane; de Souza, Claudio T.; Velloso, Licio A.] Univ Estadual Campinas, Lab Cell Signaling, Campinas, SP, Brazil; [Ropelle, Eduardo R.; Pauli, Jose R.; Carvalheira, Jose B.; Saad, Mario J.; Velloso, Licio A.] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil; [Cintra, Dennys E.] Univ Estadual Campinas, Fac Sci Appl, Campinas, SP, Brazil; [Grimaldi, Renato; Stahl, Marcela] Univ Estadual Campinas, Fac Food Engn, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Cintra, DE (corresponding author), Univ Estadual Campinas, Lab Cell Signaling, Campinas, SP, Brazil.	lavelloso.unicamp@gmail.com	Carvalheira, Jose Barreto Campello/E-8562-2013; Velloso, Licio/AAJ-3778-2020; Pauli, José Rdrigo/AAD-2763-2021; Carvalheira, Jose B/H-8405-2012; Ropelle, Eduardo R/C-3977-2012; Cintra, Dennys E/N-7758-2017; Saad, Mario/ABD-8262-2020; Morari, Joseane/G-2568-2016	Carvalheira, Jose Barreto Campello/0000-0002-0136-0943; Pauli, José Rdrigo/0000-0002-6129-1521; Ropelle, Eduardo R/0000-0003-1655-9557; Cintra, Dennys E/0000-0002-7954-5630; Morari, Joseane/0000-0002-0728-4283; Contin Moraes Garotti, Juliana/0000-0002-7143-0644	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Araujo EP, 2007, ENDOCRINOLOGY, V148, P5991, DOI 10.1210/en.2007-0132; Arruda AP, 2010, ENDOCRINOLOGY, V151, P683, DOI 10.1210/en.2009-0865; Bertelli DF, 2006, ENDOCRINOLOGY, V147, P5385, DOI 10.1210/en.2006-0280; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjornholm M, 2007, J CLIN INVEST, V117, P1354, DOI 10.1172/JCI30688; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cotero VE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1101, DOI 10.1152/ajpendo.90932.2008; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; JOHNSON AK, 1975, BRAIN RES, V86, P399, DOI 10.1016/0006-8993(75)90891-4; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Martins EF, 2004, DIABETES METAB, V30, P21, DOI 10.1016/S1262-3636(07)70085-X; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Moraes JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005045; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Reynolds CM, 2009, J NUTR, V139, P2351, DOI 10.3945/jn.109.113035; Rivellese AA, 2003, BIOMED PHARMACOTHER, V57, P84, DOI 10.1016/S0753-3322(03)00003-9; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; Velloso LA, 2008, NEUROIMMUNOMODULAT, V15, P189, DOI 10.1159/000153423; Weinstein JR, 2008, GLIA, V56, P16, DOI 10.1002/glia.20585; Wisse BE, 2009, CELL METAB, V10, P241, DOI 10.1016/j.cmet.2009.09.003; Yang L, 2008, CELL, V135, P20, DOI 10.1016/j.cell.2008.09.030; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	40	242	247	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30571	10.1371/journal.pone.0030571	http://dx.doi.org/10.1371/journal.pone.0030571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279596	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900073
J	Markovic, D; Holdich, J; Al-Sabah, S; Mistry, R; Krasel, C; Mahaut-Smith, MP; Challiss, RAJ				Markovic, Danijela; Holdich, Jonathan; Al-Sabah, Suleiman; Mistry, Rajendra; Krasel, Cornelius; Mahaut-Smith, Martyn P.; Challiss, R. A. John			FRET-Based Detection of M-1 Muscarinic Acetylcholine Receptor Activation by Orthosteric and Allosteric Agonists	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; INVERSE AGONISM; LIVING CELLS; FLUORESCENT PROTEIN; MOLECULAR-BASIS; INTERNALIZATION; IDENTIFICATION; MODULATION; MECHANISMS; DISCOVERY	Background and Objective: Muscarinic acetylcholine receptors (mAChRs) are 7-transmembrane, G protein-coupled receptors that regulate a variety of physiological processes and represent potentially important targets for therapeutic intervention. mAChRs can be stimulated by full and partial orthosteric and allosteric agonists, however the relative abilities of such ligands to induce conformational changes in the receptor remain unclear. To gain further insight into the actions of mAChR agonists, we have developed a fluorescently tagged M-1 mAChR that reports ligand-induced conformational changes in real-time by changes in Forster resonance energy transfer (FRET). Methods: Variants of CFP and YFP were inserted into the third intracellular loop and at the end of the C-terminus of the mouse M-1 mAChR, respectively. The optimized FRET receptor construct (M-1-cam5) was expressed stably in HEK293 cells. Results: The variant CFP/YFP-receptor chimera expressed predominantly at the plasma membrane of HEK293 cells and displayed ligand-binding affinities comparable with those of the wild-type receptor. It also retained an ability to interact with G alpha(q/11) proteins and to stimulate phosphoinositide turnover, ERK1/2 phosphorylation and undergo agonist-dependent internalization. Addition of the full agonist methacholine caused a reversible decrease in M-1 FRET (F-EYFP/F-ECFP) that was prevented by atropine pre-addition and showed concentration-dependent amplitude and kinetics. Partial orthosteric agonists, arecoline and pilocarpine, as well as allosteric agonists, AC-42 and 77-LH-28-1, also caused atropine-sensitive decreases in the FRET signal, which were smaller in amplitude and significantly slower in onset compared to those evoked by methacholine. Conclusion: The M-1 FRET-based receptor chimera reports that allosteric and orthosteric agonists induce similar conformational changes in the third intracellular loop and/or C-terminus, and should prove to be a valuable molecular reagent for pharmacological and structural investigations of M-1 mAChR activation.	[Markovic, Danijela; Mistry, Rajendra; Mahaut-Smith, Martyn P.; Challiss, R. A. John] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Holdich, Jonathan; Mahaut-Smith, Martyn P.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Al-Sabah, Suleiman; Krasel, Cornelius] Univ Reading, Sch Pharm, Reading, Berks, England	University of Leicester; University of Cambridge; University of Reading	Markovic, D (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	mpms1@leicester.ac.uk; jc36@leicester.ac.uk	Krasel, Cornelius/AAH-7074-2019	Al-Sabah, Suleiman/0000-0002-9808-7866; Challiss, John/0000-0001-5506-2848; Krasel, Cornelius/0000-0001-8309-8696	European Commission [FP-032275]; British Heart Foundation [FS/03/117]; Medical Research Council [G0301031] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the European Commission Framework 6 IST Programme (FP-032275) and British Heart Foundation (FS/03/117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birdsall NJM, 2005, MINI-REV MED CHEM, V5, P523, DOI 10.2174/1389557054023251; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Challiss RAJ, 2009, FUNCTIONAL SELECTIVI, P125; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Daeffler L, 1999, BRIT J PHARMACOL, V126, P1246, DOI 10.1038/sj.bjp.0702407; Dowling MR, 2006, J PHARMACOL EXP THER, V317, P1134, DOI 10.1124/jpet.106.101246; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Goldman PS, 1996, J BIOL CHEM, V271, P4215; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hulme EC, 2003, RECEPTOR CHANNEL, V9, P215, DOI 10.1080/10606820308261; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kaye RG, 2011, MOL PHARMACOL, V79, P701, DOI 10.1124/mol.110.070177; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Langmead CJ, 2008, BRIT J PHARMACOL, V154, P1104, DOI 10.1038/bjp.2008.152; Langmead CJ, 2008, PHARMACOL THERAPEUT, V117, P232, DOI 10.1016/j.pharmthera.2007.09.009; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Maier-Peuschel M, 2010, J BIOL CHEM, V285, P8793, DOI 10.1074/jbc.M109.098517; Markovic D, 2008, MOL ENDOCRINOL, V22, P689, DOI 10.1210/me.2007-0136; Marlo JE, 2009, MOL PHARMACOL, V75, P577, DOI 10.1124/mol.108.052886; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nelson CP, 2006, J PHARMACOL EXP THER, V316, P279, DOI 10.1124/jpet.105.094383; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Sawyer GW, 2008, J PHARMACOL EXP THER, V324, P196, DOI 10.1124/jpet.107.123695; Shockley MS, 1999, EUR J PHARMACOL, V377, P137, DOI 10.1016/S0014-2999(99)00303-9; Spalding TA, 2002, MOL PHARMACOL, V61, P1297, DOI 10.1124/mol.61.6.1297; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Spalding TA, 2006, MOL PHARMACOL, V70, P1974, DOI 10.1124/mol.106.024901; Thomas RL, 2008, J PHARMACOL EXP THER, V327, P365, DOI 10.1124/jpet.108.141788; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Zhang YL, 2009, AM J PHYSIOL-CELL PH, V296, pC1391, DOI 10.1152/ajpcell.00549.2008; Ziegler N, 2011, BIOORGAN MED CHEM, V19, P1048, DOI 10.1016/j.bmc.2010.07.060; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	39	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29946	10.1371/journal.pone.0029946	http://dx.doi.org/10.1371/journal.pone.0029946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272263	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400042
J	Tan, WL; Wang, ZM; Li, CX; Chu, HL; Xu, Y; Dong, YD; Wang, ZC; Chen, DY; Liu, H; Liu, DP; Liu, NN; Sun, J; Zhao, TY				Tan, Wei-Long; Wang, Zhong-Ming; Li, Chun-Xiao; Chu, Hong-Liang; Xu, Yan; Dong, Yan-De; Wang, Zhong-can; Chen, Dong-Ya; Liu, Hui; Liu, Da-Peng; Liu, Nannan; Sun, Jun; Zhao, Tongyan			First Report on Co-Occurrence Knockdown Resistance Mutations and Susceptibility to Beta-Cypermethrin in Anopheles sinensis from Jiangsu Province, China	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; MOLECULAR CHARACTERIZATION; PYRETHROID INSECTICIDES; POINT MUTATION; HORN FLIES; KDR; GAMBIAE; DDT; IDENTIFICATION; POPULATIONS	The increasing prevalence of insecticide resistance in Anopheles sinensis, a major vector of malaria in Jiangsu province in eastern China, threatens to compromise the successful use of insecticides in malaria control strategies. It is therefore vital to understand the insecticide resistance status of An. sinensis in the region. This study examined the nucleotide diversity of the para-sodium channel and knockdown resistance (kdr) in five field populations of adult An. sinensis mosquitoes collected in Jiangsu province, identifying the L1014F and L1014C substitutions for the first time. Competitive polymerase chain reaction (PCR) amplification of specific allele (cPASA) and polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) for resistance diagnosis were developed and validated. Comparing the results with direct sequencing revealed that the PCR-RFLP method was more sensitive and specific whereas the cPASA method was more convenient and suitable. The significant positive correlation between kdr allele frequency and bioassay-based resistance phenotype demonstrates that the frequency of L1014F and L1014C substitutions in the kdr gene provides a useful molecular marker for monitoring beta-cypermethrin resistance in natural populations of An. sinensis. Our results point to the L1014F substitution as the key mutation associated with beta-cypermethrin resistance. The high resistance and mutation frequency detected in the five populations also suggest cross-resistance with other pyrethroids may occur in An. sinensis, highlighting the need for further surveys to map insecticide resistance in China and the adoption of a rational management of insecticide application for resistance management and mosquito vector control.	[Tan, Wei-Long; Wang, Zhong-Ming; Li, Chun-Xiao; Dong, Yan-De; Zhao, Tongyan] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Tan, Wei-Long; Wang, Zhong-can] Huadong Res Inst Med & Biotech, Nanjing, Jiangsu, Peoples R China; [Chu, Hong-Liang; Xu, Yan; Chen, Dong-Ya; Liu, Hui; Liu, Da-Peng; Sun, Jun] Jiangsu Ctr Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China; [Liu, Nannan] Auburn Univ, Auburn, AL 36849 USA	Beijing Institute of Microbiology & Epidemiology; Auburn University System; Auburn University	Tan, WL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	jscdcsjvip@vip.sina.com; zhaoty@nic.bmi.ac.cn	tan, weilong/AAH-5009-2020		foundation from the Infective Diseases Prevention and Cure Project of China [2008zx10004-010]	foundation from the Infective Diseases Prevention and Cure Project of China	This work was supported by the foundation from the Infective Diseases Prevention and Cure Project of China (NO: 2008zx10004-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai XianZheng, 2009, China Tropical Medicine, V9, P1957; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011681; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Dong K, 1997, INSECT BIOCHEM MOLEC, V27, P93, DOI 10.1016/S0965-1748(96)00082-3; Guerrero FD, 1997, INSECT BIOCHEM MOLEC, V27, P745, DOI 10.1016/S0965-1748(97)00057-X; Huang G, 2007, CHINA J VECTOR BIOL, V5, P398; Huang GuangQuan, 1998, Zhongguo Meijieshengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V9, P202; Ingles PJ, 1996, INSECT BIOCHEM MOLEC, V26, P319, DOI 10.1016/0965-1748(95)00093-3; Jamroz RC, 1998, INSECT BIOCHEM MOLEC, V28, P1031, DOI 10.1016/S0965-1748(98)00094-0; Lee SH, 1999, INSECT BIOCHEM MOLEC, V29, P185, DOI 10.1016/S0965-1748(98)00122-2; Li J, 2009, CHINESE J VECTOR BIO, V5, P438; Li J., 2002, CHINESE J SCHISTOSOM, V1, P32; Li Peng, 1997, Chinese Journal of Parasitic Disease Control, V10, P223; Li Z, 2007, CHINESE J HYGIENIC I, V13, P256; Lu P. L., 1963, ACTA ENTOMOL SINICA, V2, P149; LUND AE, 1983, PESTIC BIOCHEM PHYS, V20, P203, DOI 10.1016/0048-3575(83)90025-1; Lynd A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-16; Ma Y., 1998, ACAD J SEC MIL MED U, V19, P237; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; Martinez-Torres D, 1999, INSECT MOL BIOL, V8, P339, DOI 10.1046/j.1365-2583.1999.83121.x; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McAbee RD, 2004, PEST MANAG SCI, V60, P359, DOI 10.1002/ps.799; MILANI R., 1954, Rivista di Parassitologia, V15, P513; Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205; NARAHASHI T, 1988, ABSTR PAP AM CHEM S, V196, P26; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Schuler TH, 1998, PESTIC BIOCHEM PHYS, V59, P169, DOI 10.1006/pest.1998.2320; Shang LeYuan, 2007, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V2, P304; Soderlund D.M., 2005, P1; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Song FL, 2007, INT J PEST MANAGE, V53, P25, DOI 10.1080/09670870601002625; Su Y., 2001, HENAN J PREVENTIVE M, V4, P195; Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Wondji CS, 2008, TROP MED INT HEALTH, V13, P548, DOI 10.1111/j.1365-3156.2008.02033.x; Wu Z, 1986, CHINESE J PARASITOLO, V4, P220; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066; Yu P H, 2000, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V18, P149; Yu PinHong, 2003, Acta Parasitologica et Medica Entomologica Sinica, V10, P152; Zhang AG, 1999, PESTIC BIOCHEM PHYS, V65, P25, DOI 10.1006/pest.1999.2421; Zhang Z, 2008, CHINESE J PARASITOLO, V5, P343	44	27	31	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29242	10.1371/journal.pone.0029242	http://dx.doi.org/10.1371/journal.pone.0029242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272229	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400008
J	van Dijk, AE; van Eijsden, M; Stronks, K; Gemke, RJBJ; Vrijkotte, TGM				van Dijk, Aimee E.; van Eijsden, Manon; Stronks, Karien; Gemke, Reinoud J. B. J.; Vrijkotte, Tanja G. M.			Prenatal Stress and Balance of the Child's Cardiac Autonomic Nervous System at Age 5-6 Years	PLOS ONE			English	Article							MATERNAL PSYCHOSOCIAL STRESS; HEART-RATE-VARIABILITY; HPA AXIS; RISK; DEPRESSION; PREGNANCY; ANXIETY; BORN; REACTIVITY; SYMPTOMS	Objective: Autonomic nervous system (ANS) misbalance is a potential causal factor in the development of cardiovascular disease. The ANS may be programmed during pregnancy due to various maternal factors. Our aim is to study maternal prenatal psychosocial stress as a potential disruptor of cardiac ANS balance in the child. Methods: Mothers from a prospective birth cohort (ABCD study) filled out a questionnaire at gestational week 16 [IQR 12-20], that included validated instruments for state anxiety, depressive symptoms, pregnancy-related anxiety, parenting daily hassles and job strain. A cumulative stress score was also calculated (based on 80(th) percentiles). Indicators of cardiac ANS in the offspring at age 5-6 years are: pre-ejection period (PEP), heart rate (HR), respiratory sinus arrhythmia (RSA) and cardiac autonomic balance (CAB), measured with electrocardiography and impedance cardiography in resting supine and sitting positions. Results: 2,624 mother-child pairs, only single births, were available for analysis. The stress scales were not significantly associated with HR, PEP, RSA and CAB (p >= 0.17). Accumulation of maternal stress was also not associated with HR, PEP, RSA and CAB (p >= 0.07). Conclusion: Results did not support the hypothesis that prenatal maternal psychosocial stress deregulates cardiac ANS balance in the offspring, at least in rest, and at the age of five-six years.	[van Dijk, Aimee E.; Stronks, Karien; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [van Dijk, Aimee E.; van Eijsden, Manon] Publ Hlth Serv Amsterdam GGD, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam	van Dijk, AE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.e.vandijk@amc.uva.nl		Stronks, Karien/0000-0002-0921-2232; Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Heart Foundation (Nederlandse Hartstichting)	Netherlands Heart Foundation (Nederlandse Hartstichting)(Netherlands Heart Foundation)	Financial support for the current study was granted by the Netherlands Heart Foundation (Nederlandse Hartstichting). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, CES D NEDERLANDSE VE; BARKER DJP, 2001, FETAL ORIGINS CARDIO; Bathula R, 2010, DIABETOLOGIA, V53, P2120, DOI 10.1007/s00125-010-1818-5; Berntson GG, 2008, PSYCHOPHYSIOLOGY, V45, P643, DOI 10.1111/j.1469-8986.2008.00652.x; BIAN XP, 1993, TERATOLOGY, V47, P109, DOI 10.1002/tera.1420470203; Camm AJ, 1996, CIRCULATION, V93, P1043; Choi JB, 2006, PSYCHOSOM MED, V68, P421, DOI 10.1097/01.psy.0000221378.09239.6a; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; CRNIC KA, 1990, CHILD DEV, V61, P1628, DOI 10.2307/1130770; Defares P, 1980, PSYCHOLOOG, V15, P460; Diego MA, 2009, EARLY HUM DEV, V85, P65, DOI 10.1016/j.earlhumdev.2008.07.002; Dierckx B, 2009, PSYCHOSOM MED, V71, P313, DOI 10.1097/PSY.0b013e318198a82c; DiPietro JA, 2003, EARLY HUM DEV, V74, P125, DOI 10.1016/j.earlhumdev.2003.07.001; Entringer S, 2010, CURR OPIN ENDOCRINOL, V17, P507, DOI 10.1097/MED.0b013e3283405921; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Field T, 2004, INFANT BEHAV DEV, V27, P216, DOI 10.1016/j.infbeh.2003.09.010; Galland BC, 2006, J APPL PHYSIOL, V100, P933, DOI 10.1152/japplphysiol.01275.2005; Gillespie CF, 2005, PSYCHOSOM MED, V67, pS26, DOI 10.1097/01.psy.0000163456.22154.d2; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Glynn LM, 2001, AM J OBSTET GYNECOL, V184, P637, DOI 10.1067/mob.2001.111066; Goedhart AD, 2008, THESIS VU U AMSTERDA; Groenendaal JH, 1996, DAGELIJKSE BESLOMMER; Houtman ILD, 1998, OCCUP ENVIRON MED, V55, P73, DOI 10.1136/oem.55.2.73; Hughes JW, 2004, J PSYCHOSOM RES, V57, P353, DOI 10.1016/j.jpsychores.2004.02.016; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; IJzerman RG, 2003, CIRCULATION, V108, P566, DOI 10.1161/01.CIR.0000081778.35370.1B; Jacob S, 2009, INFANT MENT HEALTH J, V30, P82, DOI 10.1002/imhj.20204; Jones A, 2008, EUR HEART J, V29, P2164, DOI 10.1093/eurheartj/ehn292; Jones NA, 1998, INFANT BEHAV DEV, V21, P537; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; McMillen IC, 2001, REPRODUCTION, V122, P195, DOI 10.1530/rep.0.1220195; Monk C, 2004, J AM ACAD CHILD PSY, V43, P283, DOI 10.1097/00004583-200403000-00009; Monk C, 2000, DEV PSYCHOBIOL, V36, P67, DOI 10.1002/(SICI)1098-2302(200001)36:1<67::AID-DEV7>3.3.CO;2-3; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Quigley KS, 2006, PSYCHOPHYSIOLOGY, V43, P357, DOI 10.1111/j.1469-8986.2006.00405.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riese H, 2003, BEHAV RES METH INS C, V35, P467, DOI 10.3758/BF03195525; Segar JL, 1998, AM J PHYSIOL-REG I, V274, pR160, DOI 10.1152/ajpregu.1998.274.1.R160; Spielberger C. D., 1970, STAI MANUAL STATE TR; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Van Den Bergh BRH., 1990, PREPERINAT PSYCHOL J, V5, P119; van Dijk AE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-251; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Vrijkotte TGM, 2004, PSYCHOSOM MED, V66, P656, DOI 10.1097/01.psy.0000138283.65547.78; Wadhwa PD, 2005, PSYCHONEUROENDOCRINO, V30, P724, DOI 10.1016/j.psyneuen.2005.02.004; Wadhwa PD., 2006, PERINATAL PROGRAMMIN, P29; Woods SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.041	48	23	23	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30413	10.1371/journal.pone.0030413	http://dx.doi.org/10.1371/journal.pone.0030413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272345	Green Published, gold			2022-12-25	WOS:000301454400123
J	Ceraudo, E; Hierso, R; Tan, YV; Murail, S; Rouyer-Fessard, C; Nicole, P; Robert, JC; Jamin, N; Neumann, JM; Robberecht, P; Laburthe, M; Couvineau, A				Ceraudo, Emilie; Hierso, Regine; Tan, Yossan-Var; Murail, Samuel; Rouyer-Fessard, Christiane; Nicole, Pascal; Robert, Jean-Claude; Jamin, Nadege; Neumann, Jean-Michel; Robberecht, Patrick; Laburthe, Marc; Couvineau, Alain			Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction	FASEB JOURNAL			English	Article						VIP; GPCR; inflammatory diseases; binding site	PROTEIN-COUPLED-RECEPTOR; VASOACTIVE-INTESTINAL-PEPTIDE; CLASS-B GPCR; CRYSTAL-STRUCTURE; EXTRACELLULAR DOMAIN; MOLECULAR RECOGNITION; SELECTIVE ANTAGONIST; ECTODOMAIN COMPLEX; LIGAND-BINDING; VIP1 RECEPTOR	Vasoactive intestinal peptide (VIP) plays a major role in pathophysiology. Our previous studies demonstrated that the VIP sequence 6-28 interacts with the N-terminal ectodomain (N-ted) of its receptor, VPAC1. Probes for VIP and receptor antagonist PG97-269 were synthesized with a photolabile residue/Bpa at various positions and used to explore spatial proximity with VPAC1. PG97-269 probes with Bpa at position 0, 6, and 24 behaved as high-affinity receptor antagonists (K-i=12, 9, and 7 nM, respectively). Photolabeling experiments revealed that the [Bpa(0)]-VIP probe was in physical contact with VPAC1 Q(135), while [Bpa(0)]-PG97-269 was covalently bound to G(62) residue of N-ted, indicating different binding sites. In contrast, photolabeling with [Bpa(6)]-and [Bpa(24)]-PG97-269 showed that the distal domains of PG97-269 interacted with N-ted, as we previously showed for VIP. Substitution with alanine of the K-143, T-144, and T-147 residues located in the first transmembrane domain of VPAC1 induced a loss of receptor affinity (IC50=1035, 874, and 2070 nM, respectively), and pharmacological studies using VIP2-28 indicated that these three residues play an important role in VPAC1 interaction with the first histidine residue of VIP. These data demonstrate that VIP and PG97-269 bind to distinct domains of VPAC1.-Ceraudo, E., Hierso, R., Tan, Y.-V., Murail, S., Rouyer-Fessard C., Nicole, P., Robert, J.-C., Jamin, N., Neumann, J.-M., Robberecht, P., Laburthe, M., Couvineau, A. Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction. FASEB J. 26, 2060-2071 (2012). www.fasebj.org	[Ceraudo, Emilie; Hierso, Regine; Tan, Yossan-Var; Rouyer-Fessard, Christiane; Nicole, Pascal; Robert, Jean-Claude; Laburthe, Marc; Couvineau, Alain] Univ Paris 07, Fac Med Xavier Bichat, Inst Natl Sante & Rech Med INSERM 773, Ctr Rech Biomed Bichat Beaujon, F-75018 Paris, France; [Murail, Samuel; Jamin, Nadege; Neumann, Jean-Michel] Ctr Etud Saclay, CNRS,SB2SM, URA 2096,DSV,Inst Biol & Technol Saclay iBiTecS, Commissariat Energie Atom & Energies Alternat CEA, F-91191 Gif Sur Yvette, France; [Robberecht, Patrick] Univ Libre Brussels, Brussels, Belgium	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universite Libre de Bruxelles	Couvineau, A (corresponding author), Univ Paris 07, INSERM, U773, CRB3, 16 Rue Henri Huchard, F-75018 Paris, France.	alain.couvineau@inserm.fr	couvineau, alain/T-3466-2019; couvineau, alain/G-3641-2013; Jamin, Nadege/AAA-7067-2021; Murail, Samuel/AAC-3897-2019	couvineau, alain/0000-0003-2912-5168; couvineau, alain/0000-0003-2912-5168; Murail, Samuel/0000-0002-3842-5333	Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique; Universite Paris 7; Association de Recherche sur la Polyarthrite; Fondation pour la Recherche Medicale [FDT20070910820]; Interuniversity Poles of Attraction from the Universite Libre de Bruxelles (Brussels, Belgium)	Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Universite Paris 7; Association de Recherche sur la Polyarthrite; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Interuniversity Poles of Attraction from the Universite Libre de Bruxelles (Brussels, Belgium)	This work was supported by the Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, the Universite Paris 7, and a grant from the Association de Recherche sur la Polyarthrite. E.C. is supported by grant FDT20070910820 from the Fondation pour la Recherche Medicale and by an Interuniversity Poles of Attraction Program from the Universite Libre de Bruxelles (Brussels, Belgium).	Boeckler F, 2005, J MED CHEM, V48, P694, DOI 10.1021/jm049612a; Ceraudo E, 2008, MOL ENDOCRINOL, V22, P147, DOI 10.1210/me.2007-0361; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; COUVINEAU A, 1984, BIOCHEM BIOPH RES CO, V121, P493, DOI 10.1016/0006-291X(84)90209-2; Couvineau A, 1996, BIOCHEMISTRY-US, V35, P1745, DOI 10.1021/bi952022h; COUVINEAU A, 1994, BIOCHEM BIOPH RES CO, V200, P769, DOI 10.1006/bbrc.1994.1517; Couvineau A, 2003, J BIOL CHEM, V278, P24759, DOI 10.1074/jbc.M301916200; Couvineau A, 2010, NEUROPEPTIDES, V44, P127, DOI 10.1016/j.npep.2009.11.008; COUVINEAU A, 1995, BIOCHEM BIOPH RES CO, V206, P246, DOI 10.1006/bbrc.1995.1034; Couvineau A, 2008, J MOL NEUROSCI, V36, P249, DOI 10.1007/s12031-008-9072-8; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dejda A, 2005, PHARMACOL REP, V57, P307; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Dong M, 2011, J BIOL CHEM, V286, P23888, DOI 10.1074/jbc.M111.245969; Du K, 1997, BIOCHEM BIOPH RES CO, V230, P289, DOI 10.1006/bbrc.1996.5949; Du K, 2002, J BIOL CHEM, V277, P37016, DOI 10.1074/jbc.M203049200; Gourlet P, 1997, PEPTIDES, V18, P1555, DOI 10.1016/S0196-9781(97)00230-1; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Heyda J, 2010, J PHYS CHEM B, V114, P8744, DOI 10.1021/jp101031v; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Koth CM, 2010, BIOCHEMISTRY-US, V49, P1862, DOI 10.1021/bi901848m; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; Laburthe M, 2007, PEPTIDES, V28, P1631, DOI 10.1016/j.peptides.2007.04.026; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Neumann JM, 2008, TRENDS BIOCHEM SCI, V33, P314, DOI 10.1016/j.tibs.2008.05.001; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; SALOMON R, 1993, AM J PHYSIOL, V264, pE294, DOI 10.1152/ajpendo.1993.264.2.E294; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Solano RM, 2001, J BIOL CHEM, V276, P1084, DOI 10.1074/jbc.M007686200; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; Tan YV, 2006, J BIOL CHEM, V281, P12792, DOI 10.1074/jbc.M513305200; Tan YV, 2004, J BIOL CHEM, V279, P38889, DOI 10.1074/jbc.M404460200; Tan YV, 2003, J BIOL CHEM, V278, P36531, DOI 10.1074/jbc.M304770200; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Vaudry H, 2006, ANN NY ACAD SCI, V1070, P1; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wuthrich K., 1986, PROTEINS, V1, P34	49	19	19	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2060	2071		10.1096/fj.11-196444	http://dx.doi.org/10.1096/fj.11-196444			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22291440				2022-12-25	WOS:000303680800032
J	Wu, KL; Peng, GQ; Wilken, M; Geraghty, RJ; Li, F				Wu, Kailang; Peng, Guiqing; Wilken, Matthew; Geraghty, Robert J.; Li, Fang			Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; SARS-CORONAVIRUS; BINDING DOMAIN; SPIKE PROTEIN; CRYSTAL-STRUCTURE; MOLECULAR EVOLUTION; PALM CIVETS; VIRUS; CHINA; GLYCOPROTEIN	The severe acute respiratory syndrome coronavirus (SARSCoV) from palm civets has twice evolved the capacity to infect humans by gaining binding affinity for human receptor angiotensin-converting enzyme 2 (ACE2). Numerous mutations have been identified in the receptor-binding domain (RBD) of different SARS-CoV strains isolated from humans or civets. Why these mutations were naturally selected or how SARS-CoV evolved to adapt to different host receptors has been poorly understood, presenting evolutionary and epidemic conundrums. In this study, we investigated the impact of these mutations on receptor recognition, an important determinant of SARS-CoV infection and pathogenesis. Using a combination of biochemical, functional, and crystallographic approaches, we elucidated the molecular and structural mechanisms of each of these naturally selected RBD mutations. These mutations either strengthen favorable interactions or reduce unfavorable interactions with two virus-binding hot spots on ACE2, and by doing so, they enhance viral interactions with either human (hACE2) or civet (cACE2) ACE2. Therefore, these mutations were viral adaptations to either hACE2 or cACE2. To corroborate the above analysis, we designed and characterized two optimized RBDs. The human-optimized RBD contains all of the hACE2-adapted residues (Phe-442, Phe-472, Asn-479, Asp-480, and Thr-487) and possesses exceptionally high affinity for hACE2 but relative low affinity for cACE2. The civet-optimized RBD contains all of the cACE2-adapted residues (Tyr-442, Pro-472, Arg-479, Gly-480, and Thr-487) and possesses exceptionally high affinity for cACE2 and also substantial affinity for hACE2. These results not only illustrate the detailed mechanisms of host receptor adaptation by SARS-CoV but also provide a molecular and structural basis for tracking future SARS-CoV evolution in animals.	[Wu, Kailang; Peng, Guiqing; Wilken, Matthew; Li, Fang] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Geraghty, Robert J.] Univ Minnesota, Sch Med, Ctr Drug Design, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Li, F (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-121 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	lifang@umn.edu		Geraghty, Robert/0000-0002-0560-6509	National Institutes of Health [R01 AI089728]; University of Minnesota Academic Health Center; Minnesota Partnership for Biotechnology and Medical Genomics grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Academic Health Center; Minnesota Partnership for Biotechnology and Medical Genomics grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI089728 (to F. L.). This work was also supported by a University of Minnesota Academic Health Center faculty research development grant (to F. L.) and by a Minnesota Partnership for Biotechnology and Medical Genomics grant (to the University of Minnesota).	Babcock GJ, 2004, J VIROL, V78, P4552, DOI 10.1128/JVI.78.9.4552-4560.2004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002; Hou YX, 2010, ARCH VIROL, V155, P1563, DOI 10.1007/s00705-010-0729-6; Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005; Lai M.M.C., 2001, FIELDS VIROLOGY, P1163; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2008, J VIROL, V82, P6984, DOI 10.1128/JVI.00442-08; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004; Liang GD, 2004, EMERG INFECT DIS, V10, P1774, DOI 10.3201/eid1010.040445; Liu L, 2007, J VIROL, V81, P4694, DOI 10.1128/JVI.02389-06; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Qu XX, 2005, J BIOL CHEM, V280, P29588, DOI 10.1074/jbc.M500662200; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Sheahan T, 2008, J VIROL, V82, P2274, DOI 10.1128/JVI.02041-07; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Wu KL, 2011, J VIROL, V85, P5331, DOI 10.1128/JVI.02274-10; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; Xu YH, 2004, J BIOL CHEM, V279, P49414, DOI 10.1074/jbc.M408782200; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	38	108	110	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8904	8911		10.1074/jbc.M111.325803	http://dx.doi.org/10.1074/jbc.M111.325803			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291007	Green Published, hybrid			2022-12-25	WOS:000301797800021
J	Grieschat, M; Alekov, AK				Grieschat, Matthias; Alekov, Alexi K.			Glutamate 268 Regulates Transport Probability of the Anion/Proton Exchanger ClC-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-/H+ ANTIPORTER; PATCH-CLAMP; XENOPUS OOCYTES; DENTS-DISEASE; PROTEINS; CHANNELS; PERMEATION; ANION; SELECTIVITY; ENDOCYTOSIS	The Cl-/H+ exchange mediated by ClC transporters can be uncoupled by external SCN- and mutations of the proton glutamate, a conserved residue at the internal side of the protein. We show here for the mammalian ClC transporter ClC-5 that acidic internal pH led to a greater increase in currents upon exchanging extracellular Cl- for SCN-. However, transport uncoupling, unitary current amplitudes, and the voltage dependence of the depolarization-induced activation were not altered by low pH values. Therefore, it is likely that an additional gating process regulates ClC-5 transport. Higher internal [H+] and the proton glutamate mutant E268H altered the ratio between ClC-5 transport and nonlinear capacitance, indicating that the gating charge movements in ClC-5 arise from incomplete transport cycles and that internal protons increase the transport probability of ClC-5. This was substantiated by site-directed sulfhydryl modification of the proton glutamate mutant E268C. The mutation exhibited small transport currents together with prominent gating charge movements. The charge restoration using a negatively charged sulfhydryl reagent reinstated also the WT phenotype. Neutralization of the charge of the gating glutamate 211 by the E211C mutation abolished the effect of internal protons, showing that the increased transport probability of ClC-5 results from protonation of this residue. S168P (a mutation that decreases the anion affinity of the central binding site) reduced also the internal pH dependence of ClC-5. These results support the idea that protonation of the gating glutamate 211 at the central anion-binding site of ClC-5 is mediated by the proton glutamate 268.	[Grieschat, Matthias; Alekov, Alexi K.] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany	Hannover Medical School	Alekov, AK (corresponding author), Hannover Med Sch, Inst Neurophysiol, OE4230,Carl Neuberg Str 1, D-30625 Hannover, Germany.	alekov.alexi@mh-hannover.de	Alekov, Alexi/ABE-4170-2020	Alekov, Alexi/0000-0001-6362-7247	Medical School Hannover	Medical School Hannover	This work was supported by a HiLF grant from the Medical School Hannover.	Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bossi E, 1999, J PHYSIOL-LONDON, V515, P729, DOI 10.1111/j.1469-7793.1999.729ab.x; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hazama A, 1997, J MEMBRANE BIOL, V155, P175, DOI 10.1007/s002329900169; Hebeisen S, 2003, BIOPHYS J, V84, P2306, DOI 10.1016/S0006-3495(03)75036-X; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Lim HH, 2009, J GEN PHYSIOL, V133, P131, DOI 10.1085/jgp.200810112; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Orhan G, 2011, BIOPHYS J, V100, P1233, DOI 10.1016/j.bpj.2011.01.045; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2010, J GEN PHYSIOL, V135, P653, DOI 10.1085/jgp.201010428; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Smith AJ, 2010, FASEB J, V24, P3696, DOI 10.1096/fj.09-150649; Smith AJ, 2009, AM J PHYSIOL-RENAL, V296, pF390, DOI 10.1152/ajprenal.90526.2008; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	36	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8101	8109		10.1074/jbc.M111.298265	http://dx.doi.org/10.1074/jbc.M111.298265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267722	hybrid, Green Published			2022-12-25	WOS:000301349400026
J	Azrak, S; Ayyasamy, V; Zirpoli, G; Ambrosone, C; Bandera, EV; Bovbjerg, DH; Jandorf, L; Ciupak, G; Davis, W; Pawlish, KS; Liang, P; Singh, K				Azrak, Sami; Ayyasamy, Vanniarajan; Zirpoli, Gary; Ambrosone, Christine; Bandera, Elisa V.; Bovbjerg, Dana H.; Jandorf, Lina; Ciupak, Gregory; Davis, Warren; Pawlish, Karen S.; Liang, Ping; Singh, Keshav			CAG Repeat Variants in the POLG1 Gene Encoding mtDNA Polymerase-Gamma and Risk of Breast Cancer in African-American Women	PLOS ONE			English	Article							DNA; ASSOCIATION; MUTATIONS; POLYMORPHISM	The DNA polymerase-gamma (POLG) gene, which encodes the catalytic subunit of enzyme responsible for directing mitochondrial DNA replication in humans, contains a polyglutamine tract encoded by CAG repeats of varying length. The length of the CAG repeat has been associated with the risk of testicular cancer, and other genomic variants that impact mitochondrial function have been linked to breast cancer risk in African-American (AA) women. We evaluated the potential role of germline POLG-CAG repeat variants in breast cancer risk in a sample of AA women (100 cases and 100 age-matched controls) who participated in the Women's Circle of Health Study, an ongoing multi-institutional, case-control study of breast cancer. Genotyping was done by fragment analysis in a blinded manner. Results from this small study suggest the possibility of an increased risk of breast cancer in women with minor CAG repeat variants of POLG, but no statistically significant differences in CAG repeat length were observed between cases and controls (multivariate-adjusted odds ratio 1.74; 95% CI, 0.49-6.21). Our study suggests that POLG-CAG repeat length is a potential risk factor for breast cancer that needs to be explored in larger population-based studies.	[Azrak, Sami; Liang, Ping] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Ayyasamy, Vanniarajan; Singh, Keshav] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Zirpoli, Gary; Ambrosone, Christine; Ciupak, Gregory; Davis, Warren] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Jandorf, Lina] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Pawlish, Karen S.] New Jersey Dept Hlth & Senior Serv, New Jersey State Canc Registry, Trenton, NJ USA; [Singh, Keshav] Univ Alabama Birmingham, Dept Genet, Ctr Free Rad Biol, Ctr Aging, Birmingham, AL USA; [Singh, Keshav] Univ Alabama Birmingham, Dept Pathol, Ctr Free Rad Biol, Ctr Aging, Birmingham, AL 35294 USA; [Singh, Keshav] Univ Alabama Birmingham, Dept Environm Hlth, Ctr Free Rad Biol, Ctr Aging, Birmingham, AL USA; [Singh, Keshav] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL USA	Brock University; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; New Jersey Department of Health & Senior Services; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Azrak, S (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.	kksingh@uab.edu	Azrak, Sami/ABF-3764-2021; Liang, Ping/D-2709-2009; Vanniarajan, A./AAB-4896-2022; Bandera, Elisa V/M-4169-2014; Liang, Ping/S-3790-2018	Liang, Ping/0000-0003-4423-0636; Bandera, Elisa V/0000-0002-8789-2755; Liang, Ping/0000-0003-4423-0636; AZRAK, SAMI/0000-0003-1714-0977	National Institutes of Health [R01 121904, R01 116430, R21 153097]; U.S. Army Medical Research and Material Command (USARMMC) [DAMD-17-01-1-0334]; National Cancer Institute [R01 CA100598]; Breast Cancer Research Foundation; Centers for Disease Control and Prevention for its support of the NJSCR [DP07-703]; National Cancer Institute's SEER [N01-PC-95001-20]; NATIONAL CANCER INSTITUTE [K22CA138563, R01CA100598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research and Material Command (USARMMC); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Centers for Disease Control and Prevention for its support of the NJSCR(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute's SEER; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Institutes of Health (R01 121904 and 116430 and R21 153097) to KS. The WCHS is supported by grants from the U.S. Army Medical Research and Material Command (USARMMC) (DAMD-17-01-1-0334), the National Cancer Institute (R01 CA100598), and the Breast Cancer Research Foundation. The New Jersey State Cancer Registry (NJSCR) is a participant in the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR) and is a National Cancer Institute SEER Expansion Registry. The authors acknowledge the Centers for Disease Control and Prevention for its support of the NJSCR under cooperative agreement DP07-703 awarded to the New Jersey Department of Health & Senior Services. The collection of State of New Jersey cancer incidence data is also supported by the National Cancer Institute's SEER Program under contract N01-PC-95001-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2009, J ONCOL, V2009, DOI 10.1155/2009/871250; Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; Blomberg JM, 2008, ANN ONCOL, V19, P1910; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen XH, 2002, AIDS RES HUM RETROV, V18, P531, DOI 10.1089/088922202753747879; Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021; Heidari M, 2008, NEUROL SCI, V29, P489, DOI 10.1007/s10072-008-1026-y; Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; Nowak R, 2005, ANN ONCOL, V16, P1211, DOI 10.1093/annonc/mdi205; Rovio A, 1999, EUR J HUM GENET, V7, P140, DOI 10.1038/sj.ejhg.5200244; Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; Tsezou A, 2008, BREAST, V17, P159, DOI 10.1016/j.breast.2007.08.007; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955	17	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29548	10.1371/journal.pone.0029548	http://dx.doi.org/10.1371/journal.pone.0029548			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276120	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100012
J	Iqbal, S; Zhang, SM; Driss, A; Liu, ZR; Kim, HRC; Wang, YR; Ritenour, C; Zhau, HE; Kucuk, O; Chung, LWK; Wu, DQ				Iqbal, Shareen; Zhang, Shumin; Driss, Adel; Liu, Zhi-Ren; Kim, Hyeong-Reh Choi; Wang, Yanru; Ritenour, Chad; Zhau, Haiyen E.; Kucuk, Omer; Chung, Leland W. K.; Wu, Daqing			PDGF Upregulates Mcl-1 Through Activation of beta-Catenin and HIF-1 alpha-Dependent Signaling in Human Prostate Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; TYROSINE KINASE INHIBITORS; BONE METASTASIS; PROGNOSTIC-SIGNIFICANCE; LEUKEMIA-1 EXPRESSION; IMATINIB MESYLATE; FACTOR-ALPHA; GENE; CHEMOTHERAPY	Background: Aberrant platelet derived growth factor (PDGF) signaling has been associated with prostate cancer (PCa) progression. However, its role in the regulation of PCa cell growth and survival has not been well characterized. Methodology/Principal Findings: Using experimental models that closely mimic clinical pathophysiology of PCa progression, we demonstrated that PDGF is a survival factor in PCa cells through upregulation of myeloid cell leukemia-1 (Mcl-1). PDGF treatment induced rapid nuclear translocation of beta-catenin, presumably mediated by c-Abl and p68 signaling. Intriguingly, PDGF promoted formation of a nuclear transcriptional complex consisting of b-catenin and hypoxiainducible factor (HIF)-1 alpha, and its binding to Mcl-1 promoter. Deletion of a putative hypoxia response element (HRE) within the Mcl-1 promoter attenuated PDGF effects on Mcl-1 expression. Blockade of PDGF receptor (PDGFR) signaling with a pharmacological inhibitor AG-17 abrogated PDGF induction of Mcl-1, and induced apoptosis in metastatic PCa cells. Conclusions/Significance: Our study elucidated a crucial survival mechanism in PCa cells, indicating that interruption of the PDGF-Mcl-1 survival signal may provide a novel strategy for treating PCa metastasis.	[Iqbal, Shareen; Zhang, Shumin; Wang, Yanru; Ritenour, Chad; Wu, Daqing] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; [Iqbal, Shareen; Zhang, Shumin; Wang, Yanru; Ritenour, Chad; Kucuk, Omer; Wu, Daqing] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA; [Driss, Adel] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Liu, Zhi-Ren] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Kim, Hyeong-Reh Choi] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Zhau, Haiyen E.; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA; [Kucuk, Omer] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA	Emory University; Emory University; Morehouse School of Medicine; University System of Georgia; Georgia State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Cedars Sinai Medical Center; Emory University	Iqbal, S (corresponding author), Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA.	Leland.Chung@cshs.org; dwu2@emory.edu	Driss, Adel/A-4151-2008; Driss, Adel/X-6772-2019	, Shareen/0000-0002-9489-7781	Department of Defense [PC060566, PC060866]; American Cancer Society [RSG-10-140-01]; Emory University Research Committee; National Cancer Institute [1R43CA141870, P01 CA98912, R01 CA122602]; Georgia Cancer Coalition Distinguished Scholar; NATIONAL CANCER INSTITUTE [R01CA122602, R43CA141870, P01CA098912] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Emory University Research Committee; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Scholar; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Department of Defense PC060566, American Cancer Society RSG-10-140-01, Emory University Research Committee Award, Kennedy Seed Grant (D.W.), National Cancer Institute grant 1R43CA141870 (A.W.), National Cancer Institute grants P01 CA98912, R01 CA122602, Department of Defense PC060866 (L.W.K.C.), Georgia Cancer Coalition Distinguished Scholar Grant (O.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul C, 2000, CELL MOL LIFE SCI, V57, P684, DOI 10.1007/PL00000728; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; Chott A, 1999, AM J PATHOL, V155, P1271, DOI 10.1016/S0002-9440(10)65229-7; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Clevers H, 2004, CANCER CELL, V5, P5, DOI 10.1016/S1535-6108(03)00339-8; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; FUDGE K, 1994, MODERN PATHOL, V7, P549; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; George DJ, 2002, UROLOGY, V60, P115, DOI 10.1016/S0090-4295(02)01589-3; Heldin CH, 2002, ARCH BIOCHEM BIOPHYS, V398, P284, DOI 10.1006/abbi.2001.2707; Hofer MD, 2004, NEOPLASIA, V6, P503, DOI 10.1593/neo.04157; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; KIM L, 1995, MOL CELL BIOL, V15, P4553; Kim SJ, 2004, CANCER RES, V64, P4201, DOI 10.1158/0008-5472.CAN-03-3763; Kitadai Y, 2006, INT J CANCER, V119, P2567, DOI 10.1002/ijc.22229; Ko YJ, 2001, CLIN CANCER RES, V7, P800; Kodama M, 2010, CANCER SCI, V101, P1984, DOI 10.1111/j.1349-7006.2010.01639.x; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Langley RR, 2004, CANCER RES, V64, P3727, DOI 10.1158/0008-5472.CAN-03-3863; Mathew P, 2004, J CLIN ONCOL, V22, P3323, DOI 10.1200/JCO.2004.10.116; Mathew P, 2007, CLIN CANCER RES, V13, P5816, DOI 10.1158/1078-0432.CCR-07-1269; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Ostman A, 2007, ADV CANCER RES, V97, P247, DOI 10.1016/S0065-230X(06)97011-0; Paulsson J, 2009, AM J PATHOL, V175, P334, DOI 10.2353/ajpath.2009.081030; Pienta KJ, 2005, CA-CANCER J CLIN, V55, P300, DOI 10.3322/canjclin.55.5.300; Pietras K, 2002, CANCER RES, V62, P5476; Pietras K, 2003, CANCER CELL, V3, P439, DOI 10.1016/S1535-6108(03)00089-8; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; RANA A, 1993, BRIT J UROL, V72, P933, DOI 10.1111/j.1464-410X.1993.tb16301.x; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Song N, 2009, CANCER RES, V69, P6057, DOI 10.1158/0008-5472.CAN-08-2007; Truica CI, 2000, CANCER RES, V60, P4709; Uehara H, 2003, J NATL CANCER I, V95, P458, DOI 10.1093/jnci/95.6.458; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yang LQ, 2007, J BIOL CHEM, V282, P16811, DOI 10.1074/jbc.M610488200; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yokote K, 1996, J BIOL CHEM, V271, P30942, DOI 10.1074/jbc.271.48.30942; Zhang SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-9; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1	54	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30764	10.1371/journal.pone.0030764	http://dx.doi.org/10.1371/journal.pone.0030764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276222	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100062
J	Marks, DJB; Fisk, MD; Koo, CY; Pavlou, M; Peck, L; Lee, SF; Lawrence, D; Macrae, MB; Wilson, APR; Brown, JS; Miller, RF; Zumla, AI				Marks, Daniel J. B.; Fisk, Marie D.; Koo, Chieh Y.; Pavlou, Menelaos; Peck, Lorraine; Lee, Simon F.; Lawrence, David; Macrae, M. Bruce; Wilson, A. Peter R.; Brown, Jeremy S.; Miller, Robert F.; Zumla, Alimuddin I.			Thoracic Empyema: A 12-Year Study from a UK Tertiary Cardiothoracic Referral Centre	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; COMPLICATED PARAPNEUMONIC EFFUSIONS; PLEURAL INFECTION; THORACOSCOPIC DECORTICATION; CONJUGATE VACCINE; BACTERIOLOGY; CHILDREN; DISEASE; ADULTS; TUBERCULOSIS	Background: Empyema is an increasingly frequent clinical problem worldwide, and has substantial morbidity and mortality. Our objectives were to identify the clinical, surgical and microbiological features, and management outcomes, of empyema. Methods: A retrospective observational study over 12 years (1999-2010) was carried out at The Heart Hospital, London, United Kingdom. Patients with empyema were identified by screening the hospital electronic 'Clinical Data Repository'. Demographics, clinical and microbiological characteristics, underlying risk factors, peri-operative blood tests, treatment and outcomes were identified. Univariable and multivariable statistical analyses were performed. Results: Patients (n = 406) were predominantly male (74.1%); median age = 53 years (IQR = 37-69). Most empyema were community-acquired (87.4%) and right-sided (57.4%). Microbiological diagnosis was obtained in 229 (56.4%) patients, and included streptococci (16.3%), staphylococci (15.5%), Gram-negative organisms (8.9%), anaerobes (5.7%), pseudomonads (4.4%) and mycobacteria (9.1%); 8.4% were polymicrobial. Most (68%) cases were managed by open thoracotomy and decortication. Video-assisted thoracoscopic surgery (VATS) reduced hospitalisation from 10 to seven days (P = 0.0005). All-cause complication rate was 25.1%, and 28 day mortality 5.7%. Predictors of early mortality included: older age (P = 0.006), major co-morbidity (P = 0.01), malnutrition (P = 0.001), elevated red cell distribution width (RDW, P<0.001) and serum alkaline phosphatase (P = 0.004), and reduced serum albumin (P = 0.01) and haemoglobin (P = 0.04). Conclusions: Empyema remains an important cause of morbidity and hospital admissions. Microbiological diagnosis was only achieved in just over 50% of cases, and tuberculosis is a notable causative organism. Treatment of empyema with VATS may reduce duration of hospital stay. Raised RDW appears to associate with early mortality.	[Marks, Daniel J. B.; Fisk, Marie D.; Peck, Lorraine; Lee, Simon F.] Univ Coll London Hosp NHS Fdn Trust, Heart Hosp, Dept Cardiol, London, England; [Marks, Daniel J. B.; Koo, Chieh Y.] UCL, Dept Med, London, England; [Pavlou, Menelaos; Miller, Robert F.] UCL, Sch Med, Res Dept Infect & Populat Hlth, London W1N 8AA, England; [Lee, Simon F.] Inst Mol & Cellular Biol, Div Infect & Immun, Oporto, Portugal; [Lawrence, David] Univ Coll London Hosp NHS Fdn Trust, Heart Hosp, Dept Cardiothorac Surg, London, England; [Brown, Jeremy S.] UCL, Ctr Resp Res, London, England; [Zumla, Alimuddin I.] UCL, Sch Med, Dept Infect, London W1N 8AA, England; [Macrae, M. Bruce; Wilson, A. Peter R.; Zumla, Alimuddin I.] Univ Coll London Hosp NHS Fdn Trust, Dept Clin Microbiol, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; Universidade do Porto; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London	Marks, DJB (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Heart Hosp, Dept Cardiol, London, England.	a.zumla@ucl.ac.uk	Laurell, Thomas/B-5524-2013; ZUMLA, Alimuddin/ABA-8208-2020	Laurell, Thomas/0000-0002-2486-3607; ZUMLA, Alimuddin/0000-0002-5111-5735; Miller, Robert/0000-0003-2067-4291; Wilson, Andrew Peter Richard/0000-0003-1109-5650; Brown, Jeremy/0000-0002-5650-5361; Fisk, Marie/0000-0002-1292-7642	Department of Health [813] Funding Source: Medline; National Institute for Health Research [ACF-2009-18-030] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Ahmed RA, 2006, AM J MED, V119, P877, DOI 10.1016/j.amjmed.2006.03.042; BAYNES RD, 1987, AM J CLIN PATHOL, V87, P196, DOI 10.1093/ajcp/87.2.196; Bender JM, 2009, EMERG INFECT DIS, V15, P44, DOI 10.3201/eid1501.080618; Blaschke AJ, 2011, PEDIATR INFECT DIS J, V30, P289, DOI 10.1097/INF.0b013e3182002d14; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cakal B, 2009, DIGEST DIS SCI, V54, P842, DOI 10.1007/s10620-008-0436-2; Cardillo G, 2010, EUR J CARDIO-THORAC, V37, P814, DOI 10.1016/j.ejcts.2009.10.026; Chen CH, 2007, CHEST, V132, P532, DOI 10.1378/chest.07-0005; Chen W, 2009, SOUTH MED J, V102, P909, DOI 10.1097/SMJ.0b013e3181b22c52; Christopoulou-Aletra H, 2008, ANN THORAC SURG, V85, P1132, DOI 10.1016/j.athoracsur.2007.11.031; COKER RJ, 1994, J ROY SOC MED, V87, P65; Davies CWH, 1999, AM J RESP CRIT CARE, V160, P1682, DOI 10.1164/ajrccm.160.5.9903002; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Ferrer J, 1997, EUR RESPIR J, V10, P942; Finley C, 2008, CAN RESPIR J, V15, P85, DOI 10.1155/2008/975312; Foster S, 2007, CURR OPIN PULM MED, V13, P319, DOI 10.1097/MCP.0b013e3281864691; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; HORAN TC, 1992, AM J INFECT CONTROL, V20, P271, DOI 10.1016/S0196-6553(05)80201-9; Isik T, 2011, CORON ARTERY DIS; Khwaja S, 2005, CHEST, V128, P246, DOI 10.1378/chest.128.1.246; Lee SF, 2010, CURR OPIN PULM MED, V16, P194, DOI 10.1097/MCP.0b013e32833883f5; Li STT, 2010, PEDIATRICS, V125, P26, DOI 10.1542/peds.2009-0184; Liang SJ, 2007, SOUTH MED J, V100, P1075, DOI 10.1097/SMJ.0b013e318158ba49; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; Meyer CN, 2011, SCAND J INFECT DIS, V43, P165, DOI 10.3109/00365548.2010.536162; Noursadeghi M, 2006, LANCET INFECT DIS, V6, P794, DOI 10.1016/S1473-3099(06)70656-9; Plathow C, 2005, INVEST RADIOL, V40, P173, DOI 10.1097/00004424-200503000-00007; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Roxburgh CSD, 2008, ARCH DIS CHILD, V93, P316, DOI 10.1136/adc.2007.126540; Sogaard Mette, 2011, Clin Epidemiol, V3, P85, DOI 10.2147/CLEP.S16931; St Peter SD, 2009, J PEDIATR SURG, V44, P106, DOI 10.1016/j.jpedsurg.2008.10.018; Tong BC, 2010, ANN THORAC SURG, V89, P220, DOI 10.1016/j.athoracsur.2009.09.021; Tu CY, 2006, INTENS CARE MED, V32, P570, DOI 10.1007/s00134-005-0064-7; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; Wilson APR, 2004, BRIT MED J, V329, P720, DOI 10.1136/bmj.38232.646227.DE; Wrightson JM, 2011, THORAX, V66, P450, DOI 10.1136/thx.2009.129940; Zumla A, 2009, LANCET INFECT DIS, V9, P197, DOI 10.1016/S1473-3099(09)70045-3	41	65	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30074	10.1371/journal.pone.0030074	http://dx.doi.org/10.1371/journal.pone.0030074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276145	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100024
J	Rosendahl, J; Tonjes, A; Schleinitz, D; Kovacs, P; Wiegand, J; Ruffert, C; Jesinghaus, M; Schober, R; Herms, M; Grutzmann, R; Schulz, HU; Stickel, F; Werner, J; Bugert, P; Bluher, M; Stumvoll, M; Bohm, S; Berg, T; Wittenburg, H; Mossner, J; Morsche, RT; Derikx, M; Keim, V; Witt, H; Drenth, JPH				Rosendahl, Jonas; Toenjes, Anke; Schleinitz, Dorit; Kovacs, Peter; Wiegand, Johannes; Ruffert, Claudia; Jesinghaus, Moritz; Schober, Robert; Herms, Max; Gruetzmann, Robert; Schulz, Hans-Ulrich; Stickel, Felix; Werner, Jens; Bugert, Peter; Blueher, Matthias; Stumvoll, Michael; Boehm, Stephan; Berg, Thomas; Wittenburg, Henning; Moessner, Joachim; Morsche, Rene Te; Derikx, Monique; Keim, Volker; Witt, Heiko; Drenth, Joost P. H.			A Common Variant of PNPLA3 (p.I148M) Is Not Associated with Alcoholic Chronic Pancreatitis	PLOS ONE			English	Article							HEREDITARY PANCREATITIS; LIVER; SUSCEPTIBILITY; POLYMORPHISM; INHIBITOR; MUTATION; FIBROSIS; GENE	Background: Chronic pancreatitis (CP) is an inflammatory disease that in some patients leads to exocrine and endocrine dysfunction. In industrialized countries the most common aetiology is chronic alcohol abuse. Descriptions of associated genetic alterations in alcoholic CP are rare. However, a common PNPLA3 variant (p.I148M) is associated with the development of alcoholic liver cirrhosis (ALC). Since, alcoholic CP and ALC share the same aetiology PNPLA3 variant (p.I148M) possibly influences the development of alcoholic CP. Methods: Using melting curve analysis we genotyped the variant in 1510 patients with pancreatitis or liver disease (961 German and Dutch alcoholic CP patients, 414 German patients with idiopathic or hereditary CP, and 135 patients with ALC). In addition, we included in total 2781 healthy controls in the study. Results: The previously published overrepresentation of GG-genotype was replicated in our cohort of ALC (p-value <0.0001, OR 2.3, 95% CI 1.6-3.3). Distributions of genotype and allele frequencies of the p.I148M variant were comparable in patients with alcoholic CP, idiopathic and hereditary CP and in healthy controls. Conclusions: The absence of an association of PNPLA3 p.I148M with alcoholic CP seems not to point to a common pathway in the development of alcoholic CP and alcoholic liver cirrhosis.	[Rosendahl, Jonas; Wiegand, Johannes; Ruffert, Claudia; Jesinghaus, Moritz; Schober, Robert; Herms, Max; Boehm, Stephan; Berg, Thomas; Wittenburg, Henning; Moessner, Joachim; Keim, Volker] Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Internal Med Neurol & Dermatol, Leipzig, Germany; [Toenjes, Anke; Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Div Endocrinol, Dept Internal Med Neurol & Dermatol, Leipzig, Germany; [Toenjes, Anke; Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, IFB Adipos Dis, Leipzig, Germany; [Schleinitz, Dorit; Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res Leipzig, Leipzig, Germany; [Gruetzmann, Robert] Tech Univ Dresden, Dept Gen Thorac & Vasc Surg, Univ Hosp Carl Gustav Carus, D-01062 Dresden, Germany; [Schulz, Hans-Ulrich] Univ Magdeburg, Dept Surg, D-39106 Magdeburg, Germany; [Stickel, Felix] Univ Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland; [Werner, Jens] Heidelberg Univ, Dept Surg, D-6900 Heidelberg, Germany; [Bugert, Peter] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, German Red Cross Blood Serv Baden Wurttemberg Hes, D-6800 Mannheim, Germany; [Morsche, Rene Te; Derikx, Monique; Drenth, Joost P. H.] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Witt, Heiko] Tech Univ Munich, Dept Pediat, Munich, Germany; [Witt, Heiko] Tech Univ Munich, EKFZ, Munich, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Otto von Guericke University; University of Bern; University Hospital of Bern; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Radboud University Nijmegen; Technical University of Munich; Technical University of Munich	Rosendahl, J (corresponding author), Univ Leipzig, Div Gastroenterol & Rheumatol, Dept Internal Med Neurol & Dermatol, Leipzig, Germany.	jonas.rosendahl@medizin.uni-leipzig.de	Schober, Robert/ABC-9480-2020; te Morsche, R/P-9143-2015; Drenth, J.P.H./H-8025-2014; Drenth, Joost/V-7436-2019; Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423; Berg, Thomas/0000-0003-0003-6241	Deutsche Forschungsgemeinschaft [RO 3929/1-1, RO 3939/2-1]; Colora Stiftung gGmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Colora Stiftung gGmbH	This work was supported by the Deutsche Forschungsgemeinschaft RO 3929/1-1 & RO 3939/2-1 (to Dr. Rosendahl) and by a grant of the Colora Stiftung gGmbH (to Dr. Rosendahl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; ANGELINI G, 1985, AM J GASTROENTEROL, V80, P998; Apte MV, 2003, BEST PRACT RES CL GA, V17, P593, DOI 10.1016/S1521-6918(03)00050-7; Caradonna P, 1996, ITAL J GASTROENTEROL, V28, P91; Derikx MHM, 2010, BEST PRACT RES CL GA, V24, P251, DOI 10.1016/j.bpg.2010.02.001; Gauderman W, QUANTO 1 1 COMPUTER; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Kitahara K, 2008, DIS MARKERS, V25, P175, DOI 10.1155/2008/426764; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Muller T, 2011, J HEPATOL IN PRESS; Nakamura Y, 2004, J GASTROENTEROL, V39, P879, DOI 10.1007/s00535-004-1405-y; Pace A, 2009, CLIN GASTROENTEROL H, V7, P1241, DOI 10.1016/j.cgh.2009.06.010; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2011, J HEPATOL IN PRESS; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797	25	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29433	10.1371/journal.pone.0029433	http://dx.doi.org/10.1371/journal.pone.0029433			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276112	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100009
J	Leong, HS; Lizardo, MM; Ablack, A; McPherson, VA; Wandless, TJ; Chambers, AF; Lewis, JD				Leong, Hon S.; Lizardo, Michael M.; Ablack, Amber; McPherson, Victor A.; Wandless, Thomas J.; Chambers, Ann F.; Lewis, John D.			Imaging the Impact of Chemically Inducible Proteins on Cellular Dynamics In Vivo	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; TUMOR-CELLS; DOXYCYCLINE; SPECIFICITY; METASTASIS; INHIBITION; CARCINOMA; BEHAVIOR; STEPS	The analysis of dynamic events in the tumor microenvironment during cancer progression is limited by the complexity of current in vivo imaging models. This is coupled with an inability to rapidly modulate and visualize protein activity in real time and to understand the consequence of these perturbations in vivo. We developed an intravital imaging approach that allows the rapid induction and subsequent depletion of target protein levels within human cancer xenografts while assessing the impact on cell behavior and morphology in real time. A conditionally stabilized fluorescent E-cadherin chimera was expressed in metastatic breast cancer cells, and the impact of E-cadherin induction and depletion was visualized using real-time confocal microscopy in a xenograft avian embryo model. We demonstrate the assessment of protein localization, cell morphology and migration in cells undergoing epithelial-mesenchymal and mesenchymal-epithelial transitions in breast tumors. This technique allows for precise control over protein activity in vivo while permitting the temporal analysis of dynamic biophysical parameters.	[Leong, Hon S.; Ablack, Amber; McPherson, Victor A.; Lewis, John D.] London Reg Canc Program, Translat Prostate Canc Res Grp, London, ON, Canada; [Lizardo, Michael M.; Chambers, Ann F.; Lewis, John D.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Stanford University	Leong, HS (corresponding author), London Reg Canc Program, Translat Prostate Canc Res Grp, London, ON, Canada.	John.Lewis@lhsc.on.ca	Chambers, Ann F/L-6285-2015	Chambers, Ann F/0000-0002-9509-5123; Leong, Hon/0000-0001-7801-1402	Canadian Cancer Society Research Institute [700537]; Canadian Institutes of Health Research [84535]; Canadian Breast Cancer Research Alliance from the Canadian Breast Cancer Foundation [016506]; Cancer Research Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Research Alliance from the Canadian Breast Cancer Foundation; Cancer Research Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant #700537 from the Canadian Cancer Society Research Institute and grant #84535 from the Canadian Institutes of Health Research to JDL, and grant #016506 from the Canadian Breast Cancer Research Alliance with special funding from the Canadian Breast Cancer Foundation and the Cancer Research Society. HSL is funded by a CBCF Post-Doctoral fellowship. MML is funded by the Pamela Greenaway Translational Breast Cancer Research Unit. AFC is Canada Research Chair in Oncology, supported by the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Born AK, 2009, EUR CELLS MATER, V18, P49; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; CHEN WC, 1991, J CELL BIOL, V114, P319, DOI 10.1083/jcb.114.2.319; Chi NC, 2010, P NATL ACAD SCI USA, V107, P14662, DOI 10.1073/pnas.0909432107; Fainaru O, 2008, FASEB J, V22, P3728, DOI 10.1096/fj.08-110494; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotzmann J, 2002, J CELL SCI, V115, P1189; Hashimoto T, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-1; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Maksimov VF, 2006, B EXP BIOL MED+, V142, P367, DOI 10.1007/s10517-006-0368-9; Mbalaviele G, 1996, CANCER RES, V56, P4063; Mohammadi SA, 1997, GENE THER, V4, P993, DOI 10.1038/sj.gt.3300491; Moses MA, 2006, NEW ENGL J MED, V354, P2621, DOI 10.1056/NEJMc053410; Ozduman K, 2008, J NEUROSCI, V28, P1882, DOI 10.1523/JNEUROSCI.4905-07.2008; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pincus Z, 2007, J MICROSC-OXFORD, V227, P140, DOI 10.1111/j.1365-2818.2007.01799.x; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sarrio D, 2004, ONCOGENE, V23, P3272, DOI 10.1038/sj.onc.1207439; Smith GN, 1999, ARTHRITIS RHEUM, V42, P1140, DOI 10.1002/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7; Souter LH, 2010, LAB INVEST, V90, P1247, DOI 10.1038/labinvest.2010.97; SUOMALAINEN K, 1992, ANTIMICROB AGENTS CH, V36, P227, DOI 10.1128/AAC.36.1.227; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Xylas J, 2010, BIOMED OPT EXPRESS, V1, P1387, DOI 10.1364/BOE.1.001387; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30177	10.1371/journal.pone.0030177	http://dx.doi.org/10.1371/journal.pone.0030177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276156	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200040
J	Lonneborg, R; Varga, E; Brzezinski, P				Lonneborg, Rosa; Varga, Edina; Brzezinski, Peter			Directed Evolution of the Transcriptional Regulator DntR: Isolation of Mutants with Improved DNT-Response	PLOS ONE			English	Article							NITROAROMATIC COMPOUNDS; 2,4-DINITROTOLUENE; STRAIN; GENE; BIODEGRADATION; DEGRADATION; BIOSENSORS; PATHWAYS; BENM	The transcriptional regulator DntR, which previously has been isolated from bacterial strains capable of degrading 2,4dinitrotoluene (DNT), was engineered in order to improve the ability to detect DNT. A directed evolution strategy was employed, where sequence diversity first was created by random mutagenesis in three subsequent rounds, followed by recombination of previously selected mutants. A gfp gene was used as a reporter for transcriptional activity mediated by DntR and cells with higher GFP expression after addition of DNT were sorted out using fluorescence-activated cell sorting (FACS). A DntR mutant, which displayed 10 times higher induction levels than wild-type DntR in response to DNT was isolated. This mutant still maintained low levels of gfp expression in the absence of DNT. The detection limit was,10 mM, a 25-fold improvement compared to wild-type DntR. The functional role of some substitutions found in this clone is discussed in the framework of the structural changes observed when comparing the recently determined structures of DntR with and without bound inducer ligand.	[Lonneborg, Rosa; Varga, Edina; Brzezinski, Peter] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University	Lonneborg, R (corresponding author), Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	Rosa@dbb.su.se; peterb@dbb.su.se		/0000-0002-7679-1369	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Swedish Research Council (www.vr.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; CRAWFORD RL, 1995, CURR OPIN BIOTECH, V6, P329, DOI 10.1016/0958-1669(95)80055-7; Devesse L, MOL MICROBIOL, V81, P354; Ezezika OC, 2007, J MOL BIOL, V367, P616, DOI 10.1016/j.jmb.2006.09.090; Galvao TC, 2006, CURR OPIN BIOTECH, V17, P34, DOI 10.1016/j.copbio.2005.12.002; Galvao TC, 2007, MOL MICROBIOL, V65, P907, DOI 10.1111/j.1365-2958.2007.05832.x; Huang WE, 2005, ENVIRON MICROBIOL, V7, P1339, DOI 10.1111/j.1462-5822.2005.00821.x; Jaworski JW, 2008, LANGMUIR, V24, P4938, DOI 10.1021/la7035289; Jenkins TF, 2001, TALANTA, V54, P501, DOI 10.1016/S0039-9140(00)00547-6; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Johnson GR, 2003, APPL MICROBIOL BIOT, V62, P110, DOI 10.1007/s00253-003-1341-4; Johnson GR, 2002, J BACTERIOL, V184, P4219, DOI 10.1128/JB.184.15.4219-4232.2002; Jones RM, 2003, J BACTERIOL, V185, P5847, DOI 10.1128/JB.185.19.5847-5853.2003; Ju KS, 2009, MOL MICROBIOL, V74, P826, DOI 10.1111/j.1365-2958.2009.06904.x; Lessner DJ, 2003, J BACTERIOL, V185, P3895, DOI 10.1128/JB.185.13.3895-3904.2003; Lonneborg R, 2011, SEARCH BIOSENSOR DNT; Lonneborg R, 2007, J MOL BIOL, V372, P571, DOI 10.1016/j.jmb.2007.06.076; Nagatomo K, 2009, TALANTA, V79, P1142, DOI 10.1016/j.talanta.2009.02.018; Pellinen T, 2004, ANAL BIOCHEM, V330, P52, DOI 10.1016/j.ab.2004.03.064; Radhika V, 2007, NAT CHEM BIOL, V3, P325, DOI 10.1038/nchembio882; Ruangprasert A, 2010, J MOL BIOL, V404, P568, DOI 10.1016/j.jmb.2010.09.053; SCHELL MA, 1985, GENE, V36, P301, DOI 10.1016/0378-1119(85)90185-4; Scholz O, 2003, J MOL BIOL, V329, P217, DOI 10.1016/S0022-2836(03)00427-3; Shin HJ, 2010, J BIOTECHNOL, V150, P246, DOI 10.1016/j.jbiotec.2010.09.936; Smirnova IA, 2004, J MOL BIOL, V340, P405, DOI 10.1016/j.jmb.2004.04.071; SPAIN JC, 1995, ANNU REV MICROBIOL, V49, P523, DOI 10.1146/annurev.mi.49.100195.002515; SPANGGORD RJ, 1991, APPL ENVIRON MICROB, V57, P3200, DOI 10.1128/AEM.57.11.3200-3205.1991; Stocker J, 2003, ENVIRON SCI TECHNOL, V37, P4743, DOI 10.1021/es034258b; Tang SY, 2008, J AM CHEM SOC, V130, P5267, DOI 10.1021/ja7109053; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375	31	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29994	10.1371/journal.pone.0029994	http://dx.doi.org/10.1371/journal.pone.0029994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276138	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200026
J	Yamamoto, T; Takano, T; Higuchi, W; Iwao, Y; Singur, O; Reva, I; Otsuka, Y; Nakayashiki, T; Mori, H; Reva, G; Kuznetsov, V; Potapov, V				Yamamoto, Tatsuo; Takano, Tomomi; Higuchi, Wataru; Iwao, Yasuhisa; Singur, Olga; Reva, Ivan; Otsuka, Yuta; Nakayashiki, Toru; Mori, Hirotada; Reva, Galina; Kuznetsov, Vladimir; Potapov, Vladimir			Comparative Genomics and Drug Resistance of a Geographic Variant of ST239 Methicillin-Resistant Staphylococcus aureus Emerged in Russia	PLOS ONE			English	Article							ANTIMICROBIAL AGENTS; GENETIC BACKGROUNDS; COMMUNITY; IDENTIFICATION; EVOLUTION; SEQUENCE; MRSA; HOSPITALS; OUTBREAK; CLONES	Two distinct classes of methicillin-resistant Staphylococcus aureus (MRSA) are spreading in hospitals (as hospital-acquired MRSA, HA-MRSA) and in the community (as community-acquired MRSA, CA-MRSA). Multilocus sequence type (ST) 239 MRSA, one of the most worldwide-disseminated lineages, has been noted as a representative HA-MRSA. Here, we isolated ST239 MRSA (spa type 3 [t037] and staphylococcal cassette chromosome mec [SCCmec] type III.1.1.1) and its novel variant with ST239/spa351 (t030)/SCCmecIII.1.1.4 (SCCmecIII(R)) not only from hospitals but also from patients with urethritis in the community in Russia. The Russian variant (strain 16K) possessed a hybrid genome consisting of CC8 and CC30, similar to the ST239/spa3/SCCmecIII.1.1.1 HA-MRSA (TW20) genome, but with marked diversity. The 16K' CC30 section had SCCmecIII(R) carrying the dcs-carrying unit (which corresponded to the SCCmecIVc J3 joining region of ST30 CA-MRSA), lacked SCCmercury, and possessed a novel mobile element structure (MES16K) carrying the ccrC-carrying unit (with the recombinase gene ccrC1 allele 3) and drug resistance tranposons. The Russian variant included strains with a high ability to transfer its multiple drug resistance by conjugation; e. g., for strain 16K, the transfer frequency of a chloramphenicol resistance plasmid (p16K-1 with 2.9 kb in size) reached 1.4x10(-2), followed by Tn554 conjugative transfer at 3.6x10(-4). The Russian variant, which has been increasing recently, included divergent strains with different plasmid patterns and pulsed field gel electrophoresis profiles. The data demonstrate the alternative nature of ST239 MRSA as CA-MRSA and also as a drug resistance disseminator, and its micro but dynamic evolution in Russia.	[Yamamoto, Tatsuo; Takano, Tomomi; Higuchi, Wataru; Iwao, Yasuhisa; Singur, Olga; Reva, Ivan] Niigata Univ, Div Bacteriol, Dept Infect Dis Control & Int Med, Grad Sch Med & Dent Sci, Niigata, Japan; [Singur, Olga; Reva, Galina; Kuznetsov, Vladimir; Potapov, Vladimir] Vladivostok State Med Univ, Vladivostok, Russia; [Otsuka, Yuta; Nakayashiki, Toru; Mori, Hirotada] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara, Japan	Niigata University; Nara Institute of Science & Technology	Yamamoto, T (corresponding author), Niigata Univ, Div Bacteriol, Dept Infect Dis Control & Int Med, Grad Sch Med & Dent Sci, Niigata, Japan.	tatsuoy@med.niigata-u.ac.jp		Reva, Ivan/0000-0002-3727-393X; Reva, Galina/0000-0001-6502-4271	Heiwa Nakajima Foundation, Japan	Heiwa Nakajima Foundation, Japan	This study was supported, in part, by a grant from Heiwa Nakajima Foundation, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, M100S18 CLIN LAB STA; Baranovich T, 2007, EUROSURVEILLANCE, V12; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; de Lencastre Herminia, 1997, Clin Microbiol Infect, V3, P289; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Gomez MI, 2006, J BIOL CHEM, V281, P20190, DOI 10.1074/jbc.M601956200; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Haroche J, 2002, ANTIMICROB AGENTS CH, V46, P2337, DOI 10.1128/AAC.46.8.2337-2343.2002; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Higuchi W, 2010, J INFECT CHEMOTHER, V16, P144, DOI 10.1007/s10156-010-0029-9; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P3475, DOI 10.1128/AAC.00464-10; Kahl BC, 2007, SCIENCE, V315, P1082, DOI 10.1126/science.1139628; KERR S, 1990, J HOSP INFECT, V16, P35, DOI 10.1016/0195-6701(90)90047-R; MARPLES RR, 1985, J HOSP INFECT, V6, P342, DOI 10.1016/0195-6701(85)90040-4; MURPHY E, 1984, NATURE, V307, P292, DOI 10.1038/307292a0; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Oliveira D., 1998, Clin Microbiol Infect, V4, P373, DOI 10.1111/j.1469-0691.1998.tb00081.x; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Sanches IS, 1996, MICROB DRUG RESIST, V2, P319, DOI 10.1089/mdr.1996.2.319; Shi D, 2011, PEDIATR INT, V53, P211, DOI 10.1111/j.1442-200X.2010.03246.x; Strommenger B, 2004, EUR J CLIN MICROBIOL, V23, P15, DOI 10.1007/s10096-003-1046-8; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Takano T, 2009, J INFECT CHEMOTHER, V15, P54, DOI 10.1007/s10156-008-0665-5; Takizawa Y, 2005, J CLIN MICROBIOL, V43, P3356, DOI 10.1128/JCM.43.7.3356-3363.2005; Taneike I, 2006, FEBS LETT, V580, P2323, DOI 10.1016/j.febslet.2006.03.049; TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Witte W, 1999, J ANTIMICROB CHEMOTH, V44, P1, DOI 10.1093/jac/44.suppl_1.1; Yamamoto T, 2006, ANTIMICROB AGENTS CH, V50, P4077, DOI 10.1128/AAC.00847-06; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9; Zetola N, 2005, LANCET INFECT DIS, V5, P275, DOI 10.1016/S1473-3099(05)70112-2; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	45	30	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29187	10.1371/journal.pone.0029187	http://dx.doi.org/10.1371/journal.pone.0029187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276107	Green Published, gold			2022-12-25	WOS:000301457200008
J	Bierau, J; Bakker, JA; Schippers, JA; Grashorn, JAC; Lindhout, M; Lowe, SH; Paulussen, ADC; Verbon, A				Bierau, Jorgen; Bakker, Jaap A.; Schippers, Jolanda A.; Grashorn, Janine A. C.; Lindhout, Martijn; Lowe, Selwyn H.; Paulussen, Aimee D. C.; Verbon, Annelies			Erythrocyte Inosine Triphosphatase Activity Is Decreased in HIV-Seropositive Individuals	PLOS ONE			English	Article							ITPA GENE; AZATHIOPRINE THERAPY; VARIANTS; PYROPHOSPHOHYDROLASE; DEFICIENCY; METABOLISM; DISEASE; CELLS	Background: Inosine triphosphatase (ITPase) is encoded by the polymorphic gene ITPA and maintains low intracellular levels of the inosine nucleotides ITP and dITP. The most frequently reported polymorphisms are ITPA c.94C>A (rs 1127354) and ITPA c. 124+21 A>C (rs7270101). Some nucleoside-analogues used in the treatment of HIV-seropositive (HIV+) patients are potential substrates for ITPase. Therefore, the frequency of ITPA SNPs and ITPase activity were studied in a population of HIV+-patients. Methods: The study population consisted of 222 patients, predominantly Caucasian males, >95% using HAART. Erythrocyte ITPase activity was determined by measuring the formation of IMP from ITP. ITPA genotype was determined by sequencing genomic DNA. Distribution of ITPase activity, genotype-phenotype correlation and allele frequencies were compared to 198 control subjects. The effect of nucleoside analogues on ITPase activity was studied using lymphoblastic T-cell cultures and human recombinant ITPase. Enzyme kinetic experiments were performed on erythrocyte ITPase from HIV+ patients and controls. Results: No difference was observed in the allele frequencies between the HIV+-cohort (+/- HAART) and the control population. HIV+ carriers of the wild type and ITPA c.94C>A had significantly lower ITPase activities than control subjects with the same genotype (p<0.005). This was not observed in ITPA c. 124+21 A>C carriers. Nucleoside analogues did not affect ITPase activity in cell culture and human recombinant ITPase. Conclusion: ITPA population genetics were identical in HIV+ and control populations. However, the majority of HIV+-patients had decreased erythrocyte ITPase activity compared to controls, probably due to decreased amounts of ITPase protein. It seems unlikely that ITPase activity is decreased due to nucleoside analogues (HAART). Long-term effects of HIV-infection altering ITPase protein expression or stability may explain the phenomenon observed.	[Bierau, Jorgen; Bakker, Jaap A.; Grashorn, Janine A. C.; Lindhout, Martijn; Paulussen, Aimee D. C.] Maastricht Univ, Dept Clin Genet, Med Ctr, Maastricht, Netherlands; [Schippers, Jolanda A.] Maastricht Univ, Dept Integrated Care, Med Ctr, Maastricht, Netherlands; [Lowe, Selwyn H.] Maastricht Univ, Dept Med Microbiol, Med Ctr, Maastricht, Netherlands; [Lowe, Selwyn H.; Verbon, Annelies] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands; [Verbon, Annelies] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Erasmus University Rotterdam; Erasmus MC	Bierau, J (corresponding author), Maastricht Univ, Dept Clin Genet, Med Ctr, Maastricht, Netherlands.	jorgen.bierau@mumc.nl	Bakker, J. A./H-7910-2019	Bakker, Jaap A./0000-0002-2918-7361				Arenas M, 2007, BBA-MOL BASIS DIS, V1772, P96, DOI 10.1016/j.bbadis.2006.10.006; Atanasova S, 2007, THER DRUG MONIT, V29, P6, DOI 10.1097/FTD.0b013e3180308554; Bakker JA, 2010, EUR RESPIR J, V36, P684, DOI 10.1183/09031936.00026610; Bakker JA, 2007, CURR OPIN PULM MED, V13, P458, DOI 10.1097/MCP.0b013e328273bc18; Bakker JA, 2009, CLIN CHIM ACTA, V405, P155, DOI 10.1016/j.cca.2009.04.023; Bierau J, 2006, NUCLEOS NUCLEOT NUCL, V25, P1129, DOI 10.1080/15257770600894253; Bierau J, 2007, PHARMACOGENOMICS, V8, P1221, DOI 10.2217/14622416.8.9.1221; BOFILL M, 1995, J BIOL CHEM, V270, P29690, DOI 10.1074/jbc.270.50.29682; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; FRASER JH, 1975, CLIN BIOCHEM, V8, P353, DOI 10.1016/S0009-9120(75)93685-1; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gras L, 2009, MONITORING HIV INFEC, P27; Herting G, 2010, BBA-MOL BASIS DIS, V1802, P269, DOI 10.1016/j.bbadis.2009.11.002; JACOBSSON B, 1995, AIDS RES HUM RETROV, V11, P805, DOI 10.1089/aid.1995.11.805; Jacobsson B, 1998, BIOCHEM PHARMACOL, V56, P389, DOI 10.1016/S0006-2952(98)00032-X; Lin SR, 2001, J BIOL CHEM, V276, P18695, DOI 10.1074/jbc.M011084200; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; Marsh S, 2004, J HUM GENET, V49, P579, DOI 10.1007/s10038-004-0183-y; Stepchenkova EI, 2009, J MOL BIOL, V392, P602, DOI 10.1016/j.jmb.2009.07.051; Sumi S, 2002, HUM GENET, V111, P360, DOI 10.1007/s00439-002-0798-z; VANDERHEIDEN BS, 1980, BIOCHEM MED METAB B, V23, P76, DOI 10.1016/0006-2944(80)90057-5; VANDERHEIDEN BS, 1969, BIOCHEM GENET, V3, P289, DOI 10.1007/BF00521144; von Ahsen N, 2005, CLIN CHEM, V51, P2282, DOI 10.1373/clinchem.2005.057158	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30175	10.1371/journal.pone.0030175	http://dx.doi.org/10.1371/journal.pone.0030175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272297	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400075
J	Ellis, EC; Antill, EC; Kreft, H				Ellis, Erle C.; Antill, Erica C.; Kreft, Holger			All Is Not Loss: Plant Biodiversity in the Anthropocene	PLOS ONE			English	Article							LAND-USE CHANGE; GLOBAL PATTERNS; SPECIES-RICHNESS; ANTHROPOGENIC TRANSFORMATION; BIOTIC HOMOGENIZATION; SPATIALLY EXPLICIT; INVASIONS; CONSERVATION; POPULATION; DIVERSITY	Anthropogenic global changes in biodiversity are generally portrayed in terms of massive native species losses or invasions caused by recent human disturbance. Yet these biodiversity changes and others caused directly by human populations and their use of land tend to co-occur as long-term biodiversity change processes in the Anthropocene. Here we explore contemporary anthropogenic global patterns in vascular plant species richness at regional landscape scales by combining spatially explicit models and estimates for native species loss together with gains in exotics caused by species invasions and the introduction of agricultural domesticates and ornamental exotic plants. The patterns thus derived confirm that while native losses are likely significant across at least half of Earth's ice-free land, model predictions indicate that plant species richness has increased overall in most regional landscapes, mostly because species invasions tend to exceed native losses. While global observing systems and models that integrate anthropogenic species loss, introduction and invasion at regional landscape scales remain at an early stage of development, integrating predictions from existing models within a single assessment confirms their vast global extent and significance while revealing novel patterns and their potential drivers. Effective global stewardship of plant biodiversity in the Anthropocene will require integrated frameworks for observing, modeling and forecasting the different forms of anthropogenic biodiversity change processes at regional landscape scales, towards conserving biodiversity within the novel plant communities created and sustained by human systems.	[Ellis, Erle C.; Antill, Erica C.] Univ Maryland, Dept Geog & Environm Syst, Baltimore, MD 21201 USA; [Kreft, Holger] Univ Gottingen, Biodivers Macroecol & Conservat Biogeog Grp, Gottingen, Germany	University System of Maryland; University of Maryland Baltimore; University of Gottingen	Ellis, EC (corresponding author), Univ Maryland, Dept Geog & Environm Syst, Baltimore, MD 21201 USA.	ece@umbc.edu	Ellis, Erle C./B-8264-2008; Kreft, Holger/AAY-7573-2020; Kreft, Holger/A-4736-2008	Ellis, Erle C./0000-0002-2006-3362; Kreft, Holger/0000-0003-4471-8236; Kreft, Holger/0000-0003-4471-8236				Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chytry M, 2009, DIVERS DISTRIB, V15, P98, DOI 10.1111/j.1472-4642.2008.00515.x; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Golding J, 2010, ANN BOT-LONDON, V105, P689, DOI 10.1093/aob/mcq043; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Huston MA, 2005, ECOL APPL, V15, P1864, DOI 10.1890/03-5281; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; McElwain JC, 2007, TRENDS ECOL EVOL, V22, P548, DOI 10.1016/j.tree.2007.09.003; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mittermeier RA, 2004, HOTSPOTS REVISITED; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Muchoney DM, 2010, ECOL RES, V25, P937, DOI 10.1007/s11284-010-0756-5; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Nunez MA, 2010, BIOL INVASIONS, V12, P707, DOI 10.1007/s10530-009-9517-1; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Pautasso M, 2007, ECOL LETT, V10, P16, DOI 10.1111/j.1461-0248.2006.00993.x; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pitman NCA, 2002, SCIENCE, V298, P989, DOI 10.1126/science.298.5595.989; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 2001, EVOL ECOL RES, V3, P361; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Smith RM, 2006, BIOL CONSERV, V129, P312, DOI 10.1016/j.biocon.2005.10.045; Stohigren TJ, 2008, ECOL LETT, V11, P313, DOI 10.1111/j.1461-0248.2008.01153.x; Stohlgren TJ, 2006, BIOL INVASIONS, V8, P427, DOI 10.1007/s10530-005-6422-0; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106	69	161	167	5	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30535	10.1371/journal.pone.0030535	http://dx.doi.org/10.1371/journal.pone.0030535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272360	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400138
J	Jones, PL; Pask, GM; Romaine, IM; Taylor, RW; Reid, PR; Waterson, AG; Sulikowski, GA; Zwiebel, LJ				Jones, Patrick L.; Pask, Gregory M.; Romaine, Ian M.; Taylor, Robert W.; Reid, Paul R.; Waterson, Alex G.; Sulikowski, Gary A.; Zwiebel, Laurence J.			Allosteric Antagonism of Insect Odorant Receptor Ion Channels	PLOS ONE			English	Article							CONSERVATION; GENE	Background: At a molecular level, insects utilize members of several highly divergent and unrelated families of cell-surface chemosensory receptors for detection of volatile odorants. Most odors are detected via a family of odorant receptors (ORs), which form heteromeric complexes consisting of a well-conserved OR co-receptor (Orco) ion channel and a non-conserved tuning OR that provides coding specificity to each complex. Orco functions as a non-selective cation channel and is expressed in the majority of olfactory receptor neurons (ORNs). As the destructive behaviors of many insects are principally driven by olfaction, Orco represents a novel target for behavior-based control strategies. While many natural and synthetic odorants have been shown to agonize Orco/Or complexes, only a single direct Orco modulator, VUAA1, has been described. In an effort to identify additional Orco modulators, we have investigated the structure/activity relationships around VUAA1. Results: A search of our compound library identified several VUAA1 analogs that were selected for evaluation against HEK cells expressing Orco from the malaria vector Anopheles gambiae (AgOrco). While the majority of compounds displayed no activity, many of these analogs possess no intrinsic efficacy, but instead, act as competitive VUAA1 antagonists. Using calcium mobilization assays, patch clamp electrophysiology, and single sensillum in vivo recording, we demonstrate that one such candidate, VU0183254, is a specific allosteric modulator of OR signaling, capable of broadly inhibiting odor-mediated OR complex activation. Conclusions: We have described and characterized the first Orco antagonist, that is capable of non-competitively inhibiting odorant-evoked activation of OR complexes, thereby providing additional insight into the structure/function of this unique family of ligand-gated ion channels. While Orco antagonists are likely to have limited utility in insect control programs, they represent important pharmacological tools that will facilitate the investigation of the molecular mechanisms underlying insect olfactory signal transduction.	[Jones, Patrick L.; Pask, Gregory M.; Taylor, Robert W.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Romaine, Ian M.; Reid, Paul R.; Waterson, Alex G.; Sulikowski, Gary A.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Chem, Vanderbilt Inst Chem Biol, Nashville, TN USA; [Waterson, Alex G.; Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Global Hlth, Ctr Mol Neurosci, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Program Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Jones, PL (corresponding author), Genzyme Corp, Waltham, MA 02451 USA.	l.zwiebel@vanderbilt.edu		Zwiebel, Laurence/0000-0001-6686-7289	Foundation for the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Foundation for the National Institutes of Health to Dr. Zwiebel through the Grand Challenges in Global Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Gilliot C., 2005, ENTOMOLOGY; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kenakin T, 2006, J PHARMACOL EXP THER, V319, P710, DOI 10.1124/jpet.106.107375; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	31	53	69	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30304	10.1371/journal.pone.0030304	http://dx.doi.org/10.1371/journal.pone.0030304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272331	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400109
J	Miko, I; Friedrich, F; Yoder, MJ; Hines, HM; Deitz, LL; Bertone, MA; Seltmann, KC; Wallace, MS; Deans, AR				Miko, Istvan; Friedrich, Frank; Yoder, Matthew J.; Hines, Heather M.; Deitz, Lewis L.; Bertone, Matthew A.; Seltmann, Katja C.; Wallace, Matthew S.; Deans, Andrew R.			On Dorsal Prothoracic Appendages in Treehoppers (Hemiptera: Membracidae) and the Nature of Morphological Evidence	PLOS ONE			English	Article							NUBBIN EXPRESSION PATTERNS; BEETLE HORNS; EVOLUTION; INSECT; DIVERSIFICATION; DROSOPHILA; HOMOPTERA; ORIGIN; GENE	A spectacular hypothesis was published recently, which suggested that the "helmet" (a dorsal thoracic sclerite that obscures most of the body) of treehoppers (Insecta: Hemiptera: Membracidae) is connected to the 1st thoracic segment (T1; prothorax) via a jointed articulation and therefore was a true appendage. Furthermore, the "helmet" was interpreted to share multiple characteristics with wings, which in extant pterygote insects are present only on the 2nd (T2) and 3rd (T3) thoracic segments. In this context, the "helmet" could be considered an evolutionary novelty. Although multiple lines of morphological evidence putatively supported the "helmet"-wing homology, the relationship of the "helmet" to other thoracic sclerites and muscles remained unclear. Our observations of exemplar thoraces of 10 hemipteran families reveal multiple misinterpretations relevant to the "helmet"-wing homology hypothesis as originally conceived: 1) the "helmet" actually represents T1 (excluding the fore legs); 2) the "T1 tergum" is actually the anterior dorsal area of T2; 3) the putative articulation between the "helmet" and T1 is actually the articulation between T1 and T2. We conclude that there is no dorsal, articulated appendage on the membracid T1. Although the posterior, flattened, cuticular evagination (PFE) of the membracid T1 does share structural and genetic attributes with wings, the PFE is actually widely distributed across Hemiptera. Hence, the presence of this structure in Membracidae is not an evolutionary novelty for this clade. We discuss this new interpretation of the membracid T1 and the challenges of interpreting and representing morphological data more broadly. We acknowledge that the lack of data standards for morphology is a contributing factor to misinterpreted results and offer an example for how one can reduce ambiguity in morphology by referencing anatomical concepts in published ontologies.	[Miko, Istvan; Yoder, Matthew J.; Deitz, Lewis L.; Bertone, Matthew A.; Seltmann, Katja C.; Deans, Andrew R.] N Carolina State Univ, Dept Entomol, Insect Museum, Raleigh, NC 27695 USA; [Friedrich, Frank] Univ Hamburg, Bioctr Grindel, Hamburg, Germany; [Friedrich, Frank] Univ Hamburg, Zool Museum Hamburg, Hamburg, Germany; [Hines, Heather M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Wallace, Matthew S.] E Stroudsburg State Univ, E Stroudsburg, PA USA	University of North Carolina; North Carolina State University; University of Hamburg; University of Hamburg; University of North Carolina; North Carolina State University; Pennsylvania State System of Higher Education (PASSHE); East Stroudsburg University	Miko, I (corresponding author), N Carolina State Univ, Dept Entomol, Insect Museum, Raleigh, NC 27695 USA.	ardeans@ncsu.edu	Seltmann, Katja/AAC-9120-2020; Deans, Andrew R./AAG-4166-2021; Friedrich, Frank/A-8309-2015	Seltmann, Katja/0000-0001-5354-6048; Deans, Andrew R./0000-0002-2119-4663; Miko, Istvan/0000-0001-9719-0215; Bertone, Matt/0000-0001-7985-1913	National Science Foundation (NSF) [DBI-0850223]; Phenotype Research Coordination Network [NSF DEB-0956049]; National Evolutionary Synthesis Center [NSF EF-0905606]; Direct For Biological Sciences [0850223, 1321620] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0956049] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Phenotype Research Coordination Network; National Evolutionary Synthesis Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded in part by a National Science Foundation (NSF) grant (DBI-0850223) and benefited from workshops funded by the Phenotype Research Coordination Network (NSF DEB-0956049) and the National Evolutionary Synthesis Center (NSF EF-0905606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Averof M, 1997, NATURE, V385, P627, DOI 10.1038/385627a0; Chesebro J, 2009, DEV BIOL, V329, P142, DOI 10.1016/j.ydbio.2009.01.032; Cifuentes FJ, 1997, P NATL ACAD SCI USA, V94, P11405, DOI 10.1073/pnas.94.21.11405; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; DIETRICH CH, 1993, SYST ENTOMOL, V18, P297, DOI 10.1111/j.1365-3113.1993.tb00668.x; Emlen DJ, 2007, P NATL ACAD SCI USA, V104, P8661, DOI 10.1073/pnas.0701209104; Funkhouser W. D., 1915, Annals of the Entomological Society of America, V8, DOI 10.1093/aesa/8.2.140; Li H, 2004, EVOL DEV, V6, P310, DOI 10.1111/j.1525-142X.2004.04039.x; Moczek AP, 2011, NATURE, V473, P34, DOI 10.1038/473034a; Moczek AP, 2009, P NATL ACAD SCI USA, V106, P8992, DOI 10.1073/pnas.0809668106; NG M, 1995, DEVELOPMENT, V121, P589; Pennisi E, 2011, TREEHOPPER CAMOUFLAG; Popadic A, 2005, EVOL DEV, V7, P359, DOI 10.1111/j.1525-142X.2005.05041.x; Prud'homme B, 2011, NATURE, V473, P83, DOI 10.1038/nature09977; Stegmann UE, 1998, J MORPHOL, V238, P157, DOI 10.1002/(SICI)1097-4687(199811)238:2<157::AID-JMOR3>3.0.CO;2-H; Turchyn N, 2011, DEV BIOL, V357, P83, DOI 10.1016/j.ydbio.2011.06.014; Vogt L, 2010, CLADISTICS, V26, P301, DOI 10.1111/j.1096-0031.2009.00286.x; Wasik BR, 2010, EVOL DEV, V12, P353, DOI 10.1111/j.1525-142X.2010.00422.x; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991; Yong E, 2011, 250 MILLION YEARS RE; Yoshizawa K, 2012, SYST ENTOMOL, V37, P2, DOI 10.1111/j.1365-3113.2011.00606.x	21	24	26	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30137	10.1371/journal.pone.0030137	http://dx.doi.org/10.1371/journal.pone.0030137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272287	gold, Green Submitted, Green Published			2022-12-25	WOS:000301454400065
J	Stone, CB; Sugiman-Marangos, S; Bulir, DC; Clayden, RC; Leighton, TL; Slootstra, JW; Junop, MS; Mahony, JB				Stone, Chris B.; Sugiman-Marangos, Seiji; Bulir, David C.; Clayden, Rob C.; Leighton, Tiffany L.; Slootstra, Jerry W.; Junop, Murray S.; Mahony, James B.			Structural Characterization of a Novel Chlamydia pneumoniae Type III Secretion-Associated Protein, Cpn0803	PLOS ONE			English	Article							V-ANTIGEN; SYSTEM; DELIVERY; LCRV; IPAB; TIP	Type III secretion (T3S) is an essential virulence factor used by Gram-negative pathogenic bacteria to deliver effector proteins into the host cell to establish and maintain an intracellular infection. Chlamydia is known to use T3S to facilitate invasion of host cells but many proteins in the system remain uncharacterized. The C. trachomatis protein CT584 has previously been implicated in T3S. Thus, we analyzed the CT584 ortholog in C. pneumoniae (Cpn0803) and found that it associates with known T3S proteins including the needle-filament protein (CdsF), the ATPase (CdsN), and the C-ring protein (CdsQ). Using membrane lipid strips, Cpn0803 interacted with phosphatidic acid and phosphatidylinositol, suggesting that Cpn0803 may associate with host cells. Crystallographic analysis revealed a unique structure of Cpn0803 with a hydrophobic pocket buried within the dimerization interface that may be important for binding small molecules. Also, the binding domains on Cpn0803 for CdsN, CdsQ, and CdsF were identified using Pepscan epitope mapping. Collectively, these data suggest that Cpn0803 plays a role in T3S.	[Stone, Chris B.; Bulir, David C.; Clayden, Rob C.; Leighton, Tiffany L.; Mahony, James B.] McMaster Univ, Fac Hlth Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Stone, Chris B.; Bulir, David C.; Clayden, Rob C.; Leighton, Tiffany L.; Mahony, James B.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Stone, Chris B.; Bulir, David C.; Clayden, Rob C.; Leighton, Tiffany L.; Mahony, James B.] St Josephs Healthcare, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada; [Sugiman-Marangos, Seiji; Junop, Murray S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Slootstra, Jerry W.] Pepscan Presto, Zuidersluisweg, Lelystad, Netherlands	McMaster University; McMaster University; McMaster University	Stone, CB (corresponding author), McMaster Univ, Fac Hlth Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	mahonyj@mcmaster.ca	Junop, Murray S/E-4160-2015	Junop, Murray S/0000-0001-6676-5717; Sugiman-Marangos, Seiji/0000-0002-8475-5456	Canadian Institutes of Health [MOP 89903]; Father Sean O'Sullivan Research Center, St. Joseph's Healthcare, Hamilton; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Father Sean O'Sullivan Research Center, St. Joseph's Healthcare, Hamilton; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by Canadian Institutes of Health Research Grants to MSJ (MOP 89903) and JBM. CBS received a doctoral scholarship from the Father Sean O'Sullivan Research Center, St. Joseph's Healthcare, Hamilton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; [Anonymous], PYMOL MOL GRAPH SYST; Caroline G, 2008, J BIOL CHEM, V283, P23940, DOI 10.1074/jbc.M803146200; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x; Hefty PS, 2007, J BACTERIOL, V189, P198, DOI 10.1128/JB.01034-06; Hoare A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-5; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Johnson DL, 2008, J BACTERIOL, V190, P2972, DOI 10.1128/JB.01997-07; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2; Markham AP, 2009, BIOCHEMISTRY-US, V48, P10353, DOI 10.1021/bi901200y; Moorhead AM, 2010, INFECT IMMUN, V78, P1990, DOI 10.1128/IAI.01340-09; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roehrich AD, 2010, INFECT IMMUN, V78, P1682, DOI 10.1128/IAI.00645-09; Scidmore M, 2008, MOL MICROBIOL, V39, P1638; Shen DK, 2010, INFECT IMMUN, V78, P4999, DOI 10.1128/IAI.00470-10; Slepenkin A, 2005, J BACTERIOL, V187, P473, DOI 10.1128/JB.187.2.473-479.2005; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stone CB, 2008, J BACTERIOL, V190, P6580, DOI 10.1128/JB.00761-08; Stone CB, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00021; Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846; van der Goot FG, 2004, J BIOL CHEM, V279, P47792, DOI 10.1074/jbc.M406824200; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997	36	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30220	10.1371/journal.pone.0030220	http://dx.doi.org/10.1371/journal.pone.0030220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272312	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400090
J	van Velzen, R; Weitschek, E; Felici, G; Bakker, FT				van Velzen, Robin; Weitschek, Emanuel; Felici, Giovanni; Bakker, Freek T.			DNA Barcoding of Recently Diverged Species: Relative Performance of Matching Methods	PLOS ONE			English	Article							MOLECULAR MARKERS; FEATURE-SELECTION; IDENTIFICATION; DIPTERA; FISH; CLASSIFICATION; DIVERSITY; SEQUENCES; REVEALS; ASSUMPTION	Recently diverged species are challenging for identification, yet they are frequently of special interest scientifically as well as from a regulatory perspective. DNA barcoding has proven instrumental in species identification, especially in insects and vertebrates, but for the identification of recently diverged species it has been reported to be problematic in some cases. Problems are mostly due to incomplete lineage sorting or simply lack of a 'barcode gap' and probably related to large effective population size and/or low mutation rate. Our objective was to compare six methods in their ability to correctly identify recently diverged species with DNA barcodes: neighbor joining and parsimony (both tree-based), nearest neighbor and BLAST (similarity-based), and the diagnostic methods DNA-BAR, and BLOG. We analyzed simulated data assuming three different effective population sizes as well as three selected empirical data sets from published studies. Results show, as expected, that success rates are significantly lower for recently diverged species (similar to 75%) than for older species (similar to 97%) (P<0.00001). Similarity-based and diagnostic methods significantly outperform tree-based methods, when applied to simulated DNA barcode data (P<0.00001). The diagnostic method BLOG had highest correct query identification rate based on simulated (86.2%) as well as empirical data (93.1%), indicating that it is a consistently better method overall. Another advantage of BLOG is that it offers species-level information that can be used outside the realm of DNA barcoding, for instance in species description or molecular detection assays. Even though we can confirm that identification success based on DNA barcoding is generally high in our data, recently diverged species remain difficult to identify. Nevertheless, our results contribute to improved solutions for their accurate identification.	[van Velzen, Robin; Bakker, Freek T.] Wageningen Univ, Biosystemat Grp, Wageningen, Netherlands; [van Velzen, Robin] Wageningen Univ, Netherlands Ctr Biodivers Naturalis, Sect NHN, Wageningen Branch, Wageningen, Netherlands; [Weitschek, Emanuel; Felici, Giovanni] CNR, Ist Anal Sistemi & Informat Antonio Ruberti, Rome, Italy; [Weitschek, Emanuel] Univ Roma Tre, Dept Informat & Automat, Rome, Italy	Wageningen University & Research; Wageningen University & Research; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Roma Tre University	van Velzen, R (corresponding author), Wageningen Univ, Biosystemat Grp, Wageningen, Netherlands.	robin.vanvelzen@wur.nl	Weitschek, Emanuel/U-7158-2019; van Velzen, Robin/A-1653-2009; FELICI, GIOVANNI/P-4103-2015	Weitschek, Emanuel/0000-0002-8045-2925; van Velzen, Robin/0000-0002-6444-7608; FELICI, GIOVANNI/0000-0003-0544-5407; Bakker, Freek T./0000-0003-0227-6687	NCB Naturalis	NCB Naturalis	This work was supported by the National Herbarium of the Netherlands (now NCB Naturalis). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2011, BARCODE LIFE DATA PO; [Anonymous], 2011, BLOG BARCODING LOGIC; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Armstrong KF, 1997, B ENTOMOL RES, V87, P111, DOI 10.1017/S0007485300027243; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Aveskamp MM, 2009, MOL PLANT PATHOL, V10, P403, DOI [10.1111/J.1364-3703.2009.00540.X, 10.1111/j.1364-3703.2009.00540.x]; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Bastos AD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-26; Bertolazzi P, 2008, COMPUT MATH APPL, V55, P889, DOI 10.1016/j.camwa.2006.12.093; Bertolazzi P, 2010, CH CRC DATA MIN KNOW, P257; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bonferroni CE, 1935, STUDI ONORE PROFESSO, P13; Boykin LM, 2006, B ENTOMOL RES, V96, P457, DOI 10.1079/BER2006438; Bucciarelli G, 2002, J EXP MAR BIOL ECOL, V273, P143, DOI 10.1016/S0022-0981(02)00138-7; Castillo DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-258; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; DasGupa B, 2005, BIOINFORMATICS, V21, P3424, DOI 10.1093/bioinformatics/bti547; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dexter KG, 2010, ECOL MONOGR, V80, P267, DOI 10.1890/09-0267.1; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; EDWARDS AWF, 1963, ANN HUM GENET, V27, P104; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Felici G, 2002, INFORMS J COMPUT, V14, P20, DOI 10.1287/ijoc.14.1.20.7709; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Griffiths AM, 2010, P ROY SOC B-BIOL SCI, V277, P1497, DOI 10.1098/rspb.2009.2111; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hsieh CH, 2007, ENVIRON ENTOMOL, V36, P952, DOI 10.1603/0046-225X(2007)36[952:EFMMAP]2.0.CO;2; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hudson R, 1990, OXFORD SURVEY EVOLUT, V7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kaila L, 2006, ZOOTAXA, P1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kuksa P, 2009, BMC BIOINFORMATICS, V10; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Little DP, 2008, CLADISTICS, V24, P97; Little DP, 2011, PLOS ONE, V6; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Maddison WP, 2010, COALESCENCE PACKAGE; Maddison WP, 2010, MESQUITE MODULAR SYS; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; May GE, 2006, MOL ECOL, V15, P1021, DOI 10.1111/j.1365-294X.2006.02814.x; McBride CS, 2009, MOL ECOL, V18, P3639, DOI 10.1111/j.1365-294X.2009.04309.x; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; McKeon SN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-271; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Nolan DV, 2007, VET MICROBIOL, V124, P82, DOI 10.1016/j.vetmic.2007.03.019; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paredes-Esquivel C, 2009, MOL PHYLOGENET EVOL, V50, P141, DOI 10.1016/j.ympev.2008.10.011; Petit N, 2009, J EVOLUTION BIOL, V22, P515, DOI 10.1111/j.1420-9101.2008.01672.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar IN, 2002, J BIOMED INFORM, V35, P111, DOI 10.1016/S1532-0464(02)00504-X; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sarkar IN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014689; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Seo TK, 2010, J MOL EVOL, V71, P250, DOI 10.1007/s00239-010-9380-9; Skoracka A, 2010, B ENTOMOL RES, V100, P263, DOI 10.1017/S0007485309990216; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Van Velzen R, 2009, ZOOTAXA, P53, DOI 10.11646/zootaxa.2197.1.5; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wallman JF, 2001, FORENSIC SCI INT, V120, P60, DOI 10.1016/S0379-0738(01)00426-1; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Weitschek E, 2011, 1107 IASICNR; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; WILCOXON F, 1947, BIOMETRICS, V3, P119, DOI 10.2307/3001946; Yassin A, 2008, MOL ECOL RESOUR, V8, P491, DOI 10.1111/j.1471-8286.2007.02020.x; Yassin A, 2010, MOL PHYLOGENET EVOL, V57, P509, DOI 10.1016/j.ympev.2010.08.020; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619	102	123	135	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30490	10.1371/journal.pone.0030490	http://dx.doi.org/10.1371/journal.pone.0030490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272356	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400134
J	Zhang, Y; Mager, DL				Zhang, Ying; Mager, Dixie L.			Gene Properties and Chromatin State Influence the Accumulation of Transposable Elements in Genes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN GENOME; ENDOGENOUS RETROVIRUSES; INTERSPERSED REPEATS; MAMMALIAN GENOMES; ALU ELEMENTS; EVOLUTION; RETROTRANSPOSITION; DNA; INSERTIONS	Transposable elements (TEs) are mobile DNA sequences found in the genomes of almost all species. By measuring the normalized coverage of TE sequences within genes, we identified sets of genes with conserved extremes of high/low TE density in the genomes of human, mouse and cow and denoted them as 'shared upper/lower outliers (SUOs/SLOs)'. By comparing these outlier genes to the genomic background, we show that a large proportion of SUOs are involved in metabolic pathways and tend to be mammal-specific, whereas many SLOs are related to developmental processes and have more ancient origins. Furthermore, the proportions of different types of TEs within human and mouse orthologous SUOs showed high similarity, even though most detectable TEs in these two genomes inserted after their divergence. Interestingly, our computational analysis of polymerase-II (Pol-II) occupancy at gene promoters in different mouse tissues showed that 60% of tissue-specific SUOs show strong Pol-II binding only in embryonic stem cells (ESCs), a proportion significantly higher than the genomic background (37%). In addition, our analysis of histone marks such as H3K4me3 and H3K27me3 in mouse ESCs also suggest a strong association between TE-rich genes and open-chromatin at promoters. Finally, two independent whole-transcriptome datasets show a positive association between TE density and gene expression level in ESCs. While this study focuses on genes with extreme TE densities, the above results clearly show that the probability of TE accumulation/fixation in mammalian genes is not random and is likely associated with different factors/gene properties and, most importantly, an association between the TE insertion/fixation rate and gene activity status in ES cells.	[Zhang, Ying; Mager, Dixie L.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Zhang, Ying; Mager, Dixie L.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia	Zhang, Y (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	dmager@bccrc.ca		Mager, Dixie/0000-0002-5955-2550	Canadian Institutes of Health Research [10825]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant 10825 to DLM from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca). Core support was provided by the British Columbia Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson DL, 2009, P NATL ACAD SCI USA, V106, P12855, DOI 10.1073/pnas.0901282106; Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Biemont C, 2010, GENETICS, V186, P1085, DOI 10.1534/genetics.110.124180; Black SG, 2010, AM J REPROD IMMUNOL, V64, P255, DOI 10.1111/j.1600-0897.2010.00860.x; Brady T, 2009, GENE DEV, V23, P633, DOI 10.1101/gad.1762309; Brookfield JFY, 2005, NAT REV GENET, V6, P128, DOI 10.1038/nrg1524; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cutter AD, 2005, J MOL EVOL, V61, P733, DOI 10.1007/s00239-004-0243-0; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Fontanillas P, 2007, PLOS GENET, V3, P2256, DOI 10.1371/journal.pgen.0030210; Gasior SL, 2007, GENE, V390, P190, DOI 10.1016/j.gene.2006.08.024; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; Grover D, 2003, MOL BIOL EVOL, V20, P1420, DOI 10.1093/molbev/msg153; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Jjingo D, 2011, GENOME BIOL EVOL; Jjingo D, 2011, GENOME BIOL EVOL, V3, P259, DOI 10.1093/gbe/evr015; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Malik HS, 1998, MOL BIOL EVOL, V15, P1123, DOI 10.1093/oxfordjournals.molbev.a026020; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mortada H, 2010, J MOL EVOL, V71, P180, DOI 10.1007/s00239-010-9376-5; Oldridge M, 1999, AM J HUM GENET, V64, P446, DOI 10.1086/302245; Prudhomme S, 2005, CYTOGENET GENOME RES, V110, P353, DOI 10.1159/000084967; Rebollo R, 2010, GENE, V454, P1, DOI 10.1016/j.gene.2010.01.003; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Sironi M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r120; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; van de Lagemaat LN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r86; Walters RD, 2009, IUBMB LIFE, V61, P831, DOI 10.1002/iub.227; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002046	44	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30158	10.1371/journal.pone.0030158	http://dx.doi.org/10.1371/journal.pone.0030158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272293	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400071
J	Archibald, KM; Kulbe, H; Kwong, J; Chakravarty, P; Temple, J; Chaplin, T; Flak, MB; McNeish, IA; Deen, S; Brenton, JD; Young, BD; Balkwill, F				Archibald, K. M.; Kulbe, H.; Kwong, J.; Chakravarty, P.; Temple, J.; Chaplin, T.; Flak, M. B.; McNeish, I. A.; Deen, S.; Brenton, J. D.; Young, B. D.; Balkwill, F.			Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium	ONCOGENE			English	Article						CXCR4; CXCL12; malignant transformation; high-grade serous ovarian cancer; p53	DNA COPY NUMBER; SEROUS CARCINOMA; GENOMIC ANALYSES; CANCER-CELLS; LOW-GRADE; EXPRESSION; P53; MUTATIONS; BREAST; CXCL12	Early genetic events in the development of high-grade serous ovarian cancer (HGSOC) may define the molecular basis of the profound structural and numerical instability of chromosomes in this disease. To discover candidate genetic changes we sequentially passaged cells from a karyotypically normal hTERT immortalised human ovarian surface epithelial line (IOSE25) resulting in the spontaneous formation of colonies in soft agar. Cell lines transformed ovarian surface epithelium 1 and 4 (TOSE 1 and 4) established from these colonies had an abnormal karyotype and altered morphology, but were not tumourigenic in immunodeficient mice. TOSE cells showed loss of heterozygosity (LOH) at TP53, increased nuclear p53 immunoreactivity and altered expression profile of p53 target genes. The parental IOSE25 cells contained a missense, heterozygous R175H mutation in TP53, whereas TOSE cells had LOH at the TP53 locus with a new R273H mutation at the previous wild-type TP53 allele. Cytogenetic and array CGH analysis of TOSE cells also revealed a focal genomic amplification of CXCR4, a chemokine receptor commonly expressed by HGSOC cells. TOSE cells had increased functional CXCR4 protein and its abrogation reduced epidermal growth factor receptor (EGFR) expression, as well as colony size and number. The CXCR4 ligand, CXCL12, was epigenetically silenced in TOSE cells and its forced expression increased TOSE colony size. TOSE cells had other cytogenetic changes typical of those seen in HGSOC ovarian cancer cell lines and biopsies. In addition, enrichment of CXCR4 pathway in expression profiles from HGSOC correlated with enrichment of a mutated TP53 gene expression signature and of EGFR pathway genes. Our data suggest that mutations in TP53 and amplification of the CXCR4 gene locus may be early events in the development of HGSOC, and associated with chromosomal instability. Oncogene (2012) 31, 4987-4995; doi:10.1038/onc.2011.653; published online 23 January 2012	[Balkwill, F.] Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, London EC1M 6BQ, England; [Archibald, K. M.; Kulbe, H.; Balkwill, F.] Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, London EC1M 6BQ, England; [Kwong, J.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Chakravarty, P.] Bioinformat & Biostat Serv, London, England; [Temple, J.; Brenton, J. D.] Cambridge Res Inst, Li Ka Shing Ctr, Canc Res UK, Funct Genom Ovarian Canc Lab, Cambridge, England; [Flak, M. B.; McNeish, I. A.] Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, London EC1M 6BQ, England; [Deen, S.] Univ Nottingham Hosp, Dept Histopathol, Nottingham NG7 2UH, England; [Chaplin, T.; Young, B. D.] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London EC1M 6BQ, England	University of London; Queen Mary University London; University of London; Queen Mary University London; Chinese University of Hong Kong; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; Queen Mary University London; University of Nottingham; University of London; Queen Mary University London	Balkwill, F (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Canc & Inflammat, Charterhouse Sq, London EC1M 6BQ, England.	f.balkwill@qmul.ac.uk	Flak, Magdalena B/M-7106-2016; Brenton, James D/B-3174-2008; Kwong, Joseph/H-2368-2013; Flak, Magdalena/AAG-5272-2020	Flak, Magdalena B/0000-0002-8238-9835; Brenton, James D/0000-0002-5738-6683; Kwong, Joseph/0000-0002-3380-6882; Flak, Magdalena/0000-0002-8238-9835; chakravarty, probir/0000-0003-1146-8824; McNeish, Iain/0000-0002-9387-7586; Balkwill, Frances/0000-0002-5587-9759	Cancer Research UK; Association for International Cancer Research; HEFCE; Cancer Research UK [15601] Funding Source: researchfish; Medical Research Council [G0601891] Funding Source: researchfish; MRC [G0601891] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Association for International Cancer Research; HEFCE(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Nitzan Rosenfeld and Davina Gale for their expert advice and analysis for the TP53 quantification. We also thank Debra Lillington for karyotyping TOSE cells, and the Genome Centre at Barts and the London School of Medicine and Dentistry for microsatellite analysis. This work was supported by Cancer Research UK, the Association for International Cancer Research and HEFCE.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Ansieau S, 2008, CELL CYCLE, V7, P3659, DOI 10.4161/cc.7.23.7049; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardini MQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-237; Cooke SL, 2010, ONCOGENE, V29, P4905, DOI 10.1038/onc.2010.245; Dimova I, 2009, TUMORI, V95, P357; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Farley J, 2008, CELL RES, V18, P538, DOI 10.1038/cr.2008.52; Flak MB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-175; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GODWIN AK, 1992, J NATL CANCER I, V84, P592, DOI 10.1093/jnci/84.8.592; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jazaeri AA, 2011, NEOPLASIA, V13, P899, DOI 10.1593/neo.11138; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Katoh M, 2010, INT J ONCOL, V36, P415, DOI 10.3892/ijo_00000514; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Kulbe H, 2005, CANCER RES, V65, P10355, DOI 10.1158/0008-5472.CAN-05-0957; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Li NF, 2007, CELL PROLIFERAT, V40, P780, DOI 10.1111/j.1365-2184.2007.00462.x; Maia AT, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2458; Mehra Karishma, 2011, Front Biosci (Elite Ed), V3, P625, DOI 10.2741/e275; Mehta SA, 2007, ONCOGENE, V26, P3329, DOI 10.1038/sj.onc.1210120; Micci F, 2010, J ONCOL, V2010, DOI 10.1155/2010/646340; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Okorokov AL, 2002, CARCINOGENESIS, V23, P549, DOI 10.1093/carcin/23.4.549; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Piek JMJ, 2001, J PATHOL, V195, P451, DOI 10.1002/path.1000; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Roh HJ, 2000, CANCER RES, V60, P6496; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Scotton CJ, 2001, CANCER RES, V61, P4961; Scotton CJ, 2002, CANCER RES, V62, P5930; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stoczynska-Fidelus E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-243; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Team RDC, 2008, R FDN STAT COMP; TESTA JR, 1994, CANCER RES, V54, P2778; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2006, ONCOGENE, V25, P4986, DOI 10.1038/sj.onc.1209505; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024	55	13	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	48					4987	4995		10.1038/onc.2011.653	http://dx.doi.org/10.1038/onc.2011.653			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	048CU	22266861	Green Accepted			2022-12-25	WOS:000311888600003
J	Aihara, Y; Yamamoto, T; Okajima, K; Yamamoto, K; Suzuki, T; Tokutomi, S; Tanaka, K; Nagatani, A				Aihara, Yusuke; Yamamoto, Takaharu; Okajima, Koji; Yamamoto, Kazuhiko; Suzuki, Tomomi; Tokutomi, Satoru; Tanaka, Kazuma; Nagatani, Akira			Mutations in N-terminal Flanking Region of Blue Light-sensing Light-Oxygen and Voltage 2 (LOV2) Domain Disrupt Its Repressive Activity on Kinase Domain in the Chlamydomonas Phototropin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT PHOTORECEPTOR DOMAIN; J-ALPHA HELIX; PHOSPHOLIPID TRANSLOCATION; ARABIDOPSIS PHOTOTROPIN-1; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; BINDING DOMAINS; RECEPTOR; ROLES; NPL1	Phototropin is a light-regulated kinase that mediates a variety of photoresponses such as phototropism, chloroplast positioning, and stomata opening in plants to increase the photosynthetic efficiency. Blue light stimulus first induces local conformational changes in the chromophore-bearing light-oxygen and voltage 2 (LOV2) domain of phototropin, which in turn activates the serine/threonine (Ser/Thr) kinase domain in the C terminus. To examine the kinase activity of full-length phototropin conventionally, we employed the budding yeast Saccharomyces cerevisiae. In this organism, Ser/Thr kinases (Fpk1p and Fpk2p) that show high sequence similarity to the kinase domain of phototropins exist. First, we demonstrated that the phototropin from Chlamydomonas reinhardtii (CrPHOT) could complement loss of Fpk1p and Fpk2p to allow cell growth in yeast. Furthermore, this reaction was blue light-dependent, indicating that CrPHOT was indeed light-activated in yeast cells. We applied this system to a large scale screening for amino acid substitutions in CrPHOT that elevated the kinase activity in darkness. Consequently, we identified a cluster of mutations located in the N-terminal flanking region of LOV2 (R199C, L202L, D203N/G/V, L204P, T207I, and R210H). An in vitro phosphorylation assay confirmed that these mutations substantially reduced the repressive activity of LOV2 on the kinase domain in darkness. Furthermore, biochemical analyses of the representative T207I mutant demonstrated that the mutation affected neither spectral nor multimerization properties of CrPHOT. Hence, the N-terminal flanking region of LOV2, as is the case with the C-terminal flanking J alpha region, appears to play a crucial role in the regulation of kinase activity in phototropin.	[Aihara, Yusuke; Yamamoto, Kazuhiko; Suzuki, Tomomi; Nagatani, Akira] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan; [Yamamoto, Takaharu; Tanaka, Kazuma] Hokkaido Univ, Grad Sch Life Sci, Inst Med Genet, Div Mol Interact, Sapporo, Hokkaido 0600815, Japan; [Okajima, Koji; Tokutomi, Satoru] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5998531, Japan	Kyoto University; Hokkaido University; Osaka Metropolitan University	Nagatani, A (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto 6068502, Japan.	nagatani@physiol.bot.kyoto-u.ac.jp	Tanaka, Kazuma/A-4240-2012	Suzuki, Tomomi/0000-0003-0935-5505	Ministry of Education, Culture, Sports, Science, and Technology, Japan [17084002, 22120002]; Japan Society for the Promotion of Science [21370020, 22.1094]; Grants-in-Aid for Scientific Research [22120005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported Grant-in-aid for Scientific Research on Priority Areas 17084002 (to A.N.), Grant-in-aid for Scientific Research on Innovative Areas 22120002 (to A.N.), a Grant-in-aid for the Global COE (Center of Excellence) Program "Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem" (to A.N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, Grant-in-aid for Scientific Research (B) 21370020 (to A.N.), and Research Fellowship 22.1094 from the Japan Society for the Promotion of Science (to Y.A.).	Chen EF, 2007, BIOCHEMISTRY-US, V46, P4619, DOI 10.1021/bi602544n; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 2007, BIOCHEMISTRY-US, V46, P9310, DOI 10.1021/bi700852w; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Guo HM, 2005, BIOPHYS J, V89, P402, DOI 10.1529/biophysj.104.058230; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Huang KY, 2003, P NATL ACAD SCI USA, V100, P6269, DOI 10.1073/pnas.0931459100; Im CS, 2006, PLANT J, V48, P1, DOI 10.1111/j.1365-313X.2006.02852.x; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Jones MA, 2008, PLANT SIGNAL BEHAV, V3, P44, DOI 10.4161/psb.3.1.4848; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kong SG, 2007, PLANT J, V51, P862, DOI 10.1111/j.1365-313X.2007.03187.x; Kong SG, 2006, PLANT J, V45, P994, DOI 10.1111/j.1365-313X.2006.02667.x; Kozuka T, 2011, PLANT CELL, V23, P3684, DOI 10.1105/tpc.111.085852; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kutta RJ, 2008, CHEMBIOCHEM, V9, P1931, DOI 10.1002/cbic.200800158; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Onodera A, 2005, PLANT CELL PHYSIOL, V46, P367, DOI 10.1093/pcp/pci037; Pfeifer A, 2010, BIOCHEMISTRY-US, V49, P1024, DOI 10.1021/bi9016044; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Rose MD., 1990, METHODS YEAST GENETI; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2004, FEBS LETT, V572, P8, DOI 10.1016/j.febslet.2004.06.081; SIKORSKI RS, 1989, GENETICS, V122, P19; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Yamamoto A, 2009, BIOPHYS J, V96, P2771, DOI 10.1016/j.bpj.2008.12.3924	49	43	43	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9901	9909		10.1074/jbc.M111.324723	http://dx.doi.org/10.1074/jbc.M111.324723			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22291022	Green Published, hybrid			2022-12-25	WOS:000302167200022
J	Hoeppner, CZ; Cheng, N; Ye, RD				Hoeppner, Crystal Zoe; Cheng, Ni; Ye, Richard D.			Identification of a Nuclear Localization Sequence in beta-Arrestin-1 and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; BETA-ADRENERGIC-RECEPTOR; EXPORT SIGNAL; C-SRC; CRYSTAL-STRUCTURE; PORE COMPLEX; ARRESTIN; PROTEIN; ACTIVATION; BINDING	A mounting body of evidence suggests that beta-arrestin-1 plays important roles in the nucleus, but how beta-arrestin-1 enters the nucleus remains unclear because no nuclear import signal has been identified in the beta-arrestins. We sought to characterize the cellular localization of wild type beta-arrestin-1 and a series of N domain mutants to determine the structural basis and functional implications of beta-arrestin-1 nuclear localization. A seven-residue candidate nuclear localization sequence (NLS) was identified based on sequence analysis. Mutation of the NLS led to a loss of beta-arrestin-1 nuclear localization in transfected cells. Exogenous expression of wild type beta-arrestin-1 enhanced the transcriptional activity of nuclear factor kappa B (NF-kappa B) induced by bradykinin, whereas mutation of the NLS reduced this effect by two-thirds relative to wild type controls. Loss of beta-arrestin-1 nuclear localization was accompanied by reduced recruitment of the CREB-binding protein and altered post-translational modification profile of p65/RelA. Further mutational analysis identified Lys(157) within the putative NLS as being critical to nuclear localization of beta-arrestin-1. Substitution of Lys(157) to Ala led to reduced nuclear localization, decreased promoter binding by p65/RelA and decreased IL-1 beta gene transcription. These results demonstrate a critical role for beta-arrestin-1 nuclear localization in scaffolding and transcriptional regulation.	[Hoeppner, Crystal Zoe; Cheng, Ni; Ye, Richard D.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Ye, Richard D.] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Shanghai Jiao Tong University	Ye, RD (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, 835 S Wolcott Ave, Chicago, IL 60612 USA.	yer@uic.edu	Ye, Richard/ABF-2413-2020; Ye, Richard/O-5223-2016	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620	National Institutes of Health [AI033503, HL077806, AI040176]; American Heart Association [0810133Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040176, R56AI033503, R01AI033503, R01AI040176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI033503, HL077806, and AI040176.; Recipient of American Heart Association Predoctoral Fellowship 0810133Z.	Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; CHIDA K, 1992, P NATL ACAD SCI USA, V89, P4290, DOI 10.1073/pnas.89.10.4290; DAVIS LI, 1995, ANNU REV BIOCHEM, V64, P865, DOI 10.1146/annurev.bi.64.070195.004245; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Hahn MA, 2005, ONCOGENE, V24, P6241, DOI 10.1038/sj.onc.1208778; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; KLEINSCHMIDT JA, 1988, EMBO J, V7, P1605, DOI 10.1002/j.1460-2075.1988.tb02986.x; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Leung SW, 2003, J BIOL CHEM, V278, P41947, DOI 10.1074/jbc.M307162200; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Mo W, 2008, MOL CELL, V31, P695, DOI 10.1016/j.molcel.2008.06.017; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009; Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Penela P, 2001, EMBO J, V20, P5129, DOI 10.1093/emboj/20.18.5129; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rojanathammanee L, 2009, MOL PHARMACOL, V75, P855, DOI 10.1124/mol.108.053397; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Taniguchi E, 2002, J BIOL CHEM, V277, P48884, DOI 10.1074/jbc.M206307200; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Truant R, 1999, J BIOL CHEM, V274, P32167, DOI 10.1074/jbc.274.45.32167; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yang M, 2003, MOL PHARMACOL, V64, P447, DOI 10.1124/mol.64.2.447; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	50	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8932	8943		10.1074/jbc.M111.294058	http://dx.doi.org/10.1074/jbc.M111.294058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22267743	Green Published, hybrid			2022-12-25	WOS:000301797800024
J	Gonzalez, RG; Lev, MH; Goldmacher, GV; Smith, WS; Payabvash, S; Harris, GJ; Halpern, EF; Koroshetz, WJ; Camargo, ECS; Dillon, WP; Furie, KL				Gonzalez, R. Gilberto; Lev, Michael H.; Goldmacher, Gregory V.; Smith, Wade S.; Payabvash, Seyedmehdi; Harris, Gordon J.; Halpern, Elkan F.; Koroshetz, Walter J.; Camargo, Erica C. S.; Dillon, William P.; Furie, Karen L.			Improved Outcome Prediction Using CT Angiography in Addition to Standard Ischemic Stroke Assessment: Results from the STOPStroke Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; DIAGNOSTIC-APPROACH; SCORE; MISMATCH; TISSUE; INFARCTION; RISK	Purpose: To improve ischemic stroke outcome prediction using imaging information from a prospective cohort who received admission CT angiography (CTA). Methods: In a prospectively designed study, 649 stroke patients diagnosed with acute ischemic stroke had admission NIH stroke scale scores, noncontrast CT (NCCT), CTA, and 6-month outcome assessed using the modified Rankin scale (mRS) scores. Poor outcome was defined as mRS>2. Strokes were classified as "major'' by the (1) Alberta Stroke Program Early CT Score (ASPECTS+) if NCCT ASPECTS was <= 7; (2) Boston Acute Stroke Imaging Scale (BASIS+) if they were ASPECTS+ or CTA showed occlusion of the distal internal carotid, proximal middle cerebral, or basilar arteries; and (3) NIHSS for scores>10. Results: Of 649 patients, 253 (39.0%) had poor outcomes. NIHSS, BASIS, and age, but not ASPECTS, were independent predictors of outcome. BASIS and NIHSS had similar sensitivities, both superior to ASPECTS (p<0.0001). Combining NIHSS with BASIS was highly predictive: 77.6% (114/147) classified as NIHSS>10/BASIS+ had poor outcomes, versus 21.5% (77/358) with NIHSS <= 10/BASIS- (p<0.0001), regardless of treatment. The odds ratios for poor outcome is 12.6 (95% CI: 7.9 to 20.0) in patients who are NIHSS>10/BASIS+ compared to patients who are NIHSS <= 10/BASIS-; the odds ratio is 5.4 (95% CI: 3.5 to 8.5) when compared to patients who are only NIHSS>10 or BASIS+. Conclusions: BASIS and NIHSS are independent outcome predictors. Their combination is stronger than either instrument alone in predicting outcomes. The findings suggest that CTA is a significant clinical tool in routine acute stroke assessment.	[Gonzalez, R. Gilberto; Lev, Michael H.; Goldmacher, Gregory V.; Payabvash, Seyedmehdi; Harris, Gordon J.; Halpern, Elkan F.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto; Lev, Michael H.; Goldmacher, Gregory V.; Payabvash, Seyedmehdi; Harris, Gordon J.; Halpern, Elkan F.; Camargo, Erica C. S.; Furie, Karen L.] Harvard Univ, Sch Med, Boston, MA USA; [Smith, Wade S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Halpern, Elkan F.] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Koroshetz, Walter J.] Natl Inst Neurol Disorders & Stroke, Bethesda, MD USA; [Camargo, Erica C. S.; Furie, Karen L.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Dillon, William P.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	Gonzalez, RG (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.	rggonzalez@partners.org	Payabvash, Sam/I-1859-2019	Payabvash, Sam/0000-0003-4628-0370; Dillon, William/0000-0002-7222-4615	National Institute of Health Agency for Health Care Policy and Research (AHCPR) [R01 HS11392-01A1]; GE Healthcare; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS011392] Funding Source: NIH RePORTER	National Institute of Health Agency for Health Care Policy and Research (AHCPR); GE Healthcare(General ElectricGE Healthcare); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the National Institute of Health Agency for Health Care Policy and Research (AHCPR), R01 HS11392-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Michael H. Lev has read the journal's policy and has the following conflicts: He receives research support from GE Healthcare, and is Consultant to Co-Axia, GE Healthcare, and Millennium Pharmaceuticals. Otherwise, the other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Calvet D, 2009, STROKE, V40, P187, DOI 10.1161/STROKEAHA.108.515817; Camargo ECS, 2007, RADIOLOGY, V244, P541, DOI 10.1148/radiol.2442061028; Caplan LR, 2004, JAMA-J AM MED ASSOC, V292, P1883, DOI 10.1001/jama.292.15.1883; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; Choi JY, 2006, CEREBROVASC DIS, V22, P384, DOI 10.1159/000094856; Cipriano LE, 2009, AM J NEURORADIOL, V30, P703, DOI 10.3174/ajnr.A1441; Davalos A, 2004, NEUROLOGY, V62, P2187, DOI 10.1212/01.WNL.0000130570.41127.EA; Delgado Almandoz J, 2010, ACUTE ISCHEMIC STROK, P57; Giles MF, 2010, STROKE, V41, P1907, DOI 10.1161/STROKEAHA.110.578971; Ingall TJ, 2004, STROKE, V35, P2418, DOI 10.1161/01.STR.0000140891.70547.56; Johnston KC, 2003, STROKE, V34, P200, DOI 10.1161/01.STR.0000047102.61863.E3; Lev MH, 1999, RADIOLOGY, V213, P150, DOI 10.1148/radiology.213.1.r99oc10150; Lima FO, 2010, AM J NEURORADIOL, V31, P817, DOI 10.3174/ajnr.A1927; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Nabavi DG, 2002, STROKE, V33, P2819, DOI 10.1161/01.STR.0000043074.39077.60; Obach V, 2011, STROKE J CEREBRAL CI; Paciaroni M, 2009, EXPERT OPIN BIOL TH, V9, P773, DOI 10.1517/14712590902991497; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; RANKIN J, 1957, Scott Med J, V2, P200; Rundek T, 2000, NEUROLOGY, V55, P1180, DOI 10.1212/WNL.55.8.1180; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Smith WS, 2006, NEUROCRIT CARE, V4, P14, DOI 10.1385/NCC:4:1:014; Smith WS, 2009, STROKE; Torres-Mozqueda F, 2008, AM J NEURORADIOL, V29, P1111, DOI 10.3174/ajnr.A1000; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	28	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30352	10.1371/journal.pone.0030352	http://dx.doi.org/10.1371/journal.pone.0030352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276182	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100037
J	Zhang, R; Lu, SM; Meng, LS; Min, ZX; Tian, J; Valenzuela, RK; Guo, TW; Tian, LF; Zhao, WX; Ma, J				Zhang, Rui; Lu, Shemin; Meng, Liesu; Min, Zixin; Tian, Juan; Valenzuela, Robert K.; Guo, Tingwei; Tian, Lifang; Zhao, Wenxiang; Ma, Jie			Genetic Evidence for the Association between the Early Growth Response 3 (EGR3) Gene and Schizophrenia	PLOS ONE			English	Article							NMDA RECEPTOR HYPOFUNCTION; TRANSCRIPTION FACTOR; CHINESE POPULATION; BIPOLAR DISORDER; COMMON VARIANTS; GAMMA-SUBUNIT; FAS LIGAND; SUSCEPTIBILITY; EXPRESSION; CALCINEURIN	Recently, two genome scan meta-analysis studies have found strong evidence for the association of loci on chromosome 8p with schizophrenia. The early growth response 3 (EGR3) gene located in chromosome 8p21.3 was also found to be involved in the etiology of schizophrenia. However, subsequent studies failed to replicate this finding. To investigate the genetic role of EGR3 in Chinese patients, we genotyped four SNPs (average interval similar to 2.3 kb) in the chromosome region of EGR3 in 470 Chinese schizophrenia patients and 480 healthy control subjects. The SNP rs35201266 (located in intron 1 of EGR3) showed significant differences between cases and controls in both genotype frequency distribution (P = 0.016) and allele frequency distribution (P = 0.009). Analysis of the haplotype rs35201266-rs3750192 provided significant evidence for association with schizophrenia (P = 0.0012); a significant difference was found for the common haplotype AG (P = 0.0005). Furthermore, significant associations were also found in several other two-, and three-SNP tests of haplotype analyses. The meta-analysis revealed a statistically significant association between rs35201266 and schizophrenia (P = 0.0001). In summary, our study supports the association of EGR3 with schizophrenia in our Han Chinese sample, and further functional exploration of the EGR3 gene will contribute to the molecular basis for the complex network underlying schizophrenia pathogenesis.	[Zhang, Rui; Lu, Shemin; Meng, Liesu; Min, Zixin; Tian, Juan; Tian, Lifang; Zhao, Wenxiang; Ma, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China; [Zhang, Rui; Lu, Shemin; Meng, Liesu; Min, Zixin; Tian, Juan; Tian, Lifang; Zhao, Wenxiang; Ma, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China; [Valenzuela, Robert K.] Univ Arizona, Arizona Hlth Sci Ctr, Tucson, AZ USA; [Guo, Tingwei] Albert Einstein Coll Med, New York, NY USA	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Arizona; University of Arizona Health Sciences; Yeshiva University	Ma, J (corresponding author), Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China.	majie.paper@gmail.com	Lu, Shemin/AAI-6479-2021; Lu, Shemin/M-3350-2018	Lu, Shemin/0000-0002-5535-8320; Lu, Shemin/0000-0001-8250-850X; Zhang, Rui/0000-0002-8664-6915	National Natural Science Foundation of China [30800618]; Ministry of Education, People's Republic of China [20090201120062]; President Foundation of Xi'an Jiaotong University [XJJ2008005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, People's Republic of China(Ministry of Education, China); President Foundation of Xi'an Jiaotong University	This study was supported by funding from the National Natural Science Foundation of China (No. 30800618), the Ministry of Education, People's Republic of China (No. 20090201120062), and the President Foundation of Xi'an Jiaotong University (No. XJJ2008005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts M, 2009, ARCH GEN PSYCHIAT, V66, P828, DOI 10.1001/archgenpsychiatry.2009.82; Ashe PC, 2001, PROG NEURO-PSYCHOPH, V25, P691, DOI 10.1016/S0278-5846(01)00159-2; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Bian L, 2005, BIOL PSYCHIAT, V58, P731, DOI 10.1016/j.biopsych.2005.05.013; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; du Bois TM, 2007, BRAIN RES REV, V53, P260, DOI 10.1016/j.brainresrev.2006.09.001; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Gallitano-Mendel A, 2008, NEUROPSYCHOPHARMACOL, V33, P1266, DOI 10.1038/sj.npp.1301505; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Guo AY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-10; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Hildeman DA, 2003, J CLIN INVEST, V111, P575, DOI 10.1172/JCI200318007; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; Jacobson C, 2004, P NATL ACAD SCI USA, V101, P12218, DOI 10.1073/pnas.0404240101; Kim SH, 2010, AM J MED GENET B, V153B, P1355, DOI 10.1002/ajmg.b.31115; Kyogoku C, 2011, PSYCHIAT RES, V185, P16, DOI 10.1016/j.psychres.2009.11.003; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Liu BC, 2010, PROG NEURO-PSYCHOPH, V34, P506, DOI 10.1016/j.pnpbp.2010.02.005; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lohoff FW, 2008, NEUROPSYCHOBIOLOGY, V57, P55, DOI 10.1159/000129668; Ma J, 2006, MOL PSYCHIATR, V11, P479, DOI 10.1038/sj.mp.4001788; Ma X, 2011, GENES BRAIN BEHAV; Mansour HA, 2009, BIPOLAR DISORD, V11, P701, DOI 10.1111/j.1399-5618.2009.00756.x; Mexal S, 2005, MOL BRAIN RES, V139, P317, DOI 10.1016/j.molbrainres.2005.06.006; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Nieratschker Vanessa, 2010, Front Behav Neurosci, V4, P23, DOI 10.3389/fnbeh.2010.00023; O'Donovan KJ, 2000, J NEUROCHEM, V75, P1352, DOI 10.1046/j.1471-4159.2000.0751352.x; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Roberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200; Roberts DS, 2005, P NATL ACAD SCI USA, V102, P11894, DOI 10.1073/pnas.0501434102; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; SHAM PC, 1994, ACTA PSYCHIAT SCAND, V89, P135, DOI 10.1111/j.1600-0447.1994.tb01501.x; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Tabares-Seisdedos R, 2009, MOL PSYCHIATR, V14, P563, DOI 10.1038/mp.2009.2; Wang XY, 2004, BIOCHEM BIOPH RES CO, V319, P1281, DOI 10.1016/j.bbrc.2004.05.119; Wong J, 2010, NEUROSCIENCE, V169, P1071, DOI 10.1016/j.neuroscience.2010.05.037; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104; Yamada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020468; Yamagata K, 1994, Learn Mem, V1, P140; Zhang FY, 2011, BIOL PSYCHIAT, V69, P914, DOI 10.1016/j.biopsych.2011.01.003; Zhang R, 2011, MOL PSYCHIATR, V16, P360, DOI 10.1038/mp.2010.55; Zhang R, 2010, PSYCHIAT RES, V180, P5, DOI 10.1016/j.psychres.2010.04.037	61	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30237	10.1371/journal.pone.0030237	http://dx.doi.org/10.1371/journal.pone.0030237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276163	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100027
J	Chhabra, S; Dolezal, O; Collins, BM; Newman, J; Simpson, JS; Macreadie, IG; Fernley, R; Peat, TS; Swarbrick, JD				Chhabra, Sandeep; Dolezal, Olan; Collins, Brett M.; Newman, Janet; Simpson, Jamie S.; Macreadie, Ian G.; Fernley, Ross; Peat, Thomas S.; Swarbrick, James D.			Structure of S. aureus HPPK and the Discovery of a New Substrate Site Inhibitor	PLOS ONE			English	Article							COLI 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE; THERMAL SHIFT ASSAYS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; DRUG DISCOVERY; CONFORMATIONAL TRANSITIONS; BIOLOGICAL MACROMOLECULES; DIPOLAR COUPLINGS	The first structural and biophysical data on the folate biosynthesis pathway enzyme and drug target, 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (SaHPPK), from the pathogen Staphylococcus aureus is presented. HPPK is the second essential enzyme in the pathway catalysing the pyrophosphoryl transfer from cofactor (ATP) to the substrate (6-hydroxymethyl-7,8-dihydropterin, HMDP). In-silico screening identified 8-mercaptoguanine which was shown to bind with an equilibrium dissociation constant, K-d, of similar to 13 mu M as measured by isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR). An IC50 of similar to 41 mu M was determined by means of a luminescent kinase assay. In contrast to the biological substrate, the inhibitor has no requirement for magnesium or the ATP cofactor for competitive binding to the substrate site. The 1.65 angstrom resolution crystal structure of the inhibited complex showed that it binds in the pterin site and shares many of the key intermolecular interactions of the substrate. Chemical shift and N-15 heteronuclear NMR measurements reveal that the fast motion of the pterin-binding loop (L2) is partially dampened in the SaHPPK/HMDP/alpha,beta-methylene adenosine 5'-triphosphate (AMPCPP) ternary complex, but the ATP loop (L3) remains mobile on the mu s-ms timescale. In contrast, for the SaHPPK/8-mercaptoguanine/AMPCPP ternary complex, the loop L2 becomes rigid on the fast timescale and the L3 loop also becomes more ordered - an observation that correlates with the large entropic penalty associated with inhibitor binding as revealed by ITC. NMR data, including N-15-H-1 residual dipolar coupling measurements, indicate that the sulfur atom in the inhibitor is important for stabilizing and restricting important motions of the L2 and L3 catalytic loops in the inhibited ternary complex. This work describes a comprehensive analysis of a new HPPK inhibitor, and may provide a foundation for the development of novel antimicrobials targeting the folate biosynthetic pathway.	[Chhabra, Sandeep; Simpson, Jamie S.; Swarbrick, James D.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Chhabra, Sandeep; Dolezal, Olan; Newman, Janet; Fernley, Ross; Peat, Thomas S.] CSIRO, Div Engn & Mat Sci, Parkville, Vic, Australia; [Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Macreadie, Ian G.] RMIT Univ, Sch Appl Sci, Bundoora, Vic, Australia	Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Royal Melbourne Institute of Technology (RMIT)	Chhabra, S (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	j.swarbrick@monash.edu	Simpson, Jamie S/A-1700-2012; Macreadie, Ian/L-4437-2019; Macreadie, Ian G/F-5997-2010; Dolezal, Olan/E-1691-2015; Macreadie, Ian/Q-7430-2019; Newman, Janet M/D-1857-2011; Peat, Thomas S/F-9817-2010; Chhabra, Sandeep/T-5468-2018; Collins, Brett/J-1563-2014; Simpson, Jamie/ABC-7083-2020; chhabra, sandeep/R-9942-2017	Simpson, Jamie S/0000-0002-8894-422X; Macreadie, Ian G/0000-0001-5335-7220; Macreadie, Ian/0000-0001-5335-7220; Newman, Janet M/0000-0003-2666-3219; Peat, Thomas S/0000-0002-6488-0831; Chhabra, Sandeep/0000-0002-5225-1333; Collins, Brett/0000-0002-6070-3774; Simpson, Jamie/0000-0002-8894-422X; DOLEZAL, OLAN/0000-0002-5823-6978	Australian Research Council [FT100100027]	Australian Research Council(Australian Research Council)	Brett Collins is supported by an Australian Research Council Future Fellowship (FT100100027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra M, 2004, ANN PHARMACOTHER, V38, P338, DOI 10.1345/aph.1D156; [Anonymous], 2011, LIGPREP VERS 2 3; [Anonymous], 2005, ROCS VERS 2 1 1; Bagby S, 1997, J BIOMOL NMR, V10, P279, DOI 10.1023/A:1018359305544; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Bermingham A, 2000, J BIOL CHEM, V275, P17962, DOI 10.1074/jbc.M000331200; Besier S, 2008, J CLIN MICROBIOL, V46, P3829, DOI 10.1128/JCM.01440-08; Black MT, 2005, ADV DRUG DELIVER REV, V57, P1528, DOI 10.1016/j.addr.2005.04.006; Blaszczyk J, 2004, STRUCTURE, V12, P467, DOI 10.1016/j.str.2004.02.003; Blaszczyk J, 2004, BIOCHEMISTRY-US, V43, P1469, DOI 10.1021/bi036053l; Blaszczyk J, 2003, BIOCHEMISTRY-US, V42, P1573, DOI 10.1021/bi0267994; Blaszczyk J, 2000, STRUCTURE, V8, P1049, DOI 10.1016/S0969-2126(00)00502-5; Blaszczyk J, 2007, ACTA CRYSTALLOGR D, V63, P1169, DOI 10.1107/S0907444907047452; Chhabra S, 2010, ACTA CRYSTALLOGR F, V66, P575, DOI 10.1107/S1744309110010857; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derrick JR, 2008, VITAM HORM, V79, P411, DOI 10.1016/S0083-6729(08)00415-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Frey KM, 2009, J MOL BIOL, V387, P1298, DOI 10.1016/j.jmb.2009.02.045; Garcon A, 2006, J MOL BIOL, V360, P644, DOI 10.1016/j.jmb.2006.05.038; Gibson CL, 2009, ORG BIOMOL CHEM, V7, P1829, DOI 10.1039/b818339b; Goddard T., 2001, SPARKY; GOODMAN MG, 1983, J IMMUNOL, V130, P551; Hennig M, 1999, J MOL BIOL, V287, P211, DOI 10.1006/jmbi.1999.2623; Hevener KE, 2010, J MED CHEM, V53, P166, DOI 10.1021/jm900861d; Hidron AI, 2009, LANCET INFECT DIS, V9, P384, DOI 10.1016/S1473-3099(09)70133-1; Huber W, 2005, J MOL RECOGNIT, V18, P273, DOI 10.1002/jmr.744; Kalra Sukirti, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-8; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawrence MC, 2005, J MOL BIOL, V348, P655, DOI 10.1016/j.jmb.2005.03.021; Lescop E, 2009, BIOCHEMISTRY-US, V48, P302, DOI 10.1021/bi8016262; Li GY, 2006, BIOCHEMISTRY-US, V45, P12573, DOI 10.1021/bi061057m; Li Y, 2002, BIOCHEMISTRY-US, V41, P8777, DOI 10.1021/bi025968h; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; MICHAEL MA, 1993, J MED CHEM, V36, P3431, DOI 10.1021/jm00074a025; MILLER RL, 1972, BIOCHEMISTRY-US, V11, P4723, DOI 10.1021/bi00775a014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszka DG, 1997, BIOPHYS CHEM, V64, P127, DOI 10.1016/S0301-4622(96)02230-2; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Papalia G, 2010, ANAL BIOCHEM, V403, P30, DOI 10.1016/j.ab.2010.03.044; Pemble CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014165; Proctor RA, 2008, CLIN INFECT DIS, V46, P584, DOI 10.1086/525536; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Shi GB, 2000, BBA-PROTEIN STRUCT M, V1478, P289, DOI 10.1016/S0167-4838(00)00043-1; Shi GB, 2001, J MED CHEM, V44, P1364, DOI 10.1021/jm0004493; Stammers DK, 1999, FEBS LETT, V456, P49, DOI 10.1016/S0014-5793(99)00860-1; STOECKLER JD, 1982, BIOCHEM PHARMACOL, V31, P163, DOI 10.1016/0006-2952(82)90206-4; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Swarbrick J., 2008, OPEN ENZYM INHIB J, V1, P12, DOI [10.2174/1874940200801010012, DOI 10.2174/1874940200801010012]; Swarbrick JD, 2005, J BIOL CHEM, V280, P8471, DOI 10.1074/jbc.M412318200; TALARICO TL, 1991, J BACTERIOL, V173, P7029, DOI 10.1128/jb.173.21.7029-7032.1991; Talluri S, 1996, J MAGN RESON SER B, V112, P200, DOI 10.1006/jmrb.1996.0132; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Xiao B, 1999, STRUCTURE, V7, P489, DOI 10.1016/S0969-2126(99)80065-3; Zander J, 2010, ANTIMICROB AGENTS CH, V54, P1226, DOI 10.1128/AAC.00705-09; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	71	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29444	10.1371/journal.pone.0029444	http://dx.doi.org/10.1371/journal.pone.0029444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276115	gold, Green Published, Green Submitted			2022-12-25	WOS:000301457200013
J	Haeri, M; Knox, BE				Haeri, Mohammad; Knox, Barry E.			Rhodopsin Mutant P23H Destabilizes Rod Photoreceptor Disk Membranes	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; OUTER SEGMENT MEMBRANES; TRANSGENE EXPRESSION; MODEL; PROTEIN; CELLS; DEGENERATION; DEATH; MICE; RAT	Mutations in rhodopsin cause retinitis pigmentosa in humans and retinal degeneration in a multitude of other animals. We utilized high-resolution live imaging of the large rod photoreceptors from transgenic frogs (Xenopus) to compare the properties of fluorescently tagged rhodopsin, Rho-EGFP, and Rho(P23H)-EGFP. The mutant was abnormally distributed both in the inner and outer segments (OS), accumulating in the OS to a concentration of similar to 0.1% compared to endogenous opsin. Rho(P23H)-EGFP formed dense fluorescent foci, with concentrations of mutant protein up to ten times higher than other regions. Wild-type transgenic Rho-EGFP did not concentrate in OS foci when co-expressed in the same rod with Rho P23H EGFP. Outer segment regions containing fluorescent foci were refractory to fluorescence recovery after photobleaching, while foci in the inner segment exhibited recovery kinetics similar to OS regions without foci and Rho-EGFP. The Rho P23H EGFP foci were often in older, more distal OS disks. Electron micrographs of OS revealed abnormal disk membranes, with the regular disk bilayers broken into vesiculotubular structures. Furthermore, we observed similar OS disturbances in transgenic mice expressing Rho(P23H), suggesting such structures are a general consequence of mutant expression. Together these results show that mutant opsin disrupts OS disks, destabilizing the outer segment possibly via the formation of aggregates. This may render rods susceptible to mechanical injury or compromise OS function, contributing to photoreceptor loss.	[Haeri, Mohammad] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Ctr Vis Res, Syracuse, NY USA; SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Ctr Vis Res, Syracuse, NY USA; SUNY Upstate Med Univ, Dept Ophthalmol, Ctr Vis Res, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Haeri, M (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Ctr Vis Res, Syracuse, NY USA.	knoxb@upstate.edu			National Institutes of Health [EY-11256, EY-12975]; Research to Prevent Blindness (Unrestricted Grant to State University of New York; Upstate Medical University, Department of Ophthalmology; Fight For Sight, and Lions of Central New York; NATIONAL EYE INSTITUTE [R01EY012975, R01EY011256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (Unrestricted Grant to State University of New York(Research to Prevent Blindness (RPB)); Upstate Medical University, Department of Ophthalmology; Fight For Sight, and Lions of Central New York; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health Grants EY-11256 and EY-12975 (to BEK), Research to Prevent Blindness (Unrestricted Grant to State University of New York, Upstate Medical University, Department of Ophthalmology), Fight For Sight, and Lions of Central New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batni S, 1996, J BIOL CHEM, V271, P3179, DOI 10.1074/jbc.271.6.3179; Batni S, 2000, METHOD ENZYMOL, V316, P50; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Besharse JC, 1979, LIGHT MEMBRANE BIOGE, P409; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Dillin A, 2011, PHILOS T R SOC B, V366, P94, DOI 10.1098/rstb.2010.0271; Dowling J, 1961, STRUCTURE EYE, P85; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; Galy A, 2005, HUM MOL GENET, V14, P2547, DOI 10.1093/hmg/ddi258; Haeri M, 2011, METHODS MOL IN PRESS; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Mani SS, 2001, J BIOL CHEM, V276, P36557, DOI 10.1074/jbc.M101685200; McKibbin C, 2007, J MOL BIOL, V374, P1309, DOI 10.1016/j.jmb.2007.10.013; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; Petters RM, 1997, NAT BIOTECHNOL, V15, P965, DOI 10.1038/nbt1097-965; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Saliba RS, 2002, J CELL SCI, V115, P2907; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Sullivan LS, 2002, INVEST OPHTH VIS SCI, V47, P3052; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; ULSHAFER RJ, 1986, INVEST OPHTH VIS SCI, V27, P1587; Whitaker SL, 2004, J BIOL CHEM, V279, P49010, DOI 10.1074/jbc.M406080200	34	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30101	10.1371/journal.pone.0030101	http://dx.doi.org/10.1371/journal.pone.0030101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276148	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200033
J	Ostroumova, OS; Efimova, SS; Schagina, LV				Ostroumova, Olga S.; Efimova, Svetlana S.; Schagina, Ludmila V.			Probing Amphotericin B Single Channel Activity by Membrane Dipole Modifiers	PLOS ONE			English	Article							LIPID-BILAYER MEMBRANES; POLYENE ANTIBIOTICS; MOLECULAR-DYNAMICS; H-2 NMR; CHOLESTEROL; PHLORETIN; PERMEABILITY; MODULATION; GRAMICIDIN; STEROL	The effects of dipole modifiers and their structural analogs on the single channel activity of amphotericin B in sterol-containing planar phosphocholine membranes are studied. It is shown that the addition of phloretin in solutions bathing membranes containing cholesterol or ergosterol decreases the conductance of single amphotericin B channels. Quercetin decreases the channel conductance in cholesterol-containing bilayers while it does not affect the channel conductance in ergosterol-containing membranes. It is demonstrated that the insertion of styryl dyes, such as RH 421, RH 237 or RH 160, in bilayers with either cholesterol or ergosterol leads to the increase of the current amplitude of amphotericin B pores. Introduction of 5a-androstan-3b-ol into a membrane-forming solution increases the amphotericin B channel conductance in a concentration-dependent manner. All the effects are likely to be attributed to the influence of the membrane dipole potential on the conductance of single amphotericin B channels. However, specific interactions of some dipole modifiers with polyene-sterol complexes might also contribute to the activity of single amphotericin B pores. It has been shown that the channel dwell time increases with increasing sterol concentration, and it is higher for cholesterol-containing membranes than for bilayers including ergosterol, 6-ketocholestanol, 7-ketocholestanol or 5a-androstan-3b-ol. These findings suggest that the processes of association/dissociation of channel forming molecules depend on the membrane fluidity.	[Ostroumova, Olga S.; Efimova, Svetlana S.; Schagina, Ludmila V.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Ostroumova, OS (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	ostroumova@mail.cytspb.rssi.ru	Efimova, Svetlana S./I-8716-2014; Ostroumova, Olga S./N-8636-2013	Efimova, Svetlana S./0000-0002-2429-2007; Ostroumova, Olga/0000-0002-7312-4579	Russian Foundation for Basic Research [09-04-00883]; Russian State Contract [P1372]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian State Contract	This work was partly supported by: the Russian Foundation for Basic Research (no. 09-04-00883) http://www.rfbr.ru/rffi/ru/; SS-3796.2010.4 http://www.extech.ru;the program "Molecular and Cell Biology" of the Russian Academy of Sciences http://www.molbiol.edu.ru; the Russian State Contract #P1372 (MES, FTP,, SSEPIR..) http://www.kadryedu.ru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN OS, 1976, J GEN PHYSIOL, V67, P749, DOI 10.1085/jgp.67.6.749; ANDREOLI TE, 1974, ANN NY ACAD SCI, V235, P448, DOI 10.1111/j.1749-6632.1974.tb43283.x; Asandei A, 2008, COLLOID SURFACE B, V67, P99, DOI 10.1016/j.colsurfb.2008.08.006; Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Baran M, 2009, BIOPHYS CHEM, V141, P162, DOI 10.1016/j.bpc.2009.01.010; BORISOVA MP, 1986, J MEMBRANE BIOL, V90, P13, DOI 10.1007/BF01869681; BROCKMAN H, 1994, CHEM PHYS LIPIDS, V73, P57, DOI 10.1016/0009-3084(94)90174-0; Busath DD, 1998, BIOPHYS J, V75, P2830, DOI 10.1016/S0006-3495(98)77726-4; Buzon V, 2006, BIOCHEMISTRY-US, V45, P15768, DOI 10.1021/bi060622i; Cladera J, 2003, J PHARM SCI, V92, P1018, DOI 10.1002/jps.10344; CRAVEN PC, 1985, ANTIMICROB AGENTS CH, V27, P868, DOI 10.1128/AAC.27.5.868; Cseh R, 2000, EUR BIOPHYS J BIOPHY, V29, P172, DOI 10.1007/s002490000082; Czub J, 2006, J PHYS CHEM B, V110, P16743, DOI 10.1021/jp061916g; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P30, DOI 10.1016/0005-2736(74)90330-7; Duffin RL, 2003, LANGMUIR, V19, P1439, DOI 10.1021/la025892q; Gabrielska J, 2006, FEBS LETT, V580, P2677, DOI 10.1016/j.febslet.2006.04.021; GAWRISCH K, 1992, BIOPHYS J, V61, P1213, DOI 10.1016/S0006-3495(92)81931-8; HSUCHEN CC, 1973, ANTIMICROB AGENTS CH, V4, P309, DOI 10.1128/AAC.4.3.309; JORDAN PC, 1983, BIOPHYS J, V41, P189, DOI 10.1016/S0006-3495(83)84419-1; Luchian T, 2006, LANGMUIR, V22, P8452, DOI 10.1021/la0613777; Malev VV, 2002, BIOPHYS J, V82, P1985, DOI 10.1016/S0006-3495(02)75547-1; Malkov DY, 1996, BBA-BIOMEMBRANES, V1278, P197, DOI 10.1016/0005-2736(95)00197-2; MARTY A, 1975, J GEN PHYSIOL, V65, P515, DOI 10.1085/jgp.65.4.515; Matsumori N, 2009, J AM CHEM SOC, V131, P11855, DOI 10.1021/ja9033473; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Neumann A, 2010, J AM CHEM SOC, V132, P18266, DOI 10.1021/ja1074344; Neumann A, 2009, J PHYS CHEM B, V113, P15875, DOI 10.1021/jp905133f; Ostroumova OS, 2007, LANGMUIR, V23, P6889, DOI 10.1021/la7005452; Ostroumova OS, 2011, BBA-BIOMEMBRANES, V1808, P2051, DOI 10.1016/j.bbamem.2011.04.005; Ostroumova OS, 2010, LANGMUIR, V26, P15092, DOI 10.1021/la102691y; Paquet MJ, 2002, CHEM PHYS LIPIDS, V119, P1, DOI 10.1016/S0009-3084(02)00071-3; Passechnik VI, 2002, BIOELECTROCHEMISTRY, V55, P47, DOI 10.1016/S1567-5394(01)00167-0; REYES J, 1983, J MEMBRANE BIOL, V72, P93, DOI 10.1007/BF01870317; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Rokitskaya TI, 1997, BIOPHYS J, V73, P850, DOI 10.1016/S0006-3495(97)78117-7; Severina II, 2001, IUBMB LIFE, V52, P321, DOI 10.1080/152165401317291183; Shigemi A, 2011, INT J ANTIM IN PRESS, P30; SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8; Smondyrev AM, 2001, CHEM PHYS LIPIDS, V112, P31, DOI 10.1016/S0009-3084(01)00160-8; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; THEWALT JL, 1992, BIOPHYS J, V63, P1176, DOI 10.1016/S0006-3495(92)81681-8; Venegas B, 2003, BIOPHYS J, V85, P2323, DOI 10.1016/S0006-3495(03)74656-6; ZHENG C, 1992, BIOPHYS J, V63, P935, DOI 10.1016/S0006-3495(92)81673-9	44	31	38	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30261	10.1371/journal.pone.0030261	http://dx.doi.org/10.1371/journal.pone.0030261			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276169	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200049
J	Walker, BK				Walker, Brian K.			Spatial Analyses of Benthic Habitats to Define Coral Reef Ecosystem Regions and Potential Biogeographic Boundaries along a Latitudinal Gradient	PLOS ONE			English	Article							SOUTHEAST FLORIDA; SPECIES-RICHNESS; ACROPORA-CERVICORNIS; BROWARD COUNTY; NEARSHORE HARDBOTTOM; GEOGRAPHICAL RANGE; BISCAYNE BAY; MARINE; SEAGRASS; FISH	Marine organism diversity typically attenuates latitudinally from tropical to colder climate regimes. Since the distribution of many marine species relates to certain habitats and depth regimes, mapping data provide valuable information in the absence of detailed ecological data that can be used to identify and spatially quantify smaller scale (10 s km) coral reef ecosystem regions and potential physical biogeographic barriers. This study focused on the southeast Florida coast due to a recognized, but understudied, tropical to subtropical biogeographic gradient. GIS spatial analyses were conducted on recent, accurate, shallow-water (0-30 m) benthic habitat maps to identify and quantify specific regions along the coast that were statistically distinct in the number and amount of major benthic habitat types. Habitat type and width were measured for 209 evenly-spaced cross-shelf transects. Evaluation of groupings from a cluster analysis at 75% similarity yielded five distinct regions. The number of benthic habitats and their area, width, distance from shore, distance from each other, and LIDAR depths were calculated in GIS and examined to determine regional statistical differences. The number of benthic habitats decreased with increasing latitude from 9 in the south to 4 in the north and many of the habitat metrics statistically differed between regions. Three potential biogeographic barriers were found at the Boca, Hillsboro, and Biscayne boundaries, where specific shallow-water habitats were absent further north; Middle Reef, Inner Reef, and oceanic seagrass beds respectively. The Bahamas Fault Zone boundary was also noted where changes in coastal morphologies occurred that could relate to subtle ecological changes. The analyses defined regions on a smaller scale more appropriate to regional management decisions, hence strengthening marine conservation planning with an objective, scientific foundation for decision making. They provide a framework for similar regional analyses elsewhere.	Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA	Nova Southeastern University	Walker, BK (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA.	walkerb@nova.edu			National Oceanic and Atmospheric Administration [NA03NOS4260046]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This manuscript is a result of research partially funded by the National Oceanic and Atmospheric Administration Coastal Ocean Program under award NA03NOS4260046 to Nova Southeastern University for the National Coral Reef Institute (NCRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Ashton Kyle G., 2001, Diversity and Distributions, V7, P289, DOI 10.1046/j.1366-9516.2001.00115.x; Austin DF, 1981, SPANISH RIVER PAPERS, V9, P11; Banks KW, 2007, CORAL REEFS, V26, P617, DOI 10.1007/s00338-007-0231-0; Banks KW, 2008, REEF TRACT CONTINENT, P175; Baron RM, 2004, ESTUAR COAST SHELF S, V60, P431, DOI 10.1016/j.ecss.2004.02.002; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Brock JC, 2008, CORAL REEFS, V27, P555, DOI 10.1007/s00338-008-0370-y; Brock JC, 2009, J COASTAL RES, V25, P1, DOI [10.2112/SI53-001.1, 10.2112/S153-001.1]; CALDER DR, 1992, CAN J ZOOL, V70, P1078, DOI 10.1139/z92-151; Cantillo A.Y., 2000, BISCAYNE BAY ENV HIS; Chardon R, 1982, CARTOGR GEOGR INF SC, V9, P47; CHARDON RE, 1978, GEOLOGY, V6, P333, DOI 10.1130/0091-7613(1978)6<333:CBCBBA>2.0.CO;2; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Costa BM, 2009, REMOTE SENS ENVIRON, V113, P1082, DOI 10.1016/j.rse.2009.01.015; CSA International Inc, 2009, EC FUNCT NEARSH HARD; Dahdouh-Guebas Farid, 2002, Environment Development and Sustainability, V4, P93, DOI 10.1023/A:1020887204285; DAWES CJ, 1995, B MAR SCI, V57, P59; Dodge RE, 1987, GROWTH RATE STONY CO; Engle VD, 1999, J BIOGEOGR, V26, P1007, DOI 10.1046/j.1365-2699.1999.00341.x; Finkl CW, 2008, J COASTAL RES, V24, P823, DOI 10.2112/08A-0001.1; Foster G, 2009, J COASTAL RES, V25, P16, DOI [10.2112/SI53-003.1, 10.2112/S153-003.1]; FRANCE R, 1992, AM NAT, V139, P342, DOI 10.1086/285330; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Gilliam DS, 2007, SE FLORIDA CORAL REE; GILMORE MD, 1976, J SEDIMENT PETROL, V46, P519; Ginsburg N. R., 1953, J SEDIMENT PETROL, V23, P85, DOI DOI 10.1306/D4269558-2B26-11D7-8648000102C1865D; Grober-Dunsmore R, 2007, CORAL REEFS, V26, P201, DOI 10.1007/s00338-006-0180-z; Hayden BP, 1976, J BIOGEOGR, V3, P71, DOI DOI 10.2307/3038100; HECK KL, 1979, J BIOGEOGR, V6, P183, DOI 10.2307/3038051; Herren L, 2004, 2 FLOR DEP ENV PROT; HUMM HAROLD J., 1964, BULL MAR SCI GULF CARIBBEAN, V14, P306; HUTCHINS LW, 1947, ECOL MONOGR, V17, P325, DOI 10.2307/1948663; International Hydrographic Organization, 1998, INT HYDR ORG SPEC PU; Jordan L.K.B, 2006, P 10 INT COR REEF S, P1391; Kendall MS, 2008, MAR GEOD, V31, P75, DOI 10.1080/01490410802053617; Kiessling W, 2001, GEOLOGY, V29, P751, DOI 10.1130/0091-7613(2001)029<0751:PSOPR>2.0.CO;2; Kleypas Joan A., 2007, V192, P386; LIDZ BH, 1991, J COASTAL RES, V7, P203; LIGHTY RG, 1978, NATURE, V276, P59, DOI 10.1038/276059a0; Lindeman KC, 1999, FISH B-NOAA, V97, P508; Lirman D, 2003, ESTUARIES, V26, P131, DOI 10.1007/BF02691700; Locarnini R. A., 2006, NOAA ATLAS NESDIS, V61, P182; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Lugo AE, 1999, J BIOGEOGR, V26, P1025, DOI 10.1046/j.1365-2699.1999.00329.x; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Moyer RP, 2003, CORAL REEFS, V22, P447, DOI 10.1007/s00338-003-0334-1; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; National Oceanographic Data Center, 2009, COAST WAT TEMP TABL; ODUM HT, 1957, LIMNOL OCEANOGR, V2, P85, DOI 10.4319/lo.1957.2.2.0085; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pielou E.C., 1979, BIOGEOGRAPHY; Pittman SJ, 2007, ECOL MODEL, V204, P9, DOI 10.1016/j.ecolmodel.2006.12.017; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; RAPOPORT EH, 1994, PHILOS T ROY SOC B, V343, P71, DOI 10.1098/rstb.1994.0009; Richardson LL, 2006, RE S D I PR, V9, P1, DOI 10.1007/1-4020-3968-9_1; Riegl B, 2005, DEV GIS MAPS SE FLOR; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; THORHAUG A, 1981, AMBIO, V10, P295; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Vargas-Angel B, 2006, CORAL REEFS, V25, P110, DOI 10.1007/s00338-005-0070-9; Vargas-Angel B, 2003, CORAL REEFS, V22, P465, DOI 10.1007/s00338-003-0336-z; Veron J.E.N, 1995, CORAL SPACE TIME BIO; VOSS GILBERT L., 1955, BULL MARINE SCI GULF AND CARIBBEAN, V5, P203; Walker BK, 2002, 3D VISUALIZATION COR; Walker BK, 2009, RM069 DEP; Walker BK, 2008, J COASTAL RES, V24, P1138, DOI 10.2112/06-0809.1; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	71	29	29	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30466	10.1371/journal.pone.0030466	http://dx.doi.org/10.1371/journal.pone.0030466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276204	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200065
J	Vermeer, PD; Bell, M; Lee, K; Vermeer, D; Wieking, BG; Bilal, E; Bhanot, G; Drapkin, RI; Ganesan, S; Klingelhutz, AJ; Hendriks, WJ; Lee, J				Vermeer, Paola D.; Bell, Megan; Lee, Kimberly; Vermeer, DanielW.; Wieking, Byrant G.; Bilal, Erhan; Bhanot, Gyan; Drapkin, Ronny I.; Ganesan, Shridar; Klingelhutz, Aloysius J.; Hendriks, Wiljan J.; Lee, Johnh.			ErbB2, EphrinB1, Src Kinase and PTPN13 Signaling Complex Regulates MAP Kinase Signaling in Human Cancers	PLOS ONE			English	Article							HER-2 CODON-655 POLYMORPHISM; HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; HUMAN-BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; CLINICAL-IMPLICATIONS; TRANSMEMBRANE DOMAIN; INVASIVE GROWTH; EXPRESSION	In non-cancerous cells, phosphorylated proteins exist transiently, becoming de-phosphorylated by specific phosphatases that terminate propagation of signaling pathways. In cancers, compromised phosphatase activity and/or expression occur and contribute to tumor phenotype. The non-receptor phosphatase, PTPN13, has recently been dubbed a putative tumor suppressor. It decreased expression in breast cancer correlates with decreased overall survival. Here we show that PTPN13 regulates a new signaling complex in breast cancer consisting of ErbB2, Src, and EphrinB1. To our knowledge, this signaling complex has not been previously described. Co-immunoprecipitation and localization studies demonstrate that EphrinB1, a PTPN13 substrate, interacts with ErbB2. In addition, the oncogenic V660E ErbB2 mutation enhances this interaction, while Src kinase mediates EphrinB1 phosphorylation and subsequent MAP Kinase signaling. Decreased PTPN13 function further enhances signaling. The association of oncogene kinases (ErbB2, Src), a signaling transmembrane ligand (EphrinB1) and a phosphatase tumor suppressor (PTPN13) suggest that EphrinB1 may be a relevant therapeutic target in breast cancers harboring ErbB2-activating mutations and decreased PTPN13 expression.	[Vermeer, Paola D.; Bell, Megan; Lee, Kimberly; Vermeer, DanielW.; Wieking, Byrant G.; Lee, Johnh.] Sanford Res Univ S Dakota, Canc Biol Res Ctr, Sioux Falls, SD USA; [Bilal, Erhan] IBM Res Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY USA; [Bhanot, Gyan] Rutgers State Univ, Piscataway, NJ USA; [Drapkin, Ronny I.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Ganesan, Shridar] Canc Inst New Jersey, New Brunswick, NJ USA; [Klingelhutz, Aloysius J.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Hendriks, Wiljan J.] Raboud Univ Nijmegen Med Ctr, NCMLS, Cell Biol Lab, Nijmegen, Netherlands; [Lee, Johnh.] Sanford Hlth, Dept Otolaryngol Head & Neck Surg, Sioux Falls, SD USA	Sanford Health; International Business Machines (IBM); Rutgers State University New Brunswick; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Iowa; Radboud University Nijmegen; Sanford Health	Vermeer, PD (corresponding author), Sanford Res Univ S Dakota, Canc Biol Res Ctr, Sioux Falls, SD USA.	John.Lee@SanfordHealth.org	Klingelhutz, Aloysius/L-9081-2018; Drapkin, Ronny/E-9944-2016	Klingelhutz, Aloysius/0000-0003-4258-5046; Hendriks, Wiljan/0000-0001-9481-8281; Drapkin, Ronny/0000-0002-6912-6977	National Institutes of Health/National Institute of Dental and Craniofacial Research [7R01DE018386-03]; State of South Dakota [3SB161]	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); State of South Dakota	This work was supported by 7R01DE018386-03 from the National Institutes of Health/National Institute of Dental and Craniofacial Research and the State of South Dakota Translational Cancer sub-award 3SB161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2008, CANCER METAST REV, V27, P205, DOI 10.1007/s10555-008-9114-2; Aguila B, 2007, BRIT J PHARMACOL, V152, P1312, DOI 10.1038/sj.bjp.0707497; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Beevers AJ, 2010, BIOCHEMISTRY-US, V49, P2811, DOI 10.1021/bi902087v; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Dromard M, 2007, CANCER RES, V67, P6806, DOI 10.1158/0008-5472.CAN-07-0513; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI [10.1586/era.10.226, 10.1586/ERA.10.226]; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Glondu-Lassis M, 2010, CANCER RES, V70, P5116, DOI 10.1158/0008-5472.CAN-09-4368; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hoadley KA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-258; Hoover AC, 2009, ONCOGENE, V28, P3960, DOI 10.1038/onc.2009.251; Hoover AC, 2007, ARCH OTOLARYNGOL, V133, P495, DOI 10.1001/archotol.133.5.495; Jahanzeb M, 2008, CLIN BREAST CANCER, V8, P324, DOI 10.3816/CBC.2008.n.037; Kang Y, 1990, Nihon Geka Hokan, V59, P10; Kong L, 2011, MOL CELL BIOCHEM, V348, P11, DOI 10.1007/s11010-010-0632-1; Kruszyna L, 2010, CLIN BIOCHEM, V43, P545, DOI 10.1016/j.clinbiochem.2009.12.016; Lee HS, 2009, MOL BIOL CELL, V20, P124, DOI 10.1091/mbc.E08-06-0662; Lee SH, 2001, HUM PATHOL, V32, P250, DOI 10.1053/hupa.2001.22769; Makarov R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-98; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; MOSS DW, 1976, CLIN CHIM ACTA, V67, P169, DOI 10.1016/0009-8981(76)90256-4; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niu JG, 2009, CARCINOGENESIS, V30, P2053, DOI 10.1093/carcin/bgp265; Oliveras-Ferraros C, 2008, INT J ONCOL, V33, P1165, DOI 10.3892/ijo_00000106; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Papadopoulou E, 2008, NEOPLASMA, V55, P113; Papadopoulou E, 2007, NEOPLASMA, V54, P365; Papadopoulou E, 2010, INT J BIOL MARKER, V25, P126, DOI 10.1177/172460081002500302; PAPEWALIS J, 1991, NUCLEIC ACIDS RES, V19, P5452, DOI 10.1093/nar/19.19.5452-a; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Revillion F, 2009, INT J CANCER, V124, P638, DOI 10.1002/ijc.23989; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Saad F, 2010, CANCER TREAT REV, V36, P177, DOI 10.1016/j.ctrv.2009.11.005; Schenone S, 2010, EXPERT OPIN INV DRUG, V19, P931, DOI 10.1517/13543784.2010.499898; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Song RXD, 2007, ENDOCRINOLOGY, V148, P4091, DOI 10.1210/en.2007-0240; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spanos WC, 2008, J VIROL, V82, P2493, DOI 10.1128/JVI.02188-07; Spanos WC, 2009, ARCH OTOLARYNGOL, V135, P1137, DOI 10.1001/archoto.2009.159; Tanaka M, 2005, EMBO J, V24, P3700, DOI 10.1038/sj.emboj.7600831; Ueda M, 2006, INT J GYNECOL CANCER, V16, P325, DOI 10.1111/j.1525-1438.2006.00349.x; Vogel CL, 2001, ONCOLOGY-BASEL, V61, P37, DOI 10.1159/000055400; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wu CH, 2009, ORAL ONCOL, V45, P579, DOI 10.1016/j.oraloncology.2008.07.018; Xie DW, 2000, J NATL CANCER I, V92, P412, DOI 10.1093/jnci/92.5.412; Xu Z, 2003, J BIOL CHEM, V278, P24767, DOI 10.1074/jbc.M302454200; Yeh SH, 2006, CLIN CANCER RES, V12, P1097, DOI 10.1158/1078-0432.CCR-05-1383; Yehiely F, 2006, TRENDS MOL MED, V12, P537, DOI 10.1016/j.molmed.2006.09.004; Zubor P, 2006, NEOPLASMA, V53, P49	67	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30447	10.1371/journal.pone.0030447	http://dx.doi.org/10.1371/journal.pone.0030447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279592	gold, Green Published			2022-12-25	WOS:000299771900069
J	Wallis, RS; Jakubiec, W; Mitton-Fry, M; Ladutko, L; Campbell, S; Paige, D; Silvia, A; Miller, PF				Wallis, Robert S.; Jakubiec, Wesley; Mitton-Fry, Mark; Ladutko, Lynn; Campbell, Sheldon; Paige, Darcy; Silvia, Annette; Miller, Paul F.			Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide	PLOS ONE			English	Article							BACTERICIDAL ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; DIARYLQUINOLINE TMC207; MULTIDRUG-RESISTANT; MURINE MODEL; PHARMACOKINETICS; TOLERANCE; IMMUNITY	There presently is no rapid method to assess the bactericidal activity of new regimens for tuberculosis. This study examined PNU-100480, TMC207, PA-824, SQ109, and pyrazinamide, singly and in various combinations, against intracellular M. tuberculosis, using whole blood culture (WBA). The addition of 1,25-dihydroxy vitamin D facilitated detection of the activity of TMC207 in the 3-day cultures. Pyrazinamide failed to show significant activity against a PZA-resistant strain (M. bovis BCG), and was not further considered. Low, mid, and high therapeutic concentrations of each remaining drug were tested individually and in a paired checkerboard fashion. Observed bactericidal activity was compared to that predicted by the sum of the effects of individual drugs. Combinations of PNU-100480, TMC207, and SQ109 were fully additive, whereas those including PA-824 were less than additive or antagonistic. The cumulative activities of 2, 3, and 4 drug combinations were predicted based on the observed concentration-activity relationship, published pharmacokinetic data, and, for PNU-100480, published WBA data after oral dosing. The most active regimens, including PNU-100480, TMC207, and SQ109, were predicted to have cumulative activity comparable to standard TB therapy. Further testing of regimens including these compounds is warranted. Measurement of whole blood bactericidal activity can accelerate the development of novel TB regimens.	[Wallis, Robert S.; Mitton-Fry, Mark; Paige, Darcy; Silvia, Annette; Miller, Paul F.] Pfizer Inc, Groton, CT 06340 USA; [Jakubiec, Wesley; Ladutko, Lynn; Campbell, Sheldon] VA Connecticut Healthcare, West Haven, CT USA; [Campbell, Sheldon] Yale Univ, New Haven, CT USA	Pfizer; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Wallis, RS (corresponding author), Pfizer Inc, Groton, CT 06340 USA.	robert.wallis@pfizer.com	Wallis, Robert S/A-8018-2009	Wallis, Robert S/0000-0001-6152-5183; Mitton-Fry, Mark/0000-0002-6715-8836; Jakubiec, Wesley M./0000-0002-5927-8424	Pfizer	Pfizer(Pfizer)	The study was supported by Pfizer, of which some authors are employees and shareholders. All authors jointly undertook study design, data collection, analysis, decision to publish, and preparation of the manuscript.	Ahmad Z, 2011, ANTIMICROB AGENTS CH, V55, P239, DOI 10.1128/AAC.00849-10; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Andries K, 2010, ANTIMICROB AGENTS CH, V54, P4540, DOI 10.1128/AAC.00934-10; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cheon SH, 2002, CLIN DIAGN LAB IMMUN, V9, P901, DOI 10.1128/CDLI.9.4.901-907.2002; Dhillon J, 2010, TUBERCULOSIS, V90, P301, DOI 10.1016/j.tube.2010.07.004; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Ginsberg AM, 2009, ANTIMICROB AGENTS CH, V53, P3720, DOI 10.1128/AAC.00106-09; HAXAIRETHEEUWES, 2011, UN WORLD C LUNG HLTH, V42; Hu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020958; Janulionis E, 2005, INFECT IMMUN, V73, P2595, DOI 10.1128/IAI.73.5.2595-2601.2005; Janulionis E, 2004, ANTIMICROB AGENTS CH, V48, P3133, DOI 10.1128/AAC.48.8.3133-3135.2004; Jia L, 2006, BRIT J PHARMACOL, V147, P476, DOI 10.1038/sj.bjp.0706650; KIM KS, 1987, J ANTIMICROB CHEMOTH, V19, P475, DOI 10.1093/jac/19.4.475; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Mendez S, 2009, ANTIMICROB AGENTS CH, V53, P5114, DOI 10.1128/AAC.01146-09; Reddy VM, 2010, ANTIMICROB AGENTS CH, V54, P2840, DOI 10.1128/AAC.01601-09; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07; Scorpio A, 1997, J CLIN MICROBIOL, V35, P106, DOI 10.1128/JCM.35.1.106-110.1997; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tam VH, 2004, ANTIMICROB AGENTS CH, V48, P4315, DOI 10.1128/AAC.48.11.4315-4321.2004; TASNEEN R, 2011, ANTIMICROB AGENTS CH; TUOMANEN E, 1986, REV INFECT DIS, V8, pS279; Veziris N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017556; Wallis RS, 2011, ANTIMICROB AGENTS CH, V55, P567, DOI 10.1128/AAC.01179-10; Wallis RS, 2003, J INFECT DIS, V187, P270, DOI 10.1086/346053; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; Wallis RS, 1999, ANTIMICROB AGENTS CH, V43, P2600, DOI 10.1128/AAC.43.11.2600; WALLIS RS, 2011, INT WORKSH CLIN PHAR, V4, P19; Williams KN, 2009, ANTIMICROB AGENTS CH, V53, P1314, DOI 10.1128/AAC.01182-08; Williams KN, 2009, AM J RESP CRIT CARE, V180, P371, DOI 10.1164/rccm.200904-0611OC	33	60	63	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30479	10.1371/journal.pone.0030479	http://dx.doi.org/10.1371/journal.pone.0030479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279595	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900072
J	Zhang, J; Chen, FJ; Li, WL; Xiong, Q; Yang, MK; Zheng, P; Li, CY; Pei, JF; Ge, F				Zhang, Jia; Chen, Fangjin; Li, Wenliang; Xiong, Qian; Yang, Mingkun; Zheng, Peng; Li, Chongyang; Pei, Jianfeng; Ge, Feng			14-3-3 zeta Interacts with Stat3 and Regulates Its Constitutive Activation in Multiple Myeloma Cells	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHORYLATION-DEPENDENT BINDING; MM-PBSA METHOD; IN-VIVO; PROSTATE-CANCER; PHOSPHATASE 2A; APOPTOSIS; RAF-1; 14-3-3-PROTEINS; IDENTIFICATION	The 14-3-3 proteins are a family of regulatory signaling molecules that interact with other proteins in a phosphorylation-dependent manner and function as adapter or scaffold proteins in signal transduction pathways. One family member, 14-3-3 zeta, is believed to function in cell signaling, cycle control, and apoptotic death. A systematic proteomic analysis done in our laboratory has identified signal transducers and activators of transcription 3 (Stat3) as a novel 14-3-3 zeta interacting protein. Following our initial finding, in this study, we provide evidence that 14-3-3 zeta interacts physically with Stat3. We further demonstrate that phosphorylation of Stat3 at Ser727 is vital for 14-3-3 zeta interaction and mutation of Ser727 to Alanine abolished 14-3-3 zeta/Stat3 association. Inhibition of 14-3-3 zeta protein expression in U266 cells inhibited Stat3 Ser727 phosphorylation and nuclear translocation, and decreased both Stat3 DNA binding and transcriptional activity. Moreover, 14-3-3 zeta is involved in the regulation of protein kinase C (PKC) activity and 14-3-3 zeta binding to Stat3 protects Ser727 dephosphorylation from protein phosphatase 2A (PP2A). Taken together, our findings support the model that multiple signaling events impinge on Stat3 and that 14-3-3 zeta serves as an essential coordinator for different pathways to regulate Stat3 activation and function in MM cells.	[Zhang, Jia; Xiong, Qian; Yang, Mingkun; Zheng, Peng; Li, Chongyang; Ge, Feng] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Chen, Fangjin; Pei, Jianfeng] Peking Univ, Ctr Theoret Biol, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Li, Wenliang] Tokai Univ, Sch Sci & Technol, Tokyo 151, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Peking University; Tokai University	Zhang, J (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China.	jfpei@pku.edu.cn; gefeng@ihb.ac.cn	Xiong, Qian/O-9468-2019; ge, feng/AGA-6334-2022; Pei, Jianfeng/U-9790-2019; ge, feng/E-9158-2011; Qian, Xiong/R-8785-2018	Xiong, Qian/0000-0002-0547-039X; ge, feng/0000-0002-1032-280X; Pei, Jianfeng/0000-0002-8482-1185; ge, feng/0000-0002-1032-280X; Qian, Xiong/0000-0002-0547-039X	Chinese Academy of Sciences; Japan Society for the Promotion of Science	Chinese Academy of Sciences(Chinese Academy of Sciences); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Hundred Talents Program of the Chinese Academy of Sciences (to FG) and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1995, J BIOL CHEM, V270, P5706, DOI 10.1074/jbc.270.11.5706; Aziz MH, 2010, ONCOGENE, V29, P3100, DOI 10.1038/onc.2010.63; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Brummer T, 2008, EMBO J, V27, P2305, DOI 10.1038/emboj.2008.159; Buettner R, 2002, CLIN CANCER RES, V8, P945; Campanera JM, 2010, MOLECULES, V15, P2730, DOI 10.3390/molecules15042730; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Craft JW, 2005, J BIOMOL NMR, V33, P15, DOI 10.1007/s10858-005-1199-0; Czirjak G, 2008, J BIOL CHEM, V283, P15672, DOI 10.1074/jbc.M800712200; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dhillon AS, 2009, CELL SIGNAL, V21, P1645, DOI 10.1016/j.cellsig.2009.07.001; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Ge F, 2009, J PROTEOME RES, V8, P3006, DOI 10.1021/pr9001004; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; ISOBE T, 1992, FEBS LETT, V308, P121, DOI 10.1016/0014-5793(92)81257-M; Kim JH, 2009, J BIOL CHEM, V284, P35425, DOI 10.1074/jbc.M109.051516; Kuhn B, 2004, J COMPUT CHEM, V25, P1865, DOI 10.1002/jcc.20111; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li XD, 2007, BIOORGAN MED CHEM, V15, P220, DOI 10.1016/j.bmc.2006.09.074; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mora LB, 2002, CANCER RES, V62, P6659; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Ni HY, 2003, BRIT J HAEMATOL, V121, P849, DOI 10.1046/j.1365-2141.2003.04368.x; Niemantsverdriet M, 2008, ONCOGENE, V27, P1315, DOI 10.1038/sj.onc.1210742; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; PARANT MR, 1990, FEBS LETT, V269, P331, DOI 10.1016/0014-5793(90)81187-S; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Podar K, 2007, BLOOD, V109, P1669, DOI 10.1182/blood-2006-08-042747; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rastelli G, 2010, J COMPUT CHEM, V31, P797, DOI 10.1002/jcc.21372; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; TANJI M, 1994, J NEUROCHEM, V63, P1908; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; van der Hoeven PCJ, 2000, BIOCHEM J, V347, P781, DOI 10.1042/0264-6021:3470781; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; WheelerJones CPD, 1996, BIOCHEM J, V315, P41, DOI 10.1042/bj3150041; WILLIAM LJ, 1983, CHEM PHYS J, V79, P926; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yam WK, 2009, J CHEM INF MODEL, V49, P1558, DOI 10.1021/ci8003495; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	63	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29554	10.1371/journal.pone.0029554	http://dx.doi.org/10.1371/journal.pone.0029554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279540	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900018
J	Kim, KS; Cho, CH; Park, EK; Jung, MH; Yoon, KS; Park, HK				Kim, Kyung Sook; Cho, Chang Hoon; Park, Eun Kuk; Jung, Min-Hyung; Yoon, Kyung-Sik; Park, Hun-Kuk			AFM-Detected Apoptotic Changes in Morphology and Biophysical Property Caused by Paclitaxel in Ishikawa and HeLa Cells	PLOS ONE			English	Article							STABILIZING ANTINEOPLASTIC AGENT; TAXOL; ALPHA; ACTIVATION; EXPRESSION; OVARIAN	The apoptosis of cancer cells is associated with changes in the important cell properties including morphology, surface roughness and stiffness. Therefore, the changes in morphology and biophysical properties can be a good way of evaluating the anticancer activity of a drug. This study examined the effect of paclitaxel on the properties of Ishikawa and HeLa cells using atomic force microscopy (AFM), and the relationship between the changes in morphology and the biophysical properties and apoptosis was discussed. The viability and proliferation of the cells were analyzed using the methylthiazol tetrazolium (MTT) method and a TUNEL assay to confirm cellular apoptosis due to a paclitaxel treatment. AFM observations clearly showed the apoptotic morphological and biophysical changes in Ishikawa and HeLa cells. After the paclitaxel treatment, the cell membrane was torn and holed, the surface roughness was increased, and the stiffness was decreased. These changes were observed more apparently after a 24 h treatment and in Ishikawa cells compared to HeLa cells. The MTT and TUNEL assays results revealed the Ishikawa cells to be more sensitive to paclitaxel than HeLa cells and definite apoptosis occurred after a 24 h treatment. These results showed good agreement with the AFM results. Therefore, research on the morphological and biophysical changes by AFM in cancer cells will help to evaluate the anticancer activities of the drugs.	[Kim, Kyung Sook; Park, Hun-Kuk] Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Kim, Kyung Sook; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Seoul, South Korea; [Cho, Chang Hoon; Yoon, Kyung-Sik] Kyung Hee Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Park, Eun Kuk] Kyung Hee Univ, Dept Med Zool, Coll Med, Seoul, South Korea; [Jung, Min-Hyung] Kyung Hee Univ, Div Gynecol Oncol, Coll Med, Seoul, South Korea; [Park, Hun-Kuk] Kyung Hee Univ, Program Med Engn, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Kim, KS (corresponding author), Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea.	sigmoidus@khu.ac.kr	Yoon, KyungSik/AAI-2991-2020	Yoon, KyungSik/0000-0002-2473-4493	Kyung Hee University [KHU-20110093]; Seoul Research and Business Development program [CR070054]	Kyung Hee University; Seoul Research and Business Development program(Seoul RBD program)	This work was supported by a grant from Kyung Hee University in 2011 (KHU-20110093) and the Seoul Research and Business Development program (Grant No. CR070054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTIN PB, 1981, J CELL BIOL, V90, P300, DOI 10.1083/jcb.90.2.300; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BOGDAN C, 1992, J LEUKOCYTE BIOL, V52, P119, DOI 10.1002/jlb.52.1.119; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bour-Dill C, 2000, CYTOMETRY, V39, P16, DOI 10.1002/(SICI)1097-0320(20000101)39:1<16::AID-CYTO4>3.0.CO;2-I; Brito DA, 2008, J CELL BIOL, V182, P623, DOI 10.1083/jcb.200805072; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Francis LW, 2009, BIOL CELL, V101, P481, DOI 10.1042/BC20080189; Ganguly A, 2010, MOL CANCER THER, V9, P2914, DOI 10.1158/1535-7163.MCT-10-0552; Harada T, 2007, FRONT BIOSCI-LANDMRK, V12, P3140, DOI 10.2741/2302; Isabelle A, 1993, CURR BIOL, V5, P900; James L, 1994, CANCER CHEMOTH PHARM, V33, P331; Joo-Young K, 2011, KOREAN J ANAT, V34, P1; KONINGS PNM, 1994, BRAIN RES, V654, P118, DOI 10.1016/0006-8993(94)91577-6; Lee LF, 1996, CANCER RES, V56, P1303; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Moos PJ, 1998, P NATL ACAD SCI USA, V95, P3896, DOI 10.1073/pnas.95.7.3896; Mullins DW, 1997, IMMUNOPHARMACOLOGY, V37, P63, DOI 10.1016/S0162-3109(97)00004-0; Ofir R, 2002, CELL DEATH DIFFER, V9, P636, DOI 10.1038/sj.cdd.4401012; Ohnesorge FM, 1997, BIOPHYS J, V73, P2183, DOI 10.1016/S0006-3495(97)78250-X; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Pineiro D, 2007, EXP CELL RES, V313, P369, DOI 10.1016/j.yexcr.2006.10.020; Schaus SS, 1997, BIOPHYS J, V73, P1205, DOI 10.1016/S0006-3495(97)78153-0; Selimovic D, 2008, CELL SIGNAL, V20, P311, DOI 10.1016/j.cellsig.2007.10.015; Srinivasan R, 2006, LANGMUIR, V22, P8156; Theodoropoulos PA, 1999, CANCER RES, V59, P4625; Volle CB, 2008, LANGMUIR, V24, P8102, DOI 10.1021/la8009354; Wang XP, 2008, MICRON, V39, P1216, DOI 10.1016/j.micron.2008.04.007; Zhou DX, 2008, CELL MOL NEUROBIOL, V28, P895, DOI 10.1007/s10571-008-9267-0	30	80	82	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30066	10.1371/journal.pone.0030066	http://dx.doi.org/10.1371/journal.pone.0030066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272274	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400053
J	Lardy, S; Cohas, A; Desouhant, E; Tafani, M; Allaine, D				Lardy, Sophie; Cohas, Aurelie; Desouhant, Emmanuel; Tafani, Marion; Allaine, Dominique			Paternity and Dominance Loss in Male Breeders: The Cost of Helpers in a Cooperatively Breeding Mammal	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; MARMOT MARMOTA-MARMOTA; REPRODUCTIVE SKEW; ALPINE MARMOTS; SUBORDINATE REPRODUCTION; JULIDOCHROMIS-ORNATUS; INCOMPLETE CONTROL; LAKE TANGANYIKA; MALE PRIMATES; SUCCESS	Paternity insurance and dominance tenure length are two important components of male reproductive success, particularly in species where reproduction is highly skewed towards a few individuals. Identifying the factors affecting these two components is crucial to better understand the pattern of variation in reproductive success among males. In social species, the social context (i.e. group size and composition) is likely to influence the ability of males to secure dominance and to monopolize reproduction. Most studies have analyzed the factors affecting paternity insurance and dominance tenure separately. We use a long term data set on Alpine marmots to investigate the effect of the number of subordinate males on both paternity insurance and tenure of dominant males. We show that individuals which are unable to monopolize reproduction in their family groups in the presence of many subordinate males are likely to lose dominance the following year. We also report that dominant males lose body mass in the year they lose both paternity and dominance. Our results suggest that controlling many subordinate males is energetically costly for dominant males, and those unable to support this cost lose the control over both reproduction and dominance. A large number of subordinate males in social groups is therefore costly for dominant males in terms of fitness.	[Lardy, Sophie; Cohas, Aurelie; Desouhant, Emmanuel; Tafani, Marion; Allaine, Dominique] Univ Lyon 1, CNRS, UMR Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Lardy, S (corresponding author), Univ Lyon 1, CNRS, UMR Biometrie & Biol Evolut 5558, F-69622 Villeurbanne, France.	dominique.allaine@univ-lyon1.fr	DESOUHANT, Emmanuel/A-9537-2013	DESOUHANT, Emmanuel/0000-0003-0317-4463	Agence Nationale de la Recherche (ANR) [ANR-08-BLAN-0214-03]; Centre National de la Recherche Scientique (CNRS); Earthwatch Institute	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Earthwatch Institute	Financial support was received from the Agence Nationale de la Recherche (ANR, project ANR-08-BLAN-0214-03), the Centre National de la Recherche Scientique (CNRS) and Earthwatch Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2003, ANIM BEHAV, V65, P821, DOI 10.1006/anbe.2003.2106; Allaine D, 2004, BEHAV ECOL, V15, P916, DOI 10.1093/beheco/arh096; Allaine D, 2000, BEHAV PROCESS, V51, P21, DOI 10.1016/S0376-6357(00)00116-9; [Anonymous], 2010, R LANG ENV STAT COMP; Arnold W, 1997, ANIM BEHAV, V53, P53, DOI 10.1006/anbe.1996.0277; Awata S, 2005, BEHAV ECOL SOCIOBIOL, V58, P506, DOI 10.1007/s00265-005-0934-6; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bel MC, 1995, CAN J ZOOL, V73, P2065, DOI 10.1139/z95-243; Cant MA, 2000, ANIM BEHAV, V59, P147, DOI 10.1006/anbe.1999.1279; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Clutton-Brock TH, 2010, AM NAT, V176, P664, DOI 10.1086/656492; Cohas A, 2006, BEHAV ECOL SOCIOBIOL, V59, P597, DOI 10.1007/s00265-005-0086-8; Cohas A, 2008, ANIM BEHAV, V76, P87, DOI 10.1016/j.anbehav.2008.01.012; Cohas A, 2009, BIOL LETTERS, V5, P313, DOI 10.1098/rsbl.2008.0760; COWLISHAW G, 1991, ANIM BEHAV, V41, P1045, DOI 10.1016/S0003-3472(05)80642-6; COX DR, 1972, J R STAT SOC B, V34, P187; ELLIS L, 1995, ETHOL SOCIOBIOL, V16, P257, DOI 10.1016/0162-3095(95)00050-U; EMLEN ST, 1982, AM NAT, V119, P40, DOI 10.1086/283889; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hacklander K, 2003, ANIM BEHAV, V65, P1133, DOI 10.1006/anbe.2003.2159; HALEY MP, 1994, ANIM BEHAV, V48, P1249, DOI 10.1006/anbe.1994.1361; Haydock J, 2003, AM NAT, V162, P277, DOI 10.1086/376888; HEG D, 1993, BEHAVIOUR, V126, P247, DOI 10.1163/156853993X00137; Heg D, 2006, ENVIRON BIOL FISH, V76, P265, DOI 10.1007/s10641-006-9032-5; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kalbeisch J, 2002, STAT ANAL FAILURE TI, V5; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Komdeur J, 2001, P ROY SOC B-BIOL SCI, V268, P2103, DOI 10.1098/rspb.2001.1750; Kutsukake N, 2006, BEHAV ECOL SOCIOBIOL, V60, P695, DOI 10.1007/s00265-006-0213-1; Lardy S, 2011, BEHAV ECOL, V22, P120, DOI 10.1093/beheco/arq168; Mitchell JS, 2009, ETHOLOGY, V115, P1162, DOI 10.1111/j.1439-0310.2009.01705.x; Packer C., 1988, P363; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; Rubenstein DR, 2009, AM NAT, V173, P650, DOI 10.1086/597606; Setchell JM, 2006, AM J PHYS ANTHROPOL, V131, P498, DOI 10.1002/ajpa.20478; Sparkman AM, 2011, P ROY SOC B-BIOL SCI, V278, P1381, DOI 10.1098/rspb.2010.1921; Spong GF, 2008, MOL ECOL, V17, P2287, DOI 10.1111/j.1365-294X.2008.03734.x; Steenbeek R, 2000, REPROD SUCCESS STUDI, P153; Therneau T, 2011, SURVIVAL SURVIVAL AN; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P589, DOI 10.1007/s00265-006-0198-9; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666; Young AJ, 2006, P NATL ACAD SCI USA, V103, P12005, DOI 10.1073/pnas.0510038103	49	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29508	10.1371/journal.pone.0029508	http://dx.doi.org/10.1371/journal.pone.0029508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272236	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400015
J	Maher, MC; Alemayehu, W; Lakew, T; Gaynor, BD; Haug, S; Cevallos, V; Keenan, JD; Lietman, TM; Porco, TC				Maher, M. Cyrus; Alemayehu, Wondu; Lakew, Takele; Gaynor, Bruce D.; Haug, Sara; Cevallos, Vicky; Keenan, Jeremy D.; Lietman, Thomas M.; Porco, Travis C.			The Fitness Cost of Antibiotic Resistance in Streptococcus pneumoniae: Insight from the Field	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ANTIMICROBIAL RESISTANCE; PNEUMOCOCCAL CARRIAGE; MACROLIDE RESISTANCE; AZITHROMYCIN; CLINDAMYCIN; PARAMETERS; IMPACT	Background: Laboratory studies have suggested that antibiotic resistance may result in decreased fitness in the bacteria that harbor it. Observational studies have supported this, but due to ethical and practical considerations, it is rare to have experimental control over antibiotic prescription rates. Methods and Findings: We analyze data from a 54-month longitudinal trial that monitored pneumococcal drug resistance during and after biannual mass distribution of azithromycin for the elimination of the blinding eye disease, trachoma. Prescription of azithromycin and antibiotics that can create cross-resistance to it is rare in this part of the world. As a result, we were able to follow trends in resistance with minimal influence from unmeasured antibiotic use. Using these data, we fit a probabilistic disease transmission model that included two resistant strains, corresponding to the two dominant modes of resistance to macrolide antibiotics. We estimated the relative fitness of these two strains to be 0.86 (95% CI 0.80 to 0.90), and 0.88 (95% CI 0.82 to 0.93), relative to antibiotic-sensitive strains. We then used these estimates to predict that, within 5 years of the last antibiotic treatment, there would be a 95% chance of elimination of macrolide resistance by intra-species competition alone. Conclusions: Although it is quite possible that the fitness cost of macrolide resistance is sufficient to ensure its eventual elimination in the absence of antibiotic selection, this process takes time, and prevention is likely the best policy in the fight against resistance.	[Maher, M. Cyrus; Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Alemayehu, Wondu; Lakew, Takele] ORBIS Int, New York, NY USA; [Gaynor, Bruce D.; Haug, Sara; Cevallos, Vicky; Keenan, Jeremy D.; Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Gaynor, Bruce D.; Keenan, Jeremy D.; Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Lietman, Thomas M.; Porco, Travis C.] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Maher, MC (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	travis.porco@ucsf.edu	Keenan, Jeremy David/AAO-5882-2020	Keenan, Jeremy David/0000-0002-7118-1457	International Trachoma Initiative; Bernard Osher Foundation; That Man May See; Peierls Foundation; Bodri Foundation; Harper Inglis Trust; South Asia Research Fund, Research to Prevent Blindness; National Institutes of Health [U10 EY016214, R21 AI 55752]; Gates Exploration Program [OPP1015714]; Modeling Infectious Disease Agents Study [NIH GM 1-R01-GM08778]; NATIONAL EYE INSTITUTE [U10EY016214, K23EY019881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087728] Funding Source: NIH RePORTER	International Trachoma Initiative; Bernard Osher Foundation; That Man May See; Peierls Foundation; Bodri Foundation; Harper Inglis Trust; South Asia Research Fund, Research to Prevent Blindness; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gates Exploration Program; Modeling Infectious Disease Agents Study; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the International Trachoma Initiative, the Bernard Osher Foundation, That Man May See, the Peierls Foundation, the Bodri Foundation, the Harper Inglis Trust, the South Asia Research Fund, Research to Prevent Blindness, grants U10 EY016214 and R21 AI 55752 from the National Institutes of Health, the Gates Exploration Program (OPP1015714) and the Modeling Infectious Disease Agents Study (NIH GM 1-R01-GM08778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Appelbaum PC, 2002, CLIN INFECT DIS, V34, P1613, DOI 10.1086/340400; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; D'Ignazio J, 2005, ANTIMICROB AGENTS CH, V49, P4035, DOI 10.1128/AAC.49.10.4035-4041.2005; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Dagan R, 2008, J INFECT DIS, V197, P1094, DOI 10.1086/528995; Garcia-Rey C, 2002, J CLIN MICROBIOL, V40, P159, DOI 10.1128/JCM.40.1.159-164.2002; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Haug S, 2010, CLIN INFECT DIS, V51, P571, DOI 10.1086/655697; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Isozumi R, 2007, J CLIN MICROBIOL, V45, P1440, DOI 10.1128/JCM.01430-06; Johnston NJ, 1998, ANTIMICROB AGENTS CH, V42, P2425, DOI 10.1128/AAC.42.9.2425; Kristinsson KG, 1997, MICROB DRUG RESIST, V3, P117, DOI 10.1089/mdr.1997.3.117; Levin BR, 2000, GENETICS, V154, P985; Luciani F, 2009, P NATL ACAD SCI USA, V106, P14711, DOI 10.1073/pnas.0902437106; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Melese M, 2004, JAMA-J AM MED ASSOC, V292, P721, DOI 10.1001/jama.292.6.721; Mera R, 2008, MICROB DRUG RESIST, V14, P101, DOI 10.1089/mdr.2008.0782; Paris R, 2008, J CHEMOTHERAPY, V20, P77, DOI 10.1179/joc.2008.20.1.77; Riedel S, 2007, EUR J CLIN MICROBIOL, V26, P485, DOI 10.1007/s10096-007-0321-5; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Sevillano D, 2006, J ANTIMICROB CHEMOTH, V57, P1128, DOI 10.1093/jac/dkl140; Skalet AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000377; Spizek J, 2004, APPL MICROBIOL BIOT, V64, P455, DOI 10.1007/s00253-003-1545-7; Trzcinski K, 2006, J INFECT DIS, V193, P1296, DOI 10.1086/501367; Waites K, 2000, J CLIN MICROBIOL, V38, P1731, DOI 10.1128/JCM.38.5.1731-1734.2000; Zhang QJ, 2006, MICROBES INFECT, V8, P1972, DOI 10.1016/j.micinf.2005.12.031	31	34	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29407	10.1371/journal.pone.0029407	http://dx.doi.org/10.1371/journal.pone.0029407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272234	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400013
J	Puffenberger, EG; Jinks, RN; Sougnez, C; Cibulskis, K; Willert, RA; Achilly, NP; Cassidy, RP; Fiorentini, CJ; Heiken, KF; Lawrence, JJ; Mahoney, MH; Miller, CJ; Nair, DT; Politi, KA; Worcester, KN; Setton, RA; DiPiazza, R; Sherman, EA; Eastman, JT; Francklyn, C; Robey-Bond, S; Rider, NL; Gabriel, S; Morton, DH; Strauss, KA				Puffenberger, Erik G.; Jinks, Robert N.; Sougnez, Carrie; Cibulskis, Kristian; Willert, Rebecca A.; Achilly, Nathan P.; Cassidy, Ryan P.; Fiorentini, Christopher J.; Heiken, Kory F.; Lawrence, Johnny J.; Mahoney, Molly H.; Miller, Christopher J.; Nair, Devika T.; Politi, Kristin A.; Worcester, Kimberly N.; Setton, Roni A.; DiPiazza, Rosa; Sherman, Eric A.; Eastman, James T.; Francklyn, Christopher; Robey-Bond, Susan; Rider, Nicholas L.; Gabriel, Stacey; Morton, D. Holmes; Strauss, Kevin A.			Genetic Mapping and Exome Sequencing Identify Variants Associated with Five Novel Diseases	PLOS ONE			English	Article							POSTERIOR COLUMN ATAXIA; INTERACTING PROTEIN; TRANSFER-RNA; C-MYC; MUTATIONS; DEATH; DOMAIN; SNIP1; IDENTIFICATION; DISCOVERY	The Clinic for Special Children (CSC) has integrated biochemical and molecular methods into a rural pediatric practice serving Old Order Amish and Mennonite (Plain) children. Among the Plain people, we have used single nucleotide polymorphism (SNP) microarrays to genetically map recessive disorders to large autozygous haplotype blocks (mean = 4.4 Mb) that contain many genes (mean = 79). For some, uninformative mapping or large gene lists preclude disease-gene identification by Sanger sequencing. Seven such conditions were selected for exome sequencing at the Broad Institute; all had been previously mapped at the CSC using low density SNP microarrays coupled with autozygosity and linkage analyses. Using between 1 and 5 patient samples per disorder, we identified sequence variants in the known disease-causing genes SLC6A3 and FLVCR1, and present evidence to strongly support the pathogenicity of variants identified in TUBGCP6, BRAT1, SNIP1, CRADD, and HARS. Our results reveal the power of coupling new genotyping technologies to population-specific genetic knowledge and robust clinical data.	[Puffenberger, Erik G.; Rider, Nicholas L.; Morton, D. Holmes; Strauss, Kevin A.] Clin Special Children, Strasburg, PA 17579 USA; [Puffenberger, Erik G.; Jinks, Robert N.; Willert, Rebecca A.; Achilly, Nathan P.; Cassidy, Ryan P.; Fiorentini, Christopher J.; Heiken, Kory F.; Lawrence, Johnny J.; Mahoney, Molly H.; Miller, Christopher J.; Politi, Kristin A.; Worcester, Kimberly N.; Setton, Roni A.; DiPiazza, Rosa; Rider, Nicholas L.; Morton, D. Holmes; Strauss, Kevin A.] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17604 USA; [Puffenberger, Erik G.; Jinks, Robert N.; Willert, Rebecca A.; Achilly, Nathan P.; Cassidy, Ryan P.; Fiorentini, Christopher J.; Heiken, Kory F.; Lawrence, Johnny J.; Mahoney, Molly H.; Miller, Christopher J.; Nair, Devika T.; Politi, Kristin A.; Worcester, Kimberly N.; Setton, Roni A.; DiPiazza, Rosa; Rider, Nicholas L.; Morton, D. Holmes; Strauss, Kevin A.] Franklin & Marshall Coll, Biol Fdn, Behav Program, Lancaster, PA 17604 USA; [Sougnez, Carrie; Cibulskis, Kristian; Gabriel, Stacey] Broad Inst, Boston, MA USA; [Sherman, Eric A.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; [Eastman, James T.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI USA; [Francklyn, Christopher; Robey-Bond, Susan] Univ Vermont, Coll Med, Burlington, VT USA; [Rider, Nicholas L.; Morton, D. Holmes; Strauss, Kevin A.] Lancaster Gen Hosp, Lancaster, PA USA	Franklin & Marshall College; Franklin & Marshall College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Swarthmore College; University of Wisconsin System; University of Wisconsin Madison; University of Vermont	Puffenberger, EG (corresponding author), Clin Special Children, Strasburg, PA 17579 USA.	epuffenberger@clinicforspecialchildren.org	Nair, Devika/GZK-5946-2022; Cibulskis, Kristian/AAC-7380-2019	Cibulskis, Kristian/0000-0003-1343-1582; Politi, Kristin/0000-0002-8974-6727; Setton, Roni/0000-0002-8829-364X; Sherman, Erin/0000-0002-1835-8604; Nair, Devika/0000-0002-7044-9028; Puffenberger, Erik/0000-0002-6388-9148	Howard Hughes Medical Institute; Eyler Endowment for Biochemistry at Franklin & Marshall College; Mr. Sam Lombardo; Franklin & Marshall College; National Human Genome Research Institute of the National Institutes of Health (NIH) [U54 HG003067]; DHM; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054899] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Eyler Endowment for Biochemistry at Franklin & Marshall College; Mr. Sam Lombardo; Franklin & Marshall College; National Human Genome Research Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); DHM; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the following: an award to Franklin & Marshall College from the Howard Hughes Medical Institute's Undergraduate Science Education Program; the Eyler Endowment for Biochemistry at Franklin & Marshall College; Mr. Sam Lombardo; Franklin & Marshall College; grants from the National Human Genome Research Institute of the National Institutes of Health (NIH), U54 HG003067, to the Broad Institute for the Large Scale Sequencing Program; and DHM through a gift from the John D. and Catherine T. MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglipay JA, 2006, J BIOL CHEM, V281, P9710, DOI 10.1074/jbc.M510332200; Ahmad M, 1997, CANCER RES, V57, P615; Anastasio N, 2010, AM J HUM GENET, V87, P553, DOI 10.1016/j.ajhg.2010.09.005; Barzilai A, 2010, APOPTOSIS, V15, P1371, DOI 10.1007/s10495-010-0501-0; Becker J, 2011, AM J HUM GENET; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Berube C, 2005, P NATL ACAD SCI USA, V102, P14314, DOI 10.1073/pnas.0506475102; Bhattacherjee V, 2009, INT J DEV BIOL, V53, P1097, DOI 10.1387/ijdb.072489vb; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Caliskan M, 2011, HUM MOL GENET; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Francklyn C, 2005, AMINOACYL TRNA SYNTH, P135; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fujii M, 2006, MOL CELL, V24, P771, DOI 10.1016/j.molcel.2006.11.006; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Glazer Nicole L, 2011, Circ Cardiovasc Genet, V4, P100, DOI 10.1161/CIRCGENETICS.111.959510; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; Higgins JJ, 1997, NEUROLOGY, V49, P1717, DOI 10.1212/WNL.49.6.1717; Jabado O, 2004, CELL DEATH DIFFER, V11, P618, DOI 10.1038/sj.cdd.4401397; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kim RH, 2001, J BIOL CHEM, V276, P46297, DOI 10.1074/jbc.M103819200; Kim RH, 2000, GENE DEV, V14, P1605; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; MCKUSICK VA, 1966, ARCH OPHTHALMOL-CHIC, V75, P597; MCKUSICK VA, 1964, COLD SPRING HARB SYM, V29, P99, DOI 10.1101/SQB.1964.029.01.015; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P203; MONTENEGRO G, 2011, ANN NEUROL; Morris LGT, 2010, ONCOGENE, V29, P3453, DOI 10.1038/onc.2010.127; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ostergaard P, 2011, J MED GENET; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Puffenberger EG, 2003, AM J MED GENET C, V121C, P18, DOI 10.1002/ajmg.c.20003; Puffenberger EG, 2007, BRAIN, V130, P1929, DOI 10.1093/brain/awm100; Rajadhyaksha AM, 2010, AM J HUM GENET, V87, P643, DOI 10.1016/j.ajhg.2010.10.013; ROE BA, 1975, NUCLEIC ACIDS RES, V2, P21, DOI 10.1093/nar/2.1.21; Shearwin-Whyatt LM, 2000, CELL DEATH DIFFER, V7, P155, DOI 10.1038/sj.cdd.4400632; Sherman EA, 2008, AM J HUM GENET, V83, P604, DOI 10.1016/j.ajhg.2008.09.018; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Strauss KA, 2005, AM J MED GENET A, V138A, P262, DOI 10.1002/ajmg.a.30961; Strauss KA, 2008, CLIN IMMUNOL, V128, P31, DOI 10.1016/j.clim.2008.02.016; Strauss KA, 2009, ANNU REV GENOM HUM G, V10, P513, DOI 10.1146/annurev-genom-082908-150040; Tan ZQ, 2002, BRAIN RES, V929, P129, DOI 10.1016/S0006-8993(01)03360-1; Toyo-oka K, 2004, HUM MOL GENET, V13, P1057, DOI 10.1093/hmg/ddh116; Ueberham U, 2009, INT J DEV NEUROSCI, V27, P501, DOI 10.1016/j.ijdevneu.2009.04.001; Viosca J, 2010, NEUROBIOL DIS, V37, P186, DOI 10.1016/j.nbd.2009.10.001; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wei K, 2007, GENESIS, V45, P382, DOI 10.1002/dvg.20304; Wey A, 2010, ONCOTARGET, V1, P120, DOI 10.18632/oncotarget.116; Yan W, 1996, BIOCHEMISTRY-US, V35, P6559, DOI 10.1021/bi952889f	65	204	221	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e28936	10.1371/journal.pone.0028936	http://dx.doi.org/10.1371/journal.pone.0028936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22279524	gold, Green Published			2022-12-25	WOS:000301454400004
J	Reis, Y; Bernardo-Faura, M; Richter, D; Wolf, T; Brors, B; Hamacher-Brady, A; Eils, R; Brady, NR				Reis, Yara; Bernardo-Faura, Marti; Richter, Daniela; Wolf, Thomas; Brors, Benedikt; Hamacher-Brady, Anne; Eils, Roland; Brady, Nathan R.			Multi-Parametric Analysis and Modeling of Relationships between Mitochondrial Morphology and Apoptosis	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; BAX ACTIVATION; CYTOCHROME-C; LIVING CELLS; MEMBRANE; FUSION; DYNAMICS; FISSION; HETEROGENEITY; FRAGMENTATION	Mitochondria exist as a network of interconnected organelles undergoing constant fission and fusion. Current approaches to study mitochondrial morphology are limited by low data sampling coupled with manual identification and classification of complex morphological phenotypes. Here we propose an integrated mechanistic and data-driven modeling approach to analyze heterogeneous, quantified datasets and infer relations between mitochondrial morphology and apoptotic events. We initially performed high-content, multi-parametric measurements of mitochondrial morphological, apoptotic, and energetic states by high-resolution imaging of human breast carcinoma MCF-7 cells. Subsequently, decision tree-based analysis was used to automatically classify networked, fragmented, and swollen mitochondrial subpopulations, at the single-cell level and within cell populations. Our results revealed subtle but significant differences in morphology class distributions in response to various apoptotic stimuli. Furthermore, key mitochondrial functional parameters including mitochondrial membrane potential and Bax activation, were measured under matched conditions. Data-driven fuzzy logic modeling was used to explore the non-linear relationships between mitochondrial morphology and apoptotic signaling, combining morphological and functional data as a single model. Modeling results are in accordance with previous studies, where Bax regulates mitochondrial fragmentation, and mitochondrial morphology influences mitochondrial membrane potential. In summary, we established and validated a platform for mitochondrial morphological and functional analysis that can be readily extended with additional datasets. We further discuss the benefits of a flexible systematic approach for elucidating specific and general relationships between mitochondrial morphology and apoptosis.	[Reis, Yara; Bernardo-Faura, Marti; Richter, Daniela; Wolf, Thomas; Brors, Benedikt; Hamacher-Brady, Anne; Eils, Roland] Heidelberg Univ, Div Theoret Bioinformat, German Canc Res Ctr, Bioquant, Heidelberg, Germany; [Reis, Yara; Bernardo-Faura, Marti; Richter, Daniela; Wolf, Thomas; Brors, Benedikt; Hamacher-Brady, Anne; Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Bioquant, Heidelberg, Germany; [Brady, Nathan R.] Heidelberg Univ, Dept Surg, Fac Med, D-6900 Heidelberg, Germany; [Wolf, Thomas] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Hannover Medical School	Reis, Y (corresponding author), Heidelberg Univ, Div Theoret Bioinformat, German Canc Res Ctr, Bioquant, Heidelberg, Germany.	r.eils@dkfz.de; n.brady@dkfz.de	Eils, Roland/B-6121-2009; Brors, Benedikt/E-5620-2013; Hamacher-Brady, Anne/G-4268-2013; Brady, Nathan/H-2452-2013	Eils, Roland/0000-0002-0034-4036; Brors, Benedikt/0000-0001-5940-3101; Brady, Nathan/0000-0002-1901-5996; Bernardo-Faura, Marti/0000-0002-8023-3263; Hamacher-Brady, Anne/0000-0001-5042-1338	SBCancer within the Helmholtz Alliance on Systems Biology; Helmholtz Association; The Federal Ministry of Education and Research; ForSys Centre Viroquant [FKZ 0313923]; ENDOCYTE Marie Curie Research Training Network	SBCancer within the Helmholtz Alliance on Systems Biology; Helmholtz Association(Helmholtz Association); The Federal Ministry of Education and Research; ForSys Centre Viroquant; ENDOCYTE Marie Curie Research Training Network(European Commission)	This work was supported through SBCancer within the Helmholtz Alliance on Systems Biology funded by the Initiative and Networking Fund of the Helmholtz Association. RE acknowledges support by the The Federal Ministry of Education and Research funded ForSys Centre Viroquant(FKZ 0313923). NB was supported by a fellowship of the ENDOCYTE Marie Curie Research Training Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bosl WJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-13; Bossy-Wetzelz E, 2003, MITOCHONDRIAL FISSIO, P1; Bouchier-Hayes L, 2008, METHODS, V44, P222, DOI 10.1016/j.ymeth.2007.11.007; Bradham CA, 1998, MOL CELL BIOL, V18, P1; Brady NR, 2004, BIOPHYS J, V87, P2022, DOI 10.1529/biophysj.103.035097; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Cho D-H, 2010, CELL MOL LIFE SCI, P1; Conradt B, 2006, NATURE, V443, P646, DOI 10.1038/443646a; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; FURUYA Y, 1994, CANCER RES, V54, P6167; Ganote CE, 2003, J MOL CELL CARDIOL, V35, P749, DOI 10.1016/S0022-2828(03)00114-7; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Henry-Mowatt J, 2004, ONCOGENE, V23, P2850, DOI 10.1038/sj.onc.1207534; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Korge P, 1999, FEBS, P1; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Kuznetsov AV, 2004, MOL CELL BIOCHEM, V256, P359, DOI 10.1023/B:MCBI.0000009881.01943.68; Lamprecht MR, 2007, BIOTECHNIQUES, V12, P379; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liaw A, 2002, FOREST, V2, P1; Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8; Metivier D, 1998, IMMUNOL LETT, V61, P157, DOI 10.1016/S0165-2478(98)00013-3; Minamikawa T, 1999, EXP CELL RES, V246, P26, DOI 10.1006/excr.1998.4290; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; PENEFSKY HS, 1985, P NATL ACAD SCI USA, V82, P1589, DOI 10.1073/pnas.82.6.1589; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rizzuto, 1990, NUCLEIC ACIDS RES, V18, P1; Rizzuto R, 1998, SCIENCE, P1; Sauvanet C, 2010, SEMINARS CELL DEV BI, P1; Scarlett JL, 2000, FEBS LETT, V475, P267, DOI 10.1016/S0014-5793(00)01681-1; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shimizu T, 1997, LEUKEMIA, V11, P1238, DOI 10.1038/sj.leu.2400734; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Toescu EC, 2000, PFLUG ARCH EUR J PHY, V440, P941, DOI 10.1007/s004240000390; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Ubeyli ED, 2009, J MED SYST, V33, P353, DOI 10.1007/s10916-008-9197-x; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Wang XD, 2001, GENE DEV, V15, P2922; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2005, DEV CELL, V8, P298, DOI 10.1016/j.devcel.2005.02.003	71	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e28694	10.1371/journal.pone.0028694	http://dx.doi.org/10.1371/journal.pone.0028694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272225	Green Submitted, gold, Green Published			2022-12-25	WOS:000301454400003
J	Shin, YJ; Kim, JH				Shin, Yong Jae; Kim, Jeong-Ho			The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells	PLOS ONE			English	Article							GROUP PROTEIN EZH2; TISSUE INHIBITOR; TUMOR-GROWTH; HISTONE METHYLTRANSFERASE; DNA METHYLATION; BREAST-CANCER; EXPRESSION; POLYCOMB; METASTASIS; INVASION	Degradation of the extracellular matrix (ECM), a critical step in cancer metastasis, is determined by the balance between MMPs (matrix metalloproteinases) and their inhibitors TIMPs (tissue inhibitors of metalloproteinases). In cancer cells, this balance is shifted towards MMPs, promoting ECM degradation. Here, we show that EZH2 plays an active role in this process by repressing the expression of TIMP2 and TIMP3 in prostate cancer cells. The TIMP genes are derepressed by knockdown of EZH2 expression in human prostate cancer cells but repressed by overexpression of EZH2 in benign human prostate epithelial cells. EZH2 catalyzes H3K27 trimethylation and subsequent DNA methylation of the TIMP gene promoters. Overexpression of EZH2 confers an invasive phenotype on benign prostate epithelial cells; however, this phenotype is suppressed by cooverexpression of TIMP3. EZH2 knockdown markedly reduces the proteolytic activity of MMP-9, thereby decreasing the invasive activity of prostate cancer cells. These results suggest that the transcriptional repression of the TIMP genes by EZH2 may be a major mechanism to shift the MMPs/TIMPs balance in favor of MMP activity and thus to promote ECM degradation and subsequent invasion of prostate cancer cells.	[Shin, Yong Jae; Kim, Jeong-Ho] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	George Washington University	Shin, YJ (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmjxk@gwu.edu	Shin, Yong Jae/A-3102-2012		National Institute of General Medical Sciences, the National Institute of Health [GM087470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087470] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, the National Institute of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant GM087470 (J-HK) from the National Institute of General Medical Sciences, the National Institute of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht AL, 2008, J APPL TOXICOL, V28, P283, DOI 10.1002/jat.1277; Anania MC, 2011, ONCOGENE, V30, P3011, DOI 10.1038/onc.2011.18; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Bian JH, 1996, CARCINOGENESIS, V17, P1805, DOI 10.1093/carcin/17.9.1805; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; Brehmer B, 2003, PROSTATE CANCER P D, V6, P217, DOI 10.1038/sj.pcan.4500657; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Daja MM, 2003, PROSTATE CANCER P D, V6, P15, DOI 10.1038/sj.pcan.4500609; DECLERCK YA, 1992, CANCER RES, V52, P701; Denhardt D T, 1992, Matrix Suppl, V1, P281; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Freije JMP, 2003, ADV EXP MED BIOL, V532, P91; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Imren S, 1996, CANCER RES, V56, P2891; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Karanikolas BDW, 2009, MOL CANCER RES, V7, P1456, DOI 10.1158/1541-7786.MCR-09-0121; KAWAMATA H, 1995, INT J CANCER, V63, P680, DOI 10.1002/ijc.2910630513; KHOKHA R, 1992, J NATL CANCER I, V84, P1017, DOI 10.1093/jnci/84.13.1017; KHOKHA R, 1989, SCIENCE, V243, P947, DOI 10.1126/science.2465572; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Trojan L, 2005, ANTICANCER RES, V25, P183; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang MS, 1997, ONCOGENE, V14, P2767, DOI 10.1038/sj.onc.1201245; Watanabe M, 1996, CANCER, V77, P1676, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1676::AID-CNCR14>3.3.CO;2-#; Weikert S, 2005, INT J MOL MED, V16, P349; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016	52	91	100	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30393	10.1371/journal.pone.0030393	http://dx.doi.org/10.1371/journal.pone.0030393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272343	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400121
J	Xu, J; Wang, SX; Zhang, M; Wang, QL; Asfa, S; Zou, MH				Xu, Jian; Wang, Shuangxi; Zhang, Miao; Wang, Qilong; Asfa, Sima; Zou, Ming-Hui			Tyrosine Nitration of PA700 Links Proteasome Activation to Endothelial Dysfunction in Mouse Models with Cardiovascular Risk Factors	PLOS ONE			English	Article							GTP-CYCLOHYDROLASE-I; NITRIC-OXIDE SYNTHASE; TETRAHYDROBIOPTERIN DEFICIENCY; 26S PROTEASOME; DEGRADATION; CELLS; HYPERTENSION; INHIBITION; PATHWAY; VIVO	Oxidative stress is believed to cause endothelial dysfunction, an early event and a hallmark in cardiovascular diseases (CVD) including hypertension, diabetes, and dyslipidemia. However, the targets for oxidative stress-mediated endothelial dysfunction in CVD have not been completely elucidated. Here we report that 26S proteasome activation by peroxynitrite (ONOO-) is a common pathway for endothelial dysfunction in mouse models of diabetes, hypertension, and dyslipidemia. Endothelial function, assayed by acetylcholine-induced vasorelaxation, was impaired in parallel with significantly increased 26S proteasome activity in aortic homogenates from streptozotocin (STZ)-induced type I diabetic mice, angiotensin-infused hypertensive mice, and high fat-diets -fed LDL receptor knockout (LDLr-/-) mice. The elevated 26S proteasome activities were accompanied by ONOO- -mediated PA700/S10B nitration and increased 26S proteasome assembly and caused accelerated degradation of molecules (such as GTPCH I and thioredoxin) essential to endothelial homeostasis. Pharmacological (administration of MG132) or genetic inhibition (siRNA knockdown of PA700/S10B) of the 26S proteasome blocked the degradation of the vascular protective molecules and ablated endothelial dysfunction induced by diabetes, hypertension, and western diet feeding. Taken together, these results suggest that 26S proteasome activation by ONOO--induced PA700/S10B tyrosine nitration is a common route for endothelial dysfunction seen in mouse models of hypertension, diabetes, and dyslipidemia.	[Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, Oklahoma City, OK 73104 USA; [Wang, Shuangxi; Zhang, Miao; Wang, Qilong; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Mol Med, Oklahoma City, OK USA; [Asfa, Sima] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Gastroenterol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Xu, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, Oklahoma City, OK 73104 USA.	jian-xu@ouhsc.edu	wang, qilong/O-1962-2013	Xu, Jian/0000-0002-9557-2671	National Institutes of Health (NIH) [HL079584, HL074399, HL080499, HL105157]; American Diabetes Association; Warren Chair in Diabetes Research of the University of Oklahoma Health Sciences Center; American Heart Association (AHA) [10SDG2600164]; COBRE (NIH/National Center for Research Resources) [P20 RR 024215]; Oklahoma Center for Advancement of Science and Technology [HR11-200]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110488, R01HL080499, R01HL079584, R01HL105157, R01HL074399] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Warren Chair in Diabetes Research of the University of Oklahoma Health Sciences Center; American Heart Association (AHA)(American Heart Association); COBRE (NIH/National Center for Research Resources); Oklahoma Center for Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants (HL079584, HL074399, HL080499, HL105157), a research award from the American Diabetes Association, and funds from the Warren Chair in Diabetes Research of the University of Oklahoma Health Sciences Center (All to MH-Z). MH-Z is a recipient of the National Established Investigator Award of American Heart Association (AHA). JX is supported by a Scientist Development Grant (AHA, 10SDG2600164), a COBRE grant (NIH/National Center for Research Resources: P20 RR 024215), and a research award from the Oklahoma Center for Advancement of Science and Technology (HR11-200). The funders had no role in study design, data collection and analysis.	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; Altschmied J, 2009, ANTIOXID REDOX SIGN, V11, P1733, DOI 10.1089/ARS.2008.2379; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Cooke JP, 1997, CLIN CARDIOL, V20, P45; Dai SC, 2009, ARTERIOSCL THROM VAS, V29, P495, DOI 10.1161/ATVBAHA.108.180349; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; Ebrahimian T, 2008, ANTIOXID REDOX SIGN, V10, P1127, DOI 10.1089/ars.2007.1985; Fekete MR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-114; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GRUETTER CA, 1979, J CYCLIC NUCL PROT, V5, P211; Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857; Herrmann J, 2008, J AM COLL CARDIOL, V51, P2003, DOI 10.1016/j.jacc.2008.02.047; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Katusic ZS, 2004, ARTERIOSCL THROM VAS, V24, P397, DOI 10.1161/01.ATV.0000121569.76931.0b; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Landmesser U, 2007, CURR OPIN CARDIOL, V22, P316, DOI 10.1097/HCO.0b013e3281ca710d; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Lorenz M, 2007, FASEB J, V21, P1556, DOI 10.1096/fj.06-7434com; Lorenz M, 2009, LIFE SCI, V84, P929, DOI 10.1016/j.lfs.2009.04.016; MA CP, 1994, J BIOL CHEM, V269, P3539; Madura K, 2009, NATURE, V459, P787, DOI 10.1038/459787a; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Meininger CJ, 2004, FASEB J, V18, P1900, DOI 10.1096/fj.04-1702fje; Nawa A, 2011, YAKUGAKU ZASSHI, V131, P487, DOI 10.1248/yakushi.131.487; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Reimers JI, 1996, DIABETES, V45, P771, DOI 10.2337/diabetes.45.6.771; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Stangl K, 2010, CARDIOVASC RES, V85, P281, DOI 10.1093/cvr/cvp315; Stangl V, 2004, FASEB J, V18, P272, DOI 10.1096/fj.03-0054com; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tassin J, 2000, BRAIN, V123, P1112, DOI 10.1093/brain/123.6.1112; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Wang SX, 2008, HYPERTENSION, V52, P484, DOI 10.1161/HYPERTENSIONAHA.108.112094; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Whitsett J, 2007, ARTERIOSCL THROM VAS, V27, P2340, DOI 10.1161/ATVBAHA.107.153742; World C, 2011, ARTERIOSCL THROM VAS, V31, P1890, DOI 10.1161/ATVBAHA.111.226340; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Young GW, 2008, TRENDS CARDIOVAS MED, V18, P93, DOI 10.1016/j.tcm.2008.01.004; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7	52	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29649	10.1371/journal.pone.0029649	http://dx.doi.org/10.1371/journal.pone.0029649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272240	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400019
J	Chan, KSK; Xu, J; Wardan, H; McColl, B; Orkin, S; Vadolas, J				Chan, Kasey S. K.; Xu, Jian; Wardan, Hady; McColl, Bradley; Orkin, Stuart; Vadolas, Jim			Generation of a genomic reporter assay system for analysis of gamma- and beta-globin gene regulation	FASEB JOURNAL			English	Article							SICKLE-CELL-DISEASE; FETAL-HEMOGLOBIN INDUCTION; SOLUBLE GUANYLYL CYCLASE; ERYTHROID-CELLS; EXPRESSION; BCL11A; HYDROXYUREA; THALASSEMIA; LOCUS; MICE	A greater understanding of the regulatory mechanisms that govern gamma-globin expression in humans, especially the switching from gamma- to beta-globin, which occurs after birth, would help to identify new therapeutic targets for patients with beta-hemoglobinopathy. To further elucidate the mechanisms involved in gamma-globin expression, a novel fluorescent-based cellular reporter assay system was developed. Using homologous recombination, two reporter genes, DsRed and EGFP, were inserted into a 183-kb intact human beta-globin locus under the control of (G)gamma- or (A)gamma-globin promoter and beta-globin promoter, respectively. The modified constructs were stably transfected into adult murine erythroleukaemic (MEL) cells and human embryonic or fetal erythroleukemic (K562) cells, allowing for rapid and simultaneous analysis of fetal and adult globin gene expression according to their developmental stage-specific expression. To demonstrate the utility of this system, we performed RNA interference (RNAi)-mediated knockdown of BCL11A in the presence or absence of known fetal hemoglobin inducers and demonstrated functional derepression of a gamma-globin-linked reporter in an adult erythroid environment. Our results demonstrate that the cellular assay system represents a promising approach to perform genetic and functional genomic studies to identify and evaluate key factors associated with gamma-globin gene suppression.-Chan, K. S. K., Xu, J., Wardan, H., McColl, B., Orkin, S., Vadolas, J. Generation of a genomic reporter assay system for analysis of gamma- and beta-globin gene regulation. FASEB J. 26, 1736-1744 (2012). www.fasebj.org	[Chan, Kasey S. K.; Wardan, Hady; McColl, Bradley; Vadolas, Jim] Royal Childrens Hosp, Murdoch Childrens Res Inst, Cell & Gene Therapy Res Grp, Parkville, Vic 3052, Australia; [Chan, Kasey S. K.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Chan, Kasey S. K.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Xu, Jian; Orkin, Stuart] Childrens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA; [Xu, Jian; Orkin, Stuart] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Vadolas, J (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Cell & Gene Therapy Grp, Flemington Rd, Parkville, Vic 3052, Australia.	jim.vadolas@mcri.edu.au		Vadolas, Jim/0000-0002-3072-3512	Australia National Health and Medical Research Council; Murdoch Childrens Research Institute; Victorian Government; Thalassaemia Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK093543] Funding Source: NIH RePORTER	Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Victorian Government; Thalassaemia Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Australia National Health and Medical Research Council, the Murdoch Childrens Research Institute, the Victorian Government's Operational Infrastructure Support Program, and Thalassaemia Australia supported this work. The authors declare no conflicts of interest.	Atweh GF, 1999, BLOOD, V93, P1790; Banzon V, 2011, EXP HEMATOL, V39, P26, DOI 10.1016/j.exphem.2010.10.003; Boosalis MS, 2011, BLOOD CELL MOL DIS, V47, P107, DOI 10.1016/j.bcmd.2011.04.008; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; CIOE L, 1981, CANCER RES, V41, P237; Cokic VP, 2008, BLOOD, V111, P1117, DOI 10.1182/blood-2007-05-088732; Cokic VP, 2003, J CLIN INVEST, V111, P231, DOI 10.1172/JCI200316672; Cui SAY, 2011, MOL CELL BIOL, V31, P3298, DOI 10.1128/MCB.05310-11; Fathallah H, 2009, BLOOD CELL MOL DIS, V43, P58, DOI 10.1016/j.bcmd.2009.02.006; Filipe A, 1999, EMBO J, V18, P687, DOI 10.1093/emboj/18.3.687; Howden SE, 2008, GENE THER, V15, P1372, DOI 10.1038/gt.2008.84; JANE SM, 1995, EMBO J, V14, P97, DOI 10.1002/j.1460-2075.1995.tb06979.x; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEY TJ, 1983, BLOOD, V62, P370; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Migliaccio G, 2005, BLOOD CELL MOL DIS, V34, P174, DOI 10.1016/j.bcmd.2004.11.005; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; PETERSON KR, 1993, P NATL ACAD SCI USA, V90, P7593, DOI 10.1073/pnas.90.16.7593; Rees DC, 2011, HAEMATOL-HEMATOL J, V96, P488, DOI 10.3324/haematol.2011.041988; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Saunthararajah Y, 2004, SEMIN HEMATOL, V41, P11, DOI 10.1053/j.seminhematol.2004.08.003; SINGER D, 1974, P NATL ACAD SCI USA, V71, P2668, DOI 10.1073/pnas.71.7.2668; Skarpidi E, 2000, BLOOD, V96, P321, DOI 10.1182/blood.V96.1.321.013k48_321_326; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Vadolas J, 2005, BBA-GENE STRUCT EXPR, V1728, P150, DOI 10.1016/j.bbaexp.2005.02.008; Vadolas J, 2002, BLOOD, V100, P4209, DOI 10.1182/blood-2001-12-0365; van Dijk TB, 2010, BLOOD, V116, P4349, DOI 10.1182/blood-2010-03-274399; Wilber A, 2011, BLOOD, V117, P2817, DOI 10.1182/blood-2010-08-300723; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; YARBRO JW, 1992, SEMIN ONCOL, V19, P1	37	17	17	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2012	26	4					1736	1744		10.1096/fj.11-199356	http://dx.doi.org/10.1096/fj.11-199356			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	919VS	22267339	Green Published			2022-12-25	WOS:000302359700034
J	Charlop-Powers, Z; Jakoncic, J; Gurnon, JR; Van Etten, JL; Zhou, MM				Charlop-Powers, Zachary; Jakoncic, Jean; Gurnon, James R.; Van Etten, James L.; Zhou, Ming-Ming			Paramecium bursaria Chlorella Virus 1 Encodes a Polyamine Acetyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YELLOW MOSAIC-VIRUS; VIRAL SET PROTEIN; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; DNA VIRUSES; CHROMATIN; CANCER; PROTOPLASTS; ANNOTATION; SOFTWARE; SEQUENCE	Paramecium bursaria chlorella virus 1 (PBCV-1), a large DNA virus that infects green algae, encodes a histone H3 lysine 27-specific methyltransferase that functions in global transcriptional silencing of the host. PBCV-1 has another gene a654l that encodes a protein with sequence similarity to the GCN5 family histone acetyltransferases. In this study, we report a 1.5 angstrom crystal structure of PBCV-1 A654L in a complex with coenzyme A. The structure reveals a unique feature of A654L that precludes its acetylation of histone peptide substrates. We demonstrate that A654L, hence named viral polyamine acetyltransferase (vPAT), acetylates polyamines such as putrescine, spermidine, cadaverine, and homospermidine present in both PBCV-1 and its host through a reaction dependent upon a conserved glutamate 27. Our study suggests that as the first virally encoded polyamine acetyltransferase, vPAT plays a possible key role in the regulation of polyamine catabolism in the host during viral replication.	[Charlop-Powers, Zachary] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Jakoncic, Jean] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; [Gurnon, James R.; Van Etten, James L.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Gurnon, James R.; Van Etten, James L.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA	Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zhou, MM (corresponding author), 1425 Madison Ave,Box 1677, New York, NY 10029 USA.	ming-ming.zhou@mssm.edu		Charlop-Powers, Zachary/0000-0001-8816-4680	National Institutes of Health [R01HG004508, R01CA87658]; NCRR [P30RR31151]; National Science Foundation EPSCoR [EPS-1004094]; NATIONAL CANCER INSTITUTE [R01CA087658] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR031151] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation EPSCoR(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HG004508 and R01CA87658 (to M.-M. Z.) and NCRR P30RR31151 (to J. L. V. E.). This work was also supported by National Science Foundation EPSCoR EPS-1004094 (to J. L. V. E.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Babbar N, 2006, J BIOL CHEM, V281, P24182, DOI 10.1074/jbc.M601871200; BALINT R, 1985, VIROLOGY, V144, P181, DOI 10.1016/0042-6822(85)90316-2; BALINT R, 1985, VIROLOGY, V144, P194, DOI 10.1016/0042-6822(85)90317-4; Baumann S, 2007, VIROLOGY, V360, P209, DOI 10.1016/j.virol.2006.10.010; Benson LJ, 2007, J BIOL CHEM, V282, P836, DOI 10.1074/jbc.M607464200; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; de Souza RF, 2010, BBA-GENE REGUL MECH, V1799, P302, DOI 10.1016/j.bbagrm.2009.10.006; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald LA, 2007, VIROLOGY, V362, P350, DOI 10.1016/j.virol.2006.12.028; Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034; Fitzgerald LA, 2007, VIROLOGY, V358, P472, DOI 10.1016/j.virol.2006.08.033; Forouhar F, 2005, J BIOL CHEM, V280, P40328, DOI 10.1074/jbc.M505332200; Gazzarrini S, 2003, FEBS LETT, V552, P12, DOI 10.1016/S0014-5793(03)00777-4; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hegde SS, 2007, BIOCHEMISTRY-US, V46, P7187, DOI 10.1021/bi700256z; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Kaiser A, 1999, VIROLOGY, V263, P254, DOI 10.1006/viro.1999.9972; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Persson L, 2009, ESSAYS BIOCHEM, V46, P11, DOI [10.1042/BSE0460002, 10.1042/bse0460002]; SEN D, 1986, BIOCHEMISTRY-US, V25, P1495, DOI 10.1021/bi00355a004; Shah R, 2004, J BIOL CHEM, V279, P35760, DOI 10.1074/jbc.M405366200; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wei H, 2010, P NATL ACAD SCI USA, V107, P18433, DOI 10.1073/pnas.1009911107; Wei H, 2010, BBA-GENE REGUL MECH, V1799, P296, DOI 10.1016/j.bbagrm.2009.08.007	32	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9547	9551		10.1074/jbc.C111.337816	http://dx.doi.org/10.1074/jbc.C111.337816			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277659	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000301797800085
J	Fu, GS; Xu, T; Shi, Y; Wei, N; Yang, XL				Fu, Guangsen; Xu, Tao; Shi, Yi; Wei, Na; Yang, Xiang-Lei			tRNA-controlled Nuclear Import of a Human tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COGNATE TRANSFER-RNA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EXPORT; AMINOACYLATION; RECOGNITION; CYTOKINE	Aminoacyl-tRNA synthetases, essential components of the cytoplasmic translation apparatus, also have nuclear functions that continue to be elucidated. However, little is known about how the distribution between cytoplasmic and nuclear compartments is controlled. Using a combination of methods, here we showed that human tyrosyl-tRNA synthetase (TyrRS) distributes to the nucleus and that the nuclear import of human TyrRS is regulated by its cognate tRNA(Tyr). We identified a hexapeptide motif in the anticodon recognition domain that is critical for nuclear import of the synthetase. Remarkably, this nuclear localization signal (NLS) sequence motif is also important for interacting with tRNA(Tyr). As a consequence, mutational alteration of the hexapeptide simultaneously attenuated aminoacylation and nuclear localization. Because the NLS is sterically blocked when the cognate tRNA is bound to TyrRS, we hypothesized that the nuclear distribution of TyrRS is regulated by tRNA(Tyr). This expectation was confirmed by RNAi knockdown of tRNA(Tyr) expression, which led to robust nuclear import of TyrRS. Further bioinformatics analysis showed that to have nuclear import of TyrRS directly controlled by tRNA(Tyr) in higher organisms, the NLS of lower eukaryotes was abandoned, whereas the new NLS was evolved from an anticodon-binding hexapeptide motif. Thus, higher organisms developed a strategy to make tRNA a regulator of the nuclear trafficking of its cognate synthetase. The design in principle should coordinate nuclear import of a tRNA synthetase with the demands of protein synthesis in the cytoplasm.	[Yang, Xiang-Lei] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Yang, XL (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xlyang@scripps.edu	Xu, Tao/I-1561-2014; Fu, Guangsen/D-2991-2012; Yang, Xiang-Lei/AAR-7107-2020	Xu, Tao/0000-0002-3436-3024; Yang, Xiang-Lei/0000-0003-2554-084X; Xu, Tao/0000-0002-4085-6191	National Institutes of Health [GM88278]; Skaggs Foundation; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Foundation; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM88278( to X.-L. Y.). This work was also supported by the Skaggs Foundation and a fellowship from the National Foundation for Cancer Research.	Azad AK, 2001, MOL BIOL CELL, V12, P1381, DOI 10.1091/mbc.12.5.1381; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Giege R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Grosshans H, 2000, GENE DEV, V14, P830; Hopper AK, 2008, TRENDS CELL BIOL, V18, P98, DOI 10.1016/j.tcb.2008.01.001; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Kobayashi T, 2003, NAT STRUCT BIOL, V10, P425, DOI 10.1038/nsb934; Lund E, 1998, SCIENCE, V282, P2082, DOI 10.1126/science.282.5396.2082; Nathanson L, 2000, J BIOL CHEM, V275, P31559, DOI 10.1074/jbc.C000385200; POPENKO VI, 1994, EUR J CELL BIOL, V65, P60; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Tsunoda M, 2007, NUCLEIC ACIDS RES, V35, P4289, DOI 10.1093/nar/gkm417; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Yang XL, 2003, HELV CHIM ACTA, V86, P1246, DOI 10.1002/hlca.200390107; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	22	29	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9330	9334		10.1074/jbc.C111.325902	http://dx.doi.org/10.1074/jbc.C111.325902			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291016	Green Published, hybrid			2022-12-25	WOS:000301797800064
J	Seidman, D; Johnson, D; Gerbasi, V; Golden, D; Orlando, R; Hajduk, S				Seidman, David; Johnson, Darryl; Gerbasi, Vincent; Golden, Daniel; Orlando, Ron; Hajduk, Stephen			Mitochondrial Membrane Complex That Contains Proteins Necessary for tRNA Import in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODED TRANSFER-RNA; LEISHMANIA-MITOCHONDRIA; IN-VITRO; DEVELOPMENTAL REGULATION; GENE-EXPRESSION; RIBOSOMAL-RNA; BLOOD-STREAM; SEQUENCE; DIFFERENTIATION; LOCALIZATION	The mitochondrial genome of Trypanosoma brucei does not contain genes encoding tRNAs; instead this protozoan parasite must import nuclear-encoded tRNAs from the cytosol for mitochondrial translation. Previously, it has been shown that mitochondrial tRNA import requires ATP hydrolysis and a protein-aceous mitochondrial membrane component. However, little is known about the mitochondrial membrane proteins involved in tRNA binding and translocation into the mitochondrion. Here we report the purification of a mitochondrial membrane complex using tRNA affinity purification and have identified several protein components of the putative tRNA translocon by mass spectrometry. Using an in vivo tRNA import assay in combination with RNA interference, we have verified that two of these proteins, Tb11.01.4590 and Tb09.v1.0420, are involved in mitochondrial tRNA import. Using Protein C Epitope-Tobacco Etch Virus-Protein A Epitope (PTP)-tagged Tb11.01.4590, additional associated proteins were identified including Tim17 and other mitochondrial proteins necessary for mitochondrial protein import. Results presented here identify and validate two novel protein components of the putative tRNA translocon and provide additional evidence that mitochondrial tRNA and protein import have shared components in trypanosomes.	[Seidman, David; Orlando, Ron; Hajduk, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Johnson, Darryl; Orlando, Ron] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Gerbasi, Vincent] Northwestern Univ, Dept Biochem Mol & Cell Biol, Evanston, IL 60208 USA; [Golden, Daniel] Merial Ltd, Duluth, GA 30096 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Northwestern University	Hajduk, S (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Davidson Life Sci Bldg,120 Green St, Athens, GA 30602 USA.	shajduk@bmb.uga.edu	Seidman, David/B-6697-2009	Gerbasi, Robert/0000-0001-5573-0578	National Institutes of Health [R01AI061356]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI061356.	Adhya S, 1997, J BIOL CHEM, V272, P21396, DOI 10.1074/jbc.272.34.21396; Bhattacharyya SN, 2003, MOL CELL BIOL, V23, P5217, DOI 10.1128/MCB.23.15.5217-5224.2003; Blom D, 2001, NUCLEIC ACIDS RES, V29, P2950, DOI 10.1093/nar/29.14.2950; Bomer U, 1997, EMBO J, V16, P2205, DOI 10.1093/emboj/16.9.2205; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Chatterjee S, 2006, J BIOL CHEM, V281, P25270, DOI 10.1074/jbc.M604126200; Cristodero M, 2010, MOL MICROBIOL, V78, P757, DOI 10.1111/j.1365-2958.2010.07368.x; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; Esseiva AC, 2004, MOL BIOL CELL, V15, P2750, DOI 10.1091/mbc.E03-11-0821; Goswami S, 2006, P NATL ACAD SCI USA, V103, P8354, DOI 10.1073/pnas.0510869103; Gunzl A., 2009, CURR PROTOC PROTEIN, V55; HANCOCK K, 1990, J BIOL CHEM, V265, P19208; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Lima BD, 1996, RNA, V2, P429; Mahapatra S, 1998, NUCLEIC ACIDS RES, V26, P2037, DOI 10.1093/nar/26.9.2037; MANNINGKRIEG UC, 1991, EMBO J, V10, P3273, DOI 10.1002/j.1460-2075.1991.tb04891.x; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; MICHELOTTI EF, 1987, J BIOL CHEM, V262, P927; Mukherjee S, 1999, J BIOL CHEM, V274, P31249, DOI 10.1074/jbc.274.44.31249; Mukherjee S, 2007, EMBO REP, V8, P589, DOI 10.1038/sj.embor.7400979; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Paris Z, 2009, RNA, V15, P1398, DOI 10.1261/rna.1589109; PRIEST JW, 1994, MOL BIOCHEM PARASIT, V65, P291, DOI 10.1016/0166-6851(94)90080-9; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Rusconi CP, 1996, GENE DEV, V10, P2870, DOI 10.1101/gad.10.22.2870; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schekman Randy, 2010, Proc Natl Acad Sci U S A, V107, P9476, DOI 10.1073/pnas.1004225107; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; SCHNEIDER A, 1994, MOL CELL BIOL, V14, P2317, DOI 10.1128/MCB.14.4.2317; Sherrer RL, 2003, MOL CELL BIOL, V23, P9061, DOI 10.1128/MCB.23.24.9061-9072.2003; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Tan THP, 2002, P NATL ACAD SCI USA, V99, P1152, DOI 10.1073/pnas.022522299; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; Tasker M, 2001, MOL MICROBIOL, V39, P272, DOI 10.1046/j.1365-2958.2001.02252.x; TETLEY L, 1985, J CELL SCI, V74, P1; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	51	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8892	8903		10.1074/jbc.M111.300186	http://dx.doi.org/10.1074/jbc.M111.300186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22267727	Green Published, hybrid			2022-12-25	WOS:000301797800020
J	Holten-Andersen, L; Dalsgaard, I; Buchmann, K				Holten-Andersen, Lars; Dalsgaard, Inger; Buchmann, Kurt			Baltic Salmon, Salmo salar, from Swedish River Lule Alv Is More Resistant to Furunculosis Compared to Rainbow Trout	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS WALBAUM; BACTERIAL KIDNEY-DISEASE; FARMED ATLANTIC SALMON; AEROMONAS-SALMONICIDA; GYRODACTYLUS-SALARIS; COMPARATIVE SUSCEPTIBILITY; GAIRDNERI RICHARDSON; BROOK TROUT; CLASS-I; INFECTION	Background: Furunculosis, caused by Aeromonas salmonicida, continues to be a major health problem for the growing salmonid aquaculture. Despite effective vaccination programs regular outbreaks occur at the fish farms calling for repeated antibiotic treatment. We hypothesized that a difference in natural susceptibility to this disease might exist between Baltic salmon and the widely used rainbow trout. Study Design: A cohabitation challenge model was applied to investigate the relative susceptibility to infection with A. salmonicida in rainbow trout and Baltic salmon. The course of infection was monitored daily over a 30-day period post challenge and the results were summarized in mortality curves. Results: A. salmonicida was recovered from mortalities during the entire test period. At day 30 the survival was 6.2% and 34.0% for rainbow trout and Baltic salmon, respectively. Significant differences in susceptibility to A. salmonicida were demonstrated between the two salmonids and hazard ratio estimation between rainbow trout and Baltic salmon showed a 3.36 higher risk of dying from the infection in the former. Conclusion: The finding that Baltic salmon carries a high level of natural resistance to furunculosis might raise new possibilities for salmonid aquaculture in terms of minimizing disease outbreaks and the use of antibiotics.	[Holten-Andersen, Lars; Buchmann, Kurt] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg C, Denmark; [Holten-Andersen, Lars; Dalsgaard, Inger] Tech Univ Denmark, Div Vet Diagnost & Res, Natl Vet Inst, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark	Holten-Andersen, L (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg C, Denmark.	lhoa@life.ku.dk		Dalsgaard, Inger/0000-0003-2066-1060; Buchmann, Kurt/0000-0002-2747-237X	Danish Research Council for Strategic Research [2101-07-0086]	Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was funded by the Danish Research Council for Strategic Research (Grant #2101-07-0086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKE TA, 1993, FISH RES, V17, P69, DOI 10.1016/0165-7836(93)90008-U; BAKKE TA, 1990, J FISH BIOL, V37, P577, DOI 10.1111/j.1095-8649.1990.tb05890.x; BEACHAM TD, 1992, T AM FISH SOC, V121, P456, DOI 10.1577/1548-8659(1992)121&lt;0456:GVIDRA&gt;2.3.CO;2; Berg A, 2006, FISKEN HAVET, V9; BRUNO DW, 1986, J FISH DIS, V9, P523, DOI 10.1111/j.1365-2761.1986.tb01049.x; Buchmann K, 1997, DIS AQUAT ORGAN, V28, P201, DOI 10.3354/dao028201; Buchmann K, 1997, AQUACULTURE, V156, P335, DOI 10.1016/S0044-8486(97)00097-5; Buchmann K, 2001, J FISH DIS, V24, P245, DOI 10.1046/j.1365-2761.2001.00294.x; CIPRIANO RC, 1994, J WILDLIFE DIS, V30, P577, DOI 10.7589/0090-3558-30.4.577; CIPRIANO RC, 1982, PROG FISH CULT, V44, P12, DOI 10.1577/1548-8659(1982)44[12:FIBT]2.0.CO;2; CIPRIANO RC, 1986, T AM FISH SOC, V115, P83, DOI 10.1577/1548-8659(1986)115&lt;83:SOSTF&gt;2.0.CO;2; CIPRIANO RC, 1983, T AM FISH SOC, V112, P95, DOI 10.1577/1548-8659(1983)112&lt;95:ROSTAS&gt;2.0.CO;2; Dalgaard MB, 2003, DIS AQUAT ORGAN, V53, P173, DOI 10.3354/dao053173; Dalsgaard I, 2000, J FISH DIS, V23, P199, DOI 10.1046/j.1365-2761.2000.00242.x; ELLIS AE, 1988, MICROB PATHOGENESIS, V4, P299, DOI 10.1016/0882-4010(88)90090-3; FREEDMAN SJ, 1991, COMP BIOCHEM PHYS B, V98, P549, DOI 10.1016/0305-0491(91)90252-9; GJEDREM T, 1978, AQUACULTURE, V13, P135, DOI 10.1016/0044-8486(78)90107-2; Gjedrem T., 1995, Aquaculture Research, V26, P129, DOI 10.1111/j.1365-2109.1995.tb00892.x; GRIFFIN BR, 1983, DEV COMP IMMUNOL, V7, P253, DOI 10.1016/0145-305X(83)90006-X; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; HAYFORD CO, 1930, T AM FISH SOC, V60, P109; Heinecke RD, 2007, J FISH DIS, V30, P733, DOI 10.1111/j.1365-2761.2007.00885.x; HJELMELAND K, 1983, J FISH BIOL, V23, P13, DOI 10.1111/j.1095-8649.1983.tb02878.x; Hoover GJ, 1998, COMP BIOCHEM PHYS B, V120, P559, DOI 10.1016/S0305-0491(98)10042-1; Hoover GJ, 1998, FASEB J, V12, pA807; HUNTLY PJ, 1988, BIOCHEM SOC T, V16, P999, DOI 10.1042/bst0160999; Kania PW, 2010, J HELMINTHOL, V84, P166, DOI 10.1017/S0022149X09990460; Kania P, 2007, DIS AQUAT ORGAN, V76, P81, DOI 10.3354/dao076081; Kjoglum S, 2008, SCAND J IMMUNOL, V67, P160, DOI 10.1111/j.1365-3083.2007.02052.x; Koppang EO, 2005, J FISH DIS, V28, P13, DOI 10.1111/j.1365-2761.2004.00583.x; Koppang EO, 2008, J IMMUNOL, V181, P4807, DOI 10.4049/jimmunol.181.7.4807; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; LEE KK, 1991, DIS AQUAT ORGAN, V11, P207, DOI 10.3354/dao011207; Lindenstrom T, 2006, J FISH DIS, V29, P123, DOI 10.1111/j.1365-2761.2006.00696.x; Lohm J, 2002, P ROY SOC B-BIOL SCI, V269, P2029, DOI 10.1098/rspb.2002.2114; MAGNADOTTIR B, 1995, VET IMMUNOL IMMUNOP, V49, P127, DOI 10.1016/0165-2427(95)05461-E; MCCARTHY DH, 1983, J FISH DIS, V6, P231, DOI 10.1111/j.1365-2761.1983.tb00071.x; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; MICHEL C, 1990, J FISH BIOL, V37, P617, DOI 10.1111/j.1095-8649.1990.tb05894.x; Miller RA, 2006, AM J VET RES, V67, P1837, DOI 10.2460/ajvr.67.11.1837; Nilsson J, 2001, MOL ECOL, V10, P89, DOI 10.1046/j.1365-294X.2001.01168.x; Odegard J, 2007, AQUACULTURE, V271, P173, DOI 10.1016/j.aquaculture.2007.06.006; Odegard J, 2006, AQUACULTURE, V259, P116, DOI 10.1016/j.aquaculture.2006.05.034; Ottinger CA, 1999, COMP BIOCHEM PHYS C, V123, P53, DOI 10.1016/S0742-8413(99)00009-2; Pedersen K, 2008, J FISH DIS, V31, P659, DOI 10.1111/j.1365-2761.2008.00941.x; PRESS CM, 1995, BRIT VET J, V151, P45, DOI 10.1016/S0007-1935(05)80064-8; Ringo E, 2004, CELL TISSUE RES, V318, P305, DOI 10.1007/s00441-004-0934-2; Rolland JB, 2003, J FISH DIS, V26, P511, DOI 10.1046/j.1365-2761.2003.00473.x; SAKAI M, 1991, FISH PATHOL, V26, P159, DOI 10.3147/jsfp.26.159; Smith VJ, 2000, FISH SHELLFISH IMMUN, V10, P243, DOI 10.1006/fsim.1999.0254	50	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29571	10.1371/journal.pone.0029571	http://dx.doi.org/10.1371/journal.pone.0029571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276121	Green Published, gold			2022-12-25	WOS:000301568100013
J	Abraham, CG; Kulesza, CA				Abraham, Christopher G.; Kulesza, Caroline A.			Polycomb Repressive Complex 2 Targets Murine Cytomegalovirus Chromatin for Modification and Associates with Viral Replication Centers	PLOS ONE			English	Article							HISTONE MODIFICATIONS; GENE-EXPRESSION; GROUP PROTEINS; FACULTATIVE HETEROCHROMATIN; TRANSCRIPTIONAL REPRESSORS; DENDRITIC CELLS; LATENCY; INFECTION; REACTIVATION; GENOME	Regulation of viral transcription by chromatin structure has emerged as a fundamental determinant in the establishment of lytic and latent herpesvirus infections. The Polycomb group (PcG) of epigenetic repressors promotes heterochromatin formation by trimethylating histone H3 on lysine-27 (H3K27me3) and regulates development, stem cell renewal and differentiation and the cell cycle. These cellular processes are tightly coupled to the molecular switch between lytic and latent herpesvirus infections. Using chromatin immunoprecipitation analysis, we observed enrichment of H3K27me3 at the major immediate-early (MIE) locus of murine cytomegalovirus (MCMV) very early following infection of permissive fibroblasts. As lytic replication progressed, we observed a loss of H3K27me3 enrichment concomitant with the appearance of H3K4me3. However, late during infection, as viral replication centers are established, we observed a significant increase in PcG protein association with chromatin. Additionally, in co-immunofluorescence assays using confocal microscopy, we detected strong enrichments for PcG protein within the viral replication compartment, suggesting an association between viral DNA synthesis machinery and PcG proteins. Together, our results suggest a novel, dynamic interaction between PcG epigenetic repressors and MCMV genomes.	[Abraham, Christopher G.; Kulesza, Caroline A.] Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Abraham, CG (corresponding author), Univ Colorado, Dept Microbiol, Sch Med, Aurora, CO 80045 USA.	caroline.kulesza@ucdenver.edu			University of Colorado Denver School of Medicine;  [T32AI052066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052066] Funding Source: NIH RePORTER	University of Colorado Denver School of Medicine; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by University of Colorado Denver School of Medicine Academic Enhancement Funds to CAK. CGA is supported by the pre-doctoral training grant T32AI052066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Aoto T, 2008, J BIOL CHEM, V283, P18905, DOI 10.1074/jbc.M709322200; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bartova E, 2008, J HISTOCHEM CYTOCHEM, V56, P711, DOI 10.1369/jhc.2008.951251; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Castillo JP, 2002, GENE, V290, P19, DOI 10.1016/S0378-1119(02)00566-8; Cliffe AR, 2009, J VIROL, V83, P8182, DOI 10.1128/JVI.00712-09; Cuevas-Bennett C, 2008, J VIROL, V82, P9525, DOI 10.1128/JVI.00946-08; Dittmer D, 1997, J VIROL, V71, P1629, DOI 10.1128/JVI.71.2.1629-1634.1997; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Francis NJ, 2009, CELL CYCLE, V8, P3521, DOI 10.4161/cc.8.21.9876; Giordani NV, 2008, J VIROL, V82, P6056, DOI 10.1128/JVI.02661-07; Groves IJ, 2009, J GEN VIROL, V90, P2364, DOI 10.1099/vir.0.012526-0; Gunther T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000935; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Ioudinkova E, 2006, GENE, V384, P120, DOI 10.1016/j.gene.2006.07.021; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kurz SK, 1999, J VIROL, V73, P8612, DOI 10.1128/JVI.73.10.8612-8622.1999; Kwiatkowski DL, 2009, J VIROL, V83, P8173, DOI 10.1128/JVI.00686-09; Liu XF, 2008, J VIROL, V82, P10922, DOI 10.1128/JVI.00865-08; Liu XF, 2010, J VIROL, V84, P3631, DOI 10.1128/JVI.02380-09; Lukashchuk V, 2008, J VIROL, V82, P12543, DOI 10.1128/JVI.01215-08; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; Mocarski E., 2007, FIELDS VIROLOGY; Murphy JC, 2002, EMBO J, V21, P1112, DOI 10.1093/emboj/21.5.1112; Nevels M, 2004, P NATL ACAD SCI USA, V101, P17234, DOI 10.1073/pnas.0407933101; Nitzsche A, 2008, J VIROL, V82, P11167, DOI 10.1128/JVI.01218-08; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Reddehase MJ, 2002, J CLIN VIROL, V25, pS23; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Reeves MB, 2005, P NATL ACAD SCI USA, V102, P4140, DOI 10.1073/pnas.0408994102; Sanchez V, 2003, J VIROL, V77, P13214, DOI 10.1128/JVI.77.24.13214-13224.2003; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sinclair J, 2008, J CLIN VIROL, V41, P180, DOI 10.1016/j.jcv.2007.11.014; SMITH MG, 1954, P SOC EXP BIOL MED, V86, P435; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Takacs M, 2010, BBA-GENE REGUL MECH, V1799, P228, DOI 10.1016/j.bbagrm.2009.10.005; Terhune SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000965; Toth Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001013; Trojer P, 2007, MOL CELL, V28, P1, DOI 10.1016/j.molcel.2007.09.011; Wagner M, 1999, J VIROL, V73, P7056, DOI 10.1128/JVI.73.8.7056-7060.1999; Wang QY, 2005, P NATL ACAD SCI USA, V102, P16055, DOI 10.1073/pnas.0505850102; Zhang ZG, 2003, J VIROL, V77, P12660, DOI 10.1128/JVI.77.23.12660-12670.2003	49	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29410	10.1371/journal.pone.0029410	http://dx.doi.org/10.1371/journal.pone.0029410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279536	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900014
J	Brandman, R; Brandman, Y; Pande, VS				Brandman, Relly; Brandman, Yigal; Pande, Vijay S.			Sequence Coevolution between RNA and Protein Characterized by Mutual Information between Residue Triplets	PLOS ONE			English	Article							HIGH-RESOLUTION STRUCTURES; RIBOSOME; ACID; EVOLUTION	Coevolving residues in a multiple sequence alignment provide evolutionary clues of biophysical interactions in 3D structure. Despite a rich literature describing amino acid coevolution within or between proteins and nucleic acid coevolution within RNA, to date there has been no direct evidence of coevolution between protein and RNA. The ribosome, a structurally conserved macromolecular machine composed of over 50 interacting protein and RNA chains, provides a natural example of RNA/protein interactions that likely coevolved. We provide the first direct evidence of RNA/protein coevolution by characterizing the mutual information in residue triplets from a multiple sequence alignment of ribosomal protein L22 and neighboring 23S RNA. We define residue triplets as three positions in the multiple sequence alignment, where one position is from the 23S RNA and two positions are from the L22 protein. We show that residue triplets with high mutual information are more likely than residue doublets to be proximal in 3D space. Some high mutual information residue triplets cluster in a connected series across the L22 protein structure, similar to patterns seen in protein coevolution. We also describe RNA nucleotides for which switching from one nucleotide to another (or between purines and pyrimidines) results in a change in amino acid distribution for proximal amino acid positions. Multiple crystal structures for evolutionarily distinct ribosome species can provide structural evidence for these differences. For one residue triplet, a pyrimidine in one species is a purine in another, and RNA/protein hydrogen bonds are present in one species but not the other. The results provide the first direct evidence of RNA/protein coevolution by using higher order mutual information, suggesting that biophysical constraints on interacting RNA and protein chains are indeed a driving force in their evolution.	[Brandman, Relly; Brandman, Yigal; Pande, Vijay S.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Brandman, R (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	pande@stanford.edu	Pande, Vijay/ABE-8145-2020		Stanford Bio-X	Stanford Bio-X	RB is funded by a Stanford Bio-X Graduate Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashan A, 2008, TRENDS MICROBIOL, V16, P326, DOI 10.1016/j.tim.2008.05.001; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cheng AC, 2003, J MOL BIOL, V327, P781, DOI 10.1016/S0022-2836(03)00091-3; CHIU DKY, 1991, COMPUT APPL BIOSCI, V7, P347; Cover TM, 1991, ELEMENTS INFORM THEO; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; LEVITT M, 1969, NATURE, V224, P759, DOI 10.1038/224759a0; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Morozova N, 2006, BIOINFORMATICS, V22, P2746, DOI 10.1093/bioinformatics/btl470; Poon A, 2005, GENETICS, V170, P989, DOI 10.1534/genetics.104.039438; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Unge J, 1998, STRUCTURE, V6, P1577, DOI 10.1016/S0969-2126(98)00155-5; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	23	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30022	10.1371/journal.pone.0030022	http://dx.doi.org/10.1371/journal.pone.0030022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279560	gold, Green Published, Green Submitted			2022-12-25	WOS:000299771900038
J	Chappell, JM; Iqbal, A; Abbott, D				Chappell, James M.; Iqbal, Azhar; Abbott, Derek			Analysis of Two-Player Quantum Games in an EPR Setting Using Clifford's Geometric Algebra	PLOS ONE			English	Article							HILBERT-SPACE; STRATEGIES; ENTANGLEMENT; STATES	The framework for playing quantum games in an Einstein-Podolsky-Rosen (EPR) type setting is investigated using the mathematical formalism of geometric algebra (GA). The main advantage of this framework is that the players' strategy sets remain identical to the ones in the classical mixed-strategy version of the game, and hence the quantum game becomes a proper extension of the classical game, avoiding a criticism of other quantum game frameworks. We produce a general solution for two-player games, and as examples, we analyze the games of Prisoners' Dilemma and Stag Hunt in the EPR setting. The use of GA allows a quantum-mechanical analysis without the use of complex numbers or the Dirac Bra-ket notation, and hence is more accessible to the non-physicist.	[Chappell, James M.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia; [Chappell, James M.; Iqbal, Azhar; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia.	james.m.chappell@adelaide.edu.au	Abbott, Derek/E-8352-2011; Iqbal, Azhar/E-8749-2011	Abbott, Derek/0000-0002-0945-2674; Iqbal, Azhar/0000-0002-5221-9384				Aharon N, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052310; Ahmed A, 2008, ARXIV08081391; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Bell J. S., 1987, QUANTUM MECH; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; Bell JS, 1964, PHYSICS, V1, P195, DOI [DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195, 10.1103/Physics-PhysiqueFizika.1.195]; Benjamin SC, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.030301; Binmore K., 2007, GAME THEORY VERY SHO, V173; Blaquiere A., 1980, DYNAMICAL SYSTEMS MI, P33, DOI 10.1007/978-3-7091-4330-8_2; Bleiler SA, 2008, ARXIV08081389; Bohm D., 1951, QUANTUM THEORY; Cereceda JL, 2000, FOUND PHYS LETT, V13, P427, DOI 10.1023/A:1007828731477; Chappell J, 2011, ARXIV11013619; Chappell J, 2011, ARXIV11063748; Chappell JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021623; Chappell JM, 2010, PHYS LETT A, V374, P4104, DOI 10.1016/j.physleta.2010.08.024; Chappell JM, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.054801; Cheon T, 2006, PHYS LETT A, V348, P147, DOI 10.1016/j.physleta.2005.08.066; Cheon T, 2006, AIP CONF PROC, V864, P254, DOI 10.1063/1.2400897; Christian J, 2007, QUANTPH0703179 ARXIV; CHRISTIAN J, 2011, ARXIV11060748; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; de Sabbata V., 2007, GEOMETRIC ALGEBRA AP; Doran C., 2003, GEOMETRIC ALGEBRA PH, DOI DOI 10.1017/CBO9780511807497; Du JF, 2002, PHYS LETT A, V302, P229, DOI 10.1016/S0375-9601(02)01144-1; Du JF, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137902; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Eisert J, 1999, PHYS REV LETT, V83, P3077, DOI 10.1103/PhysRevLett.83.3077; Flitney AP, 2002, FLUCT NOISE LETT, V2, pR175, DOI 10.1142/S0219477502000981; Flitney AP, 2007, PHYS LETT A, V363, P381, DOI 10.1016/j.physleta.2006.11.044; Flitney AP, 2005, J PHYS A-MATH GEN, V38, P449, DOI 10.1088/0305-4470/38/2/011; Flitney AP, 2003, P ROY SOC A-MATH PHY, V459, P2463, DOI 10.1098/rspa.2003.1136; Guo H, 2008, DECIS SUPPORT SYST, V46, P318, DOI 10.1016/j.dss.2008.07.001; Havel T, 2004, QUANTPH0403136 ARXIV; HESTENES D, 1984, CLIFFORD ALGEBRA GEO, V5; Hestenes D., 1999, NEW FDN CLASSICAL ME, VSecond; Ichikawa T, 2007, ANN PHYS-NEW YORK, V322, P531, DOI 10.1016/j.aop.2006.05.001; Ichikawa T, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/13/135303; Iqbal A, 2005, J PHYS A-MATH GEN, V38, P9551, DOI 10.1088/0305-4470/38/43/009; Iqbal A, 2004, J PHYS A-MATH GEN, V37, P5873, DOI 10.1088/0305-4470/37/22/012; Iqbal A, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052328; Iqbal A, 2001, PHYS LETT A, V280, P249, DOI 10.1016/S0375-9601(01)00082-2; Iqbal A, 2009, PHYS LETT A, V373, P2537, DOI 10.1016/j.physleta.2009.05.020; Iqbal A, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.014803; Iqbal A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061122; Iqbal A, 2008, PHYS LETT A, V372, P6564, DOI 10.1016/j.physleta.2008.09.026; Johnson N, 2001, PHYS REV A, V63; Li Q, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/44/445303; Marinatto L, 2000, PHYS LETT A, V272, P291, DOI 10.1016/S0375-9601(00)00441-2; Mendes RV, 2005, QUANTUM INF PROCESS, V4, P1, DOI 10.1007/s11128-005-3192-7; MERMIN ND, 1990, AM J PHYS, V58, P731, DOI 10.1119/1.16503; MERMIN ND, 1990, PHYS REV LETT, V65, P1838, DOI 10.1103/PhysRevLett.65.1838; Meyer DA, 1999, PHYS REV LETT, V82, P1052, DOI 10.1103/PhysRevLett.82.1052; Nawaz A, 2004, J PHYS A-MATH GEN, V37, P11457, DOI 10.1088/0305-4470/37/47/014; Ozdemir SK, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/2/043; Parker R, 2001, QUANTPH0106055 ARXIV; Peres Asher., 1993, QUANTUM THEORY CONCE, V57; Piotrowski EW, 2003, INT J THEOR PHYS, V42, P1089, DOI 10.1023/A:1025443111388; Piotrowski EW, 2002, PHYSICA A, V312, P208, DOI 10.1016/S0378-4371(02)00842-7; Ramzan M, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/5/055307; Rasmusen E., 2007, GAMES INFORM INTRO G; Shimamura J, 2004, INT J QUANTUM INF, V2, P79, DOI 10.1142/S0219749904000092; Shimamura J, 2004, PHYS LETT A, V328, P20, DOI 10.1016/j.physleta.2004.06.006; Szekeres P, 2004, COURSE MODERN MATH P; Vaidman L, 1999, FOUND PHYS, V29, P755, DOI 10.1023/A:1018826607583; van Enk SJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.024306; Wiesner S., 1983, SIGACT News, V15, P78, DOI 10.1145/1008908.1008920	67	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29015	10.1371/journal.pone.0029015	http://dx.doi.org/10.1371/journal.pone.0029015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279525	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900003
J	Toda, K; Sugase-Miyamoto, Y; Mizuhiki, T; Inaba, K; Richmond, BJ; Shidara, M				Toda, Koji; Sugase-Miyamoto, Yasuko; Mizuhiki, Takashi; Inaba, Kiyonori; Richmond, Barry J.; Shidara, Munetaka			Differential Encoding of Factors Influencing Predicted Reward Value in Monkey Rostral Anterior Cingulate Cortex	PLOS ONE			English	Article							PRIMATE FRONTAL-CORTEX; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; NEURONAL SIGNALS; DOPAMINE NEURONS; MACAQUE MONKEY; RHESUS-MONKEY; CONNECTIONS; AMYGDALA; MOTIVATION	Background: The value of a predicted reward can be estimated based on the conjunction of both the intrinsic reward value and the length of time to obtain it. The question we addressed is how the two aspects, reward size and proximity to reward, influence the responses of neurons in rostral anterior cingulate cortex (rACC), a brain region thought to play an important role in reward processing. Methods and Findings: We recorded from single neurons while two monkeys performed a multi-trial reward schedule task. The monkeys performed 1-4 sequential color discrimination trials to obtain a reward of 1-3 liquid drops. There were two task conditions, a valid cue condition, where the number of trials and reward amount were associated with visual cues, and a random cue condition, where the cue was picked from the cue set at random. In the valid cue condition, the neuronal firing is strongly modulated by the predicted reward proximity during the trials. Information about the predicted reward amount is almost absent at those times. In substantial subpopulations, the neuronal responses decreased or increased gradually through schedule progress to the predicted outcome. These two gradually modulating signals could be used to calculate the effect of time on the perception of reward value. In the random cue condition, little information about the reward proximity or reward amount is encoded during the course of the trial before reward delivery, but when the reward is actually delivered the responses reflect both the reward proximity and reward amount. Conclusions: Our results suggest that the rACC neurons encode information about reward proximity and amount in a manner that is dependent on utility of reward information. The manner in which the information is represented could be used in the moment-to-moment calculation of the effect of time and amount on predicted outcome value.	[Toda, Koji; Mizuhiki, Takashi; Inaba, Kiyonori; Shidara, Munetaka] Univ Tsukuba, Doctoral Program Kansei Behav & Brain Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Sugase-Miyamoto, Yasuko] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Mizuhiki, Takashi; Shidara, Munetaka] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Richmond, Barry J.] NIMH, Neuropsychol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Toda, K (corresponding author), Univ Tsukuba, Doctoral Program Kansei Behav & Brain Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan.	mshidara@md.tsukuba.ac.jp	sugase-miyamoto, yasuko/N-2769-2016	sugase-miyamoto, yasuko/0000-0003-3097-3789	Ministry of Education, Culture, Sports, Science and Technology of Japan [17022052]; 21st Century COE; AIST/Japan; US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002619] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AIST/Japan; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by Grant-in-Aid for JSPS Fellows (KT), Grant-in-Aid for Scientific Research on Priority Areas -System study on higher-order brain functions-from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 17022052 to MS), and 21st Century COE Program (MS) and AIST/Japan (YS). BJR is supported by the Intramural Research Program of the US National Institute of Mental Health. The authors thank JSPS for providing travel support for BJR in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1977, P IEEE, V65, P762, DOI 10.1109/PROC.1977.10559; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; ARIKUNI T, 1994, NEUROSCI RES, V21, P19, DOI 10.1016/0168-0102(94)90065-5; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Bermudez MA, 2010, J NEUROPHYSIOL, V104, P3424, DOI 10.1152/jn.00540.2010; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GOLDMANRAKIC PS, 1989, P NATL ACAD SCI USA, V86, P9015, DOI 10.1073/pnas.86.22.9015; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2011, J NEUROSCI, V31, P4178, DOI 10.1523/JNEUROSCI.4652-10.2011; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; HAYS AV, 1982, WESCON C P, P1; Hikosaka K, 2004, EUR J NEUROSCI, V19, P1046, DOI 10.1111/j.0953-816X.2004.03120.x; Hosokawa T, 2007, NEUROSCI RES, V57, P434, DOI 10.1016/j.neures.2006.12.003; Isomura Y, 2003, J NEUROSCI, V23, P8002; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Kobayashi S, 2008, J NEUROSCI, V28, P7837, DOI 10.1523/JNEUROSCI.1600-08.2008; Kondo H, 2005, J COMP NEUROL, V493, P479, DOI 10.1002/cne.20796; La Camera G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000131; Lee D, 2007, J NEUROSCI, V27, P8170, DOI 10.1523/JNEUROSCI.1561-07.2007; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Minamimoto T, 2009, J NEUROPHYSIOL, V101, P437, DOI 10.1152/jn.90959.2008; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; SAUNDERS RC, 1990, EXP BRAIN RES, V81, P443; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shidara M, 1998, J NEUROSCI, V18, P2613; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Simmons JM, 2008, CEREB CORTEX, V18, P93, DOI 10.1093/cercor/bhm034; Simmons JM, 2010, J NEUROSCI, V30, P15878, DOI 10.1523/JNEUROSCI.1802-10.2010; Sugase-Miyamoto Y, 2005, J NEUROSCI, V25, P11071, DOI 10.1523/JNEUROSCI.1796-05.2005; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Van Hoesen G. W. M., 1993, NEUROBIOLOGY CINGULA, P249, DOI DOI 10.1007/978-1-4899-6704-6_9; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wallis JD, 2010, CURR OPIN NEUROBIOL, V20, P191, DOI 10.1016/j.conb.2010.02.009; Walton ME, 2007, COGN AFFECT BEHAV NE, V7, P413, DOI 10.3758/CABN.7.4.413; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; Yukie M, 2009, CINGULATE NEUROBIOLO, P145	59	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30190	10.1371/journal.pone.0030190	http://dx.doi.org/10.1371/journal.pone.0030190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279569	Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900047
J	Zhang, YW; Luo, YL; Tian, JQ; Asiri, AM; Al-Youbi, AO; Sun, XP				Zhang, Yingwei; Luo, Yonglan; Tian, Jingqi; Asiri, Abdullah M.; Al-Youbi, Abdulrahman O.; Sun, Xuping			Rectangular Coordination Polymer Nanoplates: Large-Scale, Rapid Synthesis and Their Application as a Fluorescent Sensing Platform for DNA Detection	PLOS ONE			English	Article							PROBES; NANOBELTS; ABILITY	In this paper, we report on the large-scale, rapid synthesis of uniform rectangular coordination polymer nanoplates (RCPNs) assembled from Cu(II) and 4,4'-bipyridine for the first time. We further demonstrate that such RCPNs can be used as a very effective fluorescent sensing platform for multiple DNA detection with a detection limit as low as 30 pM and a high selectivity down to single-base mismatch. The DNA detection is accomplished by the following two steps: (1) RCPN binds dye-labeled single-stranded DNA (ssDNA) probe, which brings dye and RCPN into close proximity, leading to fluorescence quenching; (2) Specific hybridization of the probe with its target generates a double-stranded DNA (dsDNA) which detaches from RCPN, leading to fluorescence recovery. It suggests that this sensing system can well discriminate complementary and mismatched DNA sequences. The exact mechanism of fluorescence quenching involved is elucidated experimentally and its use in a human blood serum system is also demonstrated successfully.	[Zhang, Yingwei; Luo, Yonglan; Tian, Jingqi; Sun, Xuping] Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China; [Tian, Jingqi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Asiri, Abdullah M.; Al-Youbi, Abdulrahman O.; Sun, Xuping] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Asiri, Abdullah M.; Al-Youbi, Abdulrahman O.; Sun, Xuping] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; King Abdulaziz University; King Abdulaziz University	Zhang, YW (corresponding author), Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China.	sunxp@ciac.jl.cn	alyoubi, Abdulrahman/G-5962-2011; Asiri, Abdullah M./C-3458-2009	Asiri, Abdullah M./0000-0001-7905-3209; TIAN, Jingqi/0000-0002-3695-7563	National Basic Research Program of China [2011CB935800]; National Natural Science Foundation of China [21175129]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (No. 2011CB935800) and the National Natural Science Foundation of China (No. 21175129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD V, 2001, MOL FLUROSCENCE PRIN; BURR HE, 1982, NUCLEIC ACIDS RES, V10, P719, DOI 10.1093/nar/10.2.719; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Eddaoudi M, 2001, ACCOUNTS CHEM RES, V34, P319, DOI 10.1021/ar000034b; Gao H, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/28/285203; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; He SJ, 2010, ADV FUNCT MATER, V20, P453, DOI 10.1002/adfm.200901639; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; James SL, 2003, CHEM SOC REV, V32, P276, DOI 10.1039/b200393g; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li D, 2010, ACCOUNTS CHEM RES, V43, P631, DOI 10.1021/ar900245u; Li HL, 2011, SMALL, V7, P1562, DOI 10.1002/smll.201100068; Li HL, 2011, MACROMOL RAPID COMM, V32, P899, DOI 10.1002/marc.201100108; Li HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018958; Li HL, 2011, CHEM COMMUN, V47, P2625, DOI 10.1039/c0cc05394e; Li HL, 2011, CHEM COMMUN, V47, P961, DOI 10.1039/c0cc04326e; Li HX, 2004, ANAL CHEM, V76, P5414, DOI 10.1021/ac049173n; Liu S, 2011, NANOSCALE, V3, P967, DOI 10.1039/c0nr00873g; Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479; Luo YL, 2011, ELECTROCHIM ACTA, V56, P8371, DOI 10.1016/j.electacta.2011.07.024; MASLAK P, 1991, J AM CHEM SOC, V113, P1062, DOI 10.1021/ja00003a061; Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p; Mederos A, 1999, COORDIN CHEM REV, V193-5, P857, DOI 10.1016/S0010-8545(99)00050-8; Mederos A, 1999, COORDIN CHEM REV, V193-5, P913, DOI 10.1016/S0010-8545(99)00084-3; Moeller R., 2005, IEE Proceedings Nanobiotechnology, V152, P47, DOI 10.1049/ip-nbt:20045020; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Ray PC, 2007, PLASMONICS, V2, P173, DOI 10.1007/s11468-007-9036-9; Song SP, 2009, ANGEW CHEM INT EDIT, V48, P8670, DOI 10.1002/anie.200901887; Spokoyny AM, 2009, CHEM SOC REV, V38, P1218, DOI 10.1039/b807085g; Sun XP, 2005, J AM CHEM SOC, V127, P13102, DOI 10.1021/ja0534809; Tian JQ, 2011, LANGMUIR, V27, P874, DOI 10.1021/la103799e; Varghese N, 2009, CHEMPHYSCHEM, V10, P206, DOI 10.1002/cphc.200800459; Wang L, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1294; Yang RH, 2008, ANAL CHEM, V80, P7408, DOI 10.1021/ac801118p; Yang RH, 2008, J AM CHEM SOC, V130, P8351, DOI 10.1021/ja800604z; Zhang YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020569; Zhang YW, 2011, LANGMUIR, V27, P2170, DOI 10.1021/la105092f	38	37	42	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30426	10.1371/journal.pone.0030426	http://dx.doi.org/10.1371/journal.pone.0030426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279589	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900066
J	Liu, J; Lee, GY; Lawitts, JA; Toner, M; Biggers, JD				Liu, Jie; Lee, Gloria Y.; Lawitts, Joel A.; Toner, Mehmet; Biggers, John D.			Preservation of Mouse Sperm by Convective Drying and Storing in 3-O-Methyl-D-Glucose	PLOS ONE			English	Article							DESICCATION TOLERANCE; SPERMATOZOA; TRANSPORT; TEMPERATURE; EXPRESSION; INTEGRITY; CHROMATIN; CELLS	With the fast advancement in the genetics and bio-medical fields, the vast number of valuable transgenic and rare genetic mouse models need to be preserved. Preservation of mouse sperm by convective drying and subsequent storing at above freezing temperatures could dramatically reduce the cost and facilitate shipping. Mouse sperm were convectively dried under nitrogen gas in the Na-EGTA solution containing 100 mmol/L 3-O-methyl-D-glucose and stored in LiCl sorption jars (Relative Humidity, RH, 12%) at 4 degrees C and 22 degrees C for up to one year. The functionality of these sperm samples after storage was tested by intracytoplasmic injection into mouse oocytes. The percentages of blastocysts produced from sperm stored at 4 degrees C for 1, 2, 3, 6, and 12 months were 62.6%, 53.4%, 39.6%, 33.3%, and 30.4%, respectively, while those stored at 22 degrees C for 1, 2, and 3 months were 28.8%, 26.6%, and 12.2%, respectively. Transfer of 38 two-to four-cell embryos from sperm stored at 4 degrees C for 1 year produced two live pups while 59 two-to four-cell embryos from sperm stored at 22 degrees C for 3 months also produced two live pups. Although all the pups looked healthy at 3 weeks of age, normality of offspring produced using convectively dried sperm needs further investigation. The percentages of blastocyst from sperm stored in the higher relative humidity conditions of NaBr and MgCl2 jars and driest condition of P2O5 jars at 4 degrees C and 22 degrees C were all lower. A simple method of mouse sperm preservation is demonstrated. Three-O-methyl-D-glucose, a metabolically inactive derivative of glucose, offers significant protection for dried mouse sperm at above freezing temperatures without the need for poration of cell membrane.	[Liu, Jie; Lee, Gloria Y.; Toner, Mehmet; Biggers, John D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med & Surg Serv, Boston, MA 02115 USA; [Liu, Jie; Lee, Gloria Y.; Toner, Mehmet; Biggers, John D.] Shriners Hosp Children, Boston, MA USA; [Lawitts, Joel A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Biggers, John D.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Liu, J (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn Med & Surg Serv, Boston, MA 02115 USA.	jliu22@partners.org			National Institutes of Health; National Center for Research Resources [NIH/NCRR 5 R24 RR018934]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR018934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to thank funding support from the National Institutes of Health and the National Center for Research Resources (NIH/NCRR 5 R24 RR018934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 1996, MOL REPROD DEV, V45, P87, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;87::AID-MRD12&gt;3.0.CO;2-U; Angulo C, 1998, J CELL BIOCHEM, V71, P189, DOI 10.1002/(SICI)1097-4644(19981101)71:2<189::AID-JCB5>3.3.CO;2-D; Bhowmick S, 2003, BIOL REPROD, V68, P1779, DOI 10.1095/biolreprod.102.009407; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Bose SM, 2008, J CELL BIOCHEM, V103, P1636; Bucci D, 2011, J ANDROL, V32, P348, DOI 10.2164/jandrol.110.011197; Buitink J, 2008, CR BIOL, V331, P788, DOI 10.1016/j.crvi.2008.08.002; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Elmoazzen HY, 2009, CRYOBIOLOGY, V59, P113, DOI 10.1016/j.cryobiol.2009.03.005; GRAFF JC, 1978, J CELL PHYSIOL, V96, P171, DOI 10.1002/jcp.1040960206; HALL PF, 1981, J REPROD FERTIL, V63, P373, DOI 10.1530/jrf.0.0630373; Johnson GD, 2011, REPRODUCTION, V141, P21, DOI 10.1530/REP-10-0322; Kaneko T, 2003, BIOL REPROD, V68, P136, DOI 10.1095/biolreprod.102.008706; Kim ST, 2007, REPROD SCI, V14, P445, DOI 10.1177/1933719107306226; Kuretake S, 1996, BIOL REPROD, V55, P789, DOI 10.1095/biolreprod55.4.789; Kusakabe H, 2008, HUM REPROD, V23, P233, DOI 10.1093/humrep/dem252; Kusakabe H, 2001, P NATL ACAD SCI USA, V98, P13501, DOI 10.1073/pnas.241517598; Leninger, 1950, PHYSIOL REV, V30, P395; Li MW, 2007, REPRODUCTION, V133, P919, DOI 10.1530/REP-06-0096; Liu J, 2011, MICE PRODUCED ICSI C; MARHOL M, 1970, ANAL CHEM, V42, P652, DOI 10.1021/ac60288a018; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; Nakagata N, 2011, METHODS MOL BIOL, V693, P57, DOI 10.1007/978-1-60761-974-1_4; Norris MM, 2006, TISSUE ENG, V12, P1873, DOI 10.1089/ten.2006.12.1873; Spiess W.E.L, 1987, WATER ACTIVITY THEOR, P215; Spitzer J, 2011, MICROBIOL MOL BIOL R, V75, P491, DOI 10.1128/MMBR.00010-11; STOREY KB, 1994, AM J PHYSIOL, V266, pR1477, DOI 10.1152/ajpregu.1994.266.5.R1477; Sugimachi K, 2006, TISSUE ENG, V12, P579, DOI 10.1089/ten.2006.12.579; Tateno H, 2000, BIOL REPROD, V63, P341, DOI 10.1095/biolreprod63.1.341; van den Dries IJ, 2000, J PHYS CHEM B, V104, P9260, DOI 10.1021/jp000074x; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; WOHLHUETER RM, 1976, J CELL PHYSIOL, V89, P605, DOI 10.1002/jcp.1040890417; Zhang Y, 2011, J BIOL CHEM, V286, P23623, DOI 10.1074/jbc.R110.172833	35	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29924	10.1371/journal.pone.0029924	http://dx.doi.org/10.1371/journal.pone.0029924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272261	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400040
J	Vathipadiekal, V; Saxena, D; Mok, SC; Hauschka, PV; Ozbun, L; Birrer, MJ				Vathipadiekal, Vinod; Saxena, Deepa; Mok, Samuel C.; Hauschka, Peter V.; Ozbun, Laurent; Birrer, Michael J.			Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer	PLOS ONE			English	Article							DRUG EFFLUX CAPACITY; SIDE POPULATION; HEMATOPOIETIC STEM; SOLID TUMORS; SURVIVAL; PHENOTYPE; DEFINES; SUBPOPULATION; MECHANISMS; FRINGE	Identification of gene expression profiles of cancer stem cells may have significant implications in the understanding of tumor biology and for the design of novel treatments targeted toward these cells. Here we report a potential ovarian cancer stem cell gene expression profile from isolated side population of fresh ascites obtained from women with high-grade advanced stage papillary serous ovarian adenocarcinoma. Affymetrix U133 Plus 2.0 microarrays were used to interrogate the differentially expressed genes between side population (SP) and main population (MP), and the results were analyzed by paired T-test using BRB-ArrayTools. We identified 138 up-regulated and 302 down-regulated genes that were differentially expressed between all 10 SP/MP pairs. Microarray data was validated using qRT-PCR and17/19 (89.5%) genes showed robust correlations between microarray and qRT-PCR expression data. The Pathway Studio analysis identified several genes involved in cell survival, differentiation, proliferation, and apoptosis which are unique to SP cells and a mechanism for the activation of Notch signaling is identified. To validate these findings, we have identified and isolated SP cells enriched for cancer stem cells from human ovarian cancer cell lines. The SP populations were having a higher colony forming efficiency in comparison to its MP counterpart and also capable of sustained expansion and differentiation in to SP and MP phenotypes. 50,000 SP cells produced tumor in nude mice whereas the same number of MP cells failed to give any tumor at 8 weeks after injection. The SP cells demonstrated a dose dependent sensitivity to specific c-secretase inhibitors implicating the role of Notch signaling pathway in SP cell survival. Further the generated SP gene list was found to be enriched in recurrent ovarian cancer tumors.	[Vathipadiekal, Vinod; Birrer, Michael J.] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Saxena, Deepa; Hauschka, Peter V.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Orthopaed Surg, Boston, MA USA; [Mok, Samuel C.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Ozbun, Laurent] NCI, Cell & Canc Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Vathipadiekal, V (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA.	mbirrer@partners.org		/0000-0002-8181-6890	National Institutes of the Health [5R01CA142832-02 216288 2009A051746, 1RC4CA156551-01 217168 2010A053125]; National Cancer Institute; CDMRP-DOD [W81XWH-06-1-0422, W81XWH-09-1-0292]; Susan G. Komen for the Cure [BCTR 0600935]; Orthopaedic Surgery Foundation, Children's Hospital Boston; NATIONAL CANCER INSTITUTE [RC4CA156551, R01CA142832] Funding Source: NIH RePORTER	National Institutes of the Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CDMRP-DOD; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Orthopaedic Surgery Foundation, Children's Hospital Boston; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from National Institutes of the Health (5R01CA142832-02 216288 2009A051746, 1RC4CA156551-01 217168 2010A053125 and an Intramural Research Program of the National Cancer Institute) to MJB. PVH and DS were supported by grants from the CDMRP-DOD (W81XWH-06-1-0422 and W81XWH-09-1-0292), Susan G. Komen for the Cure (BCTR 0600935), and the Orthopaedic Surgery Foundation, Children's Hospital Boston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chen CZ, 2003, IMMUNITY, V19, P525, DOI 10.1016/S1074-7613(03)00265-6; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Fong MY, 2010, HISTOL HISTOPATHOL, V25, P113, DOI 10.14670/HH-25.113; Gadducci A, 2001, ANTICANCER RES, V21, P3525; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Goessler UR, 2005, CELL MOL BIOL LETT, V10, P345; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Kumar SR, 2007, BRIT J CANCER, V96, P1083, DOI 10.1038/sj.bjc.6603642; Kvinlaug BT, 2007, EXPERT OPIN THER TAR, V11, P915, DOI 10.1517/14728222.11.7.915; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Mogi M, 2003, J BIOL CHEM, V278, P39068, DOI 10.1074/jbc.M306362200; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moserle L, 2008, CANCER RES, V68, P5658, DOI 10.1158/0008-5472.CAN-07-6341; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ozols RF, 2002, CANCER J, V8, pS22; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Seigel GM, 2005, MOL VIS, V11, P729; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Vogel G, 2003, SCIENCE, V302, P371; Wamunyokoli FW, 2006, CLIN CANCER RES, V12, P690, DOI 10.1158/1078-0432.CCR-05-1110; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483	65	79	81	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29079	10.1371/journal.pone.0029079	http://dx.doi.org/10.1371/journal.pone.0029079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272227	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400006
J	Chaisaingmongkol, J; Popanda, O; Warta, R; Dyckhoff, G; Herpel, E; Geiselhart, L; Claus, R; Lasitschka, F; Campos, B; Oakes, CC; Bermejo, JL; Herold-Mende, C; Plass, C; Schmezer, P				Chaisaingmongkol, J.; Popanda, O.; Warta, R.; Dyckhoff, G.; Herpel, E.; Geiselhart, L.; Claus, R.; Lasitschka, F.; Campos, B.; Oakes, C. C.; Bermejo, J. L.; Herold-Mende, C.; Plass, C.; Schmezer, P.			Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma	ONCOGENE			English	Article						HNSCC; DNA methylation; NEIL1 expression; DNA glycosylase	HYPERMETHYLATION; TUMOR; GLYCOSYLASE; EXPRESSION; HYPOMETHYLATION; INACTIVATION; EXCISION; REVEALS; DAMAGE; METHYLTRANSFERASE	Aberrant promoter methylation of different DNA repair genes has a critical role in the development and progression of various cancer types, including head and neck squamous cell carcinomas (HNSCCs). A systematic analysis of known human repair genes for promoter methylation is however missing. We generated quantitative promoter methylation profiles in single CpG units of 160 human DNA repair genes in a set of DNAs isolated from fresh frozen HNSCC and normal tissues using MassARRAY technology. Ninety-eight percent of these genes contained CpG islands (CGIs) in their promoter region; thus, DNA methylation is a potential regulatory mechanism. Methylation data were obtained for 145 genes, from which 15 genes exhibited more than a 20% difference in methylation levels between tumor and normal tissues, manifested either as hypermethylation or as hypomethylation. Analyses of promoter methylation with mRNA expression identified the DNA glycosylase NEIL1 (nei endonuclease VIII-like 1) as the most prominent candidate gene. NEIL1 promoter hypermethylation was confirmed in additional fresh frozen HNSCC samples, normal mucosa, HNSCC cell lines and primary human skin keratinocytes. The investigation of laser-microdissected tissues further substantiated increased methylation levels in tumor versus matched non-tumor cells. Immunohistological analysis revealed significantly less NEIL1 protein expression in tumor tissues. 5-Aza-2'-deoxycytidine treatment and DNMT1 knockdown resulted in the re-expression of NEIL1 in HNSCC cell lines, which initially carried hypermethylated promoter regions. In conclusion, our results suggest that DNA methylation contributes to the downregulation of NEIL1 expression and might thus have a role in modulating the response to therapies of HNSCC. Oncogene (2012) 31, 5108-5116; doi:10.1038/onc.2011.660; published online 30 January 2012	[Chaisaingmongkol, J.; Popanda, O.; Geiselhart, L.; Claus, R.; Oakes, C. C.; Plass, C.; Schmezer, P.] German Canc Res Ctr, Div Epigen & Canc Risk Factors, D-69120 Heidelberg, Germany; [Warta, R.; Dyckhoff, G.; Herold-Mende, C.] Heidelberg Univ, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany; [Warta, R.; Campos, B.; Herold-Mende, C.] Heidelberg Univ, Dept Neurosurg, Div Neurosurg Res, Heidelberg, Germany; [Herpel, E.] Univ Heidelberg Hosp, Inst Pathol, NCT Tissue Bank, Heidelberg, Germany; [Lasitschka, F.] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Bermejo, J. L.] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schmezer, P (corresponding author), German Canc Res Ctr, Div Epigen & Canc Risk Factors C010, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.schmezer@dkfz.de	Popanda, Odilia/P-6917-2019; Oakes, Christopher C/H-7288-2014; Plass, Christoph/H-7192-2014; Claus, Rainer/AAZ-5606-2020	Oakes, Christopher C/0000-0001-8000-9694; Claus, Rainer/0000-0003-2617-8766; Chaisaingmongkol, Jittiporn/0000-0001-8019-5562	Royal Thai Government; NIDCR [DE13123]; Deutsche Forschungsgemeinschaft [SFB938 Z2]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013123] Funding Source: NIH RePORTER	Royal Thai Government; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank R Gliniorz, O Muecke, P Waas and O Zelezny ( Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center) and J Scheuerer (Institute of Pathology) for their excellent technical assistance, all other members of the Plass laboratory for their help and thoughtful discussion, M Zucknick (Division of Biostatistics, German Cancer Research Center) for statistical support and P Boukamp (Division of Genetics of Skin Carcinogenesis, German Cancer Research Center) for providing primary human skin keratinocytes. This project was in part supported by a scholarship of The Royal Thai Government to JC. This work was supported in part by NIDCR, grant DE13123 (CP). FL is funded by the Deutsche Forschungsgemeinschaft, grant SFB938 Z2.	Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Chan MK, 2009, DNA REPAIR, V8, P786, DOI 10.1016/j.dnarep.2009.03.001; Couve-Privat S, 2007, NUCLEIC ACIDS RES, V35, P5672, DOI 10.1093/nar/gkm592; Das A, 2005, J BIOL CHEM, V280, P35272, DOI 10.1074/jbc.M505526200; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Dikshit RP, 2007, CANCER-AM CANCER SOC, V110, P1745, DOI 10.1002/cncr.22975; Dokun OY, 2008, INT J CANCER, V123, P2798, DOI 10.1002/ijc.23893; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Estecio MRH, 2006, ONCOGENE, V25, P5018, DOI 10.1038/sj.onc.1209509; Esteller M, 2001, CANCER RES, V61, P4689; Freier K, 2010, J ORAL PATHOL MED, V39, P382, DOI 10.1111/j.1600-0714.2009.00864.x; Funke B, 2009, GUT, V58, P483, DOI 10.1136/gut.2008.148908; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; Ha PK, 2009, ORAL ONCOL, V45, P335, DOI 10.1016/j.oraloncology.2008.05.015; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kraunz KS, 2006, INT J CANCER, V119, P1553, DOI 10.1002/ijc.22013; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Mace-Aime G, 2010, ENVIRON MOL MUTAGEN, V51, P508, DOI 10.1002/em.20548; Marsit CJ, 2006, INT J CANCER, V119, P1761, DOI 10.1002/ijc.22051; Marsit CJ, 2009, CARCINOGENESIS, V30, P416, DOI 10.1093/carcin/bgp006; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; Martone T, 2007, CLIN CANCER RES, V13, P5089, DOI 10.1158/1078-0432.CCR-07-0119; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Ninck S, 2003, INT J CANCER, V106, P34, DOI 10.1002/ijc.11188; Pal S, 2010, J GASTROEN HEPATOL, V25, P627, DOI 10.1111/j.1440-1746.2009.06128.x; Poage GM, 2011, CLIN CANCER RES, V17, P3579, DOI 10.1158/1078-0432.CCR-11-0044; Rosenquist TA, 2003, DNA REPAIR, V2, P581, DOI 10.1016/S1568-7864(03)00025-9; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; Schmezer P, 2008, HNO, V56, P594, DOI 10.1007/s00106-008-1720-3; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Seiwert TY, 2007, NAT CLIN PRACT ONCOL, V4, P156, DOI 10.1038/ncponc0750; Sengupta S, 2007, CANCER-AM CANCER SOC, V109, P703, DOI 10.1002/cncr.22430; Shinmura K, 2004, CARCINOGENESIS, V25, P2311, DOI 10.1093/carcin/bgh267; Smith IM, 2010, ORL-J OTO-RHIN-LARYN, V72, P44, DOI 10.1159/000292104; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Wiebalk K, 2007, INT J CANCER, V121, P2340, DOI 10.1002/ijc.22981; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861	48	27	28	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2012	31	49					5108	5116		10.1038/onc.2011.660	http://dx.doi.org/10.1038/onc.2011.660			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	049RK	22286769				2022-12-25	WOS:000312000900007
J	Germann, S; Gratadou, L; Zonta, E; Dardenne, E; Gaudineau, B; Fougere, M; Samaan, S; Dutertre, M; Jauliac, S; Auboeuf, D				Germann, S.; Gratadou, L.; Zonta, E.; Dardenne, E.; Gaudineau, B.; Fougere, M.; Samaan, S.; Dutertre, M.; Jauliac, S.; Auboeuf, D.			Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor	ONCOGENE			English	Article						ddx5; ddx17; NFAT5; cancer; transcriptional coregulator; splicing	CANCER CELL MOTILITY; DEAD-BOX PROTEINS; BINDING-PROTEIN; SPLICING REGULATION; LIPOCALIN 2; P68; EXPRESSION; S100A4; GENE; COACTIVATOR	Ddx5 and ddx17 are two highly related RNA helicases involved in both transcription and splicing. These proteins coactivate transcription factors involved in cancer such as the estrogen receptor alpha, p53 and beta-catenin. Ddx5 and ddx17 are part of the splicing machinery and can modulate alternative splicing, the main mechanism increasing the proteome diversity. Alternative splicing also has a role in gene expression level regulation when it is coupled to the nonsense-mediated mRNA decay (NMD) pathway. In this work, we report that ddx5 and ddx17 have a dual role in the control of the pro-migratory NFAT5 transcription factor. First, ddx5 and ddx17 act as transcriptional coactivators of NFAT5 and are required for activating NFAT5 target genes involved in tumor cell migration. Second, at the splicing level, ddx5 and ddx17 increase the inclusion of NFAT5 exon 5. As exon 5 contains a pre-mature translation termination codon, its inclusion leads to the regulation of NFAT5 mRNAs by the NMD pathway and to a decrease in NFAT5 protein level. Therefore, we demonstrated for the first time that a transcriptional coregulator can simultaneously regulate the transcriptional activity and alternative splicing of a transcription factor. This dual regulation, where ddx5 and ddx17 enhance the transcriptional activity of NFAT5 although reducing its protein expression level, suggests a critical role for ddx5 and ddx17 in tumor cell migration through the fine regulation of NFAT5 pathway. Oncogene (2012) 31, 4536-4549; doi:10.1038/onc.2011.618; published online 23 January 2012	[Auboeuf, D.] Ctr Leon Berard, Ctr Rech Cancerol Lyon, F-69008 Lyon, France; [Germann, S.; Gratadou, L.; Zonta, E.; Dardenne, E.; Samaan, S.; Dutertre, M.; Auboeuf, D.] Univ Lyon, Lyon, France; [Germann, S.; Gratadou, L.; Zonta, E.; Dardenne, E.; Samaan, S.; Dutertre, M.; Auboeuf, D.] INSERM, U1052, F-69008 Lyon, France; [Germann, S.; Gratadou, L.; Zonta, E.; Dardenne, E.; Samaan, S.; Dutertre, M.; Auboeuf, D.] CNRS, UMR5286, Lyon, France; [Germann, S.; Gratadou, L.; Zonta, E.; Dardenne, E.; Samaan, S.; Dutertre, M.; Auboeuf, D.] Univ Lyon 1, F-69365 Lyon, France; [Gaudineau, B.; Fougere, M.; Jauliac, S.] Univ Paris Diderot, Hop St Louis, Inst Hematol, CNRS,UMR7212,INSERM,U944, Paris, France	UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Auboeuf, D (corresponding author), Ctr Leon Berard, Ctr Rech Cancerol Lyon, 28 Rue Laennec, F-69008 Lyon, France.	didier.auboeuf@inserm.fr	Auboeuf, Didier/M-4610-2014; Jauliac, Sebastien/B-7847-2010; Zonta, E/B-8928-2013; DUTERTRE, Martin/Q-1815-2019; Dutertre, Martin/N-7060-2017	Jauliac, Sebastien/0000-0002-1712-3416; Zonta, E/0000-0001-8106-0504; DUTERTRE, Martin/0000-0003-0278-4120; Dutertre, Martin/0000-0003-0278-4120; Auboeuf, Didier/0000-0002-3757-0002	EC (NoE EURASNET); Institut National du Cancer; Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche; French Ministry of Education	EC (NoE EURASNET); Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of Education	We thank S Kato and J Marie for providing wild-type and mutant ddx5 and ddx17 expression vectors. We thank Emanuele Buratti for providing pTB minigene construct. We thank Coralie Poulard and Muriel Le Romancer-Cherifi for their help with PLA. This work was supported by EC (NoE EURASNET), Institut National du Cancer, Association pour la Recherche sur le Cancer, Ligue Nationale Contre le Cancer and Agence Nationale de la Recherche. S Germann, B Gaudineau and M Fougere were supported by Association pour la Recherche sur le Cancer; L Gratadou by Agence Nationale de la Recherche; E Zonta by the French Ministry of Education; E Dardenne by Ligue Nationale Contre le Cancer.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Auboeuf D, 2007, TRENDS ENDOCRIN MET, V18, P122, DOI 10.1016/j.tem.2007.02.003; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Barbier J, 2007, MOL CELL BIOL, V27, P7315, DOI 10.1128/MCB.00272-07; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bittencourt D, 2008, MOL CELL BIOL, V28, P5811, DOI 10.1128/MCB.02231-07; Blencowe BJ, 2003, CURR BIOL, V13, pR149, DOI 10.1016/S0960-9822(03)00079-4; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Camats M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002926; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Carter CL, 2010, ONCOGENE, V29, P5427, DOI 10.1038/onc.2010.276; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Chang YF, 2007, J BIOL CHEM, V282, P29738, DOI 10.1074/jbc.M704372200; Chen M, 2011, AM J PHYSIOL-CELL PH, V300, pC1155, DOI 10.1152/ajpcell.00407.2010; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Dalski A, 2002, CYTOGENET GENOME RES, V97, P179, DOI 10.1159/000066604; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Davies MPA, 1996, ONCOGENE, V13, P1631; Dutertre M, 2010, RNA BIOL, V7, P403, DOI 10.4161/rna.7.4.12152; Dutertre M, 2010, CANCER RES, V70, P3760, DOI 10.1158/0008-5472.CAN-09-3988; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Fougere M, 2010, ONCOGENE, V29, P2292, DOI 10.1038/onc.2009.499; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Guil S, 2003, MOL CELL BIOL, V23, P2927, DOI 10.1128/MCB.23.8.2927-2941.2003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Irarrazabal CE, 2010, P NATL ACAD SCI USA, V107, P906, DOI 10.1073/pnas.0913415107; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kar A, 2011, MOL CELL BIOL, V31, P1812, DOI 10.1128/MCB.01149-10; Leng XH, 2011, J CELL PHYSIOL, V226, P309, DOI 10.1002/jcp.22403; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Maouyo D, 2002, AM J PHYSIOL-RENAL, V282, pF802, DOI 10.1152/ajprenal.00123.2001; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mooney SM, 2010, J BIOL CHEM, V285, P30443, DOI 10.1074/jbc.M110.143792; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Moore HC, 2010, ONCOGENE, V29, P6475, DOI 10.1038/onc.2010.381; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Neu-Yilik G, 2008, ADV GENET, V62, P185, DOI 10.1016/S0065-2660(08)00604-4; O'Connor RS, 2007, J CELL SCI, V120, P149, DOI 10.1242/jcs.03307; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Warner DR, 2004, BIOCHEM BIOPH RES CO, V324, P70, DOI 10.1016/j.bbrc.2004.09.017; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yang LQ, 2007, J BIOL CHEM, V282, P16811, DOI 10.1074/jbc.M610488200; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033	75	46	47	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	42					4536	4549		10.1038/onc.2011.618	http://dx.doi.org/10.1038/onc.2011.618			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	022SH	22266867				2022-12-25	WOS:000309982100005
J	Fan, C; Chou, CY; Tong, L; Xiang, S				Fan, Chen; Chou, Chi-Yuan; Tong, Liang; Xiang, Song			Crystal Structure of Urea Carboxylase Provides Insights into the Carboxyltransfer Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS PYRUVATE-CARBOXYLASE; ALLOPHANATE HYDROLASE; BIOTIN CARBOXYLASE; AMIDOLYASE; PROTEIN; ENZYME; DOMAIN; COENZYME; ATP; MECHANISM	Urea carboxylase (UC) is conserved in many bacteria, algae, and fungi and catalyzes the conversion of urea to allophanate, an essential step in the utilization of urea as a nitrogen source in these organisms. UC belongs to the biotin-dependent carboxylase superfamily and shares the biotin carboxylase (BC) and biotin carboxyl carrier protein (BCCP) domains with these other enzymes, but its carboxyltransferase (CT) domain is distinct. Currently, there is no information on the molecular basis of catalysis by UC. We report here the crystal structure of the Kluyveromyces lactis UC and biochemical studies to assess the structural information. Structural and sequence analyses indicate the CT domain of UC belongs to a large family of proteins with diverse functions, including the Bacillus subtilis KipA-KipI complex, which has important functions in sporulation regulation. A structure of the KipA-KipI complex is not currently available, and our structure provides a framework to understand the function of this complex. Most interestingly, in the structure the CT domain interacts with the BCCP domain, with biotin and a urea molecule bound at its active site. This structural information and our follow-up biochemical experiments provided molecular insights into the UC carboxyltransfer reaction. Several structural elements important for the UC carboxyltransfer reaction are found in other biotin-dependent carboxylases and might be conserved within this family, and our data could shed light on the mechanism of catalysis of these enzymes.	[Fan, Chen; Xiang, Song] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Chou, Chi-Yuan] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chou, Chi-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Columbia University	Xiang, S (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	sxiang@sibs.ac.cn	Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; Chou, Chi-Yuan/0000-0002-3400-171X; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [DK067238]; Ministry of Science and Technology of China [2011CB910500, 2010CB912502]; Chinese Academy of Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant DK067238 (to L. T.). This work was also supported by grants from the Ministry of Science and Technology of China 973 Programs 2011CB910500 and 2010CB912502 and the One Hundred Talents Program of the Chinese Academy of Sciences (to S. X.).	Andersen G, 2008, J MOL BIOL, V380, P656, DOI 10.1016/j.jmb.2008.05.029; Attwood PV, 2002, ACCOUNTS CHEM RES, V35, P113, DOI 10.1021/ar000049+; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Huang CS, 2010, NATURE, V466, P1001, DOI 10.1038/nature09302; Jacques DA, 2011, ACTA CRYSTALLOGR D, V67, P105, DOI 10.1107/S0907444910051127; Jacques DA, 2011, J MOL BIOL, V405, P214, DOI 10.1016/j.jmb.2010.10.047; Jacques DA, 2008, J MOL BIOL, V384, P422, DOI 10.1016/j.jmb.2008.09.017; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KALTWASS.H, 1966, ANAL BIOCHEM, V16, P132, DOI 10.1016/0003-2697(66)90088-1; Kanamori T, 2005, FEMS MICROBIOL LETT, V245, P61, DOI 10.1016/j.femsle.2005.02.023; Kanamori T, 2004, J BACTERIOL, V186, P2532, DOI 10.1128/JB.186.9.2532-2539.2004; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; LEFTLEY JW, 1973, J GEN MICROBIOL, V77, P109, DOI 10.1099/00221287-77-1-109; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Mochalkin I, 2008, PROTEIN SCI, V17, P1706, DOI 10.1110/ps.035584.108; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navarathna DHMLP, 2010, FEMS YEAST RES, V10, P209, DOI 10.1111/j.1567-1364.2010.00602.x; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; ROON RJ, 1972, J BIOL CHEM, V247, P4107; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Singer MA, 2003, COMP BIOCHEM PHYS B, V134, P543, DOI 10.1016/S1096-4959(03)00027-7; Sirko A, 2000, ACTA BIOCHIM POL, V47, P1189, DOI 10.18388/abp.2000_3972; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Wang L, 1997, GENE DEV, V11, P2569, DOI 10.1101/gad.11.19.2569; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; WHITNEY PA, 1972, J BIOL CHEM, V247, P1349; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008; Zeczycki TN, 2009, BIOCHEMISTRY-US, V48, P4305, DOI 10.1021/bi9003759	48	27	29	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9389	9398		10.1074/jbc.M111.319475	http://dx.doi.org/10.1074/jbc.M111.319475			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277658	Green Published, hybrid			2022-12-25	WOS:000301797800069
J	Rezk, BM; Yoshida, T; Semprun-Prieto, L; Higashi, Y; Sukhanov, S; Delafontaine, P				Rezk, Bashir M.; Yoshida, Tadashi; Semprun-Prieto, Laura; Higashi, Yusuke; Sukhanov, Sergiy; Delafontaine, Patrice			Angiotensin II Infusion Induces Marked Diaphragmatic Skeletal Muscle Atrophy	PLOS ONE			English	Article							GROWTH-FACTOR-I; OBSTRUCTIVE PULMONARY-DISEASE; CONGESTIVE-HEART-FAILURE; SATELLITE CELLS; STEM-CELL; MYOGENIC PROGENITORS; MOLECULAR REGULATION; GENE-EXPRESSION; BONE-MARROW; WEIGHT-LOSS	Advanced congestive heart failure (CHF) and chronic kidney disease (CKD) are characterized by increased angiotensin II (Ang II) levels and are often accompanied by significant skeletal muscle wasting that negatively impacts mortality and morbidity. Both CHF and CKD patients have respiratory muscle dysfunction, however the potential effects of Ang II on respiratory muscles are unknown. We investigated the effects of Ang II on diaphragm muscle in FVB mice. Ang II induced significant diaphragm muscle wasting (18.7 +/- 1.6% decrease in weight at one week) and reduction in fiber cross-sectional area. Expression of the E3 ubiquitin ligases atrogin-1 and muscle ring finger-1 (MuRF-1) and of the pro-apoptotic factor BAX was increased after 24 h of Ang II infusion (4.4 +/- 0.3 fold, 3.1 +/- 0.5 fold and 1.6 +/- 0.2 fold, respectively, compared to sham infused control) suggesting increased muscle protein degradation and apoptosis. In Ang II infused animals, there was significant regeneration of injured diaphragm muscles at 7 days as indicated by an increase in the number of myofibers with centralized nuclei and high expression of embryonic myosin heavy chain (E-MyHC, 11.2 +/- 3.3 fold increase) and of the satellite cell marker M-cadherin (59.2 +/- 22.2% increase). Furthermore, there was an increase in expression of insulin-like growth factor-1 (IGF-1, 1.8 +/- 0.3 fold increase) in Ang II infused diaphragm, suggesting the involvement of IGF-1 in diaphragm muscle regeneration. Bone-marrow transplantation experiments indicated that although there was recruitment of bone-marrow derived cells to the injured diaphragm in Ang II infused mice (267.0 +/- 74.6% increase), those cells did not express markers of muscle stem cells or regenerating myofibers. In conclusion, Ang II causes marked diaphragm muscle wasting, which may be important for the pathophysiology of respiratory muscle dysfunction and cachexia in conditions such as CHF and CKD.	[Rezk, Bashir M.; Yoshida, Tadashi; Semprun-Prieto, Laura; Higashi, Yusuke; Sukhanov, Sergiy; Delafontaine, Patrice] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA	Tulane University	Rezk, BM (corresponding author), Southern Univ, Dept Nat Sci, New Orleans, LA USA.	pdelafon@tulane.edu		Delafontaine, Patrice/0000-0003-3744-3617; Sukhanov, Sergiy/0000-0002-9223-4263; Yoshida, Tadashi/0000-0002-4544-1497	United States National Institutes of Health/National Heart, Lung, and Blood Institute [R01-HL070241, R01-HL080682]; National Institutes of Health/National Center for Research Resources [P20RR018766]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070241, R01HL080682] Funding Source: NIH RePORTER	United States National Institutes of Health/National Heart, Lung, and Blood Institute; National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants R01-HL070241 and R01-HL080682 from the United States National Institutes of Health/National Heart, Lung, and Blood Institute and grant P20RR018766 from the National Institutes of Health/National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Brink M, 1996, J CLIN INVEST, V97, P2509, DOI 10.1172/JCI118698; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Chakravarthy MV, 2000, J APPL PHYSIOL, V89, P1365, DOI 10.1152/jappl.2000.89.4.1365; Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Du J, 1996, ENDOCRINOLOGY, V137, P1378, DOI 10.1210/en.137.4.1378; Silva ACSE, 2006, PEDIATR RES, V60, P734, DOI 10.1203/01.pdr.0000246100.14061.bc; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Gonzalez-Villalobos RA, 2008, AM J PHYSIOL-RENAL, V295, pF772, DOI 10.1152/ajprenal.00019.2008; GRAZIANI G, 1993, KIDNEY INT, V44, P107, DOI 10.1038/ki.1993.219; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y; Honda H, 2010, J MUSCLE RES CELL M, V31, P71, DOI 10.1007/s10974-010-9209-6; Hughes PD, 1999, AM J RESP CRIT CARE, V160, P529, DOI 10.1164/ajrccm.160.2.9810081; Kanazawa H, 2000, AM J RESP CRIT CARE, V162, P1235, DOI 10.1164/ajrccm.162.4.9909120; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; MANCINI DM, 1992, CIRCULATION, V86, P909, DOI 10.1161/01.CIR.86.3.909; Masson S, 1998, PHARMACOL RES, V37, P213, DOI 10.1006/phrs.1998.0288; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; McKenzie DK, 2009, J APPL PHYSIOL, V107, P621, DOI 10.1152/japplphysiol.00163.2009; Meyer FJ, 2001, CIRCULATION, V103, P2153; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Ottenheijm CAC, 2007, AM J RESP CRIT CARE, V175, P1233, DOI 10.1164/rccm.200701-020PP; Ottenheijm CAC, 2006, AM J RESP CRIT CARE, V174, P997, DOI 10.1164/rccm.200605-721OC; Otto A, 2009, J ANAT, V215, P477, DOI 10.1111/j.1469-7580.2009.01138.x; Pocock SJ, 2008, EUR HEART J, V29, P2641, DOI 10.1093/eurheartj/ehn420; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Scheidegger KJ, 1999, J BIOL CHEM, V274, P3522, DOI 10.1074/jbc.274.6.3522; Schillaci R, 1998, CELL IMMUNOL, V183, P157, DOI 10.1006/cimm.1997.1237; Scime A, 2009, FRONT BIOSCI-LANDMRK, V14, P3012, DOI 10.2741/3431; Semprun-Prieto LC, 2011, BIOCHEM BIOPH RES CO, V409, P217, DOI 10.1016/j.bbrc.2011.04.122; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Strassburg S, 2005, INT J BIOCHEM CELL B, V37, P1938, DOI 10.1016/j.biocel.2005.03.013; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; van Hees HWH, 2007, AM J PHYSIOL-HEART C, V293, pH819, DOI 10.1152/ajpheart.00085.2007; Vlahakos DV, 1999, AM J MED, V106, P158, DOI 10.1016/S0002-9343(98)00390-8; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wong E, 2011, HEART LUNG CIRC, V20, P289, DOI 10.1016/j.hlc.2011.01.009; Yoshida T, 2010, AM J PHYSIOL-HEART C, V298, pH1565, DOI 10.1152/ajpheart.00146.2010; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	54	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30276	10.1371/journal.pone.0030276	http://dx.doi.org/10.1371/journal.pone.0030276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276172	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100030
J	Chen, J; Stahl, A; Krah, NM; Seaward, MR; Joyal, JS; Juan, AM; Hatton, CJ; Aderman, CM; Dennison, RJ; Willett, KL; Sapieha, P; Smith, LEH				Chen, Jing; Stahl, Andreas; Krah, Nathan M.; Seaward, Molly R.; Joyal, Jean-Sebastian; Juan, Aimee M.; Hatton, Colman J.; Aderman, Christopher M.; Dennison, Roberta J.; Willett, Keirnan L.; Sapieha, Przemyslaw; Smith, Lois E. H.			Retinal Expression of Wnt-Pathway Mediated Genes in Low-Density Lipoprotein Receptor-Related Protein 5 (Lrp5) Knockout Mice	PLOS ONE			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; BLOOD-BRAIN-BARRIER; NORRIE-DISEASE; MUTATIONS; RETINOPATHY; ANGIOGENESIS; FRIZZLED-4; GROWTH; MOUSE; HYPOXIA	Mutations in low-density lipoprotein receptor-related protein 5 (Lrp5) impair retinal angiogenesis in patients with familial exudative vitreoretinopathy (FEVR), a rare type of blinding vascular eye disease. The defective retinal vasculature phenotype in human FEVR patients is recapitulated in Lrp5 knockout (Lrp5(-/-)) mouse with delayed and incomplete development of retinal vessels. In this study we examined gene expression changes in the developing Lrp5(-/-) mouse retina to gain insight into the molecular mechanisms that underlie the pathology of FEVR in humans. Gene expression levels were assessed with an Illumina microarray on total RNA from Lrp5(-/-) and WT retinas isolated on postnatal day (P) 8. Regulated genes were confirmed using RT-qPCR analysis. Consistent with a role in vascular development, we identified expression changes in genes involved in cell-cell adhesion, blood vessel morphogenesis and membrane transport in Lrp5(-/-) retina compared to WT retina. In particular, tight junction protein claudin5 and amino acid transporter slc38a5 are both highly down-regulated in Lrp5(-/-) retina. Similarly, several Wnt ligands including Wnt7b show decreased expression levels. Plasmalemma vesicle associated protein (plvap), an endothelial permeability marker, in contrast, is up-regulated consistent with increased permeability in Lrp5(-/-) retinas. Together these data suggest that Lrp5 regulates multiple groups of genes that influence retinal angiogenesis and may contribute to the pathogenesis of FEVR.	[Chen, Jing; Stahl, Andreas; Krah, Nathan M.; Seaward, Molly R.; Joyal, Jean-Sebastian; Juan, Aimee M.; Hatton, Colman J.; Aderman, Christopher M.; Dennison, Roberta J.; Willett, Keirnan L.; Sapieha, Przemyslaw; Smith, Lois E. H.] Harvard Univ, Sch Med, Dept Ophthalmol, Childrens Hosp Boston, Boston, MA 02115 USA; [Stahl, Andreas] Univ Eye Hosp Freiburg, Freiburg, Germany; [Sapieha, Przemyslaw] Univ Montreal, Hop Maison Neuve Rosemont, Res Ctr, Dept Ophthalmol, Montreal, PQ, Canada	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Freiburg; Universite de Montreal	Chen, J (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Childrens Hosp Boston, Boston, MA 02115 USA.	lois.smith@childrens.harvard.edu		Juan, Aimee/0000-0002-0221-2280	Knights Templar Eye Foundation; Children's Hospital Boston Manton Center; Juvenile Diabetes Research Foundation International; Charles H. Hood Foundation; National Institutes of Health [EY017017, EY017017-04S1, NIH-P50-NS40828, NIH-P30-HD18655]; V. Kann Rasmussen Foundation; Children's Hospital Boston Mental Retardation and Developmental Disabilities Research Center; Research to Prevent Blindness; Alcon Research Institute; MacTel Foundation; Roche Foundation for Anemia Research; Deutsche Forschungsgemeinschaft; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017017, R01EY022275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	Knights Templar Eye Foundation; Children's Hospital Boston Manton Center; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Charles H. Hood Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V. Kann Rasmussen Foundation; Children's Hospital Boston Mental Retardation and Developmental Disabilities Research Center; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Alcon Research Institute(Novartis); MacTel Foundation; Roche Foundation for Anemia Research; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from Knights Templar Eye Foundation, Children's Hospital Boston Manton Center for Orphan Disease Research Innovation Fund, Juvenile Diabetes Research Foundation International, Charles H. Hood Foundation Child Health Research Award (to JC), National Institutes of Health (EY017017, EY017017-04S1), V. Kann Rasmussen Foundation, Children's Hospital Boston Mental Retardation and Developmental Disabilities Research Center, Research to Prevent Blindness Senior Investigator Award, Alcon Research Institute Award, MacTel Foundation and Roche Foundation for Anemia Research (LEHS). AS is supported by the Deutsche Forschungsgemeinschaft. PS holds a Canada Research Chair in Retinal Cell Biology and is supported by the Canadian Institutes of Health Research. Microarray studies were performed by the Molecular Genetics Core Facility at Children's Hospital Boston supported by NIH-P50-NS40828, and NIH-P30-HD18655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger W, 1998, ACTA ANAT, V162, P95; Campbell M, 2009, P NATL ACAD SCI USA, V106, P17817, DOI 10.1073/pnas.0908561106; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Dickinson JL, 2006, CLIN EXP OPHTHALMOL, V34, P682, DOI 10.1111/j.1442-9071.2006.01314.x; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Keuschnigg J, 2009, BLOOD, V114, P478, DOI 10.1182/blood-2008-11-188763; Kurihara T, 2010, DEVELOPMENT, V137, P1563, DOI 10.1242/dev.049015; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu CQ, 2008, DEVELOPMENT, V135, P3567, DOI 10.1242/dev.028076; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Qin MH, 2005, HUM MUTAT, V26, P104, DOI 10.1002/humu.20191; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; Shastry BS, 2009, CLIN EXP OPHTHALMOL, V37, P884, DOI 10.1111/j.1442-9071.2009.02150.x; Shastry BS, 1997, HUM MUTAT, V9, P396, DOI 10.1002/(SICI)1098-1004(1997)9:5<396::AID-HUMU3>3.3.CO;2-8; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; TOOMES C, 2005, GENEREVIEWS; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umapathy NS, 2008, INVEST OPHTH VIS SCI, V49, P5151, DOI 10.1167/iovs.08-2245; Umapathy NS, 2005, INVEST OPHTH VIS SCI, V46, P3980, DOI 10.1167/iovs.05-0488; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xia CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011676; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zhang B, 2010, DIABETES, V59, P1809, DOI 10.2337/db09-1056; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou CJ, 2010, DEV DYNAM, V239, P318, DOI 10.1002/dvdy.22054; Zhou T, 2011, DIABETOLOGIA, V54, P459, DOI 10.1007/s00125-010-1943-1; Zhou T, 2010, INVEST OPHTH VIS SCI, V51, P4371, DOI 10.1167/iovs.09-4278	51	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30203	10.1371/journal.pone.0030203	http://dx.doi.org/10.1371/journal.pone.0030203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272305	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400083
J	Deng, W; Wang, XN; Xiao, JF; Chen, KJ; Zhou, H; Shen, DF; Li, HL; Tang, QZ				Deng, Wei; Wang, Xinan; Xiao, Jinfeng; Chen, Kuoju; Zhou, Heng; Shen, Difei; Li, Hongliang; Tang, Qizhu			Loss of Regulator of G Protein Signaling 5 Exacerbates Obesity, Hepatic Steatosis, Inflammation and Insulin Resistance	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; DIET-INDUCED OBESITY; ACTIVATED RECEPTOR-GAMMA; ADIPOSE-TISSUE; FACTOR-ALPHA; BODY-WEIGHT; EXPRESSION; MICE; MECHANISMS; ADIPOGENESIS	Background: The effect of regulator of G protein signaling 5 (RGS5) on cardiac hypertrophy, atherosclerosis and angiogenesis has been well demonstrated, but the role in the development of obesity and insulin resistance remains completely unknown. We determined the effect of RGS5 deficiency on obesity, hepatic steatosis, inflammation and insulin resistance in mice fed either a normal-chow diet (NC) or a high-fat diet (HF). Methodology/Principal Findings: Male, 8-week-old RGS5 knockout (KO) and littermate control mice were fed an NC or an HF for 24 weeks and were phenotyped accordingly. RGS5 KO mice exhibited increased obesity, fat mass and ectopic lipid deposition in the liver compared with littermate control mice, regardless of diet. When fed an HF, RGS5 KO mice had a markedly exacerbated metabolic dysfunction and inflammatory state in the blood serum. Meanwhile, macrophage recruitment and inflammation were increased and these increases were associated with the significant activation of JNK, I kappa B alpha and NF-kappa Bp65 in the adipose tissue, liver and skeletal muscle of RGS5 KO mice fed an HF relative to control mice. These exacerbated metabolic dysfunction and inflammation are accompanied with decreased systemic insulin sensitivity in the adipose tissue, liver and skeletal muscle of RGS5 KO mice, reflected by weakened Akt/GSK3 beta phosphorylation. Conclusions/Significance: Our data suggest that loss of RGS5 exacerbates HF-induced obesity, hepatic steatosis, inflammation and insulin resistance.	[Deng, Wei; Wang, Xinan; Xiao, Jinfeng; Chen, Kuoju; Zhou, Heng; Shen, Difei; Li, Hongliang; Tang, Qizhu] Wuhan Univ, Renmin Hosp, Dept Cardiol, Cardiovasc Res Inst, Wuhan 430072, Peoples R China	Wuhan University	Tang, QZ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Cardiovasc Res Inst, Wuhan 430072, Peoples R China.	qztang@whu.edu.cn	Kuo, Hao-chung/ABF-9568-2020		Fundamental Research Funds for the Central Universities of China [20103020101000199]; National Basic Research Program of China (973 Program) [2011CB503900]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	Dr. Deng and Dr. Tang received the Fundamental Research Funds for the Central Universities of China [20103020101000199]. Dr. Li received the National Basic Research Program of China (973 Program) [2011CB503900]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2007, DRUG DISCOV TODAY, V12, P740, DOI 10.1016/j.drudis.2007.07.009; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; COPPACK SW, 1992, METABOLISM, V41, P264, DOI 10.1016/0026-0495(92)90269-G; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; FEINGOLD KR, 1987, J CLIN INVEST, V80, P184, DOI 10.1172/JCI113046; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Gunaje JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC478, DOI 10.1152/ajpcell.00348.2010; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang XY, 2008, DIABETES, V57, P77, DOI 10.2337/db07-0599; Huang XP, 2002, AM J PHYSIOL-CELL PH, V283, pC386, DOI 10.1152/ajpcell.00320.2001; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Kanoh Y, 2000, CELL SIGNAL, V12, P223, DOI 10.1016/S0898-6568(99)00081-9; Karpe F, 2005, BIOCHEM SOC T, V33, P1045, DOI 10.1042/BST0331045; KATHER H, 1985, J CLIN INVEST, V76, P1559, DOI 10.1172/JCI112137; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kirk EA, 2008, DIABETES, V57, P1254, DOI 10.2337/db07-1061; Kreuzer J, 2004, BIOCHEM J, V380, P831, DOI 10.1042/BJ20031659; Larminie C, 2004, MOL BRAIN RES, V122, P24, DOI 10.1016/j.molbrainres.2003.11.014; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Nunn C, 2011, CELL SIGNAL, V23, P1375, DOI 10.1016/j.cellsig.2011.03.020; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schioth Helgi B., 2006, CNS & Neurological Disorders-Drug Targets, V5, P241, DOI 10.2174/187152706777452263; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Usui I, 2004, EMBO J, V23, P2821, DOI 10.1038/sj.emboj.7600297; Villena JA, 2008, DIABETES, V57, P3258, DOI 10.2337/db07-1739; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	53	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30256	10.1371/journal.pone.0030256	http://dx.doi.org/10.1371/journal.pone.0030256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272317	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400095
J	Juuti-Uusitalo, K; Vaajasaari, H; Ryhanen, T; Narkilahti, S; Suuronen, R; Mannermaa, E; Kaarniranta, K; Skottman, H				Juuti-Uusitalo, Kati; Vaajasaari, Hanna; Ryhanen, Tuomas; Narkilahti, Susanna; Suuronen, Riitta; Mannermaa, Eliisa; Kaarniranta, Kai; Skottman, Heli			Efflux Protein Expression in Human Stem Cell-Derived Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEINS; P-GLYCOPROTEIN EXPRESSION; BLOOD-BRAIN-BARRIER; FUNCTIONAL-CHARACTERIZATION; CONFERS RESISTANCE; OCULAR BARRIERS; DRUG TRANSPORT; CHOROID-PLEXUS; DERIVATION; DISEASES	Retinal pigment epithelial (RPE) cells in the back of the eye nourish photoreceptor cells and form a selective barrier that influences drug transport from the blood to the photoreceptor cells. At the molecular level, ATP-dependent efflux transporters have a major role in drug delivery in human RPE. In this study, we assessed the relative expression of several ATP-dependent efflux transporter genes (MRP1, -2, -3, -4, -5, -6, p-gp, and BCRP), the protein expression and localization of MRP1, MRP4, and MRP5, and the functionality of MRP1 efflux pumps at different maturation stages of undifferentiated human embryonic stem cells (hESC) and RPE derived from the hESC (hESC-RPE). Our findings revealed that the gene expression of ATP-dependent efflux transporters MRP1, -3, -4, -5, and p-gp fluctuated during hESC-RPE maturation from undifferentiated hESC to fusiform, epithelioid, and finally to cobblestone hESC-RPE. Epithelioid hESC-RPE had the highest expression of MRP1, -3, -4, and P-gp, whereas the most mature cobblestone hESC-RPE had the highest expression of MRP5 and MRP6. These findings indicate that a similar efflux protein profile is shared between hESC-RPE and the human RPE cell line, ARPE-19, and suggest that hESC-RPE cells are suitable in vitro RPE models for drug transport studies. Embryonic stem cell model might provide a novel tool to study retinal cell differentiation, mechanisms of RPE -derived diseases, drug testing and targeted drug therapy.	[Juuti-Uusitalo, Kati; Vaajasaari, Hanna; Narkilahti, Susanna; Suuronen, Riitta; Skottman, Heli] Univ Tampere, FIN-33101 Tampere, Finland; [Ryhanen, Tuomas; Mannermaa, Eliisa; Kaarniranta, Kai] Univ Eastern Finland, Dept Ophthalmol, Inst Clin Med, Kuopio, Finland; [Suuronen, Riitta] Tampere Univ Hosp, Dept Eye Ear & Oral Dis, Tampere, Finland; [Suuronen, Riitta] Tampere Univ Technol, Dept Biomat Engn, FIN-33101 Tampere, Finland; [Mannermaa, Eliisa; Kaarniranta, Kai] Kuopio Univ Hosp, Dept Ophthalmol, SF-70210 Kuopio, Finland	University of Eastern Finland; Tampere University; Tampere University Hospital; Tampere University; Kuopio University Hospital; University of Eastern Finland	Juuti-Uusitalo, K (corresponding author), Univ Tampere, FIN-33101 Tampere, Finland.	Kati.Juuti-Uusitalo@uta.fi	Seppänen-Kaijasinkko, Riitta/AAE-1476-2021	Kaarniranta, Kai/0000-0003-2600-8679; Skottman, Heli/0000-0002-4127-8792; Juuti-Uusitalo, Kati/0000-0003-2275-5562	Tekes - the Finnish Funding Agency for Technology and Innovation; Finnish Cultural Foundation; Emil Aaltonen Foundation; Academy of Finland [122959, 218050, 137801]; Tampere Graduate Program in Biomedicine and Biotechnology; BioneXt Tampere	Tekes - the Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Emil Aaltonen Foundation; Academy of Finland(Academy of Finland); Tampere Graduate Program in Biomedicine and Biotechnology; BioneXt Tampere	This study was financially supported by Tekes - the Finnish Funding Agency for Technology and Innovation, the Finnish Cultural Foundation, the Emil Aaltonen Foundation, the Tampere Graduate Program in Biomedicine and Biotechnology, BioneXt Tampere, and the Academy of Finland (grant numbers 122959, 218050, and 137801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2002, J BIOL CHEM, V277, P38998, DOI 10.1074/jbc.M203262200; Algvere PV, 2002, ACTA OPHTHALMOL SCAN, V80, P136, DOI 10.1034/j.1600-0420.2002.800204.x; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Aukunuru JV, 2001, PHARM RES-DORDR, V18, P565, DOI 10.1023/A:1011060705599; BITO LZ, 1973, EXP EYE RES, V16, P299, DOI 10.1016/0014-4835(73)90095-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai H, 2006, CURR EYE RES, V31, P181, DOI 10.1080/02713680500514628; Carr A-JF, 2009, REPROGRAMMED HUMAN F; Chan GNY, 2011, METHODS MOL BIOL, V686, P313, DOI 10.1007/978-1-60761-938-3_15; Constable PA, 2006, EXP EYE RES, V83, P24, DOI 10.1016/j.exer.2005.10.029; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Graff CL, 2004, CURR DRUG METAB, V5, P95, DOI 10.2174/1389200043489126; Hirami Y, 2009, GENERATION RETINAL P; Hornof M, 2005, EUR J PHARM BIOPHARM, V60, P207, DOI 10.1016/j.ejpb.2005.01.009; Hosoya KI, 2009, PHARM RES-DORD, V26, P2055, DOI 10.1007/s11095-009-9930-2; Jin ZB, 2009, J GENET, V88, P417, DOI 10.1007/s12041-009-0063-5; Jorojuria S, 2004, ANTIVIR THER, V9, P519; Kennedy BG, 2002, MOL VIS, V8, P422; Keppler D, 2011, HANDB EXP PHARMACOL, V201, P299, DOI 10.1007/978-3-642-14541-4_8; Klement JF, 2005, MOL CELL BIOL, V25, P8299, DOI 10.1128/MCB.25.18.8299-8310.2005; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Lamba DA, 2011, INVEST OPHTH VIS SCI, V52, P4897, DOI 10.1167/iovs.10-6504; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mannermaa E, 2006, ADV DRUG DELIVER REV, V58, P1136, DOI 10.1016/j.addr.2006.07.024; Mannermaa E, 2009, PHARM RES-DORD, V26, P1785, DOI 10.1007/s11095-009-9890-6; MARMOR MF, 1986, ARCH OPHTHALMOL-CHIC, V104, P1674; Nies AT, 2004, NEUROSCIENCE, V129, P349, DOI 10.1016/j.neuroscience.2004.07.051; Pelis RM, 2009, J PHARMACOL EXP THER, V329, P479, DOI 10.1124/jpet.108.149625; Pratt S, 2005, MOL CANCER THER, V4, P855, DOI 10.1158/1535-7163.MCT-04-0291; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Scheffer GL, 2002, LAB INVEST, V82, P515, DOI 10.1038/labinvest.3780444; Skottman H, 2010, IN VITRO CELL DEV-AN, V46, P206, DOI 10.1007/s11626-010-9286-2; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; Stern JH, 2011, NEUROTHERAPEUTICS, V8, P736, DOI 10.1007/s13311-011-0077-6; Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925; Vaajasaari H, 2011, MOL VIS, V17, P558; Wijnholds J, 2000, P NATL ACAD SCI USA, V97, P7476, DOI 10.1073/pnas.120159197; Yang AK, 2010, CURR TOP MED CHEM, V10, P1732, DOI 10.2174/156802610792928040; Zhang T, 2008, DRUG METAB DISPOS, V36, P1300, DOI 10.1124/dmd.108.021121; Zhu D, INVEST OPHTHALMOL VI, V52, P1573	42	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30089	10.1371/journal.pone.0030089	http://dx.doi.org/10.1371/journal.pone.0030089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272278	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400056
J	Mayer, E; Bannert, C; Gruber, S; Klunker, S; Spittler, A; Akdis, CA; Szepfalusi, Z; Eiwegger, T				Mayer, Elisabeth; Bannert, Christina; Gruber, Saskia; Klunker, Sven; Spittler, Andreas; Akdis, Cezmi A.; Szepfalusi, Zsolt; Eiwegger, Thomas			Cord Blood Derived CD4(+)CD25(high) T Cells Become Functional Regulatory T Cells upon Antigen Encounter	PLOS ONE			English	Article							INTERFERON-GAMMA PRODUCTION; VERSUS-HOST-DISEASE; HUMAN IMMUNE-SYSTEM; MONONUCLEAR-CELLS; ENVIRONMENTAL ALLERGENS; SELF-TOLERANCE; EARLY-LIFE; EXPRESSION; RESPONSES; ADULT	Background: Upon antigen exposure, cord blood derived T cells respond to ubiquitous environmental antigens by high proliferation. To date it remains unclear whether these "excessive" responses relate to different regulatory properties of the putative T regulatory cell (Treg) compartment or even expansion of the Treg compartment itself. Methods: Cord blood (>37 week of gestation) and peripheral blood (healthy controls) were obtained and different Treg cell subsets were isolated. The suppressive potential of Treg populations after antigen exposure was evaluated via functional inhibition assays ([H-3]thymidine incorporation assay and CFSE staining) with or without allergen stimulation. The frequency and markers of CD4(+)CD25(high)FoxP(3+) T cells were characterized by mRNA analysis and flow cytometry. Results: Cord blood derived CD4(+)CD25(high) cells did not show substantial suppressor capacity upon TCR activation, in contrast to CD4(+)CD25(high) cells freshly purified from adult blood. This could not be explained by a lower frequency of FoxP3(+)CD4(+)CD25(high) cells or FOXP3 mRNA expression. However, after antigen-specific stimulation in vitro, these cells showed strong proliferation and expansion and gained potent suppressive properties. The efficiency of their suppressive capacity can be enhanced in the presence of endotoxins. If T-cells were sorted according to their CD127 expression, a tiny subset of Treg cells (CD4(+)CD25(+)CD127(low)) is highly suppressive even without prior antigen exposure. Conclusion: Cord blood harbors a very small subset of CD4(+)CD25(high) Treg cells that requires antigen-stimulation to show expansion and become functional suppressive Tregs.	[Mayer, Elisabeth; Bannert, Christina; Gruber, Saskia; Szepfalusi, Zsolt; Eiwegger, Thomas] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Klunker, Sven; Akdis, Cezmi A.; Eiwegger, Thomas] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Spittler, Andreas] Med Univ Vienna, Surg Res Labs, Vienna, Austria; [Spittler, Andreas] Med Univ Vienna, Core Facil Flow Cytometry, Vienna, Austria	Medical University of Vienna; Swiss Institute of Allergy & Asthma Research; University of Zurich; Medical University of Vienna; Medical University of Vienna	Mayer, E (corresponding author), Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria.	thomas.eiwegger@meduniwien.ac.at	Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X; Spittler, Andreas/0000-0003-2657-6836; Szepfalusi, Zsolt/0000-0003-4852-3102; Eiwegger, Thomas/0000-0002-2914-7829	Oesterreichische Nationalbank, Jubilaumsfonds fur die Forderung von Forschungs- und Lehraufgaben der Wissenschaft [13013, 13846]; Swiss National Science Foundation [320030-132899]; Christine Kuhne Center for Allergy Research and Education (CK-CARE)	Oesterreichische Nationalbank, Jubilaumsfonds fur die Forderung von Forschungs- und Lehraufgaben der Wissenschaft; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Christine Kuhne Center for Allergy Research and Education (CK-CARE)	This work was supported by the Oesterreichische Nationalbank, Jubilaumsfonds fur die Forderung von Forschungs- und Lehraufgaben der Wissenschaft (#13013 and #13846). Cezmi Akdis's lab is supported by Swiss National Science Foundation grants (No 320030-132899) and Christine Kuhne Center for Allergy Research and Education (CK-CARE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2009, NAT REV DRUG DISCOV, V8, P645, DOI 10.1038/nrd2653; ALLAN MJ, 1983, PSYCHOL REP, V53, P43, DOI 10.2466/pr0.1983.53.1.43; Chang CC, 2005, EXP HEMATOL, V33, P1508, DOI 10.1016/j.exphem.2005.09.002; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Downs SH, 2001, CLIN EXP ALLERGY, V31, P570, DOI 10.1046/j.1365-2222.2001.01070.x; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Eiwegger T, 2008, CLIN EXP ALLERGY, V38, P1627, DOI 10.1111/j.1365-2222.2008.03080.x; Godfrey WR, 2005, BLOOD, V105, P750, DOI 10.1182/blood-2004-06-2467; Heinrich J, 2002, EUR RESPIR J, V19, P1040, DOI 10.1183/09031936.02.00261802; Holloway JA, 2000, LANCET, V356, P1900, DOI 10.1016/S0140-6736(00)03265-7; Holt PG, 2008, J ALLERGY CLIN IMMUN, V122, P717, DOI 10.1016/j.jaci.2008.08.019; Hong XM, 2010, J ALLERGY CLIN IMMUN, V126, P1059, DOI 10.1016/j.jaci.2010.08.029; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kasow KA, 2004, J IMMUNOL, V172, P6123, DOI 10.4049/jimmunol.172.10.6123; Kondo N, 1998, CLIN EXP ALLERGY, V28, P1340; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Loibichler C., 2002, Clinical and Experimental Allergy, V32, P1546, DOI 10.1046/j.1365-2222.2002.01479.x; MARTINEZ FD, 1995, J ALLERGY CLIN IMMUN, V96, P652, DOI 10.1016/S0091-6749(95)70264-4; Neaville WA, 2003, J ALLERGY CLIN IMMUN, V112, P740, DOI 10.1016/S0091-6749(03)01868-2; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; PIASTRA M, 1994, INT ARCH ALLERGY IMM, V104, P358, DOI 10.1159/000236692; PICCINNI MP, 1993, INT ARCH ALLERGY IMM, V102, P301, DOI 10.1159/000236541; Porter SB, 2006, TRANSPLANTATION, V82, P23, DOI 10.1097/01.tp.0000225824.48931.af; Prescott SL, 2000, ALLERGY, V55, P470; Prescott SL, 1998, J IMMUNOL, V160, P4730; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Smillie FI, 2001, CLIN EXP ALLERGY, V31, P1194, DOI 10.1046/j.1365-2222.2001.01173.x; Smith M, 2008, J ALLERGY CLIN IMMUN, V121, P1460, DOI 10.1016/j.jaci.2008.03.025; Szepfalusi Z, 2000, PEDIATR RES, V48, P404, DOI 10.1203/00006450-200009000-00024; Szepfalusi Z, 2000, J ALLERGY CLIN IMMUN, V106, P530; Szepfalusi Z, 2006, CLIN EXP ALLERGY, V36, P1130, DOI 10.1111/j.1365-2222.2006.02559.x; Szepfalusi Z, 1997, CLIN EXP ALLERGY, V27, P28, DOI 10.1046/j.1365-2222.1997.d01-417.x; Szepfalusi Z, 1998, J ALLERGY CLIN IMMUN, V101, P514, DOI 10.1016/S0091-6749(98)70359-8; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Thornton CA, 2004, J IMMUNOL, V173, P3084, DOI 10.4049/jimmunol.173.5.3084; Warner JA, 2000, BRIT MED BULL, V56, P883, DOI 10.1258/0007142001903571; Wing K, 2005, IMMUNOLOGY, V115, P516, DOI 10.1111/j.1365-2567.2005.02186.x; Wing K, 2002, IMMUNOLOGY, V106, P190, DOI 10.1046/j.1365-2567.2002.01412.x; Wing K, 2003, EUR J IMMUNOL, V33, P579, DOI 10.1002/eji.200323701; Zelenay S, 2005, P NATL ACAD SCI USA, V102, P4091, DOI 10.1073/pnas.0408679102	45	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29355	10.1371/journal.pone.0029355	http://dx.doi.org/10.1371/journal.pone.0029355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272233	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000301454400012
J	Mormeneo, E; Jimenez-Mallebrera, C; Palomer, X; De Nigris, V; Vazquez-Carrera, M; Orozco, A; Nascimento, A; Colomer, J; Lerin, C; Gomez-Foix, AM				Mormeneo, Emma; Jimenez-Mallebrera, Cecilia; Palomer, Xavier; De Nigris, Valeria; Vazquez-Carrera, Manuel; Orozco, Anna; Nascimento, Andres; Colomer, Jaume; Lerin, Carles; Gomez-Foix, Anna M.			PGC-1 alpha Induces Mitochondrial and Myokine Transcriptional Programs and Lipid Droplet and Glycogen Accumulation in Cultured Human Skeletal Muscle Cells	PLOS ONE			English	Article							COACTIVATOR 1-ALPHA PGC-1-ALPHA; GENE-EXPRESSION; IN-VIVO; EXERCISE; OVEREXPRESSION; OXIDATION; INCREASES; CHEMOKINES; PROTEIN; ALPHA	The transcriptional coactivator peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha) is a chief activator of mitochondrial and metabolic programs and protects against atrophy in skeletal muscle (skm). Here we tested whether PGC-1 alpha overexpression could restructure the transcriptome and metabolism of primary cultured human skm cells, which display a phenotype that resembles the atrophic phenotype. An oligonucleotide microarray analysis was used to reveal the effects of PGC-1 alpha on the whole transcriptome. Fifty-three different genes showed altered expression in response to PGC-1 alpha: 42 upregulated and 11 downregulated. The main gene ontologies (GO) associated with the upregulated genes were mitochondrial components and processes and this was linked with an increase in COX activity, an indicator of mitochondrial content. Furthermore, PGC-1 alpha enhanced mitochondrial oxidation of palmitate and lactate to CO2, but not glucose oxidation. The other most significantly associated GOs for the upregulated genes were chemotaxis and cytokine activity, and several cytokines, including IL-8/CXCL8, CXCL6, CCL5 and CCL8, were within the most highly induced genes. Indeed, PGC-1 alpha highly increased IL-8 cell protein content. The most upregulated gene was PVALB, which is related to calcium signaling. Potential metabolic regulators of fatty acid and glucose storage were among mainly regulated genes. The mRNA and protein level of FITM1/FIT1, which enhances the formation of lipid droplets, was raised by PGC-1 alpha, while in oleate-incubated cells PGC-1 alpha increased the number of smaller lipid droplets and modestly triglyceride levels, compared to controls. CALM1, the calcium-modulated delta subunit of phosphorylase kinase, was downregulated by PGC-1 alpha, while glycogen phosphorylase was inactivated and glycogen storage was increased by PGC-1 alpha. In conclusion, of the metabolic transcriptome deficiencies of cultured skm cells, PGC-1 alpha rescued the expression of genes encoding mitochondrial proteins and FITM1. Several myokine genes, including IL-8 and CCL5, which are known to be constitutively expressed in human skm cells, were induced by PGC-1 alpha.	[Mormeneo, Emma; Palomer, Xavier; Vazquez-Carrera, Manuel; Orozco, Anna; Lerin, Carles; Gomez-Foix, Anna M.] CIBER Diabet & Enfermedades Metabol CIBERDEM, Barcelona, Spain; [Mormeneo, Emma; Orozco, Anna; Gomez-Foix, Anna M.] Univ Barcelona, Dept Bioquim & Biol Mol, IBUB, Barcelona, Spain; [Jimenez-Mallebrera, Cecilia; Nascimento, Andres; Colomer, Jaume] Hosp St Joan de Deu, Unitat Patol Neuromuscular, Serv Neurol, Barcelona, Spain; [Palomer, Xavier; Vazquez-Carrera, Manuel] Univ Barcelona, IBUB, Dept Farmacol & Quim Terapeut, Barcelona, Spain; [De Nigris, Valeria; Lerin, Carles] Inst Biomed Res August Pi i Sunyer IDIBAPS, Diabet & Obes Lab, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Mormeneo, E (corresponding author), CIBER Diabet & Enfermedades Metabol CIBERDEM, Barcelona, Spain.	emormeneo@ub.edu	Vázquez-Carrera, Manuel/H-2612-2015; Tarridas, Xavier Palomer/H-1494-2015; Lerin, Carles/AAP-9916-2020; Jiménez-Mallebrera, Cecilia/F-5030-2016	Vázquez-Carrera, Manuel/0000-0001-7138-8207; Lerin, Carles/0000-0003-0950-4363; Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; DE NIGRIS, VALERIA/0000-0002-7556-4906	Spain's Ministerio de Ciencia e Innovacion (MCI) [SAF2009-07559]; CIBERDEM de Diabetes y Enfermedades Metabolicas asociadas [CB07/08/0012]; MCI	Spain's Ministerio de Ciencia e Innovacion (MCI); CIBERDEM de Diabetes y Enfermedades Metabolicas asociadas; MCI	This study was supported by the following grants: SAF2009-07559 from the Spain's Ministerio de Ciencia e Innovacion (MCI) and CIBERDEM de Diabetes y Enfermedades Metabolicas asociadas (CB07/08/0012). EM was the recipient of a FPI fellowship from the MCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Akerstrom T, 2005, J PHYSIOL-LONDON, V563, P507, DOI 10.1113/jphysiol.2004.077610; Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arif SH, 2009, BIOESSAYS, V31, P410, DOI 10.1002/bies.200800170; Arnold A, 2010, GERONTOLOGY; Baque S, 1998, DIABETES, V47, P1185, DOI 10.2337/diabetes.47.8.1185; Baque S, 1996, J BIOL CHEM, V271, P2594, DOI 10.1074/jbc.271.5.2594; Beltran S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r67; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Brushia Robert J., 1999, Frontiers in Bioscience, V4, pd618, DOI 10.2741/Brushia; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Consitt LA, 2010, DIABETES, V59, P1407, DOI 10.2337/db09-1704; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; De Rossi M, 2000, INT IMMUNOL, V12, P1329, DOI 10.1093/intimm/12.9.1329; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Espinoza DO, 2010, FASEB J, V24, P1003, DOI 10.1096/fj.09-133728; Ferrer-Martinez A, 2006, GENE, V384, P145, DOI 10.1016/j.gene.2006.07.042; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jozsi AC, 2000, MECH AGEING DEV, V120, P45, DOI 10.1016/S0047-6374(00)00178-0; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kortvely E, 2004, LIFE SCI, V74, P1065, DOI 10.1016/j.lfs.2003.07.026; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kramer DK, 2006, ACTA PHYSIOL, V188, P207, DOI 10.1111/j.1748-1716.2006.01620.x; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Lucas EK, 2010, J NEUROSCI, V30, P7227, DOI 10.1523/JNEUROSCI.0698-10.2010; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Olesen J, 2010, PFLUG ARCH EUR J PHY, V460, P153, DOI 10.1007/s00424-010-0834-0; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Powers SK, 2011, J PHYSL; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; SIRCA A, 1985, J ANAT, V141, P131; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; THORSTENSSON A, 1987, ACTA PHYSIOL SCAND, V131, P195, DOI 10.1111/j.1748-1716.1987.tb08226.x; Toutenhoofd SL, 2000, CELL CALCIUM, V28, P83, DOI 10.1054/ceca.2000.0136; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106	62	39	42	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29985	10.1371/journal.pone.0029985	http://dx.doi.org/10.1371/journal.pone.0029985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272266	gold, Green Submitted, Green Published			2022-12-25	WOS:000301454400045
J	Smith, P; Siddharth, J; Pearson, R; Holway, N; Shaxted, M; Butler, M; Clark, N; Jamontt, J; Watson, RP; Sanmugalingam, D; Parkinson, SJ				Smith, Philip; Siddharth, Jay; Pearson, Ruth; Holway, Nicholas; Shaxted, Mark; Butler, Matt; Clark, Natalie; Jamontt, Joanna; Watson, Robert P.; Sanmugalingam, Devika; Parkinson, Scott J.			Host Genetics and Environmental Factors Regulate Ecological Succession of the Mouse Colon Tissue-Associated Microbiota	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; IN-SITU HYBRIDIZATION; CROHNS-DISEASE; EXPERIMENTAL COLITIS; ULCERATIVE-COLITIS; HUMAN INTESTINE; MICE; BACTERIA; SUSCEPTIBILITY; MICROFLORA	Background: The integration of host genetics, environmental triggers and the microbiota is a recognised factor in the pathogenesis of barrier function diseases such as IBD. In order to determine how these factors interact to regulate the host immune response and ecological succession of the colon tissue-associated microbiota, we investigated the temporal interaction between the microbiota and the host following disruption of the colonic epithelial barrier. Methodology/Principal Findings: Oral administration of DSS was applied as a mechanistic model of environmental damage of the colon and the resulting inflammation characterized for various parameters over time in WT and Nod2 KO mice. Results: In WT mice, DSS damage exposed the host to the commensal flora and led to a migration of the tissue-associated bacteria from the epithelium to mucosal and submucosal layers correlating with changes in proinflammatory cytokine profiles and a progressive transition from acute to chronic inflammation of the colon. Tissue-associated bacteria levels peaked at day 21 post-DSS and declined thereafter, correlating with recruitment of innate immune cells and development of the adaptive immune response. Histological parameters, immune cell infiltration and cytokine biomarkers of inflammation were indistinguishable between Nod2 and WT littermates following DSS, however, Nod2 KO mice demonstrated significantly higher tissue-associated bacterial levels in the colon. DSS damage and Nod2 genotype independently regulated the community structure of the colon microbiota. Conclusions/Significance: The results of these experiments demonstrate the integration of environmental and genetic factors in the ecological succession of the commensal flora in mammalian tissue. The association of Nod2 genotype (and other host polymorphisms) and environmental factors likely combine to influence the ecological succession of the tissue-associated microflora accounting in part for their association with the pathogenesis of inflammatory bowel diseases.	[Smith, Philip; Siddharth, Jay; Pearson, Ruth; Shaxted, Mark; Butler, Matt; Clark, Natalie; Jamontt, Joanna; Watson, Robert P.; Sanmugalingam, Devika; Parkinson, Scott J.] Novartis Inst Biomed Res, Gastrointestinal Dis Area, Horsham, W Sussex, England; [Holway, Nicholas] Novartis Inst Biomed Res Informat Technol, Horsham, W Sussex, England; [Parkinson, Scott J.] Novartis Inst Biomed Res Dev & Mol Pathways, Basel, Switzerland	Novartis; Novartis	Smith, P (corresponding author), Novartis Inst Biomed Res, Gastrointestinal Dis Area, Horsham, W Sussex, England.	scott.parkinson@novartis.com		Holway, Nicholas/0000-0002-2126-5118; Siddharth, Jay/0000-0003-3288-400X				Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barreau F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000523; Borley NR, 2002, DIS COLON RECTUM, V45, P377, DOI 10.1007/s10350-004-6186-0; Collado MC, 2007, VET MICROBIOL, V121, P299, DOI 10.1016/j.vetmic.2006.12.006; Chen CS, 2009, MOL CELL PROTEOMICS, V8, P1765, DOI 10.1074/mcp.M800593-MCP200; D'Haens GR, 2008, GASTROENTEROLOGY, V135, P1123, DOI 10.1053/j.gastro.2008.07.010; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Fellani M, 2010, J PEDIAT GASTROENTER, V51, P77; Feller M, 2010, CLIN INFECT DIS, V50, P473, DOI 10.1086/649923; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Furrie E, 2004, GUT, V53, P91, DOI 10.1136/gut.53.1.91; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Lu HF, 2011, MICROB ECOL, V61, P693, DOI 10.1007/s00248-010-9801-8; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meinzer U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002769; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Melgar S, 2008, INT IMMUNOPHARMACOL, V8, P836, DOI 10.1016/j.intimp.2008.01.036; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Perez LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010915; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Rehman A, 2011, GUT, V60, P1354, DOI 10.1136/gut.2010.216259; Savino F, 2011, ACTA PAEDIATR, V100, P75, DOI 10.1111/j.1651-2227.2010.01988.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHMIDT TM, 1994, METHOD ENZYMOL, V235, P205; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P4225, DOI 10.1128/AEM.68.9.4225-4232.2002	44	28	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30273	10.1371/journal.pone.0030273	http://dx.doi.org/10.1371/journal.pone.0030273			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272321	Green Submitted, gold, Green Published			2022-12-25	WOS:000301454400099
J	Mizuno, T; Murakami, H; Fujii, M; Ishiguro, F; Tanaka, I; Kondo, Y; Akatsuka, S; Toyokuni, S; Yokoi, K; Osada, H; Sekido, Y				Mizuno, T.; Murakami, H.; Fujii, M.; Ishiguro, F.; Tanaka, I.; Kondo, Y.; Akatsuka, S.; Toyokuni, S.; Yokoi, K.; Osada, H.; Sekido, Y.			YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes	ONCOGENE			English	Article						malignant mesothelioma; Hippo pathway; YAP; CCND1; cell cycle	YES-ASSOCIATED PROTEIN; PATHWAY; DROSOPHILA; MUTATIONS; MERLIN; NF2; PROGRESSION; COMPONENTS; APOPTOSIS; MARKER	Malignant mesothelioma (MM) shows frequent inactivation of the neurofibromatosis type 2 (NF2) -tumor-suppressor gene. Recent studies have documented that the Hippo signaling pathway, a downstream cascade of Merlin (a product of NF2), has a key role in organ size control and carcinogenesis by regulating cell proliferation and apoptosis. We previously reported that MMs show overexpression of Yes-associated protein (YAP) transcriptional coactivator, the main downstream effector of the Hippo signaling pathway, which results from the inactivation of NF2, LATS2 and/or SAV1 genes (the latter two encoding core components of the mammalian Hippo pathway) or amplification of YAP itself. However, the detailed roles of YAP remain unclear, especially the target genes of YAP that enhance MM cell growth and survival. Here, we demonstrated that YAP-knockdown inhibited cell motility, invasion and anchorage-independent growth as well as cell proliferation of MM cells in vitro. We analyzed genes commonly regulated by YAP in three MM cell lines with constitutive YAP-activation, and found that the major subsets of YAP-upregulating genes encode cell cycle regulators. Among them, YAP directly induced the transcription of CCND1 and FOXM1, in cooperation with TEAD transcription factor. We also found that knockdown of CCND1 and FOXM1 suppressed MM cell proliferation, although the inhibitory effects were less evident than those of YAP knockdown. These results indicate that constitutive YAP activation in MM cells promotes cell cycle progression giving more aggressive phenotypes to MM cells. Oncogene (2012) 31, 5117-5122; doi:10.1038/onc.2012.5; published online 30 January 2012	[Sekido, Y.] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Mizuno, T.; Ishiguro, F.; Yokoi, K.] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Nagoya, Aichi 4648601, Japan; [Akatsuka, S.; Toyokuni, S.] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4648601, Japan; [Osada, H.; Sekido, Y.] Nagoya Univ, Grad Sch Med, Program Funct Construct Med, Dept Canc Genet, Nagoya, Aichi 4648601, Japan	Aichi Cancer Center; Nagoya University; Nagoya University; Nagoya University	Sekido, Y (corresponding author), Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Kanokoden 1-1, Nagoya, Aichi 4648681, Japan.	ysekido@aichi-cc.jp	Yokoi, Kohei/I-7261-2014; Toyokuni, Shinya/C-1358-2010; Sekido, Yoshitaka/P-9756-2015; Toyokuni, Shinya/ABE-7714-2021	Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109; Sekido, Yoshitaka/0000-0002-2428-3848	Special Coordination Fund for Promoting Science and Technology from Ministry of Education, Culture, Sports, Science and Technology of Japan [H18-1-3-3-1]; KAKENHI [18390245, 22300338]; Ministry of Health, Labor and Welfare of Japan; Takeda Science Foundation; Kobayashi Foundation for Cancer Research; Grants-in-Aid for Scientific Research [23501281] Funding Source: KAKEN	Special Coordination Fund for Promoting Science and Technology from Ministry of Education, Culture, Sports, Science and Technology of Japan; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Ms Mika Yamamoto for her excellent technical assistance. This work was supported in part by a Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H18-1-3-3-1), KAKENHI (18390245, 22300338), Grant-in-Aid for Third-Term Comprehensive Control Research for Cancer from the Ministry of Health, Labor and Welfare of Japan, the Takeda Science Foundation and the Kobayashi Foundation for Cancer Research.	Anbanandam A, 2006, P NATL ACAD SCI USA, V103, P17225, DOI 10.1073/pnas.0607171103; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; BIANCHI AB, 1995, P NATL ACAD SCI USA, V92, P10854, DOI 10.1073/pnas.92.24.10854; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Carbone M, 2002, SEMIN ONCOL, V29, P2, DOI 10.1053/sonc.2002.30227; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Illei PB, 2003, CANCER CYTOPATHOL, V99, P51, DOI 10.1002/cncr.10923; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Pass HI, 2004, CURR PROB CANCER, V28, P85; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; SEKIDO Y, 1995, CANCER RES, V55, P1227; Sekido Y, 2011, PATHOL INT, V61, P331, DOI 10.1111/j.1440-1827.2011.02666.x; Sekido Y, 2010, CANCER SCI, V101, P1, DOI 10.1111/j.1349-7006.2009.01336.x; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yang HN, 2008, CURR TREAT OPTION ON, V9, P147, DOI 10.1007/s11864-008-0067-z; Yokoyama T, 2008, CARCINOGENESIS, V29, P2139, DOI 10.1093/carcin/bgn200; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	35	183	188	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2012	31	49					5117	5122		10.1038/onc.2012.5	http://dx.doi.org/10.1038/onc.2012.5			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	049RK	22286761				2022-12-25	WOS:000312000900008
J	Malik, R; Soh, UJK; Trejo, J; Marchese, A				Malik, Rohit; Soh, Unice J. K.; Trejo, JoAnn; Marchese, Adriano			Novel Roles for the E3 Ubiquitin Ligase Atrophin-interacting Protein 4 and Signal Transduction Adaptor Molecule 1 in G Protein-coupled Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; BETA-ARRESTIN; C2 DOMAIN; CLATHRIN ADAPTER; SORTING COMPLEX; ERK ACTIVATION; JANUS KINASES; LIPID RAFTS; CXCR4; ENDOCYTOSIS	The CXCL12/CXCR4 signaling axis plays an important role in human health and disease; however, the molecular mechanisms mediating CXCR4 signaling remain poorly understood. Ubiquitin modification of CXCR4 by the E3 ubiquitin ligase AIP4 is required for lysosomal sorting and degradation, which is mediated by the endosomal sorting complex required for transport (ESCRT) machinery. CXCR4 sorting is regulated by an interaction between endosomal localized arrestin-2 and STAM-1, an ESCRT-0 component. Here, we report a novel role for AIP4 and STAM-1 in regulation of CXCR4 signaling that is distinct from their function in CXCR4 trafficking. Depletion of AIP4 and STAM-1 by siRNA caused significant inhibition of CXCR4-induced ERK-1/2 activation, whereas overexpression of these proteins enhanced CXCR4 signaling. We further show that AIP4 and STAM-1 physically interact and that the proline-rich region in AIP4 and the SH3 domain in STAM-1 are essential for the interaction. Overexpression of an AIP4 catalytically inactive mutant and a mutant that shows poor binding to STAM-1 fails to enhance CXCR4-induced ERK-1/2 signaling, as compared with wild-type AIP4, suggesting that the interaction between AIP4 and STAM-1 and the ligase activity of AIP4 are essential for ERK-1/2 activation. Remarkably, a discrete subpopulation of AIP4 and STAM-1 resides in caveolar microdomains with CXCR4 and appears to mediate ERK-1/2 signaling. We propose that AIP4-mediated ubiquitination of STAM-1 in caveolae coordinates activation of ERK-1/2 signaling. Thus, our study reveals a novel function for ubiquitin in the regulation of CXCR4 signaling, which may be broadly applicable to other G protein-coupled receptors.	[Marchese, Adriano] Loyola Univ Chicago, Dept Pharmacol, Program Mol Biol, Stritch Sch Med, Maywood, IL 60153 USA; [Marchese, Adriano] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, Maywood, IL 60153 USA; [Soh, Unice J. K.; Trejo, JoAnn] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Loyola University Chicago; Loyola University Chicago; University of California System; University of California San Diego	Marchese, A (corresponding author), Loyola Univ Chicago, Dept Pharmacol, Program Mol Biol, Stritch Sch Med, 2160 S 1st Ave,Bldg 101,Rm 2721, Maywood, IL 60153 USA.	amarchese@lumc.edu		TREJO, JOANN/0000-0003-4405-6228; Malik, Rohit/0000-0003-4537-3452	National Institutes of Health [GM075159]; American Heart Association [0910098G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090689, R01GM075159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM075159 (to A. M.).; Supported by American Heart Association Predoctoral Fellowship 0910098G.	Agarwal U, 2010, CIRC RES, V107, P667, DOI 10.1161/CIRCRESAHA.110.223289; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ahn YH, 2009, J BIOL CHEM, V284, P29399, DOI 10.1074/jbc.M109.044958; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Chinni SR, 2008, MOL CANCER RES, V6, P446, DOI 10.1158/1541-7786.MCR-07-0117; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Endo K, 2000, FEBS LETT, V477, P55, DOI 10.1016/S0014-5793(00)01760-9; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jadwin JA, 2010, J VIROL, V84, P704, DOI 10.1128/JVI.01319-09; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lohi O, 1998, APOPTOSIS, V3, P335, DOI 10.1023/A:1009672903627; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Malik R, 2010, MOL BIOL CELL, V21, P2529, DOI 10.1091/mbc.E10-02-0169; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nguyen DH, 2002, J IMMUNOL, V168, P4121, DOI 10.4049/jimmunol.168.8.4121; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orsini MJ, 2000, J BIOL CHEM, V275, P25876; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wyatt D, 2011, J BIOL CHEM, V286, P3884, DOI 10.1074/jbc.M110.152116; Yamada M, 2002, MOL CELL BIOL, V22, P8648, DOI 10.1128/MCB.22.24.8648-8658.2002; Yu T, 2011, MOL CANCER RES, V9, P161, DOI 10.1158/1541-7786.MCR-10-0386; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	64	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9013	9027		10.1074/jbc.M111.336792	http://dx.doi.org/10.1074/jbc.M111.336792			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275353	Green Published, hybrid			2022-12-25	WOS:000301797800032
J	Ofengeim, D; Shi, P; Miao, BC; Fan, J; Xia, XF; Fan, YB; Lipinski, MM; Hashimoto, T; Polydoro, M; Yuan, JY; Wong, STC; Degterev, A				Ofengeim, Dimitry; Shi, Peng; Miao, Benchun; Fan, Jing; Xia, Xiaofeng; Fan, Yubo; Lipinski, Marta M.; Hashimoto, Tadafumi; Polydoro, Manuela; Yuan, Junying; Wong, Stephen T. C.; Degterev, Alexei			Identification of Small Molecule Inhibitors of Neurite Loss Induced by A beta peptide using High Content Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALZHEIMERS-DISEASE; NSAID USE; PROTEIN; NAPROXEN; MEMORY	Multiple lines of evidence indicate a strong relationship between A beta peptide-induced neurite degeneration and the progressive loss of cognitive functions in Alzheimer disease (AD) patients and in AD animal models. This prompted us to develop a high content screening assay (HCS) and Neurite Image Quantitator (NeuriteIQ) software to quantify the loss of neuronal projections induced by A beta peptide neurons and enable us to identify new classes of neurite-protective small molecules, which may represent new leads for AD drug discovery. We identified thirty-six inhibitors of A beta-induced neurite loss in the 1,040-compound National Institute of Neurological Disorders and Stroke (NINDS) custom collection of known bioactives and FDA approved drugs. Activity clustering showed that non-steroidal anti-inflammatory drugs (NSAIDs) were significantly enriched among the hits. Notably, NSAIDs have previously attracted significant attention as potential drugs for AD; however their mechanism of action remains controversial. Our data revealed that cyclooxygenase-2 (COX-2) expression was increased following A beta treatment. Furthermore, multiple distinct classes of COX inhibitors efficiently blocked neurite loss in primary neurons, suggesting that increased COX activity contributes to A beta peptide-induced neurite loss. Finally, we discovered that the detrimental effect of COX activity on neurite integrity may be mediated through the inhibition of peroxisome proliferator-activated receptor gamma(PPAR gamma) activity. Overall, our work establishes the feasibility of identifying small molecule inhibitors of A beta-induced neurite loss using the NeuriteIQ pipeline and provides novel insights into the mechanisms of neuroprotection by NSAIDs.	[Shi, Peng; Fan, Jing; Xia, Xiaofeng; Fan, Yubo; Wong, Stephen T. C.] Methodist Hosp, Res Inst, Dept Syst Med & Bioengn, Houston, TX 77030 USA; [Ofengeim, Dimitry; Lipinski, Marta M.; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Miao, Benchun; Degterev, Alexei] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Hashimoto, Tadafumi; Polydoro, Manuela] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Lab, Charlestown, MA 02129 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Harvard University; Harvard Medical School; Tufts University; Harvard University; Massachusetts General Hospital	Wong, STC (corresponding author), Cornell Univ, Weill Cornell Med Coll, Ithaca, NY 14853 USA.	alexei.degterev@tufts.edu		Hashimoto, Tadafumi/0000-0001-5442-4800; Lipinski, Marta/0000-0002-7537-9014	National Institutes of Health [R01AG028928, NIH R01 LM009161]; John S Dunn Research Foundation; TT and WF Chao Family Foundation; Smith Family Award for Excellence in Biomedical Research; NATIONAL INSTITUTE ON AGING [R01AG028928] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S Dunn Research Foundation; TT and WF Chao Family Foundation; Smith Family Award for Excellence in Biomedical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG028928, NIH R01 LM009161, John S Dunn Research Foundation, TT and WF Chao Family Foundation (to S. T. C. W.), and Smith Family Award for Excellence in Biomedical Research (to A. D.).	Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Brioni JD, 2011, J PHARMACOL EXP THER, V336, P38, DOI 10.1124/jpet.110.166876; Cakala M, 2007, PHARMACOL REP, V59, P164; Cole GM, 2010, CNS NEUROL DISORD-DR, V9, P140, DOI 10.2174/187152710791011991; Conejero-Goldberg C. T., 2008, J MOL NEUROSCI, V35, P7; Dargahi L, 2011, J MOL NEUROSCI, V45, P10, DOI 10.1007/s12031-010-9401-6; Dill J, 2010, J NEUROSCI, V30, P963, DOI 10.1523/JNEUROSCI.5045-09.2010; Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/JNEUROSCI.4353-06.2007; Grodstein F, 2008, NEUROEPIDEMIOLOGY, V30, P45, DOI 10.1159/000115749; Hayden KM, 2007, NEUROLOGY, V69, P275, DOI 10.1212/01.wnl.0000265223.25679.2a; Huang Y, 2010, J NEUROSCI METH, V190, P299, DOI 10.1016/j.jneumeth.2010.05.012; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Jellinger KA, 2009, J NEUROL, V256, pS270, DOI 10.1007/s00415-009-5243-y; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Sato T, 2011, NEUROBIOL AGING, V32, P1626, DOI 10.1016/j.neurobiolaging.2009.10.009; Schmidt ERE, 2009, PROG NEUROBIOL, V88, P286, DOI 10.1016/j.pneurobio.2009.05.004; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48; Szekely CA, 2010, CNS NEUROL DISORD-DR, V9, P132, DOI 10.2174/187152710791012026; Takeda T, 2010, J PHYS CHEM B, V114, P15394, DOI 10.1021/jp107955v; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Zhang Y, 2007, J NEUROSCI METH, V160, P149, DOI 10.1016/j.jneumeth.2006.07.028	30	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8714	8723		10.1074/jbc.M111.290957	http://dx.doi.org/10.1074/jbc.M111.290957			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277654	Green Published, hybrid			2022-12-25	WOS:000301797800005
J	Jiang, GY; Wang, Y; Dai, SD; Liu, Y; Stoecker, M; Wang, ED; Wang, EH				Jiang, Guiyang; Wang, Yan; Dai, Shundong; Liu, Yang; Stoecker, Maggie; Wang, Endi; Wang, Enhua			P120-Catenin Isoforms 1 and 3 Regulate Proliferation and Cell Cycle of Lung Cancer Cells via beta-Catenin and Kaiso Respectively	PLOS ONE			English	Article							MEDIATED TRANSCRIPTIONAL REPRESSION; NUCLEAR-LOCALIZATION; PARTNER KAISO; P120(CTN); GENE; EXPRESSION; INVASION; TARGET	Background: The different mechanisms involved in p120-catenin (p120ctn) isoforms' 1/3 regulation of cell cycle progression are still not elucidated to date. Methods and Findings: We found that both cyclin D1 and cyclin E could be effectively restored by restitution of p120ctn-1A or p120ctn-3A in p120ctn depleted lung cancer cells. When the expression of cyclin D1 was blocked by co-transfection with siRNA-cyclin D1 in p120ctn depleted cells restoring p120ctn-1A or 3A, the expression of cyclin E was slightly decreased, not increased, implying that p120ctn isoforms 1 and 3 cannot up-regulate cyclin E directly but may do so through up-regulation of cyclin D1. Interestingly, overexpression of p120ctn-1A increased beta-catenin and cyclin D1 expression, while co-transfection with siRNA targeting beta-catenin abolishes the effect of p120ctn-1A on up-regulation of cyclin D1, suggesting a role of beta-catenin in mediating p120ctn-1A's regulatory function on cyclin D1 expression. On the other hand, overexpression of p120ctn isoform 3A reduced nuclear Kaiso localization, thus decreasing the binding of Kaiso to KBS on the cyclin D1 promoter and thereby enhancing the expression of cyclin D1 gene by relieving the repressor effect of Kaiso. Because overexpressing NLS-p120ctn-3A (p120ctn-3A nuclear target localization plasmids) or inhibiting nuclear export of p120ctn-3 by Leptomycin B (LMB) caused translocation of Kaiso to the nucleus, it is plausible that the nuclear export of Kaiso is p120ctn-3-dependent. Conclusions: Our results suggest that p120ctn isoforms 1 and 3 up-regulate cyclin D1, and thereby cyclin E, resulting in the promotion of cell proliferation and cell cycle progression in lung cancer cells probably via different protein mediators, namely, beta-catenin for isoform 1 and Kaiso, a negative transcriptional factor of cyclin D1, for isoform 3.	[Jiang, Guiyang; Wang, Yan; Dai, Shundong; Liu, Yang; Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China; [Jiang, Guiyang; Wang, Yan; Dai, Shundong; Liu, Yang; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Stoecker, Maggie; Wang, Endi] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	China Medical University; China Medical University; Duke University	Jiang, GY (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China.	wangeh@hotmail.com	cmu, wy/HDO-5017-2022		National Natural Science Foundation of China [81071905, 30901475, 81071717, 30900562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81071905 to Enhua Wang, 30901475 to Yan Wang, 81071717 to Shundong Dai, and 30900562 to Yang Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Chartier NT, 2007, CANCER RES, V67, P9781, DOI 10.1158/0008-5472.CAN-07-0233; Dai SD, 2010, LUNG CANCER, V67, P205, DOI 10.1016/j.lungcan.2009.06.013; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Hong JY, 2010, J CELL SCI, V123, P4351, DOI 10.1242/jcs.067199; Iioka H, 2009, FEBS LETT, V583, P627, DOI 10.1016/j.febslet.2009.01.012; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kelly KF, 2004, J CELL SCI, V117, P6143, DOI 10.1242/jcs.01541; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Liu Y, 2009, EXP CELL RES, V315, P890, DOI 10.1016/j.yexcr.2008.12.016; Liu Y, 2009, CANCER SCI, V100, P441, DOI 10.1111/j.1349-7006.2008.01067.x; Mo YY, 1996, CANCER RES, V56, P2633; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455	21	27	27	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30303	10.1371/journal.pone.0030303	http://dx.doi.org/10.1371/journal.pone.0030303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276175	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100032
J	Rahman, MA; Spurrier, N; Mahmood, MA; Rahman, M; Choudhury, SR; Leeder, S				Rahman, Muhammad Aziz; Spurrier, Nicola; Mahmood, Mohammad Afzal; Rahman, Mahmudur; Choudhury, Sohel Reza; Leeder, Stephen			Is There Any Association between Use of Smokeless Tobacco Products and Coronary Heart Disease in Bangladesh?	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SMOKING-CESSATION; PUBLIC-HEALTH; SNUFF USERS; MOIST SNUFF; FOLLOW-UP; RISK; MORTALITY; COHORT	Background: Most epidemiological studies exploring the association between smokeless tobacco (SLT) use and coronary heart disease (CHD) have been in Western populations, and have focused on SLT products used in those countries. Few studies come from South Asian countries. Our objective was to determine the association between SLT use and CHD among non-smoking adults in Bangladesh. Methods: A matched case-control study of non-smoking Bangladeshi adults aged 40-75 years was conducted in 2010. Incident cases of CHD were selected from two cardiac hospitals. Community controls, matched to CHD cases, were selected from neighbourhoods, and hospital controls were selected from outpatient departments of the same hospitals. The Rose Angina Questionnaire (RAQ) was also used to re-classify cases and controls. Results: The study enrolled 302 cases, 1,208 community controls and 302 hospital controls. Current use was higher among community controls (38%) compared to cases (33%) and hospital controls (32%). Current use of SLT was not significantly associated with an increased risk of CHD when community controls were used (adjusted OR 0.87, 95% CI 0.63-1.19), or when hospital controls were used (adjusted OR 1.00, 95% CI 0.63-1.60), or when both control groups were combined (adjusted OR 1.00, 95% CI 0.74-1.34). Risk of CHD did not increase with use of individual types except gul, frequency, duration, past use of SLT products, or using the RAQ to re-classify cases and controls. There was a significant association between gul use and CHD when both controls were combined (adjusted OR 2.93, 95% CI 1.28-6.70). Conclusions: There was no statistically significant association between SLT use in general and CHD among non-smoking adults in Bangladesh. Further research on the association between gul use and CHD in Bangladesh along with SLT use and CHD in other parts of the subcontinent will guide public health policy and interventions that focus on SLT-related diseases.	[Rahman, Muhammad Aziz; Spurrier, Nicola; Mahmood, Mohammad Afzal] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Rahman, Mahmudur] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh; [Choudhury, Sohel Reza] Natl Heart Fdn Hosp & Res Inst, Dhaka, Bangladesh; [Leeder, Stephen] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia	University of Adelaide; University of Sydney	Rahman, MA (corresponding author), Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia.	aziz.rahman@adelaide.edu.au	Rahman, Muhammad Aziz/B-3380-2009	Rahman, Muhammad Aziz/0000-0003-1665-7966	Discipline of Public Health; University of Adelaide; Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh; National Heart Foundation Hospital & Research Institute (NHFH& RI), Dhaka, Bangladesh	Discipline of Public Health; University of Adelaide; Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh; National Heart Foundation Hospital & Research Institute (NHFH& RI), Dhaka, Bangladesh	Funding for this study was provided by the Discipline of Public Health, The University of Adelaide. Additionally, human resource and in-kind support for the research was also provided by the Institute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh and the National Heart Foundation Hospital & Research Institute (NHFH& RI), Dhaka, Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accortt NA, 2002, AM J EPIDEMIOL, V156, P730, DOI 10.1093/aje/kwf106; AOAC International, 2004, OFF METH AN NIC TOB; Asplund K, 2003, PROG CARDIOVASC DIS, V45, P383, DOI 10.1053/pcad.2003.00102; Benowitz N L, 1997, Adv Dent Res, V11, P336; BENOWITZ NL, 1991, TRENDS CARDIOVAS MED, V1, P315, DOI 10.1016/1050-1738(91)90068-P; Boffetta P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3060; BOLINDER G, 1994, AM J PUBLIC HEALTH, V84, P399, DOI 10.2105/AJPH.84.3.399; BOLINDER GM, 1992, J INTERN MED, V232, P327, DOI 10.1111/j.1365-2796.1992.tb00593.x; Choudhury K, 2007, J HEALTH POPUL NUTR, V25, P456; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Guh JY, 2007, AM J CLIN NUTR, V85, P1229, DOI 10.1093/ajcn/85.5.1229; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Haglund B, 2007, SCAND J PUBLIC HEALT, V35, P618, DOI 10.1080/14034940701436949; Hansson J, 2009, J INTERN MED, V265, P717, DOI 10.1111/j.1365-2796.2009.02081.x; Henley SJ, 2005, CANCER CAUSE CONTROL, V16, P347, DOI 10.1007/s10552-004-5519-6; Henningfield JE, 2001, TOB CONTROL, V10, P253, DOI 10.1136/tc.10.3.253; Hergens MP, 2008, J INTERN MED, V264, P187, DOI 10.1111/j.1365-2796.2008.01939.x; Hergens MP, 2005, EPIDEMIOLOGY, V16, P12, DOI 10.1097/01.ede.0000147108.92895.ba; HUHTASAARI F, 1992, BRIT MED J, V305, P1252, DOI 10.1136/bmj.305.6864.1252; Huhtasaari F, 1999, J AM COLL CARDIOL, V34, P1784, DOI 10.1016/S0735-1097(99)00409-X; Infante-Rivard C, 2003, AM J EPIDEMIOL, V157, P176, DOI 10.1093/aje/kwf174; International Agency for Research on Cancer, 2007, IARC MONOGR EVAL CAR, V89; Janzon E, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-21; Johansson SE, 2005, EUR J CARDIOV PREV R, V12, P387, DOI 10.1097/01.hjr.0000169189.22302.99; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Kochar D K, 2007, J Assoc Physicians India, V55, P271; Lee PN, 2011, REGUL TOXICOL PHARM, V59, P197, DOI 10.1016/j.yrtph.2010.12.002; Lin WY, 2008, AM J CLIN NUTR, V87, P1204, DOI 10.1093/ajcn/87.5.1204; Malson JL, 2001, TOB CONTROL, V10, P181, DOI 10.1136/tc.10.2.181; McElduff P, 1998, AUST NZ J PUBL HEAL, V22, P787, DOI 10.1111/j.1467-842X.1998.tb01494.x; McKee M, 2007, INT J EPIDEMIOL, V36, P805, DOI 10.1093/ije/dym101; Melikian AA, 2009, BIOMARKERS, V14, P85, DOI 10.1080/13547500902965401; Rahman M, 2003, J CLIN EPIDEMIOL, V56, P101, DOI 10.1016/S0895-4356(02)00507-3; Rahman M. A., 2011, Journal of Public Health and Epidemiology, V3, P593; Rahman MA, 2008, PUBLIC HEALTH, V122, P1331, DOI 10.1016/j.puhe.2008.05.015; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Stanfill SB, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037465; Stepanov I, 2005, INT J CANCER, V116, P16, DOI 10.1002/ijc.20966; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Wermberg P, 2007, J INTERN MED, V262, P360, DOI 10.1111/j.1365-2796.2007.01813.x; WEST DW, 1984, INT J EPIDEMIOL, V13, P235, DOI 10.1093/ije/13.2.235; World Health Organization-Bangladesh, 2006, IMP TOB REL ILLN BAN; World Health Organization-Bangladesh, 2009, GLOB AD TOB SURV BAN; Yatsuya H, 2010, AM J EPIDEMIOL, V172, P600, DOI 10.1093/aje/kwq191; Yen AMF, 2008, AM J CLIN NUTR, V87, P70, DOI 10.1093/ajcn/87.1.70	49	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30584	10.1371/journal.pone.0030584	http://dx.doi.org/10.1371/journal.pone.0030584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276217	Green Submitted, Green Published, gold			2022-12-25	WOS:000301568100059
J	Bhattarai, N; Charlton, J; Rudisill, C; Gulliford, MC				Bhattarai, Nawaraj; Charlton, Judith; Rudisill, Caroline; Gulliford, Martin C.			Coding, Recording and Incidence of Different Forms of Coronary Heart Disease in Primary Care	PLOS ONE			English	Article							GENERAL-PRACTICE; MORTALITY; DECLINE; PREVALENCE; MANAGEMENT; ANGINA; UK	Objectives: To evaluate the coding, recording and incidence of coronary heart disease (CHD) in primary care electronic medical records. Methods: Data were drawn from the UK General Practice Research Database. Analyses evaluated the occurrence of 271 READ medical diagnostic codes, including categories for 'Angina', 'Myocardial Infarction', 'Coronary Artery Bypass Grafting' (CABG), 'percutaneous transluminal coronary angioplasty' (PCTA) and 'Other Coronary Heart Disease'. Time-to-event analyses were implemented to evaluate occurrences of different groups of codes after the index date. Results: Among 300,020 participants aged greater than 30 years there were 75,197 unique occurrences of coronary heart disease codes in 24,244 participants, with 12,495 codes for incident events and 62,702 for prevalent events. Among incident event codes, 3,607 (28.87%) were for angina, 3,262 (26.11%) were for MI, 514 (4.11%) for PCTA, 161 (1.29%) for CABG and 4,951 (39.62%) were for 'Other CHD'. Among prevalent codes, 20,254 (32.30%) were for angina, 3,644 (5.81%) for MI, 34,542 (55.09%) for 'Other CHD' and 4,262 (6.80%) for CABG or PCTA. Among 3,685 participants initially diagnosed exclusively with 'Other CHD' codes, 17.1% were recorded with angina within 5 years, 5.6% with myocardial infarction, 6.3% with CABG and 8.6% with PCTA. From 2000 to 2010, the overall incidence of CHD declined, as did the incidence of angina, but the incidence of MI did not change. The frequency of CABG declined, while PCTA increased. Conclusion: In primary care electronic records, a substantial proportion of coronary heart disease events are recorded with codes that do not distinguish between different clinical presentations of CHD. The results draw attention to the need to improve coding practice in primary care. The results also draw attention to the importance of code selection in research studies and the need for sensitivity analyses using different sets of codes.	[Bhattarai, Nawaraj; Charlton, Judith; Gulliford, Martin C.] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Rudisill, Caroline] London Sch Econ, Dept Social Policy & LSE Hlth, London WC2A 2AE, England	University of London; King's College London; University of London; London School Economics & Political Science	Bhattarai, N (corresponding author), Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England.	nawaraj.bhattarai@kcl.ac.uk	Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075	National Prevention Research Initiative (NPRI) through the Medical Research Council; MRC [G0900845] Funding Source: UKRI; Medical Research Council [G0900845] Funding Source: researchfish	National Prevention Research Initiative (NPRI) through the Medical Research Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the National Prevention Research Initiative (NPRI) through the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, NHS CONN HLTH NHS CL; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; CLARKE KW, 1994, BRIT HEART J, V71, P38; Commission for health care audit and inspection, 2005, NAT SERV FRAM REP GE; Davies AR, 2007, EUR HEART J, V28, P2142, DOI 10.1093/eurheartj/ehm272; GANDHI MM, 1995, BRIT J GEN PRACT, V45, P11; Gulliford MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007168; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Hardoon SL, 2011, EUROPEAN HEART J; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lampe FC, 2001, HEART, V86, P499, DOI 10.1136/heart.86.5.499; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; McGovern MP, 2008, FAM PRACT, V25, P33, DOI 10.1093/fampra/cmm073; National Statistics, 2000, KEY HLTH STAT GEN PR; Scarborough P, 2010, CORONARY HEART DIS S; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; GEN PRACTICE RES DAT	18	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29776	10.1371/journal.pone.0029776	http://dx.doi.org/10.1371/journal.pone.0029776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276128	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000301457200022
J	LaPointe, LC; Pedersen, SK; Dunne, R; Brown, GS; Pimlott, L; Gaur, S; McEvoy, A; Thomas, M; Wattchow, D; Molloy, PL; Young, GP				LaPointe, Lawrence C.; Pedersen, Susanne K.; Dunne, Robert; Brown, Glenn S.; Pimlott, Letitia; Gaur, Snigdha; McEvoy, Aidan; Thomas, Melissa; Wattchow, David; Molloy, Peter L.; Young, Graeme P.			Discovery and Validation of Molecular Biomarkers for Colorectal Adenomas and Cancer with Application to Blood Testing	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; SURVEILLANCE; STANDARD; ARRAY; PCR; RNA	Background & Aims: Colorectal cancer incidence and deaths are reduced by the detection and removal of early-stage, treatable neoplasia but we lack proven biomarkers sensitive for both cancer and pre-invasive adenomas. The aims of this study were to determine if adenomas and cancers exhibit characteristic patterns of biomarker expression and to explore whether a tissue-discovered (and validated) biomarker is differentially expressed in the plasma of patients with colorectal adenomas or cancer. Methods: Candidate RNA biomarkers were identified by oligonucleotide microarray analysis of colorectal specimens (222 normal, 29 adenoma, 161 adenocarcinoma and 50 colitis) and validated in a previously untested cohort of 68 colorectal specimens using a custom-designed oligonucleotide microarray. One validated biomarker, KIAA1199, was assayed using qRT-PCR on plasma extracted RNA from 20 colonoscopy-confirmed healthy controls, 20 patients with adenoma, and 20 with cancer. Results: Genome-wide analysis uncovered reproducible gene expression signatures for both adenomas and cancers compared to controls. 386/489 (79%) of the adenoma and 439/529 (83%) of the adenocarcinoma biomarkers were validated in independent tissues. We also identified genes differentially expressed in adenomas compared to cancer. KIAA1199 was selected for further analysis based on consistent up-regulation in neoplasia, previous studies and its interest as an uncharacterized gene. Plasma KIAA1199 RNA levels were significantly higher in patients with either cancer or adenoma (31/40) compared to neoplasia-free controls (6/20). Conclusions: Colorectal neoplasia exhibits characteristic patterns of gene expression. KIAA1199 is differentially expressed in neoplastic tissues and KIAA1199 transcripts are more abundant in the plasma of patients with either cancer or adenoma compared to controls.	[LaPointe, Lawrence C.; Pimlott, Letitia; Wattchow, David; Young, Graeme P.] Flinders Univ S Australia, Flinders Ctr Canc Prevent & Control, Adelaide, SA, Australia; [LaPointe, Lawrence C.; Pedersen, Susanne K.; Gaur, Snigdha; McEvoy, Aidan; Thomas, Melissa] Clin Genom Pty Ltd, Sydney, NSW, Australia; [Brown, Glenn S.; Molloy, Peter L.] CSIRO Food & Nutr Sci, Preventat Hlth Natl Res Flagship, Sydney, NSW, Australia; [Dunne, Robert] CSIRO Math & Informat Sci, Preventat Hlth Natl Res Flagship, Sydney, NSW, Australia	Flinders University South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	LaPointe, LC (corresponding author), Flinders Univ S Australia, Flinders Ctr Canc Prevent & Control, Adelaide, SA, Australia.	larry.lapointe@flinders.edu.au	Molloy, Peter L/H-7931-2013	Molloy, Peter L/0000-0002-7788-3417; LaPointe, Lawrence/0000-0002-8906-1867; , Susanne/0000-0002-5518-1959; Young, Graeme/0000-0001-9458-8383	Flinders University of South Australia; Commonwealth Scientific and Industrial Research Organisation (CSIRO) of Australia; Clinical Genomics Pty Ltd.	Flinders University of South Australia; Commonwealth Scientific and Industrial Research Organisation (CSIRO) of Australia; Clinical Genomics Pty Ltd.	This work was co-funded by Flinders University of South Australia and the Commonwealth Scientific and Industrial Research Organisation (CSIRO) of Australia. Drs. Dunne, Molloy and Brown are employed by CSIRO. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was also provided by Clinical Genomics Pty Ltd., a company involved in the discovery and commercialization of biomarkers for colorectal cancer. Drs. LaPointe, Pedersen, Gaur, McEvoy and Thomas are employed by Clinical Genomics Pty Ltd and Prof. Young is a paid consultant of Clinical Genomics Pty Ltd. The funder thus played roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Mrs. Pimlott and Dr. Wattchow have nothing to disclose.; This work was co-funded by Clinical Genomics Pty Ltd, a company involved in the discovery and commercialization of biomarkers for colorectal cancer. Drs. LaPointe, Pedersen, Gaur, McEvoy and Thomas are employed by Clinical Genomics Pty Ltd. Prof. Young is a paid consultant of Clinical Genomics Pty Ltd. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Donia D, 2005, J VIROL METHODS, V126, P157, DOI 10.1016/j.jviromet.2005.02.004; Ebert C, 2010, MATH LANG 10 11 BIEN, VVIII, P297; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lane JM, 2010, GASTROENTEROLOGY, V139, P1918, DOI 10.1053/j.gastro.2010.08.005; LaPointe LC, 2008, PHYSIOL GENOMICS, V33, P50, DOI 10.1152/physiolgenomics.00185.2006; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Markowitz AJ, 1999, SEMIN ONCOL, V26, P485; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Michishita E, 2006, CANCER LETT, V239, P71, DOI 10.1016/j.canlet.2005.07.028; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Park DI, 2010, AM J GASTROENTEROL, V105, P2017, DOI 10.1038/ajg.2010.179; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Pradervand S, 2008, BIOTECHNIQUES, V44, P759, DOI 10.2144/000112751; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ransohoff DF, 2004, GASTROENTEROLOGY, V127, P1028, DOI 10.1053/j.gastro.2004.08.030; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Young G, 2003, TXB GASTROENTEROLOGY, V2, P1883; Young GP, 2009, NAT CLIN PRACT GASTR, V6, P140, DOI 10.1038/ncpgasthep1358	33	30	34	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29059	10.1371/journal.pone.0029059	http://dx.doi.org/10.1371/journal.pone.0029059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276102	gold, Green Submitted, Green Published			2022-12-25	WOS:000301457200004
J	Kreakie, BJ; Fan, Y; Keitt, TH				Kreakie, Betty J.; Fan, Ying; Keitt, Timothy H.			Enhanced Migratory Waterfowl Distribution Modeling by Inclusion of Depth to Water Table Data	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; SPECIES DISTRIBUTION; PHYLOGENETIC ANALYSIS; PRESENCE-ABSENCE; LAND-COVER; WETLANDS; ECOLOGY; BIRDS; ANSERIFORMES; RICHNESS	In addition to being used as a tool for ecological understanding, management and conservation of migratory waterfowl rely heavily on distribution models; yet these models have poor accuracy when compared to models of other bird groups. The goal of this study is to offer methods to enhance our ability to accurately model the spatial distributions of six migratory waterfowl species. This goal is accomplished by creating models based on species-specific annual cycles and introducing a depth to water table (DWT) data set. The DWT data set, a wetland proxy, is a simulated long-term measure of the point either at or below the surface where climate and geological/topographic water fluxes balance. For species occurrences, the USGS' banding bird data for six relatively common species was used. Distribution models are constructed using Random Forest and MaxEnt. Random Forest classification of habitat and non-habitat provided a measure of DWT variable importance, which indicated that DWT is as important, and often more important, to model accuracy as temperature, precipitation, elevation, and an alternative wetland measure. MaxEnt models that included DWT in addition to traditional predictor variables had a considerable increase in classification accuracy. Also, MaxEnt models created with DWT often had higher accuracy when compared with models created with an alternative measure of wetland habitat. By comparing maps of predicted probability of occurrence and response curves, it is possible to explore how different species respond to water table depth and how a species responds in different seasons. The results of this analysis also illustrate that, as expected, all waterfowl species are tightly affiliated with shallow water table habitat. However, this study illustrates that the intensity of affiliation is not constant between seasons for a species, nor is it consistent between species.	[Kreakie, Betty J.; Keitt, Timothy H.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Fan, Ying] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA	University of Texas System; University of Texas Austin; Rutgers State University New Brunswick	Kreakie, BJ (corresponding author), US EPA, Off Res & Dev, Narragansett, RI USA.	kreakie.betty@epa.gov	Keitt, Timothy/AAF-9787-2021	Keitt, Timothy/0000-0002-4587-1083; Fan, Ying/0000-0002-0024-7965; Kreakie, Betty/0000-0002-4982-7610	U.S. Department of Energy's Office of Science (BER) through the Southeastern Regional Center of the National Institute for Climatic Change Research at Duke University	U.S. Department of Energy's Office of Science (BER) through the Southeastern Regional Center of the National Institute for Climatic Change Research at Duke University(United States Department of Energy (DOE))	This research was supported by a grant to THK from the U.S. Department of Energy's Office of Science (BER) through the Southeastern Regional Center of the National Institute for Climatic Change Research at Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellrose F, 1980, DUCKS GEESE SWANS N; Bent AC, 1987, LIFE HIST N AM WILD; Bolduc F, 2008, ECOL MODEL, V216, P402, DOI 10.1016/j.ecolmodel.2008.05.007; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Buckley PA, 1998, J FIELD ORNITHOL, V69, P511; Casas F, 2009, ANIM CONSERV, V12, P346, DOI 10.1111/j.1469-1795.2009.00259.x; CONOVER MR, 1985, WILDLIFE SOC B, V13, P228; Coops NC, 2009, REMOTE SENS ENVIRON, V113, P668, DOI 10.1016/j.rse.2008.11.012; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Desgranges JL, 2006, ENVIRON MONIT ASSESS, V113, P329, DOI 10.1007/s10661-005-9087-3; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fan Y, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008111; Fan Y, 2011, CLIM DYNAM, V37, P253, DOI 10.1007/s00382-010-0829-8; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gomez-Rodriguez C, 2008, HERPETOL J, V18, P103; Green AJ, 2002, ACTA OECOL, V23, P177, DOI 10.1016/S1146-609X(02)01149-9; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2011, PACKAGE GEOSPHERE; Hollister JW, 2004, PHOTOGRAMM ENG REM S, V70, P405, DOI 10.14358/PERS.70.4.405; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Kaufman K., 1996, LIVES N AM BIRDS; Koneff MD, 2004, ECOL MODEL, V177, P41, DOI 10.1016/j.ecolmodel.2003.12.051; Lemoine N, 2007, GLOBAL ECOL BIOGEOGR, V16, P55, DOI 10.1111/j.1466-8238.2006.00252.x; Livezey BC, 1996, SYST BIOL, V45, P415, DOI 10.2307/2413524; Livezey BC, 1997, ZOOL J LINN SOC-LOND, V121, P361, DOI 10.1111/j.1096-3642.1997.tb01285.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McPherson JM, 2007, ECOGRAPHY, V30, P135, DOI 10.1111/j.2006.0906-7590.04823.x; Milsom TP, 2000, J APPL ECOL, V37, P706, DOI 10.1046/j.1365-2664.2000.00529.x; Neave HM, 1996, FOREST ECOL MANAG, V85, P197, DOI 10.1016/S0378-1127(96)03759-0; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Post DM, 1998, CONSERV BIOL, V12, P910, DOI 10.1046/j.1523-1739.1998.97112.x; Skagen SK, 2008, AUK, V125, P20, DOI 10.1525/auk.2008.125.1.20; Stevens DL, 2007, WETLANDS, V27, P515, DOI 10.1672/0277-5212(2007)27[515:SDEAAF]2.0.CO;2; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Tamisier A, 2003, REV ECOL-TERRE VIE, V58, P435; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Ward MP, 2009, ZOONOSES PUBLIC HLTH, V56, P1, DOI 10.1111/j.1863-2378.2008.01150.x	47	16	19	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30142	10.1371/journal.pone.0030142	http://dx.doi.org/10.1371/journal.pone.0030142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272288	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400066
J	Marie, N; Canestrelli, C; Noble, F				Marie, Nicolas; Canestrelli, Corinne; Noble, Florence			Transfer of Neuroplasticity from Nucleus Accumbens Core to Shell Is Required for Cocaine Reward	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; INDUCED STRUCTURAL PLASTICITY; MEDIUM SPINY NEURONS; DENDRITIC SPINES; PROTEIN-SYNTHESIS; BEHAVIORAL SENSITIZATION; C-FOS; ANISOMYCIN; RAT; DOPAMINE	It is well established that cocaine induces an increase of dendritic spines density in some brain regions. However, few studies have addressed the role of this neuroplastic changes in cocaine rewarding effects and have often led to contradictory results. So, we hypothesized that using a rigorous time- and subject-matched protocol would demonstrate the role of this spine increase in cocaine reward. We designed our experiments such as the same animals ( rats) were used for spine analysis and behavioral studies. Cocaine rewarding effects were assessed with the conditioned place preference paradigm. Spines densities were measured in the two subdivisions of the nucleus accumbens (NAcc), core and shell. We showed a correlation between the increase of spine density in NAcc core and shell and cocaine rewarding effects. Interestingly, when cocaine was administered in home cages, spine density was increase in NAcc core only. With anisomycin, a protein synthesis inhibitor, injected in the core we blocked spine increase in core and shell and also cocaine rewarding effects. Strikingly, whereas injection of this inhibitor in the shell immediately after conditioning had no effect on neuroplasticity or behavior, its injection 4 hours after conditioning was able to block neuroplasticity in shell only and cocaine-induced place preference. Thus, it clearly appears that the neuronal plasticity in the NAcc core is essential to induce plasticity in the shell, necessary for cocaine reward. Altogether, our data revealed a new mechanism in the NAcc functioning where a neuroplasticity transfer occurred from core to shell.	[Marie, Nicolas; Canestrelli, Corinne; Noble, Florence] CNRS, UMR 8206, Paris, France; [Marie, Nicolas; Canestrelli, Corinne; Noble, Florence] INSERM, U705, Paris, France; [Marie, Nicolas; Canestrelli, Corinne; Noble, Florence] Univ Paris 05, Lab Neuropsychopharmacol Addict, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Marie, N (corresponding author), CNRS, UMR 8206, Paris, France.	florence.noble@parisdescartes.fr	Marie, Nicolas/I-9129-2014	Marie, Nicolas/0000-0002-6491-9898; Noble, Florence/0000-0003-4497-0212	Bettencourt-Schueller (Prix Coup d'Elan)	Bettencourt-Schueller (Prix Coup d'Elan)	This work was supported by the foundation Bettencourt-Schueller (Prix Coup d'Elan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Bebien M, 2003, ONCOGENE, V22, P1836, DOI 10.1038/sj.onc.1206334; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Boudreau AC, 2007, J NEUROSCI, V27, P10621, DOI 10.1523/JNEUROSCI.2163-07.2007; Bulka A, 2004, EUR J PHARMACOL, V492, P27, DOI 10.1016/j.ejphar.2004.03.041; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dobi A, 2011, J NEUROSCI, V31, P1895, DOI 10.1523/JNEUROSCI.5375-10.2011; Ferrario CR, 2005, BIOL PSYCHIAT, V58, P751, DOI 10.1016/j.biopsych.2005.04.046; Garcia-Lopez P, 2006, J NEUROSCI, V26, P11249, DOI 10.1523/JNEUROSCI.3543-06.2006; Haber SN, 2000, J NEUROSCI, V20, P2369; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jedynak JP, 2007, EUR J NEUROSCI, V25, P847, DOI 10.1111/j.1460-9568.2007.05316.x; Johnson OL, 2004, BRAIN RES, V996, P89, DOI 10.1016/j.brainres.2003.10.011; Kalivas PW, 2007, AM J ADDICTION, V16, P71, DOI 10.1080/10550490601184142; Kim BG, 2007, J NEUROSCI METH, V162, P237, DOI 10.1016/j.jneumeth.2007.01.016; Kim J, 2011, BIOL PSYCHIAT, V69, P1026, DOI 10.1016/j.biopsych.2011.01.013; Kiraly DD, 2010, BIOL PSYCHIAT, V68, P249, DOI 10.1016/j.biopsych.2010.03.024; Knackstedt LA, 2009, CURR OPIN PHARMACOL, V9, P59, DOI 10.1016/j.coph.2008.12.003; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kukushkin AN, 2008, J CELL BIOCHEM, V103, P1005, DOI 10.1002/jcb.21471; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Liao RM, 2000, LIFE SCI, V67, P2033, DOI 10.1016/S0024-3205(00)00789-X; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MEREDITH GE, 1995, J NEUROSCI, V15, P3808; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pierce RC, 1996, J NEUROSCI, V16, P1550; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Ren Z, 2010, NEUROSCIENCE, V168, P48, DOI 10.1016/j.neuroscience.2010.03.034; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Sarti F, 2007, EUR J NEUROSCI, V26, P749, DOI 10.1111/j.1460-9568.2007.05689.x; Sellings LHL, 2006, J PHARMACOL EXP THER, V317, P1178, DOI 10.1124/jpet.105.100339; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Soderman AR, 2008, NEUROSCIENCE, V154, P1506, DOI 10.1016/j.neuroscience.2008.04.063; Taylor JR, 2007, P NATL ACAD SCI USA, V104, P4147, DOI 10.1073/pnas.0610288104; Torocsik B, 2000, EUR J NEUROSCI, V12, P527, DOI 10.1046/j.1460-9568.2000.00933.x; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; van Dongen YC, 2005, NEUROSCIENCE, V136, P1049, DOI 10.1016/j.neuroscience.2005.08.050; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Wanisch K, 2008, NEUROBIOL LEARN MEM, V90, P485, DOI 10.1016/j.nlm.2008.02.007; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2; Zhou FC, 2007, BRAIN RES, V1134, P148, DOI 10.1016/j.brainres.2006.11.046; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	55	17	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30241	10.1371/journal.pone.0030241	http://dx.doi.org/10.1371/journal.pone.0030241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272316	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400094
J	Sabatino, L; Fucci, A; Pancione, M; Carafa, V; Nebbioso, A; Pistore, C; Babbio, F; Votino, C; Laudanna, C; Ceccarelli, M; Altucci, L; Bonapace, IM; Colantuoni, V				Sabatino, L.; Fucci, A.; Pancione, M.; Carafa, V.; Nebbioso, A.; Pistore, C.; Babbio, F.; Votino, C.; Laudanna, C.; Ceccarelli, M.; Altucci, L.; Bonapace, I. M.; Colantuoni, V.			UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression	ONCOGENE			English	Article						UHRF1; PPARG; epigenetics; colorectal cancer prognosis	ISLAND METHYLATOR PHENOTYPE; PERIPHERAL-BLOOD; DNA METHYLATION; EXPRESSION; DNMT3B; NP95; CPG; PROMOTER	Peroxisome proliferator-activated receptor gamma (PPARG) inactivation has been identified as an important step in colorectal cancer (CRC) progression, although the events involved have been partially clarified. UHRF1 is emerging as a cofactor that coordinates the epigenetic silencing of tumor suppressor genes, but its role in CRC remains elusive. Here, we report that UHRF1 negatively regulates PPARG and is associated with a higher proliferative, clonogenic and migration potential. Consistently, UHRF1 ectopic expression induces PPARG repression through its recruitment on the PPARG promoter fostering DNA methylation and histone repressive modifications. In agreement, UHRF1 knockdown elicits PPARG re-activation, accompanied by positive histone marks and DNA demethylation, corroborating its role in PPARG silencing. UHRF1 overexpression, as well as PPARG-silencing, imparts higher growth rate and phenotypic features resembling those occurring in the epithelial-mesenchymal transition. In our series of 110 sporadic CRCs, high UHRF1-expressing tumors are characterized by an undifferentiated phenotype, higher proliferation rate and poor clinical outcome only in advanced stages III-IV. In addition, the inverse relationship with PPARG found in vitro is detected in vivo and UHRF1 prognostic significance appears closely related to PPARG low expression, as remarkably validated in an independent dataset. The results demonstrate that UHRF1 regulates PPARG silencing and both genes appear to be part of a complex regulatory network. These findings suggest that the relationship between UHRF1 and PPARG may have a relevant role in CRC progression. Oncogene (2012) 31, 5061-5072; doi:10.1038/onc.2012.3; published online 30 January 2012	[Sabatino, L.; Fucci, A.; Pancione, M.; Votino, C.; Laudanna, C.; Ceccarelli, M.; Colantuoni, V.] Univ Sannio, Dept Biol Geol & Environm Sci, I-82100 Benevento, Italy; [Carafa, V.; Nebbioso, A.; Altucci, L.] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Pistore, C.; Babbio, F.; Bonapace, I. M.] Univ Insubria, Dept Struct & Funct Biol, Busto Arsizio, Va, Italy	University of Sannio; Universita della Campania Vanvitelli; University of Insubria	Colantuoni, V (corresponding author), Univ Sannio, Dept Biol Geol & Environm Sci, Via PortArsa 11, I-82100 Benevento, Italy.	colantuoni@unisannio.it	Pancione, Massimo/AAF-2109-2019; Altucci, Lucia/S-8031-2019; NEBBIOSO, ANGELA/GVS-1294-2022; Ceccarelli, Michele/AGP-1739-2022; NEBBIOSO, Angela/C-3566-2016	BONAPACE, IAN MARC/0000-0001-6580-8893; PANCIONE, Massimo/0000-0003-1728-8816; altucci, lucia/0000-0002-7312-5387; LAUDANNA, Carmelo/0000-0002-0397-6020; carafa, vincenzo/0000-0002-8025-3758; Sabatino, Lina/0000-0001-5341-7430; NEBBIOSO, Angela/0000-0001-5374-3527; Ceccarelli, Michele/0000-0002-4702-6617	Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Cariplo 'Progetto Nobel'; European Union: CancerDip [200620]; European Union: Aposys [200767]; Associazione Italiana per la lotta ai linfomi e leucemie (AIL)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo 'Progetto Nobel'(Fondazione Cariplo); European Union: CancerDip(European Commission); European Union: Aposys(European CommissionEuropean Commission Joint Research Centre); Associazione Italiana per la lotta ai linfomi e leucemie (AIL)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) to LA and IMB; Fondazione Cariplo 'Progetto Nobel' to IMB; European Union: CancerDip contract no 200620, Aposys contract no 200767 to LA; Associazione Italiana per la lotta ai linfomi e leucemie (AIL) to VC. We wish to thank Prof N Zambrano for kindly providing the shRNA vectors employed.	Alhosin M, 2011, J EXP CLIN CANC RES, V15, P30; Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; BURCHILL SA, 1995, BRIT J CANCER, V71, P278, DOI 10.1038/bjc.1995.56; Capaccio D, 2010, BBA-MOL BASIS DIS, V1802, P572, DOI 10.1016/j.bbadis.2010.01.012; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Grommes C, 2004, LANCET ONCOL, V5, P419, DOI 10.1016/S1470-2045(04)01509-8; Hayashi K, 2001, JPN J CANCER RES, V92, P42, DOI 10.1111/j.1349-7006.2001.tb01046.x; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Lorenzato M, 2005, HUM PATHOL, V36, P1101, DOI 10.1016/j.humpath.2005.07.016; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Nakazawa T, 2011, HUM PATHOL; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Ogino S, 2009, GASTROENTEROLOGY, V136, P1242, DOI 10.1053/j.gastro.2008.12.048; Pancione M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014229; Pancione M, 2010, HUM PATHOL, V41, P867, DOI 10.1016/j.humpath.2009.09.019; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Phe V, 2010, BJU INT, V105, P1364, DOI 10.1111/j.1464-410X.2009.09167.x; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Sabatino L, 2005, J BIOL CHEM, V280, P26517, DOI 10.1074/jbc.M502716200; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shen CX, 2008, JPN J CLIN ONCOL, V38, P770, DOI 10.1093/jjco/hyn105; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Tien AL, 2011, BIOCHEM J, V435, P175, DOI 10.1042/BJ20100840; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Wang DZ, 2008, PPAR RES, V2008, DOI 10.1155/2008/931074	40	73	82	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2012	31	49					5061	5072		10.1038/onc.2012.3	http://dx.doi.org/10.1038/onc.2012.3			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	049RK	22286757				2022-12-25	WOS:000312000900002
J	Chuang, JY; Wang, SA; Yang, WB; Yang, HC; Hung, CY; Su, TP; Chang, WC; Hung, JJ				Chuang, J-Y; Wang, S-A; Yang, W-B; Yang, H-C; Hung, C-Y; Su, T-P; Chang, W-C; Hung, J-J			Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells	ONCOGENE			English	Article						Sp1; CDK1; PP2A; myosin; mitosis	TRANSCRIPTION FACTOR SP1; GENE-TRANSCRIPTION; HEAT-SHOCK; PROTEIN; EXPRESSION; PROMOTER; OVEREXPRESSION; ACTIVATION; STABILITY; FACTOR-1	Sp1 is important for the transcription of many genes. Our previous studies have shown that Sp1 is degraded in normal cell, but it is preserved in cancer cells during mitosis and exists a priori in the daughter cells, ready to engage in gene transcription and thereby contributes to the proliferation and survival of cancer cells. The mechanism by which Sp1 is preserved in cancer cells during mitosis remains unknown. In this study, we observed that Sp1 strongly colocalized with cyclin-dependent kinase 1 (CDK1)/cyclin B1 during mitosis. Moreover, we showed that Sp1 is a novel mitotic substrate of CDK1/cyclin B1 and is phosphorylated by it at Thr 739 before the onset of mitosis. Phospho-Sp1 reduced its DNA-binding ability and facilitated the chromatin condensation process during mitosis. Mutation of Thr739 to alanine resulted in Sp1 remaining in the chromosomes, delayed cell-cycle progression, and eventually led to apoptosis. Screening of Sp1-associated proteins during mitosis by using liquid chromatography/mass spectrometry indicated the tethering of Sp1 to myosin/F-actin. Furthermore, phospho-Sp1 and myosin/F-actin appeared to exist as a congregated ring at the periphery of the chromosome. However, at the end of mitosis and the beginning of interphase, Sp1 was dephosphorylated by PP2A and returned to the chromatin. These results indicate that cancer cells use CDK1 and PP2A to regulate the movement of Sp1 in and out of the chromosomes during cell-cycle progression, which may benefit cancer-cell proliferation. Oncogene (2012) 31, 4946-4959; doi:10.1038/onc.2011.649; published online 23 January 2012	[Chuang, J-Y; Wang, S-A; Yang, W-B; Yang, H-C; Hung, J-J] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 701, Taiwan; [Hung, C-Y; Chang, W-C; Hung, J-J] Natl Cheng Kung Univ, Coll Med, Inst Med, Tainan 70101, Taiwan; [Su, T-P] Natl Inst Drug Abuse, NIH, Baltimore, MD USA; [Chang, W-C; Hung, J-J] Dept Pharmacol, Tainan, Taiwan; [Chang, W-C; Hung, J-J] Natl Cheng Kung Univ, Ctr Infect Dis & Signal Transduct, Tainan 701, Taiwan; [Chang, W-C] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Cheng Kung University; Taipei Medical University	Hung, JJ (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan 701, Taiwan.	petehung@mail.ncku.edu.tw	Yang, Wen-Bin/AAO-3593-2021	Yang, Wen-Bin/0000-0002-6497-4176; Wang, Shao-an/0000-0002-5473-4195	National Cheng Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers; National Science Council, Taiwan [NSC 97-2320-B-006-016-MY3, NSC 97-2311-B-006-002-MY3]; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000206] Funding Source: NIH RePORTER	National Cheng Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Cheng Kung University project of the Program for Promoting Academic Excellence and Developing World Class Research Centers, together with grants NSC 97-2320-B-006-016-MY3 and NSC 97-2311-B-006-002-MY3 obtained from the National Science Council, Taiwan.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Boulon S, 2002, MOL CELL BIOL, V22, P7769, DOI 10.1128/MCB.22.22.7769-7779.2002; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Chiefari E, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-35; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chuang JY, 2011, BIOCHEM BIOPH RES CO, V407, P587, DOI 10.1016/j.bbrc.2011.03.068; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Guo T, 2010, CIRC RES, V106, P1743, DOI 10.1161/CIRCRESAHA.110.219816; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; He SH, 2006, J CELL SCI, V119, P1063, DOI 10.1242/jcs.02829; Hosoi Y, 2004, INT J ONCOL, V25, P461; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lou Z, 2005, CANCER RES, V65, P1007; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Saxena UH, 2010, J BIOL CHEM, V285, P31139, DOI 10.1074/jbc.M109.078808; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016/j.jmb.2011.09.027; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200	31	31	32	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	47					4946	4959		10.1038/onc.2011.649	http://dx.doi.org/10.1038/onc.2011.649			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	041VU	22266860	Green Accepted			2022-12-25	WOS:000311430200006
J	Chang, JS; Fernand, V; Zhang, YB; Shin, J; Jun, HJ; Joshi, Y; Gettys, TW				Chang, Ji Suk; Fernand, Vivian; Zhang, Yubin; Shin, Jeho; Jun, Hee-Jin; Joshi, Yagini; Gettys, Thomas W.			NT-PGC-1 alpha Protein Is Sufficient to Link beta(3)-Adrenergic Receptor Activation to Transcriptional and Physiological Components of Adaptive Thermogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGC-1-ALPHA MESSENGER-RNA; WHITE ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; UNCOUPLING PROTEIN; COACTIVATOR PGC-1; BROWN FAT; HEPATIC GLUCONEOGENESIS; GAMMA COACTIVATOR-1; GENE	PGC-1 alpha is an inducible transcriptional coactivator that regulates cellular energy metabolism and adaptation to environmental and nutritional stimuli. In tissues expressing PGC-1 alpha, alternative splicing produces a truncated protein (NT-PGC-1 alpha) corresponding to the first 267 amino acids of PGC-1 alpha. Brown adipose tissue also expresses two novel exon 1b-derived isoforms of PGC-1 alpha and NT-PGC-1 alpha, which are 4 and 13 amino acids shorter in the N termini than canonical PGC-1 alpha and NT-PGC-1 alpha, respectively. To evaluate the ability of NT-PGC-1 alpha to substitute for PGC-1 alpha and assess the isoform-specific role of NT-PGC-1 alpha, adaptive thermogenic responses of adipose tissue were evaluated in mice lacking full-length PGC-1 alpha (FL-PGC-1(-/-)) but expressing slightly shorter but functionally equivalent forms of NT-PGC-1 alpha (NT-PGC-1 alpha(254)). At room temperature, NT-PGC-1 alpha and NT-PGC-1 alpha(254) were produced from conventional exon 1a-derived transcripts in brown adipose tissue of wild type and FL-PGC-1 alpha(-/-) mice, respectively. However, cold exposure shifted transcription to exon 1b, increasing exon 1b-derived mRNA levels. The resulting transcriptional responses produced comparable increases in energy expenditure and maintenance of core body temperature in WT and FL-PGC-1 alpha(-/-) mice. Moreover, treatment of the two genotypes with a selective beta(3)-adrenergic receptor agonist produced similar increases in energy expenditure, mitochondrial DNA, and reductions in adiposity. Collectively, these findings illustrate that the transcriptional and physiological responses to sympathetic input are unabridged in FL-PGC-1 alpha(-/-) mice, and that NT-PGC-1 alpha is sufficient to link beta(3)-androgenic receptor activation to adaptive thermogenesis in adipose tissue. Furthermore, the transcriptional shift from exon 1a to 1b supports isoform-specific roles for NT-PGC-1 alpha in basal and adaptive thermogenesis.	[Chang, Ji Suk; Fernand, Vivian; Zhang, Yubin; Shin, Jeho; Jun, Hee-Jin; Joshi, Yagini; Gettys, Thomas W.] Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Gettys, TW (corresponding author), Pennington Biomed Res Ctr, Lab Nutrient Sensing & Adipocyte Signaling, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gettystw@pbrc.edu	Gettys, Thomas W/N-1964-2017; Chang, Ji Suk/N-1957-2017	Gettys, Thomas W/0000-0001-7125-7995; 	National Institutes of Health [RO1 DK 074772, P20-RR021945]; PBRC Nutrition Obesity Research Center (NORC) [1P30 DK072476]; COBRE (National Institutes of Health) [P20-RR021945]; NORC (National Institutes of Health) from the National Institutes of Health [1P30-DK072476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, R01DK074772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PBRC Nutrition Obesity Research Center (NORC); COBRE (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC (National Institutes of Health) from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 DK 074772 (to T. W. G.) and P20-RR021945 (to T. W. G. and J. S. C.). This work was also supported by PBRC Nutrition Obesity Research Center (NORC) Pilot and Feasibility Grant 1P30 DK072476 (to JSC). This work used Cell Biology & Bioimaging and Genomics core facilities, which are supported in part by COBRE (National Institutes of Health Grant P20-RR021945) and NORC (National Institutes of Health 1P30-DK072476) center grants from the National Institutes of Health.	Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Cheng XL, 2005, J BIOCHEM, V138, P673, DOI 10.1093/jb/mvi169; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; COUSIN B, 1992, J CELL SCI, V103, P931; Dankert JR, 2008, J NEURAL ENG, V5, P363, DOI 10.1088/1741-2560/5/4/001; Gomez-Ambrosi J, 2001, MOL CELL ENDOCRINOL, V176, P85, DOI 10.1016/S0303-7207(01)00451-8; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Norrbom J, 2011, AM J PHYSIOL-ENDOC M, V301, pE1092, DOI 10.1152/ajpendo.00119.2011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RABELO R, 1995, ENDOCRINOLOGY, V136, P1003, DOI 10.1210/en.136.3.1003; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sears IB, 1996, MOL CELL BIOL, V16, P3410; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshioka T, 2009, BIOCHEM BIOPH RES CO, V381, P537, DOI 10.1016/j.bbrc.2009.02.077; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	37	57	59	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9100	9111		10.1074/jbc.M111.320200	http://dx.doi.org/10.1074/jbc.M111.320200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22282499	hybrid, Green Published			2022-12-25	WOS:000301797800040
J	Hijazi, M; Durand, J; Pichereaux, C; Pont, F; Jamet, E; Albenne, C				Hijazi, May; Durand, Jessica; Pichereaux, Carole; Pont, Frederic; Jamet, Elisabeth; Albenne, Cecile			Characterization of the Arabinogalactan Protein 31 (AGP31) of Arabidopsis thaliana NEW ADVANCES ON THE HYP-O-GLYCOSYLATION OF THE PRO-RICH DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL PROTEINS; MASS-SPECTROMETRY; HYDROXYPROLINE; IDENTIFICATION; EXTENSIN; 4-HYDROXYLASE; GLYCOPROTEINS; PROTEOMICS; CLONING; BINDING	Proteins are important actors in plant cell walls because they contribute to their architecture and their dynamics. Among them, hydroxyproline (Hyp)-rich glycoproteins constitute a complex family of O-glycoproteins with various structures and functions. In this study, we characterized an atypical Hyp-rich glycoprotein, AGP31 (arabinogalactan protein 31), which displays a multidomain organization unique in Arabidopsis thaliana, consisting of a short arabinogalactan protein (AGP) motif, a His stretch, a Pro-rich domain, and a C-terminal PAC (PRP-AGP containing Cys) domain. The use of various mass spectrometry strategies was innovative and powerful: it permitted us to locate Hyp residues, to demonstrate the presence of carbohydrates, and to refine their distribution over the Pro-rich domain. Most Hyp were isolated within repeated motifs such as KAOV, KSOV, K(PO/OP) T, K(PO/OP) V, T(PO/OP) V, and Y(PO/OP) T. A few extensin-like motifs with contiguous Hyp (SOOA and SOOT) were also found. The Pro-rich domain was shown to carry Gal residues on isolated Hyp but also Ara residues. The existence of new type Hyp-O-Gal/Ara-rich motifs not recognized by the beta-glucosyl Yariv reagent but interacting with the peanut agglutinin lectin was proposed. In addition, the N-terminal short AGP motif was assumed to be substituted by arabinogalactans. Altogether, AGP31 was found to be highly heterogeneous in cell walls because arabinogalactans could be absent, Hyp-O-Gal/Ara-rich motifs of different sizes were observed, and truncated forms missing the C-terminal PAC domain were found, suggesting degradation in muro and/or partial glycosylation prior to secretion.	[Albenne, Cecile] CNRS, UPS, UMR 5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; Univ Toulouse, UPS, UMR 5546, Lab Rech Sci Vegetales, F-31326 Castanet Tolosan, France; [Pichereaux, Carole] Univ Toulouse, FR3450, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Pont, Frederic] INSERM, F-31300 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Albenne, C (corresponding author), CNRS, UPS, UMR 5546, Lab Rech Sci Vegetales, BP 42617, F-31326 Castanet Tolosan, France.	albenne@lrsv.ups-tlse.fr	Jamet, Elisabeth/Z-2476-2019; PONT, Frédéric/G-6289-2011	PONT, Frédéric/0000-0002-5493-527X; ALBENNE, Cecile/0000-0001-9856-9745; Pichereaux, Carole/0000-0002-7559-5358	Universite Paul Sabatier (Toulouse, France); CNRS (France); Lebanon ecological association	Universite Paul Sabatier (Toulouse, France); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Lebanon ecological association	This work was supported by the Universite Paul Sabatier (Toulouse, France), the CNRS (France), and a grant from the Lebanon ecological association (to M. H.). This work has been done in the LRSV, part of the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41).	AVERYHARTFULLARD V, 1988, P NATL ACAD SCI USA, V85, P1082, DOI 10.1073/pnas.85.4.1082; Baldwin TC, 2001, PLANT MOL BIOL, V45, P421, DOI 10.1023/A:1010637426934; Borderies G, 2003, ELECTROPHORESIS, V24, P3421, DOI 10.1002/elps.200305608; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; DATTA K, 1989, PLANT CELL, V1, P945, DOI 10.1105/tpc.1.9.945; Estevez JM, 2006, PLANT PHYSIOL, V142, P458, DOI 10.1104/pp.106.084244; Eudes A, 2008, PLANT CELL PHYSIOL, V49, P1331, DOI 10.1093/pcp/pcn108; Feiz L, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-10; Fowler TJ, 1999, PLANT PHYSIOL, V121, P1081, DOI 10.1104/pp.121.4.1081; Gaspar Y, 2001, PLANT MOL BIOL, V47, P161, DOI 10.1023/A:1010683432529; GIBEAUT DM, 1991, PLANT PHYSIOL, V97, P551, DOI 10.1104/pp.97.2.551; HATA K, 1992, PLANT PHYSIOL, V100, P388, DOI 10.1104/pp.100.1.388; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; Jamet E, 2008, PROTEOMICS, V8, P893, DOI 10.1002/pmic.200700938; Jeyaprakash AA, 2005, J MOL BIOL, V347, P181, DOI 10.1016/j.jmb.2005.01.015; KIELISZEWSKI M, 1992, PLANT PHYSIOL, V98, P919, DOI 10.1104/pp.98.3.919; KIELISZEWSKI MJ, 1990, PLANT PHYSIOL, V92, P316, DOI 10.1104/pp.92.2.316; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; KLEISSANFRANCISCO SM, 1990, PLANT PHYSIOL, V94, P1897, DOI 10.1104/pp.94.4.1897; Koski MK, 2009, J BIOL CHEM, V284, P25290, DOI 10.1074/jbc.M109.014050; Kotake T, 2005, PLANT PHYSIOL, V138, P1563, DOI 10.1104/pp.105.062562; Kotake T, 2006, J EXP BOT, V57, P2353, DOI 10.1093/jxb/erj206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPORT DTA, 1960, NATURE, V188, P665, DOI 10.1038/188665b0; Leonard R, 2005, J BIOL CHEM, V280, P7932, DOI 10.1074/jbc.M410407200; Leonard R, 2010, J BIOL CHEM, V285, P27192, DOI 10.1074/jbc.M110.127118; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; Liu CG, 2007, PLANT PHYSIOL, V145, P863, DOI 10.1104/pp.107.102657; MERKLE RK, 1994, METHOD ENZYMOL, V230, P1; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Oka T, 2010, PLANT PHYSIOL, V152, P332, DOI 10.1104/pp.109.146266; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; Sommer-Knudsen J, 1998, PHYTOCHEMISTRY, V47, P483, DOI 10.1016/S0031-9422(97)00724-3; SommerKnudsen J, 1996, PLANT J, V9, P71, DOI 10.1046/j.1365-313X.1996.09010071.x; Tan L, 2010, J BIOL CHEM, V285, P24575, DOI 10.1074/jbc.M109.100149; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Tryfona T, 2010, CARBOHYD RES, V345, P2648, DOI 10.1016/j.carres.2010.09.018; Willats WGT, 1996, PLANT J, V9, P919, DOI 10.1046/j.1365-313X.1996.9060919.x; Zhang Y, 2011, PHYTOCHEMISTRY, V72, P1109, DOI 10.1016/j.phytochem.2010.10.019	51	23	29	0	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9623	9632		10.1074/jbc.M111.247874	http://dx.doi.org/10.1074/jbc.M111.247874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270363	hybrid, Green Published			2022-12-25	WOS:000301797800093
J	Sala-Rabanal, M; Wang, SZ; Nichols, CG				Sala-Rabanal, Monica; Wang, Shizhen; Nichols, Colin G.			On Potential Interactions between Non-selective Cation Channel TRPM4 and Sulfonylurea Receptor SUR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; REACTIVE ASTROCYTES; TRAFFICKING; STOICHIOMETRY; SENSITIVITY; ACTIVATION; EXPRESSION; MUTATIONS; PROTEIN; STROKE	The sulfonylurea receptor SUR1 associates with Kir6.2 or Kir6.1 to form K-ATP channels, which link metabolism to excitability in multiple cell types. The strong physical coupling of SUR1 with Kir6 subunits appears exclusive, but recent studies argue that SUR1 also modulates TRPM4, a member of the transient receptor potential family of non-selective cation channels. It has been reported that, following stroke, brain, or spinal cord injury, SUR1 is increased in neurovascular cells at the site of injury. This is accompanied by up-regulation of a non-selective cation conductance with TRPM4-like properties and apparently sensitive to sulfonylureas, leading to the postulation that post-traumatic non-selective cation currents are determined by TRPM4/SUR1 channels. To investigate the mechanistic hypothesis for the coupling between TRPM4 and SUR1, we performed electrophysiological and FRET studies in COSm6 cells expressing TRPM4 channels with or without SUR1. TRPM4-mediated currents were Ca2+-activated, voltage-dependent, underwent desensitization, and were inhibited by ATP but were insensitive to glibenclamide and tolbutamide. These properties were not affected by cotransfection with SUR1. When the same SUR1 was cotransfected with Kir6.2, functional K-ATP channels were formed. In cells cotransfected with Kir6.2, SUR1, and TRPM4, we measured K-ATP-mediated K+ currents and Ca2+-activated, sulfonylurea-insensitive Na+ currents in the same patch, further showing that SUR1 controls K-ATP channel activity but not TRPM4 channels. FRET signal between fluorophore-tagged TRPM4 subunits was similar to that between Kir6.2 and SUR1, whereas there was no detectable FRET efficiency between TRPM4 and SUR1. Our data suggest that functional or structural association of TRPM4 and SUR1 is unlikely.	[Sala-Rabanal, Monica; Wang, Shizhen; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Wang, Shizhen; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Wang, Shizhen] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 425 S Euclid Ave, St Louis, MO 63110 USA.	cnichols@wustl.edu	Sala-Rabanal, Monica/AAU-2383-2021; Nichols, Colin/D-6336-2012; Wang, Shizhen/N-6577-2017	Wang, Shizhen/0000-0003-1065-4756	National Institutes of Health [HL95010]; American Heart Association [10POST4280056]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL95010 (to C. G. N.). This work was also supported by Postdoctoral Fellowship 10POST4280056 from the American Heart Association (to S. W.).	Akrouh A, 2009, IUBMB LIFE, V61, P971, DOI 10.1002/iub.246; Ammala C, 1996, NATURE, V379, P545, DOI 10.1038/379545a0; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Crnich R, 2010, AM J PHYSIOL-CELL PH, V299, pC682, DOI 10.1152/ajpcell.00101.2010; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Favilla CG, 2011, STROKE, V42, P710, DOI 10.1161/STROKEAHA.110.599274; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Gribble FM, 1997, J PHYSIOL-LONDON, V498, P87, DOI 10.1113/jphysiol.1997.sp021843; Guinamard R, 2006, HYPERTENSION, V48, P587, DOI 10.1161/01.HYP.0000237864.65019.a5; Guinamard R, 2011, ADV EXP MED BIOL, V704, P147, DOI 10.1007/978-94-007-0265-3_8; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hille B., 2001, ION CHANNELS EXCITAB, P237; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Kuhner P, 2012, N-S ARCH PHARMACOL, V385, P299, DOI 10.1007/s00210-011-0709-8; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Makhina EN, 2001, METHOD PHARMACOL TOX, P261; Makhina EN, 1998, J BIOL CHEM, V273, P3369, DOI 10.1074/jbc.273.6.3369; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Morita H, 2007, J PHARMACOL SCI, V103, P417, DOI 10.1254/jphs.FP0061332; Muallem D, 2009, PHILOS T R SOC B, V364, P247, DOI 10.1098/rstb.2008.0191; Murakami M, 2003, BIOCHEM BIOPH RES CO, V307, P522, DOI 10.1016/S0006-291X(03)01186-0; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Popovich P. G., 2010, EXP NEUROL, V232, P615; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Reading SA, 2007, STROKE, V38, P2322, DOI 10.1161/STROKEAHA.107.483404; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2007, BBA-MOL BASIS DIS, V1772, P947, DOI 10.1016/j.bbadis.2007.03.004; Simard JM, 2011, STROKE, V42, pE409, DOI 10.1161/STROKEAHA.111.620666; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Simard JM, 2004, J NEUROSURG ANESTH, V16, P98, DOI 10.1097/00008506-200401000-00021; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R., 2007, V179, P269; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zhu ZM, 2011, PFLUG ARCH EUR J PHY, V461, P211, DOI 10.1007/s00424-010-0902-5	57	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8746	8756		10.1074/jbc.M111.336131	http://dx.doi.org/10.1074/jbc.M111.336131			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291026	Green Published, hybrid			2022-12-25	WOS:000301797800008
J	Ber, S; Lee, C; Voiculescu, O; Surani, MA				Ber, Suzan; Lee, Caroline; Voiculescu, Octavian; Surani, M. Azim			Dedifferentiation of Foetal CNS Stem Cells to Mesendoderm-Like Cells through an EMT Process	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EARLY CHICK-EMBRYOS; GROWTH-FACTOR-BETA; NEURAL-CREST; TGF-BETA; SLUG EXPRESSION; E-CADHERIN; P53-MEDIATED APOPTOSIS; DEFINITIVE ENDODERM; SIGNALING PATHWAYS	Tissue-specific stem cells are considered to have a limited differentiation potential. Recently, this notion was challenged by reports that showed a broader differentiation potential of neural stem cells, in vitro and in vivo, although the molecular mechanisms that regulate plasticity of neural stem cells are unknown. Here, we report that neural stem cells derived from mouse embryonic cortex respond to Lif and serum in vitro and undergo epithelial to mesenchymal transition (EMT)-mediated dedifferentiation process within 48 h, together with transient upregulation of pluripotency markers and, more notably, upregulation of mesendoderm genes, Brachyury (T) and Sox17. These induced putative mesendoderm cells were injected into early gastrulating chick embryos, which revealed that they integrated more efficiently into mesoderm and endoderm lineages compared to non-induced cells. We also found that TGF beta and Jak/Stat pathways are necessary but not sufficient for the induction of mesendodermal phenotype in neural stem cells. These results provide insights into the regulation of plasticity of neural stem cells through EMT. Dissecting the regulatory pathways involved in these processes may help to gain control over cell fate decisions.	[Ber, Suzan; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England; [Voiculescu, Octavian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; University of Cambridge	Ber, S (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England.	sb681@cam.ac.uk; a.surani@gurdon.cam.ac.uk	Voiculescu, Octavian/A-7571-2010	Voiculescu, Octavian/0000-0003-0714-1482; Surani, Azim/0000-0002-8640-4318; Ber, Suzan/0000-0003-4219-6032	DTI of CellCentric Ltd [TP/4/BIO/6/I/22020]; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish	DTI of CellCentric Ltd; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by The Technology Programme (DTI Project Number TP/4/BIO/6/I/22020) of CellCentric Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; Direkze NC, 2003, STEM CELLS, V21, P514, DOI 10.1634/stemcells.21-5-514; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Gammill LS, 2003, NAT REV NEUROSCI, V4, P795, DOI 10.1038/nrn1219; Gilbert SF, 2006, DEV BIOL; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Heisenberg CP, 2008, CURR OPIN GENET DEV, V18, P311, DOI 10.1016/j.gde.2008.07.011; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mercado-Pimentel ME, 2007, CELLS TISSUES ORGANS, V185, P146, DOI 10.1159/000101315; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Park KS, 2010, DEVELOPMENT, V137, P2691, DOI 10.1242/dev.050096; Poulain M, 2006, DEVELOPMENT, V133, P2189, DOI 10.1242/dev.02387; Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Stern CD, 1997, INT J DEV BIOL, V41, P379; Swetha G, 2011, J CELL MOL MED, V15, P396, DOI 10.1111/j.1582-4934.2009.00937.x; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uchikado Y, 2005, CLIN CANCER RES, V11, P1174; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; VIDRICAIRE G, 1994, DEVELOPMENT, V120, P115; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Voiculescu O, 2008, NAT PROTOC, V3, P419, DOI 10.1038/nprot.2008.10; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	59	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30759	10.1371/journal.pone.0030759	http://dx.doi.org/10.1371/journal.pone.0030759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276221	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100061
J	Ekouevi, DK; Stringer, E; Coetzee, D; Tih, P; Creek, T; Stinson, K; Westfall, AO; Welty, T; Chintu, N; Chi, BH; Wilfert, C; Shaffer, N; Stringer, J; Dabis, F				Ekouevi, Didier K.; Stringer, Elizabeth; Coetzee, David; Tih, Pius; Creek, Tracy; Stinson, Kathryn; Westfall, Andrew O.; Welty, Thomas; Chintu, Namwinga; Chi, Benjamin H.; Wilfert, Cathy; Shaffer, Nathan; Stringer, Jeff; Dabis, Francois			Health Facility Characteristics and Their Relationship to Coverage of PMTCT of HIV Services across Four African Countries: The PEARL Study	PLOS ONE			English	Article								Background: Health facility characteristics associated with effective prevention of mother-to-child transmission of HIV (PMTCT) coverage in sub-Saharan are poorly understood. Methodology/Principal Findings: We conducted surveys in health facilities with active PMTCT services in Cameroon, Cote d'Ivoire, South Africa, and Zambia. Data was compiled via direct observation and exit interviews. We constructed composite scores to describe provision of PMTCT services across seven topical areas: antenatal quality, PMTCT quality, supplies available, patient satisfaction, patient understanding of medication, and infrastructure quality. Pearson correlations and Generalized Estimating Equations (GEE) to account for clustering of facilities within countries were used to evaluate the relationship between the composite scores, total time of visit and select individual variables with PMTCT coverage among women delivering. Between July 2008 and May 2009, we collected data from 32 facilities; 78% were managed by the government health system. An opt-out approach for HIV testing was used in 100% of facilities in Zambia, 63% in Cameroon, and none in Cote d'Ivoire or South Africa. Using Pearson correlations, PMTCT coverage (median of 55%, (IQR: 33-68) was correlated with PMTCT quality score (rho = 0.51; p = 0.003); infrastructure quality score (rho = 0.43; p = 0.017); time spent at clinic (rho = 0.47; p = 0.013); patient understanding of medications score (rho = 0.51; p = 0.006); and patient satisfaction quality score (rho = 0.38; p = 0.031). PMTCT coverage was marginally correlated with the antenatal quality score (rho = 0.304; p = 0.091). Using GEE adjustment for clustering, the, antenatal quality score became more strongly associated with PMTCT coverage (p<0.001) and the PMTCT quality score and patient understanding of medications remained marginally significant. Conclusions/Results: We observed a positive relationship between an antenatal quality score and PMTCT coverage but did not identify a consistent set of variables that predicted PMTCT coverage.	[Ekouevi, Didier K.; Welty, Thomas] Programme PAC CI, Abidjan, Cote Ivoire; [Ekouevi, Didier K.; Welty, Thomas; Dabis, Francois] Univ Victor Segalen, Inst Natl Sante & Rech Med, Bordeaux, France; [Stringer, Elizabeth; Westfall, Andrew O.; Chintu, Namwinga; Chi, Benjamin H.; Stringer, Jeff] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Coetzee, David; Stinson, Kathryn] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Tih, Pius] Cameroon Baptist Hlth Convent Hlth Board, Bamenda, Cameroon; [Creek, Tracy] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Wilfert, Cathy] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA; [Shaffer, Nathan] World Hlth Org, Geneva, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Cape Town; Centers for Disease Control & Prevention - USA; World Health Organization	Ekouevi, DK (corresponding author), Programme PAC CI, Abidjan, Cote Ivoire.	didier.ekouevi@gmail.com	EKOUEVI, Didier K/E-7960-2014; Stringer, Jeffrey S. A./AAU-2342-2021; DABIS, FRANCOIS/S-9298-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Westfall, Andrew/0000-0002-0468-4695	U.S. Centers for Disease Control and Prevention [T0906150021/CDC-Centers for Disease Control/EGPAF AM3]; Elizabeth Glaser Pediatric AIDS Foundation from the Bill and Melinda Gates Foundation [351-07]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Elizabeth Glaser Pediatric AIDS Foundation from the Bill and Melinda Gates Foundation	This study was supported by the U.S. Centers for Disease Control and Prevention, Global AIDS Program of Atlanta, Georgia (Contract T0906150021/CDC-Centers for Disease Control/EGPAF AM3) and by the Elizabeth Glaser Pediatric AIDS Foundation (grant number #351-07 from the Bill and Melinda Gates Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandisarewa W, 2007, B WORLD HEALTH ORGAN, V85, P843, DOI 10.2471/BLT.06.035188; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Doherty Tanya M, 2005, Afr Health Sci, V5, P213; Ekouevi DK, 2004, AIDS, V18, P697, DOI 10.1097/00002030-200403050-00018; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Oladapo Olufemi T, 2008, Afr J Reprod Health, V12, P71; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Stringer EM, 2011, JAMA-J AM MED ASSOC, V3, P293; WHO, 2009, UN ACC SCAL PRIOR HI; WHO, 2010, GUID CAR TREATM SUPP	10	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29823	10.1371/journal.pone.0029823	http://dx.doi.org/10.1371/journal.pone.0029823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276130	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100016
J	Lange, Y; Ye, J; Steck, TL				Lange, Yvonne; Ye, Jin; Steck, Theodore L.			Activation Mobilizes the Cholesterol in the Late Endosomes-Lysosomes of Niemann Pick Type C Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; CYCLODEXTRIN OVERCOMES; STEROL TRANSPORT; TRAFFICKING; HOMEOSTASIS; NPC2; DISEASE; RED; MOVEMENT	A variety of intercalating amphipaths increase the chemical activity of plasma membrane cholesterol. To test whether intracellular cholesterol can be similarly activated, we examined NPC1 and NPC2 fibroblasts, since they accumulate large amounts of cholesterol in their late endosomes and lysosomes (LE/L). We gauged the mobility of intracellular sterol from its appearance at the surface of the intact cells, as determined by its susceptibility to cholesterol oxidase and its isotope exchange with extracellular 2-(hydroxypropyl)-beta-cyclodextrin-cholesterol. The entire cytoplasmic cholesterol pool in these cells was mobile, exchanging with the plasma membrane with an apparent half-time of similar to 3-4 hours, similar to 4-5 times slower than that for wild type human fibroblasts (half-time similar to 0.75 hours). The mobility of the intracellular cholesterol was increased by the membrane-intercalating amphipaths chlorpromazine and 1-octanol. Chlorpromazine also promoted the net transfer of LE/L cholesterol to serum and cyclodextrin. Surprisingly, the mobility of LE/L cholesterol was greatly stimulated by treating intact NPC cells with glutaraldehyde or formaldehyde. Similar effects were seen with wild type fibroblasts in which the LE/L cholesterol pool had been expanded using U18666A. We also showed that the cholesterol in the intracellular membranes of fixed wild-type fibroblasts was mobile; it was rapidly oxidized by cholesterol oxidase and was rapidly replenished by exogenous sterol. We conclude that a) the cholesterol in NPC cells can exit the LE/L (and the extensive membranous inclusions therein) over a few hours; b) this mobility is stimulated by the activation of the cholesterol with intercalating amphipaths; c) intracellular cholesterol is even more mobile in fixed cells; and d) amphipaths that activate cholesterol might be useful in treating NPC disease.	[Lange, Yvonne; Ye, Jin] Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA; [Steck, Theodore L.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Rush University; University of Chicago	Lange, Y (corresponding author), Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA.	ylange@rush.edu	Steck, Theodore/GWM-4373-2022; Lange, Yvonne/A-7794-2009	Steck, Theodore/0000-0002-8391-9244; 	National Institutes of Health [HL28448]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028448, R55HL028448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work was supported by National Institutes of Health grant HL28448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hammed M, 2010, J LIPID RES, V51, P1747, DOI 10.1194/jlr.M003822; Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Ahn KW, 2004, BIOCHEMISTRY-US, V43, P827, DOI 10.1021/bi035697q; Bi XN, 2010, SUBCELL BIOCHEM, V51, P319, DOI 10.1007/978-90-481-8622-8_11; Blanchette-Mackie EJ, 2000, BBA-MOL CELL BIOL L, V1486, P171, DOI 10.1016/S1388-1981(00)00055-X; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; COXEY RA, 1993, J LIPID RES, V34, P1165; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Du XM, 2011, J CELL BIOL, V192, P121, DOI 10.1083/jcb.201004142; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Gallala HD, 2011, J NEUROCHEM, V116, P702, DOI 10.1111/j.1471-4159.2010.07014.x; Garver WS, 2010, J LIPID RES, V51, P406, DOI 10.1194/jlr.P000331; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Jacquez J. A., 1985, COMPARTMENTAL ANAL B; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Jimenez-Lopez JM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-33; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; KODAVANTI UP, 1990, J BIOCHEM TOXICOL, V5, P245, DOI 10.1002/jbt.2570050407; Kuroda Y, 2010, TOXICOL IN VITRO, V24, P661, DOI 10.1016/j.tiv.2009.09.018; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; LANGE Y, 1983, J BIOL CHEM, V258, P5130; Lange Y, 2005, J BIOL CHEM, V280, P36126, DOI 10.1074/jbc.M507149200; LANGE Y, 1995, J LIPID RES, V36, P1092; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lange Y, 2002, J LIPID RES, V43, P198; LANGE Y, 1991, J BIOL CHEM, V266, P21439; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; LANGE Y, 1984, BIOCHIM BIOPHYS ACTA, V769, P551, DOI 10.1016/0005-2736(84)90053-1; LANGE Y, 1980, J BIOL CHEM, V255, P9331; LANGE Y, 1994, J BIOL CHEM, V269, P29371; Lange Y, 1998, J BIOL CHEM, V273, P18915, DOI 10.1074/jbc.273.30.18915; Lange Y, 1999, J LIPID RES, V40, P2264; Lange Y, 2008, PROG LIPID RES, V47, P319, DOI 10.1016/j.plipres.2008.03.001; Lange Y, 2007, BIOCHEMISTRY-US, V46, P2233, DOI 10.1021/bi6023397; Lange Y, 2009, J LIPID RES, V50, P1881, DOI 10.1194/jlr.M900116-JLR200; Lange Y, 2009, BIOCHEMISTRY-US, V48, P8505, DOI 10.1021/bi900951r; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; MATSUZAWA Y, 1980, J LIPID RES, V21, P202; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Millat G, 2001, AM J HUM GENET, V69, P1013, DOI 10.1086/324068; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Olsen BN, 2011, BIOPHYS J, V100, P948, DOI 10.1016/j.bpj.2010.12.3728; Olsen BN, 2009, J AM CHEM SOC, V131, P4854, DOI 10.1021/ja8095224; Pham NA, 2005, J INHERIT METAB DIS, V28, P991, DOI 10.1007/s10545-005-0117-7; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Ramirez CM, 2011, J LIPID RES, V52, P688, DOI 10.1194/jlr.M013789; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Rothblat GH, 1999, J LIPID RES, V40, P781; Russell A D, 1976, Prog Med Chem, V13, P271, DOI 10.1016/S0079-6468(08)70140-1; Schoer JK, 2000, BIOCHEMISTRY-US, V39, P7662, DOI 10.1021/bi992686h; SLOTTE JP, 1989, BIOCHIM BIOPHYS ACTA, V985, P90, DOI 10.1016/0005-2736(89)90108-9; SOKOL J, 1988, J BIOL CHEM, V263, P3411; Steck TL, 2010, TRENDS CELL BIOL, V20, P680, DOI 10.1016/j.tcb.2010.08.007; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Underwood KW, 1996, J LIPID RES, V37, P1556; Vance JE, 2011, CURR OPIN LIPIDOL, V22, P204, DOI 10.1097/MOL.0b013e3283453e69	69	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30051	10.1371/journal.pone.0030051	http://dx.doi.org/10.1371/journal.pone.0030051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276143	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100023
J	Xuan, Y; Meng, C; Yang, YH; Zhu, CZ; Wang, L; Yan, Q; Lin, CL; Yu, CS				Xuan, Yun; Meng, Chun; Yang, Yanhui; Zhu, Chaozhe; Wang, Liang; Yan, Qian; Lin, Chunlan; Yu, Chunshui			Resting-State Brain Activity in Adult Males Who Stutter	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ALTERED FUNCTIONAL CONNECTIVITY; INDEPENDENT COMPONENT ANALYSIS; LOW-FREQUENCY FLUCTUATION; SUPPLEMENTARY MOTOR AREA; DEVELOPMENTAL STUTTERERS; SPEECH PRODUCTION; NONSTUTTERING ADULTS; ACTIVATION PATTERNS; PREFRONTAL CORTEX	Although developmental stuttering has been extensively studied with structural and task-based functional magnetic resonance imaging (fMRI), few studies have focused on resting-state brain activity in this disorder. We investigated resting-state brain activity of stuttering subjects by analyzing the amplitude of low-frequency fluctuation (ALFF), region of interest (ROI)-based functional connectivity (FC) and independent component analysis (ICA)-based FC. Forty-four adult males with developmental stuttering and 46 age-matched fluent male controls were scanned using resting-state fMRI. ALFF, ROI-based FCs and ICA-based FCs were compared between male stuttering subjects and fluent controls in a voxel-wise manner. Compared with fluent controls, stuttering subjects showed increased ALFF in left brain areas related to speech motor and auditory functions and bilateral prefrontal cortices related to cognitive control. However, stuttering subjects showed decreased ALFF in the left posterior language reception area and bilateral non-speech motor areas. ROI-based FC analysis revealed decreased FC between the posterior language area involved in the perception and decoding of sensory information and anterior brain area involved in the initiation of speech motor function, as well as increased FC within anterior or posterior speech-and language-associated areas and between the prefrontal areas and default-mode network (DMN) in stuttering subjects. ICA showed that stuttering subjects had decreased FC in the DMN and increased FC in the sensorimotor network. Our findings support the concept that stuttering subjects have deficits in multiple functional systems (motor, language, auditory and DMN) and in the connections between them.	[Xuan, Yun] Tianjin Med Univ, Dept Anat, Tianjin, Peoples R China; [Meng, Chun; Zhu, Chaozhe] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Yang, Yanhui] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Wang, Liang; Yu, Chunshui] Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Yan, Qian] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Lin, Chunlan] Beijing Prof Lin Stuttering Correct Ctr, Beijing, Peoples R China	Tianjin Medical University; Beijing Normal University; Capital Medical University; Tianjin Medical University; Chinese Academy of Sciences; Institute of Psychology, CAS	Xuan, Y (corresponding author), Tianjin Med Univ, Dept Anat, Tianjin, Peoples R China.	chunshuiyu@yahoo.cn	Chaozhe, Zhu/AAK-7737-2020	Chaozhe, Zhu/0000-0002-9247-9607; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of China [30870694]; Program for New Century Excellent Talents in University [NCET-07-0568]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by Natural Science Foundation of China, 30870694; and Program for New Century Excellent Talents in University, NCET-07-0568. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Beal DS, 2007, NEUROREPORT, V18, P1257, DOI 10.1097/WNR.0b013e3282202c4d; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blomgren M, 2003, J FLUENCY DISORD, V28, P337, DOI 10.1016/j.jfludis.2003.08.002; Bloodstein O., 1995, HDB STUTTERING; Bloodstein O., 2008, HDB STUTTERING; BORDEN GJ, 1983, J SPEECH HEAR RES, V26, P389, DOI 10.1044/jshr.2603.389; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chang SE, 2011, CEREB CORTE IN PRESS; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Chung SJ, 2004, MOVEMENT DISORD, V19, P1106, DOI 10.1002/mds.20136; Corbera S, 2005, NEUROLOGY, V65, P1246, DOI 10.1212/01.wnl.0000180969.03719.81; Cunnington R, 1996, HUM MOVEMENT SCI, V15, P627, DOI 10.1016/0167-9457(96)00018-8; Cykowski MD, 2008, CEREB CORTEX, V18, P571, DOI 10.1093/cercor/bhm093; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Nil LF, 2003, J FLUENCY DISORD, V28, P357, DOI 10.1016/j.jfludis.2003.07.002; De Nil LF, 2000, J SPEECH LANG HEAR R, V43, P1038, DOI 10.1044/jslhr.4304.1038; De Nil LF, 2008, BRAIN LANG, V107, P114, DOI 10.1016/j.bandl.2008.07.003; DENIL LF, 1991, BRAIN, V114, P2145, DOI 10.1093/brain/114.5.2145; Denny M, 2000, J SPEECH LANG HEAR R, V43, P1024, DOI 10.1044/jslhr.4304.1024; FISH CH, 1965, CALIF MED, V103, P337; Forster DC, 2001, DEV NEUROPSYCHOL, V19, P125, DOI 10.1207/S15326942DN1902_1; Foundas AL, 2004, NEUROLOGY, V63, P1640, DOI 10.1212/01.WNL.0000142993.33158.2A; Foundas AL, 2003, NEUROLOGY, V61, P1378, DOI 10.1212/01.WNL.0000094320.44334.86; Foundas AL, 2001, NEUROLOGY, V57, P207, DOI 10.1212/WNL.57.2.207; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Fridriksson J, 2009, J SPEECH LANG HEAR R, V52, P812, DOI 10.1044/1092-4388(2008/06-0197); Giraud AL, 2008, BRAIN LANG, V104, P190, DOI 10.1016/j.bandl.2007.04.005; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Howell P, 2010, EXP NEUROL, V225, P55, DOI 10.1016/j.expneurol.2010.06.012; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Ingham RJ, 2000, BRAIN LANG, V75, P163, DOI 10.1006/brln.2000.2351; Ingham RJ, 1996, J SPEECH HEAR RES, V39, P1208, DOI 10.1044/jshr.3906.1208; Jancke L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-23; Jeon HA, 2009, NEUROIMAGE, V48, P449, DOI 10.1016/j.neuroimage.2009.06.049; Jones RD, 2002, HUM MOVEMENT SCI, V21, P603, DOI 10.1016/S0167-9457(02)00165-3; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Loucks TMJ, 2006, J MOTOR BEHAV, V38, P238, DOI 10.3200/JMBR.38.3.238-247; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu C, 2009, NEUROSCIENCE, V161, P1008, DOI 10.1016/j.neuroscience.2009.04.020; Lu CM, 2010, EXP NEUROL, V221, P146, DOI 10.1016/j.expneurol.2009.10.016; Lu CM, 2010, CORTEX, V46, P49, DOI 10.1016/j.cortex.2009.02.017; Mechelli A, 2007, HUM BRAIN MAPP, V28, P205, DOI 10.1002/hbm.20272; Neumann K, 2005, J FLUENCY DISORD, V30, P23, DOI 10.1016/j.jfludis.2004.12.002; Neumann K, 2003, J FLUENCY DISORD, V28, P381, DOI 10.1016/j.jfludis.2003.07.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papoutsi M, 2009, CEREB CORTEX, V19, P2156, DOI 10.1093/cercor/bhn239; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; POOL KD, 1991, ARCH NEUROL-CHICAGO, V48, P509, DOI 10.1001/archneur.1991.00530170069022; Preibisch C, 2003, NEUROIMAGE, V20, P1356, DOI 10.1016/S1053-8119(03)00376-8; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riley G., 1994, STUTTERING SEVERITY; Riva-Posse P, 2008, PARKINSONISM RELAT D, V14, P415, DOI 10.1016/j.parkreldis.2007.11.006; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Schafer RJ, 2009, NEUROIMAGE, V46, P882, DOI 10.1016/j.neuroimage.2009.02.017; Scott SK, 2003, NEUROIMAGE, V19, P870, DOI 10.1016/S1053-8119(03)00083-1; Seery CH, 2007, J FLUENCY DISORD, V32, P197, DOI 10.1016/j.jfludis.2007.07.001; Smits-Bandstra S, 2007, J FLUENCY DISORD, V32, P251, DOI 10.1016/j.jfludis.2007.06.001; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Stager SV, 2003, J FLUENCY DISORD, V28, P319, DOI 10.1016/j.jfludis.2003.08.004; Toyomura A, 2011, NEUROIMAGE IN PRESS; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Borsel J, 2003, BRAIN LANG, V85, P369, DOI 10.1016/S0093-934X(02)00588-6; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; WEBSTER WG, 1986, NEUROPSYCHOLOGIA, V24, P813, DOI 10.1016/0028-3932(86)90080-1; Whitney C, 2009, J COGNITIVE NEUROSCI, V21, P697, DOI 10.1162/jocn.2009.21056; Wilson SM, 2008, CEREB CORTEX, V18, P230, DOI 10.1093/cercor/bhm049; Wirth M, 2011, NEUROIMAGE, V54, P3057, DOI 10.1016/j.neuroimage.2010.10.039; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yairi E, 2007, J FLUENCY DISORD, V32, P165, DOI 10.1016/j.jfludis.2007.04.001; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zheng ZZ, 2010, J COGNITIVE NEUROSCI, V22, P1770, DOI 10.1162/jocn.2009.21324; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	101	43	44	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30570	10.1371/journal.pone.0030570	http://dx.doi.org/10.1371/journal.pone.0030570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276215	gold, Green Submitted, Green Published			2022-12-25	WOS:000301568100057
J	Baurhoo, B; Ferket, P; Ashwell, CM; de Oliviera, J; Zhao, X				Baurhoo, Bushansingh; Ferket, Peter; Ashwell, Chris M.; de Oliviera, Jean; Zhao, Xin			Cell Walls of Saccharomyces cerevisiae Differentially Modulated Innate Immunity and Glucose Metabolism during Late Systemic Inflammation	PLOS ONE			English	Article							ADIPOSE-TISSUE; MUSCLE CATABOLISM; ESCHERICHIA-COLI; SMALL-INTESTINE; EXPRESSION; LIPOPOLYSACCHARIDE; GLUCONEOGENESIS; ACTIVATION; CHICKEN; GENES	Background: Salmonella causes acute systemic inflammation by using its virulence factors to invade the intestinal epithelium. But, prolonged inflammation may provoke severe body catabolism and immunological diseases. Salmonella has become more life-threatening due to emergence of multiple-antibiotic resistant strains. Mannose-rich oligosaccharides (MOS) from cells walls of Saccharomyces cerevisiae have shown to bind mannose-specific lectin of Gram-negative bacteria including Salmonella, and prevent their adherence to intestinal epithelial cells. However, whether MOS may potentially mitigate systemic inflammation is not investigated yet. Moreover, molecular events underlying innate immune responses and metabolic activities during late inflammation, in presence or absence of MOS, are unknown. Methods and Principal Findings: Using a Salmonella LPS-induced systemic inflammation chicken model and microarray analysis, we investigated the effects of MOS and virginiamycin (VIRG, a sub-therapeutic antibiotic) on innate immunity and glucose metabolism during late inflammation. Here, we demonstrate that MOS and VIRG modulated innate immunity and metabolic genes differently. Innate immune responses were principally mediated by intestinal IL-3, but not TNF-alpha, IL-1 or IL-6, whereas glucose mobilization occurred through intestinal gluconeogenesis only. MOS inherently induced IL-3 expression in control hosts. Consequent to LPS challenge, IL-3 induction in VIRG hosts but not differentially expressed in MOS hosts revealed that MOS counteracted LPS's detrimental inflammatory effects. Metabolic pathways are built to elucidate the mechanisms by which VIRG host's higher energy requirements were met: including gene up-regulations for intestinal gluconeogenesis (PEPCK) and liver glycolysis (ENO2), and intriguingly liver fatty acid synthesis through ATP citrate synthase (CS) down-regulation and ATP citrate lyase (ACLY) and malic enzyme (ME) up-regulations. However, MOS host's lower energy demands were sufficiently met through TCA citrate-derived energy, as indicated by CS up-regulation. Conclusions: MOS terminated inflammation earlier than VIRG and reduced glucose mobilization, thus representing a novel biological strategy to alleviate Salmonella-induced systemic inflammation in human and animal hosts.	[Baurhoo, Bushansingh; Zhao, Xin] McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada; [Ferket, Peter; Ashwell, Chris M.; de Oliviera, Jean] N Carolina State Univ, Dept Poultry Sci, Raleigh, NC 27695 USA	McGill University; University of North Carolina; North Carolina State University	Baurhoo, B (corresponding author), McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada.	baurhoo.bushansingh@mail.mcgill.ca; xin.zhao@mcgill.ca	Zhao, Xin/M-4312-2015; Ashwell, Christopher/N-1332-2016	Zhao, Xin/0000-0002-1078-7332; de Oliveira, Jean Eduardo/0000-0002-7133-9197; Ashwell, Christopher/0000-0002-8190-1147; Ferket, Peter/0000-0002-2897-4312	Saskatchewan Chicken Industry Development Fund (SCIDF); James McGill Professorship	Saskatchewan Chicken Industry Development Fund (SCIDF); James McGill Professorship	This investigation was supported by the Saskatchewan Chicken Industry Development Fund (SCIDF) and James McGill Professorship fund to XZ. BB is a doctoral fellow of the Natural Sciences and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baurhoo B, 2007, POULTRY SCI, V86, P2509, DOI 10.3382/ps.2007-00136; Baurhoo B, 2009, POULTRY SCI, V88, P2262, DOI 10.3382/ps.2008-00562; Behera AK, 2002, J BIOL CHEM, V277, P25601, DOI 10.1074/jbc.M200211200; CDC, 2011, SALM SER ENT; Ceciliani F, 2002, PROTEIN PEPTIDE LETT, V9, P211, DOI 10.2174/0929866023408779; CHEEMADH.S, 1973, EUR J BIOCHEM, V38, P98, DOI 10.1111/j.1432-1033.1973.tb03038.x; Chidakel A, 2005, THYROID, V15, P899, DOI 10.1089/thy.2005.15.899; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Croset M, 2001, DIABETES, V50, P740, DOI 10.2337/diabetes.50.4.740; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Druyan S, 2008, POULTRY SCI, V87, P2418, DOI 10.3382/ps.2007-00513; Ebner S, 2002, J IMMUNOL, V168, P6199, DOI 10.4049/jimmunol.168.12.6199; Eid A, 2006, J AM SOC NEPHROL, V17, P398, DOI 10.1681/ASN.2005070742; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; FLATT JP, 1966, J BIOL CHEM, V241, P2862; FLORES EA, 1989, J CLIN INVEST, V83, P1614, DOI 10.1172/JCI114059; Gao J, 2008, POULTRY SCI, V87, P1377, DOI 10.3382/ps.2007-00418; Garosi P, 2005, BRIT J NUTR, V93, P425, DOI 10.1079/BJN20041385; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gomez-Verduzco G, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-11; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Harden LM, 2008, BRAIN BEHAV IMMUN, V22, P838, DOI 10.1016/j.bbi.2007.12.006; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hasenstein JR, 2007, AVIAN DIS, V51, P561, DOI 10.1637/0005-2086(2007)51[561:CGGCAW]2.0.CO;2; Hillgartner FB, 1998, AM J PHYSIOL-ENDOC M, V274, pE493; Holecek M, 1995, PHYSIOL RES, V44, P399; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kochan Z, 1997, METABOLISM, V46, P10, DOI 10.1016/S0026-0495(97)90160-8; Kogut MH, 2005, ANIM BIOTECHNOL, V16, P165, DOI 10.1080/10495390500264896; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Lopez-Bojorquez L, 2004, ARCH MED RES, V35, P465, DOI 10.1016/j.arcmed.2004.07.006; Galdeano CM, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-64; Martin G, 2007, BIOCHEM J, V401, P465, DOI 10.1042/BJ20061148; Morral N, 2007, J LIPID RES, V48, P1499, DOI 10.1194/jlr.M700090-JLR200; Nsenga R, 2009, FRONT MED CHINA, V3, P437; OFEK I, 1978, INFECT IMMUN, V22, P247, DOI 10.1128/IAI.22.1.247-254.1978; OHEA EK, 1968, COMP BIOCHEM PHYSIOL, V26, P111, DOI 10.1016/0010-406X(68)90317-4; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pearce NJ, 1998, BIOCHEM J, V334, P113, DOI 10.1042/bj3340113; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Stumvoll M, 1998, AM J PHYSIOL-ENDOC M, V274, pE817, DOI 10.1152/ajpendo.1998.274.5.E817; Szymanska-Czerwinska M, 2009, CENT EUR J IMMUNOL, V34, P1; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang PH, 2009, COMP BIOCHEM PHYS B, V153, P327, DOI 10.1016/j.cbpb.2009.04.003; WATERSON RM, 1972, J BIOL CHEM, V247, P5258; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; World Health Organization, 2011, COMPL KILLS ANT RES; Xie H, 2000, POULTRY SCI, V79, P33, DOI 10.1093/ps/79.1.33; Xu JC, 2004, P NATL ACAD SCI USA, V101, P3112, DOI 10.1073/pnas.0308450100; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; Zhao CW, 2001, APPL ENVIRON MICROB, V67, P5431, DOI 10.1128/AEM.67.12.5431-5436.2001	60	27	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30323	10.1371/journal.pone.0030323	http://dx.doi.org/10.1371/journal.pone.0030323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272335	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400113
J	Hulsmans, M; Geeraert, B; De Keyzer, D; Mertens, A; Lannoo, M; Vanaudenaerde, B; Hoylaerts, M; Benhabiles, N; Tsatsanis, C; Mathieu, C; Holvoet, P				Hulsmans, Maarten; Geeraert, Benjamine; De Keyzer, Dieuwke; Mertens, Ann; Lannoo, Matthias; Vanaudenaerde, Bart; Hoylaerts, Marc; Benhabiles, Nora; Tsatsanis, Christos; Mathieu, Chantal; Holvoet, Paul			Interleukin-1 Receptor-Associated Kinase-3 Is a Key Inhibitor of Inflammation in Obesity and Metabolic Syndrome	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; IRAK-M; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ADIPONECTIN; EXPRESSION; MONOCYTES; RISK; MACROPHAGES	Background: Visceral obesity is associated with the rising incidence of type 2 diabetes and metabolic syndrome. Low-grade chronic inflammation and oxidative stress synergize in obesity and obesity-induced disorders. Objective: We searched a cluster of molecules that support interactions between these stress conditions in monocytes. Methods: RNA expressions in blood monocytes of two independent cohorts comprising 21 and 102 obese persons and 46 age-matched controls were determined by microarray and independently validated by quantitative RT-PCR analysis. The effect of three-month weight loss after bariatric surgery was determined. The effect of RNA silencing on inflammation and oxidative stress was studied in human monocytic THP-1 cells. Results: Interleukin-1 receptor-associated kinase-3 (IRAK3), key inhibitor of IRAK/NF kappa B-mediated chronic inflammation, is downregulated in monocytes of obese persons. Low IRAK3 was associated with high superoxide dismutase-2 (SOD2), a marker of mitochondrial oxidative stress. A comparable expression profile was also detected in visceral adipose tissue of the same obese subjects. Low IRAK3 and high SOD2 was associated with a high prevalence of metabolic syndrome (odds ratio: 9.3; sensitivity: 91%; specificity: 77%). By comparison, the odds ratio of high-sensitivity C-reactive protein, a widely used marker of systemic inflammation, was 4.3 (sensitivity: 69%; specificity: 66%). Weight loss was associated with an increase in IRAK3 and a decrease in SOD2, in association with a lowering of systemic inflammation and a decreasing number of metabolic syndrome components. We identified the increase in reactive oxygen species in combination with obesity-associated low adiponectin and high glucose and interleukin-6 as cause of the decrease in IRAK3 in THP-1 cells in vitro. Conclusion: IRAK3 is a key inhibitor of inflammation in association with obesity and metabolic syndrome. Our data warrant further evaluation of IRAK3 as a diagnostic and prognostic marker, and as a target for intervention.	[Hulsmans, Maarten; Geeraert, Benjamine; De Keyzer, Dieuwke; Benhabiles, Nora; Holvoet, Paul] Katholieke Univ Leuven, Dept Cardiovasc Dis, Atherosclerosis & Metab Unit, Louvain, Belgium; [Mertens, Ann; Mathieu, Chantal] Katholieke Univ Leuven, Dept Expt Med, Expt Med & Endocrinol Sect, Louvain, Belgium; [Lannoo, Matthias] Katholieke Univ Leuven, Div Abdominal Surg, Louvain, Belgium; [Vanaudenaerde, Bart] Katholieke Univ Leuven, Dept Pathophysiol, Pneumol Sect, Louvain, Belgium; [Hoylaerts, Marc] Katholieke Univ Leuven, Dept Mol & Cellular Med, Ctr Mol & Vasc Biol, Louvain, Belgium; [Tsatsanis, Christos] Univ Crete, Sch Med, Dept Clin Chem, Iraklion, Greece	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; University of Crete	Hulsmans, M (corresponding author), Katholieke Univ Leuven, Dept Cardiovasc Dis, Atherosclerosis & Metab Unit, Louvain, Belgium.	paul.holvoet@med.kuleuven.be	HOLVOET, PAUL/T-8434-2017; Hulsmans, Maarten/AAI-9547-2020; Tsatsanis, Christos/AAM-9362-2020; mathieu, chantal/ABD-5505-2021; lannoo, matthias/AAB-1706-2020	HOLVOET, PAUL/0000-0001-9201-0772; Hulsmans, Maarten/0000-0003-1009-658X; Tsatsanis, Christos/0000-0003-1214-4151; mathieu, chantal/0000-0002-4055-5233; Hoylaerts, Marc/0000-0002-6474-3933; Lannoo, matthias/0000-0001-7815-1157; Vanaudenaerde, Bart/0000-0001-6435-6901; Mertens, Ann/0000-0002-1649-4311	Belgian Federal Government [P06/30]; Bijzonder Onderzoeksfonds of the Katholieke Universiteit Leuven [OT/06/56, PF/10/014]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0548.08, G0846.11]	Belgian Federal Government; Bijzonder Onderzoeksfonds of the Katholieke Universiteit Leuven(KU Leuven); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO)	Funding was provided by the Interuniversitaire Attractiepolen Programma of the Belgian Federal Government (P06/30), the Bijzonder Onderzoeksfonds of the Katholieke Universiteit Leuven (OT/06/56 and PF/10/014) and by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G.0548.08, G0846.11, and Vascular Biology Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Camhi SM, 2010, METABOLISM, V59, P54, DOI 10.1016/j.metabol.2009.07.008; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Cummings David E., 2004, Journal of Clinical Endocrinology & Metabolism, V89, P2608, DOI 10.1210/jc.2004-0433; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Geeraert B, 2007, J THROMB HAEMOST, V5, P2529, DOI 10.1111/j.1538-7836.2007.02786.x; Holvoet P, 2006, CLIN CHEM, V52, P760, DOI 10.1373/clinchem.2005.064337; Holvoet P, 2004, DIABETES, V53, P1068, DOI 10.2337/diabetes.53.4.1068; Holvoet P, 2008, Verh K Acad Geneeskd Belg, V70, P193; Holvoet P, 2008, JAMA-J AM MED ASSOC, V299, P2287, DOI 10.1001/jama.299.19.2287; Holvoet P, 2006, ARTERIOSCL THROM VAS, V26, P1558, DOI 10.1161/01.ATV.0000226553.01555.02; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Knight J, 2001, NATURE, V410, P860, DOI 10.1038/35073680; Kobayashi H, 2011, J IMMUNOL, V186, P403, DOI 10.4049/jimmunol.1001906; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Ladunga I, 2002, CURR PROTOC BIOINFOR; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Patino R, 2000, AM J CARDIOL, V85, P1288, DOI 10.1016/S0002-9149(00)00757-8; Pickl WF, 1996, J IMMUNOL, V157, P3850; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Rosati O, 2002, BIOCHEM BIOPH RES CO, V293, P1472, DOI 10.1016/S0006-291X(02)00411-4; Salio M, 2000, EUR J IMMUNOL, V30, P705, DOI 10.1002/1521-4141(200002)30:2<705::AID-IMMU705>3.0.CO;2-P; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Standiford TJ, 2011, ONCOGENE, V30, P2475, DOI 10.1038/onc.2010.619; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Van Guilder GP, 2006, OBESITY, V14, P2127, DOI 10.1038/oby.2006.248; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Zacharioudaki V, 2009, J IMMUNOL, V182, P6444, DOI 10.4049/jimmunol.0803694	42	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30414	10.1371/journal.pone.0030414	http://dx.doi.org/10.1371/journal.pone.0030414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272346	gold, Green Submitted, Green Published			2022-12-25	WOS:000301454400124
J	Guijarro, MV; Vergel, M; Marin, JJ; Munoz-Galvan, S; Ferrer, I; Cajal, SRY; Roncador, G; Blanco-Aparicio, C; Carnero, A				Guijarro, M. V.; Vergel, M.; Marin, J. J.; Munoz-Galvan, S.; Ferrer, I.; Ramon y Cajal, S.; Roncador, G.; Blanco-Aparicio, C.; Carnero, A.			p38 alpha limits the contribution of MAP17 to cancer progression in breast tumors	ONCOGENE			English	Article						breast carcinoma; MAP17; ROS; p38	EPITHELIAL-CELL TRANSFORMATION; INDUCED GROWTH ARREST; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; SIGNAL-TRANSDUCTION; MAMMALIAN-CELLS; INDUCED SENESCENCE; HUMAN CARCINOMAS; KINASE; P38	MAP17 is a small, 17-kDa, non-glycosylated membrane protein that is overexpressed in a percentage of carcinomas. In the present work, we have analyzed the role of MAP17 expression during mammary cancer progression. We have found that MAP17 is expressed in 60% human mammary tumors while it is not expressed in normal or benign neoplasias. MAP17 levels increased with breast tumor stage and were strongly correlated with mammary tumoral progression. A significant increase in the levels of reactive oxygen species (ROS) was observed in MAP17-expressing cells, as compared with parental cells. This increase was further paralleled by an increase in the tumorigenic capacity of carcinoma cells but not in immortal non-tumoral breast epithelial cells, which provides a selective advantage once tumorigenesis has begun. Expression of specific MAP17 shRNA in protein-expressing tumor cells reduced their tumorigenic capabilities, which suggests that this effect is dependent upon MAP17 protein expression. Our data show that ROS functions as a second messenger that enhances tumoral properties, which are inhibited in non-tumoral cells. We have found that p38 alpha activation mediates this response. MAP17 triggers a ROS-dependent, senescence-like response that is abolished in the absence of p38a activation. Furthermore, in human breast tumors, MAP17 activation is correlated with a lack of phosphorylation of p38a. Therefore, MAP17 is overexpressed in late-stage breast tumors, in which oncogenic activity relies on p38 insensitivity to induce intracellular ROS. Oncogene (2012) 31, 4447-4459; doi: 10.1038/onc.2011.619; published online 23 January 2012	[Carnero, A.] Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla IBIS HUVR, Seville 41013, Spain; [Guijarro, M. V.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Marin, J. J.] Univ Seville, Dept Prevent Med & Publ Hlth, Seville, Spain; [Ferrer, I.] Inst Invest Biomed Bellvitge IDIBELL, Bellvitge, Spain; [Ramon y Cajal, S.] Recerca Hosp Vall Hebron, Fundacio Inst, Dept Pathol, Barcelona, Spain; [Roncador, G.] Spanish Natl Canc Ctr CNIO, Biotechnol Program, Madrid, Spain; [Carnero, A.] CSIC, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; New York University; University of Sevilla; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Universitari Vall d'Hebron; Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC)	Carnero, A (corresponding author), Hosp Univ Virgen del Rocio, CSIC, Inst Biomed Sevilla IBIS HUVR, Avda Manuel Siurot S-N, Seville 41013, Spain.	acarnero@us.es	IBIS, CANCER/P-3323-2015; Ramon y Cajal, Santiago/H-4955-2016; Blanco-Aparicio, Carmen/I-3162-2015; Muñoz-Galván, Sandra/K-5827-2015; Roncador, Giovanna/L-1764-2014; Marín-López, Juan J./G-7123-2012; Ferrer, Irene/C-9418-2015	Ramon y Cajal, Santiago/0000-0002-3867-1390; Blanco-Aparicio, Carmen/0000-0002-3249-6595; Roncador, Giovanna/0000-0002-9807-2875; Marín-López, Juan J./0000-0001-6072-739X; Ferrer, Irene/0000-0002-2748-2607; Carnero, Amancio/0000-0003-4357-3979; Munoz-Galvan, Sandra/0000-0003-0579-325X	Spanish Ministry of Science and Innovation; FEDER [SAF2009-08605]; Consejeria de Ciencia e Innovacion; Consejeria de Salud of the Junta de Andalucia [CTS-6844, PI-0142]; Fundacion Oncologica FERO; Fundacio Josep Botet	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Consejeria de Ciencia e Innovacion; Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); Fundacion Oncologica FERO; Fundacio Josep Botet	We thank Augusto Silva and Ricardo Sanchez Prieto for their critical reading of the manuscript and valuable suggestions. This work was supported by grants from the Spanish Ministry of Science and Innovation and FEDER (SAF2009-08605), Consejeria de Ciencia e Innovacion and Consejeria de Salud of the Junta de Andalucia (CTS-6844 and PI-0142). AC's laboratory is also funded by a fellowship from the Fundacion Oncologica FERO, supported by Fundacio Josep Botet.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Blasco T, 2003, AM J PHYSIOL-RENAL, V285, pF799, DOI 10.1152/ajprenal.00149.2003; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Burdon RH, 1996, BIOCHEM SOC T, V24, P1028, DOI 10.1042/bst0241028; Carnero A, 2004, ONCOGENE, V23, P6006, DOI 10.1038/sj.onc.1207839; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dimri G, 2005, BREAST CANCER RES, V7, P171, DOI 10.1186/bcr1275; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Dorion S, 2002, J BIOL CHEM, V277, P30792, DOI 10.1074/jbc.M203642200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; England K, 2005, REDOX REP, V10, P237, DOI 10.1179/135100005X70224; FERNANDEZPOL JA, 1982, CANCER RES, V42, P609; Guijarro MV, 2007, J CELL BIOCHEM, V101, P112, DOI 10.1002/jcb.21163; Guijarro MV, 2007, CARCINOGENESIS, V28, P2443, DOI 10.1093/carcin/bgm154; Guijarro MV, 2007, CARCINOGENESIS, V28, P2096, DOI 10.1093/carcin/bgm124; Guijarro MV, 2007, CARCINOGENESIS, V28, P1646, DOI 10.1093/carcin/bgm083; Hancock JT, 2001, BIOFACTORS, V15, P99, DOI 10.1002/biof.5520150210; Herbert BS, 2002, ONCOGENE, V21, P7897, DOI 10.1038/sj.onc.1205902; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jaeger C, 2000, J INVEST DERMATOL, V115, P375, DOI 10.1046/j.1523-1747.2000.00071.x; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Kocher O, 1996, AM J PATHOL, V149, P493; Kocher O, 1995, CLIN CANCER RES, V1, P1209; Lanaspa MA, 2007, AM J PHYSIOL-RENAL, V292, pF230, DOI 10.1152/ajprenal.00075.2006; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lewis CM, 2006, BREAST CANCER RES TR, V99, P103, DOI 10.1007/s10549-006-9189-9; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pribanic S, 2003, AM J PHYSIOL-RENAL, V285, pF784, DOI 10.1152/ajprenal.00109.2003; Ruiz L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003230; Samanta AK, 2009, CANCER-AM CANCER SOC, V115, P3897, DOI 10.1002/cncr.24445; Stampfer MR, 2003, CANCER LETT, V194, P199, DOI 10.1016/S0304-3835(02)00707-3; Stampfer MR, 2000, J MAMMARY GLAND BIOL, V5, P365, DOI 10.1023/A:1009525827514; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yan T, 1996, CANCER RES, V56, P2864; Yoon SO, 2002, MECH AGEING DEV, V123, P1597, DOI 10.1016/S0047-6374(02)00095-7; Zuluaga S, 2007, CELL SIGNAL, V19, P62, DOI 10.1016/j.cellsig.2006.05.032	59	23	24	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	41					4447	4459		10.1038/onc.2011.619	http://dx.doi.org/10.1038/onc.2011.619			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	018YR	22266858				2022-12-25	WOS:000309704500003
J	Keimling, M; Deniz, M; Varga, D; Stahl, A; Schrezenmeier, H; Kreienberg, R; Hoffmann, I; Konig, J; Wiesmuller, L				Keimling, Marlen; Deniz, Miriam; Varga, Dominic; Stahl, Andreea; Schrezenmeier, Hubert; Kreienberg, Rolf; Hoffmann, Isabell; Koenig, Jochem; Wiesmueller, Lisa			The power of DNA double-strand break (DSB) repair testing to predict breast cancer susceptibility	FASEB JOURNAL			English	Article						error-prone DNA repair; functional biomarker; single-strand annealing	HOMOLOGOUS RECOMBINATION; POLY(ADP-RIBOSE) POLYMERASE; MICRONUCLEUS FREQUENCIES; FUNCTIONAL ASSAYS; GENES; BRCA1; LYMPHOCYTES; MUTATION; CELLS; RISK	Most presently known breast cancer susceptibility genes have been linked to DSB repair. To identify novel markers that may serve as indicators for breast cancer risk, we performed DSB repair analyses using a case-control design. Thus, we examined 35 women with defined familial history of breast and/or ovarian cancer (first case group), 175 patients with breast cancer (second case group), and 245 healthy women without previous cancer or family history of breast cancer (control group). We analyzed DSB repair in peripheral blood lymphocytes (PBLs) by a GFP-based test system using 3 pathway-specific substrates. We found increases of microhomology-mediated nonhomologous end joining (mmNHEJ) and nonconservative single-strand annealing (SSA) in women with familial risk vs. controls (P=0.0001-0.0022) and patients with breast cancer vs. controls (P=0.0004-0.0042). Young age (<50) at initial diagnosis of breast cancer, which could be indicative of genetic predisposition, was associated with elevated SSA using two different substrates, amounting to similar odds ratios (ORs=2.54-4.46, P=0.0059-0.0095) as for familial risk (ORs=2.61-4.05, P=0.0007-0.0045). These findings and supporting validation data underscore the great potential of detecting distinct DSB repair activities in PBLs as method to estimate breast cancer susceptibility beyond limitations of genotyping and to predict responsiveness to therapeutics targeting DSB repair-dysfunctional tumors.-Keimling, M., Deniz, M., Varga, D., Stahl, A., Schrezenmeier, H., Kreienberg, R., Hoffmann, I., Konig, J., Wiesmuller, L. The power of DNA double-strand break (DSB) repair testing to predict breast cancer susceptibility. FASEB J. 26, 2094-2104 (2012). www.fasebj.org	[Keimling, Marlen; Deniz, Miriam; Varga, Dominic; Stahl, Andreea; Kreienberg, Rolf; Wiesmueller, Lisa] Univ Ulm, Dept Obstet & Gynecol, D-89075 Ulm, Germany; [Schrezenmeier, Hubert] Inst Klin Transfus Med & Immungenet Ulm, Ulm, Germany; [Hoffmann, Isabell; Koenig, Jochem] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, D-6500 Mainz, Germany	Ulm University; Johannes Gutenberg University of Mainz	Wiesmuller, L (corresponding author), Univ Ulm, Dept Obstet & Gynecol, Prittwitzstr 43, D-89075 Ulm, Germany.	lisa.wiesmueller@uni-ulm.de	König, Jochem/T-3500-2019	König, Jochem/0000-0003-4683-0360	Ministry for Education and Research [Bundesministerium fur Bildung und Forschung (BMBF)], Germany (BRENDA) [012P0505]; German Cancer Foundation (Deutsche Krebshilfe) [107744]; Deutsche Forschungsgemeinschaft (DFG; Klinische Forschergruppe 167: Apoptoseregulation und ihre Storungen bei Krankheiten) [WI 3099/7-1, WI 3099/7 -2]	Ministry for Education and Research [Bundesministerium fur Bildung und Forschung (BMBF)], Germany (BRENDA); German Cancer Foundation (Deutsche Krebshilfe)(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG; Klinische Forschergruppe 167: Apoptoseregulation und ihre Storungen bei Krankheiten)	The authors cordially thank Marina Wager, Heike Goggerle, and Julia Kaufmann for expert technical assistance and Kathrin Kuhr for initial statistical evaluations. This work was supported by the Ministry for Education and Research [Bundesministerium fur Bildung und Forschung (BMBF)], Germany (BRENDA, 012P0505), the German Cancer Foundation (Deutsche Krebshilfe, 107744), and the Deutsche Forschungsgemeinschaft (DFG; Klinische Forschergruppe 167: Apoptoseregulation und ihre Storungen bei Krankheiten, WI 3099/7-1 and -2).	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Baldeyron C, 2002, ONCOGENE, V21, P1401, DOI 10.1038/sj.onc.1205200; Bonassi S, 2001, ENVIRON MOL MUTAGEN, V37, P31; Broeks A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1668; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Carvalho MA, 2007, INT J BIOCHEM CELL B, V39, P298, DOI 10.1016/j.biocel.2006.08.002; Chang-Claude J, 2009, BRIT J CANCER, V100, P1680, DOI 10.1038/sj.bjc.6605036; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Decottignies A, 2007, GENETICS, V176, P1403, DOI 10.1534/genetics.107.071621; Dohrn L, 2012, BIOCHEM J, V441, P919, DOI 10.1042/BJ20110314; Farrugia DJ, 2008, CANCER RES, V68, P3523, DOI 10.1158/0008-5472.CAN-07-1587; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fu YP, 2003, CANCER RES, V63, P2440; Ganzinelli M, 2011, EUR J CANCER, V47, P1086, DOI 10.1016/j.ejca.2010.11.029; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Jaspers JE, 2009, BBA-REV CANCER, V1796, P266, DOI 10.1016/j.bbcan.2009.07.001; Jerry DJ, 2010, CELL MOL LIFE SCI, V67, P1017, DOI 10.1007/s00018-009-0244-7; Keimling M, 2008, INT J CANCER, V123, P730, DOI 10.1002/ijc.23551; Keimling M, 2011, FASEB J, V25, P3849, DOI 10.1096/fj.11-185546; Keimling M, 2009, CARCINOGENESIS, V30, P1260, DOI 10.1093/carcin/bgp117; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Megnin-Chanet F, 2010, CELL MOL LIFE SCI, V67, P3649, DOI 10.1007/s00018-010-0490-8; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Nippert Irmgard, 2003, Community Genet, V6, P249, DOI 10.1159/000079387; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rothfuss A, 2000, CANCER RES, V60, P390; Salih AK, 2001, CANCER TREAT REV, V27, P261, DOI 10.1053/ctrv.2001.0235; Speit G, 2004, CYTOGENET GENOME RES, V104, P325, DOI 10.1159/000077511; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Szpirer C, 2007, MAMM GENOME, V18, P817, DOI 10.1007/s00335-007-9073-x; Terry PD, 2006, CANCER EPIDEM BIOMAR, V15, P602, DOI 10.1158/1055-9965.EPI-05-0853; Trainer AH, 2010, NAT REV CLIN ONCOL, V7, P708, DOI 10.1038/nrclinonc.2010.175; Uhl M., 2010, ENCY BREAST CANC, P675; Varga D, 2006, MUTAGENESIS, V21, P313, DOI 10.1093/mutage/gel035; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Willers H, 2009, MOL CANCER RES, V7, P1304, DOI 10.1158/1541-7786.MCR-09-0149; Wockel A, 2008, BREAST CARE, V3, P82, DOI 10.1159/000127509	44	31	33	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					2094	2104		10.1096/fj.11-200790	http://dx.doi.org/10.1096/fj.11-200790			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22278937				2022-12-25	WOS:000303680800035
J	Fisher, N; Majid, RA; Antoine, T; Al-Helal, M; Warman, AJ; Johnson, DJ; Lawrenson, AS; Ranson, H; O'Neill, PM; Ward, SA; Biagini, GA				Fisher, Nicholas; Majid, Roslaini Abd; Antoine, Thomas; Al-Helal, Mohammed; Warman, Ashley J.; Johnson, David J.; Lawrenson, Alexandre S.; Ranson, Hilary; O'Neill, Paul M.; Ward, Stephen A.; Biagini, Giancarlo A.			Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc(1) Catalytic Turnover and Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; UBIQUINOL OXIDATION SITE; PLASMODIUM-FALCIPARUM; Q(O) SITE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-BASIS; COMPLEX; DRUG; INHIBITION; BINDING	Atovaquone is an anti-malarial drug used in combination with proguanil (e.g. Malarone (TM)) for the curative and prophylactic treatment of malaria. Atovaquone, a 2-hydroxynaphthoquinone, is a competitive inhibitor of the quinol oxidation (Q(o)) site of the mitochondrial cytochrome bc(1) complex. Inhibition of this enzyme results in the collapse of the mitochondrial membrane potential, disruption of pyrimidine biosynthesis, and subsequent parasite death. Resistance to atovaquone in the field is associated with point mutations in the Q(o) pocket of cytochrome b, most notably near the conserved Pro(260)-Glu(261)-Trp(262)-Tyr(263) (PEWY) region in the ef loop). The effect of this mutation has been extensively studied in model organisms but hitherto not in the parasite itself. Here, we have performed a molecular and biochemical characterization of an atovaquone-resistant field isolate, TM902CB. Molecular analysis of this strain reveals the presence of the Y268S mutation in cytochrome b. The Y268S mutation is shown to confer a 270-fold shift of the inhibitory constant (K-i) for atovaquone with a concomitant reduction in the V-max of the bc1 complex of similar to 40% and a 3-fold increase in the observed K-m for decylubiquinol. Western blotting analyses reveal a reduced iron-sulfur protein content in Y268S bc(1) suggestive of a weakened interaction between this subunit and cytochrome b. Gene expression analysis of the TM902CB strain reveals higher levels of expression, compared with the 3D7 (atovaquone-sensitive) control strain in bc(1) and cytochrome c oxidase genes. It is hypothesized that the observed differential expression of these and other key genes offsets the fitness cost resulting from reduced bc(1) activity.	[Fisher, Nicholas; Majid, Roslaini Abd; Antoine, Thomas; Al-Helal, Mohammed; Warman, Ashley J.; Johnson, David J.; Ranson, Hilary; Ward, Stephen A.; Biagini, Giancarlo A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Lawrenson, Alexandre S.; O'Neill, Paul M.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	Ward, SA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	saward@liv.ac.uk; Biagini@liverpool.ac.uk	Ward, Steve/G-6003-2015; Biagini, Giancarlo A/F-3449-2011	Ward, Steve/0000-0003-2331-3192; Biagini, Giancarlo A/0000-0001-6356-6595; Ranson, Hilary/0000-0003-2332-8247	Leverhulme Trust; Wellcome Trust; European Union Framework 7 Marie Curie Initial Training Network [215281]; Malaysian Government; National Institute of Health Research (BRC Liverpool)	Leverhulme Trust(Leverhulme Trust); Wellcome Trust(Wellcome TrustEuropean Commission); European Union Framework 7 Marie Curie Initial Training Network; Malaysian Government; National Institute of Health Research (BRC Liverpool)	This work was supported by grants from the Leverhulme Trust, the Wellcome Trust, the European Union Framework 7 Marie Curie Initial Training Network 215281 (InterMalTraining), the Malaysian Government, and the National Institute of Health Research (BRC Liverpool).	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Barton V, 2010, CURR OPIN CHEM BIOL, V14, P440, DOI 10.1016/j.cbpa.2010.05.005; Berry A, 2006, T ROY SOC TROP MED H, V100, P986, DOI 10.1016/j.trstmh.2006.02.004; Berry EA, 2011, BBA-BIOENERGETICS, V1807, P1349, DOI 10.1016/j.bbabio.2011.04.005; Biagini GA, 2006, ANTIMICROB AGENTS CH, V50, P1841, DOI 10.1128/AAC.50.5.1841-1851.2006; Biagini GA, 2008, MOL PHARMACOL, V73, P1347, DOI 10.1124/mol.108.045120; Bourges I, 2005, J BIOL CHEM, V280, P29743, DOI 10.1074/jbc.M505915200; BOWYER JR, 1982, J BIOL CHEM, V257, P8321; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brasseur G, 2004, J BIOL CHEM, V279, P24203, DOI 10.1074/jbc.M311576200; Brasseur G, 2001, BBA-BIOENERGETICS, V1506, P89, DOI 10.1016/S0005-2728(01)00186-4; Bulusu V, 2011, J BIOL CHEM, V286, P9236, DOI 10.1074/jbc.M110.173328; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Covian R, 2006, J BIOL CHEM, V281, P30925, DOI 10.1074/jbc.M604694200; Crofts AR, 2000, BBA-BIOENERGETICS, V1459, P456, DOI 10.1016/S0005-2728(00)00184-5; Cross RM, 2011, J MED CHEM, V54, P4399, DOI 10.1021/jm200015a; Dechering KJ, 1999, MOL CELL BIOL, V19, P967; Fisher N, 2005, PEST MANAG SCI, V61, P973, DOI 10.1002/ps.1066; Fisher N, 2004, J BIOL CHEM, V279, P12951, DOI 10.1074/jbc.M313866200; Fisher N, 2008, FEMS YEAST RES, V8, P183, DOI 10.1111/j.1567-1364.2007.00328.x; Fivelman Quinton L, 2002, Malar J, V1, P1; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; HAMMOND DJ, 1985, MOL BIOCHEM PARASIT, V14, P97, DOI 10.1016/0166-6851(85)90109-4; Hughes LM, 2011, MOL BIOCHEM PARASIT, V177, P12, DOI 10.1016/j.molbiopara.2011.01.002; Kessl JJ, 2007, TRENDS PARASITOL, V23, P494, DOI 10.1016/j.pt.2007.08.004; Kessl JJ, 2005, J BIOL CHEM, V280, P17142, DOI 10.1074/jbc.M500388200; KNAPP B, 1990, MOL BIOCHEM PARASIT, V40, P1, DOI 10.1016/0166-6851(90)90074-V; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; KUBOYAMA M, 1972, J BIOL CHEM, V247, P6375; Lalloo DG, 2008, BMJ-BRIT MED J, V336, P1362, DOI 10.1136/bmj.a153; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Looareesuwan S, 1996, AM J TROP MED HYG, V54, P62, DOI 10.4269/ajtmh.1996.54.62; Merbitz-Zahradnik T, 2003, BIOCHEMISTRY-US, V42, P13637, DOI 10.1021/bi035344r; Musset L, 2006, MICROBES INFECT, V8, P2599, DOI 10.1016/j.micinf.2006.07.011; Osei-Akoto A., 2009, COCHRANE DB SYST REV, VCD004529, P1; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; Peters JM, 2002, ANTIMICROB AGENTS CH, V46, P2435, DOI 10.1128/AAC.46.8.2435-2441.2002; Schwartz E, 2003, CLIN INFECT DIS, V37, P450, DOI 10.1086/375599; Seymour KK, 1997, ANN TROP MED PARASIT, V91, P603, DOI 10.1080/00034989760699; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Wibrand F, 2001, ANN NEUROL, V50, P540, DOI 10.1002/ana.1224	48	56	59	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					9731	9741		10.1074/jbc.M111.324319	http://dx.doi.org/10.1074/jbc.M111.324319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22282497	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000302167200007
J	Gimenez, LE; Kook, S; Vishnivetskiy, SA; Ahmed, MR; Gurevich, EV; Gurevich, VV				Gimenez, Luis E.; Kook, Seunghyi; Vishnivetskiy, Sergey A.; Ahmed, M. Rafiuddin; Gurevich, Eugenia V.; Gurevich, Vsevolod V.			Role of Receptor-attached Phosphates in Binding of Visual and Non-visual Arrestins to G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; PHOSPHORYLATION SITES; BETA-2-ADRENERGIC RECEPTOR; KINASE PHOSPHORYLATION; CONFORMATIONAL-CHANGES; FLUORESCENT PROTEIN; CLATHRIN ADAPTER; WILD-TYPE	Arrestins are a small family of proteins that regulate G protein-coupled receptors (GPCRs). Arrestins specifically bind to phosphorylated active receptors, terminating G protein coupling, targeting receptors to endocytic vesicles, and initiating G protein-independent signaling. The interaction of rhodopsin-attached phosphates with Lys-14 and Lys-15 in beta-strand I was shown to disrupt the interaction of alpha-helix I, beta-strand I, and the C-tail of visual arrestin-1, facilitating its transition into an active receptor-binding state. Here we tested the role of conserved lysines in homologous positions of non-visual arrestins by generating K2A mutants in which both lysines were replaced with alanines. K2A mutations in arrestin-1, -2, and -3 significantly reduced their binding to active phosphorhodopsin in vitro. The interaction of arrestins with several GPCRs in intact cells was monitored by a bioluminescence resonance energy transfer (BRET)-based assay. BRET data confirmed the role of Lys-14 and Lys-15 in arrestin-1 binding to non-cognate receptors. However, this was not the case for non-visual arrestins in which the K2A mutations had little effect on net BRETmax values for the M2 muscarinic acetylcholine (M2R), beta(2)-adrenergic (beta(2)AR), or D2 dopamine receptors. Moreover, a phosphorylation-deficient mutant of M2R interacted with wild type non-visual arrestins normally, whereas phosphorylation-deficient beta(2)AR mutants bound arrestins at 20-50% of the level of wild type beta(2)AR. Thus, the contribution of receptor-attached phosphates to arrestin binding varies depending on the receptor-arrestin pair. Although arrestin-1 always depends on receptor phosphorylation, its role in the recruitment of arrestin-2 and -3 is much greater in the case of beta(2)AR than M2R and D2 dopamine receptor.	[Gurevich, Vsevolod V.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Gurevich, VV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 2220 Pierce Ave,PRB 417D, Nashville, TN 37232 USA.	vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM081756, GM077561, EY011500, NS065868]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081756, GM077561, EY011500 (all to V. V. G.) and NS065868 (to E. V. G.).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Goodman O B Jr, 1998, Adv Pharmacol, V42, P429; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GrayKeller MP, 1997, BIOCHEMISTRY-US, V36, P7058, DOI 10.1021/bi963110k; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001444; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; GUREVICH VV, 1993, J BIOL CHEM, V268, P16879; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Key TA, 2003, J BIOL CHEM, V278, P4041, DOI 10.1074/jbc.M204687200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; Lee KB, 2000, J BIOL CHEM, V275, P9284, DOI 10.1074/jbc.275.13.9284; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	78	61	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9028	9040		10.1074/jbc.M111.311803	http://dx.doi.org/10.1074/jbc.M111.311803			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275358	hybrid, Green Published			2022-12-25	WOS:000301797800033
J	Kuga, A; Kanagawa, M; Sudo, A; Chan, YM; Tajiri, M; Manya, H; Kikkawa, Y; Nomizu, M; Kobayashi, K; Endo, T; Lu, QL; Wada, Y; Toda, T				Kuga, Atsushi; Kanagawa, Motoi; Sudo, Atsushi; Chan, Yiumo Michael; Tajiri, Michiko; Manya, Hiroshi; Kikkawa, Yamato; Nomizu, Motoyoshi; Kobayashi, Kazuhiro; Endo, Tamao; Lu, Qi L.; Wada, Yoshinao; Toda, Tatsushi			Absence of Post-phosphoryl Modification in Dystroglycanopathy Mouse Models and Wild-type Tissues Expressing Non-laminin Binding Form of alpha-Dystroglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; FUKUTIN-RELATED PROTEIN; EXTRACELLULAR-MATRIX; ABNORMAL GLYCOSYLATION; AGRIN RECEPTOR; MUTATIONS; COMPLEX; GLYCOSYLTRANSFERASE; GLYCOPROTEIN; REQUIRES	alpha-Dystroglycan (alpha-DG) is a membrane-associated glycoprotein that interacts with several extracellular matrix proteins, including laminin and agrin. Aberrant glycosylation of alpha-DG disrupts its interaction with ligands and causes a certain type of muscular dystrophy commonly referred to as dystroglycanopathy. It has been reported that a unique O-mannosyl tetrasaccharide (Neu5Ac-alpha 2,3-Gal-beta 1,4-GlcNAc-beta 1,2-Man) and a phosphodiester-linked modification on O-mannose play important roles in the laminin binding activity of alpha-DG. In this study, we use several dystroglycanopathy mouse models to demonstrate that, in addition to fukutin and LARGE, FKRP (fukutin-related protein) is also involved in the post-phosphoryl modification of O-mannose on alpha-DG. Furthermore, we have found that the glycosylation status of alpha-DG in lung and testis is minimally affected by defects in fukutin, LARGE, or FKRP. alpha-DG prepared from wild-type lung-or testis-derived cells lacks the post-phosphoryl moiety and shows little laminin-binding activity. These results show that FKRP is involved in post-phosphoryl modification rather than in O-mannosyl tetrasaccharide synthesis. Our data also demonstrate that post-phosphoryl modification not only plays critical roles in the pathogenesis of dystroglycanopathy but also is a key determinant of alpha-DG functional expression as a laminin receptor in normal tissues and cells.	[Toda, Tatsushi] Kobe Univ, Div Neurol Mol Brain Sci, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Chan, Yiumo Michael; Lu, Qi L.] Carolinas Med Ctr, McColl Lockwood Lab Muscular Dystrophy Res, Neuromuscular ALS Ctr, Charlotte, NC 28231 USA; [Tajiri, Michiko; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Osaka 5941101, Japan; [Tajiri, Michiko; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Manya, Hiroshi; Endo, Tamao] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan; [Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Sch Pharm, Tokyo 1920392, Japan	Kobe University; Carolinas Medical Center; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Metropolitan Institute of Gerontology; Tokyo University of Pharmacy & Life Sciences	Toda, T (corresponding author), Kobe Univ, Div Neurol Mol Brain Sci, Grad Sch Med, Chuo Ku, 7-5-1 Kusunoki Chou, Kobe, Hyogo 6500017, Japan.	toda@med.kobe-u.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021; Kikkawa, Yamato/D-1503-2010; lu, qi/HHS-2115-2022	Kobayashi, Kazuhiro/0000-0001-7801-147X; Manya, Hiroshi/0000-0003-1573-9177; Toda, Tatsushi/0000-0002-0717-1123; Kanagawa, Motoi/0000-0003-0984-6398	Ministry of Health, Labor, and Welfare of Japan [23B-5]; Research on Psychiatric and Neurological Diseases and Mental Health [H20-016]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23249049, 21790318]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [21689030] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research on Psychiatric and Neurological Diseases and Mental Health; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Health, Labor, and Welfare of Japan Intramural Research Grant (23B-5) for Neurological and Mental Disorders and The Research on Psychiatric and Neurological Diseases and Mental Health H20-016 (to T. T.), Grant-in-aid for Scientific Research (A) 23249049 (to T. T.) and a Grant-in-aid for Young Scientists (B) 21790318 (to M. K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Takeda Science Foundation (to M. K.).	Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Chan YM, 2010, HUM MOL GENET, V19, P3995, DOI 10.1093/hmg/ddq314; Chiba A, 1997, J BIOL CHEM, V272, P2156; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; de Bernabe DBV, 2009, J BIOL CHEM, V284, P11279, DOI 10.1074/jbc.C900007200; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; Hall H, 2003, MOL CELL NEUROSCI, V24, P1062, DOI 10.1016/j.mcn.2003.08.007; Higginson JR, 2005, BIOCHEM SOC T, V33, P1254, DOI 10.1042/BST0331254; Hozumi K, 2009, BIOCHEMISTRY-US, V48, P5375, DOI 10.1021/bi900542u; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2008, NEUROMUSCULAR DISORD, V18, P45, DOI 10.1016/j.nmd.2007.08.002; Michele DE, 2009, CIRC RES, V105, P984, DOI 10.1161/CIRCRESAHA.109.199489; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Miyagoe-Suzuki Y, 2009, MECH DEVELOP, V126, P107, DOI 10.1016/j.mod.2008.12.001; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Saito F, 2008, FEBS LETT, V582, P439, DOI 10.1016/j.febslet.2008.01.006; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Toda Tatsushi, 2003, Congenital Anomalies, V43, P97, DOI 10.1111/j.1741-4520.2003.tb01033.x; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Xiong H, 2006, BIOCHEM BIOPH RES CO, V350, P935, DOI 10.1016/j.bbrc.2006.09.129; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	42	25	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9560	9567		10.1074/jbc.M111.271767	http://dx.doi.org/10.1074/jbc.M111.271767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22270369	hybrid, Green Published			2022-12-25	WOS:000301797800087
J	Peake, KB; Vance, JE				Peake, Kyle B.; Vance, Jean E.			Normalization of Cholesterol Homeostasis by 2-Hydroxypropyl-beta-cyclodextrin in Neurons and Glia from Niemann-Pick C1 (NPC1)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; EVERY ORGAN; NPC1; TRANSPORT; NEURODEGENERATION; IDENTIFICATION; CYCLODEXTRINS; LIPOPROTEINS; DEFICIENCY; METABOLISM	Niemann-Pick C (NPC) disease is an inherited, progressive neurodegenerative disorder caused by mutations in the NPC1 or NPC2 gene that result in an accumulation of unesterified cholesterol in late endosomes/lysosomes (LE/L) and impaired export of cholesterol from LE/L to the endoplasmic reticulum (ER). Recent studies demonstrate that administration of cyclodextrin (CD) to Npc1(-/-) mice eliminates cholesterol sequestration in LE/L of many tissues, including the brain, delays neurodegeneration, and increases lifespan of the mice. We have now investigated cholesterol homeostasis in NPC1-deficient cells of the brain in response to CD. Primary cultures of neurons and glial cells from Npc1(-/-) mice were incubated for 24 h with 0.1 to 10 mM CD after which survival and cholesterol homeostasis were monitored. Although 10 mM CD was profoundly neurotoxic, and altered astrocyte morphology, 0.1 and 1 mM CD were not toxic but effectively mobilized stored cholesterol from the LE/L as indicated by filipin staining. However, 0.1 and 1mM CD altered cholesterol homeostasis in opposite directions. The data suggest that 0.1 mM CD releases cholesterol trapped in LE/L of neurons and astrocytes and increases cholesterol availability at the ER, whereas 1 mM CD primarily extracts cholesterol from the plasma membrane and reduces ER cholesterol. These studies in Npc1(-)/(-) neurons and astrocytes establish a dose of CD (0.1 mM) that would likely be beneficial in NPC disease. The findings are timely because treatment of NPC disease patients with CD is currently being initiated.	[Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, 328 HMRC, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca			Ara Parseghian Medical Research Foundation; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council of Canada; Alberta Heritage Foundation for Medical Research	Ara Parseghian Medical Research Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by the Ara Parseghian Medical Research Foundation and Canadian Institutes for Health Research (to J. E. V.) as well as graduate studentships from the Natural Sciences and Engineering Research Council of Canada and the Alberta Heritage Foundation for Medical Research (to K. B. P.).	Aqul A, 2011, J NEUROSCI, V31, P9404, DOI 10.1523/JNEUROSCI.1317-11.2011; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Karten B, 2005, BIOCHEM J, V387, P779, DOI 10.1042/BJ20041694; Kiss T, 2010, EUR J PHARM SCI, V40, P376, DOI 10.1016/j.ejps.2010.04.014; LISCUM L, 1987, J BIOL CHEM, V262, P17002; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Michikawa M, 1998, J NEUROSCI RES, V54, P58, DOI 10.1002/(SICI)1097-4547(19981001)54:1<58::AID-JNR7>3.0.CO;2-G; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Peake KB, 2011, BBA-MOL BASIS DIS, V1812, P1121, DOI 10.1016/j.bbadis.2011.06.003; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Vance JE, 2010, BBA-MOL CELL BIOL L, V1801, P806, DOI 10.1016/j.bbalip.2010.02.007; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Yu T, 2011, HUM MOL GENET, V20, P4440, DOI 10.1093/hmg/ddr372; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	26	77	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9290	9298		10.1074/jbc.M111.326405	http://dx.doi.org/10.1074/jbc.M111.326405			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277650	Green Published, hybrid			2022-12-25	WOS:000301797800057
J	Wu, ZC; de Keyzer, J; Kedrov, A; Driessen, AJM				Wu, Zht Cheng; de Keyzer, Jeanine; Kedrov, Alexej; Driessen, Arnold J. M.			Competitive Binding of the SecA ATPase and Ribosomes to the SecYEG Translocon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CONDUCTING CHANNEL; CROSS-CORRELATION SPECTROSCOPY; NASCENT CHAIN COMPLEXES; ESCHERICHIA-COLI; PREPROTEIN TRANSLOCATION; MEMBRANE INSERTION; IN-VIVO; CYTOPLASMIC MEMBRANE; BACTERIAL-MEMBRANE; PRECURSOR PROTEINS	During co-translational membrane insertion of membrane proteins with large periplasmic domains, the bacterial SecYEG complex needs to interact both with the ribosome and the SecA ATPase. Although the binding sites for SecA and the ribosome overlap, it has been suggested that these ligands can interact simultaneously with SecYEG. We used surface plasmon resonance and fluorescence correlation spectroscopy to examine the interaction of SecA and ribosomes with the SecYEG complex present in membrane vesicles and the purified SecYEG complex present in a detergent-solubilized state or reconstituted into nanodiscs. Ribosome binding to the SecYEG complex is strongly stimulated when the ribosomes are charged with nascent chains of the monotopic membrane protein FtsQ. This binding is competed by an excess of SecA, indicating that binding of SecA and ribosomes to SecYEG is mutually exclusive.	[Wu, Zht Cheng; de Keyzer, Jeanine; Kedrov, Alexej; Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9747 AG Groningen, Netherlands	University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012	Kedrov, Alexej/0000-0001-9117-752X; Driessen, Arnold J.M./0000-0001-9258-9104	Chemical Sciences division of the Netherlands Foundation for Scientific Research (CW-NWO)	Chemical Sciences division of the Netherlands Foundation for Scientific Research (CW-NWO)	This work was supported by the Chemical Sciences division of the Netherlands Foundation for Scientific Research (CW-NWO).	Alami M, 2007, EMBO J, V26, P1995, DOI 10.1038/sj.emboj.7601661; ANDERSSON H, 1993, EMBO J, V12, P683, DOI 10.1002/j.1460-2075.1993.tb05702.x; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; de Keyzer J, 2003, J BIOL CHEM, V278, P29581, DOI 10.1074/jbc.M303490200; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; de Keyzer J, 2007, FEBS LETT, V581, P1859, DOI 10.1016/j.febslet.2007.03.081; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Duong F, 1998, EMBO J, V17, P696, DOI 10.1093/emboj/17.3.696; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1998, J BIOL CHEM, V273, P21675, DOI 10.1074/jbc.273.34.21675; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gumbart J, 2009, STRUCTURE, V17, P1453, DOI 10.1016/j.str.2009.09.010; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Kunji ERS, 2008, METHODS, V46, P62, DOI 10.1016/j.ymeth.2008.10.020; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507; Nilsson M, 1997, BIOTECHNOL BIOENG, V54, P461, DOI 10.1002/(SICI)1097-0290(19970605)54:5<461::AID-BIT6>3.0.CO;2-C; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; SALAJSMIC E, 1978, ANTIMICROB AGENTS CH, V14, P797, DOI 10.1128/AAC.14.5.797; Sato K, 1997, J BIOL CHEM, V272, P20082, DOI 10.1074/jbc.272.32.20082; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; van der Slurs EO, 2006, J MOL BIOL, V361, P839, DOI 10.1016/j.jmb.2006.07.017; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zito CR, 2003, J BIOL CHEM, V278, P40640, DOI 10.1074/jbc.M308025200	54	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					7885	7895		10.1074/jbc.M111.297911	http://dx.doi.org/10.1074/jbc.M111.297911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267723	Green Published, hybrid			2022-12-25	WOS:000301349400005
J	Leal, MC; Puga, J; Serodio, J; Gomes, NCM; Calado, R				Leal, Miguel Costa; Puga, Joao; Serodio, Joao; Gomes, Newton C. M.; Calado, Ricardo			Trends in the Discovery of New Marine Natural Products from Invertebrates over the Last Two Decades - Where and What Are We Bioprospecting?	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; COMMUNITY; SPONGES; DEEP; DRUGS	It is acknowledged that marine invertebrates produce bioactive natural products that may be useful for developing new drugs. By exploring untapped geographical sources and/or novel groups of organisms one can maximize the search for new marine drugs to treat human diseases. The goal of this paper is to analyse the trends associated with the discovery of new marine natural products from invertebrates (NMNPI) over the last two decades. The analysis considers different taxonomical levels and geographical approaches of bioprospected species. Additionally, this research is also directed to provide new insights into less bioprospected taxa and world regions. In order to gather the information available on NMNPI, the yearly-published reviews of Marine Natural Products covering 1990-2009 were surveyed. Information on source organisms, specifically taxonomical information and collection sites, was assembled together with additional geographical information collected from the articles originally describing the new natural product. Almost 10000 NMNPI were discovered since 1990, with a pronounced increase between decades. Porifera and Cnidaria were the two dominant sources of NMNPI worldwide. The exception was polar regions where Echinodermata dominated. The majority of species that yielded the new natural products belong to only one class of each Porifera and Cnidaria phyla (Demospongiae and Anthozoa, respectively). Increased bioprospecting efforts were observed in the Pacific Ocean, particularly in Asian countries that are associated with the Japan Biodiversity Hotspot and the Kuroshio Current. Although results show comparably less NMNPI from polar regions, the number of new natural products per species is similar to that recorded for other regions. The present study provides information to future bioprospecting efforts addressing previously unexplored taxonomic groups and/or regions. We also highlight how marine invertebrates, which in some cases have no commercial value, may become highly valuable in the ongoing search for new drugs from the sea.	[Leal, Miguel Costa; Serodio, Joao; Gomes, Newton C. M.; Calado, Ricardo] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Leal, Miguel Costa; Serodio, Joao; Gomes, Newton C. M.; Calado, Ricardo] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Leal, Miguel Costa] Skidaway Inst Oceanog, Savannah, GA USA; [Puga, Joao] Bio3 Estudos & Projectos Biol & Valorizacao Recu, Ida, Almada, Portugal	Universidade de Aveiro; Universidade de Aveiro; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography	Leal, MC (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	miguecleal@ua.pt; rjcalado@hotmail.com	Gomes, Newton Carlos Marcial/K-3211-2015; Gomes, Newton CM/F-7430-2012; Puga, João/A-6694-2017; Gomes, Newton Carlos Marcial/AAV-4603-2021; Calado, Ricardo Jorge Guerra/C-7035-2008; Puga, João/U-9086-2018; Leal, Miguel Costa/C-8611-2009; Jansen, Nils/G-1835-2011; Serôdio, João/B-8201-2008	Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Gomes, Newton CM/0000-0003-1934-0091; Puga, João/0000-0003-3156-9948; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Calado, Ricardo Jorge Guerra/0000-0002-1670-9335; Puga, João/0000-0003-3156-9948; Leal, Miguel Costa/0000-0003-0672-6251; Serôdio, João/0000-0002-9047-1740	FCT [SFRH/BD/63783/2009]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was not funded by any agency or project. Only Miguel C. Leal was supported by a grant from FCT(SFRH/BD/63783/2009). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltans W, 2011, WORLD REGISTER MARIN; Ausubel J.H., 2010, 1 CENSUS MARINE LIFE; Avila C, 2008, MAR ECOL-EVOL PERSP, V29, P1, DOI 10.1111/j.1439-0485.2007.00215.x; BAKUS G J, 1974, Biotropica, V6, P229, DOI 10.2307/2989667; BERGMANN W, 1955, J ORG CHEM, V20, P1501, DOI 10.1021/jo01128a007; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blunt JW, 2008, NAT PROD REP, V25, P35, DOI 10.1039/b701534h; Blunt JW, 2007, NAT PROD REP, V24, P31, DOI 10.1039/b603047p; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Blunt JW, 2010, NAT PROD REP, V27, P165, DOI 10.1039/b906091j; Blunt JW, 2009, NAT PROD REP, V26, P170, DOI 10.1039/b805113p; Blunt JW, 2003, NAT PROD REP, V20, P1, DOI 10.1039/b207130b; Blunt JW, 2004, NAT PROD REP, V21, P1, DOI 10.1039/b305250h; Blunt JW, 2005, NAT PROD REP, V22, P15, DOI 10.1039/b415080p; Blunt JW, 2006, NAT PROD REP, V23, P26, DOI 10.1039/b502792f; Blunt JW, 2008, DICT MARINE NATURAL, P2108; Brandt A, 2004, DEEP-SEA RES PT II, V51, P1457, DOI 10.1016/j.dsr2.2004.08.006; Cavanagh R.D., 2007, OVERVIEW CONSERVATIO; Chin YW, 2006, AAPS J, V8, pE239, DOI 10.1007/BF02854894; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Davidson SK, 1999, BIOL BULL, V196, P273, DOI 10.2307/1542952; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Duckworth A, 2009, MAR BIOTECHNOL, V11, P669, DOI 10.1007/s10126-009-9213-2; Duh CY, 1998, TETRAHEDRON LETT, V39, P7121, DOI 10.1016/S0040-4039(98)01512-3; Faulkner DJ, 2000, ANTON LEEUW INT J G, V77, P135, DOI 10.1023/A:1002405815493; Faulkner DJ, 2000, NAT PROD REP, V17, P7, DOI 10.1039/a809395d; Faulkner DJ, 2001, NAT PROD REP, V18, P1, DOI 10.1039/b006897g; Faulkner DJ, 1997, NAT PROD REP, V14, P259, DOI 10.1039/np9971400259; FAULKNER DJ, 1995, NAT PROD REP, V12, P223, DOI 10.1039/np9951200223; FAULKNER DJ, 1994, NAT PROD REP, V11, P355, DOI 10.1039/np9941100355; FAULKNER DJ, 1977, TETRAHEDRON, V33, P1421, DOI 10.1016/0040-4020(77)88001-0; FAULKNER DJ, 1992, NAT PROD REP, V9, P323, DOI 10.1039/np9920900323; Faulkner DJ, 1996, NAT PROD REP, V13, P75, DOI 10.1039/np9961300075; FAULKNER DJ, 1993, NAT PROD REP, V10, P497, DOI 10.1039/np9931000497; Faulkner DJ, 1998, NAT PROD REP, V15, P113; Faulkner DJ, 1999, NAT PROD REP, V16, P155; Faulkner DJ, 2002, NAT PROD REP, V19, P1, DOI 10.1039/b009029h; Gianni M, 2004, HIGH SEAS BOTTOM TRA, P88; Haefner B, 2003, DRUG DISCOV TODAY, V8, P536, DOI 10.1016/S1359-6446(03)02713-2; Harvey A, 2000, DRUG DISCOV TODAY, V5, P294, DOI 10.1016/S1359-6446(00)01511-7; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hay ME., 1996, OCEANOGRAPHY, V9, P10, DOI [10.5670/oceanog.1996.21, DOI 10.5670/OCEANOG.1996.21]; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hooper J, 2007, UN INFORMAL CONSULTA; Ianora A, 2006, ESTUAR COAST, V29, P531, DOI 10.1007/BF02784281; Laport MS, 2009, CURR PHARM BIOTECHNO, V10, P86, DOI 10.2174/138920109787048625; Lin YS, 2009, TETRAHEDRON, V65, P9157, DOI 10.1016/j.tet.2009.09.031; Marris E, 2006, NATURE, V443, P904, DOI 10.1038/443904a; McFadden CS, 2010, INTEGR COMP BIOL, V50, P389, DOI 10.1093/icb/icq056; McGinn AP, 1999, SAFEGUARDING HLTH OC; McGovern TM, 2003, MOL ECOL, V12, P1207, DOI 10.1046/j.1365-294X.2003.01758.x; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Munro MHG, 1999, J BIOTECHNOL, V70, P15, DOI 10.1016/S0168-1656(99)00052-8; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Paul VJ, 2008, NAT PROD REP, V25, P662, DOI 10.1039/b702742g; Paul VJ, 2011, NAT PROD REP, V28, P345, DOI 10.1039/c0np00040j; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; Ramesh P, 1999, J NAT PROD, V62, P1019, DOI 10.1021/np980449u; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Sherman K, 2005, MAR ECOL PROG SER, V300, P275; Skropeta D, 2008, NAT PROD REP, V25, P1131, DOI 10.1039/b808743a; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spranger T, 2005, J INT BIOTECHNOLOGY, V2, P155; Su JH, 2009, CHEM PHARM BULL, V57, P1189, DOI 10.1248/cpb.57.1189; Tan G, 2006, CURR DRUG TARGETS, V7, P265, DOI 10.2174/138945006776054942; Wen T, 2008, J NAT PROD, V71, P1133, DOI 10.1021/np070640g; Wliffels RH, 2008, TRENDS BIOTECHNOL, V26, P26, DOI 10.1016/j.tibtech.2007.10.002; Yu SJ, 2006, STEROIDS, V71, P955, DOI 10.1016/j.steroids.2006.07.002	69	183	190	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30580	10.1371/journal.pone.0030580	http://dx.doi.org/10.1371/journal.pone.0030580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276216	gold, Green Published			2022-12-25	WOS:000301568100058
J	Lv, HN; Ren, JH; Ma, SG; Xu, S; Qu, J; Liu, ZJ; Zhou, Q; Chen, XG; Yu, SS				Lv, Haining; Ren, Jinhong; Ma, Shuanggang; Xu, Song; Qu, Jing; Liu, Zhenjia; Zhou, Qing; Chen, Xiaoguang; Yu, Shishan			Synthesis, Biological Evaluation and Mechanism Studies of Deoxytylophorinine and Its Derivatives as Potential Anticancer Agents	PLOS ONE			English	Article							PHENANTHROINDOLIZIDINE ALKALOIDS PERGULARININE; NF-KAPPA-B; CELL-GROWTH; CYNANCHUM-VINCETOXICUM; THYMIDYLATE SYNTHASE; TYLOPHORA ALKALOIDS; CYTOTOXIC ACTIVITY; PROTEIN-SYNTHESIS; INHIBITION; PHENANTHRENE	Previous studies indicated that (+)-13a-(S)-Deoxytylophorinine (1) showed profound anti-cancer activities both in vitro and in vivo and could penetrate the blood brain barrier to distribute well in brain tissues. CNS toxicity, one of the main factors to hinder the development of phenanthroindolizidines, was not obviously found in 1. Based on its fascinating activities, thirty-four derivatives were designed, synthesized; their cytotoxic activities in vitro were tested to discover more excellent anticancer agents. Considering the distinctive mechanism of 1 and interesting SAR of deoxytylophorinine and its derivatives, the specific impacts of these compounds on cellular progress as cell signaling transduction pathways and cell cycle were proceeded with seven representative compounds. 1 as well as three most potent compounds, 9, 32, 33, and three less active compounds, 12, 16, 35, were selected to proform this study to have a relatively deep view of cancer cell growth-inhibitory characteristics. It was found that the expressions of phospho-Akt, Akt, phospho-ERK, and ERK in A549 cells were greater down-regulated by the potent compounds than by the less active compounds in the Western blot analysis. To the best of our knowledge, this is the first report describing phenanthroindolizidines alkaloids display influence on the crucial cell signaling proteins, ERK. Moreover, the expressions of cyclin A, cyclin D1 and CDK2 proteins depressed more dramatically when the cells were treated with 1, 9, 32, and 33. Then, these four excellent compounds were subjected to flow cytometric analysis, and an increase in S-phase was observed in A549 cells. Since the molecular level assay results of Western blot for phospho-Akt, Akt, phospho-ERK, ERK, and cyclins were relevant to the potency of compounds in cellular level, we speculated that this series of compounds exhibit anticancer activities through blocking PI3K and MAPK signaling transduction pathways and interfering with the cell cycle progression.	[Lv, Haining] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Lv, HN (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	chxg@imm.ac.cn; yushishan@imm.ac.cn	Ma, Shuang-Gang/AAY-5970-2020		National Natural Science Foundation of China [90713039, 21132009]; National Science and Technology Project of China [2009ZX09311-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Project of China	This work was financed by National Natural Science Foundation of China (Grant No. 90713039 and No. 21132009) and National Science and Technology Project of China (Grant No. 2009ZX09311-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TY, 2001, PHYTOCHEMISTRY, V58, P1267, DOI 10.1016/S0031-9422(01)00382-X; BAUMGARTNER B, 1990, PHYTOCHEMISTRY, V29, P3327, DOI 10.1016/0031-9422(90)80209-Y; BREMMER ML, 1983, J ORG CHEM, V48, P3661, DOI 10.1021/jo00169a009; BUCKLEY TF, 1983, J ORG CHEM, V48, P4222, DOI 10.1021/jo00171a014; CAPO M, 1989, J NAT PROD, V52, P389, DOI 10.1021/np50062a030; Chuang TH, 2006, ORG BIOMOL CHEM, V4, P860, DOI 10.1039/b516152e; DOLZ H, 1982, BIOCHEMISTRY-US, V21, P3181; DONALDSO.GR, 1968, BIOCHEM BIOPH RES CO, V31, P104, DOI 10.1016/0006-291X(68)90037-5; FABER L, 1973, HELV CHIM ACTA, V56, P2882, DOI 10.1002/hlca.19730560824; Ganguly T, 2002, PHYTOMEDICINE, V9, P288, DOI 10.1078/0944-7113-00146; Gao W, 2008, BIOORG MED CHEM LETT, V18, P704, DOI 10.1016/j.bmcl.2007.11.054; Gao WL, 2007, BIOORG MED CHEM LETT, V17, P4338, DOI 10.1016/j.bmcl.2007.05.021; Gao WL, 2004, CANCER RES, V64, P678, DOI 10.1158/0008-5472.CAN-03-1904; GOVINDACHARI TR, 1978, HETEROCYCLES, V11, P587; GRANT P, 1974, J BACTERIOL, V120, P1308, DOI 10.1128/JB.120.3.1308-1314.1974; GUPTA RS, 1980, MOL PHARMACOL, V18, P136; GUPTA RS, 1977, BIOCHEMISTRY-US, V16, P3209, DOI 10.1021/bi00633a026; HUANG MT, 1972, MOL PHARMACOL, V8, P538; Huang XS, 2004, PLANTA MED, V70, P441, DOI 10.1055/s-2004-818973; Ikeda T, 2011, BIOORG MED CHEM LETT, V21, P342, DOI 10.1016/j.bmcl.2010.11.008; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Komatsu H, 2001, J MED CHEM, V44, P1833, DOI 10.1021/jm0004042; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee ER, 2006, BBA-MOL CELL RES, V1763, P958, DOI 10.1016/j.bbamcr.2006.06.006; Lee SK, 2003, PLANTA MED, V69, P21, DOI 10.1055/s-2003-37021; Li H, 2006, LETT ORG CHEM, V3, P806, DOI 10.2174/157017806779117067; Lin JC, 2009, J MED CHEM, V52, P1903, DOI 10.1021/jm801344j; Liu ZJ, 2011, J ASIAN NAT PROD RES, V13, P400, DOI 10.1080/10286020.2011.566868; Liu ZJ, 2011, CHEMOTHERAPY, V57, P310, DOI 10.1159/000329506; Min HY, 2010, CHEM BIODIVERS, V7, P409, DOI 10.1002/cbdv.200900040; MULCHANDANI N B, 1971, Chemistry and Industry, V19, P505; MULCHANDANI NB, 1976, PHYTOCHEMISTRY, V15, P1561, DOI 10.1016/S0031-9422(00)88937-2; MULCHANDANI NB, 1984, PHYTOCHEMISTRY, V23, P1206, DOI 10.1016/S0031-9422(00)82650-3; Persons DL, 1999, CLIN CANCER RES, V5, P1007; Rao KN, 1997, CHEM-BIOL INTERACT, V106, P201, DOI 10.1016/S0009-2797(97)00065-3; Rao KN, 2000, TOXICOL IN VITRO, V14, P53, DOI 10.1016/S0887-2333(99)00092-2; Rao KN, 1998, CANCER LETT, V128, P183, DOI 10.1016/S0304-3835(98)00061-5; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Shih YW, 2007, J AGR FOOD CHEM, V55, P11035, DOI 10.1021/jf072423r; Staerk D, 2002, J NAT PROD, V65, P1299, DOI 10.1021/np0106384; Su CR, 2008, BIOORGAN MED CHEM, V16, P6233, DOI 10.1016/j.bmc.2008.04.032; Suffness M., 1980, ANTICANCER AGENTS BA, P465; Takashi I, 2010, Patent, Patent No. [WO2010047126, 2010047126]; TANNER U, 1993, ARCH PHARM, V326, P67, DOI 10.1002/ardp.19933260203; Wang KL, 2008, TETRAHEDRON, V64, P7504, DOI 10.1016/j.tet.2008.06.003; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang ZW, 2011, SYNTHESIS-STUTTGART, P979, DOI 10.1055/s-0030-1259487; Wang ZW, 2010, EUR J ORG CHEM, V2010, P292, DOI 10.1002/ejoc.200900920; Yang CW, 2007, BIOCHEM BIOPH RES CO, V354, P942, DOI 10.1016/j.bbrc.2007.01.065; Yang CW, 2006, MOL PHARMACOL, V69, P749, DOI 10.1124/mol.105.017764; Yang XM, 2009, J MED CHEM, V52, P5262, DOI 10.1021/jm9009263; Zhao S, 1999, BIOORGAN MED CHEM, V7, P1637, DOI 10.1016/S0968-0896(99)00078-4	52	32	35	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30342	10.1371/journal.pone.0030342	http://dx.doi.org/10.1371/journal.pone.0030342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276180	Green Submitted, Green Published, gold			2022-12-25	WOS:000301457200054
J	Rodger, EJ; Suetani, RJ; Jones, GT; Kleffmann, T; Carne, A; Legge, M; McCormick, SPA				Rodger, Euan J.; Suetani, Rachel J.; Jones, Gregory T.; Kleffmann, Torsten; Carne, Alan; Legge, Michael; McCormick, Sally P. A.			Proteomic Analysis of Aortae from Human Lipoprotein(a) Transgenic Mice Shows an Early Metabolic Response Independent of Atherosclerosis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; EXPRESSING HUMAN APOLIPOPROTEIN(A); LOW-DENSITY-LIPOPROTEIN; OXIDIZED PHOSPHOLIPIDS; MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; PROXIMAL AORTA; HYPERCHOLESTEROLEMIA; DEFICIENT; ATHEROGENESIS	Background: Elevated low density lipoprotein (LDL) and lipoprotein(a) are independent risk factors for the development of atherosclerosis. Using a proteomic approach we aimed to determine early changes in arterial protein expression in transgenic mice containing both human LDL and lipoprotein(a) in circulation. Methods and Results: Plasma lipid analyses showed the lipoprotein(a) transgenic mice had significantly higher lipid levels than wildtype, including a much increased LDL and high density lipoprotein (HDL) cholesterol. Analysis of aortae from lipoprotein(a) mice showed lipoprotein(a) accumulation but no lipid accumulation or foam cells, leaving the arteries essentially atherosclerosis free. Using two-dimensional gel electrophoresis and mass spectrometry, we identified 34 arterial proteins with significantly altered abundance (P<0.05) in lipoprotein(a) transgenic mice compared to wildtype including 17 that showed a >= 2 fold difference. Some proteins of interest showed a similarly altered abundance at the transcript level. These changes collectively indicated an initial metabolic response that included a down regulation in energy, redox and lipid metabolism proteins and changes in structural proteins at a stage when atherosclerosis had not yet developed. Conclusions: Our study shows that human LDL and lipoprotein(a) promote changes in the expression of a unique set of arterial proteins which may be early indicators of the metabolic disturbances preceding atherosclerosis.	[Rodger, Euan J.; Suetani, Rachel J.; Carne, Alan; Legge, Michael; McCormick, Sally P. A.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Jones, Gregory T.] Univ Otago, Dept Surg Sci, Dunedin, New Zealand; [Kleffmann, Torsten] Univ Otago, Ctr Prot Res, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Rodger, EJ (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	sally.mccormick@otago.ac.nz	Carne, Alan/R-6260-2019	Carne, Alan/0000-0003-3665-1940; Kleffmann, Torsten/0000-0001-9305-5980; Jones, Gregory T/0000-0002-6950-4210; McCormick, Sally/0000-0001-9857-0703	Marsden Fund of New Zealand [UOO 010]; National Heart Foundation [1105]	Marsden Fund of New Zealand(Royal Society of New ZealandMarsden Fund (NZ)); National Heart Foundation(National Heart Foundation of Australia)	This work was funded by a grant from the Marsden Fund of New Zealand (Grant No. UOO 010, http://www.royalsociety.org.nz/programmes/funds/marsden). EJR was funded by a National Heart Foundation PhD scholarship (Grant No. 1105, http://www.heartfoundation.org.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Berg K, 2002, ATHEROSCLEROSIS, V163, P99, DOI 10.1016/S0021-9150(01)00772-9; CALLOW MJ, 1994, P NATL ACAD SCI USA, V91, P2130, DOI 10.1073/pnas.91.6.2130; CALLOW MJ, 1995, J CLIN INVEST, V96, P1639, DOI 10.1172/JCI118203; CHIESA G, 1992, J BIOL CHEM, V267, P24369; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; Feil S, 2004, CIRC RES, V94, P863, DOI 10.1161/01.RES.0000126417.38728.F6; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Julka S, 2004, J PROTEOME RES, V3, P350, DOI 10.1021/pr0340734; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; LAWN RM, 1992, NATURE, V360, P670, DOI 10.1038/360670a0; LINTON MF, 1993, J CLIN INVEST, V92, P3029, DOI 10.1172/JCI116927; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; MANCINI FP, 1995, ARTERIOSCL THROM VAS, V15, P1911, DOI 10.1161/01.ATV.15.11.1911; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; Mayr M, 2005, ARTERIOSCL THROM VAS, V25, P2135, DOI 10.1161/01.ATV.0000183928.25844.f6; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; PEDERSEN TR, 1994, LANCET, V344, P1383; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schneider M, 2005, J LIPID RES, V46, P769, DOI 10.1194/jlr.M400467-JLR200; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Tsimikas S, 2008, CURR OPIN LIPIDOL, V19, P369, DOI 10.1097/MOL.0b013e328308b622; Tsimikas S, 2006, J AM COLL CARDIOL, V47, P2219, DOI 10.1016/j.jacc.2006.03.001; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; Williamson K. S., 2003, METHODS PHARM TOXICO; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	37	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30383	10.1371/journal.pone.0030383	http://dx.doi.org/10.1371/journal.pone.0030383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276189	gold, Green Submitted, Green Published			2022-12-25	WOS:000301457200057
J	Gottfries, J; Melgar, S; Michaelsson, E				Gottfries, Johan; Melgar, Silvia; Michaelsson, Erik			Modelling of Mouse Experimental Colitis by Global Property Screens: A Holistic Approach to Assess Drug Effects in Inflammatory Bowel Disease	PLOS ONE			English	Article							GAMMA; MICE	Preclinical disease models play an important role in the establishment of new treatment paradigms, identification of biomarkers and assessment of drug efficacy and safety. However, the accuracy of these models in context of the human disease are sometimes questioned, e. g. due to trials failing to confirm efficacy in humans. We suggest that one reason behind this gap in predictability may relate to how the preclinical data is analyzed and interpreted. In the present paper, we introduce a holistic approach to analyze and illustrate data in context of one of the most commonly used colitis models, i.e. the mouse dextran sulphate sodium (DSS) colitis model. Diseased mice were followed over time along disease progression and by use of tool pharmacological compounds activating nuclear hormone receptors, respectively. A new multivariate statistics approach was applied including principal component analysis (PCA) with treatment prediction subsequent to establishing the principal component analysis model. Thus, several studies could be overlaid and compared to each other in a new, comprehensive and holistic way. This method, named mouse colitis global property screening, appears applicable not only to any animal modelling series of studies but also to human clinical studies. The prerequisites for the study set up and calculations are delineated and examples of new learnings from the global property screening will be presented.	[Gottfries, Johan] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Melgar, Silvia] Natl Univ Ireland, Alimentary Pharmabiot Ctr, Univ Coll Cork, Cork, Ireland; [Michaelsson, Erik] AstraZeneca R&D, Dept Biosci Cardiovasc & Gastrointestinal IMED, Molndal, Sweden	University of Gothenburg; University College Cork; AstraZeneca	Gottfries, J (corresponding author), Univ Gothenburg, Dept Chem, Gothenburg, Sweden.	erik.michaelsson@astrazeneca.com	Gottfries, Johan/M-3445-2016; Melgar, Silvia/I-4191-2019	Gottfries, Johan/0000-0001-7135-4664; Melgar, Silvia/0000-0001-7463-3343; Michaelsson, Erik/0000-0001-8643-2821	AstraZeneca R&D, Molndal, Sweden	AstraZeneca R&D, Molndal, Sweden(AstraZeneca)	The study was funded by and performed at AstraZeneca R&D, Molndal, Sweden. The study design, generation of data, analysis of data, decision to publish as well as preparation of the manuscript were performed by the authors, of which E. M. is employed by AstraZeneca R&D.	Byrne FR, 2006, CURR OPIN DRUG DISC, V9, P207; Calciano MA, 2010, ALZHEIMERS DEMENT, V6, P386, DOI 10.1016/j.jalz.2009.12.004; Chalmers I, 2006, J ROY SOC MED, V99, P337, DOI 10.1258/jrsm.99.7.337; GOTTFRIES CG, 2009, B IACFS ME, V17, P168; Gottfries J, 2004, CHEMOMETR INTELL LAB, V73, P47, DOI 10.1016/j.chemolab.2003.11.011; Gottfries J, 2001, J GERIATR PSYCH NEUR, V14, P109, DOI 10.1177/089198870101400302; JACKSON EJ, USERS GUIDE PRINCIPA; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Koboziev I, 2011, INFLAMM BOWEL DIS, V17, P1229, DOI 10.1002/ibd.21557; Larsson AE, 2006, INFLAMM BOWEL DIS, V12, P478, DOI 10.1097/00054725-200606000-00006; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; MODIGLIANI R, 1990, GASTROENTEROLOGY, V98, P811, DOI 10.1016/0016-5085(90)90002-I; Navarro V, 2006, J PHYSIOL BIOCHEM, V62, P137, DOI 10.1007/BF03174074; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oprea TI, 2001, J COMB CHEM, V3, P157, DOI 10.1021/cc0000388; Roth-Cline MD, 2006, CIRCULATION, V113, P2253, DOI 10.1161/CIRCULATIONAHA.105.604512; Saccenti E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020747; Tanaka T, 2001, CANCER RES, V61, P2424; van der Greef Jan, 2006, Drug Discov Today Technol, V3, P205, DOI 10.1016/j.ddtec.2006.05.003; Vanhoutte K, 2009, BIOINFORMATION, V3, P275, DOI 10.6026/97320630003275; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639	21	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30005	10.1371/journal.pone.0030005	http://dx.doi.org/10.1371/journal.pone.0030005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279558	gold, Green Submitted, Green Published			2022-12-25	WOS:000299771900036
J	Trindade, A; Djokovic, D; Gigante, J; Badenes, M; Pedrosa, AR; Fernandes, AC; Lopes-da-Costa, L; Krasnoperov, V; Liu, R; Gill, PS; Duarte, A				Trindade, Alexandre; Djokovic, Dusan; Gigante, Joana; Badenes, Marina; Pedrosa, Ana-Rita; Fernandes, Ana-Carina; Lopes-da-Costa, Luis; Krasnoperov, Valery; Liu, Ren; Gill, Parkash S.; Duarte, Antonio			Low-Dosage Inhibition of DII4 Signaling Promotes Wound Healing by Inducing Functional Neo-Angiogenesis	PLOS ONE			English	Article							TUMOR-GROWTH; VASCULAR MORPHOGENESIS; THERAPEUTIC ANGIOGENESIS; LYMPHATIC DEVELOPMENT; DLL4; NOTCH; BLOCKADE; LIGAND; REGENERATION; VESSELS	Recent findings regarding DII4 function in physiological and pathological conditions indicate that this Notch ligand may constitute an important therapeutic target. DII4 appears to be a major anti-angiogenic agent, occupying a central role in various angiogenic pathways. The first trials of anti-DII4 therapy in mice demonstrated a paradoxical effect, as it reduced tumor perfusion and growth despite leading to an increase in vascular density. This is seen as the result of insufficient maturation of the newly formed vasculature causing a circulatory defect and increased tumor hypoxia. As DII4 function is known to be closely dependent on expression levels, we envisioned that the therapeutic anti-DII4 dosage could be modulated to result in the increase of adequately functional blood vessels. This would be useful in conditions where vascular function is a limiting factor for recovery, like wound healing and tissue hypoxia, especially in diabetic patients. Our experimental results in mice confirmed this possibility, revealing that low dosage inhibition of DII4/Notch signaling causes improved vascular function and accelerated wound healing.	[Trindade, Alexandre; Djokovic, Dusan; Gigante, Joana; Badenes, Marina; Pedrosa, Ana-Rita; Fernandes, Ana-Carina; Lopes-da-Costa, Luis; Duarte, Antonio] Univ Tecn Lisboa, Ctr Interdisciplinar Invest Sanidade Anim CIISA, Lisbon, Portugal; [Trindade, Alexandre; Djokovic, Dusan; Duarte, Antonio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Krasnoperov, Valery] Vasgene Therapeut, Los Angeles, CA USA; [Liu, Ren; Gill, Parkash S.] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Gill, Parkash S.] Univ So Calif, Dept Med, Los Angeles, CA 90089 USA	Universidade de Lisboa; Instituto Gulbenkian de Ciencia; University of Southern California; University of Southern California	Trindade, A (corresponding author), Univ Tecn Lisboa, Ctr Interdisciplinar Invest Sanidade Anim CIISA, Lisbon, Portugal.	parkashg@med.usc.edu; aduarte@fmv.utl.pt	Duarte, Antonio/V-1178-2018; Trindade, Alexandre/J-3606-2013; Pedrosa, Ana Rita/AAX-9857-2021; Trindade, Alexandre/AAC-9726-2019	Duarte, Antonio/0000-0002-9255-3635; Trindade, Alexandre/0000-0002-3104-9259; Pedrosa, Ana Rita/0000-0002-4421-6968; Badenes, Marina/0000-0001-6872-891X; Gigante Carinhas, Joana/0000-0002-2414-7651; DJOKOVIC, DUSAN/0000-0002-1013-8455; Lopes-da-Costa, Luis/0000-0001-5165-3034	U.S. National Cancer Institute [RO1 CA 079218-07]; Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/CVT/71084/2006]; NATIONAL CANCER INSTITUTE [R01CA079218] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the U.S. National Cancer Institute (RO1 CA 079218-07 to P. S. G.) and by the Portuguese Fundacao para a Ciencia e Tecnologia (PTDC/CVT/71084/2006 to A. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Balfour JAB, 1999, BIODRUGS, V11, P359, DOI 10.2165/00063030-199911050-00007; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Butler MG, 2009, BIRTH DEFECTS RES C, V87, P222, DOI 10.1002/bdrc.20155; Chigurupati S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001167; Djokovic D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-641; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Eming SA, 2007, PROG HISTOCHEM CYTO, V42, P115, DOI 10.1016/j.proghi.2007.06.001; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Franz MG, 2007, CURR PROB SURG, V44, P691, DOI 10.1067/j.cpsurg.2007.07.001; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Madeddu P, 2005, EXP PHYSIOL, V90, P315, DOI 10.1113/expphysiol.2004.028571; Mosch B, 2010, J ONCOL, V2010, DOI 10.1155/2010/135285; Niessen K, 2011, BLOOD, V118, P1989, DOI 10.1182/blood-2010-11-319129; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; SAWAMIPHAK S, 2010, NATURE; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Segarra M, 2008, BLOOD, V112, P1904, DOI 10.1182/blood-2007-11-126045; Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278; Shutter JR, 2000, GENE DEV, V14, P1313; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tongers J, 2008, CIRCULATION, V118, P9, DOI 10.1161/CIRCULATIONAHA.108.784371; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; WANG Y, 2010, NATURE; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751	41	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29863	10.1371/journal.pone.0029863	http://dx.doi.org/10.1371/journal.pone.0029863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279550	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900028
J	Beermann, S; Glage, S; Jonigk, D; Seifert, R; Neumann, D				Beermann, Silke; Glage, Silke; Jonigk, Danny; Seifert, Roland; Neumann, Detlef			Opposite Effects of Mepyramine on JNJ 7777120-Induced Amelioration of Experimentally Induced Asthma in Mice in Sensitization and Provocation	PLOS ONE			English	Article							HISTAMINE H-4 RECEPTOR; AIRWAY HYPERRESPONSIVENESS; SELECTIVE HISTAMINE; MOUSE MODEL; INFLAMMATION; EOSINOPHILIA; MODULATION; DEFICIENCY; ACTIVATION; EXPRESSION	Background: Histamine is detected in high concentrations in the airways during an allergic asthma response. In a murine model of allergic asthma, JNJ 7777120, an antagonist at the histamine H-4 receptor, reduces asthmatic symptoms, while the histamine H-1 receptor-selective antagonist mepyramine is virtually without effect. In the present study, we analyzed the effect of combined antagonism at the histamine H-1 and H-4 receptors in a murine asthma model in relation to the timing of their application, i.e. sensitization or provocation. Methodology/Principal Findings: Asthma was induced in mice by sensitization and provocation with ovalbumin. JNJ 7777120 and/or mepyramine were injected subcutaneously either during sensitization or during provocation, and typical asthma parameters were analyzed. JNJ 7777120, but not mepyramine, reduced serum concentrations of anti-OVA IgE, inflammatory infiltrations in lung tissue, and eosinophilia in bronchoalveolar-lavage (BAL)-fluids independently of the timing of application. Upon application of JNJ 7777120 plus mepyramine in combination during provocation, mepyramine inhibited the effects of JNJ 7777120. In contrast, when applied during sensitization, mepyramine enhanced the disease-ameliorating effects of JNJ 7777120. Conclusions/Significance: Our study indicates that both histamine H-1 and H-4 receptors play important roles in the course of murine experimental asthma. Unexpectedly, the contribution of these receptors to the pathogenesis differs between the two phases, sensitization or provocation. Since in human asthma, repeated contact to the allergen is not only provocation but also a boost of sensitization, a combined pharmacological targeting of histamine H-1 and H-4 receptors could be taken into consideration as an option for the prevention of asthma and maybe other allergic diseases.	[Beermann, Silke; Seifert, Roland; Neumann, Detlef] Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany; [Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Jonigk, Danny] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Beermann, S (corresponding author), Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany.	neumann.detlef@mh-hannover.de	Neumann, Detlef/F-6182-2011; Seifert, Roland/G-3189-2013	Neumann, Detlef/0000-0003-0145-7507; 	German Research Foundation (DFG) via the Collaborative Research Centre (SFB) [587]	German Research Foundation (DFG) via the Collaborative Research Centre (SFB)	This study was funded by the German Research Foundation (DFG) via the Collaborative Research Centre (SFB) 587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN WA, 1949, LANCET, V257, P47; Bakker Remko A, 2002, Clin Allergy Immunol, V17, P27; Bryce PJ, 2006, J CLIN INVEST, V116, P1624, DOI 10.1172/JCI26150; Cowden JM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-86; D'Amato G, 2010, J INVEST ALLERG CLIN, V20, P95; De Bie JJ, 1998, BRIT J PHARMACOL, V124, P857, DOI 10.1038/sj.bjp.0701901; Dunford PJ, 2006, J IMMUNOL, V176, P7062, DOI 10.4049/jimmunol.176.11.7062; Durrant DM, 2010, IMMUNOL INVEST, V39, P526, DOI 10.3109/08820131003615498; Gutzmer R, 2002, J ALLERGY CLIN IMMUN, V109, P524, DOI 10.1067/mai.2002.121944; Hartwig C, 2008, EXP TOXICOL PATHOL, V60, P425, DOI 10.1016/j.etp.2008.05.010; Hartwig C, 2008, CYTOKINE, V42, P298, DOI 10.1016/j.cyto.2008.02.012; Hofstra CL, 2003, J PHARMACOL EXP THER, V305, P1212, DOI 10.1124/jpet.102.046581; Huang JF, 2008, CURR ALLERGY ASTHM R, V8, P21, DOI 10.1007/s11882-008-0005-y; James Alan L, 2002, Curr Allergy Asthma Rep, V2, P166, DOI 10.1007/s11882-002-0012-3; JARJOUR NN, 1991, AM REV RESPIR DIS, V144, P83, DOI 10.1164/ajrccm/144.1.83; Jonigk D, 2011, AM J PATHOL, V178, P599, DOI 10.1016/j.ajpath.2010.10.032; Jutel M, 2009, CLIN EXP ALLERGY, V39, P1786, DOI 10.1111/j.1365-2222.2009.03374.x; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Kenakin T, 2010, J RECEPT SIG TRANSD, V30, P313, DOI 10.3109/10799893.2010.503964; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Koarai A, 2003, AM J RESP CRIT CARE, V167, P758, DOI 10.1164/rccm.200206-619OC; Kozma GT, 2003, INT IMMUNOL, V15, P963, DOI 10.1093/intimm/dxg095; Liu CL, 2001, MOL PHARMACOL, V59, P420, DOI 10.1124/mol.59.3.420; Mehlhop PD, 1997, P NATL ACAD SCI USA, V94, P1344, DOI 10.1073/pnas.94.4.1344; Mitchell J, 2010, CURR OPIN INVEST DR, V11, P527; Miyamoto K, 2006, INT ARCH ALLERGY IMM, V140, P215, DOI 10.1159/000093246; Morgan RK, 2007, J IMMUNOL, V178, P8081, DOI 10.4049/jimmunol.178.12.8081; Neumann D, 2010, PHARMACOLOGY, V85, P217, DOI 10.1159/000285088; Nguyen T, 2001, MOL PHARMACOL, V59, P427, DOI 10.1124/mol.59.3.427; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Rosenwasser LJ, 2011, CURR ALLERGY ASTHM R, V11, P178, DOI 10.1007/s11882-011-0179-6; Rosethorne EM, 2011, MOL PHARMACOL, V79, P749, DOI 10.1124/mol.110.068395; Rossbach K, 2009, EXP DERMATOL, V18, P57, DOI 10.1111/j.1600-0625.2008.00762.x; Schnell D, 2011, NAUNYNSCHMIEDEBERGS; Seifert R, 2011, MOL PHARMACOL, V79, P631, DOI 10.1124/mol.111.071266; Seifert R, 2009, MOL PHARMACOL, V75, P13, DOI 10.1124/mol.108.052944; Thurmond RL, 2004, J PHARMACOL EXP THER, V309, P404, DOI 10.1124/jpet.103.061754; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Tschernig T, 2008, CURR DRUG TARGETS, V9, P466, DOI 10.2174/138945008784533543; Zimmermann AS, 2011, INFLAMM RES, V60, P1153, DOI 10.1007/s00011-011-0379-5; Zosky GR, 2008, CLIN EXP ALLERGY, V38, P829, DOI 10.1111/j.1365-2222.2007.02884.x	42	26	27	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30285	10.1371/journal.pone.0030285	http://dx.doi.org/10.1371/journal.pone.0030285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272324	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400102
J	Sanches, FHC; Miyai, CA; Costa, TM; Christofoletti, RA; Volpato, GL; Barreto, RE				Carretero Sanches, Fabio Henrique; Miyai, Caio Akira; Costa, Tania Marcia; Christofoletti, Ronaldo Adriano; Volpato, Gilson Luiz; Barreto, Rodrigo Egydio			Aggressiveness Overcomes Body-Size Effects in Fights Staged between Invasive and Native Fish Species with Overlapping Niches	PLOS ONE			English	Article							NILE TILAPIA; GEOPHAGUS-BRASILIENSIS; COMPETITIVE-EXCLUSION; SOCIAL-STATUS; BEHAVIOR; PERCIFORMES; DOMINANCE; CICHLIDAE; CONTESTS; PISCES	Approximately 50 years ago, Nile tilapia were accidentally introduced to Brazil, and the decline of pearl cichlid populations, which has been intensified by habitat degradation, in some locations has been associated with the presence of Nile tilapia. There is, however, little strong empirical evidence for the negative interaction of non-native fish populations with native fish populations; such evidence would indicate a potential behavioural mechanism that could cause the population of the native fish to decline. In this study, we show that in fights staged between pairs of Nile tilapia and pearl cichlids of differing body size, the Nile tilapia were more aggressive than the pearl cichlid. Because this effect prevailed over body-size effects, the pearl cichlids were at a disadvantage. The niche overlap between the Nile tilapia and the pearl cichlid in nature, and the competitive advantage shown by the Nile tilapia in this study potentially represent one of several possible results of the negative interactions imposed by an invasive species. These negative effects may reduce population viability of the native species and cause competitive exclusion.	[Carretero Sanches, Fabio Henrique; Miyai, Caio Akira; Volpato, Gilson Luiz; Barreto, Rodrigo Egydio] Univ Estadual Paulista, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil; [Christofoletti, Ronaldo Adriano] Univ Sao Paulo, Ctr Biol Marinha CEBIMar, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo	Sanches, FHC (corresponding author), Univ Estadual Paulista, Inst Biociencias, Dept Fisiol, Campus Expt Litoral Paulista, Sao Paulo, Brazil.	rebarreto@yahoo.com	Miyai, Caio A/J-7498-2013; Costa, Tânia Marcia/AAC-6750-2019; Volpato, Gilson/B-2304-2008; Christofoletti, Ronaldo A./D-3266-2012; Barreto, Rodrigo E/A-3440-2013; Sanches, Fabio H C/K-3526-2013; Costa, Tania M/C-8066-2012	Miyai, Caio A/0000-0002-6116-3159; Costa, Tânia Marcia/0000-0003-0230-8431; Christofoletti, Ronaldo A./0000-0002-2168-9527; Barreto, Rodrigo E/0000-0002-4611-0059; Sanches, Fabio H C/0000-0002-1105-4894; Costa, Tania M/0000-0003-0230-8431	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-"National Counsel of Technological and Scientific Development"-Brazil [307380/2009-2]	CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-"National Counsel of Technological and Scientific Development"-Brazil	This study had financial support from CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-"National Counsel of Technological and Scientific Development"-Brazil (Process number: 307380/2009-2) (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARENGA CMD, 1995, PHYSIOL BEHAV, V57, P75, DOI 10.1016/0031-9384(94)00206-K; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; Bailey J, 2000, J FISH BIOL, V57, P258, DOI 10.1006/jfbi.2000.1303; Barreto RE, 2011, ZOOLOGY, V114, P53, DOI 10.1016/j.zool.2010.09.001; BEAUGRAND JP, 1985, BEHAV PROCESS, V10, P1, DOI 10.1016/0376-6357(85)90116-0; Bohn T, 2008, BIOL INVASIONS, V10, P359, DOI 10.1007/s10530-007-9135-8; Briffa M, 2007, FUNCT ECOL, V21, P627, DOI 10.1111/j.1365-2435.2006.01188.x; Briffa M, 2008, ANIM BEHAV, V75, P1053, DOI 10.1016/j.anbehav.2007.08.016; Briffa M, 2010, ANIM BEHAV, V80, P583, DOI 10.1016/j.anbehav.2010.06.009; Brooks WR, 2010, BIOL INVASIONS, V12, P865, DOI 10.1007/s10530-009-9507-3; CARRIERI MP, 1991, PHYSIOL BEHAV, V50, P489, DOI 10.1016/0031-9384(91)90534-U; Chellappa S, 1999, J FISH BIOL, V55, P1163, DOI 10.1111/j.1095-8649.1999.tb02067.x; Cruz EMV, 2007, HORM BEHAV, V51, P611, DOI 10.1016/j.yhbeh.2007.02.010; Delicio HC, 2006, J ETHOL, V24, P195, DOI 10.1007/s10164-005-0175-1; Fuselier L, 2001, REV BIOL TROP, V49, P647; García Mirta L., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P117; Gibran FZ, 2007, NEOTROP ICHTHYOL, V5, P387, DOI 10.1590/S1679-62252007000300018; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Harwood AJ, 2003, BEHAV ECOL, V14, P902, DOI 10.1093/beheco/arg080; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Kadry VO, 2010, NEOTROP ICHTHYOL, V8, P329, DOI 10.1590/S1679-62252010000200011; Linde AR, 2008, AQUAT CONSERV, V18, P891, DOI 10.1002/aqc.928; Martin CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014395; McCrary JK., 2001, ENCUENTRO, V58, P9; Mills MD, 2004, OECOLOGIA, V141, P713, DOI 10.1007/s00442-004-1695-z; Morishita VR, 2009, BEHAV PROCESS, V80, P191, DOI 10.1016/j.beproc.2008.11.010; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; OGUTUOHWAYO R, 1991, CAN J FISH AQUAT SCI, V48, P8, DOI 10.1139/f91-299; PARKER GA, 1976, AM NAT, V110, P1055, DOI 10.1086/283126; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pianka E. R., 2000, EVOLUTIONARY ECOLOGY; Ridley M, 1995, ANIMAL BEHAV INTRO B, P288, DOI 10.1002/9781444313802; Vitule JRS, 2009, FISH FISH, V10, P98, DOI 10.1111/j.1467-2979.2008.00312.x; TURNER GF, 1986, ANIM BEHAV, V34, P961, DOI 10.1016/S0003-3472(86)80155-5; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Volterra V, 1931, ANIMAL ECOLOGY, P409; Watanabe WO, 2002, REV FISH SCI, V10, P465, DOI 10.1080/20026491051758; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WEINZETTL M, 1990, MEM I OSWALDO CRUZ, V85, P35, DOI 10.1590/S0074-02761990000100005; Wilson AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028024	40	33	34	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29746	10.1371/journal.pone.0029746	http://dx.doi.org/10.1371/journal.pone.0029746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272244	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400023
J	Lakshminarasimhan, H; Chattarji, S				Lakshminarasimhan, Harini; Chattarji, Sumantra			Stress Leads to Contrasting Effects on the Levels of Brain Derived Neurotrophic Factor in the Hippocampus and Amygdala	PLOS ONE			English	Article							SPATIAL MEMORY; MESSENGER-RNA; BDNF; EXPRESSION; CORTICOSTERONE; DEPRESSION; PITUITARY; INTENSITY; RECOVERY; NEUROBIOLOGY	Recent findings on stress induced structural plasticity in rodents have identified important differences between the hippocampus and amygdala. The same chronic immobilization stress (CIS, 2h/day) causes growth of dendrites and spines in the basolateral amygdala (BLA), but dendritic atrophy in hippocampal area CA3. CIS induced morphological changes also differ in their temporal longevity-BLA hypertrophy, unlike CA3 atrophy, persists even after 21 days of stress-free recovery. Furthermore, a single session of acute immobilization stress (AIS, 2h) leads to a significant increase in spine density 10 days, but not 1 day, later in the BLA. However, little is known about the molecular correlates of the differential effects of chronic and acute stress. Because BDNF is known to be a key regulator of dendritic architecture and spines, we investigated if the levels of BDNF expression reflect the divergent effects of stress on the hippocampus and amygdala. CIS reduces BDNF in area CA3, while it increases it in the BLA of male Wistar rats. CIS-induced increase in BDNF expression lasts for at least 21 days after the end of CIS in the BLA. But CIS-induced decrease in area CA3 BDNF levels, reverses to normal levels within the same period. Finally, BDNF is up regulated in the BLA 1 day after AIS and this increase persists even 10 days later. In contrast, AIS fails to elicit any significant change in area CA3 at either time points. Together, these findings demonstrate that both acute and chronic stress trigger opposite effects on BDNF levels in the BLA versus area CA3, and these divergent changes also follow distinct temporal profiles. These results point to a role for BDNF in stress-induced structural plasticity across both hippocampus and amygdala, two brain areas that have also been implicated in the cognitive and affective symptoms of stress-related psychiatric disorders.	[Lakshminarasimhan, Harini; Chattarji, Sumantra] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Lakshminarasimhan, H (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	shona@ncbs.res.in			National Centre for Biological Sciences (NCBS); Wellcome Trust, UK [GR 0701339 MA]	National Centre for Biological Sciences (NCBS); Wellcome Trust, UK(Wellcome Trust)	This work was supported by National Centre for Biological Sciences (NCBS) and grant GR 0701339 MA from the Wellcome Trust, UK (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Cordero MI, 1998, BEHAV NEUROSCI, V112, P885, DOI 10.1037/0735-7044.112.4.885; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Garcia A, 2000, NEUROENDOCRINOLOGY, V72, P114, DOI 10.1159/000054578; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; Marmigere F, 2003, HIPPOCAMPUS, V13, P646, DOI 10.1002/hipo.10109; Marquez C, 2002, BRAIN RES, V926, P181, DOI 10.1016/S0006-8993(01)03112-2; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; OTTENWELLER JE, 1992, PHYSIOL BEHAV, V51, P689, DOI 10.1016/0031-9384(92)90104-A; PITMAN DL, 1988, PHYSIOL BEHAV, V43, P47, DOI 10.1016/0031-9384(88)90097-2; Radecki DT, 2005, HIPPOCAMPUS, V15, P246, DOI 10.1002/hipo.20048; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Reznikov LR, 2007, EUR J NEUROSCI, V25, P3109, DOI 10.1111/j.1460-9568.2007.05560.x; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Schaaf MJM, 1997, J NEUROSCI RES, V48, P334, DOI 10.1002/(SICI)1097-4547(19970515)48:4<334::AID-JNR5>3.0.CO;2-C; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Taliaz D, 2011, J NEUROSCI, V31, P4475, DOI 10.1523/JNEUROSCI.5725-10.2011; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Vyas A, 2002, J NEUROSCI, V22, P6810; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8	40	167	172	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30481	10.1371/journal.pone.0030481	http://dx.doi.org/10.1371/journal.pone.0030481			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272355	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400133
J	Wozniak-Knopp, G; Stadlmann, J; Ruker, F				Wozniak-Knopp, Gordana; Stadlmann, Johannes; Rueker, Florian			Stabilisation of the Fc Fragment of Human IgG1 by Engineered Intradomain Disulfide Bonds	PLOS ONE			English	Article							THERMAL-STABILITY; CRYSTAL-STRUCTURE; CONSTANT DOMAINS; PICHIA-PASTORIS; GLYCOSYLATION; PROTEINS; RECEPTOR; BINDING; IDENTIFICATION; EXPRESSION	We report the stabilization of the human IgG1 Fc fragment by engineered intradomain disulfide bonds. One of these bonds, which connects the N-terminus of the CH3 domain with the F-strand, led to an increase of the melting temperature of this domain by 10 degrees C as compared to the CH3 domain in the context of the wild-type Fc region. Another engineered disulfide bond, which connects the BC loop of the CH3 domain with the D-strand, resulted in an increase of T-m of 5 degrees C. Combined in one molecule, both intradomain disulfide bonds led to an increase of the T-m of about 15 degrees C. All of these mutations had no impact on the thermal stability of the CH2 domain. Importantly, the binding of neonatal Fc receptor was also not influenced by the mutations. Overall, the stabilized CH3 domains described in this report provide an excellent basic scaffold for the engineering of Fc fragments for antigen-binding or other desired additional or improved properties. Additionally, we have introduced the intradomain disulfide bonds into an IgG Fc fragment engineered in C-terminal loops of the CH3 domain for binding to Her2/neu, and observed an increase of the T-m of the CH3 domain for 7.5 degrees C for CysP4, 15.5 degrees C for CysP2 and 19 degrees C for the CysP2 and CysP4 disulfide bonds combined in one molecule.	[Wozniak-Knopp, Gordana; Rueker, Florian] Univ Nat Resources & Life Sci, Dept Biotechnol, Christian Doppler Lab Antibody Engn, Vienna, Austria; [Stadlmann, Johannes] Univ Nat Resources & Life Sci, Dept Chem, Christian Doppler Lab Antibody Engn, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Wozniak-Knopp, G (corresponding author), Univ Nat Resources & Life Sci, Dept Biotechnol, Christian Doppler Lab Antibody Engn, Vienna, Austria.	florian.rueker@boku.ac.at	Stadlmann, Johannes/AAC-3157-2021; Wozniak-Knopp, Gordana/AAL-5148-2021	Stadlmann, Johannes/0000-0001-5693-6690; Wozniak-Knopp, Gordana/0000-0002-4069-070X; Rueker, Florian/0000-0001-7639-2686	Christian Doppler Forschungsgesellschaft; f-star GmbH	Christian Doppler Forschungsgesellschaft; f-star GmbH	This work was financially supported by the Christian Doppler Forschungsgesellschaft and by f-star GmbH. The Christian Doppler Laboratory is funded by joint contributions from both the Christian Doppler Forschungsgesellschaft and f-star as a company partner in this program that is interested in the research being performed in our academic laboratory. GW-K and FR are cofounders of f-star GmbH, but have no employment relationship with f-star GmbH. FR acts as a consultant to f-star and as a member of the Science Advisory Board of this company. f-star had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbabi-Ghahroudi M, 2009, PROTEIN ENG DES SEL, V22, P59, DOI 10.1093/protein/gzn071; AZUMA H, 1993, J BIOL CHEM, V268, P2821; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Bretthauer RK, 1999, BIOTECHNOL APPL BIOC, V30, P193; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Dahiyat BI, 1999, CURR OPIN BIOTECH, V10, P387, DOI 10.1016/S0958-1669(99)80070-6; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Demarest SJ, 2004, J MOL BIOL, V335, P41, DOI 10.1016/j.jmb.2003.10.040; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Gershenson A, 2000, Genet Eng (N Y), V22, P55; Ghirlando R, 1999, IMMUNOL LETT, V68, P47, DOI 10.1016/S0165-2478(99)00029-2; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; HIDER RC, 1988, BIOPHYS CHEM, V31, P45, DOI 10.1016/0301-4622(88)80007-3; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Kabat E. A., 1991, SEQUENCES PROTEINS I; Kotzia GA, 2009, FEBS J, V276, P1750, DOI 10.1111/j.1742-4658.2009.06910.x; MaAuley A, 2008, PROTEIN SCI, V17, P95, DOI 10.1110/ps.073134408; Mimura Y, 2000, MOL IMMUNOL, V37, P697, DOI 10.1016/S0161-5890(00)00105-X; PACE CN, 1988, J BIOL CHEM, V263, P11820; Powers DB, 2001, J IMMUNOL METHODS, V251, P123, DOI 10.1016/S0022-1759(00)00290-8; Ruiz M, 2002, IMMUNOGENETICS, V53, P857, DOI 10.1007/s00251-001-0408-6; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; SCHELLMAN JOHN A., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P230; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Tischenko VM, 1998, BIOCHEMISTRY-US, V37, P5576, DOI 10.1021/bi972647a; Vaughn DE, 1997, BIOCHEMISTRY-US, V36, P9374, DOI 10.1021/bi970841r; Vaughn DE, 1997, J MOL BIOL, V274, P597, DOI 10.1006/jmbi.1997.1388; Wozniak-Knopp G, 2010, PROTEIN ENG DES SEL, V23, P289, DOI 10.1093/protein/gzq005	32	47	68	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30083	10.1371/journal.pone.0030083	http://dx.doi.org/10.1371/journal.pone.0030083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272277	gold, Green Submitted, Green Published			2022-12-25	WOS:000301454400055
J	Maruani, DM; Spiegel, TN; Harris, EN; Shachter, AS; Unger, HA; Herrero-Gonzalez, S; Holz, MK				Maruani, D. M.; Spiegel, T. N.; Harris, E. N.; Shachter, A. S.; Unger, H. A.; Herrero-Gonzalez, S.; Holz, M. K.			Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation	ONCOGENE			English	Article						S6K1; mTOR; estrogen; rapamycin; breast cancer	RECEPTOR-ALPHA BINDING; 17Q23 AMPLICON; COPY NUMBER; KINASE; PROTEIN; ACTIVATION; REVEALS; TARGET; GENES; SITES	The 40S ribosomal S6 kinase 1 (S6K1) is an important regulator of cell growth. Expression of S6K1 is often elevated in breast cancer cells. However, the transcriptional mechanism of S6K1 overexpression is not understood. In this report, we demonstrate that estrogen activates expression of S6K1 via estrogen receptor (ER) a in ER-positive breast cancer cells. We also show that estrogen acts on the proximal promoter of the S6K1 gene in a mechanism involving the transcriptional factor GATA-3. Finally, we provide data that support the importance of estrogenic regulation of S6K1 expression in breast cancer cell proliferation. S6K1 directly phosphorylates and regulates ligand-independent activity of ER alpha, while ERa upregulates S6K1 expression. This S6K1-ER alpha relationship creates a positive feed-forward loop in control of breast cancer cell proliferation. Furthermore, the co-dependent association between S6K1 and ER alpha may be exploited in the development of targeted breast cancer therapies. Oncogene (2012) 31, 5073-5080; doi:10.1038/onc.2011.657; published online 30 January 2012	[Maruani, D. M.; Spiegel, T. N.; Harris, E. N.; Shachter, A. S.; Unger, H. A.; Holz, M. K.] Yeshiva Univ, Stern Coll Women, Dept Biol, New York, NY 10016 USA; [Herrero-Gonzalez, S.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Holz, M. K.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Holz, MK (corresponding author), Yeshiva Univ, Stern Coll Women, Dept Biol, 245 Lexington Ave, New York, NY 10016 USA.	mholz@yu.edu		Spiegel Strauss, Tirtza/0000-0002-3485-0850	NIH [CA151112]; Atol Charitable Trust; Wendy Will Case Cancer Fund; Yeshiva University; S Daniel Abraham Honors Program of Yeshiva University; NATIONAL CANCER INSTITUTE [R15CA151112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Atol Charitable Trust; Wendy Will Case Cancer Fund; Yeshiva University; S Daniel Abraham Honors Program of Yeshiva University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W Lee Kraus for expression constructs and Jonathan Backer for help with kinase assays. We are especially grateful to Matthew Gamble and members of his laboratory for assistance and guidance with ChIP assays. We also like to acknowledge Antonio Di Cristofano for scientific generosity and help with animal experiments. We also thank Fannie F Seligman, Faygel Beren and Miriam Ciner for technical assistance. This work was founded by grants to MKH from NIH (CA151112), Atol Charitable Trust, Wendy Will Case Cancer Fund and Yeshiva University. TNS, ENH, ASS and HAU received support from the S Daniel Abraham Honors Program of Yeshiva University.	[Anonymous], 1992, Lancet, V339, P1; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Becker MA, 2011, MOL ENDOCRINOL, V25, P516, DOI 10.1210/me.2010-0373; Bhat-Nakshatri P, 2008, MOL CELL BIOL, V28, P7487, DOI 10.1128/MCB.00799-08; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Couch FJ, 1999, CANCER RES, V59, P1408; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Ellis M, 2004, ONCOLOGIST, V9, P20, DOI 10.1634/theoncologist.9-suppl_3-20; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Han W, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-92; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Ikeda K, 2004, ARCH HISTOL CYTOL, V67, P435, DOI 10.1679/aohc.67.435; Jiang Shoulei, 2010, Hormones & Cancer, V1, P11, DOI 10.1007/s12672-010-0006-x; Johnston SRD, 2011, BREAST CANCER RES TR, V128, P607, DOI 10.1007/s10549-010-1207-2; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sathya G, 1997, MOL ENDOCRINOL, V11, P1994, DOI 10.1210/me.11.13.1994; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; van der Hage JA, 2004, BRIT J CANCER, V90, P1543, DOI 10.1038/sj.bjc.6601741; Yamnik RL, 2010, FEBS LETT, V584, P124, DOI 10.1016/j.febslet.2009.11.041; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	35	48	49	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2012	31	49					5073	5080		10.1038/onc.2011.657	http://dx.doi.org/10.1038/onc.2011.657			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	049RK	22286763	Green Accepted			2022-12-25	WOS:000312000900003
J	Zhang, YH; Li, ZG; Sacks, DB; Ames, JB				Zhang, Yonghong; Li, Zhigang; Sacks, David B.; Ames, James B.			Structural Basis for Ca2+-induced Activation and Dimerization of Estrogen Receptor alpha by Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; TARGET RECOGNITION; LIGHT-SCATTERING; CALCIUM-BINDING; COMPLEX; NMR; ASSOCIATION; MODULATION; PLASTICITY; ESTRADIOL	The estrogen receptor alpha (ER-alpha) regulates expression of target genes implicated in development, metabolism, and breast cancer. Calcium-dependent regulation of ER-alpha is critical for activating gene expression and is controlled by calmodulin (CaM). Here, we present the NMR structures for the two lobes of CaM each bound to a localized region of ER-alpha (residues 287-305). A model of the complete CaM alpha ER-alpha complex was constructed by combining these two structures with additional data. The two lobes of CaM both compete for binding at the same site on ER-alpha (residues 292, 296, 299, 302, and 303), which explains why full-length CaM binds two molecules of ER-alpha in a 1:2 complex and stabilizes ER-alpha dimerization. Exposed glutamate residues in CaM (Glu(11), Glu(14), Glu(84), and Glu(87)) form salt bridges with key lysine residues in ER-alpha (Lys(299), Lys(302), and Lys(303)), which are likely to prevent ubiquitination at these sites and inhibit degradation of ER-alpha. Mutants of ER-alpha at the CaM-binding site (W292A and K299A) weaken binding to CaM, and I298E/K299D disrupts estrogen-induced transcription. CaM facilitates dimerization of ER-alpha in the absence of estrogen, and stimulation of ER-alpha by either Ca2+ and/or estrogen may serve to regulate transcription in a combinatorial fashion.	[Zhang, Yonghong; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	University of California System; University of California Davis; National Institutes of Health (NIH) - USA	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu		Sacks, David/0000-0003-3100-0735	National Institutes of Health [EY012347, NS059969]; Intramural Research Program; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059969] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CLINICAL CENTER	This work was supported, in whole or in part, by National Institutes of Health Grants EY012347 and NS059969 (to J. B. A.) and by the Intramural Research Program.	BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Biswas DK, 1998, J BIOL CHEM, V273, P33817, DOI 10.1074/jbc.273.50.33817; BOUHOUTE A, 1995, BIOCHEM BIOPH RES CO, V208, P748, DOI 10.1006/bbrc.1995.1401; Brandt ME, 1997, J BIOL CHEM, V272, P4843, DOI 10.1074/jbc.272.8.4843; Conway K, 2005, BREAST CANCER RES, V7, pR871, DOI 10.1186/bcr1315; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickson R B, 2000, J Natl Cancer Inst Monogr, P135; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Gallo D, 2008, MOL CELL ENDOCRINOL, V291, P20, DOI 10.1016/j.mce.2008.04.011; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Herynk MH, 2007, CLIN CANCER RES, V13, P3235, DOI 10.1158/1078-0432.CCR-06-2608; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang H, 2010, PROTEIN SCI, V19, P475, DOI 10.1002/pro.325; Hurth KM, 2004, BIOCHEMISTRY-US, V43, P1891, DOI 10.1021/bi035566p; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li L, 2003, J BIOL CHEM, V278, P1195, DOI 10.1074/jbc.M210708200; Li L, 2007, CELL SIGNAL, V19, P439, DOI 10.1016/j.cellsig.2006.08.018; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Maaroufi Y, 2000, BREAST CANCER RES, V2, P444, DOI 10.1186/bcr92; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Meyer M, 2003, BIOMACROMOLECULES, V4, P1727, DOI 10.1021/bm0341531; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Park S, 2011, PROTEIN SCI, V20, P1356, DOI 10.1002/pro.662; Pedrero JMG, 2002, MOL ENDOCRINOL, V16, P947; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SCHWABE JWR, 1993, STRUCTURE, V1, P187, DOI 10.1016/0969-2126(93)90020-H; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SINGER AL, 1976, CANCER RES, V36, P60; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Tamrazi A, 2002, MOL ENDOCRINOL, V16, P2706, DOI 10.1210/me.2002-0250; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wood JR, 1998, MOL CELL BIOL, V18, P1927, DOI 10.1128/MCB.18.4.1927; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; WYATT PJ, 1991, BIOCHEM SOC T, V19, P485, DOI 10.1042/bst0190485; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Zhang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023069; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	57	32	32	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9336	9344		10.1074/jbc.M111.334797	http://dx.doi.org/10.1074/jbc.M111.334797			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275375	Green Published, hybrid			2022-12-25	WOS:000301797800065
J	Turck, M; Bierbaum, G				Tuerck, Michael; Bierbaum, Gabriele			Purification and Activity Testing of the Full-Length YycFGHI Proteins of Staphylococcus aureus	PLOS ONE			English	Article							SENSOR HISTIDINE KINASE; 2-COMPONENT SIGNAL-TRANSDUCTION; BLUE NATIVE ELECTROPHORESIS; GRAM-POSITIVE BACTERIA; TRITON X-100 MICELLES; CELL-WALL METABOLISM; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; SOLVATION DYNAMICS	Background: The YycFG two-component regulatory system (TCS) of Staphylococcus aureus represents the only essential TCS that is almost ubiquitously distributed in Gram-positive bacteria with a low G+C-content. YycG (WalK/VicK) is a sensor histidine-kinase and YycF (WalR/VicR) is the cognate response regulator. Both proteins play an important role in the biosynthesis of the cell envelope and mutations in these proteins have been involved in development of vancomycin and daptomycin resistance. Methodology/Principal Findings: Here we present high yield expression and purification of the full-length YycG and YycF proteins as well as of the auxiliary proteins YycH and YycI of Staphylococcus aureus. Activity tests of the YycG kinase and a mutated version, that harbours an Y306N exchange in its cytoplasmic PAS domain, in a detergent-micelle-model and a phosholipid-liposome-model showed kinase activity (autophosphorylation and phosphoryl group transfer to YycF) only in the presence of elevated concentrations of alkali salts. A direct comparison of the activity of the kinases in the liposome-model indicated a higher activity of the mutated YycG kinase. Further experiments indicated that YycG responds to fluidity changes in its microenvironment. Conclusions/Significance: The combination of high yield expression, purification and activity testing of membrane and membrane-associated proteins provides an excellent experimental basis for further protein-protein interaction studies and for identification of all signals received by the YycFGHI system.	[Tuerck, Michael; Bierbaum, Gabriele] Univ Bonn, IMMIP, Bonn, Germany	University of Bonn	Turck, M (corresponding author), Univ Bonn, IMMIP, Bonn, Germany.	bierbaum@mibi03.meb.uni-bonn.de			DFG (Deutsche Forschungsgemeinschaft) [Bi504-8/1-8/3]; Medical Faculty of the University of Bonn	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Medical Faculty of the University of Bonn	This study was supported by a grant of the DFG to G. Bierbaum (Deutsche Forschungsgemeinschaft Bi504-8/1-8/3) and the Bonfor program of the Medical Faculty of the University of Bonn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charlton ID, 2000, J PHYS CHEM B, V104, P8327, DOI 10.1021/jp994424v; Clausen VA, 2003, J MOL MICROB BIOTECH, V5, P252, DOI 10.1159/000071077; Cybulski LE, 2010, CURR BIOL, V20, P1539, DOI 10.1016/j.cub.2010.06.074; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Fabret C, 1998, J BACTERIOL, V180, P6375; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Gurtovenko AA, 2008, J PHYS CHEM B, V112, P1953, DOI 10.1021/jp0750708; Gutu AD, 2010, J BACTERIOL, V192, P2346, DOI 10.1128/JB.01690-09; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Howell A, 2006, MOL MICROBIOL, V59, P1199, DOI 10.1111/j.1365-2958.2005.05017.x; Howell A, 2003, MOL MICROBIOL, V49, P1639, DOI 10.1046/j.1365-2958.2003.03661.x; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Jansen A, 2007, INT J MED MICROBIOL, V297, P205, DOI 10.1016/j.ijmm.2007.02.002; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jung K, 1997, J BIOL CHEM, V272, P10847; Kumbhakar M, 2005, J PHYS CHEM B, V109, P18528, DOI 10.1021/jp0531356; Kumbhakar M, 2005, J PHYS CHEM B, V109, P14168, DOI 10.1021/jp0520291; Kumbhakar M, 2004, J PHYS CHEM B, V108, P19246, DOI 10.1021/jp0468004; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; Matias VRF, 2007, MOL MICROBIOL, V64, P195, DOI 10.1111/j.1365-2958.2007.05634.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moker N, 2007, J BACTERIOL, V189, P3645, DOI 10.1128/JB.01920-06; Molina-Bolivar JA, 2002, J PHYS CHEM B, V106, P870, DOI 10.1021/jp0119936; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Ng WL, 2004, MICROBIOL-SGM, V150, P3096, DOI 10.1099/mic.0.27550-0; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Qin ZQ, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-96; Reipert A, 2003, ANTIMICROB AGENTS CH, V47, P568, DOI 10.1128/AAC.47.2.568-576.2003; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Santelli E, 2007, J BACTERIOL, V189, P3290, DOI 10.1128/JB.01937-06; Sass P, 2007, APPL ENVIRON MICROB, V73, P347, DOI 10.1128/AEM.01616-06; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; STRELETZKY K, 1995, LANGMUIR, V11, P42, DOI 10.1021/la00001a011; Szurmant H, 2006, PROTEIN SCI, V15, P929, DOI 10.1110/ps.052064406; Szurmant H, 2005, J BACTERIOL, V187, P5419, DOI 10.1128/JB.187.15.5419-5426.2005; Szurmant H, 2008, P NATL ACAD SCI USA, V105, P5891, DOI 10.1073/pnas.0800247105; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Szurmant H, 2007, J BACTERIOL, V189, P3280, DOI 10.1128/JB.01936-06; Winkler ME, 2008, J BACTERIOL, V190, P2645, DOI 10.1128/JB.01682-07; Yamamoto K, 2001, BIOSCI BIOTECH BIOCH, V65, P2306, DOI 10.1271/bbb.65.2306; Zhao W, 2008, BIOCHIMIE, V90, P930, DOI 10.1016/j.biochi.2008.02.025	50	27	28	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30403	10.1371/journal.pone.0030403	http://dx.doi.org/10.1371/journal.pone.0030403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276191	gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100043
J	Clark, MR; Schlacher, TA; Rowden, AA; Stocks, KI; Consalvey, M				Clark, Malcolm R.; Schlacher, Thomas A.; Rowden, Ashley A.; Stocks, Karen I.; Consalvey, Mireille			Science Priorities for Seamounts: Research Links to Conservation and Management	PLOS ONE			English	Review							SPECIES RICHNESS; ORANGE ROUGHY; NEW-ZEALAND; HOPLOSTETHUS-ATLANTICUS; OCEAN ACIDIFICATION; COMMUNITY STRUCTURE; GLOBAL DISTRIBUTION; CONTINENTAL-MARGIN; PACIFIC-OCEAN; STONY CORALS	Seamounts shape the topography of all ocean basins and can be hotspots of biological activity in the deep sea. The Census of Marine Life on Seamounts (CenSeam) was a field program that examined seamounts as part of the global Census of Marine Life (CoML) initiative from 2005 to 2010. CenSeam progressed seamount science by collating historical data, collecting new data, undertaking regional and global analyses of seamount biodiversity, mapping species and habitat distributions, challenging established paradigms of seamount ecology, developing new hypotheses, and documenting the impacts of human activities on seamounts. However, because of the large number of seamounts globally, much about the structure, function and connectivity of seamount ecosystems remains unexplored and unknown. Continual, and potentially increasing, threats to seamount resources from fishing and seabed mining are creating a pressing demand for research to inform conservation and management strategies. To meet this need, intensive science effort in the following areas will be needed: 1) Improved physical and biological data; of particular importance is information on seamount location, physical characteristics (e. g. habitat heterogeneity and complexity), more complete and intensive biodiversity inventories, and increased understanding of seamount connectivity and faunal dispersal; 2) New human impact data; these shall encompass better studies on the effects of human activities on seamount ecosystems, as well as monitoring long-term changes in seamount assemblages following impacts (e. g. recovery); 3) Global data repositories; there is a pressing need for more comprehensive fisheries catch and effort data, especially on the high seas, and compilation or maintenance of geological and biodiversity databases that underpin regional and global analyses; 4) Application of support tools in a data-poor environment; conservation and management will have to increasingly rely on predictive modelling techniques, critical evaluation of environmental surrogates as faunal "proxies", and ecological risk assessment.	[Clark, Malcolm R.; Rowden, Ashley A.; Consalvey, Mireille] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Schlacher, Thomas A.] Univ Sunshine Coast, Maroochydore, Qld, Australia; [Stocks, Karen I.] Univ Calif San Diego, La Jolla, CA 92093 USA	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of the Sunshine Coast; University of California System; University of California San Diego	Clark, MR (corresponding author), Natl Inst Water & Atmospher Res, Wellington, New Zealand.	m.clark@niwa.co.nz	Rowden, Ashley/ABG-6010-2020; Stocks, Karen I/J-2393-2014; Rowden, Ashley/O-9358-2019; Schlacher, Thomas/J-4614-2016	Stocks, Karen I/0000-0002-1282-300X; Schlacher, Thomas/0000-0003-2184-9217; Rowden, Ashley/0000-0003-2975-2524	Census of Marine Life on Seamounts field project (CenSeam); Sloan Foundation; National Institute of Water & Atmospheric Research [CO1X0906]	Census of Marine Life on Seamounts field project (CenSeam); Sloan Foundation(Alfred P. Sloan Foundation); National Institute of Water & Atmospheric Research	This work was supported by the Census of Marine Life on Seamounts field project (CenSeam), as part of the Census of Marine Life programme funded by the Sloan Foundation. Additional support was given to MRC and AAR by the National Institute of Water & Atmospheric Research (project CO1X0906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain V, 2008, DEEP-SEA RES PT I, V55, P1035, DOI 10.1016/j.dsr.2008.04.004; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Anderson OF, 2003, MAR FRESHWATER RES, V54, P643, DOI 10.1071/MF02163; Anderson TJ, 2011, DEEP-SEA RES PT II, V58, P979, DOI 10.1016/j.dsr2.2010.10.053; Auster PJ, 2011, ICES J MAR SCI, V68, P254, DOI 10.1093/icesjms/fsq074; Baba K, 2008, ZOOTAXA, P1; Baco AR, 2007, OCEANOGRAPHY, V20, P108, DOI 10.5670/oceanog.2007.11; Benn AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012730; Bensch A., 2008, FAO Fisheries and Aquaculture Technical Paper; Boehlert G.W., 1987, WILEY, V43, P319, DOI [DOI 10.1029/GM043P0319, 10.1029/GM043P0319]; Boero Ferdinando, 2010, Diversity, V2, P115; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Brewin PE, 2009, MAR ECOL PROG SER, V383, P225, DOI 10.3354/meps07987; Brodie S., 2003, AQUATIC PROTECTED AR, P664; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Burgman M., 2005, RISKS DECISIONS CONS; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Castelin M, 2011, DEEP-SEA RES PT I, V58, P637, DOI 10.1016/j.dsr.2011.03.008; CBD, 2009, AZ SCI CRIT GUID ID; Cho W, 2010, MAR ECOL-EVOL PERSP, V31, P121, DOI 10.1111/j.1439-0485.2010.00395.x; Clark M, 1999, OCEANOL ACTA, V22, P593, DOI 10.1016/S0399-1784(00)88950-1; Clark M. R., 2010, 46 NZ AQ ENV BIOD; Clark M.R., 2007, SEAMOUNTS ECOL FISH, P361, DOI [10.1002/9780470691953.ch17, DOI 10.1002/9780470691953.CH17]; Clark M. R., 2007, SEAMOUNTS ECOLOGY FI, P413, DOI 10.1002/9780470691953.; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P39, DOI 10.1111/j.1439-0485.2010.00384.x; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2010.00392.x; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark MR, 2009, LAT AM J AQUAT RES, V37, P501, DOI 10.3856/vol37-issue3-fulltext-17; Clark MR, 2009, DEEP-SEA RES PT I, V56, P1540, DOI 10.1016/j.dsr.2009.04.015; Clark MR, 1996, J FISH BIOL, V49, P114, DOI 10.1111/j.1095-8649.1996.tb06070.x; Clark MR, 2011, 74 NZ AQ ENV BIOD; Clark MR, 2011, 8 INT SEAB AUTH; Clark MR, 2004, 200451 NZ FISH ASS; Consalvey Mireille, 2010, P123, DOI 10.1002/9781444325508.ch7; Costello MJ, 2010, ENVIRON SCI TECHNOL, V44, P8821, DOI 10.1021/es1012752; Danovaro R, 2009, DEEP-SEA RES PT II, V56, P738, DOI 10.1016/j.dsr2.2008.10.011; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; FAO Food and Agriculture Organization of the United Nations; Rome, 2009, INT GUID MAN DEEP SE; Farnsworth KD, 2007, MAR ECOL PROG SER, V350, P223, DOI 10.3354/meps07190; Fletcher WJ, 2005, ICES J MAR SCI, V62, P1576, DOI 10.1016/j.icesjms.2005.06.005; Francis RICC, 2005, B MAR SCI, V76, P337; Freiwald A., 2004, COLD WATER CORAL REE; Gad G, 2004, ARCH FISH MAR RES, V51, P43; Gage JD, 2005, AM FISH S S, V41, P503; Galil Bella, 1998, Senckenbergiana Maritima, V28, P111; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; GW Suter, ECOLOGICAL RISK ASSE; Hall-Spencer J, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P135; Hall-Spencer JM, 2009, MAR ECOL PROG SER, V397, P305, DOI 10.3354/meps08235; Hannington M.D., 1995, GEOPHYS MONOGRAPH, V91, P115, DOI DOI 10.1029/GM091P0115; Hein J.R., 2002, ISA TECHNICAL STUDY, V2, P36; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Holland Kim N., 2007, Fish and Aquatic Resources Series, V12, P189; Howell KL, 2010, MAR ECOL-EVOL PERSP, V31, P52, DOI 10.1111/j.1439-0485.2010.00368.x; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; Iosjpe M, 2011, J MARINE SYST, V88, P82, DOI 10.1016/j.jmarsys.2011.02.013; IUCN, 2010, APPL EC APPR FISH MA; Kitchingman A., 2004, CTR RES REP, P7; Kobyliansky S.G., 2010, J ICHTHYOL+, V50, P932, DOI [10.1134/S0032945210100036, DOI 10.1134/S0032945210100036]; Koppers AAP, 2010, OCEANOGRAPHY, V23, P37, DOI 10.5670/oceanog.2010.88; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; LEVIN LA, 1994, J MAR RES, V52, P489, DOI 10.1357/0022240943077028; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; MAC ARTHUR ROBERT H., 1967; Marques da Silva Helder, 2007, Fish and Aquatic Resources Series, V12, P335; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; Meager JJ, 2011, MAR ECOL PROG SER, V428, P1, DOI 10.3354/meps09124; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; Miller K, 2010, MAR ECOL-EVOL PERSP, V31, P144, DOI 10.1111/j.1439-0485.2010.00380.x; Miller KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019004; Mohn C, 2009, DEEP-SEA RES PT II, V56, P2582, DOI 10.1016/j.dsr2.2008.12.037; Morato T, 2006, J FISH BIOL, V68, P209, DOI 10.1111/j.0022-1112.2006.00894.x; MORATO T, 2007, BLACKWELL FISHERIES, V12, P170; Morato T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014453; Morato T, 2010, OCEANOGRAPHY, V23, P190, DOI 10.5670/oceanog.2010.71; Mortensen PB, 2008, DEEP-SEA RES PT II, V55, P142, DOI 10.1016/j.dsr2.2007.09.018; Niklitschek EJ, 2010, MAR ECOL-EVOL PERSP, V31, P168, DOI 10.1111/j.1439-0485.2010.00372.x; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; O'Hara TD, 2010, MAR ECOL-EVOL PERSP, V31, P84, DOI 10.1111/j.1439-0485.2010.00379.x; O'Hara TD, 2010, MAR ECOL-EVOL PERSP, V31, P26, DOI 10.1111/j.1439-0485.2010.00373.x; Parin NV, 1997, ADV MAR BIOL, V32, P145; Pitcher Tony J., 2007, Fish and Aquatic Resources Series, V12, P476; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; Probert P. Keith, 2007, Fish and Aquatic Resources Series, V12, P442; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; RAYMORE PA, 1982, PAC SCI, V36, P15; Roark EB, 2006, MAR ECOL PROG SER, V327, P1, DOI 10.3354/meps327001; Rogers A.D., 2010, IMPLEMENTATION UNGA, P97; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Rogers Alex D., 2007, Fish and Aquatic Resources Series, V12, P141; Rolinski S, 2001, DEEP-SEA RES PT II, V48, P3469, DOI 10.1016/S0967-0645(01)00053-4; Rowden AA, 2005, NEW ZEAL J MAR FRESH, V39, P1039, DOI 10.1080/00288330.2005.9517374; Rowden AA, 2010, NZ AQUAT ENV BIODIVE, V62, P31; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P63, DOI 10.1111/j.1439-0485.2010.00374.x; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Samadi Sarah, 2007, Fish and Aquatic Resources Series, V12, P119; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Sandwell DT, 2010, OCEANOGRAPHY, V23, P34, DOI 10.5670/oceanog.2010.87; Schlacher TA, 2007, MAR ECOL PROG SER, V340, P73, DOI 10.3354/meps340073; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2010.00396.x; Scott SD, 2007, PROCEEDINGS OF THE SEVENTH (2007) ISOPE OCEAN MINING (& GAS HYDRATES) SYMPOSIUM, P6; Shank TM, 2010, OCEANOGRAPHY, V23, P108, DOI 10.5670/oceanog.2010.65; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Sissenwine M.P., 2007, FAO Fisheries Reports, V838, P61; Smith Craig R., 2008, P334, DOI 10.1017/CBO9780511751790.030; SNELGROVE PVR, 1994, OCEANOGR MAR BIOL, V32, P111; Snelgrove PVR, 2010, DISCOVERIES CENSUS M, P286; Staudigel H, 2010, OCEANOGRAPHY, V23, P18, DOI 10.5670/oceanog.2010.59; Stocks KI, 2010, OCEANOGRAPHY, V23, P145, DOI 10.5670/oceanog.2010.94; Stocks Karen I., 2007, Fish and Aquatic Resources Series, V12, P255; Stocks KI, PLOS ONE IN PRESS; Sudek LA, 2009, GEOMICROBIOL J, V26, P581, DOI 10.1080/01490450903263400; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; Tittensor DP, 2010, MAR ECOL-EVOL PERSP, V31, P212, DOI 10.1111/j.1439-0485.2010.00393.x; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Tracey DM, 2011, MAR ECOL PROG SER, V430, P1, DOI 10.3354/meps09164; Tracey DM, 2004, NEW ZEAL J MAR FRESH, V38, P163, DOI 10.1080/00288330.2004.9517226; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; Tunnicliffe V, 2010, MAR ECOL-EVOL PERSP, V31, P158, DOI 10.1111/j.1439-0485.2010.00370.x; UNESCO, 2009, IOC TECHNICAL SERIES, V84, P87; van den Hove S, 2007, FUTURES, V39, P807, DOI 10.1016/j.futures.2006.12.004; Van Dover C.L., 2011, ISA TECHNICAL STUDY, P90; Van Dover CL, 2011, ICES J MAR SCI, V68, P341, DOI 10.1093/icesjms/fsq086; Watson R., 2007, SEAMOUNTS ECOLOGY FI, P400; Wessel P, 2001, J GEOPHYS RES-SOL EA, V106, P19431, DOI 10.1029/2000JB000083; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; White M., 2007, BLACKWELL FISHERIES, V12, P65; Williams A, 2011, FISH RES, V112, P154, DOI 10.1016/j.fishres.2011.01.028; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Wilson R. R., 1987, GEOPHYS MONOGR SER, P319; Woodby D, 2009, MAR ECOL PROG SER, V397, P227, DOI 10.3354/meps08358; Wright IC, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005138; Wright IC, 2001, MAR GEOL, V172, P287, DOI 10.1016/S0025-3227(00)00131-6; Wright SJ, 2009, CONSERV BIOL, V23, P1418, DOI 10.1111/j.1523-1739.2009.01337.x; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	148	88	91	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29232	10.1371/journal.pone.0029232	http://dx.doi.org/10.1371/journal.pone.0029232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279531	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900009
J	Ishihara, D; Dovas, A; Park, H; Isaac, BM; Cox, D				Ishihara, Dan; Dovas, Athanassios; Park, Haein; Isaac, Beth M.; Cox, Dianne			The Chemotactic Defect in Wiskott-Aldrich Syndrome Macrophages Is Due to the Reduced Persistence of Directional Protrusions	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; ACTIN POLYMERIZATION; CELL POLARIZATION; PHOSPHOLIPASE-C; LEADING-EDGE; WASP; RECEPTOR; MEMBRANE; PHAGOCYTOSIS; ACTIVATION	Wiskott-Aldrich syndrome protein (WASp) is an actin nucleation promoting factor that is required for macrophages to directionally migrate towards various chemoattractants. The chemotaxis defect of WASp-deficient cells and its activation by Cdc42 in vivo suggest that WASp plays a role in directional sensing, however, its precise role in macrophage chemotaxis is still unclear. Using shRNA-mediated downregulation of WASp in the murine monocyte/macrophage cell line RAW/LR5 (shWASp), we found that WASp was responsible for the initial wave of actin polymerization in response to global stimulation with CSF-1, which in Dictyostelium discoideum amoebae and carcinoma cells has been correlated with the ability to migrate towards chemoattractants. Real-time monitoring of shWASp cells, as well as WASp 2/2 bone marrow-derived macrophages (BMMs), in response to a CSF-1 gradient revealed that the protrusions from WASp-deficient cells were directional, showing intact directional sensing. However, the protrusions from WASp-deficient cells demonstrated reduced persistence compared to their respective control shRNA and wild-type cells. Further examination showed that tyrosine phosphorylation of WASp was required for both the first wave of actin polymerization following global CSF-1 stimulation and proper directional responses towards CSF-1. Importantly, the PI3K, Rac1 and WAVE2 proteins were incorporated normally in CSF-1 - elicited protrusions in the absence of WASp, suggesting that membrane protrusion driven by the WAVE2 complex signaling is intact. Collectively, these results suggest that WASp and its phosphorylation play critical roles in coordinating the actin cytoskeleton rearrangements necessary for the persistence of protrusions required for directional migration of macrophages towards CSF-1.	[Ishihara, Dan; Dovas, Athanassios; Park, Haein; Cox, Dianne] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Isaac, Beth M.; Cox, Dianne] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Ishihara, D (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.	dianne.cox@einstein.yu.edu		Cox, Dianne/0000-0002-0591-9767	National Institutes of Health [GM071828]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828, T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM071828 to Dianne Cox). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Kheir W, 2005, J CELL SCI, V118, P5369, DOI 10.1242/jcs.02638; Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Badolato R, 1998, J IMMUNOL, V161, P1026; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Cammer M, 2009, J BIOL CHEM, V284, P23302, DOI 10.1074/jbc.M109.036384; Chan AY, 1998, J CELL SCI, V111, P199; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Eddy RJ, 1997, J CELL BIOL, V139, P1243, DOI 10.1083/jcb.139.5.1243; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Millard TH, 2001, TRENDS BIOCHEM SCI, V26, P198, DOI 10.1016/S0968-0004(01)01788-1; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Myers SA, 2005, MOL BIOL CELL, V16, P2191, DOI 10.1091/mbc.E04-09-0844; Narang A, 2001, ANN BIOMED ENG, V29, P677, DOI 10.1114/1.1385805; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Park H, 2011, ARCH BIOCHEM BIOPHYS, V510, P101, DOI 10.1016/j.abb.2011.02.019; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pixley FJ, 2001, MOL CELL BIOL, V21, P1795, DOI 10.1128/MCB.21.5.1795-1809.2001; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Stanley E R, 1997, Methods Mol Biol, V75, P301; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Torres E, 2006, J BIOL CHEM, V281, P3513, DOI 10.1074/jbc.M509416200; Torres E, 2003, MOL CELL, V11, P1215, DOI 10.1016/S1097-2765(03)00139-4; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; WESSELS D, 1994, CELL MOTIL CYTOSKEL, V27, P1, DOI 10.1002/cm.970270102; Xiao Z, 1999, J BIOL CHEM, V274, P1440, DOI 10.1074/jbc.274.3.1440; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Zhelev DV, 2004, BIOPHYS J, V87, P688, DOI 10.1529/biophysj.103.036699; Zhu QL, 1997, BLOOD, V90, P2680, DOI 10.1182/blood.V90.7.2680.2680_2680_2689; Zicha D, 1998, BRIT J HAEMATOL, V101, P659, DOI 10.1046/j.1365-2141.1998.00767.x	50	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30033	10.1371/journal.pone.0030033	http://dx.doi.org/10.1371/journal.pone.0030033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279563	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900041
J	Horning, M; Mellish, JAE				Horning, Markus; Mellish, Jo-Ann E.			Predation on an Upper Trophic Marine Predator, the Steller Sea Lion: Evaluating High Juvenile Mortality in a Density Dependent Conceptual Framework	PLOS ONE			English	Article							SEQUENTIAL MEGAFAUNAL COLLAPSE; OTTER POPULATION DECLINES; WHALES ORCINUS-ORCA; NORTH PACIFIC-OCEAN; EUMETOPIAS-JUBATUS; KILLER WHALES; ALEUTIAN ARCHIPELAGO; TEMPORARY CAPTIVITY; BRITISH-COLUMBIA; ALASKA	The endangered western stock of the Steller sea lion (Eumetopias jubatus) - the largest of the eared seals - has declined by 80% from population levels encountered four decades ago. Current overall trends from the Gulf of Alaska to the Aleutian Islands appear neutral with strong regional heterogeneities. A published inferential model has been used to hypothesize a continuous decline in natality and depressed juvenile survival during the height of the decline in the mid-late 1980's, followed by the recent recovery of juvenile survival to pre-decline rates. However, these hypotheses have not been tested by direct means, and causes underlying past and present population trajectories remain unresolved and controversial. We determined post-weaning juvenile survival and causes of mortality using data received post-mortem via satellite from telemetry transmitters implanted into 36 juvenile Steller sea lions from 2005 through 2011. Data show high post-weaning mortality by predation in the eastern Gulf of Alaska region. To evaluate the impact of such high levels of predation, we developed a conceptual framework to integrate density dependent with density independent effects on vital rates and population trajectories. Our data and model do not support the hypothesized recent recovery of juvenile survival rates and reduced natality. Instead, our data demonstrate continued low juvenile survival in the Prince William Sound and Kenai Fjords region of the Gulf of Alaska. Our results on contemporary predation rates combined with the density dependent conceptual framework suggest predation on juvenile sea lions as the largest impediment to recovery of the species in the eastern Gulf of Alaska region. The framework also highlights the necessity for demographic models based on age-structured census data to incorporate the differential impact of predation on multiple vital rates.	[Horning, Markus] Oregon State Univ, Dept Fisheries & Wildlife, Marine Mammal Inst, Newport, OR USA; [Horning, Markus] Coastal Oregon Marine Expt Stn, Newport, OR USA; [Mellish, Jo-Ann E.] Alaska SeaLife Ctr, Seward, AK USA; [Mellish, Jo-Ann E.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA	Oregon State University; University of Alaska System; University of Alaska Fairbanks	Horning, M (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Marine Mammal Inst, Newport, OR USA.	markus.horning@oregonstate.edu	Horning, Markus/I-3019-2015	Horning, Markus/0000-0001-6178-4935	North Pacific Research Board [F4011]; United States Department of Commerce Steller Sea Lion Research Initiative [NA17FX1429]; Pollock Conservation Cooperative Research Center [01-0047, G5498]; Alaska Sea Life Center using United States Department of Commerce funds; North Pacific Marine Science Foundation [NA05NMF4391068]; North Pacific Marine Research Program [00-0029]	North Pacific Research Board; United States Department of Commerce Steller Sea Lion Research Initiative; Pollock Conservation Cooperative Research Center; Alaska Sea Life Center using United States Department of Commerce funds; North Pacific Marine Science Foundation; North Pacific Marine Research Program	Funding was provided by the North Pacific Research Board (F4011), the United States Department of Commerce Steller Sea Lion Research Initiative (NA17FX1429), the Pollock Conservation Cooperative Research Center (01-0047 & G5498), the Alaska Sea Life Center using United States Department of Commerce funds, the North Pacific Marine Science Foundation (NA05NMF4391068), and the North Pacific Marine Research Program (00-0029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MAR FISH REV; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; Atkinson S, 2008, MAMMAL REV, V38, P1, DOI 10.1111/j.1365-2907.2008.00128.x; Bakun A, 2006, PROG OCEANOGR, V68, P271, DOI 10.1016/j.pocean.2006.02.004; Bertilsson-Friedman P, 2006, J ZOOL, V268, P361, DOI 10.1111/j.1469-7998.2006.00066.x; Boyd IL, 2010, BIOL CONSERV, V143, P1664, DOI 10.1016/j.biocon.2010.04.006; Calkins D.G., 1982, ENV ASSESSMENT ALASK, V19, P445; DeMaster DP, 2006, PROG OCEANOGR, V68, P329, DOI 10.1016/j.pocean.2006.02.007; Doroff AM, 2003, J MAMMAL, V84, P55, DOI 10.1644/1545-1542(2003)084<0055:SOPDIT>2.0.CO;2; Durban J, 2010, MAR BIOL, V157, P1591, DOI 10.1007/s00227-010-1432-6; EDWARDS AWF, 1963, J R STAT SOC SER A-G, V126, P109, DOI 10.2307/2982448; Estes JA, 2009, PHILOS T R SOC B, V364, P1647, DOI 10.1098/rstb.2008.0231; Estes JA, 2005, MAR MAMMAL SCI, V21, P169, DOI 10.1111/j.1748-7692.2005.tb01218.x; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Frid A, 2009, OECOLOGIA, V158, P775, DOI 10.1007/s00442-008-1189-5; Fritz L., 2011, SURVEYS STELLER SEA; Fritz LW, 2005, MAR MAMMAL SCI, V21, P476, DOI 10.1111/j.1748-7692.2005.tb01245.x; Gascoigne JC, 2004, J APPL ECOL, V41, P801, DOI 10.1111/j.0021-8901.2004.00944.x; Heise Kathy, 2003, Aquatic Mammals, V29, P325, DOI 10.1578/01675420360736497; Hennen D, 2006, ECOL APPL, V16, P704, DOI 10.1890/1051-0761(2006)016[0704:ABTASS]2.0.CO;2; Holling C. S., 1959, Canadian Entomologist, V91, P385; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Horning M, 2005, IEEE J OCEANIC ENG, V30, P807, DOI 10.1109/JOE.2005.862135; Horning Markus, 2010, Endangered Species Research, V10, P135, DOI 10.3354/esr00220; Horning M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-51; Hunt GL, 2006, PROG OCEANOGR, V68, P115, DOI 10.1016/j.pocean.2006.02.008; JOHNSON DH, 1979, AUK, V96, P651; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Maniscalco JM, 2007, MAR MAMMAL SCI, V23, P306, DOI 10.1111/j.1748-7692.2007.00103.x; Maniscalco JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010076; Maniscalco John M., 2008, Aquatic Mammals, V34, P277, DOI 10.1578/AM.34.3.2008.277; Matkin CO, 2007, FISH B-NOAA, V105, P74; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; Mellish JA, 2007, J EXP MAR BIOL ECOL, V351, P283, DOI 10.1016/j.jembe.2007.07.015; Mellish Jo-Ann E., 2006, Aquatic Mammals, V32, P58, DOI 10.1578/AM.32.1.2006.58; National Marine Fisheries Service, 2008, REC PLAN STELL SEA L; National Research Council, 2003, DECL STELL SEA LION; Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Petrauskas L, 2008, J EXP ZOOL PART A, V309A, P73, DOI 10.1002/jez.435; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; REIJNDERS PJH, 1984, ENVIRON CONSERV, V11, P61, DOI 10.1017/S0376892900013503; Saulitis E, 2000, MAR MAMMAL SCI, V16, P94, DOI 10.1111/j.1748-7692.2000.tb00906.x; Small RJ, 2003, MAR MAMMAL SCI, V19, P344, DOI 10.1111/j.1748-7692.2003.tb01113.x; Springer AM, 2008, MAR MAMMAL SCI, V24, P414, DOI 10.1111/j.1748-7692.2008.00185.x; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Thomton Jamie D., 2008, Endangered Species Research, V4, P195, DOI 10.3354/esr00062; Trites AW, 2007, FISH OCEANOGR, V16, P46, DOI 10.1111/j.1365-2419.2006.00408.x; Trites AW, 2007, MAR MAMMAL SCI, V23, P751, DOI 10.1111/j.1748-7692.2006.00076.x; Wade PR, 2007, MAR MAMMAL SCI, V23, P766, DOI 10.1111/j.1748-7692.2006.00093.x; Walker KA, 2009, APPL ANIM BEHAV SCI, V120, P201, DOI 10.1016/j.applanim.2009.06.003; White G.C., 1999, PROGRAM MARK SURVIVA; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Winship AJ, 2001, J MAMMAL, V82, P500, DOI 10.1644/1545-1542(2001)082<0500:GIBSOT>2.0.CO;2; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x; [No title captured]	58	33	33	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30173	10.1371/journal.pone.0030173	http://dx.doi.org/10.1371/journal.pone.0030173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272296	Green Published, gold			2022-12-25	WOS:000301454400074
J	Kondapaka, KK; Prasad, SV; Satyanarayana, S; Kandi, S; Zachariah, R; Harries, AD; Nagaraja, SB; Tetali, S; Anchala, R; Kannuri, NK; Murthy, K; Koppu, D; Vangari, L; Rao, S				Kondapaka, Kiran Kumar; Prasad, Surapaneni Venkateswara; Satyanarayana, Srinath; Kandi, Subhakar; Zachariah, Rony; Harries, Anthony David; Nagaraja, Sharath Burugina; Tetali, Shailaja; Anchala, Raghupathy; Kannuri, Nanda Kishore; Murthy, Krishna; Koppu, Dhanamurthy; Vangari, Latha; Rao, Sreenivas			Are Tuberculosis Patients in a Tertiary Care Hospital in Hyderabad, India Being Managed According to National Guidelines?	PLOS ONE			English	Article								Setting: A tertiary health care facility (Government General and Chest hospital) in Hyderabad, India. Objectives: To assess a) the extent of compliance of specialists to standardized national (RNTCP) tuberculosis management guidelines and b) if patients on discharge from hospital were being appropriately linked up with peripheral health facilities for continuation of anti-Tuberculosis (TB) treatment. Methods: A descriptive study using routine programme data and involving all TB patients admitted to inpatient care from 1(st) January to 30(th) June, 2010. Results and Conclusions: There were a total of 3120 patients admitted of whom, 1218 (39%) required anti-TB treatment. Of these 1104 (98%) were treated with one of the RNTCP recommended regimens, while 28 (2%) were treated with non-RNTCP regimens. The latter included individually tailored MDR-TB treatment regimens for 19 patients and adhoc regimens for nine patients. A total of 957 (86%) patients were eventually discharged from the hospital of whom 921 (96%) had a referral form filled for continuing treatment at a peripheral health facility. Formal feedback from peripheral health facilities on continuation of TB treatment was received for 682 (74%) patients. In a tertiary health facility with specialists the great majority of TB patients are managed in line with national guidelines. However a number of short-comings were revealed and measures to rectify these are discussed.	[Kondapaka, Kiran Kumar; Prasad, Surapaneni Venkateswara; Kandi, Subhakar; Koppu, Dhanamurthy] Osmania Med Coll & Hosp, Dept Pulm Med, Hyderabad, Andhra Pradesh, India; [Satyanarayana, Srinath] Int Union TB & Lung Dis Union, SE Asia Reg Off, New Delhi, India; [Zachariah, Rony] Brussels Operat Ctr, Med Dept Operat Res, Brussels, Luxembourg; [Harries, Anthony David] Int Union TB & Lung Dis Union, Paris, France; [Harries, Anthony David] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Nagaraja, Sharath Burugina] Off WHO Representat India, New Delhi, India; [Tetali, Shailaja; Anchala, Raghupathy; Kannuri, Nanda Kishore] Indian Inst Publ Hlth Hyderabad, Publ Hlth Fdn India, Hyderabad, Andhra Pradesh, India; [Murthy, Krishna] Gandhi Med Coll, Dept Pulm Med, Hyderabad, Andhra Pradesh, India; [Vangari, Latha] Osmania Med Coll & Hosp, Dept Pediat, Hyderabad, Andhra Pradesh, India; [Rao, Sreenivas] State TB Off, Hyderabad, Andhra Pradesh, India	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Public Health Foundation of India; Gandhi Medical College & Hospital, Hyderabad	Kondapaka, KK (corresponding author), Osmania Med Coll & Hosp, Dept Pulm Med, Hyderabad, Andhra Pradesh, India.	kiran033@yahoo.com	Anchala, Raghupathy/AGD-8723-2022; Nagaraja, Sharath Burugina/ABD-7238-2021; Nagaraja, Sharath Burugina/ABD-7748-2021	Anchala, Raghupathy/0000-0003-4733-211X; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; zachariah, rony/0000-0002-2915-9328; Kannuri, Nanda Kishore/0000-0003-2352-6972; Satyanarayana, Srinath/0000-0002-5420-2551	Centre for Operational Research at The International Union Against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India (PHFI)	Centre for Operational Research at The International Union Against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India (PHFI)	This research was supported through an operational research course which was funded through a memorandum of understanding between the Centre for Operational Research at The International Union Against Tuberculosis and Lung Disease (The Union) and the Public Health Foundation of India (PHFI). The course was facilitated by faculty from the PHFI, The Union and The Operational Research Unit, Medecins sans Frontieres, Brussels Operational Centre, Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2007, LANCET, V370, P1453; [Anonymous], 2009, KEY BOTTL M XDR TB C; British Tuberculosis Association, 1950, TUBERCLE, V31, P121; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Central Tuberculosis Division (2010) Tuberculosis India, 2010, TUB IND 2010 ANN REP; Harlow T, 1999, AM J PUBLIC HEALTH, V89, P1581, DOI 10.2105/AJPH.89.10.1581; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2010, WHOHTMTB20103	8	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30281	10.1371/journal.pone.0030281	http://dx.doi.org/10.1371/journal.pone.0030281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272323	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400101
J	Pereira, R; Phillips, C; Pinto, N; Santos, C; dos Santos, SEB; Amorim, A; Carracedo, A; Gusmao, L				Pereira, Rui; Phillips, Christopher; Pinto, Nadia; Santos, Carla; Batista dos Santos, Sidney Emanuel; Amorim, Antonio; Carracedo, Angel; Gusmao, Leonor			Straightforward Inference of Ancestry and Admixture Proportions through Ancestry-Informative Insertion Deletion Multiplexing	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DETERMINING CONTINENTAL ORIGIN; MULTILOCUS GENOTYPE DATA; CELL-LINE PANEL; POPULATION-STRUCTURE; DNA MARKERS; COPY NUMBER; DIVERSITY; POLYMORPHISMS; AMERICANS	Ancestry-informative markers (AIMs) show high allele frequency divergence between different ancestral or geographically distant populations. These genetic markers are especially useful in inferring the likely ancestral origin of an individual or estimating the apportionment of ancestry components in admixed individuals or populations. The study of AIMs is of great interest in clinical genetics research, particularly to detect and correct for population substructure effects in case-control association studies, but also in population and forensic genetics studies. This work presents a set of 46 ancestry-informative insertion deletion polymorphisms selected to efficiently measure population admixture proportions of four different origins (African, European, East Asian and Native American). All markers are analyzed in short fragments (under 230 basepairs) through a single PCR followed by capillary electrophoresis (CE) allowing a very simple one tube PCR-to-CE approach. HGDP-CEPH diversity panel samples from the four groups, together with Oceanians, were genotyped to evaluate the efficiency of the assay in clustering populations from different continental origins and to establish reference databases. In addition, other populations from diverse geographic origins were tested using the HGDP-CEPH samples as reference data. The results revealed that the AIM-INDEL set developed is highly efficient at inferring the ancestry of individuals and provides good estimates of ancestry proportions at the population level. In conclusion, we have optimized the multiplexed genotyping of 46 AIM-INDELs in a simple and informative assay, enabling a more straightforward alternative to the commonly available AIM-SNP typing methods dependent on complex, multi-step protocols or implementation of large-scale genotyping technologies.	[Pereira, Rui; Pinto, Nadia; Amorim, Antonio; Gusmao, Leonor] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Pereira, Rui; Phillips, Christopher; Santos, Carla; Carracedo, Angel] Univ Santiago de Compostela, Inst Forens Sci Luis Concheiro, Santiago De Compostela, Spain; [Phillips, Christopher; Amorim, Antonio] Univ Porto, Fac Sci, P-4100 Oporto, Portugal; [Pinto, Nadia] Univ Porto, Math Res Ctr, P-4100 Oporto, Portugal; [Batista dos Santos, Sidney Emanuel] Fed Univ Para, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil; [Carracedo, Angel] Univ Santiago de Compostela, Genom Med Grp, CIBERER, Santiago De Compostela, Spain	Universidade do Porto; Universidade de Santiago de Compostela; Universidade do Porto; Universidade do Porto; Universidade Federal do Para; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela	Pereira, R (corresponding author), Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lgusmao@ipatimup.pt	Gusmao, Leonor/B-3122-2013; Gusmão, Leonor/L-8931-2019; Carracedo, Angel/D-4257-2012; Phillips, Christopher/E-4005-2012; Pereira, Rui/B-1656-2013; Santos, Carla/C-4472-2013; Amorim, Antonio/A-7938-2008; Pinto, Nadia/K-3202-2013	Gusmao, Leonor/0000-0003-0432-6481; Gusmão, Leonor/0000-0003-0432-6481; Carracedo, Angel/0000-0003-1085-8986; Phillips, Christopher/0000-0002-9601-0128; Pereira, Rui/0000-0002-3889-798X; Santos, Carla/0000-0002-4575-1807; Amorim, Antonio/0000-0002-7518-6247; Pinto, Nadia/0000-0002-1903-4206	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/30039/2006, SFRH/BD/37261/2007, SFRH/BD/75627/2010]; European Social Fund (Human Potential Thematic Operational Programme); project Xunta de Galicia [INCITER09 208 163]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund (Human Potential Thematic Operational Programme)(European Social Fund (ESF)); project Xunta de Galicia	This work was partially supported through PhD grants to RP (SFRH/BD/30039/2006), NP (SFRH/BD/37261/2007), and CS (SFRH/BD/75627/2010) awarded by the Portuguese Foundation for Science and Technology (FCT) and co-financed by the European Social Fund (Human Potential Thematic Operational Programme). This work was also partially supported by the project Xunta de Galicia INCITER09 208 163 PR (PI: Victoria Lareu). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Education and Science and is partially funded by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; [Anonymous], 2010, R LANG ENV STAT COMP; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Cann HM, 2002, SCIENCE, V296, P261; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Frudakis T, 2003, J FORENSIC SCI, V48, P771; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hirschhorn JN, 2011, ANNU REV MED, V62, P11, DOI 10.1146/annurev.med.091708.162036; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kayser M, 2011, NAT REV GENET, V12, P179, DOI 10.1038/nrg2952; Kersbergen P, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-69; Kidd Judith R, 2011, Investig Genet, V2, P1, DOI 10.1186/2041-2223-2-1; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lao O, 2006, AM J HUM GENET, V78, P680, DOI 10.1086/501531; Lao O, 2010, HUM MUTAT, V31, pE1875, DOI 10.1002/humu.21366; Londin ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013443; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; Pereira R, 2012, INT J LEGAL MED, V126, P97, DOI 10.1007/s00414-011-0593-2; Pereira R, 2009, ELECTROPHORESIS, V30, P3682, DOI 10.1002/elps.200900274; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P273, DOI 10.1016/j.fsigen.2007.06.008; Phillips C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006583; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Seldin MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040005; Shriver MD, 1997, AM J HUM GENET, V60, P957; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tandon A, 2011, GENET EPIDEMIOL, V35, P80, DOI 10.1002/gepi.20550; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Yang N, 2005, HUM GENET, V118, P382, DOI 10.1007/s00439-005-0012-1	53	167	173	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e29684	10.1371/journal.pone.0029684	http://dx.doi.org/10.1371/journal.pone.0029684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272242	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400021
J	Carpenter, EL; Haglund, EA; Mace, EM; Deng, D; Martinez, D; Wood, AC; Chow, AK; Weiser, DA; Belcastro, LT; Winter, C; Bresler, SC; Asgharzadeh, S; Seeger, RC; Zhao, H; Guo, R; Christensen, JG; Orange, JS; Pawel, BR; Lemmon, MA; Mosse, YP				Carpenter, E. L.; Haglund, E. A.; Mace, E. M.; Deng, D.; Martinez, D.; Wood, A. C.; Chow, A. K.; Weiser, D. A.; Belcastro, L. T.; Winter, C.; Bresler, S. C.; Asgharzadeh, S.; Seeger, R. C.; Zhao, H.; Guo, R.; Christensen, J. G.; Orange, J. S.; Pawel, B. R.; Lemmon, M. A.; Mosse, Y. P.			Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma	ONCOGENE			English	Article						neuroblastoma; anaplastic lymphoma kinase; immunotherapy; receptor tyrosine kinase	RECEPTOR TYROSINE KINASE; ALK KINASE; MONOCLONAL-ANTIBODIES; ACTIVATING MUTATIONS; LAPATINIB GW572016; LUNG-CANCER; PHASE-I; INHIBITOR; IDENTIFICATION; RESISTANCE	Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in neuroblastoma, a devastating pediatric cancer of the sympathetic nervous system. Germline and somatically acquired ALK aberrations induce increased autophosphorylation, constitutive ALK activation and increased downstream signaling. Thus, ALK is a tractable therapeutic target in neuroblastoma, likely to be susceptible to both small-molecule tyrosine kinase inhibitors and therapeutic antibodies-as has been shown for other receptor tyrosine kinases in malignancies such as breast and lung cancer. Small-molecule inhibitors of ALK are currently being studied in the clinic, but common ALK mutations in neuroblastoma appear to show de novo insensitivity, arguing that complementary therapeutic approaches must be developed. We therefore hypothesized that antibody targeting of ALK may be a relevant strategy for the majority of neuroblastoma patients likely to have ALK-positive tumors. We show here that an antagonistic ALK antibody inhibits cell growth and induces in vitro antibody-dependent cellular cytotoxicity of human neuroblastoma-derived cell lines. Cytotoxicity was induced in cell lines harboring either wild type or mutated forms of ALK. Treatment of neuroblastoma cells with the dual Met/ALK inhibitor crizotinib sensitized cells to antibody-induced growth inhibition by promoting cell surface accumulation of ALK and thus increasing the accessibility of antigen for antibody binding. These data support the concept of ALK-targeted immunotherapy as a highly promising therapeutic strategy for neuroblastomas with mutated or wild-type ALK.	[Mosse, Y. P.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med,Div Oncol, Ctr Childhood Canc Res,Dept Pediat, Philadelphia, PA 19104 USA; [Mace, E. M.; Lemmon, M. A.] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Bresler, S. C.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Asgharzadeh, S.; Seeger, R. C.] Univ So Calif, Childrens Hosp Angeles, Saban Res Inst, Div Hematol & Oncol, Los Angeles, CA USA; [Zhao, H.; Guo, R.] Childrens Hosp Philadelphia, Dept Pediat, Biostat & Data Management Core, Philadelphia, PA USA; [Christensen, J. G.] Pfizer Global Res & Dev, Dept Canc Biol, Jolla Labs, La Jolla, CA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Children's Hospital Los Angeles; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pfizer	Mosse, YP (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med,Div Oncol, Ctr Childhood Canc Res,Dept Pediat, Colket Translat Res Bldg,3501 Civic Ctr Blvd,Off, Philadelphia, PA 19104 USA.	mosse@chop.edu	Weiser, Daniel A./B-6160-2016	Weiser, Daniel A./0000-0001-6673-5323; Mace, Emily/0000-0003-0226-7393; orange, jordan/0000-0001-7117-7725; Belcastro, Lili/0000-0002-8666-2376; Lemmon, Mark/0000-0002-3379-5319	NIH [R01-CA140198, 2R01 CA60104-16, 2R01 CA60104-16S1]; Children's Oncology Group; Carly Hillman Fund; NIH Training Grant in Structural Biology [T32-GM008275]; St Baldrick's Foundation; US Army Peer-Reviewed Medical Research Program [W81XWH-10-1-0212/3]; NATIONAL CANCER INSTITUTE [T32CA009615, R01CA060104, R01CA140198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Oncology Group; Carly Hillman Fund; NIH Training Grant in Structural Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St Baldrick's Foundation; US Army Peer-Reviewed Medical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Pfizer for their gift of crizotinib, and Dr Marc Vigny for his gift of the ALK monoclonal antibodies 30, 49, 46 and 14. This work was supported in part by NIH Grants R01-CA140198 (YPM), 2R01 CA60104-16 (RCS), 2R01 CA60104-16S1 (RCS), the Children's Oncology Group, the Carly Hillman Fund (YPM), NIH Training Grant in Structural Biology T32-GM008275 (SCB), a fellowship grant from the St Baldrick's Foundation (ACW) and the US Army Peer-Reviewed Medical Research Program (W81XWH-10-1-0212/3 to MAL/YPM).	Baselga J, 2000, J CLIN ONCOL, V18, P904, DOI 10.1200/JCO.2000.18.4.904; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Bougherara H, 2009, MOL CANCER RES, V7, P1525, DOI 10.1158/1541-7786.MCR-09-0138; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; De Brouwer S, 2010, CLIN CANCER RES, V16, P4353, DOI 10.1158/1078-0432.CCR-09-2660; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Griffin CA, 1999, CANCER RES, V59, P2776; HANK JA, 1990, CANCER RES, V50, P5234; Haupt R, 2010, J CLIN ONCOL, V28, P2331, DOI 10.1200/JCO.2009.24.8351; Hobbie WL, 2008, PEDIATR BLOOD CANCER, V51, P679, DOI 10.1002/pbc.21683; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hughes B, 2010, NAT REV DRUG DISCOV, V9, P665, DOI 10.1038/nrd3270; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Johns TG, 2003, P NATL ACAD SCI USA, V100, P15871, DOI 10.1073/pnas.2036503100; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Kurai J, 2007, CLIN CANCER RES, V13, P1552, DOI 10.1158/1078-0432.CCR-06-1726; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matar P, 2004, CLIN CANCER RES, V10, P6487, DOI 10.1158/1078-0432.CCR-04-0870; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; Miyake I, 2002, ONCOGENE, V21, P5823, DOI 10.1038/sj.onc.1205735; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Osajima-Hakomori Y, 2005, AM J PATHOL, V167, P213, DOI 10.1016/S0002-9440(10)62966-5; Passoni L, 2009, CANCER RES, V69, P7338, DOI 10.1158/0008-5472.CAN-08-4419; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Robert F, 2001, J CLIN ONCOL, V19, P3234, DOI 10.1200/JCO.2001.19.13.3234; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tabone-Eglinger S, 2008, CLIN CANCER RES, V14, P2285, DOI 10.1158/1078-0432.CCR-07-4102; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Xia WL, 2005, ONCOGENE, V24, P6213, DOI 10.1038/sj.onc.1208774; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	49	34	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	46					4859	4867		10.1038/onc.2011.647	http://dx.doi.org/10.1038/onc.2011.647			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	038YT	22266870	Green Accepted			2022-12-25	WOS:000311210700006
J	Li, Y; Hwang, TH; Oseth, LA; Hauge, A; Vessella, RL; Schmechel, SC; Hirsch, B; Beckman, KB; Silverstein, KA; Dehm, SM				Li, Y.; Hwang, T. H.; Oseth, L. A.; Hauge, A.; Vessella, R. L.; Schmechel, S. C.; Hirsch, B.; Beckman, K. B.; Silverstein, K. A.; Dehm, S. M.			AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression	ONCOGENE			English	Article						prostate cancer; androgen receptor variants; castration-resistant; intragenic rearrangement, AR alternative splicing	CIRCULATING TUMOR-CELLS; GENE AMPLIFICATION; PROTEIN EXPRESSION; COPY NUMBER; MUTATIONS; THERAPY; RESISTANCE; GROWTH; AXIS	Reactivation of the androgen receptor (AR) during androgen depletion therapy (ADT) underlies castration-resistant prostate cancer (CRPCa). Alternative splicing of the AR gene and synthesis of constitutively active COOH-terminally truncated AR variants lacking the AR ligand-binding domain has emerged as an important mechanism of ADT resistance in CRPCa. In a previous study, we demonstrated that altered AR splicing in CRPCa 22Rv1 cells was linked to a 35-kb intragenic tandem duplication of AR exon 3 and flanking sequences. In this study, we demonstrate that complex patterns of AR gene copy number imbalances occur in PCa cell lines, xenografts and clinical specimens. To investigate whether these copy number imbalances reflect AR gene rearrangements that could be linked to splicing disruptions, we carried out a detailed analysis of AR gene structure in the LuCaP 86.2 and CWR-R1 models of CRPCa. By deletion-spanning PCR, we discovered a 8579-bp deletion of AR exons 5, 6 and 7 in the LuCaP 86.2 xenograft, which provides a rational explanation for synthesis of the truncated AR v567es AR variant in this model. Similarly, targeted resequencing of the AR gene in CWR-R1 cells led to the discovery of a 48-kb deletion in AR intron 1. This intragenic deletion marked a specific CWR-R1 cell population with enhanced expression of the truncated AR-V7/AR3 variant, a high level of androgen-independent AR transcriptional activity and rapid androgen independent growth. Together, these data demonstrate that structural alterations in the AR gene are linked to stable gain-of-function splicing alterations in CRPCa.	[Hwang, T. H.; Silverstein, K. A.] Univ Minnesota, Masonic Canc Ctr, Biostat & Bioinformat Core, Minneapolis, MN 55455 USA; [Hauge, A.; Beckman, K. B.] Univ Minnesota, Biomed Genom Ctr, Minneapolis, MN 55455 USA; [Vessella, R. L.] Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA; [Vessella, R. L.] Puget Sound VA Hlth Care Syst, Seattle, WA USA; [Schmechel, S. C.; Hirsch, B.; Dehm, S. M.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Hirsch, B.] Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; [Schmechel, S. C.] Univ Minnesota, BioNet, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Dehm, SM (corresponding author), Univ Minnesota, Masonic Canc Ctr, Biostat & Bioinformat Core, Mayo Mail Code 806,420 Delaware St SE, Minneapolis, MN 55455 USA.	dehm@umn.edu			comprehensive Masonic Cancer Center NIH [P30 CA077598]; Prostate Cancer Foundation; DOD [PC094384]; NCI [CA141011]; Institute of Human Genetics, University of Minnesota; NATIONAL CANCER INSTITUTE [P30CA077598, R21CA141011] Funding Source: NIH RePORTER	comprehensive Masonic Cancer Center NIH; Prostate Cancer Foundation; DOD(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute of Human Genetics, University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the Minnesota Supercomputing Institute and the Masonic Cancer Center Biostatistics and Bioinformatics Core for providing computing, bioinformatics, statistical, software and data storage support for this project. Cytogenetic analyses were performed in the Cytogenetics Shared Resource Laboratory at the University of Minnesota, with support from the comprehensive Masonic Cancer Center NIH Grant P30 CA077598. We thank Amanda Hemmingsen Jaeger for assistance with developing MLPA for AR gene structure analysis. SMD is a Masonic Scholar of the Masonic Cancer Center, University of Minnesota. This work was supported by a Young Investigator Award from the Prostate Cancer Foundation (SMD), DOD New Investigator Award PC094384 (SMD) NCI Grant CA141011 (SMD), and a seed grant from the Institute of Human Genetics, University of Minnesota.	Attard G, 2011, CLIN CANCER RES, V17, P1649, DOI 10.1158/1078-0432.CCR-10-0567; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; Dagvadorj A, 2008, CLIN CANCER RES, V14, P6062, DOI 10.1158/1078-0432.CCR-08-0979; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Ford OH, 2003, J UROLOGY, V170, P1817, DOI 10.1097/01.ju.0000091873.09677.f4; Gottlieb B, 2004, HUM MUTAT, V23, P527, DOI 10.1002/humu.20044; Gregory CW, 2001, CANCER RES, V61, P2892; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haapala K, 2001, LAB INVEST, V81, P1647, DOI 10.1038/labinvest.3780378; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Hyytinen ER, 2002, LAB INVEST, V82, P1591, DOI 10.1097/01.LAB.0000038924.67707.75; Leversha MA, 2009, CLIN CANCER RES, V15, P2091, DOI 10.1158/1078-0432.CCR-08-2036; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Linja MJ, 2001, CANCER RES, V61, P3550; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Locke JA, 2008, CANCER RES, V68, P6407, DOI 10.1158/0008-5472.CAN-07-5997; Mohler JL, 2011, CANCER RES, V71, P1486, DOI 10.1158/0008-5472.CAN-10-1343; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Taplin ME, 1999, CANCER RES, V59, P2511; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Thompson J, 2003, LAB INVEST, V83, P1709, DOI 10.1097/01.LAB.0000107262.40402.44; TILLEY WD, 1990, CANCER RES, V50, P5382; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107	42	140	144	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	45					4759	4767		10.1038/onc.2011.637	http://dx.doi.org/10.1038/onc.2011.637			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	036NF	22266865	Green Accepted			2022-12-25	WOS:000311033000004
J	Berdjane-Brouk, Z; Kone, AK; Djimde, AA; Charrel, RN; Ravel, C; Delaunay, P; del Giudice, P; Diarra, AZ; Doumbo, S; Goita, S; Thera, MA; Depaquit, J; Marty, P; Doumbo, OK; Izri, A				Berdjane-Brouk, Zohra; Kone, Abdoulaye K.; Djimde, Abdoulaye A.; Charrel, Remi N.; Ravel, Christophe; Delaunay, Pascal; del Giudice, Pascal; Diarra, Adama Z.; Doumbo, Siala; Goita, Siaka; Thera, Mahamadou A.; Depaquit, Jerome; Marty, Pierre; Doumbo, Ogobara K.; Izri, Arezki			First Detection of Leishmania major DNA in Sergentomyia (Spelaeomyia) darlingi from Cutaneous Leishmaniasis Foci in Mali	PLOS ONE			English	Article							DUBOSCQI NEVEU-LEMAIRE; INFECTION	Background: Leishmania major complex is the main causative agent of zoonotic cutaneous leishmaniasis (ZCL) in the Old World. Phlebotomus papatasi and Phlebotomus duboscqi are recognized vectors of L. major complex in Northern and Southern Sahara, respectively. In Mali, ZCL due to L. major is an emerging public health problem, with several cases reported from different parts of the country. The main objective of the present study was to identify the vectors of Leishmania major in the Bandiagara area, in Mali. Methodology/Principal Findings: An entomological survey was carried out in the ZCL foci of Bandiagara area. Sandflies were collected using CDC miniature light traps and sticky papers. In the field, live female Phlebotomine sandflies were identified and examined for the presence of promastigotes. The remaining sandflies were identified morphologically and tested for Leishmania by PCR in the ITS2 gene. The source of blood meal of the engorged females was determined using the cyt-b sequence. Out of the 3,259 collected sandflies, 1,324 were identified morphologically, and consisted of 20 species, of which four belonged to the genus Phlebotomus and 16 to the genus Sergentomyia. Leishmania major DNA was detected by PCR in 7 of the 446 females (1.6%), specifically 2 out of 115 Phlebotomus duboscqi specimens, and 5 from 198 Sergentomyia darlingi specimens. Human DNA was detected in one blood-fed female S. darlingi positive for L. major DNA. Conclusion: Our data suggest the possible involvement of P. duboscqi and potentially S. darlingi in the transmission of ZCL in Mali.	[Berdjane-Brouk, Zohra; Izri, Arezki] Univ Paris 13, Hop Avicenne, Paris, France; [Kone, Abdoulaye K.; Djimde, Abdoulaye A.; Diarra, Adama Z.; Doumbo, Siala; Goita, Siaka; Thera, Mahamadou A.; Doumbo, Ogobara K.] Univ Bamako, UMI CRNS Pole Mali, Malaria Res & Training Ctr, Dept Epidemiol Affect Parasitaires,Fac Med Pharm, Bamako, Mali; [Berdjane-Brouk, Zohra; Charrel, Remi N.; Izri, Arezki] Aix Marseille Univ, Unite Virus Emergents, UMR 190, IRD,EHESP, Marseille, France; [Ravel, Christophe] Univ Montpellier I, Ctr Natl Reference Leishmaniose, CHRU Montpellier, UMR5290, Montpellier, France; [Delaunay, Pascal; Marty, Pierre] Univ Nice Sophia Antipolis, CHU Nice, INSERM, U895, Nice, France; [del Giudice, Pascal] Hop Bonnet, Unite Malad Infect & Trop, F-83700 Frejus, Frejus, France; [Depaquit, Jerome] Univ Reims, JE USC ANSES Transmiss Vectorielle & Epidemiosurv, Reims, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; University of Bamako; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; CHU de Montpellier; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Reims Champagne-Ardenne	Berdjane-Brouk, Z (corresponding author), Univ Paris 13, Hop Avicenne, Paris, France.	arezki.izri@avc.aphp.fr	Ravel, Christophe/A-7369-2008; Depaquit, Jérôme/AAT-7586-2021	Depaquit, Jérôme/0000-0001-6995-0088; ravel, christophe/0000-0002-7590-582X; Thera, Mahamadou A/0000-0002-2679-035X; Charrel, Remi/0000-0002-7675-8251	Foundation MERIEUX	Foundation MERIEUX	The funding that supported this study was from the Foundation MERIEUX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABONNENC E., 1972, Mem. O. R. S. T. O. M.; Anderson JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001139; Ben-Ismail R, 1987, T R SOC TROP MED HYG, V5, P186; DEDET JP, 1982, B SOC PATHOL EXOT, V75, P588; Develoux M, 1996, T ROY SOC TROP MED H, V90, P396, DOI 10.1016/S0035-9203(96)90520-9; GARIN JP, 1985, ANN PARASIT HUM COMP, V60, P93, DOI 10.1051/parasite/198560193; Gebre-Michael T, 1993, T R SOC TROP MED HYG, V1, P118; Hanafi HA, 1996, AM J TROP MED HYG, V54, P644, DOI 10.4269/ajtmh.1996.54.644; Izri A, 1992, PARASITOL HUM COMP, V1, P31; IZRI MA, 1989, ANN PARASIT HUM COMP, V64, P510, DOI 10.1051/parasite/1989646510; IZRI MA, 1993, T ROY SOC TROP MED H, V87, P399, DOI 10.1016/0035-9203(93)90011-E; Kasiri H, 2000, B SOC PATHOL EXOT, V93, P129; Keita SFO, 2003, MALI MED, VXVIII, P3; Kervran P, 1946, ANN PARASITOL, V21, P153; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; LAWYER PG, 1990, AM J TROP MED HYG, V43, P31, DOI 10.4269/ajtmh.1990.43.31; LEGER N, 1983, ANN PARASIT HUM COMP, V58, P611, DOI 10.1051/parasite/1983586611; Mukherjee S, 1997, AM J TROP MED HYG, V57, P423, DOI 10.4269/ajtmh.1997.57.423; MUTINGA MJ, 1994, E AFR MED J, V71, P424; Niang AA, 2004, SANDFLIES AFRO TROPI; PARROT L., 1926, BULL SOC PATH EXOT, V19, P694; Parvizi P, 2008, IRAN J VET RES, V9, P9; Pratlong F, 2009, TROP MED INT HEALTH, V14, P1071, DOI 10.1111/j.1365-3156.2009.02336.x; Ranque P., 1975, Acta Tropica, V32, P348; Senghor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014773; Sergent E, 1921, CR HEBD ACAD SCI, V173, P1030; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; World Health Organization, 2008, GLOB BURD DIS 2004 U	29	53	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28266	10.1371/journal.pone.0028266	http://dx.doi.org/10.1371/journal.pone.0028266			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276095	Green Published, gold			2022-12-25	WOS:000301568100002
J	Mizuno, S; Yasuo, M; Bogaard, HJ; Kraskauskas, D; Alhussaini, A; Gomez-Arroyo, J; Farkas, D; Farkas, L; Voelkel, NF				Mizuno, Shiro; Yasuo, Masanori; Bogaard, Harm J.; Kraskauskas, Donatas; Alhussaini, Aysar; Gomez-Arroyo, Jose; Farkas, Daniela; Farkas, Laszlo; Voelkel, Norbert F.			Copper Deficiency Induced Emphysema Is Associated with Focal Adhesion Kinase Inactivation	PLOS ONE			English	Article							LYSYL OXIDASE; LUNG; SURVIVAL; ACTIVATION; EXPRESSION; APOPTOSIS; MIGRATION; MENKES; RAT	Background: Copper is an important regulator of hypoxia inducible factor 1 alpha (HIF-1 alpha) dependent vascular endothelial growth factor (VEGF) expression, and is also required for the activity of lysyl oxidase (LOX) to effect matrix protein cross-linking. Cell detachment from the extracellular matrix can induce apoptosis (anoikis) via inactivation of focal adhesion kinase (FAK). Methodology: To examine the molecular mechanisms whereby copper depletion causes the destruction of the normal alveolar architecture via anoikis, Male Sprague-Dawley rats were fed a copper deficient diet for 6 weeks while being treated with the copper chelator, tetrathiomolybdate. Other groups of rats were treated with the inhibitor of auto-phosphorylation of FAK, 1,2,4,5-benzenetetraamine tetrahydrochloride (1,2,4,5-BT) or FAK small interfering RNA (siRNA). Principal Findings: Copper depletion caused emphysematous changes, decreased HIF-1 alpha activity, and downregulated VEGF expression in the rat lungs. Cleaved caspase-3, caspase-8 and Bcl-2 interacting mediator of cell death (Bim) expression was increased, and the phosphorylation of FAK was decreased in copper depleted rat lungs. Administration of 1,2,4,5-BT and FAK siRNA caused emphysematous lung destruction associated with increased expression of cleaved capase-3, caspase-8 and Bim. Conclusions: These data indicate that copper-dependent mechanisms contribute to the pathogenesis of emphysema, which may be associated with decreased HIF-1 alpha and FAK activity in the lung.	[Mizuno, Shiro; Yasuo, Masanori; Kraskauskas, Donatas; Alhussaini, Aysar; Gomez-Arroyo, Jose; Farkas, Daniela; Farkas, Laszlo; Voelkel, Norbert F.] Virginia Commonwealth Univ, Div Pulm & Crit Care Med, Richmond, VA 23284 USA; [Mizuno, Shiro; Yasuo, Masanori; Kraskauskas, Donatas; Alhussaini, Aysar; Gomez-Arroyo, Jose; Farkas, Daniela; Farkas, Laszlo; Voelkel, Norbert F.] Virginia Commonwealth Univ, Victoria Johnson Ctr Obstruct Lung Dis, Richmond, VA USA; [Mizuno, Shiro] Kanazawa Med Univ, Div Resp Dis, Kanazawa, Ishikawa, Japan; [Bogaard, Harm J.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Virginia Commonwealth University; Virginia Commonwealth University; Kanazawa Medical University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Mizuno, S (corresponding author), Virginia Commonwealth Univ, Div Pulm & Crit Care Med, Richmond, VA 23284 USA.	nvoelkel@mcvh-vcu.edu		Bogaard, Harm Jan/0000-0001-5371-0346	Victoria Johnson Center for Lung Research of the Virginia Commonwealth University	Victoria Johnson Center for Lung Research of the Virginia Commonwealth University	This work was supported by the funds from the Victoria Johnson Center for Lung Research of the Virginia Commonwealth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Bouchard V, 2008, APOPTOSIS, V13, P531, DOI 10.1007/s10495-008-0192-y; Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516; GACHERU S, 1993, ARCH BIOCHEM BIOPHYS, V301, P325, DOI 10.1006/abbi.1993.1151; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Grange DK, 2005, AM J MED GENET A, V139A, P151, DOI 10.1002/ajmg.a.31001; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hakim ZS, 2009, J MOL CELL CARDIOL, V46, P241, DOI 10.1016/j.yjmcc.2008.10.017; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Keledjian K, 2005, J CELL BIOCHEM, V94, P374, DOI 10.1002/jcb.20240; KIDA K, 1980, AM J PATHOL, V101, P693; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; Laser M, 2000, J BIOL CHEM, V275, P35624, DOI 10.1074/jbc.M006124200; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Noda T, 2009, APOPTOSIS, V14, P287, DOI 10.1007/s10495-009-0319-9; ODELL BL, 1978, AM J PATHOL, V91, P413; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; RANGA V, 1983, EXP LUNG RES, V4, P269, DOI 10.3109/01902148309055014; Rubio ML, 1998, AM J RESP CRIT CARE, V157, P237, DOI 10.1164/ajrccm.157.1.9704038; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Shinawi M, 2005, PEDIATR PULM, V39, P374, DOI 10.1002/ppul.20174; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; SOSKEL N T, 1984, Chest, V85, p70S, DOI 10.1378/chest.85.6.70S; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P673, DOI 10.1513/pats.200605-124SF; Yasuo M, 2011, EUR RESPIR J, V37, P775, DOI 10.1183/09031936.00022910; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	32	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30678	10.1371/journal.pone.0030678	http://dx.doi.org/10.1371/journal.pone.0030678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276220	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100060
J	Srihirun, S; Sriwantana, T; Unchern, S; Kittikool, D; Noulsri, E; Pattanapanyasat, K; Fucharoen, S; Piknova, B; Schechter, AN; Sibmooh, N				Srihirun, Sirada; Sriwantana, Thanaporn; Unchern, Supeenun; Kittikool, Dusadee; Noulsri, Egarit; Pattanapanyasat, Kovit; Fucharoen, Suthat; Piknova, Barbora; Schechter, Alan N.; Sibmooh, Nathawut			Platelet Inhibition by Nitrite Is Dependent on Erythrocytes and Deoxygenation	PLOS ONE			English	Article							RED-BLOOD-CELLS; OXIDE SYNTHASE; CYTOPLASMIC DOMAIN; SMOOTH-MUSCLE; IN-VIVO; HEMOGLOBIN; NO; AGGREGATION; REDUCTION; DEOXYHEMOGLOBIN	Background: Nitrite is a nitric oxide (NO) metabolite in tissues and blood, which can be converted to NO under hypoxia to facilitate tissue perfusion. Although nitrite is known to cause vasodilation following its reduction to NO, the effect of nitrite on platelet activity remains unclear. In this study, the effect of nitrite and nitrite+erythrocytes, with and without deoxygenation, on platelet activity was investigated. Methodology/Finding: Platelet aggregation was studied in platelet-rich plasma (PRP) and PRP+erythrocytes by turbidimetric and impedance aggregometry, respectively. In PRP, DEANONOate inhibited platelet aggregation induced by ADP while nitrite had no effect on platelets. In PRP+erythrocytes, the inhibitory effect of DEANONOate on platelets decreased whereas nitrite at physiologic concentration (0.1 mu M) inhibited platelet aggregation and ATP release. The effect of nitrite+erythrocytes on platelets was abrogated by C-PTIO (a membrane-impermeable NO scavenger), suggesting an NO-mediated action. Furthermore, deoxygenation enhanced the effect of nitrite as observed from a decrease of P-selectin expression and increase of the cGMP levels in platelets. The ADP-induced platelet aggregation in whole blood showed inverse correlations with the nitrite levels in whole blood and erythrocytes. Conclusion: Nitrite alone at physiological levels has no effect on platelets in plasma. Nitrite in the presence of erythrocytes inhibits platelets through its reduction to NO, which is promoted by deoxygenation. Nitrite may have role in modulating platelet activity in the circulation, especially during hypoxia.	[Srihirun, Sirada; Sriwantana, Thanaporn; Unchern, Supeenun; Kittikool, Dusadee; Sibmooh, Nathawut] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Noulsri, Egarit; Pattanapanyasat, Kovit] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev, Bangkok 10700, Thailand; [Fucharoen, Suthat] Mahidol Univ, Thalassemia Res Ctr, Inst Sci & Technol Res & Dev, Nakhon Pathom, Thailand; [Piknova, Barbora; Schechter, Alan N.] NIDDK, Mol Med Branch, NIH, Bethesda, MD USA	Mahidol University; Mahidol University; Mahidol University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Srihirun, S (corresponding author), Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand.	scnsm@mahidol.ac.th	Noulsri, Egarit/AAW-9013-2021	Noulsri, Egarit/0000-0002-8557-8631; Srihirun, Sirada/0000-0003-1616-9487; Schechter, Alan N/0000-0002-5235-9408	Institute for the Promotion of Teaching of Science and Technology; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund; National Institute of Diabetes, and Digestive, and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025093, ZIADK025104] Funding Source: NIH RePORTER	Institute for the Promotion of Teaching of Science and Technology; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund(Thailand Research Fund (TRF)); National Institute of Diabetes, and Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the Institute for the Promotion of Teaching of Science and Technology, the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, the Thailand Research Fund - Senior Research Scholar, and the intramural program of the National Institute of Diabetes, and Digestive, and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsheye I, 2010, J CELL PHYSIOL, V224, P620, DOI 10.1002/jcp.22195; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Garthwaite J, 2010, MOL CELL BIOCHEM, V334, P221, DOI 10.1007/s11010-009-0318-8; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Goldstein S, 2003, J BIOL CHEM, V278, P50949, DOI 10.1074/jbc.M308317200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Jeffers A, 2005, COMP BIOCHEM PHYS A, V142, P130, DOI 10.1016/j.cbpb.2005.04.016; Jensen FB, 2010, AM J PHYSIOL-REG I, V298, pR972, DOI 10.1152/ajpregu.00813.2009; Keszler A, 2008, J BIOL CHEM, V283, P9615, DOI 10.1074/jbc.M705630200; Kleinbongard P, 2003, FREE RADICAL BIO MED, V35, P790, DOI 10.1016/S0891-5849(03)00406-4; LAUSTIOLA KE, 1991, PHARMACOL TOXICOL, V68, P60, DOI 10.1111/j.1600-0773.1991.tb01209.x; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; Megson IL, 2000, BRIT J PHARMACOL, V131, P1391, DOI 10.1038/sj.bjp.0703731; RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Salhany JM, 2008, BIOCHEMISTRY-US, V47, P6059, DOI 10.1021/bi8000819; Samouilov A, 2007, NITRIC OXIDE-BIOL CH, V16, P362, DOI 10.1016/j.niox.2006.12.006; Sibmooh N, 2008, BIOCHEMISTRY-US, V47, P2989, DOI 10.1021/bi702158d; Tymvios C, 2009, BRIT J PHARMACOL, V158, P1735, DOI 10.1111/j.1476-5381.2009.00408.x; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; Vitturi DA, 2009, AM J PHYSIOL-HEART C, V296, pH1398, DOI 10.1152/ajpheart.01303.2008; WALDER JA, 1984, J BIOL CHEM, V259, P238; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Yoshida S, 2008, BLOOD, V111, P2007, DOI 10.1182/blood-2007-06-097824	34	92	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30380	10.1371/journal.pone.0030380	http://dx.doi.org/10.1371/journal.pone.0030380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276188	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100041
J	Xu, P; Johnson, TL; Stoller-Conrad, JR; Schulz, RA				Xu, Peng; Johnson, Tamara L.; Stoller-Conrad, Jessica R.; Schulz, Robert A.			Spire, an Actin Nucleation Factor, Regulates Cell Division during Drosophila Heart Development	PLOS ONE			English	Article							CYCLIN-A; EARLY CARDIOGENESIS; DORSAL MESODERM; BOX GENES; MELANOGASTER; EXPRESSION; CAPPUCCINO; PANNIER; MICROTUBULE; REQUIREMENT	The Drosophila dorsal vessel is a beneficial model system for studying the regulation of early heart development. Spire (Spir), an actin-nucleation factor, regulates actin dynamics in many developmental processes, such as cell shape determination, intracellular transport, and locomotion. Through protein expression pattern analysis, we demonstrate that the absence of spir function affects cell division in Myocyte enhancer factor 2-, Tinman (Tin)-, Even-skipped-and Seven up (Svp)-positive heart cells. In addition, genetic interaction analysis shows that spir functionally interacts with Dorsocross, tin, and pannier to properly specify the cardiac fate. Furthermore, through visualization of double heterozygous embryos, we determines that spir cooperates with CycA for heart cell specification and division. Finally, when comparing the spir mutant phenotype with that of a CycA mutant, the results suggest that most Svp-positive progenitors in spir mutant embryos cannot undergo full cell division at cell cycle 15, and that Tin-positive progenitors are arrested at cell cycle 16 as double-nucleated cells. We conclude that Spir plays a crucial role in controlling dorsal vessel formation and has a function in cell division during heart tube morphogenesis.	[Xu, Peng; Johnson, Tamara L.; Stoller-Conrad, Jessica R.; Schulz, Robert A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Xu, P (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	px3x@virginia.edu			National Institutes of Health [HL059151]; American Heart Association [10POST2630076]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant to R.A.S. from the National Institutes of Health (HL059151) and a Postdoctoral Fellow Award to P.X. from the American Heart Association (10POST2630076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AD, 2003, DEVELOPMENT, V130, P3015, DOI 10.1242/dev.00488; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; CAMPOSORTEGA JA, 1997, EMBRYONIC DEV DROSOP, P287; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; Gajewski K, 1999, DEVELOPMENT, V126, P5679; Han Z, 2006, DEVELOPMENT, V133, P1175, DOI 10.1242/dev.02285; Han Z, 2003, DEVELOPMENT, V130, P3039, DOI 10.1242/dev.00484; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; Kerkhoff E, 2006, TRENDS CELL BIOL, V16, P477, DOI 10.1016/j.tcb.2006.07.005; Klinedinst SL, 2003, DEVELOPMENT, V130, P3027, DOI 10.1242/dev.00517; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; Liu R, 2009, DEVELOPMENT, V136, P2849, DOI 10.1242/dev.035246; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Mann T, 2009, DEVELOPMENT, V136, P317, DOI 10.1242/dev.022533; Medioni C, 2009, CURR OPIN GENET DEV, V19, P518, DOI 10.1016/j.gde.2009.07.004; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Reim I, 2005, DEVELOPMENT, V132, P4911, DOI 10.1242/dev.02077; Reim I, 2003, DEVELOPMENT, V130, P3187, DOI 10.1242/dev.00548; Reim I, 2010, PEDIATR CARDIOL, V31, P325, DOI 10.1007/s00246-009-9612-1; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Schumacher N, 2004, GENE EXPR PATTERNS, V4, P249, DOI 10.1016/j.modgep.2003.11.006; Tao Y, 2007, GENESIS, V45, P607, DOI 10.1002/dvg.20333; Tao Y, 2007, MOL CELL BIOL, V27, P3962, DOI 10.1128/MCB.00093-07; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; Wang JB, 2005, MOL CELL BIOL, V25, P4200, DOI 10.1128/MCB.25.10.4200-4210.2005; Ward EJ, 2000, DEVELOPMENT, V127, P4959; Wellington A, 1999, DEVELOPMENT, V126, P5267; Yin ZZ, 1998, DEV GENET, V22, P187	35	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30565	10.1371/journal.pone.0030565	http://dx.doi.org/10.1371/journal.pone.0030565			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276214	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100056
J	Eaton, HE; Metcalf, J; Lacerda, AF; Brunetti, CR				Eaton, Heather E.; Metcalf, Julie; Lacerda, Andressa Ferreira; Brunetti, Craig R.			Accumulation of Endogenous LITAF in Aggresomes	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; PROTEIN-DEGRADATION; INCLUSION-BODIES; HEREDITARY MOTOR; NEUROPATHY; GENE; MUTATIONS; DOMINANT; MAPS; IMPAIRMENT	LITAF is a 161 amino acid cellular protein which includes a proline rich N-terminus and a conserved C-terminal domain known as the simple-like domain. Mutations in LITAF have been identified in Charcot-Marie tooth disease, a disease characterized by protein aggregates. Cells transfected with cellular LITAF reveal that LITAF is localized to late endosomes/ lysosomes. Here we investigated the intracellular localization of endogenous LITAF. We demonstrated that endogenous LITAF accumulates at a discrete cytoplasmic site in BGMK cells that we identify as the aggresome. To determine the domain within LITAF that is responsible for the localization of LITAF to aggresomes, we created a construct that contained the Cterminal simple-like domain of LITAF and found that this construct also localizes to aggresomes. These data suggest the simple-like domain is responsible for targeting endogenous LITAF to the aggresome.	[Eaton, Heather E.; Metcalf, Julie; Lacerda, Andressa Ferreira; Brunetti, Craig R.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada	Trent University	Eaton, HE (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	craigbrunetti@trentu.ca			Natural Sciences and Engineering Research Council (NSERC) [288123-2009]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded through a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant to CRB (grant# 288123-2009). HEE is the recipient of a NSERC postgraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann B, 2007, BIOMED TECH, V52, P200, DOI 10.1515/BMT.2007.037; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; CHANCE PF, 1990, AM J HUM GENET, V47, P915; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P619, DOI 10.1001/archneur.1968.00470360041003; Eaton HE, SIMPLE LITAF E UNPUB; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fortun J, 2003, J NEUROSCI, V23, P10672; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Klein CJ, 2003, NEUROLOGY, V60, P1151, DOI 10.1212/01.WNL.0000055900.30217.EA; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Liu N, 2004, NEUROBIOL DIS, V17, P300, DOI 10.1016/j.nbd.2004.07.010; Lopez-Bigas N, 2001, HUM MOL GENET, V10, P947, DOI 10.1093/hmg/10.9.947; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Moriwaki Y, 2001, J BIOL CHEM, V276, P23065, DOI 10.1074/jbc.M011660200; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Nelis E, 2004, J MED GENET, V41, P193, DOI 10.1136/jmg.2003.012633; Notterpek L, 1999, NEUROBIOL DIS, V6, P450, DOI 10.1006/nbdi.1999.0274; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Ryan MC, 2002, NEUROBIOL DIS, V10, P109, DOI 10.1006/nbdi.2002.0500; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Senderek J, 2003, AM J HUM GENET, V73, P1106, DOI 10.1086/379525; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Simmen T, 1999, J CELL SCI, V112, P45; Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22; Tang BS, 2004, HUM GENET, V114, P527, DOI 10.1007/s00439-004-1102-1; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30003	10.1371/journal.pone.0030003	http://dx.doi.org/10.1371/journal.pone.0030003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276139	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200027
J	Lonchamp, E; Gambino, F; Dupont, JL; Doussau, F; Valera, A; Poulain, B; Bossu, JL				Lonchamp, Etienne; Gambino, Frederic; Dupont, Jean Luc; Doussau, Frederic; Valera, Antoine; Poulain, Bernard; Bossu, Jean-Louis			Pre and Post Synaptic NMDA Effects Targeting Purkinje Cells in the Mouse Cerebellar Cortex	PLOS ONE			English	Article							METHYL-D-ASPARTATE; LONG-TERM DEPRESSION; PARALLEL FIBER; GABA RELEASE; RECEPTOR CHANNELS; RAT CEREBELLUM; AMPA RECEPTORS; STELLATE CELLS; NR2D SUBUNITS; GRANULE CELLS	N-methyl-D-aspartate (NMDA) receptors are associated with many forms of synaptic plasticity. Their expression level and subunit composition undergo developmental changes in several brain regions. In the mouse cerebellum, beside a developmental switch between NR2B and NR2A/C subunits in granule cells, functional postsynaptic NMDA receptors are seen in Purkinje cells of neonate and adult but not juvenile rat and mice. A presynaptic effect of NMDA on GABA release by cerebellar interneurons was identified recently. Nevertheless whereas NMDA receptor subunits are detected on parallel fiber terminals, a presynaptic effect of NMDA on spontaneous release of glutamate has not been demonstrated. Using mouse cerebellar cultures and patch-clamp recordings we show that NMDA facilitates glutamate release onto Purkinje cells in young cultures via a presynaptic mechanism, whereas NMDA activates extrasynaptic receptors in Purkinje cells recorded in old cultures. The presynaptic effect of NMDA on glutamate release is also observed in Purkinje cells recorded in acute slices prepared from juvenile but not from adult mice and requires a specific protocol of NMDA application.	[Lonchamp, Etienne; Gambino, Frederic; Dupont, Jean Luc; Doussau, Frederic; Valera, Antoine; Poulain, Bernard; Bossu, Jean-Louis] Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lonchamp, E (corresponding author), Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, Strasbourg, France.	jlbossu@neurochem.u-strasbg.fr	Valera, Antoine/AAL-3519-2021; Valera, Antoine/G-9807-2014	Valera, Antoine/0000-0002-0230-9752; gambino, frederic/0000-0002-2981-5030; Doussau, Frederic/0000-0002-3769-1402	Mission pour la Recherche et l'Innovation Scientifique-Delegation Generale a l'Armement (M.R.I.S/D.G.A.-Gilles Vergnaud)	Mission pour la Recherche et l'Innovation Scientifique-Delegation Generale a l'Armement (M.R.I.S/D.G.A.-Gilles Vergnaud)	EL received a doctoral grant from the Mission pour la Recherche et l'Innovation Scientifique-Delegation Generale a l'Armement (M.R.I.S/D.G.A.-Gilles Vergnaud). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bidoret C, 2009, P NATL ACAD SCI USA, V106, P14126, DOI 10.1073/pnas.0904284106; Billups D, 2002, J NEUROPHYSIOL, V87, P1948, DOI 10.1152/jn.00599.2001; Brickley SG, 2003, J NEUROSCI, V23, P4958; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; Casado M, 2000, P NATL ACAD SCI USA, V97, P11593, DOI 10.1073/pnas.200354297; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Cathala L, 2000, J NEUROSCI, V20, P5899, DOI 10.1523/JNEUROSCI.20-16-05899.2000; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Duguid I, 2006, CURR OPIN NEUROBIOL, V16, P312, DOI 10.1016/j.conb.2006.05.008; Dupont JL, 2006, CEREBELLUM, V5, P243, DOI 10.1080/14734220600905317; DUPONT JL, 1987, DEV BRAIN RES, V34, P59, DOI 10.1016/0165-3806(87)90195-7; Fiszman ML, 2005, J NEUROSCI, V25, P2024, DOI 10.1523/JNEUROSCI.4980-04.2005; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Glitsch M, 1999, J NEUROSCI, V19, P511; Glitsch MD, 2008, NEUROSCIENCE, V151, P403, DOI 10.1016/j.neuroscience.2007.10.024; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; Iijima K, 2008, P NATL ACAD SCI USA, V105, P12010, DOI 10.1073/pnas.0805574105; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; KRUPA M, 1990, EUR J NEUROSCI, V2, P312, DOI 10.1111/j.1460-9568.1990.tb00423.x; Lachamp P, 2005, J PHYSIOL-LONDON, V564, P751, DOI 10.1113/jphysiol.2005.084517; Liu SQJ, 2007, J NEUROPHYSIOL, V98, P550, DOI 10.1152/jn.00352.2007; MACDONALD JF, 1990, TRENDS PHARMACOL SCI, V11, P167, DOI 10.1016/0165-6147(90)90070-O; Misra C, 2000, J PHYSIOL-LONDON, V524, P147, DOI 10.1111/j.1469-7793.2000.00147.x; Misra C, 2000, J PHYSIOL-LONDON, V525, P299, DOI 10.1111/j.1469-7793.2000.t01-1-00299.x; Momiyama A, 1996, J PHYSIOL-LONDON, V494, P479, DOI 10.1113/jphysiol.1996.sp021507; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Piochon C, 2007, J NEUROSCI, V27, P10797, DOI 10.1523/JNEUROSCI.2422-07.2007; Piochon Claire, 2010, J Neurosci, V30, P15330, DOI 10.1523/JNEUROSCI.4344-10.2010; Qiu DL, 2007, J NEUROSCI, V27, P3408, DOI 10.1523/JNEUROSCI.4831-06.2007; Qiu DL, 2009, PFLUG ARCH EUR J PHY, V457, P865, DOI 10.1007/s00424-008-0555-9; Renzi M, 2007, J PHYSIOL-LONDON, V585, P91, DOI 10.1113/jphysiol.2007.141531; Thompson CL, 2000, NEUROSCI LETT, V283, P85, DOI 10.1016/S0304-3940(00)00930-7; Wee KSL, 2008, J COMP NEUROL, V509, P118, DOI 10.1002/cne.21747; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yuzaki M, 1996, J NEUROSCI, V16, P4651	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30180	10.1371/journal.pone.0030180	http://dx.doi.org/10.1371/journal.pone.0030180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276158	Green Submitted, Green Published, gold			2022-12-25	WOS:000301457200042
J	Vatish, M; Tesfa, L; Grammatopoulos, D; Yamada, E; Bastie, CC; Pessin, JE				Vatish, Manu; Tesfa, Lydia; Grammatopoulos, Dimitris; Yamada, Eijiro; Bastie, Claire C.; Pessin, Jeffrey E.			Inhibition of Akt Activity and Calcium Channel Function Coordinately Drive Cell-Cell Fusion in the BeWO Choriocarcinoma Placental Cell Line	PLOS ONE			English	Article							IN-VITRO; TROPHOBLAST FUSION; SYNCYTIAL FUSION; DIFFERENTIATION; MANIPULATION; EXPRESSION; ADAMS; ASSAY; CD98	To establish a simple and quantitative live cell fusion assay for placental syncytialization, we generated stable GFP and dsRed expressing fusogenic BeWo cell lines. Fluorescent Activated Cell Sorting was shown to provide a quantitative determination of forskolin (cAMP-mediated) fusion in a time and concentration dependent manner consistent with the increased secretion of beta human chorionic gonadotrophin (beta-HCG) and appearance of multi-nucleated cells. Analyses of the fusion process demonstrated that in addition to increased cAMP levels, simultaneous reduction of intracellular calcium and inhibition of Type 1 phosphatidylinositol 3 kinase (PI3K)/Akt signaling also resulted in cell fusion. Although individual blockade of calcium channel function or PI3K/Akt signaling was without effect, the combination with forskolin resulted in a potentiation of cell fusion. These data demonstrate syncytialization is a complex process that depends upon the regulation of distinct signaling inputs that function in concert with each other.	[Vatish, Manu; Grammatopoulos, Dimitris] Univ Warwick, Div Reprod, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Tesfa, Lydia; Yamada, Eijiro; Bastie, Claire C.; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10467 USA	University of Warwick; Yeshiva University; Albert Einstein College of Medicine	Vatish, M (corresponding author), Univ Warwick, Div Reprod, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	jeffrey.pessin@einstein.yu.edu	vatish, manu/AAY-8750-2020; Vatish, Manu/B-4458-2018	vatish, manu/0000-0002-6012-2574; Bastie, Claire/0000-0001-8178-4748; grammatopoulos, dimitris/0000-0002-6296-8290	National Institutes of Health [DK082694, DK020541, DK081412]; Fulbright Commission; Winston Churchill Memorial Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081412, R01DK082694, P30DK020541, P60DK020541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Commission; Winston Churchill Memorial Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK082694, DK020541 and DK081412), The Fulbright Commission and The Winston Churchill Memorial Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaudeau S, 2006, J CELL PHYSIOL, V208, P435, DOI 10.1002/jcp.20679; Borges M, 2003, PLACENTA, V24, P959, DOI 10.1016/S0143-4004(03)00173-5; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Crocker IP, 2007, PLACENTA, V28, P408, DOI 10.1016/j.placenta.2006.05.009; Desforges M, 2010, INT J DEV BIOL, V54, P377, DOI 10.1387/ijdb.082765md; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Fujita D, 2010, J ENDOCRINOL, V206, P131, DOI 10.1677/JOE-10-0027; Hirsch E, 2007, J ENDOCRINOL, V194, P243, DOI 10.1677/JOE-07-0097; Huppertz B, 1998, HISTOCHEM CELL BIOL, V110, P495, DOI 10.1007/s004180050311; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Huppertz Berthold, 2008, V475, P135, DOI 10.1007/978-1-59745-250-2_8; Ito N, 2004, BIOCHEM BIOPH RES CO, V314, P1008, DOI 10.1016/j.bbrc.2003.12.183; KELLER PM, 1977, J CELL SCI, V28, P167; KIRBY MS, 1992, J BIOL CHEM, V267, P12545; Knofler M, 2001, PLACENTA, V22, pS83, DOI 10.1053/plac.2001.0648; Kudo Y, 2003, J PHYSIOL-LONDON, V550, P3, DOI 10.1113/jphysiol.2003.040550; Kudo Y, 2003, BBA-MOL CELL RES, V1640, P25, DOI 10.1016/S0167-4889(03)00004-1; LYDEN TW, 1993, PLACENTA, V14, P177, DOI 10.1016/S0143-4004(05)80259-0; Malassine A, 2002, ENDOCRINE, V19, P3, DOI 10.1385/ENDO:19:1:3; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Mori K, 2004, MED MICROBIOL IMMUN, V193, P155, DOI 10.1007/s00430-003-0191-0; Ramos AJ, 2008, PLACENTA, V29, P492, DOI 10.1016/j.placenta.2008.02.013; Stadler B, 2010, J MICROSC-OXFORD, V237, P63, DOI 10.1111/j.1365-2818.2009.03302.x; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	25	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29353	10.1371/journal.pone.0029353	http://dx.doi.org/10.1371/journal.pone.0029353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276109	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200010
J	Gschwend, O; Beroud, J; Carleton, A				Gschwend, Olivier; Beroud, Jonathan; Carleton, Alan			Encoding Odorant Identity by Spiking Packets of Rate-Invariant Neurons in Awake Mice	PLOS ONE			English	Article							MAMMALIAN OLFACTORY-BULB; GABAERGIC INTERNEURONS; GAMMA-OSCILLATIONS; REPRESENTATIONS; STIMULUS; SPARSE; CORTEX; DISCRIMINATION; INFORMATION; CELLS	Background: How do neural networks encode sensory information? Following sensory stimulation, neural coding is commonly assumed to be based on neurons changing their firing rate. In contrast, both theoretical works and experiments in several sensory systems showed that neurons could encode information as coordinated cell assemblies by adjusting their spike timing and without changing their firing rate. Nevertheless, in the olfactory system, there is little experimental evidence supporting such model. Methodology/Principal Findings: To study these issues, we implanted tetrodes in the olfactory bulb of awake mice to record the odorant-evoked activity of mitral/tufted (M/T) cells. We showed that following odorant presentation, most M/T neurons do not significantly change their firing rate over a breathing cycle but rather respond to odorant stimulation by redistributing their firing activity within respiratory cycles. In addition, we showed that sensory information can be encoded by cell assemblies composed of such neurons, thus supporting the idea that coordinated populations of globally rate-invariant neurons could be efficiently used to convey information about the odorant identity. We showed that different coding schemes can convey high amount of odorant information for specific read-out time window. Finally we showed that the optimal read-out time window corresponds to the duration of gamma oscillations cycles. Conclusion: We propose that odorant can be encoded by population of cells that exhibit fine temporal tuning of spiking activity while displaying weak or no firing rate change. These cell assemblies may transfer sensory information in spiking packets sequence using the gamma oscillations as a clock. This would allow the system to reach a tradeoff between rapid and accurate odorant discrimination.	[Gschwend, Olivier; Beroud, Jonathan; Carleton, Alan] Univ Geneva, Dept Basic Neurosci, Sch Med, Geneva, Switzerland; [Gschwend, Olivier; Beroud, Jonathan; Carleton, Alan] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland	University of Geneva; University of Geneva	Gschwend, O (corresponding author), Univ Geneva, Dept Basic Neurosci, Sch Med, Geneva, Switzerland.	alan.carleton@unige.ch	Carleton, Alan/C-9721-2010	Carleton, Alan/0000-0001-5633-9159	University of Geneva; Swiss National Science Foundation (SNF) [PP0033_119169]; NCCR Synapsy; European Research Council [ERC-2009-StG-243344-NEUROCHEMS]; Novartis foundation for medical research; Leenaards foundation; European Molecular Biology Organization	University of Geneva; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NCCR Synapsy; European Research Council(European Research Council (ERC)European Commission); Novartis foundation for medical research; Leenaards foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the University of Geneva, the Swiss National Science Foundation (SNF) professor grant number PP0033_119169 and NCCR Synapsy, the European Research Council (contract number ERC-2009-StG-243344-NEUROCHEMS), The Novartis foundation for medical research, the Leenaards foundation and the European Molecular Biology Organization (young investigator program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bathellier B, 2007, NEUROIMAGE, V34, P1020, DOI 10.1016/j.neuroimage.2006.10.038; Beshel J, 2007, J NEUROSCI, V27, P8358, DOI 10.1523/JNEUROSCI.1199-07.2007; Biederlack J, 2006, NEURON, V52, P1073, DOI 10.1016/j.neuron.2006.11.012; Bizley JK, 2010, J NEUROSCI, V30, P5078, DOI 10.1523/JNEUROSCI.5475-09.2010; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cang JH, 2003, J NEUROSCI, V23, P4108; CHAPUT MA, 1992, EUR J NEUROSCI, V4, P813, DOI 10.1111/j.1460-9568.1992.tb00191.x; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; David FO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000551; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; Heinzle J, 2007, COGN NEURODYNAMICS, V1, P225, DOI 10.1007/s11571-007-9017-x; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Khan AG, 2008, NEURON, V57, P571, DOI 10.1016/j.neuron.2008.01.008; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Lagier S, 2004, J NEUROSCI, V24, P4382, DOI 10.1523/JNEUROSCI.5570-03.2004; Lei H, 2002, NAT NEUROSCI, V5, P557, DOI 10.1038/nn859; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Panzeri S, 2010, TRENDS NEUROSCI, V33, P111, DOI 10.1016/j.tins.2009.12.001; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Saghatelyan A, 2003, J PHYSIOL-PARIS, V97, P517, DOI 10.1016/j.jphysparis.2004.01.009; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082	58	45	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30155	10.1371/journal.pone.0030155	http://dx.doi.org/10.1371/journal.pone.0030155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272291	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400069
J	Belguise, K; Milord, S; Galtier, F; Moquet-Torcy, G; Piechaczyk, M; Chalbos, D				Belguise, K.; Milord, S.; Galtier, F.; Moquet-Torcy, G.; Piechaczyk, M.; Chalbos, D.			The PKC theta pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells	ONCOGENE			English	Article						Fra-1; PKC theta; phosphorylation; protein stability; breast cancer cells	KINASE-C-THETA; PROTEASOMAL DEGRADATION; EXPRESSION; AP-1; TRANSFORMATION; RECEPTOR; TARGET; GENE; TUMORIGENESIS; ACTIVATION	Fra-1 is aberrantly expressed in a large number of cancer cells and tissues, and emerging evidence suggests an important role for this Fos family protein in both oncogenesis and the progression or maintenance of many tumour types. Here, we show that the concentration of Fra-1 is high in invasive oestrogen receptor (ER)-negative (ER-) breast cancer cell lines, regardless of their Ras pathway status. All of the ER-cells express high levels of activated PKC theta, and the inhibition of PKC theta activity using RNA interference or the expression of a dominant-negative mutant results in a dramatic reduction in Fra-1 abundance. Conversely, the ectopic expression of constitutively active PKC theta leads to Fra-1 phosphorylation and accumulation in poorly invasive ER+ cells. This accumulation is due to the stabilisation of the Fra-1 protein through PKC theta signalling, whereas other members of the PKC family are ineffective. Both Ste20-related proline-alanine-rich kinase (SPAK) and ERK1/2, whose activities are upregulated by PKC theta, participate in PKC theta-driven Fra-1 stabilisation. Interestingly, their relative contributions appear to be different depending on the cell line studied. ERK1/2 signalling has a major role in ER- MDA-MB-231 cells, whereas Fra-1 accumulation occurs mainly through SPAK signalling in ER- BT549 cells. Fra-1 mutational analysis shows that the phosphorylation of S265, T223 and T230 is critical for PKC theta-driven Fra-1 stabilisation. Phosphorylation of the protein was confirmed using specific antisera against Fra-1 phosphorylated on T223 or S265. In addition, Fra-1 participates in PKC theta-induced cell invasion and is necessary for PKC theta-induced cell migration. In summary, we identified PKC theta signalling as an important regulator of Fra-1 accumulation in ER- breast cancer cells. Moreover, our results suggest that PKC theta could participate in progression of some breast cancers and could be a new therapeutic target.	[Belguise, K.; Milord, S.; Galtier, F.; Chalbos, D.] IRCM, F-34298 Montpellier 5, France; [Belguise, K.; Milord, S.; Galtier, F.; Chalbos, D.] INSERM, U896, Montpellier, France; [Moquet-Torcy, G.; Piechaczyk, M.] Univ Montpellier I, CNRS, Inst Genet Mol Montpellier, Montpellier, France; [Belguise, K.; Milord, S.; Galtier, F.; Chalbos, D.] CRLC Val dAurelle Paul Lamarque, Montpellier, France; [Moquet-Torcy, G.; Piechaczyk, M.] Univ Montpellier 2, CNRS, Inst Genet Mol Montpellier, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Chalbos, D (corresponding author), IRCM, F-34298 Montpellier 5, France.	dany.chalbos@inserm.fr	PIECHACZYK, Marc/E-7896-2013	PIECHACZYK, Marc/0000-0003-1367-2597; Belguise, Karine/0000-0003-3426-8040	Institut National de la Sante et de la Recherche Medicale; University of Montpellier 1; Ligue Nationale Contre le Cancer-comite de l'Herault; Association pour la Recherche sur le Cancer; French Ministere de la Recherche et de l'Enseignement Superieur	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier 1; Ligue Nationale Contre le Cancer-comite de l'Herault(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); French Ministere de la Recherche et de l'Enseignement Superieur	We are grateful to A Altman, J Pouyssegur and A Hipskind for providing plasmids and I Jariel-Encontre for critical reading of the manuscript. This work was supported by the 'Institut National de la Sante et de la Recherche Medicale', the University of Montpellier 1, the 'Ligue Nationale Contre le Cancer-comite de l'Herault', the 'Association pour la Recherche sur le Cancer' (fellowship to K. Belguise) and the French "Ministere de la Recherche et de l'Enseignement Superieur '(fellowship to S. Milord). M. Piechaczyk's laboratory was supported as an' Equipe Labellisee 'of the 'Ligue Nationale Contre le Cancer'.	BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Basbous J, 2007, MOL CELL BIOL, V27, P3936, DOI 10.1128/MCB.01776-06; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Belguise K, 2007, J CLIN INVEST, V117, P4009, DOI 10.1172/JCI32424; Blay P, 2004, CLIN CANCER RES, V10, P4089, DOI 10.1158/1078-0432.CCR-04-0630; BRUNET A, 1994, ONCOGENE, V9, P3379; Casalino L, 2003, MOL CELL BIOL, V23, P4401, DOI 10.1128/MCB.23.12.4401-4415.2003; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chiappetta G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-17; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Debinski W, 2005, MOL CANCER RES, V3, P237; Delpire E, 2007, PHYSIOL GENOMICS, V28, P223, DOI 10.1152/physiolgenomics.00173.2006; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Elsberger B, 2010, BRIT J CANCER, V103, P899, DOI 10.1038/sj.bjc.6605829; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Kustikova O, 1998, MOL CELL BIOL, V18, P7095, DOI 10.1128/MCB.18.12.7095; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Logullo AF, 2011, HISTOPATHOLOGY, V58, P617, DOI 10.1111/j.1365-2559.2011.03785.x; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Marsland BJ, 2008, TRENDS IMMUNOL, V29, P179, DOI 10.1016/j.it.2008.01.005; Maurer M, 2009, CANCER RES, V69, P6299, DOI 10.1158/0008-5472.CAN-09-0820; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Milde-Langosch K, 2003, BREAST CANCER RES TR, V77, P265, DOI 10.1023/A:1021887100216; Mulloy R, 2003, ONCOGENE, V22, P5387, DOI 10.1038/sj.onc.1206839; Philips A, 1998, MOL ENDOCRINOL, V12, P973, DOI 10.1210/me.12.7.973; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Polek TC, 2006, BIOCHEM BIOPH RES CO, V343, P125, DOI 10.1016/j.bbrc.2006.02.125; Risse-Hackl G, 1998, ONCOGENE, V16, P3057, DOI 10.1038/sj.onc.1201845; Sayan AE, 2012, ONCOGENE, V31, P1493, DOI 10.1038/onc.2011.336; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Song YH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-298; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Vallone D, 1997, EMBO J, V16, P5310, DOI 10.1093/emboj/16.17.5310; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Wang QS, 2010, CELL RES, V20, P701, DOI 10.1038/cr.2010.52; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Young MR, 2006, GENE, V379, P1, DOI 10.1016/j.gene.2006.05.001	45	44	48	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	47					4889	4897		10.1038/onc.2011.659	http://dx.doi.org/10.1038/onc.2011.659			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	041VU	22286759	Green Submitted, Green Accepted			2022-12-25	WOS:000311430200001
J	Besserer, GM; Nicoll, DA; Abramson, J; Philipson, KD				Besserer, Gabriel Mercado; Nicoll, Debora A.; Abramson, Jeff; Philipson, Kenneth D.			Characterization and Purification of a Na+/Ca2+ Exchanger from an Archaebacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOLEMMAL NA+-CA2+ EXCHANGER; SODIUM-CALCIUM EXCHANGE; MEMBRANE-PROTEINS; INTERNAL REPEATS; CA2+ TRANSPORT; VESICLES; OVEREXPRESSION; STOICHIOMETRY; TOPOLOGY; SYSTEM	Background: Databases include many putative prokaryotic Na+/Ca2+ exchangers, but none have been functionally expressed. Results: A membrane protein (MaX1) of Methanosarcina acetivorans catalyzes electrogenic countertransport of Na+ and Ca2(+). Conclusion: MaX1 has properties similar to those of mammalian Na+/Ca2+ exchangers. Significance: The characterization and purification of MaX1 should facilitate structure/function studies.	[Besserer, Gabriel Mercado; Nicoll, Debora A.; Abramson, Jeff; Philipson, Kenneth D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Nicoll, Debora A.; Philipson, Kenneth D.] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Abramson, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	jabramson@mednet.ucla.edu; kphilipson@mednet.ucla.edu			National Institutes of Health [R01 HL49101, R21 HL093278]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093278, R01HL049101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL49101 (to K.D.P.) and R21 HL093278 (to J.A.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; ANDO A, 1981, BIOCHIM BIOPHYS ACTA, V640, P179, DOI 10.1016/0005-2736(81)90543-5; BELLIVEAU JW, 1978, ARCH BIOCHEM BIOPHYS, V186, P98, DOI 10.1016/0003-9861(78)90468-X; BERS DM, 1980, BIOCHIM BIOPHYS ACTA, V601, P358, DOI 10.1016/0005-2736(80)90540-4; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; Dong H, 2002, BIOPHYS J, V82, P1943, DOI 10.1016/S0006-3495(02)75543-4; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5; Kang TM, 2004, NATURE, V427, P544, DOI 10.1038/nature02271; LI ZP, 1991, J BIOL CHEM, V266, P1014; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Miller J.H., 1972, EXPT MOL GENETICS; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nagamori S, 2003, J BIOL CHEM, V278, P14820, DOI 10.1074/jbc.M300332200; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; Ottolia M, 2005, J BIOL CHEM, V280, P1061, DOI 10.1074/jbc.M411899200; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; PHILIPSON KD, 1980, J BIOL CHEM, V255, P6880; REEVES JP, 1984, J BIOL CHEM, V259, P7733; REEVES JP, 1983, J BIOL CHEM, V258, P3178; Saaf A, 2001, J BIOL CHEM, V276, P18905, DOI 10.1074/jbc.M101716200; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; TROMBE MC, 1993, J GEN MICROBIOL, V139, P433, DOI 10.1099/00221287-139-3-433; TROSPER TL, 1983, BIOCHIM BIOPHYS ACTA, V731, P63, DOI 10.1016/0005-2736(83)90398-X; VEMURI R, 1988, BIOCHIM BIOPHYS ACTA, V937, P258, DOI 10.1016/0005-2736(88)90248-9; Visser F, 2007, PHYSIOLOGY, V22, P185, DOI 10.1152/physiol.00001.2007; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671	35	7	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8652	8659		10.1074/jbc.M111.331280	http://dx.doi.org/10.1074/jbc.M111.331280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22287543	Green Published, hybrid			2022-12-25	WOS:000301349400077
J	Niwa, H; Ewens, CA; Tsang, C; Yeung, HO; Zhang, XD; Freemont, PS				Niwa, Hajime; Ewens, Caroline A.; Tsang, Chun; Yeung, Heidi O.; Zhang, Xiaodong; Freemont, Paul S.			The Role of the N-Domain in the ATPase Activity of the Mammalian AAA ATPase p97/VCP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; RETICULUM-ASSOCIATED DEGRADATION; FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; ENDOPLASMIC-RETICULUM; P97/VALOSIN-CONTAINING PROTEIN; CONFORMATIONAL-CHANGES; VCP MUTATIONS; D1 RING	p97/valosin-containing protein (VCP) is a type II ATPase associated with various cellular activities that forms a homohexamer with each protomer containing an N-terminal domain (N-domain); two ATPase domains, D1 and D2; and a disordered C-terminal region. Little is known about the role of the N-domain or the C-terminal region in the p97 ATPase cycle. In the p97-associated human disease inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia, the majority of missense mutations are located at the N-domain D1 interface. Structure-based predictions suggest that such mutations affect the interaction of the N-domain with D1. Here we have tested ten major inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia-linked mutants for ATPase activity and found that all have increased activity over the wild type, with one mutant, p97(A232E), having three times higher activity. Further mutagenesis of p97(A232E) shows that the increase in ATPase activity is mediated through D2 and requires both the N-domain and a flexible ND1 linker. A disulfide mutation that locks the N-domain to D1 in a coplanar position reversibly abrogates ATPase activity. A cryo-EM reconstruction of p97(A232E) suggests that the N-domains are flexible. Removal of the C-terminal region also reduces ATPase activity. Taken together, our data suggest that the conformation of the N-domain in relation to the D1-D2 hexamer is directly linked to ATP hydrolysis and that the C-terminal region is required for hexamer stability. This leads us to propose a model where the N-domain adopts either of two conformations: a flexible conformation compatible with ATP hydrolysis or a coplanar conformation that is inactive.	[Niwa, Hajime; Ewens, Caroline A.; Tsang, Chun; Yeung, Heidi O.; Zhang, Xiaodong; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, Struct Biol Ctr, London SW7 2AZ, England	Imperial College London	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Mol Biosci, Struct Biol Ctr, London SW7 2AZ, England.	p.freemont@imperial.ac.uk		Freemont, Paul/0000-0002-5658-8486; Zhang, Xiaodong/0000-0001-9786-7038	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; EGERTON M, 1994, J BIOL CHEM, V269, P11435; Ewens CA, 2010, BIOCHEM CELL BIOL, V88, P41, DOI [10.1139/O09-128, 10.1139/o09-128]; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Guinto JB, 2007, ACTA NEUROPATHOL, V114, P55, DOI 10.1007/s00401-007-0224-7; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rothballer A, 2007, FEBS LETT, V581, P1197, DOI 10.1016/j.febslet.2007.02.031; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Tanner JA, 2002, J BIOL CHEM, V277, P3073, DOI 10.1074/jbc.M106588200; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	56	89	89	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8561	8570		10.1074/jbc.M111.302778	http://dx.doi.org/10.1074/jbc.M111.302778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270372	Green Published, hybrid			2022-12-25	WOS:000301349400069
J	Rouaud, P; Vincent-Fabert, C; Fiancette, R; Cogne, M; Pinaud, E; Denizot, Y				Rouaud, Pauline; Vincent-Fabert, Christelle; Fiancette, Remi; Cogne, Michel; Pinaud, Eric; Denizot, Yves			Enhancers Located in Heavy Chain Regulatory Region (hs3a, hs1,2, hs3b, and hs4) Are Dispensable for Diversity of VDJ Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; B-CELL DEVELOPMENT; V(D)J RECOMBINATION; INTRONIC ENHANCER; IGH LOCUS; ELEMENTS; GENE; DELETION; INSULATORS; EXPRESSION	V(D)J recombination occurs during the antigen-independent early steps of B-cell ontogeny. Multiple IgH cis-regulatory elements control B-cell ontogeny. IGCR1 (intergenic control region 1), the DQ52 promoter/enhancer, and the intronic Emu enhancer, all three located upstream of Cmu, have important roles during V(D)J recombination, whereas there is no clue about a role of the IgH regulatory region (RR) encompassing the four transcriptional enhancers hs3a, hs1,2, hs3b, and hs4 during these early stages. To clarify the role of the RR in V(D)J recombination, we totally deleted it in the mouse genome. Here, we show that V(D)J recombination is unaffected by the complete absence of the IgH RR, highlighting that this region only orchestrates IgH locus activity during the late stages of B-cell differentiation. In contrast, the earliest antigen-independent steps of B-cell ontogeny would be under the control of only the upstream Cmu elements of the locus.	[Denizot, Yves] Univ Limoges, CNRS, UMR 7276, Immunol Lab, F-87025 Limoges, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Limoges	Denizot, Y (corresponding author), Univ Limoges, CNRS, UMR 7276, Immunol Lab, 2 Rue Dr Marcland, F-87025 Limoges, France.	yves.denizot@unilim.fr	Vincent-Fabert, Christelle/AGZ-5883-2022; Denizot, Yves/H-9769-2016; PINAUD, Eric/O-8443-2016; cogné, michel/D-7370-2015	PINAUD, Eric/0000-0001-7405-9273; cogné, michel/0000-0002-8519-4427; Rouaud-Tinguely, Pauline/0000-0003-2238-7077; VINCENT-FABERT, Christelle/0000-0002-5799-980X	Ligue contre le Cancer (Comite Departemental de la Haute-Vienne, de la Creuse, et de la Correze); Conseil Regional du Limousin; Agence Nationale de Recherche; Association pour la Recherche sur le Cancer (ARC)	Ligue contre le Cancer (Comite Departemental de la Haute-Vienne, de la Creuse, et de la Correze); Conseil Regional du Limousin(Region Nouvelle-Aquitaine); Agence Nationale de Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by grants from the Ligue contre le Cancer (Comite Departemental de la Haute-Vienne, de la Creuse, et de la Correze), the Conseil Regional du Limousin, and Agence Nationale de Recherche (Projets Blanc 2011).; Supported by a grant from the Association pour la Recherche sur le Cancer (ARC). Present address: Centre de Recherche en Cancerologie de Marseille, INSERM U891, 13009 Marseille, France.	Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Giallourakis CC, 2010, P NATL ACAD SCI USA, V107, P22207, DOI 10.1073/pnas.1015954107; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Guglielmi L, 2003, BBA-MOL CELL RES, V1642, P181, DOI 10.1016/j.bbamcr.2003.08.005; Guglielmi L, 2003, BIOCHEM BIOPH RES CO, V307, P466, DOI 10.1016/S0006-291X(03)01185-9; Guo CY, 2011, CELL, V147, P332, DOI 10.1016/j.cell.2011.08.049; Guo CG, 2011, NATURE, V477, P424, DOI 10.1038/nature10495; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Le Morvan C, 2003, BLOOD, V102, P1421, DOI 10.1182/blood-2002-12-3827; Nitschke L, 2001, J IMMUNOL, V166, P2540, DOI 10.4049/jimmunol.166.4.2540; Pasqual N, 2002, J EXP MED, V196, P1163, DOI 10.1084/jem.20021074; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Truffinet V, 2007, J IMMUNOL, V179, P6033, DOI 10.4049/jimmunol.179.9.6033; Vincent-Fabert C, 2010, EUR J IMMUNOL, V40, P3306, DOI 10.1002/eji.201040778; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Vincent-Fabert C, 2009, J IMMUNOL, V182, P6926, DOI 10.4049/jimmunol.0900214; Yan Y, 2011, J BIOL CHEM, V286, P27123, DOI 10.1074/jbc.M111.230995	22	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8356	8360		10.1074/jbc.M112.341024	http://dx.doi.org/10.1074/jbc.M112.341024			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22270371	hybrid, Green Published			2022-12-25	WOS:000301349400050
J	Ji, ZW; Ma, YL; Li, W; Li, XX; Zhao, GY; Yun, Z; Qian, JX; Fan, QY				Ji, Zhenwei; Ma, Yunlei; Li, Wei; Li, Xiaoxiang; Zhao, Guangyi; Yun, Zhe; Qian, Jixian; Fan, Qingyu			The Healing Process of Intracorporeally and In Situ Devitalized Distal Femur by Microwave in a Dog Model and Its Mechanical Properties In Vitro	PLOS ONE			English	Article							LIMB SALVAGE SURGERY; TERM-FOLLOW-UP; AUTOGRAFT-PROSTHESIS COMPOSITE; MUSCULOSKELETAL TUMOR SURGERY; AUTOLOGOUS BONE-GRAFT; SOFT-TISSUE SARCOMA; OF-THE-LITERATURE; INDUCED HYPERTHERMIA; CLINICAL-EXPERIENCE; IRRADIATED BONE	Background: Limb-salvage surgery has been well recognized as a standard treatment and alternative to amputation for patients with malignant bone tumors. Various limb-sparing techniques have been developed including tumor prosthesis, allograft, autograft and graft-prosthesis composite. However, each of these methods has short-and long-term disadvantages such as nonunion, mechanical failures and poor limb function. The technique of intracorporeal devitalization of tumor-bearing bone segment in situ by microwave-induced hyperthermia after separating it from surrounding normal tissues with a safe margin is a promising limb-salvage method, which may avoid some shortcomings encountered by the above-mentioned conventional techniques. The purpose of this study is to assess the healing process and revitalization potential of the devitalized bone segment by this method in a dog model. In addition, the immediate effect of microwave on the biomechanical properties of bone tissue was also explored in an in vitro experiment. Methods: We applied the microwave-induced hyperthermia to devitalize the distal femurs of dogs in situ. Using a monopole microwave antenna, we could produce a necrotic bone of nearly 20 mm in length in distal femur. Radiography, bone scintigraphy, microangiography, histology and functional evaluation were performed at 2 weeks and 1, 2, 3, 6, 9 and 12 months postoperatively to assess the healing process. In a biomechanical study, two kinds of bone specimens, 3 and 6 cm in length, were used for compression and three-point bending test respectively immediately after extracorporeally devitalized by microwave. Findings: An in vivo study showed that intracorporeally and in situ devitalized bone segment by microwave had great revitalization potential. An in vitro study revealed that the initial mechanical strength of the extracorporeally devitalized bone specimen may not be affected by microwave. Conclusion: Our results suggest that the intracorporeal microwave devitalization of tumor-bearing bone segment in situ may be a promising limb-salvage method.	[Ji, Zhenwei; Ma, Yunlei; Li, Wei; Li, Xiaoxiang; Zhao, Guangyi; Yun, Zhe; Qian, Jixian; Fan, Qingyu] Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Ji, ZW (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Shaanxi, Peoples R China.	bonetm@fmmu.edu.cn						Abed YY, 2009, J BONE JOINT SURG BR, V91B, P1366, DOI [10.1302/0301-620X.91B10.22212, 10.1302/0301-620V.91B10.22212]; Ahmed AR, 2009, ARCH ORTHOP TRAUM SU, V129, P475, DOI 10.1007/s00402-008-0659-x; Asada N, 1997, ACTA ORTHOP SCAND, V68, P392, DOI 10.3109/17453679708996184; Baumgart Rainer, 2009, V179, P59; Bohm P, 2003, LANGENBECK ARCH SURG, V387, P355, DOI 10.1007/s00423-002-0332-8; Bohm P, 1998, ARCH ORTHOP TRAUM SU, V118, P57, DOI 10.1007/s004020050312; Bullens PHJ, 2009, INT ORTHOP, V33, P757, DOI 10.1007/s00264-008-0700-2; CANADELL J, 1994, J BONE JOINT SURG BR, V76B, P127, DOI 10.1302/0301-620X.76B1.8300655; Carrafiello Gianpaolo, 2008, Int J Surg, V6 Suppl 1, pS65, DOI 10.1016/j.ijsu.2008.12.028; Chen CF, 2009, J SURG ONCOL, V100, P418, DOI 10.1002/jso.21351; Cho HS, 2009, J SURG ONCOL, V100, P227, DOI 10.1002/jso.21267; Ehara S, 2000, SKELETAL RADIOL, V29, P335, DOI 10.1007/s002560000205; Eisenschenk A, 2006, MICROSURG, V26, P412, DOI 10.1002/micr.20261; Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001; Fan QY, 2003, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000037439.23683.9c; Fan QY, 1996, BIOELECTROMAGNETICS, V17, P218, DOI 10.1002/(SICI)1521-186X(1996)17:3<218::AID-BEM7>3.0.CO;2-6; Gillams Alice, 2008, Cancer Imaging, V8 Spec No A, pS1, DOI 10.1102/1470-7330.2008.9001; Jeon DG, 2007, J SURG ONCOL, V96, P590, DOI 10.1002/jso.20840; Jeon DG, 2007, J ORTHOP SCI, V12, P542, DOI 10.1007/s00776-007-1173-7; Jeys Lee, 2009, V179, P75; Kawaguchi N, 2004, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000116308.86761.f5; Kinkel S, 2010, J SURG ONCOL, V101, P166, DOI 10.1002/jso.21441; KOLIOS MC, 1995, PHYS MED BIOL, V40, P477, DOI 10.1088/0031-9155/40/4/001; Kubo T, 2004, ANTICANCER RES, V24, P1893; Kumta SM, 2002, J PEDIATR ORTHOPED, V22, P244, DOI 10.1097/00004694-200203000-00023; Kumta SM, 1999, ARCH ORTHOP TRAUM SU, V119, P327, DOI 10.1007/s004020050420; Liapi E, 2007, J CLIN ONCOL, V25, P978, DOI 10.1200/JCO.2006.09.8657; Liebergall M, 1998, CLIN ORTHOP RELAT R, P242; Liebergall M, 2000, CLIN ORTHOP RELAT R, P272; Lu DSK, 2002, AM J ROENTGENOL, V178, P47, DOI 10.2214/ajr.178.1.1780047; Manabe J, 2004, CLIN ORTHOP RELAT R, P258, DOI 10.1097/01.blo.0000122665.47154.8f; MANKIN HJ, 1992, ORTHOPEDICS, V15, P1147; Mankin HJ, 1996, CLIN ORTHOP RELAT R, P86; Marulanda German A, 2008, Cancer Control, V15, P13; Moran M, 2009, ARCH ORTHOP TRAUM SU, V129, P1339, DOI 10.1007/s00402-008-0752-1; Morello E, 2001, J SMALL ANIM PRACT, V42, P61, DOI 10.1111/j.1748-5827.2001.tb01993.x; Muscolo DL, 2008, CLIN ORTHOP RELAT R, V466, P1856, DOI 10.1007/s11999-008-0303-7; Nielsen OS, 2001, EUR J CANCER, V37, P1587, DOI 10.1016/S0959-8049(01)00193-9; Ogilvie CM, 2009, CLIN ORTHOP RELAT R, V467, P2685, DOI 10.1007/s11999-009-0726-9; Ottaviani G, 2009, CANCER TREAT RES, V152, P421, DOI [10.1007/978-1-4419-0284-9_2, 10.1007/978-1-4419-0284-9_23]; Poffyn B, 2010, SKELETAL RADIOL, V39, P999, DOI 10.1007/s00256-010-0889-1; Quan GMY, 2005, J SURG ONCOL, V91, P159, DOI 10.1002/jso.20268; RONG Y, 1995, CLIN ORTHOP RELAT R, P227; Saghieh S, 2010, PEDIATR BLOOD CANCER, V55, P457, DOI 10.1002/pbc.22598; Shimizu K, 1999, ARCH ORTHOP TRAUM SU, V119, P57, DOI 10.1007/s004020050355; Shin S, 2005, ARCH ORTHOP TRAUM SU, V125, P1, DOI 10.1007/s00402-004-0746-6; Simon CJ, 2006, SEMIN MUSCULOSKEL R, V10, P137, DOI 10.1055/s-2006-939031; Simon Caroline J, 2005, Surg Oncol Clin N Am, V14, P419, DOI 10.1016/j.soc.2004.11.005; Tyler WK, 2009, CLIN ORTHOP RELAT R, V467, P2800, DOI 10.1007/s11999-009-0946-z; Van Laere K, 1998, J NUCL MED, V39, P1563; Watanabe Hideomi, 2003, J Orthop Sci, V8, P180; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Zouari L, 2008, EUR RADIOL, V18, P2635, DOI 10.1007/s00330-008-1045-3	53	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30505	10.1371/journal.pone.0030505	http://dx.doi.org/10.1371/journal.pone.0030505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276207	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100051
J	Jin, YN; Hwang, WY; Jo, C; Johnson, GVW				Jin, Youngnam N.; Hwang, Woong Y.; Jo, Chulman; Johnson, Gail V. W.			Metabolic State Determines Sensitivity to Cellular Stress in Huntington Disease: Normalization by Activation of PPAR gamma	PLOS ONE			English	Article							MITOCHONDRIAL UNCOUPLING PROTEINS; PERMEABILITY TRANSITION PORE; R6/2 MOUSE MODEL; RECEPTOR-GAMMA; MUTANT HUNTINGTIN; STRIATAL CELLS; OXIDATIVE STRESS; PYRUVATE-DEHYDROGENASE; AGONIST PIOGLITAZONE; TRANSGENIC MICE	Impairments in mitochondria and transcription are important factors in the pathogenesis of Huntington disease (HD), a neurodegenerative disease caused by a polyglutamine expansion in the huntingtin protein. This study investigated the effect of different metabolic states and peroxisome proliferator-activated receptor gamma (PPAR gamma) activation on sensitivity to cellular stressors such as H2O2 or thapsigargin in HD. Striatal precursor cells expressing wild type (STHdh(Q7)) or mutant huntingtin (STHdh(Q111)) were prepared in different metabolic conditions (glucose vs. pyruvate). Due to the fact that STHdh(Q111) cells exhibit mitochondrial deficits, we expected that in the pyruvate condition, where ATP is generated primarily by the mitochondria, there would be greater differences in cell death between the two cell types compared to the glucose condition. Intriguingly, it was the glucose condition that gave rise to greater differences in cell death. In the glucose condition, thapsigargin treatment resulted in a more rapid loss of mitochondrial membrane potential (Delta psi m), a greater activation of caspases (3, 8, and 9), and a significant increase in superoxide/reactive oxygen species (ROS) in STHdh(Q111) compared to STHdh(Q7), while both cell types showed similar kinetics of Delta psi m-loss and similar levels of superoxide/ROS in the pyruvate condition. This suggests that bioenergetic deficiencies are not the primary contributor to the enhanced sensitivity of STHdh(Q111) cells to stressors compared to the STHdh(Q7) cells. PPAR gamma activation significantly attenuated thapsigargin-induced cell death, concomitant with an inhibition of caspase activation, a delay in Delta psi m loss, and a reduction of superoxide/ROS generation in STHdh(Q111) cells. Expression of mutant huntingtin in primary neurons induced superoxide/ROS, an effect that was significantly reduced by constitutively active PPAR gamma. These results provide significant insight into the bioenergetic disturbances in HD with PPAR gamma being a potential therapeutic target for HD.	[Jin, Youngnam N.; Hwang, Woong Y.; Johnson, Gail V. W.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA; [Jo, Chulman; Johnson, Gail V. W.] Univ Rochester, Dept Anesthesiol, Rochester, NY USA	University of Rochester; University of Rochester	Jin, YN (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA.	gail_johnsonvoll@urmc.rochester.edu	Jin, Youngnam/G-2655-2012; Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	National Institutes of Health (NIH) [NS041744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041744] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant NS041744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sorolla MA, 2010, FREE RADICAL BIO MED, V49, P612, DOI 10.1016/j.freeradbiomed.2010.05.016; Breidert T, 2002, J NEUROCHEM, V82, P615, DOI 10.1046/j.1471-4159.2002.00990.x; Browne SE, 1999, BRAIN PATHOL, V9, P147; BUTTERWORTH J, 1985, J NEUROL SCI, V67, P161, DOI 10.1016/0022-510X(85)90112-1; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Doonan F, 2009, J NEUROCHEM, V109, P631, DOI 10.1111/j.1471-4159.2009.05995.x; Du YF, 2009, NEUROBIOL DIS, V35, P302, DOI 10.1016/j.nbd.2009.05.015; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Fong WH, 2010, MOL NEUROBIOL, V41, P180, DOI 10.1007/s12035-010-8103-y; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Gundemir S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006123; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Jin YN, 2010, J BIOENERG BIOMEMBR, V42, P199, DOI 10.1007/s10863-010-9286-7; Jo DG, 2004, MOL CELL BIOL, V24, P9763, DOI 10.1128/MCB.24.22.9763-9770.2004; Jucker BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1256, DOI 10.1152/ajpendo.00218.2007; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; King AL, 2010, AM J PHYSIOL-GASTR L, V299, pG954, DOI 10.1152/ajpgi.00246.2010; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Kress GJ, 2002, J NEUROSCI, V22, P5848; Luo YM, 2006, J NEUROCHEM, V97, P435, DOI 10.1111/j.1471-4159.2006.03758.x; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maglione V, 2006, MECH AGEING DEV, V127, P213, DOI 10.1016/j.mad.2005.09.011; Martinez JA, 2010, APOPTOSIS, V15, P1480, DOI 10.1007/s10495-010-0526-4; Matas J, 2009, J MOL CELL CARDIOL, V46, P420, DOI 10.1016/j.yjmcc.2008.10.020; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; MURTHY VV, 1995, J CLIN LAB ANAL, V9, P225, DOI 10.1002/jcla.1860090402; Nasrallah R, 2010, AM J PHYSIOL-RENAL, V298, pF1105, DOI 10.1152/ajprenal.00735.2009; Niino M, 2001, J NEUROIMMUNOL, V116, P40, DOI 10.1016/S0165-5728(01)00285-5; Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200; Perry GM, 2010, HUM MOL GENET, V19, P3354, DOI 10.1093/hmg/ddq247; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sasaya H, 2008, J BIOCHEM, V144, P251, DOI 10.1093/jb/mvn063; Schock SC, 2008, J NEUROSCI, V28, P12433, DOI 10.1523/JNEUROSCI.2897-08.2008; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Troiano L, 2007, NAT PROTOC, V2, P2719, DOI 10.1038/nprot.2007.405; Wu ZF, 2009, ANTIOXID REDOX SIGN, V11, P1805, DOI [10.1089/ars.2009.2427, 10.1089/ARS.2009.2427]; Yamaguchi H, 2003, CANCER RES, V63, P1483; Zhang X, 2007, TOXICOL APPL PHARM, V223, P10, DOI 10.1016/j.taap.2007.05.002; Zhang Y, 2003, J NEUROCHEM, V87, P1184, DOI 10.1046/j.1471-4159.2003.02105.x; Zheng Z, 2010, DIABETES, V59, P2315, DOI 10.2337/db10-0638; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	65	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30406	10.1371/journal.pone.0030406	http://dx.doi.org/10.1371/journal.pone.0030406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276192	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100044
J	Gong, HY; Kobayashi, K; Sugi, T; Takemae, H; Kurokawa, H; Horimoto, T; Akashi, H; Kato, K				Gong, Haiyan; Kobayashi, Kyousuke; Sugi, Tatsuki; Takemae, Hitoshi; Kurokawa, Hitomi; Horimoto, Taisuke; Akashi, Hiroomi; Kato, Kentaro			A Novel PAN/Apple Domain-Containing Protein from Toxoplasma gondii: Characterization and Receptor Identification	PLOS ONE			English	Article							MICRONEME PROTEINS; SULFATE PROTEOGLYCANS; CHONDROITIN SULFATE; MOLECULAR-CLONING; EIMERIA-TENELLA; CELL INVASION; APPLE DOMAINS; FC-RECEPTOR; BINDING; EXPRESSION	Toxoplasma gondii is an intracellular parasite that invades nucleated cells, causing toxoplasmosis in humans and animals worldwide. The extremely wide range of hosts susceptible to T. gondii is thought to be the result of interactions between T. gondii ligands and receptors on its target cells. In this study, a host cell-binding protein from T. gondii was characterized, and one of its receptors was identified. P104 (GenBank Access. No. CAJ20677) is 991 amino acids in length, containing a putative 26 amino acid signal peptide and 10 PAN/apple domains, and shows low homology to other identified PAN/apple domaincontaining molecules. A 104-kDa host cell-binding protein was detected in the T. gondii lysate. Immunofluorescence assays detected P104 at the apical end of extracellular T. gondii. An Fc-fusion protein of the P104 N-terminus, which contains two PAN/apple domains, showed strong affinity for the mammalian and insect cells evaluated. This binding was not related to protein-protein or protein-lipid interactions, but to a protein-glycosaminoglycan (GAG) interaction. Chondroitin sulfate (CS), a kind of GAG, was shown to be involved in adhesion of the Fc-P104 N-terminus fusion protein to host cells. These results suggest that P104, expressed at the apical end of the extracellular parasite, may function as a ligand in the attachment of T. gondii to CS or other receptors on the host cell, facilitating invasion by the parasite.	[Gong, Haiyan; Kobayashi, Kyousuke; Sugi, Tatsuki; Takemae, Hitoshi; Kurokawa, Hitomi; Horimoto, Taisuke; Akashi, Hiroomi; Kato, Kentaro] Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo	Gong, HY (corresponding author), Univ Tokyo, Dept Vet Microbiol, Grad Sch Agr & Life Sci, Tokyo, Japan.	akkato@mail.ecc.u-tokyo.ac.jp	Sugi, Tatsuki/A-9110-2012; Takemae, Hitoshi/AEP-5503-2022	Kobayashi, Kyousuke/0000-0001-5501-8396	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan; Bio-Oriented Technology Research Advancement Institution (BRAIN)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-Oriented Technology Research Advancement Institution (BRAIN)	This study was supported by a grant from the Japan Society for the Promotion of Science (JSPS); Grant-in-Aid for Young Scientists from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan; and the Bio-Oriented Technology Research Advancement Institution (BRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMANN H, 1979, J BIOL CHEM, V254, P3935; Beghetto E, 2005, J INFECT DIS, V191, P637, DOI 10.1086/427660; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Bhopale GM, 2003, MICROBES INFECT, V5, P457, DOI 10.1016/S1286-4579(03)00048-0; Bir N, 2006, INFECT IMMUN, V74, P5955, DOI 10.1128/IAI.00481-06; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown PJ, 2000, MOL BIOCHEM PARASIT, V107, P91, DOI 10.1016/S0166-6851(00)00179-1; BULOW R, 1991, J IMMUNOL, V147, P3496; Carruthers BV, 2008, SUBCELL BIOCH, V47, P33; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; CHIOFALO MS, 1988, CELL IMMUNOL, V114, P272, DOI 10.1016/0008-8749(88)90321-8; Crawford J, 2010, J BIOL CHEM, V285, P15644, DOI 10.1074/jbc.M109.092619; Deng MQ, 2002, INFECT IMMUN, V70, P6987, DOI 10.1128/IAI.70.12.6987-6995.2002; Dinglasan RR, 2007, P NATL ACAD SCI USA, V104, P15882, DOI 10.1073/pnas.0706340104; Fohl LM, 2003, MOL MICROBIOL, V50, P1319, DOI 10.1046/j.1365-2958.2003.03756.x; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; Gong HY, 2007, J INSECT PHYSIOL, V53, P1079, DOI 10.1016/j.jinsphys.2007.06.008; Jacquet A, 2001, MOL BIOCHEM PARASIT, V116, P35, DOI 10.1016/S0166-6851(01)00297-3; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; KAUFMAN H E, 1960, Arch Ophthalmol, V64, P140; Keller N, 2004, INFECT IMMUN, V72, P4791, DOI 10.1128/IAI.72.8.4791-4800.2004; KHAN IA, 1991, J IMMUNOL, V147, P3501; Klein H, 1998, GLYCOCONJUGATE J, V15, P147, DOI 10.1023/A:1006964105349; Klein H, 1996, PARASITOL RES, V82, P230, DOI 10.1007/s004360050101; Kobayashi K, 2010, J BIOL CHEM, V285, P1716, DOI 10.1074/jbc.M109.021576; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; Menard R, 2001, CELL MICROBIOL, V3, P63, DOI 10.1046/j.1462-5822.2001.00097.x; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4; Morrissette NS, 1998, EXP PARASITOL, V89, P296, DOI 10.1006/expr.1998.4277; Naguleswaran A, 2002, INT J PARASITOL, V32, P695, DOI 10.1016/S0020-7519(02)00014-0; NAKAMURA H, 1995, MECH DEVELOP, V49, P123, DOI 10.1016/0925-4773(94)00309-B; Ortega-Barria E, 1999, J BIOL CHEM, V274, P1267, DOI 10.1074/jbc.274.3.1267; ORTEGABARRIA E, 1991, CELL, V67, P411, DOI 10.1016/0092-8674(91)90192-2; PANCAKE SJ, 1992, J CELL BIOL, V117, P1351, DOI 10.1083/jcb.117.6.1351; Periz J, 2007, J BIOL CHEM, V282, P16891, DOI 10.1074/jbc.M702407200; Peyron F, 2009, MEM I OSWALDO CRUZ, V104, P316, DOI 10.1590/S0074-02762009000200028; Remington J. S., 2006, INFECT DIS FETUS NEW, P947, DOI DOI 10.1016/B0-72-160537-0/50033-5; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594; Silva LCF, 2006, ADV PHARMACOL, V53, P21, DOI 10.1016/S1054-3589(05)53002-3; Striepen B., 2007, P391, DOI 10.1016/B978-012369542-0/50017-9; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Sugi T, 2009, PARASITOL INT, V58, P416, DOI 10.1016/j.parint.2009.08.005; THERY C, 1995, DEV GENET, V17, P90, DOI 10.1002/dvg.1020170110; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; VAJDA T, 1976, ACTA BIOCHIM BIOPHYS, V11, P287; Varki A, 2008, ESSENTIALS GLYCOBIOL, P649; Velge-Roussel F, 1997, MOL IMMUNOL, V34, P1045, DOI 10.1016/S0161-5890(97)00133-8; Velge-Roussel F, 2000, INFECT IMMUN, V68, P969, DOI 10.1128/IAI.68.2.969-972.2000; Vercammen M, 1998, PARASITE IMMUNOL, V20, P37, DOI 10.1046/j.1365-3024.1998.00124.x; WALKER JC, 1990, NATURE, V345, P743, DOI 10.1038/345743a0; ZHANG JP, 1992, CELL, V69, P861, DOI 10.1016/0092-8674(92)90296-O	55	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30169	10.1371/journal.pone.0030169	http://dx.doi.org/10.1371/journal.pone.0030169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276154	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200038
J	Castro, PV; Khare, S; Young, BD; Clarke, SG				Castro, Paola V.; Khare, Shilpi; Young, Brian D.; Clarke, Steven G.			Caenorhabditis elegans Battling Starvation Stress: Low Levels of Ethanol Prolong Lifespan in L1 Larvae	PLOS ONE			English	Article							C-ELEGANS; INTERACTING GENES; CELL-CYCLE; LONGEVITY; GROWTH; EXPRESSION; RESISTANCE; GENETICS; TARGETS; DAUER	The nematode Caenorhabditis elegans arrests development at the first larval stage if food is not present upon hatching. Larvae in this stage provide an excellent model for studying stress responses during development. We found that supplementing starved larvae with ethanol markedly extends their lifespan within this L1 diapause. The effects of ethanol-induced lifespan extension can be observed when the ethanol is added to the medium at any time between 0 and 10 days after hatching. The lowest ethanol concentration that extended lifespan was 1 mM (0.005%); higher concentrations to 68 mM (0.4%) did not result in increased survival. In spite of their extended survival, larvae did not progress to the L2 stage. Supplementing starved cultures with n-propanol and n-butanol also extended lifespan, but methanol and isopropanol had no measurable effect. Mass spectrometry analysis of nematode fatty acids and amino acids revealed that L1 larvae can incorporate atoms from ethanol into both types of molecules. Based on these data, we suggest that ethanol supplementation may extend the lifespan of L1 larvae by either serving as a carbon and energy source and/or by inducing a stress response.	[Castro, Paola V.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Castro, PV (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	clarke@mbi.ucla.edu	Castro, Paola/GYU-9263-2022		National Institutes of Health [GM026020, AG032303]; Ellison Medical Foundation; University of California Los Angeles CLA MARC U*STAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008563, R01GM026020, R37GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); University of California Los Angeles CLA MARC U*STAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants GM026020 and AG032303 and by an Ellison Medical Foundation Senior Scholar in Aging Award to SGC. PVC was supported in part by the University of California Los Angeles CLA MARC U*STAR program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Banfield KL, 2008, J GERONTOL A-BIOL, V63, P798, DOI 10.1093/gerona/63.8.798; Barclay JW, 2010, BIOCHEM SOC T, V38, P172, DOI 10.1042/BST0380172; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chandler RJ, 2006, MOL GENET METAB, V89, P64, DOI 10.1016/j.ymgme.2006.06.001; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davis JR, 2008, ALCOHOL CLIN EXP RES, V32, P853, DOI 10.1111/j.1530-0277.2008.00639.x; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gomez TA, 2007, DEV BIOL, V303, P493, DOI 10.1016/j.ydbio.2006.11.023; Graham ME, 2009, MOL BIOL CELL, V20, P43, DOI 10.1091/mbc.E08-07-0689; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hill S, 2011, FREE RADICAL BIO MED, V50, P130, DOI 10.1016/j.freeradbiomed.2010.10.690; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; LARSEN PL, 1995, GENETICS, V139, P1567; Liu FZ, 1997, BIOCHEMISTRY-US, V36, P255, DOI 10.1021/bi9623800; LU NC, 1978, P SOC EXP BIOL MED, V158, P187, DOI 10.3181/00379727-158-40168; Mitchell PH, 2007, PHARMACOGENOMICS J, V7, P411, DOI 10.1038/sj.tpj.6500440; Munoz MJ, 2003, GENETICS, V163, P171; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; RAIZEN DM, 1995, GENETICS, V141, P1365; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Sizova MV, 2011, APPL ENVIRON MICROB, V77, P2282, DOI 10.1128/AEM.01219-10; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Thompson G, 2005, J BIOCHEM MOL TOXIC, V19, P87, DOI 10.1002/jbt.20060; VALLEE BL, 1955, P NATL ACAD SCI USA, V41, P327, DOI 10.1073/pnas.41.6.327; Wang XM, 2010, BIOCHEM BIOPH RES CO, V400, P613, DOI 10.1016/j.bbrc.2010.08.113; Wang XW, 2011, INT J SYST EVOL MICR, V61, P1127, DOI 10.1099/ijs.0.025338-0; WHITE JG, 1984, PHILOS T R SOC LON B, V314, P1; Wolkow CA, 2006, EXP GERONTOL, V41, P1001, DOI 10.1016/j.exger.2006.06.033; Yen K, 2011, ANTIOXID REDOX SIGN, V14, P623, DOI 10.1089/ars.2010.3490; YU X, 2011, BIOCH BIOPH IN PRESS	42	31	31	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29984	10.1371/journal.pone.0029984	http://dx.doi.org/10.1371/journal.pone.0029984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279556	gold, Green Published			2022-12-25	WOS:000299771900034
J	Della Santina, L; Piano, I; Cangiano, L; Caputo, A; Ludwig, A; Cervetto, L; Gargini, C				Della Santina, Luca; Piano, Ilaria; Cangiano, Lorenzo; Caputo, Antonella; Ludwig, Andreas; Cervetto, Luigi; Gargini, Claudia			Processing of Retinal Signals in Normal and HCN Deficient Mice	PLOS ONE			English	Article							CONE PHOTORECEPTORS; TIGER SALAMANDER; INWARD RECTIFICATION; MEMBRANE-PROPERTIES; ROD PHOTORECEPTORS; INNER SEGMENT; CHANNELS; LIGHT; CURRENTS; PHOTORESPONSE	This study investigates the role of two different HCN channel isoforms in the light response of the outer retina. Taking advantage of HCN-deficient mice models and of in vitro (patch-clamp) and in vivo (ERG) recordings of retinal activity we show that HCN1 and HCN2 channels are expressed at distinct retinal sites and serve different functions. Specifically, HCN1 operate mainly at the level of the photoreceptor inner segment from where, together with other voltage sensitive channels, they control the time course of the response to bright light. Conversely, HCN2 channels are mainly expressed on the dendrites of bipolar cells and affect the response to dim lights. Single cell recordings in HCN1(-/-) mice or during a pharmacological blockade of I-h show that, contrary to previous reports, I-kx alone is able to generate the fast initial transient in the rod bright flash response. Here we demonstrate that the relative contribution of I-h and I-kx to the rods' temporal tuning depends on the membrane potential. This is the first instance in which the light response of normal and HCN1- or HCN2-deficient mice is analyzed in single cells in retinal slice preparations and in integrated full field ERG responses from intact animals. This comparison reveals a high degree of correlation between single cell current clamp data and ERG measurements. A novel picture emerges showing that the temporal profile of the visual response to dim and bright luminance changes is separately determined by the coordinated gating of distinct voltage dependent conductances in photoreceptors and bipolar cells.	[Della Santina, Luca; Cangiano, Lorenzo; Caputo, Antonella] Univ Pisa, Dept Physiol Sci, Pisa, Italy; [Piano, Ilaria] GB Bietti Fdn Ophthalmol, Rome, Italy; [Ludwig, Andreas] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Cervetto, Luigi; Gargini, Claudia] Univ Pisa, Dept Psychiat & Neurobiol, Pisa, Italy	University of Pisa; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University of Erlangen Nuremberg; University of Pisa	Della Santina, L (corresponding author), Univ Pisa, Dept Physiol Sci, Pisa, Italy.	gargini@farm.unipi.it	Cangiano, Lorenzo/F-1482-2019; Della Santina, Luca/J-9795-2016	Cangiano, Lorenzo/0000-0001-7145-1288; Della Santina, Luca/0000-0001-6036-1295; GARGINI, MARIA CLAUDIA/0000-0002-4992-9086; piano, ilaria/0000-0002-5073-7583	Italian Ministry of Research, Research Programme of National Relevance (PRIN), Ministery of Public Instruction of the University and Scientific Research (MIUR)	Italian Ministry of Research, Research Programme of National Relevance (PRIN), Ministery of Public Instruction of the University and Scientific Research (MIUR)	Financial support was provided by the Italian Ministry of Research, Research Programme of National Relevance (PRIN), Ministery of Public Instruction of the University and Scientific Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTWELL D, 1980, J PHYSIOL-LONDON, V309, P287, DOI 10.1113/jphysiol.1980.sp013509; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BAYLOR DA, 1984, J PHYSIOL-LONDON, V354, P203, DOI 10.1113/jphysiol.1984.sp015372; BEECH DJ, 1989, NEURON, V3, P573, DOI 10.1016/0896-6273(89)90267-5; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; Cangiano L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001327; Chen XD, 2009, J NEUROPHYSIOL, V101, P129, DOI 10.1152/jn.01352.2007; Della Santina L, 2010, INVEST OPHTH VIS SCI, V51, P1016, DOI 10.1167/iovs.09-3680; Demontis GC, 2002, NEWS PHYSIOL SCI, V17, P110, DOI 10.1152/nips.01364.2001; Demontis GC, 2005, J NEUROSCI METH, V146, P13, DOI 10.1016/j.jneumeth.2005.01.007; Demontis GC, 1999, J PHYSIOL-LONDON, V515, P813, DOI 10.1111/j.1469-7793.1999.813ab.x; Demontis GC, 2009, INVEST OPHTH VIS SCI, V50, P1948, DOI 10.1167/iovs.08-2659; DETWILER PB, 1980, J PHYSIOL-LONDON, V300, P213, DOI 10.1113/jphysiol.1980.sp013159; FAIN GL, 1978, NATURE, V272, P467, DOI 10.1038/272467a0; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Gargini C, 1999, VISION RES, V39, P1759, DOI 10.1016/S0042-6989(98)00281-8; HESTRIN S, 1987, J PHYSIOL-LONDON, V390, P319, DOI 10.1113/jphysiol.1987.sp016703; Kawai F, 2002, BRAIN RES, V943, P48, DOI 10.1016/S0006-8993(02)02531-3; Knop GC, 2008, EUR J NEUROSCI, V28, P2221, DOI 10.1111/j.1460-9568.2008.06512.x; Lauritzen I, 2003, J BIOL CHEM, V278, P32068, DOI 10.1074/jbc.M302631200; Liu XD, 2004, ANN BIOMED ENG, V32, P1428, DOI 10.1114/B:ABME.0000042230.99614.8d; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; MARICQ AV, 1990, J NEUROPHYSIOL, V64, P1917, DOI 10.1152/jn.1990.64.6.1917; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; OWEN WG, 1983, BIOPHYS J, V41, P325, DOI 10.1016/S0006-3495(83)84444-0; PUIL E, 1986, J NEUROPHYSIOL, V55, P995, DOI 10.1152/jn.1986.55.5.995; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; TORRE V, 1983, BIOPHYS J, V41, P305, DOI 10.1016/S0006-3495(83)84443-9	33	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29812	10.1371/journal.pone.0029812	http://dx.doi.org/10.1371/journal.pone.0029812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279546	Green Published, gold, Green Submitted			2022-12-25	WOS:000299771900024
J	Li, H; Wang, JX; Wu, DD; Wang, HW; Tang, NLS; Zhang, YP				Li, Hui; Wang, Jia-Xin; Wu, Dong-Dong; Wang, Hua-Wei; Tang, Nelson Leung-Sang; Zhang, Ya-Ping			The Origin and Evolution of Variable Number Tandem Repeat of CLEC4M Gene in the Global Human Population	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DC-SIGNR GENE; HIV-1 SUSCEPTIBILITY; REGION POLYMORPHISMS; ENDOTHELIAL-CELLS; NECK-REGION; INFECTION; NONINTEGRIN; RECEPTORS; DIVERSITY	CLEC4M is a C-type lectin gene serving as cell adhesion receptor and pathogen recognition receptor. It recognizes several pathogens of important public health concern. In particular, a highly polymorphic variable number tandem repeat (VNTR) at the neck-region of CLEC4M had been associated with genetic predisposition to some infectious diseases. To gain insight into the origin and evolution of this VNTR in CLEC4M, we studied 21 Africans, 20 Middle Easterns, 35 Europeans, 38 Asians, 13 Oceania, and 18 Americans (a total of 290 chromosomes) from the (Human Genome Diversity Panel) HGDP-CEPH panel; these samples covered most of alleles of this VNTR locus present in human populations. We identified a limited number of haplotypes among the basic repeat subunits that is 69 base pairs in length. Only 8 haplotypes were found. Their sequence identities were determined in the 290 chromosomes. VNTR alleles of different repeat length (from 4 to 9 repeats) were analyzed for composition and orientation of these subunits. Our results showed that the subunit configuration of the same repeat number of VNTR locus from different populations were, in fact, virtually identical. It implies that most of the VNTR alleles existed before dispersion of modern humans outside Africa. Further analyses indicate that the present diversity profile of this locus in worldwide populations is generated from the effect of migration of different tribes and neutral evolution. Our findings do not support the hypothesis that the origin of the VNTR alleles were arisen by independent (separate) mutation events and caused by differential allele advantage and natural selection as suggested by previous report based on SNP data.	[Li, Hui] Southeast Univ, Sch Med, Dept Genet & Dev Biol, Nanjing, Jiangsu, Peoples R China; [Li, Hui] Southeast Univ, Key Lab Dev Genes & Human Dis, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Li, Hui; Wu, Dong-Dong; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Wang, Jia-Xin; Wang, Hua-Wei; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Wang, Jia-Xin; Wang, Hua-Wei; Zhang, Ya-Ping] Yunnan Univ, Key Lab Microbial Resources, Ministery Educ, Kunming, Peoples R China; [Wu, Dong-Dong; Tang, Nelson Leung-Sang; Zhang, Ya-Ping] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Peoples R China; [Tang, Nelson Leung-Sang] Chinese Univ Hong Kong, Dept Chem Pathol, Fac Med, Shatin, Hong Kong, Peoples R China; [Tang, Nelson Leung-Sang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Tang, Nelson Leung-Sang] Chinese Univ Hong Kong, Shenzhen Res Inst, Funct Genom & Biostat Comp Lab, Shatin, Hong Kong, Peoples R China	Southeast University - China; Southeast University - China; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Yunnan University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Li, H (corresponding author), Southeast Univ, Sch Med, Dept Genet & Dev Biol, Nanjing, Jiangsu, Peoples R China.	nelsontang@cuhk.edu.hk; zhangyp1@263.net.cn	Tang, Nelson L/P-5018-2017; Wu, Dong-Dong/AAR-5615-2020	Tang, Nelson L/0000-0002-3607-5819; 	Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China [31000955]	Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Science and Technology Committee of Yunnan Province, and the National Natural Science Foundation of China (31000955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Barreiro LB, 2007, HUM IMMUNOL, V68, P106, DOI 10.1016/j.humimm.2006.10.020; Barreiro LB, 2006, J INFECT DIS, V194, P1184, DOI 10.1086/507845; Bashirova AA, 2003, J VIROL, V77, P217, DOI 10.1128/JVI.77.1.217-227.2003; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002; Cann HM, 2002, SCIENCE, V296, P261; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Gardner JP, 2003, P NATL ACAD SCI USA, V100, P4498, DOI 10.1073/pnas.0831128100; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Li H, 2008, J MED GENET, V45, P752, DOI 10.1136/jmg.2008.058966; Lichterfeld M, 2003, CLIN IMMUNOL, V107, P55, DOI 10.1016/S1521-6616(02)00050-5; Liu HL, 2006, J INFECT DIS, V193, P698, DOI 10.1086/499820; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Nattermann J, 2006, J VIRAL HEPATITIS, V13, P42, DOI 10.1111/j.1365-2893.2005.00652.x; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tang NLS, 2007, NAT GENET, V39, P690, DOI 10.1038/ng0607-692; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weiss K M, 1997, Houst Law Rev, V33, P1431	25	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30268	10.1371/journal.pone.0030268	http://dx.doi.org/10.1371/journal.pone.0030268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279577	gold, Green Submitted, Green Published			2022-12-25	WOS:000299771900054
J	Seeliger, JC; Topp, S; Sogi, KM; Previti, ML; Gallivan, JP; Bertozzi, CR				Seeliger, Jessica C.; Topp, Shana; Sogi, Kimberly M.; Previti, Mary L.; Gallivan, Justin P.; Bertozzi, Carolyn R.			A Riboswitch-Based Inducible Gene Expression System for Mycobacteria	PLOS ONE			English	Article							TUBERCULOSIS	Research on the human pathogen Mycobacterium tuberculosis (Mtb) would benefit from novel tools for regulated gene expression. Here we describe the characterization and application of a synthetic riboswitch-based system, which comprises a mycobacterial promoter for transcriptional control and a riboswitch for translational control. The system was used to induce and repress heterologous protein overexpression reversibly, to create a conditional gene knockdown, and to control gene expression in a macrophage infection model. Unlike existing systems for controlling gene expression in Mtb, the riboswitch does not require the co-expression of any accessory proteins: all of the regulatory machinery is encoded by a short DNA segment directly upstream of the target gene. The inducible riboswitch platform has the potential to be a powerful general strategy for creating customized gene regulation systems in Mtb.	[Seeliger, Jessica C.; Previti, Mary L.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Topp, Shana; Sogi, Kimberly M.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Gallivan, Justin P.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Gallivan, Justin P.] Emory Univ, Ctr Fundamental & Appl Mol Evolut, Atlanta, GA 30322 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Emory University; Emory University	Seeliger, JC (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	crb@berkeley.edu	Seeliger, Jessica/J-3344-2014	Seeliger, Jessica/0000-0001-7148-1073	Cancer Research Institute; National Institutes of Health [AI51622, GM074070]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051622, R37AI051622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074070] Funding Source: NIH RePORTER	Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ST was supported in part by a postdoctoral fellowship from the Cancer Research Institute (http://www.cancerresearch.org/). This work was funded by National Institutes of Health (http://www.nih.gov/) grants AI51622 (to CRB) and GM074070 (to JPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Brown AC, 2006, PLASMID, V55, P81, DOI 10.1016/j.plasmid.2005.06.005; Carroll P, 2005, APPL ENVIRON MICROB, V71, P3077, DOI 10.1128/AEM.71.6.3077-3084.2005; Carroll P, 2007, FEMS MICROBIOL LETT, V274, P73, DOI 10.1111/j.1574-6968.2007.00842.x; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; Hillmann D, 2007, J BACTERIOL, V189, P958, DOI 10.1128/JB.01474-06; Hinds J, 1999, MICROBIOL-UK, V145, P519, DOI 10.1099/13500872-145-3-519; Judson N, 2000, TRENDS MICROBIOL, V8, P521, DOI 10.1016/S0966-842X(00)01865-5; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Miesel L, 2003, NAT REV GENET, V4, P442, DOI 10.1038/nrg1086; P Balbas, 2004, RECOMBINANT GENE EXP, P494; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Parish T, 1997, FEMS MICROBIOL LETT, V154, P151, DOI 10.1016/S0378-1097(97)00317-0; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Sassetti Christopher M., 2008, V465, P255, DOI 10.1007/978-1-59745-207-6_17; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Topp S, 2010, APPL ENVIRON MICROB, V76, P7881, DOI 10.1128/AEM.01537-10; Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139	28	42	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e29266	10.1371/journal.pone.0029266	http://dx.doi.org/10.1371/journal.pone.0029266			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279533	gold, Green Submitted, Green Published			2022-12-25	WOS:000299771900011
J	Xie, XQ; Li, F; Ying, SH; Feng, MG				Xie, Xue-Qin; Li, Fang; Ying, Sheng-Hua; Feng, Ming-Guang			Additive Contributions of Two Manganese-Cored Superoxide Dismutases (MnSODs) to Antioxidation, UV Tolerance and Virulence of Beauveria bassiana	PLOS ONE			English	Article							CANDIDA-ALBICANS; CRYPTOCOCCUS-NEOFORMANS; AGROBACTERIUM-TUMEFACIENS; TRANSFORMATION SYSTEM; NEUROSPORA-CRASSA; GENE; STRESS; CONIDIATION; EXPRESSION; SEQUENCES	The biocontrol potential of entomopathogenic fungi against arthropod pests depends on not only their virulence to target pests but tolerance to outdoor high temperature and solar UV irradiation. Two Beauveria bassiana superoxide dismutases (SODs), BbSod2 and BbSod3, were characterized as cytosolic and mitochondrial manganese-cored isoenzymes (MnSODs) dominating the total SOD activity of the fungal entomopathogen under normal growth conditions. To probe their effects on the biocontrol potential of B. bassiana, Delta BbSod2, Delta BbSod3, and three hairpin RNA-interfered (RNAi) mutants with the transcripts of both BbSod2 and BbSod3 being suppressed by 91-97% were constructed and assayed for various phenotypic parameters in conjunction with Delta BbSod2/BbSod2, Delta BbSod3/BbSod3 and wild-type (control strains). In normal cultures, the knockout and RNAi mutants showed significant phenotypic alterations, including delayed sporulation, reduced conidial yields, and impaired conidial quality, but little change in colony morphology. Their mycelia or conidia became much more sensitive to menadione or H2O2-induced oxidative stress but had little change in sensitivity to the hyperosmolarity of NaCl and the high temperature of 45 degrees C. Accompanied with the decreased antioxidative capability, conidial tolerances to UV-A and UV-B irradiations were reduced by 16.8% and 45.4% for Delta BbSod2, 18.7% and 44.7% for Delta BbSod3, and,33.7% and,63.8% for the RNAi mutants, respectively. Their median lethal times (LT(50)s) against Myzus persicae apterae, which were topically inoculated under a standardized spray, were delayed by 18.8%, 14.5% and 37.1%, respectively. Remarkably, the effects of cytosolic BbSod2 and mitochondrial BbSod3 on the phenotypic parameters important for the fungal bioncontrol potential were additive, well in accordance with the decreased SOD activities and the increased superoxide levels in the knockout and RNAi mutants. Our findings highlight for the first time that the two MnSODs co-contribute to the biocontrol potential of B. bassiana by mediating cellular antioxidative response.	[Xie, Xue-Qin; Li, Fang; Ying, Sheng-Hua; Feng, Ming-Guang] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xie, XQ (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	mgfeng@zju.edu.cn			Natural Science Foundation of China [30930018, 31021033]; Ministry of Science and Technology [2009CB118904, 2011AA10A204]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Natural Science Foundation of China (Grant Nos.: 30930018 and 31021033) and the Ministry of Science and Technology (Grant Nos.: 2009CB118904 and 2011AA10A204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba S, 2009, MOL PLANT MICROBE IN, V22, P1412, DOI 10.1094/MPMI-22-11-1412; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; BANNISTER JV, 1987, CRC CR REV BIOCH MOL, V22, P111, DOI 10.3109/10409238709083738; Belozerskaya TA, 2006, MICROBIOLOGY+, V75, P427, DOI 10.1134/S0026261706040102; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Duarte RTD, 2007, LETT APPL MICROBIOL, V44, P248, DOI 10.1111/j.1472-765X.2006.02092.x; Dziadkowiec D, 2007, FOLIA MICROBIOL, V52, P120, DOI 10.1007/BF02932150; Fang GC, 2002, FUNGAL GENET BIOL, V36, P155, DOI 10.1016/S1087-1845(02)00008-7; Fang WG, 2006, CAN J MICROBIOL, V52, P623, DOI 10.1139/W06-014; FENG MG, 1994, BIOCONTROL SCI TECHN, V127, P3; Frealle E, 2006, MOL PHYLOGENET EVOL, V41, P28, DOI 10.1016/j.ympev.2006.05.001; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Giles SS, 2005, EUKARYOT CELL, V4, P46, DOI 10.1128/EC.4.1.46-54.2005; Hwang CS, 2003, YEAST, V20, P929, DOI 10.1002/yea.1004; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Jeong JH, 2001, BIOCHEM BIOPH RES CO, V283, P908, DOI 10.1006/bbrc.2001.4853; Karlsson M, 2005, PHYSIOL MOL PLANT P, V66, P99, DOI 10.1016/j.pmpp.2005.05.004; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; Lamarre C, 2001, J BIOL CHEM, V276, P43784, DOI 10.1074/jbc.M108095200; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2006, FEMS MICROBIOL LETT, V261, P224, DOI 10.1111/j.1574-6968.2006.00367.x; MARKLUND S, 1974, EUR J BIOCHEM, V47, P248; Moore S, 2002, MOL PLANT PATHOL, V3, P9, DOI 10.1046/j.1464-6722.2001.00088.x; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; PARKER MW, 1988, FEBS LETT, V229, P377, DOI 10.1016/0014-5793(88)81160-8; PFANNER N, 1990, ANNU REV BIOCHEM, V59, P331, DOI 10.1146/annurev.biochem.59.1.331; Scott B, 2008, CURR OPIN MICROBIOL, V11, P488, DOI 10.1016/j.mib.2008.10.008; Wintjens R, 2004, J BIOL CHEM, V279, P9248, DOI 10.1074/jbc.M312329200; Xie XQ, 2010, APPL MICROBIOL BIOT, V86, P1543, DOI 10.1007/s00253-010-2437-2; Xie XQ, 2010, ENZYME MICROB TECH, V46, P217, DOI 10.1016/j.enzmictec.2009.09.005; Yao SL, 2010, BIOCONTROL, V55, P413, DOI 10.1007/s10526-009-9265-2; Ye SD, 2005, ANN APPL BIOL, V146, P459, DOI 10.1111/j.1744-7348.2005.040147.x; Ying SH, 2006, APPL MICROBIOL BIOT, V72, P206, DOI 10.1007/s00253-006-0447-x; Yoshida Y, 2008, MOL GENET GENOMICS, V279, P193, DOI 10.1007/s00438-007-0308-z; Zhang SZ, 2010, APPL MICROBIOL BIOT, V87, P1151, DOI 10.1007/s00253-010-2636-x; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	41	145	151	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30298	10.1371/journal.pone.0030298	http://dx.doi.org/10.1371/journal.pone.0030298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279579	Green Submitted, Green Published, gold			2022-12-25	WOS:000299771900056
J	Xiao, CX; He, MH; Nan, Y; Zhang, DJ; Chen, BY; Guan, YF; Pu, ML				Xiao, Chunxia; He, Meihua; Nan, Yan; Zhang, Dongjuan; Chen, Baiyu; Guan, Youfei; Pu, Mingliang			Physiological Effects of Superoxide Dismutase on Altered Visual Function of Retinal Ganglion Cells in db/db Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; MITOCHONDRIAL SUPEROXIDE; DIABETIC-RETINOPATHY; RESPONSE PROPERTIES; BARRIER BREAKDOWN; ABNORMALITIES; APOPTOSIS; DYSFUNCTION; DEATH; RAT	Background: The C57BLKS/J db/db (db/db) mouse is a widely used type 2 diabetic animal model, and this model develops early inner retinal neuronal dysfunction beginning at 24 weeks. The neural mechanisms that mediate early stage retinal dysfunction in this model are unknown. We evaluated visual response properties of retinal ganglion cells (RGCs) during the early stage of diabetic insult (8, 12, and 20 wk) in db/db mice and determined if increased oxidative stress plays a role in impaired visual functions of RGCs in 20 wk old db/db mice. Methodology/Principal Findings: In vitro extracellular single-unit recordings from RGCs in wholemount retinas were performed. The receptive field size, luminance threshold, and contrast gain of the RGCs were investigated. Although ON- and OFF-RGCs showed a different time course of RF size reduction, by 20 wk, the RF of ON-and OFF-RGCs were similarly affected. The LT of ON-RGCs was significantly elevated in 12 and 20 wk db/db mice compared to the LT of OFF-RGCs. The diabetic injury also affected contrast gains of ON-and OFF-RGCs differently. The generation of reactive oxidative species (ROS) in fresh retina was estimated by dihydroethidium. Superoxide dismutase (SOD) (300 unit/ml) was applied in Ames medium to the retina, and visual responses of RGCs were recorded for five hours. ROS generation in the retinas of db/db mice increased at 8wk and continued to progress at 20 wk of ages. In vitro application of SOD improved visual functions in 20 wk db/db mice but the SOD treatment affected ON-and OFF-RGCs differently in db/m retina. Conclusions/Significance: The altered visual functions of RGCs were characterized by the reduced RF center size, elevated LT, and attenuated contrast gain in 12 and 20 wk db/db mice, respectively. These altered visual functions could, at least partly, be due to oxidative stress since in vitro application of SOD effectively improves visual functions.	[Xiao, Chunxia; He, Meihua; Nan, Yan; Chen, Baiyu; Pu, Mingliang] Peking Univ, Dept Anat, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Xiao, Chunxia; He, Meihua; Nan, Yan; Chen, Baiyu; Pu, Mingliang] Peking Univ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [Xiao, Chunxia; He, Meihua; Nan, Yan; Pu, Mingliang] Peking Univ, Key Lab Visual Impairment & Restore, Beijing 100871, Peoples R China; [Zhang, Dongjuan; Guan, Youfei] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Xiao, CX (corresponding author), Peking Univ, Dept Anat, Sch Basic Med Sci, Beijing 100871, Peoples R China.	youfeiguan@bjmu.edu.cn; mpu@hsc.pku.edu.cn	He, Meihua/D-4312-2017	guan, youfei/0000-0002-5231-0209	National Science Foundation of China [30831160516, 30890041]; National Basic Research Program of China (973 Program) [2009CB320900, 2011CB510206, 2010CB912503]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Science Foundation of China grants (30831160516 to M. Pu and 30890041 to Y. Guan); National Basic Research Program of China (973 Program) (2009CB320900 and 2011CB510206 to M. Pu and 2010CB912503 to Y. Guan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 1997, FASEB J, V11, P154, DOI 10.1096/fasebj.11.2.9039958; Al-Gayyar MMH, 2011, DIABETOLOGIA, V54, P657; Ali TK, 2011, DIABETOLOGIA, V54, P657, DOI 10.1007/s00125-010-1935-1; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; AYLWARD GW, 1989, EYE, V3, P626, DOI 10.1038/eye.1989.97; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Barile GR, 2005, INVEST OPHTH VIS SCI, V46, P2916, DOI 10.1167/iovs.04-1409; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; BRESNICK GH, 1987, ARCH OPHTHALMOL-CHIC, V105, P810; BRESNICK GH, 1986, ARCH OPHTHALMOL-CHIC, V104, P989; Bui BV, 2009, EXP EYE RES, V88, P1076, DOI 10.1016/j.exer.2009.01.009; Bui BV, 2003, DIABETOLOGIA, V46, P401, DOI 10.1007/s00125-003-1042-7; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Davies N, 2003, VISION RES, V43, P2377, DOI 10.1016/S0042-6989(03)00405-X; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; El-Remessy AB, 2006, AM J PATHOL, V168, P235, DOI 10.2353/ajpath.2006.050500; El-Remessy AB, 2010, EXP DIABETES RES, DOI 10.1155/2010/247861; Ewing FME, 1998, ENDOCR REV, V19, P462, DOI 10.1210/er.19.4.462; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Fukuda M, 2011, EXP EYE RES, V92, P195, DOI 10.1016/j.exer.2011.01.001; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; GREENSTEIN VC, 1993, OPTOMETRY VISION SCI, V70, P18, DOI 10.1097/00006324-199301000-00005; Han Y, 2004, INVEST OPHTH VIS SCI, V45, P948, DOI 10.1167/iovs.03-1101; Kanamori A, 2010, BRAIN, V133, P2612, DOI 10.1093/brain/awq105; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; KODAMA H, 1994, DIABETOLOGIA, V37, P739, DOI 10.1007/s001250050173; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kowluru RA, 1997, FREE RADICAL BIO MED, V22, P587, DOI 10.1016/S0891-5849(96)00347-4; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Li WY, 1999, CELL MOL BIOL, V45, P59; Lieven CJ, 2006, INVEST OPHTH VIS SCI, V47, P1477, DOI 10.1167/iovs.05-0921; Maher P, 2005, INVEST OPHTH VIS SCI, V46, P749, DOI 10.1167/iovs.04-0883; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Nan Y, 2010, INVEST OPHTH VIS SCI, V51, P1208, DOI 10.1167/iovs.09-4179; Ng YK, 2004, BRAIN RES, V1018, P66, DOI 10.1016/j.brainres.2004.05.055; Ning X, 2004, INT J MOL MED, V13, P87; O'Connor JC, 2008, INVEST OPHTH VIS SCI, V49, P4237, DOI 10.1167/iovs.08-1963; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Phipps JA, 2006, INVEST OPHTH VIS SCI, V47, P3187, DOI 10.1167/iovs.05-1493; Pu ML, 2006, INVEST OPHTH VIS SCI, V47, P3579, DOI 10.1167/iovs.05-1450; Qi XP, 2003, INVEST OPHTH VIS SCI, V44, P1088, DOI 10.1167/iovs.02-0864; Qin YW, 2006, CURR EYE RES, V31, P967, DOI 10.1080/02713680600987674; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Seki M, 2004, DIABETES, V53, P2412, DOI 10.2337/diabetes.53.9.2412; Semkova I, 2010, EXP EYE RES, V90, P244, DOI 10.1016/j.exer.2009.10.012; SOKOL S, 1985, ARCH OPHTHALMOL-CHIC, V103, P51; Sugimoto M, 2005, OPHTHALMOLOGICA, V219, P379, DOI 10.1159/000088382; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tang L, 2011, EXP BIOL MED, V236, P1051, DOI 10.1258/ebm.2011.010400; Tzekov R, 1999, SURV OPHTHALMOL, V44, P53, DOI 10.1016/S0039-6257(99)00063-6; Vielma A, 2010, EXP EYE RES, V91, P700, DOI 10.1016/j.exer.2010.08.014	54	28	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30343	10.1371/journal.pone.0030343	http://dx.doi.org/10.1371/journal.pone.0030343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272340	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400118
J	Kumar, SM; Liu, S; Lu, H; Zhang, H; Zhang, PJ; Gimotty, PA; Guerra, M; Guo, W; Xu, X				Kumar, S. M.; Liu, S.; Lu, H.; Zhang, H.; Zhang, P. J.; Gimotty, P. A.; Guerra, M.; Guo, W.; Xu, X.			Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation	ONCOGENE			English	Article						Oct4; cancer stem cell; melanoma; dedifferentiation; hypoxia	MELANOMA-CELLS; INITIATING CELLS; GENE-EXPRESSION; HYPOXIA; DIFFERENTIATION; PROMOTES; OCT4; SUBPOPULATION; PLURIPOTENCY; GENERATION	There is enormous interest to target cancer stem cells (CSCs) for clinical treatment because these cells are highly tumorigenic and resistant to chemotherapy. Oct4 is expressed by CSC-like cells in different types of cancer. However, function of Oct4 in tumor cells is unclear. In this study, we showed that expression of Oct4 gene or transmembrane delivery of Oct4 protein promoted dedifferentiation of melanoma cells to CSC-like cells. The dedifferentiated melanoma cells showed significantly decreased expression of melanocytic markers and acquired the ability to form tumor spheroids. They showed markedly increased resistance to chemotherapeutic agents and hypoxic injury. In the subcutaneous xenograft and tail vein injection assays, these cells had significantly increased tumorigenic capacity. The dedifferentiated melanoma cells acquired features associated with CSCs such as multipotent differentiation capacity and expression of melanoma CSC markers such as ABCB5 and CD271. Mechanistically, Oct4-induced dedifferentiation was associated with increased expression of endogenous Oct4, Nanog and Klf4, and global gene expression changes that enriched for transcription factors. RNAi-mediated knockdown of Oct4 in dedifferentiated cells led to diminished CSC phenotypes. Oct4 expression in melanoma was regulated by hypoxia and its expression was detected in a sub-population of melanoma cells in clinical samples. Our data indicate that Oct4 is a positive regulator of tumor dedifferentiation. The results suggest that CSC phenotype is dynamic and may be acquired through dedifferentiation. Oct4-mediated tumor cell dedifferentiation may have an important role during tumor progression. Oncogene (2012) 31, 4898-4911; doi:10.1038/onc.2011.656; published online 30 January 2012	[Xu, X.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lu, H.; Guo, W.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Gimotty, P. A.; Guerra, M.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Xu, X (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 3400 Spruce St, Philadelphia, PA 19104 USA.	xug@mail.med.upenn.edu	Gimotty, Phyllis/GWZ-4136-2022	Gimotty, Phyllis/0000-0002-3850-9799; Zhang, Hongtao/0000-0001-9173-0049; Liu, Shujing/0000-0002-2958-093X	National Institute of Health [AR-054593, CA-116103, CA-093372]; NATIONAL CANCER INSTITUTE [P50CA093372, R21CA116103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085146] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr M Herlyn (The Wistar Institute) for providing the melanoma cell lines; Dr GQ Daley (Harvard) for providing shRNA to Oct4; Dr W Lee (University of Pennsylvania) for suggestions to manuscript editing. This work was supported by the grants AR-054593, CA-116103 and CA-093372 from National Institute of Health to XX.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENNETT DC, 1983, CELL, V34, P445, DOI 10.1016/0092-8674(83)90378-1; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Daley GQ, 2008, COLD SH Q B, V73, P171, DOI 10.1101/sqb.2008.73.041; GABBERT H, 1985, CLIN EXP METASTAS, V3, P257, DOI 10.1007/BF01585081; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Helczynska K, 2003, CANCER RES, V63, P1441; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hu L, 2010, BRIT J CANCER, V102, P1276, DOI 10.1038/sj.bjc.6605626; Hu TS, 2008, CANCER RES, V68, P6533, DOI 10.1158/0008-5472.CAN-07-6642; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Kang SK, 2006, STEM CELLS DEV, V15, P423, DOI 10.1089/scd.2006.15.423; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kumar SM, 2007, CANCER RES, V67, P3177, DOI 10.1158/0008-5472.CAN-06-3312; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Li ZZ, 2010, CURR TOP MICROBIOL, V345, P21, DOI 10.1007/82_2010_75; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Masuda K, 2006, ONCOGENE, V25, P7740, DOI 10.1038/sj.onc.1209745; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Strizzi L, 2008, CELL CYCLE, V7, P1931, DOI 10.4161/cc.7.13.6236; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Yu H, 2010, J INVEST DERMATOL, V130, P1227, DOI 10.1038/jid.2009.322; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zhang XY, 2010, JPN J CLIN ONCOL, V40, P961, DOI 10.1093/jjco/hyq066; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	46	230	243	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	47					4898	4911		10.1038/onc.2011.656	http://dx.doi.org/10.1038/onc.2011.656			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	041VU	22286766	Green Accepted			2022-12-25	WOS:000311430200002
J	Li, X; Gao, L; Cui, Q; Gary, BD; Dyess, DL; Taylor, W; Shevde, LA; Samant, RS; Dean-Colomb, W; Piazza, GA; Xi, Y				Li, X.; Gao, L.; Cui, Q.; Gary, B. D.; Dyess, D. L.; Taylor, W.; Shevde, L. A.; Samant, R. S.; Dean-Colomb, W.; Piazza, G. A.; Xi, Y.			Sulindac inhibits tumor cell invasion by suppressing NF-kappa B-mediated transcription of microRNAs	ONCOGENE			English	Article						sulindac; invasion; microRNA; NF-kappa B	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLON-CANCER; BREAST-CANCER; REDUCED EXPRESSION; E-CADHERIN; RT-PCR; APOPTOSIS; INDUCTION; GENES; METASTASIS	Non-steroidal anti-inflammatory drugs (NSAIDs) have been widely reported to display strong efficacy for cancer chemoprevention, although their mechanism of action is poorly understood. The most well-documented effects of NSAIDs include inhibition of tumor cell proliferation and induction of apoptosis, but their effect on tumor cell invasion has not been well studied. Here, we show that the NSAID, sulindac sulfide (SS) can potently inhibit the invasion of human MDA-MB-231 breast and HCT116 colon tumor cells in vitro at concentrations less than those required to inhibit tumor cell growth. To study the molecular basis for this activity, we investigated the involvement of microRNA (miRNA). A total of 132 miRNAs were found to be altered in response to SS treatment, including miR-10b, miR-17, miR-21 and miR-9, which have been previously implicated in tumor invasion and metastasis. We confirmed that these miRNA can stimulate tumor cell invasion and show that SS can attenuate their invasive effects by downregulating their expression. Employing luciferase and chromatin immunoprecipitation assays, NF-kappa B was found to bind the promoters of all four miRNAs to suppress their expression at the transcriptional level. We show that SS can inhibit the translocation of NF-kappa B to the nucleus by decreasing the phosphorylation of IKK beta and I kappa B. Analysis of the promoter sequences of the miRNAs suppressed by SS revealed that 81 of 115 sequences contained NF-kappa B-binding sites. These results show that SS can inhibit tumor cell invasion by suppressing NF-kappa B-mediated transcription of miRNAs. Oncogene (2012) 31, 4979-4986; doi:10.1038/onc.2011.655; published online 30 January 2012	[Li, X.; Gao, L.; Gary, B. D.; Taylor, W.; Shevde, L. A.; Samant, R. S.; Dean-Colomb, W.; Piazza, G. A.; Xi, Y.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36604 USA; [Cui, Q.] Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China; [Dyess, D. L.] Univ S Alabama, Dept Surg, Mobile, AL 36604 USA	University of South Alabama; Peking University; University of South Alabama	Xi, Y (corresponding author), Univ S Alabama, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	xi@usouthal.edu		Xi, Yaguang/0000-0003-3681-9352; Samant, Rajeev/0000-0001-5681-4976; Piazza, Gary/0000-0003-4418-887X	National Cancer Institute [R01CA148817]; NATIONAL CANCER INSTITUTE [R01CA148817, R01CA155638, R01CA140472, R21CA160280, R01CA131378] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the institutional start-up funding (Dr Yaguang Xi) and the National Cancer Institute grant R01CA148817 (Dr Gary A Piazza). We sincerely appreciate Mrs Margaret Sullivan for proof-reading the manuscript.	Agarwal B, 2003, APOPTOSIS, V8, P649, DOI 10.1023/A:1026199929747; ALBERTS DS, 1995, J CELL BIOCHEM, P18; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; BeazerBarclay Y, 1996, CARCINOGENESIS, V17, P1757, DOI 10.1093/carcin/17.8.1757; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Brown JWS, 2008, TRENDS PLANT SCI, V13, P335, DOI 10.1016/j.tplants.2008.04.010; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Elder DJE, 1997, CLIN CANCER RES, V3, P1679; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Gefen N, 2010, LEUKEMIA, V24, P89, DOI 10.1038/leu.2009.208; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Hanif R, 1996, BIOCHEM PHARMACOL, V52, P237, DOI 10.1016/0006-2952(96)00181-5; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huang GL, 2009, ONCOL REP, V21, P673, DOI 10.3892/or_00000270; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang MC, 2001, BIOCHEM BIOPH RES CO, V282, P671, DOI 10.1006/bbrc.2001.4637; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kashfi K, 2005, BIOCHEM PHARMACOL, V70, P969, DOI 10.1016/j.bcp.2005.05.004; Lee HC, 2005, J CELL BIOCHEM, V94, P597, DOI 10.1002/jcb.20312; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HL, 2011, BREAST CANCER RES TR, V126, P565, DOI 10.1007/s10549-010-0954-4; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; LUNDHOLM K, 1994, CANCER RES, V54, P5602; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mahmoud NN, 1998, CARCINOGENESIS, V19, P87, DOI 10.1093/carcin/19.1.87; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; NABEL GJ, 1993, GENE DEV, V7, P2063, DOI 10.1101/gad.7.11.2063; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; PIAZZA GA, 1995, CANCER RES, V55, P3110; Piazza GA, 1997, CANCER RES, V57, P2909; Piazza GA, 1997, CANCER RES, V57, P2452; Piazza GA, 2009, CANCER PREV RES, V2, P572, DOI 10.1158/1940-6207.CAPR-09-0001; Rigas B, 2000, MED HYPOTHESES, V54, P210, DOI 10.1054/mehy.1999.0023; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Seo AM, 2009, APOPTOSIS, V14, P913, DOI 10.1007/s10495-009-0367-1; Shah SA, 2006, INT J CANCER, V118, P532, DOI 10.1002/ijc.21365; Singh B, 2006, J SURG RES, V131, P267, DOI 10.1016/j.jss.2005.11.582; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Smalley W, 1999, ARCH INTERN MED, V159, P161, DOI 10.1001/archinte.159.2.161; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Stein U, 2011, NEOPLASIA, V13, P131, DOI 10.1593/neo.101172; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Thompson HJ, 1997, CANCER RES, V57, P267; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	73	58	60	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	48					4979	4986		10.1038/onc.2011.655	http://dx.doi.org/10.1038/onc.2011.655			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	048CU	22286762	Green Accepted			2022-12-25	WOS:000311888600002
J	Samanta, S; Sharma, VM; Khan, A; Mercurio, AM				Samanta, S.; Sharma, V. M.; Khan, A.; Mercurio, A. M.			Regulation of IMP3 by EGFR signaling and repression by ER beta: implications for triple-negative breast cancer	ONCOGENE			English	Article						breast cancer; IMP3; ER beta; EGFR	GROWTH-FACTOR RECEPTOR; RNA-BINDING PROTEIN; ESTROGEN-RECEPTOR; MESSENGER-RNA; CELL-PROLIFERATION; EXPRESSION; CARCINOMA; ACTIVATION; KINASE; BIOMARKER	Insulin-like growth factor II (IGF-II) mRNA-binding protein 3 (IMP3) is emerging as a useful indicator of the progression and outcome of several cancers. IMP3 expression is associated with triple-negative breast carcinomas (TNBCs), which are aggressive tumors associated with poor outcome. In this study, we addressed the hypothesis that signaling pathways, which are characteristic of TNBCs, impact the expression of IMP3 and that IMP3 contributes to the function of TNBCs. The data obtained reveal that IMP3 expression is repressed specifically by estrogen receptor beta (ER beta) and its ligand 3 beta A-diol but not by ER alpha. Epidermal growth factor receptor (EGFR) signaling and consequent activation of the mitogen-activated protein kinase pathway induce IMP3 transcription and expression. Interestingly, we discovered that the EGFR promoter contains an imperfect estrogen response element and that ER beta represses EGFR transcription. These data support a mechanism in which ER beta inhibits IMP3 expression indirectly by repressing the EGFR. This mechanism relates to the biology of TNBC, which is characterized by diminished ER beta and increased EGFR expression. We also demonstrate that IMP3 contributes to the migration and invasion of breast carcinoma cells. Given that IMP3 is an mRNA-binding protein, we determined that it binds several key mRNAs that could contribute to migration and invasion, including CD164 (endolyn) and MMP9. Moreover, expression of these mRNAs is repressed by ER beta and enhanced by EGFR signaling, consistent with our proposed mechanism for the regulation of IMP3 expression in breast cancer cells. Our findings show that IMP3 is an effector of EGFR-mediated migration and invasion and they provide the first indication of how this important mRNA-binding protein is regulated in cancer.	[Samanta, S.; Sharma, V. M.; Mercurio, A. M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Khan, A.] UMass Mem Med Ctr, Dept Pathol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 364 Plantat St,Lazare Res Bldg, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu			NIH [CA80789, 89209]; NATIONAL CANCER INSTITUTE [R01CA089209, R01CA080789] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH Grants CA80789 and 89209 supported this work. We thank Dr Xiofang Yang for her input into this project, and Drs Paul Mak and Hira Lal Goel for their valuable suggestions and technical assistance. We also thank Bryan Pursell for his technical support.	Agrawal A, 2005, ENDOCR-RELAT CANCER, V12, pS135, DOI 10.1677/erc.1.01059; Belotti D, 2003, CANCER RES, V63, P5224; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; CASTRO CG, 1993, ARCH GYNECOL OBSTET, V252, P169, DOI 10.1007/BF02426354; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Ellis MJ, 1998, BREAST CANCER RES TR, V52, P175, DOI 10.1023/A:1006127621512; Foley John, 2010, Semin Cell Dev Biol, V21, P951, DOI 10.1016/j.semcdb.2010.08.009; Guerini V, 2005, CANCER RES, V65, P5445, DOI 10.1158/0008-5472.CAN-04-1941; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Havens AM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-195; HELDIN CH, 1984, CELL, V37, P9, DOI 10.1016/0092-8674(84)90296-4; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Korsching E, 2008, J CLIN PATHOL, V61, P553, DOI 10.1136/jcp.2008.055475; Li CZ, 2007, MODERN PATHOL, V20, P242, DOI 10.1038/modpathol.3800735; Li DW, 2009, ANN SURG ONCOL, V16, P3499, DOI 10.1245/s10434-009-0648-5; Li S, 2011, HEAD NECK-J SCI SPEC, V33, P368, DOI 10.1002/hed.21457; Li Z, 2011, J BIOL CHEM, V286, P21164, DOI 10.1074/jbc.M110.207571; Liao BS, 2011, J BIOL CHEM, V286, P31145, DOI 10.1074/jbc.M111.263913; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; Lu D, 2011, AM J SURG PATHOL, V35, P1638, DOI 10.1097/PAS.0b013e31823272d4; Mak P, 2006, NEOPLASIA, V8, P896, DOI 10.1593/neo.06538; Marotti JD, 2010, MODERN PATHOL, V23, P197, DOI 10.1038/modpathol.2009.158; MARTINAZZI M, 1993, J CLIN PATHOL, V46, P1009, DOI 10.1136/jcp.46.11.1009; Mueller-Pillasch F, 1999, MECH DEVELOP, V88, P95, DOI 10.1016/S0925-4773(99)00160-4; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; NEWBY JC, 1995, BRIT J CANCER, V71, P1237, DOI 10.1038/bjc.1995.239; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Pinton G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014110; Reimers L, 1999, J BIOL CHEM, V274, P11022, DOI 10.1074/jbc.274.16.11022; Ryden L, 2010, BREAST CANCER RES TR, V120, P491, DOI 10.1007/s10549-010-0758-6; Scorilas A, 2001, BRIT J CANCER, V84, P1488, DOI 10.1054/bjoc.2001.1810; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Simon R, 2007, HUM PATHOL, V38, P1178, DOI 10.1016/j.humpath.2007.02.001; Suvasini R, 2011, J BIOL CHEM, V286, P25882, DOI 10.1074/jbc.M110.178012; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Van Meter TE, 2004, NEURO-ONCOLOGY, V6, P188, DOI 10.1215/S1152851703000486; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Webb Paul, 2003, Nucl Recept, V1, P4, DOI 10.1186/1478-1336-1-4; Xu L, 2010, ONCOGENE, V29, P2616, DOI 10.1038/onc.2010.16; Yantiss RK, 2005, AM J SURG PATHOL, V29, P188, DOI 10.1097/01.pas.0000149688.98333.54; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zeng ZS, 1999, CARCINOGENESIS, V20, P749, DOI 10.1093/carcin/20.5.749; Zhang XT, 2011, ONCOGENE, V30, P770, DOI 10.1038/onc.2010.458; Zheng WX, 2008, AM J SURG PATHOL, V32, P304, DOI 10.1097/PAS.0b013e3181483ff8	52	77	83	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2012	31	44					4689	4697		10.1038/onc.2011.620	http://dx.doi.org/10.1038/onc.2011.620			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	032MW	22266872	Green Accepted			2022-12-25	WOS:000310724400004
J	Jalava, SE; Urbanucci, A; Latonen, L; Waltering, KK; Sahu, B; Janne, OA; Seppala, J; Lahdesmaki, H; Tammela, TLJ; Visakorpi, T				Jalava, S. E.; Urbanucci, A.; Latonen, L.; Waltering, K. K.; Sahu, B.; Janne, O. A.; Seppala, J.; Lahdesmaki, H.; Tammela, T. L. J.; Visakorpi, T.			Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer	ONCOGENE			English	Article						neoplasia; prostatic; miR-32; BTG2; hormone refractory; androgen independent	MICRORNA EXPRESSION; RECEPTOR GENE; MESSENGER-RNAS; PROTEIN; CELLS; AMPLIFICATION; PROGNOSIS; MIR-148A; REGIONS; BINDING	The androgen receptor (AR) signaling pathway is involved in the emergence of castration-resistant prostate cancer (CRPC). Here, we identified several androgen-regulated microRNAs (miRNAs) that may contribute to the development of CRPC. Seven miRNAs, miR-21, miR-32, miR-99a, miR-99b, miR-148a, miR-221 and miR-590-5p, were found to be differentially expressed in CRPC compared with benign prostate hyperplasia (BPH) according to microarray analyses. Significant growth advantage for LNCaP cells transfected with pre-miR-32 and pre-miR-148a was found. miR-32 was demonstrated to reduce apoptosis, whereas miR-148a enhanced proliferation. Androgen regulation of miR-32 and miR-148a was confirmed by androgen stimulation of the LNCaP cells followed by expression analyses. The AR-binding sites in proximity of these miRNAs were demonstrated with chromatin immunoprecipitation (ChIP). To identify target genes for the miRNAs, mRNA microarray analyses were performed with LNCaP cells transfected with pre-miR-32 and pre-miR-148a. Expression of BTG2 and PIK3IP1 was reduced in the cells transfected with pre-miR-32 and pre-miR-148a, respectively. Also, the protein expression was reduced according to western blot analysis. BTG2 and PIK3IP1 were confirmed to be targets by 3'UTR-luciferase assays. Finally, immunostainings showed a statistically significant (P<0.0001) reduction of BTG2 protein in CRPCs compared with untreated prostate cancer (PC). The lack of BTG2 staining was also associated (P<0.01) with a short progression-free time in patients who underwent prostatectomy. In conclusion, androgen-regulated miR-32 is overexpressed in CRPC, leading to reduced expression of BTG2. Thus, miR-32 is a potential marker for aggressive disease and is a putative drug target in PC. Oncogene (2012) 31, 4460-4471; doi: 10.1038/onc.2011.624; published online 23 January 2012	[Jalava, S. E.; Urbanucci, A.; Latonen, L.; Waltering, K. K.; Visakorpi, T.] Tampere Univ, Inst Biomed Technol, FIN-33014 Tampere, Finland; [Sahu, B.; Janne, O. A.] Univ Helsinki, Inst Biomed Physiol, Helsinki, Finland; [Seppala, J.] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Lahdesmaki, H.] Aalto Univ, Sch Sci, Dept Informat & Comp Sci, Helsinki, Finland; [Tammela, T. L. J.] Univ Tampere, Dept Urol, FIN-33101 Tampere, Finland; [Tammela, T. L. J.] Tampere Univ Hosp, Tampere, Finland	Tampere University; University of Helsinki; Tampere University; Aalto University; Tampere University; Tampere University; Tampere University Hospital	Visakorpi, T (corresponding author), Tampere Univ, Inst Biomed Technol, FIN-33014 Tampere, Finland.	tapio.visakorpi@uta.fi	Urbanucci, Alfonso/S-4450-2019; Latonen, Leena/C-8787-2016; Sahu, Biswajyoti/U-6724-2017; Jackson, Benjamin L/C-4297-2012	Urbanucci, Alfonso/0000-0003-2931-3652; Latonen, Leena/0000-0003-4502-2193; Sahu, Biswajyoti/0000-0001-6576-5440; Visakorpi, Tapio/0000-0002-5004-0364	European Community [HEALTH-F2-2007-201438]; Academy of Finland; Cancer Society of Finland; Reino Lahtikari Foundation; Sigrid Juselius Foundation; Medical Research Fund of Tampere University Hospital	European Community(European Commission); Academy of Finland(Academy of Finland); Cancer Society of Finland; Reino Lahtikari Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Research Fund of Tampere University Hospital	We thank Ms Mariitta Vakkuri, Ms Paivi Martikainen and Mr Rolle Rahikainen for skillful technical assistance. The research leading to these results was funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. HEALTH-F2-2007-201438. In addition, grant support has been received from the Academy of Finland, the Cancer Society of Finland, the Reino Lahtikari Foundation, the Sigrid Juselius Foundation and the Medical Research Fund of Tampere University Hospital.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hong JW, 2005, J BIOL CHEM, V280, P21256, DOI 10.1074/jbc.M500318200; Hu XD, 2011, BIOCHEM BIOPH RES CO, V404, P903, DOI 10.1016/j.bbrc.2010.12.064; Jalava SE, 2009, INT J CANCER, V124, P95, DOI 10.1002/ijc.23916; Karvonen U, 1997, J BIOL CHEM, V272, P15973, DOI 10.1074/jbc.272.25.15973; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leinonen KA, 2010, CLIN CANCER RES, V16, P2845, DOI 10.1158/1078-0432.CCR-09-2505; Linja MJ, 2001, CANCER RES, V61, P3550; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Massard C, 2011, CLIN CANCER RES, V17, P3876, DOI 10.1158/1078-0432.CCR-10-2815; Mollerstrom E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-296; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Saramaki OR, 2008, CLIN CANCER RES, V14, P3395, DOI 10.1158/1078-0432.CCR-07-2051; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thompson J, 2006, EMBO J, V25, P2757, DOI 10.1038/sj.emboj.7601161; Tomlins SA, 2009, EUR UROL, V56, P275, DOI 10.1016/j.eururo.2009.04.036; Urbanucci A, 2012, ONCOGENE, V31, P2153, DOI 10.1038/onc.2011.401; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096	47	151	165	3	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2012	31	41					4460	4471		10.1038/onc.2011.624	http://dx.doi.org/10.1038/onc.2011.624			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	018YR	22266859				2022-12-25	WOS:000309704500004
J	Rao, A; Richards, TL; Simmons, D; Zahniser, NR; Sorkin, A				Rao, Anjali; Richards, Toni L.; Simmons, Diana; Zahniser, Nancy R.; Sorkin, Alexander			Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons	FASEB JOURNAL			English	Article						endocytosis; fluorescence imaging; amphetamine; endosome	NUCLEUS-ACCUMBENS; CELL-LINES; NEURONS; INTERNALIZATION; AMPHETAMINE; COCAINE; UBIQUITINATION; LOCALIZATION; MECHANISMS; MEMBRANES	The plasma membrane dopamine (DA) transporter (DAT) is essential for reuptake of extracellular DA. DAT function in heterologous cells is regulated by subcellular targeting, endocytosis, and intracellular trafficking, but the mechanisms regulating neuronal DAT remain poorly understood. Hence, we generated a knock-in mouse expressing a hemagglutinin (HA)-epitope-tagged DAT to study endogenous transporter trafficking. Introduction of the HA tag into the second extracellular loop of mouse DAT did not perturb its expression level, distribution pattern, or substrate uptake kinetics. Live-cell fluorescence microscopy imaging using fluorescently labeled HA-specific antibody and a quantitative HA-antibody endocytosis assay demonstrated that in axons HA-DAT was primarily located in the plasma membrane and internalized mostly in growth cones and varicosities, where synaptic vesicle markers were also concentrated. Formation of varicosities was frequently preceded or accompanied by highly dynamic filopodia-like membrane protrusions. Remarkably, HA-DAT often concentrated at the tips of these filopodia. This pool of HA-DATs exhibited low lateral membrane mobility. Thus, DAT-containing filopodia may be involved in synaptogenesis in developing DA neurons. Treatment of neurons with amphetamine increased mobility of filopodial HA-DAT and accelerated HA-DAT endocytosis in axons, suggesting that chronic amphetamine may interfere with DA synapse development. Interestingly, phorbol esters did not accelerate endocytosis of axonal DAT.-Rao, A., Richards, T. L., Simmons, D., Zahniser, N. R., Sorkin, A. Epitope-tagged dopamine transporter knock-in mice reveal rapid endocytic trafficking and filopodia targeting of the transporter in dopaminergic axons. FASEB J. 26, 1921-1933 (2012). www.fasebj.org	[Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Rao, Anjali; Richards, Toni L.; Simmons, Diana; Zahniser, Nancy R.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Colorado System; University of Colorado Anschutz Medical Campus	Sorkin, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S368 Biomed Sci Tower S,3500 Terrace St, Pittsburgh, PA 15261 USA.	sorkin@pitt.edu		Sorkin, Alexander/0000-0002-4446-1920	U.S. National Institutes of Health [R01 DA014204, F32 DA029357, K05 DA015050, T32 AA007464]; Transgenic Vectors Core of Rocky Mountain Neurological Disorders Core Center [University of Colorado-Anschutz Medical Campus (UC-AMC)];  [P30 NS048154]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014204, F32DA029357, K05DA015050] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transgenic Vectors Core of Rocky Mountain Neurological Disorders Core Center [University of Colorado-Anschutz Medical Campus (UC-AMC)]; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by U.S. National Institutes of Health grants R01 DA014204 (A. S., N.R.Z.), F32 DA029357 (A. R.), K05 DA015050 (N.R.Z.), and T32 AA007464 (D. S.), and the Transgenic Vectors Core of Rocky Mountain Neurological Disorders Core Center [University of Colorado-Anschutz Medical Campus (UC-AMC)], supported by P30 NS048154. The authors also thank Wallace Chick for help with making the HA-DAT mice, Dr. Rytis Prekeris (UC-AMC) for the Syntaxin13 antibody, and Dr. Trevor Williams (UC-AMC) for the beta-actin cre mice.	Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Daniel JA, 2009, J NEUROSCI, V29, P14670, DOI 10.1523/JNEUROSCI.1349-09.2009; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Gallo G, 2011, DEV NEUROBIOL, V71, P201, DOI 10.1002/dneu.20852; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Li PP, 2011, MOL BIOL CELL, V22, P2480, DOI 10.1091/mbc.E11-03-0198; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Matteoli M, 2004, TRENDS CELL BIOL, V14, P133, DOI 10.1016/j.tcb.2004.01.007; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Nirenberg MJ, 1997, J NEUROSCI, V17, P5255; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Nirenberg MJ, 1997, J NEUROSCI, V17, P6899; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; Rao A, 2011, MOL CELL NEUROSCI, V46, P148, DOI 10.1016/j.mcn.2010.08.016; Richards TL, 2009, J NEUROCHEM, V108, P1575, DOI 10.1111/j.1471-4159.2009.05910.x; Riddle EL, 2005, AAPS J, V7, pE847, DOI 10.1208/aapsj070481; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zahniser NR, 2009, SEMIN CELL DEV BIOL, V20, P411, DOI 10.1016/j.semcdb.2009.01.004	34	29	29	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					1921	1933		10.1096/fj.11-196113	http://dx.doi.org/10.1096/fj.11-196113			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22267337	Green Published			2022-12-25	WOS:000303680800020
J	Fueller, F; Jehle, B; Putzker, K; Lewis, JD; Krauth-Siegel, RL				Fueller, Florian; Jehle, Britta; Putzker, Kerstin; Lewis, Joe D.; Krauth-Siegel, R. Luise			High Throughput Screening against the Peroxidase Cascade of African Trypanosomes Identifies Antiparasitic Compounds That Inactivate Tryparedoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOTHIONE REDUCTASE; CRITHIDIA-FASCICULATA; BRUCEI TRYPAREDOXIN; CATALYTIC MECHANISM; THERAPEUTIC TARGETS; METABOLISM; THIOREDOXIN; INHIBITORS; PROTEIN; CRUZI	In African trypanosomes, the detoxification of broad spectrum hydroperoxides relies on a unique cascade composed of trypanothione (T(SH)(2)), trypanothione reductase, tryparedoxin (Tpx), and nonselenium glutathione peroxidase-type enzymes. All three proteins are essential for Trypanosoma brucei. Here, we subjected the complete system to a high throughput screening approach with nearly 80,000 chemicals. Twelve compounds inhibited the peroxidase system. All but one carried chloroalkyl substituents. The detailed kinetic analysis showed that two compounds weakly inhibited trypanothione reductase, but none of them specifically interacted with the peroxidase. They proved to be time-dependent inhibitors of Tpx-modifying Cys-40, the first cysteine of its active site WCPPC motif. Importantly, gel shift assays verified Tpx as a target in the intact parasites. T(SH)(2), present in the in vitro assays and in the cells in high molar excess, did not interfere with Tpx inactivation. The compounds inhibited the proliferation of bloodstream T. brucei with EC50 values down to < 1 mu M and exerted up to 83-fold lower toxicity toward HeLa cells. Irreversible inhibitors are traditionally regarded as unfavorable. However, a large number of anti-microbials and anticancer therapeutics acts covalently with their target protein. The compounds identified here also interacted with recombinant human thioredoxin, a distant relative of Tpx. This finding might even be exploited for thioredoxin-based anticancer drug development approaches reported recently. The fact that the T(SH)(2)/Tpx couple occupies a central position within the trypanosomal thiol metabolism and delivers electrons also for the synthesis of DNA precursors renders the parasite-specific oxidoreductase an attractive drug target molecule.	[Fueller, Florian; Krauth-Siegel, R. Luise] Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; [Jehle, Britta; Putzker, Kerstin; Lewis, Joe D.] EMBL Heidelberg, Chem Biol Core Facil, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Krauth-Siegel, RL (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	luise.krauth-siegel@bzh.uni-heidelberg.de		Lewis, Joe/0000-0002-9926-1328; Putzker, Kerstin/0000-0001-8375-5908	Deutsche Forschungsgemeinschaft [SFB 544]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 544, Project B3 (to L.K.-S.).	Alphey MS, 1999, J BIOL CHEM, V274, P25613, DOI 10.1074/jbc.274.36.25613; Arias DG, 2011, FREE RADICAL BIO MED, V50, P37, DOI 10.1016/j.freeradbiomed.2010.10.695; Bradshaw TD, 2005, CANCER RES, V65, P3911, DOI 10.1158/0008-5472.CAN-04-4141; Budde H, 2003, BIOL CHEM, V384, P1305, DOI 10.1515/BC.2003.146; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; CARNIERI EGS, 1993, MOL BIOCHEM PARASIT, V61, P79, DOI 10.1016/0166-6851(93)90160-Y; Castro H, 2008, ANTIOXID REDOX SIGN, V10, P1593, DOI 10.1089/ars.2008.2050; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Comini MA, 2009, INT J PARASITOL, V39, P1059, DOI 10.1016/j.ijpara.2009.05.002; Diechtierow M, 2011, FREE RADICAL BIO MED, V51, P856, DOI 10.1016/j.freeradbiomed.2011.05.014; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; Eberle C, 2011, CHEMMEDCHEM, V6, P292, DOI 10.1002/cmdc.201000420; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Gommel DU, 1997, EUR J BIOCHEM, V248, P913, DOI 10.1111/j.1432-1033.1997.t01-1-00913.x; Hall G, 2011, PROTEIN SCI, V20, P210, DOI 10.1002/pro.533; Hillebrand H, 2003, J BIOL CHEM, V278, P6809, DOI 10.1074/jbc.M210392200; Hofmann B, 2001, BIOL CHEM, V382, P459, DOI 10.1515/BC.2001.056; Holloway GA, 2009, ANTIMICROB AGENTS CH, V53, P2824, DOI 10.1128/AAC.01568-08; Jarvinen PP, 2010, COMB CHEM HIGH T SCR, V13, P278, DOI 10.2174/138620710790980559; Jeong W, 2004, J BIOL CHEM, V279, P3142, DOI 10.1074/jbc.M307932200; Konig J, 2011, J BIOL CHEM, V286, P8523, DOI 10.1074/jbc.M110.214833; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Ludemann H, 1998, FEBS LETT, V431, P381, DOI 10.1016/S0014-5793(98)00793-5; Mackey ZB, 2006, CHEM BIOL DRUG DES, V67, P355, DOI 10.1111/j.1747-0285.2006.00389.x; Martyn DC, 2007, BIOORG MED CHEM LETT, V17, P1280, DOI 10.1016/j.bmcl.2006.12.016; Melchers J, 2008, J BIOL CHEM, V283, P30401, DOI 10.1074/jbc.M803563200; Melchers J, 2008, BIOMOL NMR ASSIGM, V2, P65, DOI 10.1007/s12104-008-9086-8; Mukherjee A, 2007, BRIT J PHARMACOL, V151, P1167, DOI 10.1038/sj.bjp.0707342; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Ojo KK, 2008, ANTIMICROB AGENTS CH, V52, P3710, DOI 10.1128/AAC.00364-08; Otero L, 2006, J MED CHEM, V49, P3322, DOI 10.1021/jm0512241; Perez DI, 2009, BIOORGAN MED CHEM, V17, P6914, DOI 10.1016/j.bmc.2009.08.042; Rist W, 2005, ANAL BIOCHEM, V342, P160, DOI 10.1016/j.ab.2004.11.043; Rivera G, 2009, CURR MED CHEM, V16, P3286, DOI 10.2174/092986709788803303; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Sehr P, 2007, J BIOMOL SCREEN, V12, P560, DOI 10.1177/1087057107301246; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; SULLIVAN FX, 1991, MOL BIOCHEM PARASIT, V44, P145, DOI 10.1016/0166-6851(91)90231-T; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	46	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					8792	8802		10.1074/jbc.M111.338285	http://dx.doi.org/10.1074/jbc.M111.338285			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22275351	Green Published, hybrid			2022-12-25	WOS:000301797800012
J	Vogel, S; Raulf, N; Bregenhorn, S; Biniossek, ML; Maurer, U; Czabotar, P; Borner, C				Vogel, Sandra; Raulf, Nina; Bregenhorn, Stephanie; Biniossek, Martin L.; Maurer, Ulrich; Czabotar, Peter; Borner, Christoph			Cytosolic Bax DOES IT REQUIRE BINDING PROTEINS TO KEEP ITS PRO-APOPTOTIC ACTIVITY IN CHECK?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MITOCHONDRIAL OUTER-MEMBRANE; BCL-2 FAMILY-MEMBERS; CELL-DEATH; POLYACRYLAMIDE-GELS; BH3-ONLY PROTEINS; HUMANIN PEPTIDE; BCL-X(L); ACTIVATION; LOCALIZATION	Bax is kept inactive in the cytosol by refolding its C-terminal transmembrane domain into the hydrophobic binding pocket. Although energetic calculations predicted this conformation to be stable, numerous Bax binding proteins were reported and suggested to further stabilize inactive Bax. Unfortunately, most of them have not been validated in a physiological context on the endogenous level. Here we use gel filtration analysis of the cytosol of primary and established cells to show that endogenous, inactive Bax runs 20-30 kDa higher than recombinant Bax, suggesting Bax dimerization or the binding of a small protein. Dimerization was excluded by a lack of interaction of differentially tagged Bax proteins and by comparing the sizes of dimerized recombinant Bax with cytosolic Bax on blue native gels. Surprisingly, when analyzing cytosolic Bax complexes by high sensitivity mass spectrometry after anti-Bax immunoprecipitation or consecutive purification by gel filtration and blue native gel electrophoresis, we detected only one protein, called p23 hsp90 co-chaperone, which consistently and specifically co-purified with Bax. However, this protein could not be validated as a crucial inhibitory Bax binding partner as its over- or under expression did not show any apoptosis defects. By contrast, cytosolic Bax exhibits a slight molecular mass shift on SDS-PAGE as compared with recombinant Bax, which suggests a posttranslational modification and/or a structural difference between the two proteins. We propose that in most healthy cells, cytosolic endogenous Bax is a monomeric protein that does not necessarily need a binding partner to keep its pro-apoptotic activity in check.	[Vogel, Sandra; Raulf, Nina; Bregenhorn, Stephanie; Biniossek, Martin L.; Maurer, Ulrich; Borner, Christoph] Univ Freiburg, Ctr Biochem & Mol Cell Res, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Vogel, Sandra; Raulf, Nina; Bregenhorn, Stephanie] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Vogel, Sandra; Raulf, Nina; Maurer, Ulrich; Borner, Christoph] Univ Freiburg, Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Vogel, Sandra; Maurer, Ulrich; Borner, Christoph] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Czabotar, Peter] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3050, Australia; [Czabotar, Peter] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Walter & Eliza Hall Institute; University of Melbourne	Borner, C (corresponding author), Univ Freiburg, Ctr Biochem & Mol Cell Res, Inst Mol Med & Cell Res, Schaenzlestr 1,Stefan Meier Str 17, D-79104 Freiburg, Germany.	christoph.borner@uniklinik-freiburg.de		Czabotar, Peter/0000-0002-2594-496X	Deutsche Forschungsgemeinschaft [BO-1933]; Spemann Graduate School of Biology and Medicine (SGBM) [GSC-4]; Cluster BIOSS [EXC-294]; Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Spemann Graduate School of Biology and Medicine (SGBM); Cluster BIOSS; Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by the Deutsche Forschungsgemeinschaft (BO-1933) (to S. V. and C. B.) as well as by the Spemann Graduate School of Biology and Medicine (SGBM, GSC-4; to S. V. and N. R.) and the Cluster BIOSS (EXC-294; to S. V.) funded by the Excellence Initiative of the German Federal and State Governments.	ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; Antonsson B, 2001, CELL TISSUE RES, V306, P347, DOI 10.1007/s00441-001-0472-0; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Brookes PS, 2002, PROTEOMICS, V2, P969, DOI 10.1002/1615-9861(200208)2:8<969::AID-PROT969>3.0.CO;2-3; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Cheng WC, 2006, ONCOGENE, V25, P4697, DOI 10.1038/sj.onc.1209596; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Grad I, 2006, MOL CELL BIOL, V26, P8976, DOI 10.1128/MCB.00734-06; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee J, 2011, INT J EXP PATHOL, V92, P251, DOI 10.1111/j.1365-2613.2011.00762.x; Lindenboim L, 2010, CELL DEATH DIFFER, V17, P346, DOI 10.1038/cdd.2009.145; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Ott M, 2007, J BIOL CHEM, V282, P27633, DOI 10.1074/jbc.M703155200; Paschen SA, 2007, CELL CYCLE, V6, P2434, DOI 10.4161/cc.6.20.4780; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; SAWADA M, 2007, NAT CELL BIOL, V9, P480; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Walter D, 2008, HEPATOLOGY, V48, P1942, DOI 10.1002/hep.22541; Weber A, 2007, J CELL BIOL, V177, P625, DOI 10.1083/jcb.200610148; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	66	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9112	9127		10.1074/jbc.M111.248906	http://dx.doi.org/10.1074/jbc.M111.248906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22277657	Green Published, hybrid			2022-12-25	WOS:000301797800041
J	Walker, S; Ullman, O; Stultz, CM				Walker, Sophie; Ullman, Orly; Stultz, Collin M.			Using Intramolecular Disulfide Bonds in Tau Protein to Deduce Structural Features of Aggregation-resistant Conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; MICROTUBULE-BINDING; THIOFLAVIN-T; IN-VITRO; OLIGOMERS; DEMENTIA; ISOFORMS; DOMAIN; ORDER	Because tau aggregation likely plays a role in a number of neurodegenerative diseases, understanding the processes that affect tau aggregation is of considerable importance. One factor that has been shown to influence the aggregation propensity is the oxidation state of the protein itself. Tau protein, which contains two naturally occurring cysteine residues, can form both intermolecular disulfide bonds and intramolecular disulfide bonds. Several studies suggest that intermolecular disulfide bonds can promote tau aggregation in vitro. By contrast, although there are data to suggest that intramolecular disulfide bond formation retards tau aggregation in vitro, the precise mechanism underlying this observation remains unclear. While it has been hypothesized that a single intramolecular disulfide bond in tau leads to compact conformations that cannot form extended structure consistent with tau fibrils, there are few data to support this conjecture. In the present study we generate oxidized forms of the truncation mutant, K18, which contains all four microtubule binding repeats, and isolate the monomeric fraction, which corresponds to K18 monomers that have a single intramolecular disulfide bond. We study the aggregation propensity of the oxidized monomeric fraction and relate these data to an atomistic model of the K18 unfolded ensemble. Our results argue that the main effect of intramolecular disulfide bond formation is to preferentially stabilize conformers within the unfolded ensemble that place the aggregation-prone tau subsequences, PHF6* and PHF6, in conformations that are inconsistent with the formation of cross-beta-structure. These data further our understanding of the precise structural features that retard tau aggregation.	[Stultz, Collin M.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Stultz, Collin M.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Walker, Sophie] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Ullman, Orly] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Stultz, CM (corresponding author), MIT, Dept Elect Engn & Comp Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cmstultz@mit.edu			National Institutes of Health [5R21NS063185-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R21NS063185-02.	Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p; Bhattacharya K, 2001, BIOCHEM BIOPH RES CO, V285, P20, DOI 10.1006/bbrc.2001.5116; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Clos AL, 2011, BRIT J DERMATOL, V165, P1349, DOI 10.1111/j.1365-2133.2011.10508.x; DELAERE P, 1989, ACTA NEUROPATHOL, V77, P645, DOI 10.1007/BF00687893; Di Noto L, 1999, Mol Cell Biol Res Commun, V2, P71, DOI 10.1006/mcbr.1999.0153; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Fischer D, 2007, BIOCHEMISTRY-US, V46, P2574, DOI 10.1021/bi061318s; Fisher CK, 2011, J AM CHEM SOC, V133, P10022, DOI 10.1021/ja203075p; Fisher CK, 2011, CURR OPIN STRUC BIOL, V21, P426, DOI 10.1016/j.sbi.2011.04.001; Fisher CK, 2010, J AM CHEM SOC, V132, P14919, DOI 10.1021/ja105832g; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Furukawa Y, 2011, J BIOL CHEM, V286, P27236, DOI 10.1074/jbc.M111.248963; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hikosou R, 2007, CHEM PHARM BULL, V55, P1030, DOI 10.1248/cpb.55.1030; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Huang A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000155; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; Jiang CT, 2007, BIOCHEMISTRY-US, V46, P602, DOI 10.1021/bi062068i; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim ML, 2008, J NEUROSCI, V28, P12052, DOI 10.1523/JNEUROSCI.2913-08.2008; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Kurita J, 2003, J MAGN RESON, V163, P163, DOI 10.1016/S1090-7807(03)00080-6; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; LEE G, 1992, J CELL SCI, V102, P227; Meraz-Rios MA, 2010, J NEUROCHEM, V112, P1353, DOI 10.1111/j.1471-4159.2009.06511.x; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Paglini G, 2000, NEUROCHEM RES, V25, P37, DOI 10.1023/A:1007531230651; SAEED SM, 1967, AM J CLIN PATHOL, V47, P588, DOI 10.1093/ajcp/47.5.588; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sugino E, 2009, BIOCHEM BIOPH RES CO, V385, P236, DOI 10.1016/j.bbrc.2009.05.047; Tang H. Y., 2004, CURR PROTOC PROTEIN, V11, P1; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600	54	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9591	9600		10.1074/jbc.M111.336107	http://dx.doi.org/10.1074/jbc.M111.336107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22291015	Green Published, hybrid			2022-12-25	WOS:000301797800090
J	Uchida, Y; Osaki, T; Yamasaki, T; Shimomura, T; Hata, S; Horikawa, K; Shibata, S; Todo, T; Hirayama, J; Nishina, H				Uchida, Yoshimi; Osaki, Tomomi; Yamasaki, Tokiwa; Shimomura, Tadanori; Hata, Shoji; Horikawa, Kazumasa; Shibata, Shigenobu; Todo, Takeshi; Hirayama, Jun; Nishina, Hiroshi			Involvement of Stress Kinase Mitogen-activated Protein Kinase Kinase 7 in Regulation of Mammalian Circadian Clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SLEEP PHASE SYNDROME; DNA-DAMAGE; I-EPSILON; TUMOR SUPPRESSION; CULTURED-CELLS; CKI-EPSILON; JNK; BMAL1; MKK7	The stress kinase mitogen-activated protein kinase kinase 7 (MKK7) is a specific activator of c-Jun N-terminal kinase (JNK), which controls various physiological processes, such as cell proliferation, apoptosis, differentiation, and migration. Here we show that genetic inactivation of MKK7 resulted in an extended period of oscillation in circadian gene expression in mouse embryonic fibroblasts. Exogenous expression in cultured mammalian cells of an MKK7-JNK fusion protein that functions as a constitutively active form of JNK induced phosphorylation of PER2, an essential circadian component. Furthermore, JNK interacted with PER2 at both the exogenous and endogenous levels, and MKK7-mediated JNK activation increased the half-life of PER2 protein by inhibiting its ubiquitination. Notably, the PER2 protein stabilization induced by MKK7-JNK fusion protein reduced the degradation of PER2 induced by casein kinase 1 epsilon. Taken together, our results support a novel function for the stress kinase MKK7 as a regulator of the circadian clock in mammalian cells at steady state.	[Uchida, Yoshimi; Osaki, Tomomi; Yamasaki, Tokiwa; Shimomura, Tadanori; Hata, Shoji; Hirayama, Jun; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Horikawa, Kazumasa; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Shinjuku Ku, Tokyo 1628480, Japan; [Todo, Takeshi] Osaka Univ, Grad Sch Med, Dept Radiat Biol & Med Genet, Suita, Osaka 5650871, Japan	Tokyo Medical & Dental University (TMDU); Waseda University; Osaka University	Hirayama, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	hirayama.dbio@mri.tmd.ac.jp		Hirayama, Jun/0000-0002-8485-3320	Ministry of Education, Culture, Sport, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Grants-in-Aid for Scientific Research [23657085, 23241023] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on a Priority Area from the Ministry of Education, Culture, Sport, Science, and Technology of Japan and the Ministry of Health, Labor, and Welfare of Japan.	Akashi M, 2002, MOL CELL BIOL, V22, P1693, DOI 10.1128/MCB.22.6.1693-1703.2002; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chansard M, 2007, NEUROSCIENCE, V145, P812, DOI 10.1016/j.neuroscience.2006.12.037; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Kim JA, 2010, ONCOGENE, V29, P1702, DOI 10.1038/onc.2009.464; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kishimoto H, 2003, J BIOL CHEM, V278, P16595, DOI 10.1074/jbc.M213182200; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Nakamura Y, 2011, J ALLERGY CLIN IMMUN, V127, P1038, DOI 10.1016/j.jaci.2011.02.006; Nishitai G, 2004, J BIOL CHEM, V279, P1621, DOI 10.1074/jbc.M310335200; Oklejewicz M, 2008, CURR BIOL, V18, P286, DOI 10.1016/j.cub.2008.01.047; Pizzio GA, 2003, NEUROREPORT, V14, P1417, DOI 10.1097/00001756-200308060-00002; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Rennefahrt UEE, 2002, J BIOL CHEM, V277, P29510, DOI 10.1074/jbc.M203010200; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schramek D, 2011, NAT GENET, V43, P212, DOI 10.1038/ng.767; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Takano A, 2000, FEBS LETT, V477, P106, DOI 10.1016/S0014-5793(00)01755-5; Tanemura S, 2009, J BIOCHEM, V145, P345, DOI 10.1093/jb/mvn172; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tsuchiya Y, 2003, J BIOCHEM, V134, P785, DOI 10.1093/jb/mvg220; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Uchida Y, 2010, BIOL PHARM BULL, V33, P535, DOI 10.1248/bpb.33.535; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Yagita K, 2009, ACTA HISTOCHEM CYTOC, V42, P89, DOI 10.1267/ahc.09015; Yamasaki T, 2011, J NEUROSCI, V31, P16872, DOI 10.1523/JNEUROSCI.1111-11.2011; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	46	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2012	287	11					8318	8326		10.1074/jbc.M111.308908	http://dx.doi.org/10.1074/jbc.M111.308908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	906MN	22267733	Green Published, hybrid			2022-12-25	WOS:000301349400046
J	Garcia-Martinez, J; Adam, AL; Avalos, J				Garcia-Martinez, Jorge; Adam, Attila L.; Avalos, Javier			Adenylyl Cyclase Plays a Regulatory Role in Development, Stress Resistance and Secondary Metabolism in Fusarium fujikuroi	PLOS ONE			English	Article							GIBBERELLA-FUJIKUROI; CAROTENOID OXYGENASE; SIGNALING PATHWAYS; GENE; PROTEIN; BIOSYNTHESIS; VIRULENCE; PATHOGENICITY; BIKAVERIN; MUTANTS	The ascomycete fungus Fusarium fujikuroi (Gibberella fujikuroi MP-C) produces secondary metabolites of biotechnological interest, such as gibberellins, bikaverin, and carotenoids. Production of these metabolites is regulated by nitrogen availability and, in a specific manner, by other environmental signals, such as light in the case of the carotenoid pathway. A complex regulatory network controlling these processes is recently emerging from the alterations of metabolite production found through the mutation of different regulatory genes. Here we show the effect of the targeted mutation of the acyA gene of F. fujikuroi, coding for adenylyl cyclase. Mutants lacking the catalytic domain of the AcyA protein showed different phenotypic alterations, including reduced growth, enhanced production of unidentified red pigments, reduced production of gibberellins and partially derepressed carotenoid biosynthesis in the dark. The phenotype differs in some aspects from that of similar mutants of the close relatives F. proliferatum and F. verticillioides: contrary to what was observed in these species, DacyA mutants of F. fujikuroi showed enhanced sensitivity to oxidative stress (H2O2), but no change in heavy metal resistance or in the ability to colonize tomato tissue, indicating a high versatility in the regulatory roles played by cAMP in this fungal group.	[Garcia-Martinez, Jorge; Avalos, Javier] Univ Seville, Fac Biol, Dept Genet, Seville, Spain; [Adam, Attila L.] Szent Istvan Univ, Inst Plant Protect, Hungarian Acad Sci, Mycol Grp,Agr Biotechnol Ctr, Godollo, Hungary	University of Sevilla; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian University of Agriculture & Life Sciences	Garcia-Martinez, J (corresponding author), Univ Seville, Fac Biol, Dept Genet, Seville, Spain.	avalos@us.es	Avalos, Javier/B-4218-2011	Avalos, Javier/0000-0001-5484-2893	European Union; Spanish Government (Ministerio de Ciencia y Tecnologia) [BIO2006-01323, BIO2009-11131]; Acciones Integradas Hispano-Hungaras [HH2008-0004]; Andalusian Government [P07-CVI-02813]; Hungarian Government (National Research Council of Hungary) [OTKA K 76067, OMFB-00666/2009]; Office for Subsidized Research Units of the Hungarian Academy of Sciences	European Union(European Commission); Spanish Government (Ministerio de Ciencia y Tecnologia)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Acciones Integradas Hispano-Hungaras; Andalusian Government; Hungarian Government (National Research Council of Hungary); Office for Subsidized Research Units of the Hungarian Academy of Sciences	This work was supported by the European Union (European Regional Development Fund, ERDF), the Spanish Government (Ministerio de Ciencia y Tecnologia, projects BIO2006-01323 and BIO2009-11131; Acciones Integradas Hispano-Hungaras, project HH2008-0004), the Andalusian Government (project P07-CVI-02813) and the Hungarian Government (National Research Council of Hungary, grant OTKA K 76067 and Hungarian-Spanish Bilateral S and T project OMFB-00666/2009). We thank the support from the Office for Subsidized Research Units of the Hungarian Academy of Sciences (A.L.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Arrach N, 2002, MOL GENET GENOMICS, V266, P914, DOI 10.1007/s00438-001-0626-5; Avalos J, 2007, CURR ORG CHEM, V11, P721, DOI 10.2174/138527207780598729; AVALOS J, 1985, APPL ENVIRON MICROB, V49, P187, DOI 10.1128/AEM.49.1.187-191.1985; Avalos J., 1987, CURR GENET, V25, P1837, DOI DOI 10.1007/BF00384613; Avalos J, 2010, FUNGAL GENET BIOL, V47, P930, DOI 10.1016/j.fgb.2010.05.001; Bhalla K, 2010, ENVIRON MONIT ASSESS, V167, P515, DOI 10.1007/s10661-009-1068-5; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bodor AM, 2012, ACTA PHYTOP IN PRESS, V47; Britton G., 1998, CAROTENOIDS; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Limon MC, 2010, APPL MICROBIOL BIOT, V87, P21, DOI 10.1007/s00253-010-2551-1; Casas-Flores S, 2006, EUKARYOT CELL, V5, P499, DOI 10.1128/EC.5.3.499-506.2006; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Choi YE, 2010, MOL PLANT MICROBE IN, V23, P522, DOI 10.1094/MPMI-23-4-0522; CORNFORTH JW, 1971, J CHEM SOC C, P2786, DOI 10.1039/j39710002786; D'Souza CA, 2001, FEMS MICROBIOL REV, V25, P349, DOI 10.1111/j.1574-6976.2001.tb00582.x; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Diaz-Sanchez V, 2011, FEBS J, V278, P3164, DOI 10.1111/j.1742-4658.2011.08242.x; Domenech CE, 1996, EUR J BIOCHEM, V239, P720, DOI 10.1111/j.1432-1033.1996.0720u.x; Estrada AF, 2008, FUNGAL GENET BIOL, V45, P705, DOI 10.1016/j.fgb.2007.12.003; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; Giordano W, 1999, FEMS MICROBIOL LETT, V173, P389, DOI 10.1111/j.1574-6968.1999.tb13530.x; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Jain S, 2005, FEMS MICROBIOL LETT, V243, P165, DOI 10.1016/j.femsle.2004.12.009; Jain S, 2002, CURR GENET, V41, P407, DOI 10.1007/s00294-002-0322-y; Jurick WM, 2007, FUNGAL GENET BIOL, V44, P521, DOI 10.1016/j.fgb.2006.11.005; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Kohut G, 2010, J BASIC MICROB, V50, P59, DOI 10.1002/jobm.200900113; KOLAROVA N, 1992, FEMS MICROBIOL LETT, V93, P275, DOI 10.1016/0378-1097(92)90474-3; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Linnemannstons P, 2002, FUNGAL GENET BIOL, V37, P134, DOI 10.1016/S1087-1845(02)00501-7; Lory S, 2004, INT J MED MICROBIOL, V293, P479, DOI 10.1078/1438-4221-00297; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Mihlan M, 2003, MOL MICROBIOL, V47, P975, DOI 10.1046/j.1365-2958.2003.03326.x; Nagygyorgy ED, 2011, FUNGICIDES; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; Oller-Lopez JL, 2003, APPL MICROBIOL BIOT, V63, P282, DOI 10.1007/s00253-003-1376-6; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Prado MM, 2004, CURR GENET, V46, P47, DOI 10.1007/s00294-004-0508-6; Prado-Cabrero A, 2007, EUKARYOT CELL, V6, P650, DOI 10.1128/EC.00392-06; Prado-Cabrero A, 2007, MOL MICROBIOL, V64, P448, DOI 10.1111/j.1365-2958.2007.05665.x; Proctor RH, 1997, MICROBIOL-SGM, V143, P2583, DOI 10.1099/00221287-143-8-2583; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rademacher W., 1997, FUNGAL BIOTECHNOLOGY, P193; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Rodriguez-Ortiz R, 2009, APPL ENVIRON MICROB, V75, P405, DOI 10.1128/AEM.01089-08; Sambrook J, 2001, MOL CLONING LAB MANU; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; Thewes S, 2005, MOL GENET GENOMICS, V274, P217, DOI 10.1007/s00438-005-0015-6; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; Tudzynski B, 1998, FUNGAL GENET BIOL, V25, P157, DOI 10.1006/fgbi.1998.1095; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Wagner D, 2010, EUKARYOT CELL, V9, P1588, DOI 10.1128/EC.00146-10; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x	60	23	25	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e28849	10.1371/journal.pone.0028849	http://dx.doi.org/10.1371/journal.pone.0028849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22291883	Green Submitted, Green Published, gold			2022-12-25	WOS:000301703800003
J	Vathsala, PG; Dende, C; Nagaraj, VA; Bhattacharya, D; Das, G; Rangarajan, PN; Padmanaban, G				Vathsala, Palakkod G.; Dende, Chaitanya; Nagaraj, Viswanathan Arun; Bhattacharya, Debapriya; Das, Gobardhan; Rangarajan, Pundi N.; Padmanaban, Govindarajan			Curcumin-Arteether Combination Therapy of Plasmodium berghei-Infected Mice Prevents Recrudescence Through Immunomodulation	PLOS ONE			English	Article							ARTEMISININ RESISTANCE; CEREBRAL MALARIA; FALCIPARUM; IMMUNITY; RESPONSES; BLOOD; DIHYDROARTEMISININ; CHILDREN; ANTIBODY; CHABAUDI	Earlier studies in this laboratory have shown the potential of artemisinin-curcumin combination therapy in experimental malaria. In a parasite recrudescence model in mice infected with Plasmodium berghei (ANKA), a single dose of alpha, beta-arteether (ART) with three oral doses of curcumin prevented recrudescence, providing almost 95% protection. The parasites were completely cleared in blood with ART-alone (AE) or ART+curcumin (AC) treatments in the short-term, although the clearance was faster in the latter case involving increased ROS generation. But, parasites in liver and spleen were not cleared in AE or AC treatments, perhaps, serving as a reservoir for recrudescence. Parasitemia in blood reached up to 60% in AE-treated mice during the recrudescence phase, leading to death of animals. A transient increase of up to 2-3% parasitemia was observed in AC-treatment, leading to protection and reversal of splenomegaly. A striking increase in spleen mRNA levels for TLR2, IL-10 and IgG-subclass antibodies but a decrease in those for INF gamma and IL-12 was observed in AC-treatment. There was a striking increase in IL-10 and IgG subclass antibody levels but a decrease in INF gamma levels in sera leading to protection against recrudescence. AC-treatment failed to protect against recrudescence in TLR2(-/-) and IL-10(-/-) animals. IL-10 injection to AE-treated wild type mice and AC-treated TLR22/2 mice was able to prolong survival. Blood from the recrudescence phase in AE-treatment, but not from AC-treatment, was able to reinfect and kill naive animals. Sera from the recrudescence phase of AC-treated animals reacted with several parasite proteins compared to that from AE-treated animals. It is proposed that activation of TLR2-mediated innate immune response leading to enhanced IL-10 production and generation of anti-parasite antibodies contribute to protective immunity in AC-treated mice. These results indicate a potential for curcumin-based combination therapy to be tested for prevention of recrudescence in falciparum and relapse in vivax malaria.	[Vathsala, Palakkod G.; Dende, Chaitanya; Nagaraj, Viswanathan Arun; Rangarajan, Pundi N.; Padmanaban, Govindarajan] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Bhattacharya, Debapriya; Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, New Delhi, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Vathsala, PG (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	geepee@biochem.iisc.ernet.in	Dende, Chaitanya/AAC-8216-2022; Rangarajan, Pundi/A-7365-2009; Dende, Chaitanya/AAQ-1578-2021	Rangarajan, Pundi/0000-0002-6536-9891; Chaitanya, Dende/0000-0002-8135-5828	Department of Biotechnology, Government of India [BT/PR10541/Med/15/605/2008, BT/01/10/MPB/DT]; National Academy of Sciences, India-Chair	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Academy of Sciences, India-Chair	This study was supported by grants from the Department of Biotechnology, Government of India (BT/PR10541/Med/15/605/2008 and BT/01/10/MPB/DT). GP is supported by the National Academy of Sciences, India-Chair. VAN is a Ramanujan Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar F, 2011, BIOTECH ADV, V06408; Ang KKH, 2001, PARASITOL RES, V87, P715, DOI 10.1007/s004360000366; Awandare GA, 2006, J INFECT DIS, V194, P1438, DOI 10.1086/508547; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Jagetia GC, 2007, J CLIN IMMUNOL, V27, P19, DOI 10.1007/s10875-006-9066-7; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Landau I, 1999, PARASITE, V6, P311, DOI 10.1051/parasite/1999064311; Ma SH, 2007, EXP PARASITOL, V116, P266, DOI 10.1016/j.exppara.2007.01.007; Martinelli A, 2008, EXP PARASITOL, V119, P304, DOI 10.1016/j.exppara.2008.02.011; May LA, 2005, ANAL BIOCHEM, V337, P62, DOI 10.1016/j.ab.2004.10.037; Mimche PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S10; Mimche PN, 2011, MALARIA J S1, V10, P1; Nandakumar DN, 2006, ANTIMICROB AGENTS CH, V50, P1859, DOI 10.1128/AAC.50.5.1859-1860.2006; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Niikura M, 2010, INT J PARASITOL, V40, P101, DOI 10.1016/j.ijpara.2009.08.009; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Nunes JK, 2009, INFECT IMMUN, V77, P414, DOI 10.1128/IAI.00982-08; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Reddy RC, 2005, BIOCHEM BIOPH RES CO, V326, P472, DOI 10.1016/j.bbrc.2004.11.051; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sarciron ME, 2000, AM J TROP MED HYG, V62, P73, DOI 10.4269/ajtmh.2000.62.73; Shibui A, 2009, PARASITOL RES, V105, P281, DOI 10.1007/s00436-009-1435-8; Song YL, 2004, J BIOL CHEM, V279, P40629, DOI 10.1074/jbc.M407308200; Su Z, 2002, J IMMUNOL, V168, P1348, DOI 10.4049/jimmunol.168.3.1348; Tripathi AK, ANAL BIOCH, V325, P85; Waknine-Grinberg JH, 2010, EXP PARASITOL, V125, P141, DOI 10.1016/j.exppara.2010.01.005; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; Wykes MN, 2011, P NATL ACAD SCI USA, V108, P11205, DOI 10.1073/pnas.1108579108; Yeung S, 2004, AM J TROP MED HYG, V71, P179, DOI 10.4269/ajtmh.2004.71.179	40	51	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29442	10.1371/journal.pone.0029442	http://dx.doi.org/10.1371/journal.pone.0029442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276114	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000301568100011
J	Joksimovic, M; Patel, M; Taketo, MM; Johnson, R; Awatramani, R				Joksimovic, Milan; Patel, Meera; Taketo, Makoto Mark; Johnson, Randy; Awatramani, Rajeshwar			Ectopic Wnt/Beta-Catenin Signaling Induces Neurogenesis in the Spinal Cord and Hindbrain Floor Plate	PLOS ONE			English	Article							MIDBRAIN DOPAMINE NEURONS; SONIC-HEDGEHOG; DEPENDENT MANNER; BETA-CATENIN; EXPRESSION; PROGENITORS; CELLS; DIFFERENTIATION; IDENTIFICATION; GENE	The most ventral structure of the developing neural tube, the floor plate (FP), differs in neurogenic capacity along the neuraxis. The FP is largely non-neurogenic at the hindbrain and spinal cord levels, but generates large numbers of dopamine (mDA) neurons at the midbrain levels. Wnt1, and other Wnts are expressed in the ventral midbrain, and Wnt/beta catenin signaling can at least in part account for the difference in neurogenic capacity of the FP between midbrain and hindbrain levels. To further develop the hypothesis that canonical Wnt signaling promotes mDA specification and FP neurogenesis, we have generated a model wherein beta-catenin is conditionally stabilized throughout the FP. Here, we unambiguously show by fate mapping FP cells in this mutant, that the hindbrain and spinal cord FP are rendered highly neurogenic, producing large numbers of neurons. We reveal that a neurogenic hindbrain FP results in the altered settling pattern of neighboring precerebellar neuronal clusters. Moreover, in this mutant, mDA progenitor markers are induced throughout the rostrocaudal axis of the hindbrain FP, although TH+ mDA neurons are produced only in the rostral aspect of rhombomere (r) 1. This is, at least in part, due to depressed Lmx1b levels by Wnt/ beta catenin signaling; indeed, when Lmx1b levels are restored in this mutant, mDA are observed not only in rostral r1, but also at more caudal axial levels in the hindbrain, but not in the spinal cord. Taken together, these data elucidate both patterning and neurogenic functions of Wnt/ beta catenin signaling in the FP, and thereby add to our understanding of the molecular logic of mDA specification and neurogenesis.	[Joksimovic, Milan; Patel, Meera; Awatramani, Rajeshwar] Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA; [Joksimovic, Milan; Patel, Meera; Awatramani, Rajeshwar] Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA; [Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto, Japan; [Johnson, Randy] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Kyoto University; University of Texas System; UTMD Anderson Cancer Center	Joksimovic, M (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	r-awatramani@northwestern.edu		Patel, Meera/0000-0003-3510-008X; Joksimovic, Milan/0000-0002-3936-4632	Whitehall Foundation; Brain Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052785] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Whitehall Foundation; Brain Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Whitehall Foundation and the Brain Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Moreno-Bravo JA, 2010, DEV DYNAM, V239, P2094, DOI 10.1002/dvdy.22327; Blaess S, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-29; Bonilla S, 2008, GLIA, V56, P809, DOI 10.1002/glia.20654; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chilov D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010881; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hayes L, 2011, J COMP NEUROL, V519, P3001, DOI 10.1002/cne.22711; Joksimovic M, 2009, P NATL ACAD SCI USA, V106, P19185, DOI 10.1073/pnas.0904285106; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kingsbury BF, 1920, J COMP NEUROL, V32, P113, DOI 10.1002/cne.900320106; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Li Y, 2010, DEVELOPMENT, V137, P1181, DOI 10.1242/dev.045237; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Ray RS, 2009, CURR OPIN CELL BIOL, V21, P741, DOI 10.1016/j.ceb.2009.10.003; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Yu WY, 2008, DEVELOPMENT, V135, P3687, DOI 10.1242/dev.021899; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	31	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30266	10.1371/journal.pone.0030266	http://dx.doi.org/10.1371/journal.pone.0030266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276170	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200050
J	Katkoori, VR; Shanmugam, C; Jia, X; Vitta, SP; Sthanam, M; Callens, T; Messiaen, L; Chen, DQ; Zhang, B; Bumpers, HL; Samuel, T; Manne, U				Katkoori, Venkat R.; Shanmugam, Chandrakumar; Jia, Xu; Vitta, Swaroop P.; Sthanam, Meenakshi; Callens, Tom; Messiaen, Ludwine; Chen, Dongquan; Zhang, Bin; Bumpers, Harvey L.; Samuel, Temesgen; Manne, Upender			Prognostic Significance and Gene Expression Profiles of p53 Mutations in Microsatellite-Stable Stage III Colorectal Adenocarcinomas	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; NUCLEASE PROTECTION; CANCER; INSTABILITY; SURVIVAL; PROTEIN; BREAST; FAMILY; POLYMORPHISM; MECHANISM	Although the prognostic value of p53 abnormalities in Stage III microsatellite stable (MSS) colorectal cancers (CRCs) is known, the gene expression profiles specific to the p53 status in the MSS background are not known. Therefore, the current investigation has focused on identification and validation of the gene expression profiles associated with p53 mutant phenotypes in MSS Stage III CRCs. Genomic DNA extracted from 135 formalin-fixed paraffin-embedded tissues, was analyzed for microsatellite instability (MSI) and p53 mutations. Further, mRNA samples extracted from five p53-mutant and five p53-wild-type MSS-CRC snap-frozen tissues were profiled for differential gene expression by Affymetrix Human Genome U133 Plus 2.0 arrays. Differentially expressed genes were further validated by the high-throughput quantitative nuclease protection assay (qNPA), and confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) and by immunohistochemistry (IHC). Survival rates were estimated by Kaplan-Meier and Cox regression analyses. A higher incidence of p53 mutations was found in MSS (58%) than in MSI (30%) phenotypes. Both univariate (log-rank, P = 0.025) and multivariate (hazard ratio, 2.52; 95% confidence interval, 1.25-5.08) analyses have demonstrated that patients with MSS-p53 mutant phenotypes had poor CRC-specific survival when compared to MSS-p53 wild-type phenotypes. Gene expression analyses identified 84 differentially expressed genes. Of 49 down-regulated genes, LPAR6, PDLIM3, and PLAT, and, of 35 upregulated genes, TRIM29, FUT3, IQGAP3, and SLC6A8 were confirmed by qNPA, qRT-PCR, and IHC platforms. p53 mutations are associated with poor survival of patients with Stage III MSS CRCs and p53-mutant and wild-type phenotypes have distinct gene expression profiles that might be helpful in identifying aggressive subsets.	[Katkoori, Venkat R.; Shanmugam, Chandrakumar; Jia, Xu; Vitta, Swaroop P.; Sthanam, Meenakshi; Manne, Upender] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Callens, Tom; Messiaen, Ludwine] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Chen, Dongquan] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Zhang, Bin] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Bumpers, Harvey L.] Morehouse Sch Med, Dept Surg, Atlanta, GA 30310 USA; [Samuel, Temesgen] Tuskegee Univ, Dept Pathol, Tuskegee, AL 36088 USA; [Manne, Upender] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Morehouse School of Medicine; Tuskegee University; University of Alabama System; University of Alabama Birmingham	Katkoori, VR (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	manne@uab.edu	Vitta, Satish/K-7336-2015; Zhang, Bin/P-7459-2015	Vitta, Satish/0000-0003-4138-0022; 	National Institutes of Health/National Cancer Institute [U54-CA118948, R01-CA98932, R03-CA139629]; NATIONAL CANCER INSTITUTE [R03CA139629, U54CA118948, U54CA118623, R01CA098932] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from the National Institutes of Health/National Cancer Institute (2U54-CA118948, R01-CA98932, and R03-CA139629) to Dr. Manne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Allison PD, 1995, SURVIVAL ANAL USING, V292, pviii; Bashour AM, 1997, J CELL BIOL, V137, P1555, DOI 10.1083/jcb.137.7.1555; Boland CR, 1998, CANCER RES, V58, P5248; Borresen-Dale AL, 1998, CLIN CANCER RES, V4, P203; Chittenden TW, 2008, GENOMICS, V91, P508, DOI 10.1016/j.ygeno.2008.03.002; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; COX DR, 1972, J R STAT SOC B, V34, P187; Dho SH, 2003, J BIOL CHEM, V278, P31902, DOI 10.1074/jbc.M304062200; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Edge SB, 2010, AJCC CANC STAGING MA; Elsaleh H, 2001, CLIN CANCER RES, V7, P1343; Fleiss J. L., 1981, STAT METHODS RATES P, V2; GOH HS, 1994, LANCET, V344, P233, DOI 10.1016/S0140-6736(94)93000-7; GREENBLATT MS, 1994, CANCER RES, V54, P4855; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jass JR, 2002, J GASTROEN HEPATOL, V17, P17, DOI 10.1046/j.1440-1746.2002.02635.x; JASS JR, 1995, LANCET, V346, P1200, DOI 10.1016/S0140-6736(95)92902-9; Jessup J, 1997, ARCH SURG-CHICAGO, V132, P374; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Kaplan EL, 1958, J AM STAT ASSOC, P53; Katkoori VR, 2008, FRONT BIOSCI-LANDMRK, V13, P1050, DOI 10.2741/2742; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Kressner U, 1999, J CLIN ONCOL, V17, P593, DOI 10.1200/JCO.1999.17.2.593; Lee S, 2007, P NATL ACAD SCI USA, V104, P13732, DOI 10.1073/pnas.0701771104; Levine AJ, 2004, CELL, V116, pS69; Levine Arnold J., 2004, Cell, VS116, pS67, DOI 10.1016/S0092-8674(04)00036-4; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Loukola A, 2001, CANCER RES, V61, P4545; Manne U, 1997, INT J CANCER, V74, P346, DOI 10.1002/(SICI)1097-0215(19970620)74:3<346::AID-IJC19>3.0.CO;2-9; Martel RR, 2002, ASSAY DRUG DEV TECHN, V1, P61, DOI 10.1089/154065802761001310; Mollevi DG, 2007, CARCINOGENESIS, V28, P1241, DOI 10.1093/carcin/bgm012; Mooney CZ, 1993, BOOTSTRAPPING NONPAR; Nojima H, 2008, NAT CELL BIOL, V10, P971, DOI 10.1038/ncb1757; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Perucho M, 1996, BIOL CHEM, V377, P675; Popat S, 2005, EUR J CANCER, V41, P2060, DOI 10.1016/j.ejca.2005.04.039; Popat S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-150; Powell B, 2000, CLIN CANCER RES, V6, P443; Pricolo VE, 1997, ARCH SURG-CHICAGO, V132, P371; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roberts RA, 2007, LAB INVEST, V87, P979, DOI 10.1038/labinvest.3700665; Salahshor S, 2001, LAB INVEST, V81, P535, DOI 10.1038/labinvest.3780262; Samowitz WS, 2001, AM J PATHOL, V158, P1517, DOI 10.1016/S0002-9440(10)64102-8; Sanchez-Palencia A, 2010, INT J CANC EARLY ON; Shanmugam C, 2010, CANCER; Skaug V, 2000, CLIN CANCER RES, V6, P1031; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Sood AK, 1997, CANCER RES, V57, P1047; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Su GH, 2001, P NATL ACAD SCI USA, V98, P3254, DOI 10.1073/pnas.051484398; Tang RP, 2004, CANCER LETT, V210, P101, DOI 10.1016/j.canlet.2004.01.006; Thakkar Arvind D, 2010, Biomark Cancer, V2, P1, DOI 10.4137/BIC.S3793; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wagner F, 2007, J BIOTECHNOL, V129, P628, DOI 10.1016/j.jbiotec.2007.02.015; Welter S, 2007, EUR J CARDIO-THORAC, V31, P167, DOI 10.1016/j.ejcts.2006.11.004; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; *WHO, 1990, INT CLASS DIS ONC; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamashita H, 1997, CANCER, V80, P2268; Yin XY, 2010, CARBOHYD RES, V345, P2334, DOI 10.1016/j.carres.2010.07.028; Zaanan A, 2010, ANN ONCOL, V21, P772, DOI 10.1093/annonc/mdp383	68	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30020	10.1371/journal.pone.0030020	http://dx.doi.org/10.1371/journal.pone.0030020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276141	Green Published, Green Submitted, gold			2022-12-25	WOS:000301457200029
J	Rasmuson, A; Kock, A; Fuskevag, OM; Kruspig, B; Simon-Santamaria, J; Gogvadze, V; Johnsen, JI; Kogner, P; Sveinbjornsson, B				Rasmuson, Agnes; Kock, Anna; Fuskevag, Ole Martin; Kruspig, Bjorn; Simon-Santamaria, Jaione; Gogvadze, Vladimir; Johnsen, John Inge; Kogner, Per; Sveinbjornsson, Baldur			Autocrine Prostaglandin E-2 Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; E-PROSTANOID RECEPTORS; GROWTH IN-VITRO; COLORECTAL-CANCER; DIFFERENTIAL EXPRESSION; COLON CARCINOGENESIS; KNOCKOUT MICE; MYCN PROTEIN; SUBTYPE EP1; PROGRESSION	Background: Prostaglandin E-2 (PGE(2)) is an important mediator in tumor-promoting inflammation. High expression of cyclooxygenase-2 (COX-2) has been detected in the embryonic childhood tumor neuroblastoma, and treatment with COX inhibitors significantly reduces tumor growth. Here, we have investigated the significance of a high COX-2 expression in neuroblastoma by analysis of PGE(2) production, the expression pattern and localization of PGE(2) receptors and intracellular signal transduction pathways activated by PGE(2). Principal Findings: A high expression of the PGE(2) receptors, EP1, EP2, EP3 and EP4 in primary neuroblastomas, independent of biological and clinical characteristics, was detected using immunohistochemistry. In addition, mRNA and protein corresponding to each of the receptors were detected in neuroblastoma cell lines. Immunofluorescent staining revealed localization of the receptors to the cellular membrane, in the cytoplasm, and in the nuclear compartment. Neuroblastoma cells produced PGE(2) and stimulation of serum-starved neuroblastoma cells with PGE(2) increased the intracellular concentration of calcium and cyclic AMP with subsequent phosphorylation of Akt. Addition of 16,16-dimethyl PGE(2) (dmPGE(2)) increased cell viability in a time, dose- and cell line-dependent manner. Treatment of neuroblastoma cells with a COX-2 inhibitor resulted in a diminished cell growth and viability that was reversed by the addition of dmPGE(2). Similarly, PGE(2) receptor antagonists caused a decrease in neuroblastoma cell viability in a dose- dependent manner. Conclusions: These findings demonstrate that PGE(2) acts as an autocrine and/or paracrine survival factor for neuroblastoma cells. Hence, specific targeting of PGE(2) signaling provides a novel strategy for the treatment of childhood neuroblastoma through the inhibition of important mediators of tumor-promoting inflammation.	[Rasmuson, Agnes; Kock, Anna; Johnsen, John Inge; Kogner, Per; Sveinbjornsson, Baldur] Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Fuskevag, Ole Martin] Univ Hosp N Norway, Dept Clin Pharmacol, Tromso, Norway; [Kruspig, Bjorn; Gogvadze, Vladimir] Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden; [Simon-Santamaria, Jaione] Univ Tromso, Vasc Biol Res Grp, Fac Med, Tromso, Norway; [Sveinbjornsson, Baldur] Univ Tromso, Div Immunol, Fac Hlth Sci, Tromso, Norway	Karolinska Institutet; UiT The Arctic University of Tromso; University Hospital of North Norway; Karolinska Institutet; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Rasmuson, A (corresponding author), Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Agnes.Rasmuson@ki.se	Gogvadze, Vladimir/A-4392-2014	Kruspig, Bjorn/0000-0002-1712-5411; Johnsen, John Inge/0000-0003-1277-812X; Kogner, Per/0000-0002-2202-9694	Swedish Research Council; Swedish Children's Cancer Foundation; Swedish Cancer Society; Norwegian Cancer Society; Mary Beve Foundation; INTENT network; NBCNS network; ACT! thematic centre; Blix Family Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Norwegian Cancer Society(Norwegian Cancer Society); Mary Beve Foundation; INTENT network; NBCNS network; ACT! thematic centre; Blix Family Foundation	This work was supported by the Swedish Research Council, the Swedish Children's Cancer Foundation, the Swedish Cancer Society, the Norwegian Cancer Society, Mary Beve Foundation, the INTENT and NBCNS networks, the ACT! thematic centre and Blix Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN SZ, 1994, BIOCHEMISTRY-US, V33, P14496, DOI 10.1021/bi00252a016; Asano T, 2002, CLIN CANCER RES, V8, P1157; Baryawno N, 2008, NEURO-ONCOLOGY, V10, P661, DOI 10.1215/15228517-2008-035; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Breinig M, 2008, INT J CANCER, V122, P547, DOI 10.1002/ijc.23098; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Caren H, 2010, P NATL ACAD SCI USA, V107, P4323, DOI 10.1073/pnas.0910684107; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chell S, 2006, BBA-REV CANCER, V1766, P104, DOI 10.1016/j.bbcan.2006.05.002; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Choi SY, 2001, J NEUROCHEM, V79, P303; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Fischer SM, CANC PREV RES PHILA, V4, P1728; Gustafsson A, 2007, ACTA ONCOL, V46, P1107, DOI 10.1080/02841860701403061; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; Johnsen JI, 2004, CANCER RES, V64, P7210, DOI 10.1158/0008-5472.CAN-04-1795; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Kaneko M, 2009, CANCER SCI, V100, P2193, DOI 10.1111/j.1349-7006.2009.01280.x; Kempen EC, 2001, ANAL BIOCHEM, V297, P183, DOI 10.1006/abio.2001.5325; Kitamura T, 2003, CANCER SCI, V94, P618, DOI 10.1111/j.1349-7006.2003.tb01492.x; Koch A, 2011, EUR J CANCER, V47, P1546, DOI 10.1016/j.ejca.2011.03.035; Koppen A, 2008, INT J CANCER, V122, P1455, DOI 10.1002/ijc.23180; Kryh H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-443; Lau L, 2007, ONCOGENE, V26, P1920, DOI 10.1038/sj.onc.1209981; Lee JL, 2005, J INVEST DERMATOL, V125, P818, DOI 10.1111/j.0022-202X.2005.23829.x; Li Z, 2010, CANCER; Ma XR, 2010, MOL CANCER RES, V8, P1310, DOI 10.1158/1541-7786.MCR-10-0003; Midgley RS, 2010, J CLIN ONCOL, V28, P4575, DOI 10.1200/JCO.2010.29.6244; Miyata Y, 2006, UROLOGY, V68, P1360, DOI 10.1016/j.urology.2006.09.035; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Mosmann T., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4; Mutoh M, 2002, CANCER RES, V62, P28; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Ponthan F, 2007, CLIN CANCER RES, V13, P1036, DOI 10.1158/1078-0432.CCR-06-1908; Prasad KN, 2003, APOPTOSIS, V8, P579, DOI 10.1023/A:1026179324295; Rask K, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-62; Reynolds LM, 2001, NEUROSCI LETT, V309, P193, DOI 10.1016/S0304-3940(01)02071-7; Sartelet H, 2008, EXPERT REV ANTICANC, V8, P757, DOI 10.1586/14737140.8.5.757; Segerstrom L, 2011, INT J CANCER, V129, P2958, DOI 10.1002/ijc.26268; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Sugino Y, 2007, ONCOGENE, V26, P7401, DOI 10.1038/sj.onc.1210550; Takafuji VA, 2002, PROSTAG LEUKOTR ESS, V66, P71, DOI 10.1054/plef.2001.0299; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Watanabe K, 1999, CANCER RES, V59, P5093; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	51	37	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29331	10.1371/journal.pone.0029331	http://dx.doi.org/10.1371/journal.pone.0029331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22276108	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200009
J	Warrington, JP; Csiszar, A; Mitschelen, M; Lee, YW; Sonntag, WE				Warrington, Junie P.; Csiszar, Anna; Mitschelen, Matthew; Lee, Yong Woo; Sonntag, William E.			Whole Brain Radiation-Induced Impairments in Learning and Memory Are Time-Sensitive and Reversible by Systemic Hypoxia	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; COGNITIVE IMPAIRMENT; ADULT RATS; IONIZING-RADIATION; HYPOBARIC HYPOXIA; PERINATAL HYPOXIA; DENTATE GYRUS; STEM-CELLS; IRRADIATION; MICE	Whole brain radiation therapy (WBRT) is commonly used for treatment of primary and metastatic brain tumors; however, cognitive impairment occurs in 40-50% of brain tumor survivors. The etiology of the cognitive impairment following WBRT remains elusive. We recently reported that radiation-induced cerebrovascular rarefaction within hippocampal subregions could be completely reversed by systemic hypoxia. However, the effects of this intervention on learning and memory have not been reported. In this study, we assessed the time-course for WBRT-induced impairments in contextual and spatial learning and the capacity of systemic hypoxia to reverse WBRT-induced deficits in spatial memory. A clinical fractionated series of 4.5Gy WBRT was administered to mice twice weekly for 4 weeks, and after various periods of recovery, behavioral analyses were performed. To study the effects of systemic hypoxia, mice were subjected to 11% (hypoxia) or 21% oxygen (normoxia) for 28 days, initiated 1 month after the completion of WBRT. Our results indicate that WBRT induces a transient deficit in contextual learning, disruption of working memory, and progressive impairment of spatial learning. Additionally, systemic hypoxia completely reversed WBRT-induced impairments in learning and these behavioral effects as well as increased vessel density persisted for at least 2 months following hypoxia treatment. Our results provide critical support for the hypothesis that cerebrovascular rarefaction is a key component of cognitive impairment post-WBRT and indicate that processes of learning and memory, once thought to be permanently impaired after WBRT, can be restored.	[Warrington, Junie P.; Sonntag, William E.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73190 USA; [Warrington, Junie P.; Csiszar, Anna; Mitschelen, Matthew; Sonntag, William E.] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Donald W Reynolds Dept Geriatr Med, Oklahoma City, OK USA; [Lee, Yong Woo] Virginia Tech, Sch Biomed Engn & Sci, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Virginia Polytechnic Institute & State University	Warrington, JP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Neurosci, Oklahoma City, OK 73190 USA.	william-sonntag@ouhsc.edu	Warrington, Junie Paula/I-5782-2019	Warrington, Junie Paula/0000-0001-5626-8872; sonntag, William/0000-0003-1850-2407	National Institutes of Health [NS056218, AG11370]; American Heart Association; OUHSC GSA; Donald W. Reynolds Foundation; University of Oklahoma Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); OUHSC GSA; Donald W. Reynolds Foundation; University of Oklahoma Health Sciences Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the following grants: National Institutes of Health Grant: NS056218 and AG11370 (WES); American Heart Association Pre-doctoral Fellowship (JPW); OUHSC GSA Research Grant (JPW). The authors would like to express their gratitude for the support of the Donald W. Reynolds Foundation, which funds aging research at the University of Oklahoma Health Sciences Center under its Aging and Quality of Life Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta P, 2009, BEHAV NEUROSCI, V123, P1036, DOI 10.1037/a0016870; Acharya MM, 2009, P NATL ACAD SCI USA, V106, P19150, DOI 10.1073/pnas.0909293106; Akiyama K, 2001, NEUROL MED-CHIR, V41, P590, DOI 10.2176/nmc.41.590; American Brain Tumor Association, 2011, FACTS STAT; American Cancer Society, 2011, CANC FACTS FIG 2011; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BERTA S, 2007, PROTOCOL EXCHANGE; Brown WR, 2007, J NEUROL SCI, V257, P67, DOI 10.1016/j.jns.2007.01.014; Brown WR, 2005, RADIAT RES, V164, P662, DOI 10.1667/RR3453.1; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Cengiz P, 2011, DEV NEUROSCI-BASEL, V33, P270, DOI 10.1159/000328430; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Coremans V, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-2; DEANGELIS LM, 1989, NEUROLOGY, V39, P789, DOI 10.1212/WNL.39.6.789; Denko NC, 2008, NAT REV CANC; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Fisher M, 2009, STROKE, V40, pS13, DOI 10.1161/STROKEAHA.108.533117; Fishman K, 2009, FREE RADICAL BIO MED, V47, P1459, DOI 10.1016/j.freeradbiomed.2009.08.016; Hof PR, 2000, COMP CYTOACHITECTONI; Ingraham JP, 2008, J GERONTOL A-BIOL, V63, P12, DOI 10.1093/gerona/63.1.12; Jahanshahi M, 2011, FOLIA NEUROPATHOL, V49, P103; Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251; Kamiryo T, 2001, NEUROSURGERY, V49, P409, DOI 10.1097/00006123-200108000-00026; Kang SG, 2010, NEUROSURGERY, V67, P711, DOI 10.1227/01.NEU.0000377859.06219.78; Khuntia D, 2006, J CLIN ONCOL, V24, P1295, DOI 10.1200/JCO.2005.04.6185; Kim S, 2011, NEUROSCI LETT, V498, P47, DOI 10.1016/j.neulet.2011.04.059; Koopmans G, 2003, PHYSIOL BEHAV, V79, P683, DOI 10.1016/S0031-9384(03)00171-9; LEE WH, 2011, INT J RAD ONCOLOGY B; Lee WH, 2010, INT J RADIAT BIOL, V86, P132, DOI 10.3109/09553000903419346; Li J, 2008, INT J RADIAT ONCOL, V71, P64, DOI 10.1016/j.ijrobp.2007.09.059; Li YQ, 2003, CANCER RES, V63, P5950; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Liu Y, 2010, AM J NEURORADIOL, V31, P383, DOI 10.3174/ajnr.A1801; Manda K, 2009, J PINEAL RES, V46, P71, DOI 10.1111/j.1600-079X.2008.00632.x; Marin-Burgin A., 2011, BEHAV BRAIN RES; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monje M, 2008, DEV DISABIL RES REV, V14, P238, DOI 10.1002/ddrr.26; MUTHURAJU S, 2011, EUR J PHARM; Muthuraju S, 2011, INT J NEUROSCI, V121, P279, DOI 10.3109/00207454.2011.556279; Muthuraju S, 2010, EXP BRAIN RES, V203, P583, DOI 10.1007/s00221-010-2266-7; Nogues X., 2011, BEHAV BRAIN RES; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Shi L, 2008, INT J RADIAT ONCOL, V71, P526, DOI 10.1016/j.ijrobp.2008.02.015; Shi L, 2006, RADIAT RES, V166, P892, DOI 10.1667/RR0588.1; SILBER JH, 1992, J CLIN ONCOL, V10, P1390, DOI 10.1200/JCO.1992.10.9.1390; Titus ADJ, 2007, NEUROSCIENCE, V145, P265, DOI 10.1016/j.neuroscience.2006.11.037; Troen AM, 2008, P NATL ACAD SCI USA, V105, P12474, DOI 10.1073/pnas.0805350105; Udagawa T, 2007, CANCER RES, V67, P2040, DOI 10.1158/0008-5472.CAN-06-2877; Vilar J, 2008, CIRC RES, V103, P761, DOI 10.1161/CIRCRESAHA.108.182758; Warrington JP, 2011, AM J PHYSIOL-HEART C, V300, pH736, DOI 10.1152/ajpheart.01024.2010; Welzel G, 2008, STRAHLENTHER ONKOL, V184, P647, DOI 10.1007/s00066-008-1830-6; Welzel G, 2008, INT J RADIAT ONCOL, V72, P1311, DOI 10.1016/j.ijrobp.2008.03.009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x; Zhu XH, 2010, J NEUROSCI, V30, P12653, DOI 10.1523/JNEUROSCI.6414-09.2010	60	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30444	10.1371/journal.pone.0030444	http://dx.doi.org/10.1371/journal.pone.0030444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22279591	Green Submitted, gold, Green Published			2022-12-25	WOS:000299771900068
J	Fu, GL; Miles, A; Alphey, L				Fu, Guoliang; Miles, Andrea; Alphey, Luke			Multiplex Detection and SNP Genotyping in a Single Fluorescence Channel	PLOS ONE			English	Article							REAL-TIME PCR; DIAGNOSTIC VIROLOGY; PAPILLOMAVIRUS; MICROBIOLOGY; ASSAYS	Probe-based PCR is widely used for SNP (single nucleotide polymorphism) genotyping and pathogen nucleic acid detection due to its simplicity, sensitivity and cost-effectiveness. However, the multiplex capability of hydrolysis probe-based PCR is normally limited to one target (pathogen or allele) per fluorescence channel. Current fluorescence PCR machines typically have 4-6 channels. We present a strategy permitting the multiplex detection of multiple targets in a single detection channel. The technique is named Multiplex Probe Amplification (MPA). Polymorphisms of the CYP2C9 gene (cytochrome P450, family 2, subfamily C, polypeptide 9, CYP2C9*2) and human papillomavirus sequences HPV16, 18, 31, 52 and 59 were chosen as model targets for testing MPA. The allele status of the CYP2C9*2 determined by MPA was entirely concordant with the reference TaqMan (R) SNP Genotyping Assays. The four HPV strain sequences could be independently detected in a single fluorescence detection channel. The results validate the multiplex capacity, the simplicity and accuracy of MPA for SNP genotyping and multiplex detection using different probes labeled with the same fluorophore. The technique offers a new way to multiplex in a single detection channel of a closed-tube PCR.	[Fu, Guoliang; Miles, Andrea; Alphey, Luke] Oxitec Ltd, Oxford, England; [Fu, Guoliang; Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Fu, GL (corresponding author), Oxitec Ltd, Oxford, England.	guoliang.fu@genefirst.com; luke.alphey@oxitec.com		Alphey, Luke/0000-0002-2916-3802	Oxitec Ltd.	Oxitec Ltd.	This work is funded by Oxitec Ltd. As the authors are employed by the funder Oxitec Ltd, the funder did play a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Barken KB, 2007, CLIN CHIM ACTA, V384, P1, DOI 10.1016/j.cca.2007.07.004; Boulet GAV, 2008, CANCER EPIDEM BIOMAR, V17, P810, DOI 10.1158/1055-9965.EPI-07-2865; Butler JM, 2007, BIOTECHNIQUES, V43, P2; DURST M, 1987, P NATL ACAD SCI USA, V84, P1070, DOI 10.1073/pnas.84.4.1070; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Gunson RN, 2006, J CLIN VIROL, V35, P355, DOI 10.1016/j.jcv.2005.12.006; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Huang QY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016033; King CR, 2008, AM J CLIN PATHOL, V129, P876, DOI 10.1309/1E34UAPR06PJ6HML; Langley MR, 2009, J MOL DIAGN, V11, P216, DOI 10.2353/jmoldx.2009.080123; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Molenkamp R, 2007, J VIROL METHODS, V141, P205, DOI 10.1016/j.jviromet.2006.12.007; Rooney Patrick H, 2005, Methods Mol Biol, V293, P27; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Settanni L, 2007, J MICROBIOL METH, V69, P1, DOI 10.1016/j.mimet.2006.12.008; Wittwer CT, 2001, METHODS, V25, P430, DOI 10.1006/meth.2001.1265; Yeh HY, 2009, SEMIN CELL DEV BIOL, V20, P49, DOI 10.1016/j.semcdb.2009.01.012	20	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30340	10.1371/journal.pone.0030340	http://dx.doi.org/10.1371/journal.pone.0030340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272339	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400117
J	Nagaraj, RH; Panda, AK; Shanthakumar, S; Santhoshkumar, P; Pasupuleti, N; Wang, BL; Biswas, A				Nagaraj, Ram H.; Panda, Alok Kumar; Shanthakumar, Shilpa; Santhoshkumar, Puttur; Pasupuleti, NagaRekha; Wang, Benlian; Biswas, Ashis			Hydroimidazolone Modification of the Conserved Arg12 in Small Heat Shock Proteins: Studies on the Structure and Chaperone Function Using Mutant Mimics	PLOS ONE			English	Article							ALPHA-A-CRYSTALLIN; HUMAN LENS PROTEINS; N-TERMINAL REGION; B-CRYSTALLIN; MOLECULAR CHAPERONE; METHYLGLYOXAL MODIFICATION; MAILLARD REACTION; POSTTRANSLATIONAL MODIFICATIONS; NONOCULAR TISSUES; HEAT-SHOCK-PROTEIN-27	Methylglyoxal (MGO) is an alpha-dicarbonyl compound present ubiquitously in the human body. MGO reacts with arginine residues in proteins and forms adducts such as hydroimidazolone and argpyrimidine in vivo. Previously, we showed that MGO-mediated modification of alpha A-crystallin increased its chaperone function. We identified MGO-modified arginine residues in alpha A-crystallin and found that replacing such arginine residues with alanine residues mimicked the effects of MGO on the chaperone function. Arginine 12 (R12) is a conserved amino acid residue in Hsp27 as well as alpha A- and alpha B-crystallin. When treated with MGO at or near physiological concentrations (2-10 mu M), R12 was modified to hydroimidazolone in all three small heat shock proteins. In this study, we determined the effect of arginine substitution with alanine at position 12 (R12A to mimic MGO modification) on the structure and chaperone function of these proteins. Among the three proteins, the R12A mutation improved the chaperone function of only alpha A-crystallin. This enhancement in the chaperone function was accompanied by subtle changes in the tertiary structure, which increased the thermodynamic stability of alpha A-crystallin. This mutation induced the exposure of additional client protein binding sites on alpha A-crystallin. Altogether, our data suggest that MGO-modification of the conserved R12 in alpha A-crystallin to hydroimidazolone may play an important role in reducing protein aggregation in the lens during aging and cataract formation.	[Nagaraj, Ram H.; Shanthakumar, Shilpa; Pasupuleti, NagaRekha] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Panda, Alok Kumar; Biswas, Ashis] Indian Inst Technol Bhubaneswar, Sch Basic Sci, Bhubaneswar, Orissa, India; [Santhoshkumar, Puttur] Univ Missouri, Dept Ophthalmol, Columbia, MO USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Case Western Reserve University; Indian Institute of Technology System (IIT System); Indian Institute of Technology Bhubaneswar; University of Missouri System; University of Missouri Columbia; Case Western Reserve University	Nagaraj, RH (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	ram.nagaraj@case.edu; abiswas@iitbbs.ac.in	Pasupuleti, Nagarekha/B-5763-2015; PANDA, ALOK/G-6818-2015; Santhoshkumar, Puttur/G-1798-2010	PANDA, ALOK/0000-0002-4452-993X; Santhoshkumar, Puttur/0000-0002-6897-7278	NIH [R01EY-016219, R01EY-09912, P30EY-11373]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; DST SERC FAST TRACK (Department of Science & Technology Science and Engineering Research Council) India [SR/FT/CS-039/2009]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY016219, R01EY009912] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; DST SERC FAST TRACK (Department of Science & Technology Science and Engineering Research Council) India; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported from NIH grants R01EY-016219 and R01EY-09912 (RHN), P30EY-11373 (the Visual Sciences Research Center of CWRU); Research to Prevent Blindness, NY; the Ohio Lions Eye Research Foundation and a DST SERC FAST TRACK (Department of Science & Technology Science and Engineering Research Council), India grant SR/FT/CS-039/2009 (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2003, INVEST OPHTH VIS SCI, V44, P5287, DOI 10.1167/iovs.03-0573; Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bhagyalaxmi SG, 2009, BBA-MOL BASIS DIS, V1792, P974, DOI 10.1016/j.bbadis.2009.06.011; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bhattacharyya J, 2002, J PROTEIN CHEM, V21, P65, DOI 10.1023/A:1014187300930; Biswas A, 2007, PROTEIN J, V26, P247, DOI 10.1007/s10930-006-9066-8; Biswas A, 2006, BIOCHEMISTRY-US, V45, P4569, DOI 10.1021/bi052574s; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; Biswas A, 2008, J BIOCHEM, V144, P21, DOI 10.1093/jb/mvn037; Biswas A, 2007, BIOPOLYMERS, V85, P189, DOI 10.1002/bip.20630; Biswas A, 2007, BIOCHEMISTRY-US, V46, P1117, DOI 10.1021/bi061323w; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Chellan P, 1999, ARCH BIOCHEM BIOPHYS, V368, P98, DOI 10.1006/abbi.1999.1291; CHERIAN M, 1995, BIOCHEM BIOPH RES CO, V208, P675, DOI 10.1006/bbrc.1995.1391; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Derham BK, 1999, PROG RETIN EYE RES, V18, P463, DOI 10.1016/S1350-9462(98)00030-5; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Fujii N, 2001, PHOTOCHEM PHOTOBIOL, V74, P477, DOI 10.1562/0031-8655(2001)074<0477:CBTLOT>2.0.CO;2; Gangadhariah MH, 2010, BBA-MOL BASIS DIS, V1802, P432, DOI 10.1016/j.bbadis.2010.01.010; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; HAIK GM, 1994, EXP EYE RES, V59, P497, DOI 10.1006/exer.1994.1135; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; HORWITZ J, 1993, INVEST OPHTH VIS SCI, V34, P10; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Kumar MS, 2005, J BIOL CHEM, V280, P21726, DOI 10.1074/jbc.M500405200; Kumar MS, 2004, BIOCHEM J, V379, P273, DOI 10.1042/BJ20031633; Kumar P. A., 2011, J BIOPHYS STRUCTURAL, V3, P30; Kundu M, 2007, BIOPOLYMERS, V86, P177, DOI 10.1002/bip.20716; LO TWC, 1994, J BIOL CHEM, V269, P32299; Nagaraj RH, 2003, BIOCHEMISTRY-US, V42, P10746, DOI 10.1021/bi034541n; Nagaraj RH, 1996, FEBS LETT, V382, P234, DOI 10.1016/0014-5793(96)00142-1; Nagaraj RH, 2010, AMINO ACIDS IN PRESS; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Oya-Ito T, 2006, J CELL BIOCHEM, V99, P279, DOI 10.1002/jcb.20781; Oya-Ito T, 2011, BBA-MOL BASIS DIS, V1812, P769, DOI 10.1016/j.bbadis.2011.03.017; Padayatti PS, 2001, INVEST OPHTH VIS SCI, V42, P1299; Padival AK, 2003, FEBS LETT, V551, P113, DOI 10.1016/S0014-5793(03)00874-3; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Raju M, 2011, MOL VIS, V17, P7; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; Rao CM, 1998, INT J BIOL MACROMOL, V22, P271; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Saha S, 2004, PROTEINS, V57, P610, DOI 10.1002/prot.20230; Sakamoto H, 2002, J BIOL CHEM, V277, P45770, DOI 10.1074/jbc.M207485200; SPECTOR A, 1971, BIOCHEM J, V124, P337, DOI 10.1042/bj1240337; Sreelakshmi Y, 2005, BIOCHEMISTRY-US, V44, P12245, DOI 10.1021/bi051005h; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Sun TX, 1999, J BIOL CHEM, V274, P34067, DOI 10.1074/jbc.274.48.34067; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; WellsKnecht KJ, 1996, NEPHROL DIAL TRANSPL, V11, P41; Wilker SC, 2001, ANAL BIOCHEM, V290, P353, DOI 10.1006/abio.2001.4992; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a	60	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30257	10.1371/journal.pone.0030257	http://dx.doi.org/10.1371/journal.pone.0030257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272318	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400096
J	Tarus, B; Chevalier, C; Richard, CA; Delmas, B; Di Primo, C; Slama-Schwok, A				Tarus, Bogdan; Chevalier, Christophe; Richard, Charles-Adrien; Delmas, Bernard; Di Primo, Carmelo; Slama-Schwok, Anny			Molecular Dynamics Studies of the Nucleoprotein of Influenza A Virus: Role of the Protein Flexibility in RNA Binding	PLOS ONE			English	Article							MUTATIONAL ANALYSIS; H5N1 NUCLEOPROTEIN; AMINO-ACIDS; REPLICATION; OLIGOMERIZATION; IDENTIFICATION	The influenza viruses contain a segmented, negative stranded RNA genome. Each RNA segment is covered by multiple copies of the nucleoprotein (NP). X-ray structures have shown that NP contains well-structured domains juxtaposed with regions of missing electron densities corresponding to loops. In this study, we tested if these flexible loops gated or promoted RNA binding and RNA-induced oligomerization of NP. We first performed molecular dynamics simulations of wt NP monomer and trimer in comparison with the R361A protein mutated in the RNA binding groove, using the H1N1 NP as the initial structure. Calculation of the root-mean-square fluctuations highlighted the presence of two flexible loops in NP trimer: loop 1 (73-90), loop 2 (200-214). In NP, loops 1 and 2 formed a 10-15 angstrom-wide pinch giving access to the RNA binding groove. Loop 1 was stabilized by interactions with K113 of the adjacent beta-sheet 1 (91-112) that interacted with the RNA grove (linker 360-373) via multiple hydrophobic contacts. In R361A, a salt bridge formed between E80 of loop 1 and R208 of loop 2 driven by hydrophobic contacts between L79 and W207, due to a decreased flexibility of loop 2 and loop 1 unfolding. Thus, RNA could not access its binding groove in R361A; accordingly, R361A had a much lower affinity for RNA than NP. Disruption of the E80-R208 interaction in the triple mutant R361A-E80A-E81A increased its RNA binding affinity and restored its oligomerization back to wt levels in contrast with impaired levels of R361A. Our data suggest that the flexibility of loops 1 and 2 is required for RNA sampling and binding which likely involve conformational change(s) of the nucleoprotein.	[Tarus, Bogdan; Chevalier, Christophe; Richard, Charles-Adrien; Delmas, Bernard; Slama-Schwok, Anny] INRA, UR 892, Virol & Immunol Mol, Jouy En Josas, France; [Di Primo, Carmelo] Inst Europeen Chim & Biol, INSERM, ARNA Lab, U869, Pessac, France; [Di Primo, Carmelo] Univ Bordeaux, ARNA Lab, Bordeaux, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Slama-Schwok, A (corresponding author), INRA, UR 892, Virol & Immunol Mol, Jouy En Josas, France.	Anny.Schwok@jouy.inra.fr	Slama Schwok, Anny/AAD-8986-2019; Di primo, Carmelo/M-6984-2018; Chevalier, Christophe/C-2575-2009; Chevalier, Christophe/AAK-4461-2020; Chevalier, Christophe/AAW-5560-2020; Slama-Schwok, Anny/K-6826-2017	Slama Schwok, Anny/0000-0002-2703-9728; Di primo, Carmelo/0000-0002-0509-8399; Chevalier, Christophe/0000-0003-3231-9027; RICHARD, Charles-Adrien/0000-0001-5306-2297	French agency for research (Agence Nationale de la Recherche) [ANR-2010-Blanc-1307-01]; Grand Equipement National de Calcul Intensif [2010-99636, 2011-076378]	French agency for research (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Grand Equipement National de Calcul Intensif	The authors are grateful to the French agency for research (Agence Nationale de la Recherche) for funding (Flunucleovir, ANR-2010-Blanc-1307-01), to a grant of the Programme de Recherche Influenza A(H1N1), coordinated by the Institut de Microbiologie et Maladies Infectieuses (INSERM, France). This work was granted access to the HPC resources of IDRIS made by Grand Equipement National de Calcul Intensif under the grants 2010-99636 and 2011-076378 attributed to AS-S and BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2003, NATURE, V421, P347, DOI 10.1038/nature01337; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Boulo S, 2011, VIROLOGY, V409, P84, DOI 10.1016/j.virol.2010.10.001; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Primo C, 2008, J MOL RECOGNIT, V21, P37, DOI 10.1002/jmr.860; Elton D, 1999, VIROLOGY, V260, P190, DOI 10.1006/viro.1999.9818; Elton D, 1999, J VIROL, V73, P7357, DOI 10.1128/JVI.73.9.7357-7367.1999; Gerritz SW, 2011, P NATL ACAD SCI USA, V108, P15366, DOI 10.1073/pnas.1107906108; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mena I, 1999, J VIROL, V73, P1186, DOI 10.1128/JVI.73.2.1186-1194.1999; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Ng AKL, 2009, SCI CHINA SER C, V52, P439, DOI 10.1007/s11427-009-0064-x; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Tarus B, IN PRESS; Vreede FT, 2007, J VIROL, V81, P2196, DOI 10.1128/JVI.02187-06; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329; Yang M, 2008, J VIROL METHODS, V147, P265, DOI 10.1016/j.jviromet.2007.09.016; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	32	28	31	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30038	10.1371/journal.pone.0030038	http://dx.doi.org/10.1371/journal.pone.0030038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272272	Green Published, Green Submitted, gold			2022-12-25	WOS:000301454400051
J	Weng, JW; Fan, KN; Wang, WN				Weng, Jingwei; Fan, Kangnian; Wang, Wenning			The Conformational Transition Pathways of ATP-Binding Cassette Transporter BtuCD Revealed by Targeted Molecular Dynamics Simulation	PLOS ONE			English	Article							ABC TRANSPORTER; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURES; MECHANISM; PROTEIN; CYCLE; FLEXIBILITY; SUGGEST; DISEASE; SYSTEMS	BtuCD is a member of the ATP-binding cassette transporters in Escherichia coli that imports vitamin B-12 into the cell by utilizing the energy of ATP hydrolysis. Crystal structures of BtuCD and its homologous protein HI1470/1 in various conformational states support the "alternating access'' mechanism which proposes the conformational transitions of the substrate translocation pathway at transmembrane domain (TMD) between the outward-facing and inward-facing states. The conformational transition at TMD is assumed to couple with the movement of the cytoplasmic nucleotide-binding domains (NBDs) driven by ATP hydrolysis/binding. In this study, we performed targeted molecular dynamics (MD) simulations to explore the atomic details of the conformational transitions of BtuCD importer. The outward-facing to inward-facing (O -> I) transition was found to be initiated by the conformational movement of NBDs. The subsequent reorientation of the substrate translocation pathway at TMD began with the closing of the periplasmic gate, followed by the opening of the cytoplamic gate in the last stage of the conformational transition due to the extensive hydrophobic interactions at this region, consistent with the functional requirement of unidirectional transport of the substrates. The reverse inward-facing to outward-facing (I -> O) transition was found to exhibit intrinsic diversity of the conformational transition pathways and significant structural asymmetry, suggesting that the asymmetric crystal structure of BtuCD-F is an intermediate state in this process.	[Weng, Jingwei] Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China; Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Weng, JW (corresponding author), Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China.	wnwang@fudan.edu.cn	Fan, K/GXH-3734-2022		National Major Basic Research Program of China [2009CB918600, 2011CB808505]; National Science Foundation of China [20973040, 31070642]; Science and Technology Commission of Shanghai Municipality [08DZ2270500]; Shanghai Leading Academic Discipline Project [B108]	National Major Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the National Major Basic Research Program of China (2009CB918600, 2011CB808505), the National Science Foundation of China (20973040, 31070642), the Science and Technology Commission of Shanghai Municipality (08DZ2270500), and the Shanghai Leading Academic Discipline Project (B108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; Fiser A, 2003, MACROMOLECULAR CRYST; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Huang H, 2009, J CHEM THEORY COMPUT, V5, P1304, DOI 10.1021/ct9000153; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Ivetac A, 2007, BIOCHEMISTRY-US, V46, P2767, DOI 10.1021/bi0622571; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Kandt C, 2010, PROTEINS, V78, P738, DOI 10.1002/prot.22606; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Law RJ, 2008, BIOPHYS J, V95, P2739, DOI 10.1529/biophysj.107.128025; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marco E, 2007, J BIOL CHEM, V282, P28779, DOI 10.1074/jbc.M700349200; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Oloo EO, 2004, J BIOL CHEM, V279, P45013, DOI 10.1074/jbc.M405084200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sonne J, 2007, BIOPHYS J, V92, P2727, DOI 10.1529/biophysj.106.097972; Swift RV, 2008, BIOCHEMISTRY-US, V47, P4102, DOI 10.1021/bi8000209; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weng JW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.056432; Weng JW, 2008, BIOPHYS J, V94, P612, DOI 10.1529/biophysj.107.110734; Weng JW, 2009, BIOPHYS J, V96, P1918, DOI 10.1016/j.bpj.2008.11.035	48	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30465	10.1371/journal.pone.0030465	http://dx.doi.org/10.1371/journal.pone.0030465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272354	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400132
J	Zhang, JT; Liu, H; Sun, J; Li, B; Zhu, Q; Chen, SL; Zhang, HX				Zhang, Jiantao; Liu, Hua; Sun, Jian; Li, Bei; Zhu, Qiang; Chen, Shaoliang; Zhang, Hongxia			Arabidopsis Fatty Acid Desaturase FAD2 Is Required for Salt Tolerance during Seed Germination and Early Seedling Growth	PLOS ONE			English	Article							CHLOROPLAST OMEGA-3-FATTY-ACID DESATURASE; STRESS TOLERANCE; LOW-TEMPERATURE; CALCIUM SENSOR; SACCHAROMYCES-CEREVISIAE; COLD TOLERANCE; PROTEIN-KINASE; GENE; EXPRESSION; PLANTS	Fatty acid desaturases play important role in plant responses to abiotic stresses. However, their exact function in plant resistance to salt stress is unknown. In this work, we provide the evidence that FAD2, an endoplasmic reticulum localized omega-desaturase, is required for salt tolerance in Arabidopsis. Using vacuolar and plasma membrane vesicles prepared from the leaves of wild-type (Col-0) and the loss-of-function Arabidopsis mutant, fad2, which lacks the functional FAD2, we examined the fatty acid composition and Na+-dependent H+ movements of the isolated vesicles. We observed that, when compared to Col-0, the level of vacuolar and plasma membrane polyunsaturation was lower, and the Na+/H+ exchange activity was reduced in vacuolar and plasma membrane vesicles isolated from fad2 mutant. Consistent with the reduced Na+/H+ exchange activity, fad2 accumulated more Na+ in the cytoplasm of root cells, and was more sensitive to salt stress during seed germination and early seedling growth, as indicated by CoroNa-Green staining, net NaNa+ efflux and salt tolerance analyses. Our results suggest that FAD2 mediated high-level vacuolar and plasma membrane fatty acid desaturation is essential for the proper function of membrane attached Na+/H+ exchangers, and thereby to maintain a low cytosolic NaNa+ concentration for salt tolerance during seed germination and early seedling growth in Arabidopsis.	[Zhang, Jiantao; Liu, Hua; Li, Bei; Zhu, Qiang; Zhang, Hongxia] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Sun, Jian; Chen, Shaoliang] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Beijing Forestry University	Zhang, JT (corresponding author), Texas A&M Univ Syst, Texas AgriLife Res Ctr, Dept Plant Pathol & Microbiol, Weslaco, TX USA.	hxzhang@sippe.ac.cn	Zhang, Jiantao/I-5116-2014; LIU, HUA/M-7659-2019; Wang, Zhibo/GSD-3371-2022	Chen, Shaoliang/0000-0001-7511-3067; Zhang, Jiantao/0000-0002-2875-9743; Sun, Jian/0000-0002-1434-4029	National Natural Science Foundation of China [30872044, 30800880, 3100012, 31000288, 31171169, 31101154]; National Basic Research Program of China [2010CB126600]; National mega project of GMO crops [2008ZX08001-003, 2008ZX08004-002, 2008ZX08010-004]; Shanghai Science & Technology Development Fund [0853Z111C1, 08DZ2270800]; Fundamental Research Funds for the Central Universities [JC2011-2, BLYJ200903]; Foundation for the Supervisors of Excellent Doctoral Dissertations of Beijing [YB20081002201]; Beijing Natural Science Foundation [6112017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National mega project of GMO crops; Shanghai Science & Technology Development Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation for the Supervisors of Excellent Doctoral Dissertations of Beijing; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (30872044; 30800880; 3100012; 31000288; 31171169; 31101154); the National Basic Research Program of China (2010CB126600); the National mega project of GMO crops (2008ZX08001-003; 2008ZX08004-002; 2008ZX08010-004); Shanghai Science & Technology Development Fund (0853Z111C1; 08DZ2270800); the Fundamental Research Funds for the Central Universities (JC2011-2; BLYJ200903); Foundation for the Supervisors of Excellent Doctoral Dissertations of Beijing (YB20081002201); and Beijing Natural Science Foundation (6112017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 1999, P NATL ACAD SCI USA, V96, P5862, DOI 10.1073/pnas.96.10.5862; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Apse MP, 2002, CURR OPIN BIOTECH, V13, P146, DOI 10.1016/S0958-1669(02)00298-7; BLUMWALD E, 1987, PHYSIOL PLANTARUM, V69, P731, DOI 10.1111/j.1399-3054.1987.tb01993.x; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COOKE DT, 1990, PHYSIOL PLANTARUM, V78, P153, DOI 10.1111/j.1399-3054.1990.tb08730.x; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Craig W, 2008, TRANSGENIC RES, V17, P769, DOI 10.1007/s11248-008-9164-9; DEUTICKE B, 1987, ANNU REV PHYSIOL, V49, P221; Fiehn O, 2000, ANAL CHEM, V72, P3573, DOI 10.1021/ac991142i; Gevaudant F, 2007, PLANT PHYSIOL, V144, P1763, DOI 10.1104/pp.107.103762; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; GRAHAM D, 1982, ANNU REV PLANT PHYS, V33, P347, DOI 10.1146/annurev.pp.33.060182.002023; Im YJ, 2002, MOL CELLS, V13, P264; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kajiwara S, 1996, APPL ENVIRON MICROB, V62, P4309, DOI 10.1128/AEM.62.12.4309-4313.1996; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Khodakovskaya M, 2006, PLANTA, V223, P1090, DOI 10.1007/s00425-005-0161-4; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; KODAMA H, 1994, PLANT PHYSIOL, V105, P601, DOI 10.1104/pp.105.2.601; KODAMA H, 1995, PLANT PHYSIOL, V107, P1177, DOI 10.1104/pp.107.4.1177; Liu W, 2003, PLANT J, V36, P189, DOI 10.1046/j.1365-313X.2003.01866.x; Liu XY, 2006, J INTEGR PLANT BIOL, V48, P1096, DOI 10.1111/j.1744-7909.2006.00335.x; Maeda H, 2008, PLANT CELL, V20, P452, DOI 10.1105/tpc.107.054718; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Mikami K, 2003, PROG LIPID RES, V42, P527, DOI 10.1016/S0163-7827(03)00036-5; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; MIQUEL MF, 1994, PLANT PHYSIOL, V106, P421, DOI 10.1104/pp.106.2.421; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ogawa D, 2007, J EXP BOT, V58, P3373, DOI 10.1093/jxb/erm184; Oh DH, 2009, PLANT PHYSIOL, V151, P210, DOI 10.1104/pp.109.137802; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Pandey GK, 2005, PLANT PHYSIOL, V139, P1185, DOI 10.1104/pp.105.066324; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Rodriguez-Vargas S, 2007, APPL ENVIRON MICROB, V73, P110, DOI 10.1128/AEM.01360-06; Routaboul JM, 2000, PLANT PHYSIOL, V124, P1697, DOI 10.1104/pp.124.4.1697; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Steponkus P.L., 1993, ADV LOW TEMPERATURE, V2, P211; Sun J, 2009, PLANT PHYSIOL, V149, P1141, DOI 10.1104/pp.108.129494; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Verslues PE, 2007, PLANT MOL BIOL, V64, P205, DOI 10.1007/s11103-007-9145-z; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Wang B, 2006, J EXP BOT, V57, P1161, DOI 10.1093/jxb/erj116; Wang B., 1995, PLANT PHYSL COMMUN, V31, P50; Yang L, 2008, PLANT MOL BIOL, V66, P329, DOI 10.1007/s11103-007-9267-3; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhang JT, 2009, BIOCHEM BIOPH RES CO, V390, P469, DOI 10.1016/j.bbrc.2009.09.095; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x	51	147	171	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30355	10.1371/journal.pone.0030355	http://dx.doi.org/10.1371/journal.pone.0030355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22848559	Green Published, Green Submitted, gold			2022-12-25	WOS:000299771900063
J	Tian, J; Ban, XQ; Zeng, H; He, JS; Chen, YX; Wang, YW				Tian, Jun; Ban, Xiaoquan; Zeng, Hong; He, Jingsheng; Chen, Yuxin; Wang, Youwei			The Mechanism of Antifungal Action of Essential Oil from Dill (Anethum graveolens L.) on Aspergillus flavus	PLOS ONE			English	Article							IN-VITRO; MITOCHONDRIAL ATPASE; COLORIMETRIC ASSAY; ERGOSTEROL CONTENT; CANDIDA; SUSCEPTIBILITY; QUANTITATION; FLUCONAZOLE; APOPTOSIS; CELLS	The essential oil extracted from the seeds of dill (Anethum graveolens L.) was demonstrated in this study as a potential source of an eco-friendly antifungal agent. To elucidate the mechanism of the antifungal action further, the effect of the essential oil on the plasma membrane and mitochondria of Aspergillus flavus was investigated. The lesion in the plasma membrane was detected through flow cytometry and further verified through the inhibition of ergosterol synthesis. The essential oil caused morphological changes in the cells of A. flavus and a reduction in the ergosterol quantity. Moreover, mitochondrial membrane potential (MMP), acidification of external medium, and mitochondrial ATPase and dehydrogenase activities were detected. The reactive oxygen species (ROS) accumulation was also examined through fluorometric assay. Exposure to dill oil resulted in an elevation of MMP, and in the suppression of the glucose-induced decrease in external pH at 4 mu l/ml. Decreased ATPase and dehydrogenase activities in A. flavus cells were also observed in a dose-dependent manner. The above dysfunctions of the mitochondria caused ROS accumulation in A. flavus. A reduction in cell viability was prevented through the addition of L-cysteine, which indicates that ROS is an important mediator of the antifungal action of dill oil. In summary, the antifungal activity of dill oil results from its ability to disrupt the permeability barrier of the plasma membrane and from the mitochondrial dysfunction-induced ROS accumulation in A. flavus.	[Tian, Jun; Ban, Xiaoquan; Zeng, Hong; He, Jingsheng; Chen, Yuxin; Wang, Youwei] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Sch Pharmaceut Sci,Inst Tradit Chinese Med & Nat, Wuhan 430072, Peoples R China	Wuhan University	Tian, J (corresponding author), Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Sch Pharmaceut Sci,Inst Tradit Chinese Med & Nat, Wuhan 430072, Peoples R China.	wyw@whu.edu.cn		Tian, Jun/0000-0003-2371-3153	National Mega Project on Major Drug Development [2011ZX09401-302]; Commonweal Specialized Research Fund of China Agriculture [201103016]; Natural Science Foundation of Hubei Province of China [2010CBB02301]; Fundamental Research Funds for the Central Universities [20103010101000185]	National Mega Project on Major Drug Development; Commonweal Specialized Research Fund of China Agriculture; Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Mega Project on Major Drug Development (2011ZX09401-302), the Commonweal Specialized Research Fund of China Agriculture (201103016), the Key Program of Natural Science Foundation of Hubei Province of China (2010CBB02301), and the Fundamental Research Funds for the Central Universities (20103010101000185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Arthington-Skaggs BA, 2000, ANTIMICROB AGENTS CH, V44, P2081, DOI 10.1128/AAC.44.8.2081-2085.2000; Arthington-Skaggs BA, 2002, ANTIMICROB AGENTS CH, V46, P2477, DOI 10.1128/AAC.46.8.2477-2481.2002; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Balietti M, 2005, BIOGERONTOLOGY, V6, P95, DOI 10.1007/s10522-005-3463-9; BAUER KD, 1993, ANN NY ACAD SCI, V677, P59, DOI 10.1111/j.1749-6632.1993.tb38765.x; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; Cardile V, 2009, J ETHNOPHARMACOL, V126, P265, DOI 10.1016/j.jep.2009.08.034; Castelli MV, 2005, BIOCHEM PHARMACOL, V70, P82, DOI 10.1016/j.bcp.2005.04.016; Cheng JJ, 2003, MOL CELL BIOL, V23, P163, DOI 10.1128/MCB.23.1.163-177.2003; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Cox SD, 2000, J APPL MICROBIOL, V88, P170, DOI 10.1046/j.1365-2672.2000.00943.x; Deak E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007673; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Editorial Committee of National Chinese Medical Manage Bureau, 1999, CHIN HERB, V15; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kaim G, 1999, EMBO J, V18, P4118, DOI 10.1093/emboj/18.15.4118; Kang K, 2010, MYCOPATHOLOGIA, V170, P391, DOI 10.1007/s11046-010-9341-2; KELLY SL, 1995, BIOCHEM BIOPH RES CO, V207, P910, DOI 10.1006/bbrc.1995.1272; Kobayashi D, 2002, ANTIMICROB AGENTS CH, V46, P3113, DOI 10.1128/AAC.46.10.3113-3117.2002; Leiter E, 2005, ANTIMICROB AGENTS CH, V49, P2445, DOI 10.1128/AAC.49.6.2445-2453.2005; Lunde CS, 2000, ANTIMICROB AGENTS CH, V44, P1943, DOI 10.1128/AAC.44.7.1943-1953.2000; Maertens J, 2004, CLIN INFECT DIS, V39, P1563, DOI 10.1086/423381; Manavathu EK, 1999, ANTIMICROB AGENTS CH, V43, P2950, DOI 10.1128/AAC.43.12.2950; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Mello EO, 2011, CURR MICROBIOL, V62, P1209, DOI 10.1007/s00284-010-9847-3; Monsefi M, 2006, PHYTOTHER RES, V20, P865, DOI 10.1002/ptr.1959; Pinto E, 2006, J MED MICROBIOL, V55, P1367, DOI 10.1099/jmm.0.46443-0; Pinto E, 2009, J MED MICROBIOL, V58, P1454, DOI 10.1099/jmm.0.010538-0; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Qi GF, 2010, PEPTIDES, V31, P1978, DOI 10.1016/j.peptides.2010.08.003; Rafii F, 2007, CHEMOTHERAPY, V53, P21, DOI 10.1159/000098246; RODRIGUEZ RJ, 1985, BIOCHIM BIOPHYS ACTA, V837, P336, DOI 10.1016/0005-2760(85)90057-8; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; ROWLANDS RT, 1974, MOL GEN GENET, V132, P73, DOI 10.1007/BF00268232; Simbula G, 1997, AM J PHYSIOL-CELL PH, V273, pC479, DOI 10.1152/ajpcell.1997.273.2.C479; SQUIRE RA, 1981, SCIENCE, V214, P877, DOI 10.1126/science.7302565; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Tang XQ, 2005, BRAIN RES, V1057, P57, DOI 10.1016/j.brainres.2005.07.072; Tian J, 2012, FOOD CHEM, V130, P520, DOI 10.1016/j.foodchem.2011.07.061; Tian J, 2011, FOOD CONTROL, V22, P1992, DOI 10.1016/j.foodcont.2011.05.018; Varma J, 2001, INT J FOOD MICROBIOL, V68, P207, DOI 10.1016/S0168-1605(01)00506-2; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Wu XZ, 2009, BBA-GEN SUBJECTS, V1790, P770, DOI 10.1016/j.bbagen.2009.05.002; Yan L, 2009, J ANTIMICROB CHEMOTH, V64, P764, DOI 10.1093/jac/dkp273; Yazdanparast R, 2001, CYTOBIOS, V105, P185; Zeng H, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/659704; Zorov DB, 1997, BIOSCIENCE REP, V17, P507, DOI 10.1023/A:1027304122259	56	205	239	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30147	10.1371/journal.pone.0030147	http://dx.doi.org/10.1371/journal.pone.0030147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272289	Green Submitted, Green Published, gold			2022-12-25	WOS:000301454400067
J	Miller, RJ; Bennett, S; Keller, AA; Pease, S; Lenihan, HS				Miller, Robert J.; Bennett, Samuel; Keller, Arturo A.; Pease, Scott; Lenihan, Hunter S.			TiO2 Nanoparticles Are Phototoxic to Marine Phytoplankton	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; ENGINEERED NANOPARTICLES; ULTRAVIOLET-RADIATION; STRESS; NANOMATERIALS; BIOCHEMISTRY; ENVIRONMENT; MECHANISMS; BEHAVIOR; SURFACE	Nanoparticulate titanium dioxide (TiO2) is highly photoactive, and its function as a photocatalyst drives much of the application demand for TiO2. Because TiO2 generates reactive oxygen species (ROS) when exposed to ultraviolet radiation (UVR), nanoparticulate TiO2 has been used in antibacterial coatings and wastewater disinfection, and has been investigated as an anti-cancer agent. Oxidative stress mediated by photoactive TiO2 is the likely mechanism of its toxicity, and experiments demonstrating cytotoxicity of TiO2 have used exposure to strong artificial sources of ultraviolet radiation (UVR). In vivo tests of TiO2 toxicity with aquatic organisms have typically shown low toxicity, and results across studies have been variable. No work has demonstrated that photoactivity causes environmental toxicity of TiO2 under natural levels of UVR. Here we show that relatively low levels of ultraviolet light, consistent with those found in nature, can induce toxicity of TiO2 nanoparticles to marine phytoplankton, the most important primary producers on Earth. No effect of TiO2 on phytoplankton was found in treatments where UV light was blocked. Under low intensity UVR, ROS in seawater increased with increasing nano-TiO2 concentration. These increases may lead to increased overall oxidative stress in seawater contaminated by TiO2, and cause decreased resiliency of marine ecosystems. Phototoxicity must be considered when evaluating environmental impacts of nanomaterials, many of which are photoactive.	[Miller, Robert J.; Bennett, Samuel; Keller, Arturo A.; Pease, Scott; Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Miller, Robert J.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Miller, Robert J.; Bennett, Samuel; Keller, Arturo A.; Lenihan, Hunter S.] Univ Calif Santa Barbara, Univ Calif Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA; [Pease, Scott] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Washington; University of Washington Seattle	Miller, RJ (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	miller@msi.ucsb.edu		Miller, Robert/0000-0002-8350-3759; Hocevar, John/0000-0002-8346-1341	National Science Foundation [EF-0742521]; United States Environmental Protection Agency [NSF-EF0830117]	National Science Foundation(National Science Foundation (NSF)); United States Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the National Science Foundation and the United States Environmental Protection Agency under Cooperative Agreement # NSF-EF0830117, and by National Science Foundation grant EF-0742521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel DL, 1999, HELGOLAND MAR RES, V53, P209; Battin TJ, 2009, ENVIRON SCI TECHNOL, V43, P8098, DOI 10.1021/es9017046; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bennett SW, 2011, APPL CATAL B-ENVIRON, V102, P600, DOI 10.1016/j.apcatb.2010.12.045; Berliner LJ, 2001, FREE RADICAL BIO MED, V30, P489, DOI 10.1016/S0891-5849(00)00491-3; Brunet L, 2009, ENVIRON SCI TECHNOL, V43, P4355, DOI 10.1021/es803093t; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001; CHAMULITRAT W, 1992, ARCH BIOCHEM BIOPHYS, V296, P645, DOI 10.1016/0003-9861(92)90621-3; Collen J, 1999, PLANT CELL ENVIRON, V22, P1143, DOI 10.1046/j.1365-3040.1999.00477.x; Czili H, 2008, APPL CATAL B-ENVIRON, V81, P295, DOI 10.1016/j.apcatb.2008.01.001; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Farre M, 2009, ANAL BIOANAL CHEM, V393, P81, DOI 10.1007/s00216-008-2458-1; Fridovich I, 1998, J EXP BIOL, V201, P1203; Godwin HA, 2009, ENVIRON SCI TECHNOL, V43, P6453, DOI 10.1021/es8034544; Gopal NO, 2010, J AM CHEM SOC, V132, P10982, DOI 10.1021/ja909901f; Gottschalk F, 2010, ENVIRON TOXICOL CHEM, V29, P1036, DOI 10.1002/etc.135; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; He ZM, 2011, NANOSCALE, V3, P4977, DOI 10.1039/c1nr11126d; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Johnston HJ, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-33; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim J, 2010, AQUAT TOXICOL, V97, P116, DOI 10.1016/j.aquatox.2009.12.022; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Konstantinou IK, 2004, APPL CATAL B-ENVIRON, V49, P1, DOI 10.1016/j.apcatb.2003.11.010; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; Menard A, 2011, ENVIRON POLLUT, V159, P677, DOI 10.1016/j.envpol.2010.11.027; Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x; MOPPER K, 1990, SCIENCE, V250, P661, DOI 10.1126/science.250.4981.661; Musee N, 2011, J ENVIRON MONITOR, V13, P1164, DOI 10.1039/c1em10023h; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; ODA T, 1992, MAR BIOL, V112, P505, DOI 10.1007/BF00356297; Rozhkova EA, 2009, NANO LETT, V9, P3337, DOI 10.1021/nl901610f; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Theron J, 2008, CRIT REV MICROBIOL, V34, P43, DOI [10.1080/10408410701710442, 10.1080/10408410701710442 ]; YANG CZ, 1995, DIS AQUAT ORGAN, V23, P101, DOI 10.3354/dao023101; Zhang DQ, 2010, J MATER CHEM, V20, P4529, DOI 10.1039/b925342d; Zubia M, 2007, J APPL PHYCOL, V19, P449, DOI 10.1007/s10811-006-9152-5	44	231	242	6	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30321	10.1371/journal.pone.0030321	http://dx.doi.org/10.1371/journal.pone.0030321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22470486	Green Submitted, Green Published, gold			2022-12-25	WOS:000301568100035
J	Zhang, Y; Fan, SF; Yao, YY; Ding, J; Wang, Y; Zhao, Z; Liao, L; Li, PC; Zang, FC; Teng, GJ				Zhang, Yi; Fan, Shufeng; Yao, Yuyu; Ding, Jie; Wang, Yu; Zhao, Zhen; Liao, Lei; Li, Peicheng; Zang, Fengchao; Teng, Gao-Jun			In Vivo Near-Infrared Imaging of Fibrin Deposition in Thromboembolic Stroke in Mice	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; FACTOR-XIII; COAGULATION-FACTOR; CEREBRAL-ISCHEMIA; BRAIN-INJURY; MODEL	Objectives: Thrombus and secondary thrombosis plays a key role in stroke. Recent molecular imaging provides in vivo imaging of activated factor XIII (FXIIIa), an important mediator of thrombosis or fibrinolytic resistance. The present study was to investigate the fibrin deposition in a thromboembolic stroke mice model by FXIIIa-targeted near-infrared fluorescence (NIRF) imaging. Materials and Methods: The experimental protocol was approved by our institutional animal use committee. Seventy-six C57B/6J mice were subjected to thromboembolic middle cerebral artery occlusion or sham operation. Mice were either intravenously injected with the FXIIIa-targeted probe or control probe. In vivo and ex vivo NIRF imaging were performed thereafter. Probe distribution was assessed with fluorescence microscopy by spectral imaging and quantification system. MR scans were performed to measure lesion volumes in vivo, which were correlated with histology after animal euthanasia. Results: In vivo significant higher fluorescence intensity over the ischemia-affected hemisphere, compared to the contralateral side, was detected in mice that received FXIIIa-targeted probe, but not in the controlled mice. Significantly NIRF signals showed time-dependent processes from 8 to 96 hours after injection of FXIIIa-targeted probes. Ex vivo NIRF image showed an intense fluorescence within the ischemic territory only in mice injected with FXIIIa-targeted probe. The fluorescence microscopy demonstrated distribution of FXIIIa-targeted probe in the ischemic region and nearby micro-vessels, and FXIIIa-targeted probe signals showed good overlap with immune-fluorescent fibrin staining images. There was a significant correlation between total targeted signal from in vivo or ex vivo NIRF images and lesion volume. Conclusion: Non-invasive detection of fibrin deposition in ischemic mouse brain using NIRF imaging is feasible and this technique may provide an in vivo experimental tool in studying the role of fibrin in stroke.	[Zhang, Yi; Fan, Shufeng; Yao, Yuyu; Ding, Jie; Wang, Yu; Zhao, Zhen; Liao, Lei; Li, Peicheng; Zang, Fengchao; Teng, Gao-Jun] Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Zhongda Hosp, Sch Med,Dept Radiol, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Zhang, Y (corresponding author), Southeast Univ, Jiangsu Key Lab Mol & Funct Imaging, Zhongda Hosp, Sch Med,Dept Radiol, Nanjing, Jiangsu, Peoples R China.	gjteng@seu.edu.cn	Zhang, Baohong/O-4948-2016	Ding, Jie/0000-0001-9162-7850	National Natural Science Foundation of China (NSFC) [90606007, 30910103905, 30830039]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This project is sponsored by National Natural Science Foundation of China (NSFC #90606007, #30910103905, and #30830039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2004, MOL INTERV, V4, P163; ALBERS GW, 1995, AM J CARDIOL, V75, pB34, DOI 10.1016/0002-9149(95)80008-G; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Gerriets T, 2004, STROKE, V35, P566, DOI 10.1161/01.STR.0000113692.38574.57; Hare T, 2000, J CEREBR BLOOD F MET, V20, P1483, DOI 10.1097/00004647-200010000-00010; Heye N, 1996, STROKE, V27, P431, DOI 10.1161/01.STR.27.3.431; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Jaffer FA, 2004, CIRCULATION, V110, P170, DOI 10.1161/01.CIR.0000134484.11052.44; Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645; Kilic E, 1998, NEUROREPORT, V9, P2967, DOI 10.1097/00001756-199809140-00009; Kim DE, 2005, J CEREBR BLOOD F MET, V25, P226, DOI 10.1038/sj.jcbfm.9600023; Klohs J, 2008, STROKE, V39, P2845, DOI 10.1161/STROKEAHA.107.509844; Klohs J, 2006, MOL IMAGING, V5, P180; Klohs J, 2009, J CEREBR BLOOD F MET, V29, P1284, DOI 10.1038/jcbfm.2009.51; Miserus RJJHM, 2009, JACC-CARDIOVASC IMAG, V2, P987, DOI 10.1016/j.jcmg.2009.03.015; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Muszbek L., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P190, DOI 10.2174/187152508784871990; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; OKADA Y, 1994, STROKE, V25, P1847, DOI 10.1161/01.STR.25.9.1847; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Ryu JK, 2009, J THROMB HAEMOST, V7, P151, DOI 10.1111/j.1538-7836.2009.03438.x; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; SIEBLER M, 1994, LANCET, V344, P555, DOI 10.1016/S0140-6736(94)91953-4; Tabrizi P, 1999, ARTERIOSCL THROM VAS, V19, P2801, DOI 10.1161/01.ATV.19.11.2801; Tung CH, 2003, CHEMBIOCHEM, V4, P897, DOI 10.1002/cbic.200300602; Uppal R, 2010, STROKE, V41, P1271, DOI 10.1161/STROKEAHA.109.575662; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Wang L, 1997, J CEREBR BLOOD F MET, V17, P136, DOI 10.1097/00004647-199702000-00002; Zhang RL, 1997, BRAIN RES, V766, P83, DOI 10.1016/S0006-8993(97)00580-5; Zhang ZG, 1999, J NEUROSCI, V19, P10898, DOI 10.1523/JNEUROSCI.19-24-10898.1999	31	114	127	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30262	10.1371/journal.pone.0030262	http://dx.doi.org/10.1371/journal.pone.0030262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22438870	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400097
J	Collins, RA; Armstrong, KF; Meier, R; Yi, YG; Brown, SDJ; Cruickshank, RH; Keeling, S; Johnston, C				Collins, Rupert A.; Armstrong, Karen F.; Meier, Rudolf; Yi, Youguang; Brown, Samuel D. J.; Cruickshank, Robert H.; Keeling, Suzanne; Johnston, Colin			Barcoding and Border Biosecurity: Identifying Cyprinid Fishes in the Aquarium Trade	PLOS ONE			English	Article							FRESH-WATER FISHES; DNA BARCODES; MITOCHONDRIAL-DNA; ORNAMENTAL FISH; TUNA SUSHI; IDENTIFICATION; BIODIVERSITY; TELEOSTEI; HOMOGENIZATION; CONSEQUENCES	Background: Poorly regulated international trade in ornamental fishes poses risks to both biodiversity and economic activity via invasive alien species and exotic pathogens. Border security officials need robust tools to confirm identifications, often requiring hard-to-obtain taxonomic literature and expertise. DNA barcoding offers a potentially attractive tool for quarantine inspection, but has yet to be scrutinised for aquarium fishes. Here, we present a barcoding approach for ornamental cyprinid fishes by: (1) expanding current barcode reference libraries; (2) assessing barcode congruence with morphological identifications under numerous scenarios (e. g. inclusion of GenBank data, presence of singleton species, choice of analytical method); and (3) providing supplementary information to identify difficult species. Methodology/Principal Findings: We sampled 172 ornamental cyprinid fish species from the international trade, and provide data for 91 species currently unrepresented in reference libraries (GenBank/Bold). DNA barcodes were found to be highly congruent with our morphological assignments, achieving success rates of 90-99%, depending on the method used (neighbour-joining monophyly, bootstrap, nearest neighbour, GMYC, percent threshold). Inclusion of data from GenBank (additional 157 spp.) resulted in a more comprehensive library, but at a cost to success rate due to the increased number of singleton species. In addition to DNA barcodes, our study also provides supporting data in the form of specimen images, morphological characters, taxonomic bibliography, preserved vouchers, and nuclear rhodopsin sequences. Using this nuclear rhodopsin data we also uncovered evidence of interspecific hybridisation, and highlighted unrecognised diversity within popular aquarium species, including the endangered Indian barb Puntius denisonii. Conclusions/Significance: We demonstrate that DNA barcoding provides a highly effective biosecurity tool for rapidly identifying ornamental fishes. In cases where DNA barcodes are unable to offer an identification, we improve on previous studies by consolidating supplementary information from multiple data sources, and empower biosecurity agencies to confidently identify high-risk fishes in the aquarium trade.	[Collins, Rupert A.; Armstrong, Karen F.] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Meier, Rudolf; Yi, Youguang] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Meier, Rudolf; Yi, Youguang] Natl Univ Singapore, Univ Scholars Programme, Singapore 117548, Singapore; [Brown, Samuel D. J.; Cruickshank, Robert H.] Lincoln Univ, Dept Ecol, Fac Agr & Life Sci, Canterbury, New Zealand; [Keeling, Suzanne; Johnston, Colin] Minist Agr & Forestry, Hlth Anim Lab, Invest & Diagnost Ctr, Upper Hutt, New Zealand	Lincoln University - New Zealand; National University of Singapore; National University of Singapore; Lincoln University - New Zealand	Collins, RA (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand.	rupertcollins@gmail.com	Armstrong, Karen F/J-3460-2013; Meier, Rudolf/AAB-3848-2021; Meier, Rudolf/A-7099-2011; Brown, Samuel/P-8847-2017; Schuler, Herwig/E-5751-2011; Arner, Elias/J-5832-2012	Armstrong, Karen F/0000-0003-4973-2651; Meier, Rudolf/0000-0002-4452-2885; Meier, Rudolf/0000-0002-4452-2885; Brown, Samuel/0000-0001-7112-421X; Schuler, Herwig/0000-0003-4059-3501; Collins, Rupert A./0000-0002-9135-1169; Arner, Elias/0000-0002-4807-6114; Hogbom, Martin/0000-0001-5574-9383	Ministry of Agriculture and Forestry Biosecurity New Zealand; Ministry of Education (Singapore) [R377-000-040-112]	Ministry of Agriculture and Forestry Biosecurity New Zealand; Ministry of Education (Singapore)(Ministry of Education, Singapore)	This work was supported by a Ministry of Agriculture and Forestry Biosecurity New Zealand scholarship for RAC; grant R377-000-040-112 by the Ministry of Education (Singapore) for RM and YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2010, IUCN 2011 IUCN RED L; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Baensch HA, 2007, AQUARIUM ATLAS PHOTO; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Copp GH, 2010, AQUAT CONSERV, V20, P595, DOI 10.1002/aqc.1129; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Dasmahapatra KK, 2010, MOL ECOL RESOUR, V10, P264, DOI 10.1111/j.1755-0998.2009.02763.x; deWaard JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014280; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Eschmeyer WN, 2010, CATALOG FISHES ELECT; Fang Fang, 2000, Ichthyological Exploration of Freshwaters, V11, P149; Fang F, 2009, ZOOL SCR, V38, P237, DOI 10.1111/j.1463-6409.2008.00373.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gerson H, 2008, CONSERV BIOL, V22, P4, DOI 10.1111/j.1523-1739.2007.00857.x; Gerstner CL, 2006, J FISH BIOL, V68, P862, DOI 10.1111/j.1095.8649.2006.00978.x; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Go J, 2006, AQUACULTURE, V258, P140, DOI 10.1016/j.aquaculture.2006.04.033; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hensen RR, 2010, STANDARD NAMES FRESH; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hui TH, 2008, RAFFLES B ZOOL, V56, P423; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kottelat M, 2007, HDB EUROPEAN FRESHWA; Liao TY, 2011, RAFFLES B ZOOL, V59, P77; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Linthoingambi I., 2007, Zootaxa, V1450, P45; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; MAF Biosecurity New Zealand, 2011, IMP HLTH STAND ORN F; McDowall RM, 2004, NEW ZEAL J MAR FRESH, V38, P503, DOI 10.1080/00288330.2004.9517256; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Nelson J. S., 2006, FISHES WORLD; NG PKL, 1993, BIOL CONSERV, V64, P19, DOI 10.1016/0006-3207(93)90379-F; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ploeg A, 2008, OFI J, V58, P21; Ploeg A, 2009, BIOSECURITY ORNAMENT; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANG ENV STAT COMP; Raghavan R, 2007, CURR SCI INDIA, V92, P1671; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Ross HA, 2003, J HERED, V94, P111, DOI 10.1093/jhered/esg027; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rubinoff D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016361; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Silva A, 2010, ICHTHYOL EXPLOR FRES, V21, P27; Smits SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012267; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang KL, 2010, MOL PHYLOGENET EVOL, V57, P189, DOI 10.1016/j.ympev.2010.05.021; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whittington RJ, 2007, PREV VET MED, V81, P92, DOI 10.1016/j.prevetmed.2007.04.007; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Wong YT, 2011, BIOL INVASIONS, V13, P341, DOI 10.1007/s10530-010-9825-5; YOKOYAMA R, 1995, INVEST OPHTH VIS SCI, V36, P939; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x	99	110	115	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e28381	10.1371/journal.pone.0028381	http://dx.doi.org/10.1371/journal.pone.0028381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22295093	Green Submitted, gold, Green Published			2022-12-25	WOS:000301568100003
J	Liu, SY; Lin, JQ; Wu, HL; Wang, CC; Huang, SJ; Luo, YF; Sun, JH; Zhou, JX; Yan, SJ; He, JG; Wang, J; He, ZM				Liu, Si-Yang; Lin, Jian-Qing; Wu, Hong-Long; Wang, Cheng-Cheng; Huang, Shu-Jia; Luo, Yan-Feng; Sun, Ji-Hua; Zhou, Jian-Xiang; Yan, Shu-Jing; He, Jian-Guo; Wang, Jun; He, Zhu-Mei			Bisulfite Sequencing Reveals That Aspergillus flavus Holds a Hollow in DNA Methylation	PLOS ONE			English	Article							INDUCED POINT MUTATION; CYTOSINE METHYLTRANSFERASE HOMOLOG; SECONDARY METABOLISM; AFLATOXIN; CONTAINS; RIP; HETEROCHROMATIN; IDENTIFICATION; 5-AZACYTIDINE; ELEMENTS	Aspergillus flavus first gained scientific attention for its production of aflatoxin. The underlying regulation of aflatoxin biosynthesis has been serving as a theoretical model for biosynthesis of other microbial secondary metabolites. Nevertheless, for several decades, the DNA methylation status, one of the important epigenomic modifications involved in gene regulation, in A. flavus remains to be controversial. Here, we applied bisulfite sequencing in conjunction with a biological replicate strategy to investigate the DNA methylation profiling of A. flavus genome. Both the bisulfite sequencing data and the methylome comparisons with other fungi confirm that the DNA methylation level of this fungus is negligible. Further investigation into the DNA methyltransferase of Aspergillus uncovers its close relationship with RID-like enzymes as well as its divergence with the methyltransferase of species with validated DNA methylation. The lack of repeat contents of the A. flavus' genome and the high RIP-index of the small amount of remanent repeat potentially support our speculation that DNA methylation may be absent in A. flavus or that it may possess de novo DNA methylation which occurs very transiently during the obscure sexual stage of this fungal species. This work contributes to our understanding on the DNA methylation status of A. flavus, as well as reinforces our views on the DNA methylation in fungal species. In addition, our strategy of applying bisulfite sequencing to DNA methylation detection in species with low DNA methylation may serve as a reference for later scientific investigations in other hypomethylated species.	[Liu, Si-Yang; Lin, Jian-Qing; Wang, Cheng-Cheng; Luo, Yan-Feng; Zhou, Jian-Xiang; He, Jian-Guo; He, Zhu-Mei] Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Si-Yang; Wu, Hong-Long; Huang, Shu-Jia; Sun, Ji-Hua; Yan, Shu-Jing; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China	Sun Yat Sen University; Beijing Genomics Institute (BGI)	Liu, SY (corresponding author), Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn; wangj@genomics.org.cn; lsshezm@mail.sysu.edu.cn	贺, 竹梅/GVS-1592-2022; Huang, Shujia/GXG-8583-2022; Wang, Jun/A-7261-2013; Liu, Siyang/M-6127-2014; Lin, Jianqing/GYU-6251-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Huang, Shujia/0000-0003-2100-2534; Liu, Siyang/0000-0001-6780-9419; Nettleton, Dan/0000-0002-6045-1036; Wang, Jun/0000-0002-2113-5874; Yeh, Cheng-Ting/0000-0002-1392-2018; Wang, Jun/0000-0002-8540-8931; Schnable, Patrick/0000-0001-9169-5204	National Natural Science Foundation of China [30870024, 31170044]; Natural Science Foundation of Guangdong Province of China [9151027501000113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (grant no. 30870024 and grant no. 31170044), Natural Science Foundation of Guangdong Province of China (grant no. 9151027501000113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, no additional external funding received for this study.	ANTEQUERA F, 1984, J BIOL CHEM, V259, P8033; Aziz NH, 1997, NAHRUNG, V41, P150, DOI 10.1002/food.19970410307; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bestor TH, 1999, GENETICA, V107, P289, DOI 10.1023/A:1003990818251; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Cichewicz RH, 2010, NAT PROD REP, V27, P11, DOI 10.1039/b920860g; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Clutterbuck AJ, 2011, FUNGAL GENET BIOL, V48, P306, DOI 10.1016/j.fgb.2010.09.002; Dahl C, 2003, BIOGERONTOLOGY, V4, P233, DOI 10.1023/A:1025103319328; Doiron KMJ, 1999, MUTAT RES-FUND MOL M, V429, P37, DOI 10.1016/S0027-5107(99)00099-8; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Gowher H, 2001, FEMS MICROBIOL LETT, V205, P151, DOI 10.1111/j.1574-6968.2001.tb10939.x; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hayatsu Hikoya, 2006, Nucleic Acids Symp Ser (Oxf), P69, DOI 10.1093/nass/nrl034; He ZM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-104; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Lee DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002531; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; MAGILL JM, 1989, DEV GENET, V10, P63, DOI 10.1002/dvg.1020100202; Margolin BS, 1998, GENETICS, V149, P1787; Montiel MD, 2006, FUNGAL GENET BIOL, V43, P439, DOI 10.1016/j.fgb.2006.01.011; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rountree MR, 2010, HEREDITY, V105, P38, DOI 10.1038/hdy.2010.44; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TAMAME M, 1983, MOL CELL BIOL, V3, P2287, DOI 10.1128/MCB.3.12.2287; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	49	121	129	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30349	10.1371/journal.pone.0030349	http://dx.doi.org/10.1371/journal.pone.0030349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22586469	Green Published, gold, Green Submitted			2022-12-25	WOS:000301568100036
J	Yang, SY; Keshavmurthy, S; Obura, D; Sheppard, CRC; Visram, S; Chen, CA				Yang, Sung-Yin; Keshavmurthy, Shashank; Obura, David; Sheppard, Charles R. C.; Visram, Shakil; Chen, Chaolun Allen			Diversity and Distribution of Symbiodinium Associated with Seven Common Coral Species in the Chagos Archipelago, Central Indian Ocean	PLOS ONE			English	Article							SYMBIOTIC ALGAE; CLIMATE-CHANGE; SCLERACTINIAN CORALS; MOLECULAR DIVERSITY; REEF CORALS; ZOOXANTHELLAE; HOST; PATTERNS; IDENTIFICATION; COMMUNITIES	The Chagos Archipelago designated as a no-take marine protected area in 2010, lying about 500 km south of the Maldives in the Indian Ocean, has a high conservation priority, particularly because of its fast recovery from the ocean-wide massive coral mortality following the 1998 coral bleaching event. The aims of this study were to examine Symbiodinium diversity and distribution associated with scleractinian corals in five atolls of the Chagos Archipelago, spread over 10,000 km(-2). Symbiodinium clade diversity in 262 samples of seven common coral species, Acropora muricata, Isopora palifera, Pocillopora damicornis, P. verrucosa, P. eydouxi, Seriatopora hystrix, and Stylophora pistillata were determined using PCR-SSCP of the ribosomal internal transcribed spacer 1 (ITS1), PCR-DDGE of ITS2, and phylogenetic analyses. The results indicated that Symbiodinium in clade C were the dominant symbiont group in the seven coral species. Our analysis revealed types of Symbiodinium clade C specific to coral species. Types C1 and C3 (with C3z and C3i variants) were dominant in Acroporidae and C1 and C1c were the dominant types in Pocilloporidae. We also found 2 novel ITS2 types in S. hystrix and 1 novel ITS2 type of Symbiodinium in A. muricata. Some colonies of A. muricata and I. palifera were also associated with Symbiodinium A1. These results suggest that corals in the Chagos Archipelago host different assemblages of Symbiodinium types then their conspecifics from other locations in the Indian Ocean; and that future research will show whether these patterns in Symbiodinium genotypes may be due to local adaptation to specific conditions in the Chagos.	[Yang, Sung-Yin; Keshavmurthy, Shashank; Visram, Shakil; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Obura, David; Visram, Shakil] CORDIO, Mombasa, Kenya; [Obura, David; Sheppard, Charles R. C.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Chen, Chaolun Allen] Natl Taiwan Univ, Taipei 10764, Taiwan	Academia Sinica - Taiwan; University of Warwick; National Taiwan University	Yang, SY (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.	cac@gate.sinica.edu.tw	Yu, Hongjie/GZK-5351-2022; Chen, Yu/Y-3292-2019; Xiao, Yonghong/AFS-9054-2022; Keshavmurthy, Shashank/C-3672-2013; Matz, Mikhail/K-4392-2017	Keshavmurthy, Shashank/0000-0002-2235-9132; sheppard, charles/0000-0002-2579-5124; Yang, Sung-Yin/0000-0001-7431-406X; Wang, Dao Wen/0000-0002-9774-3980; Matz, Mikhail/0000-0001-5453-9819; Obura, David/0000-0003-2256-6649; Rao, Xiaoquan/0000-0001-7316-4530	Academia Sinica Thematic Grants; CORDIO; Chagos Conservation Trust; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship	Academia Sinica Thematic Grants; CORDIO; Chagos Conservation Trust; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship(Academia Sinica - Taiwan)	This study was partly funded by Academia Sinica Thematic Grants (2005-2010), CORDIO and Chagos Conservation Trust. SK was supported by National Science Council postdoctoral fellowship (2008-2010) and Academia Sinica postdoctoral fellowship (2010-2012), SV by Academia Sinica postdoctoral fellowship (2007-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Baker AC, 2004, CORAL HEALTH AND DISEASE, P177; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI 10.1016/S0065-2881(08)60224-2; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; Chen CA, 2000, MAR BIOTECHNOL, V2, P146; Chen CA, 2005, CORAL REEFS, V24, P11, DOI 10.1007/s00338-004-0389-7; Chen CA, 2003, ZOOL STUD, V42, P540; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Goulet TL, 2003, MAR BIOL, V142, P233, DOI 10.1007/s00227-002-0936-0; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Koldewey HJ, 2010, MAR POLLUT BULL, V60, P1906, DOI 10.1016/j.marpolbul.2010.10.002; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, BIOL INVASIONS, V11, P995, DOI 10.1007/s10530-008-9311-5; Lien YT, 2007, CORAL REEFS, V26, P35, DOI 10.1007/s00338-006-0185-7; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Magalon H, 2007, CORAL REEFS, V26, P551, DOI 10.1007/s00338-007-0215-0; Mangi S, 2010, WORKSH HELD 7 JAN 20; McPhaden MJ, 2009, B AM METEOROL SOC, V90, P459, DOI 10.1175/2008BAMS2608.1; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Pochon X, 2004, MAR BIOL, V146, P17, DOI 10.1007/s00227-004-1427-2; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard C, 2006, CONSERV BIOL SER, P264; Sheppard Charles R.C., 2000, P3; Sheppard CRC, 1999, AMBIO, V28, P472; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Sheppard CRC, 2012, MAR FRESHWATER RES, DOI [10.1002/aqc.1248, DOI 10.1002/AQC.1248]; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen Madeleine J. H., 2009, V205, P83; Van Woesik Robert, 2009, Galaxea - Tokyo, V11, P53; Visram S, 2006, J MAR BIOL ASSOC UK, V86, P1281, DOI 10.1017/S0025315406014299; Visram S, 2006, CORAL REEFS, V25, P172, DOI 10.1007/s00338-005-0079-0; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x	67	115	121	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35836	10.1371/journal.pone.0035836	http://dx.doi.org/10.1371/journal.pone.0035836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567113	Green Submitted, Green Published, gold			2022-12-25	WOS:000305341500031
J	Lin, YW; Lin, HY; Tsou, YL; Chitra, E; Hsiao, KN; Shao, HY; Liu, CC; Sia, C; Chong, P; Chow, YH				Lin, Yi-Wen; Lin, Hsiang-Yin; Tsou, Yueh-Liang; Chitra, Ebenezer; Hsiao, Kuang-Nan; Shao, Hsiao-Yun; Liu, Chia-Chyi; Sia, Charles; Chong, Pele; Chow, Yen-Hung			Human SCARB2-Mediated Entry and Endocytosis of EV71	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; RESPIRATORY SYNCYTIAL VIRUS; SELECTIN GLYCOPROTEIN LIGAND-1; NEUROGENIC PULMONARY-EDEMA; ENTEROVIRUS 71; CELLULAR RECEPTOR; P-SELECTIN; DEPENDENT ENDOCYTOSIS; MOUTH-DISEASE; PUBLIC-HEALTH	Enterovirus (EV) 71 infection is known to cause hand-foot-and-mouth disease (HFMD) and in severe cases, induces neurological disorders culminating in fatality. An outbreak of EV71 in South East Asia in 1997 affected over 120,000 people and caused neurological disorders in a few individuals. The control of EV71 infection through public health interventions remains minimal and treatments are only symptomatic. Recently, human scavenger receptor class B, member 2 (SCARB2) has been reported to be a cellular receptor of EV71. We expressed human SCARB2 gene in NIH3T3 cells (3T3-SCARB2) to study the mechanisms of EV71 entry and infection. We demonstrated that human SCARB2 serves as a cellular receptor for EV71 entry. Disruption of expression of SCARB2 using siRNAs can interfere EV71 infection and subsequent inhibit the expression of viral capsid proteins in RD and 3T3-SCARB2 but not Vero cells. SiRNAs specific to clathrin or dynamin or chemical inhibitor of clathrin-mediated endocytosis were all capable of interfering with the entry of EV71 into 3T3-SCARB2 cells. On the other hand, caveolin specific siRNA or inhibitors of caveolae-mediated endocytosis had no effect, confirming that only clathrin-mediated pathway was involved in EV71 infection. Endocytosis of EV71 was also found to be pH-dependent requiring endosomal acidification and also required intact membrane cholesterol. In summary, the mechanism of EV71 entry through SCARB2 as the receptor for attachment, and its cellular entry is through a clathrin-mediated and pHdependent endocytic pathway. This study on the receptor and endocytic mechanisms of EV71 infection is useful for the development of effective medications and prophylactic treatment against the enterovirus.	[Lin, Yi-Wen; Lin, Hsiang-Yin; Tsou, Yueh-Liang; Chitra, Ebenezer; Hsiao, Kuang-Nan; Shao, Hsiao-Yun; Liu, Chia-Chyi; Sia, Charles; Chong, Pele; Chow, Yen-Hung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan; [Lin, Yi-Wen] Natl Tsing Hua Univ, Inst Mol Med, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Tsou, Yueh-Liang] Natl Def Med Ctr, Grad Sch Life Sci, Taipei, Taiwan; [Sia, Charles; Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Defense Medical Center; China Medical University Taiwan	Lin, YW (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan.	pelechong@nhri.org.tw; choeyenh@nhri.org.tw	Liu, Chia-Chyi/A-8215-2012; Sia, Dwo-Yuan/E-3860-2010; Chong, Pele/E-3855-2010; Chitra, Ebenezer/F-5984-2019; Chow, Yen-Hung/E-3863-2010	Liu, Chia-Chyi/0000-0002-6257-0389; Chitra, Ebenezer/0000-0002-5818-6587; 	National Health Research Institutes [99A1-VCPP08-014]; National Science Council (NSC) of Taiwan [99-2323-B-400-014-]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes' intramural grant (99A1-VCPP08-014) (www.nhri.org.tw) and a grant (99-2323-B-400-014-) from the National Science Council (NSC) (http://web1.nsc.gov.tw) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; BROWN MS, 1980, J LIPID RES, V21, P505; Chang JY, 1998, BIOCHEM BIOPH RES CO, V249, P817, DOI 10.1006/bbrc.1998.9237; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gianni T, 2004, J VIROL, V78, P12268, DOI 10.1128/JVI.78.22.12268-12276.2004; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Hailstones D, 1998, J LIPID RES, V39, P369; He YN, 2000, P NATL ACAD SCI USA, V97, P79, DOI 10.1073/pnas.97.1.79; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin YC, 2002, VACCINE, V20, P2485, DOI 10.1016/S0264-410X(02)00182-2; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu PS, 1999, BIOCHEM BIOPH RES CO, V261, P695, DOI 10.1006/bbrc.1999.1082; LONBERGHOLM K, 1972, J VIROL, V9, P29, DOI 10.1128/JVI.9.1.29-40.1972; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; Melnick J L, 1980, Intervirology, V12, P297; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Parton RG, 1999, IMMUNOL REV, V168, P23, DOI 10.1111/j.1600-065X.1999.tb01280.x; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shu LM, 2000, ARCH BIOCHEM BIOPHYS, V373, P83, DOI 10.1006/abbi.1999.1553; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Smaby JM, 1996, BIOPHYS J, V70, P868, DOI 10.1016/S0006-3495(96)79629-7; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; SRINIVASAKUMAR N, 1991, J VIROL, V65, P4063, DOI 10.1128/JVI.65.8.4063-4069.1991; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Xing L, 2000, EMBO J, V19, P1207, DOI 10.1093/emboj/19.6.1207; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	83	76	89	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30507	10.1371/journal.pone.0030507	http://dx.doi.org/10.1371/journal.pone.0030507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272359	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400137
J	Zeng, YJ; Yang, X; Wang, J; Fan, JJ; Kong, QY; Yu, XQ				Zeng, Youjia; Yang, Xiao; Wang, Juan; Fan, Jinjin; Kong, Qingyu; Yu, Xueqing			Aristolochic Acid I Induced Autophagy Extenuates Cell Apoptosis via ERK 1/2 Pathway in Renal Tubular Epithelial Cells	PLOS ONE			English	Article							HT-29 CELLS; INHIBITION; DEATH; MACROAUTOPHAGY; TOXICITY; INJURY; VITRO	Autophagy is a lysosomal degradation pathway that is essential for cell survival and tissue homeostasis. However, limited information is available about autophagy in aristolochic acid (AA) nephropathy. In this study, we investigated the role of autophagy and related signaling pathway during progression of AAI-induced injury to renal tubular epithelial cells (NRK52E cells). The results showed that autophagy in NRK52E cells was detected as early as 3-6 hrs after low dose of AAI (10 mu M) exposure as indicated by an up-regulated expression of LC3-II and Beclin 1 proteins. The appearance of AAI-induced punctated staining of autophagosome-associated LC3-II upon GFP-LC3 transfection in NRK52E cells provided further evidence for autophagy. However, cell apoptosis was not detected until 12 hrs after AAI treatment. Blockade of autophagy with Wortmannin or 3-Methyladenine (two inhibitors of phosphoinositede 3-kinases) or small-interfering RNA knockdown of Beclin 1 or Atg7 sensitized the tubular cells to apoptosis. Treatment of NRK52E cells with AAI caused a time-dependent increase in extracellular signal-regulated kinase 1 and 2 (ERK1/2) activity, but not c-Jun N-terminal kinase (JNK) and p38. Pharmacological inhibition of ERK1/2 phosphorylation with U0126 resulted in a decreased AAI-induced autophagy that was accompanied by an increased apoptosis. Taken together, our study demonstrated for the first time that autophagy occurred earlier than apoptosis during AAI-induced tubular epithelial cell injury. Autophagy induced by AAI via ERK1/2 pathway might attenuate apoptosis, which may provide a protective mechanism for cell survival under AAI-induced pathological condition.	[Zeng, Youjia; Yang, Xiao; Wang, Juan; Fan, Jinjin; Kong, Qingyu; Yu, Xueqing] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zeng, YJ (corresponding author), Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 1, Key Lab Nephrol,Minist Hlth, Guangzhou 510275, Guangdong, Peoples R China.	yangx826@yahoo.com.cn	; Zhao, Xiubo/AAZ-9058-2021	Yu, Hai/0000-0002-6386-9761; Wang, Jiqian/0000-0002-7525-5943; Zhao, Xiubo/0000-0002-4620-2893	Chinese National Natural Science Research Grant [30873432, 81073138]	Chinese National Natural Science Research Grant	This work is supported by the Chinese National Natural Science Research Grant (Grant number 30873432, 81073138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2003, CELL DEATH DIFFER, V10, P940, DOI 10.1038/sj.cdd.4401280; Bakhiya N, 2009, TOXICOLOGY, V264, P74, DOI 10.1016/j.tox.2009.07.014; Balachandran P, 2005, KIDNEY INT, V67, P1797, DOI 10.1111/j.1523-1755.2005.00277.x; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gao RT, 2000, CHINESE MED J-PEKING, V113, P418; Hsin YH, 2006, APOPTOSIS, V11, P2167, DOI 10.1007/s10495-006-0289-0; Inoue K, 2010, CLIN EXP NEPHROL, V14, P112, DOI 10.1007/s10157-009-0254-7; Ioset JR, 2003, FOOD CHEM TOXICOL, V41, P29, DOI 10.1016/S0278-6915(02)00219-3; Ito M, 2010, CANCER GENE THER, V17, P633, DOI 10.1038/cgt.2010.20; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kovacs AL, 2000, CELL TISSUE RES, V302, P253, DOI 10.1007/s004410000275; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li J, 2010, TOXICOL IN VITRO, V24, P1092, DOI 10.1016/j.tiv.2010.03.012; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Periyasamy-Thandavan S, 2009, AM J PHYSIOL-RENAL, V297, pF244, DOI 10.1152/ajprenal.00033.2009; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Qi XM, 2007, TOXICOL APPL PHARM, V222, P105, DOI 10.1016/j.taap.2007.03.029; Sivaprasad U, 2008, J CELL MOL MED, V12, P1265, DOI 10.1111/j.1582-4934.2008.00282.x; VOM DS, 2001, BIOCHEM J, V354, P31; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yla-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0; Yu FY, 2011, TOXICOL IN VITRO, V25, P810, DOI 10.1016/j.tiv.2011.01.016	29	128	136	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30312	10.1371/journal.pone.0030312	http://dx.doi.org/10.1371/journal.pone.0030312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22276178	Green Published, Green Submitted, gold			2022-12-25	WOS:000301568100034
J	Yang, SG; Cao, B; Liang, LR; Li, XL; Xiao, YH; Cao, ZX; Jia, HY; Yu, HJ; Xu, Z; Gu, L; Yang, YD; Chen, Y; Du, WB; Yan, XX; Liang, ZA; Zhang, W; Zhang, CL; Chen, W; Guo, CP; Jiang, XL; Yang, M; Deng, GM; Yu, KJ; Hu, K; Zou, Q; Li, LJ; Wang, C				Yang, Shi-gui; Cao, Bin; Liang, Li-rong; Li, Xiao-li; Xiao, Yong-hong; Cao, Zhi-xin; Jia, Hong-yu; Yu, Hong-jie; Xu, Zhen; Gu, Li; Yang, Yi-da; Chen, Yu; Du, Wei-bo; Yan, Xi-xin; Liang, Zong-an; Zhang, Wei; Zhang, Chang-le; Chen, Wei; Guo, Cai-ping; Jiang, Xun-liang; Yang, Ming; Deng, Guang-ming; Yu, Kai-jiang; Hu, Ke; Zou, Qi; Li, Lan-juan; Wang, Chen		Natl Influenza Pandemic H1N1 2009	Antiviral Therapy and Outcomes of Patients with Pneumonia Caused by Influenza A Pandemic (H1N1) Virus	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; RISK-FACTORS; HOSPITALIZATION; OSELTAMIVIR; A(H1N1)	Background: There is limited data on the clinical outcome of patients with pandemic H1N1 (pH1N1) pneumonia who received oseltamivir treatment, especially when the treatment was administered more than 48 hours after symptom onset. Methods: During the pandemic in 2009, a cohort of pH1N1 influenza pneumonia was built in China, and their clinical information was collected systematically, and analyzed with Cox models. Results: 920 adults and 541 children with pneumonia who didn't receive corticosteroids were analyzed. In-hospital mortality was higher in adults who did not receive antiviral therapy (18.2%) than those with who received oseltamivir <= 2days (2.9%), between 2-5 days (4.6%) and >5 days after illness onset (4.9%), p<0.01. A similar trend was observed in pediatric patients. Cox regression showed that at 60 days after symptoms onset, 11 patients (10.8%) who did not receive antivirals died versus 4 (1.8%), 18 (3.3%), and 23 (3.7%) patients whose oseltamivir treatment was started <= 2days, between 2-5days, and >5 days, respectively. For males patients, aged >= 14 years and baseline PaO2/FiO(2)<200, oseltamivir administration reduced the mortality risk by 92.1%, 88% and 83.5%, respectively. Higher doses of oseltamivir (>3.8 mg/kg/d) did not improve clinical outcome (mortality, higher dose 2.5% vs standard dose 2.8%, p>0.05). Conclusions: Antiviral therapy might reduce mortality of patients with pH1N1 pneumonia, even when initiated more than 48 hours after onset of illness. Greater protective effects might be in males, patients aged 14-60 years, and patients with PaO2/FiO(2)<200.	[Yang, Shi-gui; Xiao, Yong-hong; Jia, Hong-yu; Yang, Yi-da; Chen, Yu; Du, Wei-bo; Li, Lan-juan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Cao, Bin; Liang, Li-rong; Li, Xiao-li; Cao, Zhi-xin; Gu, Li; Wang, Chen] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Beijing Key Lab Resp & Pulm Circulat, Beijing, Peoples R China; [Yu, Hong-jie; Xu, Zhen] Chinese Ctr Dis Control & Prevent, Dis Control & Emergency Response Off, Beijing, Peoples R China; [Yan, Xi-xin] Hebei Med Univ, Dept Resp Med, Hosp 2, Shijiazhuang, Peoples R China; [Liang, Zong-an] Sichuan Univ, W China Hosp, Chengdu 610064, Peoples R China; [Zhang, Wei] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China; [Zhang, Chang-le] Wenzhou 2 Peoples Hosp, Wenzhou, Peoples R China; [Chen, Wei] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China; [Guo, Cai-ping] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China; [Jiang, Xun-liang] Childrens Hosp Hunan Prov, Changsha, Hunan, Peoples R China; [Yang, Ming] Beijing Childrens Hosp, Beijing, Peoples R China; [Deng, Guang-ming] Shaoyang Cent Hosp, Shaoyang, Peoples R China; [Yu, Kai-jiang] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China; [Hu, Ke] Wuhan Univ, Remin Hosp, Wuhan 430072, Peoples R China; [Zou, Qi] Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China	Zhejiang University; Capital Medical University; Chinese Center for Disease Control & Prevention; Hebei Medical University; Sichuan University; Nanchang University; China Medical University; Capital Medical University; Capital Medical University; Harbin Medical University; Wuhan University; Fujian Medical University	Yang, SG (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; cyh-birm@263.net	Yu, Hongjie/GZK-5351-2022; Chen, Yu/Y-3292-2019; Xiao, Yonghong/AFS-9054-2022; Keshavmurthy, Shashank/C-3672-2013; Matz, Mikhail/K-4392-2017	Keshavmurthy, Shashank/0000-0002-2235-9132; sheppard, charles/0000-0002-2579-5124; Yang, Sung-Yin/0000-0001-7431-406X; Wang, Dao Wen/0000-0002-9774-3980; Matz, Mikhail/0000-0001-5453-9819; Obura, David/0000-0003-2256-6649; Rao, Xiaoquan/0000-0001-7316-4530	Ministry of Health of People's Republic of China; World Health Organization on clinical study for the influenza A pandemic A; Beijing Science Technology [Z09000700090903]; Major State Basic Research Development Program [2009CB522107]; Mega-projects of Science Research for the 11th Five-Year Plan of China [2009ZX10004-901, 2009ZX10004-210]; National Natural Science Foundation of China [81001271]	Ministry of Health of People's Republic of China; World Health Organization on clinical study for the influenza A pandemic A; Beijing Science Technology; Major State Basic Research Development Program(National Basic Research Program of China); Mega-projects of Science Research for the 11th Five-Year Plan of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the Ministry of Health of People's Republic of China and the World Health Organization on clinical study for the influenza A pandemic A (H1N1) 2009, grants from the Beijing Science & Technology (Z09000700090903), and Major State Basic Research Development Program (2009CB522107), Mega-projects of Science Research for the 11th Five-Year Plan of China (2009ZX10004-901, 2009ZX10004-210), and the National Natural Science Foundation of China (81001271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PAND INFL H1N1 2009; [Anonymous], 2010, H1N1 2009 UPD 94; Bai L, 2011, CHEST, V139, P1156, DOI 10.1378/chest.10-1036; *CDCP, 2009, CDC EST 2009 H1N1 IN; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P431; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Lee N, 2008, CLIN INFECT DIS, V46, P1323, DOI 10.1086/533477; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Weinstock DM, 2003, NEW ENGL J MED, V348, P867, DOI 10.1056/NEJM200302273480923; WHO, CDC PROT REALT RTPCR; WHO, 2009, WHO GUID PHARM MAN P; Writing Committee of the WHO Consultation on Pandemic (H1N1), 2009, NEW ENGL J MED, V362, P1708	30	115	121	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29652	10.1371/journal.pone.0029652	http://dx.doi.org/10.1371/journal.pone.0029652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22567113	gold, Green Submitted, Green Published			2022-12-25	WOS:000301568100014
J	Zhang, YQ; Chen, DL; Smith, MA; Zhang, BH; Pan, XP				Zhang, Yanqiong; Chen, Dongliang; Smith, Michael A.; Zhang, Baohong; Pan, Xiaoping			Selection of Reliable Reference Genes in Caenorhabditis elegans for Analysis of Nanotoxicity	PLOS ONE			English	Article							TRANSCRIPTION-PCR DATA; NANOPARTICLES; NORMALIZATION; MODEL; SET	Despite rapid development and application of a wide range of manufactured metal oxide nanoparticles (NPs), the understanding of potential risks of using NPs is less completed, especially at the molecular level. The nematode Caenorhabditis elegans (C. elegans) has been emerging as an environmental model to study the molecular mechanism of environmental contaminations, using standard genetic tools such as the real-time quantitative PCR (RT-qPCR). The most important factor that may affect the accuracy of RT-qPCR is to choose appropriate genes for normalization. In this study, we selected 13 reference gene candidates (act-1, cdc-42, pmp-3, eif-3. C, actin, act-2, csq-1, Y45F10D. 4, tba-1, mdh-1, ama-1, F35G12.2, and rbd-1) to test their expression stability under different doses of nano-copper oxide (CuO 0, 1, 10, and 50 mu g/mL) using RT-qPCR. Four algorithms, geNorm, NormFinder, BestKeeper, and the comparative DCt method, were employed to evaluate these 13 candidates expressions. As a result, tba-1, Y45F10D. 4 and pmp-3 were the most reliable, which may be used as reference genes in future study of nanoparticle-induced genetic response using C. elegans.	[Zhang, Yanqiong; Chen, Dongliang; Smith, Michael A.; Zhang, Baohong; Pan, Xiaoping] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Zhang, YQ (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	Panx@ecu.edu	Zhang, Baohong/O-4948-2016	Ding, Jie/0000-0001-9162-7850	East Carolina University; North Carolina Biotechnology Center	East Carolina University; North Carolina Biotechnology Center	This work was supported partially by the new faculty startup fund of East Carolina University, and partially by the North Carolina Biotechnology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BRENNER S, 1974, GENETICS, V77, P71; Chen D, 2011, J CELL PHYSL; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hoss S, 2003, TRACE METALS OTHER, V6, P529; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ivask A, 2010, ANAL BIOANAL CHEM, V398, P701, DOI 10.1007/s00216-010-3962-7; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023; Pan XP, 2010, CHEMOSPHERE, V79, P113, DOI 10.1016/j.chemosphere.2009.12.056; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Roh JY, 2010, ENVIRON TOXICOL PHAR, V29, P167, DOI 10.1016/j.etap.2009.12.003; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sochova I, 2007, ENVIRON INT, V33, P798, DOI 10.1016/j.envint.2007.03.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9	23	114	127	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2012	7	3							e31849	10.1371/journal.pone.0031849	http://dx.doi.org/10.1371/journal.pone.0031849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	932RU	22438870	Green Published, Green Submitted, gold			2022-12-25	WOS:000303309000004
J	Zhang, J; Wang, SX; Li, HH; Hu, BB; Yang, XF; Wang, ZB				Zhang, Jing; Wang, Shuxia; Li, Houhun; Hu, Bingbing; Yang, Xiaofei; Wang, Zhibo			Diffuse Coevolution between Two Epicephala Species (Gracillariidae) and Two Breynia Species (Phyllanthaceae)	PLOS ONE			English	Article							OBLIGATE POLLINATION MUTUALISM; PLASTID MATK; YUCCA MOTHS; GLOCHIDION; PHYLOGENETICS; SPECIFICITY; ASSOCIATION; FIGS	The diffuse coevolution between two moth species (Epicephala lativalvaris and E. mirivalvata) and two plant species (Breynia fruticosa and B. rostrata) is reported based on field observations and indoor experiments conducted in Hainan and Fujian, China. Study results showed that the two Epicephala species jointly pollinated the two Breynia species, which led to a unique obligate pollination mutualism of two-to-two species specificity. A single Epicephala larva exclusively fed on seeds of host plants and developed to maturity by consuming all six seeds of each fruit, whereas a fraction of intact fruits were left to ensure the reproduction of plants within the whole population. Larvae of the two Epicephala species are competitive for resources; the population of E. mirivalvata is much smaller than that of E. lativalvaris, which has resulted from the differences in the female ovipositor structures and oviposition mode. The life history of Epicephala species highly coincides with the phenology of Breynia plants, and different phenology of B. fruticosa resulted in the different life history of the two Epicephala species in Hainan and Fujian. The natural hybridization of two host plants, possibly induced by the alternate pollination of two Epicephala species, is briefly discussed.	[Zhang, Jing; Wang, Shuxia; Li, Houhun; Hu, Bingbing; Yang, Xiaofei; Wang, Zhibo] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University	Zhang, J (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	lihouhun@nankai.edu.cn	Zhang, Jiantao/I-5116-2014; LIU, HUA/M-7659-2019; Wang, Zhibo/GSD-3371-2022	Chen, Shaoliang/0000-0001-7511-3067; Zhang, Jiantao/0000-0002-2875-9743; Sun, Jian/0000-0002-1434-4029	National Natural Science Foundation of China [30930014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 30930014). Funder's website: http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; CORLETT RT, 1993, J TROP ECOL, V9, P501, DOI 10.1017/S0266467400007574; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; JANZEN DH, 1979, BIOTROPICA, V11, P48, DOI 10.2307/2388172; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Kathriarachchi H, 2006, AM J BOT, V93, P637, DOI 10.3732/ajb.93.4.637; Kato M, 2003, P NATL ACAD SCI USA, V100, P5264, DOI 10.1073/pnas.0837153100; Kawakita A, 2004, AM J BOT, V91, P1319, DOI 10.3732/ajb.91.9.1319; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Kawakita A, 2006, MOL ECOL, V15, P3567, DOI 10.1111/j.1365-294X.2006.03037.x; Kawakita A, 2010, PLANT SPEC BIOL, V25, P3, DOI 10.1111/j.1442-1984.2009.00266.x; Li B.T., 2008, FLORA CHINA, V11, P216; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Okamoto T, 2007, J CHEM ECOL, V33, P1065, DOI 10.1007/s10886-007-9287-0; Park DS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-423; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; Pellmyr O, 2003, ANN MO BOT GARD, V90, P35, DOI 10.2307/3298524; Samuel R, 2005, AM J BOT, V92, P132, DOI 10.3732/ajb.92.1.132; Svensson GP, 2010, NEW PHYTOL, V186, P995, DOI 10.1111/j.1469-8137.2010.03227.x; Swofford DL, 2005, PAUP PHYLOGENETIC AN; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Zhang J, 2012, ZOOTAXA, P43, DOI 10.11646/zootaxa.3275.1.4	25	147	171	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e41657	10.1371/journal.pone.0041657	http://dx.doi.org/10.1371/journal.pone.0041657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	22848559	Green Published, gold, Green Submitted			2022-12-25	WOS:000306950200085
J	Chen, YX; Zheng, SP; Qi, D; Zheng, SJ; Guo, JL; Zhang, SL; Weng, ZH				Chen, Yixiong; Zheng, Shaoping; Qi, Dan; Zheng, Shaojiang; Guo, Junli; Zhang, Shuling; Weng, Zhihong			Inhibition of Notch Signaling by a gamma-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; STELLATE CELLS; MAMMALIAN NOTCH; LIVER FIBROSIS; MYOFIBROBLAST DIFFERENTIATION; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; DEFICIENT MICE; PATHWAY	Notch signaling is essential to the regulation of cell differentiation, and aberrant activation of this pathway is implicated in human fibrotic diseases, such as pulmonary, renal, and peritoneal fibrosis. However, the role of Notch signaling in hepatic fibrosis has not been fully investigated. In the present study, we show Notch signaling to be highly activated in a rat model of liver fibrosis induced by carbon tetrachloride (CCl4), as indicated by increased expression of Jagged1, Notch3, and Hes1. Blocking Notch signaling activation by a gamma-secretase inhibitor, DAPT, significantly attenuated liver fibrosis and decreased the expression of snail, vimentin, and TGF-beta 1 in association with the enhanced expression of E-cadherin. The study in vitro revealed that DAPT treatment could suppress the EMT process of rat hepatic stellate cell line (HSC-T6). Interestingly, DAPT treatment was found not to affect hepatocyte proliferation in vivo. In contrast, DAPT can inhibit hepatocyte apoptosis to some degree. Our study provides the first evidence that Notch signaling is implicated in hepatic fibrogenesis and DAPT treatment has a protective effect on hepatocytes and ameliorates liver fibrosis. These findings suggest that the inhibition of Notch signaling might present a novel therapeutic approach for hepatic fibrosis.	[Chen, Yixiong; Qi, Dan; Zhang, Shuling; Weng, Zhihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Zheng, Shaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ultrasonog, Wuhan 430074, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Dept Pathol, Haikou, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Hainan Prov Key Lab Trop Med, Haikou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hainan Medical University; Hainan Medical University	Weng, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China.	wzh941@126.com	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	National Natural Science Foundation of China [30900663]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Natural Science Foundation of China (30900663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi-Ikeda K, 2011, AM J RESP CELL MOL, V45, P136, DOI 10.1165/rcmb.2010-0140OC; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; BETTENHAUSEN B, 1995, GENOMICS, V28, P436, DOI 10.1006/geno.1995.1172; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Chen SW, 2008, GENE THER, V15, P1424, DOI 10.1038/gt.2008.93; Chen YX, 2012, WORLD J GASTROENTERO, V18, P1397, DOI 10.3748/wjg.v18.i12.1397; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kinoshita K, 2007, GUT, V56, P396, DOI 10.1136/gut.2005.085704; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lin Y, 2005, LIVER INT, V25, P796, DOI 10.1111/j.1478-3231.2005.01098.x; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nijjar SS, 2002, AM J PATHOL, V160, P1695, DOI 10.1016/S0002-9440(10)61116-9; Nijjar SS, 2001, HEPATOLOGY, V34, P1184, DOI 10.1053/jhep.2001.29399; Pan Q, 2007, DIGEST DIS SCI, V52, P2591, DOI 10.1007/s10620-006-9676-1; Rao PK, 2000, EXP CELL RES, V260, P379, DOI 10.1006/excr.2000.5034; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184; Shawber C, 1996, DEVELOPMENT, V122, P3765; Sheahan S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-191; Shimizu M, 2001, HEPATOLOGY, V33, P569, DOI 10.1053/jhep.2001.22650; Teng YQ, 2007, J CLIN INVEST, V117, P304, DOI 10.1172/JCI31200; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wei P, 2010, MOL CANCER THER, V9, P1618, DOI 10.1158/1535-7163.MCT-10-0034; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu FX, 2010, AM J PATHOL, V176, P650, DOI 10.2353/ajpath.2010.090447	50	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46512	10.1371/journal.pone.0046512	http://dx.doi.org/10.1371/journal.pone.0046512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	22276200	Green Published, Green Submitted, gold			2022-12-25	WOS:000309454000052
J	Wang, HK; Yan, YH; Wang, JM; Zhang, HP; Qi, W				Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Zhang, HePing; Qi, Wei			Production and Characterization of Antifungal Compounds Produced by Lactobacillus plantarum IMAU10014	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; ANTIBIOTICS; SPOILAGE; BREAD; FOOD	Lactobacillus plantarum IMAU10014 was isolated from koumiss that produces a broad spectrum of antifungal compounds, all of which were active against plant pathogenic fungi in an agar plate assay. Two major antifungal compounds were extracted from the cell-free supernatant broth of L. plantarum IMAU10014. 3-phenyllactic acid and Benzeneacetic acid, 2-propenyl ester were carried out by HPLC, LC-MS, GC-MS, NMR analysis. It is the first report that lactic acid bacteria produce antifungal Benzeneacetic acid, 2-propenyl ester. Of these, the antifungal products also have a broad spectrum of antifungal activity, namely against Botrytis cinerea, Glomerella cingulate, Phytophthora drechsleri Tucker, Penicillium citrinum, Penicillium digitatum and Fusarium oxysporum, which was identified by the overlay and well-diffusion assay. F. oxysporum, P. citrinum and P. drechsleri Tucker were the most sensitive among molds.	[Wang, HaiKuan; Yan, YanHua; Wang, JiaMing; Qi, Wei] Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China; [Zhang, HePing] Inner Mongolia Agr Univ, Key Lab Dairy Biotechnol & Engn, Minist Educ, Hohhot, Peoples R China	Tianjin University Science & Technology; Inner Mongolia Agricultural University	Wang, HK (corresponding author), Tianjin Univ Sci & Technol, Key Lab Ind Fermentat Microbiol, Minist Educ, Coll Biotechnol, Tianjin, Peoples R China.	haikuanwangcn@yahoo.com.cn; hepingdd@vip.sina.com	Zhang, He/GXN-0028-2022		National Natural Science Foundation of China [30900961, 20876116]; Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Dairy Biotechnology; Engineering, Ministry of Education; Inner Mongolia Agricultural University	This work was supported by the National Natural Science Foundation of China (No. 30900961 and No. 20876116), the Key Laboratory of Dairy Biotechnology, the Engineering, Ministry of Education, the Inner Mongolia Agricultural University for helpful contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2008, LETT APPL MICROBIOL, V47, P180, DOI 10.1111/j.1472-765X.2008.02412.x; Coloretti F, 2007, FEMS MICROBIOL LETT, V271, P245, DOI 10.1111/j.1574-6968.2007.00723.x; Dal Bello F, 2007, J CEREAL SCI, V45, P309, DOI 10.1016/j.jcs.2006.09.004; Dalie DKD, 2010, FOOD CONTROL, V21, P370, DOI 10.1016/j.foodcont.2009.07.011; Lavermicocca P, 2000, APPL ENVIRON MICROB, V66, P4084, DOI 10.1128/AEM.66.9.4084-4090.2000; LINDGREN SE, 1990, FEMS MICROBIOL LETT, V87, P149; Gerez CL, 2009, FOOD CONTROL, V20, P144, DOI 10.1016/j.foodcont.2008.03.005; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Martens C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-353; MATSUDA T, 1994, J JPN SOC FOOD SCI, V41, P687; Mauch A, 2010, INT J FOOD MICROBIOL, V141, P116, DOI 10.1016/j.ijfoodmicro.2010.05.002; Niku-Paavola ML, 1999, J APPL MICROBIOL, V86, P29, DOI 10.1046/j.1365-2672.1999.00632.x; Prema P, 2010, FOOD BIOPROCESS TECH, V3, P379, DOI 10.1007/s11947-008-0127-1; Rouse S, 2008, J APPL MICROBIOL, V104, P915, DOI 10.1111/j.1365-2672.2007.03619.x; Schnurer J, 2005, TRENDS FOOD SCI TECH, V16, P70, DOI 10.1016/j.tifs.2004.02.014; Schwenninger SM, 2008, J FOOD PROTECT, V71, P2481, DOI 10.4315/0362-028X-71.12.2481; Sjogren J, 2003, APPL ENVIRON MICROB, V69, P7554, DOI 10.1128/AEM.69.12.7554-7557.2003; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002; Sun TS, 2009, EUR FOOD RES TECHNOL, V228, P607, DOI 10.1007/s00217-008-0969-9; Vermeulen N, 2006, J AGR FOOD CHEM, V54, P3832, DOI 10.1021/jf052733e; Wang HK, 2011, ANN MICROBIOL, V61, P879, DOI 10.1007/s13213-011-0209-6; Yang LP, 2008, WORLD J MICROB BIOT, V24, P909, DOI 10.1007/s11274-007-9626-x	22	374	401	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e29452	10.1371/journal.pone.0029452	http://dx.doi.org/10.1371/journal.pone.0029452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22844460	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200014
J	Chen, YP; Xiao, XM; Li, J; Reichetzeder, C; Wang, ZN; Hocher, B				Chen, You-Peng; Xiao, Xiao-Min; Li, Jian; Reichetzeder, Christoph; Wang, Zi-Neng; Hocher, Berthold			Paternal Body Mass Index (BMI) Is Associated with Offspring Intrauterine Growth in a Gender Dependent Manner	PLOS ONE			English	Article							HIGH-FAT DIET; IMPAIRED GLUCOSE-TOLERANCE; BIRTH-WEIGHT; FOOD-INTAKE; METABOLIC SYNDROME; SEX-DIFFERENCES; DEVELOPMENTAL ORIGINS; BLOOD-PRESSURE; PROTEIN-DIET; PREGNANCY	Background: Environmental alternations leading to fetal programming of cardiovascular diseases in later life have been attributed to maternal factors. However, animal studies showed that paternal obesity may program cardio-metabolic diseases in the offspring. In the current study we tested the hypothesis that paternal BMI may be associated with fetal growth. Methods and Results: We analyzed the relationship between paternal body mass index (BMI) and birth weight, ultrasound parameters describing the newborn's body shape as well as parameters describing the newborns endocrine system such as cortisol, aldosterone, renin activity and fetal glycated serum protein in a birth cohort of 899 father/mother/child triplets. Since fetal programming is an offspring sex specific process, male and female offspring were analyzed separately. Multivariable regression analyses considering maternal BMI, paternal and maternal age, hypertension during pregnancy, maternal total glycated serum protein, parity and either gestational age (for birth weight) or time of ultrasound investigation (for ultrasound parameters) as confounding showed that paternal BMI is associated with growth of the male but not female offspring. Paternal BMI correlated with birth parameters of male offspring only: birth weight; biparietal diameter, head circumference; abdominal diameter, abdominal circumference; and pectoral diameter. Cortisol was likewise significantly correlated with paternal BMI in male newborns only. Conclusions: Paternal BMI affects growth of the male but not female offspring. Paternal BMI may thus represent a risk factor for cardiovascular diseases of male offspring in later life. It remains to be demonstrated whether this is linked to an offspring sex specific paternal programming of cortisol secretion.	[Chen, You-Peng; Hocher, Berthold] Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Xiao, Xiao-Min; Li, Jian; Wang, Zi-Neng] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Reichetzeder, Christoph; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Nuthetal Potsdam, Germany; [Reichetzeder, Christoph; Hocher, Berthold] Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany	Jinan University; Jinan University; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chen, YP (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China.	hocher@uni-potsdam.de	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	Hoffmann La Roche Ltd, Basel, Switzerland	Hoffmann La Roche Ltd, Basel, Switzerland(Hoffmann-La Roche)	This study was supported by a grant from Hoffmann La Roche Ltd, Basel, Switzerland to Dr. B. Hocher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Aufdenblatten M, 2009, PEDIATR RES, V65, P198, DOI 10.1203/PDR.0b013e31818d6c24; Augustyniak RA, 2010, AM J PHYSIOL-REG I, V298, pR1375, DOI 10.1152/ajpregu.00848.2009; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P1198, DOI 10.1111/j.1365-2826.2010.02067.x; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hocher B, 2000, LANCET, V355, P1241, DOI 10.1016/S0140-6736(00)02094-8; Hocher B, 2007, J PHYSIOL-LONDON, V579, P287, DOI 10.1113/jphysiol.2007.127738; Hogberg U, 2000, GYNECOL OBSTET INVES, V49, P160, DOI 10.1159/000010239; Jahan-Mihan A, 2011, NUTR RES, V31, P644, DOI 10.1016/j.nutres.2011.08.003; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Leon DA, 2005, CIRCULATION, V112, P3478, DOI 10.1161/CIRCULATIONAHA.104.497610; Li J, 2012, NEUROSCI BIOBEHAV R, V36, P1085, DOI 10.1016/j.neubiorev.2011.12.006; Li J, 2011, J HYPERTENS, V29, P1712, DOI 10.1097/HJH.0b013e328349a2e6; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288; Manabe M, 2005, PEDIATR INT, V47, P60, DOI 10.1111/j.1442-200x.2004.02002.x; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Szeto IMY, 2008, AM J PHYSIOL-REG I, V295, pR575, DOI 10.1152/ajpregu.90354.2008; Tang C, 2010, CHIN J BIRTH HLTH HE, P4; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; WIDDOWSON EM, 1975, PEDIATR RES, V9, P154, DOI 10.1203/00006450-197503000-00010; Xie Y, 2007, PROG OBSTET GYNECOL, V16, P440; Yazbek SN, 2010, HUM MOL GENET, V19, P4134, DOI 10.1093/hmg/ddq332; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462	45	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36329	10.1371/journal.pone.0036329	http://dx.doi.org/10.1371/journal.pone.0036329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22276200	Green Published, gold			2022-12-25	WOS:000305343400019
J	Li, CF; Zhou, DN; Kou, ZK; Zhang, ZS; Wang, JP; Cai, ML; Cao, CG				Li Cheng-Fang; Zhou Dan-Na; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui			Effects of Tillage and Nitrogen Fertilizers on CH4 and CO2 Emissions and Soil Organic Carbon in Paddy Fields of Central China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LONG-TERM APPLICATION; RICE FIELDS; NO-TILLAGE; METHANE EMISSIONS; CHEMICAL FERTILIZER; SYSTEMS; SEQUESTRATION; FLUXES; DIOXIDE	Quantifying carbon (C) sequestration in paddy soils is necessary to help better understand the effect of agricultural practices on the C cycle. The objective of the present study was to assess the effects of tillage practices [conventional tillage (CT) and no-tillage (NT)] and the application of nitrogen (N) fertilizer (0 and 210 kg N ha(-1)) on fluxes of CH4 and CO2, and soil organic C (SOC) sequestration during the 2009 and 2010 rice growing seasons in central China. Application of N fertilizer significantly increased CH4 emissions by 13%-66% and SOC by 21%-94% irrespective of soil sampling depths, but had no effect on CO2 emissions in either year. Tillage significantly affected CH4 and CO2 emissions, where NT significantly decreased CH4 emissions by 10%-36% but increased CO2 emissions by 22%-40% in both years. The effects of tillage on the SOC varied with the depth of soil sampling. NT significantly increased the SOC by 7%-48% in the 0-5 cm layer compared with CT. However, there was no significant difference in the SOC between NT and CT across the entire 0-20 cm layer. Hence, our results suggest that the potential of SOC sequestration in NT paddy fields may be overestimated in central China if only surface soil samples are considered.	[Li Cheng-Fang; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Zhou Dan-Na] Hubei Acad Agr Sci, Inst Anim Husb & Vet Sci, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Hubei Academy of Agricultural Sciences	Li, CF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	ccgui@mail.hzau.edu.cn		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	National Technology Project for High Food Yield of China [2011BAD16B02]; National Natural Science Foundation of China [31100319]; Fundamental Research Funds for the Central Universities [2010QC032]; Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding [2011ZD152]	National Technology Project for High Food Yield of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding	The study was supported by the National Technology Project for High Food Yield of China (2011BAD16B02), National Natural Science Foundation of China (31100319), Fundamental Research Funds for the Central Universities (2010QC032) and the Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding (2011ZD152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz JJ, 2009, SOIL TILL RES, V104, P134, DOI 10.1016/j.still.2009.02.003; Alvarez R, 2005, SOIL USE MANAGE, V21, P38, DOI 10.1079/SUM2005291; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Ball BC, 1999, SOIL TILL RES, V53, P29, DOI 10.1016/S0167-1987(99)00074-4; BAO SD, 2000, ANAL SOIL AGR CHEM, P42; Burton AJ, 2004, GLOBAL CHANGE BIOL, V10, P1080, DOI 10.1111/j.1365-2486.2004.00737.x; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Causarano HJ, 2006, J ENVIRON QUAL, V35, P1374, DOI 10.2134/jeq2005.0150; Christopher SF, 2009, SOIL SCI SOC AM J, V73, P207, DOI 10.2136/sssaj2007.0336; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P330, DOI 10.1016/j.soilbio.2006.08.003; Crill PM, 1988, GLOBAL BIOGEOCHEM CY, V2, P371, DOI 10.1029/GB002i004p00371; Deen W, 2003, SOIL TILL RES, V74, P143, DOI 10.1016/S0167-1987(03)00162-4; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; DeLuca TH, 2011, FRONT ECOL ENVIRON, V9, P407, DOI 10.1890/100063; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Drury CF, 2006, SOIL SCI SOC AM J, V70, P570, DOI 10.2136/sssaj2005.0042; Gao YJ, 2000, SOIL ENV SCI, V9, P27; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Guo JP, 2007, AGR FOREST METEOROL, V142, P270, DOI 10.1016/j.agrformet.2006.03.029; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Harada H, 2007, SOIL SCI PLANT NUTR, V53, P668, DOI 10.1111/j.1747-0765.2007.00174.x; He YingYing, 2010, Journal of Agro-Environment Science, V29, P200; Hutsch BW, 1998, BIOL FERT SOILS, V27, P284, DOI 10.1007/s003740050435; IPCC, 2007, CONTRIBUTION WORKING; Iqbal J, 2009, AGR ECOSYST ENVIRON, V131, P292, DOI 10.1016/j.agee.2009.02.001; [IRRI] International Rice Research Institute, 2004, RIC STAT DAT; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; 郑循华, 1998, Advances in Atmospheric Sciences, V15, P569; Kroon PS, 2008, NUTR CYCL AGROECOSYS, V82, P175, DOI 10.1007/s10705-008-9179-x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lee DK, 2007, SOIL BIOL BIOCHEM, V39, P178, DOI 10.1016/j.soilbio.2006.07.004; Li CF, 2010, ATMOS ENVIRON, V44, P2696, DOI 10.1016/j.atmosenv.2010.04.045; Li CF, 2009, ARCH ENVIRON CON TOX, V56, P21, DOI 10.1007/s00244-008-9159-9; Li JT, 2007, PEDOSPHERE, V17, P568, DOI 10.1016/S1002-0160(07)60067-8; Liang W, 2007, PEDOSPHERE, V17, P630, DOI 10.1016/S1002-0160(07)60075-7; LINDAU CW, 1993, SOIL SCI, V156, P42, DOI 10.1097/00010694-199307000-00006; Liu XJ, 2006, PLANT SOIL, V280, P177, DOI 10.1007/s11104-005-2950-8; Lopez-Bellido RJ, 2010, AGRON J, V102, P310, DOI 10.2134/agronj2009.0165; Lou YL, 2011, SOIL TILL RES, V113, P70, DOI 10.1016/j.still.2011.01.007; Lou YS, 2003, WATER AIR SOIL POLL, V149, P281, DOI 10.1023/A:1025727504841; Lu F, 2009, GLOBAL CHANGE BIOL, V15, P281, DOI 10.1111/j.1365-2486.2008.01743.x; Lu WF, 2000, NUTR CYCL AGROECOSYS, V58, P65, DOI 10.1023/A:1009830232650; MINAMI K, 1995, FERT RES, V40, P71, DOI 10.1007/BF00749864; Mitra S, 2005, SOIL SCI SOC AM J, V69, P563, DOI 10.2136/sssaj2005.0563; Mosier AR, 2005, NUTR CYCL AGROECOSYS, V72, P67, DOI 10.1007/s10705-004-7356-0; Nayak P, 2009, NUTR CYCL AGROECOSYS, V83, P259, DOI 10.1007/s10705-008-9217-8; Neue HU, 2000, ATMOSPHERIC METHANE, P134; Nyamadzawo G, 2008, NUTR CYCL AGROECOSYS, V81, P85, DOI 10.1007/s10705-007-9154-y; OECD, 2000, ENV IND AGR METH AGR; Omonode RA, 2007, SOIL TILL RES, V95, P182, DOI 10.1016/j.still.2006.12.004; Oorts K, 2007, SOIL TILL RES, V95, P133, DOI 10.1016/j.still.2006.12.002; Pan GX, 2009, AGR ECOSYST ENVIRON, V131, P274, DOI 10.1016/j.agee.2009.01.020; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; PARKINSON KJ, 1981, J APPL ECOL, V18, P221, DOI 10.2307/2402491; Paustian K., 1997, SOIL ORGANIC MATTER; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; Roberson T, 2008, J ENVIRON QUAL, V37, P535, DOI 10.2134/jeq2006.0386; SCHUTZ H, 1989, J GEOPHYS RES-ATMOS, V94, P16405, DOI 10.1029/JD094iD13p16405; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Su YZ, 2007, SOIL TILL RES, V92, P181, DOI 10.1016/j.still.2006.03.001; Tang Xiao-hong, 2007, Yingyong Shengtai Xuebao, V18, P1027; Tong CL, 2009, SOIL TILL RES, V106, P8, DOI 10.1016/j.still.2009.09.003; Ussiri DAN, 2009, SOIL TILL RES, V104, P247, DOI 10.1016/j.still.2009.03.001; Wang CJ, 2010, SCI CHINA LIFE SCI, V53, P858, DOI 10.1007/s11427-010-4028-y; Wang MX, 2002, NUTR CYCL AGROECOSYS, V64, P43, DOI 10.1023/A:1021183706235; Wang SX, 2012, J ZHEJIANG UNIV-SC B, V13, P274, DOI 10.1631/jzus.B1100145; WASSMANN R, 1993, BIOGEOCHEMISTRY, V20, P83, DOI 10.1007/BF00004136; Wassmann R, 2000, BIOL FERT SOILS, V31, P20, DOI 10.1007/s003740050619; Wilson HM, 2008, APPL SOIL ECOL, V39, P264, DOI 10.1016/j.apsoil.2007.12.013; Wright AL, 2005, BIOL FERT SOILS, V41, P95, DOI 10.1007/s00374-004-0819-2; Wright AL, 2008, APPL SOIL ECOL, V38, P168, DOI 10.1016/j.apsoil.2007.10.006; Xiao Y, 2005, AGR ECOSYST ENVIRON, V109, P273, DOI 10.1016/j.agee.2005.03.016; Xu H, 2000, NUTR CYCL AGROECOSYS, V58, P12, DOI DOI 10.1023/A:1009823425806; Zhan M, 2011, NUTR CYCL AGROECOSYS, V89, P1, DOI 10.1007/s10705-010-9371-7	78	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e34642	10.1371/journal.pone.0034642	http://dx.doi.org/10.1371/journal.pone.0034642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574109	Green Published, gold, Green Submitted			2022-12-25	WOS:000305349800005
J	Li, CY; Harper, A; Puddick, J; Wang, WY; McMahon, C				Li, Chunyi; Harper, Anne; Puddick, Jonathan; Wang, Wenying; McMahon, Chris			Proteomes and Signalling Pathways of Antler Stem Cells	PLOS ONE			English	Article							RETINOIC ACID; PROTEIN S100A4; EMBRYONAL CARCINOMA; DEER ANTLER; C-MYC; EXPRESSION; GENE; REGENERATION; GROWTH; PEDICLE	As the only known example of complete organ regeneration in mammals, deer antler in the growing or velvet phase is of major interest in developmental biology. This regeneration event initiates from self-renewing antler stem cells that exhibit pluripotency. At present, it remains unclear how the activation and quiescence of antler stem cells are regulated. Therefore, in the present study proteins that were differentially expressed between the antler stem cells and somatic cells (facial periosteum) were identified by a gel-based proteomic technique, and analysed using Ingenuity Pathway Analysis software. Several molecular pathways (PI3K/Akt, ERK/MAPK, p38 MAPK, etc.) were found to be activated during proliferation. Also expressed were the transcription factors POU5F1, SOX2, NANOG and MYC, which are key markers of embryonic stem cells. Expression of these proteins was confirmed in both cultured cells and fresh tissues by Western blot analysis. Therefore, the molecular pathways and transcription factors identified in the current study are common to embryonic and adult stem cells. However, expression of embryonic stem cell transcription factors would suggest that antler stem cells are, potentially, an intermediary stem cell type between embryonic and the more specialized tissue-specific stem cells like those residing in muscle, fat or from a hematopoietic origin. The retention of this embryonic, pluripotent lineage may be of fundamental importance for the subsequent regenerative capacity of antlers.	[Li, Chunyi; Harper, Anne; Wang, Wenying] AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand; [Li, Chunyi] State Key Lab Mol Biol Special Econ Anim, Changchun, Peoples R China; [Puddick, Jonathan] Univ Waikato, Waikato Mass Spectrometry Facil, Hamilton, New Zealand; [McMahon, Chris] AgResearch Ltd, Dev Biol Grp, Ruakura Agr Ctr, Hamilton, New Zealand	AgResearch - New Zealand; University of Waikato; AgResearch - New Zealand	Li, CY (corresponding author), AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand.	chris.mcmahon@agresearch.co.nz		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	Foundation for Research, Science and Technology, New Zealand [C10X0207]	Foundation for Research, Science and Technology, New Zealand(New Zealand Foundation for Research, Science and Technology)	The work was funded by Foundation for Research, Science and Technology, New Zealand (C10X0207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Banks WJ, 1982, LIGHT MICROSCOPIC ST, P231; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Berg DK, 2007, BIOL REPROD, V77, P384, DOI 10.1095/biolreprod.106.058172; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brown R.D., 1982, ANTLER DEV CERVIDAE, P61; Bubenik GA, 1982, ENDOCRINE REGULATION, P73; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Clark DE, 2006, ANAT REC PART A, V288A, P1281, DOI 10.1002/ar.a.20393; Colitti M, 2005, J ANAT, V207, P339, DOI 10.1111/j.1469-7580.2005.00464.x; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Fennessy P.F., 1985, Royal Society of New Zealand Bulletin, P239; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Freemantle SJ, 2002, ONCOGENE, V21, P2880, DOI 10.1038/sj.onc.1205408; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Giguere V, 1990, MOL CLONING CDNA ENC, P6233; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; Gilbert SF, 2003, DEV BIOL, P143; Goss R.J., 1983, DEER ANTLERS REGENER; GOSS RJ, 1985, J EXP ZOOL, V235, P359, DOI 10.1002/jez.1402350307; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gyurjan I, 2007, MOL GENET GENOMICS, V277, P221, DOI 10.1007/s00438-006-0190-0; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Horie H, 1999, J NEUROSCI, V19, P9964; Kamal AM, 2005, MEM I OSWALDO CRUZ, V100, P39, DOI 10.1590/S0074-02762005000900008; Kami K, 2005, CURR DRUG TARGETS, V6, P395, DOI 10.2174/1389450054021918; Kierdorf U, 2003, ANAT REC PART A, V273A, P741, DOI 10.1002/ar.a.10082; Kierdorf U, 2007, J MORPHOL, V268, P726, DOI 10.1002/jmor.10546; Klingelhofer J, 1997, DEV DYNAM, V210, P87, DOI 10.1002/(SICI)1097-0177(199710)210:2<87::AID-AJA2>3.0.CO;2-5; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; Lai AKW, 2007, TISSUE CELL, V39, P35, DOI 10.1016/j.tice.2007.01.001; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; Li C., 2003, European Journal of Morphology, V41, P23, DOI 10.1076/ejom.41.1.23.28106; Li C, 2003, GEN COMP ENDOCR, V131, P21, DOI 10.1016/S0016-6480(02)00625-1; Li C, 2006, RECENT PROGR ANTLER; Li CY, 2007, CELL TISSUE RES, V328, P65, DOI 10.1007/s00441-006-0333-y; Li CY, 2009, CURR STEM CELL RES T, V4, P237, DOI 10.2174/157488809789057446; LI CY, 1994, ANAT REC, V239, P198, DOI 10.1002/ar.1092390211; Li CY, 2005, ANAT REC PART A, V282A, P163, DOI 10.1002/ar.a.20148; Li CY, 2002, ANAT REC, V268, P125, DOI 10.1002/ar.10120; Li CY, 2001, ANAT EMBRYOL, V204, P375, DOI 10.1007/s004290100204; Li CY, 1999, J EXP ZOOL, V284, P82, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;82::AID-JEZ11&gt;3.0.CO;2-K; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; LINCOLN GA, 1973, J EMBRYOL EXP MORPH, V29, P431; LINCOLN GA, 1976, J EXP ZOOL, V195, P247, DOI 10.1002/jez.1401950209; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Louro ID, 2002, CANCER RES, V62, P5867; Lu Y, 2000, BBA-GENE STRUCT EXPR, V1491, P13, DOI 10.1016/S0167-4781(00)00055-5; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Molnar A, 2007, MOL GENET GENOMICS, V277, P237, DOI 10.1007/s00438-006-0193-x; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Park HJ, 2004, PROTEOMICS, V4, P3642, DOI 10.1002/pmic.200401027; Phan E, 2007, MED SCI MONITOR, V13, pRA25; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; Rolf HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002064; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Stocum DL, 2006, REGENERATIVE BIOL ME; SUTTIE JM, 1995, J EXP ZOOL, V271, P120, DOI 10.1002/jez.1402710207; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; WATANABE Y, 1993, FEBS LETT, V324, P51, DOI 10.1016/0014-5793(93)81530-D; Welstead GG, 2008, CURR OPIN GENET DEV, V18, P123, DOI 10.1016/j.gde.2008.01.013	71	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30026	10.1371/journal.pone.0030026	http://dx.doi.org/10.1371/journal.pone.0030026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22574109	gold, Green Submitted, Green Published			2022-12-25	WOS:000299771900039
J	Wang, JA; Gao, F; Liu, ZZ; Qiao, M; Niu, XM; Zhang, KQ; Huang, XW				Wang, Ji'ai; Gao, Feng; Liu, Zhongzhong; Qiao, Min; Niu, Xuemei; Zhang, Ke-Qin; Huang, Xiaowei			Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp MG2	PLOS ONE			English	Article							CRYSTAL VIOLET; TRIPHENYLMETHANE; DECOLORIZATION; DYES; DEGRADATION; AZO	Malachite green (MG), N-methylated diaminotriphenylmethane, is one of the most common dyes in textile industry and has also been used as an effective antifungal agent. However, due to its negative impact on the environment and carcinogenic effects to mammalian cells, there is a significant interest in developing microbial agents to degrade this type of recalcitrant molecules. Here, an Exiguobacterium sp. MG2 was isolated from a river in Yunnan Province of China as one of the best malachite green degraders. This strain had a high decolorization capability even at the concentration of 2500 mg/l and maintained its stable activity within the pH range from 5.0 to 9.0. High-pressure liquid chromatography, liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry were employed to detect the catabolic pathway of MG. Six intermediate products were identified and a potential biodegradation pathway was proposed. This pathway involves a series of reactions of N-demethylation, reduction, benzene ring-removal, and oxidation, which eventually converted N-methylated diaminotriphenylmethane into N, N-dimethylaniline that is the key precursor to MG. Furthermore, our molecular biology experiments suggested that both triphenylmethane reductase gene tmr and cytochrome P450 participated in MG degradation, consistent with their roles in the proposed pathway. Collectively, our investigation is the first report on a biodegradation pathway of triphenylmethane dye MG in bacteria. Citation: Wang J, Gao F, Liu Z, Qiao M, Niu X, et al. (2012) Pathway and Molecular Mechanisms for Malachite Green Biodegradation in Exiguobacterium sp. MG2. PLoS ONE 7(12): e51808. doi:10.1371/journal.pone.0051808	[Huang, Xiaowei] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Huang, XW (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.	xwhuang@ynu.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	National Basic Research Program of China (Program 973) [2010CB134503]; Department of Science and Technology of Yunnan Province, China [2010GA012]	National Basic Research Program of China (Program 973)(National Basic Research Program of China); Department of Science and Technology of Yunnan Province, China	This work was supported by the National Basic Research Program of China (Program 973, grant No. 2010CB134503), and the Department of Science and Technology of Yunnan Province, China (grant No 2010GA012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; BUMPUS JA, 1988, APPL ENVIRON MICROB, V54, P1143, DOI 10.1128/AEM.54.5.1143-1150.1988; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; COOPER P, 1993, J SOC DYERS COLOUR, V109, P97; Deng DY, 2008, INT BIODETER BIODEGR, V62, P263, DOI 10.1016/j.ibiod.2008.01.017; Doerge DR, 1998, RAPID COMMUN MASS SP, V12, P1625, DOI 10.1002/(SICI)1097-0231(19981115)12:21<1625::AID-RCM373>3.0.CO;2-I; Gao GD, 2008, CHINESE J CATAL, V29, P426, DOI 10.1016/S1872-2067(08)60043-1; GEORGE KL, 1989, CAN J MICROBIOL, V35, P529, DOI 10.1139/m89-084; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; Jones JJ, 2003, ANTIMICROB AGENTS CH, V47, P2323, DOI 10.1128/AAC.47.7.2323-2326.2003; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Ortega-Calvo JJ, 2010, APPL ENVIRON MICROB, V76, P4430, DOI 10.1128/AEM.00461-10; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8; Wang JA, 2011, J MOL MICROB BIOTECH, V20, P220, DOI 10.1159/000330669; Wu J, 2009, J ENVIRON SCI-CHINA, V21, P960, DOI 10.1016/S1001-0742(08)62368-2; YATOME C, 1993, APPL MICROBIOL BIOT, V38, P565; YATOME C, 1991, J ENVIRON SCI HEAL A, V26, P75, DOI 10.1080/10934529109375621; Yoon JH, 1998, INT J SYST BACTERIOL, V48, P187, DOI 10.1099/00207713-48-1-187	21	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e51808	10.1371/journal.pone.0051808	http://dx.doi.org/10.1371/journal.pone.0051808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	22629437	gold, Green Submitted, Green Published			2022-12-25	WOS:000312386800088
J	Wang, J; Hopkins, CJ; Hou, JN; Zou, XX; Wang, CN; Long, Y; Kurup, S; King, GJ; Meng, JL				Wang, Jing; Hopkins, Clare J.; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Kurup, Smita; King, Graham J.; Meng, Jinling			Promoter Variation and Transcript Divergence in Brassicaceae Lineages of FLOWERING LOCUS T	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENTS; FUNCTIONAL DIVERGENCE; COMPARATIVE GENOMICS; FLORAL INDUCTION; GENE-EXPRESSION; EVOLUTION; NAPUS; MECHANISMS; OLERACEA	Brassica napus (AACC, 2n = 38), an oil crop of world-wide importance, originated from interspecific hybridization of B. rapa (AA, 2n = 20) and B. oleracea (CC, 2n = 18), and has six FLOWERING LOCUS T (FT) paralogues. Two located on the homeologous chromosomes A2 and C2 arose from a lineage distinct from four located on A7 and C6. A set of three conserved blocks A, B and C, which were found to be essential for FT activation by CONSTANS (CO) in Arabidopsis, was identified within the FT upstream region in B. napus and its progenitor diploids. However, on chromosome C2, insertion of a DNA transposable element (TE) and a retro-element in FT upstream blocks A and B contributed to significant structural divergence between the A and C genome orthologues. Phylogenetic analysis of upstream block A indicated the conserved evolutionary relationships of distinct FT genes within Brassicaceae. We conclude that the ancient At-a whole genome duplication contributed to distinct ancestral lineages for this key adaptive gene, which co-exist within the same genus. FT-A2 was found to be transcribed in all leaf samples from different developmental stages in both B. rapa and B. napus, whereas FT-C2 was not transcribed in either B. napus or B. oleracea. Silencing of FT-C2 appeared to result from TE insertion and consequent high levels of cytosine methylation in TE sequences within upstream block A. Interestingly, FT-A7/C6 paralogues were specifically silenced in winter type B. napus but abundantly expressed in spring type cultivars under vernalization-free conditions. Motif prediction indicated the presence of two CO protein binding sites within all Brassica block A and additional sites for FT activation in block C. We propose that the ancestral whole genome duplications have contributed to more complex mechanisms of floral regulation and niche adaptation in Brassica compared to Arabidopsis.	[King, Graham J.] So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia; [Wang, Jing; Hou, Jinna; Zou, Xiaoxiao; Wang, Chongnan; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Hopkins, Clare J.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Kurup, Smita] Rothamsted Res, Harpenden, Herts, England	Southern Cross University; Huazhong Agricultural University; University of Melbourne; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	King, GJ (corresponding author), So Cross Univ, So Cross Plant Sci, Lismore, NSW 2480, Australia.	graham.king@scu.edu.au; jmeng@mail.hzau.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Postdoctoral Science Foundation [20100480915]; 111 Project in China [B07041]; UK Biotechnology and Biological Sciences Research Council	Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 111 Project in China(Ministry of Education, China - 111 Project); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Postdoctoral Science Foundation (20100480915) and 111 Project (B07041) in China. Rothamsted Research receives grant-aided funds from the UK Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Alix K, 2008, PLANT J, V56, P1030, DOI 10.1111/j.1365-313X.2008.03660.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cardenas PD, 2012, THEOR APPL GENET, V124, P1215, DOI 10.1007/s00122-011-1781-7; Casacuberta JM, 2003, GENE, V311, P1, DOI 10.1016/S0378-1119(03)00557-2; Chen X, 2011, PLANT PHYSIOL, V155, P851, DOI 10.1104/pp.110.169482; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheung F, 2009, PLANT CELL, V21, P1912, DOI 10.1105/tpc.108.060376; Chopra S, 1999, P NATL ACAD SCI USA, V96, P15330, DOI 10.1073/pnas.96.26.15330; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Fedoroff N, 2000, P NATL ACAD SCI USA, V97, P7002, DOI 10.1073/pnas.97.13.7002; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Henry Y, 2006, TRENDS PLANT SCI, V11, P267, DOI 10.1016/j.tplants.2006.04.002; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Howell EC, 2005, GENOME, V48, P1093, DOI 10.1139/G05-069; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Kinoshita T, 2011, CURR BIOL, V21, P1232, DOI 10.1016/j.cub.2011.06.025; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lagercrantz U, 1998, GENETICS, V150, P1217; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Lukens L, 2003, GENETICS, V164, P359; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lysak MA, 2006, PLANT SYST EVOL, V259, P175, DOI 10.1007/s00606-006-0418-9; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martynov VV, 2005, RUSS J PLANT PHYSL+, V52, P242, DOI 10.1007/s11183-005-0037-2; Moon J, 2005, PLANT CELL PHYSIOL, V46, P292, DOI 10.1093/pcp/pci024; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; PEREIRA A, 1986, EMBO J, V5, P835, DOI 10.1002/j.1460-2075.1986.tb04292.x; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Qiu D, 2009, PLANT CELL REP, V28, P649, DOI 10.1007/s00299-008-0661-3; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; UN, 1953, JPN J BOT, V7, P389; Wang J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-39; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Whittle CA, 2009, PLANT CELL, V21, P2203, DOI 10.1105/tpc.109.068411; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Yang TJ, 2006, PLANT CELL, V18, P1339, DOI 10.1105/tpc.105.040535; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101	73	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47127	10.1371/journal.pone.0047127	http://dx.doi.org/10.1371/journal.pone.0047127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	22629437	Green Published, gold, Green Submitted			2022-12-25	WOS:000309807700058
J	Wang, JK; Xu, MY; Zhu, K; Li, L; Liu, XQ				Wang, Juke; Xu, Mengyuan; Zhu, Kai; Li, Lei; Liu, Xinqi			The N-terminus of FILIA Forms an Atypical KH Domain with a Unique Extension Involved in Interaction with RNA	PLOS ONE			English	Article							MATERNAL EFFECT GENE; BINDING PROTEIN; STRUCTURAL BASIS; CELLS; EXPRESSION; SEQUENCE; COMPLEX; ANTIGEN; NOVA; RECOGNITION	FILIA is a member of the recently identified oocyte/embryo expressed gene family in eutherian mammals, which is characterized by containing an N-terminal atypical KH domain. Here we report the structure of the N-terminal fragment of FILIA (FILIA-N), which represents the first reported three-dimensional structure of a KH domain in the oocyte/embryo expressed gene family of proteins. The structure of FILIA-N revealed a unique N-terminal extension beyond the canonical KH region, which plays important roles in interaction with RNA. By co-incubation with the lysates of mice ovaries, FILIA and FILIA-N could sequester specific RNA components, supporting the critical roles of FILIA in regulation of RNA transcripts during mouse oogenesis and early embryogenesis.	[Wang, Juke; Xu, Mengyuan; Liu, Xinqi] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhu, Kai; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Nankai University; Chinese Academy of Sciences; Institute of Zoology, CAS	Wang, JK (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	lil@ioz.ac.cn; liu2008@nankai.edu.cn	Zhu, Kai/Y-6079-2019; zhang, ke/AAH-8217-2019; King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Li, Lei/0000-0001-5478-5681; Kurup, Smita/0000-0003-1035-7065	Ministry of Science and Technology, China [2010CB911800]; National Basic Research Program of China [2011CB944501]; Chinese Academy of Sciences [XDA01010103]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	Liu X is supported by National Basic Research Program of China (973 program) (2010CB911800) from Ministry of Science and Technology, China. Li L is funded by National Basic Research Program of China (2011CB944501) and the Chinese Academy of Sciences (XDA01010103 and the Hundred Talents Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-11; Amarasinghe AK, 2001, RNA, V7, P1239, DOI 10.1017/S1355838201010603; ASTIGIANO S, 1991, DIFFERENTIATION, V46, P61, DOI 10.1111/j.1432-0436.1991.tb00866.x; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cai CL, 2010, MOL BIOL CELL, V21, P3137, DOI 10.1091/mbc.E10-03-0255; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; DELEON V, 1983, DEV BIOL, V98, P400, DOI 10.1016/0012-1606(83)90369-X; Diaz-Moreno I, 2009, NAT STRUCT MOL BIOL, V16, P238, DOI 10.1038/nsmb.1558; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Grishin NV, 2001, NUCLEIC ACIDS RES, V29, P638, DOI 10.1093/nar/29.3.638; Herr JC, 2008, DEV BIOL, V314, P300, DOI 10.1016/j.ydbio.2007.11.027; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JANIN J, 1990, J BIOL CHEM, V265, P16027; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Meyer NH, 2010, J BIOL CHEM, V285, P28893, DOI 10.1074/jbc.M110.126185; MuellerPillasch F, 1997, ONCOGENE, V14, P2729, DOI 10.1038/sj.onc.1201110; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NEUYILIK G, 1993, EUR J BIOCHEM, V213, P727, DOI 10.1111/j.1432-1033.1993.tb17813.x; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierre A, 2007, GENOMICS, V90, P583, DOI 10.1016/j.ygeno.2007.06.003; Pozdnyakova I, 2005, FEBS J, V272, P872, DOI 10.1111/j.1742-4658.2004.04527.x; Racki WJ, 2006, DEVELOPMENT, V133, P4527, DOI 10.1242/dev.02651; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ramos A, 2002, BIOCHEMISTRY-US, V41, P4193, DOI 10.1021/bi011994o; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; SCHMIDT C, 1992, EUR J BIOCHEM, V206, P625, DOI 10.1111/j.1432-1033.1992.tb16967.x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shain KH, 2002, J IMMUNOL, V168, P2544, DOI 10.4049/jimmunol.168.5.2544; Siomi H, 1997, CURR OPIN GENET DEV, V7, P345, DOI 10.1016/S0959-437X(97)80148-7; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tong ZB, 1999, ENDOCRINOLOGY, V140, P3720, DOI 10.1210/en.140.8.3720; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	60	218	229	7	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e30209	10.1371/journal.pone.0030209	http://dx.doi.org/10.1371/journal.pone.0030209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22629437	Green Published, gold, Green Submitted			2022-12-25	WOS:000301457200043
J	Lee, HP; Pancholi, N; Esposito, L; Previll, LA; Wang, XL; Zhu, XW; Smith, MA; Lee, HG				Lee, Hyun-Pil; Pancholi, Neel; Esposito, Luke; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon			Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity	PLOS ONE			English	Article							LIPID-PEROXIDATION; TRANSGENIC MICE; NEURODEGENERATIVE DISEASES; PLAQUE-FORMATION; DNA-DAMAGE; IN-VIVO; REDUCTION; PATHOLOGY; PROTEINS; DYSFUNCTION	While oxidative stress has been linked to Alzheimer's disease, the underlying pathophysiological relationship is unclear. To examine this relationship, we induced oxidative stress through the genetic ablation of one copy of mitochondrial antioxidant superoxide dismutase 2 (Sod2) allele in mutant human amyloid precursor protein (hAPP) transgenic mice. The brains of young (5-7 months of age) and old (25-30 months of age) mice with the four genotypes, wild-type (Sod2(+/+)), hemizygous Sod2 (Sod2(+/-)), hAPP/wild-type (Sod2(+/+)), and hAPP/hemizygous (Sod2(+/-)) were examined to assess levels of oxidative stress markers 4-hydroxy-2-nonenal and heme oxygenase-1. Sod2 reduction in young hAPP mice resulted in significantly increased oxidative stress in the pyramidal neurons of the hippocampus. Interestingly, while differences resulting from hAPP expression or Sod2 reduction were not apparent in the neurons in old mice, oxidative stress was increased in astrocytes in old, but not young hAPP mice with either Sod2(+/+) or Sod2(+/-). Our study shows the specific changes in oxidative stress and the causal relationship with the pathological progression of these mice. These results suggest that the early neuronal susceptibility to oxidative stress in the hAPP/Sod2(+/-) mice may contribute to the pathological and behavioral changes seen in this animal model.	[Lee, Hyun-Pil; Pancholi, Neel; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Esposito, Luke] Univ Calif San Francisco, Dept Neurol & Neurosci, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA	Case Western Reserve University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Lee, HP (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	hyoung-gon.lee@case.edu	Lee, Hyoung-gon/A-9637-2009; Meyer, Axel/C-9826-2009	Wang, Xinglong/0000-0001-8657-0159; Meyer, Axel/0000-0002-0888-8193; WU, LI-TZY/0000-0002-5909-2259; Oh, Yu-Kyoung/0000-0002-0969-3339; Previll, Laura/0000-0001-5541-8111	National Institutes of Health [AG028679]; Alzheimer's Association [NIRG-09-132727]; Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING [R01AG028679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work in the authors' laboratories is supported by the National Institutes of Health (AG028679 to Dr. Hyoung-gon Lee), the Alzheimer's Association (NIRG-09-132727 to Dr. Hyoung-gon Lee), and the Dr. Robert M. Kohrman Memorial Fund (to Dr. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Massaad CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010561; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Omar Rawhi A., 1999, J Alzheimers Dis, V1, P139; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pappolla MA, 1998, AM J PATHOL, V152, P871; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Sayre LM, 1996, CHEM RES TOXICOL, V9, P1194, DOI 10.1021/tx960094j; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; SMITH MA, 1994, AM J PATHOL, V145, P42; Smith MA, 2010, J ALZHEIMERS DIS, V19, P363, DOI 10.3233/JAD-2010-1239; STEELE ML, 2010, NEUROBIOL A IN PRESS; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	36	113	115	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e28033	10.1371/journal.pone.0028033	http://dx.doi.org/10.1371/journal.pone.0028033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22970282	Green Submitted, Green Published, gold			2022-12-25	WOS:000301457200001
J	Li, Y; Farooq, M; Sheng, DL; Chandramouli, C; Lan, T; Mahajan, NK; Kini, RM; Hong, YH; Lisowsky, T; Ge, RW				Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Lisowsky, Thomas; Ge, Ruowen			Augmenter of Liver Regeneration (alr) Promotes Liver Outgrowth during Zebrafish Hepatogenesis	PLOS ONE			English	Article							HEPATIC STIMULATOR SUBSTANCE; DISULFIDE RELAY SYSTEM; MITOCHONDRIAL SULFHYDRYL OXIDASE; INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; PROTEIN IMPORT; CYTOCHROME-C; GENE; HEPATOPOIETIN; YEAST	Augmenter of Liver Regeneration (ALR) is a sulfhydryl oxidase carrying out fundamental functions facilitating protein disulfide bond formation. In mammals, it also functions as a hepatotrophic growth factor that specifically stimulates hepatocyte proliferation and promotes liver regeneration after liver damage or partial hepatectomy. Whether ALR also plays a role during vertebrate hepatogenesis is unknown. In this work, we investigated the function of alr in liver organogenesis in zebrafish model. We showed that alr is expressed in liver throughout hepatogenesis. Knockdown of alr through morpholino antisense oligonucleotide (MO) leads to suppression of liver outgrowth while overexpression of alr promotes liver growth. The small-liver phenotype in alr morphants results from a reduction of hepatocyte proliferation without affecting apoptosis. When expressed in cultured cells, zebrafish Alr exists as dimer and is localized in mitochondria as well as cytosol but not in nucleus or secreted outside of the cell. Similar to mammalian ALR, zebrafish Alr is a flavin-linked sulfhydryl oxidase and mutation of the conserved cysteine in the CxxC motif abolishes its enzymatic activity. Interestingly, overexpression of either wild type Alr or enzyme-inactive Alr(C131S) mutant promoted liver growth and rescued the liver growth defect of alr morphants. Nevertheless, alr(C131S) is less efficacious in both functions. Meantime, high doses of alr MOs lead to widespread developmental defects and early embryonic death in an alr sequence-dependent manner. These results suggest that alr promotes zebrafish liver outgrowth using mechanisms that are dependent as well as independent of its sulfhydryl oxidase activity. This is the first demonstration of a developmental role of alr in vertebrate. It exemplifies that a low-level sulfhydryl oxidase activity of Alr is essential for embryonic development and cellular survival. The dose-dependent and partial suppression of alr expression through MO-mediated knockdown allows the identification of its late developmental role in vertebrate liver organogenesis.	[Li, Yan; Farooq, Muhammad; Sheng, Donglai; Chandramouli, Chanchal; Lan, Tian; Mahajan, Nilesh K.; Kini, R. Manjunatha; Hong, Yunhan; Ge, Ruowen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Farooq, Muhammad] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lisowsky, Thomas] MultiBIND Biotec GmbH, Cologne, Germany	National University of Singapore; King Saud University; Virginia Commonwealth University	Li, Y (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgerw@nus.edu.sg	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	Singapore Biomedical Research Council [BMRC/01/1/21/18/068]; Ministry of Education [R-154-000-475-112]; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Ministry of Education; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the Singapore Biomedical Research Council grant BMRC/01/1/21/18/068 and Ministry of Education grant R-154-000-475-112 to Dr. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Cao Y, 2009, FREE RADICAL BIO MED, V47, P1057, DOI 10.1016/j.freeradbiomed.2009.07.017; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XX, 2003, J BIOL CHEM, V278, P49022, DOI 10.1074/jbc.M304057200; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Gandhi CR, 1999, HEPATOLOGY, V29, P1435, DOI 10.1002/hep.510290522; Gandhi CR, 2009, J CELL PHYSL; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; GHOSH C, 1994, CELL BIOL TOXICOL, V10, P167, DOI 10.1007/BF00757560; HAGIYA M, 1994, P NATL ACAD SCI USA, V91, P8142, DOI 10.1073/pnas.91.17.8142; HE FH, 1993, HEPATOLOGY, V17, P225, DOI 10.1016/0270-9139(93)90081-W; Hofhaus G, 1999, EUR J CELL BIOL, V78, P349, DOI 10.1016/S0171-9335(99)80069-7; Ilowski M, 2011, BIOCHEM BIOPH RES CO, V404, P148, DOI 10.1016/j.bbrc.2010.11.083; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondili VG, 2005, DIGEST DIS SCI, V50, P297, DOI 10.1007/s10620-005-1598-9; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; LABRECQUE DR, 1975, J PHYSIOL-LONDON, V248, P273, DOI 10.1113/jphysiol.1975.sp010973; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Li Y, 2000, J BIOL CHEM, V275, P37443, DOI 10.1074/jbc.M004373200; Liatsos GD, 2003, DIGEST DIS SCI, V48, P1929, DOI 10.1023/A:1026157901805; LISOWSKY T, 1995, GENOMICS, V29, P690, DOI 10.1006/geno.1995.9950; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Lu CR, 2002, FASEB J, V16, P90, DOI 10.1096/fj.01-0506fje; Lu J, 2002, WORLD J GASTROENTERO, V8, P353; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Passeri MJ, 2009, HEPATOLOGY, V49, P443, DOI 10.1002/hep.22667; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Tanigawa K, 2000, J GASTROENTEROL, V35, P112, DOI 10.1007/s005350050023; Thasler WE, 2005, HISTOPATHOLOGY, V47, P57, DOI 10.1111/j.1365-2559.2005.02172.x; Thirunavukkarasu C, 2008, J HEPATOL, V48, P578, DOI 10.1016/j.jhep.2007.12.010; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Wang CP, 2006, WORLD J GASTROENTERO, V12, P4859; Wang G, 1999, J BIOL CHEM, V274, P11469, DOI 10.1074/jbc.274.17.11469; Wang WZ, 2007, BIOCHEMISTRY-US, V46, P3246, DOI 10.1021/bi602499t; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wiedenmann J, 2009, IUBMB LIFE, V61, P1029, DOI 10.1002/iub.256; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yang XM, 1997, SCI CHINA SER C, V40, P642, DOI 10.1007/BF02882695	52	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30835	10.1371/journal.pone.0030835	http://dx.doi.org/10.1371/journal.pone.0030835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22905149	gold, Green Published			2022-12-25	WOS:000301703800034
J	Li, YY; Zhu, RN; Qian, Y; Deng, J				Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie			The Characteristics of Blood Glucose and WBC Counts in Peripheral Blood of Cases of Hand Foot and Mouth Disease in China: A Systematic Review	PLOS ONE			English	Review							ENTEROVIRUS 71; OUTBREAK; INFECTIONS; MALAYSIA; TAIWAN; MANIFESTATIONS	Background: Outbreaks of Hand Foot and Mouth Disease (HFMD) have occurred in many parts of the world especially in China. We aimed to summarize the characteristics of the levels of blood glucose and white blood cell (WBC) counts in cases of HFMD in Mainland China and Taiwan, using meta-analysis based on systematic review of published articles. Methods: We systematically reviewed published studies, from the MEDLINE and WANFANG Data, about the levels of blood glucose and WBC counts in cases of HFMD until 15(th) June 2011, and quantitatively summarized the characteristics of them using meta-analysis. Results: In total, 37 studies were included in this review. In Mainland China and Taiwan, generally, the average level of blood glucose, the prevalence of hyperglycemia, WBC counts and the prevalence of leukocytosis increased with the severity of the illness. There was no significant difference in the prevalence of leukocytosis between ANS (autonomic nervous system dysregulation)/PE (pulmonary edema) group and CNS (central nervous system) group, and in the average level of blood glucose between healthy controls and mild cases of HFMD. WBC counts in cases infected by EV71 were less than those in cases infected by CA16. Conclusions: our analyses indicated that blood glucose and WBC counts increased with the severity of HFMD disease, which would help doctors to manage patients efficiently.	[Li, Yuyun; Zhu, Runan; Qian, Yuan; Deng, Jie] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Li, YY (corresponding author), Capital Inst Pediat, Virol Lab, Beijing, Peoples R China.	qybds1129@163.com	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen JH, 2010, ACTA ACAD MEDICINAE, V32, P363; Chen WB, 2000, 5 DIAGNOSTICS; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; Cui LD, 2011, CHINA PRAC MED, V6, P50; Dai W, 2011, CHINESE COMMUNITY DO, V13, P88; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding NZ, 2009, VIRUS RES, V145, P157, DOI 10.1016/j.virusres.2009.06.006; Fan XC, 2009, ANHUI MED J, V30, P253; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Huang S, 2008, ANHUI MED J, V29, P361; Huang YF, 2003, J INFECTION, V46, P238, DOI 10.1053/jinf.2002.1117; Jiang J, 2010, J QILU NURSING, V16, P119; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li CC, 2002, SCAND J INFECT DIS, V34, P104, DOI 10.1080/00365540110077119; Li JM, 2009, CHIN PEDIAT EMERG ME, V16, P142; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li Q., 2010, ANHUI MED J, V31, P1410; Li SH, 2010, CHIN PECIATR EMERG M, V17, P49; Li SH, 2010, CHIN J CLIN INFECT D, V3, P337; [李玉芬 Li Yufen], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P1011; Liao Y, 2010, JILIN MED J, P4075; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu J, 2009, ANHUI MED J, V30, P261; Liu X, 2010, CHIN J MED ULTRASOUN, V7, P1844; Liu Ying-xia, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P475; Lu CY, 2002, J MED VIROL, V67, P217, DOI 10.1002/jmv.2210; Luo LP, 2010, J N CHINA COAL MED U, V12, P356; Mai LL, 2011, CHINESE J NEW CLIN M, V4, P356; MANTEL N, 1959, J NATL CANCER I, V22, P719; [毛国顺 MAO Guoshun], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P387; [毛月燕 MAO Yue-yan], 2009, [中华传染病杂志, Chinese Journal of Infections Diseases], V27, P35; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Qian N, 2010, THESIS QINGDAO U, P17; Shen Q, 2011, J MED RES, V40, P93; Shimizu H, 1999, JPN J INFECT DIS, V52, P12; Tang LP, 2009, CHIN J M ISDIAGN, V9, P6840; Verbruggen SCAT, 2007, CLIN NUTR, V26, P677, DOI 10.1016/j.clnu.2007.08.012; Wang HC, 2010, CHINA CLIN PRAC MED, V4, P155; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wei XL, 2010, SHANDONG MED J, V50, P70; World Health Organization, 2017, GUID DRINK WAT QUAL, VFourth, DOI 10.1016/S1462-0758(00)00006-6; Yan ZW, 2011, CHIN J GEN PRACT, V10, P343; Yang T, 2010, ACTA MEDCINAE SINICA, V23, P68; Yu LX, 2011, CHIN PEDIAT EMERG ME, V18, P57; [岳保珠 Yue Baozhu], 2010, [中国全科医学, Chinese General Practice], V13, P2239; Zhang GH, 2010, CHINA CLIN PRAC MED, V4, P132; Zhang JH, 2010, CHINESE FOREIGN MED, V8, P12; Zhang Shou-Bin, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P38; Zhao H., 2008, J CLIN PEDIAT, V26, P467; Zheng NH, 2011, CHINA MODERN DOCTOR, V49, P126; Zhou AR, 2000, 5 BIOCH; [周大明 Zhou Daming], 2010, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V35, P1724	63	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29003	10.1371/journal.pone.0029003	http://dx.doi.org/10.1371/journal.pone.0029003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22905149	Green Published, Green Submitted, gold			2022-12-25	WOS:000301123400018
J	Li, YQ; He, ZG				Li, Yuqing; He, Zheng-Guo			The Mycobacterial LysR-Type Regulator OxyS Responds to Oxidative Stress and Negatively Regulates Expression of the Catalase-Peroxidase Gene	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; PATHOGENIC MYCOBACTERIA; TUBERCULOSIS; KATG; FURA; SENSITIVITY; SMEGMATIS; MACROPHAGES; RESISTANCE; PROTEINS	Protection against oxidative stress is one of the primary defense mechanisms contributing to the survival of Mycobacterium tuberculosis in the host. In this study, we provide evidence that OxyS, a LysR-type transcriptional regulator functions as an oxidative stress response regulator in mycobacteria. Overexpression of OxyS lowers expression of the catalase-peroxidase (KatG) gene in M. smegmatis. OxyS binds directly with the katG promoter region and a conserved, GC-rich T-N-11-A motif for OxyS binding was successfully characterized in the core binding site. Interestingly, the DNA-binding activity of OxyS was inhibited by H2O2, but not by dithiothreitol. Cys25, which is situated at the DNA-binding domain of OxyS, was found to have a regulatory role for the DNA-binding ability of OxyS in response to oxidative stress. In contrast, the other three cysteine residues in OxyS do not appear to have this function. Furthermore, the mycobacterial strain over-expressing OxyS had a higher sensitivity to H2O2. Thus, OxyS responds to oxidative stress through a unique cysteine residue situated in its DNA-binding domain and negatively regulates expression of the katG gene. These findings uncover a specific regulatory mechanism for mycobacterial adaptation to oxidative stress.	[Li, Yuqing; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China.	hezhengguo@mail.hzau.edu.cn	He, Zheng-Guo/P-3647-2014; Ge, Ruowen/D-8352-2012; Kini, Manjunatha/H-8029-2012; Chandramouli, Chanchal/AAF-2848-2020; Hong, Yunhan/D-4197-2009; Farooq, Muhammad/G-9838-2013; Li, Zhi-Yong/G-9701-2011; Li, Zhi-Yong/G-9701-2011	Ge, Ruowen/0000-0002-0750-7336; Farooq, Muhammad/0000-0001-9891-2443; Kini, Manjunatha/0000-0002-6100-3251; Zhang, Yuesheng/0000-0002-0976-2875; Li, Zhi-Yong/0000-0003-3039-8833; Li, Zhi-Yong/0000-0002-6814-9165	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program; NCI NIH HHS [CA120533, R01 CA124627, R01 CA120533, P30 CA016056] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program; NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (31025002, 30930003), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z-GH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Chen H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001602; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; Dhandayuthapani S, 1996, J BACTERIOL, V178, P3641, DOI 10.1128/jb.178.12.3641-3649.1996; Domenech P, 2001, MICROBES INFECT, V3, P713, DOI 10.1016/S1286-4579(01)01422-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Italiani VCS, 2011, J BACTERIOL, V193, P1734, DOI 10.1128/JB.01339-10; Jittawuttipoka T, 2009, J BACTERIOL, V191, P7372, DOI 10.1128/JB.00788-09; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Lee HI, 2010, J BIOCHEM, V147, P511, DOI 10.1093/jb/mvp197; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Master S, 2001, J BACTERIOL, V183, P4033, DOI 10.1128/JB.183.13.4033-4039.2001; Milano A, 2001, J BACTERIOL, V183, P6801, DOI 10.1128/JB.183.23.6801-6806.2001; Muraoka S, 2003, J MOL BIOL, V328, P555, DOI 10.1016/S0022-2836(03)00312-7; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pagan-Ramos E, 1998, J BACTERIOL, V180, P4856; Pym AS, 2001, MOL MICROBIOL, V40, P879, DOI 10.1046/j.1365-2958.2001.02427.x; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Sala C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-33; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Yu K., 1999, Tubercle and Lung Disease, V79, P191, DOI 10.1054/tuld.1998.0203; Zahrt TC, 2001, MOL MICROBIOL, V39, P1174, DOI 10.1046/j.1365-2958.2001.02321.x; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	36	150	169	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30186	10.1371/journal.pone.0030186	http://dx.doi.org/10.1371/journal.pone.0030186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22905149	Green Published, gold, Green Submitted			2022-12-25	WOS:000301454400077
